PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Draper, SJ; Higgins, MK				Draper, Simon J.; Higgins, Matthew K.			A new site of attack for a malaria vaccine	NATURE MEDICINE			English	Editorial Material							FALCIPARUM-MALARIA; IMMUNIZATION; CHILDREN; PHASE-3; TRIAL	A newly discovered antibody epitope on the liver-infective form of the parasite that causes malaria opens new doors for vaccine development.	[Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford, England	University of Oxford; Jenner Institute; University of Oxford	Draper, SJ (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	simon.draper@ndm.ox.ac.uk; matthew.higgins@bioch.ox.ac.uk		Higgins, Matthew/0000-0002-2870-1955; Draper, Simon/0000-0002-9415-1357				Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; De Wilde M, 2001, U.S. Patent, Patent No. [US6169171B1, 6169171]; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Scally SW, 2018, J EXP MED, V215, P63, DOI 10.1084/jem.20170869; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Vaughan AM, 2017, EXPERT REV VACCINES, V16, P765, DOI 10.1080/14760584.2017.1341835; Walk J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0923-4; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	12	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					382	383		10.1038/nm.4533	http://dx.doi.org/10.1038/nm.4533			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634679	Green Submitted			2022-12-27	WOS:000429639800004
J	Sears, CL; Pardoll, DM				Sears, Cynthia L.; Pardoll, Drew M.			The intestinal microbiome influences checkpoint blockade	NATURE MEDICINE			English	Editorial Material							MELANOMA; EFFICACY; THERAPY	Studies in metastatic melanoma, non-small-cell lung carcinoma and renal cell carcinoma indicate certain bacteria within the gut microbiota enhance clinical responses to checkpoint blockade.	[Sears, Cynthia L.; Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Immunotherapy, Balitmore, MD 21218 USA	Johns Hopkins University	Sears, CL (corresponding author), Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Immunotherapy, Balitmore, MD 21218 USA.	csears@jhmi.edu	Sears, Cynthia L/AAJ-6704-2020	Sears, Cynthia L/0000-0003-4059-1661	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK089502] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Weber JS, 2017, J CLIN ONCOL, V35, P785, DOI 10.1200/JCO.2015.66.1389	11	32	34	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					254	255		10.1038/nm.4511	http://dx.doi.org/10.1038/nm.4511			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29509750	Green Accepted			2022-12-27	WOS:000426700900004
J	Xiao, Q; Wu, JB; Wang, WJ; Chen, SY; Zheng, YX; Yu, XQ; Meeth, K; Sahraei, M; Bothwell, ALM; Chen, LP; Bosenberg, M; Chen, JF; Sexl, V; Sun, L; Li, L; Tang, WW; Wu, DQ				Xiao, Qian; Wu, Jibo; Wang, Wei-Jia; Chen, Shiyang; Zheng, Yingxia; Yu, Xiaoqing; Meeth, Katrina; Sahraei, Mahnaz; Bothwell, Alfred L. M.; Chen, Lieping; Bosenberg, Marcus; Chen, Jianfeng; Sexl, Veronika; Sun, Le; Li, Lin; Tang, Wenwen; Wu, Dianqing			DKK2 imparts tumor immunity evasion through beta-catenin-independent suppression of cytotoxic immune-cell activation	NATURE MEDICINE			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; WNT SIGNALING PATHWAY; WNT/BETA-CATENIN; CANCER-IMMUNOTHERAPY; COLORECTAL-CANCER; NK CELLS; THERAPY; DIFFERENTIATION; INTERLEUKIN-15; RESISTANCE	Immunotherapy offers new options for cancer treatment, but efficacy varies across cancer types. Colorectal cancers (CRCs) are largely refractory to immune-checkpoint blockade, which suggests the presence of yet uncharacterized immune-suppressive mechanisms. Here we report that the loss of adenomatosis polyposis coli (APC) in intestinal tumor cells or of the tumor suppressor PTEN in melanoma cells upregulates the expression of Dickkopf-related protein 2 (DKK2), which, together with its receptor LRP5, provides an unconventional mechanism for tumor immune evasion. DKK2 secreted by tumor cells acts on cytotoxic lymphocytes, inhibiting STAT5 signaling by impeding STAT5 nuclear localization via LRP5, but independently of LRP6 and the Wnt-beta-catenin pathway. Genetic or antibody-mediated ablation of DKK2 activates natural killer (NK) cells and CD8(+) T cells in tumors, impedes tumor progression, and enhances the effects of PD-1 blockade. Thus, we have identified a previously unknown tumor immune-suppressive mechanism and immunotherapeutic targets particularly relevant for CRCs and a subset of melanomas.	[Xiao, Qian; Wang, Wei-Jia; Zheng, Yingxia; Sahraei, Mahnaz; Tang, Wenwen; Wu, Dianqing] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT USA; [Xiao, Qian; Wang, Wei-Jia; Zheng, Yingxia; Sahraei, Mahnaz; Tang, Wenwen; Wu, Dianqing] Yale Sch Med, Dept Pharmacol, New Haven, CT USA; [Wu, Jibo; Li, Lin] Univ Chinese Acad Sci, State Key Lab Mol Biol,Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Bio, Innovat Ctr Cell Signaling Network,Inst Biochem &, Shanghai, Peoples R China; [Chen, Shiyang] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai, Peoples R China; [Yu, Xiaoqing] Yale Univ, Biostat Dept, New Haven, CT USA; [Meeth, Katrina; Bosenberg, Marcus] Yale Sch Med, Dept Dermatol, New Haven, CT USA; [Meeth, Katrina; Bosenberg, Marcus] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Bothwell, Alfred L. M.; Chen, Lieping; Wu, Dianqing] Yale Sch Med, Dept Immunol, New Haven, CT USA; [Bothwell, Alfred L. M.; Chen, Lieping; Bosenberg, Marcus] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA; [Sexl, Veronika] Univ Vet Med Vienna, Dept Biomed Sci, Inst Pharmacol & Toxicol, Vienna, Austria; [Sun, Le] AbMax, Beijing, Peoples R China	Yale University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Yale University; Yale University; Yale University; Yale University; Yale University; University of Veterinary Medicine Vienna	Tang, WW; Wu, DQ (corresponding author), Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT USA.; Tang, WW; Wu, DQ (corresponding author), Yale Sch Med, Dept Pharmacol, New Haven, CT USA.; Li, L (corresponding author), Univ Chinese Acad Sci, State Key Lab Mol Biol,Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Shanghai Inst Bio, Innovat Ctr Cell Signaling Network,Inst Biochem &, Shanghai, Peoples R China.; Wu, DQ (corresponding author), Yale Sch Med, Dept Immunol, New Haven, CT USA.	lin.li@sibs.ac.cn; Wenwen.tang@yale.edu; dan.wu@yale.edu	Xiao, Qian/ABC-6551-2021; Wu, Jibo/AAV-7459-2021	Xiao, Qian/0000-0002-2103-4854; 	NIH [GM112182, CA214703]; Connecticut Bioscience Innovation Fund; NSFC [31530094]; strategic priority research program of CAS [XDB19000000]; CAS/SAFEA International Partnership Program for Creative Research Teams; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA214703, P50CA196530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324, R01GM112182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Bioscience Innovation Fund; NSFC(National Natural Science Foundation of China (NSFC)); strategic priority research program of CAS; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Orsulak for technical assistance and B. Williams (Van Andel Institute, Grand Rapids, Michigan, USA) for providing the LRP5/6 floxed mice. This work was supported by the NIH (grants GM112182 and CA214703 to D.W.), the Connecticut Bioscience Innovation Fund (to D.W.), NSFC (grant 31530094 to L. L.), the strategic priority research program of CAS (grant XDB19000000 to L. L.), and the CAS/SAFEA International Partnership Program for Creative Research Teams (to L. L. and D.W.).	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Bao J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003028; Belov L, 2011, INT J MOL SCI, V12, P78, DOI 10.3390/ijms12010078; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chung KY, 2010, J CLIN ONCOL, V28, P3485, DOI 10.1200/JCO.2010.28.3994; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Crouse J, 2015, TRENDS IMMUNOL, V36, P49, DOI 10.1016/j.it.2014.11.001; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; D'Amico L, 2016, J EXP MED, V213, P827, DOI 10.1084/jem.20150950; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Hirano F, 2005, CANCER RES, V65, P1089; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hukelmann JL, 2016, NAT IMMUNOL, V17, P104, DOI 10.1038/ni.3314; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392; Kim I, 2013, J CELL BIOL, V200, P419, DOI 10.1083/jcb.201206096; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XF, 2012, P NATL ACAD SCI USA, V109, P11402, DOI 10.1073/pnas.1205015109; Li ZY, 2012, INFECT IMMUN, V80, P565, DOI 10.1128/IAI.05078-11; Little MC, 2005, J IMMUNOL, V175, P6713, DOI 10.4049/jimmunol.175.10.6713; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Marcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1; Matsui A, 2009, CANCER SCI, V100, P1923, DOI 10.1111/j.1349-7006.2009.01272.x; Mishra A, 2014, CLIN CANCER RES, V20, P2044, DOI 10.1158/1078-0432.CCR-12-3603; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Zarogoulidis P, 2014, J CANCER, V5, P765, DOI 10.7150/jca.10471	64	77	78	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					262	+		10.1038/nm.4496	http://dx.doi.org/10.1038/nm.4496			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29431745	Green Accepted			2022-12-27	WOS:000426700900008
J	Pickar, AK; Gersbach, CA				Pickar, Adrian K.; Gersbach, Charles A.			Gene therapies for hemophilia hit the mark in clinical trials	NATURE MEDICINE			English	Editorial Material							FACTOR-IX; REPLACEMENT THERAPY; FACTOR-VIII; VARIANT	Two recent studies describe clinical successes for single-dose gene therapy in trials for two forms of hemophilia.	[Pickar, Adrian K.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Pickar, Adrian K.; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA	Duke University; Duke University	Gersbach, CA (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Gersbach, CA (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.	charles.gersbach@duke.edu	Gersbach, Charles/Y-3412-2019					George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Jiang HY, 2006, BLOOD, V108, P107, DOI 10.1182/blood-2005-12-5115; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McIntosh J, 2013, BLOOD, V121, P3335, DOI 10.1182/blood-2012-10-462200; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Simioni P, 2009, NEW ENGL J MED, V361, P1671, DOI 10.1056/NEJMoa0904377; SINSHEIMER RL, 1969, AM SCI, V57, P134; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x	12	8	8	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					121	122		10.1038/nm.4492	http://dx.doi.org/10.1038/nm.4492			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414930				2022-12-27	WOS:000424327200005
J	Dai, XP; Gan, WJ; Li, XN; Wang, SQ; Zhang, W; Huang, L; Liu, SW; Zhong, Q; Guo, JP; Zhang, JF; Chen, T; Shimizu, K; Beca, F; Blattner, M; Vasudevan, D; Buckley, DL; Qi, J; Buser, L; Liu, PD; Inuzuka, H; Beck, AH; Wang, LW; Wild, PJ; Garraway, LA; Rubin, MA; Barbieri, CE; Wong, KK; Muthuswamy, SK; Huang, JT; Chen, Y; Bradner, JE; Wei, WY				Dai, Xiangpeng; Gan, Wenjian; Li, Xiaoning; Wang, Shangqian; Zhang, Wei; Huang, Ling; Liu, Shengwu; Zhong, Qing; Guo, Jianping; Zhang, Jinfang; Chen, Ting; Shimizu, Kouhei; Beca, Francisco; Blattner, Mirjam; Vasudevan, Divya; Buckley, Dennis L.; Qi, Jun; Buser, Lorenz; Liu, Pengda; Inuzuka, Hiroyuki; Beck, Andrew H.; Wang, Liewei; Wild, Peter J.; Garraway, Levi A.; Rubin, Mark A.; Barbieri, Christopher E.; Wong, Kwok-Kin; Muthuswamy, Senthil K.; Huang, Jiaoti; Chen, Yu; Bradner, James E.; Wei, Wenyi			Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4	NATURE MEDICINE			English	Article							BROMODOMAIN PROTEIN BRD4; DRUG-RESISTANCE; UBIQUITIN LIGASES; BREAST-CANCER; P-TEFB; DEGRADATION; PROMOTES; TRANSCRIPTION; RECRUITMENT; ONCOPROTEIN	The bromodomain and extraterminal (BET) family of proteins comprises four members-BRD2, BRD3, BRD4 and the testisspecific isoform BRDT-that largely function as transcriptional coactivators(1-3) and play critical roles in various cellular processes, including the cell cycle, apoptosis, migration and invasion(4,5). BET proteins enhance the oncogenic functions of major cancer drivers by elevating the expression of these drivers, such as c-Myc in leukemia(6,7), or by promoting the transcriptional activities of oncogenic factors, such as AR and ERG in prostate cancer(8). Pathologically, BET proteins are frequently overexpressed and are clinically linked to various types of human cancer(5,9,10); they are therefore being pursued as attractive therapeutic targets for selective inhibition in patients with cancer. To this end, a number of bromodomain inhibitors, including JQ1 and I-BET, have been developed(11,12) and have shown promising outcomes in early clinical trials. Although resistance to BET inhibitors has been documented in preclinical models(13-15), the molecular mechanisms underlying acquired resistance are largely unknown. Here we report that cullin-3(SPOP) earmarks BET proteins, including BRD2, BRD3 and BRD4, for ubiquitination-mediated degradation. Pathologically, prostate cancer-associated SPOP mutants fail to interact with and promote the degradation of BET proteins, leading to their elevated abundance in SPOP-mutant prostate cancer. As a result, prostate cancer cell lines and organoids derived from individuals harboring SPOP mutations are more resistant to BET-inhibitor-induced cell growth arrest and apoptosis. Therefore, our results elucidate the tumorsuppressor role of SPOP in prostate cancer in which it acts as a negative regulator of BET protein stability and also provide a molecular mechanism for resistance to BET inhibitors in individuals with prostate cancer bearing SPOP mutations.	[Dai, Xiangpeng; Gan, Wenjian; Li, Xiaoning; Guo, Jianping; Zhang, Jinfang; Shimizu, Kouhei; Beca, Francisco; Liu, Pengda; Inuzuka, Hiroyuki; Beck, Andrew H.; Wei, Wenyi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Li, Xiaoning] Jilin Univ, Dept Pathophysiol, Basic Med Coll, Changchun, Jilin, Peoples R China; [Wang, Shangqian; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Zhang, Wei; Huang, Jiaoti] Duke Univ, Dept Pathol, Sch Med, Durham, NC 27706 USA; [Zhang, Wei] Beijing Hosp, Natl Ctr Gerontol, Dept Pathol, Beijing, Peoples R China; [Huang, Ling; Muthuswamy, Senthil K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA USA; [Liu, Shengwu; Chen, Ting; Buckley, Dennis L.; Qi, Jun; Garraway, Levi A.; Wong, Kwok-Kin; Bradner, James E.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Liu, Shengwu; Chen, Ting; Buckley, Dennis L.; Qi, Jun; Wong, Kwok-Kin; Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Zhong, Qing; Buser, Lorenz; Wild, Peter J.] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland; [Blattner, Mirjam; Vasudevan, Divya; Barbieri, Christopher E.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, Dept Urol, New York, NY USA; [Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Rubin, Mark A.] Weill Cornell Med Coll, Insts Precis Med, New York, NY USA; [Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Rubin, Mark A.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Liu, Pengda] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Jilin University; Memorial Sloan Kettering Cancer Center; Duke University; Beijing Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Zurich; University Zurich Hospital; Cornell University; Mayo Clinic; Cornell University; Cornell University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Wei, WY (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA.	wwei2@bidmc.harvard.edu	huang, ling/ABB-1647-2020; Muthuswamy, Senthil K/AGY-2834-2022; 高, 雨莉/HGU-8187-2022; Zhong, Qing/ABE-2397-2021	Muthuswamy, Senthil K/0000-0001-6564-9634; Zhong, Qing/0000-0002-5340-301X; Wild, Peter Johannes/0000-0002-1017-3744; Beca, Francisco/0000-0002-4409-012X; Rubin, Mark/0000-0002-8321-9950; Shimizu, Kouhei/0000-0001-9523-4296; Chen, Ting/0000-0003-1725-7956; Gan, Wenjian/0000-0001-7599-5020; Huang, Jiaoti/0000-0003-1195-1998; Buser, Lorenz/0000-0002-9693-3221	National Research Service Award T-32 training grant; National Cancer Institute [1K99CA207867]; H2020 grant from the European Commission (PrECISE); University of Zurich, Switzerland; National Institutes of Health [GM094777, CA177910]; Grants-in-Aid for Scientific Research [16K15811] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA224079, R01CA200651, K08CA140946, R01CA193837, K99CA207867, R00CA181342, R01CA177910, R01CA200573, R01CA208100, P50CA092629, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094777, R01GM089763] Funding Source: NIH RePORTER	National Research Service Award T-32 training grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); H2020 grant from the European Commission (PrECISE); University of Zurich, Switzerland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Mitsiades (Baylor College of Medicine), P. Zhou (Weill Cornell Medical College), W. Kaelin (Dana-Farber Cancer Institute), C. French (Brigham and Women's Hospital), R.-H. Chen (Institute of Biological Chemistry, Academia Sinica), S. Uchida (Tokyo Medical and Dental University), J. Yuan (Harvard Medical School) and S.-Y. Shao (Beth Israel Deaconess Medical Center) for their contributed materials. We thank F. Wu, B. Wang, N.T. Nihira and B. North for critical reading of the manuscript and members of the Wei and Bradner laboratories for useful discussions. X.D. and J.G. are supported by a National Research Service Award T-32 training grant. W.G. is supported by 1K99CA207867 from the National Cancer Institute. D.L.B. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2196-14). P.J.W. is funded in part by a H2020 grant from the European Commission (PrECISE) and a research grant from the University of Zurich, Switzerland. W.W. is an American Cancer Society research scholar. This work was supported in part by National Institutes of Health grants (W.W., GM094777 and CA177910).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Drost J, 2016, NAT PROTOC, V11, P347, DOI 10.1038/nprot.2016.006; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; French CA, 2003, CANCER RES, V63, P304; Gan WJ, 2015, MOL CELL, V59, P917, DOI 10.1016/j.molcel.2015.07.026; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Humphrey PA, 2016, EUR UROL, V70, P106, DOI 10.1016/j.eururo.2016.02.028; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhong Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24146; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	41	167	175	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9								10.1038/nm.4378	http://dx.doi.org/10.1038/nm.4378			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28805820	Green Submitted, Green Accepted			2022-12-27	WOS:000409996200013
J	Mayorca-Guiliani, AE; Madsen, CD; Cox, TR; Horton, ER; Venning, FA; Erler, JT				Mayorca-Guiliani, Alejandro E.; Madsen, Chris D.; Cox, Thomas R.; Horton, Edward R.; Venning, Freja A.; Erler, Janine T.			ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix	NATURE MEDICINE			English	Article							SINGLE-CELL RESOLUTION; BASEMENT-MEMBRANE; QUANTITATIVE-ANALYSIS; MAMMARY-GLAND; CANCER; COLLAGEN; LAMININ; VISUALIZATION; INNERVATION; FIBRONECTIN	The extracellular matrix (ECM) is a master regulator of cellular phenotype and behavior. It has a crucial role in both normal tissue homeostasis and disease pathology. Here we present a fast and efficient approach to enhance the study of ECM composition and structure. Termed in situ decellularization of tissues (ISDoT), it allows whole organs to be decellularized, leaving native ECM architecture intact. These three-dimensional decellularized tissues can be studied using high-resolution fluorescence and second harmonic imaging, and can be used for quantitative proteomic interrogation of the ECM. Our method is superior to other methods tested in its ability to preserve the structural integrity of the ECM, facilitate high-resolution imaging and quantitatively detect ECM proteins. In particular, we performed high-resolution sub-micron imaging of matrix topography in normal tissue and over the course of primary tumor development and progression to metastasis in mice, providing the first detailed imaging of the metastatic niche. These data show that cancer-driven ECM remodeling is organ specific, and that it is accompanied by comprehensive changes in ECM composition and topological structure. We also describe differing patterns of basement-membrane organization surrounding different types of blood vessels in healthy and diseased tissues. The ISDoT procedure allows for the study of native ECM structure under normal and pathological conditions in unprecedented detail.	[Mayorca-Guiliani, Alejandro E.; Madsen, Chris D.; Cox, Thomas R.; Horton, Edward R.; Venning, Freja A.; Erler, Janine T.] Univ Copenhagen UCPH, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark; [Madsen, Chris D.] Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden; [Cox, Thomas R.] UNSW Sydney, Fac Med, St Vincents Clin Sch, Garvan Inst Med Res, Sydney, NSW, Australia; [Cox, Thomas R.] UNSW Sydney, Fac Med, St Vincents Clin Sch, Kinghorn Canc Ctr,Canc Div, Sydney, NSW, Australia	Lund University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Erler, JT (corresponding author), Univ Copenhagen UCPH, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark.	janine.erler@bric.ku.dk	Horton, Edward/F-3863-2016; Venning, Freja Albjerg/P-6762-2019; Venning, Freja Albjerg/Q-5082-2017	Horton, Edward/0000-0001-9530-9585; Venning, Freja Albjerg/0000-0001-5229-2023; Venning, Freja Albjerg/0000-0001-5229-2023; Erler, Janine/0000-0001-8675-6527; Cox, Thomas/0000-0001-9294-1745; Mayorca Guiliani, Alejandro Enrique/0000-0001-8137-4722; Madsen, Chris D/0000-0001-6838-2103	Danish Cancer Society [R56-A3342, R124-A7862]; Novo Nordisk Foundation (Hallas Moller Stipend); European Research Council [ERC-2015-CoG-682881-MATRICAN]; Ragnar Soderberg Foundation Sweden [N19/15]; Cancerfonden Sweden [CAN 2016/283]; Innovation Foundation Denmark [1311-00010B]; National Health and Medical Research Council (NHMRC) Australia [APP1129766]; Danish Council for Independent Research YDUN grant [1084181001]; Novo Nordisk Fonden [NNF12OC1015992] Funding Source: researchfish; The Danish Cancer Society [R124-A7862] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation (Hallas Moller Stipend); European Research Council(European Research Council (ERC)European Commission); Ragnar Soderberg Foundation Sweden; Cancerfonden Sweden(Swedish Cancer Society); Innovation Foundation Denmark; National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Danish Council for Independent Research YDUN grant; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	We thank I. Novak and N. Meyn Christensen (Centre for Advanced Bioimaging (CAB), University of Copenhagen) for imaging assistance. We thank J.R. Brewer (University of Southern Denmark) for providing access to his custom-built two-photon microscope. We thank J. Koch for help with decellularization procedures. We thank E. Sahai (Francis Crick Institute) for providing the MATLAB code. We thank J. Couchman, K.B. Jensen (both from Biotech Research & Innovation Centre, University of Copenhagen) and E. Sahai for their critical reading of the manuscript. We thank R. Linding (BRIC, University of Copenhagen) for providing access to mass spectrometry facilities. This work was supported by the Danish Cancer Society (R56-A3342, R124-A7862) (A. E. M.-G. and E.R.H.); the Novo Nordisk Foundation (Hallas Moller Stipend; to C.D.M. and J.T.E.); the European Research Council (ERC-2015-CoG-682881-MATRICAN; to A. E. M.-G. and E.R.H.); the Ragnar Soderberg Foundation Sweden (N19/15; C.D.M.); Cancerfonden Sweden (CAN 2016/283); the Innovation Foundation Denmark (1311-00010B; to T.R.C.); the National Health and Medical Research Council (NHMRC) Australia (APP1129766; T.R.C.); and the Danish Council for Independent Research YDUN grant (1084181001; F.V.A.).	Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Cavallotti C, 2003, ANAT HISTOL EMBRYOL, V32, P12, DOI 10.1046/j.1439-0264.2003.00431.x; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; CORNBROOKS CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3850, DOI 10.1073/pnas.80.12.3850; Cox TR, 2015, DATA BRIEF, V5, P621, DOI 10.1016/j.dib.2015.09.039; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DEXTER DL, 1978, CANCER RES, V38, P3174; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; FUJIWARA T, 1984, AM J ANAT, V170, P39, DOI 10.1002/aja.1001700104; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harunaga JS, 2014, DEV BIOL, V394, P197, DOI 10.1016/j.ydbio.2014.08.014; Hill RE, 2002, J ANAT, V201, P185, DOI 10.1046/j.1469-7580.2002.00083.x; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iijima T, 2002, MICROSC RES TECHNIQ, V56, P32, DOI 10.1002/jemt.10007; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Janssen B, 2002, AM J PHYSIOL-REG I, V282, pR928, DOI 10.1152/ajpregu.00406.2001; KAWASHIRI S, 1995, ORAL ONCOL, V31B, P216, DOI 10.1016/0964-1955(95)00027-F; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; LAURIE GW, 1982, J CELL BIOL, V95, P340, DOI 10.1083/jcb.95.1.340; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Lochhead P, 2015, MODERN PATHOL, V28, P14, DOI 10.1038/modpathol.2014.81; MANNING CS, 2013, INTRAVITAL, V2, DOI DOI 10.1038/SREP10129; MATSUMOTO M, 1992, J VET MED SCI, V54, P937, DOI 10.1292/jvms.54.937; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Pedrola N, 2015, CLIN EXP METASTAS, V32, P467, DOI 10.1007/s10585-015-9720-7; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Tseng SJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3158998; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Yang GY, 2015, NAT METHODS, V12, P137, DOI [10.1038/NMETH.3207, 10.1038/nmeth.3207]; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270	59	99	102	6	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					890	+		10.1038/nm.4352	http://dx.doi.org/10.1038/nm.4352			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28604702				2022-12-27	WOS:000405180100020
J	Liu, XA; Kenny, PJ				Liu, Xin-an; Kenny, Paul J.			alpha 5 nicotinic receptors link smoking to schizophrenia	NATURE MEDICINE			English	Editorial Material							LUNG-CANCER; RISK; DEPENDENCE; 15Q25	A new study shows that nicotinic receptors activate a particular type of interneuron in the prefrontal cortex. Deficits in this relationship give rise to behavioral abnormalities similar to those associated with schizophrenia, which can be ameliorated by nicotine.	[Liu, Xin-an; Kenny, Paul J.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Kenny, PJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	paul.kenny@mssm.edu						Fowler CD, 2008, BEHAV PHARMACOL, V19, P461, DOI 10.1097/FBP.0b013e32830c360e; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jackson KJ, 2013, PSYCHIAT GENET, V23, P20, DOI 10.1097/YPG.0b013e32835bd5f1; Koukouli F, 2017, NAT MED, V23, P347, DOI 10.1038/nm.4274; Modai S, 2016, TRENDS MOL MED, V22, P242, DOI 10.1016/j.molmed.2016.01.006; Parikh V, 2016, SCHIZOPHR RES, V171, P1, DOI 10.1016/j.schres.2016.01.020; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Whalley HC, 2008, J AFFECT DISORDERS, V109, P99, DOI 10.1016/j.jad.2007.11.009	9	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					277	278		10.1038/nm.4300	http://dx.doi.org/10.1038/nm.4300			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28267713				2022-12-27	WOS:000395848400007
J	Sheffield, NC; Pierron, G; Klughammer, J; Datlinger, P; Schoenegger, A; Schuster, M; Hadler, J; Surdez, D; Guillemot, D; Lapouble, E; Freneaux, P; Champigneulle, J; Bouvier, R; Walder, D; Ambros, IM; Hutter, C; Sorz, E; Amaral, AT; De Alava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; de Pinieux, G; Terrier, P; Laurence, V; Michon, J; Ladenstein, R; Holter, W; Windhager, R; Dirksen, U; Ambros, PF; Delattre, O; Kovar, H; Bock, C; Tomazou, EM				Sheffield, Nathan C.; Pierron, Gaelle; Klughammer, Johanna; Datlinger, Paul; Schoenegger, Andreas; Schuster, Michael; Hadler, Johanna; Surdez, Didier; Guillemot, Delphine; Lapouble, Eve; Freneaux, Paul; Champigneulle, Jacqueline; Bouvier, Raymonde; Walder, Diana; Ambros, Ingeborg M.; Hutter, Caroline; Sorz, Eva; Amaral, Ana T.; De Alava, Enrique; Schallmoser, Katharina; Strunk, Dirk; Rinner, Beate; Liegl-Atzwanger, Bernadette; Huppertz, Berthold; Leithner, Andreas; de Pinieux, Gonzague; Terrier, Philippe; Laurence, Valerie; Michon, Jean; Ladenstein, Ruth; Holter, Wolfgang; Windhager, Reinhard; Dirksen, Uta; Ambros, Peter F.; Delattre, Olivier; Kovar, Heinrich; Bock, Christoph; Tomazou, Eleni M.			DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma	NATURE MEDICINE			English	Article							GENOMIC LANDSCAPE; ENHANCERS; EPIGENOME; BINDING; CANCER; TUMOR; DIFFERENTIATION; METHYLOME; DYNAMICS; FUSION	Developmental tumors in children and young adults carry few genetic alterations, yet they have diverse clinical presentation. Focusing on Ewing sarcoma, we sought to establish the prevalence and characteristics of epigenetic heterogeneity in genetically homogeneous cancers. We performed genome-scale DNA methylation sequencing for a large cohort of Ewing sarcoma tumors and analyzed epigenetic heterogeneity on three levels: between cancers, between tumors, and within tumors. We observed consistent DNA hypomethylation at enhancers regulated by the disease-defining EWS-FLI1 fusion protein, thus establishing epigenomic enhancer reprogramming as a ubiquitous and characteristic feature of Ewing sarcoma. DNA methylation differences between tumors identified a continuous disease spectrum underlying Ewing sarcoma, which reflected the strength of an EWS-FLI1 regulatory signature and a continuum between mesenchymal and stem cell signatures. There was substantial epigenetic heterogeneity within tumors, particularly in patients with metastatic disease. In summary, our study provides a comprehensive assessment of epigenetic heterogeneity in Ewing sarcoma and thereby highlights the importance of considering nongenetic aspects of tumor heterogeneity in the context of cancer biology and personalized medicine.	[Sheffield, Nathan C.; Klughammer, Johanna; Datlinger, Paul; Schoenegger, Andreas; Schuster, Michael; Hadler, Johanna; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Pierron, Gaelle; Guillemot, Delphine; Lapouble, Eve; Laurence, Valerie; Delattre, Olivier] PSL Res Univ, Inst Curie, Unite Genet Somat, Serv Genet,Pole Med Diagnost & Theranost, Paris, France; [Surdez, Didier; Delattre, Olivier] PSL Res Univ, Inst Curie, INSERM, U830, Paris, France; [Freneaux, Paul] PSL Res Univ, Inst Curie, Serv Pathol, Pole Med Diagnost & Theranost, Paris, France; [Champigneulle, Jacqueline] Hop Adultes, Hopitaux Brabois, Serv Anat & Cytol Patholog, Nancy, France; [Bouvier, Raymonde] Hop Lyon, Ctr Pathol Pole Est, Lyon, France; [Walder, Diana; Ambros, Ingeborg M.; Sorz, Eva; Ladenstein, Ruth; Holter, Wolfgang; Ambros, Peter F.; Kovar, Heinrich; Tomazou, Eleni M.] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria; [Hutter, Caroline; Ladenstein, Ruth; Holter, Wolfgang] St Anna Childrens Hosp, St Anna Childrens Hosp, Vienna, Austria; [Hutter, Caroline; Ladenstein, Ruth; Holter, Wolfgang; Ambros, Peter F.; Kovar, Heinrich] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Amaral, Ana T.; De Alava, Enrique] Univ Seville, CSIC, Virgen del Rocio Univ Hosp, Dept Pathol,Inst Biomed Sevilla IBiS, Seville, Spain; [Schallmoser, Katharina; Strunk, Dirk] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Schallmoser, Katharina] Paracelsus Med Univ, Dept Blood Grp Serol & Transfus Med, Salzburg, Austria; [Strunk, Dirk] Paracelsus Med Univ, Inst Expt & Clin Cell Therapy, Salzburg, Austria; [Rinner, Beate] Med Univ Graz, Div Biomed Res, Graz, Austria; [Liegl-Atzwanger, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria; [Huppertz, Berthold] Med Univ Graz, Biobank Graz, Orgt Unit Res Infrastruct, Graz, Austria; [Leithner, Andreas] Med Univ Graz, Dept Orthoped Surg, Graz, Austria; [de Pinieux, Gonzague] Hop Univ Trousseau, Serv Anat & Cytol Pathol, Tours, France; [Terrier, Philippe] Gustave Roussy, Dept Pathol, Villejuif, France; [Laurence, Valerie; Michon, Jean] PSL Res Univ, Inst Curie, Dept Oncol Pediat Adolescent Jeunes Adultes, Paris, France; [Windhager, Reinhard] Med Univ Vienna, Vienna Gen Hosp, Dept Orthoped, Vienna, Austria; [Dirksen, Uta] Univ Hosp Munster, Dept Pediat & Pediat Hematol & Oncol, Munster, Germany; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, Saarland Informat Campus, Saarbrucken, Germany; [Bock, Christoph] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria; [Sheffield, Nathan C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU de Nancy; CHU Lyon; Saint Anna Children's Hospital; Saint Anna Children's Hospital; Medical University of Vienna; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; CHU Tours; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Medical University of Vienna; University of Munster; Medical University of Vienna; Max Planck Society; University of Virginia	Bock, C (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria.; Tomazou, EM (corresponding author), St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria.; Bock, C (corresponding author), Med Univ Vienna, Dept Lab Med, Vienna, Austria.; Bock, C (corresponding author), Max Planck Inst Informat, Saarland Informat Campus, Saarbrucken, Germany.; Bock, C (corresponding author), Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria.	cbock@cemm.oeaw.ac.at; eleni.tomazou@ccri.at	Strunk, Dirk/V-4598-2017; Surdez, Didier/ABG-4565-2020; Sheffield, Nathan/ABG-8124-2020; Bock, Christoph/AAE-7618-2019; Tomazou, Eleni M/J-1475-2014; de Alava, Enrique/GOH-0368-2022; Hutter, Caroline/AAD-4426-2021; Schallmoser, Katharina/V-4734-2017; Dirksen, Uta/AGX-8472-2022; Huppertz, Berthold/I-2331-2019; Ambros, Peter/AAA-1266-2021	Strunk, Dirk/0000-0003-1810-867X; Sheffield, Nathan/0000-0001-5643-4068; Bock, Christoph/0000-0001-6091-3088; de Alava, Enrique/0000-0001-8400-046X; Schallmoser, Katharina/0000-0002-7204-0058; Huppertz, Berthold/0000-0003-4814-2158; Ambros, Peter/0000-0002-5507-7211; Windhager, Reinhard/0000-0002-6321-1804; Rinner, Beate/0000-0002-6340-4905; Amaral, Ana/0000-0001-7887-4814; delattre, olivier/0000-0002-8730-2276; DEFACHELLES, Anne-Sophie/0000-0002-4277-9871; Tomazou, Eleni Marina/0000-0002-7497-4567; Hutter, Caroline/0000-0003-2059-4814	Austrian National Bank's Jubilaumsfonds [15714]; INSERM within the framework of the International Cancer Genome Consortium program; Ligue Nationale Contre Le Cancer (Equipe labellisee); Societe Francaise des Cancers de l'Enfant; European Union [602856, 282510, 01KT1310, 259348, 668724]; Human Frontier Science Program [LT000211/2014]; DOC Fellowship of the Austrian Academy of Sciences; Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program; Ministry of Economy and Competitiveness of Spain-FEDER grants (CBJERONC) [RD12/0036/0017, PI14/01466]; Maria Garcia-Estrada; CRIS contra el Cancer Foundations; Pablo Ugarte Association; New Frontiers Group award of the Austrian Academy of Sciences; European Research Council (ERC) Starting Grant (European Union's Horizon research and innovation program) [679146]; Austrian Science Fund (FWF) [M1448-B13, V506-B28]; Austrian Science Fund (FWF) [I 1225, M 1448, V 506] Funding Source: researchfish	Austrian National Bank's Jubilaumsfonds; INSERM within the framework of the International Cancer Genome Consortium program; Ligue Nationale Contre Le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Societe Francaise des Cancers de l'Enfant; European Union(European Commission); Human Frontier Science Program(Human Frontier Science Program); DOC Fellowship of the Austrian Academy of Sciences; Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program; Ministry of Economy and Competitiveness of Spain-FEDER grants (CBJERONC); Maria Garcia-Estrada; CRIS contra el Cancer Foundations; Pablo Ugarte Association; New Frontiers Group award of the Austrian Academy of Sciences; European Research Council (ERC) Starting Grant (European Union's Horizon research and innovation program); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank all patients who have donated samples for this study. We also thank the team of the Biomedical Sequencing Facility at CeMM for support with next-generation sequencing; the members of the Delattre, Kovar, and Bock labs for discussions; A. Rendeiro and C. Dietz for contributing to the analysis pipelines; K. Clement for sharing his implementation of the PDR score; A. Lankester for providing MSCs; and the following physicians for providing tumor samples: J.M. Guinebretiere, L. Brugieres, A. de Muret, R. Tichit, N. Sirvent, F. Millot, E Guilhot, J.P. Vannier, C. Michot, E. Plouvier, A. Gomez-Brouchet, J. Rivel, B. Petit, F. Dijoud, E Larousserie, A. Kurt, A. Foulet, A.S. Desfachelles, H. Sartelet, I. Quintin Roue, J. Otten, J. Chasles, C. Bouvier, C. Soler, M. Peuchmaur, and X. Rialland. This study was funded by a grant from the Austrian National Bank's Jubilaumsfonds to E.M.T. (OeNB project number: 15714) and by a peer-reviewed institutional grant to E.M.T., which was based on a charitable donation of the Kapsch group (http://www.kapsch.net/kapschgroup) to St. Anna Kinderkrebsforschung. The French samples were collected in the context of the Plateforme Hospitaliere de Genetique Moleculaire des Cancers of the Institut Curie and Centre Hospitaller de Versailles, with support by grants from INSERM within the framework of the International Cancer Genome Consortium program and from the Ligue Nationale Contre Le Cancer (Equipe labellisee), and the Societe Francaise des Cancers de l'Enfant. The following associations supported this work: Courir pour Mathieu, Dans les pas du Geant, Olivier Chape, Les Bagouzamanon, Enfants et Sant, and les Amis de Claire. The study was performed in the context of the following European Union consortia: Euro Ewing (grant agreement no. 602856), BLUEPRINT (grant agreement no. 282510), PROVABES (grant agreement no. 01KT1310), ASSET (grant agreement no. 259348), and TECHNOBEAT (grant agreement no. 668724). N.C.S. was supported by a long-term fellowship of the Human Frontier Science Program (LT000211/2014). J.K. was supported by a DOC Fellowship of the Austrian Academy of Sciences. D. Surdez was supported by the Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program. E.d.A. was supported by Ministry of Economy and Competitiveness of Spain-FEDER grants (CBJERONC, RD12/0036/0017, PI14/01466), Maria Garcia-Estrada, CRIS contra el Cancer Foundations, and Pablo Ugarte Association. C.B. was supported by a New Frontiers Group award of the Austrian Academy of Sciences and by a European Research Council (ERC) Starting Grant (European Union's Horizon 2020 research and innovation program; grant 679146). E.M.T. was supported by fellowships of the Austrian Science Fund (FWF, Lise Meitner Fellowship M1448-B13; and Elise Richter Fellowship V506-B28).	Abe M, 2005, CANCER RES, V65, P828; Agirre X, 2015, GENOME RES, V25, P478, DOI 10.1101/gr.180240.114; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Aran D, 2014, BIOESSAYS, V36, P184, DOI 10.1002/bies.201300119; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bilke S, 2013, GENOME RES, V23, P1797, DOI 10.1101/gr.151340.112; Bock C, 2016, NAT BIOTECHNOL, V34, P726, DOI 10.1038/nbt.3605; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Lin Patrick P., 2011, Sarcoma, V2011, P276463, DOI 10.1155/2011/276463; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Mazor T, 2016, CANCER CELL, V29, P440, DOI 10.1016/j.ccell.2016.03.009; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mertens, 2013, WHO CLASSIFICATION T, P306; Parham DM, 1999, HUM PATHOL, V30, P911, DOI 10.1016/S0046-8177(99)90244-7; Pinto Alfredo, 2011, Sarcoma, V2011, DOI 10.1155/2011/856190; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; SCHMIDT D, 1991, CANCER, V68, P2251, DOI 10.1002/1097-0142(19911115)68:10<2251::AID-CNCR2820681025>3.0.CO;2-X; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042	45	125	128	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					386	395		10.1038/nm.4273	http://dx.doi.org/10.1038/nm.4273			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28134926	Green Accepted			2022-12-27	WOS:000395848400020
J	Babon, JAB; DeNicola, ME; Blodgett, DM; Crevecoeur, I; Buttrick, TS; Maehr, R; Bottino, R; Naji, A; Kaddis, J; Elyaman, W; James, EA; Haliyur, R; Brissova, M; Overbergh, L; Mathieu, C; Delong, T; Haskins, K; Pugliese, A; Campbell-Thompson, M; Mathews, C; Atkinson, MA; Powers, AC; Harlan, DM; Kent, SC				Babon, Jenny Aurielle B.; DeNicola, Megan E.; Blodgett, David M.; Crevecoeur, Inne; Buttrick, Thomas S.; Maehr, Rene; Bottino, Rita; Naji, Ali; Kaddis, John; Elyaman, Wassim; James, Eddie A.; Haliyur, Rachana; Brissova, Marcela; Overbergh, Lut; Mathieu, Chantal; Delong, Thomas; Haskins, Kathryn; Pugliese, Alberto; Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.; Powers, Alvin C.; Harlan, David M.; Kent, Sally C.			Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes (vol 22, pg 1482, 2016)	NATURE MEDICINE			English	Correction													James, Eddie/V-4929-2019; mathieu, chantal/ABD-5505-2021; Elyaman, Wassim/AAJ-1562-2021; Overbergh, Lut/AAC-3515-2020; Campbell-Thompson, Martha/A-7584-2010	James, Eddie/0000-0002-7217-5729; mathieu, chantal/0000-0002-4055-5233; Campbell-Thompson, Martha/0000-0001-6878-1235; Elyaman, Wassim/0000-0001-7238-374X; Kaddis, John/0000-0002-6752-7670	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126189] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI126189] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babon JAB, 2016, NAT MED, V22, P1482, DOI 10.1038/nm.4203	1	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					264	264		10.1038/nm0217-264a	http://dx.doi.org/10.1038/nm0217-264a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170374	Bronze			2022-12-27	WOS:000393729000019
J	Caskey, M; Schoofs, T; Gruell, H; Settler, A; Karagounis, T; Kreider, EF; Murrell, B; Pfeifer, N; Nogueira, L; Oliveira, TY; Learn, GH; Cohen, YZ; Lehmann, C; Gillor, D; Shimeliovich, I; Unson-O'Brien, C; Weiland, D; Robles, A; Kummerle, T; Wyen, C; Levin, R; Witmer-Pack, M; Eren, K; Ignacio, C; Kiss, S; West, AP; Mouquet, H; Zingman, BS; Gulick, RM; Keler, T; Bjorkman, PJ; Seaman, MS; Hahn, BH; Fatkenheuer, G; Schlesinger, SJ; Nussenzweig, MC; Kleine, F				Caskey, Marina; Schoofs, Till; Gruell, Henning; Settler, Allison; Karagounis, Theodora; Kreider, Edward F.; Murrell, Ben; Pfeifer, Nico; Nogueira, Lilian; Oliveira, Thiago Y.; Learn, Gerald H.; Cohen, Yehuda Z.; Lehmann, Clara; Gillor, Daniel; Shimeliovich, Irma; Unson-O'Brien, Cecilia; Weiland, Daniela; Robles, Alexander; Kuemmerle, Tim; Wyen, Christoph; Levin, Rebeka; Witmer-Pack, Maggi; Eren, Kemal; Ignacio, Caroline; Kiss, Szilard; West, Anthony P., Jr.; Mouquet, Hugo; Zingman, Barry S.; Gulick, Roy M.; Keler, Tibor; Bjorkman, Pamela J.; Seaman, Michael S.; Hahn, Beatrice H.; Faetkenheuer, Gerd; Schlesinger, Sarah J.; Nussenzweig, Michel C.; Kleine, Florian			Antibody 10-1074 suppresses viremia in HIV-1-infected individuals	NATURE MEDICINE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; HIV-1 VACCINE; GLYCAN RECOGNITION; PASSIVE TRANSFER; IN-VIVO; POTENT; VRC01; THERAPY; PHARMACOKINETICS	Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env) protein. It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far. Here we report on its safety and activity in 33 individuals who received a single intravenous infusion of the antibody. 10-1074 was well tolerated and had a half-life of 24.0 d in participants without HIV-1 infection and 12.8 d in individuals with HIV-1 infection. Thirteen individuals with viremia received the highest dose of 30 mg/kg 10-1074. Eleven of these participants were 10-1074-sensitive and showed a rapid decline in viremia by a mean of 1.52 logic copies/ml. Virologic analysis revealed the emergence of multiple independent 10-1074-resistant viruses in the first weeks after infusion. Emerging escape variants were generally resistant to the related V3-specific antibody PGT121, but remained sensitive to antibodies targeting nonoverlapping epitopes, such as the anti-CD4-binding-site antibodies 3BNC117 and VRC01. The results demonstrate the safety and activity of 10-1074 in humans and support the idea that antibodies targeting the V3 glycan supersite might be useful for the treatment and prevention of HIV-1 infection.	[Caskey, Marina; Schoofs, Till; Settler, Allison; Karagounis, Theodora; Nogueira, Lilian; Oliveira, Thiago Y.; Cohen, Yehuda Z.; Shimeliovich, Irma; Unson-O'Brien, Cecilia; Levin, Rebeka; Witmer-Pack, Maggi; Schlesinger, Sarah J.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Gruell, Henning; Weiland, Daniela; Kleine, Florian] Univ Cologne, Expt Immunol Lab, Ctr Mol Med Cologne, Cologne, Germany; [Gruell, Henning; Lehmann, Clara; Gillor, Daniel; Weiland, Daniela; Kuemmerle, Tim; Wyen, Christoph; Faetkenheuer, Gerd; Kleine, Florian] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Gruell, Henning; Lehmann, Clara; Weiland, Daniela; Faetkenheuer, Gerd; Kleine, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Kreider, Edward F.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kreider, Edward F.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Murrell, Ben; Ignacio, Caroline] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Pfeifer, Nico] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Robles, Alexander; Seaman, Michael S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Eren, Kemal] Univ Calif San Diego, Dept Biomed Informat, San Diego, CA USA; [Eren, Kemal] Univ Calif San Diego, Bioinformat & Syst Biol, San Diego, CA 92103 USA; [Kiss, Szilard] Cornell Univ, Weill Carnell Med Coll, Dept Ophthalmol, New York, NY 10021 USA; [West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, Paris, France; [Zingman, Barry S.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA; [Zingman, Barry S.] Einstein Rockefeller CUNY Ctr AIDS Res, Bronx, NY USA; [Gulick, Roy M.] Weill Cornell Med, Div Infect Dis, New York, NY USA; [Keler, Tibor] Celldex Therapeut, Hampton, VA USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Max Planck Society; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; California Institute of Technology; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Howard Hughes Medical Institute; Rockefeller University	Caskey, M; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.; Kleine, F (corresponding author), Univ Cologne, Expt Immunol Lab, Ctr Mol Med Cologne, Cologne, Germany.; Kleine, F (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany.; Kleine, F (corresponding author), German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	mcaskey@rockefeller.edu; nussen@rockefeller.edu; florian.klein@uk-koeln.de	Mouquet, Hugo/M-2750-2014; Nussenzweig, Michel/AAE-7292-2019; Learn, Jerry/E-3356-2012; Oliveira, Thiago Y/HGA-3848-2022; Pfeifer, Nico/G-1559-2016; Kreider, Edward/GSD-5998-2022; Oliveira, Thiago Y/ABF-5186-2020; Murrell, Ben/AAM-1188-2021	Mouquet, Hugo/0000-0002-4230-610X; Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Karagounis, Theodora/0000-0003-1481-9589; Murrell, Ben/0000-0002-0393-4445; Pfeifer, Nico/0000-0002-4647-8566; Caskey, Marina/0000-0003-1727-8693; Grull, Henning/0000-0002-0725-7138; Kiss, Szilard/0000-0003-3433-8432; Cohen, Yehuda/0000-0001-6987-1478; Kreider, Edward/0000-0003-2330-8430; Hahn, Beatrice/0000-0002-9400-9887	Translational Virology Core at the UC San Diego Center for AIDS Research [P30 AI036214]; NIH/NIGMS [U01 GM110749]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) Grants [OPP1032144, OPP1092074, OPP1124068]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grant [HIVRAD P01 AI100148]; BEAT-HIV Delaney grant [UM1 AI126620]; Robertson Foundation; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; German Research Foundation [SCHO 1612/1-1]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [UL1 TR001866]; German Center for Infection Research (DZIF); Ruth L. Kirschstein National Research Service Award [F30 AI112426]; National Institute of Allergy and Infectious Diseases [R00 AI120851]; National Library of Medicine [T15 LM007092]; Heisenberg Program of the DFG [KL 2389/2-1]; European Research Council [ERC-StG639961]; German Center for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R00AI120851, F30AI112426, UM1AI126620, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110749] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	Translational Virology Core at the UC San Diego Center for AIDS Research; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) Grants; National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BEAT-HIV Delaney grant; Robertson Foundation; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); German Research Foundation(German Research Foundation (DFG)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); German Center for Infection Research (DZIF); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Heisenberg Program of the DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank all study participants for devoting their time to support our research. We thank the Clinical Research Support Teams of the Rockefeller University Hospital and the Infectious Disease Division at the University Hospital Cologne, in particular, C. Golder, G. Kremer, S. Margane and E. Thomas. We thank L. Burke, S. Durant, M. Platten, I. Suarez and the nursing staff for patient care and recruitment, and all members of the laboratories of M.C.N. and F.K. for helpful discussions. We thank P. Fast and H. Park for clinical monitoring, A. Louie, D. Jordan, C. Conrad and D. Adzic for regulatory support, C. Anthony and S. Zhou for help in establishing Primer-ID sequencing, C. Ruping, K. Jain, M. Ercanoglu, R. Patel and J. Dizon for sample processing, U. Kerkweg, R. Macarthur and A. Johnson for pharmacy services, A. Germann and H. von Briesen for HIV culture analyses, R. Kaiser for p24 measurements and D. Sok for providing PGT121 and PGDM1400 for neutralization assays. Amplification and library preparation for SMRT sequencing was performed with the support of the Translational Virology Core at the UC San Diego Center for AIDS Research (P30 AI036214). SMRT sequencing was conducted at the IGM Genomics Center, University of California, San Diego, La Jolla, California. Computational analysis of sequence data was performed, in part, on a cluster, which was supported by U01 GM110749 (NIH/NIGMS). This work was supported in part by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) Grants OPP1032144 (M.S.S.), OPP1092074 and OPP1124068 (M.C.N.), National Institute of Allergy and Infectious Diseases of the National Institutes of Health Grant HIVRAD P01 AI100148 (P.J.B.), a BEAT-HIV Delaney grant UM1 AI126620 (B.H.H.), the Robertson Foundation to M.C.N., and the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N.). T.S. was supported by a German Research Foundation postdoctoral fellowship (SCHO 1612/1-1) and is currently supported in part by grant #UL1 TR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. H:G. is supported by a fellowship from the German Center for Infection Research (DZIF). T. Karagounis is an HHMI Medical Research Fellow. E.F.K. is supported by a Ruth L. Kirschstein National Research Service Award (F30 AI112426). B.M. was supported by grant number R00 AI120851 from the National Institute of Allergy and Infectious Diseases. K.E. was supported by T15 LM007092 from the National Library of Medicine. F.K. is supported by the Heisenberg Program of the DFG (KL 2389/2-1), the European Research Council (ERC-StG639961) and the German Center for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany. M.C.N. is a Howard Hughes Medical Institute Investigator. Aspects of this work are encompassed by patent application PCT/US2013/065696.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moore PL, 2015, TRENDS MICROBIOL, V23, P204, DOI 10.1016/j.tim.2014.12.007; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Smith ML, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew018; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yoon H, 2015, NUCLEIC ACIDS RES, V43, pW213, DOI 10.1093/nar/gkv404; Zhou ST, 2015, J VIROL, V89, P8540, DOI 10.1128/JVI.00522-15	55	290	295	1	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					185	191		10.1038/nm.4268	http://dx.doi.org/10.1038/nm.4268			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28092665	Green Accepted, Green Submitted			2022-12-27	WOS:000393729000010
J	Guryanova, OA; Shank, K; Spitzer, B; Luciani, L; Koche, RP; Garrett-Bakelman, FE; Ganzel, C; Durham, BH; Mohanty, A; Hoermann, G; Rivera, SA; Chramiec, AG; Pronier, E; Bastian, L; Keller, MD; Tovbin, D; Loizou, E; Weinstein, AR; Gonzalez, AR; Lieu, YK; Rowe, JM; Pastore, F; McKenney, AS; Krivtsov, AV; Sperr, WR; Cross, JR; Mason, CE; Tallman, MS; Arcila, ME; Abdel-Wahab, O; Armstrong, SA; Kubicek, S; Staber, PB; Gonen, M; Paietta, EM; Melnick, AM; Nimer, SD; Mukherjee, S; Levine, RL				Guryanova, Olga A.; Shank, Kaitlyn; Spitzer, Barbara; Luciani, Luisa; Koche, Richard P.; Garrett-Bakelman, Francine E.; Ganzel, Chezi; Durham, Benjamin H.; Mohanty, Abhinita; Hoermann, Gregor; Rivera, Sharon A.; Chramiec, Alan G.; Pronier, Elodie; Bastian, Lennart; Keller, Matthew D.; Tovbin, Daniel; Loizou, Evangelia; Weinstein, Abby R.; Gonzalez, Adriana Rodriguez; Lieu, Yen K.; Rowe, Jacob M.; Pastore, Friederike; McKenney, Anna Sophia; Krivtsov, Andrei V.; Sperr, Wolfgang R.; Cross, Justin R.; Mason, Christopher E.; Tallman, Martin S.; Arcila, Maria E.; Abdel-Wahab, Omar; Armstrong, Scott A.; Kubicek, Stefan; Staber, Philipp B.; Goenen, Mithat; Paietta, Elisabeth M.; Melnick, Ari M.; Nimer, Stephen D.; Mukherjee, Siddhartha; Levine, Ross L.			DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling	NATURE MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; DNA METHYLTRANSFERASE DNMT3A; HEMATOPOIETIC STEM-CELLS; CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; TET2; IMPACT; LEADS; IDENTIFICATION; INACTIVATION	Although the majority of patients with acute myeloid leukemia (AML) initially respond to chemotherapy, many of them subsequently relapse, and the mechanistic basis for AML persistence following chemotherapy has not been determined. Recurrent somatic mutations in DNA methyltransferase 3A (DNMT3A), most frequently at arginine 882 (DNMT3A(R882)), have been observed in AML(1-3) and in individuals with clonal hematopoiesis in the absence of leukemic transformation(4,5). Patients with DNMT3A(R882) AML have an inferior outcome when treated with standard-dose daunorubicin-based induction chemotherapy(6,7), suggesting that DNMT3A(R882) cells persist and drive relapse(8). We found that Dnmt3a mutations induced hematopoietic stem cell expansion, cooperated with mutations in the FMS-like tyrosine kinase 3 gene (Flt3(ITD)) and the nucleophosmin gene (Npm1(c)) to induce AML in vivo, and promoted resistance to anthracycline chemotherapy. In patients with AML, the presence of DNMT3A(R882) mutations predicts minimal residual disease, underscoring their role in AML chemoresistance. DNMT3A(R882) cells showed impaired nucleosome eviction and chromatin remodeling in response to anthracycline treatment, which resulted from attenuated recruitment of histone chaperone SPT-16 following anthracycline exposure. This defect led to an inability to sense and repair DNA torsional stress, which resulted in increased mutagenesis. Our findings identify a crucial role for DNMT3A(R882) mutations in driving AML chemoresistance and highlight the importance of chromatin remodeling in response to cytotoxic chemotherapy.	[Guryanova, Olga A.; Shank, Kaitlyn; Durham, Benjamin H.; Pronier, Elodie; Bastian, Lennart; Keller, Matthew D.; Tovbin, Daniel; Weinstein, Abby R.; Gonzalez, Adriana Rodriguez; Pastore, Friederike; McKenney, Anna Sophia; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Spitzer, Barbara; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Luciani, Luisa; Nimer, Stephen D.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Koche, Richard P.; Chramiec, Alan G.; Krivtsov, Andrei V.; Armstrong, Scott A.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Koche, Richard P.; Loizou, Evangelia; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Garrett-Bakelman, Francine E.; Melnick, Ari M.] Weill Cornell Med, Dept Med, Div Hematol & Oncol, New York, NY USA; [Ganzel, Chezi; Rowe, Jacob M.] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel; [Mohanty, Abhinita; Arcila, Maria E.] Mem Sloan Kettering Canc Ctr, Diagnost Mol Pathol Lab, 1275 York Ave, New York, NY 10021 USA; [Hoermann, Gregor] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Rivera, Sharon A.; Lieu, Yen K.; Mukherjee, Siddhartha] Columbia Univ, Irving Canc Res Ctr, New York, NY 10027 USA; [Sperr, Wolfgang R.; Staber, Philipp B.] Med Univ Vienna, Comprehens Canc Ctr Vienna, Div Hematol & Hemostaseol, Vienna, Austria; [Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, 1275 York Ave, New York, NY 10021 USA; [Mason, Christopher E.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Mason, Christopher E.] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Tallman, Martin S.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Genet & Antiinfect, Vienna, Austria; [Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Paietta, Elisabeth M.] Montefiore Med Ctr, Dept Oncol, 111 E 210Th St, Bronx, NY 10467 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Miami; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Memorial Sloan Kettering Cancer Center; Medical University of Vienna; Columbia University; Medical University of Vienna; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA.; Mukherjee, S (corresponding author), Columbia Univ, Irving Canc Res Ctr, New York, NY 10027 USA.; Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.; Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA.	sm3252@columbia.edu; leviner@mskcc.org	levine, ross/AAE-7658-2019; Gonen, Mithat/E-4826-2012; Sperr, Mast/V-4767-2019; Kubicek, Stefan/C-2089-2017; Staber, Philipp Bernhard/ADK-1536-2022; Melnick, Ari/AAA-5763-2020; Mason, Christopher/HCH-3977-2022; Arcila, Maria/ABE-2235-2021; Mohanty, Abhinita S/AAM-7687-2020; Krivtsov, Andrei/AAJ-9966-2021; Hoermann, Gregor/B-8832-2016	Gonen, Mithat/0000-0001-8683-8477; Sperr, Mast/0000-0002-7778-5219; Kubicek, Stefan/0000-0003-0855-8343; Staber, Philipp Bernhard/0000-0001-6729-7708; Sperr, Wolfgang/0000-0003-3288-8027; Krivtsov, Andrei/0000-0002-5511-1686; Hoermann, Gregor/0000-0002-7374-4380; Spitzer, Barbara/0000-0003-1603-1381; Koche, Richard/0000-0002-6820-5083; Mohanty, Abhinita/0000-0002-6876-0482; Durham, Benjamin/0000-0001-8090-5448; McKenney, Anna Sophia/0000-0003-4464-6869; Guryanova, Olga/0000-0002-6514-8466	Austrian Science Fund FWF [P 27132] Funding Source: Medline; NCI NIH HHS [U10 CA180791, U10 CA180827, K08 CA169055, UG1 CA189859, R00 CA178191, P30 CA008748, R01 CA169784, U10 CA180820, F30 CA183497, U10 CA180794, K99 CA178191, U24 CA196172, K12 CA184746] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA180791, P30CA008748, UG1CA189859, K08CA169055, F30CA183497, R00CA178191, K99CA178191, U10CA180827, U24CA196172, U10CA180794, U10CA180820, R01CA169784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1545896] Funding Source: National Science Foundation	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chen XY, 2015, J CLIN ONCOL, V33, P1258, DOI 10.1200/JCO.2014.58.3518; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; Gaidzik VI, 2013, BLOOD, V121, P4769, DOI 10.1182/blood-2012-10-461624; GANZEL C, 2014, BLOOD, V124, P1016, DOI DOI 10.1182/BLOOD.V124.21.1016.1016; Garrett-Bakelman FE, 2015, JOVE-J VIS EXP, DOI 10.3791/52246; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; HAVRE PA, 1995, CANCER RES, V55, P4420; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Ostronoff F, 2013, LEUKEMIA, V27, P238, DOI 10.1038/leu.2012.168; Othus M, 2016, LEUKEMIA, V30, P2080, DOI 10.1038/leu.2016.120; Paietta E, 2015, BEST PRACT RES CL HA, V28, P98, DOI 10.1016/j.beha.2015.10.006; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Sehgal AR, 2015, CLIN CANCER RES, V21, P1614, DOI 10.1158/1078-0432.CCR-14-0327; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tie RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093353; Walter RB, 2015, LEUKEMIA, V29, P137, DOI 10.1038/leu.2014.173; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; WESTFALL PH, 1989, J AM STAT ASSOC, V84, P780, DOI 10.2307/2289666; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895	52	154	156	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1488	+		10.1038/nm.4210	http://dx.doi.org/10.1038/nm.4210			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841873	Green Accepted			2022-12-27	WOS:000389549000028
J	Lieberman, TD; Wilson, D; Misra, R; Xiong, LL; Moodley, P; Cohen, T; Kishony, R				Lieberman, Tami D.; Wilson, Douglas; Misra, Reshma; Xiong, Lealia L.; Moodley, Prashini; Cohen, Ted; Kishony, Roy			Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis	NATURE MEDICINE			English	Article							DRUG-RESISTANT TUBERCULOSIS; TRANSMISSION; MICROEVOLUTION; HETEROGENEITY; EVOLUTION; PATHOGEN; STRAINS; PATIENT; SPUTUM; CULTIVATION	Mycobacterium tuberculosis remains a leading cause of death worldwide, especially among individuals infected with HIV1. Whereas phylogenetic analysis has revealed M. tuberculosis spread throughout history(2-5) and in local outbreaks(6-8), much less is understood about its dissemination within the body. Here we report genomic analysis of 2,693 samples collected post mortem from lung and extrapulmonary biopsies of 44 subjects in KwaZulu-Natal, South Africa, who received minimal antitubercular treatment and most of whom were HIV seropositive. We found that purifying selection occurred within individual patients, without the need for patient-to-patient transmission. Despite negative selection, mycobacteria diversified within individuals to form sublineages that co-existed for years. These sublineages, as well as distinct strains from mixed infections, were differentially distributed throughout the lung, suggesting temporary barriers to pathogen migration. As a consequence, samples taken from the upper airway often captured only a fraction of the population diversity, challenging current methods of outbreak tracing and resistance diagnostics. Phylogenetic analysis indicated that dissemination from the lungs to extrapulmonary sites was as frequent as between lung sites, supporting the idea of similar migration routes within and between organs, at least in subjects with HIV. Genomic diversity therefore provides a record of pathogen diversification and repeated dissemination across the body.	[Lieberman, Tami D.; Xiong, Lealia L.; Kishony, Roy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Lieberman, Tami D.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wilson, Douglas] Univ KwaZulu Natal, Edendale Hosp, Dept Internal Med, Pietermaritzburg, South Africa; [Misra, Reshma; Moodley, Prashini] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Infect Prevent & Control, Durban, South Africa; [Cohen, Ted] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Cohen, Ted] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Cohen, Ted] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kishony, Roy] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Kishony, Roy] Technion Israel Inst Technol, Fac Comp Sci, Haifa, Israel	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Kwazulu Natal; University of Kwazulu Natal; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Kishony, R (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Cohen, T (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Cohen, T (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.; Cohen, T (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Kishony, R (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.; Kishony, R (corresponding author), Technion Israel Inst Technol, Fac Comp Sci, Haifa, Israel.	theodore.cohen@yale.edu; rkishony@technion.ac.il		/0000-0001-5430-3937; Cohen, Ted/0000-0002-8091-7198; Xiong, Lealia/0000-0001-7636-5936	NIGMS NIH HHS [R01 GM081617, U54 GM088558] Funding Source: Medline; NIH HHS [DP2 OD006663] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617, U54GM088558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006663] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Black PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2067-2; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cleary B, 2015, NAT BIOTECHNOL, V33, P1053, DOI 10.1038/nbt.3329; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; COHN ML, 1968, AM REV RESPIR DIS, V98, P295; Colijn C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018327; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Didelot X, 2014, MOL BIOL EVOL, V31, P1869, DOI 10.1093/molbev/msu121; Eldholm V, 2016, ELIFE, V5, DOI 10.7554/eLife.16644; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Garcia de Viedma D, 2003, J INFECT DIS, V187, P695, DOI 10.1086/368368; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Jiao W, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-35; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Lee RS, 2015, P NATL ACAD SCI USA, V112, P13609, DOI 10.1073/pnas.1507071112; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Liu QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17507; MANKIEWICZ E, 1975, AM REV RESPIR DIS, V111, P307; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Ssengooba W, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1737-2; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549; World Health Organization, 2015, 20151204 WHO; Zetola NM, 2014, J INFECT DIS, V209, P1754, DOI 10.1093/infdis/jiu040	51	77	77	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1470	+		10.1038/nm.4205	http://dx.doi.org/10.1038/nm.4205			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27798613	Green Accepted			2022-12-27	WOS:000389549000025
J	Li, Y; Oosting, M; Deelen, P; Ricano-Ponce, I; Smeekens, S; Jaeger, M; Matzaraki, V; Swertz, MA; Xavier, RJ; Franke, L; Wijmenga, C; Joosten, LAB; Kumar, V; Netea, MG				Li, Yang; Oosting, Marije; Deelen, Patrick; Ricano-Ponce, Isis; Smeekens, Sanne; Jaeger, Martin; Matzaraki, Vasiliki; Swertz, Morris A.; Xavier, Ramnik J.; Franke, Lude; Wijmenga, Cisca; Joosten, Leo A. B.; Kumar, Vinod; Netea, Mihai G.			Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi (vol 22, pg 1192, 2016)	NATURE MEDICINE			English	Correction													Joosten, Leo AB/H-3138-2015; Matzaraki, Vasiliki/GZB-0509-2022; Wijmenga, Cisca/AAE-7719-2019; Smeekens, Sanne/G-8307-2011; Smeekens, Sanne/AAZ-2061-2021; Netea, Mihai/N-5155-2014; Kumar, Vinod/ABC-4866-2020; Matzaraki, Vasiliki/AAK-7880-2020; Jaeger, Martin/H-3359-2015; Ricaño-Ponce, Isis/ABC-5454-2020; Franke, Lude/P-7036-2016	Joosten, Leo AB/0000-0001-6166-9830; Matzaraki, Vasiliki/0000-0002-5852-6801; Wijmenga, Cisca/0000-0002-5635-1614; Smeekens, Sanne/0000-0002-7835-914X; Smeekens, Sanne/0000-0002-7835-914X; Kumar, Vinod/0000-0002-2775-6049; Matzaraki, Vasiliki/0000-0002-5852-6801; Jaeger, Martin/0000-0001-6994-493X; Ricaño-Ponce, Isis/0000-0002-7530-9526; Franke, Lude/0000-0002-5159-8802				Li Y, 2016, NAT MED, V22, P1192, DOI 10.1038/nm1016-1192b	1	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1192	1192		10.1038/nm1016-1192b	http://dx.doi.org/10.1038/nm1016-1192b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711068	Bronze			2022-12-27	WOS:000384872500024
J	Lee, SCW; Abdel-Wahab, O				Lee, Stanley Chun-Wei; Abdel-Wahab, Omar			Therapeutic targeting of splicing in cancer	NATURE MEDICINE			English	Review							PRE-MESSENGER-RNA; PRMT5 ARGININE METHYLTRANSFERASE; U4/U6.U5 TRI-SNRNP; SR PROTEIN; PHYSICOCHEMICAL PROPERTIES; ANTISENSE OLIGONUCLEOTIDES; ANTITUMOR SUBSTANCES; RECURRENT MUTATIONS; SOMATIC MUTATIONS; INTRON RETENTION	Recent studies have highlighted that splicing patterns are frequently altered in cancer and that mutations in genes encoding spliceosomal proteins, as well as mutations affecting the splicing of key cancer-associated genes, are enriched in cancer. In parallel, there is also accumulating evidence that several molecular subtypes of cancer are highly dependent on splicing function for cell survival. These findings have resulted in a growing interest in targeting splicing catalysis, splicing regulatory proteins, and/or specific key altered splicing events in the treatment of cancer. Here we present strategies that exist and that are in development to target altered dependency on the spliceosome, as well as aberrant splicing, in cancer. These include drugs to target global splicing in cancer subtypes that are preferentially dependent on wild-type splicing for survival, methods to alter post-translational modifications of splicing-regulating proteins, and strategies to modulate pathologic splicing events and protein-RNA interactions in cancer.	[Lee, Stanley Chun-Wei; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA.; Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA.	abdelwao@mskcc.org		Lee, Stanley/0000-0001-7110-2416	Edward P. Evans Foundation; Department of Defense Bone Marrow Failure Research Program [BM150092, W81XWH-12-1-0041]; US National Institutes of Health (NIH)-NHLBI [R01 HL128239]; Josie Robertson Investigator Program; Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; Pershing Square Sohn Cancer Research Alliance; NIH [1K08CA160647-01]; Damon Runyon Clinical Investigator Award; Starr Foundation [I8-A8-075]; NATIONAL CANCER INSTITUTE [P30CA006516, R01CA201247, P30CA008748, K08CA160647] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128239] Funding Source: NIH RePORTER	Edward P. Evans Foundation; Department of Defense Bone Marrow Failure Research Program; US National Institutes of Health (NIH)-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Josie Robertson Investigator Program; Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical Investigator Award; Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.C.-W.L. is supported by a Leukemia and Lymphoma Society (LLS) Special Fellow Award. O.A.-W. is supported by grants from the Edward P. Evans Foundation, the Department of Defense Bone Marrow Failure Research Program (BM150092 and W81XWH-12-1-0041), the US National Institutes of Health (NIH)-NHLBI (R01 HL128239), the Josie Robertson Investigator Program, the Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of MSKCC and the Pershing Square Sohn Cancer Research Alliance, as well as by an NIH K08 Clinical Investigator Award (1K08CA160647-01), a Damon Runyon Clinical Investigator Award and an award from the Starr Foundation (I8-A8-075).	Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Anczukow O, 2015, MOL CELL, V60, P105, DOI 10.1016/j.molcel.2015.09.005; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Arai K, 2014, ORG LETT, V16, P5560, DOI 10.1021/ol502556c; Araki S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116929; Aukema KG, 2009, ACS CHEM BIOL, V4, P759, DOI 10.1021/cb900090z; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Castanotto D, 2014, CURR OPIN ONCOL, V26, P584, DOI 10.1097/CCO.0000000000000127; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen L, 2011, HUM MOL GENET, V20, P4422, DOI 10.1093/hmg/ddr370; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Danan-Gotthold M, 2015, NUCLEIC ACIDS RES, V43, P5130, DOI 10.1093/nar/gkv210; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DeBoever C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004105; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9; Effenberger KA, 2016, RNA, V22, P350, DOI 10.1261/rna.053108.115; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Ilagan JO, 2015, GENOME RES, V25, P14, DOI 10.1101/gr.181016.114; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue D, 2016, GENE DEV, V30, P989, DOI 10.1101/gad.278424.116; Iwata Masao, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P691; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Jung- H, 2015, NAT GENET, V47, P1242, DOI 10.1038/ng.3414; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kim H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094978, 10.1371/journal.pone.0098043]; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Lagisetti C, 2014, ACS CHEM BIOL, V9, P643, DOI 10.1021/cb400695j; Lagisetti C, 2013, J MED CHEM, V56, P10033, DOI 10.1021/jm401370h; Lai MC, 2003, BIOCHEM J, V371, P937, DOI 10.1042/BJ20021827; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Liu XY, 2013, J NAT PROD, V76, P685, DOI 10.1021/np300913h; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Ma PC, 2003, CANCER RES, V63, P6272; Mandel AL, 2007, BIOORG MED CHEM LETT, V17, P5159, DOI 10.1016/j.bmcl.2007.06.094; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; McClorey G, 2015, CURR OPIN PHARMACOL, V24, P52, DOI 10.1016/j.coph.2015.07.005; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pilch B, 2001, CANCER RES, V61, P6876; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Rzymski T, 2008, CYTOGENET GENOME RES, V121, P232, DOI 10.1159/000138890; Sakai T, 2004, J ANTIBIOT, V57, P173, DOI 10.7164/antibiotics.57.173; Sakai T, 2004, J ANTIBIOT, V57, P180, DOI 10.7164/antibiotics.57.180; Sakai Y, 2002, J ANTIBIOT, V55, P855, DOI 10.7164/antibiotics.55.855; Salton M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8103; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; SEKIASANO M, 1994, J ANTIBIOT, V47, P1395, DOI 10.7164/antibiotics.47.1395; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Shirai CL, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.1653.1653; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Siqueira RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134882; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Thompson CF, 2001, J AM CHEM SOC, V123, P9974, DOI 10.1021/ja016615t; Visconte V, 2015, LEUKEMIA, V29, P188, DOI 10.1038/leu.2014.170; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zanetta C, 2014, CLIN THER, V36, P128, DOI 10.1016/j.clinthera.2013.11.006; Zhang J, 2015, P NATL ACAD SCI USA, V112, pE4726, DOI 10.1073/pnas.1514105112; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253; Zhou QH, 2015, CANCER RES, V75, P1949, DOI 10.1158/0008-5472.CAN-14-2930; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	114	316	326	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					976	986		10.1038/nm.4165	http://dx.doi.org/10.1038/nm.4165			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27603132	Green Accepted			2022-12-27	WOS:000382542800007
J	Nolan, E; Vaillant, F; Branstetter, D; Pal, B; Giner, G; Whitehead, L; Lok, SW; Mann, GB; Rohrbach, K; Huang, LY; Soriano, R; Smyth, GK; Dougall, WC; Visvader, JE; Lindeman, GJ				Nolan, Emma; Vaillant, Francois; Branstetter, Daniel; Pal, Bhupinder; Giner, Goeknur; Whitehead, Lachlan; Lok, Sheau W.; Mann, Gregory B.; Rohrbach, Kathy; Huang, Li-Ya; Soriano, Rosalia; Smyth, Gordon K.; Dougall, William C.; Visvader, Jane E.; Lindeman, Geoffrey J.		Kathleen Cuningham Fdn Consortium	RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers	NATURE MEDICINE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MAMMARY EPITHELIAL-CELLS; BRCA2 MUTATION CARRIERS; RISK-REDUCING SURGERY; STEM-CELL; TUMOR-DEVELOPMENT; OVARIAN-CANCER; GLAND; MICE; PROLIFERATION	Individuals who have mutations in the breast-cancer-susceptibility gene BRCA1 (hereafter referred to as BRCA1-mutation carriers) frequently undergo prophylactic mastectomy to minimize their risk of breast cancer. The identification of an effective prevention therapy therefore remains a 'holy grail' for the field. Precancerous BRCA1(mut/+) tissue harbors an aberrant population of luminal progenitor cells1, and deregulated progesterone signaling has been implicated in BRCA1-associated oncogenesis(2-5). Coupled with the findings that tumor necrosis factor superfamily member 11 (TNFSF11; also known as RANKL) is a key paracrine effector of progesterone signaling(6-10) and that RANKL and its receptor TNFRSF11A (also known as RANK) contribute to mammary tumorigenesis(11-13), we investigated a role for this pathway in the pre-neoplastic phase of BRCA1-mutation carriers. We identified two subsets of luminal progenitors (RANK(+) and RANK-) in histologically normal tissue of BRCA1-mutation carriers and showed that RANK+ cells are highly proliferative, have grossly aberrant DNA repair and bear a molecular signature similar to that of basal-like breast cancer. These data suggest that RANK+ and not RANK-progenitors are a key target population in these women. Inhibition of RANKL signaling by treatment with denosumab in three-dimensional breast organoids derived from pre-neoplastic BRCA1mut/+ tissue attenuated progesterone-induced proliferation. Notably, proliferation was markedly reduced in breast biopsies from BRCA1-mutation carriers who were treated with denosumab. Furthermore, inhibition of RANKL in a Brca1-deficient mouse model substantially curtailed mammary tumorigenesis. Taken together, these findings identify a targetable pathway in a putative cell-of-origin population in BRCA1-mutation carriers and implicate RANKL blockade as a promising strategy in the prevention of breast cancer.	[Nolan, Emma; Vaillant, Francois; Pal, Bhupinder; Lok, Sheau W.; Visvader, Jane E.; Lindeman, Geoffrey J.] Walter & Eliza Hall Inst Med Res WEHI, ACRF Stem Cells & Canc Div, Parkville, Vic, Australia; [Nolan, Emma; Vaillant, Francois; Pal, Bhupinder; Giner, Goeknur; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Branstetter, Daniel; Rohrbach, Kathy; Huang, Li-Ya; Soriano, Rosalia] Amgen Inc, Dept Pathol, Seattle, WA USA; [Giner, Goeknur; Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Whitehead, Lachlan] Walter & Eliza Hall Inst Med Res, Syst Biol & Personalized Med Div, Imaging Lab, Parkville, Vic, Australia; [Lok, Sheau W.; Lindeman, Geoffrey J.] Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic, Australia; [Lok, Sheau W.; Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic, Australia; [Mann, Gregory B.] Royal Melbourne Hosp, Breast Serv, Parkville, Vic, Australia; [Mann, Gregory B.] Royal Womens Hosp, Parkville, Vic, Australia; [Mann, Gregory B.] Univ Melbourne, Dept Surg, Parkville, Vic, Australia; [Kathleen Cuningham Fdn Consortium] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic, Australia; [Dougall, William C.] Amgen Inc, Therapeut Innovat Unit, Seattle, WA USA; [Lindeman, Geoffrey J.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Lindeman, Geoffrey J.] Victorian Comprehens Canc Ctr, Familial Canc Ctr, Parkville, Vic, Australia; [Branstetter, Daniel] Cynosure Clin Res LLC, North Bend, WA USA; [Dougall, William C.] Queensland Inst Med Res, Berghofer Med Res Inst, Herston, Qld, Australia	University of Melbourne; Amgen; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Amgen; University of Melbourne; QIMR Berghofer Medical Research Institute	Visvader, JE; Lindeman, GJ (corresponding author), Walter & Eliza Hall Inst Med Res WEHI, ACRF Stem Cells & Canc Div, Parkville, Vic, Australia.; Visvader, JE (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.; Lindeman, GJ (corresponding author), Victorian Comprehens Canc Ctr, Familial Canc Ctr, Parkville, Vic, Australia.	visvader@wehi.edu.au; lindeman@wehi.edu.au	Smyth, Gordon/B-5276-2008; Pal, Bhupinder/AAF-4011-2020	Smyth, Gordon/0000-0001-9221-2892; Nolan, Emma/0000-0001-8093-8733; Pal, Bhupinder/0000-0002-3684-4331; Thorne, Heather/0000-0003-3610-2511; Dougall, William/0000-0001-9487-251X; Lindeman, Geoffrey/0000-0001-9386-2416	Victorian Government; Australian National Health and Medical Research Council (NHMRC) [1016701, 1040978, 1054618]; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS); Victorian State Government through the Victorian Cancer Agency; Victorian State Government through Operational Infrastructure Support; National Breast Cancer Foundation (Australia) [NC-13-32, PS-15-042]; Amgen Inc.; Qualtrough Cancer Research Fund; Joan Marshall Breast Cancer Research Fund; Australian Cancer Research Foundation; Cancer Council Victoria Scholarship; Cancer Therapeutics CRC Top-Up Scholarship; VCA Early Career Seed Grant [13035]; NHMRC Fellowships [1058892, 637307, 1078730]; NHMRC Australia Fellowship [1037230]; National Breast Cancer Foundation [IF-12-06, NC-13-32, PS-15-042, In-15-071] Funding Source: researchfish	Victorian Government; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government through the Victorian Cancer Agency; Victorian State Government through Operational Infrastructure Support; National Breast Cancer Foundation (Australia); Amgen Inc.(Amgen); Qualtrough Cancer Research Fund; Joan Marshall Breast Cancer Research Fund; Australian Cancer Research Foundation; Cancer Council Victoria Scholarship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Therapeutics CRC Top-Up Scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); VCA Early Career Seed Grant; NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	We are grateful to the women who generously donated breast tissue for our studies and to the surgical, pathology and tissue bank colleagues for their substantial assistance and support. We thank L. Taylor, K. Shackleton, S. Nightingale and H. Liu for expert assistance; the Animal, FACS, Imaging and Histology facilities at WEHI; C. Perou and K. Hoadley for kind provision of the PAM50 subtypes; and A. Y. Rhee (Amgen Inc.) for assistance with the manuscript submission. We are grateful to H. Thorne and all kConFab staff, members and families for their contributions to this resource and to the Victorian Cancer Biobank (supported by the Victorian Government), which also provided coded breast tissue and data. We thank H. Yasuda for advice on the antibody to mouse RANKL and K. U. Wagner (Eppley Institute, Nebraska) for MMTV-Cre A mice. This work was supported by the Australian National Health and Medical Research Council (NHMRC) (grant numbers 1016701 (J.E.V. and G.J.L.), 1040978 (G.B.M., J.E.V. and G.J.L.) and 1054618 (G.K.S.)), NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS) (to WEHI; E.N., F.V., B.P., G.G., L.W., S.W.L., G.K.S., J.E.V. and G.J.L.), the Victorian State Government through the Victorian Cancer Agency and Operational Infrastructure Support, the National Breast Cancer Foundation (Australia) (grant numbers NC-13-32 and PS-15-042; to J.E.V. and G.J.L.); Amgen Inc. (J.E.V. and G.J.L.), the Qualtrough Cancer Research Fund (J.E.V. and G.J.L.), the Joan Marshall Breast Cancer Research Fund (J.E.V. and G.J.L.) and the Australian Cancer Research Foundation (to WEHI; E.N., F.V., B.P., G.G., L.W., S.W.L., G.K.S., J.E.V. and G.J.L.). E.N. is supported by a Cancer Council Victoria Scholarship and a Cancer Therapeutics CRC Top-Up Scholarship; B.P. is supported by a VCA Early Career Seed Grant 13035; G.K.S. and G.J.L. are supported by NHMRC Fellowships 1058892 (G.K.S.), 637307 (G.J.L.) and 1078730 (G.J.L.); and J.E.V. is supported by NHMRC Australia Fellowship 1037230.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Fernandez-Valdivia R, 2012, MOL CELL ENDOCRINOL, V357, P91, DOI 10.1016/j.mce.2011.09.030; Fu NY, 2015, NAT CELL BIOL, V17, P365, DOI 10.1038/ncb3117; Gnant M, 2015, LANCET, V386, P433, DOI 10.1016/S0140-6736(15)60995-3; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Hartmann LC, 2016, NEW ENGL J MED, V374, P454, DOI 10.1056/NEJMra1503523; Heemskerk-Gerritsen BA, 2015, JNCI-J NATL CANCER I, V107, P107; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Joshi PA, 2015, STEM CELL REP, V5, P31, DOI 10.1016/j.stemcr.2015.05.012; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; King TA, 2004, CANCER RES, V64, P5051, DOI 10.1158/0008-5472.CAN-04-1283; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Pal B, 2013, CELL REP, V3, P411, DOI 10.1016/j.celrep.2012.12.020; Pasquale P, 2013, STEM CELLS, V31, P1954, DOI 10.1002/stem.1454; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips KA, 2014, FUTURE ONCOL, V10, P499, DOI 10.2217/fon.13.278; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Sedic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8505; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; To C, 2014, CANCER PREV RES, V7, P698, DOI 10.1158/1940-6207.CAPR-14-0047; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Widschwendter M, 2013, LANCET ONCOL, V14, P1226, DOI 10.1016/S1470-2045(13)70448-0; Wood CE, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3456; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	54	167	170	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					933	+		10.1038/nm.4118	http://dx.doi.org/10.1038/nm.4118			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27322743				2022-12-27	WOS:000381000200019
J	Ishizuka, AS; Lyke, KE; DeZure, A; Berry, AA; Richie, TL; Mendoza, FH; Enama, ME; Gordon, IJ; Chang, LJ; Sarwar, UN; Zephir, KL; Holman, LA; James, ER; Billingsley, PF; Gunasekera, A; Chakravarty, S; Manoj, A; Li, ML; Ruben, AJ; Li, T; Eappen, AG; Stafford, RE; Natasha, KC; Murshedkar, T; DeCederfelt, H; Plummer, SH; Hendel, CS; Novik, L; Costner, PJM; Saunders, JG; Laurens, MB; Plowe, CV; Flynn, B; Whalen, WR; Todd, JP; Noor, J; Rao, S; Sierra-Davidson, K; Lynn, GM; Epstein, JE; Kemp, MA; Fahle, GA; Mikolajczak, SA; Fishbaugher, M; Sack, BK; Kappe, SHI; Davidson, SA; Garver, LS; Bjorkstrom, NK; Nason, MC; Graham, BS; Roederer, M; Sim, BKL; Hoffman, SL; Ledgerwood, JE; Seder, RA				Ishizuka, Andrew S.; Lyke, Kirsten E.; DeZure, Adam; Berry, Andrea A.; Richie, Thomas L.; Mendoza, Floreliz H.; Enama, Mary E.; Gordon, Ingelise J.; Chang, Lee-Jah; Sarwar, Uzma N.; Zephir, Kathryn L.; Holman, LaSonji A.; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Chakravarty, Sumana; Manoj, Anita; Li, MingLin; Ruben, Adam J.; Li, Tao; Eappen, Abraham G.; Stafford, Richard E.; Natasha, K. C.; Murshedkar, Tooba; DeCederfelt, Hope; Plummer, Sarah H.; Hendel, Cynthia S.; Novik, Laura; Costner, Pamela J. M.; Saunders, Jamie G.; Laurens, Matthew B.; Plowe, Christopher V.; Flynn, Barbara; Whalen, William R.; Todd, J. P.; Noor, Jay; Rao, Srinivas; Sierra-Davidson, Kailan; Lynn, Geoffrey M.; Epstein, Judith E.; Kemp, Margaret A.; Fahle, Gary A.; Mikolajczak, Sebastian A.; Fishbaugher, Matthew; Sack, Brandon K.; Kappe, Stefan H. I.; Davidson, Silas A.; Garver, Lindsey S.; Bjorkstrom, Niklas K.; Nason, Martha C.; Graham, Barney S.; Roederer, Mario; Sim, B. Kim Lee; Hoffman, Stephen L.; Ledgerwood, Julie E.; Seder, Robert A.		VRC 312& VRC Study Teams	Protection against malaria at 1 year and immune correlates following PfSPZ vaccination	NATURE MEDICINE			English	Article							DELTA T-CELLS; MONOCLONAL-ANTIBODIES; SPOROZOITE VACCINE; PLASMODIUM-YOELII; IMMUNIZATION; MICE; MEMORY; ENHANCEMENT; ELIMINATION; INTERFERON	An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown. We assessed how vaccine dosage, regimen, and route of administration affected durable protection in malaria-naive adults. After four intravenous immunizations with 2.7 x 10(5) PfSPZ, 6/11 (55%) vaccinated subjects remained without parasitemia following CHMI 21 weeks after immunization. Five non-parasitemic subjects from this dosage group underwent repeat CHMI at 59 weeks, and none developed parasitemia. Although Pf-specific serum antibody levels correlated with protection up to 21-25 weeks after immunization, antibody levels waned substantially by 59 weeks. Pf-specific T cell responses also declined in blood by 59 weeks. To determine whether T cell responses in blood reflected responses in liver, we vaccinated nonhuman primates with PfSPZ Vaccine. Pf-specific interferon-g-producing CD8 T cells were present at similar to 100-fold higher frequencies in liver than in blood. Our findings suggest that PfSPZ Vaccine conferred durable protection to malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection.	[Ishizuka, Andrew S.; DeZure, Adam; Mendoza, Floreliz H.; Enama, Mary E.; Gordon, Ingelise J.; Chang, Lee-Jah; Sarwar, Uzma N.; Zephir, Kathryn L.; Holman, LaSonji A.; Plummer, Sarah H.; Hendel, Cynthia S.; Novik, Laura; Costner, Pamela J. M.; Saunders, Jamie G.; Flynn, Barbara; Whalen, William R.; Todd, J. P.; Noor, Jay; Rao, Srinivas; Sierra-Davidson, Kailan; Lynn, Geoffrey M.; Graham, Barney S.; Roederer, Mario; Ledgerwood, Julie E.; Seder, Robert A.] NIAID, VRC, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lyke, Kirsten E.; Berry, Andrea A.; Laurens, Matthew B.; Plowe, Christopher V.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Lyke, Kirsten E.; Berry, Andrea A.; Laurens, Matthew B.; Plowe, Christopher V.] Univ Maryland, Sch Med, Div Malaria Res, Baltimore, MD 21201 USA; [Richie, Thomas L.; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Chakravarty, Sumana; Manoj, Anita; Li, MingLin; Ruben, Adam J.; Li, Tao; Eappen, Abraham G.; Stafford, Richard E.; Natasha, K. C.; Murshedkar, Tooba; Sim, B. Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Li, MingLin; Stafford, Richard E.; Natasha, K. C.; Sim, B. Kim Lee] Prot Potential LLC, Rockville, MD USA; [DeCederfelt, Hope] NIH, Ctr Clin, Pharmaceut Dev Sect, Bethesda, MD 20892 USA; [Epstein, Judith E.] NMRC, Malaria Dept, Silver Spring, MD USA; [Kemp, Margaret A.; Fahle, Gary A.] NIH, Ctr Clin, Dept Lab Med, Bethesda, MD 20892 USA; [Mikolajczak, Sebastian A.; Fishbaugher, Matthew; Sack, Brandon K.; Kappe, Stefan H. I.] Ctr Infect Dis Res, Seattle, WA USA; [Davidson, Silas A.; Garver, Lindsey S.] Walter Reed Army Inst Res, Entomol Branch, Silver Spring, MD USA; [Bjorkstrom, Niklas K.] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chang, Lee-Jah] Sanofi, Swiftwater, PA USA; [Sarwar, Uzma N.] Montefiore Med Ctr, Albert Einstein Coll Med, New York, NY USA; [Rao, Srinivas] Sanofi, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Sanaria Inc.; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sanofi-Aventis; Montefiore Medical Center; Yeshiva University; Sanofi-Aventis	Seder, RA (corresponding author), NIAID, VRC, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@mail.nih.gov	Björkström, Niklas/N-2919-2017; Laurens, Matthew/E-7293-2013; Graham, Barney S./AAC-5898-2019; Roederer, Mario/G-1887-2011	Björkström, Niklas/0000-0002-0967-076X; Laurens, Matthew/0000-0003-3874-581X; Graham, Barney S./0000-0001-8112-0853; Chang, Lee-Jah/0000-0003-1766-3153; Berry, Andrea/0000-0003-3140-3868; Richie, Thomas/0000-0002-2946-5456; Mikolajczak, Sebastian/0000-0003-1996-9703; Ishizuka, Andrew/0000-0002-3024-7536	VRC, NIAID, NIH; NIAID [5R44AI055229-11, 5R44AI058499-08, 5R44AI058375-08]; Bill and Melinda Gates Foundation [24922];  [6000.RADI.F.A0309]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005021, ZICAI005103, F32AI114113, R44AI058499, ZIAAI005047, R44AI055229, ZIAAI005107, ZICAI005101, R44AI058375] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF14OC0009347] Funding Source: researchfish	VRC, NIAID, NIH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank the vaccine trials participants for their contribution and commitment to vaccine research. We acknowledge the contributions of: our US National Institutes of Health (NIH) Clinical Center (CC) and National Institute of Allergy and Infectious Diseases (NIAID) colleagues, especially J. Stein, J. Pierson, R. Eckes, P. Driscoll, L. Ediger, and the nursing staff of the 5NW, SCSU, 5SE-S, and 5SE-N units; our VRC colleagues, especially A. Mittelman, H. Harvey, M. Young, C. Artis, R. Hicks, P. Darrah, and T. Abram; our Sanaria and Protein Potential colleagues, especially Y. Abebe, J. Jackson, A. Awe, M. King, H. Huang, A. Patil, S. Matheny, J. Overby, Y. Wen, K. Nelson, V. Pich, M. Orozco, D. Padilla, E. Saverino, B. Jiang, L. Gao, R. Xu, E. Fomumbod, M. Laskowski, T. T. Wai, F. Beams, R. Thompson, and A. Hoffman for administrative, operations, and legal support, and T. Luke for insight and inspiration; the EMMES Corporation; the NIAID Institutional Review Board; the NIAID Office of Communications and Government Relations; the NIH CC Department of Laboratory Medicine; the NIH CC IND Pharmacy, and the NIH CC Patient Recruitment and Public Liaison Office. We appreciate the expert reviews of the Safety Monitoring Committee (A. Durbin, K. Kester, and A. Cross) and the assistance from the US Military Malaria Vaccine Program, the Walter Reed Army Institute of Research Entomology Branch, and the Naval Medical Research Center (NMRC), especially A. Reyes, Y. Alcorta, G. Banania, C. Fedders, M. Dowler, T. Savransky, D. Patel, C. Brando, K. Kobylinski, and K. Walker. This work was supported by the intramural research program of the VRC, NIAID, NIH. Production and characterization of the PfSPZ Vaccine were supported in part by NIAID Small Business Innovation Research grants 5R44AI055229-11 (S. L. H.), 5R44AI058499-08 (S. L. H.), and 5R44AI058375-08 (S. L. H.). The humanized mouse experiments reported here were funded by the Bill and Melinda Gates Foundation (Investment ID: 24922; to S. H. I. K.). The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency or collaborators. The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of the Army, the Department of Defense, or the US Government. This work was supported in part by work unit number 6000.RADI.F.A0309 to NMRC. J. E. E. and S. A. D. are military service members, and this work was prepared as part of their official duties. Title 17 U.S.C. $101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties.	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P58, DOI 10.1038/cmi.2012.46; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Food and Drug Administration (FDA), 2007, GUID IND TOX GRAD SC; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Hoffman SL, 2015, VACCINE, V33, pD13, DOI 10.1016/j.vaccine.2015.07.091; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Inoue SI, 2012, P NATL ACAD SCI USA, V109, P12129, DOI 10.1073/pnas.1204480109; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; KRAMER LD, 1975, AM J TROP MED HYG, V24, P913, DOI 10.4269/ajtmh.1975.24.913; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; LeCluyse EL, 2010, METHODS MOL BIOL, V640, P57, DOI 10.1007/978-1-60761-688-7_3; Lyke KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013490; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112; Miller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060820; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; National Research Council, 2011, GUIDE CARE USE LAB A; Nganou-Makamdop K, 2012, PARASITE IMMUNOL, V34, P562, DOI 10.1111/pim.12000.x; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Sack BK, 2014, INFECT IMMUN, V82, P808, DOI 10.1128/IAI.01249-13; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tse SW, 2013, GENES IMMUN, V14, P302, DOI 10.1038/gene.2013.20; Tse SW, 2014, J INFECT DIS, V210, P1508, DOI 10.1093/infdis/jiu281; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; World Health Organization, 2015, ORGANIZATION	49	222	225	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					614	+		10.1038/nm.4110	http://dx.doi.org/10.1038/nm.4110			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158907	Green Published			2022-12-27	WOS:000377476000014
J	Joyal, JS; Sun, Y; Gantner, ML; Shao, Z; Evans, LP; Saba, N; Fredrick, T; Burnim, S; Kim, JS; Patel, G; Juan, AM; Hurst, CG; Hatton, CJ; Cui, ZH; Pierce, KA; Bherer, P; Aguilar, E; Powner, MB; Vevis, K; Boisvert, M; Fu, ZJ; Levy, E; Fruttiger, M; Packard, A; Rezende, FA; Maranda, B; Sapieha, P; Chen, J; Friedlander, M; Clish, CB; Smith, LEH				Joyal, Jean-Sebastien; Sun, Ye; Gantner, Marin L.; Shao, Zhuo; Evans, Lucy P.; Saba, Nicholas; Fredrick, Thomas; Burnim, Samuel; Kim, Jin Sung; Patel, Gauri; Juan, Aimee M.; Hurst, Christian G.; Hatton, Colman J.; Cui, Zhenghao; Pierce, Kerry A.; Bherer, Patrick; Aguilar, Edith; Powner, Michael B.; Vevis, Kristis; Boisvert, Michel; Fu, Zhongjie; Levy, Emile; Fruttiger, Marcus; Packard, Alan; Rezende, Flavio A.; Maranda, Bruno; Sapieha, Przemyslaw; Chen, Jing; Friedlander, Martin; Clish, Clary B.; Smith, Lois E. H.			Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1 (vol 22, pg 439, 2016)	NATURE MEDICINE			English	Correction													Powner, Michael/CAG-7455-2022; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Fruttiger, Marcus/0000-0002-6962-5485; Juan, Aimee/0000-0002-0221-2280; Powner, Michael/0000-0003-4913-1004				Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059	1	4	4	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					692	692		10.1038/nm0616-692a	http://dx.doi.org/10.1038/nm0616-692a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270778	Bronze			2022-12-27	WOS:000377476000015
J	Marsland, BJ				Marsland, Benjamin J.			Regulating inflammation with microbial metabolites	NATURE MEDICINE			English	Editorial Material							BOWEL-DISEASE; INNATE; GUT	Two new studies in mice show that the gut microbiota produces metabolites from dietary tryptophan that regulate inflammation in the gut and central nervous system.	[Marsland, Benjamin J.] Univ Lausanne, Fac Biol & Med, Serv Pneumol, CHU Vaudois, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marsland, BJ (corresponding author), Univ Lausanne, Fac Biol & Med, Serv Pneumol, CHU Vaudois, Lausanne, Switzerland.	benjamin.marsland@chuv.ch		Marsland, Benjamin/0000-0003-1457-3160				Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	11	44	48	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					581	583		10.1038/nm.4117	http://dx.doi.org/10.1038/nm.4117			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270775				2022-12-27	WOS:000377476000008
J	Becker, R				Becker, Rachel			Beyond building proteins: tRNA synthetases outside of translation	NATURE MEDICINE			English	News Item																		Fang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7402; Fox PL, 2015, RNA, V21, P615, DOI 10.1261/rna.050187.115; Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kim D, 2014, TOP CURR CHEM, V344, P207, DOI 10.1007/128_2013_455; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Mirando AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13160; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wellman TL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-620; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhou JJ, 2014, J BIOL CHEM, V289, P19269, DOI 10.1074/jbc.C114.571026	14	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					452	453		10.1038/nm0516-452	http://dx.doi.org/10.1038/nm0516-452			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149213				2022-12-27	WOS:000375514000003
J	Gautam, R; Nishimura, Y; Gaughan, N; Gazumyan, A; Schoofs, T; Buckler-White, A; Seaman, MS; Swihart, BJ; Follmann, DA; Nussenzweig, MC; Martin, MA				Gautam, Rajeev; Nishimura, Yoshiaki; Gaughan, Natalie; Gazumyan, Anna; Schoofs, Till; Buckler-White, Alicia; Seaman, Michael S.; Swihart, Bruce J.; Follmann, Dean A.; Nussenzweig, Michel C.; Martin, Malcolm A.			A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection	NATURE MEDICINE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; GLYCAN RECOGNITION; HIV-1 ANTIBODY; POTENT; THERAPY; VIREMIA; HUMANS; VRC01	In the absence of an effective and safe vaccine against HIV-1, the administration of broadly neutralizing antibodies (bNAbs) represents a logical alternative approach to prevent virus transmission. Here, we introduced two mutations encoding amino acid substitutions (M428L and N434S, collectively referred to as 'LS') into the genes encoding the crystallizable fragment domains of the highly potent HIV-specific 3BNC117 and 10-1074 bNAbs to increase their half-lives and evaluated their efficacy in blocking infection following repeated low-dose mucosal challenges of rhesus macaques (Macaca mulatta) with the tier 2 SHIVAD8-EO. A single intravenous infusion of 10-1074-LS monoclonal antibodies markedly delayed virus acquisition for 18 to 37 weeks (median, 27 weeks), whereas the protective effect of the 3BNC117-LS bNAb was more modest (provided protection for 11-23 weeks; median, 17 weeks). Serum concentrations of the 10-1074-LS monoclonal antibody gradually declined and became undetectable in all recipients between weeks 26 and 41, whereas the 3BNC117-LS bNAb exhibited a shorter half-life. To model immunoprophylaxis against genetically diverse and/or neutralization-resistant HIV-1 strains, a combination of the 3BNC117-LS plus 10-1074-LS monoclonal antibodies was injected into macaques via the more clinically relevant subcutaneous route. Even though the administered mixture contained an amount of each bNAb that was nearly threefold less than the quantity of the single monoclonal antibody in the intravenous injections, the monoclonal antibody combination still protected macaques for a median of 20 weeks. The extended period of protection observed in macaques for the 3BNC117-LS plus 10-1074-LS combination could translate into an effective semiannual or annual immunoprophylaxis regimen for preventing HIV-1 infections in humans.	[Gautam, Rajeev; Nishimura, Yoshiaki; Gaughan, Natalie; Buckler-White, Alicia; Martin, Malcolm A.] NIAID, Lab Mol Microbiol, NIH, Bethesda, MD 20892 USA; [Gazumyan, Anna; Schoofs, Till; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Swihart, Bruce J.; Follmann, Dean A.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Rockefeller University	Martin, MA (corresponding author), NIAID, Lab Mol Microbiol, NIH, Bethesda, MD 20892 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	nussen@rockefeller.edu; malm@nih.gov	Nussenzweig, Michel/AAE-7292-2019		Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grants [OPP1033115, OPP1092074]; NIH [AI-100148, UM1 AI100663-01]; Robertson Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, R01AI129795, ZIAAI001213, UM1AI100663] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Plishka, A. Peach, P. King and O. Abegunrin for determining plasma viral RNA loads and R. Engel, R. Petros, Nero Ramera, B. Ahlin and M. Boursiquot for diligently assisting in the maintenance of animals and assisting with procedures. We thank National Institutes of Health (NIH) AIDS Research and Reference Reagent Program for TZM-bl and HEK293 T cells. This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH. The research was also funded in part by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grants OPP1033115 and OPP1092074 (to M.C.N.) and by the NIH under award numbers AI-100148 and UM1 AI100663-01. M.C.N. is supported by the Robertson Foundation and Howard Hughes Medical Institute.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Gruell H, 2013, J VIROL, V87, P8535, DOI 10.1128/JVI.00868-13; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julg B, 2017, J VIROL, V91, DOI 10.1128/JVI.00498-17; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	36	72	72	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					610	+		10.1038/s41591-018-0001-2	http://dx.doi.org/10.1038/s41591-018-0001-2			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29662199	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000432126800018
J	Zhang, ZZ; Zi, ZZ; Lee, EE; Zhao, JW; Contreras, DC; South, AP; Abel, ED; Chong, BF; Vandergriff, T; Hosler, GA; Scherer, PE; Mettlen, M; Rathmell, JC; DeBerardinis, RJ; Wang, RC				Zhang, Zhuzhen; Zi, Zhenzhen; Lee, Eunice E.; Zhao, Jiawei; Contreras, Diana C.; South, Andrew P.; Abel, E. Dale; Chong, Benjamin F.; Vandergriff, Travis; Hosler, Gregory A.; Scherer, Philipp E.; Mettlen, Marcel; Rathmell, Jeffrey C.; DeBerardinis, Ralph J.; Wang, Richard C.			Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis	NATURE MEDICINE			English	Article							PENTOSE-PHOSPHATE PATHWAY; TNF-ALPHA TREATMENT; T-CELL-ACTIVATION; HUMAN LUNG-TUMORS; TRANSPORTER GLUT1; IN-VITRO; EPIDERMAL-KERATINOCYTES; OXIDATIVE STRESS; UP-REGULATION; CANCER-CELLS	Proliferating cells, compared with quiescent cells, are more dependent on glucose for their growth. Although glucose transport in keratinocytes is mediated largely by the Glut1 facilitative transporter, we found that keratinocyte-specific ablation of Glut1 did not compromise mouse skin development and homeostasis. Ex vivo metabolic profiling revealed altered sphingolipid, hexose, amino acid, and nucleotide metabolism in Glut1-deficient keratinocytes, thus suggesting metabolic adaptation. However, cultured Glut1-deficient keratinocytes displayed metabolic and oxidative stress and impaired proliferation. Similarly, Glut1 deficiency impaired in vivo keratinocyte proliferation and migration within wounded or UV-damaged mouse skin. Notably, both genetic and pharmacological Glut1 inactivation decreased hyperplasia in mouse models of psoriasis-like disease. Topical application of a Glut1 inhibitor also decreased inflammation in these models. Glut1 inhibition decreased the expression of pathology-associated genes in human psoriatic skin organoids. Thus, Glut1 is selectively required for injury-and inflammation-associated keratinocyte proliferation, and its inhibition offers a novel treatment strategy for psoriasis.	[Zhang, Zhuzhen; Lee, Eunice E.; Zhao, Jiawei; Chong, Benjamin F.; Vandergriff, Travis; Hosler, Gregory A.; Wang, Richard C.] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA; [Zi, Zhenzhen] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA; [Contreras, Diana C.; Rathmell, Jeffrey C.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [South, Andrew P.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Abel, E. Dale] Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Abel, E. Dale] Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Endocrinol & Metab, Iowa City, IA USA; [Hosler, Gregory A.] ProPath, Dallas, TX USA; [Scherer, Philipp E.] UT Southwestern Med Ctr, Touchstone Diabet Ctr, Dept Internal Med, Dallas, TX USA; [Scherer, Philipp E.; Mettlen, Marcel] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA; [DeBerardinis, Ralph J.] UT Southwestern Med Ctr, Childrens Med Ctr Res Inst, Dallas, TX USA; [DeBerardinis, Ralph J.] UT Southwestern Med Ctr, Dept Pediat, Dallas, TX USA; [DeBerardinis, Ralph J.] UT Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Jefferson University; University of Iowa; University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, RC (corresponding author), UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA.	richard.wang@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; Wang, Richard/AAW-3066-2021; Mettlen, Marcel B/A-2357-2011; Zhao, Jiawei/AAV-1778-2020	Scherer, Philipp E/0000-0003-0680-3392; Wang, Richard/0000-0003-4543-8295; Mettlen, Marcel B/0000-0001-7047-2749; Zhao, Jiawei/0000-0003-0682-4601; Contreras Healey, Diana C/0000-0001-6981-8386; Abel, E. Dale/0000-0001-5290-0738; Zhang, Zhuzhen/0000-0001-6787-3920	NCI [R35 CA220449-01]; Welch Foundation [I-1733-06]; NIAMS [K23AR061441, 1R01AR072655]; NIDDK [DK10550]; Burroughs Wellcome Fund CAMS [1010978]; American Cancer Society/Simmons Cancer Center [ACS-IRG-02-196]; NATIONAL CANCER INSTITUTE [R35CA220449, K08CA164047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR061441, R01AR072655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Burroughs Wellcome Fund CAMS(Burroughs Wellcome Fund); American Cancer Society/Simmons Cancer Center(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the R. Gordillo for help with lipidomic studies; C. Yang, J. Sudderth, L. Zacharias, and J. Galvan Resendiz and the Children's Research Institute Metabolomics Facility for help with metabolomic studies; L.-C. Tseng for help with patient sample collection; and P. Gerami for help with psoriasis models. This work was supported by the following grants: NCI R35 CA220449-01 and the Welch Foundation (I-1733-06) to R.J.D.; NIAMS K23AR061441 to B.F.C.; NIDDK DK10550 to J.C.R.; and NIAMS 1R01AR072655, Burroughs Wellcome Fund CAMS (1010978), and American Cancer Society/Simmons Cancer Center (ACS-IRG-02-196) to R.C.W.	Amen N, 2013, HUM MOL GENET, V22, P4164, DOI 10.1093/hmg/ddt264; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; CARLES J, 1956, B SOC CHIM BIOL, V38, P255; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Checa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12017; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Elson DA, 2000, CANCER RES, V60, P6189; EUGUI EM, 1991, SCAND J IMMUNOL, V33, P161, DOI 10.1111/j.1365-3083.1991.tb03746.x; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; FREINKEL RK, 1960, J INVEST DERMATOL, V34, P37, DOI 10.1038/jid.1960.7; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GHERZI R, 1992, J CELL PHYSIOL, V150, P463, DOI 10.1002/jcp.1041500306; Greb JE, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.82; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hawkes JE, 2017, J INVEST DERMATOL, V137, P546, DOI 10.1016/j.jid.2016.10.024; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kamleh MA, 2015, J PROTEOME RES, V14, P557, DOI 10.1021/pr500782g; Kang H, 2017, BRIT J DERMATOL, V176, P713, DOI 10.1111/bjd.15008; Koo SW, 2007, BRIT J DERMATOL, V156, P957, DOI 10.1111/j.1365-2133.2007.07812.x; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Lee EE, 2015, MOL CELL, V58, P845, DOI 10.1016/j.molcel.2015.04.015; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu Y, 2012, MOL CANCER THER, V11, P1672, DOI 10.1158/1535-7163.MCT-12-0131; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mehta NN, 2011, ARCH DERMATOL, V147, P1031, DOI 10.1001/archdermatol.2011.119; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Raja, 2007, Front Biosci, V12, P2849; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Schafer M, 2015, FREE RADICAL BIO MED, V88, P243, DOI 10.1016/j.freeradbiomed.2015.04.018; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; SPARKS JW, 1982, J PEDIATR-US, V100, P255, DOI 10.1016/S0022-3476(82)80651-3; Takashima A, 1996, PHOTOCHEM PHOTOBIOL, V63, P397, DOI 10.1111/j.1751-1097.1996.tb03054.x; Tao J, 2008, J DERMATOL SCI, V51, P203, DOI 10.1016/j.jdermsci.2008.04.012; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tochio T, 2013, INT J DERMATOL, V52, P300, DOI 10.1111/j.1365-4632.2011.05299.x; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Wellberg EA, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0795-0; Zhang ZZZ, 2016, J BIOL CHEM, V291, P22861, DOI 10.1074/jbc.C116.748848; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	59	59	60	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					617	+		10.1038/s41591-018-0003-0	http://dx.doi.org/10.1038/s41591-018-0003-0			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29662201	Green Accepted			2022-12-27	WOS:000432126800019
J	Miller, RA; Shi, YJ; Lu, WY; Pirman, DA; Jatkar, A; Blatnik, M; Wu, H; Cardenas, C; Wan, M; Foskett, JK; Park, JO; Zhang, YY; Holland, WL; Rabinowitz, JD; Birnbaum, MJ				Miller, Russell A.; Shi, Yuji; Lu, Wenyun; Pirman, David A.; Jatkar, Aditi; Blatnik, Matthew; Wu, Hong; Cardenas, Cesar; Wan, Min; Foskett, J. Kevin; Park, Junyoung O.; Zhang, Yiyi; Holland, William L.; Rabinowitz, Joshua D.; Birnbaum, Morris J.			Targeting hepatic glutaminase activity to ameliorate hyperglycemia	NATURE MEDICINE			English	Article							METABOLOMIC ANALYSIS; LIVER-MITOCHONDRIA; GLUCAGON TREATMENT; CYCLIC-AMP; RAT; STIMULATION; TRANSPORT; CA2+; GLUCONEOGENESIS; PRECURSOR	Glucagon levels increase under homeostatic, fasting conditions, promoting the release of glucose from the liver by accelerating the breakdown of glycogen (also known as glycogenolysis). Glucagon also enhances gluconeogenic flux, including from an increase in the hepatic consumption of amino acids(1). In type 2 diabetes, dysregulated glucagon signaling contributes to the elevated hepatic glucose output and fasting hyperglycemia that occur in this condition. Yet, the mechanism by which glucagon stimulates gluconeogenesis remains incompletely understood. Contrary to the prevailing belief that glucagon acts primarily on cytoplasmic and nuclear targets, we find glucagon-dependent stimulation of mitochondrial anaplerotic flux from glutamine that increases the contribution of this amino acid to the carbons of glucose generated during gluconeogenesis. This enhanced glucose production is dependent on protein kinase A (PKA) and is associated with glucagon-stimulated calcium release from the endoplasmic reticulum, activation of mitochondrial alpha-ketoglutarate dehydrogenase, and increased glutaminolysis. Mice with reduced levels of hepatic glutaminase 2 (GLS2), the enzyme that catalyzes the first step in glutamine metabolism, show lower glucagon-stimulated glutamine-to-glucose flux in vivo, and GLS2 knockout results in higher fasting plasma glucagon and glutamine levels with lower fasting blood glucose levels in insulin-resistant conditions. As found in genome-wide association studies (GWAS), human genetic variation in the region of GLS2 is associated with higher fasting plasma glucose(2,3); here we show in human cryopreserved primary hepatocytes in vitro that these natural gain-of-function missense mutations in GLS2 result in higher glutaminolysis and glucose production. These data emphasize the importance of gluconeogenesis from glutamine, particularly in pathological states of increased glucagon signaling, while suggesting a possible new therapeutic avenue to treat hyperglycemia.	[Miller, Russell A.; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Miller, Russell A.; Shi, Yuji; Jatkar, Aditi; Wan, Min; Birnbaum, Morris J.] Pfizer Internal Med Res Units, Cambridge, MA 02139 USA; [Lu, Wenyun; Park, Junyoung O.; Rabinowitz, Joshua D.] Princeton Univ, Chem & Integrat Genom, Princeton, NJ 08544 USA; [Pirman, David A.; Blatnik, Matthew; Wu, Hong] Pfizer Worldwide Res & Dev, Groton, CT USA; [Cardenas, Cesar] Univ Chile, Inst Biomed Sci, Anat & Dev Biol Program, Santiago, Chile; [Cardenas, Cesar] Gerosci Ctr Brain Hlth & Metab, Santiago, Chile; [Cardenas, Cesar] Buck Inst Res Aging, Novato, CA USA; [Cardenas, Cesar] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Park, Junyoung O.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Zhang, Yiyi; Holland, William L.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX USA	University of Pennsylvania; Pennsylvania Medicine; Pfizer; Princeton University; Pfizer; Universidad de Chile; Buck Institute for Research on Aging; University of California System; University of California Santa Barbara; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Miller, RA; Birnbaum, MJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Miller, RA; Birnbaum, MJ (corresponding author), Pfizer Internal Med Res Units, Cambridge, MA 02139 USA.; Birnbaum, MJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	russell.miller@pfizer.com; morris.birnbaum@pfizer.com	Foskett, Kevin/R-2549-2019; Park, Junyoung/AAL-8090-2020	Foskett, J. Kevin/0000-0002-8854-0268; Park, Jun/0000-0001-9869-8993; Birnbaum, Morris/0000-0001-9972-8680	US NIH [CA211437]; FONDECYT [1160332]; CONICYT/FONDAP [15150012]; NATIONAL CANCER INSTITUTE [R50CA211437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108833, R01DK112826] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT/FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All data generated and analyzed within this study are presented in the article and supplementary procedures. The stable-isotope-based metabolomics work was supported by US NIH grant CA211437 to W.L. This work was also supported by FONDECYT grant 1160332 to C.C. and CONICYT/FONDAP 15150012 to C.C.	Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Battezzati A, 1998, METABOLISM, V47, P713, DOI 10.1016/S0026-0495(98)90036-1; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; BYGRAVE FL, 1993, BIOCHEM J, V292, P19, DOI 10.1042/bj2920019; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; EXTON JH, 1968, J BIOL CHEM, V243, P4189; Fernando KC, 1998, BIOCHEM J, V330, P1179; HALESTRAP AP, 1978, BIOCHEM J, V172, P399, DOI 10.1042/bj1720399; Hankard RG, 1997, DIABETES, V46, P1535, DOI 10.2337/diabetes.46.10.1535; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; HUGHES BP, 1978, BIOCHEM J, V176, P295, DOI 10.1042/bj1760295; JOSEPH SK, 1978, BIOCHIM BIOPHYS ACTA, V543, P16, DOI 10.1016/0304-4165(78)90450-6; KEPPENS S, 1977, BIOCHIM BIOPHYS ACTA, V496, P448, DOI 10.1016/0304-4165(77)90327-0; Krishna MG, 2000, AM J PHYSIOL-ENDOC M, V279, pE638, DOI 10.1152/ajpendo.2000.279.3.E638; LACEY JH, 1981, BIOCHEM J, V194, P29, DOI 10.1042/bj1940029; LOW SY, 1993, BIOCHEM J, V295, P617, DOI 10.1042/bj2950617; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MAUGER JP, 1989, J BIOL CHEM, V264, P8821; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Miller RA, 2016, DIABETOLOGIA, V59, P1376, DOI 10.1007/s00125-016-3955-y; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; NURJHAN N, 1995, J CLIN INVEST, V95, P272, DOI 10.1172/JCI117651; PERRIELLO G, 1995, AM J PHYSIOL-ENDOC M, V269, pE443, DOI 10.1152/ajpendo.1995.269.3.E443; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; SIESS EA, 1978, FEBS LETT, V93, P301, DOI 10.1016/0014-5793(78)81126-0; Stumvoll M, 1998, METABOLISM, V47, P1227, DOI 10.1016/S0026-0495(98)90328-6; Stumvoll M, 1996, DIABETES, V45, P863, DOI 10.2337/diabetes.45.7.863; Stumvoll M, 1999, KIDNEY INT, V55, P778, DOI 10.1046/j.1523-1755.1999.055003778.x; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; WATFORD M, 1990, BIOCHEM J, V267, P265, DOI 10.1042/bj2670265; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Williamson J R, 1987, Soc Gen Physiol Ser, V42, P93; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P5055; YAMAZAKI RK, 1975, J BIOL CHEM, V250, P7924; Young VR, 2001, J NUTR, V131, p2449S, DOI 10.1093/jn/131.9.2449S	38	30	30	4	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					518	+		10.1038/nm.4514	http://dx.doi.org/10.1038/nm.4514			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29578539	Green Accepted, Green Submitted			2022-12-27	WOS:000429639800024
J	Christian, KM; Song, HJ; Ming, GL				Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li			A previously undetected pathology of Zika virus infection	NATURE MEDICINE			English	Editorial Material							BRAIN; NEUROGENESIS	In a nonhuman primate model of Zika virus infection, structural and cellular pathology deficits that could have a long-lasting impact on neural development and neurocognitive function are detected in offspring of infected mothers.	[Christian, Kimberly M.] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Christian, Kimberly M.] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA; [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Song, Hongjun; Ming, Guo-li] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Ming, GL (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.	gming@pennmedicine.upenn.edu		Ming, Guo-li/0000-0002-2517-6075	NIAID NIH HHS [U19 AI131130] Funding Source: Medline; NINDS NIH HHS [R35 NS097370] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI131130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097370] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193	12	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					258	259		10.1038/nm.4510	http://dx.doi.org/10.1038/nm.4510			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29509754	Green Accepted			2022-12-27	WOS:000426700900006
J	Montagne, A; Nikolakopoulou, AM; Zhao, Z; Sagare, AP; Si, G; Lazic, D; Barnes, SR; Daianu, M; Ramanathan, A; Go, A; Lawson, EJ; Wang, YM; Mack, WJ; Thompson, PM; Schneider, JA; Varkey, J; Langen, R; Mullins, E; Jacobs, RE; Zlokovic, BV				Montagne, Axel; Nikolakopoulou, Angeliki M.; Zhao, Zhen; Sagare, Abhay P.; Si, Gabriel; Lazic, Divna; Barnes, Samuel R.; Daianu, Madelaine; Ramanathan, Anita; Go, Ariel; Lawson, Erica J.; Wang, Yaoming; Mack, William J.; Thompson, Paul M.; Schneider, Julie A.; Varkey, Jobin; Langen, Ralf; Mullins, Eric; Jacobs, Russell E.; Zlokovic, Berislav V.			Pericyte degeneration causes white matter dysfunction in the mouse central nervous system	NATURE MEDICINE			English	Article							BLOOD-BRAIN-BARRIER; SMALL VESSEL DISEASE; ALZHEIMERS-DISEASE; CELL DIFFERENTIATION; CAPILLARY PERICYTES; MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; VASCULAR DEMENTIA; OLIGODENDROCYTE; FIBRINOGEN	Diffuse white-matter disease associated with small-vessel disease and dementia is prevalent in the elderly. The biological mechanisms, however, remain elusive. Using pericyte-deficient mice, magnetic resonance imaging, viral-based tract-tracing, and behavior and tissue analysis, we found that pericyte degeneration disrupted white-matter microcirculation, resulting in an accumulation of toxic blood-derived fibrin(ogen) deposits and blood-flow reductions, which triggered a loss of myelin, axons and oligodendrocytes. This disrupted brain circuits, leading to white-matter functional deficits before neuronal loss occurs. Fibrinogen and fibrin fibrils initiated autophagy-dependent cell death in oligodendrocyte and pericyte cultures, whereas pharmacological and genetic manipulations of systemic fibrinogen levels in pericyte-deficient, but not control mice, influenced the degree of white-matter fibrin(ogen) deposition, pericyte degeneration, vascular pathology and white-matter changes. Thus, our data indicate that pericytes control white-matter structure and function, which has implications for the pathogenesis and treatment of human white-matter disease associated with small-vessel disease.	[Montagne, Axel; Nikolakopoulou, Angeliki M.; Zhao, Zhen; Sagare, Abhay P.; Si, Gabriel; Lazic, Divna; Ramanathan, Anita; Go, Ariel; Lawson, Erica J.; Wang, Yaoming; Varkey, Jobin; Langen, Ralf; Jacobs, Russell E.; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Montagne, Axel; Nikolakopoulou, Angeliki M.; Zhao, Zhen; Sagare, Abhay P.; Lazic, Divna; Ramanathan, Anita; Lawson, Erica J.; Wang, Yaoming; Varkey, Jobin; Langen, Ralf; Jacobs, Russell E.; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA; [Lazic, Divna] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia; [Barnes, Samuel R.; Jacobs, Russell E.] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Daianu, Madelaine; Thompson, Paul M.] Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA USA; [Mack, William J.] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90033 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Mullins, Eric] Univ Cincinnati, Coll Med, Div Hematol, Cincinnati, OH USA; [Mullins, Eric] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst,Med Ctr, Cincinnati, OH USA	University of Southern California; University of Southern California; University of Belgrade; California Institute of Technology; University of Southern California; University of Southern California; Rush University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Varkey, Jobin/I-5845-2019; Sagare, Abhay/Y-3273-2019; zhao, zhen/A-2080-2012; Montagne, Axel/AAV-4343-2020; Thompson, Paul M/C-4194-2018; Mullins, Eric/GQQ-3022-2022; Barnes, Samuel/B-7673-2013; Jacobs, Russell/H-1087-2011	Sagare, Abhay/0000-0002-8178-3785; zhao, zhen/0000-0001-8967-5570; Montagne, Axel/0000-0001-5564-985X; Thompson, Paul M/0000-0002-4720-8867; Mullins, Eric/0000-0002-1544-9068; Barnes, Samuel/0000-0002-1065-8442; Jacobs, Russell/0000-0002-1382-8486	US National Institute of Health [NS100459, AG039452, NS034467, AG023084]; Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease [16 CVD 05, ES024936]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345, R37NS034467, R01NS034467, R01NS100459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG039452, P30AG010161, R01AG039452, P50AG005142, R37AG023084, R01AG023084, P01AG052350] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by US National Institute of Health grants NS100459, AG039452, NS034467 and AG023084 to B.V.Z., the Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease reference no. 16 CVD 05, and ES024936 to W.J.M. The authors thank M.T. Huuskonen for assistance with MRI scanning sessions.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Baloyannis SJ, 2012, J NEUROL SCI, V322, P117, DOI 10.1016/j.jns.2012.07.010; Barnes SR, 2016, MAGN RESON MED, V75, P1967, DOI 10.1002/mrm.25793; Barnes SR, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0062-3; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cizkova D, 2009, J NEUROSCI METH, V184, P88, DOI 10.1016/j.jneumeth.2009.07.030; Cortes-Canteli M, 2015, NEUROBIOL AGING, V36, P608, DOI 10.1016/j.neurobiolaging.2014.10.030; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Daianu M, 2015, PROC SPIE, V9413, DOI 10.1117/12.2081491; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; De La Fuente AG, 2017, CELL REP, V20, P1755, DOI 10.1016/j.celrep.2017.08.007; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Gorkun OV, 1997, BLOOD, V89, P4407, DOI 10.1182/blood.V89.12.4407; Guo H, 2009, EUR J NEUROSCI, V29, P1119, DOI 10.1111/j.1460-9568.2009.06664.x; Hachinski V, 2015, STROKE, V46, P3039, DOI 10.1161/STROKEAHA.115.011237; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Hanaoka T, 2016, GERIATR GERONTOL INT, V16, P836, DOI 10.1111/ggi.12563; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Liu S, 2011, STROKE, V42, P3277, DOI 10.1161/STROKEAHA.111.622753; Lu ZH, 2014, J THORAC CARDIOV SUR, V147, P1939, DOI 10.1016/j.jtcvs.2013.09.054; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Miners JS, 2018, J CEREBR BLOOD F MET, V38, P103, DOI 10.1177/0271678X17690761; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Muir ER, 2014, METHODS MOL BIOL, V1135, P205, DOI 10.1007/978-1-4939-0320-7_17; Nikolakopoulou AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176225; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Phillips OR, 2016, HUM BRAIN MAPP, V37, P1321, DOI 10.1002/hbm.23105; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Potter GM, 2015, INT J STROKE, V10, P376, DOI 10.1111/ijs.12054; Rosenzweig S, 2013, STROKE, V44, P2579, DOI 10.1161/STROKEAHA.113.001796; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schalomon PM, 2002, BRAIN RES BULL, V57, P27, DOI 10.1016/S0361-9230(01)00633-5; Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shaw MA, 2017, J NEUROSCI, V37, P3776, DOI 10.1523/JNEUROSCI.2932-15.2017; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Takenouchi T, 2015, J PEDIATR-US, V166, P483, DOI 10.1016/j.jpeds.2014.10.015; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wang T, 2015, J MED CHEM, V58, P3025, DOI 10.1021/jm501586m; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zhu H, 2010, ANAT REC, V293, P865, DOI 10.1002/ar.21105; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023; Zuchero JB, 2015, DEV CELL, V34, P152, DOI 10.1016/j.devcel.2015.06.011	80	193	197	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					326	+		10.1038/nm.4482	http://dx.doi.org/10.1038/nm.4482			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29400711	Green Accepted			2022-12-27	WOS:000426700900015
J	Goswami, S; Basu, S; Sharma, P				Goswami, Sangeeta; Basu, Sreyashi; Sharma, Padmanee			A potential biomarker for anti-PD-1 immunotherapy	NATURE MEDICINE			English	Editorial Material							IMMUNE CHECKPOINT; COMBINED NIVOLUMAB; IPILIMUMAB; CANCER; MELANOMA; THERAPY; MONOCYTES; BLOCKADE	A recent study identifies an immune cell type known as classical monocytes in the peripheral blood as a potential biomarker for response to anti-PD-1 immune checkpoint therapy in metastatic melanoma.	[Goswami, Sangeeta; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Basu, Sreyashi; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	padsharma@mdanderson.org		Goswami, Sangeeta/0000-0001-9201-4503				Gao JJ, 2017, NAT MED, V23, P551, DOI 10.1038/nm.4308; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2016, CANCER J, V22, P68, DOI 10.1097/PPO.0000000000000185; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849	12	12	13	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					123	124		10.1038/nm.4489	http://dx.doi.org/10.1038/nm.4489			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414936				2022-12-27	WOS:000424327200006
J	Hartl, D				Hartl, Dominik			Macrophages and platelets join forces to release kidney-damaging DNA traps	NATURE MEDICINE			English	Editorial Material							EXTRACELLULAR TRAPS; RHABDOMYOLYSIS; PHAGOCYTE; INJURY	A recent study in mice dissects the mechanisms through which muscle damage leads to kidney dysfunction and identifies macrophage extracellular trap (MET) formation as a new pathogenic driver and potential therapeutic target.	[Hartl, Dominik] Univ Tubingen, Childrens Hosp, Tubingen, Germany; [Hartl, Dominik] Roche Innovat Ctr, Roche Pharma Res & Early Dev pRED, Immunol Inflammat & Infect Dis I3 Discovery & Tra, Basel, Switzerland	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Roche Holding	Hartl, D (corresponding author), Univ Tubingen, Childrens Hosp, Tubingen, Germany.; Hartl, D (corresponding author), Roche Innovat Ctr, Roche Pharma Res & Early Dev pRED, Immunol Inflammat & Infect Dis I3 Discovery & Tra, Basel, Switzerland.	dominik.hartl@med.uni-tuebingen.de						Belliere J, 2015, J AM SOC NEPHROL, V26, P1363, DOI 10.1681/ASN.2014040320; Boe DM, 2015, J LEUKOCYTE BIOL, V97, P1023, DOI 10.1189/jlb.4RI1014-521R; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Doster R.S., 2017, J INNATE IMMUN; Okubo K, 2018, NAT MED, V24, P232, DOI 10.1038/nm.4462; Okubo K, 2016, EBIOMEDICINE, V10, P204, DOI 10.1016/j.ebiom.2016.07.012; Peschel A, 2012, NAT MED, V18, P1336, DOI 10.1038/nm.2918; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	10	2	3	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					128	129		10.1038/nm.4486	http://dx.doi.org/10.1038/nm.4486			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414933				2022-12-27	WOS:000424327200009
J	de Carcer, G; Wachowicz, P; Martinez-Martinez, S; Oller, J; Mendez-Barbero, N; Escobar, B; Gonzalez-Loyola, A; Takaki, T; El Bakkali, A; Camara, JA; Jimenez-Borreguero, LJ; Bustelo, XR; Canamero, M; Mulero, F; Sevilla, MD; Montero, MJ; Redondo, JM; Malumbres, M				de Carcer, Guillermo; Wachowicz, Paulina; Martinez-Martinez, Sara; Oller, Jorge; Mendez-Barbero, Nerea; Escobar, Beatriz; Gonzalez-Loyola, Alejandra; Takaki, Tohru; El Bakkali, Aicha; Camara, Juan A.; Jimenez-Borreguero, Luis J.; Bustelo, Xose R.; Canamero, Marta; Mulero, Francisca; de los Angeles Sevilla, Maria; Jose Montero, Maria; Miguel Redondo, Juan; Malumbres, Marcos			Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis	NATURE MEDICINE			English	Article							POLO-LIKE KINASE-1; LIGHT-CHAIN KINASE; ANGIOTENSIN-II; AURORA KINASES; PHASE-I; RHO; ECT2; CYTOKINESIS; ACTIVATION; INHIBITOR	Polo-like kinase 1 (PLK1), an essential regulator of cell division, is currently undergoing clinical evaluation as a target for cancer therapy. We report an unexpected function of Plk1 in sustaining cardiovascular homeostasis. Plk1 haploinsufficiency in mice did not induce obvious cell proliferation defects but did result in arterial structural alterations, which frequently led to aortic rupture and death. Specific ablation of Plk1 in vascular smooth muscle cells (VSMCs) led to reduced arterial elasticity, hypotension, and an impaired arterial response to angiotensin II in vivo. Mechanistically, we found that Plk1 regulated angiotensin II-dependent activation of RhoA and actomyosin dynamics in VSMCs in a mitosis-independent manner. This regulation depended on Plk1 kinase activity, and the administration of small-molecule Plk1 inhibitors to angiotensin II-treated mice led to reduced arterial fitness and an elevated risk of aneurysm and aortic rupture. We thus conclude that a partial reduction of Plk1 activity that does not block cell division can nevertheless impair aortic homeostasis. Our findings have potentially important implications for current approaches aimed at PLK1 inhibition for cancer therapy.	[de Carcer, Guillermo; Wachowicz, Paulina; Escobar, Beatriz; Gonzalez-Loyola, Alejandra; El Bakkali, Aicha; Malumbres, Marcos] Spanish Natl Canc Res Ctr CNIO, Cell Div & Canc Grp, Madrid, Spain; [Martinez-Martinez, Sara; Oller, Jorge; Mendez-Barbero, Nerea; Miguel Redondo, Juan] Spanish Natl Cardiovasc Ctr CNIC, Gene Regulat Cardiovasc Remodelling & Inflammat G, Madrid, Spain; [Martinez-Martinez, Sara; Oller, Jorge; Jimenez-Borreguero, Luis J.; Miguel Redondo, Juan] Ctr Invest Biomed RED CIBERCV, Madrid, Spain; [Takaki, Tohru] London Res Inst, Clare Hall Labs, London, England; [Camara, Juan A.; Mulero, Francisca] Spanish Natl Canc Res Ctr CNIO, Mol Imaging Unit, Madrid, Spain; [Jimenez-Borreguero, Luis J.] Hosp Princesa, Spanish Natl Cardiovasc Ctr CNIC, Adv Imaging Unit, Madrid, Spain; [Jimenez-Borreguero, Luis J.] Hosp Princesa, Cardiac Imaging Dept, Madrid, Spain; [Bustelo, Xose R.] Univ Salamanca, CSIC, Ctr Invest Canc Salamanca, Salamanca, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Comparat Pathol Unit, Madrid, Spain; [de los Angeles Sevilla, Maria; Jose Montero, Maria] Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain; [de los Angeles Sevilla, Maria; Jose Montero, Maria] Univ Salamanca, Biomed Res Inst Salamanca IBSAL, Salamanca, Spain; [Bustelo, Xose R.; de los Angeles Sevilla, Maria; Jose Montero, Maria] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Canamero, Marta] Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev, Penzberg, Germany	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital de La Princesa; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Salamanca; University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	de Carcer, G; Malumbres, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Cell Div & Canc Grp, Madrid, Spain.; Redondo, JM (corresponding author), Spanish Natl Cardiovasc Ctr CNIC, Gene Regulat Cardiovasc Remodelling & Inflammat G, Madrid, Spain.; Redondo, JM (corresponding author), Ctr Invest Biomed RED CIBERCV, Madrid, Spain.	gcarcer@cnio.es; jmredondo@cnic.es; malumbres@cnio.es	Redondo, Juan Miguel/H-6351-2015; Camara, Juan A/M-6821-2018; Mendez-Barbero, Nerea/AAV-4643-2020; /AAI-3238-2021; Malumbres, Marcos/E-8834-2011; Bustelo, Xose R./AAD-2081-2022; Montero, María José MJ/C-3084-2018; Serrano, Juan/T-1991-2019; Sevilla, M Angeles/J-8146-2017; Gonzalez Loyola, Alejandra/B-5935-2019; Bustelo, Xose R./A-9526-2010; Mulero, Francisca/R-2387-2019; de Cárcer, Guillermo/B-7105-2011; Jimenez-Borreguero, Luis Jesus/L-8107-2014	Redondo, Juan Miguel/0000-0001-5779-9122; Mendez-Barbero, Nerea/0000-0003-1620-3067; Malumbres, Marcos/0000-0002-0829-6315; Bustelo, Xose R./0000-0001-9398-6072; Montero, María José MJ/0000-0003-2125-0378; Sevilla, M Angeles/0000-0003-2960-8514; Gonzalez Loyola, Alejandra/0000-0001-8612-0393; Bustelo, Xose R./0000-0001-9398-6072; Mulero, Francisca/0000-0001-9584-4211; de Cárcer, Guillermo/0000-0002-3220-1785; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X; Camara Serrano, Juan Antonio/0000-0001-7494-1127; Oller Pedrosa, Jorge/0000-0002-2224-2954	Marie Curie activities of the European Commission (Oncotrain program); Spanish Ministry of Economy and Competitiveness (MINECO); CENIT AMIT Project "Advanced Molecular Imaging Technologies" [TEC2008-06715-C02-1, RD07/0014/2009]; Red de investigacion Cardiovascular (RIC); FEDER [RD12/004240022, RD12/0042/0056]; Fundacio La Marato TV3 [20151331]; Castilla-Leon Autonomous Government [BIO/SA01/15, CS049U16]; Solorzano Foundation; Ramon Areces Foundation; MINECO [RD12/0036/0002, SAF2015-64556-R, SAF2015-63633-R, SAF2015-69920-R, SEV-2015-0510, SEV-2015-0505]; Consolider-Ingenio 2010 Programme [SAF2014-57791-REDC]; Red Tematica CellSYS [BFU2014-52125-REDT]; Comunidad de Madrid (OncoCycle Programme) [S2010/BMD-2470]; Worldwide Cancer Research [14-1248, 15-0278]; MitoSys project (European Union) [HEALTH-F5-2010-241548]; Pro-CNIC Foundation	Marie Curie activities of the European Commission (Oncotrain program); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); CENIT AMIT Project "Advanced Molecular Imaging Technologies"; Red de investigacion Cardiovascular (RIC); FEDER(European Commission); Fundacio La Marato TV3; Castilla-Leon Autonomous Government; Solorzano Foundation; Ramon Areces Foundation; MINECO(Spanish Government); Consolider-Ingenio 2010 Programme(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica CellSYS; Comunidad de Madrid (OncoCycle Programme)(Comunidad de Madrid); Worldwide Cancer Research; MitoSys project (European Union); Pro-CNIC Foundation	We are fully indebted to K. Burridge (The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina,USA), C.J. Der (The University of North Carolina at Chapel Hill, Chapel I lilt North Carolina, USA), A.P. Fields (Mayo Clinic, Jacksonville, Florida, USA), M. Glotzer (University of Chicago, Chicago, Illinois, USA), M. Angel del Pozo (CNIC, Madrid, Spain) and M. Yaffe (The Koch Institute, MIT, Cambridge, Massachusetts, USA) for reagents. We thank A. Borgia for help with biochemical studies; the ultrasonographers A.V. Alonso and L. Flores; A. Peral and R. Alberca for technical assistance; J. Regadera for advice on mouse echocardiography and pathological samples; and members of the Histopathology and Transgenic Units of the CNIO for excellent technical support. We also thank D. Olmos for discussion on the effect of Plk1 inhibitors in the clinic. This work-was supported by the Marie Curie activities of the European Commission (Oncotrain program; fellowship to P.W), the Spanish Ministry of Economy and Competitiveness (MINECO; fellowship to A.G.-L.), the CENIT AMIT Project "Advanced Molecular Imaging Technologies" (TEC2008-06715-C02-1, RD07/0014/2009 to F.M.), the Red de investigacion Cardiovascular (RIC), cofunded by FEDER (grant RD12/004240022 to J.M.R.; grant RD12/0042/0056 to L.J.J.-B), Fundacio La Marato TV3 (grant 20151331 to J.M.R.), the Castilla-Leon Autonomous Government (BIO/SA01/15, CS049U16 to X.R.B.), the Solorzano and Ramon Areces Foundations (to X.R.B.), MINECO (grants RD12/0036/0002 and SAF2015-64556-R to X.R.B.; SAF2015-63633-R to J.M.R.; and SAF2015-69920-R to M.M.), Consolider-Ingenio 2010 Programme (grant SAF2014-57791-REDC to M.M.), Red Tematica CellSYS (grant BFU2014-52125-REDT to M.M.), Comunidad de Madrid (OncoCycle Programme; grant S2010/BMD-2470 to M.M.), Worldwide Cancer Research (grants 14-1248 to X.R.B., and 15-0278 to M.M.) and the MitoSys project (European Union Seventh Framework Programme; grant HEALTH-F5-2010-241548 to M.M.). CNIC is supported by MINECO and the Pro-CNIC Foundation. CNIO and CNIC are Severo Ochoa Centers of Excellence (MINECO awards SEV-2015-0510 and SEV-2015-0505, respectively).	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Ban LA, 2004, NAT REV MOL CELL BIO, V5, P429; Bellini C, 2015, J BIOMECH, V48, P113, DOI 10.1016/j.jbiomech.2014.10.031; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Carlo-Toumaniante C., 2012, AM J PHYSIOL-CELL PH, V302, pC1394; de Carcer G, 2011, MOL CELL BIOL, V31, P1225, DOI 10.1128/MCB.00607-10; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Gjertsen BT, 2015, LEUKEMIA, V29, P11, DOI 10.1038/leu.2014.222; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kormokji R. S., 2013, BRIT J HAEMATOL, V162, P517; Kuang SQ, 2012, CIRC RES, V110, P1411, DOI 10.1161/CIRCRESAHA.111.261743; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li J, 2016, J BIOL CHEM, V291, P23693, DOI 10.1074/jbc.M116.749341; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Lindsay M. E., 2014, MED, V4; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Loirand Gervaise, 2014, Small GTPases, V5, P1, DOI 10.4161/sgtp.28846; lrakala M, 2015, BLOOD, V126, P1707; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Lush Ilen V., 2011, J BIOL CHEM, V286, P8149; Marclilovich K., 2012, FUTURE ONCOL, V8, P165; Matthews HK, 2012, DEV CELL, V23, P371, DOI 10.1016/j.devcel.2012.06.003; McInnes C, 2011, DRUG DISCOV TODAY, V16, P619, DOI 10.1016/j.drudis.2011.05.002; Milewicz DM, 2014, TRENDS CARDIOVAS MED, V24, P53, DOI 10.1016/j.tcm.2013.06.004; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Olmos D, 2011, CLIN CANCER RES, V17, P3420, DOI 10.1158/1078-0432.CCR-10-2946; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; SUNKEL CE, 1988, J CELL SCI, V89, P25; Suzuki K, 2015, SCI REP-UK, V5, DOI 10.1038/srep07929; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wachowicz P, 2016, BIOESSAYS, V38, pS96, DOI 10.1002/bies.201670908; Waheed F., 2012, JOVE-J VIS EXP, V61, pe3932; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wuertz CM, 2010, FASEB J, V24, P4865, DOI 10.1096/fj.10-155499; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Zhang DL, 2015, ELIFE, V4, DOI 10.7554/eLife.08898; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	71	30	30	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					964	+		10.1038/nm.4364	http://dx.doi.org/10.1038/nm.4364			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28692064	Green Accepted			2022-12-27	WOS:000406947600012
J	Wang, PX; Ji, YX; Zhang, XJ; Zhao, LP; Yan, ZZ; Zhang, P; Shen, LJ; Yang, X; Fang, J; Tian, S; Zhu, XY; Gong, J; Zhang, X; Wei, QF; Wang, Y; Li, J; Wan, L; Xie, QG; She, ZG; Wang, ZH; Huang, Z; Li, HL				Wang, Pi-Xiao; Ji, Yan-Xiao; Zhang, Xiao-Jing; Zhao, Ling-Ping; Yan, Zhen-Zhen; Zhang, Peng; Shen, Li-Jun; Yang, Xia; Fang, Jing; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Zhang, Xin; Wei, Qiao-Fang; Wang, Yong; Li, Jing; Wan, Lu; Xie, Qingguo; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang			Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates	NATURE MEDICINE			English	Article							FATTY-LIVER-DISEASE; PATHOLOGICAL CARDIAC-HYPERTROPHY; INHIBITORY PROTEIN PROTECTS; HEPATIC INSULIN-RESISTANCE; MEDIATED APOPTOSIS; VITAMIN-E; C-FLIP; CARDIOMETABOLIC DISEASES; SIGNAL-TRANSDUCTION; CONTROLLED-TRIAL	Nonalcoholic steatohepatitis (NASH) is a progressive disease that is often accompanied by metabolic syndrome and poses a high risk of severe liver damage. However, no effective pharmacological treatment is currently available for NASH. Here we report that CASP8 and FADD-like apoptosis regulator (CFLAR) is a key suppressor of steatohepatitis and its metabolic disorders. We provide mechanistic evidence that CFLAR directly targets the kinase MAP3K5 (also known as ASK1) and interrupts its N-terminus-mediated dimerization, thereby blocking signaling involving ASK1 and the kinase MAPK8 (also known as JNK1). Furthermore, we identified a small peptide segment in CFLAR that effectively attenuates the progression of steatohepatitis and metabolic disorders in both mice and monkeys by disrupting the N-terminus-mediated dimerization of ASK1 when the peptide is expressed from an injected adenovirus-associated virus 8-based vector. Taken together, these findings establish CFLAR as a key suppressor of steatohepatitis and indicate that the development of CFLAR-peptide-mimicking drugs and the screening of small-molecular inhibitors that specifically block ASK1 dimerization are new and feasible approaches for NASH treatment.	[Wang, Pi-Xiao; Zhang, Xiao-Jing; Shen, Li-Jun; Tian, Song; Zhu, Xue-Yong; Wei, Qiao-Fang; She, Zhi-Gang; Wang, Zhihua; Li, Hongliang] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Peoples R China; [Wang, Pi-Xiao; Ji, Yan-Xiao; Zhang, Xiao-Jing; Zhao, Ling-Ping; Yan, Zhen-Zhen; Zhang, Peng; Shen, Li-Jun; Yang, Xia; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Zhang, Xin; Wei, Qiao-Fang; Wang, Yong; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang] Wuhan Univ, Basic Med Sch, Wuhan, Peoples R China; [Wang, Pi-Xiao; Ji, Yan-Xiao; Zhang, Xiao-Jing; Zhao, Ling-Ping; Yan, Zhen-Zhen; Zhang, Peng; Shen, Li-Jun; Yang, Xia; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Zhang, Xin; Wei, Qiao-Fang; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang] Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China; [Wang, Pi-Xiao; Ji, Yan-Xiao; Zhang, Xiao-Jing; Zhao, Ling-Ping; Yan, Zhen-Zhen; Zhang, Peng; Shen, Li-Jun; Yang, Xia; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Zhang, Xin; Wei, Qiao-Fang; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang] Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Peoples R China; [Yan, Zhen-Zhen; Gong, Jun; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Fang, Jing] Huazhong Univ Sci & Technol, Sino Swiss Heart Lung Transplantat Inst, Tongji Hosp,Tongji Med Coll, Div Cardiothorac & Vasc Surg,Heart Lung Transplan, Wuhan, Peoples R China; [Li, Jing; Wan, Lu; Xie, Qingguo] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, HL (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Basic Med Sch, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Peoples R China.	lihl@whu.edu.cn	Wang, Zhihua/AAM-1486-2021	Huang, Zan/0000-0001-5623-6950	National Science Fund for Distinguished Young Scholars [81425005]; National Natural Science Foundation [81330005, 81630011]; National Science and Technology Support Project [2014BAI02B01, 2015BAI08B01]; National Key Research and Development Program [2013YQ030923-05, 2016YFF0101504]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Project; National Key Research and Development Program	We thank L. Ma (Wuhan University), a biostatistical expert, for his help with the statistical analyses in our present study and L. Zhang (Chinese Academy of Medical Sciences) for the Jnk1-KO (B6.129S1-Mapk8) and Jnk2-KO (B6.129S2-Mapk9) mice. This work was supported by grants from the National Science Fund for Distinguished Young Scholars (no. 81425005; H.L.), the Key Project of the National Natural Science Foundation (no. 81330005 and 81630011; H.L.), the National Science and Technology Support Project (no. 2014BAI02B01 and 2015BAI08B01; H.L.), the National Key Research and Development Program (no. 2013YQ030923-05 (H.L.) and 2016YFF0101504 (Z.-G.S.)).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; [Anonymous], 2016, EUR HEART J, V37, P3257; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Cha SI, 2010, AM J RESP CELL MOL, V42, P140, DOI 10.1165/rcmb.2008-0419OC; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Czech MP, 2013, NAT MED, V19, P969, DOI 10.1038/nm.3293; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng KQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11432; Esmailzadeh S, 2015, LEUKEMIA, V29, P1402, DOI 10.1038/leu.2015.9; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gehrke N, 2015, CELL DEATH DIFFER, V22, P826, DOI 10.1038/cdd.2014.178; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ji YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11267; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kodama Y, 2009, HEPATOLOGY, V49, P6, DOI 10.1002/hep.22710; Kohl T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.228; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Li HL, 2010, HYPERTENSION, V56, P1109, DOI 10.1161/HYPERTENSIONAHA.110.157412; Li M, 2016, GUT; Lin JH, 2015, NEPHRON, V129, P29, DOI 10.1159/000369152; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mittal S, 2016, CLIN GASTROENTEROL H, V14, P124, DOI 10.1016/j.cgh.2015.07.019; Monteleone I, 2006, GASTROENTEROLOGY, V130, P389, DOI 10.1053/j.gastro.2005.10.021; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Negash AA, 2015, IMMUNOL REV, V265, P143, DOI 10.1111/imr.12279; Neuschwander-Tetri B. A., 2016, Current Hepatology Reports, V15, P125, DOI 10.1007/s11901-016-0300-3; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nobili V, 2006, ALIMENT PHARM THER, V24, P1553, DOI 10.1111/j.1365-2036.2006.03161.x; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Ratziu V, 2015, J HEPATOL, V62, pS65, DOI 10.1016/j.jhep.2015.02.041; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schattenberg JM, 2012, AM J PHYSIOL-GASTR L, V303, pG498, DOI 10.1152/ajpgi.00525.2011; Schattenberg JM, 2011, J HEPATOL, V55, P1272, DOI 10.1016/j.jhep.2011.03.008; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Wang PX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10592; Wang WJ, 2017, CANCER LETT, V387, P46, DOI 10.1016/j.canlet.2016.06.004; Wang XA, 2014, HEPATOLOGY, V59, P870, DOI 10.1002/hep.26751; Wang XA, 2013, HEPATOLOGY, V58, P603, DOI 10.1002/hep.26368; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Xiang M, 2016, J HEPATOL, V64, P1365, DOI 10.1016/j.jhep.2016.02.002; Xiao JF, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0239-z; Xie LF, 2016, J HEPATOL, V65, P113, DOI 10.1016/j.jhep.2016.03.008; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zhang HJ, 2016, JAMA INTERN MED, V176, P1074, DOI 10.1001/jamainternmed.2016.3202; Zhang XJ, 2015, HYPERTENSION, V66, P222, DOI 10.1161/HYPERTENSIONAHA.115.04898; Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333	67	138	144	4	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					439	+		10.1038/nm.4290	http://dx.doi.org/10.1038/nm.4290			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28218919				2022-12-27	WOS:000398768100012
J	Zee, T; Bose, N; Zee, J; Beck, JN; Yang, S; Parihar, J; Yang, M; Damodar, S; Hall, D; O'Leary, MN; Ramanathan, A; Gerona, RR; Killilea, DW; Chi, T; Tischfield, J; Sahota, A; Kahn, A; Stoller, ML; Kapahi, P				Zee, Tiffany; Bose, Neelanjan; Zee, Jarcy; Beck, Jennifer N.; Yang, See; Parihar, Jaspreet; Yang, Min; Damodar, Sruthi; Hall, David; O'Leary, Monique N.; Ramanathan, Arvind; Gerona, Roy R.; Killilea, David W.; Chi, Thomas; Tischfield, Jay; Sahota, Amrik; Kahn, Arnold; Stoller, Marshall L.; Kapahi, Pankaj			alpha-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria	NATURE MEDICINE			English	Article							KIDNEY-STONES; GLUTATHIONE; DISEASE	Cystinuria is an incompletely dominant disorder characterized by defective urinary cystine reabsorption that results in the formation of cystine-based urinary stones. Current treatment options are limited in their effectiveness at preventing stone recurrence and are often poorly tolerated. We report that the nutritional supplement alpha-lipoic acid inhibits cystine stone formation in the Slc3a1(-/-) mouse model of cystinuria by increasing the solubility of urinary cystine. These findings identify a novel therapeutic strategy for the clinical treatment of cystinuria.	[Zee, Tiffany; Bose, Neelanjan; Beck, Jennifer N.; Killilea, David W.; Chi, Thomas; Stoller, Marshall L.; Kapahi, Pankaj] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94117 USA; [Zee, Tiffany; Bose, Neelanjan; Beck, Jennifer N.; Yang, See; Damodar, Sruthi; Hall, David; O'Leary, Monique N.; Ramanathan, Arvind; Kahn, Arnold; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA 94945 USA; [Zee, Jarcy] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Parihar, Jaspreet] Rutgers State Univ, Robert Wood Johnson Med Sch, Div Urol, New Brunswick, NJ USA; [Yang, Min; Tischfield, Jay; Sahota, Amrik] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Yang, Min; Tischfield, Jay; Sahota, Amrik] Rutgers State Univ, Human Genet Inst New Jersey, Piscataway, NJ USA; [Gerona, Roy R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Killilea, David W.] Childrens Hosp, Oakland Res Inst, Nutr & Metab Ctr, 747 52nd St, Oakland, CA 94609 USA	University of California System; University of California San Francisco; Buck Institute for Research on Aging; Arbor Research Collaborative for Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Stoller, ML; Kapahi, P (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94117 USA.; Kapahi, P (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	marshall.stoller@ucsf.edu; pkapahi@buckinstitute.org	Bose, Neelanjan/B-8054-2017; Wilson, Matthew H/K-3193-2013	Bose, Neelanjan/0000-0002-3817-4757; Tischfield, Jay/0000-0003-3217-8287; Zee, Jarcy/0000-0003-0586-1160; Killilea, David/0000-0002-8929-6527	American Federation of Aging Research; Larry L. Hillblom Foundation; Boston Scientific Foundation; NIH [R01 AG038688, R01 AG045835, R21 DK091727, P20 DK100863, R21 DE025961, K12 DK083021, R21 DK109433]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083021, P20DK100863, R21DK091727, R21DK109433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038688, R01AG045835] Funding Source: NIH RePORTER	American Federation of Aging Research; Larry L. Hillblom Foundation; Boston Scientific Foundation(Boston Scientific); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Murphy and S. Melov for their advice regarding mu CT; T. Te Koi for histology assistance; M. Chamoli and N. Mathew for help with imaging; and D. Chrzan for helpful discussions. This work was supported by grants from the American Federation of Aging Research (to P.K.), the Larry L. Hillblom Foundation (to P.K.), the Boston Scientific Foundation (to M.L.S.), and the NIH (R01 AG038688 and R01 AG045835 to P.K.; R21 DK091727 to P.K. and M.L.S.; P20 DK100863 and R21 DE025961 to M.L.S.; K12 DK083021 and R21 DK109433 to T.C.).	Becker G, 2007, NEPHROLOGY, V12, pS4, DOI 10.1111/j.1440-1797.2006.00722.x; Han D, 1997, BIOFACTORS, V6, P321, DOI 10.1002/biof.5520060303; Ishak R, 2013, AM J CLIN DERMATOL, V14, P223, DOI 10.1007/s40257-013-0022-z; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Livrozet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102700; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; Morgan MSC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i52; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Sahota A, 2014, UROLOGY, V84, DOI 10.1016/j.urology.2014.07.043; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Schupke H, 2001, DRUG METAB DISPOS, V29, P855; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Teichert J, 2005, J CLIN PHARMACOL, V45, P313, DOI 10.1177/0091270004270792; Varda BK, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2015.08.019; Wagner CA, 2010, J NEPHROL, V23, pS165; Yoon HY, 2008, BIOCHEM PHARMACOL, V75, P2214, DOI 10.1016/j.bcp.2008.02.029; Zheng ZF, 2014, RENAL FAILURE, V36, P1455, DOI 10.3109/0886022X.2014.926754; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	20	36	37	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					288	290		10.1038/nm.4280	http://dx.doi.org/10.1038/nm.4280			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28165480	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000395848400009
J	Zhou, HJ; Qin, LF; Zhang, HF; Tang, WW; Ji, WD; He, Y; Liang, XL; Wang, ZR; Yuan, QY; Vortmeyer, A; Toomre, D; Fuh, G; Yan, MH; Kluger, MS; Wu, DQ; Min, W				Zhou, Huanjiao Jenny; Qin, Lingfeng; Zhang, Haifeng; Tang, Wenwen; Ji, Weidong; He, Yun; Liang, Xiaoling; Wang, Zongren; Yuan, Qianying; Vortmeyer, Alexander; Toomre, Derek; Fuh, Germaine; Yan, Minghong; Kluger, Martin S.; Wu, Dianqing; Min, Wang			Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation (vol 22, pg 1033, 2016)	NATURE MEDICINE			English	Correction													wang, zongren/AAO-6888-2021	wang, zongren/0000-0002-4925-7232				Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169	1	10	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1502	1502		10.1038/nm1216-1502c	http://dx.doi.org/10.1038/nm1216-1502c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923033	Bronze			2022-12-27	WOS:000389549000032
J	Hanse, RJ; Pritchard, CC; Shendure, J; Salipante, SJ				Hanse, Ronald J.; Pritchard, Colin C.; Shendure, Jay; Salipante, Stephen J.			Classification and characterization of microsatellite instability across 18 cancer types	NATURE MEDICINE			English	Article							DNA MISMATCH REPAIR; COLORECTAL-CANCER; GASTRIC CANCERS; HUMAN GENOME; MSI-H; MUTATIONS; CARCINOMA; EXPRESSION; TUMORS; GENES	Microsatellite instability (MSI), the spontaneous loss or gain of nucleotides from repetitive DNA tracts, is a diagnostic phenotype for gastrointestinal, endometrial, and colorectal tumors, yet the landscape of instability events across a wider variety of cancer types remains poorly understood. To explore MSI across malignancies, we examined 5,930 cancer exomes from 18 cancer types at more than 200,000 microsatellite loci and constructed a genomic classifier for MSI. We identified MSI-positive tumors in 14 of the 18 cancer types. We also identified loci that were more likely to be unstable in particular cancer types, resulting in specific instability signatures that involved cancer-associated genes, suggesting that instability patterns reflect selective pressures and can potentially identify novel cancer drivers. We also observed a correlation between survival outcomes and the overall burden of unstable microsatellites, suggesting that MSI may be a continuous, rather than discrete, phenotype that is informative across cancer types. These analyses offer insight into conserved and cancer-specific properties of MSI and reveal opportunities for improved methods of clinical MSI diagnosis and cancer gene discovery.	[Hanse, Ronald J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pritchard, Colin C.; Salipante, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Salipante, SJ (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	shendure@uw.edu; stevesal@uw.edu	Shendure, Jay/AAU-3684-2021	Hause, Ronald/0000-0002-5229-7366	Damon Runyon Cancer Research Foundation [DRG-2224-15]; Congressionally Directed Medical Research Program [PC131820]; Young Investigator Award from the Prostate Cancer Foundation	Damon Runyon Cancer Research Foundation; Congressionally Directed Medical Research Program(United States Department of Defense); Young Investigator Award from the Prostate Cancer Foundation	We thank A. McKenna and other members of S.J.S. and J.S.'s laboratories for helpful advice and assistance. This work was supported in part by the Damon Runyon Cancer Research Foundation (DRG-2224-15 to R.J.H.), a Congressionally Directed Medical Research Program (PC131820 to C.C.P.), and a Young Investigator Award from the Prostate Cancer Foundation (to C.C.P.).	Altavilla G, 2010, ONCOL REP, V24, P927, DOI 10.3892/or_00000938; Amira N, 2003, J UROLOGY, V170, P1151, DOI 10.1097/01.ju.0000086551.22844.cd; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; Dacic S, 2007, AM J CLIN PATHOL, V127, P282, DOI 10.1309/CRCU356U7146YC31; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Duval A, 2002, CANCER RES, V62, P1609; Duval A, 2001, HUM MOL GENET, V10, P513, DOI 10.1093/hmg/10.5.513; Eckert A, 2007, BRAIN PATHOL, V17, P146, DOI 10.1111/j.1750-3639.2007.00049.x; Eckert KA, 2009, MOL CARCINOGEN, V48, P379, DOI 10.1002/mc.20499; FIELD JK, 1995, BRIT J CANCER, V71, P1065, DOI 10.1038/bjc.1995.205; Forgacs E, 2001, ONCOGENE, V20, P1005, DOI 10.1038/sj.onc.1204211; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Huang MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13321; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Jensen KC, 2008, AM J SURG PATHOL, V32, P1029, DOI 10.1097/PAS.0b013e31816380c4; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Kazachkov Y, 1998, LIVER, V18, P156; Kim MS, 2013, DIGEST DIS SCI, V58, P3376, DOI 10.1007/s10620-013-2808-5; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Laiho P, 2002, CANCER RES, V62, P1166; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063056; Martinez R, 2005, J CANCER RES CLIN, V131, P87, DOI 10.1007/s00432-004-0592-5; McIver LJ, 2014, BREAST CANCER RES TR, V145, P791, DOI 10.1007/s10549-014-2908-8; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mori Y, 2002, CANCER RES, V62, P3641; Murphy KM, 2006, J MOL DIAGN, V8, P305, DOI 10.2353/jmoldx.2006.050092; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Oki E, 1999, ONCOGENE, V18, P2143, DOI 10.1038/sj.onc.1202583; Onda M, 2001, CLIN CANCER RES, V7, P3444; Pawlik TM, 2004, DIS MARKERS, V20, P199, DOI 10.1155/2004/368680; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shin N, 2011, INT J CANCER, V128, P2872, DOI 10.1002/ijc.25641; Sonay TB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1902-9; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112	50	458	484	5	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1342	1350		10.1038/nm.4191	http://dx.doi.org/10.1038/nm.4191			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27694933				2022-12-27	WOS:000387302300028
J	Rusert, P; Kouyos, RD; Kadelka, C; Ebner, H; Schanz, M; Huber, M; Braun, DL; Hoze, N; Scherrer, A; Magnus, C; Weber, J; Uhr, T; Cippa, V; Thorball, CW; Kuster, H; Cavassini, M; Bernasconi, E; Hoffmann, M; Calmy, A; Battegay, M; Rauch, A; Yerly, S; Aubert, V; Klimkait, T; Boni, J; Fellay, J; Regoes, RR; Gunthard, HF; Trkola, A				Rusert, Peter; Kouyos, Roger D.; Kadelka, Claus; Ebner, Hanna; Schanz, Merle; Huber, Michael; Braun, Dominique L.; Hoze, Nathanael; Scherrer, Alexandra; Magnus, Carsten; Weber, Jacqueline; Uhr, Therese; Cippa, Valentina; Thorball, Christian W.; Kuster, Herbert; Cavassini, Matthias; Bernasconi, Enos; Hoffmann, Matthias; Calmy, Alexandra; Battegay, Manuel; Rauch, Andri; Yerly, Sabine; Aubert, Vincent; Klimkait, Thomas; Boni, Jurg; Fellay, Jacques; Regoes, Roland R.; Gunthard, Huldrych F.; Trkola, Alexandra		Swiss HIV Cohort Studys	Determinants of HIV-1 broadly neutralizing antibody induction	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; RESPONSES; TRANSMISSION; SWITZERLAND; PROGRESSION; EVOLUTION; THERAPY; 3BNC117; BREADTH	Broadly neutralizing antibodies (bnAbs) are a focal component of HIV-1 vaccine design, yet basic aspects of their induction remain poorly understood. Here we report on viral, host and disease factors that steer bnAb evolution using the results of a systematic survey in 4,484 HIV-1-infected individuals that identified 239 bnAb inducers. We show that three parameters that reflect the exposure to antigen-viral load, length of untreated infection and viral diversity-independently drive bnAb evolution. Notably, black participants showed significantly (P = 0.0086-0.038) higher rates of bnAb induction than white participants. Neutralization fingerprint analysis, which was used to delineate plasma specificity, identified strong virus subtype dependencies, with higher frequencies of CD4-binding-site bnAbs in infection with subtype B viruses (P = 0.02) and higher frequencies of V2-glycan-specific bnAbs in infection with non-subtype B viruses (P = 1 x 10(-5)). Thus, key host, disease and viral determinants, including subtype specific envelope features that determine bnAb specificity, remain to be unraveled and harnessed for bnAb-based vaccine design.	[Rusert, Peter; Kouyos, Roger D.; Kadelka, Claus; Ebner, Hanna; Schanz, Merle; Huber, Michael; Braun, Dominique L.; Scherrer, Alexandra; Magnus, Carsten; Weber, Jacqueline; Uhr, Therese; Cippa, Valentina; Kuster, Herbert; Boni, Jurg; Gunthard, Huldrych F.; Trkola, Alexandra] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Kouyos, Roger D.; Kadelka, Claus; Braun, Dominique L.; Scherrer, Alexandra; Kuster, Herbert; Gunthard, Huldrych F.] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Hoze, Nathanael] ETH, Inst Integrat Biol, Zurich, Switzerland; [Thorball, Christian W.; Fellay, Jacques; Regoes, Roland R.] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Thorball, Christian W.; Fellay, Jacques] Swiss Inst Bioinformat, Lausanne, Switzerland; [Cavassini, Matthias] Univ Lausanne, Univ Hosp Lausanne, Lausanne, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Hoffmann, Matthias] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis, Basel, Switzerland; [Rauch, Andri] Univ Hosp Bern, Inselspital, Dept Infect Dis, Bern, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Div Infect Dis, Virol Lab, Geneva, Switzerland; [Aubert, Vincent] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed, Peterspl, Basel, Switzerland; [Magnus, Carsten] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn DBSSE, Computat Evolut, Basel, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital St. Gallen; University of Geneva; University of Basel; University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gunthard, HF; Trkola, A (corresponding author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.; Gunthard, HF (corresponding author), Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	huldrych.guenthard@usz.ch; trkola.alexandra@virology.uzh.ch	Boeni, Juerg/B-8386-2015; Kouyos, Roger/G-6226-2014; Ciuffi, Angela/K-5798-2017; gunthard, huldrych f/F-1724-2011; Regoes, Roland R/A-6538-2008; Fellay, Jacques/A-6681-2009; Huber, Michael/B-8509-2015; Kouyos, Roger/ABB-2291-2021; Rauch, Andri/E-9948-2017; Trkola, Alexandra/K-2115-2012; Kadelka, C/ABL-5824-2022; cavassini, matthias/F-8987-2017	Kouyos, Roger/0000-0002-9220-8348; Ciuffi, Angela/0000-0003-2333-513X; gunthard, huldrych f/0000-0002-1142-6723; Regoes, Roland R/0000-0001-8319-5293; Fellay, Jacques/0000-0002-8240-939X; Huber, Michael/0000-0002-0384-0000; Kouyos, Roger/0000-0002-9220-8348; Rauch, Andri/0000-0001-5297-6062; Trkola, Alexandra/0000-0003-1013-876X; TARR, Philip/0000-0002-1488-5407; Kuster, Herbert/0000-0001-6873-0091; Thorball, Christian Wandall/0000-0002-6869-6943; Magnus, Carsten/0000-0003-1125-2783; cavassini, matthias/0000-0003-0933-7833; Klimkait, Thomas/0000-0003-4945-6511; Kadelka, Claus/0000-0002-5712-8529; Braun, Dominique Laurent/0000-0003-4036-1030; Egger, Matthias/0000-0001-7462-5132	Swiss National Science Foundation [310030_152663, PZ00P3-142411, BSSGI0_155851, 33CS30_148522]; Clinical Priority Research Priority Program of the University of Zurich (viral infectious diseases: Zurich Primary HIV Infection Study); Yvonne-Jacob Foundation; Swiss Vaccine Research Institute; SystemsX.ch grant (AntibodyX); small nested SHCS project [744]; SHCS research foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Clinical Priority Research Priority Program of the University of Zurich (viral infectious diseases: Zurich Primary HIV Infection Study); Yvonne-Jacob Foundation; Swiss Vaccine Research Institute; SystemsX.ch grant (AntibodyX); small nested SHCS project; SHCS research foundation	We thank the patients participating in the ZPHI and the SHCS and their physicians and study nurses for patient care; B. Remy, F. Schoeni-Affolter and Y. Vallet from the SHCS Data Center in Lausanne for data management; M. Robbiani, D. Perraudin and M. Minichiello for administrative assistance. We thank D. Burton (the Scripps Research Institute), J. Mascola (US National Institutes of Health (NIH) Vaccine Research Center), M. Nussenzweig (Rockefeller University), M. Connors (NIH), D. Katinger (Polymun), P. Moore and L. Morris (Center for Communicable Diseases, South Africa) for providing antibodies and/or antibody expression plasmids for this study, either directly or via the NIH AIDS Research and Reference Reagent Program. Financial support for this study was provided by the Swiss National Science Foundation (grant 310030_152663 to A.T.), the Clinical Priority Research Priority Program of the University of Zurich (viral infectious diseases: Zurich Primary HIV Infection Study to H.F.G. and A.T.), the Yvonne-Jacob Foundation (to H.F.G.) the Swiss Vaccine Research Institute (to A.T, H.F.G., R.D.K., R.R.R. and J.F.) and a SystemsX.ch grant (AntibodyX to A.T. and R.R.R.). R.D.K. was supported by the Swiss National Science Foundation (PZ00P3-142411 and BSSGI0_155851). This study was cofunded within the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant 33CS30_148522 to H.F.G.), the small nested SHCS project 744 (to A.T.) and the SHCS research foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chuang GY, 2013, J VIROL, V87, P10047, DOI 10.1128/JVI.00984-13; Cortez V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004973; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Goo L, 2014, NAT MED, V20, P655, DOI 10.1038/nm.3565; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Kelsoe G, 2014, VACCINES, V2, P1, DOI 10.3390/vaccines2010001; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Luo SS, 2015, P NATL ACAD SCI USA, V112, P11654, DOI 10.1073/pnas.1505207112; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Montefiori DC, 2004, J INFECT DIS, V190, P1962, DOI 10.1086/425518; Moore PL, 2015, TRENDS MICROBIOL, V23, P204, DOI 10.1016/j.tim.2014.12.007; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	42	101	104	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1260	1267		10.1038/nm.4187	http://dx.doi.org/10.1038/nm.4187			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668936	Green Published, Bronze			2022-12-27	WOS:000387302300018
J	Svensson, RU; Parker, SJ; Eichner, LJ; Kolar, MJ; Wallace, M; Brun, SN; Lombardo, PS; Van Nostrand, JL; Hutchins, A; Vera, L; Gerken, L; Greenwood, J; Bhat, S; Harriman, G; Westlin, WF; Harwood, HJ; Saghatelian, A; Kapeller, R; Metallo, CM; Shaw, RJ				Svensson, Robert U.; Parker, Seth J.; Eichner, Lillian J.; Kolar, Matthew J.; Wallace, Martina; Brun, Sonja N.; Lombardo, Portia S.; Van Nostrand, Jeanine L.; Hutchins, Amanda; Vera, Lilliana; Gerken, Laurie; Greenwood, Jeremy; Bhat, Sathesh; Harriman, Geraldine; Westlin, William F.; Harwood, H. James, Jr.; Saghatelian, Alan; Kapeller, Rosana; Metallo, Christian M.; Shaw, Reuben J.			Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models	NATURE MEDICINE			English	Article							PHOSPHORYLATION SITES; HEPATIC STEATOSIS; AMPK; PROSTATE; SURVIVAL; SYNTHASE; ALPHA; HOMEOSTASIS; LIPOGENESIS; METABOLISM	Continuous de novo fatty acid synthesis is a common feature of cancer that is required to meet the biosynthetic demands of a growing tumor. This process is controlled by the rate-limiting enzyme acetyl-CoA carboxylase (ACC), an attractive but traditionally intractable drug target. Here we provide genetic and pharmacological evidence that in preclinical models ACC is required to maintain the de novo fatty acid synthesis needed for growth and viability of non-small-cell lung cancer (NSCLC) cells. We describe the ability of ND-646-an allosteric inhibitor of the ACC enzymes ACC1 and ACC2 that prevents ACC subunit dimerization to suppress fatty acid synthesis in vitro and in vivo. Chronic ND-646 treatment of xenograft and genetically engineered mouse models of NSCLC inhibited tumor growth. When administered as a single agent or in combination with the standard-of-care drug carboplatin, ND-646 markedly suppressed lung tumor growth in the Kras;Trp53(-/-) (also known as KRAS p53) and Kras;Stk11(-/-) (also known as KRAS Lkb1) mouse models of NSCLC. These findings demonstrate that ACC mediates a metabolic liability of NSCLC and that ACC inhibition by ND-646 is detrimental to NSCLC growth, supporting further examination of the use of ACC inhibitors in oncology.	[Svensson, Robert U.; Eichner, Lillian J.; Brun, Sonja N.; Lombardo, Portia S.; Van Nostrand, Jeanine L.; Hutchins, Amanda; Vera, Lilliana; Gerken, Laurie; Shaw, Reuben J.] Salk Inst Biol Studies, Dept Mol & Cell Biol, San Diego, CA 92138 USA; [Parker, Seth J.; Wallace, Martina; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA USA; [Greenwood, Jeremy; Bhat, Sathesh] Schrodinger, New York, NY USA; [Harriman, Geraldine; Westlin, William F.; Harwood, H. James, Jr.; Kapeller, Rosana] Nimbus Therapeut, Cambridge, MA 02141 USA; [Metallo, Christian M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Dept Mol & Cell Biol, San Diego, CA 92138 USA.; Kapeller, R (corresponding author), Nimbus Therapeut, Cambridge, MA 02141 USA.	rosana.kapeller@nimbustx.com; shaw@salk.edu	Metallo, Christian/HCH-3476-2022	Metallo, Christian/0000-0003-2404-3040; Kolar, Matthew/0000-0001-8054-9121; Parker, Seth/0000-0001-7971-8848; Wallace, Martina/0000-0001-8272-5678; Van Nostrand, Jeanine/0000-0003-1363-9527	US National Institutes of Health (NIH) [R01CA172229, P01CA120964, R01CA188652]; Samuel Waxman Cancer Research Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG- MED002]; US Department of Defense [W81-XWH-13-1-01-5]; American Cancer Society (ACS) [124183-PF-13-023-01-CSM]; T32 postdoctoral training grant [5 T32 CA009370, T32: 5T32CA009370-33]; American Cancer Society [PF-15-037-01-DMC]; F31 NIH predoctoral training fellowship [F31CA196066-01]; UCSD Medical Scientist Training Program fellowship [2 T32 GM007198]; T32 predoctoral training grant [T32 GM 007240]; Damon Runyon Cancer Research Foundation fellowship [DRG-2219-15]; Salk [CCSG P30 CA014195]; next-generation sequencing (NGS) core facility at the Salk Institute - NIH-NCI [CCSG P30 014195]; Chapman Foundation; Glenn Foundation; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA188652, T32CA009370, P30CA014195, R01CA172229, P01CA120964, F31CA196066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, T32GM007240] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; Leona M. and Harry B. Helmsley Charitable Trust; US Department of Defense(United States Department of Defense); American Cancer Society (ACS)(American Cancer Society); T32 postdoctoral training grant; American Cancer Society(American Cancer Society); F31 NIH predoctoral training fellowship; UCSD Medical Scientist Training Program fellowship; T32 predoctoral training grant; Damon Runyon Cancer Research Foundation fellowship; Salk; next-generation sequencing (NGS) core facility at the Salk Institute - NIH-NCI; Chapman Foundation; Glenn Foundation; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the US National Institutes of Health (NIH) (grant no. R01CA172229 (R.J.S.), P01CA120964 (R.J.S.) and R01CA188652 (C.M.M.)), the Samuel Waxman Cancer Research Foundation (R.J.S.), The Leona M. and Harry B. Helmsley Charitable Trust (grant no. 2012-PG- MED002; R.J.S.) and the US Department of Defense (grant no. W81-XWH-13-1-01-5; C.M.M. and R.J.S.). R.U.S. was supported by a postdoctoral fellowship from the American Cancer Society (ACS#124183-PF-13-023-01-CSM). L.J.E. was supported by a T32 postdoctoral training grant to the Salk Institute Cancer Center (5 T32 CA009370) and a postdoctoral fellowship from the American Cancer Society (PF-15-037-01-DMC). S.J.P. was supported by an F31 NIH predoctoral training fellowship (F31CA196066-01). M.J.K. is supported by a UCSD Medical Scientist Training Program fellowship (2 T32 GM007198). P.S.L. was supported by a T32 predoctoral training grant (T32 GM 007240). S.N.B. is supported by a T32 postdoctoral training grant to the Salk Institute Cancer Center (T32: 5T32CA009370-33), J.L.V.N. is supported by a Damon Runyon Cancer Research Foundation fellowship (DRG-2219-15). We thank K. McIntyre and the histology core at the Salk Institute, which is also supported in part through the Salk CCSG P30 CA014195 grant, as well as the next-generation sequencing (NGS) core facility at the Salk Institute, which is supported with funding from the NIH-NCI CCSG P30 014195 grant, the Chapman Foundation, the Glenn Foundation and the Helmsley Charitable Trust. We also thank R. Farid for Figure 2b, E. Smith for Figure 2j, G. Wahl for the p53-specific antibody used in the IHC experiments and P. Hollstein for technical assistance.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gandhi L, 2009, CANCER PREV RES, V2, P330, DOI 10.1158/1940-6207.CAPR-08-0213; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; O'Brien AJ, 2015, BIOCHEM J, V469, P177, DOI 10.1042/BJ20150122; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang C, 2009, BIOCHEM BIOPH RES CO, V385, P302, DOI 10.1016/j.bbrc.2009.05.045; Wei J, 2015, NATURE, V526, P723, DOI 10.1038/nature15375; Zadra G, 2014, EMBO MOL MED, V6, P519, DOI 10.1002/emmm.201302734; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	33	266	277	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1108	1119		10.1038/nm.4181	http://dx.doi.org/10.1038/nm.4181			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27643638	Green Submitted, Green Accepted			2022-12-27	WOS:000384872500014
J	Lee, J; Liu, JL; Feng, XD; Hernandez, MAS; Mucka, P; Ibi, D; Choi, JW; Ozcan, U				Lee, Jaemin; Liu, Junli; Feng, Xudong; Hernandez, Mario Andres Salazar; Mucka, Patrick; Ibi, Dorina; Choi, Jae Won; Ozcan, Umut			Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice	NATURE MEDICINE			English	Article							CONNECTS ER STRESS; ENERGY-BALANCE; WITHANIA-SOMNIFERA; BODY-WEIGHT; MOUSE MODEL; OBESE GENE; RESISTANCE; NEURONS; PROTEIN; IDENTIFICATION	The increasing global prevalence of obesity and its associated disorders points to an urgent need for the development of novel and effective therapeutic strategies that induce healthy weight loss. Obesity is characterized by hyperleptinemia and central leptin resistance. In an attempt to identify compounds that could reverse leptin resistance and thus promote weight loss, we analyzed a library of small molecules that have mRNA expression profiles similar to that of celastrol, a naturally occurring compound that we previously identified as a leptin sensitizer. Through this process, we identified another naturally occurring compound, withaferin A, that also acts as a leptin sensitizer. We found that withaferin-A treatment of mice with diet-induced obesity (DIO) resulted in a 20-25% reduction of body weight, while also decreasing obesity-associated abnormalities, including hepatic steatosis. Withaferin-A treatment marginally affected the body weight of ob/ob and db/db mice, both of which are deficient in leptin signaling. In addition, withaferin A, unlike celastrol, has beneficial effects on glucose metabolism that occur independently of its leptin-sensitizing effect. Our results show that the metabolic abnormalities of DIO can be mitigated by sensitizing animals to endogenous leptin, and they indicate that withaferin A is a potential leptin sensitizer with additional antidiabetic actions.	[Lee, Jaemin; Liu, Junli; Feng, Xudong; Hernandez, Mario Andres Salazar; Mucka, Patrick; Ibi, Dorina; Choi, Jae Won; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Ozcan, U (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu	Salazar, Mario/GSN-2646-2022; Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	Department of Medicine, Boston Children's Hospital; US National Institutes of Health [R01DK098496]; American Diabetes Association Career Development grant [7-09-CD-10]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098496] Funding Source: NIH RePORTER	Department of Medicine, Boston Children's Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We greatly appreciate M. White for his time spent on critical reading of our manuscript and for his contributions and suggestions. We thank S. Cabi and I. Cakir for their initial experimental contributions to this work. We also thank S. Mert and B. Akosman for their help on some of the experiments, and S. Huang and M. Mulcahey-Maynard for measurement of serum T3 levels. TSC<SUP>+/+</SUP> and TSC<SUP>-/-</SUP> MEFs were kindly provided by D. Kwiatkowski (Dana-Farber Cancer Institute). This work was mainly supported by funds provided to U.O. from the Department of Medicine, Boston Children's Hospital, and also by grant R01DK098496 (U.O.) from the US National Institutes of Health and American Diabetes Association Career Development grant #7-09-CD-10 (U.O.).	Arch JRS, 1998, INT J OBESITY, V22, P1159, DOI 10.1038/sj/ijo/0800779; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dalamaga M, 2013, CELL METAB, V18, P29, DOI 10.1016/j.cmet.2013.05.010; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Hakansson ML, 1998, J NEUROSCI, V18, P559; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harris RBS, 2006, ENDOCRINOLOGY, V147, P1365, DOI 10.1210/en.2005-1156; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; KAPLAN MM, 1979, ENDOCRINOLOGY, V104, P58, DOI 10.1210/endo-104-1-58; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Long LH, 2014, J CLIN INVEST, V124, P4017, DOI 10.1172/JCI76220; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Ramirez S, 2015, FEBS LETT, V589, P1678, DOI 10.1016/j.febslet.2015.04.025; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; Winters M, 2006, ALTERN MED REV, V11, P269; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	57	150	155	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1023	+		10.1038/nm.4145	http://dx.doi.org/10.1038/nm.4145			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27479085	Green Submitted, Green Accepted			2022-12-27	WOS:000382542800013
J	Ben-Shaanan, TL; Azulay-Debby, H; Dubovik, T; Starosvetsky, E; Korin, B; Schiller, M; Green, NL; Admon, Y; Hakim, F; Shen-Orr, SS; Rolls, A				Ben-Shaanan, Tamar L.; Azulay-Debby, Hilla; Dubovik, Tania; Starosvetsky, Elina; Korin, Ben; Schiller, Maya; Green, Nathaniel L.; Admon, Yasmin; Hakim, Fahed; Shen-Orr, Shai S.; Rolls, Asya			Activation of the reward system boosts innate and adaptive immunity	NATURE MEDICINE			English	Article							DOPAMINE; PLACEBO; BRAIN; STIMULATION; RESPONSES; ACCUMBENS; BEHAVIOR; RELEASE; NEURONS; DISEASE	Positive expectations contribute to the clinical benefits of the placebo effect(1,2). Such positive expectations are mediated by the brain's reward system(3,4); however, it remains unknown whether and how reward system activation affects the body's physiology and, specifically, immunity. Here we show that activation of the ventral tegmental area (VTA), a key component of the reward system, strengthens immunological host defense. We used 'designer receptors exclusively activated by designer drugs' (DREADDs) to directly activate dopaminergic neurons in the mouse VTA and characterized the subsequent immune response after exposure to bacteria (Escherichia coli), using time-of-flight mass cytometry (CyTOF) and functional assays. We found an increase in innate and adaptive immune responses that were manifested by enhanced antibacterial activity of monocytes and macrophages, reduced in vivo bacterial load and a heightened T cell response in the mouse model of delayed-type hypersensitivity. By chemically ablating the sympathetic nervous system (SNS), we showed that the reward system's effects on immunity are, at least partly, mediated by the SNS. Thus, our findings establish a causal relationship between the activity of the VTA and the immune response to bacterial infection.	[Ben-Shaanan, Tamar L.; Azulay-Debby, Hilla; Dubovik, Tania; Starosvetsky, Elina; Korin, Ben; Schiller, Maya; Green, Nathaniel L.; Admon, Yasmin; Hakim, Fahed; Shen-Orr, Shai S.; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, Haifa, Israel; [Ben-Shaanan, Tamar L.; Azulay-Debby, Hilla; Korin, Ben; Schiller, Maya; Green, Nathaniel L.; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Ctr Sci & Engn Neuronal Syst, Haifa, Israel; [Hakim, Fahed] Rambam Hlth Care Campus, Pediat Pulm Unit, Haifa, Israel; [Shen-Orr, Shai S.] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology	Shen-Orr, SS; Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, Haifa, Israel.; Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Ctr Sci & Engn Neuronal Syst, Haifa, Israel.; Shen-Orr, SS (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.	shenorr@technion.ac.il; rolls@technion.ac.il		Rolls, Asya/0000-0001-5862-4287; Shen-Orr, Shai/0000-0002-6991-7736; Ben-Shaanan, Tamar L./0000-0001-6519-1715	FP-7-CIG grant [618654]; Israel Science Foundation (ISF) grants [1862/15, 1365/12]; Technion V.P.R. Fund-Malat Family; Adelis Foundation; Rappaport Institute of Biomedical Research	FP-7-CIG grant; Israel Science Foundation (ISF) grants; Technion V.P.R. Fund-Malat Family; Adelis Foundation; Rappaport Institute of Biomedical Research	We would like to thank A. Ziv-Kenet for his help with CyTOF data analysis, A. D. Eban-Rothchild, C. Tourino, D. Melamed, N. Karin, G. Wildbaum, R. Hershberg and M. Rahat for helpful discussions, A. Mor, F. Zaknoon, J. Jammal, S. Yaron and S. Katz for their help with bacterial experiments, Y. Posen, G. Ginzburg and E. Reisin-Tzur for editing the paper, H. Amitay for her help with the behavioral analysis, and O. Goldberger and the Biomedical core facility at the Technion Faculty of Medicine for technical support. This research was supported by the FP-7-CIG grant 618654 (A.R.), the Israel Science Foundation (ISF) grants 1862/15 (A.R.) and 1365/12 (S.S.S.-O.), the Technion V.P.R. Fund-Malat Family (A.R.), the Adelis Foundation (A.R.) and the Rappaport Institute of Biomedical Research (S.S.S.-O.).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Barak Y, 2006, AUTOIMMUN REV, V5, P523, DOI 10.1016/j.autrev.2006.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; D'Acquisto F, 2014, BIOCHEM PHARMACOL, V91, P287, DOI 10.1016/j.bcp.2014.07.016; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; GRATTON A, 1988, BRAIN RES BULL, V21, P319, DOI 10.1016/0361-9230(88)90247-X; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; HELLER ED, 1990, AVIAN PATHOL, V19, P345, DOI 10.1080/03079459008418685; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Huston JP, 2013, TRENDS PHARMACOL SCI, V34, P162, DOI 10.1016/j.tips.2013.01.004; Koopman FA, 2011, MOL MED, V17, P937, DOI 10.2119/molmed.2011.00065; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; LACOSTA S, 1994, BRAIN RES, V664, P225, DOI 10.1016/0006-8993(94)91976-3; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; MITTWOCHJAFFE T, 1995, NEUROREPORT, V6, P789, DOI 10.1097/00001756-199503270-00021; Nakamoto T, 2011, J APPL PHYSIOL, V110, P1342, DOI 10.1152/japplphysiol.01233.2010; National Research Council, 2011, GUIDE CARE USE LAB A; Nieh EH, 2013, BRAIN RES, V1511, P73, DOI 10.1016/j.brainres.2012.11.001; Parmigiani G, 2002, J ROY STAT SOC B, V64, P717, DOI 10.1111/1467-9868.00358; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Saurer TB, 2009, J PHARMACOL EXP THER, V329, P1040, DOI 10.1124/jpet.108.148627; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; Segerstrom SC, 2010, PSYCHOL SCI, V21, P448, DOI 10.1177/0956797610362061; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Walach H, 2011, PHILOS T R SOC B, V366, P1870, DOI 10.1098/rstb.2010.0401	38	104	107	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					940	+		10.1038/nm.4133	http://dx.doi.org/10.1038/nm.4133			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376577				2022-12-27	WOS:000381000200020
J	Sasca, D; Huntly, BJP				Sasca, Daniel; Huntly, Brian J. P.			Independence of epigenetic and genetic diversity in AML	NATURE MEDICINE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; EVOLUTION; CANCER	A new study provides the first insights into epigenetic heterogeneity in AML. The study highlights a striking independence of genetic and epigenetic variation, and links the kinetics of epigenetic change to clinical outcome.	[Sasca, Daniel; Huntly, Brian J. P.] Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England; [Sasca, Daniel; Huntly, Brian J. P.] Univ Cambridge, Dept Haematol, Cambridge, England; [Sasca, Daniel; Huntly, Brian J. P.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1TN, England; [Sasca, Daniel; Huntly, Brian J. P.] Cambridge Canc Ctr, Cambridge, England; [Sasca, Daniel] German Canc Aid, Mildred Scheel Org, Bonn, Germany	University of Cambridge; University of Cambridge	Huntly, BJP (corresponding author), Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England.; Huntly, BJP (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.; Huntly, BJP (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1TN, England.; Huntly, BJP (corresponding author), Cambridge Canc Ctr, Cambridge, England.	bjph2@cam.ac.uk	; huntly, brian/E-6725-2014	Sasca, Daniel/0000-0003-0330-7959; huntly, brian/0000-0003-0312-161X	MRC [MR/M010392/1] Funding Source: UKRI; Medical Research Council [MR/M010392/1, MC_PC_12009] Funding Source: Medline; Worldwide Cancer Research [14-1069] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Worldwide Cancer Research		Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Li S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0472-5; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Pan H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7921	10	4	4	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					708	709		10.1038/nm.4136	http://dx.doi.org/10.1038/nm.4136			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387883	Green Accepted			2022-12-27	WOS:000379366900006
J	Li, M; Jaffe, AE; Straub, RE; Tao, R; Shin, JH; Wang, YH; Chen, Q; Li, C; Jia, YK; Ohi, K; Maher, BJ; Brandon, NJ; Cross, A; Chenoweth, JG; Hoeppner, DJ; Wei, HJ; Hyde, TM; McKay, R; Kleinman, JE; Weinberger, DR				Li, Ming; Jaffe, Andrew E.; Straub, Richard E.; Tao, Ran; Shin, Joo Heon; Wang, Yanhong; Chen, Qiang; Li, Chao; Jia, Yankai; Ohi, Kazutaka; Maher, Brady J.; Brandon, Nicholas J.; Cross, Alan; Chenoweth, Joshua G.; Hoeppner, Daniel J.; Wei, Huijun; Hyde, Thomas M.; McKay, Ronald; Kleinman, Joel E.; Weinberger, Daniel R.			A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus	NATURE MEDICINE			English	Article							MAJOR DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; POSTMORTEM HUMAN BRAIN; COMMON VARIANTS; GENETIC POLYMORPHISMS; BIPOLAR DISORDER; EXPRESSION; GENOTYPE; METHYLTRANSFERASE; SUSCEPTIBILITY	Genome-wide association studies (GWASs) have reported many single nucleotide polymorphisms (SNPs) associated with psychiatric disorders, but knowledge is lacking regarding molecular mechanisms. Here we show that risk alleles spanning multiple genes across the 10q24.32 schizophrenia-related locus are associated in the human brain selectively with an increase in the expression of both BLOC-1 related complex subunit 7 (BORCS7) and a previously uncharacterized, human-specific arsenite methyltransferase (AS3MT) isoform (AS3MT(d2d3)), which lacks arsenite methyltransferase activity and is more abundant in individuals with schizophrenia than in controls. Conditional-expression analysis suggests that BORCS7 and AS3MT(d2d3) signals are largely independent. GWAS risk SNPs across this region are linked with a variable number tandem repeat (VNTR) polymorphism in the first exon of AS3MT that is associated with the expression of AS3MT(d2d3) in samples from both Caucasians and African Americans. The VNTR genotype predicts promoter activity in luciferase assays, as well as DNA methylation within the AS3MT gene. Both AS3MT(d2d3) and BORCS7 are expressed in adult human neurons and astrocytes, and they are upregulated during human stem cell differentiation toward neuronal fates. Our results provide a molecular explanation for the prominent 10q24.32 locus association, including a novel and evolutionarily recent protein that is involved in early brain development and confers risk for psychiatric illness.	[Li, Ming; Jaffe, Andrew E.; Straub, Richard E.; Tao, Ran; Shin, Joo Heon; Wang, Yanhong; Chen, Qiang; Li, Chao; Jia, Yankai; Ohi, Kazutaka; Maher, Brady J.; Chenoweth, Joshua G.; Hoeppner, Daniel J.; Wei, Huijun; Hyde, Thomas M.; McKay, Ronald; Kleinman, Joel E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA; [Jaffe, Andrew E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Maher, Brady J.; Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Maher, Brady J.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Brandon, Nicholas J.; Cross, Alan] AstraZeneca, Neurosci Innovat Med & Early Dev Biotech Unit, Cambridge, MA USA; [Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; AstraZeneca; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Weinberger, DR (corresponding author), Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.	drweinberger@libd.org	Ohi, Kazutaka/J-7851-2019; chen, qiang/GWZ-7308-2022; Cross, Alan J/L-5456-2016; Maher, Brady/GPC-8697-2022; Jaffe, Andrew/GPF-5693-2022; Jaffe, Andrew/L-3089-2016; chen, qiang/HGU-5418-2022; Maher, Brady/L-8314-2016	Ohi, Kazutaka/0000-0001-9577-9640; Cross, Alan J/0000-0002-2992-2258; Jaffe, Andrew/0000-0001-6886-1454; Jaffe, Andrew/0000-0001-6886-1454; Maher, Brady/0000-0001-5930-885X; Brandon, Nicholas/0000-0002-3917-0096	Lieber Institute for Brain Development; Maltz Research Laboratories; Brain Behavior Research Foundation; Common Fund of the Office of the Director of the US National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NCI\SAIC-Frederick, Inc. (SAIC-F) [10XS170]; Roswell Park Cancer Institute [10XS171]; Science Care, Inc. [X10S172]; SAIC-F [10ST1035, HHSN261200800001E]; Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche, Ltd.; NIH [R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, MH06692];  [HHSN268201000029C];  [DA006227];  [DA033684];  [N01MH000028];  [MH090941];  [MH101814];  [MH090951];  [MH090937];  [MH101820];  [MH101825];  [MH090936];  [MH101819];  [MH090948];  [MH101782];  [MH101810];  [MH101822]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101810, R01MH090936, R01MH101814, R01MH093725, P50MH084053, P50MH066392, R37MH057881, R01MH085542, R01MH097276, R01MH101820, R01MH090948, R01MH090941, R01MH101819, R01MH101825, R01MH090951, R01MH090937, P50MH096891, R01MH101822, R01MH101782, R01MH075916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227, R01DA033684] Funding Source: NIH RePORTER	Lieber Institute for Brain Development; Maltz Research Laboratories; Brain Behavior Research Foundation(NARSAD); Common Fund of the Office of the Director of the US National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI\SAIC-Frederick, Inc. (SAIC-F); Roswell Park Cancer Institute; Science Care, Inc.; SAIC-F; Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche, Ltd.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Deep-Soboslay (Lieber Institute for Brain Development) for her tireless efforts in clinical diagnosis and demographic characterization; R. Zielke, R.D. Vigorito and R.M. Johnson (National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland) for their provision of fetal, pediatric and adolescent brain tissue specimens; X. Xiao (Johns Hopkins Bloomberg School of Public Health) for her technical assistance. This work was supported by funding from the Lieber Institute for Brain Development and the Maltz Research Laboratories, and from a Senior Investigator grant from the Brain Behavior Research Foundation (J.E.K.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the US National Institutes of Health. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH and the NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI\SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171) and Science Care, Inc. (X10S172). The Laboratory, Data Analysis and Coordinating Center (LDACC) were funded through a contract (HHSN268201000029C) to the Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by supplements to University of Miami grants DA006227 & DA033684, and to contract N01MH000028. Statistical Methods development grants were made to the University of Geneva (MH090941 & MH101814), the University of Chicago (MH090951, MH090937, MH101820, MH101825), the University of North Carolina at Chapel Hill (MH090936 & MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St. Louis (MH101810) and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from dbGaP accession number phs000424.v6.p1 on October 6, 2015. Data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited, F. Hoffman-La Roche, Ltd. and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881 and R37MH057881S1, HHSN271201300031C, AG02219, AG05138 and MH06692. Brain tissue for the study was obtained from the following brain-bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer's Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories and the NIMH Human Brain Collection Core. CMC Leadership: P. Sklar, J. Buxbaum (Icahn School of Medicine at Mount Sinai), B. Devlin, D. Lewis (University of Pittsburgh), R. Gur, C.-G. Hahn (University of Pennsylvania), K. Hirai, H. Toyoshiba (Takeda Pharmaceuticals Company, Ltd.), E. Domenici, L. Essioux (F. Hoffman-La Roche, Ltd.), L. Mangravite, M. Peters (Sage Bionetworks), T. Lehner, B. Lipska (NIMH).	Agusa T, 2011, INT J MOL SCI, V12, P2351, DOI 10.3390/ijms12042351; Antonelli R, 2014, ENVIRON RES, V132, P156, DOI 10.1016/j.envres.2014.03.012; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Kunii Y, 2014, MOL PSYCHIATR, V19, P192, DOI 10.1038/mp.2012.174; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Oberdoerffer S, 2012, TRANSCR-AUSTIN, V3, P106, DOI 10.4161/trns.19816; Prata DP, 2009, ARCH GEN PSYCHIAT, V66, P1162, DOI 10.1001/archgenpsychiatry.2009.147; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodrigues EG, 2012, BIOMARKERS, V17, P240, DOI 10.3109/1354750X.2012.658863; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; Valluy J, 2015, NAT NEUROSCI, V18, P666, DOI 10.1038/nn.3996; Wedenoja J, 2010, BIOL PSYCHIAT, V67, P983, DOI 10.1016/j.biopsych.2009.09.026; Wood TC, 2006, J BIOL CHEM, V281, P7364, DOI 10.1074/jbc.M512227200; Zhang JX, 2010, BIOL PSYCHIAT, V68, P795, DOI 10.1016/j.biopsych.2010.06.004	39	99	101	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					649	+		10.1038/nm.4096	http://dx.doi.org/10.1038/nm.4096			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158905				2022-12-27	WOS:000377476000022
J	Fraietta, JA; Lacey, SF; Orlando, EJ; Pruteanu-Malinici, I; Gohil, M; Lundh, S; Boesteanu, AC; Wang, Y; O'Connor, RS; Hwang, WT; Pequignot, E; Ambrose, DE; Zhang, CF; Wilcox, N; Bedoya, F; Dorfmeier, C; Chen, F; Tian, LF; Parakandi, H; Gupta, M; Young, RM; Johnson, FB; Kulikovskaya, I; Liu, L; Xu, J; Kassim, SH; Davis, MM; Levine, BL; Frey, NV; Siegel, DL; Huang, AC; Wherry, EJ; Bitter, H; Brogdon, JL; Porter, DL; June, CH; Melenhorst, JJ				Fraietta, Joseph A.; Lacey, Simon F.; Orlando, Elena J.; Pruteanu-Malinici, Iulian; Gohil, Mercy; Lundh, Stefan; Boesteanu, Alina C.; Wang, Yan; O'Connor, Roddy S.; Hwang, Wei-Ting; Pequignot, Edward; Ambrose, David E.; Zhang, Changfeng; Wilcox, Nicholas; Bedoya, Felipe; Dorfmeier, Corin; Chen, Fang; Tian, Lifeng; Parakandi, Harit; Gupta, Minnal; Young, Regina M.; Johnson, F. Brad; Kulikovskaya, Irina; Liu, Li; Xu, Jun; Kassim, Sadik H.; Davis, Megan M.; Levine, Bruce L.; Frey, Noelle V.; Siegel, Donald L.; Huang, Alexander C.; Wherry, E. John; Bitter, Hans; Brogdon, Jennifer L.; Porter, David L.; June, Carl H.; Melenhorst, J. Joseph			Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia	NATURE MEDICINE			English	Article							TELOMERASE ACTIVITY; EXPRESSION ANALYSIS; EFFECTOR FUNCTION; B-CELL; IDENTIFICATION; EXHAUSTION; EFFICACY; SUBSETS; GENE; PD-1	Tolerance to self-antigens prevents the elimination of cancer by the immune system(1,2). We used synthetic chimeric antigen receptors (CARs) to overcome immunological tolerance and mediate tumor rejection in patients with chronic lymphocytic leukemia (CLL). Remission was induced in a subset of subjects, but most did not respond. Comprehensive assessment of patient-derived CAR T cells to identify mechanisms of therapeutic success and failure has not been explored. We performed genomic, phenotypic and functional evaluations to identify determinants of response. Transcriptomic profiling revealed that CAR T cells from complete-responding patients with CLL were enriched in memory-related genes, including IL-6/STAT3 signatures, whereas T cells from nonresponders upregulated programs involved in effector differentiation, glycolysis, exhaustion and apoptosis. Sustained remission was associated with an elevated frequency of CD27(+)CD45RO-CD8(+)T cells before CAR T cell generation, and these lymphocytes possessed memory-like characteristics. Highly functional CAR T cells from patients produced STAT3-related cytokines, and serum IL-6 correlated with CAR T cell expansion. IL-6/STAT3 blockade diminished CAR T cell proliferation. Furthermore, a mechanistically relevant population of CD27(+)PD-1-CD8(+)CAR T cells expressing high levels of the IL-6 receptor predicts therapeutic response and is responsible for tumor control. These findings uncover new features of CAR T cell biology and underscore the potential of using pretreatment biomarkers of response to advance immunotherapies.	[Fraietta, Joseph A.; Lacey, Simon F.; Johnson, F. Brad; Davis, Megan M.; Porter, David L.; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fraietta, Joseph A.; Lacey, Simon F.; Gohil, Mercy; Lundh, Stefan; Boesteanu, Alina C.; Wang, Yan; O'Connor, Roddy S.; Pequignot, Edward; Ambrose, David E.; Zhang, Changfeng; Wilcox, Nicholas; Bedoya, Felipe; Dorfmeier, Corin; Chen, Fang; Tian, Lifeng; Parakandi, Harit; Gupta, Minnal; Young, Regina M.; Kulikovskaya, Irina; Liu, Li; Xu, Jun; Davis, Megan M.; Levine, Bruce L.; Frey, Noelle V.; Siegel, Donald L.; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Fraietta, Joseph A.; Lacey, Simon F.; Huang, Alexander C.; Wherry, E. John; June, Carl H.; Melenhorst, J. Joseph] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Orlando, Elena J.; Pruteanu-Malinici, Iulian; Kassim, Sadik H.; Brogdon, Jennifer L.] Novartis Inst BioMed Res, Cambridge, MA USA; [Hwang, Wei-Ting] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Frey, Noelle V.; Porter, David L.] Univ Penn, Dept Internal Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Siegel, Donald L.] Univ Penn, Div Transfus Med & Therapeut Pathol, Philadelphia, PA 19104 USA; [Lacey, Simon F.; Orlando, Elena J.; Huang, Alexander C.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Novartis; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Melenhorst, JJ (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Melenhorst, JJ (corresponding author), Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; Melenhorst, JJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	mej@upenn.edu	Melenhorst, Jan/AAW-2546-2020; Wherry, John/ABI-1280-2020	Melenhorst, Jan/0000-0001-7677-537X; 	NCI [T32CA009140, R01CA165206, P01CA214278]; Stand Up to Cancer Phillip A. Sharp Innovation in Collaboration Award; Novartis; NATIONAL CANCER INSTITUTE [R01CA165206, P01CA214278, T32CA009140, P30CA016520] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up to Cancer Phillip A. Sharp Innovation in Collaboration Award; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients for their participation in the clinical trials from which research samples were obtained. We also acknowledge A. Fesnak, A. Lamontagne, A. Malykhin, C. Corl, Y. Ohayon and other members of the Clinical Cell and Vaccine Production Facility for cell manufacturing and testing. In addition, we are grateful to V. Gonzalez, J. Finklestein, F. Nazimuddin, J.-M. Navenot, M. Bogush, Y. Tanner, N. Kengle, K. Marcucci, A. Chew, C. Pletcher, P. Hallberg and R. Schretzenmair for contributions to correlative studies and/or other research support. D. Campana, C. Imai and others at St. Jude Children's Research Hospital designed, developed and provided, under materialtransfer agreements, the CAR used in this study. B. Jena and L. Cooper (MD Anderson Cancer Center) are acknowledged for providing the CAR anti-idiotype detection reagent. The functional anti-idiotypic antibody that was used for in vitro CAR stimulation experiments was a kind gift from Novartis Pharmaceutical Corporation. This work was supported by funding from NCI T32CA009140 (J.A.F.) R01CA165206 (D.L.P. and C.H.J.), P01CA214278 (C.H.J), a Stand Up to Cancer Phillip A. Sharp Innovation in Collaboration Award (C.H.J) and Novartis.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betz UAK, 1998, INT IMMUNOL, V10, P1175, DOI 10.1093/intimm/10.8.1175; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Campia I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126159; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunne PJ, 2002, BLOOD, V100, P933, DOI 10.1182/blood-2002-01-0160; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fraietta JA, 2016, BLOOD, V127, P1117, DOI 10.1182/blood-2015-11-679134; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Jain P, 2015, BLOOD, V125, P2062, DOI 10.1182/blood-2014-09-603670; Jena B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057838; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kawalekar OU, 2016, IMMUNITY, V44, P712, DOI 10.1016/j.immuni.2016.02.023; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kueberuwa G, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0216-7; Laport GG, 2003, BLOOD, V102, P2004, DOI 10.1182/blood-2003-01-0095; Lecuroux C, 2009, BLOOD, V113, P3209, DOI 10.1182/blood-2008-07-167601; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Makkouk A, 2015, CANCER RES, V75, P5, DOI 10.1158/0008-5472.CAN-14-2538; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Ruella M, 2016, CLIN CANCER RES, V22, P2684, DOI 10.1158/1078-0432.CCR-15-1527; Rufer N, 2003, BLOOD, V102, P1779, DOI 10.1182/blood-2003-02-0420; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014	55	709	738	16	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					563	+		10.1038/s41591-018-0010-1	http://dx.doi.org/10.1038/s41591-018-0010-1			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29713085	Green Accepted			2022-12-27	WOS:000432126800012
J	Haubrich, J; Nader, K				Haubrich, Josue; Nader, Karim			A molecular mechanism governing memory precision	NATURE MEDICINE			English	Editorial Material							SYSTEMS CONSOLIDATION	A key molecular mechanism has been identified that dictates whether memory will maintain or lose its details over time and that is relevant in post-traumatic stress disorder and dementia.	[Haubrich, Josue; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Nader, K (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	karim.nader@mcgill.ca	Haubrich, Josue/W-4053-2019	Haubrich, Josue/0000-0002-3632-5566				Besnard A, 2016, NEUROPSYCHOPHARMACOL, V41, P24, DOI 10.1038/npp.2015.167; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Guo NN, 2018, NAT MED, V24, P438, DOI 10.1038/nm.4491; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Leal SL, 2015, TRENDS NEUROSCI, V38, P800, DOI 10.1016/j.tins.2015.10.003; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Wiltgen BJ, 2013, NEUROBIOL LEARN MEM, V106, P365, DOI 10.1016/j.nlm.2013.06.001	10	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					390	391		10.1038/nm.4532	http://dx.doi.org/10.1038/nm.4532			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634686				2022-12-27	WOS:000429639800009
J	Chakradhar, S				Chakradhar, Shraddha			Animals on the verge What different species can teach us about human puberty	NATURE MEDICINE			English	News Item							TRANSITION; GROWTH; AGE	We all go through it: The often-awkward years of adolescence, marked by puberty. This transition period has a dramatic effect, yet surprisingly little attention has been given to studying it. Researchers have even struggled to come up with a universal definition of puberty. Still, most agree that puberty is the process involving a cascade of hormonal events that allows a juvenile organism to become sexually mature. And, even though entering puberty alone might be sufficient for animals to reproduce, many organisms-humans included-tend to reproduce after this transition phase. Female macaques, for instance, can have babies when they are as young as three years old, but there's a higher rate of infant mortality at this age and they typically mate a little later. Among humans, teen moms have a higher risk of complications for themselves and their babies than those who give birth in their prime reproductive years. Puberty, by being a drawn-out process in many creatures, might help ease animals into reproductive maturity to ensure better survival of offspring, some scientists believe. What still confounds researchers in large part is what initially triggers puberty. Those who study the biochemical properties of puberty wonder whether environmental factors, an internal clock of some kind, or a combination of these determines when humans enter puberty. The answers to many such questions are being investigated in laboratory organisms, such as rodents. But unexpected insights are also coming from the study of an exotic mix across the animal kingdom. "Puberty is amazing in that it literally affects pretty much every species, and so there's a lot to be learned from all that diversity," says Melissa Holmes, a behavioral neuroscientist at the University of Toronto in Mississauga, Canada. "We know that most all animals go through this, so the devil is really in the details."										Barson NJ, 2015, NATURE, V528, P405, DOI 10.1038/nature16062; Bellofiore N, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.041; Bogin B, 1999, ANNU REV ANTHROPOL, V28, P109, DOI 10.1146/annurev.anthro.28.1.109; Chen WT, 2013, MOL REPROD DEV, V80, P384, DOI 10.1002/mrd.22172; Deardorff J, 2011, J ADOLESCENT HEALTH, V48, P441, DOI 10.1016/j.jadohealth.2010.07.032; Desaulniers AT, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00269; Edwards TM, 2004, GEN COMP ENDOCR, V135, P372, DOI 10.1016/j.ygcen.2003.11.003; Ellison PT, 2012, ANN HUM BIOL, V39, P352, DOI 10.3109/03014460.2012.693199; Hariharan IK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003238; Perfito N, 2015, ENDOCRINOLOGY, V156, P694, DOI 10.1210/en.2014-1450	10	7	7	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					114	117		10.1038/nm0218-114	http://dx.doi.org/10.1038/nm0218-114			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414929				2022-12-27	WOS:000424327200002
J	Kovar, H				Kovar, Heinrich			Selective enhancer changes in osteosarcoma lung metastasis	NATURE MEDICINE			English	Editorial Material							PANCREATIC-CANCER; HETEROGENEITY	A recent study investigates the contribution of epigenomic plasticity to lung metastasis in osteosarcoma. Changes in the enhancer landscape were found to be nonrandom and driven by selective forces in the microenvironment.	[Kovar, Heinrich] Childrens Canc Res Inst, St Anna Kinderkrebsforsch, Vienna, Austria; [Kovar, Heinrich] Med Univ, Dept Pediat, Vienna, Austria	Saint Anna Children's Hospital	Kovar, H (corresponding author), Childrens Canc Res Inst, St Anna Kinderkrebsforsch, Vienna, Austria.; Kovar, H (corresponding author), Med Univ, Dept Pediat, Vienna, Austria.	heinrich.kovar@ccri.at		Kovar, Heinrich/0000-0001-6873-9109				Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Morrow JJ, 2018, NAT MED, V24, P176, DOI 10.1038/nm.4475; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Sheffield NC, 2017, NAT MED, V23, P386, DOI 10.1038/nm.4273; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	10	8	11	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					126	127		10.1038/nm.4487	http://dx.doi.org/10.1038/nm.4487			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414935				2022-12-27	WOS:000424327200008
J	Nir, Y; Andrillon, T; Marmelshtein, A; Suthana, N; Cirelli, C; Tononi, G; Fried, I				Nir, Yuval; Andrillon, Thomas; Marmelshtein, Amit; Suthana, Nanthia; Cirelli, Chiara; Tononi, Giulio; Fried, Itzhak			Selective neuronal lapses precede human cognitive lapses following sleep deprivation	NATURE MEDICINE			English	Article							SINGLE-NEURON; HUMAN BRAIN; ATTENTION; WAKING; PERFORMANCE; ACTIVATION; CORTEX; EEG; WAKEFULNESS; RESPONSES	Sleep deprivation is a major source of morbidity with widespread health effects, including increased risk of hypertension, diabetes, obesity, heart attack, and stroke(1). Moreover, sleep deprivation brings about vehicle accidents and medical errors(2-4) and is therefore an urgent topic of investigation. During sleep deprivation, homeostatic and circadian processes interact to build up sleep pressure5, which results in slow behavioral performance (cognitive lapses) typically attributed to attentional thalamic and frontoparietal circuits(6-14), but the underlying mechanisms remain unclear(3,15). Recently, through study of electroencephalograms (EEGs) in humans(16,17) and local field potentials (LFPs) in nonhuman primates(18) and rodents(19) it was found that, during sleep deprivation, regional 'sleep-like' slow and theta (slow/theta) waves co-occur with impaired behavioral performance during wakefulness. Here we used intracranial electrodes to record single-neuron activities and LFPs in human neurosurgical patients performing a face/nonface categorization psychomotor vigilance task (PVT)(20-24) over multiple experimental sessions, including a session after fullnight sleep deprivation. We find that, just before cognitive lapses, the selective spiking responses of individual neurons in the medial temporal lobe (MTL) are attenuated, delayed, and lengthened. These 'neuronal lapses' are evident on a trial-by-trial basis when comparing the slowest behavioral PVT reaction times to the fastest. Furthermore, during cognitive lapses, LFPs exhibit a relative local increase in slow/theta activity that is correlated with degraded single-neuron responses and with baseline theta activity. Our results show that cognitive lapses involve local state-dependent changes in neuronal activity already present in the MTL.	[Nir, Yuval; Marmelshtein, Amit] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Nir, Yuval; Marmelshtein, Amit] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Andrillon, Thomas] Ecole Normale Super, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist UMR8554, Paris, France; [Andrillon, Thomas] Ecole Doctorale Cerveau Cognit Comportement, Paris, France; [Andrillon, Thomas; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biobehav Sci, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Fried, Itzhak] Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Nir, Y (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel.; Nir, Y (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.; Fried, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.; Fried, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA.; Fried, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biobehav Sci, Los Angeles, CA 90095 USA.; Fried, I (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.; Fried, I (corresponding author), Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, Tel Aviv, Israel.; Fried, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	ynir@post.tau.ac.il; gtononi@wisc.edu; ifried@mednet.ucla.edu	Andrillon, Thomas/P-6440-2019	Andrillon, Thomas/0000-0003-2794-8494; Nir, Yuval/0000-0002-5433-6349	Human Frontier Science Program (HFSP) Organization; Planning and Budgeting Committee of the Israeli Centers of Research Excellence (I-CORE) program; Israel Science Foundation [51/11]; FP7 Marie Curie Career Integration Grant; Adelis Foundation; Societe Francaise de Recherche et Medecine du Sommeil (SFRMS); Institute of Cognitive Studies of Ecole Normale Superieure (IEC-ENS) [ANR-10-LABX-0087, ANR-10-IDEX-0001-02]; National Institute of Mental Health (NIMH) [R01MH099231]; National Institute of Neurological Disorders and Stroke (NINDS) [P01NS083514]; National Institute of General Medical Sciences [R01GM116916]; NINDS [R01NS033221, R01NS084017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221, R01NS084017, P01NS083514] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) Organization; Planning and Budgeting Committee of the Israeli Centers of Research Excellence (I-CORE) program; Israel Science Foundation(Israel Science Foundation); FP7 Marie Curie Career Integration Grant; Adelis Foundation; Societe Francaise de Recherche et Medecine du Sommeil (SFRMS); Institute of Cognitive Studies of Ecole Normale Superieure (IEC-ENS); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the subjects for their cooperation; M. Tran, E. Behnke, T. Fields, H. Gelbard-Sagiv, and M. Sagiv for assistance with data acquisition; and B. Salaz and N. Regev for administrative help. This work was supported by a Human Frontier Science Program (HFSP) Organization long-term fellowship (Y.N.), the Planning and Budgeting Committee of the Israeli Centers of Research Excellence (I-CORE) program and the Israel Science Foundation (grant no. 51/11, Y.N.), the FP7 Marie Curie Career Integration Grant (Y.N.), the Adelis Foundation (Y.N.), Societe Francaise de Recherche et Medecine du Sommeil (SFRMS, T.A.), the Institute of Cognitive Studies of Ecole Normale Superieure (IEC-ENS) (ANR-10-LABX-0087 and ANR-10-IDEX-0001-02 PSL*, T. A.), National Institute of Mental Health (NIMH) grant no. R01MH099231 (C.C. and G.T.), National Institute of Neurological Disorders and Stroke (NINDS) grant no. P01NS083514 (C.C. and G.T.), National Institute of General Medical Sciences grant no. R01GM116916 (G.T.), and NINDS grant nos. R01NS033221 and R01NS084017 (I.F.).	Andrillon T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8884; Basner M, 2013, CURR OPIN NEUROBIOL, V23, P854, DOI 10.1016/j.conb.2013.02.008; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bernardi G, 2015, J NEUROSCI, V35, P4487, DOI 10.1523/JNEUROSCI.4567-14.2015; Borbely A A, 1982, Hum Neurobiol, V1, P195; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Colten H. R., 2006, SLEEP DISORDERS SLEE; DAWSON MRW, 1988, BEHAV RES METH INSTR, V20, P54, DOI 10.3758/BF03202603; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2005, SLEEP, V28, P1059; Duffy Jeanne F, 2015, Rev Hum Factors Ergon, V10, P29; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hung CS, 2013, SLEEP, V36, P59, DOI 10.5665/sleep.2302; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Ma N, 2015, SLEEP, V38, P233, DOI 10.5665/sleep.4404; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Padilla ML, 2006, J COGNITIVE NEUROSCI, V18, P1477, DOI 10.1162/jocn.2006.18.9.1477; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Pigarev IN, 1997, NEUROREPORT, V8, P2557, DOI 10.1097/00001756-199707280-00027; Portas CM, 1998, J NEUROSCI, V18, P8979; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Suthana N, 2012, TRENDS COGN SCI, V16, P427, DOI 10.1016/j.tics.2012.06.006; Suthana NA, 2015, P NATL ACAD SCI USA, V112, P10503, DOI 10.1073/pnas.1423036112; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2003, J SLEEP RES, V12, P181, DOI 10.1046/j.1365-2869.2003.00357.x; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166	48	82	85	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1474	+		10.1038/nm.4433	http://dx.doi.org/10.1038/nm.4433			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29106402	Green Accepted			2022-12-27	WOS:000417278200017
J	Rauber, S; Luber, M; Weber, S; Maul, L; Soare, A; Wohlfahrt, T; Lin, NY; Dietel, K; Bozec, A; Herrmann, M; Kaplan, MH; Weigmann, B; Zaiss, MM; Fearon, U; Veale, DJ; Canete, JD; Distler, O; Rivellese, F; Pitzalis, C; Neurath, MF; McKenzie, ANJ; Wirtz, S; Schett, G; Distler, JHW; Ramming, A				Rauber, Simon; Luber, Markus; Weber, Stefanie; Maul, Lisa; Soare, Alina; Wohlfahrt, Thomas; Lin, Neng-Yu; Dietel, Katharina; Bozec, Aline; Herrmann, Martin; Kaplan, Mark H.; Weigmann, Benno; Zaiss, Mario M.; Fearon, Ursula; Veale, Douglas J.; Canete, Juan D.; Distler, Oliver; Rivellese, Felice; Pitzalis, Costantino; Neurath, Markus F.; McKenzie, Andrew N. J.; Wirtz, Stefan; Schett, Georg; Distler, Joerg H. W.; Ramming, Andreas			Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR PU.1; T-CELLS; GROWTH-FACTOR; IL-9; ARTHRITIS; RECEPTOR; IMAGE; DIFFERENTIATION; INDUCTION; PROMOTES	Inflammatory diseases such as arthritis are chronic conditions that fail to resolve spontaneously. While the cytokine and cellular pathways triggering arthritis are well defined, those responsible for the resolution of inflammation are incompletely characterized. Here we identified interleukin (IL)-9-producing type 2 innate lymphoid cells (ILC2s) as the mediators of a molecular and cellular pathway that orchestrates the resolution of chronic inflammation. In mice, the absence of IL-9 impaired ILC2 proliferation and activation of regulatory T (T-reg) cells, and resulted in chronic arthritis with excessive cartilage destruction and bone loss. In contrast, treatment with IL-9 promoted ILC2-dependent T-reg activation and effectively induced resolution of inflammation and protection of bone. Patients with rheumatoid arthritis in remission exhibited high numbers of IL-9(+) ILC2s in joints and the circulation. Hence, fostering IL-9-mediated ILC2 activation may offer a novel therapeutic approach inducing resolution of inflammation rather than suppression of inflammatory responses.	[Ramming, Andreas] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany; [Rauber, Simon; Ramming, Andreas] Univ Klinkum Erlangen, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Ramming, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany.; Ramming, A (corresponding author), Univ Klinkum Erlangen, Erlangen, Germany.	andreas.ramming@uk-erlangen.de	Cañete, Juan D/AAV-8910-2021; crespillo, Juan D. cañete/M-4428-2017; Rivellese, Felice/AAA-6290-2020; Herrmann, Martin/A-9597-2013; Bozec, Aline/M-6942-2015; Rauber, Simon/L-6550-2019; Zaiss, Mario M./ABE-7125-2021; Distler, Oliver/AAE-6225-2019; herrmann, martin/AAT-9836-2020	Cañete, Juan D/0000-0003-2606-0573; crespillo, Juan D. cañete/0000-0003-2606-0573; Rivellese, Felice/0000-0002-6759-7521; Herrmann, Martin/0000-0002-0258-2484; Bozec, Aline/0000-0001-8174-2118; Rauber, Simon/0000-0001-8306-9334; Zaiss, Mario M./0000-0003-3844-1664; Distler, Oliver/0000-0002-0546-8310; Kaplan, Mark/0000-0002-2923-8245; Veale, Douglas/0000-0003-2802-4971; LIN, NENG-YU/0000-0003-0746-0483; Pitzalis, Costantino/0000-0003-1326-5051; Fearon, Ursula/0000-0001-8084-0429	Deutsche Forschungsgemeinschaft [RA 2506/3-1, RA 2506/4-1, DI 1537/5-1, DI 1537/7-1, DI 1537/8-1, DI 1537/9-1, AK 144/2-1, DI 1537/11-1, SCHE 1583/7-1, SPP1468-IMMUNOBONE, CRC1181]; Bundesministerium fur Bildung und Forschung (METHARTHROS); Marie Curie project OSTEOIMMUNE; European Union; IMI; Else Kroner-Fresenius-Stiftung [2014_A184]; Wilhelm Sander Foundation [2013.056.1]; Interdisciplinary Centre for Clinical Research, Erlangen [A64]; ELAN Fonds of the Universitatsklinikum Erlangen [16-10-05-1]; Medicine of the Ernst Jung Foundation; SNF Sinergia [CRSII3_154490]; UK MRC [UI015178805]; Wellcome Trust [100963/Z/13/Z]; US NIH [AI057459]; Medical Research Council [G0800648, MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805, G0800648] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057459, R01AI129241] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (METHARTHROS)(Federal Ministry of Education & Research (BMBF)); Marie Curie project OSTEOIMMUNE; European Union(European Commission); IMI; Else Kroner-Fresenius-Stiftung; Wilhelm Sander Foundation; Interdisciplinary Centre for Clinical Research, Erlangen; ELAN Fonds of the Universitatsklinikum Erlangen; Medicine of the Ernst Jung Foundation; SNF Sinergia; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank M. Pascual, K. Dreissigacker, R. Kleinlein, M. Comazzi, D. Weidner and B. Happich for excellent technical assistance. We thank U. Appelt and M. Mroz of the Core Unit Cell Sorting and Immunomonitoring Erlangen for cell sorting. This work was supported by the Deutsche Forschungsgemeinschaft (RA 2506/3-1 and RA 2506/4-1 to A.R.; DI 1537/5-1, DI 1537/7-1, DI 1537/8-1, DI 1537/9-1, AK 144/2-1 and DI 1537/11-1 to J.H.W.D.; SCHE 1583/7-1 to G.S.; SPP1468-IMMUNOBONE and CRC1181 to G.S. and J.H.W.D.), the Bundesministerium fur Bildung und Forschung (METHARTHROS to G.S. and J.H.W.D.), the Marie Curie project OSTEOIMMUNE (to G.S. and J.H.W.D.), the TEAM project of the European Union and the IMI-funded project RTCure (to G.S.), Else Kroner-Fresenius-Stiftung 2014_A184 (to A.R.), the Wilhelm Sander Foundation (2013.056.1 to J.H.W.D.), the Interdisciplinary Centre for Clinical Research, Erlangen (A64 to J.H.W.D.; J40 to A.R.), the ELAN Fonds of the Universitatsklinikum Erlangen (16-10-05-1 to A.R.), the Career Support Award of Medicine of the Ernst Jung Foundation (to J.H.W.D.), SNF Sinergia CRSII3_154490 (to O.D.), the UK MRC (UI015178805; to A.N.J.M.), the Wellcome Trust (100963/Z/13/Z to A.N.J.M.) and US NIH grant AI057459 (to M.H.K.).	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Ciccia F, 2015, RHEUMATOLOGY, V54, P2264, DOI 10.1093/rheumatology/kev252; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kehoe O, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-157; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kundu-Raychaudhuri S, 2016, CYTOKINE, V79, P45, DOI 10.1016/j.cyto.2015.12.020; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ramming A, 2012, BLOOD, V119, P4665, DOI 10.1182/blood-2011-11-392589; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schett G, 2013, NAT MED, V19, P822, DOI 10.1038/nm.3260; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	40	181	190	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					938	+		10.1038/nm.4373	http://dx.doi.org/10.1038/nm.4373			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28714991	Green Accepted			2022-12-27	WOS:000406947600009
J	Giles, DA; Moreno-Fernandez, ME; Stankiewicz, TE; Graspeuntner, S; Cappelletti, M; Wu, D; Mukherjee, R; Chan, CC; Lawson, MJ; Klarquist, J; Sunderhauf, A; Softic, S; Kahn, CR; Stemmer, K; Iwakura, Y; Aronow, BJ; Karns, R; Steinbrecher, KA; Karp, CL; Sheridan, R; Shanmukhappa, SK; Reynaud, D; Haslam, DB; Sina, C; Rupp, J; Hogan, SP; Divanovic, S				Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Graspeuntner, Simon; Cappelletti, Monica; Wu, David; Mukherjee, Rajib; Chan, Calvin C.; Lawson, Matthew J.; Klarquist, Jared; Suenderhauf, Annika; Softic, Samir; Kahn, C. Ronald; Stemmer, Kerstin; Iwakura, Yoichiro; Aronow, Bruce J.; Karns, Rebekah; Steinbrecher, Kris A.; Karp, Christopher L.; Sheridan, Rachel; Shanmukhappa, Shiva K.; Reynaud, Damien; Haslam, David B.; Sina, Christian; Rupp, Jan; Hogan, Simon P.; Divanovic, Senad			Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling	NATURE MEDICINE			English	Article							STEATOHEPATITIS NASH; INFLAMMATION; OBESITY; MOUSE; TEMPERATURE; ACTIVATION; RESISTANCE; EXPRESSION; RECEPTORS; RESPONSES	Nonalcoholic fatty liver disease (NAFLD), a common prelude to cirrhosis and hepatocellular carcinoma, is the most common chronic liver disease worldwide. Defining the molecular mechanisms underlying the pathogenesis of NAFLD has been hampered by a lack of animal models that closely recapitulate the severe end of the disease spectrum in humans, including bridging hepatic fibrosis. Here we demonstrate that a novel experimental model employing thermoneutral housing, as opposed to standard housing, resulted in lower stress-driven production of corticosterone, augmented mouse proinflammatory immune responses and markedly exacerbated high-fat diet (HFD)-induced NAFLD pathogenesis. Disease exacerbation at thermoneutrality was conserved across multiple mouse strains and was associated with augmented intestinal permeability, an altered microbiome and activation of inflammatory pathways that are associated with the disease in humans. Depletion of Gram-negative microbiota, hematopoietic cell deletion of Toll-like receptor 4 (TLR4) and inactivation of the IL-17 axis resulted in altered immune responsiveness and protection from thermoneutral-housing-driven NAFLD amplification. Finally, female mice, typically resistant to HFD-induced obesity and NAFLD, develop full disease characteristics at thermoneutrality. Thus, thermoneutral housing provides a sex-independent model of exacerbated NAFLD in mice and represents a novel approach for interrogation of the cellular and molecular mechanisms underlying disease pathogenesis.	[Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Mukherjee, Rajib; Chan, Calvin C.; Lawson, Matthew J.; Klarquist, Jared; Divanovic, Senad] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA; [Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Wu, David; Mukherjee, Rajib; Chan, Calvin C.; Lawson, Matthew J.; Klarquist, Jared; Aronow, Bruce J.; Karns, Rebekah; Steinbrecher, Kris A.; Sheridan, Rachel; Shanmukhappa, Shiva K.; Reynaud, Damien; Haslam, David B.; Hogan, Simon P.; Divanovic, Senad] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Giles, Daniel A.; Chan, Calvin C.; Klarquist, Jared] Cincinnati Childrens Hosp Med Ctr, Immunol Grad Program, Cincinnati, OH 45229 USA; [Graspeuntner, Simon; Rupp, Jan] Univ Lubeck, Dept Infect Dis & Microbiol, Lubeck, Germany; [Wu, David; Hogan, Simon P.] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH USA; [Suenderhauf, Annika; Sina, Christian] Univ Hosp Schleswig Holstein, Inst Nutr Med, Campus Lubeck, Lubeck, Germany; [Softic, Samir; Kahn, C. Ronald] Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Stemmer, Kerstin] Helmholtz Diabet Ctr, Inst Diabet & Obes, Neuherberg, Germany; [Stemmer, Kerstin] Helmholtz Zentrum Munchen, German Ctr Diabet Res DZD, Neuherberg, Germany; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba, Japan; [Aronow, Bruce J.] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Biomed Informat, Cincinnati, OH USA; [Karns, Rebekah; Steinbrecher, Kris A.] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Karp, Christopher L.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sheridan, Rachel; Shanmukhappa, Shiva K.] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Pathol & Lab Med, Cincinnati, OH USA; [Reynaud, Damien] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Haslam, David B.] Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Infect Dis, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Lubeck; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Kiel; Schleswig Holstein University Hospital; Harvard University; Joslin Diabetes Center, Inc.; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Tokyo University of Science; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Bill & Melinda Gates Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Divanovic, S (corresponding author), Cincinnati Childrens Hosp Res Fdn, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA.; Divanovic, S (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.	senad.divanovic@cchmc.org	Rupp, Jan/C-8794-2011; Graspeuntner, Simon/B-2176-2013; Mukherjee, Rajib/J-9195-2019; Haslam, David/AAS-3175-2020; Kahn, Ronald/AAY-2435-2021; Softic, Samir/ABD-4612-2020; Graspeuntner, Simon/S-2036-2019; Chan, Calvin/S-4496-2017	Rupp, Jan/0000-0001-8722-1233; Graspeuntner, Simon/0000-0002-2546-2223; Mukherjee, Rajib/0000-0002-3509-4997; Kahn, Ronald/0000-0002-7583-9228; Graspeuntner, Simon/0000-0002-2546-2223; Reynaud, Damien/0000-0001-8765-8419; Sunderhauf, Annika/0000-0003-0591-8809; Stemmer, Kerstin/0000-0002-7526-2326; Chan, Calvin/0000-0002-9933-3061	NIH [R01DK099222, R01DK099222-S1, T32AI118697]; CCHMC Pediatric Diabetes and Obesity Center initiative; NIEHS [P30 ES006096]; PHS [P30 DK078392]; German Research Foundation [IRTG 1911];  [R01DK033201];  [K12-HD000850]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, T32AI118697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099222, P30DK078392, R01DK033201, R24DK085610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCHMC Pediatric Diabetes and Obesity Center initiative; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); German Research Foundation(German Research Foundation (DFG)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by NIH R01DK099222 and R01DK099222-S1 (to S.D.), the CCHMC Pediatric Diabetes and Obesity Center initiative (to S.D.), R01DK033201 (to C.R.K.), K12-HD000850 (to S.S.), NIH T32AI118697 (associated with D.A.G.), NIEHS Grant P30 ES006096 University of Cincinnati Center for Environmental Genomics (associated with D.A.G.), PHS Grant P30 DK078392 Pathology of the Digestive Disease Research Core Center at CCHMC (associated with S.D.) and German Research Foundation IRTG 1911 (projects A6 and B8 to C.S. and J.R.). We would also like to acknowledge C. Chougnet (CCHMC) for providing access to human PBMC samples and C. Woods (CCHMC) for technical assistance.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Alisi A, 2014, EXPERT REV MOL DIAGN, V14, P763, DOI 10.1586/14737159.2014.928205; Athyros VG, 2015, WORLD J GASTROENTERO, V21, P6820, DOI 10.3748/wjg.v21.i22.6820; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castaneda TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032631; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001316; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Eng JWL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7426; Finkelman F., 2003, CURR PROTOC IMMUNOL, V54; Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112; Giles DA, 2016, MOL METAB, V5, P1121, DOI 10.1016/j.molmet.2016.09.008; Giles DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149783; Giles DA, 2015, CURR DRUG TARGETS, V16, P1315, DOI 10.2174/1389450116666150531153627; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; Harley ITW, 2014, HEPATOLOGY, V59, P1830, DOI 10.1002/hep.26746; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988; Kiziltas S, 2014, METAB SYNDR RELAT D, V12, P165, DOI 10.1089/met.2013.0120; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kox M, 2014, P NATL ACAD SCI USA, V111, P7379, DOI 10.1073/pnas.1322174111; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li L., 2011, CHIN J PROCESS ENG, V1, P1; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Maloney SK, 2014, PHYSIOLOGY, V29, P413, DOI 10.1152/physiol.00029.2014; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; McKee C, 2013, BIOCHEM BIOPH RES CO, V437, P597, DOI 10.1016/j.bbrc.2013.07.005; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Moragues V, 1944, J EXP MED, V79, P41, DOI 10.1084/jem.79.1.41; Nagaya T, 2010, J HEPATOL, V53, P724, DOI 10.1016/j.jhep.2010.04.033; Overton JM, 2010, INT J OBESITY, V34, pS53, DOI 10.1038/ijo.2010.240; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; Puddu A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/162021; Rahman K, 2016, GASTROENTEROLOGY, V151, P733, DOI 10.1053/j.gastro.2016.06.022; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Rau M, 2016, J IMMUNOL, V196, P97, DOI 10.4049/jimmunol.1501175; do Nascimento JHR, 2013, ACAD RADIOL, V20, P1436, DOI 10.1016/j.acra.2013.08.016; Rinella ME, 2011, HEPATOLOGY, V54, P1118, DOI 10.1002/hep.24634; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sorrentino P, 2010, AM J GASTROENTEROL, V105, P336, DOI 10.1038/ajg.2009.587; Stemmer K, 2015, INT J OBESITY, V39, P791, DOI 10.1038/ijo.2014.187; Swoap SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1581, DOI 10.1152/ajpheart.01000.2007; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Tian XY, 2016, CELL METAB, V23, P165, DOI 10.1016/j.cmet.2015.10.003; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vespasiani-Gentilucci U, 2015, LIVER INT, V35, P569, DOI 10.1111/liv.12531; Wahle M, 2005, J INTERF CYTOK RES, V25, P384, DOI 10.1089/jir.2005.25.384; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Wu D, 2011, J BIOL CHEM, V286, P13357, DOI 10.1074/jbc.M110.214965; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	71	113	117	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					829	+		10.1038/nm.4346	http://dx.doi.org/10.1038/nm.4346			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28604704	Green Accepted, Green Submitted			2022-12-27	WOS:000405180100011
J	Fujiu, K; Shibata, M; Nakayama, Y; Ogata, F; Matsumoto, S; Noshita, K; Iwami, S; Nakae, S; Komuro, I; Nagai, R; Manabe, I				Fujiu, Katsuhito; Shibata, Munehiko; Nakayama, Yukiteru; Ogata, Fusa; Matsumoto, Sahohime; Noshita, Koji; Iwami, Shingo; Nakae, Susumu; Komuro, Issei; Nagai, Ryozo; Manabe, Ichiro			A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation	NATURE MEDICINE			English	Article							RENAL DENERVATION; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; CARDIORENAL SYNDROME; NEUROTROPHIC FACTOR; STEADY-STATE; CELLS; DYSFUNCTION; RECEPTOR; FAILURE	Heart failure is a complex clinical syndrome characterized by insufficient cardiac function. In addition to abnormalities intrinsic to the heart, dysfunction of other organs and dysregulation of systemic factors greatly affect the development and consequences of heart failure. Here we show that the heart and kidneys function cooperatively in generating an adaptive response to cardiac pressure overload. In mice subjected to pressure overload in the heart, sympathetic nerve activation led to activation of renal collecting-duct (CD) epithelial cells. Cell-cell interactions among activated CD cells, tissue macrophages and endothelial cells within the kidney led to secretion of the cytokine CSF2, which in turn stimulated cardiac-resident Ly6C(lo) macrophages, which are essential for the myocardial adaptive response to pressure overload. The renal response to cardiac pressure overload was disrupted by renal sympathetic denervation, adrenergic beta 2-receptor blockade or CD-cell-specific deficiency of the transcription factor KLF5. Moreover, we identified amphiregulin as an essential cardioprotective mediator produced by cardiac Ly6C(lo) macrophages. Our results demonstrate a dynamic interplay between the heart, brain and kidneys that is necessary for adaptation to cardiac stress, and they highlight the homeostatic functions of tissue macrophages and the sympathetic nervous system.	[Fujiu, Katsuhito; Shibata, Munehiko; Nakayama, Yukiteru; Ogata, Fusa; Matsumoto, Sahohime; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Fujiu, Katsuhito] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo, Japan; [Fujiu, Katsuhito; Iwami, Shingo; Nakae, Susumu] Japan Sci & Technol Agcy JST, PRESTO, Res Div, Gobancho Bldg, Tokyo, Japan; [Noshita, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Iwami, Shingo] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan; [Iwami, Shingo] Japan Sci & Technol Agcy, CREST, Res Div, Gobancho Bldg, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Lab Syst Biol, Tokyo, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Manabe, Ichiro] Chiba Univ, Grad Sch Med, Dept Dis Biol & Mol Med, Chiba, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Kyushu University; Japan Science & Technology Agency (JST); University of Tokyo; Jichi Medical University; Chiba University	Nagai, R (corresponding author), Jichi Med Univ, Shimotsuke, Tochigi, Japan.; Manabe, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Dis Biol & Mol Med, Chiba, Japan.	rnagai@jichi.ac.jp; manabe-tky@umin.ac.jp	Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021; Noshita, Koji/AAQ-9345-2020	Noshita, Koji/0000-0002-9510-5897	Japan Society for the Promotion of Science; MEXT Japan [26461125, 15H01506, 16H05295, 16K15437]; MEXT; AMED-CREST from the Japan Agency for Medical Research and Development (AMED); PRESTO from JST; Kanae foundation; Japan Research Promotion Society for Cardiovascular Diseases; Banyu Life Science Foundation; Takeda Science Foundation; Mitsubishi Foundation; SENSHIN Medical Science Foundation; Grants-in-Aid for Scientific Research [15H01506, 17H05594, 15H04824] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); PRESTO from JST(Japan Science & Technology Agency (JST)); Kanae foundation; Japan Research Promotion Society for Cardiovascular Diseases; Banyu Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; SENSHIN Medical Science Foundation(SENSHIN Medical Research FoundationMukai Science and Technology FoundationKayamori FoundationFukuda Foundation for Medical TechnologyInoue Foundation for Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We gratefully acknowledge the excellent technical assistance of M. Hayashi, N. Yamanaka, A. Ono, X. Yingda and H. Tomita. Areg-knockout mice were a generous gift from D. Lee (University of Georgia). This study was supported in part by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (R.N.), and by grants-in-aid (26461125 (K.F.), 15H01506 (I.M.), 16H05295 (I.M.), 16K15437 ((I.M.))) from the MEXT Japan, a grant for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of MEXT (R.N.), the AMED-CREST from the Japan Agency for Medical Research and Development (AMED) (I.M.), PRESTO from JST (K.F.), grants from the Kanae foundation (K.F.); a Sakakibara Memorial Research Grant from the Japan Research Promotion Society for Cardiovascular Diseases (K.F.), the Banyu Life Science Foundation (K.F.), the Takeda Science Foundation (I.M.), the Mitsubishi Foundation (I.M.), and the SENSHIN Medical Science Foundation (I.M.).	Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Birks EJ, 2011, CIRCULATION, V123, P381, DOI 10.1161/CIRCULATIONAHA.109.933960; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660; Damman K, 2011, PROG CARDIOVASC DIS, V54, P144, DOI 10.1016/j.pcad.2011.01.003; Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; GOUGH NM, 1984, NATURE, V309, P763, DOI 10.1038/309763a0; Haque MZ, 2004, HYPERTENSION, V43, P335, DOI 10.1161/01.HYP.0000111137.15873.4a; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Johnson RA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-10-j0005.2000; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kim SM, 2007, AM J PHYSIOL-RENAL, V292, pF415, DOI 10.1152/ajprenal.00317.2006; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li LJ, 2013, AM J PHYSIOL-RENAL, V304, pF279, DOI 10.1152/ajprenal.00161.2012; Li XC, 2009, KIDNEY INT, V76, P169, DOI 10.1038/ki.2009.134; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Munoz C, 1996, BLOOD, V88, P3482, DOI 10.1182/blood.V88.9.3482.bloodjournal8893482; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naito K, 2008, J IMMUNOL, V181, P5691, DOI 10.4049/jimmunol.181.8.5691; Nelson RD, 1998, AM J PHYSIOL-CELL PH, V275, pC216, DOI 10.1152/ajpcell.1998.275.1.C216; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; OLIVER JA, 1980, AM J PHYSIOL, V239, pF371, DOI 10.1152/ajprenal.1980.239.4.F371; Parissis JT, 2003, J INTERF CYTOK RES, V23, P329, DOI 10.1089/107999003766628179; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Salman IM, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0571-z; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; Spach MS, 2004, HEART RHYTHM, V1, P500, DOI 10.1016/j.hrthm.2004.06.010; Stegbauer J, 2011, J AM SOC NEPHROL, V22, P2237, DOI 10.1681/ASN.2010101095; Stender RN, 2007, J AM ASSOC LAB ANIM, V46, P47; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Tilley DG, 2014, CIRCULATION, V130, P1800, DOI 10.1161/CIRCULATIONAHA.114.010434; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Verloop WL, 2013, EUR J HEART FAIL, V15, P1429, DOI 10.1093/eurjhf/hft119; Wang HJ, 2014, HYPERTENSION, V64, P745, DOI 10.1161/HYPERTENSIONAHA.114.03699; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064611; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; Woo AYH, 2015, BRIT J PHARMACOL, V172, P5444, DOI 10.1111/bph.12965; Yamada H, 2010, BIOCHEM BIOPH RES CO, V397, P425, DOI 10.1016/j.bbrc.2010.05.112; Yan D, 2013, INT J CARDIOL, V164, P334, DOI 10.1016/j.ijcard.2011.07.026; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	69	89	94	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					611	+		10.1038/nm.4326	http://dx.doi.org/10.1038/nm.4326			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28394333				2022-12-27	WOS:000400650700016
J	Abi-Dargham, A; Horga, G				Abi-Dargham, Anissa; Horga, Guillermo			The search for imaging biomarkers in psychiatric disorders	NATURE MEDICINE			English	Article							VOXEL-BASED MORPHOMETRY; COCAINE DEPENDENCE; SCHIZOPHRENIA; PSYCHOSIS; DOPAMINE; DEPRESSION; PATTERN; NEUROINFLAMMATION; CLASSIFICATION; METAANALYSIS	The field of medicine is moving toward the use of biomarkers for the optimization of individualized care. This is a particular challenge for the field of psychiatry, in which diagnosis is based on a descriptive collection of behaviors without the availability of any objective test to stratify patients. Neuroimaging techniques such as molecular imaging with positron-emission tomography (PET) or structural and functional magnetic resonance imaging (MRI) provide an opportunity to bring psychiatry from an era of subjective descriptive classification into objective and tangible brain-based measures. Here we provide steps toward the development of robust, reliable and valid biomarkers. The success of such development is crucial because it will enable the field of psychiatry to move forward into the era of modern medicine.	[Abi-Dargham, Anissa; Horga, Guillermo] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Abi-Dargham, Anissa; Horga, Guillermo] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Abi-Dargham, Anissa] Columbia Univ, Dept Radiol, New York, NY 10027 USA	Columbia University; New York State Psychiatry Institute; Columbia University	Abi-Dargham, A (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.; Abi-Dargham, A (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.; Abi-Dargham, A (corresponding author), Columbia Univ, Dept Radiol, New York, NY 10027 USA.	aa324@cumc.columbia.edu	Horga, Guillermo/M-8036-2016	Horga, Guillermo/0000-0002-9049-9786	US National Institutes of Health [K23MH101637]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH101637] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	G.H. is funded by the US National Institutes of Health (grant K23MH101637).	Addington J, 2015, J NERV MENT DIS, V203, P328, DOI 10.1097/NMD.0000000000000290; Bansal R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050698; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Demjaha A, 2012, AM J PSYCHIAT, V169, P1203, DOI 10.1176/appi.ajp.2012.12010144; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; El Achkar CM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0559-8; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fritz HC, 2014, NEUROPSYCHOPHARMACOL, V39, P2594, DOI 10.1038/npp.2014.112; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Horga G, 2014, J CHILD PSYCHOL PSYC, V55, P659, DOI 10.1111/jcpp.12185; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Huys QJM, 2016, NAT NEUROSCI, V19, P404, DOI 10.1038/nn.4238; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kenk M, 2015, SCHIZOPHRENIA BULL, V41, P85, DOI 10.1093/schbul/sbu157; Kessler RC, 2008, AM J PSYCHIAT, V165, P703, DOI 10.1176/appi.ajp.2008.08010126; Konova AB, 2012, EUR J NEUROSCI, V36, P2979, DOI 10.1111/j.1460-9568.2012.08211.x; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Laughren TP, 2010, J CLIN PSYCHIAT, V71, P1196, DOI 10.4088/JCP.10m06262gry; Marquand AF, 2012, NEUROIMAGE, V60, P1015, DOI 10.1016/j.neuroimage.2012.01.058; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Martinez D, 2012, BIOL PSYCHIAT, V71, P192, DOI 10.1016/j.biopsych.2011.08.024; Martinez D, 2011, AM J PSYCHIAT, V168, P634, DOI 10.1176/appi.ajp.2010.10050748; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Normanno N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1147-7; Perlis RH, 2011, MOL PSYCHIATR, V16, P1076, DOI 10.1038/mp.2011.63; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Radua J, 2015, JAMA PSYCHIAT, V72, P1243, DOI 10.1001/jamapsychiatry.2015.2196; Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70; Schmaal L., 2016, MOL PSYCHIAT; Schnack HG, 2014, NEUROIMAGE, V84, P299, DOI 10.1016/j.neuroimage.2013.08.053; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Schobel SA, 2009, ARCH GEN PSYCHIAT, V66, P938, DOI 10.1001/archgenpsychiatry.2009.115; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Slifstein M, 2015, JAMA PSYCHIAT, V72, P316, DOI 10.1001/jamapsychiatry.2014.2414; Soni A., 2009, 5 MOST COSTLY CONDIT, P1; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Van Snellenberg JX, 2016, BIOL PSYCHIAT, V80, P617, DOI 10.1016/j.biopsych.2016.02.017	42	105	105	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1248	1255		10.1038/nm.4190	http://dx.doi.org/10.1038/nm.4190			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783066				2022-12-27	WOS:000387302300016
J	Linnemann, C; van Buuren, MM; Bies, L; Verdegaal, EME; Schotte, R; Calis, JJA; Behjati, S; Velds, A; Hilkmann, H; el Atmioui, D; Visser, M; Stratton, MR; Haanen, JBAG; Spits, H; van der Burg, SH; Schumacher, TNM				Linnemann, Carsten; van Buuren, Marit M.; Bies, Laura; Verdegaal, Els M. E.; Schotte, Remko; Calis, Jorg J. A.; Behjati, Sam; Velds, Arno; Hilkmann, Henk; el Atmioui, Dris; Visser, Marten; Stratton, Michael R.; Haanen, John B. A. G.; Spits, Hergen; van der Burg, Sjoerd H.; Schumacher, Ton N. M.			High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma (vol 21, pg 81, 2015)	NATURE MEDICINE			English	Correction													Verdegaal, Elizabeth/Y-2597-2018; Schumacher, Ton/Y-2432-2019; van der Burg, Sjoerd H/T-1875-2017; Haanen, John/AAD-8534-2022; Haanen, John/AAD-8578-2022	Verdegaal, Elizabeth/0000-0002-4449-8707; Schumacher, Ton/0000-0003-0517-8804; van der Burg, Sjoerd H/0000-0002-6556-0354; Haanen, John/0000-0001-5884-7704; Velds, Arno/0000-0003-4333-8872				Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773	1	6	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1192	1192		10.1038/nm1016-1192d	http://dx.doi.org/10.1038/nm1016-1192d			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711057	Bronze			2022-12-27	WOS:000384872500026
J	Wang, YM; Zhao, Z; Rege, SV; Wang, M; Si, G; Zhou, Y; Wang, S; Griffin, JH; Goldman, SA; Zlokovic, BV				Wang, Yaoming; Zhao, Zhen; Rege, Sanket V.; Wang, Min; Si, Gabriel; Zhou, Yi; Wang, Su; Griffin, John H.; Goldman, Steven A.; Zlokovic, Berislav V.			3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice	NATURE MEDICINE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ISCHEMIC-STROKE; THERAPEUTIC WINDOW; NEUROGENESIS; ANALOG; BRAIN; MOUSE; APOPTOSIS; 3K3A-APC; DEFICITS	Activated protein C (APC) is a blood protease with anticoagulant activity and cell-signaling activities mediated by the activation of protease-activated receptor 1 (F2R, also known as PAR1) and F2RL1 (also known as PAR3) via noncanonical cleavage(1). Recombinant variants of APC, such as the 3K3A-APC (Lys191-193Ala) mutant in which three Lys residues (KKK191-193) were replaced with alanine, and/or its other mutants with reduced (> 90%) anticoagulant activity, engineered to reduce APC-associated bleeding risk while retaining normal cell-signaling activity, have shown benefits in preclinical models of ischemic stroke(2-6), brain trauma(7), multiple sclerosis(8), amyotrophic lateral sclerosis(9), sepsis(10,11), ischemic and reperfusion injury of heart(12), kidney and liver(13), pulmonary, kidney and gastrointestinal inflammation(1,11), diabetes(14) and lethal body radiation(15). On the basis of proof-of-concept studies and an excellent safety profile in humans, 3K3A-APC has advanced to clinical trials as a neuroprotectant in ischemic stroke(16,17). Recently, 3K3A-APC has been shown to stimulate neuronal production by human neural stem and progenitor cells (NSCs) in vitro18 via a PAR1-PAR3-sphingosine-1-phosphate-receptor 1-Akt pathway(19), which suggests the potential for APC-based treatment as a strategy for structural repair in the human central nervous (CNS) system. Here we report that late postischemic treatment of mice with 3K3A-APC stimulates neuronal production by transplanted human NSCs, promotes circuit restoration and improves functional recovery. Thus, 3K3A-APC-potentiated neuronal recruitment from engrafted NSCs might offer a new approach to the treatment of stroke and related neurological disorders.	[Wang, Yaoming; Zhao, Zhen; Rege, Sanket V.; Wang, Min; Si, Gabriel; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Wang, Yaoming; Zhao, Zhen; Rege, Sanket V.; Wang, Min; Si, Gabriel; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Zhou, Yi] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing, Peoples R China; [Wang, Su; Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Wang, Su; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Wang, Su; Goldman, Steven A.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, Copenhagen, Denmark; [Griffin, John H.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Griffin, John H.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA	University of Southern California; University of Southern California; Army Medical University; University of Rochester; University of Rochester; University of Copenhagen; Scripps Research Institute; University of California System; University of California San Diego	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Zlokovic, Berislav/ABE-7362-2020; zhao, zhen/A-2080-2012	Zlokovic, Berislav/0000-0002-6802-8232; zhao, zhen/0000-0001-8967-5570; Griffin, John/0000-0002-4302-2547; Goldman, Steven/0000-0002-5498-4303	NIH [9R01NS090904-16, RO1HL052246, PO1 HL031950, R01NS75345]; National Natural Science Foundation of China [31371116]; Adelson Medical Research Foundation; New York State Stem Cell Research Board (NYSTEM); Novo Nordisk Foundation; Lundbeck Foundation; National Multiple Sclerosis Society; ALS Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052246, P01HL031950, R01HL021544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099578, R01MH104701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345, R01NS090904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Adelson Medical Research Foundation; New York State Stem Cell Research Board (NYSTEM); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); National Multiple Sclerosis Society(National Multiple Sclerosis Society); ALS Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors want to acknowledge the NIH grants 9R01NS090904-16 (B.V.Z.), RO1HL052246 and PO1 HL031950 (J.H.G.), R01NS75345 (S.A.G.); National Natural Science Foundation of China grant 31371116 (Y.Z.); and grants from the Adelson Medical Research Foundation, New York State Stem Cell Research Board (NYSTEM), Novo Nordisk Foundation, Lundbeck Foundation, National Multiple Sclerosis Society and ALS Association (S.A.G.).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; [Anonymous], 2014, SAFETY EVALUATION 3K; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Fuchs EJ, 2014, IMMUNOL REV, V258, P64, DOI 10.1111/imr.12154; Furukawa N, 2006, J BIOCHEM, V140, P831, DOI 10.1093/jb/mvj216; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Goldman SA, 2016, CELL STEM CELL, V18, P174, DOI 10.1016/j.stem.2016.01.012; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Li DD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00193; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; MARKGRAF CG, 1994, STROKE, V25, P153, DOI 10.1161/01.STR.25.1.153; Park SW, 2009, KIDNEY INT, V76, P739, DOI 10.1038/ki.2009.255; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Savitz SI, 2013, STROKE, V44, pS107, DOI 10.1161/STROKEAHA.112.679605; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vanni MP, 2014, J NEUROSCI, V34, P15931, DOI 10.1523/JNEUROSCI.1818-14.2014; Walker CT, 2010, BRAIN RES, V1347, P125, DOI 10.1016/j.brainres.2010.05.075; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wang YM, 2013, BRAIN RES, V1507, P97, DOI 10.1016/j.brainres.2013.02.023; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Wen ZM, 2012, NEURAL REGEN RES, V7, P578, DOI 10.3969/j.issn.1673-5374.2012.08.003; Williams PD, 2012, CURR PHARM DESIGN, V18, P4215; Winkler EA, 2014, P NATL ACAD SCI USA, V111, pE1035, DOI 10.1073/pnas.1401595111; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	43	58	58	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1050	+		10.1038/nm.4154	http://dx.doi.org/10.1038/nm.4154			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27548576	Green Accepted			2022-12-27	WOS:000382542800016
J	Li, PL; Kaiser, P; Lampiris, HW; Kim, P; Yukl, SA; Havlir, DV; Greene, WC; Wong, JK				Li, Peilin; Kaiser, Philipp; Lampiris, Harry W.; Kim, Peggy; Yukl, Steven A.; Havlir, Diane V.; Greene, Warner C.; Wong, Joseph K.			Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation	NATURE MEDICINE			English	Article							SIGNAL-ACTIVATION; RETINOIC ACID; T-CELL; RNA; REPLICATION; RECOGNITION; ACITRETIN	The persistence of latent HIV proviruses in long-lived CD4(+) T cells despite antiretroviral therapy (ART)(1-3) is a major obstacle to viral eradication(4-6). Because current candidate latency reversing agents (LRAs) induce HIV transcription, but fail to clear these cellular reservoirs(7,8), new approaches for killing these reactivated latent HIV reservoir cells are urgently needed. HIV latency depends upon the transcriptional quiescence of the integrated provirus and the circumvention of immune defense mechanisms(4-6,9). These defenses include cell-intrinsic innate responses that use pattern-recognition receptors (PRRs) to detect viral pathogens, and that subsequently induce apoptosis of the infected cell(10). Retinoic acid (RA)-inducible gene I (RIG-I, encoded by DDX58) forms one class of PRRs that mediates apoptosis and the elimination of infected cells after recognition of viral RNA(11-14). Here we show that acitretin, an RA derivative approved by the US Food and Drug Administration (FDA), enhances RIG-I signaling ex vivo, increases HIV transcription, and induces preferential apoptosis of HIV-infected cells. These effects are abrogated by DDX58 knockdown. Acitretin also decreases proviral DNA levels in CD4(+) T cells from HIV-positive subjects on suppressive ART, an effect that is amplified when combined with suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor. Pharmacological enhancement of an innate cellular-defense network could provide a means by which to eliminate reactivated cells in the latent HIV reservoir.	[Li, Peilin; Kaiser, Philipp; Lampiris, Harry W.; Kim, Peggy; Yukl, Steven A.; Wong, Joseph K.] San Francisco VA Med Ctr, Med Serv, Infect Dis Sect, San Francisco, CA 94121 USA; [Li, Peilin; Lampiris, Harry W.; Yukl, Steven A.; Havlir, Diane V.; Greene, Warner C.; Wong, Joseph K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Havlir, Diane V.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Biol, San Francisco, CA 94143 USA; [Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Li, PL (corresponding author), San Francisco VA Med Ctr, Med Serv, Infect Dis Sect, San Francisco, CA 94121 USA.; Li, PL (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	peilin.li@ucsf.edu	Li, Peilin/CAG-5411-2022		NIH [1R21AI104445-01A1, R56 AI116342, R21 AI116218]; Department of Veterans Affairs Merit Review Award [5101 BX001048]; UCSF-Gladstone Center for AIDS Research Virology Core [P30AI027763, U19 AI096113]; amfAR Institute for HIV Cure Research [109301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI116218, R21AI104445, P30AI027763, U19AI096113, R33AI116218, R56AI116342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108349] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000520, I01BX001048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); UCSF-Gladstone Center for AIDS Research Virology Core; amfAR Institute for HIV Cure Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank the study participants, without whom this research could not have been performed. We thank S. Deeks, H. Gunthard, C. Lopez, and H. Hatano for their helpful comments and support, and M. Vu for assistance with participant recruitment. We thank J.C.W. Carroll for graphics arts, S. Ordway for editorial assistance, and S. Wilcox for administrative assistance. We thank the US National Institutes of Health (NIH) AIDS Reagent Program, Division of AIDS, NIAID, NIH for cell lines, plasmid, and reagents. This work was supported by the NIH (grants 1R21AI104445-01A1 (P.L.), R56 AI116342 and R21 AI116218 (J.K.W.)), the Department of Veterans Affairs Merit Review Award 5101 BX001048 (J.K.W.), the UCSF-Gladstone Center for AIDS Research Virology Core P30AI027763 (W.C.G. and J.K.W.), U19 AI096113 (W.C.G.) and research supported as part of the amfAR Institute for HIV Cure Research with grant number 109301(W.G., J.K.W., and P.L.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Badley AD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.248; Berg RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029291; Britto AMA, 2013, AIDS, V27, P1879, DOI 10.1097/QAD.0b013e328361cfbf; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Buccheri L, 1997, ARCH DERMATOL, V133, P711, DOI 10.1001/archderm.133.6.711; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Doehle BP, 2009, J VIROL, V83, P10395, DOI 10.1128/JVI.00849-09; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Huang SL, 2000, MOL CELL ENDOCRINOL, V159, P15, DOI 10.1016/S0303-7207(99)00207-5; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Ortiz NEG, 2013, DERMATOL THER, V26, P390, DOI 10.1111/dth.12086; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Rehwinkel J, 2010, J CLIN IMMUNOL, V30, P491, DOI 10.1007/s10875-010-9384-7; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Wang YZ, 2013, J LEUKOCYTE BIOL, V94, P337, DOI 10.1189/jlb.0313158; Wiegand UW, 1998, J AM ACAD DERMATOL, V39, pS25, DOI 10.1016/S0190-9622(98)70441-4; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida T, 2004, BIOCHEM BIOPH RES CO, V321, P961, DOI 10.1016/j.bbrc.2004.07.054	39	64	66	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					807	811		10.1038/nm.4124	http://dx.doi.org/10.1038/nm.4124			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27294875	Green Accepted			2022-12-27	WOS:000379366900020
J	Biermann, M; Kamp, TJ				Biermann, Mitch; Kamp, Timothy J.			Cardiotoxicity in a dish: new insights for personalized therapy	NATURE MEDICINE			English	Editorial Material								A recent study identifies differences in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes from patients with breast cancer who were treated with doxorubicin and either did or did not develop cardiotoxicity. The results open up new avenues for the development of personalized therapy and the prevention of cardiotoxicity.	[Biermann, Mitch; Kamp, Timothy J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Biol, Madison, WI USA; [Biermann, Mitch; Kamp, Timothy J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI USA; [Biermann, Mitch; Kamp, Timothy J.] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kamp, TJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Biol, Madison, WI USA.; Kamp, TJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI USA.; Kamp, TJ (corresponding author), Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI USA.	tjk@medicinel.wisc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Ewer MS, 2015, NAT REV CARDIOL, V12, P547, DOI 10.1038/nrcardio.2015.65; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101	4	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					459	460		10.1038/nm.4095	http://dx.doi.org/10.1038/nm.4095			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149216				2022-12-27	WOS:000375514000005
J	Willyard, C				Willyard, Cassandra			Foretelling toxicity: FDA researchers work to predict risk of liver injury from drugs	NATURE MEDICINE			English	News Item																			0	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					450	451		10.1038/nm0516-450	http://dx.doi.org/10.1038/nm0516-450			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149212				2022-12-27	WOS:000375514000002
J	Martin-Subero, JI				Ignacio Martin-Subero, Jose			Predicting leukemia relapse	NATURE MEDICINE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE CELLS; CLONAL EVOLUTION; MASS CYTOMETRY	Mass cytometry of acute B cell lymphoblastic leukemias at diagnosis reveals intrapatient phenotypic heterogeneity and specific signatures that mimic cell developmental stage and predict future relapse.	[Ignacio Martin-Subero, Jose] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Ignacio Martin-Subero, Jose] Univ Barcelona, Dept Basic Clin Practice, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Martin-Subero, JI (corresponding author), Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.; Martin-Subero, JI (corresponding author), Univ Barcelona, Dept Basic Clin Practice, Barcelona, Spain.	imartins@clinic.cat		Martin-Subero, Jose Ignacio/0000-0001-8809-5195				Behbehani GK, 2017, CLIN LAB MED, V37, P945, DOI 10.1016/j.cll.2017.07.010; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Ferrando AA, 2017, NAT MED, V23, P1135, DOI 10.1038/nm.4410; Frei AP, 2016, NAT METHODS, V13, P269, DOI [10.1038/NMETH.3742, 10.1038/nmeth.3742]; Good Z, 2018, NAT MED, V24, P474, DOI 10.1038/nm.4505; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Macaulay IC, 2017, TRENDS GENET, V33, P155, DOI 10.1016/j.tig.2016.12.003; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Somasundaram R, 2015, BLOOD, V126, P144, DOI 10.1182/blood-2014-12-575688; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019	11	0	0	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					385	387		10.1038/nm.4529	http://dx.doi.org/10.1038/nm.4529			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634681				2022-12-27	WOS:000429639800006
J	Seiler, M; Yoshimi, A; Darman, R; Chan, B; Keaney, G; Thomas, M; Agrawal, AA; Caleb, B; Csibi, A; Sean, E; Fekkes, P; Karr, C; Klimek, V; Lai, G; Lee, L; Kumar, P; Lee, SCW; Liu, X; Mackenzie, C; Meeske, C; Mizui, Y; Padron, E; Park, E; Pazolli, E; Peng, SY; Prajapati, S; Taylor, J; Teng, T; Wang, J; Warmuth, M; Yao, HL; Yu, LH; Zhu, P; Abdel-Wahab, O; Smith, PG; Buonamici, S				Seiler, Michael; Yoshimi, Akihide; Darman, Rachel; Chan, Betty; Keaney, Gregg; Thomas, Michael; Agrawal, Anant A.; Caleb, Benjamin; Csibi, Alfredo; Sean, Eckley; Fekkes, Peter; Karr, Craig; Klimek, Virginia; Lai, George; Lee, Linda; Kumar, Pavan; Lee, Stanley Chun-Wei; Liu, Xiang; Mackenzie, Crystal; Meeske, Carol; Mizui, Yoshiharu; Padron, Eric; Park, Eunice; Pazolli, Ermira; Peng, Shouyong; Prajapati, Sudeep; Taylor, Justin; Teng, Teng; Wang, John; Warmuth, Markus; Yao, Huilan; Yu, Lihua; Zhu, Ping; Abdel-Wahab, Omar; Smith, Peter G.; Buonamici, Silvia			H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers	NATURE MEDICINE			English	Article							MUTATIONS; SF3B1; RECOGNITION; MYELODYSPLASIA; EXPRESSION; SELECTION; DATABASE; REVEALS; CAPTURE; PRODUCT	Genomic analyses of cancer have identified recurrent point mutations in the RNA splicing factor-encoding genes SF3B1, U2AF1, and SRSF2 that confer an alteration of function(1-6). Cancer cells bearing these mutations are preferentially dependent on wild-type (WT) spliceosome function(7-11), but clinically relevant means to therapeutically target the spliceosome do not currently exist. Here we describe an orally available modulator of the SF3b complex, H3B-8800, which potently and preferentially kills spliceosome-mutant epithelial and hematologic tumor cells. These killing effects of H3B-8800 are due to its direct interaction with the SF3b complex, as evidenced by loss of H3B-8800 activity in drug-resistant cells bearing mutations in genes encoding SF3b components. Although H3B-8800 modulates WT and mutant spliceosome activity, the preferential killing of spliceosome-mutant cells is due to retention of short, GC-rich introns, which are enriched for genes encoding spliceosome components. These data demonstrate the therapeutic potential of splicing modulation in spliceosome-mutant cancers.	[Seiler, Michael; Darman, Rachel; Chan, Betty; Keaney, Gregg; Thomas, Michael; Agrawal, Anant A.; Caleb, Benjamin; Csibi, Alfredo; Fekkes, Peter; Karr, Craig; Lee, Linda; Kumar, Pavan; Liu, Xiang; Mackenzie, Crystal; Meeske, Carol; Mizui, Yoshiharu; Park, Eunice; Pazolli, Ermira; Peng, Shouyong; Prajapati, Sudeep; Teng, Teng; Wang, John; Warmuth, Markus; Yao, Huilan; Yu, Lihua; Zhu, Ping; Smith, Peter G.; Buonamici, Silvia] H3 Biomed Inc, Cambridge, MA 02139 USA; [Yoshimi, Akihide; Lee, Stanley Chun-Wei; Taylor, Justin; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Sean, Eckley; Lai, George] Eisai Inc, Andover, MA USA; [Klimek, Virginia; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Padron, Eric] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol Malignancies & Immunol Program, Tampa, FL USA	Memorial Sloan Kettering Cancer Center; Eisai Co Ltd; Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute	Buonamici, S (corresponding author), H3 Biomed Inc, Cambridge, MA 02139 USA.	silvia_buonamici@h3biomedicine.com	Yoshimi, Akihide/I-3792-2019	Yoshimi, Akihide/0000-0002-0664-7281; Lee, Stanley/0000-0001-7110-2416	Aplastic Anemia and Myelodysplastic Syndromes (MDS) International Foundation; Lauri Strauss Leukemia Foundation; Edward P. Evans Foundation; Taub Foundation; Department of Defense Bone Marrow Failure Research Program [BM150092, W81XWH-12-1-0041]; National Institutes of Health National Heart, Lung and Blood Institute [R01 HL128239]; Josie Robertson Investigator Program; Starr Foundation [I8-A8-075]; Leukemia and Lymphoma Society [2314-17]; Pershing Square Sohn Cancer Research Alliance; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Aplastic Anemia and Myelodysplastic Syndromes (MDS) International Foundation; Lauri Strauss Leukemia Foundation; Edward P. Evans Foundation; Taub Foundation; Department of Defense Bone Marrow Failure Research Program; National Institutes of Health National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Josie Robertson Investigator Program; Starr Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H3 Biomedicine employees for their support in this project. A.Y. was supported by grants from the Aplastic Anemia and Myelodysplastic Syndromes (MDS) International Foundation and the Lauri Strauss Leukemia Foundation. O.A.-W. was supported by grants from the Edward P. Evans Foundation, the Taub Foundation, the Department of Defense Bone Marrow Failure Research Program (BM150092 and W81XWH-12-1-0041), National Institutes of Health National Heart, Lung and Blood Institute (R01 HL128239), the Josie Robertson Investigator Program, an award from the Starr Foundation (I8-A8-075), the Leukemia and Lymphoma Society (2314-17) and the Pershing Square Sohn Cancer Research Alliance.	Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cvitkovic I, 2013, NUCLEIC ACIDS RES, V41, pD132, DOI 10.1093/nar/gks999; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fei DL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006384; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ilagan JO, 2015, GENOME RES, V25, P14, DOI 10.1101/gr.181016.114; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jenkins JL, 2013, NUCLEIC ACIDS RES, V41, P3859, DOI 10.1093/nar/gkt046; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; Obeng EA, 2016, CANCER CELL, V30, P404, DOI 10.1016/j.ccell.2016.08.006; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sgouropoulos N, 2015, J AM STAT ASSOC, V110, P742, DOI 10.1080/01621459.2014.929522; Shirai CL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14060; Teng T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15522; Nguyen THD, 2016, CURR OPIN STRUC BIOL, V36, P48, DOI 10.1016/j.sbi.2015.12.005; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yoshimi A, 2017, BLOOD, V130, P397, DOI 10.1182/blood-2017-01-763219; Zhang J, 2015, P NATL ACAD SCI USA, V112, pE4726, DOI 10.1073/pnas.1514105112; Zhou QH, 2015, CANCER RES, V75, P1949, DOI 10.1158/0008-5472.CAN-14-2930	41	241	248	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					497	+		10.1038/nm.4493	http://dx.doi.org/10.1038/nm.4493			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29457796	Green Accepted			2022-12-27	WOS:000429639800021
J	He, YM; Li, X; Perego, M; Nefedova, Y; Kossenkov, AV; Jensen, EA; Kagan, V; Liu, YF; Fu, SY; Ye, QJ; Zhou, YH; Wei, L; Gabrilovich, DI; Zhou, J				He, Yu-Mei; Li, Xing; Perego, Michela; Nefedova, Yulia; Kossenkov, Andrew V.; Jensen, Erik A.; Kagan, Valerian; Liu, Yu-Feng; Fu, Shu-Yu; Ye, Qing-Jian; Zhou, Yan-Hong; Wei, Lai; Gabrilovich, Dmitry I.; Zhou, Jie			Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation	NATURE MEDICINE			English	Article							NECROTIZING ENTEROCOLITIS; T-CELLS; LACTOFERRIN; CANCER; ACCUMULATION; PATHOGENESIS; INHIBITION; EXPRESSION; PREVENT; CD11B	Myeloid-derived suppressor cells (MDSCs) are pathologically activated and relatively immature myeloid cells that have been implicated in the immunological regulation of many pathologic conditions(1,2). Phenotypically and morphologically, MDSCs are similar to neutrophils (PMN-MDSCs) and monocytes (M-MDSCs). However, they have potent suppressive activity and distinct gene expression profiles and biochemical characteristics(3). No or very few MDSCs are observed in steady-state physiological conditions. Therefore, until recently, accumulation of MDSCs was considered a consequence of pathological processes or pregnancy. Here, we report that MDSCs with a potent ability to suppress T cells are present during the first weeks of life in mice and humans. MDSC suppressive activity was triggered by lactoferrin and mediated by nitric oxide, PGE2, and S100A9 and S100A8 proteins. MDSCs from newborns had a transcriptome similar to that of tumor MDSCs, but with strong upregulation of an antimicrobial gene network, and had potent antibacterial activity. MDSCs played a critical role in control of experimental necrotizing enterocolitis (NEC) in newborn mice. MDSCs in infants with very low weight, who are prone to NEC, had lower MDSC levels and suppressive activity than did infants with normal weight. Thus, the transitory presence of MDSCs may be critical for regulation of inflammation in newborns.	[He, Yu-Mei; Li, Xing; Liu, Yu-Feng; Fu, Shu-Yu; Gabrilovich, Dmitry I.; Zhou, Jie] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [He, Yu-Mei; Li, Xing; Gabrilovich, Dmitry I.; Zhou, Jie] Chinese Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China; [Li, Xing; Ye, Qing-Jian] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Perego, Michela; Nefedova, Yulia; Kossenkov, Andrew V.; Gabrilovich, Dmitry I.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Jensen, Erik A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kagan, Valerian] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Zhou, Yan-Hong; Zhou, Jie] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wei, Lai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sun Yat Sen University	Gabrilovich, DI; Zhou, J (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China.; Gabrilovich, DI; Zhou, J (corresponding author), Chinese Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.; Gabrilovich, DI (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.; Zhou, J (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China.	dgabrilovich@wistar.org; zhouj72@mail.sysu.edu.cn	Fu, Shuyu/AAM-6361-2020; perego, michela/W-4650-2019; Gabrilovich, Dmitry/ABE-7122-2020	perego, michela/0000-0002-5671-928X; Kagan, Valerian E./0000-0002-7245-1885; Fu, Shuyu/0000-0003-3249-6269; Nefedova, Yulia/0000-0002-5121-9294	NIH [CA165065]; Recruitment Program for Foreign Experts (Thousand Talents Plan) [WQ2014440O204]; Start-up Fund for High-level Talents of Sun Yat-sen University; Leading Talents of Guangdong Province Program; Introduction of Innovative RAMP;D Team Program of Guangdong Province [2009010058]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); National Natural Science Foundation of China [91542112, 81571520, 81771665, 81742002]; Provincial Talents Cultivated by the 'Thousand-Hundred-Ten' Program of Guangdong Province, 111 Project [B12003]; NATIONAL CANCER INSTITUTE [R01CA165065, P30CA010815, R50CA211199] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Recruitment Program for Foreign Experts (Thousand Talents Plan); Start-up Fund for High-level Talents of Sun Yat-sen University; Leading Talents of Guangdong Province Program; Introduction of Innovative RAMP;D Team Program of Guangdong Province; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Talents Cultivated by the 'Thousand-Hundred-Ten' Program of Guangdong Province, 111 Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Wistar Institute Animal and Bioinformatics core facilities as well as NIH grant CA165065 to D.I.G. and V.K. The work was also supported by the Recruitment Program for Foreign Experts (Thousand Talents Plan, WQ2014440O204), the Start-up Fund for High-level Talents of Sun Yat-sen University, and the Leading Talents of Guangdong Province Program (D.I.G.). This work was supported by the following grants to J.Z.: the Introduction of Innovative R&D Team Program of Guangdong Province (2009010058), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS, 2014), the National Natural Science Foundation of China (91542112; 81571520, 81771665, and 81742002), and the Provincial Talents Cultivated by the 'Thousand-Hundred-Ten' Program of Guangdong Province, 111 Project (B12003). We thank S. Grey-Owen (University of Toronto) and O.M. Conneely (Baylor College of Medicine) for providing LF-KO mice and T. Vogl and J. Roth (Institute of Immunology, Muenster) for providing S100A9-KO mice. We thank Y. Yu (Tianjin Medical University) for providing Cox-2-KO mice and H. Zhang (Sun Yat-sen University) for providing OT-1 transgenic mice.	Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Curran CS, 2012, J INTERF CYTOK RES, V32, P450, DOI 10.1089/jir.2011.0111; Denning TW, 2017, SEMIN PERINATOL, V41, P15, DOI 10.1053/j.semperi.2016.09.014; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dominguez GA, 2017, CLIN CANCER RES, V23, P2942, DOI 10.1158/1078-0432.CCR-16-1784; Egan CE, 2016, J CLIN INVEST, V126, P495, DOI 10.1172/JCI83356; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gervassi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107816; Heinemann AS, 2017, FASEB J, V31, P1153, DOI 10.1096/fj.201601083R; James BR, 2014, CANCER IMMUNOL IMMUN, V63, P1213, DOI 10.1007/s00262-014-1598-8; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Mosconi E, 2010, MUCOSAL IMMUNOL, V3, P461, DOI 10.1038/mi.2010.23; Nagaraj S, 2012, CANCER RES, V72, P928, DOI 10.1158/0008-5472.CAN-11-2863; Nino DF, 2016, NAT REV GASTRO HEPAT, V13, P590, DOI 10.1038/nrgastro.2016.119; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Rager TM, 2016, J PEDIATR SURG, V51, P942, DOI 10.1016/j.jpedsurg.2016.02.061; Rasheed N, 2016, PHARMACOGN RES, V8, P135, DOI 10.4103/0974-8490.175612; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; Talukder JR, 2014, CAN J PHYSIOL PHARM, V92, P9, DOI 10.1139/cjpp-2013-0211; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Trentini A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3648719; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/O2012-016, 10.1139/o2012-016]; Warner BB, 2016, SEMIN FETAL NEONAT M, V21, P394, DOI 10.1016/j.siny.2016.06.001; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177	35	111	115	2	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					224	+		10.1038/nm.4467	http://dx.doi.org/10.1038/nm.4467			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29334374	Green Accepted			2022-12-27	WOS:000424327200019
J	Okubo, K; Kurosawa, M; Kamiya, M; Urano, Y; Suzuki, A; Yamamoto, K; Hase, K; Homma, K; Sasaki, J; Miyauchi, H; Hoshino, T; Hayashi, M; Mayadas, TN; Hirahashi, J				Okubo, Koshu; Kurosawa, Miho; Kamiya, Mako; Urano, Yasuteru; Suzuki, Akari; Yamamoto, Kazuhiko; Hase, Koji; Homma, Koichiro; Sasaki, Junichi; Miyauchi, Hiroaki; Hoshino, Tatsuo; Hayashi, Matsuhiko; Mayadas, Tanya N.; Hirahashi, Junichi			Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury	NATURE MEDICINE			English	Article							SICKLE-CELL-DISEASE; RENAL-FAILURE; NEUTROPHILS; MICE; MAC-1; INFLAMMATION; MONOCYTES; ATHEROSCLEROSIS; CD11B/CD18; CONTRIBUTE	Rhabdomyolysis is a serious syndrome caused by skeletal muscle injury and the subsequent release of breakdown products from damaged muscle cells into systemic circulation(1). The muscle damage most often results from strenuous exercise, muscle hypoxia, medications, or drug abuse and can lead to life-threatening complications, such as acute kidney injury (AKI)(1). Rhabdomyolysis and the AKI complication can also occur during crush syndrome, an emergency condition that commonly occurs in victims of natural disasters, such as earthquakes, and man-made disasters, such as wars and terrorism(2). Myoglobin released from damaged muscle is believed to trigger renal dysfunction in this form of AKI. Recently, macrophages were implicated in the disease pathogenesis of rhabdomyolysis-induced AKI(3,4), but the precise molecular mechanism remains unclear. In the present study, we show that macrophages released extracellular traps (ETs) comprising DNA fibers and granule proteins in a mouse model of rhabdomyolysis. Heme-activated platelets released from necrotic muscle cells during rhabdomyolysis enhanced the production of macrophage extracellular traps (METs) through increasing intracellular reactive oxygen species generation and histone citrullination. Here we report, for the first time to our knowledge, this unanticipated role for METs and platelets as a sensor of myoglobin-derived heme in rhabdomyolysis-induced AKI. This previously unknown mechanism might be targeted for treatment of the disease. Finally, we found a new therapeutic tool for prevention of AKI after rhabdomyolysis, which might rescue some sufferers of this pathology.	[Okubo, Koshu; Hayashi, Matsuhiko; Hirahashi, Junichi] Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Tokyo, Japan; [Okubo, Koshu; Kurosawa, Miho; Miyauchi, Hiroaki; Hayashi, Matsuhiko; Hirahashi, Junichi] Keio Univ, Ctr Gen Med Educ, Sch Med, Tokyo, Japan; [Kamiya, Mako; Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Lab Chem Biol & Mol Imaging, Tokyo, Japan; [Suzuki, Akari; Yamamoto, Kazuhiko] RIKEN, Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Hase, Koji] Keio Univ, Div Biochem, Fac Pharm, Tokyo, Japan; [Hase, Koji] Univ Tokyo, Inst Med Sci, Div Mucosal Biol, Int Res & Dev Ctr Mucosal Vaccine, Tokyo, Japan; [Homma, Koichiro; Sasaki, Junichi] Keio Univ, Dept Emergency & Crit Care Med, Sch Med, Tokyo, Japan; [Hoshino, Tatsuo] NRL Pharma Inc, Kawasaki, Kanagawa, Japan; [Mayadas, Tanya N.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Keio University; Keio University; University of Tokyo; RIKEN; University of Tokyo; Keio University; University of Tokyo; Keio University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hirahashi, J (corresponding author), Keio Univ, Apheresis & Dialysis Ctr, Sch Med, Tokyo, Japan.; Hirahashi, J (corresponding author), Keio Univ, Ctr Gen Med Educ, Sch Med, Tokyo, Japan.	jhira@keio.jp	Suzuki, Akari/N-5389-2015; Sasaki, Junichi/E-6992-2016	Sasaki, Junichi/0000-0002-5190-8524; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09459, 16K19497]; National Heart, Lung and Blood Institute (NLHBI), National Institutes of Health [HL065095]; Research on Rare and Intractable Diseases, Ministry of Health, Labour and Welfare, Japan [nannti-ippann-004]; study group for strategic exploration of drug seeds for antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis and construction of clinical evidence from Japan Agency for Medical Research and development, AMED [JP17ek0109104]; Grants-in-Aid for Scientific Research [15K09459] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Heart, Lung and Blood Institute (NLHBI), National Institutes of Health; Research on Rare and Intractable Diseases, Ministry of Health, Labour and Welfare, Japan; study group for strategic exploration of drug seeds for antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis and construction of clinical evidence from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Collaborative Research Resources, School of Medicine, Keio University for technical assistance. We gratefully thank T. Shimosawa (University of Tokyo) for animal care assistance. This work was supported in part by a grant-in-aid from Ministry of Education, Culture, Sports, Science and Technology of Japan (15K09459 (J.H.) and 16K19497 (K.O.)). T.N.M. was supported by National Heart, Lung and Blood Institute (NLHBI), National Institutes of Health (HL065095). J.H. was also supported by grants from Research on Rare and Intractable Diseases, Ministry of Health, Labour and Welfare, Japan (nannti-ippann-004) and the study group for strategic exploration of drug seeds for antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis and construction of clinical evidence from Japan Agency for Medical Research and development, AMED under grant number JP17ek0109104.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; ARNAOUT MA, 1990, BLOOD, V75, P1037; Behnen M, 2014, J IMMUNOL, V193, P1954, DOI 10.4049/jimmunol.1400478; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Belliere J, 2015, J AM SOC NEPHROL, V26, P1363, DOI 10.1681/ASN.2014040320; Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Boutaud O, 2010, P NATL ACAD SCI USA, V107, P2699, DOI 10.1073/pnas.0910174107; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chen G, 2014, BLOOD, V123, P3818, DOI 10.1182/blood-2013-10-529982; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Meijer AR, 2003, INTENS CARE MED, V29, P1121, DOI 10.1007/s00134-003-1800-5; Finsterbusch M, 2016, P NATL ACAD SCI USA, V113, pE5172, DOI 10.1073/pnas.1606253113; Golas JM, 2003, CANCER RES, V63, P375; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064631; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kim JH, 2014, NEPHRON EXP NEPHROL, V128, P21, DOI 10.1159/000365851; Kuijper PHM, 1998, THROMB HAEMOSTASIS, V80, P443, DOI 10.1055/s-0037-1615227; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Miller RE, 2012, P NATL ACAD SCI USA, V109, P20602, DOI 10.1073/pnas.1209294110; Okubo K, 2016, EBIOMEDICINE, V10, P204, DOI 10.1016/j.ebiom.2016.07.012; Panizo N, 2015, KIDNEY BLOOD PRESS R, V40, P520, DOI 10.1159/000368528; Pratico D, 1999, CIRCULATION, V99, P3118, DOI 10.1161/01.CIR.99.24.3118; Rosetti F, 2016, IMMUNOL REV, V269, P175, DOI 10.1111/imr.12373; Rossaint J, 2014, BLOOD, V123, P2573, DOI 10.1182/blood-2013-07-516484; Rubio-Navarro A, 2016, THERANOSTICS, V6, P896, DOI 10.7150/thno.14915; Sakatsume M, 2007, NEPHROLOGY, V12, P191, DOI 10.1111/j.1440-1797.2006.00739.x; Sever MS, 2006, NEW ENGL J MED, V354, P1052, DOI 10.1056/NEJMra054329; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Sinniah R, 2000, AM J NEPHROL, V20, P339, DOI 10.1159/000013611; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Tanikawa C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1676; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; ZAGER RA, 1992, J CLIN INVEST, V90, P711, DOI 10.1172/JCI115942; Zanardo RCO, 2004, BLOOD, V104, P3766, DOI 10.1182/blood-2004-02-0578	47	86	93	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					232	+		10.1038/nm.4462	http://dx.doi.org/10.1038/nm.4462			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29309057				2022-12-27	WOS:000424327200020
J	Duerrschmid, C; He, YL; Wang, CM; Li, C; Bournat, JC; Romere, C; Saha, PK; Lee, ME; Phillips, KJ; Jain, M; Jia, PL; Zhao, ZM; Farias, M; Wu, Q; Milewicz, DM; Sutton, VR; Moore, DD; Butte, NF; Krashes, MJ; Xu, Y; Chopra, AR				Duerrschmid, Clemens; He, Yanlin; Wang, Chunmei; Li, Chia; Bournat, Juan C.; Romere, Chase; Saha, Pradip K.; Lee, Mark E.; Phillips, Kevin J.; Jain, Mahim; Jia, Peilin; Zhao, Zhongming; Farias, Monica; Wu, Qi; Milewicz, Dianna M.; Sutton, V. Reid; Moore, David D.; Butte, Nancy F.; Krashes, Michael J.; Xu, Yong; Chopra, Atul R.			Asprosin is a centrally acting orexigenic hormone	NATURE MEDICINE			English	Article							DOUBLY LABELED WATER; SEROTONIN 2C RECEPTORS; AGRP NEURONS; ENERGY-EXPENDITURE; PROOPIOMELANOCORTIN NEURONS; ARCUATE NUCLEUS; FOOD-INTAKE; MICE; HOMEOSTASIS; ACTIVATION	Asprosin is a recently discovered fasting-induced hormone that promotes hepatic glucose production. Here we demonstrate that asprosin in the circulation crosses the blood-brain barrier and directly activates orexigenic AgRP+ neurons via a cAMP-dependent pathway. This signaling results in inhibition of downstream anorexigenic proopiomelanocortin (POMC)-positive neurons in a GABA-dependent manner, which then leads to appetite stimulation and a drive to accumulate adiposity and body weight. In humans, a genetic deficiency in asprosin causes a syndrome characterized by low appetite and extreme leanness; this is phenocopied by mice carrying similar mutations and can be fully rescued by asprosin. Furthermore, we found that obese humans and mice had pathologically elevated concentrations of circulating asprosin, and neutralization of asprosin in the blood with a monoclonal antibody reduced appetite and body weight in obese mice, in addition to improving their glycemic profile. Thus, in addition to performing a glucogenic function, asprosin is a centrally acting orexigenic hormone that is a potential therapeutic target in the treatment of both obesity and diabetes.	[Duerrschmid, Clemens; Bournat, Juan C.; Romere, Chase; Saha, Pradip K.; Lee, Mark E.; Phillips, Kevin J.; Moore, David D.; Xu, Yong; Chopra, Atul R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [He, Yanlin; Wang, Chunmei; Farias, Monica; Wu, Qi; Butte, Nancy F.; Xu, Yong] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA; [Li, Chia; Krashes, Michael J.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Li, Chia; Krashes, Michael J.] NIDA, NIH, Baltimore, MD USA; [Jain, Mahim] Kennedy Krieger Inst, Baltimore, MD USA; [Jia, Peilin; Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA; [Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA; [Sutton, V. Reid; Chopra, Atul R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Kennedy Krieger Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Xu, Y; Chopra, AR (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Xu, Y (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA.; Chopra, AR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	yongx@bcm.edu; chopra@bcm.edu	WU, QI/GNP-0495-2022; , PEP-MX Core/AGV-4051-2022; Duerrschmid, Clemens/D-9933-2013; Krashes, Michael/P-7677-2019	WU, QI/0000-0003-0303-4065; Duerrschmid, Clemens/0000-0001-7718-5152; He, Yanlin/0000-0002-5471-9016; Xu, Yong/0000-0002-4908-1572; Chopra, Atul/0000-0002-1304-3777	Baylor College of Medicine Mouse Metabolism Core - NIH [P30 DK079638]; Protein and Monoclonal Antibody Production Core - NIH [P30 CA125123]; Mouse Phenotyping Core - NIH [UM1HG006348]; NIH [P30 CA016086]; American Heart Association [16POST29630010, 16POST27260254]; American Diabetes Association [1-17-PDF-138, 1-17-JDF-009]; NIDDK [1R01DK111631, DK075087, DK101379, 1K08DK102529]; NLM grant [LM012806]; NHGRI Baylor-Johns Hopkins Center for Mendelian Genomics [UM1 HG006542]; R.P. Doherty, Jr.-Welch Chair in Science [Q-0022]; Intramural Research Program of the NIH; USDA-CRIS [3092-5-001-059]; Chao Physician-scientist Award; Caroline Wiess Law scholar award; departmental laboratory startup package; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075088, R01DK101379, R01DK093587, K08DK102529, ZIADK075087, ZIADK075090, ZIADK075089] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012806] Funding Source: NIH RePORTER	Baylor College of Medicine Mouse Metabolism Core - NIH; Protein and Monoclonal Antibody Production Core - NIH; Mouse Phenotyping Core - NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM grant; NHGRI Baylor-Johns Hopkins Center for Mendelian Genomics; R.P. Doherty, Jr.-Welch Chair in Science; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-CRIS(United States Department of Agriculture (USDA)); Chao Physician-scientist Award; Caroline Wiess Law scholar award; departmental laboratory startup package; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Baylor College of Medicine Mouse Metabolism Core (funded by NIH grant P30 DK079638), the Protein and Monoclonal Antibody Production Core (funded by NIH grant P30 CA125123), and the Mouse Phenotyping Core (funded by NIH grant UM1HG006348). Mammalian asprosin was provided by the University of North Carolina at Chapel Hill Protein Expression and Purification Core (funded by NIH grant P30 CA016086). Support was also provided by American Heart Association postdoctoral fellowships 16POST29630010 (C.D.) and 16POST27260254 (C.W.), the American Diabetes Association (grants 1-17-PDF-138 (Y.H.) and 1-17-JDF-009 (K.J.P.)), the NIDDK (grants 1R01DK111631 (K.J.P.), DK075087 (M.J.K.), DK101379 (Y.X.), and 1K08DK102529 (A.R.C.)), the NLM (grant LM012806; Z.Z.), the NHGRI Baylor-Johns Hopkins Center for Mendelian Genomics (grant UM1 HG006542; V.R.S.), the R.P. Doherty, Jr.-Welch Chair in Science Q-0022 (D.D.M.), the Intramural Research Program of the NIH (M.J.K.), and the USDA-CRIS (3092-5-001-059; Y.X.). A.R.C. is also supported by the Chao Physician-scientist Award, the Caroline Wiess Law scholar award, and a departmental laboratory startup package.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Butte NF, 2001, J NUTR, V131, P53, DOI 10.1093/jn/131.1.53; Cao XH, 2014, J CLIN INVEST, V124, P4351, DOI 10.1172/JCI74726; Denis RGP, 2015, CELL METAB, V22, P646, DOI 10.1016/j.cmet.2015.07.011; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Jacquinet A, 2014, EUR J MED GENET, V57, P230, DOI 10.1016/j.ejmg.2014.02.012; Johnson RK, 1996, J AM DIET ASSOC, V96, P1140, DOI 10.1016/S0002-8223(96)00293-3; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Nakajima KI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10268; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; National Research Council, 2011, GUIDE CARE USE LAB A; O'Neill B, 2007, AM J MED GENET A, V143A, P1421, DOI 10.1002/ajmg.a.31840; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; ROBERTS SB, 1989, CAN J PHYSIOL PHARM, V67, P1190, DOI 10.1139/y89-189; Romere C, 2016, CELL, V165, P566, DOI 10.1016/j.cell.2016.02.063; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Xu PW, 2017, BIOL PSYCHIAT, V81, P737, DOI 10.1016/j.biopsych.2016.06.005; Yan CL, 2016, NEUROENDOCRINOLOGY, V103, P476, DOI 10.1159/000439436	32	149	164	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1444	+		10.1038/nm.4432	http://dx.doi.org/10.1038/nm.4432			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29106398	Green Submitted, Green Accepted			2022-12-27	WOS:000417278200014
J	Fennell, KA; Dawson, MA				Fennell, Katie A.; Dawson, Mark A.			SPOP tips the balance of BETs in cancer	NATURE MEDICINE			English	Editorial Material							PROSTATE-CANCER; RESISTANCE; MUTATIONS	Cancer-associated mutations in speckle-type POZ (pox virus and zinc-finger) protein confer neomorphic activity, altering its substrate affinities and its response to bromodomain and extraterminal inhibitors in prostate and endometrial cancer.	[Fennell, Katie A.; Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia; [Fennell, Katie A.; Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Dawson, Mark A.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Dawson, Mark A.] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.	mark.dawson@petermac.org	Dawson, Mark A/B-9317-2017	Dawson, Mark A/0000-0002-5464-5029; Fennell, Katie/0000-0002-9476-5914				Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Dai XP, 2017, NAT MED, V23, DOI 10.1038/nm.4378; Dawson MA, 2017, SCIENCE, V355, P1147, DOI 10.1126/science.aam7304; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Janouskova H, 2017, NAT MED, V23, P1046, DOI 10.1038/nm.4372; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Mani RS, 2014, DRUG DISCOV TODAY, V19, P1498, DOI 10.1016/j.drudis.2014.07.009; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Zhang PZ, 2017, NAT MED, V23, P1055, DOI 10.1038/nm.4379	11	2	3	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1014	1015		10.1038/nm.4398	http://dx.doi.org/10.1038/nm.4398			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886001				2022-12-27	WOS:000409996200006
J	Schneider, C; Oellerich, T; Baldauf, HM; Schwarz, SM; Thomas, D; Flick, R; Bohnenberger, H; Kaderali, L; Stegmann, L; Cremer, A; Martin, M; Lohmeyer, J; Michaelis, M; Hornung, V; Schliemann, C; Berdel, WE; Hartmann, W; Wardelmann, E; Comoglio, F; Hansmann, ML; Yakunin, AF; Geisslinger, G; Strobel, P; Ferreiros, N; Serve, H; Keppler, OT; Cinatl, J				Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Strobel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T.; Cinatl, Jindrich, Jr.			SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia (vol 23, pg 250, 2017)	NATURE MEDICINE			English	Correction													Hornung, Veit/C-3565-2012; Bohnenberger, Hanibal/F-2317-2013; Hartmann, Wolfgang/G-1893-2017	Hornung, Veit/0000-0002-4150-194X; Hartmann, Wolfgang/0000-0002-7609-5021; Michaelis, Martin/0000-0002-5710-5888; Kaderali, Lars/0000-0002-2359-2294				Schneider C, 2017, NAT MED, V23, P250, DOI 10.1038/nm.4255	1	1	1	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					788	788		10.1038/nm0617-788a	http://dx.doi.org/10.1038/nm0617-788a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586337	Bronze			2022-12-27	WOS:000402768000023
J	Workman, MJ; Mahe, MM; Trisno, S; Poling, HM; Watson, CL; Sundaram, N; Chang, CF; Schiesser, J; Aubert, P; Stanley, EG; Elefanty, AG; Miyaoka, Y; Mandegar, MA; Conklin, BR; Neunlist, M; Brugmann, SA; Helmrath, MA; Wells, JM				Workman, Michael J.; Mahe, Maxime M.; Trisno, Stephen; Poling, Holly M.; Watson, Carey L.; Sundaram, Nambirajan; Chang, Ching-Fang; Schiesser, Jacqueline; Aubert, Philippe; Stanley, Edouard G.; Elefanty, Andrew G.; Miyaoka, Yuichiro; Mandegar, Mohammad A.; Conklin, Bruce R.; Neunlist, Michel; Brugmann, Samantha A.; Helmrath, Michael A.; Wells, James M.			Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system	NATURE MEDICINE			English	Article							HIRSCHSPRUNG DISEASE; NEURONS; MOUSE; GUT; COLON; EXPRESSION; LINEAGES; MOTILITY; THERAPY; PHOX2B	The enteric nervous system (ENS) of the gastrointestinal tract controls many diverse functions, including motility and epithelial permeability. Perturbations in ENS development or function are common, yet there is no human model for studying ENS-intestinal biology and disease. We used a tissue-engineering approach with embryonic and induced pluripotent stem cells (PSCs) to generate human intestinal tissue containing a functional ENS. We recapitulated normal intestinal ENS development by combining human-PSC-derived neural crest cells (NCCs) and developing human intestinal organoids (HIOs). NCCs recombined with HIOs in vitro migrated into the mesenchyme, differentiated into neurons and glial cells and showed neuronal activity, as measured by rhythmic waves of calcium transients. ENS-containing HIOs grown in vivo formed neuroglial structures similar to a myenteric and submucosal plexus, had functional interstitial cells of Cajal and had an electromechanical coupling that regulated waves of propagating contraction. Finally, we used this system to investigate the cellular and molecular basis for Hirschsprung's disease caused by a mutation in the gene PHOX2B. This is, to the best of our knowledge, the first demonstration of human-PSC-derived intestinal tissue with a functional ENS and how this system can be used to study motility disorders of the human gastrointestinal tract.	[Workman, Michael J.; Trisno, Stephen; Chang, Ching-Fang; Schiesser, Jacqueline; Brugmann, Samantha A.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Mahe, Maxime M.; Poling, Holly M.; Watson, Carey L.; Sundaram, Nambirajan; Helmrath, Michael A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Chang, Ching-Fang; Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Plast Surg, Cincinnati, OH 45229 USA; [Aubert, Philippe; Neunlist, Michel] Univ Nantes, INSERM, CHU Nantes Inst Malad Appareil Digestif, UMR 913, Nantes, France; [Stanley, Edouard G.; Elefanty, Andrew G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Stanley, Edouard G.; Elefanty, Andrew G.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Pediat, Parkville, Vic 3052, Australia; [Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Miyaoka, Yuichiro; Mandegar, Mohammad A.; Conklin, Bruce R.] Gladstone Inst, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol Med, San Francisco, CA 94143 USA; [Conklin, Bruce R.; Wells, James M.] Univ Calif San Francisco, Dept Cellular Pharmacol, San Francisco, CA 94143 USA; [Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Dev Endocrinol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center	Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Helmrath, MA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA.; Wells, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dev Endocrinol, Cincinnati, OH 45229 USA.	michael.helmrath@cchmc.org; james.wells@cchmc.org	Neunlist, Michel/K-2388-2015; Conklin, Bruce/E-4738-2019; Mahe, Maxime M/G-5552-2017; Stanley, Ed G/A-2985-2013	Mahe, Maxime M/0000-0003-2560-193X; Stanley, Ed G/0000-0002-6389-3665; Miyaoka, Yuichiro/0000-0002-8874-4738; Workman, Michael/0000-0003-2113-5580; Trisno, Stephen/0000-0003-0937-4474; Chang, Ching-Fang/0000-0001-6754-2769; Conklin, Bruce/0000-0003-1463-6061; Aubert, Philippe/0000-0002-3126-6202; Mandegar, Mohammad Ali/0000-0002-5323-7891; Schiesser, Jacqueline/0000-0002-5655-4382; poling, holly/0000-0002-3595-1944; Elefanty, Andrew/0000-0001-6448-8314	US National Institutes of Health [U18TR000546, U18EB021780, U01DK103117, R0IDK098350, R01DK092456]; Athena Blackburn Research Scholar Award in Neuroenteric Diseases; Cincinnati Digestive Disease Center Award [P30 DK0789392]; Clinical Translational Science Award [U54 RR025216]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U18EB021780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092456, U01DK103117, K99DK110414, R01DK098350, P30DK078392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Athena Blackburn Research Scholar Award in Neuroenteric Diseases; Cincinnati Digestive Disease Center Award; Clinical Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Zorn, N. Shroyer and members of the Wells and Zorn laboratories for reagents and feedback. We thank M. Kofron for assistance with confocal imaging. We thank S. Danzer, R. Pun, J. Piero, M. Marotta and M. Oria for help with the equipment for the electrical field stimulation experiments. We thank K. Campbell and J. Kuerbitz for providing antibodies for the neurochemical analysis. This work was supported by US National Institutes of Health grants U18TR000546 (J.M.W.), U18EB021780 (J.M.W. and M.A.H.), U01DK103117 (J.M.W. and M.A.H.), R0IDK098350 (J.M.W.) and R01DK092456 (J.M.W.), and an Athena Blackburn Research Scholar Award in Neuroenteric Diseases (M.M.M.). We also acknowledge core support from the Cincinnati Digestive Disease Center Award (P30 DK0789392; Pilot and Feasibility Award), Clinical Translational Science Award (U54 RR025216) and technical support from Cincinnati Children's Hospital Medical Center (CCHMC) Confocal Imaging Core and the CCHMC human Pluripotent Stem Cell Facility.	Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; Anlauf M, 2003, J COMP NEUROL, V459, P90, DOI 10.1002/cne.10599; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; Bajaj R, 2005, PEDIATRICS, V115, pE737, DOI 10.1542/peds.2004-1910; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bergner AJ, 2014, J COMP NEUROL, V522, P514, DOI 10.1002/cne.23423; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Burns AJ, 2016, DEV BIOL, V417, P229, DOI 10.1016/j.ydbio.2016.04.001; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Burns AJ, 2009, SEMIN PEDIATR SURG, V18, P196, DOI 10.1053/j.sempedsurg.2009.07.001; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Denham M, 2015, STEM CELLS, V33, P1759, DOI 10.1002/stem.1991; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Hao MM, 2016, DEV BIOL, V417, P168, DOI 10.1016/j.ydbio.2016.05.030; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lui VCH, 2008, GASTROENTEROLOGY, V134, P1104, DOI 10.1053/j.gastro.2008.01.028; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Saffrey MJ, 2013, DEV BIOL, V382, P344, DOI 10.1016/j.ydbio.2013.03.015; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Young HM, 1999, DEV DYNAM, V216, P137, DOI 10.1002/(SICI)1097-0177(199910)216:2<137::AID-DVDY5>3.0.CO;2-6; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100	39	312	325	3	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					49	59		10.1038/nm.4233	http://dx.doi.org/10.1038/nm.4233			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869805	Green Accepted			2022-12-27	WOS:000391646800013
J	Das, R; Strowig, T; Verma, R; Koduru, S; Hafemann, A; Hopf, S; Kocoglu, MH; Borsotti, C; Zhang, L; Branagan, A; Eynon, E; Manz, MG; Flavell, RA; Dhodapkar, MV				Das, Rituparna; Strowig, Till; Verma, Rakesh; Koduru, Srinivas; Hafemann, Anja; Hopf, Stephanie; Kocoglu, Mehmet H.; Borsotti, Chiara; Zhang, Lin; Branagan, Andrew; Eynon, Elizabeth; Manz, Markus G.; Flavell, Richard A.; Dhodapkar, Madhav V.			Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice	NATURE MEDICINE			English	Article							MULTIPLE-MYELOMA CELLS; MONOCLONAL GAMMOPATHY; DISEASE PROGRESSION; MODEL; INTERLEUKIN-6; HETEROGENEITY; MEDICINE; FREQUENT; IMMUNITY	Most human cancers, including myeloma, are preceded by a precursor state. There is an unmet need for in vivo models to study the interaction of human preneoplastic cells in the bone marrow microenvironment with non-malignant cells. Here, we genetically humanized mice to permit the growth of primary human preneoplastic and malignant plasma cells together with non-malignant cells in vivo. Growth was largely restricted to the bone marrow, mirroring the pattern in patients with myeloma. Xenografts captured the genomic complexity of parental tumors and revealed additional somatic changes. Moreover, xenografts from patients with preneoplastic gammopathy showed progressive growth, suggesting that the clinical stability of these lesions may in part be due to growth controls extrinsic to tumor cells. These data demonstrate a new approach to investigate the entire spectrum of human plasma cell neoplasia and illustrate the utility of humanized models for understanding the functional diversity of human tumors.	[Das, Rituparna; Verma, Rakesh; Koduru, Srinivas; Kocoglu, Mehmet H.; Zhang, Lin; Branagan, Andrew; Dhodapkar, Madhav V.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Strowig, Till; Hafemann, Anja; Hopf, Stephanie; Branagan, Andrew; Eynon, Elizabeth; Flavell, Richard A.; Dhodapkar, Madhav V.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Borsotti, Chiara; Manz, Markus G.] Univ Zurich Hosp, Div Hematol, Zurich, Switzerland; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Dhodapkar, Madhav V.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Strowig, Till] Helmholtz Ctr Infect Res, Braunschweig, Germany	Yale University; Yale University; University of Zurich; University Zurich Hospital; Howard Hughes Medical Institute; Yale University; Yale University; Helmholtz Association; Helmholtz-Center for Infection Research	Dhodapkar, MV (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.; Flavell, RA; Dhodapkar, MV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Dhodapkar, MV (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.	richard.flavell@yale.edu; madhav.dhodapkar@yale.edu	Koduru, Srinivas V/L-3637-2019; Borsotti, Chiara/ABF-8176-2020	Koduru, Srinivas V/0000-0001-6827-2908; Borsotti, Chiara/0000-0001-9704-0647; Strowig, Till/0000-0003-0185-1459; Branagan, Andrew/0000-0002-3868-9267; Manz, Markus/0000-0002-4676-7931; Das, Rituparna/0000-0002-6497-5240	US National Institutes of Health [CA156689, CA106802, CA197603]; clinical research priority program of the University of Zurich; NATIONAL CANCER INSTITUTE [R35CA197603, P30CA016359, R01CA156689, R01CA106802] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); clinical research priority program of the University of Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funds from the US National Institutes of Health (CA156689, CA106802, CA197603) and the clinical research priority program of the University of Zurich. The authors thank F. Giraldez-Lopez, I. Tikhonova, S. Mane and M. Youngblood for assistance with sequencing analyses and C. Weibel, J. Alderman and C. Foster (all at Yale School of Medicine) for assistance with mouse colonies.	Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dhodapkar MV, 2015, BLOOD, V126, P2475, DOI 10.1182/blood-2015-03-632919; Dhodapkar MV, 2015, SEMIN ONCOL, V42, P617, DOI 10.1053/j.seminoncol.2015.05.009; Dhodapkar MV, 2014, BLOOD, V123, P78, DOI 10.1182/blood-2013-07-515239; Dhodapkar MV, 2003, J EXP MED, V198, P1753, DOI 10.1084/jem.20031030; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Hanamura I, 2006, BLOOD, V108, P1724, DOI 10.1182/blood-2006-03-009910; Hosen N, 2012, LEUKEMIA, V26, P2135, DOI 10.1038/leu.2012.80; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koduru S, 2012, BLOOD, V119, P2302, DOI 10.1182/blood-2011-08-376236; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Lawson MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9983; Lopez-Corral L, 2011, CLIN CANCER RES, V17, P1692, DOI 10.1158/1078-0432.CCR-10-1066; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Nair S, 2016, NEW ENGL J MED, V374, P555, DOI 10.1056/NEJMoa1508808; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Schuler J, 2013, EXPERT OPIN BIOL TH, V13, pS111, DOI 10.1517/14712598.2013.799131; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Tassone P, 2005, BLOOD, V106, P713, DOI 10.1182/blood-2005-01-0373; Walker BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/leu.2013.199; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Zhao S, 2014, LEUKEMIA, V28, P1548, DOI 10.1038/leu.2014.59	31	83	89	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1351	1357		10.1038/nm.4202	http://dx.doi.org/10.1038/nm.4202			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27723723	Green Accepted			2022-12-27	WOS:000387302300029
J	Schnappinger, D; Ehrt, S				Schnappinger, Dirk; Ehrt, Sabine			A broader spectrum of tuberculosis	NATURE MEDICINE			English	Editorial Material							POSITRON-EMISSION; MESSENGER-RNA	Two new studies show that high-resolution imaging can detect active tuberculosis (TB) in people otherwise diagnosed as healthy. Individuals with these signs of active infection with Mycobacterium tuberculosis (Mtb) were at an increased risk of developing clinical TB.	[Schnappinger, Dirk; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Schnappinger, D (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	dis2003@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020					Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Chengalroyen MD, 2016, AM J RESP CRIT CARE; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Esmail H, 2016, NAT MED, V22, P1090, DOI 10.1038/nm.4161; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177; Manina G, 2015, CELL HOST MICROBE, V17, P32, DOI 10.1016/j.chom.2014.11.016; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; PRABHAKAR R, 1986, AM REV RESPIR DIS, V134, P27; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Turapov O, 2016, ANTIMICROB AGENTS CH, V60, P2476, DOI 10.1128/AAC.01380-15; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	12	10	10	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1076	1077		10.1038/nm.4186	http://dx.doi.org/10.1038/nm.4186			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711059				2022-12-27	WOS:000384872500008
J	Vaccari, M; Gordon, SN; Fourati, S; Schifanella, L; Liyanage, NPM; Cameron, M; Keele, BF; Shen, XY; Tomaras, GD; Billings, E; Rao, M; Chung, AW; Dowell, KG; Bailey-Kellogg, C; Brown, EP; Ackerman, ME; Vargas-Inchaustegui, DA; Whitney, S; Doster, MN; Binello, N; Pegu, P; Montefiori, DC; Foulds, K; Quinn, DS; Donaldson, M; Liang, F; Lore, K; Roederer, M; Koup, RA; McDermott, A; Ma, ZM; Miller, CJ; Phan, TB; Forthal, DN; Blackburn, M; Caccuri, F; Bissa, M; Ferrari, G; Kalyanaraman, V; Ferrari, MG; Thompson, D; Robert-Guroff, M; Ratto-Kim, S; Kim, JH; Michael, NL; Phogat, S; Barnett, SW; Tartaglia, J; Venzon, D; Stablein, DM; Alter, G; Sekaly, RP; Franchini, G				Vaccari, Monica; Gordon, Shari N.; Fourati, Slim; Schifanella, Luca; Liyanage, Namal P. M.; Cameron, Mark; Keele, Brandon F.; Shen, Xiaoying; Tomaras, Georgia D.; Billings, Erik; Rao, Mangala; Chung, Amy W.; Dowell, Karen G.; Bailey-Kellogg, Chris; Brown, Eric P.; Ackerman, Margaret E.; Vargas-Inchaustegui, Diego A.; Whitney, Stephen; Doster, Melvin N.; Binello, Nicolo; Pegu, Poonam; Montefiori, David C.; Foulds, Kathryn; Quinn, David S.; Donaldson, Mitzi; Liang, Frank; Lore, Karin; Roederer, Mario; Koup, Richard A.; McDermott, Adrian; Ma, Zhong-Min; Miller, Christopher J.; Phan, Tran B.; Forthal, Donald N.; Blackburn, Matthew; Caccuri, Francesca; Bissa, Massimiliano; Ferrari, Guido; Kalyanaraman, Vaniambadi; Ferrari, Maria G.; Thompson, DeVon; Robert-Guroff, Marjorie; Ratto-Kim, Silvia; Kim, Jerome H.; Michael, Nelson L.; Phogat, Sanjay; Barnett, Susan W.; Tartaglia, Jim; Venzon, David; Stablein, Donald M.; Alter, Galit; Sekaly, Rafick-Pierre; Franchini, Genoveffa			Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (vol 22, pg 762, 2016)	NATURE MEDICINE			English	Correction													Quinn, David/N-3730-2019; Liyanage, Namal P M/AAU-1392-2021; Caccuri, Francesca/AAC-1281-2022; Liang, Frank/AAT-6566-2020; Roederer, Mario/G-1887-2011	Quinn, David/0000-0002-1411-0417; Liyanage, Namal P M/0000-0001-7362-3282; Caccuri, Francesca/0000-0002-1923-9033; Chung, Amy/0000-0003-0020-9704; Bissa, Massimiliano/0000-0003-3455-3992; Ratto-Kim, Silvia/0000-0003-2025-6399	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI131975] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI102691, R01 AI118581, R01 AI131975, R01 AI102715] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105	1	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1192	1192		10.1038/nm1016-1192a	http://dx.doi.org/10.1038/nm1016-1192a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711066	Bronze			2022-12-27	WOS:000384872500023
J	Moon, JS; Nakahira, K; Chung, KP; DeNicola, GM; Koo, MJ; Pabon, MA; Rooney, KT; Yoon, JH; Ryter, SW; Stout-Delgado, H; Choi, AMK				Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; DeNicola, Gina M.; Koo, Michael Jakun; Pabon, Maria A.; Rooney, Kristen T.; Yoon, Joo-Heon; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.			NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; BETA-CELL; PALMITOYLTRANSFERASE-I; DIABETES-MELLITUS; NAD(P)H OXIDASE; NOX4; CARNITINE; DISEASE; STRESS; METABOLISM	Altered metabolism has been implicated in the pathogenesis of inflammatory diseases. NADPH oxidase 4 (NOX4), a source of cellular superoxide anions, has multiple biological functions that may be of importance in inflammation and in the pathogenesis of human metabolic diseases, including diabetes. However, the mechanisms by which NOX4-dependent metabolic regulation affect the innate immune response remain unclear. Here we show that deficiency of NOX4 resulted in reduced expression of carnitine palmitoyltransferase 1A (CPT1A), which is a key mitochondrial enzyme in the fatty acid oxidation (FAO) pathway. The reduced FAO resulted in less activation of the nucleotide-binding domain, leucine-rich-repeat-containing receptor (NLR), pyrin-domain-containing 3 (NLRP3) inflammasome in human and mouse macrophages. In contrast, NOX4 deficiency did not inhibit the activation of the NLR family, CARD-domain-containing 4 (NLRC4), the NLRP1 or the absent in melanoma 2 (AIM2) inflammasomes. We also found that inhibition of FAO by etomoxir treatment suppressed NLRP3 inflammasome activation. Furthermore, Nox4-deficient mice showed substantial reduction in caspase-1 activation and in interleukin (IL)-1b and IL-18 production, and there was improved survival in a mouse model of NLRP3-mediated Streptococcus pneumoniae infection. The pharmacologic inhibition of NOX4 by either GKT137831, which is currently in phase 2 clinical trials, or VAS-2870 attenuated NLRP3 inflammasome activation. Our results suggest that NOX4-mediated FAO promotes NLRP3 inflammasome activation.	[Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; DeNicola, Gina M.; Koo, Michael Jakun; Pabon, Maria A.; Rooney, Kristen T.; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA; [Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; DeNicola, Gina M.; Koo, Michael Jakun; Pabon, Maria A.; Rooney, Kristen T.; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.] New York Presbyterian Hosp, New York, NY USA; [Moon, Jong-Seok; Nakahira, Kiichi; Chung, Kuei-Pin; Koo, Michael Jakun; Rooney, Kristen T.; Ryter, Stefan W.; Stout-Delgado, Heather; Choi, Augustine M. K.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY USA; [Chung, Kuei-Pin] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chung, Kuei-Pin] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Nat Human Def Syst, Seoul, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea	Cornell University; NewYork-Presbyterian Hospital; Cornell University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, AMK (corresponding author), Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA.; Choi, AMK (corresponding author), New York Presbyterian Hosp, New York, NY USA.; Choi, AMK (corresponding author), Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY USA.	amc2056@med.cornell.edu	Pabon Porras, Maria/CAG-5118-2022; Stout-Delgado, Heather/ABB-5628-2020; Moon, James C/F-1031-2014	Moon, James C/0000-0001-8071-1491; CHUNG, KUEI-PIN/0000-0003-1916-8068; Stout-Delgado, Heather/0000-0002-2387-6924; DeNicola, Gina/0000-0001-6611-6696; Rooney, Kristen T/0000-0002-7495-1437	US National Institutes of Health [P01 HL108801, R01 HL079904, R01 HL055330]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132198, R01HL079904, R01HL055330, P01HL108801, P01HL114501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044755, K01AG034999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (grant no. P01 HL108801, R01 HL079904, R01 HL055330; all to A.M.K.C.). We thank E. Finkelsztein for technical assistance.	Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Choi AMK, 2011, NAT IMMUNOL, V12, P379, DOI 10.1038/ni.2028; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Mensink RP, 2005, LIPIDS, V40, P1201, DOI 10.1007/s11745-005-1486-x; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; TUTWILER GF, 1985, P SOC EXP BIOL MED, V178, P288; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VARANASI U, 1994, P NATL ACAD SCI USA, V91, P3107, DOI 10.1073/pnas.91.8.3107; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	53	198	207	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1002	+		10.1038/nm.4153	http://dx.doi.org/10.1038/nm.4153			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27455510	Green Accepted			2022-12-27	WOS:000382542800011
J	Li, Y; Oosting, M; Deelen, P; Ricano-Ponce, I; Smeekens, S; Jaeger, M; Matzaraki, V; Swertz, MA; Xavier, RJ; Franke, L; Wijmenga, C; Joosten, LAB; Kumar, V; Netea, MG				Li, Yang; Oosting, Marije; Deelen, Patrick; Ricano-Ponce, Isis; Smeekens, Sanne; Jaeger, Martin; Matzaraki, Vasiliki; Swertz, Morris A.; Xavier, Ramnik J.; Franke, Lude; Wijmenga, Cisca; Joosten, Leo A. B.; Kumar, Vinod; Netea, Mihai G.			Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi	NATURE MEDICINE			English	Article							HUMAN IMMUNE-SYSTEM; INFECTIOUS-DISEASE; PROTEIN ABUNDANCE; STAT1 MUTATIONS; LOW-FREQUENCY; WHOLE-BLOOD; VARIANTS; GENOME; RNA; ARCHITECTURE	Little is known about the inter-individual variation of cytokine responses to different pathogens in healthy individuals. To systematically describe cytokine responses elicited by distinct pathogens and to determine the effect of genetic variation on cytokine production, we profiled cytokines produced by peripheral blood mononuclear cells from 197 individuals of European origin from the 200 Functional Genomics (200FG) cohort in the Human Functional Genomics Project (http://www.humanfunctionalgenomics.org), obtained over three different years. We compared bacteria- and fungi-induced cytokine profiles and found that most cytokine responses were organized around a physiological response to specific pathogens, rather than around a particular immune pathway or cytokine. We then correlated genome-wide single-nucleotide polymorphism (SNP) genotypes with cytokine abundance and identified six cytokine quantitative trait loci (QTLs). Among them, a cytokine QTL at the NAA35-GOLM1 locus markedly modulated interleukin (IL)-6 production in response to multiple pathogens and was associated with susceptibility to candidemia. Furthermore, the cytokine QTLs that we identified were enriched among SNPs previously associated with infectious diseases and heart diseases. These data reveal and begin to explain the variability in cytokine production by human immune cells in response to pathogens.	[Li, Yang; Deelen, Patrick; Ricano-Ponce, Isis; Matzaraki, Vasiliki; Swertz, Morris A.; Franke, Lude; Wijmenga, Cisca; Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Oosting, Marije; Smeekens, Sanne; Jaeger, Martin; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Oosting, Marije; Smeekens, Sanne; Jaeger, Martin; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Deelen, Patrick; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [Xavier, Ramnik J.] Harvard Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA USA; [Xavier, Ramnik J.] Harvard Med Sch, Boston, MA USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kumar, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.	v.kumar@umcg.nl; mihai.netea@radboudumc.nl	Joosten, Leo AB/H-3138-2015; Li, Yang/HGT-8446-2022; Wijmenga, Cisca/D-2173-2009; Kumar, Vinod/ABC-4866-2020; Smeekens, Sanne/AAZ-2061-2021; Jaeger, Martin/H-3359-2015; Matzaraki, Vasiliki/V-7081-2018; Wijmenga, Cisca/AAE-7719-2019; Ricaño-Ponce, Isis/ABC-5454-2020; Oosting, Marije/H-7437-2015; Deelen, Patrick/B-3566-2013; Franke, Lude/P-7036-2016; Matzaraki, Vasiliki/GZB-0509-2022; Smeekens, Sanne/G-8307-2011; Netea, Mihai/N-5155-2014; Matzaraki, Vasiliki/AAK-7880-2020	Joosten, Leo AB/0000-0001-6166-9830; Li, Yang/0000-0003-4022-7341; Kumar, Vinod/0000-0002-2775-6049; Smeekens, Sanne/0000-0002-7835-914X; Jaeger, Martin/0000-0001-6994-493X; Matzaraki, Vasiliki/0000-0002-5852-6801; Wijmenga, Cisca/0000-0002-5635-1614; Ricaño-Ponce, Isis/0000-0002-7530-9526; Deelen, Patrick/0000-0002-5654-3966; Franke, Lude/0000-0002-5159-8802; Matzaraki, Vasiliki/0000-0002-5852-6801; Smeekens, Sanne/0000-0002-7835-914X; Matzaraki, Vasiliki/0000-0002-5852-6801	ERC Consolidator Grant [3310372]; ERC Advanced Grant (FP)/ERC [2012-322698]; Dutch Digestive Diseases Foundation [MLDS WO11-30]; European Union's Seventh Framework Programme (EU FP7) TANDEM project [HEALTH-F3-2012-305279]; Netherlands Organization for Scientific Research (NWO) VENI grant [863.13.011]; Netherlands Organization for Scientific Research [184021007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	ERC Consolidator Grant(Estonian Research Council); ERC Advanced Grant (FP)/ERC; Dutch Digestive Diseases Foundation; European Union's Seventh Framework Programme (EU FP7) TANDEM project; Netherlands Organization for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank all volunteers from the 200 Functional Genomics cohort of the Human Functional Genomics Project for participation in the study. The authors would like to thank K. McIntyre for editing the final text. This study was partially supported by a ERC Consolidator Grant (3310372) to M.G.N. and by the ERC Advanced Grant (FP/2007-2013/ERC grant 2012-322698 to C.W.), the Dutch Digestive Diseases Foundation (MLDS WO11-30 to C.W. and V.K.), the European Union's Seventh Framework Programme (EU FP7) TANDEM project (HEALTH-F3-2012-305279 to C.W. and V.K.), and a Netherlands Organization for Scientific Research (NWO) VENI grant (863.13.011 to Y.L.). This study made use of data generated by the 'Genome of the Netherlands' project, which is funded by the Netherlands Organization for Scientific Research (grant no. 184021007). The data were made available as a Rainbow Project of BBMRI-NL.	Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Deelen Patrick, 2014, BMC Res Notes, V7, P901, DOI 10.1186/1756-0500-7-901; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ENDRES S, 1988, CLIN IMMUNOL IMMUNOP, V49, P424, DOI 10.1016/0090-1229(88)90130-4; ENDRES S, 1989, EUR J IMMUNOL, V19, P2327, DOI 10.1002/eji.1830191222; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Zambrano-Zaragoza JF, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/651503; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Hill AVS, 2012, PHILOS T R SOC B, V367, P840, DOI 10.1098/rstb.2011.0275; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juschke C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r133; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Kayama Hisako, 2013, Immune Netw, V13, P227, DOI 10.4110/in.2013.13.6.227; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Kumar V, 2014, CURR OPIN IMMUNOL, V31, P51, DOI 10.1016/j.coi.2014.09.007; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Liang HY, 2012, CANCER BIOMARK, V11, P161, DOI 10.3233/CBM-2012-00276; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Liu XY, 2011, CLIN CHEM LAB MED, V49, P1311, DOI 10.1515/CCLM.2011.640; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Netea MG, 1996, CYTOKINE, V8, P739, DOI 10.1006/cyto.1996.0098; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Rubicz R, 2015, EUR J HUM GENET, V23, P1544, DOI 10.1038/ejhg.2015.24; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; van Crevel R, 1999, J IMMUNOL METHODS, V222, P145, DOI 10.1016/S0022-1759(98)00192-6; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	54	107	110	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					952	+		10.1038/nm.4139	http://dx.doi.org/10.1038/nm.4139			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376574	Green Accepted			2022-12-27	WOS:000381000200022
J	Rothhammer, V; Mascanfroni, ID; Bunse, L; Takenaka, MC; Kenison, JE; Mayo, L; Chao, CC; Patel, B; Yan, R; Blain, M; Alvarez, JI; Kebir, H; Anandasabapathy, N; Izquierdo, G; Jung, S; Obholzer, N; Pochet, N; Clish, CB; Prinz, M; Prat, A; Antel, J; Quintana, FJ				Rothhammer, Veit; Mascanfroni, Ivan D.; Bunse, Lukas; Takenaka, Maisa C.; Kenison, Jessica E.; Mayo, Lior; Chao, Chun-Cheih; Patel, Bonny; Yan, Raymond; Blain, Manon; Alvarez, Jorge I.; Kebir, Hania; Anandasabapathy, Niroshana; Izquierdo, Guillermo; Jung, Steffen; Obholzer, Nikolaus; Pochet, Nathalie; Clish, Clary B.; Prinz, Marco; Prat, Alexandre; Antel, Jack; Quintana, Francisco J.			Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; REGULATORY T-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; MYELOID CELLS; BETA; DIFFERENTIATION; EXPRESSION; RESPONSES	Astrocytes have important roles in the central nervous system (CNS) during health and disease. Through genome-wide analyses we detected a transcriptional response to type I interferons (IFN-Is) in astrocytes during experimental CNS autoimmunity and also in CNS lesions from patients with multiple sclerosis (MS). IFN-I signaling in astrocytes reduces inflammation and experimental autoimmune encephalomyelitis (EAE) disease scores via the ligand-activated transcription factor aryl hydrocarbon receptor (AHR) and the suppressor of cytokine signaling 2 (SOCS2). The anti-inflammatory effects of nasally administered interferon (IFN)-beta are partly mediated by AHR. Dietary tryptophan is metabolized by the gut microbiota into AHR agonists that have an effect on astrocytes to limit CNS inflammation. EAE scores were increased following ampicillin treatment during the recovery phase, and CNS inflammation was reduced in antibiotic-treated mice by supplementation with the tryptophan metabolites indole, indoxyl-3-sulfate, indole-3-propionic acid and indole-3-aldehyde, or the bacterial enzyme tryptophanase. In individuals with MS, the circulating levels of AHR agonists were decreased. These findings suggest that IFN-Is produced in the CNS function in combination with metabolites derived from dietary tryptophan by the gut flora to activate AHR signaling in astrocytes and suppress CNS inflammation.	[Rothhammer, Veit; Mascanfroni, Ivan D.; Bunse, Lukas; Takenaka, Maisa C.; Kenison, Jessica E.; Mayo, Lior; Chao, Chun-Cheih; Patel, Bonny; Yan, Raymond; Obholzer, Nikolaus; Pochet, Nathalie; Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA; [Blain, Manon; Antel, Jack] McGill Univ, Montreal Neurol Inst, Neuroimmunol Unit, Montreal, PQ, Canada; [Alvarez, Jorge I.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kebir, Hania; Prat, Alexandre] Univ Montreal, Neuroimmunol Res Lab, Ctr Excellence Neur CRCHUM, Montreal, PQ, Canada; [Anandasabapathy, Niroshana] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Izquierdo, Guillermo] Univ Seville, Mol Biol Serv, Seville, Spain; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Obholzer, Nikolaus; Pochet, Nathalie] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Clish, Clary B.] Broad Inst MIT & Harvard Univ, Metabolite Profiling Platform, Cambridge, MA USA; [Prinz, Marco] Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; McGill University; University of Pennsylvania; Universite de Montreal; Harvard University; Brigham & Women's Hospital; University of Sevilla; Weizmann Institute of Science; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Freiburg	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Clish, Clary B/ABB-9374-2021; Quintana, Francisco Javier/AAB-6915-2020; m, Lior/AGK-3671-2022; Bunse, Lukas/L-2975-2016; Jung, Steffen/K-1409-2012; Clish, Clary/AAB-7124-2019; Pochet, Nathalie/Q-1322-2017	Clish, Clary B/0000-0001-8259-9245; m, Lior/0000-0002-1296-6692; Bunse, Lukas/0000-0002-4490-7574; Jung, Steffen/0000-0003-4290-5716; Pochet, Nathalie/0000-0003-1820-5656; Chao, Chun-Cheih/0000-0003-4108-2658; antel, jack/0000-0002-5148-0636; Anandasabapathy, Niroshana/0000-0002-0473-8358; Prat, Alexandre/0000-0001-6188-0580; Kenison, Jessica/0000-0002-5599-3228; Kebir, Hania/0000-0001-6174-8846	National Institutes of Health (NIH) [AI075285, AI093903]; National Multiple Sclerosis Society [RG4111A1, FG 2036-A1/1, FG1941A1/2]; International Progressive MS Alliance grants [PA0069, PA-1501-02847]; Mallinckrodt Pharmaceuticals [A219074]; German Research Foundation (DFG) [RO4866 1/1]; International Academy of Life Sciences; Ministry of Science and Technology, Taiwan [104-2917-I-564 -024]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [BEX 0571/15-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI075285, R01AI126880, R01AI093903, K99AI075285] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); International Progressive MS Alliance grants; Mallinckrodt Pharmaceuticals; German Research Foundation (DFG)(German Research Foundation (DFG)); International Academy of Life Sciences; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) grants AI075285 (F.J.Q.) and AI093903 (F.J.Q.), the National Multiple Sclerosis Society grant RG4111A1 (F.J.Q.), the International Progressive MS Alliance grants PA0069 (F.J.Q.) and PA-1501-02847 (F.J.Q.), an educational grant from Mallinckrodt Pharmaceuticals (A219074; V.R.), a fellowship from the German Research Foundation (DFG RO4866 1/1; V.R.), postdoctoral fellowships from the National Multiple Sclerosis Society (FG 2036-A1/1 (I.D.M) and FG1941A1/2 (L.M.)), a fellowship from the International Academy of Life Sciences (L.B.), a postdoctoral Research Abroad Program award from the Ministry of Science and Technology, Taiwan (104-2917-I-564 -024; C.-C.C.) and a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (BEX 0571/15-6; M.C.T.). Cx3cr1-CreERT2 mice were a kind gift from S. Jung (Weizmann Institute of science). The pLenti-Gfap-eGFP-mir30-shAct1 vector was a gift from G.-X. Zhang.	Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Alvarez JI, 2015, NEUROBIOL DIS, V74, P14, DOI 10.1016/j.nbd.2014.09.016; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Boverhof DR, 2004, MOL PHARMACOL, V66, P1662, DOI 10.1124/mol.104.002915; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khorooshi R, 2015, ACTA NEUROPATHOL, V130, P107, DOI 10.1007/s00401-015-1418-z; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Lassmann H, 2014, GLIA, V62, P1816, DOI 10.1002/glia.22597; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Mc Guire C, 2013, TRENDS MOL MED, V19, P604, DOI 10.1016/j.molmed.2013.08.001; Mitsdoerffer M, 2009, ANN NEUROL, V65, P487, DOI 10.1002/ana.21722; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Rieckmann P, 2003, NAT MED, V9, P828, DOI 10.1038/nm0703-828; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	65	669	691	16	242	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					586	+		10.1038/nm.4106	http://dx.doi.org/10.1038/nm.4106			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158906	Green Accepted, Green Submitted			2022-12-27	WOS:000377476000011
J	Robichaux, JP; Elamin, YY; Tan, Z; Carter, BW; Zhang, SX; Liu, SW; Li, S; Chen, T; Poteete, A; Estrada-Bernal, A; Le, AT; Truini, A; Nilsson, MB; Sun, HY; Roarty, E; Goldberg, SB; Brahmer, JR; Altan, M; Lu, C; Papadimitrakopoulou, V; Politi, K; Doebele, RC; Wong, KK; Heymach, JV				Robichaux, Jacqulyne P.; Elamin, Yasir Y.; Tan, Zhi; Carter, Brett W.; Zhang, Shuxing; Liu, Shengwu; Li, Shuai; Chen, Ting; Poteete, Alissa; Estrada-Bernal, Adriana; Le, Anh T.; Truini, Anna; Nilsson, Monique B.; Sun, Huiying; Roarty, Emily; Goldberg, Sarah B.; Brahmer, Julie R.; Altan, Mehmet; Lu, Charles; Papadimitrakopoulou, Vassiliki; Politi, Katerina; Doebele, Robert C.; Wong, Kwok-Kin; Heymach, John V.			Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer	NATURE MEDICINE			English	Article							ADVANCED SOLID TUMORS; FACTOR RECEPTOR GENE; GROUP-STUDY BR.21; PHASE-II TRIAL; 1ST-LINE TREATMENT; 20 INSERTIONS; OPEN-LABEL; MUTATIONS; GEFITINIB; ERLOTINIB	Although most activating mutations of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancers (NSCLCs) are sensitive to available EGFR tyrosine kinase inhibitors (TKIs), a subset with alterations in exon 20 of EGFR and HER2 are intrinsically resistant and lack an effective therapy. We used in silico, in vitro, and in vivo testing to model structural alterations induced by exon 20 mutations and to identify effective inhibitors. 3D modeling indicated alterations restricted the size of the drug-binding pocket, limiting the binding of large, rigid inhibitors. We found that poziotinib, owing to its small size and flexibility, can circumvent these steric changes and is a potent inhibitor of the most common EGFR and HER2 exon 20 mutants. Poziotinib demonstrated greater activity than approved EGFR TKIs in vitro and in patient-derived xenograft models of EGFR or HER2 exon 20 mutant NSCLC and in genetically engineered mouse models of NSCLC. In a phase 2 trial, the first 11 patients with NSCLC with EGFR exon 20 mutations receiving poziotinib had a confirmed objective response rate of 64%. These data identify poziotinib as a potent, clinically active inhibitor of EGFR and HER2 exon 20 mutations and illuminate the molecular features of TKIs that may circumvent steric changes induced by these mutations.	[Robichaux, Jacqulyne P.; Elamin, Yasir Y.; Poteete, Alissa; Nilsson, Monique B.; Sun, Huiying; Roarty, Emily; Altan, Mehmet; Lu, Charles; Papadimitrakopoulou, Vassiliki; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Tan, Zhi; Zhang, Shuxing] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Carter, Brett W.] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Liu, Shengwu; Li, Shuai; Chen, Ting] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Estrada-Bernal, Adriana; Le, Anh T.; Doebele, Robert C.] Univ Colorado, Canc Ctr, Aurora, CO USA; [Truini, Anna; Goldberg, Sarah B.; Politi, Katerina] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [Goldberg, Sarah B.; Politi, Katerina] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Brahmer, Julie R.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Politi, Katerina] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Wong, Kwok-Kin] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Yale University; Johns Hopkins University; Johns Hopkins Medicine; Yale University; New York University; NYU Langone Medical Center	Heymach, JV (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	jheymach@mdanderson.org	Doebele, Robert C./I-8230-2019; Altan, Orhan/AAD-4550-2022; Truini, Anna/K-1901-2018; Tan, Zhi/B-9065-2017; Heymach, John/AAG-2361-2019	Doebele, Robert C./0000-0001-6728-6857; Truini, Anna/0000-0002-4600-6497; Tan, Zhi/0000-0003-1895-0285; Heymach, John/0000-0001-9068-8942; Chen, Ting/0000-0003-1725-7956; Robichaux, Jacqulyne/0000-0001-8812-7054; wong, kwok kin/0000-0001-6323-235X; chen, ting/0000-0001-8414-6346	Lung SPORE grant [P50 CA070907, P50 CA196530]; Lung Cancer Research Fund; NIH [R01 CA190628]; NIH Cancer Center Support Grant [P30 CA016672]; Rexanna Foundation for Fighting Lung Cancer; Exon 20 Group; University of Texas MD Anderson Cancer Center Bruton Endowed Chair in Tumor Biology; Stading Fund for EGFR inhibitor resistance; Hallman fund; Fox Lung EGFR Inhibitor Fund; Christine J. Burge Endowment for Lung Cancer Research at the University of Colorado Cancer Center; Burge family; Miramont Cares foundation; Italian Association for Cancer Research; Cancer Prevention Research Institute of Texas [DP150086]; National Science Foundation [CHE-1411859]; National Institute of General Medical Sciences [GM070737]; Spectrum Pharmaceutical; NATIONAL CANCER INSTITUTE [P50CA196530, P50CA058187, P50CA070907, P30CA016672, R01CA166480, R01CA140594, R01CA190628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070737] Funding Source: NIH RePORTER	Lung SPORE grant; Lung Cancer Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rexanna Foundation for Fighting Lung Cancer; Exon 20 Group; University of Texas MD Anderson Cancer Center Bruton Endowed Chair in Tumor Biology; Stading Fund for EGFR inhibitor resistance; Hallman fund; Fox Lung EGFR Inhibitor Fund; Christine J. Burge Endowment for Lung Cancer Research at the University of Colorado Cancer Center; Burge family; Miramont Cares foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Cancer Prevention Research Institute of Texas; National Science Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spectrum Pharmaceutical; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank the patients and their families for participation in this study and Spectrum Pharmaceuticals for providing the drug used in the compassionate-use protocol. The authors also wish to thank J.S. (a patient) for efforts in initiating the poziotinib trial. This work was supported by the Lung SPORE grant P50 CA070907 and P50 CA196530 (J.V.H.); the Lung Cancer Research Fund (Y.Y.E.); generous philanthropic contributions to the University of Texas MD Anderson Lung Cancer Moon Shots Program (J.V.H.); NIH R01 CA190628 (J.V.H.), NIH Cancer Center Support Grant P30 CA016672 (J.V.H.), the Rexanna Foundation for Fighting Lung Cancer (J.V.H.), the Exon 20 Group (J.V.H.), the University of Texas MD Anderson Cancer Center Bruton Endowed Chair in Tumor Biology (J.V.H.), the Stading Fund for EGFR inhibitor resistance (J.V.H.), the Hallman fund (J.V.H.), and the Fox Lung EGFR Inhibitor Fund (J.V.H.). Additional support was provided from the Christine J. Burge Endowment for Lung Cancer Research at the University of Colorado Cancer Center, the Burge family, the Miramont Cares foundation (R.C.D.), a fellowship from the Italian Association for Cancer Research (A.T.), and Cancer Prevention Research Institute of Texas DP150086, National Science Foundation CHE-1411859, and National Institute of General Medical Sciences GM070737 (S.Z.). The clinical study was supported by Spectrum Pharmaceuticals.	Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Arcila ME, 2012, CLIN CANCER RES, V18, P4910, DOI 10.1158/1078-0432.CCR-12-0912; Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cha MY, 2012, INT J CANCER, V130, P2445, DOI 10.1002/ijc.26276; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Cho J, 2013, CANCER RES, V73, P6770, DOI 10.1158/0008-5472.CAN-13-1145; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; Costa DB, 2016, J THORAC ONCOL, V11, P918, DOI 10.1016/j.jtho.2016.02.016; Davies KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082236; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Han JY, 2017, CANCER RES TREAT, V49, P10, DOI 10.4143/crt.2016.058; Hong J, 2007, J BIOL CHEM, V282, P19781, DOI 10.1074/jbc.M700128200; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Ito Y, 2012, JPN J CLIN ONCOL, V42, P278, DOI 10.1093/jjco/hys012; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Kim DW, 2013, J THORAC ONCOL, V8, pS607; Kim TM, 2012, J CLIN ONCOL, V30; Kosaka T, 2017, CANCER RES, V77, P2712, DOI 10.1158/0008-5472.CAN-16-3404; Kourie HR, 2016, EXPERT OPIN DRUG MET, V12, P947, DOI 10.1080/17425255.2016.1198317; Kris MG, 2015, ANN ONCOL, V26, P1421, DOI 10.1093/annonc/mdv186; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mazieres J, 2016, ANN ONCOL, V27, P281, DOI 10.1093/annonc/mdv573; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Nilsson MB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4307; Noh YH, 2015, CANCER CHEMOTH PHARM, V75, P97, DOI 10.1007/s00280-014-2621-7; Oxnard GR, 2013, J THORAC ONCOL, V8, P179, DOI 10.1097/JTO.0b013e3182779d18; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Planchard D, 2016, CANCER CHEMOTH PHARM, V77, P767, DOI 10.1007/s00280-016-2992-z; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Shen XK, 2016, J RECEPT SIG TRANSD, V36, P89, DOI 10.3109/10799893.2015.1049361; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tsigelny IF, 2015, ONCOTARGET, V6, P6029, DOI 10.18632/oncotarget.3472; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wang YS, 2012, THER ADV MED ONCOL, V4, P19, DOI 10.1177/1758834011427927; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Wheler J, 2013, ONCOTARGET, V4, P772, DOI 10.18632/oncotarget.1028; Wheler JJ, 2013, MOL CANCER THER, V12, P2167, DOI 10.1158/1535-7163.MCT-12-1208; Wind S, 2013, CLIN PHARMACOKINET, V52, P1101, DOI 10.1007/s40262-013-0091-4; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yang MM, 2016, INT J CANCER, V139, P171, DOI 10.1002/ijc.30047; Yasuda H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007205; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	53	236	253	5	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					638	+		10.1038/s41591-018-0007-9	http://dx.doi.org/10.1038/s41591-018-0007-9			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29686424	Green Accepted			2022-12-27	WOS:000432126800021
J	Wang, CZ; Najm, R; Xu, Q; Jeong, DE; Walker, D; Balestra, ME; Yoon, SY; Yuan, HD; Li, G; Miller, ZA; Miller, BL; Malloy, MJ; Huang, YD				Wang, Chengzhong; Najm, Ramsey; Xu, Qin; Jeong, Dah-eun; Walker, David; Balestra, Maureen E.; Yoon, Seo Yeon; Yuan, Heidi; Li, Gang; Miller, Zachary A.; Miller, Bruce L.; Malloy, Mary J.; Huang, Yadong			Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; FAMILIAL ALZHEIMERS-DISEASE; A-BETA ACCUMULATION; GABAERGIC INTERNEURONS; TRANSGENIC MICE; DEPENDENT IMPAIRMENT; TAU-PHOSPHORYLATION; MEMORY DEFICITS; IN-VIVO; PROTEIN	Efforts to develop drugs for Alzheimer's disease (AD) have shown promise in animal studies, only to fail in human trials, suggesting a pressing need to study AD in human model systems. Using human neurons derived from induced pluripotent stem cells that expressed apolipoprotein E4 (ApoE4), a variant of the APOE gene product and the major genetic risk factor for AD, we demonstrated that ApoE4-expressing neurons had higher levels of tau phosphorylation, unrelated to their increased production of amyloid-beta (A beta) peptides, and that they displayed GABAergic neuron degeneration. ApoE4 increased A beta production in human, but not in mouse, neurons. Converting ApoE4 to ApoE3 by gene editing rescued these phenotypes, indicating the specific effects of ApoE4. Neurons that lacked APOE behaved similarly to those expressing ApoE3, and the introduction of ApoE4 expression recapitulated the pathological phenotypes, suggesting a gain of toxic effects from ApoE4. Treatment of ApoE4-expressing neurons with a small-molecule structure corrector ameliorated the detrimental effects, thus showing that correcting the pathogenic conformation of ApoE4 is a viable therapeutic approach for ApoE4-related AD.	[Wang, Chengzhong; Najm, Ramsey; Xu, Qin; Jeong, Dah-eun; Walker, David; Balestra, Maureen E.; Yoon, Seo Yeon; Yuan, Heidi; Li, Gang; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Wang, Chengzhong; Najm, Ramsey; Xu, Qin; Li, Gang; Miller, Zachary A.; Miller, Bruce L.; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Najm, Ramsey; Huang, Yadong] Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; [Miller, Zachary A.; Miller, Bruce L.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Malloy, Mary J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Huang, YD (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Huang, YD (corresponding author), Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA.; Huang, YD (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	yadong.huang@gladstone.ucsf.edu		Li, Gang/0000-0002-1933-484X; Miller, Zachary/0000-0002-5991-3053	US National Institutes of Health [AG048030, AG048017, AG056305, AG023501]; California Institute for Regenerative Medicine [RN2-00952, TRAN1-09394]; California Institute for Regenerative Medicine; NATIONAL INSTITUTE ON AGING [RF1AG048030, R01AG048017, P50AG023501, K23AG048291, R01AG056305] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Karydas for assistance with skin biopsies, S. Ordway and T. Pak for editorial assistance and P. Davies (Albert Einstein College of Medicine) for the PHF1 antibody. This work was supported by funding from the US National Institutes of Health (grant nos. AG048030 (Y.H.), AG048017 (Y.H.), AG056305 (Y.H.) and AG023501 (B.L.M. and Y.H.)) and the California Institute for Regenerative Medicine (grant nos. RN2-00952 and TRAN1-09394; both to Y.H.) and by a gift from the Roddenberry Foundation. C.W. was partially supported by a fellowship from the California Institute for Regenerative Medicine.	Ahn S, 2016, METHODS, V101, P103, DOI 10.1016/j.ymeth.2015.09.009; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Bien-Ly N, 2012, J NEUROSCI, V32, P4803, DOI 10.1523/JNEUROSCI.0033-12.2012; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Huynh TPV, 2017, NEURON, V96, P1013, DOI 10.1016/j.neuron.2017.11.014; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Knoferle J, 2014, J NEUROSCI, V34, P14069, DOI 10.1523/JNEUROSCI.2281-14.2014; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; Leung L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053569; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2017, NEURON, V96, P1024, DOI 10.1016/j.neuron.2017.11.013; Liu Q, 2014, JAMA NEUROL, V71, P1481, DOI 10.1001/jamaneurol.2014.2482; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mak ACY, 2014, JAMA NEUROL, V71, P1228, DOI 10.1001/jamaneurol.2014.2011; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nuriel T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01444-0; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Ulrich JD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-13; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788	59	171	177	5	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					647	+		10.1038/s41591-018-0004-z	http://dx.doi.org/10.1038/s41591-018-0004-z			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29632371	Green Submitted, Green Accepted			2022-12-27	WOS:000432126800022
J	Palomero, T; Ferrando, A				Palomero, Teresa; Ferrando, Adolfo			Targeted cellular immunotherapy for T cell malignancies	NATURE MEDICINE			English	Editorial Material							DIVERSITY; LYMPHOMA	In a recent study, Maciocia et al. develop a novel T cell receptor beta (TCRB) constant C1-chain-directed cellular immunotherapy for the treatment of T cell malignancies.	[Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Ferrando, Adolfo] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Palomero, T (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Palomero, T (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	f2196@cumc.columbia.edu			NCI NIH HHS [R01 CA197945] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA197945] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Pishko A, 2017, TRANSL CANCER RES, V6, P93, DOI 10.21037/tcr.2017.01.08; Ramos CA, 2016, J CLIN INVEST, V126, P2588, DOI 10.1172/JCI86000; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; TOYONAGA B, 1985, P NATL ACAD SCI USA, V82, P8624, DOI 10.1073/pnas.82.24.8624; Warner K, 2013, CURR HEMATOL MALIG R, V8, P163, DOI 10.1007/s11899-013-0165-2	6	6	6	2	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1402	1403		10.1038/nm.4458	http://dx.doi.org/10.1038/nm.4458			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216040	Green Accepted			2022-12-27	WOS:000417278200006
J	Czech, MP				Czech, Michael P.			Macrophages dispose of catecholamines in adipose tissue	NATURE MEDICINE			English	Editorial Material							ALTERNATIVELY ACTIVATED MACROPHAGES; ADAPTIVE THERMOGENESIS; OBESITY	Recent research has identified sympathetic neuron-associated macrophages in adipose tissue that take up and degrade catecholamines released from neurons. Obesity and aging enhance this system, decreasing responses to cold stress and starvation.	[Czech, Michael P.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA.	michael.czech@umassmed.edu						Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Guilherme A, 2017, MOL METAB, V6, P781, DOI 10.1016/j.molmet.2017.05.012; Guo TQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03245; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397	10	8	8	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1255	1257		10.1038/nm.4440	http://dx.doi.org/10.1038/nm.4440			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29117176				2022-12-27	WOS:000414548300007
J	Pirzgalska, RM; Seixas, E; Seidman, JS; Link, VM; Sanchez, NM; Mahu, I; Mendes, R; Gres, V; Kubasova, N; Morris, I; Arus, BA; Larabee, CM; Vasques, M; Tortosa, F; Sousa, AL; Anandan, S; Tranfield, E; Hahn, MK; Iannacone, M; Spann, NJ; Glass, CK; Domingos, AI				Pirzgalska, Roksana M.; Seixas, Elsa; Seidman, Jason S.; Link, Verena M.; Sanchez, Noelia Martinez; Mahu, Ines; Mendes, Raquel; Gres, Vitka; Kubasova, Nadiya; Morris, Imogen; Arus, Bernardo A.; Larabee, Chelsea M.; Vasques, Miguel; Tortosa, Francisco; Sousa, Ana L.; Anandan, Sathyavathy; Tranfield, Erin; Hahn, Maureen K.; Iannacone, Matteo; Spann, Nathanael J.; Glass, Christopher K.; Domingos, Ana I.			Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine	NATURE MEDICINE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; ADIPOSE-TISSUE MACROPHAGES; CENTRAL-NERVOUS-SYSTEM; GLIAL-CELLS; ADAPTIVE THERMOGENESIS; GLUTAMATE TRANSPORTERS; GENE-EXPRESSION; RAT-BRAIN; LOCALIZATION; MICROGLIA	The cellular mechanism(s) linking macrophages to norepinephrine (NE)-mediated regulation of thermogenesis have been a topic of debate. Here we identify sympathetic neuron-associated macrophages (SAMs) as a population of cells that mediate clearance of NE via expression of solute carrier family 6 member 2 (SLC6A2), an NE transporter, and monoamine oxidase A (MAOA), a degradation enzyme. Optogenetic activation of the sympathetic nervous system (SNS) upregulates NE uptake by SAMs and shifts the SAM profile to a more proinflammatory state. NE uptake by SAMs is prevented by genetic deletion of Slc6a2 or inhibition of the encoded transporter. We also observed an increased proportion of SAMs in the SNS of two mouse models of obesity. Genetic ablation of Slc6a2 in SAMs increases brown adipose tissue (BAT) content, causes browning of white fat, increases thermogenesis, and leads to substantial and sustained weight loss in obese mice. We further show that this pathway is conserved, as human sympathetic ganglia also contain SAMs expressing the analogous molecular machinery for NE clearance, which thus constitutes a potential target for obesity treatment.	[Pirzgalska, Roksana M.; Seixas, Elsa; Sanchez, Noelia Martinez; Mahu, Ines; Mendes, Raquel; Gres, Vitka; Kubasova, Nadiya; Morris, Imogen; Arus, Bernardo A.; Larabee, Chelsea M.; Vasques, Miguel; Anandan, Sathyavathy; Domingos, Ana I.] Inst Gulbenkian Ciencias, Howard Hughes Med Inst, Oeiras, Portugal; [Pirzgalska, Roksana M.; Seixas, Elsa; Sanchez, Noelia Martinez; Mahu, Ines; Mendes, Raquel; Gres, Vitka; Kubasova, Nadiya; Morris, Imogen; Arus, Bernardo A.; Larabee, Chelsea M.; Vasques, Miguel; Anandan, Sathyavathy; Domingos, Ana I.] Inst Gulbenkian Ciencias, Obes Lab, Oeiras, Portugal; [Seidman, Jason S.; Link, Verena M.; Spann, Nathanael J.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Link, Verena M.] Ludwig Maximilians Univ Munchen, Dept 2, Fac Biol, Plariegg Martinsried, Germany; [Arus, Bernardo A.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil; [Vasques, Miguel] Ctr Hosp Lisboa Cent, Dept Endocrinol, Curry Cabral Hosp, Lisbon, Portugal; [Tortosa, Francisco] Hosp Santa Maria, Dept Pathol, Ctr Hosp Lisboa Norte, EPE, Lisbon, Portugal; [Sousa, Ana L.; Tranfield, Erin] Inst Gulbenkian Ciencias, Electron Microscopy Unit, Oeiras, Portugal; [Hahn, Maureen K.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA; [Iannacone, Matteo] Ist Sci San Raffaele, IRCCS, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Domingos, Ana I.] Howard Hughes Med Inst, New York, NY 10065 USA	Instituto Gulbenkian de Ciencia; Instituto Gulbenkian de Ciencia; University of California System; University of California San Diego; University of Munich; Universidade Federal do Rio Grande do Sul; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Instituto Gulbenkian de Ciencia; Vanderbilt University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Howard Hughes Medical Institute	Domingos, AI (corresponding author), Inst Gulbenkian Ciencias, Howard Hughes Med Inst, Oeiras, Portugal.; Domingos, AI (corresponding author), Inst Gulbenkian Ciencias, Obes Lab, Oeiras, Portugal.; Domingos, AI (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	dominan@igc.gulbenkian.pl	Iannacone, Matteo/I-8507-2018; Yampolska, Kseniya/C-7419-2018; Pirzgalska, Roksana/AAM-3922-2020; Glass, Christopher/AAI-3933-2021; Tranfield, Erin M/AAU-4177-2020	Iannacone, Matteo/0000-0002-9370-2671; Yampolska, Kseniya/0000-0001-7106-048X; Pirzgalska, Roksana/0000-0003-2314-0439; Glass, Christopher/0000-0003-4344-3592; Tranfield, Erin M/0000-0002-1542-7459; Seixas, Elsa/0000-0003-2819-2051; Domingos, Ana/0000-0002-7938-4814; Larabee, Chelsea/0000-0001-8828-6995; Martinez-Sanchez, Noelia/0000-0003-4580-8196; Albuquerque Simoes Baeta Mendes, Raquel/0000-0003-3079-6647; Gres, Vitka/0000-0002-5034-4691; Link, Verena/0000-0002-3207-312X; Mahu, Ines/0000-0001-9215-7598; Sousa, Ana Laura/0000-0001-6067-8794; TORTOSA, FRANCISCO/0000-0001-5830-5139; Vasques, Miguel/0000-0002-6112-8951; Arus, Bernardo/0000-0001-6132-7793; Kubasova, Nadiya/0000-0003-0063-1825	Fundacao para a Ciencia e Tecnologia (FCT); European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP), Maratona da Saude; US National Institutes of Health (NIH); FCT [SFRH/BD/88454/2012]; American Heart Association [16PRE30980030]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Xunta de Galicia [ED481B 2016/168-0];  [T32DK007541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007541] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP), Maratona da Saude; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); American Heart Association(American Heart Association); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Xunta de Galicia(Xunta de GaliciaEuropean Commission); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank the Unit for Imaging and Cytometry at the Instituto Gulbenkian de Ciencia (IGC) for assistance with flow cytometry, cell sorting, and multiphoton microscopy. We also want to thank the Antibody Service at the IGC for the antibodies produced in house and the Histopathology facility at the IGC for tissue processing and histological assessment. This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT), the European Molecular Biology Organization (EMBO), the Human Frontier Science Program (HFSP), Maratona da Saude, and the US National Institutes of Health (NIH). R.M.P. was supported by FCT (SFRH/BD/88454/2012), J.S.S. was supported by the American Heart Association (16PRE30980030) and a training grant (T32DK007541), B.A.A. was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and N.M.-S. was supported by Xunta de Galicia (ED481B 2016/168-0). We thank M. Aouadi for helpful discussions.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Anlauf Enrico, 2013, Front Endocrinol (Lausanne), V4, P144, DOI 10.3389/fendo.2013.00144; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Galle-Treger L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13202; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2010, BRAIN RES REV, V64, P304, DOI 10.1016/j.brainresrev.2010.04.009; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kettenmann H., 2013, NEUROGLIA; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; MEAROW KM, 1989, MOL BRAIN RES, V6, P223, DOI 10.1016/0169-328X(89)90068-5; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Reitman ML, 2017, CELL METAB, V26, P14, DOI 10.1016/j.cmet.2017.06.011; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rusnakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069734; Schroeder C, 2012, AM J PHYSIOL-HEART C, V303, pH1273, DOI 10.1152/ajpheart.00492.2012; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Shirey-Rice JK, 2013, DIS MODEL MECH, V6, P1001, DOI 10.1242/dmm.012203; Spadaro O, 2017, CELL REP, V19, P225, DOI 10.1016/j.celrep.2017.03.046; STJARNE L, 1989, REV PHYSIOL BIOCH P, V112, P1; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055	48	218	224	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1309	+		10.1038/nm.4422	http://dx.doi.org/10.1038/nm.4422			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035364	Green Submitted, Green Accepted			2022-12-27	WOS:000414548300013
J	Bal, E; Park, HS; Belaid-Choucair, Z; Kayserili, H; Naville, M; Madrange, M; Chiticariu, E; Hadj-Rabia, S; Cagnard, N; Kuonen, F; Bachmann, D; Huber, M; Le Gall, C; Cote, F; Hanein, S; Rosti, RO; Aslanger, AD; Waisfisz, Q; Bodemer, C; Hermine, O; Morice-Picard, F; Labeille, B; Caux, F; Mazereeuw-Hautier, J; Philip, N; Levy, N; Taieb, A; Avril, MF; Headon, DJ; Gyapay, G; Magnaldo, T; Fraitag, S; Roest Crollius, H; Vabres, P; Hohl, D; Munnich, A; Smahi, A				Bal, Elodie; Park, Hyun-Sook; Belaid-Choucair, Zakia; Kayserili, Hulya; Naville, Magali; Madrange, Marine; Chiticariu, Elena; Hadj-Rabia, Smail; Cagnard, Nicolas; Kuonen, Francois; Bachmann, Daniel; Huber, Marcel; Le Gall, Cindy; Cote, Francine; Hanein, Sylvain; Rosti, Rasim Ozgur; Aslanger, Ayca Dilruba; Waisfisz, Quinten; Bodemer, Christine; Hermine, Olivier; Morice-Picard, Fanny; Labeille, Bruno; Caux, Frederic; Mazereeuw-Hautier, Juliette; Philip, Nicole; Levy, Nicolas; Taieb, Alain; Avril, Marie-Francoise; Headon, Denis J.; Gyapay, Gabor; Magnaldo, Thierry; Fraitag, Sylvie; Roest Crollius, Hugues; Vabres, Pierre; Hohl, Daniel; Munnich, Arnold; Smahi, Asma			Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas	NATURE MEDICINE			English	Article							ACTIN-RELATED PROTEINS; LONG NONCODING RNAS; SWI/SNF COMPLEXES; ROLES; GENE; TRANSCRIPTION; MECHANISMS; NUCLEUS	Basal cell carcinoma (BCC), the most common human cancer, results from aberrant activation of the Hedgehog signaling pathway(1). Although most cases of BCC are sporadic, some forms are inherited, such as Bazex-Dupre-Christol syndrome (BDCS)-a cancer-prone genodermatosis with an X-linked, dominant inheritance pattern(2). We have identified mutations in the ACTRT1 gene, which encodes actin-related protein T1 (ARP-T1), in two of the six families with BDCS that were examined in this study. High-throughput sequencing in the four remaining families identified germline mutations in noncoding sequences surrounding ACTRT1. These mutations were located in transcribed sequences encoding enhancer RNAs (eRNAs)(3-5) and were shown to impair enhancer activity and ACTRT1 expression. ARP-T1 was found to directly bind to the GLI1 promoter, thus inhibiting GLI1 expression, and loss of ARP-T1 led to activation of the Hedgehog pathway in individuals with BDCS. Moreover, exogenous expression of ACTRT1 reduced the in vitro and in vivo proliferation rates of cell lines with aberrant activation of the Hedgehog signaling pathway. In summary, our study identifies a disease mechanism in BCC involving mutations in regulatory noncoding elements and uncovers the tumor-suppressor properties of ACTRT1.	[Bal, Elodie; Belaid-Choucair, Zakia; Madrange, Marine; Hadj-Rabia, Smail; Le Gall, Cindy; Cote, Francine; Hanein, Sylvain; Bodemer, Christine; Hermine, Olivier; Munnich, Arnold; Smahi, Asma] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France; [Bal, Elodie; Belaid-Choucair, Zakia; Madrange, Marine; Hadj-Rabia, Smail; Le Gall, Cindy; Cote, Francine; Hanein, Sylvain; Bodemer, Christine; Hermine, Olivier; Munnich, Arnold; Smahi, Asma] INSERM, IMAGINE Inst, UMR 1163, Paris, France; [Park, Hyun-Sook; Chiticariu, Elena; Kuonen, Francois; Bachmann, Daniel; Huber, Marcel; Hohl, Daniel] Hop Beaumont, Lausanne Univ Hosp, Dept Dermatol, Lausanne, Switzerland; [Belaid-Choucair, Zakia; Cote, Francine; Hermine, Olivier] Hop Necker Enfants Malad, Dept Hematol, Paris, France; [Kayserili, Hulya] Koc Univ, Sch Med, Med Genet Dept, Istanbul, Turkey; [Kayserili, Hulya; Rosti, Rasim Ozgur; Aslanger, Ayca Dilruba] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkey; [Naville, Magali; Roest Crollius, Hugues] Ecole Normale Super, IBENS, Paris, France; [Naville, Magali; Roest Crollius, Hugues] CNRS, UMR 8197, Paris, France; [Naville, Magali; Roest Crollius, Hugues] INSERM, U1024, Paris, France; [Hadj-Rabia, Smail; Bodemer, Christine] Hop Necker Enfants Malad, Dept Dermatol, Paris, France; [Cagnard, Nicolas] INSERM, Struct Federat Rech Necker, Plateforme Bioinformat, US24,CNRS,UMS 3633, Paris, France; [Rosti, Rasim Ozgur] Rockefeller Univ, Lab Genome Maintenance, 1230 York Ave, New York, NY 10021 USA; [Waisfisz, Quinten] Vrije Univ, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Hermine, Olivier] IMAGINE Inst, GR Ex Lab Excellence, Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, Ctr Reference Natl Mastocytoses, Paris, France; [Morice-Picard, Fanny; Taieb, Alain] Ctr Hosp Univ Bordeaux, Serv Dermatol, Ctr Reference Malad Rares Peau, Bordeaux, France; [Labeille, Bruno] Ctr Hosp Univ Nord, Dept Dermatol, St Etienne, France; [Caux, Frederic] Hop Avicenne, Dept Dermatol, Bobigny, France; [Mazereeuw-Hautier, Juliette] Hop Larrey, Ctr Reference Malad Rares Peau, Dept Dermatol, Toulouse, France; [Philip, Nicole; Levy, Nicolas] Hop La Timone, Dept Med Genet, Marseille, France; [Philip, Nicole; Levy, Nicolas] Aix Marseille Univ, INSERM, Fac Med Marseille, UMR S910, Marseille, France; [Taieb, Alain] Univ Bordeaux, INSERM, U1035, Bordeaux, France; [Avril, Marie-Francoise] Hop Cochin, Dept Dermatol, Paris, France; [Headon, Denis J.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Headon, Denis J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Gyapay, Gabor] Univ Evry, CNRS, UMR 8030, Genoscope CEA, Evry, France; [Magnaldo, Thierry] Univ Nice Sophia Antipolis, Inst Res Canc & Aging, CNRS, UMR 7284,INSERM,U1081, Nice, France; [Fraitag, Sylvie] Hop Necker Enfants Malad, Dept Pathol Anat, Paris, France; [Vabres, Pierre] Hop Bocage, Ctr Hosp Univ, Dept Dermatol, Dijon, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Koc University; Istanbul University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Vrije Universiteit Amsterdam; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; CHU de St Etienne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Toulouse; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne	Bal, E; Smahi, A (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Paris, France.; Bal, E; Smahi, A (corresponding author), INSERM, IMAGINE Inst, UMR 1163, Paris, France.	elodie.bal@inserm.fr; asma.smahi@inserm.fr	MORICE-PICARD, Fanny/M-5125-2014; LEVY, Nicolas/J-1632-2014; hanein, sylvain/AAG-4933-2019; TAIEB, ALAIN/AAB-1085-2021; Vabres, Pierre/V-3850-2019; Kayserili, Hülya/AAA-5593-2021; Hermine, Olivier/Q-7072-2018; Cagnard, Nicolas/K-2754-2014	LEVY, Nicolas/0000-0001-5171-6365; hanein, sylvain/0000-0001-5817-6330; Vabres, Pierre/0000-0001-8693-3183; Kayserili, Hülya/0000-0003-0376-499X; Waisfisz, Quinten/0000-0002-7384-9182; Cagnard, Nicolas/0000-0002-9051-1896; Thierry, Magnaldo/0000-0001-9174-8599; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; Kuonen, Francois/0000-0001-6137-7483	TUBITAK [112S398]; Swiss National Science Foundation; Placide Nicod Foundation; Dind Cottier Foundation; Association pour la Recherche contre le Cancer; Societe Francaise de Dermatologie; Agence Nationale de la Recherche [ANR-10-IAHU-01]; TUBITAK [112S398]; Swiss National Science Foundation; Placide Nicod Foundation; Dind Cottier Foundation; Association pour la Recherche contre le Cancer; Societe Francaise de Dermatologie; Agence Nationale de la Recherche [ANR-10-IAHU-01]	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Placide Nicod Foundation; Dind Cottier Foundation; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Societe Francaise de Dermatologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Placide Nicod Foundation; Dind Cottier Foundation; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Societe Francaise de Dermatologie; Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors wish to thank P. Guigue, A. Vincent-Salomon, L. Fuhrmann, M. Oufadem, S. Thomas, S. Petit, F. Mouchrik, V. Geoffroy, A. Julien, O. Duchamp de Lageneste, L. Galmiche-Rolland, J. Cottineau, J. Rossignol, S. Saunier and D. Pouly for technical assistance and advice; M. Sahbatou for performing linkage analysis; M.-E. Huang for providing cell lines for this study; A. Schmitt and J.-M. Masse at the Cochin Imaging Facility (CNRS UMR 8104) for their assistance and help with transmission electron microscopy; C. Bole-Feysot at the Genomic Platform of IMAGINE Institute for acquiring transcriptomic data; M. Garfa-Traore, N. Goudin and R. Desvaux at the Cell Imaging Platform of IMAGINE Institute for technical assistance and advice; P. Guigue-Rodet and V. Martin-Bouret for providing skin biopsies from some individuals with BDCS; and M.- C. Hors-Cayla and J.-L. Bonafe for initiating genetic research on BDCS. We are grateful to all subjects and their families for their participation in the study. H.E. was supported by TUBITAK (grant no. 112S398). H.-S.P., E.C., F.K., D.B., M.H. and D.H. were supported by the Swiss National Science Foundation, the Placide Nicod Foundation and the Dind Cottier Foundation. This work was funded by the Association pour la Recherche contre le Cancer and the Societe Francaise de Dermatologie. This work was supported by funding from the Agence Nationale de la Recherche (ANR-10-IAHU-01).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bartonicek N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0530-6; BAZEX A, 1966, ANN DERMATOL SYPHIL, V93, P241; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Heid HW, 2002, EXP CELL RES, V279, P177, DOI 10.1006/excr.2002.5603; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Kohashi K, 2017, CANCER SCI, V108, P547, DOI 10.1111/cas.13173; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Krepischi ACV, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3109; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lo WW, 2014, CANCER-AM CANCER SOC, V120, P537, DOI 10.1002/cncr.28439; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Mousavi K, 2014, RNA BIOL, V11, P106, DOI 10.4161/rna.27950; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nelson AC, 2013, DEVELOPMENT, V140, P1385, DOI 10.1242/dev.084459; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Noubissi FK, 2014, J INVEST DERMATOL, V134, P1718, DOI 10.1038/jid.2014.17; Oma Y, 2011, NUCLEUS-PHILA, V2, P38, DOI 10.4161/nucl.2.1.14510; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; RAPELANORO R, 1994, AM J MED GENET, V52, P487, DOI 10.1002/ajmg.1320520417; St Pierre R, 2017, CURR OPIN GENET DEV, V42, P56, DOI 10.1016/j.gde.2017.02.004; Tang YY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0612-0; VABRES P, 1995, J INVEST DERMATOL, V105, P87, DOI 10.1111/1523-1747.ep12313359; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wei JW, 2017, ONCOL REP, V37, P3, DOI 10.3892/or.2016.5236; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004610; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yang S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2070-7; Yang W, 2013, J ORTHOP RES, V31, P502, DOI 10.1002/jor.22230; Zabidi MA, 2016, TRENDS GENET, V32, P801, DOI 10.1016/j.tig.2016.10.003; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108	39	46	48	2	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1226	+		10.1038/nm.4368	http://dx.doi.org/10.1038/nm.4368			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28869610	Green Submitted			2022-12-27	WOS:000412431800018
J	Hayek, SS; Koh, KH; Grams, ME; Wei, CL; Ko, YA; Li, J; Samelko, B; Lee, H; Dande, RR; Lee, HW; Hahm, E; Peev, V; Tracy, M; Tardi, NJ; Gupta, V; Altintas, MM; Garborcauskas, G; Stojanovic, N; Winkler, CA; Lipkowitz, MS; Tin, A; Inker, LA; Levey, AS; Zeier, M; Freedman, BI; Kopp, JB; Skorecki, K; Coresh, J; Quyyumi, AA; Sever, S; Reiser, J				Hayek, Salim S.; Koh, Kwi Hye; Grams, Morgan E.; Wei, Changli; Ko, Yi-An; Li, Jing; Samelko, Beata; Lee, Hyun; Dande, Ranadheer R.; Lee, Ha Won; Hahm, Eunsil; Peev, Vasil; Tracy, Melissa; Tardi, Nicholas J.; Gupta, Vineet; Altintas, Mehmet M.; Garborcauskas, Garrett; Stojanovic, Nikolina; Winkler, Cheryl A.; Lipkowitz, Michael S.; Tin, Adrienne; Inker, Lesley A.; Levey, Andrew S.; Zeier, Martin; Freedman, Barry I.; Kopp, Jeffrey B.; Skorecki, Karl; Coresh, Josef; Quyyumi, Arshed A.; Sever, Sanja; Reiser, Jochen			A tripartite complex of suPAR, APOL1 risk variants and alpha(v)beta(3) integrin on podocytes mediates chronic kidney disease	NATURE MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; SOLUBLE UROKINASE RECEPTOR; APOLIPOPROTEIN L1; PROTEIN; ENDOCYTOSIS; MORTALITY; CORRELATE; BINDING; UPAR	Soluble urokinase plasminogen activator receptor (suPAR) independently predicts chronic kidney disease (CKD) incidence and progression. Apolipoprotein L1 (APOL1) gene variants G1 and G2, but not the reference allele (G0), are associated with an increased risk of CKD in individuals of recent African ancestry. Here we show in two large, unrelated cohorts that decline in kidney function associated with APOL1 risk variants was dependent on plasma suPAR levels: APOL1-related risk was attenuated in patients with lower suPAR, and strengthened in those with higher suPAR levels. Mechanistically, surface plasmon resonance studies identified high-affinity interactions between suPAR, APOL1 and avb3 integrin, whereby APOL1 protein variants G1 and G2 exhibited higher affinity for suPAR-activated alpha(v)beta(3) integrin than APOL1 G0. APOL1 G1 or G2 augments alpha(v)beta(3) integrin activation and causes proteinuria in mice in a suPAR-dependent manner. The synergy of circulating factor suPAR and APOL1 G1 or G2 on alpha(v)beta(3) integrin activation is a mechanism for CKD.	[Hayek, Salim S.] Emory Univ Sch Med, Div Cardiol, Emory Clin Cardiovascular Res Inst, Atlanta, GA USA; [Dande, Ranadheer R.; Lee, Ha Won] Rush Univ Med Ctr, Dept Internal Med, Chicago, IL USA; [Samelko, Beata; Winkler, Cheryl A.; Reiser, Jochen] Johns Hopkins Univ, Welch Ctr Prevent & Johns Hopkins Bloomberg Sch P, Epidemiol & Clin Res, Baltimore, MD USA; [Tardi, Nicholas J.; Garborcauskas, Garrett; Winkler, Cheryl A.; Tin, Adrienne] Emory Univ, Dept Biostatist & Bioinformat, Atlanta, GA USA	Emory University; Rush University; Johns Hopkins University; Emory University	Hayek, SS (corresponding author), Emory Univ Sch Med, Div Cardiol, Emory Clin Cardiovascular Res Inst, Atlanta, GA USA.	ssever@mgh.harvard.edu; jochen_reiser@rush.edu	Kopp, Jeffrey B/O-2681-2015; Stojanović, Nikolina/ABT-8237-2022; Altintas, Mehmet Mete/T-5333-2018; Hayek, Salim S./E-6932-2013; Altintas, Mehmet Mete/ABI-5904-2020; Stojanovic, Nikolina/GWV-1059-2022	Kopp, Jeffrey B/0000-0001-9052-186X; Altintas, Mehmet Mete/0000-0002-1871-6985; Hayek, Salim S./0000-0003-0180-349X; Stojanovic, Nikolina/0000-0002-7763-4154; Winkler, Cheryl/0000-0001-5552-0917; Lee, Ha Won/0000-0001-5382-9646; Hahm, Eunsil/0000-0002-0343-7473; Lee, Hyun/0000-0003-2570-8120; Garborcauskas, Garrett/0000-0003-0316-461X	NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101398, R01HL095479, R56HL126558, P01HL086773, U10HL110302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101350, ZIADK043308, R01DK108803, DP3DK094346, U01DK085689, R01DK106051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG051633] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025008] Funding Source: Medline; NHLBI NIH HHS [R56 HL126558, P01 HL086773, U10 HL110302, P01 HL101398, R01 HL095479] Funding Source: Medline; NIA NIH HHS [RF1 AG051633] Funding Source: Medline; NIDDK NIH HHS [DP3 DK094346, R01 DK101350, R01 DK106051, U01 DK085689, R01 DK108803] Funding Source: Medline; NINDS NIH HHS [R01 NS064162] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson D. R., 2015, PLOS GENET, V11; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bruggeman LA, 2016, J AM SOC NEPHROL, V27, P3600, DOI 10.1681/ASN.2015111220; Bruggeman LA, 2014, J AM SOC NEPHROL, V25, P634, DOI 10.1681/ASN.2013070700; Chen TK, 2016, CURR OPIN NEPHROL HY, V25, P217, DOI 10.1097/MNH.0000000000000222; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Fapen D.J., 2014, J AM HEART ASSOC, V3; Foster MC, 2013, J AM SOC NEPHROL, V24, P1484, DOI 10.1681/ASN.2013010113; Friedman DJ, 2016, TRENDS ENDOCRIN MET, V27, P204, DOI 10.1016/j.tem.2016.02.002; Fu YL, 2017, J AM SOC NEPHROL, V28, P1106, DOI 10.1681/ASN.2016050550; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Harrell FE, 2001, REGRESSION MODELING; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kobayashi N, 2015, AM J PHYSIOL-RENAL, V308, pF614, DOI 10.1152/ajprenal.00616.2014; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kruzel-Davila E, 2017, J AM SOC NEPHROL, V28, P1117; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Lee H, 2012, ANAL BIOCHEM, V423, P46, DOI 10.1016/j.ab.2012.01.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y., 2001, J MOT BIOL, V365, P1117; Ma LJ, 2017, J AM SOC NEPHROL, V28, P1093, DOI 10.1681/ASN.2016050567; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Outinen TK, 2014, J INTERN MED, V276, P387, DOI 10.1111/joim.12257; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Patel RS, 2015, CIRC RES, V116, P289, DOI 10.1161/CIRCRESAHA.116.304187; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Shukha K, 2017, J AM SOC NEPHROL, V28, P1079, DOI 10.1681/ASN.2016040441; Sidenius N, 2000, BLOOD, V96, P4091; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Weckerle A, 2016, J LIPID RES, V57, P120, DOI 10.1194/jlr.M063453; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wu MJ, 2014, TRANSPL P, V46, P1226, DOI 10.1016/j.transproceed.2013.12.011; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; Yu CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9672	46	136	136	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					945	+		10.1038/nm.4362	http://dx.doi.org/10.1038/nm.4362			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28650456	Green Accepted			2022-12-27	WOS:000406947600010
J	Roediger, B; Weninger, W				Roediger, Ben; Weninger, Wolfgang			Resolving a chronic inflammation mystery	NATURE MEDICINE			English	Editorial Material							INNATE LYMPHOID-CELLS; LUNG INFLAMMATION; RESOLUTION		[Roediger, Ben] Royal Prince Alfred Hosp, Camperdown, NSW, Australia	University of Sydney	Roediger, B (corresponding author), Royal Prince Alfred Hosp, Camperdown, NSW, Australia.	b.roediger@centenary.org.au; w.weninger@centenary.org.au		Roediger, Ben/0000-0002-4593-091X				Baring C., 2013, AL SCI TRANS MED, V5; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Perretti M, 2017, NAT REV RHEUMATOL, V13, P87, DOI 10.1038/nrrheum.2016.193; Purvvar R., 2012, NAT MED, V18, P1248; Rauber S, 2017, NAT MED, V23, P938, DOI 10.1038/nm.4373; Schlapbach C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007828; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133	11	5	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					914	916		10.1038/nm.4384	http://dx.doi.org/10.1038/nm.4384			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28777793				2022-12-27	WOS:000406947600006
J	Rickman, DS; Beltran, H; Demichelis, F; Rubin, MA				Rickman, David S.; Beltran, Himisha; Demichelis, Francesca; Rubin, Mark A.			Biology and evolution of poorly differentiated neuroendocrine tumors	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; PANCREATIC ENDOCRINE NEOPLASMS; AUTOCHTHONOUS PROSTATE-CANCER; N-MYC; MOUSE MODEL; T-ANTIGEN; MOLECULAR CHARACTERIZATION; TRANSGENIC ADENOCARCINOMA; GASTROINTESTINAL-TRACT; MUTATIONAL LANDSCAPE	Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on advances in our understanding of the tumorigenesis and treatment of poorly differentiated neuroendocrine tumors. Recent evidence from sequencing indicates that, although neuroendocrine tumors can arise de novo, they can also develop as a result of lineage plasticity in response to pressure from targeted therapies. We discuss the shared genomic alterations of these tumors independently of their site of origin, and we explore potential therapeutic strategies on the basis of recent biological findings.	[Rickman, David S.; Beltran, Himisha; Demichelis, Francesca; Rubin, Mark A.] New York Presbyterian Hosp, Caryl & Israel Englander Inst Precis Med, Weill Cornell Med, New York, NY 10038 USA; [Rickman, David S.; Rubin, Mark A.] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Rickman, David S.; Beltran, Himisha; Rubin, Mark A.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Beltran, Himisha] Weill Cornell Med, Div Med Oncol, Dept Med, New York, NY USA; [Demichelis, Francesca] Weill Cornell Med, Inst Computat Biomed, New York, NY USA; [Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, Trento, Italy	Cornell University; NewYork-Presbyterian Hospital; Cornell University; Cornell University; Cornell University; Cornell University; University of Trento	Rubin, MA (corresponding author), New York Presbyterian Hosp, Caryl & Israel Englander Inst Precis Med, Weill Cornell Med, New York, NY 10038 USA.; Rubin, MA (corresponding author), Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA.; Rubin, MA (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.	rubinma@med.cornell.edu	Demichelis, Francesca/J-9829-2016	Demichelis, Francesca/0000-0002-8266-8631; Rubin, Mark/0000-0002-8321-9950				Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Akamatsu S, 2015, CELL REP, V12, P922, DOI 10.1016/j.celrep.2015.07.012; Althoff K, 2015, ONCOGENE, V34, P3357, DOI 10.1038/onc.2014.269; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Berman-Booty LD, 2015, TOXICOL PATHOL, V43, P186, DOI 10.1177/0192623314531351; Berman-Booty LD, 2015, ENDOCR-RELAT CANCER, V22, pR33, DOI 10.1530/ERC-14-0393; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bishop JL, 2017, CANCER DISCOV, V7, P54, DOI 10.1158/2159-8290.CD-15-1263; Borromeo MD, 2016, CELL REP, V16, P1259, DOI 10.1016/j.celrep.2016.06.081; Brenner B, 2007, SEMIN ONCOL, V34, P43, DOI 10.1053/j.seminoncol.2006.10.022; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brodeur GM, 1993, PRINCIPLES PRACTICE, P739; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chen HB, 2012, ENDOCR-RELAT CANCER, V19, P321, DOI 10.1530/ERC-11-0368; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cui M, 2014, MOL CANCER RES, V12, P654, DOI 10.1158/1541-7786.MCR-13-0554; Dardenne E, 2016, CANCER CELL, V30, P563, DOI 10.1016/j.ccell.2016.09.005; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; den Bakker MA, 2013, J CLIN PATHOL, V66, P862, DOI 10.1136/jclinpath-2012-201310; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Duan WM, 2005, ONCOGENE, V24, P1510, DOI 10.1038/sj.onc.1208229; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Epstein JI, 2014, AM J SURG PATHOL, V38, P756, DOI 10.1097/PAS.0000000000000208; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Cuesta L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4518; Ferrone CR, 2007, J CLIN ONCOL, V25, P5609, DOI 10.1200/JCO.2007.12.9809; FONTAINE J, 1977, J EMBRYOL EXP MORPH, V41, P209; Gabril MY, 2005, MOL THER, V11, P348, DOI 10.1016/j.ymthe.2004.12.005; Gabril MY, 2002, GENE THER, V9, P1589, DOI 10.1038/sj.gt.3301895; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gazdar AF, 2015, J THORAC ONCOL, V10, P553, DOI 10.1097/JTO.0000000000000459; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Gingrich JR, 1996, CANCER RES, V56, P4096; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015; Hochwald SN, 2002, J CLIN ONCOL, V20, P2633, DOI 10.1200/JCO.2002.10.030; Hofner T, 2013, J UROLOGY, V190, P2263, DOI 10.1016/j.juro.2013.06.053; Hook KE, 2012, MOL CANCER THER, V11, P710, DOI 10.1158/1535-7163.MCT-11-0184; Huijbers IJ, 2014, EMBO MOL MED, V6, P212, DOI 10.1002/emmm.201303297; Huss WJ, 2004, PROSTATE, V60, P91, DOI 10.1002/pros.20032; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jahchan NS, 2016, CELL REP, V16, P644, DOI 10.1016/j.celrep.2016.06.021; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kareta MS, 2015, CELL STEM CELL, V16, P39, DOI 10.1016/j.stem.2014.10.019; Kelly K, 2017, SCIENCE, V355, P29, DOI 10.1126/science.aam5355; Khoo KH, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4288; Kidd M, 2016, NAT REV CLIN ONCOL, V13, P691, DOI 10.1038/nrclinonc.2016.85; Kim DW, 2016, GENE DEV, V30, P1289, DOI 10.1101/gad.279307.116; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kobayashi S, 1999, TOHOKU J EXP MED, V189, P37, DOI 10.1620/tjem.189.37; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; LAI SL, 1995, ANTICANCER RES, V15, P225; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu TC, 2013, AM J SURG PATHOL, V37, P853, DOI 10.1097/PAS.0b013e31827fcc18; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Mantovani F, 2017, FEBS J, V284, P837, DOI 10.1111/febs.13948; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; Martin P, 2011, AM J PATHOL, V179, P422, DOI 10.1016/j.ajpath.2011.03.035; Masumori N, 2001, CANCER RES, V61, P2239; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; NAKAMURA T, 1991, JPN J CLIN ONCOL, V21, P325; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Niederst MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7377; Noordzij MA, 1996, AM J PATHOL, V149, P859; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Oser MG, 2015, LANCET ONCOL, V16, pE165, DOI 10.1016/S1470-2045(14)71180-5; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; PerezStable C, 1996, LAB INVEST, V74, P363; Perren A, 2017, NEUROENDOCRINOLOGY; Pinthus JH, 2000, CANCER RES, V60, P6563; Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38; Powers JT, 2016, NATURE, V535, P246, DOI 10.1038/nature18632; Priemer DS, 2016, ENDOCR PATHOL, V27, P123, DOI 10.1007/s12022-016-9421-z; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Reid MD, 2014, ENDOCR PATHOL, V25, P65, DOI 10.1007/s12022-013-9295-2; Rekhtman N, 2016, CLIN CANCER RES, V22, P3618, DOI 10.1158/1078-0432.CCR-15-2946; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rosai J, 2011, MODERN PATHOL, V24, pS53, DOI 10.1038/modpathol.2010.166; Rouzbahman M, 2013, SEMIN DIAGN PATHOL, V30, P224, DOI 10.1053/j.semdp.2013.06.007; Rudin CM, 2014, CANCER DISCOV, V4, P273, DOI 10.1158/2159-8290.CD-14-0069; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Scarpa A, 2017, NATURE, V543, P65, DOI 10.1038/nature21063; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shia J, 2008, AM J SURG PATHOL, V32, P719, DOI 10.1097/PAS.0b013e318159371c; Shibayama T, 2001, LUNG CANCER-J IASLC, V32, P61, DOI 10.1016/S0169-5002(00)00205-1; Shuda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142329; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Spurgeon ME, 2015, CANCER RES, V75, P1068, DOI 10.1158/0008-5472.CAN-14-2425; Suttie AW, 2005, TOXICOL PATHOL, V33, P386, DOI 10.1080/01926230590930272; Tan HL, 2014, CLIN CANCER RES, V20, P890, DOI 10.1158/1078-0432.CCR-13-1982; Tang LH, 2016, CLIN CANCER RES, V22, P1011, DOI 10.1158/1078-0432.CCR-15-0548; Tani Y, 2005, VET PATHOL, V42, P306, DOI 10.1354/vp.42-3-306; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teicher BA, 2014, BIOCHEM PHARMACOL, V87, P211, DOI 10.1016/j.bcp.2013.09.014; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; True LD, 2002, AM J PATHOL, V161, P705, DOI 10.1016/S0002-9440(10)64226-5; VANHAAFTENDAY C, 1987, PROSTATE, V11, P271, DOI 10.1002/pros.2990110307; Verhaegen ME, 2015, J INVEST DERMATOL, V135, P1415, DOI 10.1038/jid.2014.446; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yachida S, 2012, AM J SURG PATHOL, V36, P173, DOI 10.1097/PAS.0b013e3182417d36; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zou M, 2017, CANC DISCOV	139	114	116	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					664	673		10.1038/nm.4341	http://dx.doi.org/10.1038/nm.4341			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586335				2022-12-27	WOS:000402768000008
J	Furman, D; Chang, JL; Lartigue, L; Bolen, CR; Haddad, F; Gaudilliere, B; Ganio, EA; Fragiadakis, GK; Spitzer, MH; Douchet, I; Daburon, S; Moreau, JF; Nolan, GP; Blanco, P; Dechanet-Merville, J; Dekker, CL; Jojic, V; Kuo, CJ; Davis, MM; Faustin, B				Furman, David; Chang, Junlei; Lartigue, Lydia; Bolen, Christopher R.; Haddad, Francois; Gaudilliere, Brice; Ganio, Edward A.; Fragiadakis, Gabriela K.; Spitzer, Matthew H.; Douchet, Isabelle; Daburon, Sophie; Moreau, Jean-Francois; Nolan, Garry P.; Blanco, Patrick; Dechanet-Merville, Julie; Dekker, Cornelia L.; Jojic, Vladimir; Kuo, Calvin J.; Davis, Mark M.; Faustin, Benjamin			Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states	NATURE MEDICINE			English	Article							ESSENTIAL-HYPERTENSION; CARDIOVASCULAR-DISEASE; INTERLEUKIN-18 LEVELS; T-CELLS; ACTIVATION; RECEPTOR; PROTEINS; PATHWAY; AGE	Low-grade, chronic inflammation has been associated with many diseases of aging, but the mechanisms responsible for producing this inflammation remain unclear. Inflammasomes can drive chronic inflammation in the context of an infectious disease or cellular stress, and they trigger the maturation of interleukin-1 beta (IL-1 beta). Here we find that the expression of specific inflarnmasome gene modules stratifies older individuals into two extremes: those with constitutive expression of IL-1 beta, nucleotide metabolism dysfunction, elevated oxidative stress, high rates of hypertension and arterial stiffness; and those without constitutive expression of 1L-1 beta, who lack these characteristics. Adenine and N4-acetylcytidine, nucleotide-derived metabolites that are detectable in the blood of the former group, prime and activate the NLRC4 inflammasome, induce the production of IL-1 beta, activate platelets and neutrophils and elevate blood pressure in mice. In individuals over 85 years of age, the elevated expression of inflammasome gene modules was associated with all-cause mortality. Thus, targeting inflammasome components may ameliorate chronic inflammation and various other age-associated conditions.	[Furman, David; Davis, Mark M.] Stanford Univ, Sch Med, Inst Transplantat Immunol & Infect, Stanford, CA 94305 USA; [Furman, David] Sidra Med & Res Ctr, Div Translat Med, Dept Syst Biol, Doha, Qatar; [Chang, Junlei; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Lartigue, Lydia] INSERM U916 VINCO, Inst Bergonie, Bordeaux, France; [Bolen, Christopher R.; Gaudilliere, Brice; Ganio, Edward A.; Fragiadakis, Gabriela K.; Spitzer, Matthew H.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Haddad, Francois] Stanford Univ, Sch Med, Inst Cardiovasc Med, Stanford, CA 94305 USA; [Douchet, Isabelle; Daburon, Sophie; Moreau, Jean-Francois; Blanco, Patrick; Dechanet-Merville, Julie; Faustin, Benjamin] Univ Bordeaux 2, UMR CNRS 5164, CIRID, Bordeaux, France; [Dekker, Cornelia L.] Stanford Univ, Dept Pediat, Div Infect Dis, Stanford, CA 94305 USA; [Jojic, Vladimir] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Bolen, Christopher R.] Genentech Inc, Bioinformat Dept, San Francisco, CA 94080 USA	Stanford University; Sidra Medical & Research Center; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; Stanford University; Roche Holding; Genentech	Furman, D; Davis, MM (corresponding author), Stanford Univ, Sch Med, Inst Transplantat Immunol & Infect, Stanford, CA 94305 USA.; Furman, D (corresponding author), Sidra Med & Res Ctr, Div Translat Med, Dept Syst Biol, Doha, Qatar.; Faustin, B (corresponding author), Univ Bordeaux 2, UMR CNRS 5164, CIRID, Bordeaux, France.; Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	furmand@stanford.edu; mmdavis@stanford.edu; bfaustin@cirid.org	Nolan, Garry/AAE-7903-2019; Chang, Junlei/K-2696-2017	Chang, Junlei/0000-0002-0319-9022; Nolan, Garry/0000-0002-8862-9043; Spitzer, Matthew/0000-0002-5291-3819; Gaudilliere, Brice/0000-0002-3475-5706; Kuo, Calvin/0000-0002-7427-5985; Davis, Mark/0000-0001-6868-657X	NIH [U19 AI090019]; Howard Hughes Medical Institute; Fondation pour la Recherche Medicale [DEQ20110421287]; INCa-Canceropole GSO; Ligue contre le Cancer de la Dordogne; Conseil Regional d'Aquitaine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090019, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM111657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INCa-Canceropole GSO(Institut National du Cancer (INCA) France); Ligue contre le Cancer de la Dordogne; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Ellison longitudinal cohort volunteers for their participation; Project/Regulatory/Data Manager S. Mackey; Research Nurses S. Swope, C. Walsh, S. French, B. Sullivan, S. Cathey, T. Trela and N. Mastman; Clinical Research Associates A. Goel, T. Quan, K. Span, R. Fleischmann, B. Tse, I. Chang and S. Batra. We also are grateful to The Ellison Medical Foundation for initial support and to the NIH (U19 AI090019) and the Howard Hughes Medical Institute for the remainder (M.M.D.). We also thank H. Maecker and Y. Rosenberg-Hasson (Human Immune Monitoring Core) at Stanford, and R.E. Vance and I. Rauch at the University of California, Berkeley, for kindly providing us with material from NLRC4 and caspase-1 knockout mice. B.F., J.D-M. and J.F.M. were funded by Fondation pour la Recherche Medicale (DEQ20110421287), INCa-Canceropole GSO, Ligue contre le Cancer de la Dordogne, and the Conseil Regional d'Aquitaine. We thank the Metabolon Inc. for the metabolite analysis.	Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194; Dai HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00032; Dorffel Y, 1999, HYPERTENSION, V34, P113, DOI 10.1161/01.HYP.34.1.113; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gkaliagkousi E, 2010, AM J HYPERTENS, V23, P229, DOI 10.1038/ajh.2009.247; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johansson A, 2015, CIRC-CARDIOVASC GENE, V8, P498, DOI 10.1161/CIRCGENETICS.114.000724; Kirabo A, 2014, J CLIN INVEST, V124, P4642, DOI 10.1172/JCI74084; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Minuz P, 2004, HYPERTENSION, V43, P64, DOI 10.1161/01.HYP.0000105109.44620.1B; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Niwa T, 1998, KIDNEY INT, V53, P1801, DOI 10.1046/j.1523-1755.1998.00944.x; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Omi T, 2006, EUR J HUM GENET, V14, P1295, DOI 10.1038/sj.ejhg.5201698; Ouyang XS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3909; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Rauch I, 2016, J EXP MED, V213, P657, DOI 10.1084/jem.20151809; Sardi F, 2011, AUTOIMMUN REV, V11, P149, DOI 10.1016/j.autrev.2011.09.005; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Song F, 2016, J GERONTOL A-BIOL, V71, P747, DOI 10.1093/gerona/glv078; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang C, 2014, J IMMUNOL, V192, P603, DOI 10.4049/jimmunol.1301384; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zeller T, 2015, CIRC-CARDIOVASC GENE, V8, P717, DOI 10.1161/CIRCGENETICS.115.001079; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	46	208	216	7	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					174	184		10.1038/nm.4267	http://dx.doi.org/10.1038/nm.4267			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28092664	Green Accepted, Green Submitted			2022-12-27	WOS:000393729000009
J	Ghosh, A; Smith, M; James, SE; Davila, ML; Velardi, E; Argyropoulos, KV; Gunset, G; Perna, F; Kreines, FM; Levy, ER; Lieberman, S; Jay, HV; Tuckett, AZ; Zakrzewski, JL; Tan, L; Young, LF; Takvorian, K; Dudakov, JA; Jenq, RR; Hanash, AM; Motta, ACF; Murphy, GF; Liu, C; Schietinger, A; Sadelain, M; van den Brink, MRM				Ghosh, Arnab; Smith, Melody; James, Scott E.; Davila, Marco L.; Velardi, Enrico; Argyropoulos, Kimon V.; Gunset, Gertrude; Perna, Fabiana; Kreines, Fabiana M.; Levy, Emily R.; Lieberman, Sophie; Jay, Hillary V.; Tuckett, Andrea Z.; Zakrzewski, Johannes L.; Tan, Lisa; Young, Lauren F.; Takvorian, Kate; Dudakov, Jarrod A.; Jenq, Robert R.; Hanash, Alan M.; Motta, Ana Carolina F.; Murphy, George F.; Liu, Chen; Schietinger, Andrea; Sadelain, Michel; van den Brink, Marcel R. M.			Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity	NATURE MEDICINE			English	Article							CHIMERIC ANTIGEN RECEPTOR; CD19-TARGETED T-CELLS; MALIGNANCIES; TRANSPLANTATION; PERSISTENCE; REMISSIONS; INFUSION; THERAPY; TUMORS; GVHD	Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for hematological malignancies. However, graft-versus-host disease (GVHD) and relapse after allo-HSCT remain major impediments to the success of allo-HSCT. Chimeric antigen receptors (CARs) direct tumor cell recognition of-adoptively transferred T cells(1-5). CD19 is an attractive CAR target, which is expressed in most B cell malignancies, as well as in healthy B cells(6,7). Clinical trials using autologous CD19-targeted T cells have shown remarkable promise in various B cell malignancies(8-15). However, the use of allogeneic CAR T cells poses a concern in that it may increase risk of the occurrence of GVHD, although this has not been reported in selected patients infused with donor-derived CD19 CAR T cells after allo-HSCT16,17. To understand the mechanism whereby allogeneic CD19 CAR T cells may mediate anti-lymphoma activity without causing a significant increase in the incidence of GVHD, we studied donor-derived CD19 CAR T cells in allo-HSCT and lyMphoma models in mice. We demonstrate that alloreactive. I cells expressing CD28-costimulated CD19 CARs experience enhanced stimulation, resulting in the progressive loss of both their effector function and proliferative potential, clonal deletion, and significantly decreased occurrence of GVHD. Concurrently, the other CAR T cells that were present in bulk donor T cell populations retained their anti-lymphoma activity in accordance with the requirement that both the T cell receptor (TCR) and CAR be engaged to accelerate T cell exhaustion. In contrast, first-generation and 4-1BB-costimulated CAR T cells increased the occurrence of GVHD. These findings could explain the reduced risk of GVHD occurring with cumulative TCR and CAR signaling.	[Ghosh, Arnab; Smith, Melody; James, Scott E.; Velardi, Enrico; Argyropoulos, Kimon V.; Kreines, Fabiana M.; Levy, Emily R.; Lieberman, Sophie; Jay, Hillary V.; Tuckett, Andrea Z.; Tan, Lisa; Young, Lauren F.; Takvorian, Kate; Dudakov, Jarrod A.; Jenq, Robert R.; Hanash, Alan M.; Schietinger, Andrea; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Ghosh, Arnab; Smith, Melody; James, Scott E.; Velardi, Enrico; Argyropoulos, Kimon V.; Kreines, Fabiana M.; Levy, Emily R.; Lieberman, Sophie; Jay, Hillary V.; Tuckett, Andrea Z.; Tan, Lisa; Young, Lauren F.; Takvorian, Kate; Dudakov, Jarrod A.; Jenq, Robert R.; Hanash, Alan M.; Schietinger, Andrea; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [James, Scott E.; Davila, Marco L.; Gunset, Gertrude; Perna, Fabiana; Sadelain, Michel; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA; [Zakrzewski, Johannes L.] Mem Sloan Kettering Canc Ctr, Pediat, 1275 York Ave, New York, NY 10021 USA; [Motta, Ana Carolina F.; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Program Dermatopathol, 75 Francis St, Boston, MA 02115 USA; [Motta, Ana Carolina F.; Murphy, George F.] Harvard Med Sch, Boston, MA USA; [Liu, Chen] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Newark, NJ USA; [Davila, Marco L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL USA; [Dudakov, Jarrod A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA; [Motta, Ana Carolina F.] Univ Sao Paulo, Sao Paulo, Brazil	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; H Lee Moffitt Cancer Center & Research Institute; Fred Hutchinson Cancer Center; Universidade de Sao Paulo	Sadelain, M; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA.	sadelaim@mskcc.org; vandenbm@mskcc.org	Velardi, Enrico/AAB-7443-2019; velardi, Enrico/AAC-5440-2022; Kreines, Fabiana/AAV-8837-2020; van den Brink, Marcel R. M./HGB-9434-2022; Motta, Ana Carolina F/J-2683-2012; Davila, Marco/P-7912-2014	Velardi, Enrico/0000-0001-8383-0453; Motta, Ana Carolina F/0000-0002-3887-9239; Davila, Marco/0000-0002-6270-3065; Ghosh, Arnab/0000-0003-3355-5427; Smith, Melody/0000-0002-2702-0381	National Institutes of Health [R01-HL069929, R01-A1101406, P01-CA023766, R01-AI100288]; LLS; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; MSK Cancer Center Support Grant/Core Grant [P30-CA008748]; NIH [PA-16-288, R01-AI100288-08S1]; M.J. Lacher Research Fellowship (The Lymphoma Foundation); American Society for Blood and Marrow Transplantation New Investigator Award; NIH T32 grant [T32-CA009207]; ASH-AMFDP career development award; Damon Runyon Fund [K08-CA148821]; LLS TRP grant [6465-15, K08-CA160659]; Imaging and Radiation Sciences (IMRAS) Program of MSKCC; NATIONAL CANCER INSTITUTE [K08CA160659, K08CA148821, P01CA023766, P30CA008748, T32CA009207, R00CA176376] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL115355, R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101406, R01AI100288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; MSK Cancer Center Support Grant/Core Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Lacher Research Fellowship (The Lymphoma Foundation); American Society for Blood and Marrow Transplantation New Investigator Award; NIH T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASH-AMFDP career development award; Damon Runyon Fund; LLS TRP grant; Imaging and Radiation Sciences (IMRAS) Program of MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to M. Sayegh (Brigham and Women's Hospital and Children's Hospital Boston) for ABM mice, R. Negrin (Stanford University) for the A20-TGL cell line, E. Campeau (University of Massachusetts) for pENTR1A, D. Vignali (University of Pittsburgh Medical Center) for mouse TCR OTI-2A.pMIG II, and P. Khavari (Stanford University) for LZRS-Rfa plasmid. We appreciate the help of J. White, LCP, RARC, the flow cytometry core facility, the integrative genomics core, and the computational biology core at MSKCC. We also appreciate the help of H. Poeck in critical reading of the manuscript. This research was supported by National Institutes of Health award numbers R01-HL069929 (M.R.M.v.d.B.), R01-A1101406 (M.R.M.v.d.B.), P01-CA023766 (M.R.M.v.d.B.), and R01-AI100288 (M.R.M.v.d.B.), LLS (M. Sadelain), the Lymphoma Foundation, the Susan and Peter Solomon Divisional Genomics Program, MSKCC Cycle for Survival, and P30-CA008748 MSK Cancer Center Support Grant/Core Grant. A.G. is a fellow of the Lymphoma Research Foundation. M. Smith received funding from an NIH Diversity Supplement (PA-16-288) under R01-AI100288-08S1, the M.J. Lacher Research Fellowship (The Lymphoma Foundation), and the American Society for Blood and Marrow Transplantation New Investigator Award. M. Smith and S.J. are supported under an NIH T32 grant (T32-CA009207). S.J. is also a Young Investigator Awardee from the Conquer Cancer Foundation of ASCO. M.L.D. is supported by an ASH-AMFDP career development award, the Damon Runyon Fund, and K08-CA148821 (NCI). J.L.Z. is supported by LLS TRP grant 6465-15 and K08-CA160659 (NCI). A.Z.T. is supported by a grant from the Imaging and Radiation Sciences (IMRAS) Program of MSKCC. The content is solely the responsibility of the authors and does not represent the official views of the National Cancer Institute or the National Institutes of Health.	Bar M, 2013, BIOL BLOOD MARROW TR, V19, P949, DOI 10.1016/j.bbmt.2013.03.001; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Davila ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061338; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ghosh A, 2013, CANCER RES, V73, P4687, DOI 10.1158/0008-5472.CAN-12-4699; Ghosh A, 2013, J CLIN INVEST, V123, P2654, DOI 10.1172/JCI66301; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hasan M, 2002, EUR J IMMUNOL, V32, P3463, DOI 10.1002/1521-4141(200212)32:12<3463::AID-IMMU3463>3.0.CO;2-B; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Jacoby E, 2016, BLOOD, V127, P1361, DOI 10.1182/blood-2015-08-664250; James SE, 2009, BLOOD, V114, P5454, DOI 10.1182/blood-2009-08-232967; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2015, J CLIN INVEST, V125, P3392, DOI 10.1172/JCI80010; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Small TN, 2009, BIOL BLOOD MARROW TR, V15, P104, DOI 10.1016/j.bbmt.2008.10.016; Srinivasan M, 2012, BLOOD, V119, P1570, DOI 10.1182/blood-2011-07-364414; Teague RM, 2008, IMMUNITY, V28, P662, DOI 10.1016/j.immuni.2008.03.012; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	36	136	148	1	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					242	249		10.1038/nm.4258	http://dx.doi.org/10.1038/nm.4258			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28067900	Green Accepted			2022-12-27	WOS:000393729000016
J	Cheng, CW; Yilmaz, OH				Cheng, Chia-Wei; Yilmaz, Omer H.			Starving leukemia to induce differentiation	NATURE MEDICINE			English	Editorial Material							STEM-CELLS; DIETARY; CANCER; LEPTIN	A new study shows that fasting induces the differentiation and elimination of some types of leukemia in mice, which implicates fasting or its mimetics as a novel strategy for the treatment of this disease.	[Cheng, Chia-Wei; Yilmaz, Omer H.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cheng, Chia-Wei; Yilmaz, Omer H.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yilmaz, Omer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yilmaz, Omer H.] Harvard Med Sch, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yilmaz, OH (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Yilmaz, OH (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Yilmaz, OH (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Yilmaz, OH (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.	ohyilmaz@mit.edu		/0000-0003-1088-923X	NATIONAL CANCER INSTITUTE [R01CA211184, R01CA034992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG045144] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA211184, R01 CA034992] Funding Source: Medline; NIA NIH HHS [R00 AG045144] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Crunkhorn S, 2016, NAT REV DRUG DISCOV, V15, P15, DOI [10.1038/nrd.2015.32, 10.1038/nrd.2016.271]; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Dorantes-Acosta E, 2012, BONE MARROW RES, DOI 10.1155/2012/406796; Lu ZG, 2017, NAT MED, V23, P79, DOI 10.1038/nm.4252; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Park J, 2011, ENDOCR-RELAT CANCER, V18, pC25, DOI 10.1530/ERC-11-0163; Riether C, 2015, CELL DEATH DIFFER, V22, P187, DOI 10.1038/cdd.2014.89; Vernieri C, 2016, CANCER DISCOV, V6, P1315, DOI 10.1158/2159-8290.CD-16-0615	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					14	15		10.1038/nm.4259	http://dx.doi.org/10.1038/nm.4259			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	28060803	Green Accepted, Green Published			2022-12-27	WOS:000391646800008
J	van de Veerdonk, FL; Netea, MG				van de Veerdonk, Frank L.; Netea, Mihai G.			CBLB ubiquitin ligase: a major regulator of antifungal immunity	NATURE MEDICINE			English	Editorial Material							CANDIDA-ALBICANS; HOST-DEFENSE; PATHWAY; INDUCTION	Little is known about the regulatory mechanisms of antifungal host defense. Two complementary studies show that the E3 ubiquitin ligase CBLB targets dectin-1 and dectin-2 for degradation, and thus exerts a strong anti-inflammatory effect.	[van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands.	mihai.netea@radboudumc.nl	Netea, Mihai/N-5155-2014; van de Veerdonk, Frank L/C-7256-2008	van de Veerdonk, Frank L/0000-0002-1121-4894				Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Gazendam RP, 2014, BLOOD, V124, P590, DOI 10.1182/blood-2014-01-551473; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Wirnsberger G, 2016, NAT MED, V22, P915, DOI 10.1038/nm.4134; Xiao Y, 2016, NAT MED, V22, P906, DOI 10.1038/nm.4141	12	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					834	835		10.1038/nm.4160	http://dx.doi.org/10.1038/nm.4160			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27490434				2022-12-27	WOS:000381000200006
J	Fukawa, T; Yan-Jiang, BC; Min-Wen, JC; Jun-Hao, ET; Huang, D; Qian, CN; Ong, P; Li, ZM; Chen, SW; Mak, SY; Lim, WJ; Kanayama, HO; Mohan, RE; Wang, RR; Lai, JH; Chua, C; Ong, HS; Tan, KK; Ho, YS; Tan, IB; Teh, B; Shyh-Chang, N				Fukawa, Tomoya; Yan-Jiang, Benjamin Chua; Min-Wen, Jason Chua; Jun-Hao, Elwin Tan; Huang, Dan; Qian, Chao-Nan; Ong, Pauline; Li, Zhimei; Chen, Shuwen; Mak, Shi Ya; Lim, Wan Jun; Kanayama, Hiro-omi; Mohan, Rosmin Elsa; Wang, Ruiqi Rachel; Lai, Jiunn Herng; Chua, Clarinda; Ong, Hock Soo; Tan, Ker-Kan; Ho, Ying Swan; Tan, Iain Beehuat; Teh, Bin Tean; Shyh-Chang, Ng			Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; STIMULATES LIPOLYSIS; CELLS; LIPASE; MICE; METABOLISM	Cachexia is a devastating muscle-wasting syndrome that occurs in patients who have chronic diseases. It is most commonly observed in individuals with advanced cancer(1,2), presenting in 80% of these patients, and it is one of the primary causes of morbidity and mortality associated with cancer(3-5). Additionally, although many people with cachexia show hypermetabolism(3,6), the causative role of metabolism in muscle atrophy has been unclear. To understand the molecular basis of cachexia-associated muscle atrophy, it is necessary to develop accurate models of the condition. By using transcriptomics and cytokine profiling of human muscle stem cell-based models and human cancer-induced cachexia models in mice, we found that cachectic cancer cells secreted many inflammatory factors that rapidly led to high levels of fatty acid metabolism and to the activation of a p38 stress-response signature in skeletal muscles, before manifestation of cachectic muscle atrophy occurred. Metabolomics profiling revealed that factors secreted by cachectic cancer cells rapidly induce excessive fatty acid oxidation in human myotubes, which leads to oxidative stress, p38 activation and impaired muscle growth. Pharmacological blockade of fatty acid oxidation not only rescued human myotubes, but also improved muscle mass and body weight in cancer cachexia models in vivo. Therefore, fatty acid-induced oxidative stress could be targeted to prevent cancer-induced cachexia.	[Fukawa, Tomoya; Ong, Pauline; Li, Zhimei; Teh, Bin Tean] Duke Natl Univ, Program Canc & Stem Cell Biol, Lab Canc Therapeut, Singapore Med Sch, Singapore, Singapore; [Fukawa, Tomoya; Huang, Dan; Ong, Pauline; Li, Zhimei; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Fukawa, Tomoya; Kanayama, Hiro-omi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Urol, Tokushima 770, Japan; [Yan-Jiang, Benjamin Chua; Min-Wen, Jason Chua; Jun-Hao, Elwin Tan; Chua, Clarinda; Tan, Iain Beehuat; Shyh-Chang, Ng] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Qian, Chao-Nan] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shuwen; Mak, Shi Ya; Ho, Ying Swan] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Lim, Wan Jun; Chua, Clarinda; Tan, Iain Beehuat; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Mohan, Rosmin Elsa; Wang, Ruiqi Rachel] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Lai, Jiunn Herng] Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore; [Ong, Hock Soo] Singapore Gen Hosp, Dept Upper Gastrointestinal & Bariatr Surg, Singapore, Singapore; [Tan, Ker-Kan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Tan, Iain Beehuat] Duke Natl Univ, Program Canc & Stem Cell Biol, Singapore Med Sch, Singapore, Singapore; [Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Teh, Bin Tean] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Teh, Bin Tean] Duke Natl Univ, Singapore Precis Med Inst, SingHlth, Natl Heart Ctr, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Tokushima University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); State Key Lab Oncology South China; Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National Cancer Centre Singapore (NCCS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Heart Centre Singapore	Teh, B (corresponding author), Duke Natl Univ, Program Canc & Stem Cell Biol, Lab Canc Therapeut, Singapore Med Sch, Singapore, Singapore.; Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.; Tan, IB; Shyh-Chang, N (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.; Tan, IB; Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.; Tan, IB (corresponding author), Duke Natl Univ, Program Canc & Stem Cell Biol, Singapore Med Sch, Singapore, Singapore.; Teh, B (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.; Teh, B (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.; Teh, B (corresponding author), Duke Natl Univ, Singapore Precis Med Inst, SingHlth, Natl Heart Ctr, Singapore, Singapore.	iain.tan.b.h@singhealth.com.sg; teh.bin.tean@singhealth.com.sg; ngsc1@gis.a-star.edu.sg	Huang, Dejian/A-7439-2010; Tan, Ker Kan/K-2506-2017; Fukawa, Tomoya/AFV-7106-2022	Tan, Ker Kan/0000-0002-0410-0450; Wang, Ruiqi Rachel/0000-0002-5099-8177; Ho, Ying Swan/0000-0002-9292-3106; Chen, Shuwen/0000-0003-1245-1469; Mohan, Rosmin Elsa/0000-0001-6809-7679; Teh, Bin Tean/0000-0003-1514-1124; Chua, Benjamin Yan-Jiang/0000-0002-9529-291X; Shyh-Chang, Ng/0000-0003-3138-9525	Agency for Science Technology and Research (ASTAR) Joint Council Office grant [1431AFG128]; Singapore National Medical Research Council [NMRC/STaR/0024/2014, NMRC/GMS/CIRG/1332/2012]; Duke-NUS Medical School; National Cancer Centre Singapore; Polaris program under ASTAR Strategic Positioning Fund [SPF2012/001]; Genome Institute of Singapore	Agency for Science Technology and Research (ASTAR) Joint Council Office grant(Agency for Science Technology & Research (A*STAR)); Singapore National Medical Research Council(National Medical Research Council, Singapore); Duke-NUS Medical School; National Cancer Centre Singapore; Polaris program under ASTAR Strategic Positioning Fund; Genome Institute of Singapore	We thank all our respective lab mates for their helpful discussion, and E. Peh for technical assistance with mass spectrometry. This work was supported by the Agency for Science Technology and Research (ASTAR) Joint Council Office grant 1431AFG128 (N.S.-C.), the Singapore National Medical Research Council grants NMRC/STaR/0024/2014 and NMRC/GMS/CIRG/1332/2012, Duke-NUS Medical School, and National Cancer Centre Singapore (all to B.T.T.), Polaris program grant SPF2012/001 under the ASTAR Strategic Positioning Fund (Y.S.H.) and the Genome Institute of Singapore (I.B.T. and N.S.-C.).	Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Ebadi M., 2016, CLIN NUTR; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Gao S, 2016, AM J PHYSIOL-CELL PH, V310, pC66, DOI 10.1152/ajpcell.00052.2015; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; KAWAKAMI M, 1987, J BIOCHEM-TOKYO, V101, P331, DOI 10.1093/oxfordjournals.jbchem.a121917; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Lopatin YM, 2016, INT J CARDIOL, V203, P909, DOI 10.1016/j.ijcard.2015.11.060; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Min-Wen JC, 2016, SEMIN CELL DEV BIOL, V52, P110, DOI 10.1016/j.semcdb.2016.02.005; MORI M, 1991, CANCER RES, V51, P6656; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Skuk D, 2010, MOL THER, V18, P1689, DOI 10.1038/mt.2010.128; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Tan AHM, 2014, CELL REP, V9, P24, DOI 10.1016/j.celrep.2014.08.043; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Woods MN, 2009, AM J CLIN NUTR, V90, P1566, DOI 10.3945/ajcn.2009.28137; Zuijdgeest-van Leeuwen SD, 2000, METABOLISM, V49, P931, DOI 10.1053/meta.2000.6740	33	125	130	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					666	+		10.1038/nm.4093	http://dx.doi.org/10.1038/nm.4093			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135739				2022-12-27	WOS:000377476000024
J	Nair, A; Chung, HC; Sun, TT; Tyagi, S; Dobrolecki, LE; Dominguez-Vidana, R; Kurley, SJ; Orellana, M; Renwick, A; Henke, DM; Katsonis, P; Schmitt, E; Chan, DW; Li, H; Mao, SF; Petrovic, I; Creighton, CJ; Gutierrez, C; Dubrulle, J; Stossi, F; Tyner, JW; Lichtarge, O; Lin, CY; Zhang, B; Scott, KL; Hilsenbeck, SG; Sun, JP; Yu, X; Osborne, CK; Schiff, R; Christensen, JG; Shields, DJ; Rimawi, MF; Ellis, MJ; Shaw, CA; Lewis, MT; Westbrook, TF				Nair, Amritha; Chung, Hsiang-Ching; Sun, Tingting; Tyagi, Siddhartha; Dobrolecki, Lacey E.; Dominguez-Vidana, Rocio; Kurley, Sarah J.; Orellana, Mayra; Renwick, Alexander; Henke, David M.; Katsonis, Panagiotis; Schmitt, Earlene; Chan, Doug W.; Li, Hui; Mao, Sufeng; Petrovic, Ivana; Creighton, Chad J.; Gutierrez, Carolina; Dubrulle, Julien; Stossi, Fabio; Tyner, Jeffrey W.; Lichtarge, Olivier; Lin, Charles Y.; Zhang, Bing; Scott, Kenneth L.; Hilsenbeck, Susan G.; Sun, Jinpeng; Yu, Xiao; Osborne, C. Kent; Schiff, Rachel; Christensen, James G.; Shields, David J.; Rimawi, Mothaffar F.; Ellis, Matthew J.; Shaw, Chad A.; Lewis, Michael T.; Westbrook, Thomas F.			Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer	NATURE MEDICINE			English	Article							NONRECEPTOR TYPE 12; PROTEIN COMPLEXES; PROGNOSTIC-FACTOR; BASAL-LIKE; PHASE-II; PHOSPHATASE; EXPRESSION; IDENTIFICATION; CARCINOMA; TRIAL	Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer diagnosed in more than 200,000 women each year(1) and is recalcitrant to targeted therapies(2,3). Although TNBCs harbor multiple hyperactive receptor tyrosine kinases (RTKs)(4-8), RTK inhibitors have been largely ineffective in TNBC patients thus far. We developed a broadly effective therapeutic strategy for TNBC that is based on combined inhibition of receptors that share the negative regulator PTPN12. Previously, we and others identified the tyrosine phosphatase PTPN12 as a tumor suppressor that is frequently inactivated in TNBC9,10. PTPN12 restrains several RTKs(9,11-17), suggesting that PTPN12 deficiency leads to aberrant activation of multiple RTKs and a co-dependency on these receptors. This in turn leads to the therapeutic hypothesis that PTPN12-deficient TNBCs may be responsive to combined RTK inhibition. However, the repertoire of RTKs that are restrained by PTPN12 in human cells has not been systematically explored. By methodically identifying the suite of RTK substrates (MET, PDGFR beta, EGFR, and others) inhibited by PTPN12, we rationalized a combination RTK-inhibitor therapy that induced potent tumor regression across heterogeneous models of TNBC. Orthogonal approaches revealed that PTPN12 was recruited to and inhibited these receptors after ligand stimulation, thereby serving as a feedback mechanism to limit receptor signaling. Cancer-associated mutation of PTPN12 or reduced PTPN12 protein levels diminished this feedback mechanism, leading to aberrant activity of these receptors. Restoring PTPN12 protein levels restrained signaling from RTKs, including PDGFRb and MET, and impaired TNBC survival. In contrast with single agents, combined inhibitors targeting the PDGFR beta and MET receptors induced the apoptosis in TNBC cells in vitro and in vivo. This therapeutic strategy resulted in tumor regressions in chemo-refractory patient-derived TNBC models. Notably, response correlated with PTPN12 deficiency, suggesting that impaired receptor feedback may establish a combined addiction to these proto-oncogenic receptors. Taken together, our data provide a rationale for combining RTK inhibitors in TNBC and other malignancies that lack receptor-activating mutations.	[Nair, Amritha; Chung, Hsiang-Ching; Sun, Tingting; Tyagi, Siddhartha; Dominguez-Vidana, Rocio; Kurley, Sarah J.; Orellana, Mayra; Renwick, Alexander; Henke, David M.; Katsonis, Panagiotis; Schmitt, Earlene; Lichtarge, Olivier; Lin, Charles Y.; Scott, Kenneth L.; Shaw, Chad A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA; [Nair, Amritha; Chung, Hsiang-Ching; Sun, Tingting; Tyagi, Siddhartha; Dominguez-Vidana, Rocio; Kurley, Sarah J.; Orellana, Mayra; Schmitt, Earlene; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA; [Chung, Hsiang-Ching; Dominguez-Vidana, Rocio; Westbrook, Thomas F.] Baylor Coll Med, Interdept Program Mol & Biomed Sci, One Baylor Plaza, Houston, TX 77030 USA; [Dobrolecki, Lacey E.; Chan, Doug W.; Mao, Sufeng; Petrovic, Ivana; Gutierrez, Carolina; Zhang, Bing; Hilsenbeck, Susan G.; Osborne, C. Kent; Schiff, Rachel; Rimawi, Mothaffar F.; Ellis, Matthew J.; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, One Baylor Plaza, Houston, TX 77030 USA; [Li, Hui] Shandong Univ, Sch Med, Dept Physiol, Jinan, Shandong, Peoples R China; [Creighton, Chad J.; Scott, Kenneth L.; Hilsenbeck, Susan G.; Osborne, C. Kent; Schiff, Rachel; Ellis, Matthew J.; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, One Baylor Plaza, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.] Baylor Coll Med, Div Biostat, One Baylor Plaza, Houston, TX 77030 USA; [Gutierrez, Carolina] Baylor Coll Med, Dept Pathol, One Baylor Plaza, Houston, TX 77030 USA; [Dubrulle, Julien; Stossi, Fabio; Osborne, C. Kent; Schiff, Rachel; Ellis, Matthew J.; Lewis, Michael T.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Lin, Charles Y.; Westbrook, Thomas F.] Baylor Coll Med, Therapeut Innovat Ctr, Houston, TX 77030 USA; [Sun, Jinpeng] Shandong Univ, Sch Med, Dept Mol Biol & Biochem, Jinan, Shandong, Peoples R China; [Osborne, C. Kent; Schiff, Rachel; Ellis, Matthew J.] Baylor Coll Med, Dept Med, One Baylor Plaza, Houston, TX 77030 USA; [Christensen, James G.; Shields, David J.] Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Shandong University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Oregon Health & Science University; Baylor College of Medicine; Shandong University; Baylor College of Medicine; Pfizer	Westbrook, TF (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA.; Westbrook, TF (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA.; Westbrook, TF (corresponding author), Baylor Coll Med, Interdept Program Mol & Biomed Sci, One Baylor Plaza, Houston, TX 77030 USA.; Westbrook, TF (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, One Baylor Plaza, Houston, TX 77030 USA.; Westbrook, TF (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.; Westbrook, TF (corresponding author), Baylor Coll Med, Therapeut Innovat Ctr, Houston, TX 77030 USA.	thomasw@bcm.edu	Rimawi, Mothaffar/AAI-3520-2020; Lewis, Michael T/A-9572-2009; sun, Jinpeng/AAR-9196-2020; Katsonis, Panagiotis/L-6391-2019; Vidana, Rocio Dominguez/A-1153-2009; Tyagi, siddhartha/J-1838-2019	Rimawi, Mothaffar/0000-0002-4284-5656; Vidana, Rocio Dominguez/0000-0003-3855-5178; Kurley, Sarah/0000-0002-4127-1443; , SIDDHARTHA/0000-0001-5543-4787	NCI Center Grant [P30CA125123]; Cytometry and Cell Sorting [P30 AI036211, S10 RR024574]; Susan G. Komen Foundation [KG120001, KG090355]; NCI/NIH SPORE Supplement Award [P50 CA186784]; Cancer Center Support Grant [NCI-CA125123]; CPRIT [RP120583]; NIH [1R01CA178039-01]; DOD Breast Cancer Research Program [BC120604]; NATIONAL CANCER INSTITUTE [T32CA174647, P30CA125123, R01CA178039, P50CA186784] Funding Source: NIH RePORTER	NCI Center Grant; Cytometry and Cell Sorting; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NCI/NIH SPORE Supplement Award; Cancer Center Support Grant; CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank members of T.F.W. laboratory for helpful comments. The authors also acknowledge the joint participation of the Adrienne Helis Melvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine for cancer research. The Dan L. Duncan Cancer Center Shared Resources was supported by the NCI P30CA125123 Center Grant and provided technical assistance including Cell-Based Assay Screening Service (D. Liu), Biostatistics & Informatics Shared Resource (S. Hilsenbeck), and Cytometry and Cell Sorting (J. Sederstrom; P30 AI036211 and S10 RR024574). M.T.L. was supported by the Susan G. Komen Foundation (KG120001), a NCI/NIH SPORE Supplement Award (P50 CA186784), and the Patient-derived Xenograft and Advance In vivo Models Core at Baylor College of Medicine and P30 Cancer Center Support Grant (NCI-CA125123). T.F.W. was supported by CPRIT (RP120583), the Susan G. Komen Foundation (KG090355), the NIH (1R01CA178039-01) and the DOD Breast Cancer Research Program (BC120604).	Ambjorn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065371; Anders C, 2008, ONCOLOGY-NY, V22, P1233; Anders CK, 2013, HEMATOL ONCOL CLIN N, V27, P737, DOI 10.1016/j.hoc.2013.05.003; Baameur F, 2010, MOL PHARMACOL, V77, P405, DOI 10.1124/mol.109.058115; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bianchi G, 2009, ANTI-CANCER DRUG, V20, P616, DOI 10.1097/CAD.0b013e32832b2ea0; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Cao X, 2015, ONCOTARGET, V6, P11704, DOI 10.18632/oncotarget.3588; Cao X, 2012, ANN THORAC SURG, V93, P1674, DOI 10.1016/j.athoracsur.2011.12.056; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Guida T, 2007, CLIN CANCER RES, V13, P3363, DOI 10.1158/1078-0432.CCR-06-2667; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Katsonis P, 2014, GENOME RES, V24, P2050, DOI 10.1101/gr.176214.114; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li H, 2016, CELL REP, V15, P1345, DOI 10.1016/j.celrep.2016.04.016; Li J, 2015, MOL CELL BIOL, V35, P4069, DOI 10.1128/MCB.00741-15; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lua RC, 2010, BIOINFORMATICS, V26, P2981, DOI 10.1093/bioinformatics/btq566; Luo RZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085592; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mihalek I, 2003, J MOL BIOL, V331, P263, DOI 10.1016/S0022-2836(03)00663-6; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prenen H, 2006, CLIN CANCER RES, V12, P2622, DOI 10.1158/1078-0432.CCR-05-2275; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su Z, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0618-4; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Villa-Moruzzi E, 2013, MOL CELL BIOCHEM, V375, P151, DOI 10.1007/s11010-012-1537-y; Wu MQ, 2013, ASIAN PAC J CANCER P, V14, P287, DOI 10.7314/APJCP.2013.14.1.287; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Yao Z, 2017, MOL CELL, V65, P347, DOI 10.1016/j.molcel.2016.12.004; Yardley DA, 2015, BREAST CANCER RES TR, V152, P557, DOI 10.1007/s10549-015-3482-4; Yuan XY, 2012, BRAZ J MED BIOL RES, V45, P1334, DOI 10.1590/S0100-879X2012007500163; Zagouri F, 2013, BRIT J CANCER, V108, P1100, DOI 10.1038/bjc.2013.31; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhang XK, 2015, TUMOR BIOL, V36, P5201, DOI 10.1007/s13277-015-3176-x; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	52	35	36	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					505	+		10.1038/nm.4507	http://dx.doi.org/10.1038/nm.4507			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29578538	Green Accepted			2022-12-27	WOS:000429639800022
J	Yu, GY; Tzouvelekis, A; Wang, R; Herazo-Maya, JD; Ibarra, GH; Srivastava, A; de Castro, JPW; DeIuliis, G; Ahangari, F; Woolard, T; Aurelien, N; Drigo, RAE; Gan, Y; Graham, M; Liu, XR; Homer, RJ; Scanlan, TS; Mannam, P; Lee, PJ; Herzog, EL; Bianco, AC; Kaminski, N				Yu, Guoying; Tzouvelekis, Argyris; Wang, Rong; Herazo-Maya, Jose D.; Ibarra, Gabriel H.; Srivastava, Anup; Werneck de Castro, Joao Pedro; DeIuliis, Giuseppe; Ahangari, Farida; Woolard, Tony; Aurelien, Nachelle; Arrojo e Drigo, Rafael; Gan, Ye; Graham, Morven; Liu, Xinran; Homer, Robert J.; Scanlan, Thomas S.; Mannam, Praveen; Lee, Patty J.; Herzog, Erica L.; Bianco, Antonio C.; Kaminski, Naftali			Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function	NATURE MEDICINE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; AUTOPHAGY; BIOGENESIS; DEIODINASE; RESISTANCE; REGULATOR; MITOPHAGY; APOPTOSIS; NETWORKS; DISEASE	Thyroid hormone (TH) is critical for the maintenance of cellular homeostasis during stress responses, but its role in lung fibrosis is unknown. Here we found that the activity and expression of iodothyronine deiodinase 2 (DIO2), an enzyme that activates TH, were higher in lungs from patients with idiopathic pulmonary fibrosis than in control individuals and were correlated with disease severity. We also found that Dio2-knockout mice exhibited enhanced bleomycin-induced lung fibrosis. Aerosolized TH delivery increased survival and resolved fibrosis in two models of pulmonary fibrosis in mice (intratracheal bleomycin and inducible TGF-beta 1). Sobetirome, a TH mimetic, also blunted bleomycin-induced lung fibrosis. After bleomycin-induced injury, TH promoted mitochondrial biogenesis, improved mitochondrial bioenergetics and attenuated mitochondria-regulated apoptosis in alveolar epithelial cells both in vivo and in vitro. TH did not blunt fibrosis in Ppargc1a-or Pink1-knockout mice, suggesting dependence on these pathways. We conclude that the antifibrotic properties of TH are associated with protection of alveolar epithelial cells and restoration of mitochondrial function and that TH may thus represent a potential therapy for pulmonary fibrosis.	[Yu, Guoying; Tzouvelekis, Argyris; Wang, Rong; Herazo-Maya, Jose D.; Ibarra, Gabriel H.; Srivastava, Anup; DeIuliis, Giuseppe; Ahangari, Farida; Woolard, Tony; Aurelien, Nachelle; Gan, Ye; Mannam, Praveen; Lee, Patty J.; Herzog, Erica L.; Kaminski, Naftali] Yale Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA; [Tzouvelekis, Argyris] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece; [Werneck de Castro, Joao Pedro; Bianco, Antonio C.] Rush Univ, Med Ctr, Div Endocrinol Metab, Chicago, IL 60612 USA; [Werneck de Castro, Joao Pedro] Univ Fed Rio de Janeiro, Biophys Inst, Rio De Janeiro, Brazil; [Arrojo e Drigo, Rafael] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Graham, Morven; Liu, Xinran] Yale Univ, Sch Med, CCMI Electron Microscopy Core Facil, New Haven, CT USA; [Homer, Robert J.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Homer, Robert J.] VA Connecticut HealthCare Syst, Pathol & Lab Med Serv, West Haven, CT USA; [Scanlan, Thomas S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Wang, Rong] Shandong Univ, Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Wang, Rong] Shandong Univ, Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Hlth, Jinan, Shandong, Peoples R China; [Wang, Rong] Shandong Univ, State & Prov Joint Key Lab Translat Cardiovasc Me, Qilu Hosp, Jinan, Shandong, Peoples R China	Yale University; Alexander Fleming Biomedical Sciences Research Center; Rush University; Universidade Federal do Rio de Janeiro; Salk Institute; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Oregon Health & Science University; Shandong University; Shandong University; Shandong University	Kaminski, N (corresponding author), Yale Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA.	naftali.kaminski@yale.edu	ahangari, farida/HGC-0407-2022; Bianco, Antonio/AAK-6336-2020; homer, robert/P-3884-2019; Herazo-Maya, Jose/ABG-7214-2021	Bianco, Antonio/0000-0001-7737-6813; homer, robert/0000-0002-2055-5885; Yu, Guoying/0000-0002-4124-1359; DeIuliis, Giuseppe/0000-0003-0841-8156; Werneck-de-Castro, Joao Pedro/0000-0001-9242-7930; Kaminski, Naftali/0000-0001-5917-4601	US National Institutes of Health (NIH) [R01HL095397, R01HL127349, R01HL1109233, R01HL125250, RO1DK65055, RO1DK52798]; Flight Attendant Medical Research Institute; American Lung Association Award [RT 350419, RG-415350]; Marie Sklodowska/Curie ERS/EU-RESPIRE grant [2-8860-2015]; Pulmonary Fibrosis Foundation (PPF) Albert Rose Established Investigator Award [415245]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138396, T32HL007778, R01HL125850, RC2HL101715, R01HL127349, UH2HL123886, UH3HL123886, R01HL109233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065055, R01DK052798, R01DK058538, P30DK045735] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; American Lung Association Award; Marie Sklodowska/Curie ERS/EU-RESPIRE grant; Pulmonary Fibrosis Foundation (PPF) Albert Rose Established Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was in part supported by US National Institutes of Health (NIH) grants R01HL095397, R01HL127349 (N.K.), R01HL1109233, R01HL125250 (E.L.H.), RO1DK65055 (A.C.B.) and RO1DK52798 (T.S.S.), the Flight Attendant Medical Research Institute (P.J.L.), American Lung Association Award RT 350419, Marie Sklodowska/Curie ERS/EU-RESPIRE 2-8860-2015 grant (A.T.), American Lung Association Award RG-415350 (A.S.) and Pulmonary Fibrosis Foundation (PPF) Albert Rose Established Investigator Award 415245 (G.Y.).	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Alonso-Merino E, 2016, P NATL ACAD SCI USA, V113, pE3451, DOI 10.1073/pnas.1506113113; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214; Barca-Mayo O, 2011, P NATL ACAD SCI USA, V108, pE1321, DOI 10.1073/pnas.1109926108; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Bernard K, 2017, J BIOL CHEM, V292, P3029, DOI 10.1074/jbc.M116.752261; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Bhargava M, 2008, AM J RESP CRIT CARE, V178, P506, DOI 10.1164/rccm.200709-1429OC; BRENT GA, 1986, J CLIN ENDOCR METAB, V63, P1; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Buettner C, 2000, ENDOCRINOLOGY, V141, P4606, DOI 10.1210/en.141.12.4606; Chiellini G, 1998, CHEM BIOL, V5, P299, DOI 10.1016/S1074-5521(98)90168-5; Chiellini G, 2000, BIOORG MED CHEM LETT, V10, P2607, DOI 10.1016/S0960-894X(00)00531-X; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Cloonan SM, 2016, J CLIN INVEST, V126, P809, DOI 10.1172/JCI81113; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246; El-Sikhry HE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160380; Fliers E, 2015, LANCET DIABETES ENDO, V3, P816, DOI 10.1016/S2213-8587(15)00225-9; Forini F, 2014, ENDOCRINOLOGY, V155, P4581, DOI 10.1210/en.2014-1106; Friberg L, 2002, ARCH INTERN MED, V162, P1388, DOI 10.1001/archinte.162.12.1388; Gereke M, 2012, JOVE-J VIS EXP, V70, P4322; Gu LL, 2017, FASEB J, V31, P3072, DOI 10.1096/fj.201601371R; Han C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135233; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; Kim S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2170-4; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lesmana R, 2016, ENDOCRINOLOGY, V157, P23, DOI 10.1210/en.2015-1632; Lu XZ, 2013, CELL SIGNAL, V25, P1949, DOI 10.1016/j.cellsig.2013.06.005; Mannam P, 2014, AM J PHYSIOL-LUNG C, V306, pL604, DOI 10.1152/ajplung.00272.2013; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Mora AL, 2017, J CLIN INVEST, V127, P405, DOI 10.1172/JCI87440; Myllarniemi M, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.26385; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Oldham JM, 2015, CHEST, V148, P692, DOI 10.1378/chest.14-2714; Oral O, 2012, APOPTOSIS, V17, P810, DOI 10.1007/s10495-012-0735-0; Pandit KV, 2015, BIOCHEM CELL BIOL, V93, P129, DOI 10.1139/bcb-2014-0101; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Porter RK, 1999, INT J OBESITY, V23, pS12, DOI 10.1038/sj.ijo.0800937; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Ryu C, 2017, AM J RESP CRIT CARE, V195; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Salvatore D, 2014, NAT REV ENDOCRINOL, V10, P206, DOI 10.1038/nrendo.2013.238; Scanlan TS, 2010, HEART FAIL REV, V15, P177, DOI 10.1007/s10741-008-9122-x; Sgalla G, 2016, RESPIROLOGY, V21, P427, DOI 10.1111/resp.12683; Thannickal VJ, 2013, BIOGERONTOLOGY, V14, P609, DOI 10.1007/s10522-013-9451-6; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tzouvelekis A, 2017, AM J RESP CRIT CARE, V195, P500, DOI 10.1164/rccm.201602-0329OC; van Beeren HC, 2003, ENDOCRINOLOGY, V144, P552, DOI 10.1210/en.2002-220604; Verga Falzacappa C, 2012, J ENDOCRINOL, V215, P281, DOI 10.1530/JOE-12-0153; Williams GR, 2011, J ENDOCRINOL, V209, P261, DOI 10.1530/JOE-10-0448; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Yu GY, 2012, AM J RESP CRIT CARE, V186, P752, DOI 10.1164/rccm.201202-0302OC	62	167	174	5	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					39	+		10.1038/nm.4447	http://dx.doi.org/10.1038/nm.4447			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29200204	Green Accepted			2022-12-27	WOS:000422965900009
J	Shimanaka, Y; Kono, N; Taketomi, Y; Arita, M; Okayama, Y; Tanaka, Y; Nishito, Y; Mochizuki, T; Kusuhara, H; Adibekian, A; Cravatt, BF; Murakami, M; Arai, H				Shimanaka, Yuta; Kono, Nozomu; Taketomi, Yoshitaka; Arita, Makoto; Okayama, Yoshimichi; Tanaka, Yuki; Nishito, Yasumasa; Mochizuki, Tatsuki; Kusuhara, Hiroyuki; Adibekian, Alexander; Cravatt, Benjamin F.; Murakami, Makoto; Arai, Hiroyuki			Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation	NATURE MEDICINE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); FC-EPSILON-RI; PPAR-GAMMA; HIGH-AFFINITY; FACTOR-ACETYLHYDROLASE; FATTY-ACIDS; RECEPTOR; ASTHMA; METABOLISM; HYDROLASE	Critical to the function of mast cells in immune responses including allergy is their production of lipid mediators, among which only omega-6 (v-6) arachidonate-derived eicosanoids have been well characterized. Here, by employing comprehensive lipidomics, we identify omega-3 (omega-3) fatty acid epoxides as new mast cell-derived lipid mediators and show that they are produced by PAF-AH2, an oxidized-phospholipid-selective phospholipase A2. Genetic or pharmacological deletion of PAF-AH2 reduced the steady-state production of omega-3 epoxides, leading to attenuated mast cell activation and anaphylaxis following Fc epsilon R1 cross-linking. Mechanistically, the omega-3 epoxides promote IgE-mediated activation of mast cells by downregulating Srcin1, a Src-inhibitory protein that counteracts Fc. RI signaling, through a pathway involving PPAR gamma. Thus, the PAF-AH2-omega-3 epoxide-Srcin1 axis presents new potential drug targets for allergic diseases.	[Shimanaka, Yuta; Kono, Nozomu; Tanaka, Yuki; Arai, Hiroyuki] Univ Tokyo, Lab Hlth Chem, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Kono, Nozomu] Japan Agcy Med Res & Dev, PRIME, Tokyo, Japan; [Taketomi, Yoshitaka; Murakami, Makoto] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Microenvironm & Metab Hlth Sci, Tokyo, Japan; [Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo, Japan; [Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metab, Yokohama, Kanagawa, Japan; [Okayama, Yoshimichi] Nihon Univ, Ctr Inst Res & Med Educ, Allergy Immunol Project Team, Sch Med, Tokyo, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo, Japan; [Mochizuki, Tatsuki; Kusuhara, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan; [Adibekian, Alexander; Cravatt, Benjamin F.] Scripps Res Inst, Chem Physiol, La Jolla, CA 92037 USA; [Murakami, Makoto; Arai, Hiroyuki] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; RIKEN; Nihon University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Scripps Research Institute	Arai, H (corresponding author), Univ Tokyo, Lab Hlth Chem, Grad Sch Pharmaceut Sci, Tokyo, Japan.; Murakami, M (corresponding author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Microenvironm & Metab Hlth Sci, Tokyo, Japan.; Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo, Japan.; Murakami, M; Arai, H (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.	makmurak@m.u-tokyo.ac.jp; harai@mol.f.u-tokyo.ac.jp	KONO, nozomu/AAM-3178-2020; Okayama, Yoshimichi/AAG-4352-2021; Shimanaka, Yuta/AHA-3394-2022	Shimanaka, Yuta/0000-0002-2333-0091; Kono, Nozomu/0000-0002-0871-8477; Arita, Makoto/0000-0001-9902-0463	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; AMED-CREST, AMED; PRIME, AMED; Ono Medical Research Foundation; Cosmetology Research Foundation;  [21790060];  [16H02613];  [16K15122];  [23227004];  [17H06164];  [15H05905];  [17H06418]; Grants-in-Aid for Scientific Research [17H06413, 15H04648, 15H05898, 15H05897, 16K15122] Funding Source: KAKEN	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; AMED-CREST, AMED; PRIME, AMED; Ono Medical Research Foundation; Cosmetology Research Foundation; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Mukai, Y. Takada, T. Fusuma (University of Tokyo) and T. Sakamoto (Nihon University School of Medicine) for their assistance and Y. Nozaki, M. Mikamoto (Eisai Co. Ltd.) and T. Imai (Kumamoto University) for their suggestions on the in vivo pharmacokinetic studies in mice. This work was supported by Grants-in-Aid for JSPS Research Fellow (Y.S.), for Young Scientists (B) (grant number 21790060 to N.K.), for Scientific Research (A) (grant number 16H02613 to M.M.), for Challenging Research (16K15122 to Y.T.), for Scientific Research (S) (grant numbers 23227004 and 17H06164 to H.A.) and for Scientific Research on Innovative Areas (grant numbers 15H05905 to M.M. and 17H06418 to H.A.); by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (H.A.); by AMED-CREST, AMED (H.A. and M.M.); by PRIME, AMED (N.K.); by the Ono Medical Research Foundation (N.K.); and by the Cosmetology Research Foundation (N.K.).	Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aldrovandi M, 2013, J LIPID RES, V54, P3085, DOI 10.1194/jlr.M041533; Almqvist C, 2007, J ALLERGY CLIN IMMUN, V119, P1438, DOI 10.1016/j.jaci.2007.01.046; Bae KA, 2000, J BIOL CHEM, V275, P26704; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broadfield EC, 2004, CLIN EXP ALLERGY, V34, P1232, DOI 10.1111/j.1365-2222.2004.02032.x; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Costello PS, 1996, ONCOGENE, V13, P2595; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Fujisawa D, 2014, J ALLERGY CLIN IMMUN, V134, P622, DOI 10.1016/j.jaci.2014.05.004; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Hercule HC, 2007, EXP PHYSIOL, V92, P1067, DOI 10.1113/expphysiol.2007.038166; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lee H, 2013, ARTHRITIS RHEUM-US, V65, P109, DOI 10.1002/art.37741; Lee JH, 2011, J IMMUNOL, V187, P1807, DOI 10.4049/jimmunol.1100296; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Miki Y, 2016, J BIOL CHEM, V291, P15588, DOI 10.1074/jbc.M116.734624; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nagakura T, 2000, EUR RESPIR J, V16, P861, DOI 10.1183/09031936.00.16586100; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; Peat JK, 2004, J ALLERGY CLIN IMMUN, V114, P807, DOI 10.1016/j.jaci.2004.06.057; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Sugiyama H, 2000, EUR J IMMUNOL, V30, P3363, DOI 10.1002/1521-4141(2000012)30:12<3363::AID-IMMU3363>3.0.CO;2-B; Sugiyama H, 2000, FEBS LETT, V467, P259, DOI 10.1016/S0014-5793(00)01169-8; Suzuki R, 2014, SCIENCE, V343, P1021, DOI 10.1126/science.1246976; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Torres RC, 2012, EUR J PHARMACOL, V691, P261, DOI 10.1016/j.ejphar.2012.06.010; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Woods RK, 2004, THORAX, V59, P105, DOI 10.1136/thorax.2003.009498; Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	49	33	33	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1287	+		10.1038/nm.4417	http://dx.doi.org/10.1038/nm.4417			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035365				2022-12-27	WOS:000414548300011
J	Kurup, SP; Obeng-Adjei, N; Anthony, SM; Traore, B; Doumbo, OK; Butler, NS; Crompton, PD; Harty, JT				Kurup, Samarchith P.; Obeng-Adjei, Nyamekye; Anthony, Scott M.; Traore, Boubacar; Doumbo, Ogobara K.; Butler, Noah S.; Crompton, Peter D.; Harty, John T.			Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4	NATURE MEDICINE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; FOLLICULAR HELPER; CHECKPOINT BLOCKADE; ACQUIRED-IMMUNITY; IN-VIVO; INFECTION; RESPONSES; IMMUNOTHERAPY; PATHOGENESIS	Malaria, caused by the protozoan Plasmodium, is a devastating mosquito-borne disease with the potential to affect nearly half the world's population(1). Despite mounting substantial T and B cell responses, humans fail to efficiently control blood-stage malaria or develop sterilizing immunity to reinfections(2). Although forkhead box P3 (FOXP3)(+)CD4(+) regulatory T (T-reg) cells form a part of these responses(3-5), their influence remains disputed and their mode of action is unknown. Here we show that T-reg cells expand in both humans and mice in blood-stage malaria and interfere with conventional T helper cell responses and follicular T helper (T-FH)-B cell interactions in germinal centers. Mechanistically, T-reg cells function in a critical temporal window to impede protective immunity through cytotoxic-T-lymphocyte-associated protein-4 (CTLA-4). Targeting T-reg cells or CTLA-4 in this precise window accelerated parasite clearance and generated species-transcending immunity to blood-stage malaria in mice. Our study uncovers a critical mechanism of immunosuppression associated with blood-stage malaria that delays parasite clearance and prevents development of potent adaptive immunity to reinfection. These data also reveal a temporally discrete and potentially therapeutically amenable functional role for T-reg cells and CTLA-4 in limiting antimalarial immunity.	[Kurup, Samarchith P.; Anthony, Scott M.; Butler, Noah S.; Harty, John T.] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Obeng-Adjei, Nyamekye; Crompton, Peter D.] NIAID, Immunogenet Lab, US NIH, Rockville, MD 20852 USA; [Traore, Boubacar; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Int Ctr Excellence Res, Dept Epidemiol Parasit Dis,Univ Sci, Bamako, Mali; [Butler, Noah S.; Harty, John T.] Univ Iowa, Carver Coll Med, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; Harty, JT (corresponding author), Univ Iowa, Carver Coll Med, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA.; Harty, JT (corresponding author), Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		Kurup, Samarchith/0000-0002-0640-0502; Anthony, Scott/0000-0002-1590-7401; Butler, Noah/0000-0002-1429-0796; Harty, John/0000-0001-7266-2802	National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID/NIH) [AI42767, AI85515, AI95178, AI100527]; NIAID/NIH [AI125446, AI127481]; National Institute of General Medical Science of the NIH [GM103447]; Division of Intramural Research, NIAID/NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125446, R01AI100527, R01AI127481, R01AI085515, R01AI095178, ZIAAI001155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID/NIH); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Science of the NIH; Division of Intramural Research, NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Epping and S. Hartwig for assistance; S. Varga (University of Iowa, PC61.5 antibody), T. Waldschmidt (University of Iowa, MR-1 antibody), and D.A.A. Vignali (University of Pittsburgh, hybridoma clone C9B7W) for reagents; S. Perlman and V. Badovinac for constructive comments; the University of Iowa Central Microscopy Research Facility; and the New York University Insectary Core Facility. Support for these studies was provided by grants from the National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID/NIH) (AI42767, AI85515, AI95178, and AI100527 to J.T.H.). Support for the laboratory of N.S.B. was provided by grants from NIAID/NIH (AI125446 and AI127481) and the National Institute of General Medical Science of the NIH (GM103447). The Malian study and the analysis of human samples were funded by the Division of Intramural Research, NIAID/NIH.	Abel S, 2012, J IMMUNOL, V188, P5467, DOI 10.4049/jimmunol.1102223; Ahlborg N, 2002, INFECT IMMUN, V70, P820, DOI 10.1128/IAI.70.2.820-825.2002; Aloulou M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10579; Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; Finney OC, 2010, TRENDS IMMUNOL, V31, P63, DOI 10.1016/j.it.2009.12.002; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Hannani D, 2015, CELL RES, V25, P208, DOI [10.1038/cr.2015.3, 10.1038/cr.2015.28]; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kim MT, 2016, J IMMUNOL, V197, P1754, DOI 10.4049/jimmunol.1600641; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Maceiras AR, 2015, METHODS MOL BIOL, V1291, P143, DOI 10.1007/978-1-4939-2498-1_12; McKenzie FE, 1999, J PARASITOL, V85, P12, DOI 10.2307/3285692; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Randall LM, 2008, INFECT IMMUN, V76, P3312, DOI 10.1128/IAI.01475-07; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Van Braeckel-Budimir N, 2016, CURR OPIN IMMUNOL, V42, P91, DOI 10.1016/j.coi.2016.06.008; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wei YB, 2015, METHODS MOL BIOL, V1291, P199, DOI 10.1007/978-1-4939-2498-1_17; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yusuf I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102791; Zander RA, 2015, CELL HOST MICROBE, V17, P628, DOI 10.1016/j.chom.2015.03.007; 2013, WORLD MAL REP 2014, P1	48	69	76	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1220	+		10.1038/nm.4395	http://dx.doi.org/10.1038/nm.4395			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28892065	Green Accepted			2022-12-27	WOS:000412431800017
J	Letai, A				Letai, Anthony			Functional precision cancer medicine-moving beyond pure genomics	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; DRUG-SENSITIVITY; TARGETED THERAPY; RESISTANCE; DEATH; INHIBITOR; MUTATIONS; ONCOLOGY; STRATEGY; PATIENT	The essential job of precision medicine is to match the right drugs to the right patients. In cancer, precision medicine has been nearly synonymous with genomics. However, sobering recent studies have generally shown that most patients with cancer who receive genomic testing do not benefit from a genomic precision medicine strategy. Although some call the entire project of precision cancer medicine into question, I suggest instead that the tools employed must be broadened. Instead of relying exclusively on big data measurements of initial conditions, we should also acquire highly actionable functional information by perturbing-for example, with cancer therapies-viable primary tumor cells from patients with cancer.	[Letai, Anthony] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Letai, A (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.	anthony_letai@dfci.harvard.edu	He, Liye/C-8843-2015	He, Liye/0000-0002-6632-2112	National Institutes of Health [R01CA205967]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I would like to acknowledge P. Bhola for assistance with Figure 1 and the entire Letai laboratory for conversations over years that have stimulated ideas contained in this article. I also gratefully acknowledge funding from National Institutes of Health grant R01CA205967.	Andre F, 2014, ANN ONCOL, V25, P2295, DOI 10.1093/annonc/mdu478; Armand P, 2016, J CLIN ONCOL, V34, P1, DOI [DOI 10.1200/JC0.2016.67.3467, 10.1200/JC0.2016.67.3467]; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Carr TH, 2016, NAT REV CANCER, V16, P319, DOI 10.1038/nrc.2016.35; Cermak N, 2016, NAT BIOTECHNOL, V34, P1052, DOI 10.1038/nbt.3666; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Etchin J, 2016, LEUKEMIA, V30, P190, DOI 10.1038/leu.2015.194; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fojo T, 2016, SEMIN ONCOL, V43, P9, DOI 10.1053/j.seminoncol.2016.01.005; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Frismantas V, 2017, BLOOD, V129, pE26, DOI 10.1182/blood-2016-09-738070; Halfter K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1491-7; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jain N, 2016, BLOOD REV, V30, P233, DOI 10.1016/j.blre.2015.12.002; Jonas O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010564; KERN DH, 1990, J NATL CANCER I, V82, P582, DOI 10.1093/jnci/82.7.582; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Lopez-Chavez A, 2015, J CLIN ONCOL, V33, P1000, DOI 10.1200/JCO.2014.58.2007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meric-Bernstam F, 2015, JNCI-J NATL CANCER I, V107, P107; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Pietarinen PO, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.30; Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a; Prasad V, 2016, LANCET ONCOL, V17, pE81, DOI 10.1016/S1470-2045(15)00620-8; Prasad V, 2015, MAYO CLIN PROC, V90, P1639, DOI 10.1016/j.mayocp.2015.08.017; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ryan J, 2016, BIOL CHEM, V397, P671, DOI 10.1515/hsz-2016-0107; Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Sholl LM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87062; Stevens MM, 2016, NAT BIOTECHNOL, V34, P1161, DOI 10.1038/nbt.3697; Swanton C, 2016, ANN ONCOL, V27, P1443, DOI 10.1093/annonc/mdw192; Tannock IF, 2016, NEW ENGL J MED, V375, P1289, DOI 10.1056/NEJMsb1607705; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Townsend EC, 2016, CANCER CELL, V29, P574, DOI 10.1016/j.ccell.2016.03.008; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Tsimberidou AM, 2015, LANCET ONCOL, V16, pE579, DOI 10.1016/S1470-2045(15)00397-6; Tsimberidou AM, 2014, CLIN CANCER RES, V20, P4827, DOI 10.1158/1078-0432.CCR-14-0603; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Vasan N, 2014, ONCOLOGIST, V19, P453, DOI 10.1634/theoncologist.2013-0377; Voss MH, 2014, CLIN CANCER RES, V20, P1955, DOI 10.1158/1078-0432.CCR-13-2345; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; West H, 2016, JAMA ONCOL, V2, P717, DOI 10.1001/jamaoncol.2016.0075; Wu SC, 2015, CANCER CELL, V28, P29, DOI 10.1016/j.ccell.2015.06.005; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193; Younes A, 2016, LANCET ONCOL, V17, P1283, DOI 10.1016/S1470-2045(16)30167-X; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533	64	163	167	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1028	1035		10.1038/nm.4389	http://dx.doi.org/10.1038/nm.4389			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886003				2022-12-27	WOS:000409996200009
J	Salter, MW; Stevens, B				Salter, Michael W.; Stevens, Beth			Microglia emerge as central players in brain disease	NATURE MEDICINE			English	Review							GENE-EXPRESSION SIGNATURE; NEURONAL NMDA RECEPTORS; HIPPOCAMPAL NEUROGENESIS; ADULT; CELL; MACROPHAGES; REVEALS; ACTIVATION; DEATH; PLASTICITY	There has been an explosion of new findings recently giving us insights into the involvement of microglia in central nervous system (CNS) disorders. A host of new molecular tools and mouse models of disease are increasingly implicating this enigmatic type of nervous system cell as a key player in conditions ranging from neurodevelopmental disorders such as autism to neurodegenerative disorders such as Alzheimer's disease and chronic pain. Contemporaneously, diverse roles are emerging for microglia in the healthy brain, from sculpting developing neuronal circuits to guiding learning-associated plasticity. Understanding the physiological functions of these cells is crucial to determining their roles in disease. Here we focus on recent developments in our rapidly expanding understanding of the function, as well as the dysfunction, of microglia in disorders of the CNS.	[Salter, Michael W.] Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Dept Physiol,Fac Med, Toronto, ON, Canada; [Stevens, Beth] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Stevens, Beth] Harvard Med Sch, Boston, MA USA; [Stevens, Beth] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Salter, MW (corresponding author), Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Dept Physiol,Fac Med, Toronto, ON, Canada.	michael.salter@sickkids.ca			CIHR; Brain Canada; Krembil Foundation; NIH [NIH RO1NS071008]; Simons Foundation SFARi; CIHR; Brain Canada; Krembil Foundation; NIH [NIH RO1NS071008]; Simons Foundation SFARi; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Brain Canada; Krembil Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation SFARi; CIHR(Canadian Institutes of Health Research (CIHR)); Brain Canada; Krembil Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation SFARi; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Sengar (Hospital for Sick Children) for important discussions about the review and assistance with the manuscript and figures. Work of the authors is supported by CIHR, Brain Canada, Krembil Foundation (M.W.S.) and NIH, NIH RO1NS071008 (B.S.), Simons Foundation SFARi (B.S.). M.W.S. holds the Northbridge Chair in Paediatric Research at the Hospital for Sick Children.	Abiega O, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002508, 10.1371/journal.pbio.1002554, 10.1371/journal.pbio.1002466]; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Bliss TVP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0129; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229; George J, 2016, EUR J NEUROSCI, V43, P1366, DOI 10.1111/ejn.13191; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Koeglsperger T, 2013, GLIA, V61, P985, DOI 10.1002/glia.22490; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pannell M, 2016, BRAIN STRUCT FUNCT, V221, P1157, DOI 10.1007/s00429-014-0962-y; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sierra A, 2016, GLIA, V64, P1801, DOI 10.1002/glia.23046; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Sipe GO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10905; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wlodarczyk A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00463; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	65	785	802	24	286	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1018	1027		10.1038/nm.4397	http://dx.doi.org/10.1038/nm.4397			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886007				2022-12-27	WOS:000409996200008
J	Schmidt, LS; Linehan, WM				Schmidt, Laura S.; Linehan, W. Marston			A mouse model of renal cell carcinoma	NATURE MEDICINE			English	Editorial Material							COMBINED DELETION; VHL; TRP53	A mouse model with combined renal epithelium-specific deletion of Vhl, Trp53 and Rb1 that develops clear-cell renal cell carcinoma provides a research tool for investigating the mechanisms that drive this cancer, and for evaluating the efficacy of novel therapeutic agents.	[Schmidt, Laura S.] Frederick Natl Lab Canc Res, Basic Sci Program, Leidos Biomed Res, Frederick, MD USA; [Schmidt, Laura S.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Linehan, WM (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	WML@nih.gov			Intramural Research Program of the US National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research; Federal funds from the Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011038] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research; Federal funds from the Frederick National Laboratory for Cancer Research, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the US National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research. This work has been funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsements by the US Government.	Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Guinot A, 2016, J PATHOL, V239, P365, DOI 10.1002/path.4736; Harlander S, 2017, NAT MED, V23, P869, DOI 10.1038/nm.4343; Lehmann H, 2015, J AM SOC NEPHROL, V26, P2778, DOI 10.1681/ASN.2014090875; Linehan WM, 2012, GENOME RES, V22, P2089, DOI 10.1101/gr.131110.111; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Wang SS, 2014, P NATL ACAD SCI USA, V111, P16538, DOI 10.1073/pnas.1414789111	12	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					802	803		10.1038/nm.4366	http://dx.doi.org/10.1038/nm.4366			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28697179				2022-12-27	WOS:000405180100007
J	West, NR; Hegazy, AN; Owens, BMJ; Bullers, SJ; Linggi, B; Buonocore, S; Coccia, M; Gortz, D; This, S; Stockenhuber, K; Pott, J; Friedrich, M; Ryzhakov, G; Baribaud, F; Brodmerkel, C; Cieluch, C; Rahman, N; Muller-Newen, G; Owens, RJ; Kuhl, AA; Maloy, KJ; Plevy, SE; Keshav, S; Travis, SPL; Powrie, F				West, Nathaniel R.; Hegazy, Ahmed N.; Owens, Benjamin M. J.; Bullers, Samuel J.; Linggi, Bryan; Buonocore, Sofia; Coccia, Margherita; Goertz, Dieter; This, Sebastien; Stockenhuber, Krista; Pott, Johanna; Friedrich, Matthias; Ryzhakov, Grigory; Baribaud, Frederic; Brodmerkel, Carrie; Cieluch, Constanze; Rahman, Nahid; Mueller-Newen, Gerhard; Owens, Raymond J.; Kuehl, Anja A.; Maloy, Kevin J.; Plevy, Scott E.; Keshav, Satish; Travis, Simon P. L.; Powrie, Fiona		Oxford IBD Cohort Investigators	Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease	NATURE MEDICINE			English	Article							GENE-EXPRESSION; ULCERATIVE-COLITIS; SKIN INFLAMMATION; STROMAL CELLS; IN-VITRO; INDUCTION; IBD; MAINTENANCE; DESTRUCTION; MICROBIOME	Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex chronic inflammatory conditions of the gastrointestinal tract that are driven by perturbed cytokine pathways. Anti-tumor necrosis factor-alpha (TNF) antibodies are mainstay therapies for IBD. However, up to 40% of patients are nonresponsive to anti-TNF agents, which makes the identification of alternative therapeutic targets a priority. Here we show that, relative to healthy controls, inflamed intestinal tissues from patients with IBD express high amounts of the cytokine oncostatin M (OSM) and its receptor (OSMR), which correlate closely with histopathological disease severity. The OSMR is expressed in nonhematopoietic, nonepithelial intestinal stromal cells, which respond to OSM by producing various proinflammatory molecules, including interleukin (IL)-6, the leukocyte adhesion factor ICAM1, and chemokines that attract neutrophils, monocytes, and T cells. In an animal model of anti-TNF-resistant intestinal inflammation, genetic deletion or pharmacological blockade of OSM significantly attenuates colitis. Furthermore, according to an analysis of more than 200 patients with IBD, including two cohorts from phase 3 clinical trials of infliximab and golimumab, high pretreatment expression of OSM is strongly associated with failure of anti-TNF therapy. OSM is thus a potential biomarker and therapeutic target for IBD, and has particular relevance for anti-TNF-resistant patients.	[West, Nathaniel R.; Hegazy, Ahmed N.; Bullers, Samuel J.; Stockenhuber, Krista; Friedrich, Matthias; Ryzhakov, Grigory; Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [West, Nathaniel R.; Hegazy, Ahmed N.; This, Sebastien; Stockenhuber, Krista; Keshav, Satish; Travis, Simon P. L.; Powrie, Fiona] Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England; [Owens, Benjamin M. J.] Univ Oxford, Somerville Coll, Oxford, England; [Linggi, Bryan; Baribaud, Frederic; Brodmerkel, Carrie; Plevy, Scott E.] Janssen Res & Dev, Raritan, NJ USA; [Buonocore, Sofia; Coccia, Margherita; Pott, Johanna; Maloy, Kevin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Goertz, Dieter; Mueller-Newen, Gerhard] Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, Aachen, Germany; [Cieluch, Constanze; Kuehl, Anja A.] Charite, Div Gastroenterol Infectiol & Rheumatol, Med Dept, Berlin, Germany; [Rahman, Nahid; Owens, Raymond J.] OPPF UK, Res Complex Harwell, Rutherford Appleton Lab, Oxford, England; [Owens, Raymond J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; University of Oxford; Johnson & Johnson; Janssen Pharmaceuticals; University of Oxford; RWTH Aachen University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford; Wellcome Centre for Human Genetics	Powrie, F (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.; Powrie, F (corresponding author), Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England.	fiona.powrie@kennedy.ox.ac.uk	This, Sébastien/AAB-8888-2020; Braden, Barbara/AAI-7869-2020	Braden, Barbara/0000-0002-8534-6873; West, Nathaniel/0000-0001-9991-0503; This, Sebastien/0000-0003-2931-9050; Maloy, Kevin/0000-0001-5795-7688; Kuhl, Anja/0000-0003-2293-5387; Pott, Johanna/0000-0003-4439-725X; Simmons, Alison/0000-0003-3454-0710; Stockenhuber, Krista/0000-0003-3608-064X; Travis, Simon/0000-0002-2690-4361; Owens, Benjamin/0000-0003-4710-6841; Gortz, Dieter/0000-0002-1321-0416; Barnes, Eleanor/0000-0002-0860-0831; klenerman, paul/0000-0003-4307-9161; Keshav, Satish/0000-0003-0508-8665; Hegazy, Ahmed N./0000-0002-2946-8251	NIHR Oxford Biomedical Research Centre [HBRWAE04 Task HB81.G]; Irvington Institute (Cancer Research Institute); European Molecular Biology Organization (EMBO) [ALTF 116-2012]; Marie Curie fellowship (FP7-PEOPLE-IEF) [330621]; Ecole Normale Superieure of Lyon; French Ministry of Education; Medical Research Council [MR/K018779/1]; Edward Penley Abraham Trust; Wellcome Trust [102972]; Wellcome Trust; Foundation Louis Jeantet; MRC [G0200231, MC_UU_00008/7, MR/K018779/1, MC_UU_12010/7] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL7-Bird-Lieberman] Funding Source: researchfish; Medical Research Council [MC_UU_12010/7, MC_UU_00008/7, G0200231] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026, NF-SI-0515-10005] Funding Source: researchfish; Wellcome Trust [102974/Z/13/Z] Funding Source: researchfish	NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Irvington Institute (Cancer Research Institute); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie fellowship (FP7-PEOPLE-IEF); Ecole Normale Superieure of Lyon; French Ministry of Education; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Edward Penley Abraham Trust; Wellcome Trust(Wellcome Trust); Wellcome Trust(Wellcome Trust); Foundation Louis Jeantet; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank J. Middleton, S. Rogatti Granados, C. Arancibia, P. Siddhanathi, J. Chivenga, N. Charumbira, J. Schulthess, C. Pearson, and S. Spieckermann for excellent technical support, patient-sample collection, and lab management. We thank H. Uhlig and all members of the laboratory for valuable discussions and support. We also thank V. Malmstrom and E. Thompson for critical review of this manuscript. We thank V. Cerundolo for providing IL-1R1 knockout mice. We gratefully acknowledge the contributions of the Oxford Radcliffe and GI Biobanks and the Oxford IBD cohort study, which are supported by the NIHR Oxford Biomedical Research Centre (grant no. HBRWAE04 Task HB81.G). We thank the flow cytometry core-facility staff at the University of Oxford Translational Gastroenterology Unit and Kennedy Institute of Rheumatology, as well as the staff of the Kennedy Institute histology core facility for excellent tissue preparation. We thank all volunteers, patients, and their families for agreeing to contribute to this study. N.R.W. was supported by an Irvington Institute Postdoctoral Fellowship (Cancer Research Institute). A.N.H. was supported by a European Molecular Biology Organization (EMBO) long-term fellowship (ALTF 116-2012) and a Marie Curie fellowship (FP7-PEOPLE-2012-IEF, proposal 330621). B.M.J.O. is a lecturer at Somerville College, University of Oxford. S.T. was supported by the Ecole Normale Superieure of Lyon and the French Ministry of Education. R.J.O. and N.R. are supported by Medical Research Council grant no. MR/K018779/1. M.C. and K.J.M. were supported by the Edward Penley Abraham Trust. K.J.M. is supported by the Wellcome Trust (Investigator Award 102972). F.P. is supported by the Wellcome Trust and Foundation Louis Jeantet.	Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Arnold IC, 2016, MUCOSAL IMMUNOL, V9, P352, DOI 10.1038/mi.2015.65; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Baptista AP, 2013, MUCOSAL IMMUNOL, V6, P511, DOI 10.1038/mi.2012.90; Basson A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00290; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093498; Ben-Horin S, 2014, NAT REV GASTRO HEPAT, V11, P243, DOI 10.1038/nrgastro.2013.253; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Brolund L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-3; Chen ML, 2016, INFLAMM BOWEL DIS, V22, P1157, DOI 10.1097/MIB.0000000000000714; Choy EH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4312; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Guerra I, 2014, CLIN EXP GASTROENTER, V7, P359, DOI 10.2147/CEG.S45297; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hamada T, 2007, AM J PATHOL, V171, P872, DOI 10.2353/ajpath.2007.060972; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hintzen C, 2009, ARTHRITIS RHEUM-US, V60, P1932, DOI 10.1002/art.24602; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hui W, 2005, ARTHRITIS RES THER, V7, pR57, DOI 10.1186/ar1460; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Komori T, 2014, J BIOL CHEM, V289, P13821, DOI 10.1074/jbc.M113.542399; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Langdon C, 2000, AM J PATHOL, V157, P1187, DOI 10.1016/S0002-9440(10)64634-2; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McLean LP, 2014, EXPERT REV GASTROENT, V8, P223, DOI 10.1586/17474124.2014.881715; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Murdaca G, 2015, EXPERT OPIN DRUG SAF, V14, P571, DOI 10.1517/14740338.2015.1009036; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Ott C, 2013, NAT REV GASTRO HEPAT, V10, P585, DOI 10.1038/nrgastro.2013.117; Owens BMJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00319; Owens BMJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00307; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Planell N, 2013, GUT, V62, P967, DOI 10.1136/gutjnl-2012-303333; Poling J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0396-3; Pohin M, 2016, EUR J IMMUNOL, V46, P1737, DOI 10.1002/eji.201546216; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; Ryan RE, 2015, CYTOKINE, V72, P71, DOI 10.1016/j.cyto.2014.11.007; Sanchez AL, 2003, J INTERF CYTOK RES, V23, P193, DOI 10.1089/107999003765027393; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI 10.1053/j.gastro.2009.06.061; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Toedter G, 2011, AM J GASTROENTEROL, V106, P1272, DOI 10.1038/ajg.2011.83; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Vanhove W, 2015, INFLAMM BOWEL DIS, V21, P2673, DOI 10.1097/MIB.0000000000000535; Venema WTCU, 2017, J PATHOL, V241, P146, DOI 10.1002/path.4817; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; West NR, 2014, ONCOGENE, V33, P1485, DOI 10.1038/onc.2013.105; West NR, 2012, ENDOCR-RELAT CANCER, V19, P181, DOI 10.1530/ERC-11-0326	66	365	369	8	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					579	+		10.1038/nm.4307	http://dx.doi.org/10.1038/nm.4307			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28368383	Green Submitted, Green Accepted			2022-12-27	WOS:000400650700013
J	Creasy, CL				Creasy, Caretha L.			Untangling the role of mutant histone H3 in diffuse intrinsic pontine glioma	NATURE MEDICINE			English	Editorial Material							PEDIATRIC GLIOBLASTOMA; GENE-EXPRESSION; MUTATIONS	New studies advance the mechanistic understanding of mutant histone H3 in diffuse intrinsic pontine glioma (DIPG) and demonstrate two epigenetic approaches, BET inhibition and EZH2 inhibition, as potential therapeutic strategies for DIPG.	[Creasy, Caretha L.] GlaxoSmithKline, Canc Epigenet, Collegeville, PA 19426 USA	GlaxoSmithKline	Creasy, CL (corresponding author), GlaxoSmithKline, Canc Epigenet, Collegeville, PA 19426 USA.	caretha.l.creasy@gsk.com						Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Buczkowicz P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00147; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Kallappagoudar S, 2015, CHROMOSOMA, V124, P177, DOI 10.1007/s00412-015-0510-4; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mohammad F, 2017, NAT MED, V23, P483, DOI 10.1038/nm.4293; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Schroeder KM, 2014, PEDIATR RES, V75, P205, DOI 10.1038/pr.2013.194; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938	11	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					413	414		10.1038/nm.4320	http://dx.doi.org/10.1038/nm.4320			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388610				2022-12-27	WOS:000398768100008
J	Kracht, MJL; van Lummel, M; Nikolic, T; Joosten, AM; Laban, S; van der Slik, AR; van Veelen, PA; Carlotti, F; de Koning, EJP; Hoeben, RC; Zaldumbide, A; Roep, BO				Kracht, Maria J. L.; van Lummel, Menno; Nikolic, Tatjana; Joosten, Antoinette M.; Laban, Sandra; van der Slik, Arno R.; van Veelen, Peter A.; Carlotti, Francoise; de Koning, Eelco J. P.; Hoeben, Rob C.; Zaldumbide, Arnaud; Roep, Bart O.			Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes	NATURE MEDICINE			English	Article							CD8 T-CELLS; UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA; RECENT-ONSET; POSTTRANSLATIONAL MODIFICATION; HUMAN ISLETS; BETA-CELLS; ER STRESS; TRANSLATION; BINDING	Identification of epitopes that are recognized by diabetogenic T cells and cause selective beta cell destruction in type 1 diabetes (T1D) has focused on peptides originating from native beta cell proteins. Translational errors represent a major potential source of antigenic peptides to which central immune tolerance is lacking(1,2). Here, we describe an alternative open reading frame within human insulin mRNA encoding a highly immunogenic polypeptide that is targeted by T cells in T1D patients. We show that cytotoxic T cells directed against the N-terminal peptide of this nonconventional product are present in the circulation of individuals diagnosed with T1D, and we provide direct evidence that such CD8(+) T cells are capable of killing human beta cells and thereby may be diabetogenic. This study reveals a new source of nonconventional polypeptides that act as self-epitopes in clinical autoimmune disease.	[Kracht, Maria J. L.; Hoeben, Rob C.; Zaldumbide, Arnaud] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Kracht, Maria J. L.; van Lummel, Menno; Nikolic, Tatjana; Joosten, Antoinette M.; Laban, Sandra; van der Slik, Arno R.; Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohematol, Leiden, Netherlands; [Kracht, Maria J. L.; van Lummel, Menno; Nikolic, Tatjana; Joosten, Antoinette M.; Laban, Sandra; van der Slik, Arno R.; Roep, Bart O.] Leiden Univ, Med Ctr, Dept Blood Transfus, Leiden, Netherlands; [van Veelen, Peter A.] Leiden Univ, Med Ctr, Ctr Prote & Metab, Leiden, Netherlands; [Carlotti, Francoise; de Koning, Eelco J. P.] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands; [Roep, Bart O.] City Hope Natl Med Ctr, Dept Diabet Immunol, Diabet & Metab Res Inst, Beckman Diabet Res Inst, Duarte, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; City of Hope	Roep, BO (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol, Leiden, Netherlands.; Roep, BO (corresponding author), Leiden Univ, Med Ctr, Dept Blood Transfus, Leiden, Netherlands.; Roep, BO (corresponding author), City Hope Natl Med Ctr, Dept Diabet Immunol, Diabet & Metab Res Inst, Beckman Diabet Res Inst, Duarte, CA USA.	broep@coh.org	Carlotti, Françoise/H-1060-2014; Roep, Bart/AAD-7609-2021; Hoeben, Rob C./A-5771-2008; Carlotti, Françoise/AAN-5018-2021; de Koning, Eelco JP/H-6030-2011; NIkolic, Tatjana/I-2162-2012	Carlotti, Françoise/0000-0001-7929-8468; Hoeben, Rob C./0000-0001-9443-8377; Carlotti, Françoise/0000-0001-7929-8468; de Koning, Eelco JP/0000-0002-1232-7022; van Veelen, Peter/0000-0002-7898-9408; Laban, Sandra/0000-0003-2710-4531; van der Slik, Arno/0000-0002-8920-0118	Dutch Diabetes Research Foundation; DON Foundation; Juvenile Diabetes Research foundation; ReumaFonds [LLP-16] Funding Source: researchfish	Dutch Diabetes Research Foundation; DON Foundation; Juvenile Diabetes Research foundation(Juvenile Diabetes Research Foundation); ReumaFonds	We thank H.-J. Aanstoot (Diabeter), L. Mearin (Department of Pediatrics, LUMC), L. Wicker and J. Todd (Cambridge University, UK) for providing patient blood samples; M. Peakman (King's College, London, UK) for kindly sharing the PPIspecific CD8<SUP>+</SUP> T cell clone; S.J. Cramer, M.J.W.E. Rabelink, T.J.M. Pool, K. Franken and A.H. de Ru for expert technical support; and J.R.F. Abreu for qDot analysis. This work is supported by the Dutch Diabetes Research Foundation, the DON Foundation and the Juvenile Diabetes Research foundation.	Abreu JRF, 2012, CLIN EXP IMMUNOL, V170, P57, DOI 10.1111/j.1365-2249.2012.04635.x; Anton LC, 2014, J LEUKOCYTE BIOL, V95, P551, DOI 10.1189/jlb.1113599; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Berglund P, 2007, J VIROL, V81, P7220, DOI 10.1128/JVI.00137-07; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; de Jong VM, 2013, GENES IMMUN, V14, P58, DOI 10.1038/gene.2012.38; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; FENNESSY M, 1994, DIABETOLOGIA, V37, P937, DOI 10.1007/s001250050200; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kracht MJL, 2016, TRENDS ENDOCRIN MET, V27, P353, DOI 10.1016/j.tem.2016.03.013; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; McLaughlin RJ, 2016, CLIN EXP IMMUNOL, V185, P133, DOI 10.1111/cei.12775; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; O'Sullivan-Murphy B, 2012, DIABETES, V61, P780, DOI 10.2337/db12-0091; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Robles DT, 2002, CLIN IMMUNOL, V102, P217, DOI 10.1006/clim.2001.5171; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schloot NC, 1998, J AUTOIMMUN, V11, P169, DOI 10.1006/jaut.1997.0183; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Toma A, 2005, P NATL ACAD SCI USA, V102, P10581, DOI 10.1073/pnas.0504230102; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; van Lummel M, 2016, J IMMUNOL, V196, P3253, DOI 10.4049/jimmunol.1501282; van Lummel M, 2016, DIABETES, V65, P732, DOI 10.2337/db15-1031; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; van Lummel M, 2013, CURR OPIN ENDOCRINOL, V20, P299, DOI 10.1097/MED.0b013e3283631417; van Lummel M, 2012, J BIOL CHEM, V287, P9514, DOI 10.1074/jbc.M111.313940; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Yewdell JW, 2013, MOL IMMUNOL, V55, P110, DOI 10.1016/j.molimm.2012.10.023; Zaldumbide A, 2013, MOL THER, V21, P1592, DOI 10.1038/mt.2013.105; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	53	128	131	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					501	+		10.1038/nm.4289	http://dx.doi.org/10.1038/nm.4289			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28263308				2022-12-27	WOS:000398768100018
J	Chesi, M; Mirza, NN; Garbitt, VM; Sharik, ME; Dueck, AC; Asmann, YW; Akhmetzyanova, I; Kosiorek, HE; Calcinotto, A; Riggs, DL; Keane, N; Ahmann, GJ; Morrison, KM; Fonseca, R; Lacy, MQ; Dingli, D; Kumar, SK; Ailawadhi, S; Dispenzieri, A; Buadi, F; Gertz, MA; Reeder, CB; Lin, Y; Chanan-Khan, AA; Stewart, AK; Fooksman, D; Bergsagel, PL				Chesi, Marta; Mirza, Noweeda N.; Garbitt, Victoria M.; Sharik, Meaghen E.; Dueck, Amylou C.; Asmann, Yan W.; Akhmetzyanova, Ilseyar; Kosiorek, Heidi E.; Calcinotto, Arianna; Riggs, Daniel L.; Keane, Niamh; Ahmann, Gregory J.; Morrison, Kevin M.; Fonseca, Rafael; Lacy, Martha Q.; Dingli, David; Kumar, Shaji K.; Ailawadhi, Sikander; Dispenzieri, Angela; Buadi, Francis; Gertz, Morie A.; Reeder, Craig B.; Lin, Yi; Chanan-Khan, Asher A.; Stewart, A. Keith; Fooksman, David; Bergsagel, P. Leif			IAP antagonists induce anti-tumor immunity in multiple myeloma	NATURE MEDICINE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SMAC MIMETICS; APOPTOSIS PROTEINS; CANCER-CELLS; MOUSE MODEL; T-CELLS; INHIBITORS; ACTIVATION; CARCINOMA	The cellular inhibitors of apoptosis (cIAP) 1 and 2 are amplified in about 3% of cancers and have been identified in multiple malignancies as being potential therapeutic targets as a result of their role in the evasion of apoptosis. Consequently, small-molecule IAP antagonists, such as LCL161, have entered clinical trials for their ability to induce tumor necrosis factor (TNF)mediated apoptosis of cancer cells. However, cIAP1 and cIAP2 are recurrently homozygously deleted in multiple myeloma (MM), resulting in constitutive activation of the noncanonical nuclear factor (NF)-kappa B pathway. To our surprise, we observed robust in vivo anti-myeloma activity of LCL161 in a transgenic myeloma mouse model and in patients with relapsed-refractory MM, where the addition of cyclophosphamide resulted in a median progression-free-survival of 10 months. This effect was not a result of direct induction of tumor cell death, but rather of upregulation of tumor-cell-autonomous type I interferon (IFN) signaling and a strong inflammatory response that resulted in the activation of macrophages and dendritic cells, leading to phagocytosis of tumor cells. Treatment of a MM mouse model with LCL161 established long-term anti-tumor protection and induced regression in a fraction of the mice. Notably, combination of LCL161 with the immune-checkpoint inhibitor anti-PD1 was curative in all of the treated mice.	[Chesi, Marta; Mirza, Noweeda N.; Garbitt, Victoria M.; Sharik, Meaghen E.; Dueck, Amylou C.; Asmann, Yan W.; Kosiorek, Heidi E.; Calcinotto, Arianna; Riggs, Daniel L.; Keane, Niamh; Ahmann, Gregory J.; Morrison, Kevin M.; Fonseca, Rafael; Reeder, Craig B.; Stewart, A. Keith; Bergsagel, P. Leif] Mayo Clin Arizona, Dept Med, Scottsdale, AZ 85259 USA; [Akhmetzyanova, Ilseyar; Fooksman, David] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Lacy, Martha Q.; Dingli, David; Kumar, Shaji K.; Dispenzieri, Angela; Buadi, Francis; Gertz, Morie A.; Lin, Yi] Mayo Clin, Dept Med, Rochester, MN USA; [Ailawadhi, Sikander; Chanan-Khan, Asher A.] Mayo Clin Florida, Dept Med, Jacksonville, FL USA; [Calcinotto, Arianna] Oncol Inst Southern Switzerland, Oncol Res Inst, Bellinzona, Switzerland	Mayo Clinic; Mayo Clinic Phoenix; Yeshiva University; Mayo Clinic; Mayo Clinic; Institute of Oncology Research (IOR)	Chesi, M (corresponding author), Mayo Clin Arizona, Dept Med, Scottsdale, AZ 85259 USA.	chesi.marta@mayo.edu	Lin, Yi/K-1510-2013; Bergsagel, Peter Leif/A-7842-2011; Gertz, Morie/K-2873-2019; Kumar, Shaji K/A-9853-2008	Bergsagel, Peter Leif/0000-0003-1523-7388; Kumar, Shaji K/0000-0001-5392-9284; Dispenzieri, Angela/0000-0001-8780-9512; Lin, Yi/0000-0002-1556-6416; Calcinotto, Arianna/0000-0003-1746-6424	National Cancer Institute [CA190045, CA186781]; NATIONAL CANCER INSTITUTE [R01CA190045, P30CA015083, P50CA186781] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank U. Jariwala, E. Slosberg and colleagues at Novartis for providing LCL161 and supporting the clinical trial. We are grateful to L. Rimsza for assistance with histological evaluation of splenocytes from LCL161 treated Vk*MYC mice and to F. Asimakopoulos for assistance with experimental design. We are indebted to M.S. Diamond (Washington University) for sharing IRF3/7<SUP>null</SUP> mice, to David Shealy from Centocor for donating the murine TNF blocking antibody and to P. Cohen (Mayo Clinic Arizona) for donating CD4, CD8 and NK1.1 blocking antibodies. M.C. was supported by research grants from the National Cancer Institute: CA190045 and CA186781.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baz RC, 2016, BLOOD, V127, P2561, DOI 10.1182/blood-2015-11-682518; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Beug ST, 2014, NAT BIOTECHNOL, V32, P182, DOI 10.1038/nbt.2806; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Buhtoiarov IN, 2011, IMMUNOLOGY, V132, P226, DOI 10.1111/j.1365-2567.2010.03357.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chauhan D, 2007, BLOOD, V109, P1220, DOI 10.1182/blood-2006-04-015149; Chen KF, 2012, BIOCHEM PHARMACOL, V84, P268, DOI 10.1016/j.bcp.2012.04.023; Chen SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161299; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Christiansen AJ, 2011, P NATL ACAD SCI USA, V108, P4141, DOI 10.1073/pnas.1011037108; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Falkenhorst J., 2016, ONCOTARGET, DOI 10.18632/oncotarget.9159.; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gardam S, 2011, BLOOD, V117, P4041, DOI 10.1182/blood-2010-10-312793; Gerges S, 2016, CANCER LETT, V375, P127, DOI 10.1016/j.canlet.2016.02.040; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hope C, 2014, BLOOD, V123, P3305, DOI 10.1182/blood-2014-02-554071; Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993; Jourdan M, 1999, EUR CYTOKINE NETW, V10, P65; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Knights AJ, 2013, CANCER IMMUNOL IMMUN, V62, P321, DOI 10.1007/s00262-012-1342-1; Kumar S, 2016, LANCET ONCOL, V17, pE328, DOI 10.1016/S1470-2045(16)30206-6; Lecis D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.449; MOAV B, 1986, GENE, V48, P297, DOI 10.1016/0378-1119(86)90089-2; Morgan GJ, 2011, BLOOD, V118, P1231, DOI 10.1182/blood-2011-02-338665; Muller-Sienerth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021556; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Najem S., 2016, ONCOTARGET; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Pallasch CP, 2014, CELL, V156, P590, DOI 10.1016/j.cell.2013.12.041; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Proietti E, 1998, J CLIN INVEST, V101, P429, DOI 10.1172/JCI1348; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qin Q, 2014, TUMOR BIOL, V35, P2565, DOI 10.1007/s13277-013-1338-2; Ramakrishnan V, 2014, LEUKEMIA, V28, P1519, DOI 10.1038/leu.2014.2; Ramakrishnan V., 2016, ONCOTARGET; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shekhar TM, 2016, ONCOTARGET, V7, P33866, DOI 10.18632/oncotarget.8980; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Tian AP, 2014, CANCER LETT, V351, P232, DOI 10.1016/j.canlet.2014.06.006; Tveita AA, 2014, EUR J IMMUNOL, V44, P2625, DOI 10.1002/eji.201444659; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Weisberg E, 2010, LEUKEMIA, V24, P2100, DOI 10.1038/leu.2010.212; West AC, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.26; Yang YB, 2016, CANCER CELL, V29, P494, DOI 10.1016/j.ccell.2016.03.006; Yuan Z, 2013, CANCER GENE THER, V20, P46, DOI 10.1038/cgt.2012.83; Zaias J, 2009, J AM ASSOC LAB ANIM, V48, P387	66	102	112	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1411	+		10.1038/nm.4229	http://dx.doi.org/10.1038/nm.4229			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841872	Green Accepted			2022-12-27	WOS:000389549000018
J	Eisenberg, T; Abdellatif, M; Schroeder, S; Primessnig, U; Stekovic, S; Pendl, T; Harger, A; Schipke, J; Zimmermann, A; Schmidt, A; Tong, MM; Ruckenstuhl, C; Dammbrueck, C; Gross, AS; Herbst, V; Magnes, C; Trausinger, G; Narath, S; Meinitzer, A; Hu, ZH; Kirsch, A; Eller, K; Carmona-Gutierrez, D; Buttner, S; Pietrocola, F; Knittelfelder, O; Schrepfer, E; Rockenfeller, P; Simonini, C; Rahn, A; Horsch, M; Moreth, K; Beckers, J; Fuchs, H; Gailus-Durner, V; Neff, F; Janik, D; Rathkolb, B; Rozman, J; de Angelis, MH; Moustafa, T; Haemmerle, G; Mayr, M; Willeit, P; von Frieling-Salewsky, M; Pieske, B; Scorrano, L; Pieber, T; Pechlaner, R; Willeit, J; Sigrist, SJ; Linke, WA; Muhlfeld, C; Sadoshima, J; Dengjel, J; Kiechl, S; Kroemer, G; Sedej, S; Madeo, F				Eisenberg, Tobias; Abdellatif, Mahmoud; Schroeder, Sabrina; Primessnig, Uwe; Stekovic, Slaven; Pendl, Tobias; Harger, Alexandra; Schipke, Julia; Zimmermann, Andreas; Schmidt, Albrecht; Tong, Mingming; Ruckenstuhl, Christoph; Dammbrueck, Christopher; Gross, Angelina S.; Herbst, Viktoria; Magnes, Christoph; Trausinger, Gert; Narath, Sophie; Meinitzer, Andreas; Hu, Zehan; Kirsch, Alexander; Eller, Kathrin; Carmona-Gutierrez, Didac; Buettner, Sabrina; Pietrocola, Federico; Knittelfelder, Oskar; Schrepfer, Emilie; Rockenfeller, Patrick; Simonini, Corinna; Rahn, Alexandros; Horsch, Marion; Moreth, Kristin; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; Neff, Frauke; Janik, Dirk; Rathkolb, Birgit; Rozman, Jan; de Angelis, Martin Hrabe; Moustafa, Tarek; Haemmerle, Guenter; Mayr, Manuel; Willeit, Peter; von Frieling-Salewsky, Marion; Pieske, Burkert; Scorrano, Luca; Pieber, Thomas; Pechlaner, Raimund; Willeit, Johann; Sigrist, Stephan J.; Linke, Wolfgang A.; Muehlfeld, Christian; Sadoshima, Junichi; Dengjel, Joern; Kiechl, Stefan; Kroemer, Guido; Sedej, Simon; Madeo, Frank			Cardioprotection and lifespan extension by the natural polyamine spermidine	NATURE MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; EJECTION FRACTION; ARGININE BIOAVAILABILITY; MITOCHONDRIAL AUTOPHAGY; MYOCARDIAL HYPERTROPHY; ROBUST QUANTIFICATION; AMINO-ACIDS; MICE; MASS; DYSFUNCTION	Aging is associated with an increased risk of cardiovascular disease and death. Here we show that oral supplementation of the natural polyamine spermidine extends the lifespan of mice and exerts cardioprotective effects, reducing cardiac hypertrophy and preserving diastolic function in old mice. Spermidine feeding enhanced cardiac autophagy, mitophagy and mitochondrial respiration, and it also improved the mechano-elastical properties of cardiomyocytes in vivo, coinciding with increased titin phosphorylation and suppressed subclinical inflammation. Spermidine feeding failed to provide cardioprotection in mice that lack the autophagy-related protein Atg5 in cardiomyocytes. In Dahl salt-sensitive rats that were fed a high-salt diet, a model for hypertension-induced congestive heart failure, spermidine feeding reduced systemic blood pressure, increased titin phosphorylation and prevented cardiac hypertrophy and a decline in diastolic function, thus delaying the progression to heart failure. In humans, high levels of dietary spermidine, as assessed from food questionnaires, correlated with reduced blood pressure and a lower incidence of cardiovascular disease. Our results suggest a new and feasible strategy for protection against cardiovascular disease.	[Eisenberg, Tobias; Schroeder, Sabrina; Stekovic, Slaven; Pendl, Tobias; Harger, Alexandra; Zimmermann, Andreas; Ruckenstuhl, Christoph; Dammbrueck, Christopher; Gross, Angelina S.; Carmona-Gutierrez, Didac; Buettner, Sabrina; Knittelfelder, Oskar; Rockenfeller, Patrick; Moustafa, Tarek; Haemmerle, Guenter; Madeo, Frank] Graz Univ, Inst Mol Biosci, NAWI Graz, Graz, Austria; [Eisenberg, Tobias; Sedej, Simon; Madeo, Frank] BioTechMed Graz, Graz, Austria; [Abdellatif, Mahmoud; Primessnig, Uwe; Schmidt, Albrecht; Herbst, Viktoria; Simonini, Corinna; Pieske, Burkert; Sedej, Simon] Med Univ Graz, Dept Cardiol, Graz, Austria; [Primessnig, Uwe; Pieske, Burkert] Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum, Berlin, Germany; [Harger, Alexandra; Moustafa, Tarek; Pieber, Thomas] Med Univ Graz, Dept Internal Med, Graz, Austria; [Schipke, Julia; Rahn, Alexandros; Muehlfeld, Christian] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Schipke, Julia; Muehlfeld, Christian] Cluster Excellence REBIRTH Regenerat Biol Reconst, Hannover, Germany; [Tong, Mingming; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ USA; [Magnes, Christoph; Trausinger, Gert; Narath, Sophie; Pieber, Thomas] Joanneum Res Forsch Gesell mbH, HLTH, Inst Biomed & Hlth Sci, Graz, Austria; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Hu, Zehan; Dengjel, Joern] Univ Freiburg, FRIAS Freiburg Inst Adv Studies, ZBSA Ctr Biol Syst Anal, Dept Dermatol,Med Ctr,BIOSS Ctr Biol Signalling S, Freiburg, Germany; [Hu, Zehan; Dengjel, Joern] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Kirsch, Alexander; Eller, Kathrin] Med Univ Graz, Clin Div Nephrol, Graz, Austria; [Buettner, Sabrina] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Pietrocola, Federico; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France; [Kroemer, Guido] INSERM, U1138, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 06, Paris, France; [Schrepfer, Emilie; Scorrano, Luca] Univ Padua, Dept Biol, Padua, Italy; [Schrepfer, Emilie; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Rockenfeller, Patrick] Univ Kent, Sch Biosci, Kent Fungal Grp, Canterbury, Kent, England; [Horsch, Marion; Moreth, Kristin; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; Neff, Frauke; Janik, Dirk; Rathkolb, Birgit; Rozman, Jan; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, German Mouse Clin, Inst Expt Genet, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Beckers, Johannes; Rathkolb, Birgit; Rozman, Jan; de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Neff, Frauke; Janik, Dirk] Helmholtz Zentrum Munchen, Inst Pathol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Rathkolb, Birgit] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Mayr, Manuel] Kings Coll London, Kings British Heart Fdn Ctr, London, England; [Willeit, Peter; Pechlaner, Raimund; Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [von Frieling-Salewsky, Marion; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, Bochum, Germany; [Pieske, Burkert] German Heart Ctr Berlin, Dept Internal Med & Cardiol, Berlin, Germany; [Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Berlin, Germany; [Sigrist, Stephan J.] Charite, NeuroCure, Berlin, Germany; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, Stockholm, Sweden	University of Graz; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Graz; Hannover Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Medical University of Graz; University of Freiburg; University of Fribourg; Medical University of Graz; Stockholm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Kent; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of London; King's College London; Medical University of Innsbruck; University of Cambridge; Ruhr University Bochum; German Heart Center Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, NAWI Graz, Graz, Austria.; Sedej, S; Madeo, F (corresponding author), BioTechMed Graz, Graz, Austria.; Sedej, S (corresponding author), Med Univ Graz, Dept Cardiol, Graz, Austria.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France.; Kroemer, G (corresponding author), INSERM, U1138, Paris, France.; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Kroemer, G (corresponding author), Univ Paris 06, Paris, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, Stockholm, Sweden.	kroemer@orange.fr; simon.sedej@medunigraz.at; frank.madeo@uni-graz.at	Gailus-Durner, Valerie/M-7337-2014; Eisenberg, Tobias/AAV-7806-2021; de Angelis, Martin Hrabe/F-5531-2012; Kroemer, Guido/AAY-9859-2020; Hu, Zehan/AAZ-8321-2021; Willeit, Peter/HCI-7091-2022; Beckers, Johannes/K-7237-2012; Schipke, Julia/AAU-6891-2021; Abdellatif, Mahmoud/AAD-5810-2019; Pietrocola, Federico/AAW-9621-2020; KROEMER, Guido/B-4263-2013; Rozman, Jan/A-2540-2010; Sedej, Simon/L-3066-2015; Scorrano, Luca/K-3967-2019; Dengjel, Joern/AAI-3682-2020; Pieske, Burkert/M-8089-2016; Moustafa, Tarek/P-9509-2016	de Angelis, Martin Hrabe/0000-0002-7898-2353; Willeit, Peter/0000-0002-1866-7159; Beckers, Johannes/0000-0001-7874-3822; Abdellatif, Mahmoud/0000-0002-5042-9054; Pietrocola, Federico/0000-0002-2930-234X; KROEMER, Guido/0000-0002-9334-4405; Rozman, Jan/0000-0002-8035-8904; Sedej, Simon/0000-0002-4419-6821; Scorrano, Luca/0000-0002-8515-8928; Pieske, Burkert/0000-0002-6466-5306; Eller, Kathrin/0000-0002-6214-5008; Haemmerle, Guenter/0000-0001-9900-5896; Hu, Zehan/0000-0001-6182-4781; Knittelfelder, Oskar/0000-0002-1565-7238; Pieber, Thomas/0000-0003-3554-0405; Kirsch, Alexander/0000-0001-6711-7834; Eisenberg, Tobias/0000-0003-3559-1130; Moustafa, Tarek/0000-0002-6755-4687; Buttner, Sabrina/0000-0002-2786-8542; Magnes, Christoph/0000-0002-5153-7444; Madeo, Frank/0000-0002-5070-1329; Gross, Angelina Sarah/0000-0002-8096-0831; Schmidt, Albrecht/0000-0003-4783-4603; Linke, Wolfgang/0000-0003-0801-3773; Mayr, Manuel/0000-0002-0597-829X; Sadoshima, Junichi/0000-0003-3724-4132; Zimmermann, Andreas/0000-0003-2249-944X; Pechlaner, Raimund/0000-0001-9006-5606; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Rockenfeller, Patrick/0000-0002-1643-3885; Ruckenstuhl, Christoph/0000-0002-4338-4679; Dengjel, Joern/0000-0002-9453-4614	Austrian Science Fund FWF (Austria) [P23490-B12, P24381, P 27893, I1000]; BMWFW; Karl-Franzens University; Austrian Science Fund FWF [P27637-B28, P27183-B24]; Austrian Heart Foundation (Osterreichischer Herzfonds); Austrian Academy of Sciences; FWF [P27637-B28]; Swedish Research Council [2015-05468]; DFG [CRC1140]; Swiss National Science Foundation [31003A-166482/1]; Austrian Science Fund (FWF) [J3742-B28]; NAWI Graz; EU (FP7) program MEDIA; German Research Foundation [SFB1002, TPA8]; LeDucq Foundation; Canceropole Ile-de-France; Institut National du Cancer (INCa); European Research Council (ERC); LabEx Immuno-Oncology; Paris Alliance of Cancer Research Institutes (PACRI); Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease (ICEMED)'; Helmholtz Alliance ('Imaging and Curing Environmental Metabolic Diseases (ICEMED)'); German Federal Ministry of Education and Research [01KX1012]; Bundesministerium fur Bildung und Forschung [01GQ1420A]; Forschungszentrum fur neurodegenerative Erkrankungen; Deutsche Forschungsgemeinschaft [Exc 257]; Austrian Research Promotion Agency FFG: ' Research Center of Excellence in Vascular Ageing-Tyrol, VASCage' - BMVIT [843536]; Wirtschaftsagentur Wien; Standortagentur Tirol; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust; King's College London; King's College Hospital; British Heart Foundation [FS/11/29/28759, FS/13/2/29892] Funding Source: researchfish	Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); BMWFW; Karl-Franzens University; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Heart Foundation (Osterreichischer Herzfonds); Austrian Academy of Sciences; FWF(Austrian Science Fund (FWF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NAWI Graz; EU (FP7) program MEDIA; German Research Foundation(German Research Foundation (DFG)); LeDucq Foundation(Leducq Foundation); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); European Research Council (ERC)(European Research Council (ERC)European Commission); LabEx Immuno-Oncology; Paris Alliance of Cancer Research Institutes (PACRI); Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease (ICEMED)'; Helmholtz Alliance ('Imaging and Curing Environmental Metabolic Diseases (ICEMED)'); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Forschungszentrum fur neurodegenerative Erkrankungen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Research Promotion Agency FFG: ' Research Center of Excellence in Vascular Ageing-Tyrol, VASCage' - BMVIT; Wirtschaftsagentur Wien; Standortagentur Tirol; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust; King's College London(General Electric); King's College Hospital; British Heart Foundation(British Heart Foundation)	We thank N. Mizushima (University of Tokyo) for providing Atg5<SUP>fl/fl</SUP> mice and K. Chien (Harvard University) for providing MLC2a-Cre mice. We are grateful to R. Schreiber for assistance with high-resolution respirometry. F.M. is grateful to the Austrian Science Fund FWF (Austria) for grants P23490-B12, P24381, P 27893, I1000 and 'SFB Lipotox', as well as to BMWFW and the Karl-Franzens University for grant 'Unkonventionelle Forschung'. S. Sedej is supported by the Austrian Science Fund FWF through grant P27637-B28 and by a grant from the Austrian Heart Foundation (Osterreichischer Herzfonds). T.E. is recipient of an APART fellowship from the Austrian Academy of Sciences. M.A. received funding from the FWF (grant P27637-B28) and was trained within the frame of the Ph. D Program Molecular Medicine of the Medical University of Graz. S.B. is supported by the Austrian Science Fund FWF (grant P27183-B24) and the Swedish Research Council (grant 2015-05468). J.D. is supported by the DFG via grant CRC1140 and by the Swiss National Science Foundation, grant 31003A-166482/1. P. R. is supported by the Austrian Science Fund (FWF) project J3742-B28 and NAWI Graz. W.A.L. is supported by EU (FP7) program MEDIA and the German Research Foundation grant SFB1002, TPA8. G.K. is supported by the LeDucq Foundation, the Canceropole Ile-de-France, the Institut National du Cancer (INCa), the European Research Council (ERC), LabEx Immuno-Oncology and the Paris Alliance of Cancer Research Institutes (PACRI). The project was supported by grants from the Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease' (J.B.), the Helmholtz Alliance ('Imaging and Curing Environmental Metabolic Diseases (ICEMED)'; J.B.) and the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012) (M.H.d.A.). S. J. S. was supported by grants from the Bundesministerium fur Bildung und Forschung (Smartage, 01GQ1420A), the Forschungszentrum fur neurodegenerative Erkrankungen and the Deutsche Forschungsgemeinschaft (Exc 257). S. K., J.W., R. P., P.W. and M.M. are supported by an excellence initiative (Competence Centers for Excellent Technologies; COMET) of the Austrian Research Promotion Agency FFG: ' Research Center of Excellence in Vascular Ageing-Tyrol, VASCage' (K-Project Nr. 843536) funded by the BMVIT, BMWFW, the Wirtschaftsagentur Wien and the Standortagentur Tirol. This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's NHS Foundation Trust and King's College London in partnership with King's College Hospital. M. M. is a Senior Research fellow of the British Heart Foundation. The authors are grateful for the support by staff members of the animal facilities of the Institutes of Biomedical Research (IBF, Medical University of Graz) and Molecular Biosciences (IMB, University of Graz) and acknowledge the Center for Medical Research (ZMF) of the Medical University of Graz for assistance.	Abdellatif M, 2016, AM J PHYSIOL-HEART C, V310, pH4, DOI 10.1152/ajpheart.00399.2015; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Braun RJ, 2015, CELL REP, V10, P1557, DOI 10.1016/j.celrep.2015.02.009; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; Chiao YA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025148; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gori M, 2014, EUR HEART J, V35, P3442, DOI 10.1093/eurheartj/ehu254; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Hamdani N, 2013, CIRC RES, V112, P664, DOI 10.1161/CIRCRESAHA.111.300105; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Heinzel FR, 2015, J APPL PHYSIOL, V119, P1233, DOI 10.1152/japplphysiol.00374.2015; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Klotz S, 2006, HYPERTENSION, V47, P901, DOI 10.1161/01.HYP.0000215579.81408.8e; Ky B, 2013, J AM COLL CARDIOL, V62, P1165, DOI 10.1016/j.jacc.2013.03.085; LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004; Leoncini G, 2009, J HYPERTENS, V27, P1064, DOI 10.1097/HJH.0b013e3283281213; Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946; Magnes C, 2014, J CHROMATOGR A, V1331, P44, DOI 10.1016/j.chroma.2013.12.061; Mayhew TM, 2008, PLACENTA, V29, P1, DOI 10.1016/j.placenta.2007.05.010; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MENDEZ J, 1960, METABOLISM, V9, P184; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Muehlfeld C, 2010, CARDIOVASC PATHOL, V19, P65, DOI 10.1016/j.carpath.2008.10.015; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Ommen SR, 2000, CIRCULATION, V102, P1788; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Qu P, 2000, HYPERTENS RES, V23, P613, DOI 10.1291/hypres.23.613; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Rozman Jan, 2015, Curr Protoc Mouse Biol, V5, P65, DOI 10.1002/9780470942390.mo140111; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470; Schindler CE, 2014, AM J PHYSIOL-REG I, V307, pR434, DOI 10.1152/ajpregu.00123.2014; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; Sedej S, 2014, J AM COLL CARDIOL, V63, P1569, DOI 10.1016/j.jacc.2013.11.010; Sedej S, 2010, CARDIOVASC RES, V87, P50, DOI 10.1093/cvr/cvq007; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Shirakabe A, 2016, J MOL CELL CARDIOL, V92, P134, DOI 10.1016/j.yjmcc.2016.02.007; Soda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064357; Sourij H, 2011, ATHEROSCLEROSIS, V218, P220, DOI 10.1016/j.atherosclerosis.2011.04.041; Sprenger Adrian, 2013, Methods Mol Biol, V961, P179, DOI 10.1007/978-1-62703-227-8_10; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tournoux F, 2011, J AM SOC ECHOCARDIOG, V24, P465, DOI 10.1016/j.echo.2010.12.019; Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813; TROY BL, 1972, CIRCULATION, V45, P602, DOI 10.1161/01.CIR.45.3.602; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wei JW, 2012, AMINO ACIDS, V42, P2031, DOI 10.1007/s00726-011-0924-0; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Willeit P, 2014, J AM COLL CARDIOL, V64, P851, DOI 10.1016/j.jacc.2014.03.061; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolf D, 2005, J AM SOC NEPHROL, V16, P1360, DOI 10.1681/ASN.2004100837; Yeganeh B, 2014, PHARMACOL THERAPEUT, V143, P87, DOI 10.1016/j.pharmthera.2014.02.007; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	88	568	586	10	197	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1428	+		10.1038/nm.4222	http://dx.doi.org/10.1038/nm.4222			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841876	Green Accepted, Green Submitted			2022-12-27	WOS:000389549000020
J	Hammond, TR; Stevens, B				Hammond, Timothy R.; Stevens, Beth			Increasing the neurological-disease toolbox using iPSC-derived microglia	NATURE MEDICINE			English	Editorial Material								A new study presents a protocol to differentiate human induced pluripotent stem cells (iPSCs) into microglia that closely resemble their in vivo counterparts. These cells offer an exciting new tool for learning more about the role of microglia in disease.	[Hammond, Timothy R.; Stevens, Beth] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Stevens, B (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	Beth.Stevens@childrens.harvard.edu						Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hong S, 2016, DEV CELL, V38, P126, DOI 10.1016/j.devcel.2016.07.006; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Schafer DP, 2016, ELIFE, V5, DOI 10.7554/eLife.15224; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764	11	5	5	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1206	1207		10.1038/nm.4226	http://dx.doi.org/10.1038/nm.4226			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27824814				2022-12-27	WOS:000387302300007
J	Stanley, D; Mason, LJ; Mackin, KE; Srilchanta, YN; Lyras, D; Prakash, MD; Nurgali, K; Venegas, A; Hill, MD; Moore, RJ; Wong, CHY				Stanley, Dragana; Mason, Linda J.; Mackin, Kate E.; Srilchanta, Yogitha N.; Lyras, Dena; Prakash, Monica D.; Nurgali, Kulmira; Venegas, Andres; Hill, Michael D.; Moore, Robert J.; Wong, Connie H. Y.			Translocation and dissemination of commensal bacteria in post-stroke infection	NATURE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; VENTILATOR-ASSOCIATED PNEUMONIA; CENTRAL-NERVOUS-SYSTEM; STAPHYLOCOCCUS-AUREUS; ASPIRATION PNEUMONIA; STROKE; COMPLICATIONS; DYSFUNCTION; RESISTANCE; MICROBIOTA	Bacterial infection is highly prevalent in patients who have had a stroke. Despite the potential contribution of micro-aspiration in post-stroke pneumonia, we found that the majority of the microorganisms detected in the patients who developed infections after having a stroke were common commensal bacteria that normally reside in the intestinal tracts. In a mouse model of ischemic stroke, post-stroke infection was only observed in mice that were born and raised in specific-pathogen-free facilities; this was not seen in mice that were born and raised in germ-free facilities. Using high-throughput 16S rRNA gene amplicon sequencing and bioinformatics analyses, we provide evidence demonstrating that the source of the bacteria forming the microbial community in the lungs of post-stroke mice was indeed the host small intestine. Additionally, stroke-induced gut barrier permeability and dysfunction preceded the dissemination of orally inoculated bacteria to peripheral tissues. This study identifies a novel pathway in which stroke promotes the translocation and dissemination of selective strains of bacteria that originated from the host gut microbiota.	[Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld, Australia; [Mason, Linda J.] Monash Univ, Dept Biochem, Clayton, Vic, Australia; [Mackin, Kate E.; Srilchanta, Yogitha N.; Lyras, Dena; Moore, Robert J.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Mackin, Kate E.; Srilchanta, Yogitha N.; Lyras, Dena; Moore, Robert J.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [Prakash, Monica D.; Nurgali, Kulmira] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, St Albans, Vic, Australia; [Venegas, Andres; Hill, Michael D.] Univ Calgary, Dept Clin Neurosci, Stroke Unit, Calgary, AB, Canada; [Venegas, Andres; Hill, Michael D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Moore, Robert J.] RMIT Univ, Sch Sci, Bundoora, Vic, Australia; [Wong, Connie H. Y.] Monash Univ, Sch Clin Sci, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia	Central Queensland University; Monash University; Monash University; Monash University; Victoria University; University of Calgary; University of Calgary; Royal Melbourne Institute of Technology (RMIT); Monash University	Wong, CHY (corresponding author), Monash Univ, Sch Clin Sci, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.	connie.wong@monash.edu	Stanley, Dragana/AAC-2596-2020; Prakash, Monica/AAK-1548-2021; Hill, Michael D/C-9073-2012; Moore, Robert J/D-8352-2011	Stanley, Dragana/0000-0001-7019-4726; Hill, Michael D/0000-0002-6269-1543; Moore, Robert J/0000-0002-0776-5861; Wong, Connie/0000-0002-9020-1847; Prakash, Monica/0000-0002-2814-7560; Lyras, Dena/0000-0003-2345-9271; Srikhanta, Yogitha/0000-0002-7513-9969; Nurgali, Kulmira/0000-0002-2597-6929	Australia Research Council (ARC); Australian National Heart Foundation (NHF); Australian National Health and Medical Research Council (NHMRC); Alberta Innovates [201300690] Funding Source: researchfish	Australia Research Council (ARC)(Australian Research Council); Australian National Heart Foundation (NHF)(National Heart Foundation of Australia); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Alberta Innovates	We thank the staff at Monash Animal Research Facilities, Monash Micromon, Monash Micro Imaging and Monash Histology Platform, which are managed by Monash University The bioinformatics data was analyzed using the Isaac Newton high-performance computing system at Central Queensland University We wish to acknowledge the help from J. Bell that was provided for all aspects of the high-performance computing. We thank E.A. Palombo (Swinburne University of Technology) for providing a streptomycin-resistant derivative of the E. coli strain ATCC700927 (EDL933), designated DLL206. The work was supported by the Australia Research Council (ARC) (D.S. and C.H.Y.W.), the Australian National Heart Foundation (NHF) (C.H.Y.W.) and the Australian National Health and Medical Research Council (NHMRC) (C.H.Y.W.).	Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gauguet S, 2015, INFECT IMMUN, V83, P4003, DOI 10.1128/IAI.00037-15; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Hill LT, 2013, NUTRITION, V29, P948, DOI 10.1016/j.nut.2012.12.023; Ho PL, 2009, CHEST, V136, P1119, DOI 10.1378/chest.09-0285; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; Martinez RM, 2014, J CLIN MICROBIOL, V52, P30, DOI 10.1128/JCM.02072-13; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Menuet Magalie, 2008, J Med Case Rep, V2, P373, DOI 10.1186/1752-1947-2-373; Messika J, 2012, INTENS CARE MED, V38, P2007, DOI 10.1007/s00134-012-2699-5; Miller RF, 2005, INT J STD AIDS, V16, P763, DOI 10.1258/095646205774763243; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Stechmiller J K, 1997, Am J Crit Care, V6, P204; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Umar Shahid, 2010, Curr Gastroenterol Rep, V12, P340, DOI 10.1007/s11894-010-0130-3; Valentine S., 2013, EXAMINATION BEHAV BA; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	35	201	215	7	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1277	1284		10.1038/nm.4194	http://dx.doi.org/10.1038/nm.4194			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27694934				2022-12-27	WOS:000387302300020
J	Esmail, H; Lai, RP; Lesosky, M; Wilkinson, KA; Graham, CM; Coussens, AK; Oni, T; Warwick, JM; Said-Hartley, Q; Koegelenberg, CF; Walzl, G; Flynn, JL; Young, DB; Barry, CE; O'Garra, A; Wilkinson, RJ				Esmail, Hanif; Lai, Rachel P.; Lesosky, Maia; Wilkinson, Katalin A.; Graham, Christine M.; Coussens, Anna K.; Oni, Tolu; Warwick, James M.; Said-Hartley, Qonita; Koegelenberg, Coenraad F.; Walzl, Gerhard; Flynn, JoAnne L.; Young, Douglas B.; Barry, Clifton E., III; O'Garra, Anne; Wilkinson, Robert J.			Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[F-18] fluoro-D-glucose positron emission and computed tomography	NATURE MEDICINE			English	Article							PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; FUTURE-PROSPECTS; INFECTION; PREVALENCE; STRATEGIES; DISEASE; ADULTS; LUNG	Tuberculosis is classically divided into states of latent infection and active disease. Using combined positron emission and computed tomography in 35 asymptomatic, antiretroviral-therapy-naive, HIV-1-infected adults with latent tuberculosis, we identified ten individuals with pulmonary abnormalities suggestive of subclinical, active disease who were substantially more likely to progress to clinical disease. Our findings challenge the conventional two-state paradigm and may aid future identification of biomarkers that are predictive of progression.	[Esmail, Hanif; Young, Douglas B.; Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England; [Esmail, Hanif; Lesosky, Maia; Wilkinson, Katalin A.; Coussens, Anna K.; Oni, Tolu; Barry, Clifton E., III; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa; [Esmail, Hanif] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Lai, Rachel P.; Wilkinson, Katalin A.; Graham, Christine M.; Young, Douglas B.; O'Garra, Anne; Wilkinson, Robert J.] Francis Crick Inst Mill Hill Lab, London, England; [Lesosky, Maia] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Warwick, James M.] Univ Stellenbosch, Dept Med Imaging & Clin Oncol, Cape Town, South Africa; [Said-Hartley, Qonita] Groote Schuur Hosp, Dept Radiol, Cape Town, South Africa; [Koegelenberg, Coenraad F.; Walzl, Gerhard] Univ Stellenbosch, Dept Med, Cape Town, South Africa; [Walzl, Gerhard; Barry, Clifton E., III] Univ Stellenbosch, Dept Biomed Sci, Fac Med & Hlth Sci, Cape Town, South Africa; [Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Barry, Clifton E., III] Univ Cape Town, Dept Pathol, Cape Town, South Africa; [O'Garra, Anne] Imperial Coll London, Natl Heart & Lung Inst, London, England	Imperial College London; University of Cape Town; University of Oxford; Francis Crick Institute; University of Cape Town; Stellenbosch University; University of Cape Town; Stellenbosch University; Stellenbosch University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Imperial College London	Esmail, H; Wilkinson, RJ (corresponding author), Imperial Coll London, Dept Med, London, England.; Esmail, H; Wilkinson, RJ (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa.; Esmail, H (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.; Wilkinson, RJ (corresponding author), Francis Crick Inst Mill Hill Lab, London, England.	hanif.esmail@ndcls.ox.ac.uk; r.j.wilkinson@imperial.ac.uk	Wilkinson, Katalin/AAQ-7713-2021; Barry, Clifton E/ABE-7992-2020; Coussens, Anna Kathleen/AAN-2949-2021; Barry, III, Clifton/H-3839-2012; Lesosky, Maia/AAM-4174-2020; Wilkinson, Katalin/AAF-6805-2020; Flynn, JoAnne/ABC-7371-2020; Walzl, Gerhard/N-6371-2016	Wilkinson, Katalin/0000-0002-9796-2040; Barry, Clifton E/0000-0002-2927-270X; Coussens, Anna Kathleen/0000-0002-7086-2621; Barry, III, Clifton/0000-0002-2927-270X; Lesosky, Maia/0000-0002-2026-958X; Graham, Christine/0000-0001-9329-6231; Wilkinson, Robert/0000-0002-2753-1800; O'Garra, Anne/0000-0001-9845-6134; Walzl, Gerhard/0000-0003-2487-125X; Warwick, James/0000-0002-2810-0543; Esmail, Hanif/0000-0002-4278-9316; Lai, Rachel/0000-0003-3418-850X; Oni, Tolu/0000-0003-4499-1910	Wellcome Trust [090170, 104803]; Bill and Melinda Gates Foundation-Wellcome Trust Grand challenges in Global Health [37822]; US National Institutes of Health (NIH) [R01 HL106804]; intramural research program of the NIH-NIAID; European Union [FP& HEALTH F3-2012-305578]; National Research Foundation of South Africa [96841]; Research Councils of the UK via the Francis Crick Institute [10218, U117565642]; Medical Research Council of South Africa (Strategic Health Innovations partnership); Medical Research Council [MC_U117565642, 1365570, 1105853, MC_U117588499] Funding Source: researchfish; Wellcome Trust [104803/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10126, 10222, 10218] Funding Source: researchfish; MRC [MC_U117565642, MC_U117588499] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106804] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation-Wellcome Trust Grand challenges in Global Health; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural research program of the NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); National Research Foundation of South Africa(National Research Foundation - South Africa); Research Councils of the UK via the Francis Crick Institute; Medical Research Council of South Africa (Strategic Health Innovations partnership)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Wellcome Trust (grant no. 090170 (H.E.) and 104803 (R.J.W.)), the Bill and Melinda Gates Foundation-Wellcome Trust Grand challenges in Global Health (grant no. 37822; D.B.Y.), the US National Institutes of Health (NIH) (grant no. R01 HL106804; J.L.F.) and the intramural research program of the NIH-NIAID (C.E.B.). R.J.W. also received support from the European Union (grant no. FP& HEALTH F3-2012-305578), the National Research Foundation of South Africa (grant no. 96841), the Research Councils of the UK via the Francis Crick Institute (grant no. 10218 and U117565642) and the Medical Research Council of South Africa (Strategic Health Innovations partnership).	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Corbett EL, 2013, INT J TUBERC LUNG D, V17, P1125, DOI 10.5588/ijtld.13.0117; CRAVEN SA, 1979, S AFR MED J, V55, P89; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Ghesani N, 2014, AM J RESP CRIT CARE, V189, P748, DOI 10.1164/rccm.201311-1976LE; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Opie EL, 1917, J EXP MED, V25, P855, DOI 10.1084/jem.25.6.855; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Rybicki BA, 2007, SEMIN RESP CRIT CARE, V28, P22, DOI 10.1055/s-2007-970331; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; STEAD WW, 1967, NEW ENGL J MED, V277, P1008, DOI 10.1056/NEJM196711092771906; STEINBRUECK P, 1972, Bulletin of the International Union Against Tuberculosis, V47, P135; TRAMONTANA JM, 1995, MOL MED, V1, P384, DOI 10.1007/BF03401576; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	20	108	113	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1090	1093		10.1038/nm.4161	http://dx.doi.org/10.1038/nm.4161			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595321	Green Submitted, Green Accepted			2022-12-27	WOS:000384872500011
J	Deeks, SG; Lewin, SR; Ross, AL; Ananworanich, J; Benkirane, M; Cannon, P; Chomont, N; Douek, D; Lifson, JD; Lo, YR; Kuritzkes, D; Margolis, D; Mellors, J; Persaud, D; Tucker, JD; Barre-Sinoussi, F; Alter, G; Auerbach, J; Autran, B; Barouch, DH; Behrens, G; Cavazzana, M; Chen, ZW; Cohen, EA; Corbelli, GM; Eholie, S; Eyal, N; Fidler, S; Garcia, L; Grossman, C; Henderson, G; Henrich, TJ; Jefferys, R; Kiem, HP; McCune, J; Moodley, K; Newman, PA; Nijhuis, M; Nsubuga, MS; Ott, M; Palmer, S; Richman, D; Saez-Cirion, A; Sharp, M; Siliciano, J; Silvestri, G; Singh, J; Spire, B; Taylor, J; Tolstrup, M; Valente, S; van Lunzen, J; Walensky, R; Wilson, I; Zack, J				Deeks, Steven G.; Lewin, Sharon R.; Ross, Anna Laura; Ananworanich, Jintanat; Benkirane, Monsef; Cannon, Paula; Chomont, Nicolas; Douek, Daniel; Lifson, Jeffrey D.; Lo, Ying-Ru; Kuritzkes, Daniel; Margolis, David; Mellors, John; Persaud, Deborah; Tucker, Joseph D.; Barre-Sinoussi, Francoise; Alter, Galit; Auerbach, Judith; Autran, Brigitte; Barouch, Dan H.; Behrens, Georg; Cavazzana, Marina; Chen, Zhiwei; Cohen, Eric A.; Corbelli, Giulio Maria; Eholie, Serge; Eyal, Nir; Fidler, Sarah; Garcia, Laurindo; Grossman, Cynthia; Henderson, Gail; Henrich, Timothy J.; Jefferys, Richard; Kiem, Hans-Peter; McCune, Joseph; Moodley, Keymanthri; Newman, Peter A.; Nijhuis, Monique; Nsubuga, Moses Supercharger; Ott, Melanie; Palmer, Sarah; Richman, Douglas; Saez-Cirion, Asier; Sharp, Matthew; Siliciano, Janet; Silvestri, Guido; Singh, Jerome; Spire, Bruno; Taylor, Jeffrey; Tolstrup, Martin; Valente, Susana; van Lunzen, Jan; Walensky, Rochelle; Wilson, Ira; Zack, Jerome		Int AIDS Soc Cure Working Grp	International AIDS Society global scientific strategy: towards an HIV cure 2016	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; BROADLY NEUTRALIZING ANTIBODIES; HISTONE DEACETYLASE INHIBITOR; HIGHLY PATHOGENIC SIV; LATENT HIV-1; VIRAL RESERVOIR; IN-VIVO; RALTEGRAVIR INTENSIFICATION; STAKEHOLDER ENGAGEMENT	Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a global population of more than 35 million people living with HIV, there is intense interest in developing a cure for HIV infection. The International AIDS Society convened a group of international experts to develop a scientific strategy for research towards an HIV cure. This Perspective summarizes the group's strategy.	[Deeks, Steven G.; Auerbach, Judith; Henrich, Timothy J.; McCune, Joseph] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia; [Ross, Anna Laura] ANRS, Int & Sci Relat Off, Paris, France; [Ananworanich, Jintanat] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Ananworanich, Jintanat] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Benkirane, Monsef] Univ Montpellier, CNRS UPR 1142, Inst Human Genet, Mol Virol Lab, Montpellier, France; [Cannon, Paula] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Chomont, Nicolas] Univ Montreal, Fac Med, CRCHUM, Montreal, PQ, Canada; [Chomont, Nicolas] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Douek, Daniel] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Lo, Ying-Ru] World Hlth Org Reg Off Western Pacific, Manila, Philippines; [Kuritzkes, Daniel; Henrich, Timothy J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Margolis, David; Henderson, Gail] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Mellors, John] Univ Pittsburgh, Dept Med, Div Infect Dis, 930 Scaife Hall, Pittsburgh, PA 15260 USA; [Persaud, Deborah] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Persaud, Deborah] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Barre-Sinoussi, Francoise] Inst Pasteur, Paris, France; [Alter, Galit; Barouch, Dan H.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA; [Autran, Brigitte] Univ Paris 06, Sorbonne Univ, CIMI, Paris, France; [Autran, Brigitte] CIMI Paris, INSERM, U1135, Paris, France; [Autran, Brigitte] Hop La Pitie Salpetriere, AP HP, Dept Immunol, Paris, France; [Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Behrens, Georg] Hannover Med Sch, Clin Immunol & Rhematol, Hannover, Germany; [Cavazzana, Marina] Hop Necker Enfants Malad, Ctr Invest Clin Biotherapie, Paris, France; [Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Pok Fu Lam, Hong Kong, Peoples R China; [Cohen, Eric A.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Corbelli, Giulio Maria] European AIDS Treatment Grp, Rome, Italy; [Eholie, Serge] Ctr Hosp Univ Treichville, Programme PAC CI, Abidjan, Cote Ivoire; [Eyal, Nir] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Fidler, Sarah] Imperial Coll London, Dept Med, London, England; [Garcia, Laurindo] B Change Grp, Manila, Philippines; [Grossman, Cynthia] NIMH, NIH, Bethesda, MD 20892 USA; [Jefferys, Richard] Treatment Act Grp, New York, NY 10016 USA; [Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Moodley, Keymanthri] Univ Stellenbosch, Dept Med, Ctr Med Eth & Law, Western Cape, South Africa; [Newman, Peter A.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Nijhuis, Monique] Univ Med Ctr Utrecht, Dept Med Microbiol, Virol, Utrecht, Netherlands; [Nsubuga, Moses Supercharger] Joint Clin Res Ctr, Kampala, Uganda; [Ott, Melanie] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Palmer, Sarah] Univ Sydney, Westmead Millennium Inst Med Res, Sydney, NSW, Australia; [Richman, Douglas] Virginia San Diego Healthcare Syst, San Diego, CA 92161 USA; [Richman, Douglas] Univ Calif San Diego, San Diego, CA 92103 USA; [Saez-Cirion, Asier] Inst Pasteur, Paris, France; [Sharp, Matthew] Independent HIV Educ & Advocacy Consultant, San Francisco, CA USA; [Siliciano, Janet] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Singh, Jerome] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Spire, Bruno] INSERM, UMR S912, Marseille, France; [Taylor, Jeffrey] CARE Collaboratory Community Advisory Board, Palm Springs, CA USA; [Tolstrup, Martin] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Valente, Susana] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA; [van Lunzen, Jan] ViiV Healthcare, London, England; [Walensky, Rochelle] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wilson, Ira] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Zack, Jerome] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of Melbourne; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; Monash University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Southern California; Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hong Kong; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Fred Hutchinson Cancer Center; Stellenbosch University; University of Toronto; Utrecht University; Utrecht University Medical Center; Joint Clinic Research Center - United Arab Emirates; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Sydney; University of California System; University of California San Diego; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Johns Hopkins University; Emory University; University of Kwazulu Natal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Aarhus University; Scripps Research Institute; GlaxoSmithKline; Harvard University; Harvard Medical School; Massachusetts General Hospital; Brown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Deeks, SG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	steven.deeks@ucsf.edu	Barouch, Dan/Y-3918-2019; Behrens, Georg MN/Q-4486-2016; Chomont, Nicolas/ABG-2545-2020; Lewin, Sharon/Z-3297-2019; Chen, Zhiwei/B-7793-2019; Spire, Bruno/F-5546-2013; Newman, Peter A/P-7056-2019; Singh, Jerome Amir/ABG-1573-2021; Saez-Cirion, Asier/A-8640-2008; Ananworanich, Jintanat/AAC-6348-2021; Eholie, Serge/T-6008-2019	Chomont, Nicolas/0000-0001-9747-5018; Chen, Zhiwei/0000-0002-4511-2888; Spire, Bruno/0000-0002-3546-8020; Newman, Peter A/0000-0003-0444-5915; Saez-Cirion, Asier/0000-0003-2406-7536; Ananworanich, Jintanat/0000-0003-1369-3224; Tolstrup, Martin/0000-0001-7020-5173; Walensky, Rochelle P./0000-0002-8795-379X; Fidler, Sarah/0000-0003-1676-7583; Tucker, Joseph/0000-0003-2804-1181; Lewin, Sharon Ruth/0000-0002-0330-8241; Deeks, Steven/0000-0001-6371-747X; Cavazzana, Marina/0000-0002-0264-0891	federal funds from the NCI/NIH [HHSN261200800001E]; MRC [MR/L00528X/1] Funding Source: UKRI; Medical Research Council [MR/L00528X/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, P30AI042853, U19AI096113, R01AI108366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	federal funds from the NCI/NIH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.L. is supported in part by federal funds from the NCI/NIH under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. government. The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army, the Department of Defense or the US National Institutes of Health. Y.-R.L. is a World Health Organization (WHO) staff member. The opinions herein are those of the authors and should not be construed as official or representing the views of the WHO. The authors acknowledge T. Rasmussen, T. Mota and M. Crane for assistance with preparation of figures.	Amon JJ, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-5; Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Assoumou L, 2015, AIDS, V29, P2003, DOI 10.1097/QAD.0000000000000734; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bui JK, 2016, J VIROL, V90, P1673, DOI 10.1128/JVI.02520-15; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Calantone N, 2014, IMMUNITY, V41, P493, DOI 10.1016/j.immuni.2014.08.014; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Casazza JP, 2013, J INFECT DIS, V207, P1829, DOI 10.1093/infdis/jit098; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cheret A, 2015, J ANTIMICROB CHEMOTH, V70, P2108, DOI 10.1093/jac/dkv084; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chu CE, 2015, AIDS RES HUM RETROV, V31, P78, DOI [10.1089/aid.2014.0200, 10.1089/AID.2014.0200]; Chun TW, 2014, P NATL ACAD SCI USA, V111, P13151, DOI 10.1073/pnas.1414148111; Churchill MJ, 2015, J NEUROVIROL, V21, P290, DOI 10.1007/s13365-014-0271-5; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; De Maria A, 2014, NEW ENGL J MED, V370, P678, DOI 10.1056/NEJMc1315498; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Del Prete GQ, 2016, ANTIMICROB AGENTS CH, V60, P1560, DOI 10.1128/AAC.02625-15; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Denton PW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003872; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Elliott JH, 2015, LANCET HIV, V2, pE520, DOI 10.1016/S2352-3018(15)00226-X; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Euler Z, 2015, AIDS RES HUM RETROV, V31, P13, DOI [10.1089/aid.2014.0235, 10.1089/AID.2014.0235]; Evans VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003799; Fauci AS, 2014, JAMA-J AM MED ASSOC, V312, P335, DOI 10.1001/jama.2014.4754; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Frange P, 2016, LANCET HIV, V3, pE49, DOI 10.1016/S2352-3018(15)00232-5; Freedberg KA, 2015, J VIRUS ERAD, V1, P245; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Henderson GE, 2015, AIDS RES HUM RETROV, V31, P56, DOI [10.1089/aid.2014.0219, 10.1089/AID.2014.0219]; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Imamichi H, 2014, AIDS, V28, P1091, DOI 10.1097/QAD.0000000000000223; Jiang GC, 2014, AIDS, V28, P1555, DOI 10.1097/QAD.0000000000000289; Jones RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004287; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Katlama C, 2016, AIDS, V30, P221, DOI 10.1097/QAD.0000000000000894; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Khoury G., AIDS IN PRESS; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li JZ, 2016, AIDS, V30, P343, DOI 10.1097/QAD.0000000000000953; Lo YR, 2015, AIDS PATIENT CARE ST, V29, P389, DOI 10.1089/apc.2014.0348; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Lorenzo-Redondol R., NATURE IN PRESS; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Micci L, 2015, J CLIN INVEST, V125, P4497, DOI 10.1172/JCI81400; Moodley K, 2016, AIDS CARE, V28, P524, DOI 10.1080/09540121.2015.1112351; Mousseau G, 2015, MBIO, V6, DOI 10.1128/mBio.00465-15; Mousseau G, 2015, CURR TOP MICROBIOL, V389, P121, DOI 10.1007/82_2015_435; Muenchhoff M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00391; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Newman PA, 2014, EXPERT REV VACCINES, V13, P1553, DOI 10.1586/14760584.2014.953484; Pate KAM, 2015, J INFECT DIS, V212, P1387, DOI 10.1093/infdis/jiv230; Peay HL, 2015, J VIRUS ERAD, V1, P51; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Sax PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113031; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Smith DJ, 2015, P NATL ACAD SCI USA, V112, P1523, DOI 10.1073/pnas.1424877112; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Stock PG, 2014, AM J TRANSPLANT, V14, P1136, DOI 10.1111/ajt.12699; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tucker JD, 2014, JAIDS-J ACQ IMM DEF, V67, pE110, DOI 10.1097/QAI.0000000000000305; Tucker JD, 2014, AIDS, V28, P1247, DOI 10.1097/QAD.0000000000000210; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; UNAIDS, 2014, THE GAP REP; Uprety P, 2015, CLIN INFECT DIS, V61, P1862, DOI 10.1093/cid/civ688; van der Sluis RM, 2015, AIDS, V29, P1003, DOI 10.1097/QAD.0000000000000637; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wightman F, 2015, AIDS, V29, P504, DOI 10.1097/QAD.0000000000000562; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821; Younan PM, 2013, BLOOD, V122, P179, DOI 10.1182/blood-2013-01-482224; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	125	324	330	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					839	850		10.1038/nm.4108	http://dx.doi.org/10.1038/nm.4108			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27400264	Green Published, Green Accepted			2022-12-27	WOS:000381000200009
J	Cherepanova, OA; Gomez, D; Shankman, LS; Swiatlowska, P; Williams, J; Sarmento, OF; Alencar, GF; Hess, DL; Bevard, MH; Greene, ES; Murgai, M; Turner, SD; Geng, YJ; Bekiranov, S; Connelly, JJ; Tomilin, A; Owens, GK				Cherepanova, Olga A.; Gomez, Delphine; Shankman, Laura S.; Swiatlowska, Pamela; Williams, Jason; Sarmento, Olga F.; Alencar, Gabriel F.; Hess, Daniel L.; Bevard, Melissa H.; Greene, Elizabeth S.; Murgai, Meera; Turner, Stephen D.; Geng, Yong-Jian; Bekiranov, Stefan; Connelly, Jessica J.; Tomilin, Alexey; Owens, Gary K.			Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective	NATURE MEDICINE			English	Article							DNA METHYLATION; EXPRESSION; DIFFERENTIATION; MOUSE; ATHEROSCLEROSIS; INACTIVATION; GENERATION; INDUCTION; MARKERS; HYPOXIA	Although somatic cell activation of the embryonic stem cell (ESC) pluripotency factor OCT4 has been reported, this previous work has been controversial and has not demonstrated a functional role for OCT4 in somatic cells. Here we demonstrate that smooth muscle cell (SMC)-specific conditional knockout of Oct4 in Apoe(-/-) mice resulted in increased lesion size and changes in lesion composition that are consistent with decreased plaque stability, including a thinner fibrous cap, increased necrotic core area, and increased intraplaque hemorrhage. Results of SMC-lineage-tracing studies showed that these effects were probably the result of marked reductions in SMC numbers within lesions and SMC investment within the fibrous cap, which may result from impaired SMC migration. The reactivation of Oct4 within SMCs was associated with hydroxymethylation of the Oct4 promoter and was hypoxia inducible factor-1 alpha (HIF-1 alpha, encoded by HIF1A) and Kruppel-like factor-4 (KLF4)-dependent. These results provide the first direct evidence that OCT4 has a functional role in somatic cells, and they highlight the potential role of OCT4 in normal and diseased somatic cells.	[Cherepanova, Olga A.; Gomez, Delphine; Shankman, Laura S.; Swiatlowska, Pamela; Alencar, Gabriel F.; Hess, Daniel L.; Bevard, Melissa H.; Greene, Elizabeth S.; Murgai, Meera; Connelly, Jessica J.; Owens, Gary K.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Gomez, Delphine; Shankman, Laura S.; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA; [Swiatlowska, Pamela] Univ Gdansk, Intercoll Fac Biotechnol, PL-80952 Gdansk, Poland; [Williams, Jason; Geng, Yong-Jian] Univ Texas Houston Med Sch, Ctr Cardiovasc Biol & Atherosclerosis Res, Houston, TX USA; [Sarmento, Olga F.] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Alencar, Gabriel F.; Hess, Daniel L.; Bekiranov, Stefan] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Murgai, Meera] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Turner, Stephen D.] Univ Virginia, Sch Med, Bioinformat Core, Charlottesville, VA 22908 USA; [Connelly, Jessica J.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Tomilin, Alexey] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	University of Virginia; University of Virginia; Fahrenheit Universities; University of Gdansk; University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Owens, GK (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA.; Owens, GK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA.	gko@virginia.edu	Gomez, Delphine/J-6349-2019; Turner, Stephen/GXM-4654-2022; Murgai, Meera/AAW-1114-2021; Tomilin, Alexey/AAA-8774-2022; Tomilin, Alexey N/C-3361-2014; Cherepanova, Olga E./K-1277-2015; Tomilin, Alexey/AAK-3068-2021	Gomez, Delphine/0000-0002-3880-6961; Tomilin, Alexey/0000-0002-1137-7167; Tomilin, Alexey N/0000-0002-1137-7167; Cherepanova, Olga E./0000-0001-7775-6488; Murgai, Meera/0000-0001-5015-839X; Turner, Stephen/0000-0001-9140-9028	US National Institutes of Health (NIH) [R01 HL057353, R01 HL087867, R01 HL098538]; AHA [11PRE17008, 13POST17080043, 15SDG25860021, 11PRE7750030, 15PRE25670040, 15PRE25730011]; Russian Science Foundation [14-14-00718]; Federal Agency of Scientific Organization; US Department of Defense [W81XWH-10-2-0125];  [R01 HL100257];  [R00 HL089412]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098538, R01HL057353, R00HL089412, R01HL100257, T32HL007284, R01HL038854, R01HL121008, R01HL087867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Russian Science Foundation(Russian Science Foundation (RSF)); Federal Agency of Scientific Organization; US Department of Defense(United States Department of Defense); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank R. Tripathi, M. McCanna, T. Karaoli, T. Lillard and J. Sanders for their technical assistance; A. Newman, M. Quetsch, E. Schutzenhofer, J. Roithmayr and R. Haskins for their help with image analysis and cell culture experiments; S. Guillot at the Advanced Microscopy Facility at the University of Virginia for help with confocal microscopy; BioConnector Service, University of Virginia, for help with statistical analysis; D. Trono from Swiss Institutes of Technology, Lausanne, Switzerland, for the pLVTHM vector; H.R. Scholer from Max Plank Institute for the Oct4<SUP>flox/flox</SUP> mice; S. Offermanns from Max Plank Institute for the Myh11-CreER<SUP>T2</SUP> mice; and G. Randolph for the LysM<SUP>Cre/Cre</SUP> mice. This work was supported by US National Institutes of Health (NIH) grants R01 HL057353, R01 HL087867 and R01 HL098538 (to G.K.O.); AHA 11PRE17008 (to L.S.S.); Russian Science Foundation grant 14-14-00718 and Federal Agency of Scientific Organization (to A.T.); R01 HL100257 and R00 HL089412 (to J.J.C.); US Department of Defense Grant (W81XWH-10-2-0125, to Y.-J.G); AHA 13POST17080043 and 15SDG25860021 (to D.G.); AHA 11PRE7750030 (to M.M.); AHA 15PRE25670040 (to D.L.H.); and AHA 15PRE25730011 (to G.F.A.).	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Firth AL, 2010, AM J PHYSIOL-LUNG C, V298, pL548, DOI 10.1152/ajplung.00314.2009; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; He W, 2012, WORLD J GASTROENTERO, V18, P712, DOI 10.3748/wjg.v18.i7.712; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089546; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Lambert CM, 2010, CARDIOVASC RES, V88, P196, DOI 10.1093/cvr/cvq152; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marsch E, 2013, CURR OPIN LIPIDOL, V24, P393, DOI 10.1097/MOL.0b013e32836484a4; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shatrov VA, 2003, BLOOD, V101, P4847, DOI 10.1182/blood-2002-09-2711; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang SW, 2015, TISSUE CELL, V47, P115, DOI 10.1016/j.tice.2014.12.004; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974	47	116	117	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					657	+		10.1038/nm.4109	http://dx.doi.org/10.1038/nm.4109			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27183216	Green Accepted			2022-12-27	WOS:000377476000023
J	Goh, JY; Feng, M; Wang, WY; Oguz, G; Yatim, SMJM; Lee, PL; Bao, Y; Lim, TH; Wang, PP; Tam, WL; Kodahl, AR; Lyng, MB; Sarma, S; Lin, SY; Lezhava, A; Yap, YS; Lim, AST; Hoon, DSB; Ditzel, HJ; Lee, SC; Tan, EY; Yu, Q				Goh, Jian Yuan; Feng, Min; Wang, Wenyu; Oguz, Gokce; Yatim, Siti Maryam J. M.; Lee, Puay Leng; Bao, Yi; Lim, Tse Hui; Wang, Panpan; Tam, Wai Leong; Kodahl, Annette R.; Lyng, Maria B.; Sarma, Suman; Lin, Selena Y.; Lezhava, Alexander; Yap, Yoon Sim; Lim, Alvin S. T.; Hoon, Dave S. B.; Ditzel, Henrik J.; Lee, Soo Chin; Tan, Ern Yu; Yu, Qiang			Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence	NATURE MEDICINE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; CIRCULATING TUMOR DNA; STEM-CELLS; S100A14; MARKER; RESISTANCE; PLASMA; RECOMMENDATIONS; PROGNOSIS	Tumor recurrence remains the main reason for breast cancer-associated mortality, and there are unmet clinical demands for the discovery of new biomarkers and development of treatment solutions to benefit patients with breast cancer at high risk of recurrence. Here we report the identification of chromosomal copy-number amplification at 1q21.3 that is enriched in subpopulations of breast cancer cells bearing characteristics of tumor-initiating cells (TICs) and that strongly associates with breast cancer recurrence. Amplification is present in similar to 10-30% of primary tumors but in more than 70% of recurrent tumors, regardless of breast cancer subtype. Detection of amplification in cell-free DNA (cfDNA) from blood is strongly associated with early relapse in patients with breast cancer and could also be used to track the emergence of tumor resistance to chemotherapy. We further show that 1q21.3-encoded S100 calcium-binding protein (S100A) family members, mainly S100A7, S100A8, and S100A9 (S100A7/8/9), and IL-1 receptor-associated kinase 1 (IRAK1) establish a reciprocal feedback loop driving tumorsphere growth. Notably, this functional circuitry can be disrupted by the small-molecule kinase inhibitor pacritinib, leading to preferential impairment of the growth of 1q21.3-amplified breast tumors. Our study uncovers the 1q21.3-directed S100A7/8/9-IRAK1 feedback loop as a crucial component of breast cancer recurrence, serving as both a trackable biomarker and an actionable therapeutic target for breast cancer.	[Goh, Jian Yuan; Feng, Min; Wang, Wenyu; Oguz, Gokce; Yatim, Siti Maryam J. M.; Lee, Puay Leng; Bao, Yi; Tam, Wai Leong; Sarma, Suman; Lezhava, Alexander; Yu, Qiang] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Oguz, Gokce; Yu, Qiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Lim, Tse Hui; Lim, Alvin S. T.] Singapore Gen Hosp, Cytogenet Lab, Dept Pathol, Singapore, Singapore; [Wang, Panpan] Jinan Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Wang, Panpan] Jinan Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China; [Tam, Wai Leong; Lee, Soo Chin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Kodahl, Annette R.; Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Lyng, Maria B.; Ditzel, Henrik J.] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Lin, Selena Y.; Hoon, Dave S. B.] John Wayne Canc Inst, Dept Translat Mol Med, Santa Monica, CA USA; [Yap, Yoon Sim] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Lee, Soo Chin] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore; [Tan, Ern Yu] Tan Tock Seng Hosp, Dept Gen Surg, Singapore, Singapore; [Tan, Ern Yu] ASTAR, Inst Mol & Cellular Biol, Singapore, Singapore; [Yu, Qiang] Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Singapore General Hospital; Jinan University; Jinan University; National University of Singapore; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; John Wayne Cancer Institute; National Cancer Centre Singapore (NCCS); National University of Singapore; Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Yu, Q (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.; Yu, Q (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.; Lee, SC (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.; Ditzel, HJ (corresponding author), Odense Univ Hosp, Dept Oncol, Odense, Denmark.; Ditzel, HJ (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark.; Lee, SC (corresponding author), Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore.; Tan, EY (corresponding author), Tan Tock Seng Hosp, Dept Gen Surg, Singapore, Singapore.; Tan, EY (corresponding author), ASTAR, Inst Mol & Cellular Biol, Singapore, Singapore.; Yu, Q (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore, Singapore.	hditzel@health.sdu.dk; csilsc@nus.edu.sg; ern_yu_tan@ttsh.com.sg; yuq@gis.a-star.edu.sg	Tam, Wai Leong/P-1497-2019; Lee, Soo Chin/S-9111-2016	Tam, Wai Leong/0000-0003-2365-5264; Lee, Soo Chin/0000-0002-5835-6419; Hoon, Dave/0000-0003-1915-3683; Yap, Yoon-Sim/0000-0002-0347-5066; WANG, Wenyu/0000-0001-8947-4867; Kodahl, Annette/0000-0003-0515-9144; Ditzel, Henrik J./0000-0003-3927-5135; Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology and Research of Singapore (A*STAR); Margie Petersen Breast Cancer Program; Association of Breast Cancer; Singapore Ministry of Health's National Medical Research Council (NMRC) Clinician Scientist Individual Research Grants [NMRC/CIRG/1464/2016, NMRC/CG/017/2013, NMRC/CSA/015/2009, NMRC/CSA-SI/0004/2015]; Danish Cancer Society [R99-A6362, R146-A9164]; A*STAR Graduate Academy (A*GA) SINGA (Singapore International Graduate Award) scholarship; The Danish Cancer Society [R72-A4565, R99-A6362, R146-A9164] Funding Source: researchfish	Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Margie Petersen Breast Cancer Program; Association of Breast Cancer; Singapore Ministry of Health's National Medical Research Council (NMRC) Clinician Scientist Individual Research Grants(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Danish Cancer Society(Danish Cancer Society); A*STAR Graduate Academy (A*GA) SINGA (Singapore International Graduate Award) scholarship(Agency for Science Technology & Research (A*STAR)); The Danish Cancer Society(Danish Cancer Society)	This work was supported by the Agency for Science, Technology and Research of Singapore (A*STAR), the Margie Petersen Breast Cancer Program, and the Association of Breast Cancer (D.S.B.H.), Singapore Ministry of Health's National Medical Research Council (NMRC) Clinician Scientist Individual Research Grants (NMRC/CIRG/1464/2016 and NMRC/CG/017/2013 to E.Y.T.; NMRC/CSA/015/2009 and NMRC/CSA-SI/0004/2015 to S.C.L.), and the Danish Cancer Society (R99-A6362 and R146-A9164 to H.J.D.). This work was also supported by an A*STAR Graduate Academy (A*GA) SINGA (Singapore International Graduate Award) scholarship to G.O. We thank the Histopathology Department from the Institute of Molecular and Cell Biology, A*STAR, for their service in IHC staining and analysis.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Beauverd Y, 2015, EXPERT OPIN PHARMACO, V16, P2381, DOI 10.1517/14656566.2015.1088831; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan D, 2010, INVEST NEW DRUG, V28, P859, DOI 10.1007/s10637-009-9305-x; Cho H, 2014, ONCOTARGET, V5, P3482, DOI 10.18632/oncotarget.1947; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Duffy MJ, 2000, INT J BIOL MARKER, V15, P330, DOI 10.1177/172460080001500410; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Marcato P, 2015, MOL ONCOL, V9, P17, DOI 10.1016/j.molonc.2014.07.010; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Ono S, 2015, ONCOTARGET, V6, P7053, DOI 10.18632/oncotarget.3142; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; PEREIRA B, 2016, NAT COMMUN, V7; Romanel A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9511; Shoda K, 2017, GASTRIC CANCER, V20, P126, DOI 10.1007/s10120-016-0599-z; Singer Jack W, 2016, J Exp Pharmacol, V8, P11, DOI 10.2147/JEP.S110702; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Siravegna G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0449-4; Sturgeon C, 2002, CLIN CHEM, V48, P1151; Tanaka M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1059-6; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Verstovsek S, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0367-x; Wang XY, 2015, AM J CANCER RES, V5, P1484; Wee ZN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10054; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zhang QY, 2015, J CANCER RES CLIN, V141, P691, DOI 10.1007/s00432-014-1830-0	47	91	93	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1319	+		10.1038/nm.4405	http://dx.doi.org/10.1038/nm.4405			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	28967919				2022-12-27	WOS:000414548300014
J	Farr, JN; Xu, M; Weivoda, MM; Monroe, DG; Fraser, DG; Onken, JL; Negley, BA; Sfeir, JG; Ogrodnik, MB; Hachfeld, CM; LeBrasseur, NK; Drake, MT; Pignolo, RJ; Pirtskhalava, T; Tchkonia, T; Oursler, MJ; Kirkland, JL; Khosla, S				Farr, Joshua N.; Xu, Ming; Weivoda, Megan M.; Monroe, David G.; Fraser, Daniel G.; Onken, Jennifer L.; Negley, Brittany A.; Sfeir, Jad G.; Ogrodnik, Mikolaj B.; Hachfeld, Christine M.; LeBrasseur, Nathan K.; Drake, Matthew T.; Pignolo, Robert J.; Pirtskhalava, Tamar; Tchkonia, Tamara; Oursler, Merry Jo; Kirkland, James L.; Khosla, Sundeep			Targeting cellular senescence prevents age-related bone loss in mice	NATURE MEDICINE			English	Article							SECRETORY PHENOTYPE; CELLS; IDENTIFICATION; MASS; OSTEOCLASTOGENESIS; DYSFUNCTION; FRACTURES; ACTIVATOR; ESTROGEN; MATURE	Aging is associated with increased cellular senescence, which is hypothesized to drive the eventual development of multiple comorbidities(1). Here we investigate a role for senescent cells in age-related bone loss through multiple approaches. In particular, we used either genetic (i.e., the INK-ATTAC 'suicide' transgene encoding an inducible caspase 8 expressed specifically in senescent cells(2-4)) or pharmacological (i.e., 'senolytic' compounds(5,6)) means to eliminate senescent cells. We also inhibited the production of the proinflammatory secretome of senescent cells using a JAK inhibitor (JAKi)(3,7). In aged (20- to 22-month-old) mice with established bone loss, activation of the INK-ATTAC caspase 8 in senescent cells or treatment with senolytics or the JAKi for 2-4 months resulted in higher bone mass and strength and better bone microarchitecture than in vehicle-treated mice. The beneficial effects of targeting senescent cells were due to lower bone resorption with either maintained (trabecular) or higher (cortical) bone formation as compared to vehicle-treated mice. In vitro studies demonstrated that senescent-cell conditioned medium impaired osteoblast mineralization and enhanced osteoclast-progenitor survival, leading to increased osteoclastogenesis. Collectively, these data establish a causal role for senescent cells in bone loss with aging, and demonstrate that targeting these cells has both anti-resorptive and anabolic effects on bone. Given that eliminating senescent cells and/or inhibiting their proinflammatory secretome also improves cardiovascular function(4), enhances insulin sensitivity(3), and reduces frailty(7), targeting this fundamental mechanism to prevent age-related bone loss suggests a novel treatment strategy not only for osteoporosis, but also for multiple age-related comorbidities.	[Farr, Joshua N.; Xu, Ming; Weivoda, Megan M.; Monroe, David G.; Fraser, Daniel G.; Onken, Jennifer L.; Negley, Brittany A.; Sfeir, Jad G.; Ogrodnik, Mikolaj B.; Hachfeld, Christine M.; LeBrasseur, Nathan K.; Drake, Matthew T.; Pignolo, Robert J.; Pirtskhalava, Tamar; Tchkonia, Tamara; Oursler, Merry Jo; Kirkland, James L.; Khosla, Sundeep] Mayo Clin, Coll Med, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA; [Farr, Joshua N.; Xu, Ming; Weivoda, Megan M.; Monroe, David G.; Fraser, Daniel G.; Onken, Jennifer L.; Negley, Brittany A.; Sfeir, Jad G.; Ogrodnik, Mikolaj B.; Hachfeld, Christine M.; LeBrasseur, Nathan K.; Drake, Matthew T.; Pignolo, Robert J.; Pirtskhalava, Tamar; Tchkonia, Tamara; Oursler, Merry Jo; Kirkland, James L.; Khosla, Sundeep] Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kirkland, JL; Khosla, S (corresponding author), Mayo Clin, Coll Med, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.; Kirkland, JL; Khosla, S (corresponding author), Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN 55905 USA.	kirkland.james@mayo.edu; khosla.sundeep@mayo.edu	Xu, Ming/L-4044-2019; Ogrodnik, Mikolaj/GSI-9480-2022; Sfeir, Jad G./X-4788-2018; Xu, Ming/AAR-1681-2021; Khosla, Sundeep/AAE-6170-2020	Xu, Ming/0000-0002-4477-939X; Sfeir, Jad G./0000-0003-1576-1534; Khosla, Sundeep/0000-0002-2936-4372; Tchkonia, Tamar/0000-0003-4623-7145; Ogrodnik, Mikolaj/0000-0003-3137-2037	NIH [P01 AG004875, R01 AG048792, K01 AR070241, K01 AR070281, R01 AR068275, R37 AG013925, AG R21 049182]; Connor Group; Noaber; Ted Nash Foundations; Glenn Foundation; High-Risk Pilot Award; Career Development Awards from the Mayo Clinic Robert and Arlene Kogod Center on Aging; Richard F. Emslander Career Development Award in Endocrinology; James A. Ruppe Career Development Award in Endocrinology; Glenn/American Federation for Aging Research Postdoctoral Fellowship for Translational Research on Aging; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067129, R01AR068275, T32AR056950, R01AR065402, K01AR070281, K01AR070241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG049182, R01AG048792, P01AG004875, R37AG013925, R01AG013925] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1369828] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connor Group; Noaber; Ted Nash Foundations; Glenn Foundation; High-Risk Pilot Award; Career Development Awards from the Mayo Clinic Robert and Arlene Kogod Center on Aging; Richard F. Emslander Career Development Award in Endocrinology; James A. Ruppe Career Development Award in Endocrinology; Glenn/American Federation for Aging Research Postdoctoral Fellowship for Translational Research on Aging; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by NIH grants P01 AG004875 (S.K.), R01 AG048792 (S.K.), K01 AR070241 (J.N.F.), K01 AR070281 (M.M.W.), R01 AR068275 (D.G.M.), R37 AG013925 (J.L.K.), AG R21 049182 (J.L.K.), the Connor Group, the Noaber, and the Ted Nash Foundations (J.L.K.), the Glenn Foundation (J.L.K., N.K.L.), and both a High-Risk Pilot Award (J.N.F. and S.K.) and Career Development Awards (J.N.F. and M.M.W.) from the Mayo Clinic Robert and Arlene Kogod Center on Aging, as well as the Richard F. Emslander Career Development Award in Endocrinology (J.N.F.), the James A. Ruppe Career Development Award in Endocrinology (M.M.W.), and the Glenn/American Federation for Aging Research Postdoctoral Fellowship for Translational Research on Aging (M.X.). We thank M. Ruan, G.L. Evans, B.S. Thicke, and J.M. Peterson (Mayo Clinic) for their technical assistance. We also thank A.R. Thoreson, A.W. Hooke (Mayo Clinic), and the Mayo Clinic Materials and Structural Testing Resource Laboratory for performing the bone biomechanical compression and nano-indentation testing.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; BELLIDO T, 1995, J CLIN INVEST, V95, P2886, DOI 10.1172/JCI117995; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Khosla S, 2012, J BONE MINER RES, V27, P506, DOI 10.1002/jbmr.1541; Kirkland JL, 2015, EXP GERONTOL, V68, P19, DOI 10.1016/j.exger.2014.10.012; LeBrasseur NK, 2015, NESTLE NUTR WORKS SE, V83, P11, DOI 10.1159/000382054; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P669, DOI 10.1038/nrd.2016.207; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458; Silva MJ, 2004, BONE, V35, P425, DOI 10.1016/j.bone.2004.03.027; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Swanson EC, 2013, J CELL BIOL, V203, P929, DOI 10.1083/jcb.201306073; Syed FA, 2005, J BONE MINER RES, V20, P1992, DOI 10.1359/JBMR.050713; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; WANG E, 1995, CANCER RES, V55, P2284; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997; Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112; Yi JS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90220; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344; Zhu Y, 2014, CURR OPIN CLIN NUTR, V17, P324, DOI 10.1097/MCO.0000000000000065	45	481	501	13	159	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1072	+		10.1038/nm.4385	http://dx.doi.org/10.1038/nm.4385			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28825716	Green Accepted			2022-12-27	WOS:000409996200014
J	Shan, C; Muruato, AE; Nunes, BTD; Luo, HL; Xie, XP; Medeiros, DBA; Wakamiya, M; Tesh, RB; Barrett, AD; Wang, T; Weaver, SC; Vasconcelos, PFC; Rossi, SL; Shi, PY				Shan, Chao; Muruato, Antonio E.; Nunes, Bruno T. D.; Luo, Huanle; Xie, Xuping; Medeiros, Daniele B. A.; Wakamiya, Maki; Tesh, Robert B.; Barrett, Alan D.; Wang, Tian; Weaver, Scott C.; Vasconcelos, Pedro F. C.; Rossi, Shannan L.; Shi, Pei-Yong			A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models	NATURE MEDICINE			English	Article							YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; CD8(+) T-CELLS; RNA REPLICATION; PROTECTIVE ROLE; INFECTION; MICE; TRANSCOMPLEMENTATION; TRANSLATION; POLYMERASE	Zika virus (ZIKV) infection of pregnant women can cause a wide range of congenital abnormalities, including microcephaly, in the infant, a condition now collectively known as congenital ZIKV syndrome(1). A vaccine to prevent or significantly attenuate viremia in pregnant women who are residents of or travelers to epidemic or endemic regions is needed to avert congenital ZIKV syndrome, and might also help to suppress epidemic transmission. Here we report on a live-attenuated vaccine candidate that contains a 10-nucleotide deletion in the 3' untranslated region of the ZIKV genome (10-del ZIKV). The 10-del ZIKV is highly attenuated, immunogenic, and protective in type 1 interferon receptor-deficient A129 mice. Crucially, a single dose of 10-del ZIKV induced sterilizing immunity with a saturated neutralizing antibody titer, which no longer increased after challenge with an epidemic ZIKV, and completely prevented viremia. The immunized mice also developed a robust T cell response. Intracranial inoculation of 1-d-old immunocompetent CD-1 mice with 1 x 10(4) infectious focus units (IFU) of 10-del ZIKV caused no mortality, whereas infections with 10 IFU of wild-type ZIKV were lethal. Mechanistically, the attenuated virulence of 10-del ZIKV may be due to decreased viral RNA synthesis and increased sensitivity to type-1-interferon inhibition. The attenuated 10-del ZIKV was incapable of infecting mosquitoes after oral feeding of spiked-blood meals, representing an additional safety feature. Collectively, the safety and efficacy results suggest that further development of this promising, live-attenuated ZIKV vaccine candidate is warranted.	[Shan, Chao; Nunes, Bruno T. D.; Xie, Xuping; Medeiros, Daniele B. A.; Wakamiya, Maki; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Muruato, Antonio E.; Tesh, Robert B.; Barrett, Alan D.; Weaver, Scott C.; Rossi, Shannan L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Muruato, Antonio E.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil; [Luo, Huanle; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Tesh, Robert B.; Barrett, Alan D.; Wang, Tian; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Tesh, Robert B.; Barrett, Alan D.; Wang, Tian; Rossi, Shannan L.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA; [Wang, Tian; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Vasconcelos, Pedro F. C.] Para State Univ, Dept Pathol, Belem, Para, Brazil; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Instituto Evandro Chagas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Universidade do Estado do Para (UEPA); University of Texas System; University of Texas Medical Branch Galveston	Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	slrossi@utmb.edu; peshi@utmb.edu	Weaver, Scott C/D-6490-2011; Shan, Chao/AAN-8190-2021; Xie, Xuping/AAD-7406-2019; amsalu, ribka/G-8780-2019; Vasconcelos, Pedro/AAH-3142-2019	Weaver, Scott C/0000-0001-8016-8556; Shan, Chao/0000-0002-3953-3782; 	University of Texas Medical Branch (UTMB) start-up award; UTMB Innovation and Commercialization award; University of Texas STARs Award; CDC grant for the Western Gulf Center of Excellence for Vector-Borne Diseases; Pan American Health Organization [SCON2016-01353]; UTMB CTSA [UL1TR-001439]; US National Institutes of Health [AI120942]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI120942] Funding Source: NIH RePORTER	University of Texas Medical Branch (UTMB) start-up award; UTMB Innovation and Commercialization award; University of Texas STARs Award; CDC grant for the Western Gulf Center of Excellence for Vector-Borne Diseases; Pan American Health Organization; UTMB CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank colleagues at the University of Texas Medical Branch for their helpful discussions during the course of this study. We are grateful to M.A. Garcia-Blanco and S.S. Brarick for providing lab space and equipment during the early stage of this work. P.-Y.S. was supported by a University of Texas Medical Branch (UTMB) start-up award, UTMB Innovation and Commercialization award, University of Texas STARs Award, CDC grant for the Western Gulf Center of Excellence for Vector-Borne Diseases, Pan American Health Organization grant SCON2016-01353, and UTMB CTSA UL1TR-001439. This research was also partially supported by a US National Institutes of Health grant AI120942 to S.C.W.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631; Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23; Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990; Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302; Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845; Khromykh AA, 1999, J VIROL, V73, P9247, DOI 10.1128/JVI.73.11.9247-9255.1999; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004; Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727; *WHO, 1987, WHO TECH REP SER, V747, P1; Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]; Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013; Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004; Yun SI, 2016, J GEN VIROL, V97, P2575, DOI 10.1099/jgv.0.000574	36	180	193	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					763	+		10.1038/nm.4322	http://dx.doi.org/10.1038/nm.4322			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28394328	Green Accepted			2022-12-27	WOS:000402768000019
J	Zhang, B; Pinsky, BA; Ananta, JS; Zhao, S; Arulkumar, S; Wan, H; Sahoo, MK; Abeynayake, J; Waggoner, JJ; Hopes, C; Tang, MJ; Dai, HJ				Zhang, Bo; Pinsky, Benjamin A.; Ananta, Jeyarama S.; Zhao, Su; Arulkumar, Shylaja; Wan, Hao; Sahoo, Malaya K.; Abeynayake, Janaki; Waggoner, Jesse J.; Hopes, Clay; Tang, Meijie; Dai, Hongjie			Diagnosis of Zika virus infection on a nanotechnology platform	NATURE MEDICINE			English	Article								We developed a multiplexed assay on a plasmonic-gold platform for measuring IgG and IgA antibodies and IgG avidity against both Zika virus (ZIKV) and dengue virus (DENV) infections. In contrast to IgM cross-reactivity, IgG and IgA antibodies against ZIKV nonstructural protein 1 (NS1) antigen were specific to ZIKV infection, and IgG avidity revealed recent ZIKV infection and past DENV-2 infection in patients in dengue-endemic regions. This assay could enable specific diagnosis of ZIKV infection over other flaviviral infections.	[Zhang, Bo; Ananta, Jeyarama S.; Zhao, Su; Arulkumar, Shylaja; Hopes, Clay; Tang, Meijie] Nirmidas Biotech, Palo Alto, CA 94303 USA; [Pinsky, Benjamin A.; Sahoo, Malaya K.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Pinsky, Benjamin A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA; [Wan, Hao] South Univ Sci & Technol China, Dept Mat Sci & Engn, Shenzhen, Peoples R China; [Abeynayake, Janaki] Med Res Inst, Colombo, Sri Lanka; [Waggoner, Jesse J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University; Southern University of Science & Technology; Medical Research Institute Sri Lanka (MRI); Emory University; Stanford University	Zhang, B (corresponding author), Nirmidas Biotech, Palo Alto, CA 94303 USA.; Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bo.zhang@nirmidas.com; hdai1@stanford.edu	Dai, Hongjie/ABC-4574-2021; Zhang, Bo/J-9536-2018; Sahoo, Malaya Kumar/AAS-6907-2020	Zhang, Bo/0000-0003-0743-4816; Sahoo, Malaya Kumar/0000-0001-9837-4032; Pinsky, Benjamin/0000-0001-8751-4810; Arulkumar, Shylaja/0000-0001-5313-0595; Zhang, Bo/0000-0001-8745-2752				Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Li X, 2016, J CLIN MICROBIOL; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426; Tabakman SM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1477; US Centers for Disease Control and Prevention-Division of Vector-Borne Diseases, 2016, MEM; Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326; Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16; WELLIVER RC, 1980, J PEDIATR-US, V96, P808, DOI 10.1016/S0022-3476(80)80547-6; Wong S. J., 2017, EBIOMEDICINE; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zhang B, 2014, NAT MED, V20, P948, DOI 10.1038/nm.3619	15	97	104	4	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					548	+		10.1038/nm.4302	http://dx.doi.org/10.1038/nm.4302			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28263312				2022-12-27	WOS:000400650700009
J	Jorch, SK; Kubes, P				Jorch, Selina K.; Kubes, Paul			An emerging role for neutrophil extracellular traps in noninfectious disease	NATURE MEDICINE			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PEPTIDYLARGININE-DEIMINASE TYPE-4; SMALL-VESSEL VASCULITIS; STAPHYLOCOCCUS-AUREUS; NET FORMATION; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; NETTING NEUTROPHILS; MITOCHONDRIAL-DNA; PROSTAGLANDIN E-2	The production of neutrophil extracellular traps (NETs) is a process that enables neutrophils to help catch and kill bacteria. However, increasing evidence suggests that this process might also occur in noninfectious, sterile inflammation. In this Review, we describe the role of NETosis in autoimmunity, coagulation, acute injuries and cancer, and discuss NETs as potential therapeutic targets. Furthermore, we consider whether extracellular DNA is always detrimental in sterile inflammation and whether the source is always NETs.	[Jorch, Selina K.; Kubes, Paul] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Immunol Res Grp, Calgary, AB, Canada	University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Kubes, P (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Immunol Res Grp, Calgary, AB, Canada.	pkubes@ucalgary.ca			Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Heart and Stroke Foundation of Canada; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chairs program(Canada Research Chairs)	We thank C. Deppermann for proofreading the manuscript. Work in the authors' laboratory is supported by grants from the Canadian Institutes of Health Research, Alberta Innovates Health Solutions, the Heart and Stroke Foundation of Canada and the Canada Research Chairs program.	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Barnado A, 2016, J LEUKOCYTE BIOL, V99, P265, DOI 10.1189/jlb.5BT0615-234R; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Carmona-Rivera C, 2015, ANN RHEUM DIS, V74, P1417, DOI 10.1136/annrheumdis-2013-204837; Cedervall J, 2015, CANCER RES, V75, P2653, DOI 10.1158/0008-5472.CAN-14-3299; Chang HH, 2015, ARTHRITIS RHEUMATOL, V67, P2323, DOI 10.1002/art.39215; Chowdhury CS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4579; Christensen AD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00213; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Demers M, 2014, SEMIN THROMB HEMOST, V40, P277, DOI 10.1055/s-0034-1370765; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Domingo-Gonzalez R, 2016, AM J RESP CRIT CARE, V193, P186, DOI 10.1164/rccm.201501-0161OC; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Garcia RJ, 2013, ARTHRITIS RHEUM-US, V65, P1313, DOI 10.1002/art.37893; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Guglietta S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11037; Gupta S, 2016, NAT REV NEPHROL, V12, P402, DOI 10.1038/nrneph.2016.71; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hampson P., 2016, ANN SURG; Harper L, 2001, KIDNEY INT, V59, P1729, DOI 10.1046/j.1523-1755.2001.0590051729.x; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Ho-Tin-Noe B, 2009, AM J PATHOL, V175, P1699, DOI 10.2353/ajpath.2009.090460; Huang XF, 2015, CELL REP, V12, P1120, DOI 10.1016/j.celrep.2015.07.021; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Imamoto T, 2014, CLIN EXP RHEUMATOL, V32, P149; Jenne CN, 2016, NAT REV GASTRO HEPAT, V13, P381, DOI 10.1038/nrgastro.2016.90; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Kallenberg CGM, 2014, NAT REV RHEUMATOL, V10, P484, DOI 10.1038/nrrheum.2014.104; Kambas K, 2014, ANN RHEUM DIS, V73, P1854, DOI 10.1136/annrheumdis-2013-203430; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knight JS, 2014, CIRC RES, V114, P947, DOI 10.1161/CIRCRESAHA.114.303312; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Lee HT, 2016, MITOCHONDRION, V30, P1, DOI 10.1016/j.mito.2016.05.007; Levi M, 2016, THROMB RES, V140, pS66, DOI 10.1016/S0049-3848(16)30101-3; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; Maicas N, 2011, ANTIOXID REDOX SIGN, V15, P889, DOI 10.1089/ars.2010.3835; Malachowa N, 2013, J IMMUNOL, V191, P6022, DOI 10.4049/jimmunol.1301821; Martinod K, 2016, J THROMB HAEMOST, V14, P551, DOI 10.1111/jth.13239; Martinod K, 2015, BLOOD, V125, P1948, DOI 10.1182/blood-2014-07-587709; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Nahrendorf M, 2015, SCIENCE, V349, P237, DOI 10.1126/science.aac7801; Papayannopoulos V, 2015, IMMUNITY, V43, P223, DOI 10.1016/j.immuni.2015.08.002; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pendergraft WF, 2004, NAT MED, V10, P72, DOI 10.1038/nm968; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Rai R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166312; Range H, 2014, ATHEROSCLEROSIS, V236, P448, DOI 10.1016/j.atherosclerosis.2014.07.034; Rao AN, 2015, WORLD J CARDIOL, V7, P829, DOI 10.4330/wjc.v7.i12.829; Rochael NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18302; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Rohrbach AS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3829; Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Seri Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13041; Shishikura K, 2016, BRIT J PHARMACOL, V173, P319, DOI 10.1111/bph.13373; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Slaba I, 2015, HEPATOLOGY, V62, P1593, DOI 10.1002/hep.28003; Soderberg D, 2015, RHEUMATOLOGY, V54, P2085, DOI 10.1093/rheumatology/kev217; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stakos DA, 2015, EUR HEART J, V36, P1405, DOI 10.1093/eurheartj/ehv007; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Van Avondt K, 2016, J IMMUNOL, V196, P3686, DOI 10.4049/jimmunol.1501650; Van Avondt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078459; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wang W, 2014, LIFE SCI, V117, P19, DOI 10.1016/j.lfs.2014.09.012; Wang YD, 2014, DIABETES, V63, P4239, DOI 10.2337/db14-0480; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zheng W, 2015, J PHARMACOL EXP THER, V353, P288, DOI 10.1124/jpet.114.221788	94	582	609	15	176	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					279	287		10.1038/nm.4294	http://dx.doi.org/10.1038/nm.4294			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28267716				2022-12-27	WOS:000395848400008
J	Wong, YC; Krainc, D				Wong, Yvette C.; Krainc, Dimitri			alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies	NATURE MEDICINE			English	Review							MULTIPLE-SYSTEM ATROPHY; A-BETA COMPONENT; CHAPERONE-MEDIATED AUTOPHAGY; SPORADIC PARKINSONS-DISEASE; MIDBRAIN DOPAMINE NEURONS; SUBSTANTIA-NIGRA NEURONS; TRANSGENIC MOUSE MODEL; LEWY BODY; IN-VIVO; ALZHEIMERS-DISEASE	Alterations in a-synuclein dosage lead to familial Parkinson's disease (PD), and its accumulation results in synucleinopathies that include PD, dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). Furthermore, alpha-synuclein contributes to the fibrilization of amyloid-beta and tau, two key proteins in Alzheimer's disease, which suggests a central role for alpha-synuclein toxicity in neurodegeneration. Recent studies of factors contributing to alpha-synuclein toxicity and its disruption of downstream cellular pathways, have expanded our understanding of disease pathogenesis in synucleinopathies.	[Wong, Yvette C.; Krainc, Dimitri] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Krainc, D (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	krainc@northwestern.edu			NIH/NINDS [R01 NS076054, 5T32NS041234]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076054] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS R01 NS076054 (D.K.) and NIH/NINDS 5T32NS041234 (Y.C.W.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Abounit S, 2016, EMBO J, V35, P2120, DOI 10.15252/embj.201593411; Aflaki E, 2016, J NEUROSCI, V36, P7441, DOI 10.1523/JNEUROSCI.0636-16.2016; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Arber CE, 2016, NEUROPATH APPL NEURO, V42, P220, DOI 10.1111/nan.12242; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bachhuber T, 2015, NAT MED, V21, P802, DOI 10.1038/nm.3885; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bergstrom AL, 2016, MOVEMENT DISORD, V31, P203, DOI 10.1002/mds.26481; Blanz J, 2016, J NEUROCHEM, V139, P198, DOI 10.1111/jnc.13517; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Caraveo G, 2014, P NATL ACAD SCI USA, V111, pE3544, DOI 10.1073/pnas.1413201111; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Chen-Plotkin AS, 2014, NEURON, V84, P594, DOI 10.1016/j.neuron.2014.10.031; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Chutna O, 2014, HUM MOL GENET, V23, P6732, DOI 10.1093/hmg/ddu391; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cooper JM, 2014, MOVEMENT DISORD, V29, P1476, DOI 10.1002/mds.25978; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Daher JPL, 2015, J BIOL CHEM, V290, P19433, DOI 10.1074/jbc.M115.660001; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Daniele SG, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005965; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dettmer U, 2015, P NATL ACAD SCI USA, V112, P9596, DOI 10.1073/pnas.1505953112; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Eschbach J, 2015, ANN NEUROL, V77, P15, DOI 10.1002/ana.24294; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Fares MB, 2016, P NATL ACAD SCI USA, V113, pE912, DOI 10.1073/pnas.1512876113; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fonseca-Ornelas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6857; Frigerio R, 2011, NEUROBIOL AGING, V32, P857, DOI 10.1016/j.neurobiolaging.2009.05.019; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goldman JG, 2014, MOVEMENT DISORD, V29, P608, DOI 10.1002/mds.25866; Gould N, 2014, J BIOL CHEM, V289, P7929, DOI 10.1074/jbc.C113.538249; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Halliday GM, 2005, BRAIN, V128, P2272, DOI 10.1093/brain/awh596; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kim C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0455-9; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lewis J, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-19; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Lindstrom V, 2014, NEUROBIOL DIS, V69, P134, DOI 10.1016/j.nbd.2014.05.009; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Luo J, 2014, HUM MOL GENET, V23, P6567, DOI 10.1093/hmg/ddu377; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Mazzulli JR, 2016, J NEUROSCI, V36, P7693, DOI 10.1523/JNEUROSCI.0628-16.2016; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oaks AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070872; Oh SH, 2016, CELL REP, V14, P835, DOI 10.1016/j.celrep.2015.12.075; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Pchelina SN, 2014, NEUROSCI LETT, V583, P188, DOI 10.1016/j.neulet.2014.09.041; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qin HW, 2016, J NEUROSCI, V36, P5144, DOI 10.1523/JNEUROSCI.4658-15.2016; Rey NL, 2016, J EXP MED, V213, P1759, DOI 10.1084/jem.20160368; Rocha EM, 2015, NEUROBIOL DIS, V82, P495, DOI 10.1016/j.nbd.2015.09.009; Rockenstein E, 2016, HUM MOL GENET, V25, P2645, DOI 10.1093/hmg/ddw124; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rothaug M, 2014, P NATL ACAD SCI USA, V111, P15573, DOI 10.1073/pnas.1405700111; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Rousseaux MWC, 2016, ELIFE, V5, DOI 10.7554/eLife.19809; Roy B, 2014, HUM MOL GENET, V23, P3008, DOI 10.1093/hmg/ddu011; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Schneeberger A, 2016, MOVEMENT DISORD, V31, P214, DOI 10.1002/mds.26377; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Sybertz E, 2014, J LIPID RES, V55, P1996, DOI 10.1194/jlr.R047381; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Thome AD, 2016, J NEUROSCI, V36, P2383, DOI 10.1523/JNEUROSCI.3900-15.2016; Tilve S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16524; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Trinh J, 2014, JAMA NEUROL, V71, P1535, DOI 10.1001/jamaneurol.2014.1909; Tsunemi T, 2014, J NEUROSCI, V34, P15281, DOI 10.1523/JNEUROSCI.1629-14.2014; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; Valera E, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0320-x; Van der Perren A, 2015, NEUROBIOL AGING, V36, P1559, DOI 10.1016/j.neurobiolaging.2015.01.014; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Volpicelli-Daley LA, 2016, J NEUROSCI, V36, P7415, DOI 10.1523/JNEUROSCI.3642-15.2016; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Wang SJ, 2015, P NATL ACAD SCI USA, V112, pE1926, DOI 10.1073/pnas.1417883112; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Woerman AL, 2015, P NATL ACAD SCI USA, V112, pE4949, DOI 10.1073/pnas.1513426112; Wong YC, 2016, MOVEMENT DISORD, V31, P1610, DOI 10.1002/mds.26802; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	215	429	446	9	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					151	163		10.1038/nm.4269	http://dx.doi.org/10.1038/nm.4269			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170377	Green Accepted			2022-12-27	WOS:000393729000007
J	Anhe, FF; Marette, A				Anhe, Fernando Forato; Marette, Andre			A microbial protein that alleviates metabolic syndrome	NATURE MEDICINE			English	Editorial Material							AKKERMANSIA-MUCINIPHILA; BACTERIUM	A recent study shows that pasteurization of Akkermansia muciniphila enhances the bacterium's ability to reduce fat mass and metabolic syndrome in mice with diet-induced obesity, and that Amuc_1100*, a thermostable outer-membrane protein of A. muciniphila, can reproduce these beneficial effects.	[Anhe, Fernando Forato; Marette, Andre] Univ Laval, Fac Med Cardiol Axis, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ, Canada; [Anhe, Fernando Forato; Marette, Andre] Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute; Laval University	Marette, A (corresponding author), Univ Laval, Fac Med Cardiol Axis, Quebec Heart & Lung Inst, Dept Med, Quebec City, PQ, Canada.; Marette, A (corresponding author), Univ Laval, Inst Nutr & Funct Foods, Quebec City, PQ, Canada.	andre.marette@criucpq.ulaval.ca	Anhê, Fernando Forato/ABD-3859-2020	Forato Anhe, Fernando/0000-0003-1543-4154; Marette, Andre/0000-0003-3950-5973				Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M., 2016, MICROB PATHOG; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Ottman N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01157; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11	10	24	27	6	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					11	12		10.1038/nm.4261	http://dx.doi.org/10.1038/nm.4261			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	28060804				2022-12-27	WOS:000391646800006
J	Wager, TD; Woo, CW				Wager, Tor D.; Woo, Choong-Wan			Imaging biomarkers and biotypes for depression	NATURE MEDICINE			English	Editorial Material								A new study identifies four distinct 'biotypes' of depression on the basis of fMRI resting-state functional connectivity in a diverse sample of more than 1,000 individuals. The biotypes are diagnostic of depression and predict treatment response.	[Wager, Tor D.; Woo, Choong-Wan] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Wager, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	tor.wager@colorado.edu	Woo, Choong-Wan/J-2030-2019	Woo, Choong-Wan/0000-0002-7423-5422				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250; Sanislow CA, 2010, J ABNORM PSYCHOL, V119, P631, DOI 10.1037/a0020909; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471	9	21	22	2	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					16	17		10.1038/nm.4264	http://dx.doi.org/10.1038/nm.4264			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	28060802				2022-12-27	WOS:000391646800009
J	Babon, JAB; DeNicola, ME; Blodgett, DM; Crevecoeur, I; Buttrick, TS; Maehr, R; Bottino, R; Naji, A; Kaddis, J; Elyaman, W; James, EA; Haliyur, R; Brissova, M; Overbergh, L; Mathieu, C; Delong, T; Haskins, K; Pugliese, A; Campbell-Thompson, M; Mathews, C; Atkinson, MA; Powers, AC; Harlan, DM; Kent, SC				Babon, Jenny Aurielle B.; DeNicola, Megan E.; Blodgett, David M.; Crevecoeur, Inne; Buttrick, Thomas S.; Maehr, Rene; Bottino, Rita; Naji, Ali; Kaddis, John; Elyaman, Wassim; James, Eddie A.; Haliyur, Rachana; Brissova, Marcela; Overbergh, Lut; Mathieu, Chantal; Delong, Thomas; Haskins, Kathryn; Pugliese, Alberto; Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.; Powers, Alvin C.; Harlan, David M.; Kent, Sally C.			Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes	NATURE MEDICINE			English	Article							POSTTRANSLATIONAL MODIFICATION; RECENT-ONSET; PANCREAS; INSULIN; MELLITUS; EPITOPES; PATHOGENESIS; PEPTIDE; IMMUNOSUPPRESSION; AUTOANTIGENS	A major therapeutic goal for type 1 diabetes (T1D) is to induce autoantigen-specific tolerance of T cells. This could suppress autoimmunity in those at risk for the development of T1D, as well as in those with established disease who receive islet replacement or regeneration therapy. Because functional studies of human autoreactive T cell responses have been limited largely to peripheral blood-derived T cells(1-3), it is unclear how representative the peripheral T cell repertoire is of T cells infiltrating the islets. Our knowledge of the insulitic T cell repertoire is derived from histological and immunohistochemical analyses of insulitis(4-8), the identification of autoreactive CD8(+) T cells in situ, in islets of human leukocyte antigen (HLA)-A2(+) donors(9) and isolation and identification of DQ8 and DQ2-DQ8 heterodimer-restricted, proinsulin-reactive CD4(+) T cells grown from islets of a single donor with T1D(10). Here we present an analysis of 50 of a total of 236 CD4(+) and CD8(+) T cell lines grown from individual handpicked islets or clones directly sorted from handpicked, dispersed islets from nine donors with T1D. Seventeen of these T cell lines and clones reacted to a broad range of studied native islet antigens and to post-translationally modified peptides. These studies demonstrate the existence of a variety of islet-infiltrating, islet-autoantigen reactive T cells in individuals with T1D, and these data have implications for the design of successful immunotherapies.	[Babon, Jenny Aurielle B.; DeNicola, Megan E.; Blodgett, David M.; Harlan, David M.; Kent, Sally C.] Univ Massachusetts, Sch Med, Dept Med, Div Diabet,Diabet Ctr Excellence, Worcester, MA 01655 USA; [Crevecoeur, Inne; Overbergh, Lut; Mathieu, Chantal] Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Clin & Expt Endocrinol, Leuven, Belgium; [Buttrick, Thomas S.; Elyaman, Wassim] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Buttrick, Thomas S.; Elyaman, Wassim] Harvard Med Sch, Boston, MA USA; [Maehr, Rene] Univ Massachusetts, Sch Med, Program Mol Med, Diabet Ctr Excellence, Worcester, MA USA; [Bottino, Rita] Allegheny Singer Res Inst, Inst Cellular Therapeut, 320 E N Ave, Pittsburgh, PA 15212 USA; [Bottino, Rita] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Naji, Ali] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Kaddis, John] City Hope Natl Med Ctr, Beckman Res Inst, Dept Informat Sci, Duarte, CA USA; [James, Eddie A.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA; [Haliyur, Rachana; Brissova, Marcela; Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Delong, Thomas; Haskins, Kathryn] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA; [Pugliese, Alberto] Univ Miami, Diabet Res Inst, Miami, FL USA; [Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.] Univ Florida, Dept Immunol, Gainesville, FL USA; [Campbell-Thompson, Martha; Mathews, Clayton; Atkinson, Mark A.] Univ Florida, Dept Lab Med, Gainesville, FL USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	University of Massachusetts System; University of Massachusetts Worcester; KU Leuven; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Carnegie Mellon University; University of Pennsylvania; City of Hope; Beckman Research Institute of City of Hope; Benaroya Research Institute; Virginia Mason Medical Center; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Kent, SC (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Diabet,Diabet Ctr Excellence, Worcester, MA 01655 USA.	Sally.Kent@umassmed.edu	Elyaman, Wassim/AAJ-1562-2021; mathieu, chantal/ABD-5505-2021; Overbergh, Lut/AAC-3515-2020; James, Eddie/V-4929-2019; Campbell-Thompson, Martha/A-7584-2010	mathieu, chantal/0000-0002-4055-5233; James, Eddie/0000-0002-7217-5729; Campbell-Thompson, Martha/0000-0001-6878-1235; Elyaman, Wassim/0000-0001-7238-374X; Kaddis, John/0000-0002-6752-7670; Haliyur, Rachana/0000-0002-3916-4286	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126189, P01AI042288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R24DK106755, U01DK089572, UC4DK104155, P30DK020593, UC4DK104194, R01DK074656, R01DK081166, UC4DK104211, UC4DK108120, U01DK072473, U01DK104162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI126189, P01 AI042288] Funding Source: Medline; NIDDK NIH HHS [P30 DK020593, P60 DK020593, R01 DK074656, U01 DK104162, UC4 DK104155, R24 DK106755, UC4 DK104194, UC4 DK104211, U01 DK089572, R01 DK081166, UC4 DK108120, U01 DK072473] Funding Source: Medline; NIGMS NIH HHS [T32 GM007347] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Atkinson MA, 2015, DIABETES CARE, V38, P979, DOI 10.2337/dc15-0144; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Bottino R., 2012, J TRANSPLANT, V2012; Campbell-Thompson ML, 2013, DIABETOLOGIA, V56, P2541, DOI 10.1007/s00125-013-3043-5; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Codina-Busqueta E, 2011, J IMMUNOL, V186, P3787, DOI 10.4049/jimmunol.1002423; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Delong T, 2012, DIABETES, V61, P3239, DOI 10.2337/db12-0112; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gudmann NS, 2015, AUTOIMMUNITY, V48, P73, DOI 10.3109/08916934.2014.962024; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Joffe M, 2012, INT IMMUNOL, V24, P447, DOI 10.1093/intimm/dxs042; Krogvold L, 2016, DIABETOLOGIA, V59, P492, DOI 10.1007/s00125-015-3820-4; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Liu EH, 2009, DIABETOLOGIA, V52, P1369, DOI 10.1007/s00125-009-1342-7; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; McGinty JW, 2014, DIABETES, V63, P3033, DOI 10.2337/db13-1952; McLaughlin RJ, 2016, CLIN EXP IMMUNOL, V185, P133, DOI 10.1111/cei.12775; Nepom GT, 2005, ADV IMMUNOL, V88, P51, DOI 10.1016/S0065-2776(05)88002-2; Pathiraja V, 2015, DIABETES, V64, P172, DOI 10.2337/db14-0858; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Rondas Dieter, 2015, Diabetes, V64, P573, DOI 10.2337/db14-0621; Rowe PA, 2011, SEMIN IMMUNOPATHOL, V33, P29, DOI 10.1007/s00281-010-0208-x; SIBLEY RK, 1985, LAB INVEST, V53, P132; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Staeva TP, 2013, DIABETES, V62, P9, DOI 10.2337/db12-0562; Strollo R, 2015, DIABETOLOGIA, V58, P2851, DOI 10.1007/s00125-015-3746-x; van Lummel M, 2016, DIABETES, V65, P732, DOI 10.2337/db15-1031; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; VELD PI, 2010, DIABETES, V59, P1702, DOI DOI 10.2337/DB09-1698; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Yin L, 2013, PROTEIN CELL, V4, P8, DOI 10.1007/s13238-012-2077-7	40	189	191	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1482	+		10.1038/nm.4203	http://dx.doi.org/10.1038/nm.4203			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27798614	Green Accepted			2022-12-27	WOS:000389549000027
J	Muffat, J; Yuan, BB; Mitalipoya, M; Omer, A; Corcoran, S; Bakiasi, G; Tsai, LH; Aubourg, P; Ransohoff, RM; Jaenisch, R				Muffat, Julien; Yuan, Bingbing; Mitalipoya, Maisam; Omer, Attya; Corcoran, Sean; Bakiasi, Grisilda; Tsai, Li-Huei; Aubourg, Patrick; Ransohoff, Richard M.; Jaenisch, Rudolf			Efficient derivation of microglia-like cells from human pluripotent stem cells	NATURE MEDICINE			English	Article							TISSUE-RESIDENT MACROPHAGES; RETT-SYNDROME; MYELOID CELLS; BRAIN; NEURONS; MOUSE; PU.1; DIFFERENTIATION; PRECURSORS; ONTOGENY	Microglia, the only lifelong resident immune cells of the central nervous system (CNS), are highly specialized macrophages that have been recognized to have a crucial role in neurodegenerative diseases such as Alzheimer's, Parkinson's and adrenoleukodystrophy (ALD). However, in contrast to other cell types of the human CNS, bona fide microglia have not yet been derived from cultured human pluripotent stem cells. Here we establish a robust and efficient protocol for the rapid production of microglia-like cells from human (h) embryonic stem (ES) and induced pluripotent stem (iPS) cells that uses defined serum free culture conditions. These in vitro pluripotent stem cell-derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and characteristics of their in vivo counterparts, and they resemble primary fetal human and mouse microglia. We generated these cells from multiple disease-specific cell lines and find that pMGLs derived from an hES model of Rett syndrome are smaller than their isogenic controls. We further describe a platform to study the integration and live behavior of pMGLs in organotypic 3D cultures. This modular differentiation system allows for the study of microglia in highly defined conditions as they mature in response to developmentally relevant cues, and it provides a framework in which to study the long-term interactions of microglia residing in a tissue-like environment.	[Muffat, Julien; Yuan, Bingbing; Mitalipoya, Maisam; Omer, Attya; Corcoran, Sean; Bakiasi, Grisilda; Tsai, Li-Huei; Jaenisch, Rudolf] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Omer, Attya] Univ Paris 11, INSERM, U1169, Orsay, France; [Corcoran, Sean; Jaenisch, Rudolf] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bakiasi, Grisilda] Bryn Mawr Coll, Bryn Mawr, PA 19010 USA; [Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Aubourg, Patrick] GTDesign, Le Kremlin Bicetre, France; [Ransohoff, Richard M.] Biogen, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Massachusetts Institute of Technology (MIT); Bryn Mawr College; Massachusetts Institute of Technology (MIT); Northwell Health; Biogen	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jaenisch@wi.mit.edu	Li, Yun/C-3367-2011	Li, Yun/0000-0002-5849-5910; OMER JAVED, Attya/0000-0001-8889-5686; Muffat, Julien/0000-0003-1889-7023	European Leukodystrophy Association; Brain & Behavior Research Foundation; Simons postdoctoral fellowship; International Rett Syndrome Foundation (IRSF) postdoctoral fellowship; Simons undergraduate scholarship; Amgen Scholarship; H.H.M.I.; Simons Foundation [SFARI 204106]; NIH [HD 045022, R37-CA084198, NS088538, IRF1 AG042978]; ELA foundation; Emerald foundation and Biogen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG048029, RF1AG042978] Funding Source: NIH RePORTER	European Leukodystrophy Association; Brain & Behavior Research Foundation(NARSAD); Simons postdoctoral fellowship; International Rett Syndrome Foundation (IRSF) postdoctoral fellowship; Simons undergraduate scholarship; Amgen Scholarship; H.H.M.I.(Howard Hughes Medical Institute); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ELA foundation; Emerald foundation and Biogen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank L. Freland-Gobaille, D. Fu, R. Alagappan, T. Lungjangwa and S. Elmsaouri for technical support, and all members of the Jaenisch lab for helpful discussions. We thank P. Thiru and G. Bell at WIBR's Bioinformatics and Research Computing group for help and advice with sequencing-data analysis. Confocal microscopy and wound assays were performed at the Keck Facility, with the precious help of W Salmon. We thank P. Wisniewski and C. Zollo for help with cell sorting. We thank T. Volkert, J. Love and S. Gupta at the WIGTC for help with library preparation and sequencing. J.M. received funding from the European Leukodystrophy Association and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. Y.L. received funding from a Simons postdoctoral fellowship, an International Rett Syndrome Foundation (IRSF) postdoctoral fellowship and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. S.C. was the recipient of a Simons undergraduate scholarship and an Amgen Scholarship. G.B. was supported by H.H.M.I. Work for this project was supported by a grant from the Simons Foundation (SFARI 204106 R.J.), NIH grants HD 045022, R37-CA084198 and NS088538, the ELA foundation, the Emerald foundation and Biogen (to R.J.) and NIH IRF1 AG042978 to L.-H.T.	Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Aubourg P, 2015, BRAIN, V138, DOI 10.1093/brain/awv271; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Beutner C, 2010, NAT PROTOC, V5, P1481, DOI 10.1038/nprot.2010.90; Butovsky O, 2007, MOL CELL NEUROSCI, V35, P490, DOI 10.1016/j.mcn.2007.04.009; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Smith Amy M, 2013, Methods Mol Biol, V1041, P41, DOI 10.1007/978-1-62703-520-0_6; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Vitner EB, 2015, BIOL CHEM, V396, P659, DOI 10.1515/hsz-2014-0301; Vitry S, 2003, J NEUROSCI, V23, P10724; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	43	351	359	8	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1358	1367		10.1038/nm.4189	http://dx.doi.org/10.1038/nm.4189			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668937	Green Accepted, Green Published			2022-12-27	WOS:000387302300030
J	Quadrato, G; Brown, J; Arlotta, P				Quadrato, Giorgia; Brown, Juliana; Arlotta, Paola			The promises and challenges of human brain organoids as models of neuropsychiatric disease	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; IPSC-DERIVED NEURONS; PSYCHIATRIC-DISORDERS; HUMAN ES; CEREBRAL ORGANOIDS; SELF-ORGANIZATION; GENETIC RISK; SCHIZOPHRENIA; DIFFERENTIATION; DYSREGULATION	Neuropsychiatric disorders such as autism spectrum disorder (ASD), schizophrenia (SCZ) and bipolar disorder (BPD) are of great societal and medical importance, but the complexity of these diseases and the challenges of modeling the development and function of the human brain have made these disorders difficult to study experimentally. The recent development of 3D brain organoids derived from human pluripotent stem cells offers a promising approach for investigating the phenotypic underpinnings of these highly polygenic disorders and for understanding the contribution of individual risk variants and complex genetic background to human pathology. Here we discuss the advantages, limitations and future applications of human brain organoids as in vitro models of neuropsychiatric disease.	[Quadrato, Giorgia; Brown, Juliana; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	paola_arlotta@harvard.edu	Quadrato, Giorgia/G-7808-2018	Quadrato, Giorgia/0000-0003-0717-4874; Brown, Juliana/0000-0002-0412-8197	US National Institutes of Health [NS078164, MH101268]; Stanley Center for Psychiatric Disease of the Broad Institute of MIT and Harvard; Harvard Brain Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078164] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Center for Psychiatric Disease of the Broad Institute of MIT and Harvard; Harvard Brain Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Hyman, L. Rubin, E. Robinson and K. Lilliehook for their critical discussion and suggestions for this manuscript. We are grateful to N. Maria and J. Nguyen for editing of the manuscript, and D. Sun for creating the illustrations for this article. P.A. is a NYSC Robertson Investigator. Work in the Arlotta lab is supported by grants to P.A. the US National Institutes of Health (NS078164 and MH101268), the Stanley Center for Psychiatric Disease of the Broad Institute of MIT and Harvard, and the Harvard Brain Initiative. We apologize to colleagues whose work we could not cite because of space limitations.	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; de Bartolomeis A, 2014, MOL NEUROBIOL, V49, P484, DOI 10.1007/s12035-013-8534-3; Doherty JL, 2014, GENOME MED, V6, DOI 10.1186/gm546; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Egbujo CN, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0710-5; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Elsayed M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00468; Falk A, 2016, MOL PSYCHIATR, V21, P1167, DOI 10.1038/mp.2016.89; Flaherty E.K., 2015, BRAIN RES; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141; Hashimoto-Torii K, 2014, NEURON, V82, P560, DOI 10.1016/j.neuron.2014.03.002; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Heyes S, 2015, PROG NEUROBIOL, V134, P36, DOI 10.1016/j.pneurobio.2015.09.002; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Larimore J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065069; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lencz T, 2014, MOL PSYCHIATR, V19, P168, DOI 10.1038/mp.2013.166; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Martinez-Cerdeno V., 2016, DEV NEUROBIOL; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mouchlianitis E, 2016, LANCET PSYCHIAT, V3, P451, DOI 10.1016/S2215-0366(15)00540-4; Moyer CE, 2015, NEUROSCI LETT, V601, P46, DOI 10.1016/j.neulet.2014.11.042; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Rigamonti A, 2016, STEM CELL REP, V6, P993, DOI 10.1016/j.stemcr.2016.05.010; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896; Sanders SJ, 2014, CURR GENET MED REP, V2, P151, DOI DOI 10.1007/S40142-014-0045-7; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Scholvin J, 2016, IEEE T BIO-MED ENG, V63, P120, DOI 10.1109/TBME.2015.2406113; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5; Tieng V, 2014, STEM CELLS DEV, V23, P1535, DOI 10.1089/scd.2013.0442; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Woodhams PL, 1996, EXP NEUROL, V140, P68, DOI 10.1006/exnr.1996.0116; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Young-Pearse TL, 2016, CURR OPIN NEUROBIOL, V36, P66, DOI 10.1016/j.conb.2015.10.006; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zikopoulos B, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00609	99	159	164	2	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1220	1228		10.1038/nm.4214	http://dx.doi.org/10.1038/nm.4214			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783065				2022-12-27	WOS:000387302300013
J	Ni, J; Ramkissoon, SH; Xie, SZ; Goel, S; Stover, DG; Guo, HB; Luu, V; Marco, E; Ramkissoon, LA; Kang, YJ; Hayashi, M; Nguyen, QD; Ligon, AH; Du, R; Claus, EB; Alexander, BM; Yuan, GC; Wang, ZGC; Iglehart, JD; Krop, IE; Roberts, TM; Winer, EP; Lin, NU; Ligon, KL; Zhao, JJ				Ni, Jing; Ramkissoon, Shakti H.; Xie, Shaozhen; Goel, Shom; Stover, Daniel G.; Guo, Hanbing; Luu, Victor; Marco, Eugenio; Ramkissoon, Lori A.; Kang, Yun Jee; Hayashi, Marika; Quang-De Nguyen; Ligon, Azra H.; Du, Rose; Claus, Elizabeth B.; Alexander, Brian M.; Yuan, Guo-Cheng; Wang, Zhigang C.; Iglehart, J. Dirk; Krop, Ian E.; Roberts, Thomas M.; Winer, Eric P.; Lin, Nancy U.; Ligon, Keith L.; Zhao, Jean J.			Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases	NATURE MEDICINE			English	Article							PTEN LOSS; EVEROLIMUS	Brain metastases represent the greatest clinical challenge in treating HER2-positive breast cancer. We report the development of orthotopic patient-derived xenografts (PDXs) of HER2-expressing breast cancer brain metastases (BCBM), and their use for the identification of targeted combination therapies. Combined inhibition of PI3K and mTOR resulted in durable tumor regressions in three of five PDXs, and therapeutic response was correlated with a reduction in the phosphorylation of 4EBP1, an mTORC1 effector. The two nonresponding PDXs showed hypermutated genomes with enrichment of mutations in DNA-repair genes, which suggests an association of genomic instability with therapeutic resistance. These findings suggest that a biomarker-driven clinical trial of PI3K inhibitor in combination with an mTOR inhibitor should be conducted for patients with HER2-positive BCBM.	[Ni, Jing; Xie, Shaozhen; Goel, Shom; Guo, Hanbing; Luu, Victor; Wang, Zhigang C.; Iglehart, J. Dirk; Roberts, Thomas M.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ni, Jing; Xie, Shaozhen; Guo, Hanbing; Luu, Victor; Roberts, Thomas M.; Zhao, Jean J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ramkissoon, Shakti H.; Goel, Shom; Stover, Daniel G.; Ramkissoon, Lori A.; Kang, Yun Jee; Hayashi, Marika; Wang, Zhigang C.; Iglehart, J. Dirk; Krop, Ian E.; Winer, Eric P.; Lin, Nancy U.; Ligon, Keith L.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ramkissoon, Shakti H.; Ligon, Azra H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Quang-De Nguyen] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Du, Rose; Claus, Elizabeth B.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Claus, Elizabeth B.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Alexander, Brian M.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Alexander, Brian M.] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Zhao, JJ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Lin, NU; Ligon, KL (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Ligon, KL (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	nancy_lin@dfci.harvard.edu; keith_ligon@dfci.harvard.edu; jean_zhao@dfci.harvard.edu	Goel, Shom/E-2399-2011; Du, Rose/AAJ-2873-2020; Marco, Eugenio/F-4583-2011; Du, Rose/I-5402-2012	Goel, Shom/0000-0001-8329-9084; Du, Rose/0000-0003-2641-6496; Marco, Eugenio/0000-0002-3675-263X; Stover, Daniel/0000-0001-9003-8165	Breast Cancer Research Foundation; Aid for Cancer Research; Breast Cancer Alliance; Komen scholar grant; US National Institutes of Health (NIH) [R01 CA187918, CA172461, 1K08NS087118, P50 CA165962, P01 CA142536, 1P50CA168504]; NATIONAL CANCER INSTITUTE [R01CA187918, R01CA172461, P50CA168504, P50CA165962, P01CA142536] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS087118] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Aid for Cancer Research; Breast Cancer Alliance; Komen scholar grant; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Livingston for reading the manuscript. We thank R. Modiste and G. Dai at the Dana-Farber Lurie Family Image Center for MRI imaging. We thank R. Bronson and the Dana-Farber/Harvard Cancer Center Rodent Histoplathology Core for histopathological analyses. We thank F. Pan, D. Light and R. Qi (Life Technologies, Thermo Fisher) for assistance with WES and transcriptome analyses with the Ion Torrent sequencing system. We thank J. Ruan and M. Ruan (VigeneTech) for quantification of pS6RP and p4EBP IHC data by the Cellvigene data-analysis program. This work was supported by the Breast Cancer Research Foundation (N.U.L., E.P.W., Z.W. and J.J.Z.); Aid for Cancer Research (E.P.W. and J.J.Z.); Breast Cancer Alliance (J.J.Z.); Komen scholar grant (E.P.W.); and US National Institutes of Health (NIH) grants R01 CA187918 (T.M.R. and J.J.Z.), CA172461 (J.J.Z.), 1K08NS087118 (S.H.R.), P50 CA165962 (T.M.R., K.L.L. and J.J.Z.), P01 CA142536 (J.J.Z.) and 1P50CA168504 (T.M.R., I.E.K., E.P.W., N.U.L., and J.J.Z.).	Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Creighton CJ, 2007, ONCOGENE, V26, P4648, DOI 10.1038/sj.onc.1210245; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Hortobagyi GN, 2016, J CLIN ONCOL, V34, P419, DOI 10.1200/JCO.2014.60.1971; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Maire CL, 2014, STEM CELLS, V32, P313, DOI 10.1002/stem.1590; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Wikman H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3150; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	13	73	77	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					723	726		10.1038/nm.4120	http://dx.doi.org/10.1038/nm.4120			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27270588	Green Submitted, Green Accepted			2022-12-27	WOS:000379366900010
J	Sleiman, P; Hakonarson, H				Sleiman, Patrick; Hakonarson, Hakon			From schizophrenia risk locus to schizophrenia genes	NATURE MEDICINE			English	Editorial Material							RAT	A new study in humans links genetic variants associated with schizophrenia to changes in the expression of two genes, arsenite methyltransferase (AS3MT) and BLOC-1 related complex subunit 7 (BORCS7). Subsequent investigations provide compelling evidence that AS3MT is involved in the etiology of schizophrenia.	[Sleiman, Patrick; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Sleiman, Patrick; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Div Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.; Hakonarson, H (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Div Human Genet, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu			NICHD NIH HHS [U54 HD086984] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Vahidnia A, 2007, HUM EXP TOXICOL, V26, P823, DOI 10.1177/0960327107084539; Zhang H, 2015, TOXICOL SCI, V146, P354, DOI 10.1093/toxsci/kfv101	8	3	3	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					583	584		10.1038/nm.4122	http://dx.doi.org/10.1038/nm.4122			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270776				2022-12-27	WOS:000377476000009
J	Wang, JJ; Zou, JX; Xue, XQ; Cai, DM; Zhang, Y; Duan, ZJ; Xiang, QP; Yang, JC; Louie, MC; Borowsky, AD; Gao, AC; Evans, CP; Lam, KS; Xu, JZ; Kung, HJ; Evans, RM; Xu, Y; Chen, HW				Wang, Junjian; Zou, June X.; Xue, Xiaoqian; Cai, Demin; Zhang, Yan; Duan, Zhijian; Xiang, Qiuping; Yang, Joy C.; Louie, Maggie C.; Borowsky, Alexander D.; Gao, Allen C.; Evans, Christopher P.; Lam, Kit S.; Xu, Jianzhen; Kung, Hsing-Jien; Evans, Ronald M.; Xu, Yong; Chen, Hong-Wu			ROR-gamma drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer (vol 22, pg 488, 2016)	NATURE MEDICINE			English	Correction													Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Cai, Demin/0000-0003-0500-5292	NHLBI NIH HHS [P01 HL088093, R01 HL105278] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Wang JJ, 2016, NAT MED, V22, P488, DOI 10.1038/nm.4070	1	5	5	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					692	692		10.1038/nm0616-692b	http://dx.doi.org/10.1038/nm0616-692b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270780				2022-12-27	WOS:000377476000016
J	Kagoya, Y; Tanaka, S; Guo, TX; Anczurowski, M; Wang, CH; Saso, K; Butler, MO; Minden, MD; Hirano, N				Kagoya, Yuki; Tanaka, Shinya; Guo, Tingxi; Anczurowski, Mark; Wang, Chung-Hsi; Saso, Kayoko; Butler, Marcus O.; Minden, Mark D.; Hirano, Naoto			A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects	NATURE MEDICINE			English	Article							MODIFIED T-CELLS; ADOPTIVE IMMUNOTHERAPY; TUMOR REJECTION; CLINICAL-TRIAL; IN-VIVO; MEMORY; CYTOKINE; LEUKEMIA; LYMPHOMA; CANCER	The adoptive transfer of T cells engineered with a chimeric antigen receptor (CAR) (hereafter referred to as CAR-T cells) specific for the B lymphocyte antigen CD19 has shown impressive clinical responses in patients with refractory B cell malignancies(1-7). However, the therapeutic effects of CAR-T cells that target other malignancies have not yet resulted in significant clinical benefit(8-11). Although inefficient tumor trafficking and various immunosuppressive mechanisms can impede CAR-T cell effector responses, the signals delivered by the current CAR constructs may still be insufficient to fully activate antitumor T cell functions. Optimal T cell activation and proliferation requires multiple signals, including T cell receptor (TCR) engagement (signal 1), co-stimulation (signal 2) and cytokine engagement (signal 3)(12). However, CAR constructs currently being tested in the clinic contain a CD3z (TCR signaling) domain and co-stimulatory domain(s) but not a domain that transmits signal 3 (refs. 13-18). Here we have developed a novel CAR construct capable of inducing cytokine signaling after antigen stimulation. This new-generation CD19 CAR encodes a truncated cytoplasmic domain from the interleukin (IL)-2 receptor beta-chain (IL-2R beta) and a STAT3-binding tyrosine-X-X-glutamine (YXXQ) motif, together with the TCR signaling (CD3z) and co-stimulatory (CD28) domains (hereafter referred to as 28-Delta IL2RB-z(YXXQ)). The 28-Delta IL2RBz(YXXQ) CAR-T cells showed antigen-dependent activation of the JAK kinase and of the STAT3 and STAT5 transcription factors signaling pathways, which promoted their proliferation and prevented terminal differentiation in vitro. The 28-Delta IL2RB-z(YXXQ) CAR-T cells demonstrated superior in vivo persistence and antitumor effects in models of liquid and solid tumors as compared with CAR-T cells expressing a CD28 or 4-1BB co-stimulatory domain alone. Taken together, these results suggest that our new-generation CAR has the potential to demonstrate superior antitumor effects with minimal toxicity in the clinic and that clinical translation of this novel CAR is warranted.	[Kagoya, Yuki; Tanaka, Shinya; Guo, Tingxi; Anczurowski, Mark; Wang, Chung-Hsi; Saso, Kayoko; Butler, Marcus O.; Hirano, Naoto] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Campbell Family Canc Res Inst, Tumor Immunotherapy Program,Princess Margaret Can, Toronto, ON, Canada; [Tanaka, Shinya] Takara Bio Inc, Kusatsu, Japan; [Guo, Tingxi; Anczurowski, Mark; Wang, Chung-Hsi; Butler, Marcus O.; Hirano, Naoto] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Butler, Marcus O.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Minden, Mark D.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Hematol Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Takara Bio Inc.; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Hirano, N (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, Campbell Family Canc Res Inst, Tumor Immunotherapy Program,Princess Margaret Can, Toronto, ON, Canada.; Hirano, N (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	naoto.hirano@uhnresearch.ca	Kagoya, Yuki/GQH-4875-2022; Kagoya, Yuki/AAD-9870-2019	Guo, Tingxi/0000-0003-2968-7187; Butler, Marcus/0000-0002-9840-7057	CIHR Project [362860]; Ontario Institute for Cancer Research Clinical Investigator Award [IA-039]; BioCanRX Catalyst Program [FY17CAT7]; Princess Margaret Cancer Foundation; Japan Society for the Promotion of Science Postdoctoral Fellowship for Overseas Researchers; Guglietti Fellowship Award; Canadian Institutes of Health Research Canada Graduate Scholarship; Province of Ontario; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship; Takara Bio, Inc.; NATIONAL CANCER INSTITUTE [R01CA148673] Funding Source: NIH RePORTER	CIHR Project(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research Clinical Investigator Award; BioCanRX Catalyst Program; Princess Margaret Cancer Foundation(University of Toronto); Japan Society for the Promotion of Science Postdoctoral Fellowship for Overseas Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Guglietti Fellowship Award; Canadian Institutes of Health Research Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Province of Ontario; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Takara Bio, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CIHR Project Grant 362860 (N.H.), Ontario Institute for Cancer Research Clinical Investigator Award IA-039 (N.H.), BioCanRX Catalyst Program grant FY17CAT7 (N.H.), the Princess Margaret Cancer Foundation (M.O.B. and N.H.), a Japan Society for the Promotion of Science Postdoctoral Fellowship for Overseas Researchers (Y.K.), a Guglietti Fellowship Award (Y.K.), a Canadian Institutes of Health Research Canada Graduate Scholarship (T.G.), the Province of Ontario (T.G. and M.A.) and a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (T.G.). This study was partly sponsored by Takara Bio, Inc.	Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Butler MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030229; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Hsu C, 2007, BLOOD, V109, P5168, DOI 10.1182/blood-2006-06-029173; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Markley JC, 2010, BLOOD, V115, P3508, DOI 10.1182/blood-2009-09-241398; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Quintarelli C, 2007, BLOOD, V110, P2793, DOI 10.1182/blood-2007-02-072843; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sabatino M, 2016, BLOOD, V128, P519, DOI 10.1182/blood-2015-11-683847; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zhang L, 2015, CLIN CANCER RES, V21, P2278, DOI 10.1158/1078-0432.CCR-14-2085	42	210	231	5	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					352	+		10.1038/nm.4478	http://dx.doi.org/10.1038/nm.4478			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29400710	Green Accepted			2022-12-27	WOS:000426700900017
J	Lagares, D; Ghassemi-Kakroodi, P; Tremblay, C; Santos, A; Probst, CK; Franklin, A; Santos, DM; Grasberger, P; Ahluwalia, N; Montesi, SB; Shea, BS; Black, KE; Knipe, R; Blati, M; Baron, M; Wu, B; Fahmi, H; Gandhi, R; Pardo, A; Selman, M; Wu, JP; Pelletier, JP; Martel-Pelletier, J; Tager, AM; Kapoor, M				Lagares, David; Ghassemi-Kakroodi, Parisa; Tremblay, Caroline; Santos, Alba; Probst, Clemens K.; Franklin, Alicia; Santos, Daniela M.; Grasberger, Paula; Ahluwalia, Neil; Montesi, Sydney B.; Shea, Barry S.; Black, Katharine E.; Knipe, Rachel; Blati, Meryem; Baron, Murray; Wu, Brian; Fahmi, Hassan; Gandhi, Rajiv; Pardo, Annie; Selman, Moises; Wu, Jiangping; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Tager, Andrew M.; Kapoor, Mohit			ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis	NATURE MEDICINE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SYSTEMIC-SCLEROSIS; PROSTATE-CANCER; SKIN FIBROSIS; RECEPTOR; EPH; MECHANISMS; EXPRESSION; METALLOPROTEINASES	Maladaptive wound healing responses to chronic tissue injury result in organ fibrosis. Fibrosis, which entails excessive extracellular matrix (ECM) deposition and tissue remodeling by activated myofibroblasts, leads to loss of proper tissue architecture and organ function; however, the molecular mediators of myofibroblast activation have yet to be fully identified. Here we identify soluble ephrin-B2 (sEphrin-B2) as a new profibrotic mediator in lung and skin fibrosis. We provide molecular, functional and translational evidence that the ectodomain of membrane-bound ephrin-B2 is shed from fibroblasts into the alveolar airspace after lung injury. Shedding of sEphrin-B2 promotes fibroblast chemotaxis and activation via EphB3 and/or EphB4 receptor signaling. We found that mice lacking ephrin-B2 in fibroblasts are protected from skin and lung fibrosis and that a disintegrin and metalloproteinase 10 (ADAM10) is the major ephrin-B2 sheddase in fibroblasts. ADAM10 expression is increased by transforming growth factor (TGF)-beta 1, and ADAM10-mediated sEphrin-B2 generation is required for TGF-beta 1-induced myofibroblast activation. Pharmacological inhibition of ADAM10 reduces sEphrin-B2 levels in bronchoalveolar lavage and prevents lung fibrosis in mice. Consistent with the mouse data, ADAM10-sEphrin-B2 signaling is upregulated in fibroblasts from human subjects with idiopathic pulmonary fibrosis. These results uncover a new molecular mechanism of tissue fibrogenesis and identify sEphrin-B2, its receptors EphB3 and EphB4 and ADAM10 as potential therapeutic targets in the treatment of fibrotic diseases.	[Lagares, David; Santos, Alba; Probst, Clemens K.; Franklin, Alicia; Santos, Daniela M.; Grasberger, Paula; Ahluwalia, Neil; Montesi, Sydney B.; Shea, Barry S.; Black, Katharine E.; Knipe, Rachel; Tager, Andrew M.] Harvard Med Sch, Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Fibrosis Res Ctr, Boston, MA 02115 USA; [Lagares, David; Santos, Alba; Probst, Clemens K.; Franklin, Alicia; Santos, Daniela M.; Grasberger, Paula; Ahluwalia, Neil; Montesi, Sydney B.; Shea, Barry S.; Black, Katharine E.; Knipe, Rachel; Tager, Andrew M.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Dept Med, Boston, MA 02115 USA; [Ghassemi-Kakroodi, Parisa; Tremblay, Caroline; Blati, Meryem; Fahmi, Hassan; Wu, Jiangping; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Kapoor, Mohit] Univ Montreal, Hosp Res Ctr CRCHUM, Dept Med, Montreal, PQ, Canada; [Baron, Murray] McGill Univ, Jewish Gen Hosp, Div Rheumatol, Montreal, PQ, Canada; [Wu, Brian; Gandhi, Rajiv; Kapoor, Mohit] Univ Hlth Network, Arthrit Program, Toronto, ON, Canada; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Kapoor, Mohit] Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Kapoor, Mohit] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Kapoor, Mohit] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universite de Montreal; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universidad Nacional Autonoma de Mexico; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Lagares, D (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Fibrosis Res Ctr, Boston, MA 02115 USA.; Lagares, D (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Dept Med, Boston, MA 02115 USA.; Kapoor, M (corresponding author), Univ Montreal, Hosp Res Ctr CRCHUM, Dept Med, Montreal, PQ, Canada.; Kapoor, M (corresponding author), Univ Hlth Network, Arthrit Program, Toronto, ON, Canada.; Kapoor, M (corresponding author), Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Kapoor, M (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.; Kapoor, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	dlagares@mgh.harvard.edu; mkapoor@uhnresearch.ca	Santos, Daniela/W-3903-2019; Martel-Pelletier, Johanne/AAG-2928-2019; Pelletier, Jean-Pierre/AAG-2896-2019; Baron, Murray/AAF-9486-2019	Moutinho Dos Santos, Daniela/0000-0002-3740-1305; Lagares, David/0000-0002-7317-8796	University of Montreal Hospital Research Centre; University of Montreal; Campaign to Cure Arthritis via Toronto General and Western Foundation, University Health Network, Toronto; American Thoracic Society Foundation; Pulmonary Fibrosis Foundation Research Grant; Marie A. Coyle Research Grant from Scleroderma Foundation; National Institutes of Health [HL108975]; Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108975] Funding Source: NIH RePORTER	University of Montreal Hospital Research Centre; University of Montreal; Campaign to Cure Arthritis via Toronto General and Western Foundation, University Health Network, Toronto; American Thoracic Society Foundation; Pulmonary Fibrosis Foundation Research Grant; Marie A. Coyle Research Grant from Scleroderma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Authors would like to thank P. Datta, S. Nakamura, H. Endisha and J. Rockel (all from the University Health Network) for their technical assistance with mouse breeding and genotyping. The authors gratefully acknowledge funding support by University of Montreal Hospital Research Centre and University of Montreal (M.K.); Campaign to Cure Arthritis via the Toronto General and Western Foundation, University Health Network, Toronto (M.K.); an American Thoracic Society Foundation and Pulmonary Fibrosis Foundation Research Grant and the Marie A. Coyle Research Grant from the Scleroderma Foundation (D.L.), and by the National Institutes of Health, HL108975 and a grant from the Scleroderma Research Foundation (A.M.T).	Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Avouac J, 2011, RHEUMATOLOGY, V50, P1494, DOI 10.1093/rheumatology/keq448; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Falivelli G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081445; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Ho YY, 2014, NAT REV RHEUMATOL, V10, P390, DOI 10.1038/nrrheum.2014.53; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Ji YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4516; Kapoor M, 2009, ARTHRITIS RHEUM-US, V60, P2822, DOI 10.1002/art.24761; Kida Y, 2013, J AM SOC NEPHROL, V24, P559, DOI 10.1681/ASN.2012080871; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lagares D, 2012, ARTHRITIS RHEUM-US, V64, P1653, DOI 10.1002/art.33482; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Lisle JE, 2015, EXP CELL RES, V333, P136, DOI 10.1016/j.yexcr.2015.02.014; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Selman M, 2016, EUR RESPIR J, V48, P538, DOI 10.1183/13993003.00398-2016; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; ZHANG K, 1995, AM J PATHOL, V147, P352	41	71	72	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1405	+		10.1038/nm.4419	http://dx.doi.org/10.1038/nm.4419			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29058717	Green Accepted, Green Submitted			2022-12-27	WOS:000417278200008
J	Smith, AR; Kuo, CJ				Smith, Amber R.; Kuo, Calvin J.			Organoids lead the cancer attack	NATURE MEDICINE			English	Editorial Material							MODELS	In an article published recently in Nature Medicine, the authors generate organoid models of liver neoplasia. In doing so, they highlight both the diversity of current organoid methodologies and their application to cancer modeling and therapeutics discovery.	[Smith, Amber R.; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA	Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA.	cjkuo@stanford.edu		Kuo, Calvin/0000-0002-7427-5985	NHLBI NIH HHS [T32 HL098049] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438; Neal JT, 2016, ANNU REV PATHOL-MECH, V11, P199, DOI 10.1146/annurev-pathol-012615-044249; Pauli C, 2017, CANCER DISCOV, V7, P462, DOI 10.1158/2159-8290.CD-16-1154; Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053	5	1	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1399	1400		10.1038/nm.4454	http://dx.doi.org/10.1038/nm.4454			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216041	Green Accepted			2022-12-27	WOS:000417278200004
J	Keener, A				Keener, Amanda			Uncovering cancer: How enlisting T cells can boost the power of immunotherapy	NATURE MEDICINE			English	News Item							CHECKPOINT BLOCKADE; ANTITUMOR; EXPOSURE; TUMORS											Charych DH, 2016, CLIN CANCER RES, V22, P680, DOI 10.1158/1078-0432.CCR-15-1631; Klarquist J, 2014, J IMMUNOL, V193, P6124, DOI 10.4049/jimmunol.1401869; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Yamazaki T, 2016, CELL DEATH DIFFER, V23, P1004, DOI 10.1038/cdd.2016.35; Yarchoan M, 2017, NAT REV CANCER, V17, P209, DOI 10.1038/nrc.2016.154	7	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1006	1008		10.1038/nm0917-1006	http://dx.doi.org/10.1038/nm0917-1006			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886004				2022-12-27	WOS:000409996200002
J	Legoff, J; Resche-Rigon, M; Bouquet, J; Robin, M; Naccache, SN; Mercier-Delarue, S; Federman, S; Samayoa, E; Rousseau, C; Piron, P; Kapel, N; Simon, F; Socie, G; Chiu, CY				Legoff, Jerome; Resche-Rigon, Matthieu; Bouquet, Jerome; Robin, Marie; Naccache, Samia N.; Mercier-Delarue, Severine; Federman, Scot; Samayoa, Erik; Rousseau, Clotilde; Piron, Prescillia; Kapel, Nathalie; Simon, Francois; Socie, Gerard; Chiu, Charles Y.			The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease	NATURE MEDICINE			English	Article							HUMAN PICOBIRNAVIRUSES; FECAL CALPROTECTIN; VIRUSES; CHILDREN; DIARRHEA; GENERATION; INFLAMMATION; DIVERSITY; INFECTION; KOLKATA	Much attention has been focused on the role of the bacterial microbiome in human health, but the virome is understudied. Although previously investigated in individuals with inflammatory bowel diseases or solid-organ transplants(1,2), virome dynamics in allogeneic hematopoietic stem cell transplantation (HSCT) and enteric graft-versus-host disease (GVHD) remain unexplored. Here we characterize the longitudinal gut virome in 44 recipients of HSCT using metagenomics. A viral 'bloom' was identified, and significant increases were demonstrated in the overall proportion of vertebrate viral sequences following transplantation (P = 0.02). Increases in both the rates of detection (P < 0.0001) and number of sequences (P = 0.047) of persistent DNA viruses (anelloviruses, herpesviruses, papillomaviruses and polyomaviruses) over time were observed in individuals with enteric GVHD relative to those without, a finding accompanied by a reduced phage richness (P = 0.01). Picobirnaviruses were detected in 18 individuals (40.9%), more frequently before or within a week after transplant than at later time points (P = 0.008). In a time-dependent Cox proportional-hazards model, picobirnaviruses were predictive of the occurrence of severe enteric GVHD (hazard ratio, 2.66; 95% confidence interval (CI) = 1.46-4.86; P = 0.001), and correlated with higher fecal levels of two GVHD severity markers, calprotectin and alpha 1-antitrypsin. These results reveal a progressive expansion of vertebrate viral infections over time following HSCT, and they suggest an unexpected association of picobirnaviruses with early post-transplant GVHD.	[Legoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Univ Paris Diderot, Hop St Louis, APHP, INSERM,U941,Sorbonne Paris Cite,Microbiol Lab, Paris, France; [Legoff, Jerome; Bouquet, Jerome; Naccache, Samia N.; Federman, Scot; Samayoa, Erik; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA; [Resche-Rigon, Matthieu; Piron, Prescillia] Univ Paris Diderot, Hop St Louis, APHP,Sorbonne Paris Cite, INSERM,U1153,ECSTRA Team,Biostat Unit, Paris, France; [Bouquet, Jerome; Naccache, Samia N.; Federman, Scot; Samayoa, Erik; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Robin, Marie; Rousseau, Clotilde] Univ Paris 05, Hop St Louis, APHP, EA4065,Microbiol Lab, Paris, France; [Kapel, Nathalie] Univ Paris 05, GH Pitie Salpetriere Charles Foix, APHP, Lab Coprol Fonct,EA4065, Paris, France; [Socie, Gerard] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Socie, Gerard] INSERM, Unite Mixte Rech Sci 1160, Hematol & Transplantat, Paris, France; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco	Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu	Resche-Rigon, Matthieu/ABA-5374-2021; le goff, jerome/B-3447-2016; LeGoff, jerome/AAP-7880-2021	le goff, jerome/0000-0001-7111-1865; Bouquet, Jerome/0000-0001-8077-6025; resche-rigon, matthieu/0000-0003-2220-5085; Robin, Marie/0000-0003-1388-9876	Abbott Laboratories; US-France Fulbright Commission; Foundation Monahan; Foundation Phillippe	Abbott Laboratories(Abbott Laboratories); US-France Fulbright Commission; Foundation Monahan; Foundation Phillippe	This study was supported by a research grant from Abbott Laboratories to C.Y.C. We would also like to acknowledge funding from the US-France Fulbright Commission, Foundation Monahan and Foundation Phillippe for funding J.L. for a research sabbatical year to perform this research.	Abraham J, 2014, TRANSPLANTATION, V97, P965, DOI 10.1097/01.TP.0000438209.50089.60; Alhabbab R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11554; Baanyai K, 2003, ARCH VIROL, V148, P2281, DOI 10.1007/s00705-003-0200-z; Bhattacharya R, 2007, INFECT GENET EVOL, V7, P229, DOI 10.1016/j.meegid.2006.09.005; Bhattacharya R, 2006, INFECT GENET EVOL, V6, P453, DOI 10.1016/j.meegid.2006.02.005; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Feghoul L, 2015, CLIN MICROBIOL INFEC, V21, P701, DOI 10.1016/j.cmi.2015.03.011; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Ganesh B, 2012, REV MED VIROL, V22, P245, DOI 10.1002/rmv.1707; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Lan YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032491; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Masachessi G, 2015, INFECT GENET EVOL, V29, P196, DOI 10.1016/j.meegid.2014.11.019; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; O'Meara A, 2015, BONE MARROW TRANSPL, V50, P1105, DOI 10.1038/bmt.2015.109; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Pichereau C, 2012, BIOL BLOOD MARROW TR, V18, P141, DOI 10.1016/j.bbmt.2011.07.018; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rodriguez-Otero P, 2012, BLOOD, V119, P5909, DOI 10.1182/blood-2011-12-397968; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Smits SL, 2014, EMERG INFECT DIS, V20, P1218, DOI 10.3201/eid2007.140190; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zaharia M, 2011, ARXIV, p1111.5572; Zerr DM, 2012, BIOL BLOOD MARROW TR, V18, P1700, DOI 10.1016/j.bbmt.2012.05.012; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	38	80	84	1	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1080	+		10.1038/nm.4380	http://dx.doi.org/10.1038/nm.4380			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28759053				2022-12-27	WOS:000409996200015
J	Karimy, JK; Zhang, JW; Kurland, DB; Theriault, BC; Duran, D; Stokum, JA; Furey, CG; Zhou, X; Mansuri, MS; Montejo, J; Vera, A; DiLuna, ML; Delpire, E; Alper, SL; Gunel, M; Gerzanich, V; Medzhitov, R; Simard, JM; Kahle, KT				Karimy, Jason K.; Zhang, Jinwei; Kurland, David B.; Theriault, Brianna Carusillo; Duran, Daniel; Stokum, Jesse A.; Furey, Charuta Gavankar; Zhou, Xu; Mansuri, M. Shahid; Montejo, Julio; Vera, Alberto; DiLuna, Michael L.; Delpire, Eric; Alper, Seth L.; Gunel, Murat; Gerzanich, Volodymyr; Medzhitov, Ruslan; Simard, J. Marc; Kahle, Kristopher T.			Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus	NATURE MEDICINE			English	Article							CATION-CHLORIDE COTRANSPORTERS; INTRAVENTRICULAR HEMORRHAGE; RECEPTOR 4; NERVOUS-SYSTEM; SPAK; KINASES; BUMETANIDE; STRESS; OSR1; MECHANISMS	The choroid plexus epithelium (CPE) secretes higher volumes of fluid (cerebrospinal fluid, CSF) than any other epithelium and simultaneously functions as the blood-CSF barrier to gate immune cell entry into the central nervous system(1). Posthemorrhagic hydrocephalus (PHH), an expansion of the cerebral ventricles due to CSF accumulation following intraventricular hemorrhage (IVH), is a common disease usually treated by suboptimal CSF shunting techniques(2). PHH is classically attributed to primary impairments in CSF reabsorption, but little experimental evidence supports this concept. In contrast, the potential contribution of CSF secretion to PHH has received little attention. In a rat model of PHH, we demonstrate that IVH causes a Toll-like receptor 4 (TLR4)- and NF-kappa B-dependent inflammatory response in the CPE that is associated with a similar to 3-fold increase in bumetanide-sensitive CSF secretion. IVH-induced hypersecretion of CSF is mediated by TLR4-dependent activation of the Ste20-type stress kinase SPAK, which binds, phosphorylates, and stimulates the NKCC1 co-transporter at the CPE apical membrane. Genetic depletion of TLR4 or SPAK normalizes hyperactive CSF secretion rates and reduces PHH symptoms, as does treatment with drugs that antagonize TLR4-NF-kappa B signaling or the SPAK-NKCC1 co-transporter complex. These data uncover a previously unrecognized contribution of CSF hypersecretion to the pathogenesis of PHH, demonstrate a new role for TLRs in regulation of the internal brain milieu, and identify a kinase-regulated mechanism of CSF secretion that could be targeted by repurposed US Food and Drug Administration (FDA)-approved drugs to treat hydrocephalus.	[Karimy, Jason K.; Zhang, Jinwei; Duran, Daniel; Furey, Charuta Gavankar; Mansuri, M. Shahid; Montejo, Julio; Vera, Alberto; DiLuna, Michael L.; Gunel, Murat; Kahle, Kristopher T.] Yale Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Zhang, Jinwei] Univ Exeter, Med Sch, Hatherly Lab, Inst Biomed & Clin Sci, Exeter, Devon, England; [Kurland, David B.; Theriault, Brianna Carusillo; Stokum, Jesse A.; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Zhou, Xu; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Zhou, Xu; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Alper, Seth L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA USA; [Alper, Seth L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Dept Med, Boston, MA USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kahle, Kristopher T.] Yale Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Kahle, Kristopher T.] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Kahle, Kristopher T.] Yale Sch Med, Ctr Mendelian Genom, New Haven, CT 06510 USA	Yale University; University of Exeter; University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; Yale University; Yale University; Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Yale University; Yale University; Yale University	Kahle, KT (corresponding author), Yale Sch Med, Dept Neurosurg, New Haven, CT 06510 USA.; Kahle, KT (corresponding author), Yale Sch Med, Dept Pediat, New Haven, CT 06510 USA.; Kahle, KT (corresponding author), Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.; Kahle, KT (corresponding author), Yale Sch Med, Ctr Mendelian Genom, New Haven, CT 06510 USA.	kristopher.kahle@yale.edu	Montejo, Julio/I-5438-2018; Zhang, Jinwei/N-8584-2017; Mansuri, Mohammad Shahid/AAU-9350-2021; Zhang, Jinwei/Q-7959-2019; Kurland, David/GVT-2707-2022; Zhou, Xu/AAI-9269-2020	Montejo, Julio/0000-0003-2166-4861; Zhang, Jinwei/0000-0001-8683-509X; Zhang, Jinwei/0000-0001-8683-509X; Furey, Charuta/0000-0003-3313-2563; Zhou, Xu/0000-0002-1692-6823; Kurland, David/0000-0002-4074-7497; Duran, Daniel/0000-0001-6888-252X	March of Dimes Basil O'Connor Award; Simons Foundation SFAR1 Grant; Hydrocephalus Association Innovator Award; NIH [4K12NS080223-05]; National Institute of Neurological Disorders and Stroke (NINDS) [NS060801, NS061808]; US Department of Veterans Affairs [IBX002889]; Howard Hughes Medical Institute	March of Dimes Basil O'Connor Award(March of Dimes); Simons Foundation SFAR1 Grant; Hydrocephalus Association Innovator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Department of Veterans Affairs(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank DR. Alessi (Dundee) and R.P. Litton (Rockefeller) for their support. K.T.K. is supported by the March of Dimes Basil O'Connor Award, a Simons Foundation SFAR1 Grant, the Hydrocephalus Association Innovator Award, and the NIH (4K12NS080223-05).J.M.S. is supported by the National Institute of Neurological Disorders and Stroke (NINDS) (NS060801; NS061808) and the US Department of Veterans Affairs (IBX002889); R.M. is supported by the Howard Hughes Medical Institute.	Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; Bcrkes J., 2003, GUT, V52, P439; Boivin MJ, 2015, NATURE, V527, pS155, DOI 10.1038/nature16029; Chen QW, 2017, J NEUROL SCI, V375, P220, DOI 10.1016/j.jns.2017.01.072; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; de Los Heros P., 2014, BIOCHEM J, V458, P559; DOYLE WJ, 1994, ANN OTO RHINOL LARYN, V103, P59, DOI 10.1177/000348949410300111; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Ferguson C, 2013, ALCOHOL, V47, P595, DOI 10.1016/j.alcohol.2013.09.043; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Garate I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-8; Gram M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0200-9; JAVAHERI S, 1993, J CLIN INVEST, V92, P2257, DOI 10.1172/JCI116829; Jirino F., 2011, ARZNEIMITTELFORSCH, V61, P458; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Karimy JK, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16278; Karimy JK, 2015, J NEUROSCI METH, V241, P78, DOI 10.1016/j.jneumeth.2014.12.015; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kikuchi E, 2015, J AM SOC NEPHROL, V26, P1525, DOI 10.1681/ASN.2014060560; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kwon MS, 2015, INT J MOL SCI, V16, P5028, DOI 10.3390/ijms16035028; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Lodhia KR, 2006, ACTA NEUROCHIR SUPPL, V96, P207; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; McAllister JP, 2015, J NEUROSURG, V123, P1427, DOI 10.3171/2014.12.JNS132352; Medzhitov R, 2007, SEMIN IMMUNOL, V19, P1, DOI 10.1016/j.smim.2007.02.001; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; Nugent BM, 2012, J NEUROSCI, V32, P593, DOI 10.1523/JNEUROSCI.5415-11.2012; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Qian YW, 1999, CIRCULATION, V100, P50; Romermann K, 2017, NEUROPHARMACOLOGY, V117, P182, DOI 10.1016/j.neuropharm.2017.02.006; Simard PF, 2011, TRANSL STROKE RES, V2, P227, DOI 10.1007/s12975-011-0070-8; Sin Betul, 2011, Proc Am Thorac Soc, V8, P106, DOI 10.1513/pats.201008-057RN; Skipor J, 2015, ACTA VET HUNG, V63, P69, DOI 10.1556/AVet.2014.027; Stone SSD, 2014, J NEUROSURG-PEDIATR, V14, P439, DOI 10.3171/2014.7.PEDS14152; Su F, 2015, ANTIMICROB AGENTS CH, V59, P5654, DOI 10.1128/AAC.01381-15; Thiagarajah JR, 2015, NAT REV GASTRO HEPAT, V12, P446, DOI 10.1038/nrgastro.2015.111; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; VOGH BP, 1981, BRAIN RES, V221, P171, DOI 10.1016/0006-8993(81)91071-4; Whitelaw A, 2001, Cochrane Database Syst Rev, pCD002270, DOI 10.1002/14651858.CD002270; Wilson Ft, 1987, FUR J RESPIR DIS, V70, P212; Yan Y, 2008, AM J PATHOL, V173, P1013, DOI 10.2353/ajpath.2008.080339; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Yen Y., 2007, BIOCHIM BIOPHYS ACTA, V1769, P106	47	155	158	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					997	+		10.1038/nm.4361	http://dx.doi.org/10.1038/nm.4361			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28692063	Green Accepted			2022-12-27	WOS:000406947600016
J	Eide, CA; Druker, BJ				Eide, Christopher A.; Druker, Brian J.			Understanding cancer from the stem cells up	NATURE MEDICINE			English	Editorial Material							IMATINIB; THERAPY	A new study that uses an integrated single-cell transcriptomics approach to characterize cancer stem cell populations during treatment with molecularly targeted therapies offers insights into disease evolution and points to new therapeutic targets.	[Eide, Christopher A.; Druker, Brian J.] Howard Hughes Med Inst Portland, Portland, OR 97201 USA; [Eide, Christopher A.; Druker, Brian J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA	Oregon Health & Science University	Druker, BJ (corresponding author), Howard Hughes Med Inst Portland, Portland, OR 97201 USA.; Druker, BJ (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA.	drukerb@ohsu.edu		Eide, Christopher/0000-0001-8835-8928; Druker, Brian/0000-0001-8331-8206				Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Ellsworth DL, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0145-6; Giustacchini A, 2017, NAT MED, V23, P692, DOI 10.1038/nm.4336; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Warfvinge R, 2017, BLOOD, V129, P2384, DOI 10.1182/blood-2016-07-728873	12	11	11	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					656	657		10.1038/nm.4353	http://dx.doi.org/10.1038/nm.4353			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586338				2022-12-27	WOS:000402768000004
J	Stevenson, M				Stevenson, Mario			HIV persistence in macrophages	NATURE MEDICINE			English	Editorial Material							REPLICATION IN-VIVO; CD4(+) T-CELLS; RESERVOIR	A recent study using a humanized mouse model shows that HIV-1 can persist in macrophages during antiretroviral therapy (ART), and suggests that macrophages may represent an obstacle to efforts to cure HIV-1 infection.	[Stevenson, Mario] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami	Stevenson, M (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	mstevenson@med.miami.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH100942] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Calantone N, 2014, IMMUNITY, V41, P493, DOI 10.1016/j.immuni.2014.08.014; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Ho DD, 1997, J CLIN INVEST, V99, P2565, DOI 10.1172/JCI119443; Honeycutt JB, 2017, NAT MED, V23, P638, DOI 10.1038/nm.4319; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125500; Sattentau QJ, 2016, CELL HOST MICROBE, V19, P304, DOI 10.1016/j.chom.2016.02.013; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Siliciano JM, 2015, J INFECT DIS, V212, P1345, DOI 10.1093/infdis/jiv219	11	13	13	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					538	539		10.1038/nm.4337	http://dx.doi.org/10.1038/nm.4337			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28475569				2022-12-27	WOS:000400650700007
J	Braso-Maristany, F; Filosto, S; Catchpole, S; Marlow, R; Quist, J; Francesch-Domenech, E; Plumb, DA; Zakka, L; Gazinska, P; Liccardi, G; Meier, P; Gris-Oliver, A; Cheang, MCU; Perdrix-Rosell, A; Shafat, M; Noel, E; Patel, N; McEachern, K; Scaltriti, M; Castel, P; Noor, F; Buus, R; Mathew, S; Watkins, J; Serra, V; Marra, P; Grigoriadis, A; Tutt, AN				Braso-Maristany, Fara; Filosto, Simone; Catchpole, Steven; Marlow, Rebecca; Quist, Jelmar; Francesch-Domenech, Erika; Plumb, Darren A.; Zakka, Leila; Gazinska, Patrycja; Liccardi, Gianmaria; Meier, Pascal; Gris-Oliver, Albert; Cheang, Maggie Chon U.; Perdrix-Rosell, Anna; Shafat, Manar; Noel, Elodie; Patel, Nirmesh; McEachern, Kristen; Scaltriti, Maurizio; Castel, Pau; Noor, Farzana; Buus, Richard; Mathew, Sumi; Watkins, Johnathan; Serra, Violeta; Marra, Pierfrancesco; Grigoriadis, Anita; Tutt, Andrew N.			PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer (vol 22, pg 1303, 2016)	NATURE MEDICINE			English	Correction													Serra, Violeta/AAG-8328-2019; Watkins, Johnathan/ABI-8343-2020	Watkins, Johnathan/0000-0001-8370-6022; Meier, Pascal/0000-0003-2760-6523; Cheang, Maggie Chon U/0000-0001-5718-2501; Tutt, Andrew/0000-0001-8715-2901; Shafat, Manar/0000-0002-3493-9089				Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198	1	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					526	526		10.1038/nm0417-526c	http://dx.doi.org/10.1038/nm0417-526c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388604	Bronze			2022-12-27	WOS:000398768100023
J	Raymond, DD; Stewart, SM; Lee, J; Ferdman, J; Bajic, G; Do, KT; Ernandes, MJ; Suphaphiphat, P; Settembre, EC; Dormitzer, PR; Del Giudice, G; Finco, O; Kang, TH; Ippolito, GC; Georgiou, G; Kepler, TB; Haynes, BF; Moody, MA; Liao, HX; Schmidt, AG; Harrison, SC				Raymond, Donald D.; Stewart, Shaun M.; Lee, Jiwon; Ferdman, Jack; Bajic, Goran; Do, Khoi T.; Ernandes, Michael J.; Suphaphiphat, Pirada; Settembre, Ethan C.; Dormitzer, Philip R.; Del Giudice, Giuseppe; Finco, Oretta; Kang, Tae Hyun; Ippolito, Gregory C.; Georgiou, George; Kepler, Thomas B.; Haynes, Barton F.; Moody, M. Anthony; Liao, Hua-Xin; Schmidt, Aaron G.; Harrison, Stephen C.			Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain	NATURE MEDICINE			English	Article							RECEPTOR-BINDING SITE; AFFINITY MATURATION; VIRUS HEMAGGLUTININ; SIALIC-ACID; H1N1; HIV-1; NEUTRALIZATION; SELECTION; ORIGIN	For broad protection against infection by viruses such as influenza or HIV, vaccines should elicit antibodies that bind conserved viral epitopes, such as the receptor-binding site (RBS). RBS-directed antibodies have been described for both HIV1-3 and influenza virus(4-8), and the design of immunogens to elicit them is a goal of vaccine research in both fields. Residues in the RBS of influenza virus hemagglutinin (HA) determine a preference for the avian or human receptor, alpha-2,3-linked sialic acid and alpha-2,6-linked sialic acid, respectively(9,10). Transmission of an avian-origin virus between humans generally requires one or more mutations in the sequences encoding the influenza virus RBS to change the preferred receptor from avian to human(9,11,12), but passage of a human-derived vaccine candidate in chicken eggs can select for reversion to avian receptor preference(13-15). For example, the X-181 strain of the 2009 new pandemic H1N1 influenza virus, derived from the A/California/07/2009 isolate and used in essentially all vaccines since 2009, has arginine at position 226, a residue known to confer preference for an alpha-2,3 linkage in H1 subtype viruses(13,14); the wild-type A/California/07/2009 isolate, like most circulating human H1N1 viruses, has glutamine at position 226. We describe, from three different individuals, RBS-directed antibodies that recognize the avian-adapted H1 strain in current influenza vaccines but not the circulating new pandemic 2009 virus; Arg226 in the vaccine-strain RBS accounts for the restriction. The polyclonal sera of the three donors also reflect this preference. Therefore, when vaccines produced from strains that are never passaged in avian cells become widely available, they may prove more capable of eliciting RBS-directed, broadly neutralizing antibodies than those produced from egg-adapted viruses, extending the established benefits of current seasonal influenza immunizations.	[Raymond, Donald D.; Bajic, Goran; Do, Khoi T.; Ernandes, Michael J.; Schmidt, Aaron G.; Harrison, Stephen C.] Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Cambridge, MA 02138 USA; [Stewart, Shaun M.; Ferdman, Jack; Suphaphiphat, Pirada; Settembre, Ethan C.; Dormitzer, Philip R.] Seqirus, 45 Sidney St, Cambridge, MA USA; [Lee, Jiwon; Kang, Tae Hyun; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ernandes, Michael J.] Harvard Med Sch, Grad Program Virol, Boston, MA USA; [Del Giudice, Giuseppe; Finco, Oretta] Novartis Vaccines & Diagnost, Siena, Italy; [Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Haynes, Barton F.; Moody, M. Anthony; Liao, Hua-Xin] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Haynes, Barton F.; Liao, Hua-Xin] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Moody, M. Anthony] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Stewart, Shaun M.] Incyte, Wilmington, DE USA; [Dormitzer, Philip R.] Pfizer Vaccines Res & Dev, Pearl River, NY USA; [Del Giudice, Giuseppe; Finco, Oretta] GSK Vaccines, Siena, Italy	Harvard University; Boston Children's Hospital; CSL; University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School; Novartis; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Boston University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Incyte; Pfizer; GlaxoSmithKline	Harrison, SC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Cambridge, MA 02138 USA.; Harrison, SC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Ippolito, Gregory C./AAR-2930-2021; Moody, M/AAB-6947-2020	Ippolito, Gregory C./0000-0002-7565-7002; Moody, M/0000-0002-3890-5855; Lee, Jiwon/0000-0001-7835-3621; Ernandes, Michael/0000-0001-8218-0145; Bajic, Goran/0000-0003-0480-4324	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089618, U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19 AI057234, P01 AI089618] Funding Source: Medline; NIGMS NIH HHS [P41 GM103403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kepler TB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00170; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; KOZLOV JV, 1981, J GEN VIROL, V56, P437, DOI 10.1099/0022-1317-56-2-437; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lee J, 2016, NAT MED; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schmidt AG, 2015, CELL REP, V13, P2842, DOI 10.1016/j.celrep.2015.11.063; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Tan YC, 2014, CLIN IMMUNOL, V151, P55, DOI 10.1016/j.clim.2013.12.008; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	37	73	74	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1465	+		10.1038/nm.4223	http://dx.doi.org/10.1038/nm.4223			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27820604	Green Accepted			2022-12-27	WOS:000389549000024
J	[Anonymous]				[Anonymous]			Mental health horizons	NATURE MEDICINE			English	Editorial Material								From organoids to population-level studies, mental health research has begun to crack long-standing mysteries. Longitudinal investigations into brain and cognitive development among adolescents, such as the forthcoming 10,000-person ABCD project, will help to mature the field.											0	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1213	1213						1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27824817	Bronze			2022-12-27	WOS:000387302300011
J	Notarangelo, LD; Holland, SM				Notarangelo, Luigi D.; Holland, Steven M.			Friendly fire: anti-cytokine antibodies elicited by microbes	NATURE MEDICINE			English	Editorial Material							NONTUBERCULOUS MYCOBACTERIAL INFECTIONS; IFN-GAMMA AUTOANTIBODIES; MENDELIAN SUSCEPTIBILITY	A recent study suggests that exposure to the mold Aspergillus induces the production of antibodies that neutralize interferon-gamma (IFN-gamma), which increases the risk of mycobacterial disease.	[Notarangelo, Luigi D.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Holland, Steven M.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Notarangelo, LD (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	luigi.notarangelo@childrens.harvard.edu; sholland@niaid.nih.gov	Notarangelo, Luigi/F-9718-2016	Notarangelo, Luigi/0000-0002-8335-0262				Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Chi CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003927; Holland SM, 2000, MICROBES INFECT, V2, P1579, DOI 10.1016/S1286-4579(00)01314-9; Ku CL, 2016, J ALLERGY CLIN IMMUN, V137, P945, DOI 10.1016/j.jaci.2015.09.018; Lin CH, 2016, NAT MED, V22, P994, DOI 10.1038/nm.4158; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rosen LB, 2013, J IMMUNOL, V190, P3959, DOI 10.4049/jimmunol.1202526; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Walter JE, 2015, J CLIN INVEST, V125, P4135, DOI 10.1172/JCI80477	11	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					973	975		10.1038/nm.4175	http://dx.doi.org/10.1038/nm.4175			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27603131				2022-12-27	WOS:000382542800006
J	Frost, EL; Lukens, JR				Frost, Elizabeth L.; Lukens, John R.			The brain's reward circuitry regulates immunity	NATURE MEDICINE			English	Editorial Material							SYSTEM; STRESS; HEALTH; NERVE; KEY	A new study in mice shows that activation of the brain's reward system boosts beneficial antibacterial immunity in the periphery. These findings provide biological insights into the association between psychological and physical well-being.	[Frost, Elizabeth L.; Lukens, John R.] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA	University of Virginia	Lukens, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA.	jrl7n@virginia.edu		Lukens, John/0000-0002-6795-0866				Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566	10	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					835	837		10.1038/nm.4157	http://dx.doi.org/10.1038/nm.4157			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27490435				2022-12-27	WOS:000381000200007
J	Bergsagel, PL; Chesi, M				Bergsagel, P. Leif; Chesi, Marta			Promiscuous mechanisms underlie the antitumor effects of thalidomide analogs	NATURE MEDICINE			English	Editorial Material							DEGRADATION; TARGET	Two recent studies provide novel insights into the mechanism of action of thalidomide analogs in multiple myeloma and del(5q) myelodysplastic syndrome. They show that the role of the chaperone function of cereblon, and a calcium- and caplain-dependent pathway, are important in anticancer functions.	[Bergsagel, P. Leif; Chesi, Marta] Mayo Clin, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Bergsagel, PL (corresponding author), Mayo Clin, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA.	bergsagel.leif@mayo.edu	Bergsagel, Peter Leif/A-7842-2011	Bergsagel, Peter Leif/0000-0003-1523-7388	NATIONAL CANCER INSTITUTE [R01CA195688, P50CA186781] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA195688, P50 CA186781] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Affer M, 2014, LEUKEMIA, V28, P1725, DOI 10.1038/leu.2014.70; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fang J, 2016, NAT MED, V22, P727, DOI 10.1038/nm.4127; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032	11	4	4	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					706	707		10.1038/nm.4144	http://dx.doi.org/10.1038/nm.4144			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387882				2022-12-27	WOS:000379366900005
J	Lee, SCW; Dvinge, H; Kim, E; Cho, H; Micol, JB; Chung, YR; Durham, BH; Yoshimi, A; Kim, YJ; Thomas, M; Lobry, C; Chen, CW; Pastore, A; Taylor, J; Wang, XJ; Krivtsov, A; Armstrong, SA; Palacino, J; Buonamici, S; Smith, PG; Bradley, RK; Abdel-Wahab, O				Lee, Stanley Chun-Wei; Dvinge, Heidi; Kim, Eunhee; Cho, Hana; Micol, Jean-Baptiste; Chung, Young Rock; Durham, Benjamin H.; Yoshimi, Akihide; Kim, Young Joon; Thomas, Michael; Lobry, Camille; Chen, Chun-Wei; Pastore, Alessandro; Taylor, Justin; Wang, Xujun; Krivtsov, Andrei; Armstrong, Scott A.; Palacino, James; Buonamici, Silvia; Smith, Peter G.; Bradley, Robert K.; Abdel-Wahab, Omar			Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins	NATURE MEDICINE			English	Article							CLONAL HEMATOPOIESIS; SRSF2 MUTATIONS; PHASE-I; RNA; EXPRESSION; E7107; SF3B; MYELODYSPLASIA; VISUALIZATION; VALIDATION	Mutations in genes encoding splicing factors (which we refer to as spliceosomal genes) are commonly found in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)(1-3). These mutations recurrently affect specific amino acid residues, leading to perturbed normal splice site and exon recognition(4-6). Spliceosomal gene mutations are always heterozygous and rarely occur together with one another, suggesting that cells may tolerate only a partial deviation from normal splicing activity. To test this hypothesis, we engineered mice to express a mutated allele of serine/arginine-rich splicing factor 2 (Srsf2(P95H))-which commonly occurs in individuals with MDS and AML-in an inducible, hemizygous manner in hematopoietic cells. These mice rapidly succumbed to fatal bone marrow failure, demonstrating that Srsf2-mutated cells depend on the wild-type Srsf2 allele for survival. In the context of leukemia, treatment with the spliceosome inhibitor E7107 (refs. 7,8) resulted in substantial reductions in leukemic burden, specifically in isogenic mouse leukemias and patient-derived xenograft AMLs carrying spliceosomal mutations. Whereas E7107 treatment of mice resulted in widespread intron retention and cassette exon skipping in leukemic cells regardless of Srsf2 genotype, the magnitude of splicing inhibition following E7107 treatment was greater in Srsf2-mutated than in Srsf2-wild-type leukemia, consistent with the differential effect of E7107 on survival. Collectively, these data provide genetic and pharmacologic evidence that leukemias with spliceosomal gene mutations are preferentially susceptible to additional splicing perturbations in vivo as compared to leukemias without such mutations. Modulation of spliceosome function may thus provide a new therapeutic avenue in genetically defined subsets of individuals with MDS or AML.	[Lee, Stanley Chun-Wei; Kim, Eunhee; Cho, Hana; Micol, Jean-Baptiste; Chung, Young Rock; Durham, Benjamin H.; Yoshimi, Akihide; Kim, Young Joon; Pastore, Alessandro; Taylor, Justin; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Dvinge, Heidi; Bradley, Robert K.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA; [Dvinge, Heidi; Bradley, Robert K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Thomas, Michael; Palacino, James; Buonamici, Silvia; Smith, Peter G.] H3 Biomed Inc, Cambridge, MA USA; [Lobry, Camille] Inst Gustave Roussy, INSERM, U1170, F-94805 Villejuif, France; [Chen, Chun-Wei; Wang, Xujun; Krivtsov, Andrei; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Bradley, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.; Bradley, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.	rbradley@fredhutch.org; abdelwao@mskcc.org	/AGZ-3814-2022; Kim, Young Joon/GPF-6451-2022; Krivtsov, Andrei/AAJ-9966-2021; lobry, camille/A-6188-2015; /AAR-7818-2021; Kim, Eunhee/AAK-3650-2020; Kim, Eunhee/Q-9162-2016; Yoshimi, Akihide/I-3792-2019	/0000-0002-3621-4807; lobry, camille/0000-0003-0550-4921; /0000-0002-3621-4807; Kim, Eunhee/0000-0001-7143-7769; Yoshimi, Akihide/0000-0002-0664-7281; Krivtsov, Andrei/0000-0002-5511-1686; Kim, Young Joon/0000-0002-9106-6077; Bradley, Robert/0000-0002-8046-1063; Chung, Young Rock/0000-0001-5752-8322; Chen, Chun-Wei/0000-0002-8737-6830; Durham, Benjamin/0000-0001-8090-5448; Lee, Stanley/0000-0001-7110-2416; Dvinge, Heidi/0000-0003-1741-0738	Leukemia and Lymphoma Society; US Department of Defense Breast Cancer Research Program [W81XWH-14-1-0044]; US Department of Defense Bone Marrow Failure Research Program [BM150092, W81XWH-12-1-0041]; Worldwide Cancer Research Fund; Fondation de France; American Society of Hematology; Edward P. Evans Foundation; US National Institutes of Health (NIH)-NHLBI [R01 HL128239]; NIH-NCI [1K08CA160647-01]; Ellison Medical Foundation [AG-NS-1030-13]; Damon Runyon Foundation; NIH-NIDDK [R01 DK103854]; Starr Foundation [I8-A8-075]; Josie Robertson Investigator Program; Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; NATIONAL CANCER INSTITUTE [K08CA160647, R00CA197498, P30CA006516, P30CA008748, K99CA197498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103854] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); US Department of Defense Breast Cancer Research Program(United States Department of Defense); US Department of Defense Bone Marrow Failure Research Program; Worldwide Cancer Research Fund; Fondation de France(Fondation de France); American Society of Hematology; Edward P. Evans Foundation; US National Institutes of Health (NIH)-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Foundation; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Starr Foundation; Josie Robertson Investigator Program; Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Leukemia and Lymphoma Society (S.C.-W.L. and O.A.-W.), the US Department of Defense Breast Cancer Research Program grant W81XWH-14-1-0044 (H.D.), the US Department of Defense Bone Marrow Failure Research Program grants BM150092 (O.A.-W.) and W81XWH-12-1-0041 (R.K.B. and O.A.-W.), the Worldwide Cancer Research Fund (E.K.), the Fondation de France (J.-B.M.), the American Society of Hematology (B.H.D. and O.A.-W.), the Edward P. Evans Foundation (R.K.B. and O.A.-W.), the US National Institutes of Health (NIH)-NHLBI grant R01 HL128239 (R.K.B. and O.A.-W.), the NIH-NCI grant 1K08CA160647-01 (O.A.-W.), the Ellison Medical Foundation grant AG-NS-1030-13 (R.K.B.), the Damon Runyon Foundation (R.K.B. and O.A.-W.), the NIH-NIDDK grant R01 DK103854 (R.K.B.), the Starr Foundation grant I8-A8-075 (O.A.-W.), the Josie Robertson Investigator Program (O.A.-W.), the Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research (O.A.-W.), and the Experimental Therapeutics Center of MSKCC (O.A.-W.).	Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Effenberger KA, 2016, RNA, V22, P350, DOI 10.1261/rna.053108.115; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Guberman Jonathan M, 2011, Database (Oxford), V2011, pbar041, DOI 10.1093/database/bar041; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Ilagan JO, 2015, GENOME RES, V25, P14, DOI 10.1101/gr.181016.114; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavallee VP, 2015, NAT GENET, V47, P1030, DOI 10.1038/ng.3371; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; National Research Council, 2011, GUIDE CARE USE LAB A; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shirai CL, 2015, CANCER CELL, V27, P631, DOI 10.1016/j.ccell.2015.04.008; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yan B, 2015, NEW ENGL J MED, V372, P1071, DOI 10.1056/NEJMc1500684; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang J, 2015, P NATL ACAD SCI USA, V112, pE4726, DOI 10.1073/pnas.1514105112; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252	43	214	223	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					672	+		10.1038/nm.4097	http://dx.doi.org/10.1038/nm.4097			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135740	Green Accepted			2022-12-27	WOS:000377476000025
J	Velardi, E; Tsai, JJ; Radtke, S; Cooper, K; Argyropoulos, KV; Jae-Hung, S; Young, LF; Lazrak, A; Smith, OM; Lieberman, S; Kreines, F; Shono, Y; Wertheimer, T; Jenq, RR; Hanash, AM; Narayan, P; Lei, Z; Moore, MA; Kiem, HP; van den Brink, MRM; Dudakov, JA				Velardi, Enrico; Tsai, Jennifer J.; Radtke, Stefan; Cooper, Kirsten; Argyropoulos, Kimon V.; Jae-Hung, Shieh; Young, Lauren F.; Lazrak, Amina; Smith, Odette M.; Lieberman, Sophie; Kreines, Fabiana; Shono, Yusuke; Wertheimer, Tobias; Jenq, Robert R.; Hanash, Alan M.; Narayan, Prema; Lei, Zhenmin; Moore, Malcolm A.; Kiem, Hans-Peter; van den Brink, Marcel R. M.; Dudakov, Jarrod A.			Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury (vol 24, pg 239, 2018)	NATURE MEDICINE			English	Correction													Velardi, Enrico/AAB-7443-2019; velardi, Enrico/AAC-5440-2022; Kreines, Fabiana/AAV-8837-2020; van den Brink, Marcel R. M./HGB-9434-2022	Velardi, Enrico/0000-0001-8383-0453; 				Velardi E, 2018, NAT MED, V24, P239, DOI 10.1038/nm.4470	1	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					525	525		10.1038/nm0418-525b	http://dx.doi.org/10.1038/nm0418-525b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634695	Bronze			2022-12-27	WOS:000429639800026
J	Azvolinsky, A				Azvolinsky, Anna			Gut checkpoint A rising cancer treatment may get a boost from intestinal bacteria	NATURE MEDICINE			English	News Item							MELANOMA PATIENTS; MICROBIOTA; EFFICACY; THERAPY											Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kumar R, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0020-7; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537	10	0	0	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					251	253		10.1038/nm0318-251	http://dx.doi.org/10.1038/nm0318-251			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29509755				2022-12-27	WOS:000426700900003
J	Velardi, E; Tsai, JJ; Radtke, S; Cooper, K; Argyropoulos, KV; Jae-Hung, S; Young, LF; Lazrak, A; Smith, OM; Lieberman, S; Kreines, F; Shono, Y; Wertheimer, T; Jenq, RR; Hanash, AM; Narayan, P; Lei, ZM; Moore, MA; Kiem, HP; van den Brink, MRM; Dudakov, JA				Velardi, Enrico; Tsai, Jennifer J.; Radtke, Stefan; Cooper, Kirsten; Argyropoulos, Kimon V.; Jae-Hung, Shieh; Young, Lauren F.; Lazrak, Amina; Smith, Odette M.; Lieberman, Sophie; Kreines, Fabiana; Shono, Yusuke; Wertheimer, Tobias; Jenq, Robert R.; Hanash, Alan M.; Narayan, Prema; Lei, Zhenmin; Moore, Malcolm A.; Kiem, Hans-Peter; van den Brink, Marcel R. M.; Dudakov, Jarrod A.			Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury	NATURE MEDICINE			English	Article							STEM-CELLS; PROGENITOR CELLS; SELF-RENEWAL; REGENERATION; QUIESCENCE; MICE; HOMEOSTASIS; ACTIVATION; DEFECTS	There is a substantial unmet clinical need for new strategies to protect the hematopoietic stem cell (HSC) pool and regenerate hematopoiesis after radiation injury from either cancer therapy or accidental exposure(1,2). Increasing evidence suggests that sex hormones, beyond their role in promoting sexual dimorphism, regulate HSC self-renewal, differentiation, and proliferation(3-5). We and others have previously reported that sex-steroid ablation promotes bone marrow (BM) lymphopoiesis and HSC recovery in aged and immunodepleted mice(5-7). Here we found that a luteinizing hormone (LH)-releasing hormone antagonist (LHRH-Ant), currently in wide clinical use for sex-steroid inhibition, promoted hematopoietic recovery and mouse survival when administered 24 h after an otherwise-lethal dose of total-body irradiation (L-TBI). Unexpectedly, this protective effect was independent of sex steroids and instead relied on suppression of LH levels. Human and mouse long-term self-renewing HSCs (LT-HSCs) expressed high levels of the LH/choriogonadotropin receptor (LHCGR) and expanded ex vivo when stimulated with LH. In contrast, the suppression of LH after L-TBI inhibited entry of HSCs into the cell cycle, thus promoting HSC quiescence and protecting the cells from exhaustion. These findings reveal a role of LH in regulating HSC function and offer a new therapeutic approach for hematopoietic regeneration after hematopoietic injury.	[Velardi, Enrico; Tsai, Jennifer J.; Argyropoulos, Kimon V.; Young, Lauren F.; Lazrak, Amina; Smith, Odette M.; Lieberman, Sophie; Kreines, Fabiana; Shono, Yusuke; Wertheimer, Tobias; Hanash, Alan M.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA; [Velardi, Enrico] Univ Perugia, Dept Clin & Expt Med, Perugia, Italy; [Tsai, Jennifer J.; Cooper, Kirsten; Dudakov, Jarrod A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA; [Tsai, Jennifer J.; Cooper, Kirsten; Dudakov, Jarrod A.] Fred Hutchinson Canc Res Ctr, Immunotherapy Integrated Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Tsai, Jennifer J.; Cooper, Kirsten; Dudakov, Jarrod A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Radtke, Stefan; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Div Clin Res, Stem Cell & Gene Therapy Program, 1124 Columbia St, Seattle, WA 98104 USA; [Radtke, Stefan] Univ Duisburg Essen, Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Jae-Hung, Shieh; Moore, Malcolm A.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Genom Med, Houston, TX 77030 USA; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Stem Cell Transplantat Cellular Therapy, Houston, TX 77030 USA; [Hanash, Alan M.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Narayan, Prema] Southern Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL USA; [Lei, Zhenmin] Univ Louisville, Sch Med, Dept OB GYN & Women s Hlth, Louisville, KY 40292 USA; [Moore, Malcolm A.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Kiem, Hans-Peter] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [van den Brink, Marcel R. M.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; University of Perugia; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Duisburg Essen; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Southern Illinois University System; Southern Illinois University; University of Louisville; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cornell University	Velardi, E; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA.; Velardi, E (corresponding author), Univ Perugia, Dept Clin & Expt Med, Perugia, Italy.; Dudakov, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA.; Dudakov, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Immunotherapy Integrated Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.; Dudakov, JA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; van den Brink, MRM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; van den Brink, MRM (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	velardie@mskcc.org; vandenbm@mskcc.org; jdudakov@fredhutch.org	Kreines, Fabiana/AAV-8837-2020; van den Brink, Marcel R. M./HGB-9434-2022; velardi, Enrico/AAC-5440-2022; Velardi, Enrico/AAB-7443-2019	Velardi, Enrico/0000-0001-8383-0453; van den Brink, Marcel/0000-0003-0696-4401; Radtke, Stefan/0000-0002-2842-4820	National Institutes of Health [R00-CA176376, R01-HL069929, R01-AI080455, R01-AI101406, P30 CA008748, P01-CA023766, 1R01HL123340-01A1, P01-AG52359]; Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [602587]; Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center; Italian Foundation for Cancer Research; Italian Society of Pharmacology; American Society of Bone Marrow Transplantation new investigator award; C.J. Martin fellowship from the Australian National Health and Medical Research Council; Scholar Award from the American Society of Hematology; Mechtild Harf Research Grant from the DKMS Foundation for Giving Life; Dorris J. Hutchison Student Fellowship from the Sloan Kettering Institute; Boehringer Ingelheim Fonds MD fellowship; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA016672, R00CA176376, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL123340, K08HL115355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455, R01AI101406, R01AI100288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG052359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Foundation; Susan and Peter Solomon Divisional Genomics Program; MSKCC Cycle for Survival; European Union's Seventh Framework Programme for Research, Technological Development and Demonstration; Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center; Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Society of Pharmacology; American Society of Bone Marrow Transplantation new investigator award; C.J. Martin fellowship from the Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scholar Award from the American Society of Hematology; Mechtild Harf Research Grant from the DKMS Foundation for Giving Life; Dorris J. Hutchison Student Fellowship from the Sloan Kettering Institute; Boehringer Ingelheim Fonds MD fellowship(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge M. Calafiore, H. Jay, J. Gupta, and E. Levy for technical assistance; A. Gomes for assistance with statistical analysis; and the MSKCC Research Animal Resource Center for excellent animal care. We also gratefully acknowledge C. Delaney (Fred Hutchinson Cancer Research Center) for providing UCB units and K.J. Mori (Niigata University) for providing cells. This research was supported by National Institutes of Health awards R00-CA176376 (J.A.D.), R01-HL069929 (M.R.M.v.d.B.), R01-AI080455 (M.R.M.v.d.B.), R01-AI101406 (M.R.M.v.d.B.), P30 CA008748 (C. Thompson, Memorial Sloan Kettering Cancer Center), Project 4 (M.R.M.v.d.B.) of P01-CA023766 (R.J. O'Reilly, Memorial Sloan Kettering Cancer Center), 1R01HL123340-01A1 (K.H. Cadwell, New York University) and Project 2 (M.R.M.v.d.B. and J.A.D.) of P01-AG52359 (J. Nikolich-Zugich, University of Arizona). Support was also received from The Lymphoma Foundation (M.R.M.v.d.B.), The Susan and Peter Solomon Divisional Genomics Program (M.R.M.v.d.B.), and MSKCC Cycle for Survival (M.R.M.v.d.B.). This project received funding from the European Union's Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement 602587 (Project 7, M.R.M.v.d.B.). This research was also supported by the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center (M.R.M.v.d.B., codirector). E.V. was supported by fellowships from the Italian Foundation for Cancer Research, the Italian Society of Pharmacology, and an American Society of Bone Marrow Transplantation new investigator award. J.A.D. was also supported by a C.J. Martin fellowship from the Australian National Health and Medical Research Council, a Scholar Award from the American Society of Hematology, and the Mechtild Harf Research Grant from the DKMS Foundation for Giving Life. J.J.T. was also supported by a Dorris J. Hutchison Student Fellowship from the Sloan Kettering Institute. T.W. was supported by a Boehringer Ingelheim Fonds MD fellowship.	Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Brenet F, 2013, J EXP MED, V210, P623, DOI 10.1084/jem.20121610; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choi J, 2014, MOL CELL ENDOCRINOL, V383, P203, DOI 10.1016/j.mce.2013.12.009; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Doan PL, 2013, NAT MED, V19, P295, DOI 10.1038/nm.3070; Dudakov JA, 2009, J IMMUNOL, V183, P7084, DOI 10.4049/jimmunol.0900196; Dudakov JA, 2009, J IMMUNOL, V182, P6247, DOI 10.4049/jimmunol.0802446; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Goldberg GL, 2010, J IMMUNOL, V184, P6014, DOI 10.4049/jimmunol.0802445; Goncalves KA, 2016, CELL, V166, P894, DOI 10.1016/j.cell.2016.06.042; He SH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3986; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; ITOH K, 1989, EXP HEMATOL, V17, P145; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; KATAYAMA N, 1993, BLOOD, V82, P2353; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Khong DM, 2015, STEM CELL REP, V4, P445, DOI 10.1016/j.stemcr.2015.01.018; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; McGee SR, 2013, ENDOCRINOLOGY, V154, P3900, DOI 10.1210/en.2012-2179; Meistrich ML, 2009, PEDIATR BLOOD CANCER, V53, P261, DOI 10.1002/pbc.22004; Mierzejewska K, 2015, STEM CELLS DEV, V24, P927, DOI 10.1089/scd.2014.0546; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Qing YL, 2014, BLOOD, V123, P1002, DOI 10.1182/blood-2013-08-521716; Radtke S, 2016, EXP HEMATOL, V44, P502, DOI 10.1016/j.exphem.2016.02.011; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Sanchez-Aguilera A, 2014, CELL STEM CELL, V15, P791, DOI 10.1016/j.stem.2014.11.002; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shiraishi K, 2007, ENDOCRINOLOGY, V148, P3214, DOI 10.1210/en.2007-0160; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Velardi E, 2014, J EXP MED, V211, P2341, DOI 10.1084/jem.20131289; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang YYV, 2011, GENE DEV, V25, P1426, DOI 10.1101/gad.2024411; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	46	22	23	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					239	+		10.1038/nm.4470	http://dx.doi.org/10.1038/nm.4470			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29309056	Green Accepted			2022-12-27	WOS:000424327200021
J	Choi, YK; Maki, T; Mandeville, ET; Koh, SH; Hayakawa, K; Arai, K; Kim, YM; Whalen, MJ; Xing, CH; Wang, XY; Kim, KW; Lo, EH				Choi, Yoon Kyung; Maki, Takakuni; Mandeville, Emiri T.; Koh, Seong-Ho; Hayakawa, Kazuhide; Arai, Ken; Kim, Young-Myeong; Whalen, Michael J.; Xing, Changhong; Wang, Xiaoying; Kim, Kyu-Won; Lo, Eng H.			Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury	NATURE MEDICINE			English	Article							ADULT BRAIN; DISEASE	At low levels, carbon monoxide (CO) has physiological roles as a second messenger and neuromodulator(1,2). Here we assess the effects of CO in a mouse model of traumatic brain injury (TBI). Treatment with CO-releasing molecule (CORM)-3 reduced pericyte death and ameliorated the progression of neurological deficits. In contrast, although treatment with the radical scavenger N-tert-butyl-a-phenylnitrone (PBN) also reduced pericyte death, neurological outcomes were not rescued. As compared to vehicle-treated control and PBN-treated mice, CORM-3-treated mice showed higher levels of phosphorylated neural nitric oxide synthase within neural stem cells (NSCs). Inhibition of nitric oxide synthase diminished the CORM-3-mediated increase in the number of cells that stained positive for both the neuronal marker NeuN and 5-bromo-2'-deoxyuridine (BrdU; a marker for proliferating cells) in vivo, consequently interfering with neurological recovery after TBI. Because NSCs seemed to be in close proximity to pericytes, we asked whether cross-talk between pericytes and NSCs was induced by CORM-3, thereby promoting neurogenesis. In pericyte cultures that were undergoing oxygen and glucose deprivation, conditioned cell culture medium collected after CORM-3 treatment enhanced the in vitro differentiation of NSCs into mature neurons. Taken together, these findings suggest that CO treatment may provide a therapeutic approach for TBI by preventing pericyte death, rescuing cross-talk with NSCs and promoting neurogenesis.	[Choi, Yoon Kyung; Maki, Takakuni; Mandeville, Emiri T.; Koh, Seong-Ho; Hayakawa, Kazuhide; Arai, Ken; Xing, Changhong; Wang, Xiaoying; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Choi, Yoon Kyung; Maki, Takakuni; Mandeville, Emiri T.; Koh, Seong-Ho; Hayakawa, Kazuhide; Arai, Ken; Xing, Changhong; Wang, Xiaoying; Lo, Eng H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Koh, Seong-Ho] Hanyang Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Gangwon Do, South Korea; [Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA USA; [Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hanyang University; Kangwon National University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Seoul National University (SNU)	Choi, YK; Lo, EH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA.; Choi, YK; Lo, EH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.	yoonkyung@kangwon.ac.kr; lo@helix.mgh.harvard.edu	眞木, 崇州/AAO-1160-2020; Kim, Kyu Won/AAJ-7213-2020; Choi, Yoon Kyung/AGX-0481-2022	Choi, Yoon Kyung/0000-0003-0242-9612; Koh, Seong-Ho/0000-0001-5419-5761	US National Institutes of Health; Rappaport Foundation; National Research Foundation of Korea; Global Research Laboratory Program of Korea	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rappaport Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Global Research Laboratory Program of Korea	This work was supported in part by grants from the US National Institutes of Health (K.H., K.A., M.J.W., C.X., X.W. and E.H.L.), the Rappaport Foundation (E.H.L.), the Research Abroad grant from the National Research Foundation of Korea (Y.K.C., S.-H.K., Y.-M.K. and K.-W.K.) and the Global Research Laboratory Program of Korea (K.-WK.). The vector expressing the HIF-1 alpha double mutant was kindly provided by G.L. Semenza (Johns Hopkins University School of Medicine).	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Chen JJ, 2004, DEV BIOL, V269, P165, DOI 10.1016/j.ydbio.2004.01.024; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Lo EH, 2014, VASCULAR MECH CNS TR; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xing C., 2016, PROG NEUROBIOL; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	17	86	90	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1335	1341		10.1038/nm.4188	http://dx.doi.org/10.1038/nm.4188			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668935				2022-12-27	WOS:000387302300027
J	Shen, CH; Kim, SH; Trousil, S; Frederick, DT; Piris, A; Yuan, P; Cai, L; Gu, L; Li, M; Lee, JH; Mitra, D; Fisher, DE; Sullivan, RJ; Flaherty, KT; Zheng, B				Shen, Che-Hung; Kim, Sun Hye; Trousil, Sebastian; Frederick, Dennie T.; Piris, Adriano; Yuan, Ping; Cai, Li; Gu, Lei; Li, Man; Lee, Jung Hyun; Mitra, Devarati; Fisher, David E.; Sullivan, Ryan J.; Flaherty, Keith T.; Zheng, Bin			Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; ACQUIRED-RESISTANCE; BLADDER-CANCER; METASTATIC MELANOMA; CELL-PROLIFERATION; GENOMIC LANDSCAPE; EWING SARCOMA; BINDING SITES; B-RAF; MUTATIONS	The protein kinase B-Raf proto-oncogene, serine/threonine kinase (BRAF) is an oncogenic driver and therapeutic target in melanoma. Inhibitors of BRAF (BRAFi) have shown high response rates and extended survival in patients with melanoma who bear tumors that express mutations encoding BRAF proteins mutant at Val600, but a vast majority of these patients develop drug resistance(1,2). Here we show that loss of stromal antigen 2 (STAG2) or STAG3, which encode subunits of the cohesin complex, in melanoma cells results in resistance to BRAFi. We identified loss-of-function mutations in STAG2, as well as decreased expression of STAG2 or STAG3 proteins in several tumor samples from patients with acquired resistance to BRAFi and in BRAFi-resistant melanoma cell lines. Knockdown of STAG2 or STAG3 expression decreased sensitivity of BRAF(Val600Glu)-mutant melanoma cells and xenograft tumors to BRAFi. Loss of STAG2 inhibited CCCTCbinding- factor-mediated expression of dual specificity phosphatase 6 (DUSP6), leading to reactivation of mitogenactivated protein kinase (MAPK) signaling (via the MAPKs ERK1 and ERK2; hereafter referred to as ERK). Our studies unveil a previously unknown genetic mechanism of BRAFi resistance and provide new insights into the tumor suppressor function of STAG2 and STAG3.	[Shen, Che-Hung; Kim, Sun Hye; Trousil, Sebastian; Yuan, Ping; Cai, Li; Li, Man; Lee, Jung Hyun; Mitra, Devarati; Fisher, David E.; Zheng, Bin] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Shen, Che-Hung; Kim, Sun Hye; Trousil, Sebastian; Yuan, Ping; Cai, Li; Li, Man; Lee, Jung Hyun; Mitra, Devarati; Fisher, David E.; Zheng, Bin] Harvard Med Sch, Charlestown, MA 02129 USA; [Frederick, Dennie T.; Fisher, David E.; Sullivan, Ryan J.; Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Dept Med Oncol, Boston, MA 02114 USA; [Piris, Adriano] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Piris, Adriano] Harvard Med Sch, Boston, MA USA; [Gu, Lei] Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Shen, Che-Hung] China Med Univ, China Med Univ Hosp, Dept Dermatol, Taichung, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zheng, B (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.; Zheng, B (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	bin.zheng@cbrc2.mgh.harvard.edu	Fisher, David/AAH-2878-2019; Gu, Lei/GWQ-6785-2022	Zheng, Bin/0000-0002-0998-7177; Cai, Li/0000-0002-2160-5055	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; V Foundation; Harry J. Lloyd Charitable Trust; Melanoma Research Alliance; US National Institutes of Health (NIH) [P01 CA163222, R01 AR043369, R21 CA175907, R01 CA166717]; NATIONAL CANCER INSTITUTE [R01CA166717, P01CA163222, R21CA175907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; V Foundation; Harry J. Lloyd Charitable Trust; Melanoma Research Alliance; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Swanson, Y. Zhang and G. Zhao for critical comments on the manuscript. We also thank L. Chin (MD Anderson Cancer Center), M. Herlyn (Wistar Institute), C. Pritchard (University of Leicester) and J. Zippin (Weill Cornell Medical College) for providing cell lines. This work is supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.E.F.), the V Foundation (B.Z.), the Harry J. Lloyd Charitable Trust (B.Z.), the Melanoma Research Alliance (B.Z.) and the US National Institutes of Health (NIH) grants P01 CA163222 (D.E.F.), R01 AR043369 (D.E.F.), R21 CA175907 (D.E.F.) and R01 CA166717 (B.Z.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Kamata T, 2005, BLOOD, V106, P833, DOI 10.1182/blood-2004-11-4458; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kwong LN, 2015, J CLIN INVEST, V125, P1459, DOI 10.1172/JCI78954; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Ribas A, 2011, NAT REV CLIN ONCOL, V8, P426, DOI 10.1038/nrclinonc.2011.69; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Thol F, 2014, BLOOD, V123, P914, DOI 10.1182/blood-2013-07-518746; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xiao TJ, 2011, MOL CELL BIOL, V31, P2174, DOI 10.1128/MCB.05093-11; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	39	52	53	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1056	+		10.1038/nm.4155	http://dx.doi.org/10.1038/nm.4155			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27500726	Green Submitted, Green Accepted			2022-12-27	WOS:000382542800017
J	Jiang, H; Hegde, S; Knolhoff, BL; Zhu, Y; Herndon, JM; Meyer, MA; Nywening, TM; Hawkins, WG; Shapiro, IM; Weaver, DT; Pachter, JA; Wang-Gillam, A; DeNardo, DG				Jiang, Hong; Hegde, Samarth; Knolhoff, Brett L.; Zhu, Yu; Herndon, John M.; Meyer, Melissa A.; Nywening, Timothy M.; Hawkins, William G.; Shapiro, Irina M.; Weaver, David T.; Pachter, Jonathan A.; Wang-Gillam, Andrea; DeNardo, David G.			Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy	NATURE MEDICINE			English	Article							TUMOR-INFILTRATING MACROPHAGES; SKIN WOUND REPAIR; T-CELLS; DECREASES GROWTH; TISSUE STIFFNESS; FAK; INHIBITION; FIBROSIS; IMPROVES; PYK2	Single-agent immunotherapy has achieved limited clinical benefit to date in patients with pancreatic ductal adenocarcinoma (PDAC). This may be a result of the presence of a uniquely immunosuppressive tumor microenvironment (TME). Critical obstacles to immunotherapy in PDAC tumors include a high number of tumor-associated immunosuppressive cells and a uniquely desmoplastic stroma that functions as a barrier to T cell infiltration. We identified hyperactivated focal adhesion kinase (FAK) activity in neoplastic PDAC cells as an important regulator of the fibrotic and immunosuppressive TME. We found that FAK activity was elevated in human PDAC tissues and correlated with high levels of fibrosis and poor CD8(+) cytotoxic T cell infiltration. Single-agent FAK inhibition using the selective FAK inhibitor VS-4718 substantially limited tumor progression, resulting in a doubling of survival in the p48-Cre; LSL-Kras(G12D); Trp53(flox/+) (KPC) mouse model of human PDAC. This delay in tumor progression was associated with markedly reduced tumor fibrosis and decreased numbers of tumor-infiltrating immunosuppressive cells. We also found that FAK inhibition rendered the previously unresponsive KPC mouse model responsive to T cell immunotherapy and PD-1 antagonists. These data suggest that FAK inhibition increases immune surveillance by overcoming the fibrotic and immunosuppressive PDAC TME and renders tumors responsive to immunotherapy.	[Jiang, Hong; Hegde, Samarth; Knolhoff, Brett L.; Zhu, Yu; Herndon, John M.; Meyer, Melissa A.; Wang-Gillam, Andrea; DeNardo, David G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Jiang, Hong; Hegde, Samarth; Knolhoff, Brett L.; Zhu, Yu; Herndon, John M.; Meyer, Melissa A.; DeNardo, David G.] Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63130 USA; [Nywening, Timothy M.; Hawkins, William G.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Hawkins, William G.; Wang-Gillam, Andrea; DeNardo, David G.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA; [Shapiro, Irina M.; Weaver, David T.; Pachter, Jonathan A.] Verastem Inc, Needham, MA USA; [DeNardo, David G.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	DeNardo, DG (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Integrating Commun Canc Environm ICCE Inst, St Louis, MO 63130 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA.; DeNardo, DG (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	ddenardo@dom.wustl.edu	Jiang, Hong/AAE-1145-2019	DeNardo, David/0000-0002-3655-5783; Meyer, Melissa/0000-0003-3050-4819; Jiang, Hong/0000-0001-9481-9807; Herndon, John/0000-0002-8378-9654; Hegde, Samarth/0000-0001-6319-0372	Lustgarten Foundation; AACR/PANCAN Award; NCI awards [R01-CA177670, R01-CA203890, R21-CA182701]; BJCIH/Siteman Cancer Center Cancer Frontier Fund; Washington University Clinical and Translational Grant [KL2TR000450]; NATIONAL CANCER INSTITUTE [R01CA177670, T32CA009621, P30CA091842, R21CA182701, F99CA223043, P50CA196510, T32CA113275, R01CA203890] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER	Lustgarten Foundation; AACR/PANCAN Award; NCI awards; BJCIH/Siteman Cancer Center Cancer Frontier Fund; Washington University Clinical and Translational Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	KC (Kras<SUP>G12D</SUP>) cells were obtained from P. Mukherjee (University of North Carolina). HPNE, HPAC, Capan-1, Capan-2, Hs766T, MIA PaCa-2 and SW1990 cells were obtained from K. Lim (Washington University). pBABEpuro K-Ras G12V used to express Kras<SUP>G12V</SUP> was obtained from J. Weber (Washington University). This work was supported by funding awarded to D.G.D. by Lustgarten Foundation, an AACR/PANCAN Award, NCI awards R01-CA177670, R01-CA203890 and R21-CA182701, the BJCIH/Siteman Cancer Center Cancer Frontier Fund, and Washington University Clinical and Translational Grant KL2TR000450 awarded to A.W.G.	Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Balasubramanian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140273; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Chapman NM, 2014, IMMUNOL RES, V59, P23, DOI 10.1007/s12026-014-8527-y; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chapman NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053011; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Crompton BD, 2013, CANCER RES, V73, P2873, DOI 10.1158/0008-5472.CAN-12-1944; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Francois RA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv123; Goedegebuure P, 2011, CURR CANCER DRUG TAR, V11, P734, DOI 10.2174/156800911796191024; Golubovskaya V, 2015, J CANCER RES CLIN, V141, P1613, DOI 10.1007/s00432-015-1924-3; Graves DT, 2014, AM J PHYSIOL-CELL PH, V306, pC887, DOI 10.1152/ajpcell.00098.2014; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Konstantinidou G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388; Koppel AC, 2014, AM J PHYSIOL-CELL PH, V306, pC899, DOI 10.1152/ajpcell.00331.2013; Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Panni RZ, 2013, IMMUNOTHERAPY-UK, V5, P1075, DOI 10.2217/imt.13.102; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Rustad KC, 2013, DIFFERENTIATION, V86, P87, DOI 10.1016/j.diff.2013.02.003; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Stewart JE, 2015, MOL CARCINOGEN, V54, P9, DOI 10.1002/mc.22070; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tavora B, 2014, NATURE, V514, P112, DOI 10.1038/nature13541; Weischenfeldt J., 2008, COLD SPRING HARB PRO, V12; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; You K, 2015, INT J CLIN EXP MED, V8, P18284; Zhao XK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19276; Zheng DH, 2010, MOL CARCINOGEN, V49, P200, DOI 10.1002/mc.20590; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	56	533	551	14	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					851	+		10.1038/nm.4123	http://dx.doi.org/10.1038/nm.4123			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376576	Green Accepted			2022-12-27	WOS:000381000200010
J	Ryu, D; Mouchiroud, L; Andreux, PA; Katsyuba, E; Moullan, N; Nicolet-dit-Felix, AA; Williams, EG; Jha, P; Lo Sasso, G; Huzard, D; Aebischer, P; Sandi, C; Rinsch, C; Auwerx, J				Ryu, Dongryeol; Mouchiroud, Laurent; Andreux, Penelope A.; Katsyuba, Elena; Moullan, Norman; Nicolet-dit-Felix, Amandine A.; Williams, Evan G.; Jha, Pooja; Lo Sasso, Giuseppe; Huzard, Damien; Aebischer, Patrick; Sandi, Carmen; Rinsch, Chris; Auwerx, Johan			Urolithin A induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents	NATURE MEDICINE			English	Article							ELLAGIC ACID METABOLITES; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; AUTOPHAGY; POMEGRANATE; EXTENSION; UBIQUITIN; FOOD; ELLAGITANNINS; MITOCHONDRIA	The biological effects of urolithins remain poorly characterized, despite wide-spread human exposure via the dietary consumption of their metabolic precursors, the ellagitannins, which are found in the pomegranate fruit, as well as in nuts and berries. We identified urolithin A (UA) as a first-in-class natural compound that induces mitophagy both in vitro and in vivo following oral consumption. In C. elegans, UA prevented the accumulation of dysfunctional mitochondria with age and extended lifespan. Likewise, UA prolonged normal activity during aging in C. elegans, including mobility and pharyngeal pumping, while maintaining mitochondrial respiratory capacity. These effects translated to rodents, where UA improved exercise capacity in two different mouse models of age-related decline of muscle function, as well as in young rats. Our findings highlight the health benefits of urolithin A and its potential application in strategies to improve mitochondrial and muscle function.	[Ryu, Dongryeol; Mouchiroud, Laurent; Andreux, Penelope A.; Katsyuba, Elena; Moullan, Norman; Nicolet-dit-Felix, Amandine A.; Williams, Evan G.; Jha, Pooja; Lo Sasso, Giuseppe; Auwerx, Johan] Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Andreux, Penelope A.; Rinsch, Chris] Ecole Polytech Fed Lausanne, Amazentis SA, Innovat Pk,Batiment C, Lausanne, Switzerland; [Huzard, Damien; Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland; [Aebischer, Patrick] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland.; Rinsch, C (corresponding author), Ecole Polytech Fed Lausanne, Amazentis SA, Innovat Pk,Batiment C, Lausanne, Switzerland.	contact@amazentis.com; admin.auwerx@epfl.ch	Ryu, Dongryeol/AAQ-3642-2020; Auwerx, Johan/ABE-9307-2021; Williams, Evan/M-7539-2017	Ryu, Dongryeol/0000-0001-5905-6760; Williams, Evan/0000-0002-9746-376X; Jha, Pooja/0000-0002-0293-9287; Auwerx, Johan/0000-0002-5065-5393; Sandi, Carmen/0000-0001-7713-8321	Ecole Polytechnique Federale de Lausanne; Systems X [SysX.ch 2013/153]; Commission for Technology and Innovation (CTI) [15171.1 PFLS-LS]; Fondation Medicale pour la Recherche (FRM)	Ecole Polytechnique Federale de Lausanne; Systems X; Commission for Technology and Innovation (CTI); Fondation Medicale pour la Recherche (FRM)(Fondation pour la Recherche Medicale)	We thank P. Gonczy (Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Federale de Lausanne) for sharing reagents and equipment, the Caenorhabditis Genetics Center for providing worm strains and the Auwerx team members for discussions. We thank the team of the Phenotyping Unit, Center of PhenoGenomics, School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL) for their technical and scientific expertise in the mouse experiments. We thank K.H. Kim (Yonsei University College of Medicine) for providing mRFP-GFP-LC3B reporter and for discussion. We thank G. Yellen (Department of Neurobiology, Harvard Medical School) for providing mitochondrial pHRed-expressing plasmid and D. Kaiserlian (INSERM) for the Mode-K cell line. J.A. is the Nestle Chair in Energy Metabolism. Work in the Auwerx laboratory is supported by the Ecole Polytechnique Federale de Lausanne and Systems X (SysX.ch 2013/153), and was co-financed by the Commission for Technology and Innovation (CTI) (15171.1 PFLS-LS). L.M. was supported by a fellowship from Fondation Medicale pour la Recherche (FRM).	Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; [Anonymous], 2005, GUID IND EST MAX SAF; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Bakkalbasi E, 2009, CRIT REV FOOD SCI, V49, P283, DOI 10.1080/10408390802064404; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Espin JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garber K, 2016, NAT BIOTECHNOL, V34, P458, DOI 10.1038/nbt.3557; Gasperotti M, 2015, ACS CHEM NEUROSCI, V6, P1341, DOI 10.1021/acschemneuro.5b00051; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Gonzalez-Sarrias A, 2010, MOL NUTR FOOD RES, V54, P311, DOI 10.1002/mnfr.200900152; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Johanningsmeier SD, 2011, ANNU REV FOOD SCI T, V2, P181, DOI 10.1146/annurev-food-030810-153709; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kang I, 2016, MOL NUTR FOOD RES, V60, P1129, DOI 10.1002/mnfr.201500796; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kirienko NV, 2015, P NATL ACAD SCI USA, V112, P1821, DOI 10.1073/pnas.1424954112; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Nunez-Sanchez MA, 2014, MOL NUTR FOOD RES, V58, P1199, DOI 10.1002/mnfr.201300931; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Piwowarski JP, 2015, MOL NUTR FOOD RES, V59, P2168, DOI 10.1002/mnfr.201500264; Robinson S, 2016, CLINICAL NUTRITION AND AGING: SARCOPENIA AND MUSCLE METABOLISM, P3, DOI 10.1155/2012/510801; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Seeram NP, 2007, J AGR FOOD CHEM, V55, P7732, DOI 10.1021/jf071303g; Seeram NP, 2006, J NUTR, V136, P2481, DOI 10.1093/jn/136.10.2481; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tomas-Barberan FA, 2014, J AGR FOOD CHEM, V62, P6535, DOI 10.1021/jf5024615; Truchado P, 2012, J AGR FOOD CHEM, V60, P5749, DOI 10.1021/jf203641r; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wilkinson DS, 2012, METHOD CELL BIOL, V107, P353, DOI 10.1016/B978-0-12-394620-1.00012-6; Xu ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109141; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	63	460	482	34	222	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					879	+		10.1038/nm.4132	http://dx.doi.org/10.1038/nm.4132			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27400265				2022-12-27	WOS:000381000200013
J	Cejas, P; Li, L; O'Neill, NK; Duarte, M; Rao, P; Bowden, M; Zhou, CSW; Mendiola, M; Burgos, E; Feliu, J; Moreno-Rubio, J; Guadalajara, H; Moreno, V; Garcia-Olmo, D; Bellmunt, J; Mullane, S; Hirsch, M; Sweeney, CJ; Richardson, A; Liu, XS; Brown, M; Shivdasani, RA; Long, HW				Cejas, Paloma; Li, Lewyn; O'Neill, Nicholas K.; Duarte, Melissa; Rao, Prakash; Bowden, Michaela; Zhou, Chensheng W.; Mendiola, Marta; Burgos, Emilio; Feliu, Jaime; Moreno-Rubio, Juan; Guadalajara, Hector; Moreno, Victor; Garcia-Olmo, Damin; Bellmunt, Joaquim; Mullane, Stephanie; Hirsch, Michelle; Sweeney, Christopher J.; Richardson, Andrea; Liu, X. Shirley; Brown, Myles; Shivdasani, Ramesh A.; Long, Henry W.			Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles	NATURE MEDICINE			English	Article							EMBRYONIC STEM-CELLS; CIS-REGULATORY REGIONS; TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; ANTIGEN RETRIEVAL; GENE-EXPRESSION; SELF-RENEWAL; GENOME; CANCER; IMMUNOHISTOCHEMISTRY	Extensive cross-linking introduced during routine tissue fixation of clinical pathology specimens severely hampers chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) analysis from archived tissue samples. This limits the ability to study the epigenomes of valuable, clinically annotated tissue resources. Here we describe fixed-tissue chromatin immunoprecipitation sequencing (FiT-seq), a method that enables reliable extraction of soluble chromatin from formalin-fixed paraffin-embedded (FFPE) tissue samples for accurate detection of histone marks. We demonstrate that FiT-seq data from FFPE specimens are concordant with ChIP-seq data from fresh-frozen samples of the same tumors. By using multiple histone marks, we generate chromatinstate maps and identify cis-regulatory elements in clinical samples from various tumor types that can readily allow us to distinguish between cancers by the tissue of origin. Tumor-specific enhancers and superenhancers that are elucidated by FiT-seq analysis correlate with known oncogenic drivers in different tissues and can assist in the understanding of how chromatin states affect gene regulation.	[Cejas, Paloma; Li, Lewyn; Duarte, Melissa; Rao, Prakash; Liu, X. Shirley; Brown, Myles; Shivdasani, Ramesh A.; Long, Henry W.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Cejas, Paloma; Li, Lewyn; O'Neill, Nicholas K.; Duarte, Melissa; Rao, Prakash; Bellmunt, Joaquim; Mullane, Stephanie; Sweeney, Christopher J.; Brown, Myles; Shivdasani, Ramesh A.; Long, Henry W.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cejas, Paloma; Mendiola, Marta; Feliu, Jaime] Hosp La Paz, Inst Hlth Res IdiPAZ, Dept Med Oncol, Madrid, Spain; [Bowden, Michaela; Zhou, Chensheng W.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Mendiola, Marta; Burgos, Emilio] Hosp La Paz, Dept Pathol, Inst Hlth Res IdiPAZ, Madrid, Spain; [Moreno-Rubio, Juan] Infanta Sofia Univ Hosp, Precis Oncol Lab, Madrid, Spain; [Guadalajara, Hector; Garcia-Olmo, Damin] Fdn Jimenez Diaz, Dept Surg, E-28040 Madrid, Spain; [Moreno, Victor] Fdn Jimenez Diaz, Clin Res Unit, E-28040 Madrid, Spain; [Hirsch, Michelle; Richardson, Andrea] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Hirsch, Michelle; Richardson, Andrea] Harvard Univ, Sch Med, Boston, MA USA; [Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Hospital Universitario Infanta Sofia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Shivdasani, RA; Long, HW (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Shivdasani, RA; Long, HW (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu; henry_long@dfci.harvard.edu	Moreno, Victor/GNN-0449-2022; Brown, Myles/AAX-5332-2021; Moreno-Rubio, Juan/M-4597-2015; Bellmunt, Joaquim/B-8151-2019; Guadalajara, Hector/AAG-6209-2021; Brown, Myles/B-6906-2008	Moreno, Victor/0000-0001-6099-4236; Brown, Myles/0000-0002-8213-1658; Moreno-Rubio, Juan/0000-0003-3335-8749; Bellmunt, Joaquim/0000-0003-2328-3421; Guadalajara, Hector/0000-0001-6297-9347; Zhou, Chensheng/0000-0001-6593-7994; Bowden, Michaela/0000-0003-4375-7823; Wankowicz, Stephanie/0000-0002-4225-7459; Garcia Olmo, Damian/0000-0002-9369-2338	DFCI-Novartis Drug Discovery Program; US NIH [P50CA127003]; Susan F. Smith Center for Women's Cancers; Susan G. Komen foundation; Breast Cancer Research foundation; Medical Oncology Translational Grant Program from Dana-Farber Cancer Institute; Instituto de Salud Carlos III the Spanish Economy and Competitiveness Ministry [PI13-01818]; ConSEPOC-Comunidad de Madrid [S2010/BMD-2542]; Asociacion Espanola Contra el Cancer (Programa de Formacion Avanzada en Oncologia); Fundacion Caja Madrid	DFCI-Novartis Drug Discovery Program; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan F. Smith Center for Women's Cancers; Susan G. Komen foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research foundation; Medical Oncology Translational Grant Program from Dana-Farber Cancer Institute; Instituto de Salud Carlos III the Spanish Economy and Competitiveness Ministry; ConSEPOC-Comunidad de Madrid; Asociacion Espanola Contra el Cancer (Programa de Formacion Avanzada en Oncologia); Fundacion Caja Madrid	This work was supported by the DFCI-Novartis Drug Discovery Program (R.A.S.), the US NIH grant P50CA127003 (R.A.S.), the Susan F. Smith Center for Women's Cancers (M. Brown), grants from the Susan G. Komen and the Breast Cancer Research foundations (M. Brown), the Medical Oncology Translational Grant Program from the Dana-Farber Cancer Institute (C.J.S.), a grant from Instituto de Salud Carlos III the Spanish Economy and Competitiveness Ministry (grant PI13-01818; P.C.), the ConSEPOC-Comunidad de Madrid (grant S2010/BMD-2542; P.C.), and fellowships from the Asociacion Espanola Contra el Cancer (Programa de Formacion Avanzada en Oncologia 2010; P.C.) and the Fundacion Caja Madrid (P.C.). We thank E. Diaz and M. de Miguel for technical assistance.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balasubramanian D, 2012, GENOME MED, V4, DOI 10.1186/gm346; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fanelli M, 2010, P NATL ACAD SCI USA, V107, P21535, DOI 10.1073/pnas.1007647107; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Shi SR, 2005, J HISTOCHEM CYTOCHEM, V53, P1167, DOI 10.1369/jhc.5B6691.2005; SHI SR, 1995, J HISTOCHEM CYTOCHEM, V43, P193, DOI 10.1177/43.2.7822775; Shin Hyunjin, 2013, Quant Biol, V1, P54; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Bragt MPA, 2014, ELIFE, V3, DOI 10.7554/eLife.03881; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	37	45	63	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					685	+		10.1038/nm.4085	http://dx.doi.org/10.1038/nm.4085			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27111282				2022-12-27	WOS:000377476000027
J	Chakradhar, S				Chakradhar, Shraddha			Prime pick: Researchers get selective about T cells for cancer therapy	NATURE MEDICINE			English	News Item							IN-VIVO; CD8(+); EFFECTOR; SUBSETS											Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002	6	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					456	458		10.1038/nm0516-456	http://dx.doi.org/10.1038/nm0516-456			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149215				2022-12-27	WOS:000375514000004
J	Rath, N; Olson, MF				Rath, Nicola; Olson, Michael F.			Regulation of pancreatic cancer aggressiveness by stromal stiffening	NATURE MEDICINE			English	Editorial Material							DUCTAL ADENOCARCINOMA; PROGRESSION; COOPERATE	Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extensive stromal component that hinders treatment. A new study shows how the genetic identity of pancreatic tumors might influence the physical properties of the associated stroma to promote tumor progression.	[Rath, Nicola; Olson, Michael F.] Canc Res UK Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland	Beatson Institute	Olson, MF (corresponding author), Canc Res UK Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland.	m.olson@beatson.gla.ac.uk	Olson, Michael/ABA-4240-2021	Olson, Michael/0000-0003-3428-3507	Cancer Research UK [18276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Lee JJ, 2014, P NATL ACAD SCI USA, V111, pE3091, DOI 10.1073/pnas.1411679111; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018	12	24	25	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					462	463		10.1038/nm.4099	http://dx.doi.org/10.1038/nm.4099			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149218	Green Accepted			2022-12-27	WOS:000375514000007
J	McKinnon, LR; Liebenberg, LJ; Yende-Zuma, N; Archary, D; Ngcapu, S; Sivro, A; Nagelkerke, N; Lerma, JGG; Kashuba, AD; Masson, L; Mansoor, LE; Karim, QA; Karim, SSA; Passmore, JAS				McKinnon, Lyle R.; Liebenberg, Lenine J.; Yende-Zuma, Nonhlanhla; Archary, Derseree; Ngcapu, Sinaye; Sivro, Aida; Nagelkerke, Nico; Lerma, Jose Gerardo Garcia; Kashuba, Angela D.; Masson, Lindi; Mansoor, Leila E.; Karim, Quarraisha Abdool; Karim, Salim S. Abdool; Passmore, Jo-Ann S.			Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women	NATURE MEDICINE			English	Article							PREEXPOSURE PROPHYLAXIS; AFRICAN WOMEN; HIGH-RISK; INFECTION; EFFICACY; MEN; TRACT; TRIAL; EMTRICITABINE; TRANSMISSION	Several clinical trials have demonstrated that antiretroviral (ARV) drugs taken as pre-exposure prophylaxis (PrEP) can prevent HIV infection1, with the magnitude of protection ranging from -49 to 86% (refs. 2-11). Although these divergent outcomes are thought to be due primarily to differences in product adherence(12), biological factors likely contribute(13). Despite selective recruitment of higher-risk participants for prevention trials, HIV risk is heterogeneous even within higher-risk groups(14-16). To determine whether this heterogeneity could influence patient outcomes following PrEP, we undertook a post hoc prospective analysis of results from the CAPRISA 004 trial for 1% tenofovir gel (n = 774 patients), one of the first trials to demonstrate protection against HIV infection. Concentrations of nine proinflammatory cytokines were measured in cervicovaginal lavages at >2,000 visits, and a graduated cytokine score was used to define genital inflammation. In women without genital inflammation, tenofovir was 57% protective against HIV (95% confidence interval (CI): 7-80%) but was 3% protective (95% CI: -104-54%) if genital inflammation was present. Among women who highly adhered to the gel, tenofovir protection was 75% (95% CI: 25-92%) in women without inflammation compared to -10% (95% CI: -184-57%) in women with inflammation. Immunological predictors of HIV risk may modify the effectiveness of tools for HIV prevention; reducing genital inflammation in women may augment HIV prevention efforts.	[McKinnon, Lyle R.; Liebenberg, Lenine J.; Yende-Zuma, Nonhlanhla; Archary, Derseree; Ngcapu, Sinaye; Sivro, Aida; Masson, Lindi; Mansoor, Leila E.; Karim, Quarraisha Abdool; Karim, Salim S. Abdool; Passmore, Jo-Ann S.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [McKinnon, Lyle R.; Sivro, Aida; Nagelkerke, Nico] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [McKinnon, Lyle R.; Liebenberg, Lenine J.; Archary, Derseree; Ngcapu, Sinaye; Sivro, Aida] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa; [Lerma, Jose Gerardo Garcia] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Kashuba, Angela D.] Univ North Carolina Chapel Hill, Eschelman Sch Pharm, Chapel Hill, NC USA; [Masson, Lindi; Passmore, Jo-Ann S.] Univ Cape Town, Inst Infect Dis & Mol Med IDM, Cape Town, South Africa; [Karim, Quarraisha Abdool; Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Passmore, Jo-Ann S.] Natl Hlth Lab Serv, Cape Town, South Africa	University of Manitoba; University of Kwazulu Natal; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Cape Town; Columbia University	McKinnon, LR; Passmore, JAS (corresponding author), Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.; McKinnon, LR (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.; McKinnon, LR (corresponding author), Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa.; Passmore, JAS (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med IDM, Cape Town, South Africa.; Passmore, JAS (corresponding author), Natl Hlth Lab Serv, Cape Town, South Africa.	lyle.mckinnon@caprisa.org; jo-ann.passmore@uct.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022; Liebenberg, Lenine/AAV-5224-2021; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019	Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Abdool/0000-0002-4986-2133; McKinnon, Lyle/0000-0002-7157-0700; Masson, Lindi/0000-0002-2539-817X; Liebenberg, Lenine Julie Phillips/0000-0001-6768-8776; Sivro, Aida/0000-0001-9215-5285	National Institutes of Health [5R01AI111936]; DST-NRF Centre of Excellence in HIV Prevention at CAPRISA; United States Agency for International Development (USAID) through FHI360; United States Agency for International Development (USAID) through CONRAD; South African Department of Science and Technology (DST); Canadian Institutes of Health Research (CIHR) New Investigator Award; South African National Research Foundation (NRF) Research Career Advancement Fellowship awards; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R01AI111936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DST-NRF Centre of Excellence in HIV Prevention at CAPRISA; United States Agency for International Development (USAID) through FHI360(United States Agency for International Development (USAID)); United States Agency for International Development (USAID) through CONRAD(United States Agency for International Development (USAID)); South African Department of Science and Technology (DST); Canadian Institutes of Health Research (CIHR) New Investigator Award(Canadian Institutes of Health Research (CIHR)); South African National Research Foundation (NRF) Research Career Advancement Fellowship awards; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank W. Heneine and D. Kwon for important discussions regarding these data. The study was funded by the National Institutes of Health (5R01AI111936 to J.S.P.) and the DST-NRF Centre of Excellence in HIV Prevention at CAPRISA. The original CAPRISA 004 1% tenofovir gel trial was funded principally by the United States Agency for International Development (USAID) through FHI360 and CONRAD with additional support provided by the South African Department of Science and Technology (DST). We would like to thank all study participants and CAPRISA staff for making the CAPRISA 004 trial possible. L.R.M. is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Award. L.J.L., D.A., and L.M. are funded by South African National Research Foundation (NRF) Research Career Advancement Fellowship awards.	Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Arnold KB, 2016, MUCOSAL IMMUNOL, V9, P194, DOI 10.1038/mi.2015.51; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Buchbinder SP, 2014, LANCET INFECT DIS, V14, P468, DOI 10.1016/S1473-3099(14)70025-8; Cohen J., 2016, SCIENCE; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Garcia-Lerma JG, 2011, J VIROL, V85, P6610, DOI 10.1128/JVI.00311-11; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Heffron R, 2017, LANCET HIV, V4, pE449, DOI 10.1016/S2352-3018(17)30110-8; Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2013, LANCET, V381, P2060, DOI 10.1016/S0140-6736(13)61140-X; Kashuba ADM, 2015, JAIDS-J ACQ IMM DEF, V69, P264, DOI 10.1097/QAI.0000000000000607; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Liebenberg LJP, 2017, JAIDS-J ACQ IMM DEF, V74, P318, DOI 10.1097/QAI.0000000000001218; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Masson L, 2014, SEX TRANSM INFECT, V90, P580, DOI 10.1136/sextrans-2014-051601; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McKinnon LR, 2016, CURR HIV-AIDS REP, V13, P158, DOI 10.1007/s11904-016-0314-z; McKinnon LR, 2015, AIDS BEHAV, V19, P2204, DOI 10.1007/s10461-015-1118-7; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Nagelkerke NJD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003459; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rees H, 2015, C RETR OPP INF CROI; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Seifert SM, 2016, AIDS RES HUM RETROV, V32, P981, DOI 10.1089/aid.2016.0008; Selhorst P, 2017, CLIN INFECT DIS, V64, P79, DOI 10.1093/cid/ciw663; Shannon B, 2017, J INFECT DIS, V215, P1366, DOI 10.1093/infdis/jix088; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van de Wijgert J, 2017, LANCET HIV, V4, pE427, DOI 10.1016/S2352-3018(17)30130-3	39	77	77	3	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					491	+		10.1038/nm.4506	http://dx.doi.org/10.1038/nm.4506			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29480895	Green Accepted, Green Submitted			2022-12-27	WOS:000429639800020
J	Shi, YX; Lin, SY; Staats, KA; Li, YC; Chang, WH; Hung, ST; Hendricks, E; Linares, GR; Wang, YM; Son, EY; Wen, XM; Kisler, K; Wilkinson, B; Menendez, L; Sugawara, T; Woolwine, P; Huang, M; Cowan, MJ; Ge, B; Koutsodendris, N; Sandor, KP; Komberg, J; Vangoor, VR; Senthilkumar, K; Hennes, V; Seah, C; Nelson, AR; Cheng, TY; Lee, SJJ; August, PR; Chen, JA; Wisniewski, N; Hanson-Smith, V; Belgard, TG; Zhang, A; Coba, M; Grunseich, C; Ward, ME; van den Berg, LH; Pasterkamp, RJ; Trotti, D; Zlokovic, BV; Ichida, JK				Shi, Yingxiao; Lin, Shaoyu; Staats, Kim A.; Li, Yichen; Chang, Wen-Hsuan; Hung, Shu-Ting; Hendricks, Eric; Linares, Gabriel R.; Wang, Yaoming; Son, Esther Y.; Wen, Xinmei; Kisler, Kassandra; Wilkinson, Brent; Menendez, Louise; Sugawara, Tohru; Woolwine, Phillip; Huang, Mickey; Cowan, Michael J.; Ge, Brandon; Koutsodendris, Nicole; Sandor, Kaitlin P.; Komberg, Jacob; Vangoor, Vamshidhar R.; Senthilkumar, Ketharini; Hennes, Valerie; Seah, Carina; Nelson, Amy R.; Cheng, Tze-Yuan; Lee, Shih-Jong J.; August, Paul R.; Chen, Jason A.; Wisniewski, Nicholas; Hanson-Smith, Victor; Belgard, T. Grant; Zhang, Alice; Coba, Marcelo; Grunseich, Chris; Ward, Michael E.; van den Berg, Leonard H.; Pasterkamp, R. Jeroen; Trotti, Davide; Zlokovic, Berislav V.; Ichida, Justin K.			Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; REPEAT EXPANSION; HEXANUCLEOTIDE REPEAT; HUMAN FIBROBLASTS; GGGGCC REPEAT; TRAFFICKING; ALS; BIOGENESIS; PROTEINS; MICE	An intronic GGGGCC repeat expansion in C9ORF72 is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), but the pathogenic mechanism of this repeat remains unclear. Using human induced motor neurons (iMNs), we found that repeat-expanded C9ORF72 was haploinsufficient in ALS. We found that C9ORF72 interacted with endosomes and was required for normal vesicle trafficking and lysosomal biogenesis in motor neurons. Repeat expansion reduced C9ORF72 expression, triggering neurodegeneration through two mechanisms: accumulation of glutamate receptors, leading to excitotoxicity, and impaired clearance of neurotoxic dipeptide repeat proteins derived from the repeat expansion. Thus, cooperativity between gain- and loss-of-function mechanisms led to neurodegeneration. Restoring C9ORF72 levels or augmenting its function with constitutively active RAB5 or chemical modulators of RAB5 effectors rescued patient neuron survival and ameliorated neurodegenerative processes in both gain- and loss-of-function C9ORF72 mouse models. Thus, modulating vesicle trafficking was able to rescue neurodegeneration caused by the C9ORF72 repeat expansion. Coupled with rare mutations in ALS2, FIG4, CHMP2B, OPTN and SQSTM1, our results reveal mechanistic convergence on vesicle trafficking in ALS and FTD.	[Shi, Yingxiao; Lin, Shaoyu; Staats, Kim A.; Li, Yichen; Chang, Wen-Hsuan; Hung, Shu-Ting; Hendricks, Eric; Linares, Gabriel R.; Menendez, Louise; Sugawara, Tohru; Woolwine, Phillip; Huang, Mickey; Cowan, Michael J.; Ge, Brandon; Koutsodendris, Nicole; Sandor, Kaitlin P.; Komberg, Jacob; Hennes, Valerie; Seah, Carina; Ichida, Justin K.] Univ Southern Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA; [Shi, Yingxiao; Lin, Shaoyu; Staats, Kim A.; Li, Yichen; Chang, Wen-Hsuan; Hung, Shu-Ting; Hendricks, Eric; Linares, Gabriel R.; Menendez, Louise; Sugawara, Tohru; Woolwine, Phillip; Huang, Mickey; Cowan, Michael J.; Ge, Brandon; Koutsodendris, Nicole; Sandor, Kaitlin P.; Komberg, Jacob; Hennes, Valerie; Seah, Carina; Ichida, Justin K.] USC, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90033 USA; [Shi, Yingxiao; Lin, Shaoyu; Staats, Kim A.; Li, Yichen; Chang, Wen-Hsuan; Hung, Shu-Ting; Hendricks, Eric; Linares, Gabriel R.; Wang, Yaoming; Kisler, Kassandra; Wilkinson, Brent; Menendez, Louise; Sugawara, Tohru; Woolwine, Phillip; Huang, Mickey; Cowan, Michael J.; Ge, Brandon; Koutsodendris, Nicole; Sandor, Kaitlin P.; Komberg, Jacob; Hennes, Valerie; Seah, Carina; Nelson, Amy R.; Coba, Marcelo; Zlokovic, Berislav V.; Ichida, Justin K.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Wang, Yaoming; Kisler, Kassandra; Nelson, Amy R.; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Son, Esther Y.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA; [Wen, Xinmei; Trotti, Davide] Thomas Jefferson Univ, Jefferson Weinberg ALS Ctr, Vickie & Jack Farber Inst Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA; [Vangoor, Vamshidhar R.; Senthilkumar, Ketharini; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Cheng, Tze-Yuan; Lee, Shih-Jong J.] DRVis Technol LLC, Washington, DC USA; [August, Paul R.] Icagen Corp, Oro Valley, AZ USA; [Chen, Jason A.; Wisniewski, Nicholas; Hanson-Smith, Victor; Belgard, T. Grant; Zhang, Alice] Verge Genom, San Francisco, CA USA; [Coba, Marcelo] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Grunseich, Chris; Ward, Michael E.] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA; [van den Berg, Leonard H.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Stanford University; Jefferson University; Utrecht University; Utrecht University Medical Center; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Utrecht University; Utrecht University Medical Center	Ichida, JK (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA.; Ichida, JK (corresponding author), USC, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Los Angeles, CA 90033 USA.; Ichida, JK (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	ichida@usc.edu	Sugawara, Tohru/W-5304-2019; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Vangoor, Vamshidhar/AAR-3865-2021; Nelson, Amy R./HCH-3772-2022; Ward, Michael Emmerson/ABG-5892-2021	Nelson, Amy R./0000-0003-2025-1408; Ward, Michael Emmerson/0000-0002-5296-8051; Ge, Brandon/0000-0002-8775-8521; Chang, Wen-Hsuan/0000-0002-6155-8644; Staats, Kim/0000-0001-8392-7992; Trotti, Davide/0000-0001-6338-6404; Vangoor, Vamshi/0000-0003-0751-9772; Belgard, Tildon/0000-0002-6962-7894; Seah, Carina/0000-0003-1604-1838; Wilkinson, Brent/0000-0001-7852-1218	Muscular Dystrophy Association Development Grant; NIH [T32DC009975-04, AG039452, AG023084, NS034467, R00NS077435, R01NS097850]; ALS Foundation Netherlands (TOTALS); VICI grant Netherlands Organization for Scientific Research (NWO); US Department of Defense [W81XWH-15-1-0187]; Donald E. and Delia B. Baxter Foundation; Tau Consortium; Frick Foundation for ALS Research; Muscular Dystrophy Association; New York Stem Cell Foundation; USC Keck School of Medicine Regenerative Medicine Initiative; USC Broad Innovation Award; Southern California Clinical and Translational Science Institute; Epilepsiefonds [12-08, 15-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097850, R37NS034467, K99NS077435, ZIANS003038, R01NS034467, R00NS077435, R21NS090912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, P50AG005142, R01AG039452, P01AG052350, R01AG023084, RF1AG039452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015530, T32DC009975] Funding Source: NIH RePORTER	Muscular Dystrophy Association Development Grant(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Foundation Netherlands (TOTALS); VICI grant Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); US Department of Defense(United States Department of Defense); Donald E. and Delia B. Baxter Foundation; Tau Consortium; Frick Foundation for ALS Research; Muscular Dystrophy Association(Muscular Dystrophy Association); New York Stem Cell Foundation; USC Keck School of Medicine Regenerative Medicine Initiative; USC Broad Innovation Award; Southern California Clinical and Translational Science Institute; Epilepsiefonds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the NINDS Biorepository at Coriell Institute for providing the following cell lines for this study: ND12133, ND03231, ND01751, ND11976, ND03719, ND00184, ND5280, ND06769, ND10689, ND12099, ND14954, ND08957, ND12100 and ND014587. We thank H. Chui and C. Miller (University of Southern California Alzheimer's Disease Research Center) and N. Shneider (Columbia University Medical Center) for control and C9ORF72 patient tissue. We thank the Choi Family Therapeutic Screening Facility for chemical screening support and the Translational Imaging Center at USC for imaging support. We thank M. Koppers, Y, Adolfs, C. van der Meer and M. Broekhoven for help with mouse breeding and kainate injection experiments. We thank S. Waguri (Fukushima Medical University) for providing the M6PR-GFP construct. We thank C, Buser for assistance with electron microscopy. We also thank S. Alworth (DRVision Technologies), K. Hebestreit and R. Bhatnagar (Verge Genomics), B. Baloh (Cedars Sinai Medical Center), J. O'Rourke (Cedars Sinai Medical Center), C. Donnelly, C. Tong, A. McMahon and Q. Liu-Michael for reagents, technical support and discussions. E.Y.S. is a Walter V. and Idun Berry Postdoctoral Fellow. K. A. S. was supported in part by a Muscular Dystrophy Association Development Grant. L.M. was supported by NIH grant T32DC009975-04. This work was supported by NIH grants AG039452, AG023084 and NS034467 to B.V.Z.R.J.P. was supported by grants from ALS Foundation Netherlands (TOTALS), Epilepsiefonds (12-08, 15-05), and VICI grant Netherlands Organization for Scientific Research (NWO). This work was also supported by NIH grants R00NS077435 and R01NS097850, US Department of Defense grant W81XWH-15-1-0187, and grants from the Donald E. and Delia B. Baxter Foundation, the Tau Consortium, the Frick Foundation for ALS Research, the Muscular Dystrophy Association, the New York Stem Cell Foundation, the USC Keck School of Medicine Regenerative Medicine Initiative, the USC Broad Innovation Award, and the Southern California Clinical and Translational Science Institute to J.K.I. J.K.I. is a New York Stem Cell Foundation-Robertson Investigator.	Amick J, 2016, MOL BIOL CELL, V27, P3040, DOI 10.1091/mbc.E16-01-0003; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Aoki Y, 2017, BRAIN, V140, P887, DOI 10.1093/brain/awx024; Burberry A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6038; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Farg MA, 2014, HUM MOL GENET, V23, P3579, DOI 10.1093/hmg/ddu068; Fratta P, 2013, ACTA NEUROPATHOL, V126, P401, DOI 10.1007/s00401-013-1147-0; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Highley JR, 2014, NEUROPATH APPL NEURO, V40, P670, DOI 10.1111/nan.12148; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Koppers M, 2015, ANN NEUROL, V78, P426, DOI 10.1002/ana.24453; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Li J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6716; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu EY, 2014, ACTA NEUROPATHOL, V128, P525, DOI 10.1007/s00401-014-1286-y; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Lodhi IJ, 2008, MOL BIOL CELL, V19, P2718, DOI 10.1091/mbc.E08-01-0105; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Martin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060152; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; NEISS WF, 1983, HISTOCHEMISTRY, V77, P63, DOI 10.1007/BF00496637; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Su ZM, 2014, NEURON, V84, P239, DOI 10.1016/j.neuron.2014.09.019; Sullivan PM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0324-5; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364; Webster CP, 2016, EMBO J, V35, P1656, DOI 10.15252/embj.201694401; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010	65	279	283	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					313	+		10.1038/nm.4490	http://dx.doi.org/10.1038/nm.4490			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29400714	Green Accepted			2022-12-27	WOS:000426700900014
J	Jayaraman, K				Jayaraman, Killugudi			A shot at contraception In India, a nonagenarian renews testing of a birth control vaccine	NATURE MEDICINE			English	News Item							HUMAN CHORIONIC-GONADOTROPIN; BETA-SUBUNIT; PREGNANCY; WOMEN											ALDHOUS P, 1994, SCIENCE, V266, P1484, DOI 10.1126/science.7985014; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; NASH H, 1980, FERTIL STERIL, V34, P328; Singh M, 1998, AM J REPROD IMMUNOL, V39, P395; Singh S, 2018, LANCET GLOB HEALTH, V6, pE111, DOI [10.1016/S2214-109X(17)30453-9, 10.1016/s2214-109x(17)30453-9]; TALWAR GP, 1976, P NATL ACAD SCI USA, V73, P218, DOI 10.1073/pnas.73.1.218; TALWAR GP, 1976, CONTRACEPTION, V13, P237, DOI 10.1016/0010-7824(76)90037-8; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; van Kammen J.R., 2000, THESIS	9	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					118	120		10.1038/nm0218-118	http://dx.doi.org/10.1038/nm0218-118			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414934				2022-12-27	WOS:000424327200004
J	Broutier, L; Mastrogiovanni, G; Verstegen, MMA; Francies, HE; Gavarro, LM; Bradshaw, CR; Allen, GE; Arnes-Benito, R; Sidorova, O; Gaspersz, MP; Georgakopoulos, N; Koo, BK; Dietmann, S; Davies, SE; Praseedom, RK; Lieshout, R; IJzermans, JNM; Wigmore, SJ; Saeb-Parsy, K; Garnett, MJ; van der Laan, LJW; Huch, M				Broutier, Laura; Mastrogiovanni, Gianmarco; Verstegen, Monique M. A.; Francies, Hayley E.; Gavarro, Lena Morrill; Bradshaw, Charles R.; Allen, George E.; Arnes-Benito, Robert; Sidorova, Olga; Gaspersz, Marcia P.; Georgakopoulos, Nikitas; Koo, Bon-Kyoung; Dietmann, Sabine; Davies, Susan E.; Praseedom, Raaj K.; Lieshout, Ruby; IJzermans, Jan N. M.; Wigmore, Stephen J.; Saeb-Parsy, Kourosh; Garnett, Mathew J.; van der Laan, Luc J. W.; Huch, Meritxell			Human primary liver cancer-derived organoid cultures for disease modeling and drug screening	NATURE MEDICINE			English	Article							IN-VITRO EXPANSION; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; INACTIVATING MUTATIONS; ADULT LIVER; CHOLANGIOCARCINOMA; EXPRESSION; GENOME; ESTABLISHMENT; MOUSE	Human liver cancer research currently lacks in vitro models that can faithfully recapitulate the pathophysiology of the original tumor. We recently described a novel, near-physiological organoid culture system, wherein primary human healthy liver cells form long-term expanding organoids that retain liver tissue function and genetic stability. Here we extend this culture system to the propagation of primary liver cancer (PLC) organoids from three of the most common PLC subtypes: hepatocellular carcinoma (HCC), cholangiocarcinoma (CC) and combined HCC/CC (CHC) tumors. PLC-derived organoid cultures preserve the histological architecture, gene expression and genomic landscape of the original tumor, allowing for discrimination between different tumor tissues and subtypes, even after long-term expansion in culture in the same medium conditions. Xenograft studies demonstrate that the tumorogenic potential, histological features and metastatic properties of PLC-derived organoids are preserved in vivo. PLC-derived organoids are amenable for biomarker identification and drug-screening testing and led to the identification of the ERK inhibitor SCH772984 as a potential therapeutic agent for primary liver cancer. We thus demonstrate the wide-ranging biomedical utilities of PLC-derived organoid models in furthering the understanding of liver cancer biology and in developing personalized-medicine approaches for the disease.	[Broutier, Laura; Mastrogiovanni, Gianmarco; Bradshaw, Charles R.; Allen, George E.; Arnes-Benito, Robert; Sidorova, Olga; Huch, Meritxell] Univ Cambridge, CRUK Gurdon Inst, Wellcome Trust, Cambridge, England; [Mastrogiovanni, Gianmarco; Gavarro, Lena Morrill; Koo, Bon-Kyoung; Dietmann, Sabine; Huch, Meritxell] Univ Cambridge, Med Res Council Stem Cell Inst, Wellcome Trust, Cambridge, England; [Verstegen, Monique M. A.; Gaspersz, Marcia P.; Lieshout, Ruby; IJzermans, Jan N. M.; van der Laan, Luc J. W.] Erasmus MC Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Francies, Hayley E.; Garnett, Mathew J.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Georgakopoulos, Nikitas; Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Cambridge, England; [Georgakopoulos, Nikitas; Saeb-Parsy, Kourosh] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Davies, Susan E.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Praseedom, Raaj K.] Cambridge Univ Hosp NHS Fdn Trust, Dept Hepato Pancreato Biliary Surg, Cambridge, England; [Wigmore, Stephen J.] Royal Infirm Edinburgh NHS Trust, Dept Clin Surg, Edinburgh, Midlothian, Scotland; [Huch, Meritxell] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Royal Infirmary of Edinburgh; University of Edinburgh; University of Cambridge	Huch, M (corresponding author), Univ Cambridge, CRUK Gurdon Inst, Wellcome Trust, Cambridge, England.; Huch, M (corresponding author), Univ Cambridge, Med Res Council Stem Cell Inst, Wellcome Trust, Cambridge, England.; Huch, M (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	m.huch@gurdon.cam.ac.uk	Wigmore, Stephen/AAF-3562-2019; Koo, Bon-Kyoung/V-5219-2017; van der Laan, Luc/M-5495-2019; BROUTIER, Laura/X-8536-2019	Wigmore, Stephen/0000-0002-3614-8002; Koo, Bon-Kyoung/0000-0002-4134-8033; van der Laan, Luc/0000-0002-0651-5334; BROUTIER, Laura/0000-0001-5163-5573; Georgakopoulos, Nikitas/0000-0002-1879-6583; Dietmann, Sabine./0000-0001-6672-8457; Lieshout, Ruby/0000-0002-7848-3933; Morrill Gavarro, Lena/0000-0002-2242-4010; Bradshaw, Charles/0000-0002-3528-458X; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Verstegen, Monique/0000-0001-9908-6673	Wellcome Trust [104151/Z/14/Z, 102696]; Royal Society [104151/Z/14/Z]; EMBO Postdoctoral Fellowship (EMBO) [ALTF 794-2014]; Marie-Curie Postdoctoral Fellowship [656193_H2020-MSCA-IF-2014]; Marie Curie Initial Training Network (Marie Curie ITN WntsApp) [608180]; H2020 LSMF4LIFE grant [ECH2020-668350]; NC3Rs International prize; Beit Prize; Cambridge Cancer Center-pump priming award [CRUK-RG83267]; NC3Rs project grant [NC/R001162/1]; research program InnoSysTox [114027003]; Netherlands Organisation for Health Research and Development (ZonMw); Dutch Digestive Foundation (MLDS-Diagnostics) [D16-26]; Stand Up To Cancer [SU2C-AACRDT1213]; Cancer Research UK [C44943/A22536]; Cancer Research UK [22536] Funding Source: researchfish; National Centre for the Replacement [NC/R001162/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); EMBO Postdoctoral Fellowship (EMBO); Marie-Curie Postdoctoral Fellowship(European Commission); Marie Curie Initial Training Network (Marie Curie ITN WntsApp); H2020 LSMF4LIFE grant; NC3Rs International prize(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Beit Prize; Cambridge Cancer Center-pump priming award; NC3Rs project grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); research program InnoSysTox; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Digestive Foundation (MLDS-Diagnostics); Stand Up To Cancer; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Centre for the Replacement	M.H. is a Wellcome Trust Sir Henry Dale Fellow and is jointly funded by the Wellcome Trust and the Royal Society (104151/Z/14/Z). L.B. is supported by an EMBO Postdoctoral Fellowship (EMBO ALTF 794-2014) and Marie-Curie Postdoctoral Fellowship (grant no. 656193_H2020-MSCA-IF-2014). G.M. was supported by a Marie Curie Initial Training Network (Marie Curie ITN WntsApp 608180) and a H2020 LSMF4LIFE grant (ECH2020-668350). This work was funded by an NC3Rs International prize, a Beit Prize, a Cambridge Cancer Center-pump priming award (CRUK-RG83267) and, partially, by a NC3Rs project grant (NC/R001162/1), all of them awarded to M.H. Work at the L.J.W.v.d.L lab was funded by the research program InnoSysTox (project number 114027003), by the Netherlands Organisation for Health Research and Development (ZonMw), and part of the research program financed by the Dutch Digestive Foundation (MLDS-Diagnostics project number D16-26). Work in the M.J.G. lab is funded by the Wellcome Trust (102696), Stand Up To Cancer (SU2C-AACRDT1213) and Cancer Research UK (C44943/A22536). We thank C. Pacini (Wellcome Trust-Cancer Research UK Gurdon Institute) for help with the clustering analysis of the HCC and CC TCGA cohorts and the samples used in this study. We also thank C. Olpe and N. Hircq (Wellcome Trust-Cancer Research UK Gurdon Institute) for help in the early phases of the project, C. Hindley (Wellcome Trust-Cancer Research UK Gurdon Institute) for editorial assistance, the Gurdon Institute facilities for help with imaging and animal care, S. Moss, K. Harnish (Wellcome Trust-Cancer Research UK Gurdon Institute), M. Paramor and J. Martinez (Wellcome Trust-Medical Research Council Stem Cell Institute) for assistance with sequencing analysis and A. Jah (Cambridge University Hospitals NHS Trust) and J. de Jonge (Erasmus Rotterdam Center) for facilitating the recruitment of patients. Finally, M.H. would like to thank B. Hogan (University of North Carolina-Chapel Hill) and M. Zernicka-Goetz (University of Cambridge) for helpful discussions and critical comments.	Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; [Anonymous], [No title captured]; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Brunt E. M. P. V., 2015, HEPAT ONCOL, V2, P18; Cavalloni G, 2016, TUMOR BIOL, V37, P4041, DOI 10.1007/s13277-015-4215-3; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Crespo M, 2017, NAT MED, V23, P878, DOI 10.1038/nm.4355; De Minicis S, 2013, DIGEST LIVER DIS, V45, P450, DOI 10.1016/j.dld.2012.10.008; Drexler HG, 2000, LEUKEMIA, V14, P198, DOI 10.1038/sj.leu.2401604; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0064-8; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gu QY, 2015, ONCOTARGET, V6, P20160, DOI 10.18632/oncotarget.3969; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hindley CJ, 2016, DEV BIOL, V420, P251, DOI 10.1016/j.ydbio.2016.06.039; Hirohashi S., 2000, WHO CLASSIFICATION T; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Kalinich M, 2017, P NATL ACAD SCI USA, V114, P1123, DOI 10.1073/pnas.1617032114; Kamlua S, 2012, ONCOL REP, V27, P1207, DOI 10.3892/or.2011.1583; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Kraiklang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089337; Ku JL, 2002, BRIT J CANCER, V87, P187, DOI 10.1038/sj.bjc.6600440; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SD, 2014, HEPATOB PANCREAT DIS, V13, P594, DOI 10.1016/S1499-3872(14)60275-7; LEE YTM, 1987, J SURG ONCOL, V36, P26, DOI 10.1002/jso.2930360107; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marquardt JU, 2015, HEPAT ONCOL, V2, P79, DOI 10.2217/HEP.14.24; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moeini A, 2017, J HEPATOL, V66, P952, DOI 10.1016/j.jhep.2017.01.010; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Ohguchi S, 1998, HEPATOLOGY, V27, P599, DOI 10.1002/hep.510270239; Oikawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9070; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vis DJ, 2016, PHARMACOGENOMICS, V17, P691, DOI 10.2217/pgs.16.15; Wang AQ, 2016, WORLD J GASTROENTERO, V22, P4459, DOI 10.3748/wjg.v22.i18.4459; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Yakaboski Elizabeth, 2014, Hepatology, V60, P419, DOI 10.1002/hep.26956; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297; Zhang F, 2008, HISTOPATHOLOGY, V52, P224, DOI 10.1111/j.1365-2559.2007.02929.x; Zhao YJ, 2013, MOL CLIN ONCOL, V1, P593, DOI 10.3892/mco.2013.119; Zou SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6696	73	579	605	57	344	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1424	+		10.1038/nm.4438	http://dx.doi.org/10.1038/nm.4438			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29131160	Green Submitted, Green Accepted			2022-12-27	WOS:000417278200012
J	Emmerson, PJ; Wang, F; Du, Y; Liu, Q; Pickard, RT; Gonciarz, MD; Coskun, T; Hamang, MJ; Sindelar, DK; Ballman, KK; Foltz, LA; Muppidi, A; Alsina-Fernandez, J; Barnard, GC; Tang, JX; Liu, XL; Mao, XD; Siegel, R; Sloan, JH; Mitchell, PJ; Zhang, BB; Gimeno, RE; Shan, B; Wu, XL				Emmerson, Paul J.; Wang, Feng; Du, Yong; Liu, Qian; Pickard, Richard T.; Gonciarz, Malgorzata D.; Coskun, Tamer; Hamang, Matthew J.; Sindelar, Dana K.; Ballman, Kimberly K.; Foltz, Lisa A.; Muppidi, Avinash; Alsina-Fernandez, Jorge; Barnard, Gavin C.; Tang, Jason X.; Liu, Xilin; Mao, Xudong; Siegel, Robert; Sloan, John H.; Mitchell, Pamela J.; Zhang, Bei B.; Gimeno, Ruth E.; Shan, Bei; Wu, Xinle			The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL	NATURE MEDICINE			English	Article							TGF-BETA SUPERFAMILY; GDNF FAMILY; INHIBITORY CYTOKINE-1; EXPRESSION; BINDING; WEIGHT; AMYLIN; MIC-1; GENE	Growth/differentiation factor 15 (GDF15), also known as MIC-1, is a distant member of the transforming growth factor-beta (TGF-beta) superfamily and has been implicated in various biological functions, including cancer cachexia, renal and heart failure, atherosclerosis and metabolism(1). A connection between GDF15 and body-weight regulation was initially suggested on the basis of an observation that increasing GDF15 levels in serum correlated with weight loss in individuals with advanced prostate cancer(2). In animal models, overexpression of GDF15 leads to a lean phenotype, hypophagia and other improvements in metabolic parameters(3), suggesting that recombinant GDF15 protein could potentially be used in the treatment of obesity and type 2 diabetes. However, the signaling and mechanism of action of GDF15 are poorly understood owing to the absence of a clearly identified cognate receptor. Here we report that GDNF-family receptor alpha-like (GFRAL), an orphan member of the GFR-alpha family, is a high-affinity receptor for GDF15. GFRAL binds to GDF15 in vitro and is required for the metabolic actions of GDF15 with respect to body weight and food intake in vivo in mice. Gfral(-/-) mice were refractory to the effects of recombinant human GDF15 on body-weight, food-intake and glucose parameters. Blocking the interaction between GDF15 and GFRAL with a monoclonal antibody prevented the metabolic effects of GDF15 in rats. Gfral mRNA is highly expressed in the area postrema of mouse, rat and monkey, in accordance with previous reports implicating this region of the brain in the metabolic actions of GDF15 (refs. 4-6). Together, our data demonstrate that GFRAL is a receptor for GDF15 that mediates the metabolic effects of GDF15.	[Emmerson, Paul J.; Pickard, Richard T.; Gonciarz, Malgorzata D.; Coskun, Tamer; Hamang, Matthew J.; Sindelar, Dana K.; Ballman, Kimberly K.; Foltz, Lisa A.; Muppidi, Avinash; Alsina-Fernandez, Jorge; Barnard, Gavin C.; Tang, Jason X.; Siegel, Robert; Sloan, John H.; Mitchell, Pamela J.; Gimeno, Ruth E.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA; [Wang, Feng; Du, Yong; Liu, Qian; Liu, Xilin; Mao, Xudong; Zhang, Bei B.; Shan, Bei; Wu, Xinle] Eli Lilly & Co, LCRDC, Shanghai, Peoples R China	Eli Lilly; Eli Lilly	Wu, XL (corresponding author), Eli Lilly & Co, LCRDC, Shanghai, Peoples R China.	wu_xin_le@lilly.com	Coskun, Tamer/AAR-8422-2021	Siegel, Robert/0000-0002-0833-5580				Adela R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/490842; Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Borner T, 2017, J CACHEXIA SARCOPENI, V8, P417, DOI 10.1002/jcsm.12169; Brown DA, 2007, ARTHRITIS RHEUM, V56, P753, DOI 10.1002/art.22410; Chrysovergis K, 2014, INT J OBESITY, V38, P1555, DOI 10.1038/ijo.2014.27; Cik M, 2000, J BIOL CHEM, V275, P27505; DAY HEW, 1994, NEUROPHARMACOLOGY, V33, P719, DOI 10.1016/0028-3908(94)90111-2; Dill MJ, 2013, PHARMACOL BIOCHEM BE, V112, P1, DOI 10.1016/j.pbb.2013.09.003; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Li ZH, 2005, J NEUROCHEM, V95, P361, DOI 10.1111/j.1471-4159.2005.03372.x; Lutz TA, 2001, INT J OBESITY, V25, P1005, DOI 10.1038/sj.ijo.0801664; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Riediger T, 2004, AM J PHYSIOL-REG I, V286, pR114, DOI 10.1152/ajpregu.00333.2003; Tsai VWW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100370; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	20	274	290	3	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1215	+		10.1038/nm.4393	http://dx.doi.org/10.1038/nm.4393			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28846098				2022-12-27	WOS:000412431800016
J	Worthmann, A; John, C; Ruhlemann, MC; Baguhl, M; Heinsen, FA; Schaltenberg, N; Heine, M; Schlein, C; Evangelakos, I; Mineo, C; Fischer, M; Dandri, M; Kremoser, C; Scheja, L; Franke, A; Shaul, PW; Heeren, J				Worthmann, Anna; John, Clara; Ruehlemann, Malte C.; Baguhl, Miriam; Heinsen, Femke-Anouska; Schaltenberg, Nicola; Heine, Markus; Schlein, Christian; Evangelakos, Ioannis; Mineo, Chieko; Fischer, Markus; Dandri, Maura; Kremoser, Claus; Scheja, Ludger; Franke, Andre; Shaul, Philip W.; Heeren, Joerg			Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; ENERGY-EXPENDITURE; FAT; METABOLISM; HOMEOSTASIS; OBESITY; GENE; ATHEROSCLEROSIS; CONTRIBUTES; EXPOSURE	Adaptive thermogenesis is an energy-demanding process that is mediated by cold-activated beige and brown adipocytes, and it entails increased uptake of carbohydrates, as well as lipoprotein-derived triglycerides and cholesterol, into these thermogenic cells. Here we report that cold exposure in mice triggers a metabolic program that orchestrates lipoprotein processing in brown adipose tissue (BAT) and hepatic conversion of cholesterol to bile acids via the alternative synthesis pathway. This process is dependent on hepatic induction of cytochrome P450, family 7, subfamily b, polypeptide 1 (CYP7B1) and results in increased plasma levels, as well as fecal excretion, of bile acids that is accompanied by distinct changes in gut microbiota and increased heat production. Genetic and pharmacological interventions that targeted the synthesis and biliary excretion of bile acids prevented the rise in fecal bile acid excretion, changed the bacterial composition of the gut and modulated thermogenic responses. These results identify bile acids as important metabolic effectors under conditions of sustained BAT activation and highlight the relevance of cholesterol metabolism by the host for diet-induced changes of the gut microbiota and energy metabolism.	[Worthmann, Anna; John, Clara; Baguhl, Miriam; Schaltenberg, Nicola; Heine, Markus; Schlein, Christian; Evangelakos, Ioannis; Scheja, Ludger; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Ruehlemann, Malte C.; Heinsen, Femke-Anouska; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Mineo, Chieko; Shaul, Philip W.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX USA; [Fischer, Markus] Univ Hamburg, Inst Food Chem, Hamburg, Germany; [Dandri, Maura] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 1, Hamburg, Germany; [Kremoser, Claus] Phenex Pharmaceut AG, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heeren, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	heeren@uke.de	Dandri, Maura/ABG-4773-2021; Franke, Andre/B-2151-2010; Fischer, Markus/AFT-1856-2022; Worthmann, Anna/AAF-9563-2020; Rühlemann, Malte Christoph/AAA-6528-2019	Dandri, Maura/0000-0002-0073-6689; Franke, Andre/0000-0003-1530-5811; Fischer, Markus/0000-0001-7243-4199; Rühlemann, Malte Christoph/0000-0002-0685-0052; Evangelakos, Ioannis/0000-0001-7328-6319; Heinsen, Femke-Anouska/0000-0003-3652-6402	Deutsche Forschungsgemeinschaft [SFB841, KFO306, HE3645/7-1, DA1063/3-2]; Merck Sharp Dohme; EU FP7 project RESOLVE [FP7-HEALTH-2012-305707]; University Medical Center Hamburg-Eppendorf MD/PhD fellowship; US National Institutes of Health [HL087564]; European Foundation for the Study of Diabetes [MSD 2016_1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Merck Sharp Dohme(Merck & Company); EU FP7 project RESOLVE; University Medical Center Hamburg-Eppendorf MD/PhD fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Foundation for the Study of Diabetes	We thank S. Ehret, B. Henkel, A. Kuhl and E.-M. Azizi for excellent technical assistance, P. Dawson (Emory University School of Medicine) for the ASBT-specific polyclonal antibody, and J. Nedergaard and B. Cannon (Wenner-Gren Institute, Stockholm University) for the UCP1-spcific polyclonal antibody. This work was supported by grants funded by the Deutsche Forschungsgemeinschaft (SFB841, "Liver inflammation: infection, immune regulation und consequences" (J.H. and M.D.); KFO306, "Primary sclerosing cholangitis (J.H. and to A.F.)), a Heisenberg Professorship (HE3645/7-1 (J.H.) and DA1063/3-2 (M.D.)), an EFSD award supported by Merck Sharp Dohme (MSD) (J.H.), the EU FP7 project RESOLVE FP7-HEALTH-2012-305707 (J.H.), a University Medical Center Hamburg-Eppendorf MD/PhD fellowship (C.S.) and the US National Institutes of Health grant HL087564 (P.W.S.).	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Hambruch E, 2012, J PHARMACOL EXP THER, V343, P556, DOI 10.1124/jpet.112.196519; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; John C, 2014, J CHROMATOGR A, V1371, P184, DOI 10.1016/j.chroma.2014.10.064; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Meiss E, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0958-0; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Ruhlemann MC, 2017, GUT, V66, P753, DOI 10.1136/gutjnl-2016-312180; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Scheja L, 2016, J HEPATOL, V64, P1176, DOI 10.1016/j.jhep.2016.01.025; Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang GX, 2014, NAT MED, V20, P1436, DOI 10.1038/nm.3713; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhong CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10512; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	53	159	161	14	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					839	+		10.1038/nm.4357	http://dx.doi.org/10.1038/nm.4357			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28604703				2022-12-27	WOS:000405180100013
J	Qi, W; Keenan, HA; Li, Q; Ishikado, A; Kannt, A; Sadowski, T; Yorek, MA; Wu, IH; Lockhart, S; Coppey, LJ; Pfenninger, A; Liew, CW; Qiang, G; Burkart, AM; Hastings, S; Pober, D; Cahill, C; Niewczas, MA; Israelsen, WJ; Tinsley, L; Stillman, IE; Amenta, PS; Feener, EP; Heiden, MGV; Stanton, RC; King, GL				Qi, Weier; Keenan, Hillary A.; Li, Qian; Ishikado, Atsushi; Kannt, Aimo; Sadowski, Thorsten; Yorek, Mark A.; Wu, I-Hsien; Lockhart, Samuel; Coppey, Lawrence J.; Pfenninger, Anja; Liew, Chong Wee; Qiang, Guifen; Burkart, Alison M.; Hastings, Stephanie; Pober, David; Cahill, Christopher; Niewczas, Monika A.; Israelsen, William J.; Tinsley, Liane; Stillman, Isaac E.; Amenta, Peter S.; Feener, Edward P.; Heiden, Matthew G. Vander; Stanton, Robert C.; King, George L.			Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; QUANTITATIVE-ANALYSIS; PKC-DELTA; NEPHROPATHY; PKM2; COMPLICATIONS; PODOCYTES; SUSCEPTIBILITY; HYPERGLYCEMIA; SUPEROXIDE	Diabetic nephropathy (DN) is a major cause of end-stage renal disease, and therapeutic options for preventing its progression are limited. To identify novel therapeutic strategies, we studied protective factors for DN using proteomics on glomeruli from individuals with extreme duration of diabetes (>= 50 years) without DN and those with histologic signs of DN. Enzymes in the glycolytic, sorbitol, methylglyoxal and mitochondrial pathways were elevated in individuals without DN. In particular, pyruvate kinase M2 (PKM2) expression and activity were upregulated. Mechanistically, we showed that hyperglycemia and diabetes decreased PKM2 tetramer formation and activity by sulfenylation in mouse glomeruli and cultured podocytes. Pkm-knockdown immortalized mouse podocytes had higher levels of toxic glucose metabolites, mitochondrial dysfunction and apoptosis. Podocyte-specific Pkm2-knockout (KO) mice with diabetes developed worse albuminuria and glomerular pathology. Conversely, we found that pharmacological activation of PKM2 by a small-molecule PKM2 activator, TEPP-46, reversed hyperglycemia-induced elevation in toxic glucose metabolites and mitochondrial dysfunction, partially by increasing glycolytic flux and PGC-1 alpha mRNA in cultured podocytes. In intervention studies using DBA2/J and Nos3 (eNos) KO mouse models of diabetes, TEPP-46 treatment reversed metabolic abnormalities, mitochondrial dysfunction and kidney pathology. Thus, PKM2 activation may protect against DN by increasing glucose metabolic flux, inhibiting the production of toxic glucose metabolites and inducing mitochondrial biogenesis to restore mitochondrial function.	[Qi, Weier; Keenan, Hillary A.; Li, Qian; Ishikado, Atsushi; Wu, I-Hsien; Burkart, Alison M.; Hastings, Stephanie; Pober, David; Cahill, Christopher; Niewczas, Monika A.; Tinsley, Liane; Amenta, Peter S.; Feener, Edward P.; Stanton, Robert C.; King, George L.] Harvard Med Sch, Joslin Diabet Ctr, Res Div, Boston, MA 02115 USA; [Kannt, Aimo; Sadowski, Thorsten; Pfenninger, Anja] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany; [Yorek, Mark A.; Coppey, Lawrence J.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Lockhart, Samuel] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Liew, Chong Wee; Qiang, Guifen] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Qiang, Guifen] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China; [Qiang, Guifen] Peking Union Med Coll, Beijing, Peoples R China; [Qiang, Guifen] Beijing Key Lab Drug Target & Screening Res, Beijing, Peoples R China; [Israelsen, William J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Stillman, Isaac E.] Beth Israel Deaconess Med Ctr, Div Anat Pathol, Boston, MA 02215 USA; [Heiden, Matthew G. Vander] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Sanofi-Aventis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Queens University Belfast; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT)	King, GL (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Res Div, Boston, MA 02115 USA.	George.King@Joslin.harvard.edu	Lockhart, Sam/Q-2604-2015; Yorek, Mark/AAC-3136-2021; Stanton, Robert C/AAG-7584-2020; Kannt, Aimo/AAZ-6898-2020; Stillman, Isaac E/ABC-7278-2020	Lockhart, Sam/0000-0003-2092-4350; Yorek, Mark/0000-0001-7737-5554; Stanton, Robert C/0000-0002-3056-1277; Israelsen, William/0000-0002-3653-9353; Kannt, Aimo/0000-0002-5197-2286; Liew, Chong Wee/0000-0001-9904-0958	Juvenile Diabetes Research Foundation; Mary Iacocca Research Foundation; NIH [1DP3DK112192-01, DK094333-01, 1R24DK090961-01]; DRC grant [P30DK036836-30]; JDRF [8-2005-358, 18-2008-363, CDA-2015-89-A-B]; Thomas Beatson, Jr Foundation; Brehm Foundation; Sanofi-Aventis; Harold Whitworth Pierce Charitable Trust Postdoctoral Fellowship;  [JDRF17-2011-47];  [JDRF17-2013-310];  [DK107339-02];  [R01 DK109015];  [R00 DK090210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094333, R01DK107399, P30DK036836, R24DK090961, R00DK090210, R01DK109015, DP3DK112192] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Mary Iacocca Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DRC grant; JDRF(Juvenile Diabetes Research Foundation); Thomas Beatson, Jr Foundation; Brehm Foundation; Sanofi-Aventis(Sanofi-Aventis); Harold Whitworth Pierce Charitable Trust Postdoctoral Fellowship; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to all the fellows who participated in Medalist Kidneys collection, D. Anastasiou, J. Lee, C. Thomas and M. Lauterbach for their technical advice. We also thank the technical support from E. Yu, daily-oral-gavaging team members, Z. Zsengeller and E. Pernicone. We are grateful to M. Maurer, who gave us technical advice on human kidney pathology assessment. We thank C. Clish for plasma metabolomics analysis. We are grateful to J. Hourihan for technical advice and review of the manuscript. W. Qi was a recipient of awards from the Juvenile Diabetes Research Foundation and Mary Iacocca Research Foundation. Mouse podocytes and human podocytes cell lines were kind gifts from P.M. and J.K. This project was funded by NIH 1DP3DK112192-01 (G.L.K.); DK094333-01 (G.L.K. and H.A.K.), 1R24DK090961-01 (G.L.K.); DRC grant-P30DK036836-30 (G.L.K.); JDRF 8-2005-358 (G.L.K.); JDRF 18-2008-363 (G.L.K.); JDRF17-2011-47 (G.L.K.); and JDRF17-2013-310 (H.A.K.). Additional research support was provided by the Thomas Beatson, Jr Foundation, the Brehm Foundation and a research grant from Sanofi-Aventis (G.L.K.). Other co-authors were supported by the following funding: DK107339-02 (M.A.Y.); Harold Whitworth Pierce Charitable Trust Postdoctoral Fellowship (A.M.B.); R01 DK109015 and R00 DK090210 (C.W.L.) and JDRF CDA-2015-89-A-B (M.A.N.).	Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Aiello LP, 2005, DIABETES, V54, P2188; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bolton WK, 2004, AM J NEPHROL, V24, P32, DOI 10.1159/000075627; Breyer MD, 2016, NAT REV DRUG DISCOV, V15, P568, DOI 10.1038/nrd.2016.67; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Brown JM, 2003, J LIPID RES, V44, P1287, DOI 10.1194/jlr.M300001-JLR200; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Coppey LJ, 2001, DIABETES, V50, P1927, DOI 10.2337/diabetes.50.8.1927; Dayton TL, 2016, GENE DEV, V30, P1020, DOI 10.1101/gad.278549.116; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Fogo AB, 2011, J CLIN INVEST, V121, P2142, DOI 10.1172/JCI57935; FRANK RN, 1994, DIABETES, V43, P169, DOI 10.2337/diab.43.2.169; Gao BB, 2008, MOL CELL PROTEOMICS, V7, P2399, DOI 10.1074/mcp.M800104-MCP200; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Giacco F, 2014, DIABETES, V63, P291, DOI 10.2337/db13-0316; GREENE DA, 1987, NEW ENGL J MED, V316, P599; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; INOGUCHI T, 1994, AM J PHYSIOL, V267, pE369, DOI 10.1152/ajpendo.1994.267.3.E369; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Khamaisi M, 2016, J CLIN INVEST, V126, P837, DOI 10.1172/JCI82788; Khan SS, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0685-3; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma LJ, 2004, KIDNEY INT, V65, P106, DOI 10.1111/j.1523-1755.2004.00381.x; Massart Julie, 2014, BMC Res Notes, V7, P391, DOI 10.1186/1756-0500-7-391; Mima A, 2012, FASEB J, V26, P2963, DOI 10.1096/fj.11-202994; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakatsu D, 2015, P NATL ACAD SCI USA, V112, pE1067, DOI 10.1073/pnas.1417197112; Nemet I, 2004, CLIN BIOCHEM, V37, P875, DOI 10.1016/j.clinbiochem.2004.05.024; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Reddy MA, 2011, J AM SOC NEPHROL, V22, P2182, DOI 10.1681/ASN.2011060629; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Sun JK, 2011, DIABETES CARE, V34, P968, DOI 10.2337/dc10-1675; Susztak K, 2014, J AM SOC NEPHROL, V25, P10, DOI 10.1681/ASN.2013050461; Sweetwyne MT, 2015, DIABETES, V64, P4099, DOI 10.2337/db15-0260; Takahashi T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/590541; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	66	242	259	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					753	+		10.1038/nm.4328	http://dx.doi.org/10.1038/nm.4328			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28436957	Green Accepted, Green Published			2022-12-27	WOS:000402768000018
J	Daley, D; Mani, VR; Mohan, N; Akkad, N; Ochi, A; Heindel, DW; Lee, KB; Zambirinis, CP; Pandian, GSDB; Savadkar, S; Torres-Hernandez, A; Nayak, S; Wang, D; Hundeyin, M; Diskin, B; Aykut, B; Werba, G; Barilla, RM; Rodriguez, R; Chang, S; Gardner, L; Mahal, LK; Ueberheide, B; Miller, G				Daley, Donnele; Mani, Vishnu R.; Mohan, Navyatha; Akkad, Neha; Ochi, Atsuo; Heindel, Daniel W.; Lee, Ki Buom; Zambirinis, Constantinos P.; Pandian, Gautam S. D. Balasubramania; Savadkar, Shivraj; Torres-Hernandez, Alejandro; Nayak, Shruti; Wang, Ding; Hundeyin, Mautin; Diskin, Brian; Aykut, Berk; Werba, Gregor; Barilla, Rocky M.; Rodriguez, Robert; Chang, Steven; Gardner, Lawrence; Mahal, Lara K.; Ueberheide, Beatrix; Miller, George			Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance	NATURE MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; DUCTAL ADENOCARCINORNA; LECTIN RECEPTORS; PD-1 BLOCKADE; CELLS; INNATE; MICE; CARCINOGENESIS; CANCER; MINCLE	The progression of pancreatic oncogenesis requires immune-suppressive inflammation in cooperation with oncogenic mutations. However, the drivers of intratumoral immune tolerance are uncertain. Dectin 1 is an innate immune receptor crucial for anti-fungal immunity, but its role in sterile inflammation and oncogenesis has not been well defined. Furthermore, non-pathogen-derived ligands for dectin 1 have not been characterized. We found that dectin 1 is highly expressed on macrophages in pancreatic ductal adenocarcinoma (PDA). Dectin 1 ligation accelerated the progression of PDA in mice, whereas deletion of Clec7a-the gene encoding dectin 1-or blockade of dectin 1 downstream signaling was protective. We found that dectin 1 can ligate the lectin galectin 9 in mouse and human PDA, which results in tolerogenic macrophage programming and adaptive immune suppression. Upon disruption of the dectin 1-galectin 9 axis, CD4(+) and CD8(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity. These data suggest that targeting dectin 1 signaling is an attractive strategy for developing an immunotherapy for PDA.	[Daley, Donnele; Mani, Vishnu R.; Mohan, Navyatha; Akkad, Neha; Ochi, Atsuo; Lee, Ki Buom; Zambirinis, Constantinos P.; Pandian, Gautam S. D. Balasubramania; Savadkar, Shivraj; Torres-Hernandez, Alejandro; Hundeyin, Mautin; Diskin, Brian; Aykut, Berk; Werba, Gregor; Barilla, Rocky M.; Rodriguez, Robert; Chang, Steven; Miller, George] NYU, Dept Surg, Sch Med, SA Localio Lab, New York, NY 10016 USA; [Heindel, Daniel W.; Mahal, Lara K.] NYU, Dept Chem, New York, NY USA; [Nayak, Shruti; Ueberheide, Beatrix] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Wang, Ding; Gardner, Lawrence] NYU, Sch Med, Dept Med, New York, NY USA; [Miller, George] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Miller, G (corresponding author), NYU, Dept Surg, Sch Med, SA Localio Lab, New York, NY 10016 USA.; Miller, G (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	george.miller@nyumc.org	Mani, Vishnu/AAF-1916-2020; Hundeyin, Mautin/AAU-6792-2020; Pandian, Gautam Shanmuga Dharmar Balasubramania/ABA-5188-2020; Mahal, Lara/GRY-7287-2022	Mani, Vishnu/0000-0003-3121-9497; Pandian, Gautam Shanmuga Dharmar Balasubramania/0000-0002-5597-6284; Gardner, Lawrence/0000-0003-0191-0172; Zambirinis, Constantinos/0000-0003-2740-3259; Mahal, Lara/0000-0003-4791-8524; Werba, Gregor/0000-0003-1464-9065; Ochi, Atsuo/0000-0003-2374-7249; Ueberheide, Beatrix/0000-0003-2512-0204; Barilla, Rocky/0000-0002-8062-7246	National Pancreas Foundation; AACR-Pancreatic Cancer Action Network; Lustgarten Foundation; Department of Defense; Panpaphian Association of America; Irene and Bernard Schwartz Fellowship in GI Oncology; National Institute of Health [CA155649, CA168611, CA193111]; NYU School of Medicine Office of Therapeutics Alliances; National Center for the Advancement of Translational Science (NCATS) [UL1 TR000038];  [P30CA016087]; NATIONAL CANCER INSTITUTE [T32CA193111, R01CA206105, R01CA168611, R21CA155649, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK085278] Funding Source: NIH RePORTER	National Pancreas Foundation; AACR-Pancreatic Cancer Action Network; Lustgarten Foundation; Department of Defense(United States Department of Defense); Panpaphian Association of America; Irene and Bernard Schwartz Fellowship in GI Oncology; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU School of Medicine Office of Therapeutics Alliances; National Center for the Advancement of Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Pancreas Foundation (to C.P.Z.), the AACR-Pancreatic Cancer Action Network (to G.M.), the Lustgarten Foundation (to G.M.), Department of Defense Peer Reviewed Medical Research Program (to G.M.), Panpaphian Association of America (to C.Z.), the Irene and Bernard Schwartz Fellowship in GI Oncology (D.D.), and National Institute of Health Awards CA155649 (to G.M.), CA168611 (to G.M.), CA193111 (to G.M. and A.T.-H.) and the NYU School of Medicine Office of Therapeutics Alliances. We thank the New York University Langone Medical Center (NYU LMC) Histopathology Core Facility, the NYU LMC Flow Cytometry Core Facility, the NYU LMC Microscopy Core Facility and the NYU LMC BioRepository Center, each supported in part by the Cancer Center Support grant P30CA016087 and by grant UL1 TR000038 from the National Center for the Advancement of Translational Science (NCATS). Clec7a<SUP>-/-</SUP> mice were a gift of G. Brown (University of Aberdeen, UK). KC mice were a gift of D. Bar-Sagi and KPC mice were a gift of M. Philips, both New York University). The pCI-neo-cOVA vector was a gift of M. Castro (University of Michigan).	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; AndrenSandberg A, 1997, SCAND J GASTROENTERO, V32, P97, DOI 10.3109/00365529709000177; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bedrosian AS, 2011, GASTROENTEROLOGY, V141, P1915, DOI 10.1053/j.gastro.2011.07.033; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Greco SH, 2016, J LEUKOCYTE BIOL, V100, P185, DOI 10.1189/jlb.3A0515-185R; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Jiang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106741; Leitner J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003253; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Martinez-Bosch N, 2014, CANCER RES, V74, P3512, DOI 10.1158/0008-5472.CAN-13-3013; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Ochi A, 2012, J CLIN INVEST, V122, P4118, DOI 10.1172/JCI63606; Ochi A, 2012, J EXP MED, V209, P1671, DOI 10.1084/jem.20111706; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Seifert L, 2015, CELL REP, V13, P1909, DOI 10.1016/j.celrep.2015.10.058; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Walachowski S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148464; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zheng L, 2013, GASTROENTEROLOGY, V144, P1230, DOI 10.1053/j.gastro.2012.12.042; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	47	167	177	12	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					556	+		10.1038/nm.4314	http://dx.doi.org/10.1038/nm.4314			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28394331	Green Accepted			2022-12-27	WOS:000400650700011
J	June, CH; Warshauer, JT; Bluestone, JA				June, Carl H.; Warshauer, Jeremy T.; Bluestone, Jeffrey A.			Is autoimmunity the Achilles' heel of cancer immunotherapy?	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; VERSUS-HOST-DISEASE; ADVERSE EVENTS; CHECKPOINT-BLOCKADE; CTLA-4 BLOCKADE; TUMOR MICROENVIRONMENT; THYMIC DEVELOPMENT; MELANOMA PATIENTS; MOUSE MODELS; STAGE-III	The emergence of immuno-oncology as the first broadly successful strategy for metastatic cancer will require clinicians to integrate this new pillar of medicine with chemotherapy, radiation, and targeted small-molecule compounds. Of equal importance is gaining an understanding of the limitations and toxicities of immunotherapy. Immunotherapy was initially perceived to be a relatively less toxic approach to cancer treatment than other available therapies-and surely it is, when compared to those. However, as the use of immunotherapy becomes more common, especially as first-and second-line treatments, immunotoxicity and autoimmunity are emerging as the Achilles' heel of immunotherapy. In this Perspective, we discuss evidence that the occurrence of immunotoxicity bodes well for the patient, and describe mechanisms that might be related to the induction of autoimmunity. We then explore approaches to limit immunotoxicity, and discuss the future directions of research and reporting that are needed to diminish it.	[June, Carl H.; Bluestone, Jeffrey A.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [June, Carl H.] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Warshauer, Jeremy T.] Univ Calif San Francisco, Dept Med, Endocrine Div, San Francisco, CA USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA	University of Pennsylvania; University of California System; University of California San Francisco; University of California System; University of California San Francisco	June, CH (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; June, CH (corresponding author), Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.	cjune@upenn.edu			Parker Institute for Cancer Immunotherapy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046643, R34AI095135, R21AI107328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Parker Institute for Cancer Immunotherapy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.H.J. and J.A.B. are members of the Parker Institute for Cancer Immunotherapy, which supported this study and which supports the University of Pennsylvania and University of San Francisco Cancer Immunotherapy Programs. The authors thank B. Levine for constructive comments, and the authors apologize to colleagues for work that we are unable to cite owing to space constraints.	Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Amos SM, 2011, BLOOD, V118, P499, DOI 10.1182/blood-2011-01-325266; Anderson MS, 2016, NAT REV IMMUNOL, V16, P247, DOI 10.1038/nri.2016.9; Aranow C, 2015, ARTHRITIS RHEUMATOL, V67, P1848, DOI 10.1002/art.39108; Bansal P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00239; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blank C, 2003, J IMMUNOL, V171, P4574, DOI 10.4049/jimmunol.171.9.4574; Bluestone JA, 2011, IMMUNOL REV, V241, P5, DOI 10.1111/j.1600-065X.2011.01019.x; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Chapuis AG, 2016, J CLIN ONCOL, V34, P3787, DOI 10.1200/JCO.2015.65.5142; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; de Filette J, 2016, J CLIN ENDOCR METAB, V101, P4431, DOI 10.1210/jc.2016-2300; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Freeman-Keller M, 2016, CLIN CANCER RES, V22, P886, DOI 10.1158/1078-0432.CCR-15-1136; Gainor JF, 2016, J CLIN ONCOL, V34, P2953, DOI 10.1200/JCO.2016.68.1205; Ghosh A, 2017, NAT MED, V23, P242, DOI 10.1038/nm.4258; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Iwama S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008002; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jin HT, 2011, CURR TOP MICROBIOL, V350, P17, DOI 10.1007/82_2010_116; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kakihana K, 2016, BLOOD, V128, P2083, DOI 10.1182/blood-2016-05-717652; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Klocke K, 2016, P NATL ACAD SCI USA, V113, pE2383, DOI 10.1073/pnas.1603892113; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kwek SS, 2012, J IMMUNOL, V189, P3759, DOI 10.4049/jimmunol.1201529; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Liu J, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.18; Lowe JR, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0196-z; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Maddison P, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(05)76153-5; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Mirsoian A, 2014, J EXP MED, V211, P2373, DOI 10.1084/jem.20140116; Munn DH, 2016, TRENDS IMMUNOL, V37, P193, DOI 10.1016/j.it.2016.01.002; Muratori L, 2013, J AUTOIMMUN, V46, P74, DOI 10.1016/j.jaut.2013.06.016; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Oh DY, 2017, CANCER RES, V77, P1322, DOI 10.1158/0008-5472.CAN-16-2324; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ren J., 2016, CLIN CANC RES; Ribas A, 2015, NEW ENGL J MED, V373, P1490, DOI 10.1056/NEJMp1510079; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Ryder M, 2014, ENDOCR-RELAT CANCER, V21, P371, DOI 10.1530/ERC-13-0499; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Teulings HE, 2015, J CLIN ONCOL, V33, P773, DOI 10.1200/JCO.2014.57.4756; Umansky V, 2012, SEMIN CANCER BIOL, V22, P273, DOI 10.1016/j.semcancer.2012.05.001; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van den Berg JH, 2015, MOL THER, V23, P1541, DOI 10.1038/mt.2015.60; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vigneron Nathalie, 2013, Cancer Immun, V13, P15; von Bahr L, 2015, BONE MARROW TRANSPL, V50, P1217, DOI 10.1038/bmt.2015.123; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Ward JP, 2016, ADV IMMUNOL, V130, P25, DOI 10.1016/bs.ai.2016.01.001; Weber JS, 2015, J CLIN ONCOL, V33, P2092, DOI 10.1200/JCO.2014.60.0379; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Whiteside TL, 2014, CANCER IMMUNOL IMMUN, V63, P67, DOI 10.1007/s00262-013-1490-y; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zhong S, 2013, P NATL ACAD SCI USA, V110, P6973, DOI 10.1073/pnas.1221609110; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	105	266	278	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					540	+		10.1038/nm.4321	http://dx.doi.org/10.1038/nm.4321			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28475571	Green Published			2022-12-27	WOS:000400650700008
J	Davies, H; Glodzik, D; Morganella, S; Yates, LR; Staaf, J; Zou, XQ; Ramakrishna, M; Martin, S; Boyault, S; Sieuwerts, AM; Simpson, PT; King, TA; Raine, K; Eyfjord, JE; Kong, G; Borg, A; Birney, E; Stunnenberg, HG; van de Vijver, MJV; Borresen-Dale, AL; Martens, JWM; Span, PN; Lakhani, SR; Vincent-Salomon, A; Sotiriou, C; Tutt, A; Thompson, AM; Van Laere, S; Richardson, AL; Viari, A; Campbell, PJ; Stratton, MR; Nik-Zainal, S				Davies, Helen; Glodzik, Dominik; Morganella, Sandro; Yates, Lucy R.; Staaf, Johan; Zou, Xueqing; Ramakrishna, Manasa; Martin, Sancha; Boyault, Sandrine; Sieuwerts, Anieta M.; Simpson, Peter T.; King, Tari A.; Raine, Keiran; Eyfjord, Jorunn E.; Kong, Gu; Borg, Ake; Birney, Ewan; Stunnenberg, Hendrik G.; van de Vijver, Marc J.; Borresen-Dale, Anne-Lise; Martens, John W. M.; Span, Paul N.; Lakhani, Sunil R.; Vincent-Salomon, Anne; Sotiriou, Christos; Tutt, Andrew; Thompson, Alastair M.; Van Laere, Steven; Richardson, Andrea L.; Viari, Alain; Campbell, Peter J.; Stratton, Michael R.; Nik-Zainal, Serena			HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures	NATURE MEDICINE			English	Article							COPY NUMBER ANALYSIS; BREAST-CANCER; REPAIR DEFECTS; CHEMOTHERAPY; PREVALENCE; RESISTANCE; LANDSCAPE; OLAPARIB; THERAPY; GENOMES	Approximately 1-5% of breast cancers are attributed to inherited mutations in BRCA1 or BRCA2 and are selectively sensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. In other cancer types, germline and/or somatic mutations in BRCA1 and/or BRCA2 (BRCA1/BRCA2) also confer selective sensitivity to PARP inhibitors. Thus, assays to detect BRCA1/BRCA2-deficient tumors have been sought. Recently, somatic substitution, insertion/deletion and rearrangement patterns, or 'mutational signatures', were associated with BRCA1/BRCA2 dysfunction. Herein we used a lasso logistic regression model to identify six distinguishing mutational signatures predictive of BRCA1/BRCA2 deficiency. A weighted model called HRDetect was developed to accurately detect BRCA1/BRCA2-deficient samples. HRDetect identifies BRCA1/BRCA2-deficient tumors with 98.7% sensitivity (area under the curve (AUC) = 0.98). Application of this model in a cohort of 560 individuals with breast cancer, of whom 22 were known to carry a germline BRCA1 or BRCA2 mutation, allowed us to identify an additional 22 tumors with somatic loss of BRCA1 or BRCA2 and 47 tumors with functional BRCA1/BRCA2 deficiency where no mutation was detected. We validated HRDetect on independent cohorts of breast, ovarian and pancreatic cancers and demonstrated its efficacy in alternative sequencing strategies. Integrating all of the classes of mutational signatures thus reveals a larger proportion of individuals with breast cancer harboring BRCA1/BRCA2 deficiency (up to 22%) than hitherto appreciated (similar to 1-5%) who could have selective therapeutic sensitivity to PARP inhibition.	[Davies, Helen; Glodzik, Dominik; Morganella, Sandro; Yates, Lucy R.; Zou, Xueqing; Ramakrishna, Manasa; Martin, Sancha; Raine, Keiran; Birney, Ewan; Campbell, Peter J.; Stratton, Michael R.; Nik-Zainal, Serena] Wellcome Trust Sanger Inst, Hinxton, England; [Yates, Lucy R.] Guys & St Thomas NHS Trust, London, England; [Staaf, Johan] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden; [Ramakrishna, Manasa] AstraZeneca, Oncol, Innovat Med & Early Dev Biotech Unit, Saffron Walden, England; [Boyault, Sandrine] Ctr Leon Berard, Translat Res Lab Dept, Lyon, France; [Sieuwerts, Anieta M.; Martens, John W. M.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst & Canc Genom, Dept Med Oncol, Rotterdam, Netherlands; [Simpson, Peter T.; Lakhani, Sunil R.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [Simpson, Peter T.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [King, Tari A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Eyfjord, Jorunn E.] Univ Iceland, Canc Res Lab, Fac Med, Reykjavik, Iceland; [Kong, Gu] Hanyang Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Birney, Ewan] European Bioinformat Inst, Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, Belgium; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci & Med, Dept Mol Biol, Nijmegen, Netherlands; [van de Vijver, Marc J.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Inst Canc Res, Norwegian Radium Hosp, Dept Canc Genet, Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, KG Jebsen Ctr Breast Canc Res, Inst Clin Med, Oslo, Norway; [Span, Paul N.] Radboud Univ Nijmegen, Dept Radiat Oncol, Med Ctr, Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, Nijmegen, Netherlands; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld, Australia; [Vincent-Salomon, Anne] Inst Curie, Dept Pathol, Paris, France; [Vincent-Salomon, Anne] Inst Curie, INSERM U934, Paris, France; [Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; [Tutt, Andrew] Kings Coll London, Breast Canc Now Res Unit, London, England; [Tutt, Andrew] Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, London, England; [Thompson, Alastair M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Van Laere, Steven] Univ Antwerp, Canc Res Unit, Oncol Res Ctr, Fac Med & Hlth Sci, Antwerp, Belgium; [Van Laere, Steven] HistoGeneX, Antwerp, Belgium; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Viari, Alain] INRIA Grenoble Rhone Alpes, Equipe Erable, Montbonnot St Martin, France; [Viari, Alain] Synergie Lyon Canc, Ctr Lyon Berard, Lyon, France; [Nik-Zainal, Serena] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge, England	Wellcome Trust Sanger Institute; Guy's & St Thomas' NHS Foundation Trust; Lund University; AstraZeneca; UNICANCER; Centre Leon Berard; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Queensland; University of Queensland; Memorial Sloan Kettering Cancer Center; University of Iceland; Hanyang University; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Oslo; University of Oslo; Radboud University Nijmegen; Radboud University Nijmegen; Royal Brisbane & Women's Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Jules Bordet; Universite Libre de Bruxelles; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; University of Antwerp; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Cambridge	Nik-Zainal, S (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.; Nik-Zainal, S (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge, England.	snz@sanger.ac.uk	Stunnenberg, Hendrik G./D-6875-2012; Lakhani, Sunil R/I-1970-2018; Nik-Zainal, Serena/ABD-4437-2020; Van Laere, Steven/GQA-8872-2022; Span, Paul/G-4710-2012; Simpson, Peter/F-1225-2010	Stunnenberg, Hendrik G./0000-0002-0066-1576; Lakhani, Sunil R/0000-0003-4067-2760; Van Laere, Steven/0000-0002-2640-0040; Span, Paul/0000-0002-1930-6638; Simpson, Peter/0000-0002-4816-8289; van de Vijver, Marc/0000-0002-0385-4787; Martin, Sancha/0000-0001-6213-5259; Raine, Keiran/0000-0002-5634-1539; Zou, Xueqing/0000-0003-1143-1028; Birney, Ewan/0000-0001-8314-8497; Tutt, Andrew/0000-0001-8715-2901; Glodzik, Dominik/0000-0001-8112-9073; Yates, Lucy/0000-0003-4519-7794; Nik-Zainal, Serena/0000-0001-5054-1727	ICGC Breast Cancer Working group by Breast Cancer Somatic Genetics Study (BASIS); European research project by European Community [242006]; Wellcome Trust [077012/Z/05/Z, WT100183MA]; Institut National du Cancer (INCa) in France [226-2009, 02-2011, 41-2012, 144-2008, 06-2012]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111218-SC01]; EU-FP7-SUPPRESSTEM project; Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer (NIH/NCI) [5 P50 CA168504-02]; Cancer Genomics Netherlands through Netherlands Organisation of Scientific research (NWO); Breast Cancer Research Foundation; EMBL; NIHR Biomedical Research Centres at Guy's and St Thomas' and Royal Marsden Hospital NHS Foundation Trusts; National Research Foundation of Korea (NRF) - Korean government [NRF 2015R1A2A1A10052578]; Cancer Research UK [22932, 23916, 23433] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA168504] Funding Source: NIH RePORTER	ICGC Breast Cancer Working group by Breast Cancer Somatic Genetics Study (BASIS); European research project by European Community; Wellcome Trust(Wellcome TrustEuropean Commission); Institut National du Cancer (INCa) in France(Institut National du Cancer (INCA) France); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; EU-FP7-SUPPRESSTEM project; Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer (NIH/NCI); Cancer Genomics Netherlands through Netherlands Organisation of Scientific research (NWO); Breast Cancer Research Foundation; EMBL; NIHR Biomedical Research Centres at Guy's and St Thomas' and Royal Marsden Hospital NHS Foundation Trusts; National Research Foundation of Korea (NRF) - Korean government; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been performed on data that were previously published. They were generated and funded through the ICGC Breast Cancer Working group by the Breast Cancer Somatic Genetics Study (BASIS), a European research project funded by the European Community's Seventh Framework Programme (FP7/2010-2014) under grant agreement number 242006; the Triple Negative project funded by the Wellcome Trust (grant reference 077012/Z/05/Z) and the HER2+ project funded by Institut National du Cancer (INCa) in France (grants 226-2009, 02-2011, 41-2012, 144-2008, 06-2012). The ICGC Asian Breast Cancer Project was funded through a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111218-SC01). The Oslo Breast Cancer Research Consortium (OSBREAC), Norway (http://www.osbreac.no/), contributed samples to the study. D.G. was supported by the EU-FP7-SUPPRESSTEM project. A.L.R. is partially supported by the Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer (NIH/NCI 5 P50 CA168504-02). A.S. was supported by Cancer Genomics Netherlands (CGC.nl) through a grant from the Netherlands Organisation of Scientific research (NWO). C.S. is supported by a grant from the Breast Cancer Research Foundation. E.B. was funded by EMBL. A.T. acknowledges infrastructure support funding from the NIHR Biomedical Research Centres at Guy's and St Thomas' and Royal Marsden Hospital NHS Foundation Trusts. G.K. is supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (NRF 2015R1A2A1A10052578). S.N.-Z. is a Wellcome Beit Fellow and personally funded by a Wellcome Trust Intermediate Fellowship (WT100183MA). Finally, we would like to acknowledge all members of the ICGC Breast Cancer Working Group and ICGC Asian Breast Cancer Project, for without the foresight of engaging in this scale of collaboration we would not have gained these insights.	Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9683; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chapppuis PO, 2002, J MED GENET, V39, P608, DOI 10.1136/jmg.39.8.608; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Jazaeri AA, 2002, JNCI-J NATL CANCER I, V94, P990, DOI 10.1093/jnci/94.13.990; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; King MC, 2014, SCIENCE, V343, P1462, DOI 10.1126/science.1251900; Larsen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064268; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Natrajan R, 2014, J PATHOL, V232, P553, DOI 10.1002/path.4325; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Peng G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4361; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Rodriguez AA, 2010, BREAST CANCER RES TR, V123, P189, DOI 10.1007/s10549-010-0983-z; Ruscito I, 2014, EUR J CANCER, V50, P2090, DOI 10.1016/j.ejca.2014.05.001; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Stefansson OA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3020; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Watkins JA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3670; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	51	481	489	6	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					517	+		10.1038/nm.4292	http://dx.doi.org/10.1038/nm.4292			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28288110	Green Accepted, Green Submitted			2022-12-27	WOS:000398768100020
J	Gollner, S; Oellerich, T; Agrawal-Singh, S; Schenk, T; Klein, HU; Rohde, C; Pabst, C; Sauer, T; Lerdrup, M; Tavor, S; Stolzel, F; Herold, S; Ehninger, G; Kohler, G; Pan, KT; Urlaub, H; Serve, H; Dugas, M; Spiekermann, K; Vick, B; Jeremias, I; Berdel, WE; Hansen, K; Zelent, A; Wickenhauser, C; Muller, LP; Thiede, C; Muller-Tidow, C				Goellner, Stefanie; Oellerich, Thomas; Agrawal-Singh, Shuchi; Schenk, Tino; Klein, Hans-Ulrich; Rohde, Christian; Pabst, Caroline; Sauer, Tim; Lerdrup, Mads; Tavor, Sigal; Stoelzel, Friedrich; Herold, Sylvia; Ehninger, Gerhard; Koehler, Gabriele; Pan, Kuan-Ting; Urlaub, Henning; Serve, Hubert; Dugas, Martin; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela; Berdel, Wolfgang E.; Hansen, Klaus; Zelent, Arthur; Wickenhauser, Claudia; Mueller, Lutz P.; Thiede, Christian; Mueller-Tidow, Carsten			Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; GENE EZH2; CELLS; CANCER; TRANSFORMATION; EXPRESSION; INHIBITOR; THERAPY; PHOSPHORYLATION; DIFFERENTIATION	In acute myeloid leukemia (AML), therapy resistance frequently occurs, leading to high mortality among patients. However, the mechanisms that render leukemic cells drug resistant remain largely undefined. Here, we identified loss of the histone methyltransferase EZH2 and subsequent reduction of histone H3K27 trimethylation as a novel pathway of acquired resistance to tyrosine kinase inhibitors (TKIs) and cytotoxic drugs in AML. Low EZH2 protein levels correlated with poor prognosis in AML patients. Suppression of EZH2 protein expression induced chemoresistance of AML cell lines and primary cells in vitro and in vivo. Low EZH2 levels resulted in derepression of HOX genes, and knockdown of HOXB7 and HOXA9 in the resistant cells was sufficient to improve sensitivity to TKIs and cytotoxic drugs. The endogenous loss of EZH2 expression in resistant cells and primary blasts from a subset of relapsed AML patients resulted from enhanced CDK1-dependent phosphorylation of EZH2 at Thr487. This interaction was stabilized by heat shock protein 90 (HSP9O) and followed by proteasomal degradation of EZH2 in drug-resistant cells. Accordingly, inhibitors of HSP9O, CDK1 and the proteasome prevented EZH2 degradation, decreased HOX gene expression and restored drug sensitivity. Finally, patients with reduced EZH2 levels at progression to standard therapy responded to the combination of bortezomib and cytarabine, concomitant with the re-establishment of EZH2 expression and blast clearance. These data suggest restoration of EZH2 protein as a viable approach to overcome treatment resistance in this AML patient population.	[Goellner, Stefanie; Rohde, Christian; Pabst, Caroline; Mueller, Lutz P.; Mueller-Tidow, Carsten] Univ Hosp Halle Saale, Dept Med Hematol & Oncol 4, Halle, Saale, Germany; [Oellerich, Thomas; Serve, Hubert] Goethe Univ, Dept Med Hematol Oncol 2, Frankfurt, Germany; [Oellerich, Thomas; Serve, Hubert; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela] German Canc Consortium DKTK, Heidelberg, Germany; [Oellerich, Thomas; Serve, Hubert; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela] German Canc Res Ctr, Heidelberg, Germany; [Agrawal-Singh, Shuchi; Lerdrup, Mads; Hansen, Klaus] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Agrawal-Singh, Shuchi; Dugas, Martin; Hansen, Klaus] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Schenk, Tino] ICR, Mol Pathol, London, England; [Klein, Hans-Ulrich; Dugas, Martin] Univ Hosp Munster, Inst Med Informat, Munster, Germany; [Sauer, Tim] Univ Hosp Munster, Dept Med A Hematol & Oncol, Munster, Germany; [Tavor, Sigal; Thiede, Christian] Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Stoelzel, Friedrich; Herold, Sylvia; Ehninger, Gerhard] Univ Hosp Carl Gustav Carus, Dept Med Mol Hematol, Dresden, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Pan, Kuan-Ting; Urlaub, Henning] Max Plank Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt, Gottingen, Germany; [Spiekermann, Karsten] Univ Hosp Munich, Dept Med 3, Munich, Germany; [Vick, Binje; Jeremias, Irmela] Helmholtz Ctr Munich, Res Unit Gene Vectors, Munich, Germany; [Zelent, Arthur; Wickenhauser, Claudia] UMHC, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Wickenhauser, Claudia] Univ Hosp Halle Saale, Dept Pathol, Halle, Saale, Germany; [Schenk, Tino] Univ Hosp Jena, Dept Med Hematol & Oncol 2, Jena, Germany; [Klein, Hans-Ulrich] Brigham & Womens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA USA; [Tavor, Sigal] Assuta Med Ctr, Dept Hematooncol, Tel Aviv, Israel; [Koehler, Gabriele] Klinikum Fulda gAG, Inst Pathol, Fulda, Germany	Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Copenhagen; University of Copenhagen; University of London; Institute of Cancer Research - UK; University of Munster; University of Munster; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster; Max Planck Society; University of Gottingen; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Martin Luther University Halle Wittenberg; Friedrich Schiller University of Jena; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Klinikum Fulda	Gollner, S; Muller-Tidow, C (corresponding author), Univ Hosp Halle Saale, Dept Med Hematol & Oncol 4, Halle, Saale, Germany.	stefanie.goellner@uk-halle.de; carsten.mueller-tidow@uk-halle.de	Jeremias, Irmela/Q-5934-2019; Müller-Tidow, Carsten/O-7207-2018; Schenk, Tino/P-4381-2019; Göllner, Stefanie/AAX-3901-2020; Stölzel, Friedrich/AAZ-8613-2021; Müller, Lutz/ABE-2941-2020; Klein, Hans-Ulrich/O-5118-2019	Jeremias, Irmela/0000-0003-1773-7677; Müller-Tidow, Carsten/0000-0002-7166-5232; Schenk, Tino/0000-0003-3430-5876; Klein, Hans-Ulrich/0000-0002-6382-9428; Vick, Binje/0000-0003-1956-2778; Hansen, Klaus/0000-0001-9657-8816; Zelent, Arthur/0000-0002-7968-9888; Serve, Hubert/0000-0001-8472-5516; Lerdrup, Mads/0000-0002-7730-8973; Thiede, Christian/0000-0003-1241-2048	Deutsche Forschungsgemeinschaft [SPP1463, MU1328/9-2, DFG EXC 1003]; German Cancer Aid Foundation [111286]; German Jose-Carreras Leukemia Foundation [DJCLS R 13/04]; state of Sachsen-Anhalt [FZK 28/43]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid Foundation; German Jose-Carreras Leukemia Foundation; state of Sachsen-Anhalt	We are grateful to J.H. Song and T.S. Kim (Korea University, Seoul, Republic of Korea) and to S. Chouaib (INSEAM U1186, Gustave Roussy Cancer Campus, Villejuif, France) for providing cell lines. The authors thank D. Wendt-Cousin and A. Kiittner for excellent technical assistance, and K. Agelopoulos and I. Schulze for assistance with exome library preparation and processing. We are grateful to the University of Munster core facilities IFG/IZKF for performing the Affymetrix gene expression arrays and the LIFA for Illumina sequencing of Exome libraries. We thank atelier42 for designing the graphical model of chemoresistance. S.G. and C.M.-T. hold the copyright for the graphic art. The Munster laboratory of W.E.B. was supported by the Deutsche Forschungsgemeinschaft, DFG EXC 1003 Cells in Motion-Cluster of Excellence. This work was further supported by grants from the Deutsche Forschungsgemeinschaft (SPP1463, MU1328/9-2 to C.M.-T.), the German Cancer Aid Foundation (111286 to C.M.-T.), the German Jose-Carreras Leukemia Foundation (DJCLS R 13/04 to C.M.-T.) and the state of Sachsen-Anhalt (FZK 28/43 to C.M.-T.).	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Armstrong SA, 2003, SEMIN HEMATOL, V40, P268, DOI 10.1016/S0037-1963(03)00196-3; Attar EC, 2013, J CLIN ONCOL, V31, P923, DOI 10.1200/JCO.2012.45.2177; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chou WC, 2011, BLOOD, V118, P3803, DOI 10.1182/blood-2011-02-339747; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Khan SN, 2013, LEUKEMIA, V27, P1301, DOI 10.1038/leu.2013.80; Klein HU, 2014, BIOINFORMATICS, V30, P1154, DOI 10.1093/bioinformatics/btu003; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Krug U, 2011, DTSCH ARZTEBL INT, V108, P863, DOI 10.3238/arztebl.2011.0863; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pabst C, 2016, BLOOD, V127, P2018, DOI 10.1182/blood-2015-11-683649; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Roboz GJ, 2011, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2011.1.43; Sashida G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5177; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	44	136	139	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					69	78		10.1038/nm.4247	http://dx.doi.org/10.1038/nm.4247			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27941792	Green Accepted			2022-12-27	WOS:000391646800015
J	Lu, ZG; Xie, JJ; Wu, GJ; Shen, JH; Collins, R; Chen, WN; Kang, XL; Luo, M; Zou, YZ; Huang, LJS; Amatruda, JF; Slone, T; Winick, N; Scherer, PE; Zhang, CC				Lu, Zhigang; Xie, Jingjing; Wu, Guojin; Shen, Jinhui; Collins, Robert; Chen, Weina; Kang, Xunlei; Luo, Min; Zou, Yizhou; Huang, Lily Jun-Shen; Amatruda, James F.; Slone, Tamra; Winick, Naomi; Scherer, Philipp E.; Zhang, Cheng Cheng			Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; CHILDHOOD-CANCER SURVIVOR; TUMOR-SUPPRESSOR GENE; MOLECULAR-MECHANISMS; CALORIE RESTRICTION; ARSENIC TRIOXIDE; ADIPOSE-TISSUE; RETINOIC ACID	New therapeutic approaches are needed to treat leukemia effectively. Dietary restriction regimens, including fasting, have been considered for the prevention and treatment of certain solid tumor types. However, whether and how dietary restriction affects hematopoietic malignancies is unknown. Here we report that fasting alone robustly inhibits the initiation and reverses the leukemic progression of both B cell and T cell acute lymphoblastic leukemia (B-ALL and T-ALL, respectively), but not acute myeloid leukemia (AML), in mouse models of these tumors. Mechanistically, we found that attenuated leptin-receptor (LEPR) expression is essential for the development and maintenance of ALL, and that fasting inhibits ALL development by upregulation of LEPR and its downstream signaling through the protein PR/SET domain 1 (PRDM1). The expression of LEPR signaling-related genes correlated with the prognosis of pediatric patients with pre-B-ALL, and fasting effectively inhibited B-ALL growth in a human xenograft model. Our results indicate that the effects of fasting on tumor growth are cancer-type dependent, and they suggest new avenues for the development of treatment strategies for leukemia.	[Lu, Zhigang; Xie, Jingjing; Wu, Guojin; Shen, Jinhui; Kang, Xunlei; Zhang, Cheng Cheng] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Xie, Jingjing; Zhang, Cheng Cheng] Binzhou Med Univ, BMU, UTSW Joint Taishan Immunol Grp, Yantai, Shandong, Peoples R China; [Collins, Robert; Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Chen, Weina] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Luo, Min] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Zou, Yizhou] Cent S Univ, Sch Xiangya Med, Dept Immunol, Changsha, Hunan, Peoples R China; [Huang, Lily Jun-Shen; Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Amatruda, James F.; Slone, Tamra; Winick, Naomi] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Binzhou Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Central South University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lu, ZG; Zhang, CC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Zhang, CC (corresponding author), Binzhou Med Univ, BMU, UTSW Joint Taishan Immunol Grp, Yantai, Shandong, Peoples R China.	zhigang.lu@utsouthwestern.edu; Alec.Zhang@UTSouthwestern.edu	Zhang, Cheng/GRS-8698-2022; xie, jing/GRY-1689-2022; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Lu, Zhigang/0000-0002-2880-7848; Kang, Xunlei/0000-0003-1853-1881	US National Institutes of Health [1R01CA172268]; Leukemia & Lymphoma Society [1024-14, TRP-6024-14]; CPRIT [RP140402, 1R01HL089966, R01-DK55758, RP140412]; NATIONAL CANCER INSTITUTE [R01CA172268] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055758] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge the support by grants from the US National Institutes of Health 1R01CA172268 (C.C.Z.), Leukemia & Lymphoma Society Awards 1024-14 (C.C.Z.) and TRP-6024-14 (C.C.Z.), CPRIT RP140402 (C.C.Z.), 1R01HL089966 (L.J.H.), R01-DK55758 (P.E.S.) and RP140412 (P.E.S.).	Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Baskin DG, 1998, DIABETES, V47, P538, DOI 10.2337/diabetes.47.4.538; Bifulco M, 2015, HAEMATOLOGICA, V100, pE118, DOI 10.3324/haematol.2014.122168; Boi M, 2015, LEUKEMIA LYMPHOMA, V56, P1223, DOI 10.3109/10428194.2014.953155; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Butturini AM, 2007, J CLIN ONCOL, V25, P2063, DOI 10.1200/JCO.2006.07.7792; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Efficace F, 2014, J CLIN ONCOL, V32, P3406, DOI 10.1200/JCO.2014.55.3453; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Hangaishi A, 2010, INT J HEMATOL, V91, P46, DOI 10.1007/s12185-009-0472-5; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kang XL, 2015, NAT CELL BIOL, V17, P665, DOI 10.1038/ncb3158; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pramanik R, 2013, LEUKEMIA RES, V37, P503, DOI 10.1016/j.leukres.2012.12.013; Ross JA, 2004, J CLIN ONCOL, V22, P3558, DOI 10.1200/JCO.2004.11.152; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sheng X, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00053; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; Teras LR, 2012, ENERG BALANCE CANCER, V5, P1, DOI 10.1007/978-1-4614-2403-1_1; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vishalakshi N., 2011, J PROTEOM BIOINFORM, V4, P184; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yun JP, 2010, CANCER PREV RES, V3, P1259, DOI 10.1158/1940-6207.CAPR-10-0087; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng JK, 2014, BLOOD, V123, P992, DOI 10.1182/blood-2013-04-498469; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003	57	63	68	5	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					79	90		10.1038/nm.4252	http://dx.doi.org/10.1038/nm.4252			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27941793	Green Accepted			2022-12-27	WOS:000391646800016
J	Zackular, JP; Moore, JL; Jordan, AT; Juttukonda, LJ; Noto, MJ; Nicholson, MR; Crews, JD; Semler, MW; Zhang, Y; Ware, LB; Washington, MK; Chazin, WJ; Caprioli, RM; Skaar, EP				Zackular, Joseph P.; Moore, Jessica L.; Jordan, Ashley T.; Juttukonda, Lillian J.; Noto, Michael J.; Nicholson, Maribeth R.; Crews, Jonathan D.; Semler, Matthew W.; Zhang, Yaofang; Ware, Lorraine B.; Washington, M. Kay; Chazin, Walter J.; Caprioli, Richard M.; Skaar, Eric P.			Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection	NATURE MEDICINE			English	Article							ANTIBIOTIC-ASSOCIATED COLITIS; FECAL CALPROTECTIN; EPIDEMIOLOGY; COMMENSALS	Clostridium difficile is the most commonly reported nosocomial pathogen in the United States and is an urgent public health concern worldwide(1). Over the past decade, incidence, severity and costs associated with C. difficile infection (CDI) have increased dramatically(2). CDI is most commonly initiated by antibiotic-mediated disruption of the gut microbiota; however, non-antibiotic-associated CDI cases are well documented and on the rise(3,4). This suggests that unexplored environmental, nutrient and host factors probably influence CDI. Here we show that excess dietary zinc (Zn) substantially alters the gut microbiota and, in turn, reduces the minimum amount of antibiotics needed to confer susceptibility to CDI. In mice colonized with C. difficile, excess dietary Zn severely exacerbated C. difficile associated disease by increasing toxin activity and altering the host immune response. In addition, we show that the Zn-binding S100 protein calprotectin has antimicrobial effects against C. difficile and is an essential component of the innate immune response to CDI. Taken together, these data suggest that nutrient Zn levels have a key role in determining susceptibility to CDI and severity of disease, and that calprotectin-mediated metal limitation is an important factor in the host immune response to C. difficile.	[Zackular, Joseph P.; Jordan, Ashley T.; Juttukonda, Lillian J.; Noto, Michael J.; Zhang, Yaofang; Ware, Lorraine B.; Washington, M. Kay; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Moore, Jessica L.; Chazin, Walter J.; Caprioli, Richard M.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Moore, Jessica L.; Caprioli, Richard M.] Vanderbilt Univ, Mass Spectrometry Res Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Noto, Michael J.; Semler, Matthew W.; Ware, Lorraine B.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Nicholson, Maribeth R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Crews, Jonathan D.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chazin, Walter J.; Caprioli, Richard M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Caprioli, Richard M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Skaar, Eric P.] US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Skaar, EP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.; Skaar, EP (corresponding author), US Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	eric.skaar@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702; Nicholson, Maribeth/0000-0003-3941-5599; Zackular, Joseph/0000-0002-3228-3055; Moore, Jessica/0000-0003-2519-6209	US Department of Veterans Affairs (Merit Review Award) [1I01BX002482]; US National Institutes of Health (NIH) [R01 AI101171, P41 GM103391-05]; Vanderbilt Digestive Disease Research Center (VDDRC) [P30DK058404]; NIH-NIDDK [T32DK007673]; NIH-NIAID [F32AI120553]; NIH-NIGMS [T32GM065086]; Thrasher Research Fund Early Career Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101171, F32AI120553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, T32DK007673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103391, T32GM007347, T32GM008320] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002482] Funding Source: NIH RePORTER	US Department of Veterans Affairs (Merit Review Award)(US Department of Veterans Affairs); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center (VDDRC); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thrasher Research Fund Early Career Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank P. Schloss and J. Sorg for critical feedback on this study, and D. Aronoff and S. Walk for providing C. difficile strains. This research was supported by the US Department of Veterans Affairs (Merit Review Award no. 1I01BX002482; E.P.S.), the US National Institutes of Health (NIH) (grant no. R01 AI101171 (E.P.S.) and P41 GM103391-05 (R.M.C.)) and the Vanderbilt Digestive Disease Research Center (VDDRC) (grant no. P30DK058404; E.P.S.). J.P.Z. was supported by NIH-NIDDK grant no. T32DK007673 and NIH-NIAID grant no. F32AI120553. J.L.M. was supported by NIH-NIGMS grant no. T32GM065086. M.R.N. was supported by the Thrasher Research Fund Early Career Award.	Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; Fischer W. C., 2004, ANNU REV NUTR, V24, P255, DOI DOI 10.1146/ANNUREV.NUTR.23.011702.073054; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Hanania A, 2016, INFECT DIS CLIN PRAC, V24, P31, DOI 10.1097/IPC.0000000000000312; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hensbergen PJ, 2015, FEBS LETT, V589, P3952, DOI 10.1016/j.febslet.2015.10.027; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Leffler DA, 2015, NEW ENGL J MED, V373, P287, DOI 10.1056/NEJMc1506004; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Rao K, 2016, INFECT DIS-NOR, V48, P663, DOI 10.1080/23744235.2016.1186832; Rubino JT, 2016, J BIOL INORG CHEM, V21, P185, DOI 10.1007/s00775-015-1319-6; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Theriot CM, 2011, GUT MICROBES, V2, P326, DOI [10.4161/gmic.2.6.19142, 10.4161/gmic.19142]; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; WUST J, 1982, J CLIN MICROBIOL, V16, P1096; Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085	29	142	145	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1330	1334		10.1038/nm.4174	http://dx.doi.org/10.1038/nm.4174			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27668938	Green Accepted			2022-12-27	WOS:000387302300026
J	Modjarrad, K; Moorthy, VS; Ben Embarek, P; Van Kerkhove, M; Kim, J; Kieny, MP				Modjarrad, Kayvon; Moorthy, Vasee S.; Ben Embarek, Peter; Van Kerkhove, Maria; Kim, Jerome; Kieny, Marie-Paule			A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation	NATURE MEDICINE			English	Article							EAST RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS INFECTION; MOUSE MODEL; GENERATION	As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV.	[Modjarrad, Kayvon] US Mil HIV Res Program, Walter Reed Army Inst Res, Silver Spring, MD USA; [Moorthy, Vasee S.; Ben Embarek, Peter; Kieny, Marie-Paule] WHO, Geneva, Switzerland; [Van Kerkhove, Maria] Inst Pasteur, Ctr Global Hlth, Paris, France; [Kim, Jerome] Int Vaccine Inst, Seoul, South Korea	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; International Vaccine Institute	Moorthy, VS (corresponding author), WHO, Geneva, Switzerland.	moorthyv@who.int	Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy, Vasee/0000-0002-6535-2854	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9; Ben Embarek Peter K, 2015, Wkly Epidemiol Rec, V90, P245; Cohen J, 2016, SCIENCE, V351, P16, DOI 10.1126/science.351.6268.16; Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812; Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Modjarrad K., VIRUS RES IN PRESS; Modjarrad K, 2016, J VIRUS ERAD, V2, P1; Ng DL, 2016, AM J PATHOL, V186, P652, DOI 10.1016/j.ajpath.2015.10.024; Park SW, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.41.30042; Pas SD, 2015, J CLIN VIROL, V69, P81, DOI 10.1016/j.jcv.2015.05.022; Reusken CBEM, 2015, EMERG INFECT DIS, V21, P1422, DOI 10.3201/eid2108.150481; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Warren T., 2015, IDWEEK SAN DIEGO; World Health Organization, 2015, WHOMERSLAB151; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	21	42	43	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					701	705		10.1038/nm.4131	http://dx.doi.org/10.1038/nm.4131			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387881	Green Published, Bronze			2022-12-27	WOS:000379366900004
J	Bezzi, M; Seitzer, N; Ishikawa, T; Reschke, M; Chen, M; Wang, GC; Mitchell, C; Ng, C; Katon, J; Lunardi, A; Signoretti, S; Clohessy, JG; Zhang, JW; Pandolfi, PP				Bezzi, Marco; Seitzer, Nina; Ishikawa, Tomoki; Reschke, Markus; Chen, Ming; Wang, Guocan; Mitchell, Caitlin; Ng, Christopher; Katon, Jesse; Lunardi, Andrea; Signoretti, Sabina; Clohessy, John G.; Zhang, Jiangwen; Pandolfi, Pier Paolo			Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms	NATURE MEDICINE			English	Article							RESISTANT PROSTATE-CANCER; SUPPRESSOR-CELLS; CELLULAR SENESCENCE; MYELOID CELLS; DOUBLE-BLIND; MICROENVIRONMENT; METASTASIS; MACROPHAGES; NEUTROPHILS; MELANOMA	Multiple immune-cell types can infiltrate tumors and promote progression and metastasis through different mechanisms, including immunosuppression. How distinct genetic alterations in tumors affect the composition of the immune landscape is currently unclear. Here, we characterized the immune-cell composition of prostate cancers driven by the loss of the critical tumor suppressor gene Pten, either alone or in combination with the loss of Trp53, Zbtb7a or Pml. We observed a striking quantitative and qualitative heterogeneity that was directly dependent on the specific genetic events in the tumor and ranged from 'cold', noninflamed tumors to massively infiltrated landscapes-results with important therapeutic implications. Further, we showed these qualitative differences in transcriptomic analysis of human prostate cancer samples. These data suggest that patient stratification on the basis of integrated genotypic-immunophenotypic analyses may be necessary for successful clinical trials and tailored precision immunological therapies.	[Bezzi, Marco; Seitzer, Nina; Ishikawa, Tomoki; Reschke, Markus; Chen, Ming; Wang, Guocan; Mitchell, Caitlin; Ng, Christopher; Katon, Jesse; Lunardi, Andrea; Clohessy, John G.; Pandolfi, Pier Paolo] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Canc Res Inst,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Clohessy, John G.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Preclin Murine Pharmacogenet Facil, Boston, MA USA; [Zhang, Jiangwen] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Hong Kong	Pandolfi, PP (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Canc Res Inst,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; chen, ming/0000-0002-3470-1062; Clohessy, John/0000-0001-5186-9775; Bezzi, Marco/0000-0001-9376-690X; Pandolfi, Pier Paolo/0000-0002-5352-5295; Ng, Christopher/0000-0001-8815-7958	NIH [R01 CA102142, R35 CA197529]; Jane Coffin Childs Postdoctoral Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Postdoctoral Fellowship	We thank the members of the laboratory of P.P.P. for critically reading and discussing the manuscript. We thank N. Pandell of the Preclinical Murine Pharmacogenetics Core at BIDMC, K. Berry and the members of the Center of Life Science animal facility for helping with all in vivo work. We thank the members of the Dana Farber Flow Cytometry Facility and the BIDMC Flow Cytometry Core for the help with all cell sorting. We also thank the Small Animal Imaging Core at BIDMC for the magnetic resonance imaging (MRI) work. This work was funded by NIH grants R01 CA102142 and R35 CA197529 awarded to P.P.P. and was supported by a Jane Coffin Childs Postdoctoral Fellowship to M.B.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Atkins D, 2004, INT J CANCER, V109, P265, DOI 10.1002/ijc.11681; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bradley SD, 2015, CANCER IMMUNOL RES, V3, P602, DOI 10.1158/2326-6066.CIR-15-0030; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen M., 2018, NAT GENET IN PRESS; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638; Drost J, 2016, NAT PROTOC, V11, P347, DOI 10.1038/nprot.2016.006; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia AJ, 2014, MOL CELL BIOL, V34, P2017, DOI 10.1128/MCB.00090-14; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676; Lunardi A, 2013, NAT GENET, V45, P747, DOI 10.1038/ng.2650; Lunardi Andrea, 2011, Genes Cancer, V2, P10, DOI 10.1177/1947601911402682; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Matsui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044080; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Patnaik A, 2017, CANCER DISCOV, V7, P750, DOI 10.1158/2159-8290.CD-16-0778; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Pili R, 2011, J CLIN ONCOL, V29, P4022, DOI 10.1200/JCO.2011.35.6295; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Seliger B, 1998, EUR J IMMUNOL, V28, P122, DOI 10.1002/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F; Slovin SF, 2013, ANN ONCOL, V24, P1813, DOI 10.1093/annonc/mdt107; Small EJ, 2007, CLIN CANCER RES, V13, P1810, DOI 10.1158/1078-0432.CCR-06-2318; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Williamson SC, 2013, DRUG DES DEV THER, V7, P167, DOI 10.2147/DDDT.S31500; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	62	93	96	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					165	+		10.1038/nm.4463	http://dx.doi.org/10.1038/nm.4463			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29309058	Green Submitted			2022-12-27	WOS:000424327200013
J	Lagares, D; Ghassemi-Kakroodi, P; Tremblay, C; Santos, A; Probst, CK; Franklin, A; Santos, DM; Grasberger, P; Ahluwalia, N; Montesi, SB; Shea, BS; Black, KE; Knipe, R; Blati, M; Baron, M; Wu, B; Fahmi, H; Gandhi, R; Pardo, A; Selman, M; Wu, JP; Pelletier, JP; Martel-Pelletier, J; Tager, AM; Kapoor, M				Lagares, David; Ghassemi-Kakroodi, Parisa; Tremblay, Caroline; Santos, Alba; Probst, Clemens K.; Franklin, Alicia; Santos, Daniela M.; Grasberger, Paula; Ahluwalia, Neil; Montesi, Sydney B.; Shea, Barry S.; Black, Katharine E.; Knipe, Rachel; Blati, Meryem; Baron, Murray; Wu, Brian; Fahmi, Hassan; Gandhi, Rajiv; Pardo, Annie; Selman, Moises; Wu, Jiangping; Pelletier, Jean-Pierre; Martel-Pelletier, Johanne; Tager, Andrew M.; Kapoor, Mohit			ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis (vol 23, pg 1405, 2017)	NATURE MEDICINE			English	Correction													Baron, Murray/AAF-9486-2019; Martel-Pelletier, Johanne/AAG-2928-2019	Moutinho Dos Santos, Daniela/0000-0002-3740-1305				Lagares D, 2017, NAT MED, V23, P1405, DOI 10.1038/nm.4419	1	1	1	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1499	1499		10.1038/nm1217-1499b	http://dx.doi.org/10.1038/nm1217-1499b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216045	Bronze			2022-12-27	WOS:000417278200010
J	Lu, YY; Zhao, XD; Liu, Q; Li, CX; Graves-Deal, R; Cao, Z; Singh, B; Franklin, JL; Wang, J; Hu, HY; Wei, TY; Yang, ML; Yeatman, TJ; Lee, E; Saito-Diaz, K; Hinger, S; Patton, JG; Chung, CH; Emmrich, S; Klusmann, JH; Fan, DM; Coffey, RJ				Lu, Yuanyuan; Zhao, Xiaodi; Liu, Qi; Li, Cunxi; Graves-Deal, Ramona; Cao, Zheng; Singh, Bhuminder; Franklin, Jeffrey L.; Wang, Jing; Hu, Huaying; Wei, Tianying; Yang, Mingli; Yeatman, Timothy J.; Lee, Ethan; Saito-Diaz, Kenyi; Hinger, Scott; Patton, James G.; Chung, Christine H.; Emmrich, Stephan; Klusmann, Jan-Henning; Fan, Daiming; Coffey, Robert J.			IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/beta-catenin signaling	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; BETA-CATENIN; MICRORNA SPONGES; NONCODING RNAS; TGF-BETA; EXPRESSION; CELLS; TANKYRASE; PROMOTES	De novo and acquired resistance, which are largely attributed to genetic alterations, are barriers to effective anti-epidermal-growth-factor-receptor ( EGFR) therapy. To generate cetuximab-resistant cells, we exposed cetuximab-sensitive colorectal cancer cells to cetuximab in three-dimensional culture. Using whole-exome sequencing and transcriptional profiling, we found that the long non-coding RNA MIR100HG and two embedded microRNAs, miR-100 and miR-125b, were overexpressed in the absence of known genetic events linked to cetuximab resistance. MIR100HG, miR-100 and miR-125b overexpression was also observed in cetuximab-resistant colorectal cancer and head and neck squamous cell cancer cell lines and in tumors from colorectal cancer patients that progressed on cetuximab. miR-100 and miR-125b coordinately repressed five Wnt/beta-catenin negative regulators, resulting in increased Wnt signaling, and Wnt inhibition in cetuximab-resistant cells restored cetuximab responsiveness. Our results describe a double-negative feedback loop between MIR100HG and the transcription factor GATA6, whereby GATA6 represses MIR100HG, but this repression is relieved by miR-125b targeting of GATA6. These findings identify a clinically actionable, epigenetic cause of cetuximab resistance.	[Lu, Yuanyuan; Zhao, Xiaodi; Graves-Deal, Ramona; Cao, Zheng; Singh, Bhuminder; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Lu, Yuanyuan; Zhao, Xiaodi; Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, Xian, Shaanxi, Peoples R China; [Lu, Yuanyuan; Zhao, Xiaodi; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China; [Liu, Qi; Wang, Jing] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Liu, Qi; Wang, Jing] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN USA; [Li, Cunxi; Hu, Huaying; Wei, Tianying] Beijing Jiaen Hosp, Jiaen Genet Lab, Beijing, Peoples R China; [Li, Cunxi; Hu, Huaying; Wei, Tianying] Xiamen Univ, Mol Pathol, Canc Res Ctr, Med Coll, Xiamen, Peoples R China; [Yang, Mingli; Yeatman, Timothy J.] Gibbs Canc Ctr & Res Inst, Spartanburg, SC USA; [Lee, Ethan; Saito-Diaz, Kenyi] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Lee, Ethan; Saito-Diaz, Kenyi] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Hinger, Scott; Patton, James G.] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37212 USA; [Chung, Christine H.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Emmrich, Stephan; Klusmann, Jan-Henning] Hannover Med Sch, Pediat Hematol & Oncol, Hannover, Germany; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Air Force Military Medical University; Air Force Military Medical University; Vanderbilt University; Vanderbilt University; Xiamen University; Vanderbilt University; Vanderbilt University; Vanderbilt University; H Lee Moffitt Cancer Center & Research Institute; Hannover Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Coffey, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.; Fan, DM (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, Xian, Shaanxi, Peoples R China.; Fan, DM (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China.; Coffey, RJ (corresponding author), Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA.	fandaim@fmmu.edu.cn; robert.coffey@vanderbilt.edu	Klusmann, Jan-Henning/M-9655-2015; Singh, Bhuminder/AAL-4503-2020	Klusmann, Jan-Henning/0000-0002-1070-0727; Singh, Bhuminder/0000-0003-1357-2158; Wang, Jing/0000-0003-2775-9001; Saito-Diaz, Kenyi/0000-0002-9829-2536; Coffey, Robert/0000-0002-2180-3844; Yang, Mingli/0000-0002-4781-690X	Vanderbilt University Cell Imaging, Chemical Biology Synthesis; Flow Cytometry Shared Resources; National Cancer Institute (NCI) [R01 CA046413, R35 CA197570, P50 CA095103]; Natural Science Foundation of China (NSFC) [81430072, 81421003]; National Key RD Program [2016YFC1303200]; Emmy Noether-Programme of the German Research Foundation [KL 2374/2-1]; NATIONAL CANCER INSTITUTE [P50CA095103, U19CA179514, R01CA046413, R35CA197570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122516] Funding Source: NIH RePORTER	Vanderbilt University Cell Imaging, Chemical Biology Synthesis; Flow Cytometry Shared Resources; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key RD Program; Emmy Noether-Programme of the German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the support of the Vanderbilt University Cell Imaging, Chemical Biology Synthesis, and Flow Cytometry Shared Resources. We thank J. Higginbotham for help with flow cytometry, W. Fry for help with plasmid construction, and E. Poulin and N. Markham for critical editing of the manuscript. We thank X. Wang and Y. Nie (Xijing Hospital of Digestive Diseases) for providing clinically annotated samples. This work was supported by National Cancer Institute (NCI) R01 CA046413, R35 CA197570 and P50 CA095103 GI Specialized Programs of Research Excellence to R.J.C., Natural Science Foundation of China (NSFC) 81430072 and 81421003 and National Key R&D Program 2016YFC1303200 to D.F., and Emmy Noether-Programme of the German Research Foundation KL 2374/2-1 to J.H.K.	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Arena S, 2015, CLIN CANCER RES, V21, P2157, DOI 10.1158/1078-0432.CCR-14-2821; Aronson BE, 2014, AM J PHYSIOL-GASTR L, V306, pG474, DOI 10.1152/ajpgi.00119.2013; Augoff K, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-5; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bertotti A, 2015, NATURE, V526, P263, DOI 10.1038/nature14969; Bond CE, 2016, ONCOTARGET, V7, P70589, DOI 10.18632/oncotarget.12130; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chen CJ, 2012, BIOINFORMATICS, V28, P3147, DOI 10.1093/bioinformatics/bts587; Chen DH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004177; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Croy HE, 2016, J BIOL CHEM, V291, P12747, DOI 10.1074/jbc.M115.705442; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Dhir A, 2015, NAT STRUCT MOL BIOL, V22, P319, DOI 10.1038/nsmb.2982; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Emmrich S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-171; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jiang XM, 2015, MOL CELL, V58, P522, DOI 10.1016/j.molcel.2015.03.015; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kawasaki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14291; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kikuchi K, 2009, NUCLEIC ACIDS RES, V37, P4987, DOI 10.1093/nar/gkp426; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li CX, 2017, P NATL ACAD SCI USA, V114, pE2852, DOI 10.1073/pnas.1618297114; Li CX, 2014, J CLIN INVEST, V124, P2172, DOI 10.1172/JCI71103; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martinelli P, 2017, GUT, V66, P1665, DOI 10.1136/gutjnl-2015-311256; Martinelli P, 2016, GUT, V65, P476, DOI 10.1136/gutjnl-2014-308042; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Nakayama S, 2014, CANCER RES, V74, P5891, DOI 10.1158/0008-5472.CAN-14-0184; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schell MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11743; Schell MJ, 2016, CLIN CANCER RES, V22, P734, DOI 10.1158/1078-0432.CCR-15-0143; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Schneikert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068072; Shang CL, 2016, ONCOL REP, V35, P3185, DOI 10.3892/or.2016.4715; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stintzing S, 2016, LANCET ONCOL, V17, P1426, DOI 10.1016/S1470-2045(16)30269-8; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Tsuji S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4150; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Yu XF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42226; Zhang L, 2014, GENE DEV, V28, P2532, DOI 10.1101/gad.248377.114; Zhao XD, 2015, J CELL BIOL, V210, P613, DOI 10.1083/jcb.201501073; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	71	237	252	2	65	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1331	+		10.1038/nm.4424	http://dx.doi.org/10.1038/nm.4424			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035371	Green Accepted			2022-12-27	WOS:000414548300015
J	Mai, WX; Gosa, L; Daniels, VW; Ta, L; Tsang, JE; Higgins, B; Gilmore, WB; Bayley, NA; Harati, MD; Lee, JT; Yong, WH; Kornblum, HI; Bensinger, SJ; Mischel, PS; Rao, PN; Clark, PM; Cloughesy, TF; Letai, A; Nathanson, DA				Mai, Wilson X.; Gosa, Laura; Daniels, Veerle W.; Ta, Lisa; Tsang, Jonathan E.; Higgins, Brian; Gilmore, W. Blake; Bayley, Nicholas A.; Harati, Mitra Dehghan; Lee, Jason T.; Yong, William H.; Kornblum, Harley I.; Bensinger, Steven J.; Mischel, Paul S.; Rao, P. Nagesh; Clark, Peter M.; Cloughesy, Timothy F.; Letai, Anthony; Nathanson, David A.			Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma	NATURE MEDICINE			English	Article							BRAIN-TUMOR CONSORTIUM; CELL-GROWTH; PHASE I/II; STEM-CELLS; CANCER; EGFR; DEATH; MDM2; BAX; TEMSIROLIMUS	Cross-talk among oncogenic signaling and metabolic pathways may create opportunities for new therapeutic strategies in cancer. Here we show that although acute inhibition of EGFR-driven glucose metabolism induces only minimal cell death, it lowers the apoptotic threshold in a subset of patient-derived glioblastoma (GBM) cells. Mechanistic studies revealed that after attenuated glucose consumption, Bcl-xL blocks cytoplasmic p53 from triggering intrinsic apoptosis. Consequently, targeting of EGFR-driven glucose metabolism in combination with pharmacological stabilization of p53 with the brain-penetrant small molecule idasanutlin resulted in synthetic lethality in orthotopic glioblastoma xenograft models. Notably, neither the degree of EGFR-signaling inhibition nor genetic analysis of EGFR was sufficient to predict sensitivity to this therapeutic combination. However, detection of rapid inhibitory effects on [F-18] fluorodeoxyglucose uptake, assessed through noninvasive positron emission tomography, was an effective predictive biomarker of response in vivo. Together, these studies identify a crucial link among oncogene signaling, glucose metabolism, and cytoplasmic p53, which may potentially be exploited for combination therapy in GBM and possibly other malignancies.	[Mai, Wilson X.; Gosa, Laura; Ta, Lisa; Tsang, Jonathan E.; Gilmore, W. Blake; Bayley, Nicholas A.; Lee, Jason T.; Kornblum, Harley I.; Clark, Peter M.; Nathanson, David A.] David Geffen UCLA Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Daniels, Veerle W.; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Higgins, Brian] Roche Innovat Ctr, Pharma Res & Early Dev, New York, NY USA; [Harati, Mitra Dehghan; Yong, William H.; Rao, P. Nagesh] David Geffen UCLA Sch Med, Dept Pathol, Los Angeles, CA USA; [Lee, Jason T.; Yong, William H.; Kornblum, Harley I.; Bensinger, Steven J.; Clark, Peter M.; Cloughesy, Timothy F.; Nathanson, David A.] David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] David Geffen UCLA Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92103 USA; [Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Dept Neurol, Los Angeles, CA USA; [Nathanson, David A.] David Geffen UCLA Sch Med, Ahmanson Translat Imaging Div, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nathanson, DA (corresponding author), David Geffen UCLA Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Nathanson, DA (corresponding author), David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Nathanson, DA (corresponding author), David Geffen UCLA Sch Med, Ahmanson Translat Imaging Div, Los Angeles, CA 90095 USA.	dnathanson@mednet.ucla.edu	Cloughesy, Timothy Francis/AGV-1013-2022	Lee, Jason/0000-0003-2590-2011; Daniels, Veerle/0000-0002-2052-1423; Gilmore, William/0000-0002-0653-4439; Rao, Nagesh/0000-0003-0920-7027	National Institutes of Health (NIH)/National Cancer Institute (NCI) [R01 CA 213133]; NIH/NCI UCLA SPORE in Brain Cancer [P50 CA 211015]; Nanosystems Biology Cancer Center [U54 CA 199090]; Jonsson Comprehensive Cancer Center Foundation/Seed Grant; Uncle Kory Foundation; B Hasso Family Foundation; Spiegelman Family Foundation in Memory of Barry Spiegelman; Art of the Brain; Ziering Family Foundation; National Brain Tumor Society; Ben And Catherine Ivy Foundation; Ludwig Institute for Cancer Research; NIH [R01 CA 205967, NS 052563]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP) [DGE-114087]; NATIONAL CANCER INSTITUTE [P50CA211015, R01CA213133, U54CA199090, R01CA205967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS052563, R01NS052563, R01NS073831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI UCLA SPORE in Brain Cancer; Nanosystems Biology Cancer Center; Jonsson Comprehensive Cancer Center Foundation/Seed Grant; Uncle Kory Foundation; B Hasso Family Foundation; Spiegelman Family Foundation in Memory of Barry Spiegelman; Art of the Brain; Ziering Family Foundation; National Brain Tumor Society; Ben And Catherine Ivy Foundation; Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Herschman, M. Teitell, and T. Graeber for their critical review of the manuscript. This work was funded by National Institutes of Health (NIH)/National Cancer Institute (NCI) R01 CA 213133 (D.A.N.), NIH/NCI UCLA SPORE in Brain Cancer P50 CA 211015 (D.A.N., T.F.C., S.J.B., H.I.K., and W.H.Y.), Nanosystems Biology Cancer Center U54 CA 199090 (D.A.N., T.F.C., and J.T.L.), a Jonsson Comprehensive Cancer Center Foundation/Seed Grant (D.A.N.), the Uncle Kory Foundation (D.A.N. and T.F.C.), the B Hasso Family Foundation (D.A.N. and T.F.C.), the Spiegelman Family Foundation in Memory of Barry Spiegelman (D.A.N. and T.F.C.), the Art of the Brain (T.F.C.), the Ziering Family Foundation (T.F.C. and P.S.M.), the National Brain Tumor Society (T.F.C. and P.S.M.), and the Ben And Catherine Ivy Foundation (T.F.C. and P.S.M.). A.L. and V.W.D. were supported by the Ludwig Institute for Cancer Research and NIH grant R01 CA 205967. H.I.K. was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and NIH grant NS 052563. W.X.M. was supported by National Science Foundation (NSF) Graduate Research Fellowship Program (GRFP) DGE-114087. We thank L. Abrey, J. Garcia, G. Nichols, S. Middleton, and L. Chen (all at Roche Pharmaceuticals) for their medical and scientific advice regarding idasanutlin; G. Coppola (UCLA) and Y. Qin (UCLA) for assistance in analyzing exome-sequencing data; K. Faull (UCLA) for help with mass spectrometry; L. Baufeld (UCLA) for technical assistance; J. Heath (Caltech) and M. Phelps (UCLA) for helpful discussions; and W. Fromer (Stanford), S. Korsmeyer (Dana-Farber Cancer Institute), R. Agami (The Netherlands Cancer Institute), and G. Lahav (Harvard) for reagents.	Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Clark PM, 2017, J NUCL MED, V58, P689, DOI 10.2967/jnumed.116.181693; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Ding QJ, 2013, J MED CHEM, V56, P5979, DOI 10.1021/jm400487c; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Jiang D, 2015, CELL REP, V10, P1096, DOI 10.1016/j.celrep.2015.01.043; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee EQ, 2012, NEURO-ONCOLOGY, V14, P1511, DOI 10.1093/neuonc/nos264; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Nathanson DA, 2014, J EXP MED, V211, P473, DOI 10.1084/jem.20131738; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Reardon DA, 2014, NEURO-ONCOLOGY, V16, pviii7, DOI 10.1093/neuonc/nou232; Spence AM, 2004, J NUCL MED, V45, P1653; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wei W, 2016, CANCER CELL, V29, P563, DOI 10.1016/j.ccell.2016.03.012; Wen PY, 2014, NEURO-ONCOLOGY, V16, P567, DOI 10.1093/neuonc/not247; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	54	54	55	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1342	+		10.1038/nm.4418	http://dx.doi.org/10.1038/nm.4418			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035366	Green Accepted, Green Submitted			2022-12-27	WOS:000414548300016
J	Batlle, E; Clevers, H				Batlle, Eduard; Clevers, Hans			Cancer stem cells revisited	NATURE MEDICINE			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; ANTIBODY-DRUG CONJUGATE; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR SNAIL; BREAST-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; COLON-CANCER; INTESTINAL CRYPT	The cancer stem cell (CSC) concept was proposed four decades ago, and states that tumor growth, analogous to the renewal of healthy tissues, is fueled by small numbers of dedicated stem cells. It has gradually become clear that many tumors harbor CSCs in dedicated niches, and yet their identification and eradication has not been as obvious as was initially hoped. Recently developed lineage-tracing and cell-ablation strategies have provided insights into CSC plasticity, quiescence, renewal, and therapeutic response. Here we discuss new developments in the CSC field in relationship to changing insights into how normal stem cells maintain healthy tissues. Expectations in the field have become more realistic, and now, the first successes of therapies based on the CSC concept are emerging.	[Batlle, Eduard] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Batlle, Eduard] ICREA, Barcelona, Spain; [Batlle, Eduard] Ctr Invest Biomed Red Canc CIBERONC, CiberONC, Barcelona, Spain; [Clevers, Hans] Royal Netherlands Acad Arts & Sci, Univ Med Ctr Utrecht, Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Princess Maxima Ctr, Utrecht, Netherlands	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Batlle, E (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Batlle, E (corresponding author), ICREA, Barcelona, Spain.; Batlle, E (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, CiberONC, Barcelona, Spain.; Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Univ Med Ctr Utrecht, Hubrecht Inst, Utrecht, Netherlands.; Clevers, H (corresponding author), Princess Maxima Ctr, Utrecht, Netherlands.	eduard.batlle@irbbarcelona.org; h.clevers@hubrecht.eu	Batlle, Eduard/K-8080-2014	Batlle, Eduard/0000-0003-2422-0326	Fundacion Botin, through Santander University; European Research Council [340176]; Banco Santander, through Santander University	Fundacion Botin, through Santander University; European Research Council(European Research Council (ERC)European Commission); Banco Santander, through Santander University	Work in the laboratory of E.B. is supported by Fundacion Botin and Banco Santander, through Santander Universities and the European Research Council (advanced grant no. 340176). We thank E. Sancho and J. Stanisavljevic for proofreading the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Ball CR, 2017, EMBO MOL MED, V9, P918, DOI 10.15252/emmm.201607354; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borst P, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120066; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; CLARKSON B, 1970, CANCER, V25, P1237, DOI 10.1002/1097-0142(197006)25:6<1237::AID-CNCR2820250602>3.0.CO;2-7; CLARKSON B D, 1974, P945; CLARKSON BD, 1971, MED CLIN N AM, V55, P561, DOI 10.1016/S0025-7125(16)32504-4; CLARKSON BD, 1969, NATL CANCER I MONOGR, P81; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clevers H, 2015, SCIENCE, V350, P1319, DOI 10.1126/science.aad7016; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cortina C, 2017, EMBO MOL MED, V9, P869, DOI 10.15252/emmm.201707550; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cronkite E P, 1970, Proc Natl Cancer Conf, V6, P113; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; de Goeij BECG, 2016, CURR OPIN IMMUNOL, V40, P14, DOI 10.1016/j.coi.2016.02.008; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Fumagalli A, 2017, P NATL ACAD SCI USA, V114, pE2357, DOI 10.1073/pnas.1701219114; Gong X, 2016, MOL CANCER THER, V15, P1580, DOI 10.1158/1535-7163.MCT-16-0114; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Junttila MR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7433; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; KILLMANN SA, 1963, LAB INVEST, V12, P671; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Laszlo GS, 2014, BLOOD REV, V28, P143, DOI 10.1016/j.blre.2014.04.001; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liau BB, 2017, CELL STEM CELL, V20, P233, DOI 10.1016/j.stem.2016.11.003; Llorens-Bobadilla E, 2017, CURR OPIN NEUROBIOL, V42, P68, DOI 10.1016/j.conb.2016.11.008; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nassar D, 2016, ANNU REV PATHOL-MECH, V11, P47, DOI 10.1146/annurev-pathol-012615-044438; Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Peiris-Pages M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0712-6; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rodriguez-Colman MJ, 2017, NATURE, V543, P424, DOI 10.1038/nature21673; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Sancho P, 2016, BRIT J CANCER, V114, P1305, DOI 10.1038/bjc.2016.152; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Saunders LR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9459; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schmidt JM, 2015, CELL REP, V10, P131, DOI 10.1016/j.celrep.2014.12.032; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stahl M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006193; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Storm EE, 2016, NATURE, V529, P97, DOI 10.1038/nature16466; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tata PR, 2016, CURR OPIN CELL BIOL, V43, P46, DOI 10.1016/j.ceb.2016.07.005; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; UCKUN FM, 1995, BLOOD, V85, P873, DOI 10.1182/blood.V85.4.873.bloodjournal854873; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wei L, 2016, J CLIN INVEST, V126, P4076, DOI 10.1172/JCI88410; Wuidart A, 2016, GENE DEV, V30, P1261, DOI 10.1101/gad.280057.116; Ye HB, 2016, CELL STEM CELL, V19, P23, DOI 10.1016/j.stem.2016.06.001; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zomer A, 2013, STEM CELLS, V31, P602, DOI 10.1002/stem.1296	163	1245	1276	35	405	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1124	1134		10.1038/nm.4409	http://dx.doi.org/10.1038/nm.4409			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985214				2022-12-27	WOS:000412431800007
J	Neumann, JE; Wefers, AK; Lambo, S; Bianchi, E; Bockstaller, M; Dorostkar, MM; Meister, V; Schindler, P; Korshunov, A; von Hoff, K; Nowak, J; Warmuth-Metz, M; Schneider, MR; Renner-Muller, I; Merk, DJ; Shakarami, M; Sharma, T; Chavez, L; Glass, R; Chan, JA; Taketo, MM; Neumann, P; Kool, M; Schuller, U				Neumann, Julia E.; Wefers, Annika K.; Lambo, Sander; Bianchi, Edoardo; Bockstaller, Marie; Dorostkar, Mario M.; Meister, Valerie; Schindler, Pia; Korshunov, Andrey; von Hoff, Katja; Nowak, Johannes; Warmuth-Metz, Monika; Schneider, Marlon R.; Renner-Mueller, Ingrid; Merk, Daniel J.; Shakarami, Mehdi; Sharma, Tanvi; Chavez, Lukas; Glass, Rainer; Chan, Jennifer A.; Taketo, M. Mark; Neumann, Philipp; Kool, Marcel; Schueller, Ulrich			A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors	NATURE MEDICINE			English	Article							BETA-CATENIN; MOLECULAR CLASSIFICATION; NEURAL PROGENITORS; ABUNDANT NEUROPIL; TRUE ROSETTES; MRI FINDINGS; BRAIN-STEM; MEDULLOBLASTOMA; PATHWAY; MICE	Embryonal tumors with multilayered rosettes (ETMRs) have recently been described as a new entity of rare pediatric brain tumors with a fatal outcome. We show here that ETMRs are characterized by a parallel activation of Shh and Wnt signaling. Co-activation of these pathways in mouse neural precursors is sufficient to induce ETMR-like tumors in vivo that resemble their human counterparts on the basis of histology and global gene-expression analyses, and that point to apical radial glia cells as the possible tumor cell of origin. Overexpression of LIN28A, which is a hallmark of human ETMRs, augments Sonic-hedgehog (Shh) and Wnt signaling in these precursor cells through the downregulation of let7-miRNA, and LIN28A/let7a interaction with the Shh pathway was detected at the level of Gli mRNA. Finally, human ETMR cells that were transplanted into immunocompromised host mice were responsive to the SHH inhibitor arsenic trioxide (ATO). Our work provides a novel mouse model in which to study this tumor type, demonstrates the driving role of Wnt and Shh activation in the growth of ETMRs and proposes downstream inhibition of Shh signaling as a therapeutic option for patients with ETMRs.	[Neumann, Julia E.; Wefers, Annika K.; Bianchi, Edoardo; Bockstaller, Marie; Dorostkar, Mario M.; Meister, Valerie; Schindler, Pia; Merk, Daniel J.; Shakarami, Mehdi; Schueller, Ulrich] Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany; [Neumann, Julia E.; Schueller, Ulrich] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Neumann, Julia E.; Schindler, Pia; Schueller, Ulrich] Res Inst Childrens Canc Ctr Hamburg, Hamburg, Germany; [Wefers, Annika K.; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [Wefers, Annika K.; Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Wefers, Annika K.; Korshunov, Andrey] German Canc Consortium DKTK, Core Ctr Heidelberg, Heidelberg, Germany; [Lambo, Sander; Sharma, Tanvi; Chavez, Lukas; Kool, Marcel] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Dorostkar, Mario M.] German Ctr Neurodegenerat Dis, Munich, Germany; [von Hoff, Katja] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, HIT MED Study Ctr, Hamburg, Germany; [Nowak, Johannes; Warmuth-Metz, Monika] Univ Hosp Wurzburg, Reference Ctr Neuroradiol, Wurzburg, Germany; [Nowak, Johannes] Univ Hosp Wurzburg, Dept Diagnost & Intervent Radiol, Wurzburg, Germany; [Schneider, Marlon R.; Renner-Mueller, Ingrid] Ludwig Maximilians Univ Munchen, Mol Anim Breeding & Biotechnol Gene Ctr, Munich, Germany; [Shakarami, Mehdi] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr, Munich, Germany; [Glass, Rainer] Ludwig Maximilians Univ Munchen, Neurosurg Res, Munich, Germany; [Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Kyoto, Japan; [Neumann, Philipp] Univ Hamburg, Dept Informat, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Merk, Daniel J.] Dana Farber Canc Inst, Canc Biol & Pediat Oncol, Boston, MA 02115 USA	University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Wurzburg; University of Munich; University of Munich; University of Munich; University of Calgary; Kyoto University; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Dana-Farber Cancer Institute	Schuller, U (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany.; Schuller, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.; Schuller, U (corresponding author), Res Inst Childrens Canc Ctr Hamburg, Hamburg, Germany.; Schuller, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany.	u.schueller@uke.de	Neumann, Philipp/AAC-4880-2021; Bockstaller, Michael R/A-9124-2011; Wefers, Annika K./ABF-3832-2020; Dorostkar, Mario/AAF-6399-2020; Glass, Rainer/GMW-7952-2022	Bockstaller, Michael R/0000-0001-9046-9539; Wefers, Annika K./0000-0001-9394-8519; Dorostkar, Mario/0000-0001-8037-4907; Sharma, Tanvi/0000-0002-0850-1673; Schuller, Ulrich/0000-0002-8731-1121; von Hoff, Katja/0000-0002-5669-8546; Korshunov, Andrey/0000-0002-5257-3623; Neumann, Julia E./0000-0002-1162-8771; Chavez, Lukas/0000-0002-8718-8848; Neumann, Philipp/0000-0001-8604-8846	Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Deutsche Krebshilfe; Wilhelm Sander Foundation; Else-KronerFresenius Foundation; K.L. Weigand foundation; Association "Forderung von Wissenschaft und Forschung an der Medizinischen Fakultut der LMU Munchen e.V."	Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander Foundation; Else-KronerFresenius Foundation; K.L. Weigand foundation; Association "Forderung von Wissenschaft und Forschung an der Medizinischen Fakultut der LMU Munchen e.V."	We thank T. Kobayashi (Harvard University, Boston, USA) for providing the LIN28A(3x)-IRES-eGFP plasmid, D. Rowitch (University of Cambridge, Cambridge, USA) for providing MSCV-IRES-GFP and MSCV-Cre-IRES-GFP plasmids, and D. Baltimore (Pasadena, CA, USA) for providing the Lin28A-IRES-GFP plasmid. We thank R. Toftgard, (Karolinska Institute, Stockholm, Sweden), for providing Sufu<SUP>-/-</SUP> MEFs, J. Chen (Stanford University School of Medicine, Stanford, USA) for providing Smo<SUP>-/-</SUP> MEFs, and R. Lipinski (University of Wisconsin, Madison, USA) for providing Gli1<SUP>-/-</SUP>, Gli2<SUP>-/-</SUP>, and Gli3<SUP>-/-</SUP> MEFs. We thank H. Blum and S. Krebs for assistance with murine gene-expression data (Gene Center Munich, Germany). We thank S. Occhionero, M. Burmester, M. Wagner, and M. Schmidt (LMU, Munich, Germany) and M. Gregersen and I. Nachtigall (UKE Hamburg, Germany) for excellent technical support, and P. Bonert, P. Liebmann, C. Mann, and M. Wellisch (LMU, Munich, Germany) for animal husbandry. We thank K. Hartmann from the mouse pathology core facility (UKE Hamburg, Germany) for processing immunohistochemical stainings. We are indebted to all members of the Schuller group for very fruitful discussions. This work was supported by the Fordergemeinschaft Kinderkrebs-Zentrum Hamburg and grants from the Deutsche Krebshilfe (Max-Eder junior research program to U.S.), the Wilhelm Sander Foundation (to U.S.), the Else-KronerFresenius Foundation (to U.S. and J.E.N.), the K.L. Weigand foundation (to J.E.N.) and the Association "Forderung von Wissenschaft und Forschung an der Medizinischen Fakultut der LMU Munchen e.V." (to J.E.N.).	Al-Fageeh M, 2004, ONCOGENE, V23, P4839, DOI 10.1038/sj.onc.1207634; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dierks C, 2010, RECENT RESULTS CANC, V184, P235, DOI 10.1007/978-3-642-01222-8_17; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Friedrich C, 2015, J NEUROSURG-PEDIATR, V15, P227, DOI 10.3171/2014.9.PEDS14213; Gessi M, 2009, AM J SURG PATHOL, V33, P211, DOI 10.1097/PAS.0b013e318186235b; Grammel D, 2012, ACTA NEUROPATHOL, V123, P601, DOI 10.1007/s00401-012-0961-0; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Iland HJ, 2015, LANCET HAEMATOL, V2, pE357, DOI 10.1016/S2352-3026(15)00115-5; Ishizaki Y, 2004, INT J ONCOL, V24, P1077; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Kingston Robert E, 2003, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2003s19; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Korshunov A, 2012, ACTA NEUROPATHOL, V124, P875, DOI 10.1007/s00401-012-1068-3; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Lei XX, 2012, NUCLEIC ACIDS RES, V40, P3574, DOI 10.1093/nar/gkr1279; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Nowak J, 2014, AM J NEURORADIOL, V35, P1996, DOI 10.3174/ajnr.A4002; Nowak J, 2015, NEURO-ONCOLOGY, V17, P1157, DOI 10.1093/neuonc/nov063; Nowak J, 2014, PEDIATR BLOOD CANCER, V61, P1132, DOI 10.1002/pbc.24915; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Papaioannou G, 2013, P NATL ACAD SCI USA, V110, pE3291, DOI 10.1073/pnas.1302797110; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Poschl J, 2011, ONCOGENE, V30, P4721, DOI 10.1038/onc.2011.173; Poschl J, 2014, ACTA NEUROPATHOL, V128, P123, DOI 10.1007/s00401-014-1297-8; Poschl J, 2014, ACTA NEUROPATHOL, V127, P605, DOI 10.1007/s00401-014-1258-2; Poschl J, 2013, DEV BIOL, V374, P319, DOI 10.1016/j.ydbio.2012.12.001; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sahm F, 2016, ACTA NEUROPATHOL, V131, P903, DOI 10.1007/s00401-015-1519-8; Sato H, 2015, J NEUROSURG-PEDIATR, V16, P291, DOI 10.3171/2015.3.PEDS14727; Schmidt C., 2017, NEUROONCOL; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Schwalbe EC, 2011, CLIN CANCER RES, V17, P1883, DOI 10.1158/1078-0432.CCR-10-2210; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Spence T, 2014, ACTA NEUROPATHOL, V128, P291, DOI 10.1007/s00401-014-1291-1; Spence T, 2014, NEURO-ONCOLOGY, V16, P62, DOI 10.1093/neuonc/not162; Stock K, 2012, NAT MED, V18, P1232, DOI 10.1038/nm.2827; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wani S, 2014, PROFILING DIRECT MRN; Weingart MF, 2015, ONCOTARGET, V6, P3165, DOI 10.18632/oncotarget.3078; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang M, 2015, DEVELOPMENT, V142, P1616, DOI 10.1242/dev.120543; Zeng YX, 2016, MOL CELL, V61, P153, DOI 10.1016/j.molcel.2015.11.020; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zurawel RH, 1998, CANCER RES, V58, P896	71	29	31	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1191	+		10.1038/nm.4402	http://dx.doi.org/10.1038/nm.4402			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28892064				2022-12-27	WOS:000412431800014
J	Wu, H; Esteve, E; Tremaroli, V; Khan, MT; Caesar, R; Manneras-Holm, L; Stahlman, M; Olsson, LM; Serino, M; Planas-Felix, M; Xifra, G; Mercader, JM; Torrents, D; Burcelin, R; Ricart, W; Perkins, R; Fernandez-Real, JM; Backhed, F				Wu, Hao; Esteve, Eduardo; Tremaroli, Valentina; Khan, Muhammad Tanweer; Caesar, Robert; Manneras-Holm, Louise; Stahlman, Marcus; Olsson, Lisa M.; Serino, Matteo; Planas-Felix, Mercs; Xifra, Gemma; Mercader, Josep M.; Torrents, David; Burcelin, Remy; Ricart, Wifredo; Perkins, Rosie; Fernandez-Real, Jose Manuel; Backhed, Fredrik			Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug	NATURE MEDICINE			English	Article							DIET-INDUCED OBESITY; AKKERMANSIA-MUCINIPHILA; GLUCOSE-HOMEOSTASIS; BACTERIAL; GLUCONEOGENESIS; ASSOCIATION; MODULATION; EXTRACTION; RESISTANCE; POPULATION	Metformin is widely used in the treatment of type 2 diabetes (T2D), but its mechanism of action is poorly defined. Recent evidence implicates the gut microbiota as a site of metformin action. In a double-blind study, we randomized individuals with treatment-naive T2D to placebo or metformin for 4 months and showed that metformin had strong effects on the gut microbiome. These results were verified in a subset of the placebo group that switched to metformin 6 months after the start of the trial. Transfer of fecal samples (obtained before and 4 months after treatment) from metformin-treated donors to germ-free mice showed that glucose tolerance was improved in mice that received metformin-altered microbiota. By directly investigating metformin-microbiota interactions in a gut simulator, we showed that metformin affected pathways with common biological functions in species from two different phyla, and many of the metformin-regulated genes in these species encoded metalloproteins or metal transporters. Our findings provide support for the notion that altered gut microbiota mediates some of metformin's antidiabetic effects.	[Wu, Hao; Tremaroli, Valentina; Khan, Muhammad Tanweer; Caesar, Robert; Manneras-Holm, Louise; Stahlman, Marcus; Olsson, Lisa M.; Perkins, Rosie; Backhed, Fredrik] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Esteve, Eduardo; Xifra, Gemma; Ricart, Wifredo; Fernandez-Real, Jose Manuel] Hosp Josep Trueta, Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Esteve, Eduardo; Xifra, Gemma; Ricart, Wifredo; Fernandez-Real, Jose Manuel] Univ Girona, Fac Med, Dept Med, Girona, Spain; [Esteve, Eduardo; Xifra, Gemma; Ricart, Wifredo; Fernandez-Real, Jose Manuel] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Serino, Matteo] Univ Toulouse, IRSD, INSERM, INRA,ENVT,UPS, Toulouse, France; [Planas-Felix, Mercs; Mercader, Josep M.; Torrents, David] BSC, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Torrents, David] ICREA, Barcelona, Spain; [Burcelin, Remy] INSERM, Toulouse, France; [Burcelin, Remy] UPS, UMR 1048, Inst Malad Metab & Cardiovasc, Toulouse, France; [Backhed, Fredrik] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark	University of Gothenburg; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sahlgrenska University Hospital; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.; Fernandez-Real, JM (corresponding author), Hosp Josep Trueta, Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain.; Fernandez-Real, JM (corresponding author), Univ Girona, Fac Med, Dept Med, Girona, Spain.; Fernandez-Real, JM (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.; Backhed, F (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.; Backhed, F (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark.	jmfreal@idibgi.org; fredrik.backhed@wlab.gu.se	Serino, Matteo/O-3310-2018; Caesar, Robert/AAX-3205-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Backhed, Fredrik/ABE-6613-2020; burcelin, remy/M-6013-2014; StÃhlman, Marcus/M-4597-2019; Tremaroli, Valentina/AAE-8001-2019; Torrents, David/G-5785-2015	Serino, Matteo/0000-0003-4644-8532; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Backhed, Fredrik/0000-0002-4871-8818; Tremaroli, Valentina/0000-0002-9150-4233; Mercader, Josep M/0000-0001-8494-3660; Wu, Hao/0000-0003-1314-4954; Henricsson, Marcus/0000-0002-4202-0339; Planas-Felix, Merce/0000-0002-8267-576X; Torrents, David/0000-0002-6086-9037	Swedish Diabetes Foundation; Swedish Research Council; Swedish Heart Lung Foundation; Torsten Soderberg's Foundation; Goran Gustafsson's Foundation; Inga Britt and Arne Lundberg's Foundation; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Region Vastra Gotaland; Sahlgrenska University Hospital; Ministerio de Economia y Competitividad [PI11-00214, PI15/01934]; FEDER funds; Obra Social Fundacion la Caixa fellowship under the Severo Ochoa program; Sara Borrell Fellowship from the Instituto Carlos III; EFSD/Lilly Research Fellowship; Beatriu de Pinos Fellowship from the Agency for Management of University and Research Grants (AGAUR); ERC Consolidator Grant (European Research Council) [615362-METABASE]; NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016798, NNF13OC0008163] Funding Source: researchfish	Swedish Diabetes Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderberg's Foundation; Goran Gustafsson's Foundation; Inga Britt and Arne Lundberg's Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Region Vastra Gotaland; Sahlgrenska University Hospital; Ministerio de Economia y Competitividad(Spanish Government); FEDER funds(European Commission); Obra Social Fundacion la Caixa fellowship under the Severo Ochoa program; Sara Borrell Fellowship from the Instituto Carlos III; EFSD/Lilly Research Fellowship; Beatriu de Pinos Fellowship from the Agency for Management of University and Research Grants (AGAUR); ERC Consolidator Grant (European Research Council)(European Research Council (ERC)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank C. Arvidsson, S. Nordin-Larsson, C. Wennberg, and U. Enqvist for superb mouse husbandry. The administrative and technical help of J.M. Moreno Navarrete, E. Huertos, M. Sabater, and O. Rovira is also acknowledged. The strain Akkermansia muciniphila DSM22959 was kindly provided by W. de Vos (Wageningen University and Helsinki University). The strain Bifidobacterium adolescentis L2-32 was kindly provided by K. Scott (The Rowett Institute of Nutrition and Health, University of Aberdeen). Whole-genome shotgun sequencing was performed at the Genomics Core Facility at the Sahlgrenska Academy, University of Gothenburg. The computations for metagenomics analyses were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). This study was supported by the Swedish Diabetes Foundation; Swedish Research Council; Swedish Heart Lung Foundation; Torsten Soderberg's Foundation; Goran Gustafsson's Foundation; Inga Britt and Arne Lundberg's Foundation; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; the Novo Nordisk Foundation; the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital; the Ministerio de Economia y Competitividad (PI11-00214 and PI15/01934); and FEDER funds. CIBEROBN Fisiopatologia de la Obesidad y Nutricion is an initiative from the Instituto de Salud Carlos III from Spain. M.P.-F. is funded by the Obra Social Fundacion la Caixa fellowship under the Severo Ochoa 2013 program. J. M. M. was supported by the Sara Borrell Fellowship from the Instituto Carlos III, EFSD/Lilly Research Fellowship and Beatriu de Pinos Fellowship from the Agency for Management of University and Research Grants (AGAUR). F.B. is a recipient of ERC Consolidator Grant (European Research Council, Consolidator grant 615362-METABASE).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; CASPARY WF, 1977, DIABETOLOGIA, V13, P187, DOI 10.1007/BF01219698; Chen JJ, 2012, BRIT J NUTR, V107, P1429, DOI 10.1017/S0007114511004491; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Greer RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13329; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003706; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kindt R., 2005, WORLD; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015; Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Lee YS, 2016, MOL METAB, V5, P263, DOI 10.1016/j.molmet.2016.01.007; Leucht S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0494-1; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Logie L, 2012, DIABETES, V61, P1423, DOI 10.2337/db11-0961; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Fernandez-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8; McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Murphy NR, 1996, BIOTECHNIQUES, V21, P934; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Park SK, 2012, INT J SYST EVOL MICR, V62, P776, DOI 10.1099/ijs.0.031625-0; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Scarpello JHB, 1998, DIABETIC MED, V15, P651, DOI 10.1002/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.3.CO;2-1; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Stepensky D, 2002, DRUG METAB DISPOS, V30, P861, DOI 10.1124/dmd.30.8.861; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Team R. C. R, 2015, LANG ENV STAT COMP; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26; Wahlstrom A, 2017, J LIPID RES, V58, P412, DOI 10.1194/jlr.M072819; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HS, 2015, ISME J, V9, P770, DOI 10.1038/ismej.2014.165; Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14405; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143	71	771	817	14	431	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					850	+		10.1038/nm.4345	http://dx.doi.org/10.1038/nm.4345			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28530702				2022-12-27	WOS:000405180100014
J	Wei, JJ; Yewdell, JW				Wei, Jiajie; Yewdell, Jonathan W.			Autoimmune T cell recognition of alternative-reading-frame-encoded peptides	NATURE MEDICINE			English	Editorial Material							MHC CLASS-I; ANTIGENIC PEPTIDES; MAJOR SOURCE; TRANSLATION; PATHWAY; PRODUCTS; CODONS; GENOME	A recent study shows that a self-peptide generated in pancreatic islet beta cells through the translation of a noncanonical alternative reading frame in human insulin mRNA is recognized by both CD4(+) and CD8(+) T cells in type 1 diabetes.	[Wei, Jiajie; Yewdell, Jonathan W.] NIAID, Cellular Biol Sect, Viral Dis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Cellular Biol Sect, Viral Dis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@niaid.nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012		Division of Intramural Research, NIAID, Bethesda, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001210] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, Bethesda, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are supported by the Division of Intramural Research, NIAID, Bethesda, Maryland.	Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Apcher S, 2011, P NATL ACAD SCI USA, V108, P11572, DOI 10.1073/pnas.1104104108; BOON T, 1989, IMMUNOGENETICS, V29, P75, DOI 10.1007/BF00395854; Bullock TNJ, 1997, J EXP MED, V186, P1051, DOI 10.1084/jem.186.7.1051; Goodenough E, 2014, P NATL ACAD SCI USA, V111, P5670, DOI 10.1073/pnas.1402670111; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Kracht MJL, 2017, NAT MED, V23, P501, DOI 10.1038/nm.4289; Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Zhao YX, 2015, EUR J IMMUNOL, V45, P2494, DOI 10.1002/eji.201445378	12	5	6	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					409	410		10.1038/nm.4317	http://dx.doi.org/10.1038/nm.4317			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388603				2022-12-27	WOS:000398768100006
J	Crome, SQ; Nguyen, LT; Lopez-Verges, S; Yang, SYC; Martin, B; Yam, JY; Johnson, DJ; Nie, J; Pniak, M; Yen, PH; Milea, A; Sowamber, R; Katz, SR; Bernardini, MQ; Clarke, BA; Shaw, PA; Lang, PA; Berman, HK; Pugh, TJ; Lanier, LL; Ohashi, PS				Crome, Sarah Q.; Nguyen, Linh T.; Lopez-Verges, Sandra; Yang, S. Y. Cindy; Martin, Bernard; Yam, Jennifer Y.; Johnson, Dylan J.; Nie, Jessica; Pniak, Michael; Yen, Pei Hua; Milea, Anca; Sowamber, Ramlogan; Katz, Sarah Rachel; Bernardini, Marcus Q.; Clarke, Blaise A.; Shaw, Patricia A.; Lang, Philipp A.; Berman, Hal K.; Pugh, Trevor J.; Lanier, Lewis L.; Ohashi, Pamela S.			A distinct innate lymphoid cell population regulates tumor-associated T cells	NATURE MEDICINE			English	Article							NK CELLS; DENDRITIC CELLS; PROLIFERATION; RECEPTORS; RESPONSES; PATHWAYS; MICE	Antitumor T cells are subject to multiple mechanisms of negative regulation(1-3). Recent findings that innate lymphoid cells (ILCs) regulate adaptive T cell responses(4-6) led us to examine the regulatory potential of ILCs in the context of cancer. We identified a unique ILC population that inhibits tumor -infiltrating lymphocytes (TILs) from high-grade serous tumors, defined their suppressive capacity in vitro, and performed a comprehensive analysis of their phenotype. Notably, the presence of this CD56+CD3- population in TIL cultures was associated with reduced T cell numbers, and further functional studies demonstrated that this population suppressed TIL expansion and altered TIL cytokine production. Transcriptome analysis and phenotypic characterization determined that regulatory CD56+CD3-cells exhibit low cytotoxic activity, produce IL-22, and have an expression profile that overlaps with those of natural killer (NK) cells and other ILCs. NKp46 was highly expressed by these cells, and addition of anti-NKp46 antibodies to TIL cultures abrogated the ability of these regulatory ILCs to suppress T cell expansion. Notably, the presence of these regulatory ILCs in TIL cultures corresponded with a striking reduction in the time to disease recurrence. These studies demonstrate that a previously uncharacterized ILC population regulates the activity and expansion of tumor-associated T cells.	[Crome, Sarah Q.; Nguyen, Linh T.; Yang, S. Y. Cindy; Martin, Bernard; Yam, Jennifer Y.; Johnson, Dylan J.; Nie, Jessica; Pniak, Michael; Yen, Pei Hua; Milea, Anca; Sowamber, Ramlogan; Shaw, Patricia A.; Lang, Philipp A.; Berman, Hal K.; Ohashi, Pamela S.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lopez-Verges, Sandra; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lopez-Verges, Sandra; Lanier, Lewis L.] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA; [Lopez-Verges, Sandra] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Yang, S. Y. Cindy; Johnson, Dylan J.; Pugh, Trevor J.; Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Yang, S. Y. Cindy; Johnson, Dylan J.; Pugh, Trevor J.; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Katz, Sarah Rachel; Bernardini, Marcus Q.] Univ Hlth Network, Div Gynecol Oncol, Toronto, ON, Canada; [Clarke, Blaise A.; Shaw, Patricia A.; Berman, Hal K.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lang, Philipp A.] Heinrich Heine Univ, Fac Med, Dept Mol Med 2, Dusseldorf, Germany	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Instituto Conmemorativo Gorgas de Estudios de la Salud; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Heinrich Heine University Dusseldorf	Ohashi, PS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	pohashi@uhnresearch.ca	Crome, Sarah/GXV-8138-2022; Lanier, Lewis L/E-2139-2014; Pugh, Trevor/Y-2535-2019	Crome, Sarah/0000-0001-5117-7453; Lanier, Lewis L/0000-0003-1308-3952; Pugh, Trevor/0000-0002-8073-5888; Clarke, Blaise/0000-0002-2585-8391; Ohashi, Pamela S./0000-0003-2915-9317	Knudson postdoctoral fellowship; Cancer Research Institute/Irvington Institute; Sistema Nacional de Investigacion (SNI) de SENACYT, Panama; Princess Margaret Cancer Foundation; Canada Foundation for Innovation; Leaders Opportunity Fund [CFI 32383]; Ontario Ministry of Research and Innovation, Ontario Research Fund Small Infrastructure Program; Alexander von Humboldt Foundation [SKA2010]; German Research Council [LA2558/3-1, LA2558/5-1, SFB974, RTG1949]; US National Institutes of Health [AI066897, AI068129]; Parker Institute for Cancer Immunotherapy; Canada Research Chair in Autoimmunity and Tumor Immunity; Canadian Institutes for Health Research [CCM 104887]; CIHR Foundation [FDN143220]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129, R37AI066897] Funding Source: NIH RePORTER	Knudson postdoctoral fellowship; Cancer Research Institute/Irvington Institute; Sistema Nacional de Investigacion (SNI) de SENACYT, Panama; Princess Margaret Cancer Foundation(University of Toronto); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Leaders Opportunity Fund; Ontario Ministry of Research and Innovation, Ontario Research Fund Small Infrastructure Program; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Council(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Canada Research Chair in Autoimmunity and Tumor Immunity; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the donors for participating in this study and C. Tran and C. Garcia-Batres for helpful comments. We thank the Princess Margaret Genomics Centre (Toronto, Canada) for performing RNA sequencing. We thank M. Pintiles for her advice regarding statistical analysis of results. S.Q.C. is a Banting Fellow and was supported by a Knudson postdoctoral fellowship. S.L.-V. was supported by a Cancer Research Institute/Irvington Institute postdoctoral fellowship and is now part of Sistema Nacional de Investigacion (SNI) de SENACYT, Panama. T.J.P. is supported by the Princess Margaret Cancer Foundation, the Canada Foundation for Innovation, the Leaders Opportunity Fund (CFI 32383), and the Ontario Ministry of Research and Innovation, Ontario Research Fund Small Infrastructure Program. P.A.L. is supported by the Alexander von Humboldt Foundation (SKA2010) and the German Research Council (LA2558/3-1, LA2558/5-1, SFB974, RTG1949). L.L.L. is an American Cancer Society Professor funded by US National Institutes of Health grants AI066897 and AI068129 and the Parker Institute for Cancer Immunotherapy. P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity. Canadian Institutes for Health Research grant CCM 104887 and CIHR Foundation award FDN143220 to P.S.O. supported this work.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Beilke JN, 2005, NAT MED, V11, P1059, DOI 10.1038/nm1296; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; CHE SL, 1994, NAT IMMUN, V13, P258; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013940; Noone CM, 2008, J VIROL, V82, P9299, DOI 10.1128/JVI.00717-08; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Rivas MN, 2010, J IMMUNOL, V184, P6790, DOI 10.4049/jimmunol.0902598; Roy S, 2008, J IMMUNOL, V180, P1729, DOI 10.4049/jimmunol.180.3.1729; Rydyznski CE, 2015, TRENDS IMMUNOL, V36, P536, DOI 10.1016/j.it.2015.07.004; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; Tai LH, 2008, J EXP MED, V205, P3187, DOI 10.1084/jem.20080718; TAKEDA K, 1993, J EXP MED, V177, P155, DOI 10.1084/jem.177.1.155; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Villanueva J, 2005, ARTHRITIS RES THER, V7, pR30, DOI 10.1186/ar1453; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Zhou RB, 2007, J IMMUNOL, V178, P2141, DOI 10.4049/jimmunol.178.4.2141	41	104	106	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					368	375		10.1038/nm.4278	http://dx.doi.org/10.1038/nm.4278			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28165478	Green Published, Green Accepted			2022-12-27	WOS:000395848400018
J	Palucka, K; Banchereau, J				Palucka, Karolina; Banchereau, Jacques			Diversity and collaboration for effective immunotherapy	NATURE MEDICINE			English	Editorial Material							DENDRITIC CELLS; THERAPY		[Palucka, Karolina; Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT 06032 USA	Jackson Laboratory	Palucka, K (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.	Karolina.palucka@jax.org						Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Moynihan KD, 2016, NAT MED, V22, P1402, DOI 10.1038/nm.4200; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Palucka K, 2014, CELL, V157, P516, DOI 10.1016/j.cell.2014.03.044; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Stromnes IM, 2015, CANCER CELL, V28, P638, DOI 10.1016/j.ccell.2015.09.022; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]	10	9	9	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1390	1391		10.1038/nm.4249	http://dx.doi.org/10.1038/nm.4249			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923023				2022-12-27	WOS:000389549000015
J	Horiuchi, D; Camarda, R; Zhou, AY; Yau, C; Momcilovic, O; Balakrishnan, S; Corella, AN; Eyob, H; Kessenbrock, K; Lawson, DA; Marsh, LA; Anderton, BN; Rohrberg, J; Kunder, R; Bazarov, AV; Yaswen, P; McManus, MT; Rugo, HS; Werb, Z; Goga, A				Horiuchi, Dai; Camarda, Roman; Zhou, Alicia Y.; Yau, Christina; Momcilovic, Olga; Balakrishnan, Sanjeev; Corella, Alexandra N.; Eyob, Henok; Kessenbrock, Kai; Lawson, Devon A.; Marsh, Lindsey A.; Anderton, Brittany N.; Rohrberg, Julia; Kunder, Ratika; Bazarov, Alexey V.; Yaswen, Paul; McManus, Michael T.; Rugo, Hope S.; Werb, Zena; Goga, Andrei			PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression	NATURE MEDICINE			English	Article							C-MYC; DEPENDENT PHOSPHORYLATION; CANCER; GROWTH; ACTIVATION; P27(KIP1); PHOSPHATASE; BINDING; CELLS; CYCLE	Triple-negative breast cancer (TNBC), in which cells lack expression of the estrogen receptor (ER), the progesterone receptor (PR) and the ERBB2 (also known as HER2) receptor, is the breast cancer subtype with the poorest outcomes. No targeted therapy is available against this subtype of cancer owing to a lack of validated molecular targets. We previously reported that signaling involving MYC-an essential, pleiotropic transcription factor that regulates the expression of hundreds of genes-is disproportionally higher in triple-negative (TN) tumors than in receptor-positive (RP) tumors(2). Direct inhibition of the oncogenic transcriptional activity of MYC has been challenging to achieve(3). Here, by conducting a shRNA screen targeting the kinome, we identified PIM1, a non-essential serine-threonine kinase, in a synthetic lethal interaction with MYC. PIM1 expression was higher in TN tumors than in RP tumors and was associated with poor prognosis in patients with hormone-and HER2-negative tumors. Small-molecule PIM kinase inhibitors halted the growth of human TN tumors with elevated MYC expression in patient-derived tumor xenograft (PDX) and MYC-driven transgenic mouse models of breast cancer by inhibiting the oncogenic transcriptional activity of MYC and restoring the function of the endogenous cell cycle inhibitor, p27. Our findings warrant clinical evaluation of PIM kinase inhibitors in patients with TN tumors that have elevated MYC expression.	[Horiuchi, Dai; Camarda, Roman; Zhou, Alicia Y.; Momcilovic, Olga; Balakrishnan, Sanjeev; Corella, Alexandra N.; Eyob, Henok; Anderton, Brittany N.; Rohrberg, Julia; Goga, Andrei] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Horiuchi, Dai; Werb, Zena; Goga, Andrei] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Horiuchi, Dai; Marsh, Lindsey A.; Kunder, Ratika] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Horiuchi, Dai; Marsh, Lindsey A.; Kunder, Ratika] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Yau, Christina] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Yau, Christina] Buck Inst Res Aging, Canc & Dev Therapeut Program, Novato, CA USA; [Kessenbrock, Kai; Lawson, Devon A.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Bazarov, Alexey V.; Yaswen, Paul] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Rugo, Hope S.; Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Zhou, Alicia Y.] Color Genom, Burlingame, CA USA; [Balakrishnan, Sanjeev] Dovetail Genom, Santa Cruz, CA USA; [Corella, Alexandra N.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Corella, Alexandra N.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Eyob, Henok] Boston Consulting Grp Inc, Summit, NJ USA; [Kessenbrock, Kai] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA; [Lawson, Devon A.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Anderton, Brittany N.] Univ Calif Davis, Biol Educ Res Grp, Davis, CA 95616 USA; [Bazarov, Alexey V.] Cypre Inc, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of California System; University of California San Francisco; Buck Institute for Research on Aging; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Boston Consulting Group (BCG); University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Davis	Horiuchi, D; Goga, A (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Horiuchi, D; Goga, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Horiuchi, D (corresponding author), Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA.; Horiuchi, D (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	dai.horiuchi@northwestern.edu; andrei.goga@ucsf.edu	mcmanus, michael/AAB-1239-2020; Kunder, Ratika/AFQ-3698-2022; Kessenbrock, Kai/B-6936-2011	mcmanus, michael/0000-0003-3013-6569; Corella, Alexandra/0000-0002-5435-0335; Rohrberg, Julia/0000-0001-6965-3905; Zhou, Alicia/0000-0003-0388-8909	US National Institutes of Health [K99CA175700, R00CA175700, 5T32DK007418, K99CA181490, ES019458, U01CA168370, P30DK63720, R01CA180039, R01CA170447]; Susan G. Komen Foundation [PDF15331114]; UCSF Program for Breakthrough Biomedical Research; California Breast Cancer Research Program [17lB-0024]; CDMRP Breast Cancer Research Program [W81XWH-12-1-0272, W81XWH-16-1-0603]; LLS Scholar Award; V-Foundation Award; Breast Cancer Research Foundation; Northwestern Medicine Catalyst Funds; NATIONAL CANCER INSTITUTE [R01CA180039, T32CA108462, R00CA175700, K22CA190511, R01CA170447, K99CA175700, U01CA168370, R00CA181490, K99CA181490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, T32DK007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); UCSF Program for Breakthrough Biomedical Research; California Breast Cancer Research Program; CDMRP Breast Cancer Research Program; LLS Scholar Award; V-Foundation Award; Breast Cancer Research Foundation; Northwestern Medicine Catalyst Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the US National Institutes of Health (K99CA175700 (D.H.), R00CA175700 (D.H.), 5T32DK007418 (R.C.), K99CA181490 (K.K.), ES019458 (P.Y. and Z.W.), U01CA168370 (M.T.M.), P30DK63720 (M.T.M.), R01CA180039 (Z.W.) and R01CA170447 (A.G.)), the Susan G. Komen Foundation (PDF15331114; J.R.), the UCSF Program for Breakthrough Biomedical Research (M.T.M.), an Innovative, Developmental, and Exploratory Award from the California Breast Cancer Research Program (17lB-0024; A.G.), an Era of Hope Scholar Award from the CDMRP Breast Cancer Research Program (W81XWH-12-1-0272 and W81XWH-16-1-0603; both to AG.), an LLS Scholar Award (A.G.), a V-Foundation Award (A.G.), the Breast Cancer Research Foundation (H.S.R. and A.G.) and the Northwestern Medicine Catalyst Funds (D.H.). The authors thank A. Welm for her guidance with the use of the patient derived orthotopic tumor xenograft models, J.W. Smyth for his assistance with the generation of the transgenic breast cancer cell lines, and D.B. Udy, C.L. Hueschen and A. Vasilopoulos for their assistance with microscopy. We thank S. Samson, C. Baas, H. Klein-Connolly and D. Roth for consumer advocacy support and feedback related to this project, and J.M. Bishop for his insights into the project and his mentorship to D.H.	Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bazarov AV, 2009, CELL CYCLE, V8, P3373, DOI 10.4161/cc.8.20.9856; Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198; Burger MT, 2015, J MED CHEM, V58, P8373, DOI 10.1021/acs.jmedchem.5b01275; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kirschner AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju407; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Mohanty AR, 2012, J BIOL CHEM, V287, P21757, DOI 10.1074/jbc.M112.346254; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Mukhopadhyay R, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2477; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Sato M, 2015, ONCOTARGET, V6, P3292, DOI 10.18632/oncotarget.3203; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang J, 2012, ONCOGENE, V31, P1794, DOI 10.1038/onc.2011.371; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388	38	106	112	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1321	1329		10.1038/nm.4213	http://dx.doi.org/10.1038/nm.4213			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27775705	Green Accepted			2022-12-27	WOS:000387302300025
J	Wang, WZ; Wang, LW; Lu, JJ; Siedlak, SL; Fujioka, H; Liang, JJ; Jiang, SR; Ma, XP; Jiang, Z; da Rocha, EL; Sheng, M; Choi, H; Lerou, PH; Li, H; Wang, XL				Wang, Wenzhang; Wang, Luwen; Lu, Junjie; Siedlak, Sandra L.; Fujioka, Hisashi; Liang, Jingjing; Jiang, Sirui; Ma, Xiaopin; Jiang, Zhen; da Rocha, Edroaldo Lummertz; Sheng, Max; Choi, Heewon; Lerou, Paul H.; Li, Hu; Wang, Xinglong			The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; SPLICING REGULATION; PROTEIN-PROTEIN; TRANSGENIC MICE; MOTOR-NEURONS; RNA TARGETS; MUTATIONS; DEMENTIA	Genetic mutations in TAR DNA-binding protein 43 (TARDBP, also known as TDP-43) cause amyotrophic lateral sclerosis (ALS), and an increase in the presence of TDP-43 (encoded by TARDBP) in the cytoplasm is a prominent histopathological feature of degenerating neurons in various neurodegenerative diseases. However, the molecular mechanisms by which TDP-43 contributes to ALS pathophysiology remain elusive. Here we have found that TDP-43 accumulates in the mitochondria of neurons in subjects with ALS or frontotemporal dementia (FTD). Disease-associated mutations increase TDP-43 mitochondrial localization. In mitochondria, wild-type (WT) and mutant TDP-43 preferentially bind mitochondria-transcribed messenger RNAs (mRNAs) encoding respiratory complex I subunits ND3 and ND6, impair their expression and specifically cause complex I disassembly. The suppression of TDP-43 mitochondrial localization abolishes WT and mutant TDP-43-induced mitochondrial dysfunction and neuronal loss, and improves phenotypes of transgenic mutant TDP-43 mice. Thus, our studies link TDP-43 toxicity directly to mitochondrial bioenergetics and propose the targeting of TDP-43 mitochondrial localization as a promising therapeutic approach for neurodegeneration.	[Wang, Wenzhang; Wang, Luwen; Siedlak, Sandra L.; Jiang, Sirui; Ma, Xiaopin; Jiang, Zhen; Sheng, Max; Choi, Heewon; Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Lu, Junjie] Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Electron Microscopy Core Facil, Cleveland, OH 44106 USA; [Liang, Jingjing] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [da Rocha, Edroaldo Lummertz; Li, Hu] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Lerou, Paul H.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA	Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Case Western Reserve University; Mayo Clinic; Harvard University; Massachusetts General Hospital	Wang, XL (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xinglong.wang@case.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Lu, Junjie/A-6611-2009	Lu, Junjie/0000-0002-4175-1762; Jiang, Sirui/0000-0003-1515-7433; Wang, Wenzhang/0000-0003-4426-019X; , luwen/0000-0001-7629-412X; Lummertz da Rocha, Edroaldo/0000-0003-0537-4223	US National Institutes of Health [R03AG044680, 1R01NS089604]; US Alzheimer's Association [2014-NIRG-301299]; University Hospitals of Cleveland, USA (SPITZ Innovation Pilot Grant); Eunice Kennedy Shriver National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland, USA [HHSN275200900011C, N01-HD-9-0011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085747, T32NS077888, R01NS089604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG044680] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Alzheimer's Association(Alzheimer's Association); University Hospitals of Cleveland, USA (SPITZ Innovation Pilot Grant); Eunice Kennedy Shriver National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland, USA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is supported by grants from the US National Institutes of Health (R03AG044680 and 1R01NS089604 to X.W.), the US Alzheimer's Association (2014-NIRG-301299 to X.W.) and the University Hospitals of Cleveland, USA (2012 SPITZ Innovation Pilot Grant to X.W.). Human spinal cord frozen tissues were obtained from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland, USA, contract HHSN275200900011C, ref. no. N01-HD-9-0011. We also thank G. Perry and X. Zhu for providing paraffin-embedded human spinal cord tissues.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Austin JA, 2014, P NATL ACAD SCI USA, V111, P4309, DOI 10.1073/pnas.1317317111; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Brandmeir NJ, 2008, ACTA NEUROPATHOL, V115, P123, DOI 10.1007/s00401-007-0315-5; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Chanson JB, 2010, NEURODEGENER DIS, V7, P260, DOI 10.1159/000273591; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Dang TNT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00015; Dang TNT, 2013, DIS MODEL MECH, V6, P1198, DOI 10.1242/dmm.011460; Davidson Y, 2009, ACTA NEUROPATHOL, V118, P359, DOI 10.1007/s00401-009-0526-z; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujioka H, 2012, ANAT REC, V295, P1455, DOI 10.1002/ar.22523; Fujioka H, 2011, ANAT REC, V294, P1825, DOI 10.1002/ar.21486; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Hansson Petersen C. A., 2008, P NATL ACAD SCI USA, V105, P13145, DOI DOI 10.1073/PNAS.0806192105; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hatzipetros T, 2014, BRAIN RES, V1584, P59, DOI 10.1016/j.brainres.2013.10.013; Herdewyn S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-24; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lu JJ, 2014, CELL REP, V7, P70, DOI 10.1016/j.celrep.2014.03.007; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Narayanan RK, 2013, AMYOTROPH LAT SCL FR, V14, P252, DOI 10.3109/21678421.2012.734520; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7019; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	61	198	200	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					869	+		10.1038/nm.4130	http://dx.doi.org/10.1038/nm.4130			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27348499	Green Accepted			2022-12-27	WOS:000381000200012
J	He, ZH; Guo, JL; McBride, JD; Narasimhan, S; Kim, H; Changolkar, L; Zhang, B; Gathagan, RJ; Yue, CY; Dengler, C; Stieber, A; Nitla, M; Coulter, DA; Abel, T; Brunden, KR; Trojanowski, JQ; Lee, VMY				He, Zhuohao; Guo, Jing L.; McBride, Jennifer D.; Narasimhan, Sneha; Kim, Hyesung; Changolkar, Lakshmi; Zhang, Bin; Gathagan, Ronald J.; Yue, Cuiyong; Dengler, Christopher; Stieber, Anna; Nitla, Magdalena; Coulter, Douglas A.; Abel, Ted; Brunden, Kurt R.; Trojanowski, John Q.; Lee, Virginia M-Y			Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation	NATURE MEDICINE			English	Article							A-BETA; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; MOUSE MODEL; DISEASE; DEPOSITION; TAUOPATHY; APP; AGE; TRANSMISSION	Alzheimer's disease (AD) is characterized by extracellular amyloid-beta (A beta) plaques and intracellular tau inclusions. However, the exact mechanistic link between these two AD lesions remains enigmatic. Through injection of human AD-brain-derived pathological tau (AD-tau) into A beta plaque-bearing mouse models that do not overexpress tau, we recapitulated the formation of three major types of AD-relevant tau pathologies: tau aggregates in dystrophic neurites surrounding A beta plaques (NP tau), AD-like neurofibrillary tangles (NFTs) and neuropil threads (NTs). These distinct tau pathologies have different temporal onsets and functional consequences on neural activity and behavior. Notably, we found that A beta plaques created a unique environment that facilitated the rapid amplification of proteopathic AD-tau seeds into large tau aggregates, initially appearing as NP tau, which was followed by the formation and spread of NFTs and NTs, likely through secondary seeding events. Our study provides insights into a new multistep mechanism underlying A beta plaque-associated tau pathogenesis.	[He, Zhuohao; Guo, Jing L.; McBride, Jennifer D.; Narasimhan, Sneha; Kim, Hyesung; Changolkar, Lakshmi; Zhang, Bin; Gathagan, Ronald J.; Stieber, Anna; Nitla, Magdalena; Brunden, Kurt R.; Trojanowski, John Q.; Lee, Virginia M-Y] Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [He, Zhuohao; Guo, Jing L.; McBride, Jennifer D.; Narasimhan, Sneha; Kim, Hyesung; Changolkar, Lakshmi; Zhang, Bin; Gathagan, Ronald J.; Stieber, Anna; Nitla, Magdalena; Brunden, Kurt R.; Trojanowski, John Q.; Lee, Virginia M-Y] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Yue, Cuiyong; Dengler, Christopher; Coulter, Douglas A.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Abel, Ted] Univ Iowa, Iowa Neurosci Inst, Carver Coll Med, Iowa City, IA USA; [Abel, Ted] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Iowa; University of Iowa	Lee, VMY (corresponding author), Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Lee, VMY (corresponding author), Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.	vmylee@upenn.edu	Abel, Ted/AAX-2825-2021; He, Zhuohao/A-2154-2017	Abel, Ted/0000-0003-2423-4592; He, Zhuohao/0000-0003-1505-8750; Coulter, Douglas/0000-0002-1486-119X; Gathagan, Ronald/0000-0002-8626-9785	National Institute on Aging (NIA) [AG10124, AG17586, AG017628]; CurePSP; Woods Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG017586] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CurePSP; Woods Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Kim, B. Zoll, H. Brown, F. Bassil, J. Robinson, T. Schuck and M. Byrne for technical assistance. We thank W. O'Brien and the Penn Neurobehavioral Testing Core for help with behavior tests, S. Xie for help with statistical analyses and E. Lee for helpful comments. We thank N. Kanaan (Michigan State University) for providing TOC1 antibody, which was generated and initially provided by L. Binder (deceased), P. Davies (Hofstra Northwell School of Medicine) for contributing PHF1, MC1 and TG3 antibodies, and M. Goedert (University of Cambridge) for contributing pS422 antibody. T. Saido (RIKEN Brain Science Institute) is thanked for providing APP-KI mice. This work was funded by National Institute on Aging (NIA) AG10124 (J.Q.T.), AG17586 (V.M.-Y.L.), AG017628 (T.A.), CurePSP (J.Q.T.) and the Woods Foundation (V.M.-Y.L.).	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bennett RE, 2017, AM J PATHOL, V187, P1601, DOI 10.1016/j.ajpath.2017.03.011; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Lee EB, 2003, J BIOL CHEM, V278, P4458, DOI 10.1074/jbc.M210105200; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Montine TJ, 2016, ALZHEIMERS DEMENT, V12, P164, DOI 10.1016/j.jalz.2015.07.492; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Schwarz AJ, 2016, BRAIN, V139, P1539, DOI 10.1093/brain/aww023; Sepulcre J, 2016, J NEUROSCI, V36, P7364, DOI 10.1523/JNEUROSCI.0639-16.2016; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003	39	287	289	8	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					29	+		10.1038/nm.4443	http://dx.doi.org/10.1038/nm.4443			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29200205	Green Accepted			2022-12-27	WOS:000422965900008
J	Malherbe, ST; Shenai, S; Ronacher, K; Loxton, AG; Dolganov, G; Kriel, M; Van, T; Chen, RY; Warwick, J; Via, LE; Song, T; Lee, M; Schoolnik, G; Tromp, G; Alland, D; Barry, CE; Winter, J; Walzl, G				Malherbe, Stephanus T.; Shenai, Shubhada; Ronacher, Katharina; Loxton, Andre G.; Dolganov, Gregory; Kriel, Magdalena; Tran Van; Chen, Ray Y.; Warwick, James; Via, Laura E.; Song, Taeksun; Lee, Myungsun; Schoolnik, Gary; Tromp, Gerard; Alland, David; Barry, Clifton E., III; Winter, Jill; Walzl, Gerhard		Catalysis TB-Biomarker Consortium	Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure (vol 22, pg 1094, 2016)	NATURE MEDICINE			English	Correction													Barry, Clifton E/ABE-7992-2020; Chen, Ray/GRJ-6736-2022; Via, Laura/AAD-3917-2021; Tromp, Gerard/B-2677-2017; Ronacher, Katharina/N-9603-2016	Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521; Tromp, Gerard/0000-0002-7761-0806; Loxton, Andre/0000-0003-0659-9803; Ronacher, Katharina/0000-0002-6371-1462; Warwick, James/0000-0002-2810-0543	Intramural NIH HHS [ZIA AI001214-01] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177	1	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1499	1499		10.1038/nm1217-1499a	http://dx.doi.org/10.1038/nm1217-1499a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216039	Green Accepted, Bronze			2022-12-27	WOS:000417278200009
J	Giles, DA; Moreno-Fernandez, ME; Stankiewicz, TE; Graspeuntner, S; Cappelletti, M; Wu, D; Mukherjee, R; Chan, CC; Lawson, MJ; Klarquist, J; Snderhauf, A; Softic, S; Kahn, CR; Stemmer, K; Iwakura, Y; Aronow, BJ; Karns, R; Steinbrecher, KA; Karp, CL; Sheridan, R; Shanmukhappa, SK; Reynaud, D; Haslam, DB; Sina, C; Rupp, J; Hogan, SP; Divanovic, S				Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Graspeuntner, Simon; Cappelletti, Monica; Wu, David; Mukherjee, Rajib; Chan, Calvin C.; Lawson, Matthew J.; Klarquist, Jared; Snderhauf, Annika; Softic, Samir; Kahn, C. Ronald; Stemmer, Kerstin; Iwakura, Yoichiro; Aronow, Bruce J.; Karns, Rebekah; Steinbrecher, Kris A.; Karp, Christopher L.; Sheridan, Rachel; Shanmukhappa, Shiva K.; Reynaud, Damien; Haslam, David B.; Sina, Christian; Rupp, Jan; Hogan, Simon P.; Divanovic, Senad			Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling (vol 23, pg 829, 2017)	NATURE MEDICINE			English	Correction													Kahn, Ronald/AAY-2435-2021; Softic, Samir/ABD-4612-2020; Chan, Calvin/S-4496-2017	Kahn, Ronald/0000-0002-7583-9228; Chan, Calvin/0000-0002-9933-3061; Rupp, Jan/0000-0001-8722-1233	NIDDK NIH HHS [P30 DK036836] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033201, P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Giles DA, 2017, NAT MED, V23, P829, DOI 10.1038/nm.4346	1	4	4	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1241	1241		10.1038/nm1017-1241c	http://dx.doi.org/10.1038/nm1017-1241c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985207				2022-12-27	WOS:000412431800022
J	Firestone, AJ; Settleman, J				Firestone, Ari J.; Settleman, Jeff			A three-drug combination to treat BRAF-mutant cancers	NATURE MEDICINE			English	Editorial Material							VEMURAFENIB; MELANOMA		[Firestone, Ari J.; Settleman, Jeff] Calico Life Sci, San Francisco, CA 62335 USA		Firestone, AJ (corresponding author), Calico Life Sci, San Francisco, CA 62335 USA.	settleman@calicolabs.com						Bock C., 2012, NAT REV CANCER, V12, P191; Brioli A, 2014, BRIT J HAEMATOL, V165, P441, DOI 10.1111/bjh.12805; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Holderfield M, 2014, BRIT J CANCER, V111, P640, DOI 10.1038/bjc.2014.139; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Loug G. V., 2014, ENGL J MED, V371, P1877; Pratilas C. A., 2010, CURR TOP MICROBIOL I, V355, P83; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Skonlidis F., 2017, CLIN CANCER RES, V23, P618; Xue YH, 2017, NAT MED, V23, P929, DOI 10.1038/nm.4369	10	5	5	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					913	914		10.1038/nm.4382	http://dx.doi.org/10.1038/nm.4382			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28777790				2022-12-27	WOS:000406947600005
J	Nus, M; Sage, AP; Lu, YN; Masters, L; Lam, BYH; Newland, S; Weller, S; Tsiantoulas, D; Raffort, J; Marcus, D; Finigan, A; Kitt, L; Figg, N; Schirmbeck, R; Kneilling, M; Yeo, GSH; Binder, CJ; de la Pompa, JL; Mallat, Z				Nus, Meritxell; Sage, Andrew P.; Lu, Yuning; Masters, Leanne; Lam, Brian Y. H.; Newland, Stephen; Weller, Sandra; Tsiantoulas, Dimitrios; Raffort, Juliette; Marcus, Damienne; Finigan, Alison; Kitt, Lauren; Figg, Nichola; Schirmbeck, Reinhold; Kneilling, Manfred; Yeo, Giles S. H.; Binder, Christoph J.; Luis de la Pompa, Jose; Mallat, Ziad			Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet	NATURE MEDICINE			English	Article							OXIDATION-SPECIFIC EPITOPES; ATHEROSCLEROSIS; MICE; DIFFERENTIATION; ATF3; MIGRATION; IMMUNITY; IDENTIFICATION; ACCUMULATION; REGULATORS	Splenic marginal zone B (MZB) cells, positioned at the interface between circulating blood and lymphoid tissue, detect and respond to blood-borne antigens. Here we show that MZB cells in mice activate a homeostatic program in response to a high-cholesterol diet (HCD) and regulate both the differentiation and accumulation of T follicular helper (T-FH) cells. Feeding mice an HCD resulted in upregulated MZB cell surface expression of the immunoregulatory ligand PDL1 in an ATF3-dependent manner and increased the interaction between MZB cells and pre-T-FH cells, leading to PDL1-mediated suppression of TFH cell motility, alteration of T-FH cell differentiation, reduced T-FH abundance and suppression of the proatherogenic T-FH response. Our findings reveal a previously unsuspected role for MZB cells in controlling the T-FH-germinal center response to a cholesterol-rich diet and uncover a PDL1-dependent mechanism through which MZB cells use their innate immune properties to limit an exaggerated adaptive immune response.	[Nus, Meritxell; Sage, Andrew P.; Lu, Yuning; Masters, Leanne; Newland, Stephen; Raffort, Juliette; Marcus, Damienne; Finigan, Alison; Kitt, Lauren; Figg, Nichola; Mallat, Ziad] Univ Cambridge, Div Cardiovasc Med, Cambridge, England; [Lam, Brian Y. H.; Yeo, Giles S. H.] Univ Cambridge, Metab Res Labs, Cambridge, England; [Lam, Brian Y. H.; Yeo, Giles S. H.] Wellcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Cambridge, England; [Weller, Sandra] Univ Paris 05, CNRS UMR 8253, INSERM U1151, Sorbonne Paris Cite,Inst Necker Enfants Malad, Paris, France; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med CeMM, Vienna, Austria; [Schirmbeck, Reinhold] Ulm Univ Hosp, Dept Internal Med 1, Ulm, Germany; [Kneilling, Manfred] Eberhard Karls Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany; [Kneilling, Manfred] Eberhard Karls Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Luis de la Pompa, Jose] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Intercellular Signalling Cardiovasc Dev & Dis Lab, Madrid, Spain; [Luis de la Pompa, Jose] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain; [Mallat, Ziad] INSERM, Unit 970, Paris Cardiovasc Res Ctr, Paris, France	University of Cambridge; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Ulm University; Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mallat, Z (corresponding author), Univ Cambridge, Div Cardiovasc Med, Cambridge, England.; Mallat, Z (corresponding author), INSERM, Unit 970, Paris Cardiovasc Res Ctr, Paris, France.	zm255@medchl.cam.ac.uk	Tsiantoulas, Dimitrios/AAK-9521-2021; Lam, Brian YH/AAH-5749-2021; Nus Chimeno, Meritxell/AGZ-0460-2022; De La Pompa, José Luis/F-9719-2014; Weller, Sandra/N-1947-2018; Mallat, Ziad/D-4041-2012	Tsiantoulas, Dimitrios/0000-0002-7743-3192; Lam, Brian YH/0000-0002-3638-9025; De La Pompa, José Luis/0000-0001-6761-7265; Weller, Sandra/0000-0003-4725-2793; Mallat, Ziad/0000-0003-0443-7878; Sage, Andrew/0000-0001-7255-3497; Nus Chimeno, Meritxell Edurne/0000-0002-6378-8910; Binder, Christoph J./0000-0001-8313-7050; Yeo, Giles See How/0000-0001-8823-3615	BHF [PG/15/76/31756, PG/13/73/30466]; ERC [2891164]; EC FP7 VIA [HEALTH-F4-2013-603131]; Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2013-45543-R]; Instituto Nacional de Salud Carlos III (Spain) [CD09/00452]; BHF; European Union under REA [608765]; Wellcome Trust; British Heart Foundation [FS/15/57/31557] Funding Source: researchfish	BHF(British Heart Foundation); ERC(European Research Council (ERC)European Commission); EC FP7 VIA; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Instituto Nacional de Salud Carlos III (Spain); BHF(British Heart Foundation); European Union under REA; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	We acknowledge A. Petrunkina, E. Perez, C. Bowman, S. McCallum, J. Markovic Djuric and N. Savinykh in the Phenotyping Hub of the Department of Medicine (University of Cambridge) for their help in flow cytometry and sorting and M. Ozsvar Kozma (Medical University of Vienna) for help in antibody measurements. We also acknowledge M. Ma for support during library preparation for RNA-seq. This work was supported by BHF grant no. PG/15/76/31756, BHF grant no. PG/13/73/30466, ERC grant no. 2891164 and EC FP7 VIA grant no. HEALTH-F4-2013-603131 to Z.M. and by SAF2013-45543-R from the Spanish Ministry of Economy and Competitiveness (MINECO) to J.L.d.l.P.M.N. was first supported by a Sara Borrell grant (CD09/00452) from the Instituto Nacional de Salud Carlos III (Spain) and then by a 2-year BHF Project Grant. M.N. has also received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no. 608765. We acknowledge measurements of lipids in blood by K. Burling. The Wellcome Trust supported the Cambridge Mouse Biochemistry Laboratory.	Ait-Oufella H, 2014, CIRC RES, V114, P1640, DOI 10.1161/CIRCRESAHA.114.302761; Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Candando KM, 2014, IMMUNOL REV, V259, P259, DOI 10.1111/imr.12176; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Clement M, 2015, CIRCULATION, V131, P560, DOI 10.1161/CIRCULATIONAHA.114.010988; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Grasset EK, 2015, P NATL ACAD SCI USA, V112, pE2030, DOI 10.1073/pnas.1421227112; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Herieka M, 2014, MOL NUTR FOOD RES, V58, P136, DOI 10.1002/mnfr.201300104; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kyaw T, 2012, TRENDS CARDIOVAS MED, V22, P48, DOI 10.1016/j.tcm.2012.06.011; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Sage AP, 2015, ARTERIOSCL THROM VAS, V35, P1770, DOI 10.1161/ATVBAHA.115.305568; Sage AP, 2014, ANN MED, V46, P297, DOI 10.3109/07853890.2014.900272; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Soh SY, 2016, J IMMUNOL, V197, P3894, DOI 10.4049/jimmunol.1500999; Strom AC, 2015, THROMB HAEMOSTASIS, V114, P835, DOI 10.1160/TH14-12-1084; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tsiantoulas D, 2015, ARTERIOSCL THROM VAS, V35, P296, DOI 10.1161/ATVBAHA.114.303569; Dang VD, 2014, CURR OPIN IMMUNOL, V28, P77, DOI 10.1016/j.coi.2014.02.009; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	56	79	79	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					601	+		10.1038/nm.4315	http://dx.doi.org/10.1038/nm.4315			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28414328	Green Submitted			2022-12-27	WOS:000400650700015
J	Bruno, PM; Liu, YP; Park, GY; Murai, J; Koch, CE; Eisen, TJ; Pritchard, JR; Pommier, Y; Lippard, SJ; Hemann, MT				Bruno, Peter M.; Liu, Yunpeng; Park, Ga Young; Murai, Junko; Koch, Catherine E.; Eisen, Timothy J.; Pritchard, Justin R.; Pommier, Yves; Lippard, Stephen J.; Hemann, Michael T.			A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress	NATURE MEDICINE			English	Article							ANTICANCER DRUG SCREEN; BREAST-CANCER; PHASE-II; COLON-CANCER; EXPRESSION PROFILE; LUNG-CANCER; OXALIPLATIN; COMBINATION; MECHANISMS; RESISTANT	Cisplatin and its platinum analogs, carboplatin and oxaliplatin, are some of the most widely used cancer chemotherapeutics. Although cisplatin and carboplatin are used primarily in germ cell, breast and lung malignancies, oxaliplatin is instead used almost exclusively to treat colorectal and other gastrointestinal cancers. Here we utilize a unique, multi-platform genetic approach to study the mechanism of action of these clinically established platinum anti-cancer agents, as well as more recently developed cisplatin analogs. We show that oxaliplatin, unlike cisplatin and carboplatin, does not kill cells through the DNA-damage response. Rather, oxaliplatin kills cells by inducing ribosome biogenesis stress. This difference in drug mechanism explains the distinct clinical implementation of oxaliplatin relative to cisplatin, and it might enable mechanistically informed selection of distinct platinum drugs for distinct malignancies. These data highlight the functional diversity of core components of front-line cancer therapy and the potential benefits of applying a mechanism-based rationale to the use of our current arsenal of anti-cancer drugs.	[Bruno, Peter M.; Liu, Yunpeng; Koch, Catherine E.; Pritchard, Justin R.; Lippard, Stephen J.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bruno, Peter M.; Liu, Yunpeng; Koch, Catherine E.; Eisen, Timothy J.; Pritchard, Justin R.; Hemann, Michael T.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Park, Ga Young; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Murai, Junko; Pommier, Yves] NIH, Dev Therapeut Branch, Bldg 10, Bethesda, MD 20892 USA; [Murai, Junko; Pommier, Yves] NIH, Mol Pharmacol Lab, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Eisen, Timothy J.] Whitehead Inst Biomed Res, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lippard, SJ; Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Hemann, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lippard, SJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lippard@mit.edu; hemann@mit.edu	Pritchard, Justin/AAI-2475-2021; Murai, Junko/AAU-9516-2021	Pritchard, Justin/0000-0001-7749-4473; /0000-0003-3383-0118	Koch Institute Frontier Research Program through Michael and Inara Erdei Fund; Kathy and Curt Marble Cancer Research Fund; Koch Institute from National Cancer Institute [P30-CA14051]; National Cancer Institute [CA034992]; Integrative Cancer Biology Program [U54-CA112967-09]; Center of Cancer Research; Intramural Program of the National Cancer Institute, NIH [Z01 BC006150-19]; National Institute of General Medical Sciences [T32GM007753]; Misrock Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051, Z01BC006150, R37CA034992, ZIABC006150, R01CA034992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER	Koch Institute Frontier Research Program through Michael and Inara Erdei Fund; Kathy and Curt Marble Cancer Research Fund; Koch Institute from National Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Integrative Cancer Biology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center of Cancer Research; Intramural Program of the National Cancer Institute, NIH; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Misrock Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Koch Institute Frontier Research Program through the Michael (1957) and Inara Erdei Fund and the Kathy and Curt Marble Cancer Research Fund, by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute, by National Cancer Institute Grant CA034992 (S.J.L.), by the Integrative Cancer Biology Program grant #U54-CA112967-09 and by the Center of Cancer Research, the Intramural Program of the National Cancer Institute, NIH (Z01 BC006150-19). M.T.H. is the Chang and Eisen Associate Professor of Biology, C.E.K. was supported by award Number T32GM007753 from the National Institute of General Medical Sciences and G.Y.P. was supported by a Misrock Postdoctoral Fellowship. The authors would also like to thank the Koch Institute Swanson Biotechnology Center for technical support, specifically G. Paradis of the Flow Cytometry Core Facility. We thank J. Wilson for providing platinum compounds ([Pt(tfbz)(NH<INF>3</INF>)<INF>2</INF>](NO<INF>3</INF>)) and [Pt(acac)(NH<INF>3</INF>)<INF>2</INF>] (SO<INF>4</INF>)<INF>0.5</INF>) and D. Bartel for advice and discussion regarding translation and ribosome translation experiments. The authors also thank G. Walker, A. Koehler, E. Bent, C. Braun, E. Kreidl and B. Zhao for comments and discussion on the paper and N. Fenouille, H. Criscione and F. Lam for technical assistance. The authors thank S. Takeda and M. Takata (Kyoto University, Japan) for providing us with the mutant DT40 cell lines used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	ALVAREZ M, 1995, J CLIN INVEST, V95, P2205, DOI 10.1172/JCI117910; Arango D, 2005, GASTROENTEROLOGY, V129, P874, DOI 10.1053/j.gastro.2005.06.066; Atmaca A, 2013, BRIT J CANCER, V108, P265, DOI 10.1038/bjc.2012.555; Awuah SG, 2015, J AM CHEM SOC, V137, P14854, DOI 10.1021/jacs.5b10182; Bandres E, 2007, ONCOL REP, V17, P1089; Barnes JC, 2016, J AM CHEM SOC, V138, P12494, DOI 10.1021/jacs.6b06321; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boodram JN, 2016, ANGEW CHEM INT EDIT, V55, P2845, DOI 10.1002/anie.201510443; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chu E., 2008, PHYS CANC CHEMOTHERA; Cressey PB, 2016, CHEMBIOCHEM, V17, P1713, DOI 10.1002/cbic.201600368; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Fojo T, 2005, CRIT REV ONCOL HEMAT, V53, P25, DOI 10.1016/j.critrevonc.2004.09.008; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Guerrero A, 2011, ANTI-CANCER DRUG, V22, P283, DOI 10.1097/CAD.0b013e3283425c55; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiang H, 2011, NAT CHEM BIOL, V7, P92, DOI 10.1038/NCHEMBIO.503; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim MK, 2012, MOL CANCER THER, V11, P1500, DOI 10.1158/1535-7163.MCT-11-0937; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Machover D, 1996, ANN ONCOL, V7, P95; Maede Y, 2014, MOL CANCER THER, V13, P214, DOI 10.1158/1535-7163.MCT-13-0551; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Njiaju UO, 2013, CANCER CHEMOTH PHARM, V71, P613, DOI 10.1007/s00280-012-2044-2; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Park GY, 2012, P NATL ACAD SCI USA, V109, P11987, DOI 10.1073/pnas.1207670109; Pritchard JR, 2013, MOL BIOSYST, V9, P1604, DOI 10.1039/c2mb25459j; Pritchard JR, 2013, P NATL ACAD SCI USA, V110, pE170, DOI 10.1073/pnas.1210419110; Raez LE, 2006, LUNG CANCER, V53, P347, DOI 10.1016/j.lungcan.2006.05.023; Raymond E, 1998, CLIN CANCER RES, V4, P1021; Raymond E, 1998, ANN ONCOL, V9, P1053, DOI 10.1023/A:1008213732429; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Samimi G, 2005, CANCER CHEMOTH PHARM, V55, P1, DOI 10.1007/s00280-004-0819-9; Scagliotti GV, 2005, CLIN CANCER RES, V11, P690; Shelley MD, 2002, CANCER TREAT REV, V28, P237, DOI 10.1016/S0305-7372(02)00059-2; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suntharalingam K, 2015, J AM CHEM SOC, V137, P2967, DOI 10.1021/ja511978y; Suntharalingam K, 2014, J AM CHEM SOC, V136, P14413, DOI 10.1021/ja508808v; Suntharalingam K, 2013, J AM CHEM SOC, V135, P14060, DOI 10.1021/ja4075375; Voss MH, 2014, CLIN CANCER RES, V20, P1955, DOI 10.1158/1078-0432.CCR-13-2345; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Yamasaki M, 2007, INT J ONCOL, V30, P129; Yardley DA, 2010, CANCER INVEST, V28, P865, DOI 10.3109/07357901003631031; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zhao BY, 2014, CANCER DISCOV, V4, P166, DOI 10.1158/2159-8290.CD-13-0465; Zheng YR, 2016, INORG CHIM ACTA, V452, P125, DOI 10.1016/j.ica.2016.03.021; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	67	261	263	10	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					461	+		10.1038/nm.4291	http://dx.doi.org/10.1038/nm.4291			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28263311	Green Submitted, Green Accepted			2022-12-27	WOS:000398768100014
J	Malherbe, ST; Shenai, S; Ronacher, K; Loxton, AG; Dolganov, G; Kriel, M; Van, T; Chen, RY; Warwick, J; Via, LE; Song, T; Lee, M; Schoolnik, G; Tromp, G; Alland, D; Barry, CE; Winter, J; Walzl, G; Du Plessis, N				Malherbe, Stephanus T.; Shenai, Shubhada; Ronacher, Katharina; Loxton, Andre G.; Dolganov, Gregory; Kriel, Magdalena; Van, Tran; Chen, Ray Y.; Warwick, James; Via, Laura E.; Song, Taeksun; Lee, Myungsun; Schoolnik, Gary; Tromp, Gerard; Alland, David; Barry, Clifton E., III; Winter, Jill; Walzl, Gerhard; Du Plessis, Nelita			Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure (vol 22, pg 1094, 2016)	NATURE MEDICINE			English	Correction													Tromp, Gerard/B-2677-2017; Chen, Ray/GRJ-6736-2022; Ronacher, Katharina/N-9603-2016; Barry, Clifton E/ABE-7992-2020; Via, Laura/AAD-3917-2021	Tromp, Gerard/0000-0002-7761-0806; Ronacher, Katharina/0000-0002-6371-1462; Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001214, ZIAAI001081] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177	1	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					526	526		10.1038/nm0417-526a	http://dx.doi.org/10.1038/nm0417-526a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388609	Bronze			2022-12-27	WOS:000398768100021
J	Reinwald, C; Schauer, C; Csepregi, JZ; Kienhofer, D; Weidner, D; Malissen, M; Mocsai, A; Schett, G; Herrmann, M; Hoffmann, M				Reinwald, Christiane; Schauer, Christine; Csepregi, Janka Zsofia; Kienhoefer, Deborah; Weidner, Daniela; Malissen, Marie; Mocsai, Attila; Schett, Georg; Herrmann, Martin; Hoffmann, Markus			Reply to "Neutrophils are not required for resolution of acute gouty arthritis in mice" (vol 22, pg 1384, 2016)	NATURE MEDICINE			English	Correction													herrmann, martin/AAT-9836-2020; Herrmann, Martin/A-9597-2013	Herrmann, Martin/0000-0002-0258-2484				REINWALD C, 2016, REPLY NEUTROPHILS AR, V22, P1384	1	2	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					526	526		10.1038/nm0417-526b	http://dx.doi.org/10.1038/nm0417-526b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388613	Bronze			2022-12-27	WOS:000398768100022
J	Vikram, A; Lewarchik, CM; Yoon, JY; Naqvi, A; Kumar, S; Morgan, GM; Jacobs, JS; Li, Q; Kim, YR; Kassan, M; Liu, J; Gabani, M; Kumar, A; Mehdi, H; Zhu, XD; Guan, XQ; Kutschke, W; Zhang, XM; Boudreau, RL; Dai, SC; Matasic, DS; Jung, SB; Margulies, KB; Kumar, V; Bachschmid, MM; London, B; Irani, K				Vikram, Ajit; Lewarchik, Christopher M.; Yoon, Jin-Young; Naqvi, Asma; Kumar, Santosh; Morgan, Gina M.; Jacobs, Julia S.; Li, Qiuxia; Kim, Young-Rae; Kassan, Modar; Liu, Jing; Gabani, Mohanad; Kumar, Ajay; Mehdi, Haider; Zhu, Xiaodong; Guan, Xiaoqun; Kutschke, William; Zhang, Xiaoming; Boudreau, Ryan L.; Dai, Shengchuan; Matasic, Daniel S.; Jung, Saet-Byel; Margulies, Kenneth B.; Kumar, Vikas; Bachschmid, Markus M.; London, Barry; Irani, Kaikobad			Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channel	NATURE MEDICINE			English	Article							BRUGADA-SYNDROME; DEPENDENT PHOSPHORYLATION; CONDUCTION; MUTATIONS; SCN5A; EXCITABILITY; TRAFFICKING; ARRHYTHMIA; ASSOCIATE; DISEASE	The voltage-gated cardiac Na+ channel (Na(v)1.5), encoded by the SCN5A gene, conducts the inward depolarizing cardiac Na+ current (/Na) and is vital for normal cardiac electrical activity. Inherited loss-of-function mutations in SCN5A lead to defects in the generation and conduction of the cardiac electrical impulse and are associated with various arrhythmia phenotypes(1). Here we show that sirtuin 1 deacetylase (Sirt1) deacetylates Na(v)1.5 at lysine 1479 (K1479) and stimulates /Na via lysine-deacetylation-mediated trafficking of Nav1.5 to the plasma membrane. Cardiac Sirt1 deficiency in mice induces hyperacetylation of K1479 in Na(v)1.5, decreases expression of Na(v)1.5 on the cardiomyocyte membrane, reduces /Na and leads to cardiac conduction abnormalities and premature death owing to arrhythmia. The arrhythmic phenotype of cardiac-Sirtl-deficient mice recapitulated human cardiac arrhythmias resulting from loss of function of Na(v)1.5. Increased Sirtl activity or expression results in decreased lysine acetylation of Na(v)1.5, which promotes the trafficking of Na(v)1.5 to the plasma membrane and stimulation of /Na. As compared to wild-type Na(v)1.5, Na(v)1.5 with K1479 mutated to a nonacetylatable residue increases peak /Na and is not regulated by Sirtl, whereas Na(v)1.5 with K1479 mutated to mimic acetylation decreases I. Na(v)1.5 is hyperacetylated on K1479 in the hearts of patients with cardiomyopathy and clinical conduction disease. Thus, Sirt1, by deacetylating Na(v)1.5, plays an essential part in the regulation of /Na and cardiac electrical activity.	[Vikram, Ajit; Yoon, Jin-Young; Kumar, Santosh; Morgan, Gina M.; Jacobs, Julia S.; Li, Qiuxia; Kim, Young-Rae; Kassan, Modar; Liu, Jing; Gabani, Mohanad; Mehdi, Haider; Zhu, Xiaodong; Guan, Xiaoqun; Kutschke, William; Zhang, Xiaoming; Boudreau, Ryan L.; Dai, Shengchuan; Matasic, Daniel S.; London, Barry; Irani, Kaikobad] Univ Iowa, Carver Coll Med, Abboud Cardiovasc Res Ctr, Div Cardiovasc Med,Dept Med, Iowa City, IA 52242 USA; [Lewarchik, Christopher M.; Naqvi, Asma; Kumar, Ajay] Univ Pittsburgh, Pittsburgh, PA USA; [Jung, Saet-Byel] Chungnam Natl Univ, Sch Med, Res Ctr Endocrine & Metab Dis, Daejeon, South Korea; [Margulies, Kenneth B.] Univ Penn, Dept Med, Perelman Sch Med, Div Cardiovasc, Philadelphia, PA 19104 USA; [Kumar, Vikas; Bachschmid, Markus M.] Boston Univ, Sch Med, Cardiovasc Prote Ctr, Vasc Biol Sect, Boston, MA 02118 USA; [Irani, Kaikobad] Univ Iowa, Pappajohn Biomed Inst, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Irani, Kaikobad] Univ Iowa, Heart & Vasc Ctr, Iowa City, IA 52242 USA	University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chungnam National University; University of Pennsylvania; Pennsylvania Medicine; Boston University; University of Iowa; University of Iowa	London, B; Irani, K (corresponding author), Univ Iowa, Carver Coll Med, Abboud Cardiovasc Res Ctr, Div Cardiovasc Med,Dept Med, Iowa City, IA 52242 USA.; Irani, K (corresponding author), Univ Iowa, Pappajohn Biomed Inst, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA.; Irani, K (corresponding author), Univ Iowa, Heart & Vasc Ctr, Iowa City, IA 52242 USA.	barry-london@uiowa.edu; kaikobad-irani@uiowa.edu	Kumar, Santosh/N-9922-2014; Vikram, Ajit/AFJ-7072-2022; zhang, xiaoming/A-7126-2018; Vikram, Ajit/AAF-4757-2022; Kassan, Modar/L-6433-2019	Kumar, Santosh/0000-0003-1418-2020; Vikram, Ajit/0000-0003-3724-3842; Vikram, Ajit/0000-0003-3724-3842; Kassan, Modar/0000-0002-9728-063X; London, Barry/0000-0003-1506-3947; Irani, Kaikobad/0000-0001-9194-7387; Bartleson, Gina/0000-0003-2579-1657; Bachschmid, Markus Michael/0000-0002-0748-5528; Matasic, Daniel/0000-0001-7010-6298; Li, Qiuxia/0000-0001-5835-0749; Yoon, Jin-Young/0000-0002-5707-3636	NIH [HL115955, HL105993, HL068758, HL104017, DK103750, HHSN268201000031, 1S10RR02543901, 1S10ODO019941]; University of Iowa Endowed Professorship; Cardiovascular Institutional Research Fellowship [T32 HL007121]; Training Program in Hematology: Molecular & Cell Biology of Blood Cells [T32 HL007344]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL104017, T32HL007344, T32HL007121, R01HL115955, P01HL068758, R01HL105993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Endowed Professorship; Cardiovascular Institutional Research Fellowship; Training Program in Hematology: Molecular & Cell Biology of Blood Cells; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant HL115955 to K.I. and B.L., and University of Iowa Endowed Professorship to K.I. M.K. was supported by a Cardiovascular Institutional Research Fellowship (T32 HL007121, PI: F. Abboud). Q.L. was supported by the Training Program in Hematology: Molecular & Cell Biology of Blood Cells (T32 HL007344, PI: S. Lentz). Procurement of human heart tissue was enabled by NIH grant HL105993 to K.B.M. Proteomics studies were supported by NIH grants HL068758 and HL104017 (PI: R.A. Cohen) and DK103750 to M.M.B. We acknowledge NIH support for services that we received under contract HHSN268201000031 (PI: C. Costello). We acknowledge J. Lee at the Dana-Farber Molecular Biology Core Facility for his support with the MALDI and Orbitrap MS instruments. Cardiomyocyte imaging data were acquired at the University of Iowa Central Microscopy Research Facility, with NIH 1S10RR02543901 funding for the shared Zeiss LSM 710 Confocal Microscope. Mouse echocardiograms were made possible with the NIH shared instrument grant 1S10ODO019941. We thank S. Dudley for the Na<INF>v</INF>1.5-expressing cell line, T. Kouzarides for the Sirt1 constructs and D. Roden for the Scn5a<SUP>+/-</SUP> mice.	[Anonymous], 1989, NEW ENGL J MED, V321, P406; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Chandra R, 1998, AM J PHYSIOL-HEART C, V274, pH1643, DOI 10.1152/ajpheart.1998.274.5.H1643; Chen-Izu Y, 2015, J PHYSIOL-LONDON, V593, P1347, DOI 10.1113/jphysiol.2014.281428; de Jong S, 2011, J CARDIOVASC PHARM, V57, P630, DOI 10.1097/FJC.0b013e318207a35f; Gao G, 2011, CIRCULATION, V124, P1124, DOI 10.1161/CIRCULATIONAHA.111.044495; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; Hallaq H, 2006, CARDIOVASC RES, V72, P250, DOI 10.1016/j.cardiores.2006.08.007; Hallaq H, 2012, AM J PHYSIOL-HEART C, V302, pH782, DOI 10.1152/ajpheart.00817.2010; Herren AW, 2013, AM J PHYSIOL-HEART C, V305, pH431, DOI 10.1152/ajpheart.00306.2013; Lei M, 2007, CARDIOVASC RES, V74, P356, DOI 10.1016/j.cardiores.2007.01.009; Liu M, 2009, CIRC RES, V105, P737, DOI 10.1161/CIRCRESAHA.109.197277; Marionneau C, 2015, J MOL CELL CARDIOL, V82, P36, DOI 10.1016/j.yjmcc.2015.02.013; McNair WP, 2011, J AM COLL CARDIOL, V57, P2160, DOI 10.1016/j.jacc.2010.09.084; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Pei ZF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12035; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Yokokawa M, 2007, AM J CARDIOL, V100, P649, DOI 10.1016/j.amjcard.2007.03.078; Zhang ZS, 2007, AM J PHYSIOL-HEART C, V292, pH399, DOI 10.1152/ajpheart.01025.2005; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	30	48	52	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					361	367		10.1038/nm.4284	http://dx.doi.org/10.1038/nm.4284			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28191886	Green Accepted			2022-12-27	WOS:000395848400017
J	Hong, SG; Zhou, WJ; Fang, B; Lu, WY; Loro, E; Damle, M; Ding, GL; Jager, J; Zhang, SS; Zhang, YX; Feng, D; Chug, QW; Dill, BD; Molina, H; Khurana, TS; Rabinowitz, JD; Lazar, MA; Sun, Z				Hong, Sungguan; Zhou, Wenjun; Fang, Bin; Lu, Wenyun; Loro, Emanuele; Damle, Manashree; Ding, Guolian; Jager, Jennifer; Zhang, Sisi; Zhang, Yuxiang; Feng, Dan; Chug, Qingwei; Dill, Brian D.; Molina, Henrik; Khurana, Tejvir S.; Rabinowitz, Joshua D.; Lazar, Mitchell A.; Sun, Zheng			Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion	NATURE MEDICINE			English	Article							PURINE NUCLEOTIDE CYCLE; HUMAN SKELETAL-MUSCLE; ACID CYCLE; OXIDATIVE CAPACITY; DIABETES-MELLITUS; FUEL SELECTION; RESISTANCE; METABOLISM; EXPRESSION; MITOCHONDRIA	Type 2 diabetes and insulin resistance are associated with reduced glucose utilization in the muscle and poor exercise performance. Here we find that depletion of the epigenome modifier histone deacetylase 3 (HDAC3) specifically in skeletal muscle causes severe systemic insulin resistance in mice but markedly enhances endurance and resistance to muscle fatigue, despite reducing muscle force. This seemingly paradoxical phenotype is due to lower glucose utilization and greater lipid oxidation in HDAC3-depleted muscles, a fuel switch caused by the activation of anaplerotic reactions driven by AMP deaminase 3 (Ampd3) and catabolism of branched-chain amino acids. These findings highlight the pivotal role of amino acid catabolism in muscle fatigue and type 2 diabetes pathogenesis. Further, as genome occupancy of HDAC3 in skeletal muscle is controlled by the circadian clock, these results delineate an epigenomic regulatory mechanism through which the circadian clock governs skeletal muscle bioenergetics. These findings suggest that physical exercise at certain times of the day or pharmacological targeting of HDAC3 could potentially be harnessed to alter systemic fuel metabolism and exercise performance.	[Hong, Sungguan; Zhou, Wenjun; Ding, Guolian; Sun, Zheng] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Fang, Bin; Damle, Manashree; Jager, Jennifer; Zhang, Yuxiang; Feng, Dan; Chug, Qingwei; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Fang, Bin; Damle, Manashree; Jager, Jennifer; Zhang, Yuxiang; Feng, Dan; Chug, Qingwei; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Lu, Wenyun; Zhang, Sisi; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ding, Guolian] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Dill, Brian D.; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Sun, Zheng] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; Rockefeller University; Baylor College of Medicine	Sun, Z (corresponding author), Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.; Sun, Z (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	lazar@mail.med.upenn.edu; zheng.sun@bcm.edu	Lazar, Mitchell A/AAF-3738-2019; Ding, Guolian/GXG-7578-2022; Zhou, Wenjun/H-2824-2016; Loro, Emanuele/J-5212-2019; Rabinowitz, Joshua/GPP-4019-2022	Ding, Guolian/0000-0002-0099-9980; Zhou, Wenjun/0000-0003-4042-4329; Loro, Emanuele/0000-0002-0822-4514; Rabinowitz, Joshua/0000-0002-1247-4727; Dill, Brian/0000-0002-4532-3044; Jager, Jennifer/0000-0003-3740-9742; Feng, Dan/0000-0001-5926-8894	Leona M. and Harry B. Helmsley Charitable Trust; NIH [CA211437, DK043806, DK099443]; NATIONAL CANCER INSTITUTE [R50CA211437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK099443, U2CDK059637, K99DK099443, U24DK059637, R37DK043806, P30DK019525] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Burden (New York University) for MLC-Cre mice, J. Hogenesch (University of Pennsylvania) for processed data from circaDB, M. Birnbaum and J. Baur (University of Pennsylvania) for helpful discussion, S. Guo (Texas A&M University) for help with the EPS procedure, P. Zhang (Baylor College of Medicine) for adenoviral plasmids, S. Hui and J. Park (Princeton University) for analysis of metabolomics data, V. Narkar (University of Texas Health Science Center) for the immunostaining protocol, M. Goncalves and C. Lanzillotta (University of Pennsylvania) for technical assistance. We thank the Penn Diabetes Center (DK19525) Functional Genomics Core for nucleotide sequencing, the Mouse Metabolic Phenotyping Core for clamp experiments, the Penn Muscle Institute Muscle Physiology Assessment Core for muscle contraction study, and the Princeton/Penn Regional Metabolomics Core for flux and lipid analysis. We thank the Baylor Diabetes Center (DK079638) Metabolism Core for Seahorse analysis and Vanderbilt MMPC (DK59637) for lipidomics analysis. The Rockefeller Proteomics Resource Center is supported by the Leona M. and Harry B. Helmsley Charitable Trust. This work was supported by NIH grants CA211437 (W.L.), DK043806 (M.A.L.) and DK099443 (Z.S.).	Arinze IJ, 2005, BIOCHEM MOL BIOL EDU, V33, P165, DOI 10.1002/bmb.2005.494033032469; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Bowtell JL, 2007, SPORTS MED, V37, P1071, DOI 10.2165/00007256-200737120-00005; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Cheng J, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-96; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; Gineviciene V, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-58; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; Holloszy JO, 2013, DIABETES, V62, P1036, DOI 10.2337/db12-1107; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Kang S, 2016, TRENDS CELL BIOL, V26, P341, DOI 10.1016/j.tcb.2016.01.002; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lau P, 2011, DIABETOLOGIA, V54, P1169, DOI 10.1007/s00125-011-2046-3; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Loro E, 2015, AM J PHYSIOL-REG I, V309, pR835, DOI 10.1152/ajpregu.00505.2014; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mayeuf-Louchart A, 2015, DIABETES OBES METAB, V17, P39, DOI 10.1111/dom.12517; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Operti MG, 1998, MUSCLE NERVE, V21, P401; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Paoli A, 2015, EXERC SPORT SCI REV, V43, P153, DOI 10.1249/JES.0000000000000050; Phinney Stephen D, 2004, Nutr Metab (Lond), V1, P2, DOI 10.1186/1743-7075-1-2; RANDLE PJ, 1963, LANCET, V1, P785; Samant SA, 2015, J BIOL CHEM, V290, P15559, DOI 10.1074/jbc.M115.653048; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Sun Z, 2011, COLD SH Q B, V76, P49, DOI 10.1101/sqb.2011.76.011494; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Templeman NM, 2012, AM J PHYSIOL-REG I, V303, pR101, DOI 10.1152/ajpregu.00511.2011; VANDENBERGHE G, 1992, PROG NEUROBIOL, V39, P547, DOI 10.1016/0301-0082(92)90006-Z; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wong KE, 2015, DIABETES, V64, P1532, DOI 10.2337/db14-0827; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	60	60	64	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					223	234		10.1038/nm.4245	http://dx.doi.org/10.1038/nm.4245			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	27991918	Green Accepted			2022-12-27	WOS:000393729000014
J	Drysdale, AT; Grosenick, L; Downar, J; Dunlop, K; Mansouri, F; Meng, Y; Fetcho, RN; Zebley, B; Oathes, DJ; Etkin, A; Schatzberg, AF; Sudheimer, K; Keller, J; Mayberg, HS; Gunning, FM; Alexopoulos, GS; Fox, MD; Pascual-Leone, A; Voss, HU; Casey, BJ; Dubin, MJ; Liston, C				Drysdale, Andrew T.; Grosenick, Logan; Downar, Jonathan; Dunlop, Katharine; Mansouri, Farrokh; Meng, Yue; Fetcho, Robert N.; Zebley, Benjamin; Oathes, Desmond J.; Etkin, Amit; Schatzberg, Alan F.; Sudheimer, Keith; Keller, Jennifer; Mayberg, Helen S.; Gunning, Faith M.; Alexopoulos, George S.; Fox, Michael D.; Pascual-Leone, Alvaro; Voss, Henning U.; Casey, B. J.; Dubin, Marc J.; Liston, Conor			Resting-state connectivity biomarkers define neurophysiological subtypes of depression	NATURE MEDICINE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTRINSIC FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; PREFRONTAL CORTEX; MAJOR DEPRESSION; DENDRITIC MORPHOLOGY; HEAD MOTION; AMYGDALA; ANTIDEPRESSANT; ORGANIZATION	Biomarkers have transformed modern medicine but remain largely elusive in psychiatry, partly because there is a weak correspondence between diagnostic labels and their neurobiological substrates. Like other neuropsychiatric disorders, depression is not a unitary disease, but rather a heterogeneous syndrome that encompasses varied, co-occurring symptoms and divergent responses to treatment. By using functional magnetic resonance imaging (fMRI) in a large multisite sample (n = 1,188), we show here that patients with depression can be subdivided into four neurophysiological subtypes ('biotypes') defined by distinct patterns of dysfunctional connectivity in limbic and frontostriatal networks. Clustering patients on this basis enabled the development of diagnostic classifiers (biomarkers) with high (82-93%) sensitivity and specificity for depression subtypes in multisite validation (n = 711) and out-of-sample replication (n = 477) data sets. These biotypes cannot be differentiated solely on the basis of clinical features, but they are associated with differing clinical-symptom profiles. They also predict responsiveness to transcranial magnetic stimulation therapy (n = 154). Our results define novel subtypes of depression that transcend current diagnostic boundaries and may be useful for identifying the individuals who are most likely to benefit from targeted neurostimulation therapies.	[Drysdale, Andrew T.; Meng, Yue; Fetcho, Robert N.; Dubin, Marc J.; Liston, Conor] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10017 USA; [Drysdale, Andrew T.; Gunning, Faith M.; Alexopoulos, George S.; Dubin, Marc J.; Liston, Conor] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10017 USA; [Drysdale, Andrew T.; Liston, Conor] Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10017 USA; [Grosenick, Logan] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Grosenick, Logan] Stanford Univ, Ctr Mind Brain & Computat, Stanford, CA 94305 USA; [Grosenick, Logan] Columbia Univ, Med Ctr, Dept Stat, New York, NY USA; [Downar, Jonathan; Dunlop, Katharine] Toronto Western Hosp, Dept Psychiat, Toronto, ON, Canada; [Zebley, Benjamin] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA; [Oathes, Desmond J.] Univ Penn, Perelman Sch Med, Ctr Neuromodulat Depress & Stress, Philadelphia, PA USA; [Oathes, Desmond J.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA USA; [Etkin, Amit; Schatzberg, Alan F.; Sudheimer, Keith; Keller, Jennifer] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Etkin, Amit] Stanford Univ, Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA 94305 USA; [Mayberg, Helen S.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; [Gunning, Faith M.; Alexopoulos, George S.] Weill Cornell Med Coll, Inst Geriatr Psychiat, New York, NY USA; [Fox, Michael D.; Pascual-Leone, Alvaro] Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA USA; [Fox, Michael D.; Pascual-Leone, Alvaro] Harvard Med Sch, Boston, MA USA; [Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Casey, B. J.] Yale Univ, Dept Psychol, New Haven, CT USA	Cornell University; Cornell University; Cornell University; Stanford University; Stanford University; Columbia University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Emory University; Cornell University; Harvard University; Harvard Medical School; Cornell University; Yale University	Liston, C (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10017 USA.; Liston, C (corresponding author), Weill Cornell Med Coll, Dept Psychiat, New York, NY 10017 USA.; Liston, C (corresponding author), Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10017 USA.	col2004@med.cornell.edu	Oathes, Desmond/AAW-3048-2021; Downar, Jonathan/I-9002-2016; Etkin, Amit/ABD-5761-2021; Fox, Michael D./AAZ-3928-2020; Dubin, Marc/L-8915-2013; Oathes, Desmond/X-4088-2019; Pascual-Leone, Alvaro/AAC-5101-2019; Voss, Henning/C-2194-2009; , Conor Liston/GQH-8931-2022	Downar, Jonathan/0000-0002-5140-174X; Fox, Michael D./0000-0001-8848-6399; Dubin, Marc/0000-0002-5542-2978; Oathes, Desmond/0000-0001-7346-2669; Pascual-Leone, Alvaro/0000-0001-8975-0382; Voss, Henning/0000-0003-2811-2074; Sudheimer, Keith/0000-0002-9909-0063; Fetcho, Robert/0000-0002-4557-4177; Dunlop, Katharine/0000-0003-4366-7692	NIMH; NIDA; Autism Speaks; NINDS; NIH COBRE grant [1P20RR021938-01A2]; Dana Foundation; Hartwell Foundation; International Mental Health Research Organization; Klingenstein-Simons Foundations; NIMH [R00 MH097822, R01 MH109685, P50 MH077083]; HHMI; NARSAD; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH097822, R21MH099196, R01MH109685, P50MH077083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS083741] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Autism Speaks; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH COBRE grant; Dana Foundation; Hartwell Foundation; International Mental Health Research Organization; Klingenstein-Simons Foundations; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HHMI(Howard Hughes Medical Institute); NARSAD(NARSAD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank all investigators who volunteered to share MRI data via the 1000 Functional Connectomes Project (http://fcon_1000.projects.nitrc.org/index.html), which was supported by grants from the NIMH, NIDA, Autism Speaks, NINDS and HHMI. Principal investigators from sites that provided data used here include: R.L. Buckner (Harvard-MGH), F.X. Castellanos (NYU), A.C. Evans (ICBM), B. Leventhal (Nathan Kline Institute), S.J. Li (Medical College of Wisconsin), M.J. Lowe (Cleveland Clinic), H.M. Mayberg (Emory), M.P. Milham (Nathan Kline Institute), V. Riedl (Munchen), C. Sorg (Munchen), A. Villringer (Leipzig) and Y.F. Zang (Beijing Normal University). We also thank the following investigators at the University of New Mexico who provided public access to MRI data from patients diagnosed with schizophrenia through the Center of Biomedical Research Excellence in Brain Function and Mental Illness (COBRE): C. Aine, V. Calhoun, J. Canive, F. Hanlon, R. Jung, K. Kiehl, A. Mayer, N. Perrone-Bizzozero, J. Stephen and C. Tesche, who were supported by NIH COBRE grant 1P20RR021938-01A2. We also thank D. Fair (OHSU) and J. Power (NIMH, Weill Cornell) for providing comments on the data analysis, as well as members of the Liston Lab and Sackler Institute, for their helpful comments on the manuscript. H.S.M. was supported by a grant from the NIMH (P50 MH077083). C.L. was supported by grants from the Dana Foundation, Hartwell Foundation, International Mental Health Research Organization, Klingenstein-Simons Foundations, NARSAD and NIMH (R00 MH097822, R01 MH109685).	Baker JT, 2014, JAMA PSYCHIAT, V71, P109, DOI 10.1001/jamapsychiatry.2013.3469; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen CH, 2007, BIOL PSYCHIAT, V62, P407, DOI 10.1016/j.biopsych.2006.09.018; Clementz BA, 2016, AM J PSYCHIAT, V173, P373, DOI 10.1176/appi.ajp.2015.14091200; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Downar J, 2014, BIOL PSYCHIAT, V76, P176, DOI 10.1016/j.biopsych.2013.10.026; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill SK, 2013, AM J PSYCHIAT, V170, P1275, DOI 10.1176/appi.ajp.2013.12101298; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2014, BIOL PSYCHIAT, V76, P517, DOI 10.1016/j.biopsych.2014.01.023; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nielsen JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00599; Oathes DJ, 2015, BIOL PSYCHIAT, V77, P385, DOI 10.1016/j.biopsych.2014.08.006; Pankevich DE, 2014, NEURON, V84, P546, DOI 10.1016/j.neuron.2014.10.007; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Plitt M, 2015, NEUROIMAGE-CLIN, V7, P359, DOI 10.1016/j.nicl.2014.12.013; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Rosa MJ, 2015, NEUROIMAGE, V105, P493, DOI 10.1016/j.neuroimage.2014.11.021; Salvadore G, 2009, BIOL PSYCHIAT, V65, P289, DOI 10.1016/j.biopsych.2008.08.014; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	59	973	1003	37	387	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					28	38		10.1038/nm.4246	http://dx.doi.org/10.1038/nm.4246			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27918562	Green Accepted			2022-12-27	WOS:000391646800011
J	Emblem, KE; Jain, RK				Emblem, Kyrre E.; Jain, Rakesh K.			Improving treatment of liver metastases by targeting nonangiogenic mechanisms	NATURE MEDICINE			English	Editorial Material							HYPOXIA; TUMORS	A recent study confirms an association between vessel co-option and resistance to bevacizumab, an anti-vascular endothelial growth factor-A (VEGFA) antibody, in patients with liver metastases. The authors suggest a combined therapeutic strategy that reduces co-option in mice.	[Emblem, Kyrre E.] Oslo Univ Hosp, Intervent Ctr, Dept Diagnost Phys, Oslo, Norway; [Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs Tumor Biol, Boston, MA 02114 USA; [Jain, Rakesh K.] Harvard Med Sch, Boston, MA USA	University of Oslo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Emblem, KE (corresponding author), Oslo Univ Hosp, Intervent Ctr, Dept Diagnost Phys, Oslo, Norway.	kyrre.eeg.emblem@rr-research.no	Jain, Rakesh K/I-1384-2017; Emblem, Kyrre/H-6691-2012	Jain, Rakesh K/0000-0001-7571-3548; Emblem, Kyrre/0000-0002-6580-9519				Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Frentzas S, 2016, NAT MED, V22, P1294, DOI 10.1038/nm.4197; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jeong HS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv155; Rahbari NN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5219; Stessels F, 2004, BRIT J CANCER, V90, P1429, DOI 10.1038/sj.bjc.6601727; Vermeulen PB, 2001, J PATHOL, V195, P336, DOI 10.1002/path.966	10	3	3	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1209	1210		10.1038/nm.4228	http://dx.doi.org/10.1038/nm.4228			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27824818				2022-12-27	WOS:000387302300009
J	Paiardini, M; Lichterfeld, M				Paiardini, Mirko; Lichterfeld, Mathias			Follicular T helper cells: hotspots for HIV-1 persistence	NATURE MEDICINE			English	Editorial Material							REPLICATION; RESERVOIR	Reservoirs of virally infected cells that are resistant to standard antiretroviral therapy make HIV-1 infection an incurable disease. A new study shows that follicular T helper cells in lymph node germinal centers are prime niches for HIV-1 persistence during antiviral therapy.	[Paiardini, Mirko] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Paiardini, Mirko] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Lichterfeld, Mathias] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Lichterfeld, Mathias] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lichterfeld, Mathias] Harvard Univ, Cambridge, MA 02138 USA	Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Lichterfeld, M (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.; Lichterfeld, M (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lichterfeld, M (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	mlichterfeld@partners.org	Lichterfeld, Mathias/B-2042-2008	Lichterfeld, Mathias/0000-0001-9865-8350	NIAID NIH HHS [R01 AI120008, U01 AI117841, R01 AI098487, U01 AI114235, R21 AI106468, R01 AI110334, R21 AI104278] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110334, U01AI114235, R21AI106468, R01AI098487, R01AI120008, R21AI104278, U01AI117841] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alters K, 2011, BLOOD, V117, P2791, DOI [10.1182/blood-2010-09-309591, DOI 10.1182/BLOOD-2010-09-309591]; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Heesters BA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005285; Kohler SL, 2016, J IMMUNOL, V196, P2711, DOI 10.4049/jimmunol.1502174; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	9	9	9	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					711	712		10.1038/nm.4138	http://dx.doi.org/10.1038/nm.4138			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387885				2022-12-27	WOS:000379366900008
J	Tamburini, S; Shen, N; Wu, HC; Clemente, JC				Tamburini, Sabrina; Shen, Nan; Wu, Han Chih; Clemente, Jose C.			The microbiome in early life: implications for health outcomes	NATURE MEDICINE			English	Review							HUMAN GUT MICROBIOME; FECAL MICROBIOTA; HUMAN-MILK; ANTIBIOTIC EXPOSURE; CESAREAN-SECTION; ATOPIC-DERMATITIS; ALLERGIC SENSITIZATION; INTESTINAL MICROBIOTA; CHILDHOOD OVERWEIGHT; COMMENSAL BACTERIA	Recent studies have characterized how host genetics, prenatal environment and delivery mode can shape the newborn microbiome at birth. Following this, postnatal factors, such as antibiotic treatment, diet or environmental exposure, further modulate the development of the infant's microbiome and immune system, and exposure to a variety of microbial organisms during early life has long been hypothesized to exert a protective effect in the newborn. Furthermore, epidemiological studies have shown that factors that alter bacterial communities in infants during childhood increase the risk for several diseases, highlighting the importance of understanding early-life microbiome composition. In this review, we describe how prenatal and postnatal factors shape the development of both the microbiome and the immune system. We also discuss the prospects of microbiome-mediated therapeutics and the need for more effective approaches that can reconfigure bacterial communities from pathogenic to homeostatic configurations.	[Tamburini, Sabrina; Shen, Nan; Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Wu, Han Chih; Clemente, Jose C.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Wu, Han Chih; Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Med, Div Clin Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Clemente, JC (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Clemente, JC (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.; Clemente, JC (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Clin Immunol, New York, NY 10029 USA.	jose.clemente@mssm.edu		Tamburini, Sabrina/0000-0002-2485-7418	SUCCESS philanthropic grant [GCO14-0560]; Crohn's and Colitis Foundation of America (CCFA) [362048]	SUCCESS philanthropic grant; Crohn's and Colitis Foundation of America (CCFA)	J.C.C. was supported by the SUCCESS philanthropic grant (GCO14-0560) and by the Crohn's and Colitis Foundation of America (CCFA) (362048). We thank J.-F. Colombel for suggestions on Figure 3.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Adkins B, 1998, J IMMUNOL, V160, P4217; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Andersen AD, 2011, J PEDIATR GASTR NUTR, V53, P303, DOI 10.1097/MPG.0b013e31821d298f; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; BENNET R, 1987, INFECTION, V15, P332, DOI 10.1007/BF01647733; Bergmann H, 2014, BRIT J NUTR, V112, P1119, DOI 10.1017/S0007114514001949; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Boggess KA, 1996, OBSTET GYNECOL, V87, P779, DOI 10.1016/0029-7844(96)00037-3; Braegger C, 2011, J PEDIATR GASTR NUTR, V52, P238, DOI 10.1097/MPG.0b013e3181fb9e80; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Brunser O, 2006, ASIA PAC J CLIN NUTR, V15, P368; Buchanan E, 2009, ALIMENT PHARM THER, V30, P501, DOI 10.1111/j.1365-2036.2009.04067.x; Bunyavanich S., 2016, J ALLERGY CLIN IMMUN; Chang FY, 2011, INT ARCH ALLERGY IMM, V154, P49, DOI 10.1159/000319208; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Cleary B, 2015, NAT BIOTECHNOL, V33, P1053, DOI 10.1038/nbt.3329; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cuello-Garcia CA, 2015, J ALLERGY CLIN IMMUN, V136, P952, DOI [10.1016/j.jaci.2015.04.031, 10.1016/j.jaci.2015.07.021]; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Deshpande G, 2015, AUST NZ J OBSTET GYN, V55, P210, DOI 10.1111/ajo.12328; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Doege K, 2012, BRIT J NUTR, V107, P1, DOI 10.1017/S0007114511003400; Dogaru CM, 2012, AM J RESP CRIT CARE, V185, P874, DOI 10.1164/rccm.201108-1490OC; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Faden D, 2009, PEDIATR INFECT DIS J, V28, P539, DOI 10.1097/INF.0b013e318193ef38; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Foolad N, 2013, JAMA DERMATOL, V149, P350, DOI 10.1001/jamadermatol.2013.1495; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez-Perez G, 2016, J IMMUNOL, V196, P3768, DOI 10.4049/jimmunol.1502322; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; GOPLERUD C P, 1976, American Journal of Obstetrics and Gynecology, V126, P858; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Grinspan AM, 2015, GASTROENTEROLOGY, V149, P15, DOI 10.1053/j.gastro.2015.05.030; Guilbert TW, 2007, AM J RESP CRIT CARE, V176, P843, DOI 10.1164/rccm.200610-1507OC; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Ic-Jusufagic AS, 2014, LANCET RESP MED, V2, P621, DOI 10.1016/S2213-2600(14)70096-7; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabeerdoss J, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2013.6; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kim SO, 2014, ANN ALLERG ASTHMA IM, V113, P217, DOI 10.1016/j.anai.2014.05.021; Kliman HJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009864; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Lang A. J., 2016, General Technical Report - Southern Research Station, USDA Forest Service, P8; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Liu AH, 2006, J ALLERGY CLIN IMMUN, V117, P1063, DOI 10.1016/j.jaci.2006.03.027; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Mah KW, 2007, PEDIATR RES, V62, P674, DOI 10.1203/PDR.0b013e31815991d5; Maldonado J, 2012, J PEDIATR GASTR NUTR, V54, P55, DOI 10.1097/MPG.0b013e3182333f18; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Martinez Fernando D, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS7, DOI 10.1513/AnnalsATS.201306-186MG; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Metsala J, 2013, EPIDEMIOLOGY, V24, P303, DOI 10.1097/EDE.0b013e31827f520f; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P3633, DOI 10.1210/jc.2015-2696; Muniyappa P, 2009, J PEDIATR GASTR NUTR, V49, P400, DOI 10.1097/MPG.0b013e3181a0d269; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Normand AC, 2011, OCCUP ENVIRON MED, V68, P849, DOI 10.1136/oem.2010.061879; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Oh KJ, 2010, J PERINAT MED, V38, P261, DOI [10.1515/JPM.2010.040, 10.1515/jpm.2010.040]; Ortqvist AK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6979; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Panduru M, 2015, J EUR ACAD DERMATOL, V29, P232, DOI 10.1111/jdv.12496; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Saari A, 2015, PEDIATRICS, V135, P617, DOI 10.1542/peds.2014-3407; Sadeharju K, 2007, PEDIATRICS, V119, P941, DOI 10.1542/peds.2006-0780; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Schwartz BS, 2016, INT J OBESITY, V40, P615, DOI 10.1038/ijo.2015.218; Schwarz EB, 2009, OBSTET GYNECOL, V113, P974, DOI 10.1097/01.AOG.0000346884.67796.ca; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Shen N, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0538-9; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stewart CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17141; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner D, 2014, J CROHNS COLITIS, V8, P1464, DOI 10.1016/j.crohns.2014.05.010; Vandenplas Y, 2015, BRIT J NUTR, V113, P1339, DOI 10.1017/S0007114515000823; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Virtanen SM, 2014, JAMA PEDIATR, V168, P755, DOI 10.1001/jamapediatrics.2014.296; von Hertzen L, 2007, ALLERGY, V62, P288, DOI 10.1111/j.1398-9995.2006.01281.x; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; Witkin SS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003944; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zaura E, 2015, MBIO, V6, DOI 10.1128/mBio.01693-15; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	156	547	584	9	299	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					713	722		10.1038/nm.4142	http://dx.doi.org/10.1038/nm.4142			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387886				2022-12-27	WOS:000379366900009
J	Carlson, JM; Du, VY; Pfeifer, N; Bansal, A; Tan, VYF; Power, K; Brumme, CJ; Kreimer, A; DeZiel, CE; Fusi, N; Schaefer, M; Brockman, MA; Gilmour, J; Price, MA; Kilembe, W; Haubrich, R; John, M; Mallal, S; Shapiro, R; Frater, J; Harrigan, PR; Ndung'u, T; Allen, S; Heckerman, D; Sidney, J; Allen, TM; Goulder, PJR; Brumme, ZL; Hunter, E; Goepfert, PA				Carlson, Jonathan M.; Du, Victor Y.; Pfeifer, Nico; Bansal, Anju; Tan, Vincent Y. F.; Power, Karen; Brumme, Chanson J.; Kreimer, Anat; DeZiel, Charles E.; Fusi, Nicolo; Schaefer, Malinda; Brockman, Mark A.; Gilmour, Jill; Price, Matt A.; Kilembe, William; Haubrich, Richard; John, Mina; Mallal, Simon; Shapiro, Roger; Frater, John; Harrigan, P. Richard; Ndung'u, Thumbi; Allen, Susan; Heckerman, David; Sidney, John; Allen, Todd M.; Goulder, Philip J. R.; Brumme, Zabrina L.; Hunter, Eric; Goepfert, Paul A.			Impact of pre-adapted HIV transmission	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; IMMUNE ESCAPE PATHWAYS; REPLICATION CAPACITY; MAXIMUM-LIKELIHOOD; VIRAL-LOAD; LYMPHOCYTE RESPONSE; DISCORDANT COUPLES; TYPE-1 VIREMIA; HLA ALLELES	Human leukocyte antigen class I (HLA)-restricted CD8(+) T lymphocyte (CTL) responses are crucial to HIV-1 control. Although HIV can evade these responses, the longer-term impact of viral escape mutants remains unclear, as these variants can also reduce intrinsic viral fitness. To address this, we here developed a metric to determine the degree of HIV adaptation to an HLA profile. We demonstrate that transmission of viruses that are pre-adapted to the HLA molecules expressed in the recipient is associated with impaired immunogenicity, elevated viral load and accelerated CD4(+) T cell decline. Furthermore, the extent of pre-adaptation among circulating viruses explains much of the variation in outcomes attributed to the expression of certain HLA alleles. Thus, viral pre-adaptation exploits 'holes' in the immune response. Accounting for these holes may be key for vaccine strategies seeking to elicit functional responses from viral variants, and to HIV cure strategies that require broad CTL responses to achieve successful eradication of HIV reservoirs.	[Carlson, Jonathan M.; Pfeifer, Nico; Tan, Vincent Y. F.; Kreimer, Anat; DeZiel, Charles E.; Fusi, Nicolo; Heckerman, David] Microsoft Res, Redmond, WA USA; [Du, Victor Y.; Bansal, Anju; Goepfert, Paul A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Power, Karen; Ndung'u, Thumbi; Allen, Todd M.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA; [Brumme, Chanson J.; Brockman, Mark A.; Harrigan, P. Richard; Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Schaefer, Malinda; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Brockman, Mark A.; Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Gilmour, Jill; Price, Matt A.] Int AIDS Vaccine Initiat, New York, NY USA; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London, England; [Price, Matt A.] Univ San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94117 USA; [Kilembe, William; Allen, Todd M.; Hunter, Eric] Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia; [Haubrich, Richard] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [John, Mina; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [John, Mina] Royal Perth Hosp, Dept Clin Immunol, GPO Box X2213, Perth, WA 6001, Australia; [Mallal, Simon] Vanderbilt Univ, Sch Med, Ctr Translat Immunol & Infect Dis, Nashville, TN 37212 USA; [Shapiro, Roger] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Frater, John] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Frater, John] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England; [Frater, John] Univ Oxford, Oxford Martin Sch, Inst Emerging Infect, Oxford, England; [Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Nelson R Mandela Sch Med, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany; [Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Sidney, John] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford, England; [Pfeifer, Nico] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Tan, Vincent Y. F.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Tan, Vincent Y. F.] Natl Univ Singapore, Dept Math, 10 Kent Ridge Crescent, Singapore 117548, Singapore; [Kreimer, Anat] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	Microsoft; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; B.C. Centre for Excellence in HIV/AIDS; Emory University; Simon Fraser University; International AIDS Vaccine Initiative; Imperial College London; University of San Francisco; Gilead Sciences; Murdoch University; Royal Perth Hospital; University of Western Australia; Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; University of Oxford; University of Oxford; University of British Columbia; University of Kwazulu Natal; University of Kwazulu Natal; Max Planck Society; Emory University; Emory University; Rollins School Public Health; La Jolla Institute for Immunology; University of Oxford; Max Planck Society; National University of Singapore; National University of Singapore; University of California System; University of California Berkeley	Carlson, JM (corresponding author), Microsoft Res, Redmond, WA USA.; Goepfert, PA (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Hunter, E (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Hunter, E (corresponding author), Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia.; Hunter, E (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	carlson@microsoft.com; ehunte4@emory.edu; paulg@uab.edu	Allen, Todd/F-5473-2011; Price, Matt/AAK-6881-2021; Pfeifer, Nico/G-1559-2016; Mallal, Simon Alexander/HDM-9561-2022; Brockman, Mark/D-1669-2016	Allen, Todd/0000-0002-6609-1318; Price, Matt/0000-0002-2918-1373; Mallal, Simon Alexander/0000-0002-7036-1309; Brumme, Zabrina/0000-0002-8157-1037; Frater, John/0000-0001-7163-7277; Brumme, Chanson/0000-0003-2722-5288; Brockman, Mark/0000-0001-6432-1426; Carlson, Jonathan/0000-0001-6618-3653; Ndung'u, Thumbi/0000-0003-2962-3992; Pfeifer, Nico/0000-0002-4647-8566	Merck; NIH National Institute of Allergy and Infectious Diseases (NIAID); NIAID [R01 AI112566, R56 AI098551, R01 AI64060, R37 AI51231, P01 AI074415, U01 AI 66454, RO1 AI46995, R01 AI071906]; Canadian Institutes of Health Research [MOP-93536, HOP-115700]; Wellcome Trust [WT104748MA]; NIH [U01 AI 068636]; National Institute of Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); International AIDS Vaccine Initiative; Virology Core at the Emory Center for AIDS Research [P30 AI050409]; Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research [P30 AI027767]; Tennessee Center for AIDS Research [P30 AI110527]; Yerkes National Primate Research Center through NIH Office of the Director [P51OD11132]; Action Cycling Fellowship; South African Department of Science and Technology; National Research Foundation through South Africa Research Chairs Initiative; Howard Hughes Medical Institute; Victor Daitz Foundation; CIHR/GSK; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, U01AI066454, R01AI046995, R56AI098551, R01AI064060, P30AI110527, UM1AI068636, P30AI050409, UM1AI068634, R01AI112566, UM1AI068614, U01AI068636, P01AI074415, R37AI051231, P30AI027767, R01AI071906] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Medical Research Council [MR/L006588/1] Funding Source: researchfish; MRC [MR/L006588/1] Funding Source: UKRI	Merck(Merck & Company); NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); International AIDS Vaccine Initiative; Virology Core at the Emory Center for AIDS Research; Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research; Tennessee Center for AIDS Research; Yerkes National Primate Research Center through NIH Office of the Director; Action Cycling Fellowship; South African Department of Science and Technology; National Research Foundation through South Africa Research Chairs Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Victor Daitz Foundation; CIHR/GSK(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Carrington for comments on the manuscript, S. Riddler (University of Pittsburgh, Pittsburgh, Pennsylvania, USA) for access to HLA and sequence data from the ACTG trials, D. Claiborne (Emory University, Atlanta, Georgia, USA) for providing MJ4 proviruses with nonadapted and adapted epitopes, R.A. Kaslow and J. Tang (University of Alabama, Birmingham, Alabama, USA) for access to Zambian HLA data, and D. Goedhals and C. van Vuuren (University of Free State, Bloemfontein, South Africa) for curating additional clinical data from the Bloemfontein cohort. We thank Merck, the NIH National Institute of Allergy and Infectious Diseases (NIAID) and the NIAID-funded HIV Vaccine Trials Network for providing the clinical data set, viral sequences, HLA types and CTL response data from the Step Study (HVTN 502). We also thank the Step and ACTG 5142 and 5128 staff and trial participants, as well as the staff and volunteers of the HOMER, WAHCS, ZEHRP, Durban, Gaborone, Kimberley and Bloemfontain cohorts, for their contributions. This study was funded by NIAID (grants R01 AI112566 (P.A.G.), R56 AI098551 (P.A.G.), R01 AI64060 (E.H.), R37 AI51231 (E.H.), P01 AI074415 (T.M.A.), U01 AI 66454 (R.S.), RO1 AI46995 (P.J.R.G.) and R01 AI071906 (R. A. Kaslow and J. Tang)), the Canadian Institutes of Health Research (grants MOP-93536 and HOP-115700 (both to M.A.B. and Z.L.B.)) and the Wellcome Trust (grant WT104748MA (P.J.R.G.)). HLA typing and viral sequencing of the ACTG cohorts were supported by the NIH (grant U01 AI 068636 to R.H.), the National Institute of Mental Health (NIMH) and the National Institute of Dental and Craniofacial Research (NIDCR). Support for the ZEHRP cohort was also provided by the International AIDS Vaccine Initiative (S. A.) and made possible in part by the support of the American people through the US Agency for International Development (USAID). A full list of IAVI donors is available at http://www.iavi.org. This work was also supported in part by the Virology Core at the Emory Center for AIDS Research (grant P30 AI050409 (E.H.)), the Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research (grant P30 AI027767 (P.A.G.)), the Tennessee Center for AIDS Research (P30 AI110527 (S. M.)) and the Yerkes National Primate Research Center base (grant P51OD11132 (E.H.)) through the NIH Office of the Director. M. S. was supported in part by an Action Cycling Fellowship. T.N. was supported by the International AIDS Vaccine Initiative, the South African Department of Science and Technology and the National Research Foundation through the South Africa Research Chairs Initiative, by an International Early Career Scientist award from the Howard Hughes Medical Institute, and by the Victor Daitz Foundation. P.R.H. is supported by a CIHR/GSK Professorship in Clinical Virology. Z.L.B. is supported by a Scholar Award from the Michael Smith Foundation for Health Research.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Almeida CAM, 2011, J IMMUNOL, V187, P2502, DOI 10.4049/jimmunol.1100691; Andrew G., 2007, P 24 INT C MACH LEAR, DOI [10.1145/1273496.1273501, DOI 10.1145/1273496.1273501]; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Bansal A, 2008, J VIROL, V82, P6458, DOI 10.1128/JVI.00068-08; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carlson J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000591; Carlson JM, 2015, TRENDS MICROBIOL, V23, P212, DOI 10.1016/j.tim.2014.12.008; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cotton LA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004295; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas DW, 2003, HIV CLIN TRIALS, V4, P287, DOI 10.1310/MUQC-QXBC-8118-BPM5; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holmes I, 2002, J MOL BIOL, V317, P753, DOI 10.1006/jmbi.2002.5405; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Janes H, 2015, NAT MED, V21, P1139, DOI 10.1038/nm.3932; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris HN, 2015, J IMMUNOL, V194, P5329, DOI 10.4049/jimmunol.1400854; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Llano A., 2009, HIV MOL IMMUNOLOGY, P3; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mailliard RB, 2013, J IMMUNOL, V191, P2570, DOI 10.4049/jimmunol.1300373; Mallal SA, 1998, J ACQ IMMUN DEF SYND, V17, pS23, DOI 10.1097/00042560-199801001-00008; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2012, J VIROL, V86, P12643, DOI 10.1128/JVI.01381-12; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McKenna SL, 1997, AIDS, V11, pS103; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Ntale RS, 2012, J VIROL, V86, P12013, DOI 10.1128/JVI.00539-12; Oxenius A, 2004, J INFECT DIS, V190, P713, DOI 10.1086/422760; Payne RP, 2014, J VIROL, V88, P4668, DOI 10.1128/JVI.03303-13; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poon AFY, 2015, J INFECT DIS, V211, P926, DOI 10.1093/infdis/jiu560; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; van Dorp CH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003899; Vance DE, 2011, J ASSOC NURSE AIDS C, V22, P17, DOI 10.1016/j.jana.2010.04.002; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Wright JK, 2012, J VIROL, V86, P3193, DOI 10.1128/JVI.06682-11; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12	109	66	67	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					606	+		10.1038/nm.4100	http://dx.doi.org/10.1038/nm.4100			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27183217	Green Accepted, Green Submitted			2022-12-27	WOS:000377476000013
J	Gelinas, JN; Khodagholy, D; Thesen, T; Devinsky, O; Buzsaki, G				Gelinas, Jennifer N.; Khodagholy, Dion; Thesen, Thomas; Devinsky, Orrin; Buzsaki, Gyorgy			Interictal epileptiform discharges induce hippocampal-cortical coupling in temporal lobe epilepsy	NATURE MEDICINE			English	Article							PREFRONTAL CORTEX; SPATIAL MEMORY; COGNITIVE IMPAIRMENT; SLOW WAVES; SLEEP; RAT; OSCILLATIONS; RIPPLES; NETWORK; SPIKES	Interactions between the hippocampus and the cortex are critical for memory. Interictal epileptiform discharges (IEDs) identify epileptic brain regions and can impair memory, but the mechanisms by which they interact with physiological patterns of network activity are mostly undefined. We show in a rat model of temporal lobe epilepsy that spontaneous hippocampal IEDs correlate with impaired memory consolidation, and that they are precisely coordinated with spindle oscillations in the prefrontal cortex during nonrapid-eye-movement (NREM) sleep. This coordination surpasses the normal physiological ripple-spindle coupling and is accompanied by decreased ripple occurrence. IEDs also induce spindles during rapid-eye movement (REM) sleep and wakefulness-behavioral states that do not naturally express these oscillations-by generating a cortical 'down' state. In a pilot clinical examination of four subjects with focal epilepsy, we confirm a similar correlation of temporofrontal IEDs with spindles over anatomically restricted cortical regions. These findings imply that IEDs may impair memory via the misappropriation of physiological mechanisms for hippocampal-cortical coupling, which suggests a target for the treatment of memory impairment in epilepsy.	[Gelinas, Jennifer N.; Khodagholy, Dion; Buzsaki, Gyorgy] NYU, Sch Med, Inst Neurosci, New York, NY USA; [Thesen, Thomas; Devinsky, Orrin] NYU, Dept Neurol, Comprehens Epilepsy Ctr, Sch Med, New York, NY 10016 USA; [Buzsaki, Gyorgy] NYU, Ctr Neural Sci, Sch Med, New York, NY 10003 USA	New York University; New York University; New York University	Buzsaki, G (corresponding author), NYU, Sch Med, Inst Neurosci, New York, NY USA.; Buzsaki, G (corresponding author), NYU, Ctr Neural Sci, Sch Med, New York, NY 10003 USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800; Devinsky, Orrin/0000-0003-0044-4632	US National Institute of Health [NS90583, MH54671, MH107396, MH102840]; US National Science Foundation PIRE; Mathers Foundation; March of Dimes Foundation; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671, R01MH107396, R01MH102840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015, U01NS090583] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation PIRE; Mathers Foundation; March of Dimes Foundation(March of Dimes); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institute of Health grants (NS90583, MH54671, MH107396, MH102840; G.B.), the US National Science Foundation PIRE (G.B.), and the Mathers Foundation (G.B.). J.N.G. is a fellow of the Pediatric Scientist Development Program, and this project was supported through the March of Dimes Foundation. D.K. is supported through the Simons Foundation (junior fellow). We thank A. Peyrache for fruitful discussion; J. Long for use of the cheeseboard maze and advice on behavioral protocol; and Z. Zhao for technical support. We thank K. Berry, A. Boomhaur and P. del Prato for providing access to the sleep electrocorticography epilepsy data. Thanks also to H.X. Wang for providing the MRI-based electrode localizations for this data.	Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Binnie CD, 2003, LANCET NEUROL, V2, P725, DOI 10.1016/S1474-4422(03)00584-2; Boukhezra O, 2003, EPILEPSY RES, V55, P165, DOI 10.1016/S0920-1211(03)00111-6; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Brinciotti M, 1989, Funct Neurol, V4, P235; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 1991, Hippocampus, V1, P163, DOI 10.1002/hipo.450010205; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chersi F, 2015, NEURON, V88, P64, DOI 10.1016/j.neuron.2015.09.021; Churchwell JC, 2010, NEUROBIOL LEARN MEM, V93, P415, DOI 10.1016/j.nlm.2009.12.008; Colgin LL, 2011, CURR OPIN NEUROBIOL, V21, P467, DOI 10.1016/j.conb.2011.04.006; de Guzman PH, 2010, J NEUROPHYSIOL, V104, P2194, DOI 10.1152/jn.00418.2010; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ebus S, 2012, EUR J PAEDIATR NEURO, V16, P697, DOI 10.1016/j.ejpn.2012.05.010; Fahoum F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068038; Ferrillo F, 2000, CLIN NEUROPHYSIOL, V111, P916, DOI 10.1016/S1388-2457(00)00246-7; Frauscher B, 2015, BRAIN, V138, P1629, DOI 10.1093/brain/awv073; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hermann BP, 2006, ANN NEUROL, V60, P80, DOI 10.1002/ana.20872; Holmes GL, 2006, EPILEPSY BEHAV, V8, P504, DOI 10.1016/j.yebeh.2005.11.014; Holmes GL, 2013, EPILEPSIA, V54, P60, DOI 10.1111/epi.12186; Inostroza M, 2013, ANNU REV NEUROSCI, V36, P79, DOI 10.1146/annurev-neuro-062012-170429; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Johnson LA, 2010, J NEUROSCI, V30, P2650, DOI 10.1523/JNEUROSCI.1617-09.2010; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Khan OI, 2010, NEUROBIOL DIS, V39, P362, DOI 10.1016/j.nbd.2010.05.002; Kleen JK, 2013, NEUROLOGY, V81, P18, DOI 10.1212/WNL.0b013e318297ee50; Kleen JK, 2011, J NEUROSCI, V31, P15397, DOI 10.1523/JNEUROSCI.2196-11.2011; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; Krauss GL, 1997, NEUROLOGY, V49, P975, DOI 10.1212/WNL.49.4.975; Krook-Magnuson E, 2015, JAMA NEUROL, V72, P823, DOI 10.1001/jamaneurol.2015.0608; Lenck-Santini PP, 2008, J NEUROSCI, V28, P5053, DOI 10.1523/JNEUROSCI.5024-07.2008; Liu XZ, 2003, J NEUROSCI, V23, P11505; Lv YD, 2013, EPILEPSY BEHAV, V29, P205, DOI 10.1016/j.yebeh.2013.07.014; Malow BA, 1998, EPILEPSIA, V39, P1309, DOI 10.1111/j.1528-1157.1998.tb01329.x; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nobili L, 1999, CLIN NEUROPHYSIOL, V110, P39, DOI 10.1016/S0168-5597(98)00041-0; PEELE DB, 1992, BEHAV BRAIN RES, V48, P65, DOI 10.1016/S0166-4328(05)80140-8; Peyrache A, 2011, P NATL ACAD SCI USA, V108, P17207, DOI 10.1073/pnas.1103612108; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Shatskikh TN, 2006, EPILEPSY BEHAV, V9, P549, DOI 10.1016/j.yebeh.2006.08.014; SHEWMON DA, 1988, ELECTROEN CLIN NEURO, V69, P319, DOI 10.1016/0013-4694(88)90004-1; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Stark E, 2009, J NEUROSCI METH, V179, P90, DOI 10.1016/j.jneumeth.2008.12.029; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Takita M, 1999, EUR J NEUROSCI, V11, P4145, DOI 10.1046/j.1460-9568.1999.00870.x; Titiz AS, 2014, HIPPOCAMPUS, V24, P1129, DOI 10.1002/hipo.22297; Varela C, 2014, BRAIN STRUCT FUNCT, V219, P911, DOI 10.1007/s00429-013-0543-5; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; WADMAN WJ, 1983, ELECTROEN CLIN NEURO, V55, P314, DOI 10.1016/0013-4694(83)90209-2; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang AI, 2012, NEUROIMAGE, V63, P157, DOI 10.1016/j.neuroimage.2012.06.039	67	126	126	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					641	+		10.1038/nm.4084	http://dx.doi.org/10.1038/nm.4084			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27111281	Green Accepted			2022-12-27	WOS:000377476000021
J	Keener, AB				Keener, Amanda B.			Saving face: The search for alternatives to life-long immunosuppression for face transplants	NATURE MEDICINE			English	News Item																		Dolgin E, 2012, NAT MED, V18, P12, DOI 10.1038/nm0112-12; Fryer M, 2015, EXPERT REV CLIN IMMU, V11, P1189, DOI 10.1586/1744666X.2015.1078729; HIVELIN M, 2015, ARCH IMMUNOL; Leonard DA, 2014, AM J TRANSPLANT, V14, P343, DOI 10.1111/ajt.12560; Plock JA, 2015, TRANSPLANTATION, V99, P1765, DOI 10.1097/TP.0000000000000731; Schneeberger S, 2013, ANN SURG, V257, P345, DOI 10.1097/SLA.0b013e31826d90bb	6	7	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					448	449		10.1038/nm0516-448	http://dx.doi.org/10.1038/nm0516-448			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149211				2022-12-27	WOS:000375514000021
J	Hope, TJ				Hope, Thomas J.			Inflammation weakens HIV prevention	NATURE MEDICINE			English	Editorial Material							PREEXPOSURE PROPHYLAXIS; WOMEN; EFFICACY; SAFETY; MEN	The presence of multiple inflammatory cytokines predicts the failure of a topical 1% tenofovir microbicide gel to protect women against HIV infection.	[Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hope, TJ (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA.	thope@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hope TJ, 2015, AIDS RES HUM RETROV, V31, P1055, DOI [10.1089/aid.2015.0310, 10.1089/AID.2015.0310]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McKinnon LR, 2018, NAT MED, V24, P491, DOI 10.1038/nm.4506; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Notario-Perez F, 2017, DRUG DES DEV THER, V11, P1767, DOI 10.2147/DDDT.S133170	11	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					384	385		10.1038/nm.4534	http://dx.doi.org/10.1038/nm.4534			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634687				2022-12-27	WOS:000429639800005
J	Gagnon, M; Bergeron, MJ; Perez-Sanchez, J; Plasencia-Fernandez, I; Lorenzo, LE; Godin, AG; Castonguay, A; Bonin, RP; De Koninck, Y				Gagnon, Martin; Bergeron, Marc J.; Perez-Sanchez, Jimena; Plasencia-Fernandez, Isabel; Lorenzo, Louis-Etienne; Godin, Antoine G.; Castonguay, Annie; Bonin, Robert P.; De Koninck, Yves			The small molecule CLP257 does not modify activity of the K+-Cl- co-transporter KCC2 but does potentiate GABA(A) receptor activity Reply	NATURE MEDICINE			English	Letter							CHLORIDE		[Gagnon, Martin; Bergeron, Marc J.; Perez-Sanchez, Jimena; Plasencia-Fernandez, Isabel; Lorenzo, Louis-Etienne; Godin, Antoine G.; Castonguay, Annie; Bonin, Robert P.; De Koninck, Yves] Quebec Mental Hlth Inst, CERVO Brain Res Ctr, Quebec City, PQ, Canada; [Gagnon, Martin] Exactis Innovat, Montreal, PQ, Canada; [Bergeron, Marc J.; De Koninck, Yves] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Perez-Sanchez, Jimena; Plasencia-Fernandez, Isabel; De Koninck, Yves] Univ Laval, Grad Program Neurobiol, Quebec City, PQ, Canada; [Bonin, Robert P.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	Laval University; Laval University; University of Toronto	De Koninck, Y (corresponding author), Quebec Mental Hlth Inst, CERVO Brain Res Ctr, Quebec City, PQ, Canada.; De Koninck, Y (corresponding author), Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada.; De Koninck, Y (corresponding author), Univ Laval, Grad Program Neurobiol, Quebec City, PQ, Canada.	yves.dekoninck@neuro.ulaval.ca	De Koninck, Yves/C-2659-2008; Lorenzo, Louis-Etienne/A-5409-2012	De Koninck, Yves/0000-0002-5779-9330; Lorenzo, Louis-Etienne/0000-0002-5514-0049; Bonin, Robert/0000-0002-3287-6803; Godin, Antoine/0000-0003-2417-2563; Perez-Sanchez, Jimena/0000-0002-4967-5418	Canadian Institutes for Health Research (CIHR); Consejo Nacional de Ciencia y Tecnologia (CONACYT); Canada Research Chairs	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canada Research Chairs(Canada Research ChairsCGIAR)	We thank J. Asselin and D. Boudreau for characterization of the emission spectrum of CLP257. This work was supported by the Canadian Institutes for Health Research (CIHR), a Consejo Nacional de Ciencia y Tecnologia (CONACYT) scholarship to J.P.-S., and Canada Research Chairs to Y.D.K. and R.P.B.	Cardarelli RA, 2017, NAT MED, V23, P1394, DOI 10.1038/nm.4442; Chen M, 2017, ELIFE, V6, DOI 10.7554/eLife.20142; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Doyon N, 2016, NEURON, V89, P1157, DOI 10.1016/j.neuron.2016.02.030; Doyon N, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00516; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Du Y, 2015, ACS CHEM NEUROSCI, V6, P871, DOI 10.1021/acschemneuro.5b00004; Ferrini F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04209-3; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Grimley JS, 2013, J NEUROSCI, V33, P16297, DOI 10.1523/JNEUROSCI.4616-11.2013; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Ostroumov A, 2016, NEURON, V92, P493, DOI 10.1016/j.neuron.2016.09.029; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Zhou X, 2011, CELL DEATH DIFFER, V18, P493, DOI 10.1038/cdd.2010.120	18	7	7	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1396	+		10.1038/nm.4449	http://dx.doi.org/10.1038/nm.4449			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216044				2022-12-27	WOS:000417278200003
J	Yang, LD; Chang, CC; Sun, Z; Madsen, D; Zhu, HS; Padkjaer, SB; Wu, XA; Huang, T; Hultman, K; Paulsen, SJ; Wang, JS; Bugge, A; Frantzen, JB; Norgaard, P; Jeppesen, JF; Yang, ZR; Secher, A; Chen, HB; Li, X; John, LM; Shan, B; He, ZH; Gao, X; Su, J; Hansen, KT; Yang, W; Jorgensen, SB				Yang, Linda; Chang, Chih-Chuan; Sun, Zhe; Madsen, Dennis; Zhu, Haisun; Padkjaer, Soren B.; Wu, Xiaoai; Huang, Tao; Hultman, Karin; Paulsen, Sarah J.; Wang, Jishu; Bugge, Anne; Frantzen, Jane Boesen; Norgaard, Per; Jeppesen, Jacob Fuglsbjerg; Yang, Zhiru; Secher, Anna; Chen, Haibin; Li, Xun; John, Linu Mary; Shan, Bing; He, Zhenhua; Gao, Xiang; Su, Jing; Hansen, Kristian T.; Yang, Wei; Jorgensen, Sebastian Beck			GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand	NATURE MEDICINE			English	Article							TGF-BETA SUPERFAMILY; GDNF FAMILY LIGANDS; VAGAL AFFERENT; FOOD-INTAKE; MIC-1; RAT; RET; IDENTIFICATION; ACTIVATION; CYTOKINE	Growth differentiation factor 15 (GDF15; also known as MIC-1) is a divergent member of the TGF-beta superfamily and is associated with body-weight regulation in humans and rodents. However, the cognate receptor of GDF15 is unknown. Here we show that GDF15 binds specifically to GDNF family receptor a-like (GFRAL) with high affinity, and that GFRAL requires association with the coreceptor RET to elicit intracellular signaling in response to GDF15 stimulation. We also found that GDF15-mediated reductions in food intake and body weight of mice with obesity were abolished in GFRAL-knockout mice. We further found that GFRAL expression was limited to hindbrain neurons and not present in peripheral tissues, which suggests that GDF15-GFRAL-mediated regulation of food intake is by a central mechanism. Lastly, given that GDF15 did not increase energy expenditure in treated mice with obesity, the anti-obesity actions of the cytokine are likely driven primarily by a reduction in food intake.	[Yang, Linda; Chang, Chih-Chuan; Sun, Zhe; Zhu, Haisun; Wu, Xiaoai; Huang, Tao; Wang, Jishu; Yang, Zhiru; Chen, Haibin; Li, Xun; Shan, Bing; He, Zhenhua; Gao, Xiang; Su, Jing; Yang, Wei] Novo Nordisk AS, Novo Nordisk Res Ctr China, Beijing, Peoples R China; [Madsen, Dennis; Padkjaer, Soren B.; Hultman, Karin; Paulsen, Sarah J.; Bugge, Anne; Frantzen, Jane Boesen; Norgaard, Per; Jeppesen, Jacob Fuglsbjerg; Secher, Anna; John, Linu Mary; Hansen, Kristian T.; Jorgensen, Sebastian Beck] Novo Nordisk AS, Global Res, Malov, Denmark	Novo Nordisk; Novo Nordisk	Jorgensen, SB (corresponding author), Novo Nordisk AS, Global Res, Malov, Denmark.	sbbj@novonordisk.com	Chen, Haibin/GWC-4803-2022; Yang, Wei/U-6557-2017	Yang, Wei/0000-0002-7634-6601; John, Linu M./0000-0002-1698-1400; Chen, Haibin/0000-0003-2589-7347; Li, Xun/0000-0002-6773-491X; Bugge, Anne/0000-0001-5885-4541; Jorgensen, Sebastian Beck/0000-0002-9648-0971				Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Artz A, 2016, BLOOD, V128, P529, DOI 10.1182/blood-2016-01-696617; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, GENE, V237, P105, DOI 10.1016/S0378-1119(99)00309-1; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Chrysovergis K, 2014, INT J OBESITY, V38, P1555, DOI 10.1038/ijo.2014.27; Fairlie WD, 2001, BIOCHEMISTRY-US, V40, P65, DOI 10.1021/bi001064p; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Li ZH, 2005, J NEUROCHEM, V95, P361, DOI 10.1111/j.1471-4159.2005.03372.x; Liu DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28653; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Mazagova M, 2013, AM J PHYSIOL-RENAL, V305, pF1249, DOI 10.1152/ajprenal.00387.2013; Moran TH, 1997, AM J PHYSIOL-REG I, V272, pR1245; Mwangi SM, 2014, AM J PHYSIOL-GASTR L, V306, pG515, DOI 10.1152/ajpgi.00364.2013; NORGREN R, 1994, AM J PHYSIOL-REG I, V267, pR1136, DOI 10.1152/ajpregu.1994.267.4.R1136; Park H, 2016, ONCOTARGET, V7, P9634, DOI 10.18632/oncotarget.7457; Quartu M, 2007, BRAIN RES, V1173, P36, DOI 10.1016/j.brainres.2007.07.064; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Tsai VWW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133362; Tsai VWW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100370; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Valdimarsdottir G, 2005, APMIS, V113, P773, DOI 10.1111/j.1600-0463.2005.apm_3181.x; Wong A, 2005, MOL CELL BIOL, V25, P9661, DOI 10.1128/MCB.25.21.9661-9673.2005; Yang CH, 2006, J MOL HISTOL, V37, P69, DOI 10.1007/s10735-006-9035-8	34	286	305	4	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1158	+		10.1038/nm.4394	http://dx.doi.org/10.1038/nm.4394			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28846099				2022-12-27	WOS:000412431800011
J	Wetsman, N				Wetsman, Nicole			Inflammatory illness: Why the next wave of antidepressants may target the immune system	NATURE MEDICINE			English	News Item							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; MAJOR DEPRESSION; INTERLEUKIN-6; ASSOCIATION; CYTOKINES											AUSTIN SC, 1992, JAMA-J AM MED ASSOC, V268, P516, DOI 10.1001/jama.268.4.516; Cartmell T, 2003, J PHYSIOL-LONDON, V549, P653, DOI 10.1113/jphysiol.2002.037291; Cattaneo A, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw045; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Leday G.R.G., 2017, BIOL PSYCHIAT; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Powell TR, 2013, EUR NEUROPSYCHOPHARM, V23, P1105, DOI 10.1016/j.euroneuro.2012.09.009; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Valentine AD, 1998, SEMIN ONCOL, V25, P39; Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029	12	7	9	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1009	1011		10.1038/nm0917-1009	http://dx.doi.org/10.1038/nm0917-1009			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886000				2022-12-27	WOS:000409996200003
J	Busse, WW				Busse, William W.			A role for neutrophils in asthma exacerbations	NATURE MEDICINE			English	Editorial Material							NETOSIS	A recent study has found that rhinovirus-induced exacerbation of asthma is in part mediated by the release of neutrophil extracellular traps and double-stranded DNA by neutrophils in the airway.	[Busse, William W.] Univ Wisconsin, Sch Med, Div Allergy Pulm & Crit Care Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Busse, WW (corresponding author), Univ Wisconsin, Sch Med, Div Allergy Pulm & Crit Care Med, Madison, WI 53706 USA.	wwb@medicine.wisc.edu		Busse, William/0000-0003-2591-4696				Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jarjour NN, 2000, J ALLERGY CLIN IMMUN, V105, P1169, DOI 10.1067/mai.2000.106376; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671	10	15	15	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					658	659		10.1038/nm.4351	http://dx.doi.org/10.1038/nm.4351			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586342				2022-12-27	WOS:000402768000005
J	Gantois, I; Khoutorsky, A; Popic, J; Aguilar-Valles, A; Freemantle, E; Cao, RF; Sharma, V; Pooters, T; Nagpal, A; Skalecka, A; Truong, VT; Wiebe, S; Groves, IA; Jafarnejad, SM; Chapat, C; McCullagh, EA; Gamache, K; Nader, K; Lacaille, JC; Gkogkas, CG; Sonenberg, N				Gantois, Ilse; Khoutorsky, Arkady; Popic, Jelena; Aguilar-Valles, Argel; Freemantle, Erika; Cao, Ruifeng; Sharma, Vijendra; Pooters, Tine; Nagpal, Anmol; Skalecka, Agnieszka; Truong, Vinh T.; Wiebe, Shane; Groves, Isabelle A.; Jafarnejad, Seyed Mehdi; Chapat, Clement; McCullagh, Elizabeth A.; Gamache, Karine; Nader, Karim; Lacaille, Jean-Claude; Gkogkas, Christos G.; Sonenberg, Nahum			Metformin ameliorates core deficits in a mouse model of fragile X syndrome	NATURE MEDICINE			English	Article							PROTEIN-SYNTHESIS; GENETIC REMOVAL; PHENOTYPES; ABNORMALITIES; MINOCYCLINE; MICROBIOTA; KINASE; BRAIN; MICE	Fragile X syndrome (FXS) is the leading monogenic cause of autism spectrum disorders (ASD). Trinucleotide repeat expansions in FMR1 abolish FMRP expression, leading to hyperactivation of ERK and mTOR signaling upstream of mRNA translation. Here we show that metformin, the most widely used drug for type 2 diabetes, rescues core phenotypes in Fmr1(-/y) mice and selectively normalizes ERK signaling, eIF4E phosphorylation and the expression of MMP-9. Thus, metformin is a potential FXS therapeutic.	[Gantois, Ilse; Khoutorsky, Arkady; Popic, Jelena; Aguilar-Valles, Argel; Cao, Ruifeng; Sharma, Vijendra; Nagpal, Anmol; Skalecka, Agnieszka; Truong, Vinh T.; Wiebe, Shane; Jafarnejad, Seyed Mehdi; Chapat, Clement; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Gantois, Ilse; Khoutorsky, Arkady; Popic, Jelena; Aguilar-Valles, Argel; Cao, Ruifeng; Sharma, Vijendra; Nagpal, Anmol; Skalecka, Agnieszka; Truong, Vinh T.; Wiebe, Shane; Jafarnejad, Seyed Mehdi; Chapat, Clement; Sonenberg, Nahum] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Khoutorsky, Arkady] McGill Univ, Dept Anesthesia, Montreal, PQ, Canada; [Khoutorsky, Arkady] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Aguilar-Valles, Argel; Freemantle, Erika; Lacaille, Jean-Claude] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Aguilar-Valles, Argel; Freemantle, Erika; Lacaille, Jean-Claude] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Cao, Ruifeng] Univ Minnesota, Med Sch, Dept Biomed Sci, Duluth, MN 55812 USA; [Pooters, Tine; Groves, Isabelle A.; Gkogkas, Christos G.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland; [Pooters, Tine; Groves, Isabelle A.; Gkogkas, Christos G.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [McCullagh, Elizabeth A.] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO USA; [Gamache, Karine; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of Minnesota System; University of Minnesota Duluth; University of Edinburgh; University of Edinburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; McGill University	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Sonenberg, N (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada.	nahum.sonenberg@mcgill.ca	Gkogkas, Christos/GLR-5348-2022; Jafarnejad, Sadegh/D-2075-2018; Cao, Ruifeng/P-3819-2019; Gkogkas, Christos/GQH-2659-2022; Sharma, Vijendra/AAQ-2555-2021; Nagpal, Anmol/AAQ-5850-2020; Aguilar-Valles, Argel/B-4259-2009	Cao, Ruifeng/0000-0001-5105-7726; Gkogkas, Christos/0000-0001-6281-3419; Sharma, Vijendra/0000-0002-0945-2623; Aguilar-Valles, Argel/0000-0002-2272-1138; Khoutorsky, Arkady/0000-0003-3846-8728; Pooters, Tine/0000-0002-2568-5021; Wiebe, Shane/0000-0002-2751-0209; Chapat, Clement/0000-0002-5806-7959; Popic, Jelena/0000-0002-0959-3856; Jafarnejad, Seyed Mehdi/0000-0002-5129-7081; Nagpal, Anmol/0000-0002-3269-0494	FRAXA Research Foundation; Brain Canada/FNC; CIHR foundation [FDN-148423]; Brain & Behavior Research Foundation [24365]; Wellcome Trust/Royal Society Sir Henry Dale grant [107687/Z/15/Z]; Canada Research Chair Program [950-231066]; Brain Canada/NeuroDevNet Postdoctoral Training Award	FRAXA Research Foundation; Brain Canada/FNC; CIHR foundation(Canadian Institutes of Health Research (CIHR)); Brain & Behavior Research Foundation(NARSAD); Wellcome Trust/Royal Society Sir Henry Dale grant; Canada Research Chair Program(Canada Research Chairs); Brain Canada/NeuroDevNet Postdoctoral Training Award	This work is supported by the FRAXA Research Foundation, Brain Canada/FNC, a CIHR foundation grant (FDN-148423) and Brain & Behavior Research Foundation grants (24365) to N.S.; a Wellcome Trust/Royal Society Sir Henry Dale grant (107687/Z/15/Z) to C.G.G.; the Canada Research Chair Program (950-231066) to J.-C.L.; and a Brain Canada/NeuroDevNet Postdoctoral Training Award to J.P.	Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Dziembowska M, 2013, AM J MED GENET A, V161, P1897, DOI 10.1002/ajmg.a.36023; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Gkogkas CG, 2014, CELL REP, V9, P1742, DOI 10.1016/j.celrep.2014.10.064; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z; Khang R, 2014, NEUROSCI LETT, V579, P145, DOI 10.1016/j.neulet.2014.07.029; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Leigh MJS, 2013, J DEV BEHAV PEDIATR, V34, P147, DOI 10.1097/DBP.0b013e318287cd17; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Ming M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114573; Mogil JS, 2006, PAIN, V126, P24, DOI 10.1016/j.pain.2006.06.004; Monyak R. E., 2016, MOL PSYCHIAT; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sidhu H, 2014, J NEUROSCI, V34, P9867, DOI 10.1523/JNEUROSCI.1162-14.2014; Singh J, 2016, J NEUROCHEM, V138, P86, DOI 10.1111/jnc.13562; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Udagawa T, 2013, NAT MED, V19, P1473, DOI 10.1038/nm.3353; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016	27	115	118	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					674	+		10.1038/nm.4335	http://dx.doi.org/10.1038/nm.4335			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28504725	Green Published, Green Accepted			2022-12-27	WOS:000402768000009
J	Mohammad, F; Weissmann, S; Leblanc, B; Pandey, DP; Hojfeldt, JW; Comet, I; Zheng, CQ; Johansen, JV; Rapin, N; Porse, BT; Tvardovskiy, A; Jensen, ON; Olaciregui, NG; Lavarino, C; Sunol, M; de Torres, C; Mora, J; Carcaboso, AM; Helin, K				Mohammad, Faizaan; Weissmann, Simon; Leblanc, Benjamin; Pandey, Deo P.; Hojfeldt, Jonas W.; Comet, Itys; Zheng, Chunqin; Johansen, Jens Vilstrup; Rapin, Nicolas; Porse, Bo T.; Tvardovskiy, Andrey; Jensen, Ole N.; Olaciregui, Nagore G.; Lavarino, Cinzia; Sunol, Mariona; de Torres, Carmen; Mora, Jaume; Carcaboso, Angel M.; Helin, Kristian			EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas	NATURE MEDICINE			English	Article							SOMATIC MUTATIONS; H3K27 METHYLATION; GENOMIC ANALYSIS; INHIBITION; CELLS; ACVR1; SUBGROUPS; LYMPHOMA; PATTERNS; CHILDREN	Diffuse intrinsic pontine glioma (DIPG) is an aggressive brain tumor that is located in the pons and primarily affects children. Nearly 80% of DIPGs harbor mutations in histone H3 genes, wherein lysine 27 is substituted with methionine (H3K27M). H3K27M has been shown to inhibit polycomb repressive complex 2 (PRC2), a multiprotein complex responsible for the methylation of H3 at lysine 27 (H3K27me), by binding to its catalytic subunit EZH2. Although DIPGs with the H3K27M mutation show global loss of H3K27me3, several genes retain H3K27me3. Here we describe a mouse model of DIPG in which H3K27M potentiates tumorigenesis. Using this model and primary patient-derived DIPG cell lines, we show that H3K27M-expressing tumors require PRC2 for proliferation. Furthermore, we demonstrate that small-molecule EZH2 inhibitors abolish tumor cell growth through a mechanism that is dependent on the induction of the tumor-suppressor protein p16INK4A. Genome-wide enrichment analyses show that the genes that retain H3K27me3 in H3K27M cells are strong polycomb targets. Furthermore, we find a highly significant overlap between genes that retain H3K27me3 in the DIPG mouse model and in human primary DIPGs expressing H3K27M. Taken together, these results show that residual PRC2 activity is required for the proliferation of H3K27M-expressing DIPGs, and that inhibition of EZH2 is a potential therapeutic strategy for the treatment of these tumors.	[Mohammad, Faizaan; Weissmann, Simon; Leblanc, Benjamin; Pandey, Deo P.; Hojfeldt, Jonas W.; Comet, Itys; Zheng, Chunqin; Johansen, Jens Vilstrup; Rapin, Nicolas; Porse, Bo T.; Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Mohammad, Faizaan; Weissmann, Simon; Leblanc, Benjamin; Pandey, Deo P.; Hojfeldt, Jonas W.; Comet, Itys; Zheng, Chunqin; Tvardovskiy, Andrey; Jensen, Ole N.; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Leblanc, Benjamin; Rapin, Nicolas; Porse, Bo T.; Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr Danstem, Fac Hlth & Med Sci, Copenhagen, Denmark; [Rapin, Nicolas; Porse, Bo T.] Univ Copenhagen, Fac Hlth & Med Sci, Finsen Lab, Rigshosp, Copenhagen, Denmark; [Rapin, Nicolas] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Tvardovskiy, Andrey; Jensen, Ole N.] Univ Southern Denmark, Dept Biochem & Mol Biol, VILLUM Ctr Bioanalyt Sci, Odense M, Denmark; [Olaciregui, Nagore G.; Lavarino, Cinzia; de Torres, Carmen; Mora, Jaume; Carcaboso, Angel M.] Hosp St Joan de Deu Barcelona, Dept Pediat Hematol & Oncol, Barcelona, Spain; [Sunol, Mariona] Hosp St Joan de Deu Barcelona, Pathol, Barcelona, Spain	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Southern Denmark	Helin, K (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.; Helin, K (corresponding author), Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark.; Helin, K (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr Danstem, Fac Hlth & Med Sci, Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Jensen, Ole N/J-1763-2012	Helin, Kristian/0000-0003-1975-6097; Jensen, Ole N/0000-0003-1862-8528; Pandey, Deo Prakash/0000-0001-5493-3197; Porse, Bo/0000-0001-6043-0844; Carcaboso, Angel/0000-0002-8485-426X; Vilstrup Johansen, Jens/0000-0001-7094-6801; Rapin, Nicolas/0000-0001-5208-8874; Mora, Jaume/0000-0002-9386-5980; Hojfeldt, Jonas/0000-0003-1260-2247; Leblanc, Benjamin/0000-0002-8657-2821; Tvardovskiy, Andrey/0000-0003-3252-280X; Comet, Itys/0000-0001-7265-2284	EMBO [874-2011, 1411-2011]; Danish Medical Research Council; Lundbeck Foundation; Danish Medical Research Council [DFF - 4004-00081]; Danish National Research Foundation [DNRF 82]; Novo Nordisk Foundation (Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease); Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya; Fondo Alicia Pueyo; AECC Scientific Foundation; European Union [PIRG-08-GA-2010-276998]; ISCIII-FEDER [CP13/00189]; Villum Fonden [00007292] Funding Source: researchfish; Novo Nordisk Foundation Section for Basic Stem Cell Biology [Porse group, Helin group NNF] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation (Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease); Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya; Fondo Alicia Pueyo; AECC Scientific Foundation; European Union(European Commission); ISCIII-FEDER; Villum Fonden(Villum Fonden); Novo Nordisk Foundation Section for Basic Stem Cell Biology	We thank members of the Helin laboratory for discussions. F.M. was supported by a postdoctoral fellowship from EMBO (874-2011). D.P. was supported by a postdoctoral fellowship from EMBO (1411-2011) and the Danish Medical Research Council. I.C. was supported by a fellowship from the Lundbeck Foundation. The work in the Helin laboratory was supported by the Danish Medical Research Council (DFF - 4004-00081), the Danish National Research Foundation (DNRF 82), and through a center grant from the Novo Nordisk Foundation (The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease). A.M.C. acknowledges support from the Xarxa de Bancs de Tumors de Catalunya (XBTC) sponsored by Pla Director d'Oncologia de Catalunya, and funding from the Fondo Alicia Pueyo, AECC Scientific Foundation, European Union Seventh Framework Programme (FP7/2007-2013) under Marie Curie International Reintegration Grant (PIRG-08-GA-2010-276998) and ISCIII-FEDER (CP13/00189). We thank S. Pollard for the gift of GNS cell lines, N. Gupta for providing the SF7761 and SF8628 cell lines and L. Uhrbom and P. Lewis for plasmids.	Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Caretti V, 2011, BRAIN PATHOL, V21, P441, DOI 10.1111/j.1750-3639.2010.00468.x; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Laigle-Donadey F, 2008, CURR OPIN ONCOL, V20, P662, DOI 10.1097/CCO.0b013e32831186e0; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schroeder KM, 2014, PEDIATR RES, V75, P205, DOI 10.1038/pr.2013.194; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sidoli S, 2014, PROTEOMICS, V14, P2200, DOI 10.1002/pmic.201400084; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhang P, 2015, INT J CANCER, V137, P2007, DOI 10.1002/ijc.29566	42	274	282	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					483	+		10.1038/nm.4293	http://dx.doi.org/10.1038/nm.4293			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28263309				2022-12-27	WOS:000398768100016
J	Puig, S; Gutstein, HB				Puig, Stephanie; Gutstein, Howard B.			Opioids: keeping the good, eliminating the bad	NATURE MEDICINE			English	Editorial Material							LONG-TERM POTENTIATION; INDUCED HYPERALGESIA; TOLERANCE; MECHANISMS	Two new studies show that mechanisms mediating the opioid side effects of tolerance, hyperalgesia and physical dependence are mediated spinally and can be dissociated from analgesia. These side effects can be selectively targeted by clinically available drugs without affecting their pain-relieving effects.	[Puig, Stephanie; Gutstein, Howard B.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Puig, Stephanie; Gutstein, Howard B.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gutstein, HB (corresponding author), Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA.; Gutstein, HB (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA.	gutsteinhb@upmc.edu	Puig, Stephanie/GXF-5432-2022	Puig, Stephanie/0000-0001-7200-1094	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036680] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA036680] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Burma N., 2017, NAT MED; Cahill CM, 2016, TRENDS PHARMACOL SCI, V37, P963, DOI 10.1016/j.tips.2016.08.002; Corder G., 2017, NAT MED; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; GUTSTEIN HB, 1993, BRAIN RES, V626, P332, DOI 10.1016/0006-8993(93)90597-G; KIM DH, 1990, BRAIN RES, V516, P37, DOI 10.1016/0006-8993(90)90894-H; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Wise RA, 2014, NEUROPSYCHOPHARMACOL, V39, P254, DOI 10.1038/npp.2013.261; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	12	7	7	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					272	273		10.1038/nm.4277	http://dx.doi.org/10.1038/nm.4277			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28134927	Green Accepted			2022-12-27	WOS:000395848400004
J	Khurana, S; Fuentes, S; Coyle, EM; Ravichandran, S; Davey, RT; Beigel, JH				Khurana, Surender; Fuentes, Sandra; Coyle, Elizabeth M.; Ravichandran, Supriya; Davey, Richard T., Jr.; Beigel, John H.			Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies (vol 22, pg 1439, 2016)	NATURE MEDICINE			English	Correction													Samuthirapandiyan, Ravichandran/AAI-6658-2020; Beigel, John H/GNP-2628-2022; Beigel, John/AAQ-4289-2021	Samuthirapandiyan, Ravichandran/0000-0002-8632-5062; Beigel, John/0000-0002-4879-4941	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Khurana S, 2016, NAT MED, V22, P1439, DOI 10.1038/nm.4201	1	0	0	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					264	264		10.1038/nm0217-264c	http://dx.doi.org/10.1038/nm0217-264c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170379				2022-12-27	WOS:000393729000021
J	Papapetrou, EP				Papapetrou, Eirini P.			Patient-derived induced pluripotent stem cells in cancer research and precision oncology	NATURE MEDICINE			English	Article							COPY NUMBER; HEMATOPOIETIC PROGENITORS; GENOMIC INSTABILITY; ORGANOID CULTURES; GENE-EXPRESSION; SOMATIC-CELLS; DISEASE; MODEL; GENERATION; DIFFERENTIATION	Together with recent advances in the processing and culture of human tissue, bioengineering, xenotransplantation and genome editing, Induced pluripotent stem cells (iPSCs) present a range of new opportunities for the study of human cancer. Here we discuss the main advantages and limitations of iPSC modeling, and how the method intersects with other patient-derived models of cancer, such as organoids, organson- chips and patient-derived xenografts (PDXs). We highlight the opportunities that iPSC models can provide beyond those offered by existing systems and animal models and present current challenges and crucial areas for future improvements toward wider adoption of this technology.	[Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Papapetrou, Eirini P.] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.; Papapetrou, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA.	eirini.papapetrou@mssm.edu		Papapetrou, Eirini/0000-0001-7002-417X	US National Institutes of Health (NIH) [R00 DK087923, R01 HL121570]; Lawrence Ellison Foundation; Damon Runyon Cancer Research Foundation; Edward Evans Foundation; Taub Foundation for MDS research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK087923] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Ellison Foundation(Lawrence Ellison Foundation); Damon Runyon Cancer Research Foundation; Edward Evans Foundation; Taub Foundation for MDS research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	E.P.P. is supported by US National Institutes of Health (NIH) grants R00 DK087923 and R01 HL121570; by the Lawrence Ellison Foundation; by the Damon Runyon Cancer Research Foundation; by the Edward Evans Foundation; and by the Taub Foundation for MDS research.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Antony-Debre I, 2015, BLOOD, V125, P930, DOI 10.1182/blood-2014-06-585513; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Burrows CK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005793; Cao LS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7653; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005; Chen YJ, 2015, CELL STEM CELL, V17, P233, DOI 10.1016/j.stem.2015.06.001; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Corominas-Faja B, 2013, CELL CYCLE, V12, P3109, DOI 10.4161/cc.26173; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Engle SJ, 2014, J BIOL CHEM, V289, P4562, DOI 10.1074/jbc.R113.529156; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Feraud O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149291; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Gandre-Babbe S, 2013, BLOOD, V121, P4925, DOI 10.1182/blood-2013-01-478412; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Garbes L, 2013, HUM MOL GENET, V22, P398, DOI 10.1093/hmg/dds437; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Giobbe GG, 2015, NAT METHODS, V12, P637, DOI [10.1038/nmeth.3411, 10.1038/NMETH.3411]; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Guye P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10243; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HENDERSON E, 1977, VIROLOGY, V76, P152, DOI 10.1016/0042-6822(77)90292-6; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hosoi M, 2014, EXP HEMATOL, V42, P816, DOI 10.1016/j.exphem.2014.03.010; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ingber DE, 2016, CELL, V164, P1105, DOI 10.1016/j.cell.2016.02.049; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim J, 2015, EMBO J, V34, P739, DOI 10.15252/embj.201490736; Kim J, 2013, CELL REP, V3, P2088, DOI 10.1016/j.celrep.2013.05.036; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee DF, 2015, CELL, V161, P240, DOI 10.1016/j.cell.2015.02.045; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Majumder B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7169; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Maqsood MI, 2013, CELL BIOL INT, V37, P1038, DOI 10.1002/cbin.10137; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Mulero-Navarro S, 2015, CELL REP, V13, P504, DOI 10.1016/j.celrep.2015.09.019; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Papapetrou EP, 2016, SCIENCE, V353, P991, DOI 10.1126/science.aai7626; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Passier R, 2016, CELL STEM CELL, V18, P309, DOI [10.1016/j.stem.2016.02.011, 10.1016/j.stem.2016.02.013]; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Rowe RG, 2016, CELL STEM CELL, V18, P707, DOI 10.1016/j.stem.2016.05.016; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Soyombo AA, 2013, STEM CELL REP, V1, P336, DOI 10.1016/j.stemcr.2013.08.004; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tapia N, 2016, CELL STEM CELL, V19, P298, DOI 10.1016/j.stem.2016.06.017; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; van den Berg CW, 2015, DEVELOPMENT, V142, P3231, DOI 10.1242/dev.123810; Varela C, 2012, J CLIN INVEST, V122, P569, DOI 10.1172/JCI46268; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu J, 2016, CELL, V165, P1572, DOI 10.1016/j.cell.2016.05.043; Ye ZH, 2014, STEM CELLS, V32, P269, DOI 10.1002/stem.1545; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zeltner N, 2015, CURR OPIN CELL BIOL, V37, P102, DOI 10.1016/j.ceb.2015.10.008; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237	128	88	92	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1392	1401		10.1038/nm.4238	http://dx.doi.org/10.1038/nm.4238			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923030	Green Accepted			2022-12-27	WOS:000389549000016
J	Yun, S; Reynolds, RP; Masiulis, I; Eisch, AJ				Yun, Sanghee; Reynolds, Ryan P.; Masiulis, Irene; Eisch, Amelia J.			Re-evaluating the link between neuropsychiatric disorders and dysregulated adult neurogenesis	NATURE MEDICINE			English	Article							DEEP-BRAIN-STIMULATION; DENTATE GRANULE CELLS; NEURAL PROGENITOR CELLS; HIPPOCAMPAL NEUROGENESIS; PATTERN SEPARATION; ENVIRONMENTAL ENRICHMENT; VENTRAL HIPPOCAMPUS; DRUG-ADDICTION; ANIMAL-MODEL; MICE IMPAIRS	People diagnosed with neuropsychiatric disorders such as depression, anxiety, addiction or schizophrenia often have dysregulated memory, mood, pattern separation and/or reward processing. These symptoms are indicative of a disrupted function of the dentate gyrus (DG) subregion of the brain, and they improve with treatment and remission. The dysfunction of the DG is accompanied by structural maladaptations, including dysregulation of adult-generated neurons. An increasing number of studies using modern inducible approaches to manipulate new neurons show that the behavioral symptoms in animal models of neuropsychiatric disorders can be produced or exacerbated by the inhibition of DG neurogenesis. Thus, here we posit that the connection between neuropsychiatric disorders and dysregulated DG neurogenesis is beyond correlation or epiphenomenon, and that the regulation of adult generated DG neurogenesis merits continued and focused attention in the ongoing effort to develop novel treatments for neuropsychiatric disorders.	[Yun, Sanghee; Reynolds, Ryan P.; Eisch, Amelia J.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Masiulis, Irene; Eisch, Amelia J.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Eisch, Amelia J.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Eisch, Amelia J.] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Eisch, AJ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA.; Eisch, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.; Eisch, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.; Eisch, AJ (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.	eischa@email.chop.edu	Yun, Sanghee/AAL-7543-2020	Yun, Sanghee/0000-0001-7505-0836; Reynolds, Ryan/0000-0002-3781-0766; Eisch, Amelia/0000-0001-6476-5385	US National Institutes of Health [DA023701, DA023555, MH107945]; US National Aeronautics and Space Administration [NNX15AE09G];  [NIMH T32-MH076690]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107945, T32MH076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290, K02DA023555, R21DA023701] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants to A.J.E. from the US National Institutes of Health (DA023701, DA023555, MH107945) and the US National Aeronautics and Space Administration (NNX15AE09G). S.Y. was funded by a postdoctoral institutional training grant (NIMH T32-MH076690, Basic Science Training Program in the Neurobiology of Mental Illness, PI, C. Tamminga).	Ahmed AIA, 2013, J CLIN PSYCHOPHARM, V33, P55, DOI 10.1097/JCP.0b013e31827c0117; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Alia-Klein N, 2011, ARCH GEN PSYCHIAT, V68, P283, DOI 10.1001/archgenpsychiatry.2011.10; Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; Altman J., 1975, HIPPOCAMPUS STRUCTUR, P95, DOI [10.1007/978-1-4684-2976-3_5, DOI 10.1007/978-1-4684-2976-3_5]; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Amrein I, 2004, EUR J NEUROSCI, V20, P3342, DOI 10.1111/j.1460-9568.2004.03795.x; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bayer R, 2015, DRUG ALCOHOL DEPEN, V156, P139, DOI 10.1016/j.drugalcdep.2015.09.005; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bedard A, 2011, NEUROGENESIS IN THE ADULT BRAIN II: CLINICAL IMPLICATIONS, P1, DOI 10.1007/978-4-431-53945-2_1; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Bystritsky A, 2006, MOL PSYCHIATR, V11, P805, DOI 10.1038/sj.mp.4001852; Cameron H.A., 2007, HDB CONT NEUROPHARMA; Canales JJ, 2010, BEHAV PHARMACOL, V21, P379, DOI 10.1097/FBP.0b013e32833e16b6; Castilla-Ortega E, 2016, NEUROSCI BIOBEHAV R, V66, P15, DOI 10.1016/j.neubiorev.2016.03.030; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Culpepper L, 2004, J CLIN PSYCHIAT, V65, P742; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Das T, 2014, SCHIZOPHR RES, V159, P193, DOI 10.1016/j.schres.2014.05.006; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Elvsashagen T, 2013, BIPOLAR DISORD, V15, P167, DOI 10.1111/bdi.12046; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fattore L, 2016, NEUROSCI BIOBEHAV R, V65, P341, DOI 10.1016/j.neubiorev.2016.04.006; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; Gilpin N.W., 2015, BRAIN REWARD STRESS; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Henn FA, 2004, BIOL PSYCHIAT, V56, P146, DOI 10.1016/j.biopsych.2004.04.011; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Johnston ST, 2016, NEUROBIOL LEARN MEM, V129, P60, DOI 10.1016/j.nlm.2015.10.013; Jonas P, 2015, STRUCTURE FUNCTION P; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Keilhoff G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/832757; Kempermann G., 2006, ADULT NEUROGENSIS ST; Kempermann G, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P271, DOI 10.1007/978-4-431-53933-9_11; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Koob GF, 2005, NEUROBIOLOGY ADDICTI; Kropff E, 2015, CURR OPIN NEUROBIOL, V35, P21, DOI 10.1016/j.conb.2015.06.002; Lacar Benjamin, 2014, F1000Prime Rep, V6, P8, DOI 10.12703/P6-8; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lemaire V, 2012, J NEUROSCI, V32, P3101, DOI 10.1523/JNEUROSCI.4731-11.2012; Lepousez G, 2015, NEURON, V86, P387, DOI 10.1016/j.neuron.2015.01.002; Lerner TN, 2016, CELL, V164, P1136, DOI 10.1016/j.cell.2016.02.027; Levone BR, 2015, NEUROBIOL STRESS, V1, P147, DOI 10.1016/j.ynstr.2014.11.003; Liberzon I., 2016, NEUROBIOLOGY PTSD BR; Liu KY, 2016, HIPPOCAMPUS, V26, P705, DOI 10.1002/hipo.22561; Lopez-Rojas J, 2016, NEUROSCI BIOBEHAV R, V64, P167, DOI 10.1016/j.neubiorev.2016.02.021; Lucassen PJ, 2013, MOL PSYCHIATR, V18, P396, DOI 10.1038/mp.2012.39; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mackey S, 2013, NEUROSCI BIOBEHAV R, V37, P300, DOI 10.1016/j.neubiorev.2012.12.003; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mandyam CD, 2012, TRENDS NEUROSCI, V35, P250, DOI 10.1016/j.tins.2011.12.005; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Manji Husseini K, 2003, World Psychiatry, V2, P136; Marvel CL, 2004, PSYCHIAT CLIN N AM, V27, P19, DOI 10.1016/S0193-953X(03)00106-0; McAvoy KM, 2016, NEURON, V91, P1356, DOI 10.1016/j.neuron.2016.08.009; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Mouchlianitis E, 2016, LANCET PSYCHIAT, V3, P451, DOI 10.1016/S2215-0366(15)00540-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mustroph ML, 2011, EUR J NEUROSCI, V34, P1161, DOI 10.1111/j.1460-9568.2011.07828.x; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Narayan VA, 2016, NAT REV DRUG DISCOV, V15, P71, DOI 10.1038/nrd.2015.20; Niibori Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2261; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; O'Leary OF, 2014, TRENDS PHARMACOL SCI, V35, P675, DOI 10.1016/j.tips.2014.09.011; Otten M, 2015, J AFFECT DISORDERS, V174, P113, DOI 10.1016/j.jad.2014.11.001; Peng ZW, 2013, BEHAV BRAIN RES, V244, P1, DOI 10.1016/j.bbr.2013.01.032; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Platel JC, 2013, CELL MOL LIFE SCI, V70, P3591, DOI 10.1007/s00018-013-1262-z; Player MJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2101, DOI 10.1038/npp.2013.126; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scharfman H. E., 2011, DENTATE GYRUS COMPRE; Schoenfeld TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P113, DOI 10.1038/npp.2014.230; Seo DO, 2015, J NEUROSCI, V35, P11330, DOI 10.1523/JNEUROSCI.0483-15.2015; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Song J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018937; Song J, 2013, NAT NEUROSCI, V16, P1728, DOI 10.1038/nn.3572; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Suthana N, 2014, NEUROIMAGE, V85, P996, DOI 10.1016/j.neuroimage.2013.07.066; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Sweeney P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10188; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Tannenholz L, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00147; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Toni N, 2011, EUR J NEUROSCI, V33, P1062, DOI 10.1111/j.1460-9568.2011.07604.x; Tsai CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9373; Vaidya V. A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P358, DOI 10.2174/187152707783220910; van Dijk RM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00022; Vivar Carmen, 2013, Curr Top Behav Neurosci, V15, P189, DOI 10.1007/7854_2012_220; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Wadiche JI, 2015, NEURON, V85, P3, DOI 10.1016/j.neuron.2014.12.047; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; WEST MJ, 1988, BRAIN RES, V448, P167, DOI 10.1016/0006-8993(88)91114-6; Wosiski-Kuhn M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00096; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yang SM, 2015, J NEUROSCI, V35, P15379, DOI 10.1523/JNEUROSCI.2345-15.2015; Yu EP, 2013, J NEUROSCI, V33, P2947, DOI 10.1523/JNEUROSCI.1868-12.2013; Zhai TY, 2014, BEHAV BRAIN RES, V272, P209, DOI 10.1016/j.bbr.2014.06.054	148	80	81	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1239	1247		10.1038/nm.4218	http://dx.doi.org/10.1038/nm.4218			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783068	Green Accepted			2022-12-27	WOS:000387302300015
J	Wang, ZH; Zhang, XJ; Ji, YX; Zhang, P; Deng, KQ; Gong, J; Ren, SX; Wang, XH; Chen, I; Wang, H; Gao, C; Yokota, T; Ang, YS; Li, S; Cass, A; Vondriska, TM; Li, GP; Deb, A; Srivastava, D; Yang, HT; Xiao, XS; Li, HL; Wang, YB				Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Ren, Shuxun; Wang, Xinghua; Chen, Iris; Wang, He; Gao, Chen; Yokota, Tomohiro; Ang, Yen Sin; Li, Shen; Cass, Ashley; Vondriska, Thomas M.; Li, Guangping; Deb, Arjun; Srivastava, Deepak; Yang, Huang-Tian; Xiao, Xinshu; Li, Hongliang; Wang, Yibin			The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy	NATURE MEDICINE			English	Article							HISTONE METHYLATION; GENE-EXPRESSION; HEART; BINDING; MTOR; RAPTOR; IDENTIFICATION; REPRESSION; REGULATOR; CHROMATIN	Epigenetic reprogramming is a critical process of pathological gene induction during cardiac hypertrophy and remodeling, but the underlying regulatory mechanisms remain to be elucidated. Here we identified a heart-enriched long noncoding (Inc)RNA, named cardiac-hypertrophy-associated epigenetic regulator (Chaer), which is necessary for the development of cardiac hypertrophy. Mechanistically, Chaer directly interacts with the catalytic subunit of polycomb repressor complex 2 (PRC2). This interaction, which is mediated by a 66-mer motif in Chaer, interferes with PRC2 targeting to genomic loci, thereby inhibiting histone H3 lysine 27 methylation at the promoter regions of genes involved in cardiac hypertrophy. The interaction between Chaer and PRC2 is transiently induced after hormone or stress stimulation in a process involving mammalian target of rapamycin complex 1, and this interaction is a prerequisite for epigenetic reprogramming and induction of genes involved in hypertrophy. Inhibition of Chaer expression in the heart before, but not after, the onset of pressure overload substantially attenuates cardiac hypertrophy and dysfunction. Our study reveals that stress-induced pathological gene activation in the heart requires a previously uncharacterized IncRNA-dependent epigenetic checkpoint.	[Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Li, Hongliang] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China; [Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Li, Hongliang] Wuhan Univ, Anim Expt Ctr, Anim Biosafety Level Lab 3, Wuhan, Peoples R China; [Wang, Zhihua; Zhang, Xiao-Jing; Ji, Yan-Xiao; Zhang, Peng; Deng, Ke-Qiong; Gong, Jun; Li, Hongliang] Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Peoples R China; [Wang, Zhihua; Ren, Shuxun; Chen, Iris; Wang, He; Gao, Chen; Yokota, Tomohiro; Vondriska, Thomas M.; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Wang, Xinghua; Li, Guangping] Tianjin Med Univ, Hosp 2, Tianjin Inst Cardiol, Dept Cardiol, Tianjin, Peoples R China; [Ang, Yen Sin] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Ang, Yen Sin] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Li, Shen; Deb, Arjun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Li, Shen; Deb, Arjun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Cass, Ashley; Xiao, Xinshu] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Integrat Biol & Physiol,Coll Life Sci, Los Angeles, CA 90095 USA; [Cass, Ashley; Xiao, Xinshu] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA; [Yang, Huang-Tian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Yang, Huang-Tian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Mol Cardiol, Shanghai, Peoples R China; [Yang, Huang-Tian] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China	Wuhan University; Wuhan University; Wuhan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tianjin Medical University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Li, HL (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Anim Expt Ctr, Anim Biosafety Level Lab 3, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Med Res Inst, Sch Med, Wuhan, Peoples R China.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA.	lihl@whu.edu.cn; yibinwang@mednet.ucla.edu	Wang, Zhihua/AAM-1486-2021; wang, xinghua/AAE-4659-2022	Wang, Yibin/0000-0003-0852-0767; Yokota, Tomohiro/0000-0003-2540-3810; Srivastava, Deepak/0000-0002-3480-5953; Wang, Zhihua/0000-0002-1800-2384; Xiao, Xinshu/0000-0002-9362-8029	US National Institute of Health (NIH) [HL070079, HL103205, HL108186, HL110667, HL115238, R01HG006264, U01HG007013]; University of California at Los Angeles CTSI-Cardiovascular Pilot Team research grant [UL1TR000124]; National Science Fund for Distinguished Young Scholars [81425005]; Key Project of the National Natural Science Foundation [81330005, 81630011]; National Science and Technology Support Project [2013YQ030923-05, 2014BAI02B01, 2015BAI08801]; American Heart Association Western States Affiliate Postdoctoral Fellowship [15POST24970034]; UCLA Eli and Edythe Broad Center Predoctoral Fellowship in Stem Cell Science; China Scholarship Council [201406280042]; Jennifer S. Buchwald Graduate Fellowship in Physiology; NIH [T90DE022734]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL110667, R01HL070079, R01HL123295, R01HL114437, R01HL108186, R01HL137241, R01HL115238, R01HL122737, R01HL129178, R01HL103205, R01HL129639] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006264, U01HG007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022734] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Los Angeles CTSI-Cardiovascular Pilot Team research grant; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project of the National Natural Science Foundation; National Science and Technology Support Project; American Heart Association Western States Affiliate Postdoctoral Fellowship(American Heart Association); UCLA Eli and Edythe Broad Center Predoctoral Fellowship in Stem Cell Science; China Scholarship Council(China Scholarship Council); Jennifer S. Buchwald Graduate Fellowship in Physiology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the US National Institute of Health (NIH) (grant no. HL070079 (Y.W.), HL103205 (Y.W.), HL108186 (Y.W.), HL110667 (Y.W.), HL115238 (T.M.V.), R01HG006264 (X.X.) and U01HG007013 (X.X.)), the University of California at Los Angeles CTSI-Cardiovascular Pilot Team research grant UL1TR000124 (Y.W., X.X. and T.M.V.), the National Science Fund for Distinguished Young Scholars (grant no. 81425005; H.L.), the Key Project of the National Natural Science Foundation (grant no. 81330005 and 81630011; both to H.L.), the National Science and Technology Support Project (grant no. 2013YQ030923-05, 2014BAI02B01 and 2015BAI08801; all to H.L.) and an American Heart Association Western States Affiliate Postdoctoral Fellowship (15POST24970034; Z.W.). C.G. was a recipient of the UCLA Eli and Edythe Broad Center Predoctoral Fellowship in Stem Cell Science. H.W. was supported by the China Scholarship Council (award no. 201406280042) and was a recipient of a Jennifer S. Buchwald Graduate Fellowship in Physiology. A.C. was supported by NIH predoctoral training grant T90DE022734. The authors wish to acknowledge outstanding technical support from H. Pu and Core support from the UCLA Cardiovascular Research Laboratories and the Division of Molecular Medicine at UCLA.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Angrisano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106024; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Han P, 2014, NATURE, V514, P102, DOI 10.1038/nature13596; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Jiang F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152767; Joh RI, 2014, BBA-GENE REGUL MECH, V1839, P1385, DOI 10.1016/j.bbagrm.2014.06.006; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kaneda R, 2009, GENES CELLS, V14, P69, DOI 10.1111/j.1365-2443.2008.01252.x; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Kurian L, 2015, CIRCULATION, V131, P1278, DOI 10.1161/CIRCULATIONAHA.114.013303; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li Q, 2015, P NATL ACAD SCI USA, V112, P899, DOI 10.1073/pnas.1420695112; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078; Liu XQ, 2015, EXP CELL RES, V335, P123, DOI 10.1016/j.yexcr.2015.04.012; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Marketou ME, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5720758; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Matkovich SJ, 2014, P NATL ACAD SCI USA, V111, P12264, DOI 10.1073/pnas.1410622111; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Ounzain S, 2015, EUR HEART J, V36, P353, DOI 10.1093/eurheartj/ehu180; Papait R, 2013, P NATL ACAD SCI USA, V110, P20164, DOI 10.1073/pnas.1315155110; Peters T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150236; Sala V, 2012, MOL MED, V18, P938, DOI 10.2119/molmed.2011.00512; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shende P, 2016, CARDIOVASC RES, V109, P103, DOI 10.1093/cvr/cvv252; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Viereck J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1475; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang K, 2014, CIRC RES, V114, P1377, DOI 10.1161/CIRCRESAHA.114.302476; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wang ZH, 2015, CIRC RES, V116, P235, DOI 10.1161/CIRCRESAHA.114.305490; Wu L, 2013, BIOCHEMISTRY-US, V52, P9519, DOI 10.1021/bi401085h; Xu N, 2015, J PATHOL, V235, P672, DOI 10.1002/path.4480; Yang T, 2013, BIOCHEM BIOPH RES CO, V436, P578, DOI 10.1016/j.bbrc.2013.05.079	54	257	269	0	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1131	1139		10.1038/nm.4179	http://dx.doi.org/10.1038/nm.4179			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27618650	Green Accepted, Green Submitted			2022-12-27	WOS:000384872500016
J	Morton, NM; Beltram, J; Carter, RN; Michailidou, Z; Gorjanc, G; McFadden, C; Barrios-Llerena, ME; Rodriguez-Cuenca, S; Gibbins, MTG; Aird, RE; Moreno-Navarrete, JM; Munger, SC; Svenson, KL; Gastaldello, A; Ramage, L; Naredo, G; Zeyda, M; Wang, ZV; Howie, AF; Saari, A; Sipila, P; Stulnig, TM; Gudnason, V; Kenyon, CJ; Seckl, JR; Walker, BR; Webster, SP; Dunbar, DR; Churchill, GA; Vidal-Puig, A; Fernandez-Real, JM; Emilsson, V; Horvat, S				Morton, Nicholas M.; Beltram, Jasmina; Carter, Roderick N.; Michailidou, Zoi; Gorjanc, Gregor; McFadden, Clare; Barrios-Llerena, Martin E.; Rodriguez-Cuenca, Sergio; Gibbins, Matthew T. G.; Aird, Rhona E.; Maria Moreno-Navarrete, Jose; Munger, Steven C.; Svenson, Karen L.; Gastaldello, Annalisa; Ramage, Lynne; Naredo, Gregorio; Zeyda, Maximilian; Wang, Zhao V.; Howie, Alexander F.; Saari, Aila; Sipila, Petra; Stulnig, Thomas M.; Gudnason, Vilmundur; Kenyon, Christopher J.; Seckl, Jonathan R.; Walker, Brian R.; Webster, Scott P.; Dunbar, Donald R.; Churchill, Gary A.; Vidal-Puig, Antonio; Manuel Fernandez-Real, Jose; Emilsson, Valur; Horvat, Simon			Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESITY; RHODANESE; FAT; DIFFERENTIATION; DEHYDROGENASE; PREVALENCE; VARIANTS; CAPACITY	The discovery of genetic mechanisms for resistance to obesity and diabetes may illuminate new therapeutic strategies for the treatment of this global health challenge. We used the polygenic 'lean' mouse model, which has been selected for low adiposity over 60 generations, to identify mitochondrial thiosulfate sulfurtransferase (Tst; also known as rhodanese) as a candidate obesity resistance gene with selectively increased expression in adipocytes. Elevated adipose Tst expression correlated with indices of metabolic health across diverse mouse strains. Transgenic overexpression of Tst in adipocytes protected mice from diet-induced obesity and insulin-resistant diabetes. Tst-deficient mice showed markedly exacerbated diabetes, whereas pharmgcological activation of TST ameliorated diabetes in mice. Mechanistically, TST selectively augmented mitochondrial function combined with degradation of reactive oxygen species and sulfide. In humans, TST mRNA expression in adipose tissue correlated positively with insulin sensitivity in adipose tissue and negatively with fat mass. Thus, the genetic identification of Tst as a beneficial regulator of adipocyte mitochondrial function may have therapeutic significance for individuals with type 2 diabetes.	[Morton, Nicholas M.; Carter, Roderick N.; Michailidou, Zoi; McFadden, Clare; Barrios-Llerena, Martin E.; Gibbins, Matthew T. G.; Aird, Rhona E.; Gastaldello, Annalisa; Ramage, Lynne; Naredo, Gregorio; Kenyon, Christopher J.; Seckl, Jonathan R.; Walker, Brian R.; Webster, Scott P.; Dunbar, Donald R.] Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Beltram, Jasmina; Gorjanc, Gregor; Horvat, Simon] Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia; [Rodriguez-Cuenca, Sergio; Vidal-Puig, Antonio] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Level 4, Cambridge, England; [Maria Moreno-Navarrete, Jose; Manuel Fernandez-Real, Jose] Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Maria Moreno-Navarrete, Jose; Manuel Fernandez-Real, Jose] Univ Girona, Dept Med, Girona, Spain; [Maria Moreno-Navarrete, Jose; Manuel Fernandez-Real, Jose] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Girona, Spain; [Munger, Steven C.; Svenson, Karen L.; Churchill, Gary A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Clin Div Endocrinol & Metab, Dept Med 3, Vienna, Austria; [Wang, Zhao V.] Univ Texas Southwestern Med Ctr, Touchstone Diabet Ctr, Dept Internal Med, Dallas, TX USA; [Howie, Alexander F.] Univ Edinburgh, Queens Med Res Inst, Med Res Council MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Saari, Aila] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland; [Sipila, Petra] Univ Turku, Cent Anim Lab, Turku, Finland; [Gudnason, Vilmundur; Emilsson, Valur] Iceland Heart Assoc, Kopavogur, Iceland; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Emilsson, Valur] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia	University of Edinburgh; University of Ljubljana; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Jackson Laboratory; Medical University of Vienna; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Edinburgh; University of Turku; University of Turku; Icelandic Heart Association; Wellcome Trust Sanger Institute; University of Iceland; National Institute of Chemistry - Slovenia	Morton, NM (corresponding author), Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.; Horvat, S (corresponding author), Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia.; Horvat, S (corresponding author), Natl Inst Chem, Ljubljana, Slovenia.	nik.morton@ed.ac.uk; simon.horvat@bf.uni-lj.si	Gorjanc, Gregor/D-3684-2014; Gastaldello, Annalisa/AAV-1629-2021; Gudnason, Vilmundur/AAE-7126-2019; Barrios-LLerena, Martin/AAM-8152-2020; Churchill, Gary/AAY-7496-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Morton, NICHOLAS/ABF-3774-2020; Moreno-Navarrete, José María/ABG-5548-2021; Sipilä, Petra/GYE-3323-2022; Moreno-Navarrete, José María/H-9772-2015; Gastaldello, Annalisa/H-9108-2019	Gorjanc, Gregor/0000-0001-8008-2787; Gudnason, Vilmundur/0000-0001-5696-0084; Churchill, Gary/0000-0001-9190-9284; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Gastaldello, Annalisa/0000-0002-4365-1191; Vidal-Puig, Antonio/0000-0003-4220-9577; Emilsson, Valur/0000-0001-9982-0524; Sipila, Petra/0000-0001-8187-7143; Stulnig, Thomas/0000-0003-3300-6161; Zeyda, Maximilian/0000-0001-5000-1974; Barrios-LLerena, Martin/0000-0002-1416-8686; Webster, Scott/0000-0003-4656-4744	Wellcome Trust [100981/Z/13/Z]; Research Councils UK Fellowship; British Heart Foundation Centre of Research Excellence exchange award; Slovenian Research Agency [P4-0220, N5-0003 Syntol, J4-6804]; British Heart Foundation Research Excellence Award; Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; US National Institutes of Health [R01GM 070683]; FIS [PI11/00214]; UK Medical Research Council (MRC) MDU; MRC Programme grant; MRC DMC Core; MITIN [HEALTH-F4-2008-223450]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074299] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468, R01GM070683] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J009865/1] Funding Source: researchfish; Medical Research Council [G0400192, G0600717, MC_UU_12012/5, MC_UU_12012/5/B, G0802051, MC_G0802535, MC_UU_12012/2] Funding Source: researchfish; BBSRC [BB/J009865/1] Funding Source: UKRI; MRC [MC_UU_12012/2, MC_UU_12012/5, MC_G0802535, G0802051, G0400192, G0600717] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Research Councils UK Fellowship(UK Research & Innovation (UKRI)); British Heart Foundation Centre of Research Excellence exchange award; Slovenian Research Agency(Slovenian Research Agency - Slovenia); British Heart Foundation Research Excellence Award; Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIS(Instituto de Salud Carlos III); UK Medical Research Council (MRC) MDU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC DMC Core(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MITIN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	N.M.M. was supported by a Career Development Fellowship, an Institutional Strategic Support Fund award and a New Investigator Award from the Wellcome Trust (100981/Z/13/Z), a Research Councils UK Fellowship and a British Heart Foundation Centre of Research Excellence exchange award. We thank the Slovenian Research Agency for support (core funding P4-0220; project N5-0003 Syntol and J4-6804; all to S.H.) and for a Young Scientist Fellowship (J.B.). We acknowledge support of the British Heart Foundation Research Excellence Award in support of the contribution by the Bioinformatics Core (D.R.D.). T.M.S. received funding from the Federal Ministry of Economy, Family and Youth and from the Austrian National Foundation for Research, Technology and Development. G.A.C. was supported by the US National Institutes of Health grant R01GM 070683. J.M.F.-R. acknowledges funding from FIS PI11/00214. A.V.-P. was funded by the UK Medical Research Council (MRC) MDU, an MRC Programme grant, MRC DMC Core and MITIN (HEALTH-F4-2008-223450). We thank M. Wabitsch (University of Ulm) for the gift of the SGBS human preadipocyte cell line.	BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gauss KA, 2003, FASEB J, V17, pC97; Geng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073892; Hall AH, 2009, CRIT REV TOXICOL, V39, P541, DOI 10.1080/10408440802304944; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Held IM, 2010, NAT GENET, V42, P949; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Moreno-Navarrete JM, 2013, DIABETES, V62, P1923, DOI 10.2337/db12-0977; Mathes WF, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511001905; Morton NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023944; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; PAGANI S, 1983, BIOCHIM BIOPHYS ACTA, V742, P278, DOI 10.1016/0167-4838(83)90312-6; Prevorsek Z, 2010, MAMM GENOME, V21, P172, DOI 10.1007/s00335-010-9252-z; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sabelli R, 2008, FEBS J, V275, P3884, DOI 10.1111/j.1742-4658.2008.06535.x; Sen U, 2008, PHARMACOLOGY, V82, P201, DOI 10.1159/000156486; Simoncic M, 2008, BEHAV GENET, V38, P292, DOI 10.1007/s10519-008-9199-y; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Vigouroux C, 2011, INT J BIOCHEM CELL B, V43, P862, DOI 10.1016/j.biocel.2011.03.002; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	40	40	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					771	779		10.1038/nm.4115	http://dx.doi.org/10.1038/nm.4115			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27270587	Green Accepted			2022-12-27	WOS:000379366900016
J	Lamas, B; Richard, ML; Leducq, V; Pham, HP; Michel, ML; Da Costa, G; Bridonneau, C; Jegou, S; Hoffmann, TW; Natividad, JM; Brot, L; Taleb, S; Couturier-Maillard, A; Nion-Larmurier, I; Merabtene, F; Seksik, P; Bourrier, A; Cosnes, J; Ryffel, B; Beaugerie, L; Launay, JM; Langella, P; Xavier, RJ; Sokol, H				Lamas, Bruno; Richard, Mathias L.; Leducq, Valentin; Pham, Hang-Phuong; Michel, Marie-Laure; Da Costa, Gregory; Bridonneau, Chantal; Jegou, Sarah; Hoffmann, Thomas W.; Natividad, Jane M.; Brot, Loic; Taleb, Soraya; Couturier-Maillard, Aurelie; Nion-Larmurier, Isabelle; Merabtene, Fatiha; Seksik, Philippe; Bourrier, Anne; Cosnes, Jacques; Ryffel, Bernhard; Beaugerie, Laurent; Launay, Jean-Marie; Langella, Philippe; Xavier, Ramnik J.; Sokol, Harry			CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands	NATURE MEDICINE			English	Article							ADAPTER PROTEIN CARD9; BACTERIAL-INFECTION; IL-22; CELLS; RESPONSES; INTERLEUKIN-22; IDENTIFICATION; PREVALENCE; DEFICIENCY; ACTIVATION	Complex interactions between the host and the gut microbiota govern intestinal homeostasis but remain poorly understood. Here we reveal a relationship between gut microbiota and caspase recruitment domain family member 9 (CARD9), a susceptibility gene for inflammatory bowel disease (IBD) that functions in the immune response against microorganisms. CARD9 promotes recovery from colitis by promoting interleukin (IL)-22 production, and Card9(-/-) mice are more susceptible to colitis. The microbiota is altered in Card9(-/-) mice, and transfer of the microbiota from Card9(-/-) to wild-type, germ-free recipients increases their susceptibility to colitis. The microbiota from Card9(-/-) mice fails to metabolize tryptophan into metabolites that act as aryl hydrocarbon receptor (AHR) ligands. Intestinal inflammation is attenuated after inoculation of mice with three Lactobacillus strains capable of metabolizing tryptophan or by treatment with an AHR agonist. Reduced production of AHR ligands is also observed in the microbiota from individuals with IBD, particularly in those with CARD9 risk alleles associated with IBD. Our findings reveal that host genes affect the composition and function of the gut microbiota, altering the production of microbial metabolites and intestinal inflammation.	[Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] Univ Paris 06, Sorbonne Univ, Paris, France; [Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] INSERM, Avenir Team Gut Microbiota & Immun, Equipe Rech Labelisee ERL 1157, Paris, France; [Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] CNRS, Unite Mixte Rech UMR 7203, Paris, France; [Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] Ctr Hosp Univ CHU St Antoine, Lab BioMol LBM, 27 Rue Chaligny, Paris, France; [Lamas, Bruno; Richard, Mathias L.; Michel, Marie-Laure; Da Costa, Gregory; Bridonneau, Chantal; Hoffmann, Thomas W.; Natividad, Jane M.; Langella, Philippe; Sokol, Harry] Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, Jouy En Josas, France; [Lamas, Bruno; Richard, Mathias L.; Leducq, Valentin; Michel, Marie-Laure; Da Costa, Gregory; Bridonneau, Chantal; Jegou, Sarah; Hoffmann, Thomas W.; Natividad, Jane M.; Brot, Loic; Langella, Philippe; Sokol, Harry] Inflammat Immunopathol Biotherapy Dept DHU i2B, Paris, France; [Pham, Hang-Phuong] Hop La Pitie Salpetriere, ILTOO Pharma Incubateur & Pepiniere Entreprises P, Paris, France; [Taleb, Soraya] INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France; [Taleb, Soraya] Univ Paris 05, Paris, France; [Couturier-Maillard, Aurelie; Ryffel, Bernhard] Univ Orleans, CNRS, Lab Expt & Mol Immunol & Neurogenet, UMR 7355, Orleans, France; [Nion-Larmurier, Isabelle; Seksik, Philippe; Bourrier, Anne; Cosnes, Jacques; Beaugerie, Laurent; Sokol, Harry] UPMC, St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France; [Merabtene, Fatiha] INSERM, Ctr Rech St Antoine, Plateforme Morphol Petit Anim, UMR S938, Paris, France; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa; [Launay, Jean-Marie] Hop Lariboisiere, INSERM, Dept Biochem, UMR S942, F-75475 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, Ctr Biol Resources BB 0033 00064, F-75475 Paris, France; [Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Cape Town; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Sokol, H (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.; Sokol, H (corresponding author), INSERM, Avenir Team Gut Microbiota & Immun, Equipe Rech Labelisee ERL 1157, Paris, France.; Sokol, H (corresponding author), CNRS, Unite Mixte Rech UMR 7203, Paris, France.; Sokol, H (corresponding author), Ctr Hosp Univ CHU St Antoine, Lab BioMol LBM, 27 Rue Chaligny, Paris, France.; Sokol, H (corresponding author), Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, Jouy En Josas, France.; Sokol, H (corresponding author), Inflammat Immunopathol Biotherapy Dept DHU i2B, Paris, France.; Sokol, H (corresponding author), UPMC, St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France.	harry.sokol@aphp.fr	Langella, Philippe/N-8368-2017; sokol, harry/ABA-8991-2020; Taleb, Soraya/K-8176-2017; Richard, Mathias L./GRR-7524-2022; Sokol, Harry/E-2290-2019; SEKSIK, Philippe/ABE-2962-2020	Langella, Philippe/0000-0001-5960-4341; sokol, harry/0000-0002-2914-1822; Taleb, Soraya/0000-0002-6650-619X; Richard, Mathias L./0000-0002-9256-8191; Sokol, Harry/0000-0002-2914-1822; Michel, Marie-Laure/0000-0003-2657-4662; PHAM, Hang-Phuong/0000-0002-7896-7401; DA COSTA, Gregory/0000-0003-1436-916X; SEKSIK, Philippe/0000-0003-3596-9893; , blamas/0000-0002-7777-2127	Equipe ATIP-Avenir; INSERM-ITMO SP; ECCO grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Equipe ATIP-Avenir; INSERM-ITMO SP; ECCO grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the ANAXEM germ-free platform, the members of the animal facilities of INRA, and T. Ledent of the animal facilities of Saint-Antoine Hospital for their assistance in mouse care; M. Moroldo and J. Lecardonnel from the CRB GADIE core facility for technical assistance in performing the microarray analyses; S. Dumont for technical help in histology and immunochemistry; and C. Aubry, N.M. Breyner, F. Chain, S. Le Guin, C. Cherbuy, N. Lapaque, and D. Skurnik for fruitful discussions and technical help. We also thank E. Drouet and the Clinical Research Assistant team of Unite de Recherche Clinique de l'Est Parisien for their help in obtaining samples from patients with IBD. Ido1<SUP>-/-</SUP> and Il22<SUP>-/-</SUP> mice were provided by S. Taleb (INSERM Unit 970) and B. Ryffel (CNRS, UMR7355), respectively. The H1L1.1c2 cell line was provided by M.S. Denison (University of California, Davis). Funding was provided by Equipe ATIP-Avenir 2012 (H.S.), INSERM-ITMO SP 2013 (H.S.) and ECCO grant 2012 (H.S.).	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Silva MJB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/321241; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chung KT, 2011, ENVIRON MOL MUTAGEN, V52, P81, DOI 10.1002/em.20588; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; He GC, 2011, ENVIRON TOXICOL CHEM, V30, P1915, DOI 10.1002/etc.581; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim K, 2014, CARCINOGENESIS, V35, P1352, DOI 10.1093/carcin/bgu044; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lin L, 2013, CURR MICROBIOL, V67, P209, DOI 10.1007/s00284-013-0348-z; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maneglier B, 2004, CLIN CHEM, V50, P2166, DOI 10.1373/clinchem.2004.037465; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Richard ML, 2015, INFLAMM BOWEL DIS, V21, P656, DOI 10.1097/MIB.0000000000000261; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056860	52	685	731	28	293	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					598	+		10.1038/nm.4102	http://dx.doi.org/10.1038/nm.4102			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158904	Green Accepted			2022-12-27	WOS:000377476000012
J	Binnewies, M; Roberts, EW; Kersten, K; Chan, V; Fearon, DF; Merad, M; Coussens, LM; Gabrilovich, DI; Ostrand-Rosenberg, S; Hedrick, CC; Vonderheide, RH; Pittet, MJ; Jain, RK; Zou, WP; Howcroft, TK; Woodhouse, EC; Weinberg, RA; Krummel, MF				Binnewies, Mikhail; Roberts, Edward W.; Kersten, Kelly; Chan, Vincent; Fearon, Douglas F.; Merad, Miriam; Coussens, Lisa M.; Gabrilovich, Dmitry I.; Ostrand-Rosenberg, Suzanne; Hedrick, Catherine C.; Vonderheide, Robert H.; Pittet, Mikael J.; Jain, Rakesh K.; Zou, Weiping; Howcroft, T. Kevin; Woodhouse, Elisa C.; Weinberg, Robert A.; Krummel, Matthew F.			Understanding the tumor immune microenvironment (TIME) for effective therapy	NATURE MEDICINE			English	Review							TERTIARY LYMPHOID STRUCTURES; T-CELL DYSFUNCTION; BREAST-CANCER; DENDRITIC CELLS; COLORECTAL-CANCER; MACROPHAGE ACTIVATION; MOLECULAR SUBTYPES; PANCREATIC-CANCER; LABORATORY MICE; PROMOTES	The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical response with immunotherapeutic intervention; however, many more patients have experienced minimal or no clinical benefit when provided the same treatment. As technology has advanced, so has the understanding of the complexity and diversity of the immune context of the tumor microenvironment and its influence on response to therapy. It has been possible to identify different subclasses of immune environment that have an influence on tumor initiation and response and therapy; by parsing the unique classes and subclasses of tumor immune microenvironment (TIME) that exist within a patient's tumor, the ability to predict and guide immunotherapeutic responsiveness will improve, and new therapeutic targets will be revealed.	[Binnewies, Mikhail; Roberts, Edward W.; Kersten, Kelly; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA; [Fearon, Douglas F.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Coussens, Lisa M.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Gabrilovich, Dmitry I.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Ostrand-Rosenberg, Suzanne] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Ostrand-Rosenberg, Suzanne] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Ostrand-Rosenberg, Suzanne] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Vonderheide, Robert H.] Univ Penn, Dept Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs Tumor Biol, Boston, MA 02114 USA; [Jain, Rakesh K.] Harvard Med Sch, Boston, MA USA; [Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Howcroft, T. Kevin; Woodhouse, Elisa C.] NCI, Div Canc Biol, NIH, Bethesda, MD 20892 USA; [Weinberg, Robert A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cold Spring Harbor Laboratory; Icahn School of Medicine at Mount Sinai; Oregon Health & Science University; The Wistar Institute; University System of Maryland; University of Maryland Baltimore County; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; La Jolla Institute for Immunology; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Massachusetts Institute of Technology (MIT); Whitehead Institute	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.; Krummel, MF (corresponding author), Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA.; Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu; matthew.krummel@ucsf.edu	Gabrilovich, Dmitry/ABE-7122-2020; Pittet, Mikael/ABD-6300-2021; Jain, Rakesh K/I-1384-2017; Coussens, Lisa/ABH-9834-2020	Jain, Rakesh K/0000-0001-7571-3548; Ostrand-Rosenberg, Suzanne/0000-0002-2095-9732; Roberts, Edward/0000-0002-8229-1715	NCI NIH HHS [R01 CA190400, P30 CA010815, R35 CA197743, R01 CA202987, R01 CA173861, R01 CA206890, R01 CA208205, R01 CA211016, P01 CA080124] Funding Source: Medline; NIAID NIH HHS [R01 AI114787] Funding Source: Medline; NICHD NIH HHS [T32 HD007470] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R35CA197743, P30CA010815, P01CA080124, R01CA211016, R01CA202987, R01CA173861, R01CA206890, R01CA190400, R01CA208205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114787] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ademmer K, 1998, CLIN EXP IMMUNOL, V112, P21; Ali HR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002194; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Boland PM, 2017, CANCERS, V9, DOI 10.3390/cancers9050050; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Evans RA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88328; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290; Flint TR, 2016, CELL METAB, V24, P672, DOI 10.1016/j.cmet.2016.10.010; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Garbe AI, 2006, CANCER RES, V66, P508, DOI 10.1158/0008-5472.CAN-05-2383; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hale M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118784; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Khalili JS, 2012, CLIN CANCER RES, V18, P5329, DOI 10.1158/1078-0432.CCR-12-1632; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Koelwyn GJ, 2017, NAT REV CANCER, V17, P620, DOI 10.1038/nrc.2017.78; Kokolus KM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00023; Kokolus KM, 2013, P NATL ACAD SCI USA, V110, P20176, DOI 10.1073/pnas.1304291110; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lee HJ, 2016, J CLIN PATHOL, V69, P422, DOI 10.1136/jclinpath-2015-203089; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Lutz ER, 2014, CANCER IMMUNOL RES, V2, P616, DOI 10.1158/2326-6066.CIR-14-0027; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Nywening TM, 2016, LANCET ONCOL, V17, P651, DOI 10.1016/S1470-2045(16)00078-4; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pucci F, 2016, CELL REP, V17, P1764, DOI 10.1016/j.celrep.2016.10.031; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Qian BZ, 2015, J EXP MED, V212, P1433, DOI 10.1084/jem.20141555; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2016, INT IMMUNOL, V28, P383, DOI 10.1093/intimm/dxw014; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Svoronos N, 2017, CANCER DISCOV, V7, P72, DOI 10.1158/2159-8290.CD-16-0502; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Thompson MG, 2017, CANCER IMMUNOL IMMUN, V66, P615, DOI 10.1007/s00262-017-1972-4; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tsujikawa T, 2017, CELL REP, V19, P203, DOI 10.1016/j.celrep.2017.03.037; Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	111	2036	2080	157	1200	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					541	550		10.1038/s41591-018-0014-x	http://dx.doi.org/10.1038/s41591-018-0014-x			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29686425	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000432126800009
J	Tan, J; Sack, BK; Oyen, D; Zenklusen, I; Piccoli, L; Barbieri, S; Foglierini, M; Fregni, CS; Marcandalli, J; Jongo, S; Abdulla, S; Perez, L; Corradin, G; Varani, L; Sallusto, F; Sim, BKL; Hoffman, SL; Kappe, SHI; Daubenberger, C; Wilson, IA; Lanzavecchia, A				Tan, Joshua; Sack, Brandon K.; Oyen, David; Zenklusen, Isabelle; Piccoli, Luca; Barbieri, Sonia; Foglierini, Mathilde; Fregni, Chiara Silacci; Marcandalli, Jessica; Jongo, Said; Abdulla, Salim; Perez, Laurent; Corradin, Giampietro; Varani, Luca; Sallusto, Federica; Sim, Betty Kim Lee; Hoffman, Stephen L.; Kappe, Stefan H. I.; Daubenberger, Claudia; Wilson, Ian A.; Lanzavecchia, Antonio			A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein	NATURE MEDICINE			English	Article							MEMORY B-CELLS; PLASMODIUM-FALCIPARUM; MONOCLONAL-ANTIBODIES; VACCINE; EFFICACY; IMMUNIZATION; SPOROZOITES; PROTECTION; IMMUNITY; MEMBRANE	Immunization with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria, but the features of the antibody response induced by this treatment remain unclear. To investigate this response in detail, we isolated IgM and IgG monoclonal antibodies from Tanzanian volunteers who were immunized with repeated injection of Sanaria PfSPZ Vaccine and who were found to be protected from controlled human malaria infection with infectious homologous PfSPZs. All isolated IgG monoclonal antibodies bound to P. falciparum circumsporozoite protein (PfCSP) and recognized distinct epitopes in its N terminus, NANP-repeat region, and C terminus. Strikingly, the most effective antibodies, as determined in a humanized mouse model, bound not only to the repeat region, but also to a minimal peptide at the PfCSP N-terminal junction that is not in the RTS, S vaccine. These dual-specific antibodies were isolated from different donors and were encoded by VH3-30 or VH3-33 alleles that encode tryptophan or arginine at position 52. Using structural and mutational data, we describe the elements required for germline recognition and affinity maturation. Our study provides potent neutralizing antibodies and relevant information for lineage-targeted vaccine design and immunization strategies.	[Tan, Joshua; Piccoli, Luca; Barbieri, Sonia; Foglierini, Mathilde; Fregni, Chiara Silacci; Marcandalli, Jessica; Perez, Laurent; Varani, Luca; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Tan, Joshua] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford, England; [Sack, Brandon K.; Kappe, Stefan H. I.] Ctr Infect Dis Res, Seattle, WA USA; [Oyen, David; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Zenklusen, Isabelle; Daubenberger, Claudia] Univ Basel, Fac Sci, Basel, Switzerland; [Zenklusen, Isabelle] Swiss Trop & Publ Hlth Inst, Clin Immunol Unit, Basel, Switzerland; [Foglierini, Mathilde] Swiss Inst Bioinformat SIB, Lausanne, Switzerland; [Jongo, Said; Abdulla, Salim] Ifakara Hlth Inst, Bagamoyo Clin Trial Unit, Bagamoyo, Tanzania; [Corradin, Giampietro] Univ Lausanne, Biochem Dept, Epalinges, Switzerland; [Sallusto, Federica; Lanzavecchia, Antonio] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Sim, Betty Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Universita della Svizzera Italiana; University of Oxford; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Scripps Research Institute; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Swiss Institute of Bioinformatics; Ifakara Health Institute; University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Sanaria Inc.; Scripps Research Institute	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland.; Lanzavecchia, A (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	lanzavecchia@irb.usi.ch	Perez, Laurent/ABA-4145-2021	Perez, Laurent/0000-0002-8860-7928; Daubenberger, Claudia/0000-0001-7136-0642; Varani, Luca/0000-0002-0963-0987; Piccoli, Luca/0000-0002-1085-6502; Foglierini, Mathilde/0000-0001-7538-4262	Swiss Vaccine Research Institute; European Research Council [670955]; Fondazione Aldo e Cele Dacco; Wellcome Trust [204689/Z/16/Z]; National Institutes of Health [F32 AI 114113]; PATH's Malaria Vaccine Initiative; Scripps Research Institute; Bill and Melinda Gates Foundation; Helmut Horten Foundation; DOE Office of Science User Facility [DE-AC02-05CH11231]; Tanzanian Commission on Science and Technology (COSTECH); Ifakara Health Institute; Swiss Tropical Public Health Institute; Bill and Melinda Gates foundation [24922]; National Institute of Allergy and Infectious Diseases (NIAID) [5R44AI055229]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI055229, F32AI114113] Funding Source: NIH RePORTER	Swiss Vaccine Research Institute; European Research Council(European Research Council (ERC)European Commission); Fondazione Aldo e Cele Dacco; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PATH's Malaria Vaccine Initiative; Scripps Research Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Helmut Horten Foundation; DOE Office of Science User Facility(United States Department of Energy (DOE)); Tanzanian Commission on Science and Technology (COSTECH); Ifakara Health Institute; Swiss Tropical Public Health Institute; Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank M. Nussenzweig (Rockefeller University) and H. Wardemann (German Cancer Research Center) for providing reagents for antibody cloning and expression. This work was supported in part by the Swiss Vaccine Research Institute, by the European Research Council (grant no. 670955 BROADimmune) and by the Fondazione Aldo e Cele Dacco. J.T. is funded by the Wellcome Trust (grant no. 204689/Z/16/Z). B.S. is funded by the National Institutes of Health (grant no. F32 AI 114113). The authors would like to thank first and foremost the study volunteers for their participation in the study. We also thank the entire study team at the Bagamoyo branch of the Ifakara Health Institute and the manufacturing, quality control, regulatory and clinical teams at Sanaria, Inc. for their contributions to the conduct of the trial. We would like to thank M. Tanner (former director of the Swiss Tropical and Public Health Institute, Basel) for his vision and support of the development of the clinical trial platform enabling whole sporozoite-based malaria vaccine trials in Bagamoyo, Tanzania. D.O. and I.A.W. are funded by PATH's Malaria Vaccine Initiative under a collaborative agreement with The Scripps Research Institute and by the Bill and Melinda Gates Foundation. A.L. and F.S. are supported by the Helmut Horten Foundation. This research used resources of the Advanced Light Source, which is a DOE Office of Science User Facility under contract no. DE-AC02-05CH11231. The Tanzanian Commission on Science and Technology (COSTECH), the Ifakara Health Institute, and the Swiss Tropical Public Health Institute provided funding for the clinical trial. The functional assays were supported by the Bill and Melinda Gates foundation (Investment ID: 24922). The development, manufacturing, and quality control release and stability studies of PfSPZ Vaccine and PfSPZ Challenge were supported in part by National Institute of Allergy and Infectious Diseases (NIAID) Small Business Innovation Research grant 5R44AI055229. Sanaria supported transport of PfSPZ Vaccine and PfSPZ Challenge to the study site and syringe preparation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Dups JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00625; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hernandez EC, 2005, TISSUE ANTIGENS, V66, P640, DOI 10.1111/j.1399-0039.2005.00491.x; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Hsia Y, 2016, NATURE, V540, DOI 10.1038/nature20108; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kaushansky A, 2012, MOL BIOCHEM PARASIT, V183, P100, DOI 10.1016/j.molbiopara.2012.01.006; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lepore R, 2017, NUCLEIC ACIDS RES, V45, pW17, DOI 10.1093/nar/gkx334; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; Sack BK, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0028-2; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; World Health Organization, 2017, WORLD MAL REP 2016; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	64	122	129	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					401	+		10.1038/nm.4513	http://dx.doi.org/10.1038/nm.4513			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29554084	Green Accepted			2022-12-27	WOS:000429639800011
J	He, XL; Zhang, LG; Queme, LF; Liu, XZ; Lu, A; Waclaw, RR; Dong, XR; Zhou, WH; Kidd, G; Yoon, SO; Buonanno, A; Rubin, JB; Xin, M; Nave, KA; Trapp, BD; Jankowski, MP; Lu, QR				He, Xuelian; Zhang, Liguo; Queme, Luis F.; Liu, Xuezhao; Lu, Andrew; Waclaw, Ronald R.; Dong, Xinran; Zhou, Wenhao; Kidd, Grahame; Yoon, Sung-Ok; Buonanno, Andres; Rubin, Joshua B.; Xin, Mei; Nave, Klaus-Armin; Trapp, Bruce D.; Jankowski, Michael P.; Lu, Q. Richard			A histone deacetylase 3-dependent pathway delimits peripheral myelin growth and functional regeneration	NATURE MEDICINE			English	Article							SCHWANN-CELL DEVELOPMENT; INHERITED DEMYELINATING NEUROPATHIES; NERVOUS-SYSTEM; MOLECULAR-MECHANISMS; AXON REGENERATION; REPAIR; INJURY; DISEASE; DIFFERENTIATION; ACTIVATION	Deficits in Schwann cell-mediated remyelination impair functional restoration after nerve damage, contributing to peripheral neuropathies. The mechanisms mediating block of remyelination remain elusive. Here, through small-molecule screening focusing on epigenetic modulators, we identified histone deacetylase 3 (HDAC3; a histone-modifying enzyme) as a potent inhibitor of peripheral myelinogenesis. Inhibition of HDAC3 enhanced myelin growth and regeneration and improved functional recovery after peripheral nerve injury in mice. HDAC3 antagonizes the myelinogenic neuregulin-PI3K-AKT signaling axis. Moreover, genome-wide profiling analyses revealed that HDAC3 represses promyelinating programs through epigenetic silencing while coordinating with p300 histone acetyltransferase to activate myelination-inhibitory programs that include the HIPPO signaling effector TEAD4 to inhibit myelin growth. Schwann cell-specific deletion of either Hdac3 or Tead4 in mice resulted in an elevation of myelin thickness in sciatic nerves. Thus, our findings identify the HDAC3-TEAD4 network as a dual-function switch of cell-intrinsic inhibitory machinery that counters myelinogenic signals and maintains peripheral myelin homeostasis, highlighting the therapeutic potential of transient HDAC3 inhibition for improving peripheral myelin repair.	[He, Xuelian; Zhang, Liguo; Queme, Luis F.; Liu, Xuezhao; Lu, Andrew; Waclaw, Ronald R.; Xin, Mei; Jankowski, Michael P.; Lu, Q. Richard] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Queme, Luis F.; Jankowski, Michael P.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA; [Dong, Xinran; Zhou, Wenhao; Lu, Q. Richard] Fudan Univ, Childrens Hosp, Key Lab Birth Defects, Shanghai, Peoples R China; [Kidd, Grahame; Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Yoon, Sung-Ok] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Buonanno, Andres] NICHHD, Sect Mol Neurobiol, NIH, Bethesda, MD 20892 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Fudan University; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Washington University (WUSTL); Washington University (WUSTL); Max Planck Society	Lu, QR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Lu, QR (corresponding author), Fudan Univ, Childrens Hosp, Key Lab Birth Defects, Shanghai, Peoples R China.	richard.lu@cchmc.org	wenhao, zhou/AAA-1505-2020	Zhou, Wenhao/0000-0001-8956-7238; Queme Cobar, Luis/0000-0003-4225-4060; Kidd, Grahame/0000-0003-3956-2206	US National Institutes of Health (NIH) [R37NS096359, R01NS075243, R35NS097303, R01AR064551-01A1]; National Multiple Sclerosis Society [NMSS-RG1507]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097303, R01NS072427, R01NS075243, R37NS096359] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Wegner, J. Wells, and E. Hurlock for critical reading of the manuscript. We are grateful to E. Olson (University of Texas Southwestern Medical Center), D. Meijer (University of Edinburgh), and M. Wegner (Friedrich-Alexander-Universitat Erlangen- Nurnberg (FAU)) for Hdac3-floxed mice, Dhh-Cre mice, and antibodies against EGR2 and KROX20, respectively, and to N. Wu and L. Xu for technical support. This study was funded in part by the US National Institutes of Health (NIH; grant no. R37NS096359 and R01NS075243 to Q.R.L.; R35NS097303 to B.D.T.; and R01AR064551-01A1 to M.P.J.) and the National Multiple Sclerosis Society (grant no. NMSS-RG1507 to Q.R.L.).	Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Brugger V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14272; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15161; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Emery B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020461; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Feltri ML, 2016, NEUROSCIENTIST, V22, P252, DOI 10.1177/1073858415572361; Fernando RN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12186; Grove M, 2017, ELIFE, V6, DOI 10.7554/eLife.20982; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Huang LL, 2015, NEURAL REGEN RES, V10, P65, DOI 10.4103/1673-5374.150708; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Jia HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152498; Jiang YD, 2014, P NATL ACAD SCI USA, V111, P13541, DOI 10.1073/pnas.1411939111; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Li YX, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026831; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Ma KH, 2016, NEURAL REGEN RES, V11, P1930, DOI 10.4103/1673-5374.197133; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Monk KR, 2015, GLIA, V63, P1376, DOI 10.1002/glia.22852; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Norrmen C, 2013, BIOCHEM SOC T, V41, P944, DOI 10.1042/BST20130046; Noseda R, 2013, J NEUROSCI, V33, P15295, DOI 10.1523/JNEUROSCI.2408-13.2013; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Poitelon Y, 2016, NAT NEUROSCI, V19, P879, DOI 10.1038/nn.4316; Quintes S, 2016, NAT NEUROSCI, V19, P1050, DOI 10.1038/nn.4321; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Salzer JL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020529; Scherer SS, 2008, GLIA, V56, P1578, DOI 10.1002/glia.20751; Sheean ME, 2014, GENE DEV, V28, P290, DOI 10.1101/gad.230045.113; Stolt CC, 2016, BRAIN RES, V1641, P101, DOI 10.1016/j.brainres.2015.09.025; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Suzuki M, 2013, HAND CLINIC, V115, P803, DOI 10.1016/B978-0-444-52902-2.00046-1; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Wu LMN, 2016, NAT NEUROSCI, V19, P1060, DOI 10.1038/nn.4322; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zhang LG, 2016, DEV CELL, V36, P316, DOI 10.1016/j.devcel.2016.01.002; Zhou Y, 2016, EXP NEUROL, V283, P573, DOI 10.1016/j.expneurol.2016.04.007	60	58	59	5	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					338	+		10.1038/nm.4483	http://dx.doi.org/10.1038/nm.4483			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29431744	Green Accepted			2022-12-27	WOS:000426700900016
J	Awazawa, M; Gabel, P; Tsaousidou, E; Nolte, H; Kruger, M; Schmitz, J; Ackermann, PJ; Brandt, C; Altmuller, J; Motameny, S; Wunderlich, FT; Kornfeld, JW; Bluher, M; Bruning, JC				Awazawa, Motoharu; Gabel, Paula; Tsaousidou, Eva; Nolte, Hendrik; Krueger, Marcus; Schmitz, Joel; Ackermann, P. Justus; Brandt, Claus; Altmueller, Janine; Motameny, Susanne; Wunderlich, F. Thomas; Kornfeld, Jan-Wilhelm; Blueher, Matthias; Bruning, Jens C.			A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle	NATURE MEDICINE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; LARGE GENE LISTS; GLUCOSE-PRODUCTION; ADIPOSE-TISSUE; MOUSE; MICE; IDENTIFICATION; DEFICIENCY; HOMOLOG; DOMAINS	Over 40% of microRNAs (miRNAs) are located in introns of protein-coding genes, and many of these intronic miRNAs are co-regulated with their host genes(1,2). In such cases of co-regulation, the products of host genes and their intronic miRNAs can cooperate to coordinately regulate biologically important pathways(3,4). Therefore, we screened intronic miRNAs dysregulated in the livers of mouse models of obesity to identify previously uncharacterized protein-coding host genes that may contribute to the pathogenesis of obesity-associated insulin resistance and type 2 diabetes mellitus. Our approach revealed that expression of both the gene encoding ectodysplasin A (Eda), the causal gene in X-linked hypohidrotic ectodermal dysplasia (XLHED)(5), and its intronic miRNA, miR-676, was increased in the livers of obese mice. Moreover, hepatic EDA expression is increased in obese human subjects and reduced upon weight loss, and its hepatic expression correlates with systemic insulin resistance. We also found that reducing miR-676 expression in db/db mice increases the expression of proteins involved in fatty acid oxidation and reduces the expression of inflammatory signaling components in the liver. Further, we found that Eda expression in mouse liver is controlled via PPAR gamma and RXR-alpha, increases in circulation under conditions of obesity, and promotes JNK activation and inhibitory serine phosphorylation of IRS1 in skeletal muscle. In accordance with these findings, gain-and loss-of-function approaches reveal that liver-derived EDA regulates systemic glucose metabolism, suggesting that EDA is a hepatokine that can contribute to impaired skeletal muscle insulin sensitivity in obesity.	[Awazawa, Motoharu; Gabel, Paula; Tsaousidou, Eva; Schmitz, Joel; Ackermann, P. Justus; Brandt, Claus; Wunderlich, F. Thomas; Kornfeld, Jan-Wilhelm; Bruning, Jens C.] Max Planck Inst Metab Res, Dept Neuronal Control Metab, Cologne, Germany; [Awazawa, Motoharu; Gabel, Paula; Tsaousidou, Eva; Schmitz, Joel; Ackermann, P. Justus; Brandt, Claus; Bruning, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Cologne, Germany; [Awazawa, Motoharu; Gabel, Paula; Tsaousidou, Eva; Nolte, Hendrik; Krueger, Marcus; Schmitz, Joel; Ackermann, P. Justus; Brandt, Claus; Kornfeld, Jan-Wilhelm; Bruning, Jens C.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Cologne, Germany; [Awazawa, Motoharu; Gabel, Paula; Tsaousidou, Eva; Nolte, Hendrik; Krueger, Marcus; Schmitz, Joel; Ackermann, P. Justus; Brandt, Claus; Kornfeld, Jan-Wilhelm; Bruning, Jens C.] Univ Cologne, CMMC, Cologne, Germany; [Altmueller, Janine; Motameny, Susanne] Univ Cologne, CCG, Cologne, Germany; [Altmueller, Janine] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Bruning, Jens C.] Natl Ctr Diabet Res DZD, Neuherberg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Leipzig University	Bruning, JC (corresponding author), Max Planck Inst Metab Res, Dept Neuronal Control Metab, Cologne, Germany.; Bruning, JC (corresponding author), Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Cologne, Germany.; Bruning, JC (corresponding author), Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Cologne, Germany.; Bruning, JC (corresponding author), Univ Cologne, CMMC, Cologne, Germany.; Bruning, JC (corresponding author), Natl Ctr Diabet Res DZD, Neuherberg, Germany.	bruening@sf.mpg.de	Kornfeld, Jan-Wilhelm/AAF-1170-2019; Tsaousidou, Eva/L-7602-2017; Brandt, Claus/AAB-2695-2020	Kornfeld, Jan-Wilhelm/0000-0002-6802-4442; Tsaousidou, Eva/0000-0003-2751-1911; Brandt, Claus/0000-0002-7871-7437; Altmuller, Janine/0000-0003-4372-1521	German Research Foundation (DFG) [BR 1492/7-1]; DFG [TRR134]; German Federal and State Governments (CECAD); Helmholtz Alliance (Imaging and Curing Environmental Metabolic Diseases, ICEMED) through Initiative and Networking Fund of the Helmholtz Association; Emmy Noether program of DFG [KO 4728/1-1]; Manpei Suzuki Diabetes Foundation fellowship	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); German Federal and State Governments (CECAD); Helmholtz Alliance (Imaging and Curing Environmental Metabolic Diseases, ICEMED) through Initiative and Networking Fund of the Helmholtz Association; Emmy Noether program of DFG(German Research Foundation (DFG)); Manpei Suzuki Diabetes Foundation fellowship	We acknowledge J. Alber, B. Hampel, P. Scholl, N. Spenrath and D. Kutyniok for outstanding technical assistance. We greatly appreciate P. Schneider (Lausanne University) for providing Tabby mice and EDA expression vectors as well as outstanding support in performance of the EDA AlphaLISA assay. We acknowledge J. Wilson (University of Pennsylvania) for providing the pXR8 plasmid and J. Samulski (University of North Carolina) for providing the pXX6-80 plasmid. We acknowledge P. Frommolt for bioinformatics support and H. Buning for support of AAV production. This work was supported by a grant from the German Research Foundation (DFG) (BR 1492/7-1) to J.C.B., and we received funding from DFG within the framework of TRR134 and within the Excellence Initiative by German Federal and State Governments (CECAD). This work was funded (in part) by the Helmholtz Alliance (Imaging and Curing Environmental Metabolic Diseases, ICEMED) through the Initiative and Networking Fund of the Helmholtz Association. J.W.K. greatly appreciates funding from the Emmy Noether program of DFG (KO 4728/1-1). M.A. gratefully acknowledges support from a Manpei Suzuki Diabetes Foundation fellowship.	Amrutkar M, 2016, DIABETOLOGIA, V59, P341, DOI 10.1007/s00125-015-3801-7; Awazawa M, 2009, BIOCHEM BIOPH RES CO, V382, P51, DOI 10.1016/j.bbrc.2009.02.131; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Fete M, 2014, AM J MED GENET A, V164, P2437, DOI 10.1002/ajmg.a.36436; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gromak N, 2012, BIOCHEM SOC T, V40, P759, DOI 10.1042/BST20120023; Hashimoto T, 2006, GENE, V371, P42, DOI 10.1016/j.gene.2005.11.003; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kannt A, 2015, DIABETOLOGIA, V58, P799, DOI 10.1007/s00125-014-3490-7; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Kowalczyk-Quintas C, 2015, J INVEST DERMATOL, V135, P359, DOI 10.1038/jid.2014.382; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lindfors PH, 2013, J MAMMARY GLAND BIOL, V18, P165, DOI 10.1007/s10911-013-9277-5; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mikkola ML, 2009, AM J MED GENET A, V149A, P2031, DOI 10.1002/ajmg.a.32855; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; Motil KJ, 2005, PEDIATRICS, V116, pE229, DOI 10.1542/peds.2004-2830; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Newton K, 2004, MOL CELL BIOL, V24, P1608, DOI 10.1128/MCB.24.4.1608-1613.2004; Pal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054247; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; POCHI PE, 1970, J INVEST DERMATOL, V55, P303, DOI 10.1111/1523-1747.ep12260136; Podzus J, 2017, J DENT RES, V96, P217, DOI 10.1177/0022034516673562; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Tanikawa C, 2010, MOL CANCER RES, V8, P855, DOI 10.1158/1541-7786.MCR-09-0484; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Wagle P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1695-x; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yosipovitch G, 2007, J AM ACAD DERMATOL, V56, P901, DOI 10.1016/j.jaad.2006.12.004	53	33	35	4	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1466	+		10.1038/nm.4420	http://dx.doi.org/10.1038/nm.4420			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29106399				2022-12-27	WOS:000417278200016
J	Johnson, BS; Zhao, YT; Fasolino, M; Lamonica, JM; Kim, YJ; Georgakilas, G; Wood, KH; Bu, D; Cui, Y; Goffin, D; Vahedi, G; Kim, TH; Zhou, ZL				Johnson, Brian S.; Zhao, Ying-Tao; Fasolino, Maria; Lamonica, Janine M.; Kim, Yoon Jung; Georgakilas, George; Wood, Kathleen H.; Bu, Daniel; Cui, Yue; Goffin, Darren; Vahedi, Golnaz; Kim, Tae Hoon; Zhou, Zhaolan			Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome	NATURE MEDICINE			English	Article							GENE-EXPRESSION; HISTONE DEACETYLASE; SYNDROME MUTATIONS; METHYLATED DNA; PROTEIN MECP2; BINDING; REPRESSION; DYNAMICS; SEQUENCE; BIOTINYLATION	Mutations in MECP2 cause Rett syndrome (RTT), an X-linked neurological disorder characterized by regressive loss of neurodevelopmental milestones and acquired psychomotor deficits. However, the cellular heterogeneity of the brain impedes an understanding of how MECP2 mutations contribute to RTT. Here we developed a Cre-inducible method for cell-type-specific biotin tagging of MeCP2 in mice. Combining this approach with an allelic series of knock-in mice carrying frequent RTT-associated mutations (encoding T158M and R106W) enabled the selective profiling of RTT-associated nuclear transcriptomes in excitatory and inhibitory cortical neurons. We found that most gene-expression changes were largely specific to each RTT-associated mutation and cell type. Lowly expressed cell-type-enriched genes were preferentially disrupted by MeCP2 mutations, with upregulated and downregulated genes reflecting distinct functional categories. Subcellular RNA analysis in MeCP2-mutant neurons further revealed reductions in the nascent transcription of long genes and uncovered widespread post-transcriptional compensation at the cellular level. Finally, we overcame X-linked cellular mosaicism in female RTT models and identified distinct gene-expression changes between neighboring wild-type and mutant neurons, providing contextual insights into RTT etiology that support personalized therapeutic interventions.	[Johnson, Brian S.; Zhao, Ying-Tao; Fasolino, Maria; Lamonica, Janine M.; Georgakilas, George; Wood, Kathleen H.; Bu, Daniel; Cui, Yue; Goffin, Darren; Vahedi, Golnaz; Zhou, Zhaolan] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Kim, Yoon Jung; Kim, Tae Hoon] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA; [Kim, Yoon Jung; Kim, Tae Hoon] Univ Texas Dallas, Ctr Syst Biol, Richardson, TX 75083 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Zhou, ZL (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	zhaolan@mail.med.upenn.edu	Georgakilas, Georgios/W-5874-2019; Zhao, Ying-Tao/L-2288-2016	Wood, Kathleen/0000-0001-6566-4885; Goffin, Darren/0000-0001-6284-1452; Zhao, Yingtao/0000-0003-3748-8428; Johnson, Brian/0000-0003-3711-5920; Georgakilas, Georgios/0000-0003-1160-5753; Kim, Tae Hoon/0000-0003-3950-7557; Bu, Daniel/0000-0003-2503-0399	Cell and Molecular Biology Training Grant [TG32GM072290]; UNCF/Merck Graduate Research Dissertation Fellowship; NIH [K22AI112570, R21AI107067, R01CA140485, R01MH091850, R01NS081054]; Rettsyndrome; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107067, K22AI112570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081054] Funding Source: NIH RePORTER	Cell and Molecular Biology Training Grant; UNCF/Merck Graduate Research Dissertation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rettsyndrome; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the IDDRC Mouse Gene Manipulation Core at Children's Hospital Boston (U54HD090255, M. Thompson), the Gene Targeting Core (P01DK049210, K. Kaestner) and the Transgenic and Chimeric Mouse Facility (J. Richa) at University of Pennsylvania for help in generating transgenic mice, the Flow Cytometry and Cell Sorting Resource Laboratory (H. Pletcher, W. DeMuth), and the Next Generation Sequencing Core (J. Schug) for technical assistance. B.S.J. is supported by a Cell and Molecular Biology Training Grant (TG32GM072290) and the UNCF/Merck Graduate Research Dissertation Fellowship. This work is supported by NIH grants K22AI112570 (G.V.), R21AI107067 and R01CA140485 (T.H.K.), R01MH091850 and R01NS081054 (Z.Z.), and a basic research grant from Rettsyndrome. org (Z.Z.). Z.Z. is a Pew Scholar in the Biomedical Sciences.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; [Anonymous], 2014, R LANG ENV STAT COMP; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brown K, 2016, HUM MOL GENET, V25, P558, DOI 10.1093/hmg/ddv496; Buxbaum AR, 2015, TRENDS CELL BIOL, V25, P468, DOI 10.1016/j.tcb.2015.05.005; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cuddapah VA, 2014, J MED GENET, V51, P152, DOI 10.1136/jmedgenet-2013-102113; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Ghosh RP, 2008, J BIOL CHEM, V283, P20523, DOI 10.1074/jbc.M803021200; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Greer CB, 2015, CELL REP, V13, P1444, DOI 10.1016/j.celrep.2015.10.013; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Khwaja OS, 2014, P NATL ACAD SCI USA, V111, P4596, DOI 10.1073/pnas.1311141111; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamonica JM, 2017, J CLIN INVEST, V127, P1889, DOI 10.1172/JCI90967; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Linhoff MW, 2015, CELL, V163, P246, DOI 10.1016/j.cell.2015.09.002; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyst MJ, 2015, NAT REV GENET, V16, P261, DOI 10.1038/nrg3897; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mauger O, 2016, NEURON, V92, P1266, DOI 10.1016/j.neuron.2016.11.032; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Muller M, 2014, BIOCHEM SOC T, V42, P959, DOI 10.1042/BST20140071; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nott A, 2016, NAT NEUROSCI, V19, P1497, DOI 10.1038/nn.4347; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rube HT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11025; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhao YT, 2013, NEUROBIOL DIS, V59, P257, DOI 10.1016/j.nbd.2013.08.001; Zylka MJ, 2015, NEURON, V86, P353, DOI 10.1016/j.neuron.2015.03.059	65	61	61	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1203	+		10.1038/nm.4406	http://dx.doi.org/10.1038/nm.4406			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28920956	Green Accepted			2022-12-27	WOS:000412431800015
J	Willyard, C				Willyard, Cassandra			The epigenome editors: How tools such as CRISPR offer new details about epigenetics	NATURE MEDICINE			English	News Item							ACTIVATION; GENOME; ACETYLTRANSFERASE; METHYLATION; EXPRESSION											Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Cano-Rodriguez D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12284; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Song J, 2017, AM J PHYSIOL-LUNG C, V312, P1334, DOI 10.1152/ajplung.00059.2016; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	13	6	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					900	903		10.1038/nm0817-900	http://dx.doi.org/10.1038/nm0817-900			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV0XB	28777784				2022-12-27	WOS:000424283400001
J	Braso-Maristany, F; Filosto, S; Catchpole, S; Marlow, R; Quist, J; Francesch-Domenech, E; Plumb, DA; Zakka, L; Gazinska, P; Liccardi, G; Meier, P; Gris-Oliver, A; Cheang, MCU; Perdrix-Rosell, A; Shafat, M; Noel, E; Patel, N; McEachern, K; Scaltriti, M; Castel, P; Noor, F; Buus, R; Mathew, S; Watkins, J; Serra, V; Marra, P; Grigoriadis, A; Tutt, AN				Braso-Maristany, Fara; Filosto, Simone; Catchpole, Steven; Marlow, Rebecca; Quist, Jelmar; Francesch-Domenech, Erika; Plumb, Darren A.; Zakka, Leila; Gazinska, Patrycja; Liccardi, Gianmaria; Meier, Pascal; Gris-Oliver, Albert; Cheang, Maggie Chon U.; Perdrix-Rosell, Anna; Shafat, Manar; Noel, Elodie; Patel, Nirmesh; McEachern, Kristen; Scaltriti, Maurizio; Castel, Pau; Noor, Farzana; Buus, Richard; Mathew, Sumi; Watkins, Johnathan; Serra, Violeta; Marra, Pierfrancesco; Grigoriadis, Anita; Tutt, Andrew N.			PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer (vol 22, pg 1303, 2016)	NATURE MEDICINE			English	Correction													Watkins, Johnathan/ABI-8343-2020	Watkins, Johnathan/0000-0001-8370-6022; Tutt, Andrew/0000-0001-8715-2901; Cheang, Maggie Chon U/0000-0001-5718-2501; Shafat, Manar/0000-0002-3493-9089; Meier, Pascal/0000-0003-2760-6523				Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198	1	4	5	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					788	788		10.1038/nm0617-788b	http://dx.doi.org/10.1038/nm0617-788b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586336	Bronze			2022-12-27	WOS:000402768000024
J	Li, YQ; Lucas-Osma, AM; Black, S; Bandet, MV; Stephens, MJ; Vavrek, R; Sanelli, L; Fenrich, KK; Di Narzo, AF; Dracheva, S; Winship, IR; Fouad, K; Bennett, DJ				Li, Yaqing; Lucas-Osma, Ana M.; Black, Sophie; Bandet, Mischa V.; Stephens, Marilee J.; Vavrek, Romana; Sanelli, Leo; Fenrich, Keith K.; Di Narzo, Antonio F.; Dracheva, Stella; Winship, Ian R.; Fouad, Karim; Bennett, David J.			Pericytes impair capillary blood flow and motor function after chronic spinal cord injury	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRACE AMINES; SYNAPTIC-TRANSMISSION; LOCOMOTOR FUNCTION; CEREBRAL-ARTERIES; PIAL VESSELS; BRAIN; RAT; HYPOXIA; INNERVATION	Blood vessels in the central nervous system (CNS) are controlled by neuronal activity. For example, widespread vessel constriction (vessel tone) is induced by brainstem neurons that release the monoamines serotonin and noradrenaline, and local vessel dilation is induced by glutamatergic neuron activity. Here we examined how vessel tone adapts to the loss of neuron-derived monoamines after spinal cord injury (SCI) in rats. We find that, months after the imposition of SCI, the spinal cord below the site of injury is in a chronic state of hypoxia owing to paradoxical excess activity of monoamine receptors (5-HT1 ) on pericytes, despite the absence of monoamines. This monoamine-receptor activity causes pericytes to locally constrict capillaries, which reduces blood flow to ischemic levels. Receptor activation in the absence of monoamines results from the production of trace amines (such as tryptamine) by pericytes that ectopically express the enzyme aromatic l-amino acid decarboxylase (AADC), which synthesizes trace amines directly from dietary amino acids (such as tryptophan). Inhibition of monoamine receptors or of AADC, or even an increase in inhaled oxygen, produces substantial relief from hypoxia and improves motoneuron and locomotor function after SCI.	[Li, Yaqing; Lucas-Osma, Ana M.; Black, Sophie; Bandet, Mischa V.; Stephens, Marilee J.; Vavrek, Romana; Sanelli, Leo; Fenrich, Keith K.; Fouad, Karim; Bennett, David J.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Li, Yaqing; Lucas-Osma, Ana M.; Black, Sophie; Stephens, Marilee J.; Vavrek, Romana; Sanelli, Leo; Fenrich, Keith K.; Fouad, Karim; Bennett, David J.] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Bandet, Mischa V.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Di Narzo, Antonio F.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Dracheva, Stella] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Dracheva, Stella] James J Peters Virginia Med Ctr, Bronx, NY USA	University of Alberta; University of Alberta; University of Alberta; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bennett, DJ (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.; Bennett, DJ (corresponding author), Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada.	bennettd@ualberta.ca	Fenrich, Keith/AAG-2780-2020; Lucas-Osma, Ana M/ABC-2135-2020	Fenrich, Keith/0000-0003-4360-064X; Fouad, Karim/0000-0003-3654-7852	Canadian Institutes of Health Research [MOP 14697]; US National Institutes of Health (NIH) [R01NS47567]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047567] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002343] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank F. Geddes and Y. Ma for technical assistance. This research was supported by the Canadian Institutes of Health Research (MOP 14697; D.J.B.) and the US National Institutes of Health (NIH, R01NS47567; D.J.B. and K.F.).	Acker T, 2004, J EXP BIOL, V207, P3171, DOI 10.1242/Jeb.01075; Anwar MA, 2012, BRIT J PHARMACOL, V165, P2191, DOI 10.1111/j.1476-5381.2011.01706.x; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barcroft H, 1943, J PHYSIOL-LONDON, V102, P21, DOI 10.1113/jphysiol.1943.sp004010; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Berry MD, 2004, J NEUROCHEM, V90, P257, DOI 10.1111/j.1471-4159.2004.02501.x; BOESS FG, 1994, NEUROPHARMACOLOGY, V33, P275, DOI 10.1016/0028-3908(94)90059-0; BONVENTO G, 1991, J NEUROCHEM, V56, P681, DOI 10.1111/j.1471-4159.1991.tb08203.x; Broadley KJ, 2013, EUR J PHARMACOL, V715, P370, DOI 10.1016/j.ejphar.2013.04.034; Brown A, 2014, J NEUROSURG-SPINE, V20, P164, DOI 10.3171/2013.10.SPINE13113; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Burchett SA, 2006, PROG NEUROBIOL, V79, P223, DOI 10.1016/j.pneurobio.2006.07.003; Burdyga T, 2014, J VASC RES, V51, P190, DOI 10.1159/000362687; BUSIJA DW, 1987, DEV PHARMACOL THERAP, V10, P36, DOI 10.1159/000457726; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Cohen Z, 1999, J CEREBR BLOOD F MET, V19, P908, DOI 10.1097/00004647-199908000-00010; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; COMMISSIONG JW, 1985, BRAIN RES, V347, P104, DOI 10.1016/0006-8993(85)90893-5; Dalkara T, 2011, ACTA NEUROPATHOL, V122, P1, DOI 10.1007/s00401-011-0847-6; Di Narzo AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12615; EDVINSSON L, 1983, NATURE, V306, P55, DOI 10.1038/306055a0; GESSA GL, 1974, J NEUROCHEM, V22, P869, DOI 10.1111/j.1471-4159.1974.tb04308.x; GLAESER BS, 1983, J NEUROCHEM, V41, P1016, DOI 10.1111/j.1471-4159.1983.tb09045.x; Gorassini MA, 2009, J NEUROPHYSIOL, V101, P969, DOI 10.1152/jn.91131.2008; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gozal EA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00134; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Kang CE, 2010, J NEUROTRAUM, V27, P2041, DOI 10.1089/neu.2010.1345; Kapitza S, 2012, EXP NEUROL, V236, P179, DOI 10.1016/j.expneurol.2012.04.023; Kundi S, 2013, NEUROSCI RES, V76, P1, DOI 10.1016/j.neures.2013.03.013; Li YQ, 2014, J NEUROPHYSIOL, V111, P145, DOI 10.1152/jn.00508.2013; Lincoln J, 1995, PHARMACOL THERAPEUT, V68, P473, DOI 10.1016/0163-7258(95)02017-9; Marina N, 2015, HYPERTENSION, V65, P775, DOI 10.1161/HYPERTENSIONAHA.114.04683; Martirosyan NL, 2011, J NEUROSURG-SPINE, V15, P238, DOI 10.3171/2011.4.SPINE10543; Miller GM, 2011, J NEUROCHEM, V116, P164, DOI 10.1111/j.1471-4159.2010.07109.x; Murray KC, 2011, J NEUROPHYSIOL, V106, P925, DOI 10.1152/jn.01011.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navarrete-Opazo A, 2014, AM J PHYSIOL-REG I, V307, pR1181, DOI 10.1152/ajpregu.00208.2014; Pena F, 2005, MOL NEUROBIOL, V32, P251, DOI 10.1385/MN:32:3:251; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Rank MM, 2011, J NEUROPHYSIOL, V105, P410, DOI 10.1152/jn.00775.2010; Reber F, 2003, GRAEF ARCH CLIN EXP, V241, P140, DOI 10.1007/s00417-002-0560-1; RENNELS ML, 1975, AM J ANAT, V144, P233, DOI 10.1002/aja.1001440208; Schroeder JL, 2008, J NEUROSURG-SPINE, V9, P213, DOI 10.3171/SPI/2008/9/8/213; Sinescu Crina, 2010, J Med Life, V3, P254; Unekawa M, 2010, BRAIN RES, V1320, P69, DOI 10.1016/j.brainres.2010.01.032; UPRICHARD DC, 1977, MOL PHARMACOL, V13, P454; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Westcott EB, 2013, MICROCIRCULATION, V20, P217, DOI 10.1111/micc.12035; Wienecke J, 2014, J NEUROSCI, V34, P11984, DOI 10.1523/JNEUROSCI.3838-13.2014; Wilson RJA, 2003, NEUROSCIENCE, V117, P183, DOI 10.1016/S0306-4522(02)00831-X; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; XIONG ZL, 1995, J MOL CELL CARDIOL, V27, P75, DOI 10.1016/S0022-2828(08)80009-0	60	90	94	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					733	+		10.1038/nm.4331	http://dx.doi.org/10.1038/nm.4331			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28459438	Green Accepted			2022-12-27	WOS:000402768000016
J	Lynes, MD; Leiria, LO; Lundh, M; Bartelt, A; Shamsi, F; Huang, TL; Takahashi, H; Hirshman, MF; Schlein, C; Lee, A; Baer, LA; May, FJ; Gao, F; Narain, NR; Chen, EY; Kiebish, MA; Cypess, AM; Bluher, M; Goodyear, LJ; Hotamisligil, GS; Stanford, KI; Tseng, YH				Lynes, Matthew D.; Leiria, Luiz O.; Lundh, Morten; Bartelt, Alexander; Shamsi, Farnaz; Huang, Tian Lian; Takahashi, Hirokazu; Hirshman, Michael F.; Schlein, Christian; Lee, Alexandra; Baer, Lisa A.; May, Francis J.; Gao, Fei; Narain, Niven R.; Chen, Emily Y.; Kiebish, Michael A.; Cypess, Aaron M.; Blueher, Matthias; Goodyear, Laurie J.; Hotamisligil, Gokhan S.; Stanford, Kristin I.; Tseng, Yu-Hua			The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue	NATURE MEDICINE			English	Article							PLASMA TRIGLYCERIDES; TARGETED DISRUPTION; EPOXIDE HYDROLASE; WHITE; EXPOSURE; GENE; THERMOGENESIS; ACTIVATION; REVEALS; CELLS	Brown adipose tissue (BAT) and beige adipose tissue combust fuels for heat production in adult humans, and so constitute an appealing target for the treatment of metabolic disorders such as obesity, diabetes and hyperlipidemia(1,2). Cold exposure can enhance energy expenditure by activating BAT, and it has been shown to improve nutrient metabolism(3-5). These therapies, however, are time consuming and uncomfortable, demonstrating the need for pharmacological interventions. Recently, lipids have been identified that are released from tissues and act locally or systemically to promote insulin sensitivity and glucose tolerance; as a class, these lipids are referred to as 'lipokines'(6-8). Because BAT is a specialized metabolic tissue that takes up and burns lipids and is linked to systemic metabolic homeostasis, we hypothesized that there might be thermogenic lipokines that activate BAT in response to cold. Here we show that the lipid 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) is a stimulator of BAT activity, and that its levels are negatively correlated with body-mass index and insulin sensitivity. Using a global lipidomic analysis, we found that 12,13-diHOME was increased in the circulation of humans and mice exposed to cold. Furthermore, we found that the enzymes that produce 12,13-diHOME were uniquely induced in BAT by cold stimulation. The injection of 12,13-diHOME acutely activated BAT fuel uptake and enhanced cold tolerance, which resulted in decreased levels of serum triglycerides. Mechanistically, 12,13-diHOME increased fatty acid (FA) uptake into brown adipocytes by promoting the translocation of the FA transporters FATP1 and CD36 to the cell membrane. These data suggest that 12,13-diHOME, or a functional analog, could be developed as a treatment for metabolic disorders.	[Lynes, Matthew D.; Leiria, Luiz O.; Lundh, Morten; Shamsi, Farnaz; Huang, Tian Lian; Takahashi, Hirokazu; Hirshman, Michael F.; Goodyear, Laurie J.; Tseng, Yu-Hua] Harvard Med Sch, Sect Integrat Physiol & Metab, Joslin Diabet Ctr, Boston, MA USA; [Lundh, Morten] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Bartelt, Alexander; Schlein, Christian; Lee, Alexandra; Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Bartelt, Alexander; Schlein, Christian; Lee, Alexandra; Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA USA; [Baer, Lisa A.; May, Francis J.; Stanford, Kristin I.] Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Gao, Fei; Narain, Niven R.; Chen, Emily Y.; Kiebish, Michael A.] BERG, Framingham, MA USA; [Cypess, Aaron M.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Tseng, Yu-Hua] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Novo Nordisk Foundation; University of Copenhagen; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; Leipzig University; Harvard University	Tseng, YH (corresponding author), Harvard Med Sch, Sect Integrat Physiol & Metab, Joslin Diabet Ctr, Boston, MA USA.; Tseng, YH (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	yu-hua.tseng@joslin.harvard.edu	Bartelt, Alexander/ABC-2525-2020; Tseng, Yu-Hua/AAE-6471-2021	Tseng, Yu-Hua/0000-0003-2053-9559; Lundh, Morten/0000-0003-0918-577X; Lynes, Matthew/0000-0003-0746-0854	US National Institutes of Health (NIH) [R01DK077097, R01DK102898, R01DK099511, K01DK105109, T32DK007260, F32DK102320, P30DK036836]; American Diabetes Foundation [ADA 7-12-BS-191]; Deutsche Forschungsgemeinschaft [BA 4925/1-1]; Danish Council for Independent Research; NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099511, ZIADK075116, T32DK007260, K01DK111714, R01DK077097, R01DK102898, K01DK105109, F32DK102320, ZIADK075112, P30DK036836, ZIADK075115] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Foundation(American Diabetes Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US National Institutes of Health (NIH) grants R01DK077097 and R01DK102898 (to Y.-H.T.), R01DK099511 (to L.J.G.), K01DK105109 (to K.I.S.), institutional research training grant T32DK007260 and individual research fellowship F32DK102320 (to M.D.L.); P30DK036836 (to Joslin Diabetes Center's Diabetes Research Center); a research grant from the American Diabetes Foundation (ADA 7-12-BS-191 to Y.-H.T.); a Deutsche Forschungsgemeinschaft Research Fellowship (BA 4925/1-1 to A.B.); and a grant from the Danish Council for Independent Research (to M.L.). This research was supported in part by the Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). We thank K. Longval and A. Clermont of the Joslin Diabetes Center Animal Physiology core, H. Rockwell, K. Schlosser and J. McDaniel at BERG for expert technical assistance. We thank K. Inouye and P. Lizotte for critical discussion.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; Hao Q, 2015, AM J PHYSIOL-ENDOC M, V308, pE380, DOI 10.1152/ajpendo.00277.2014; Henkin AH, 2012, ACS CHEM BIOL, V7, P1884, DOI 10.1021/cb300194b; Hoene M, 2014, BBA-MOL CELL BIOL L, V1841, P1563, DOI 10.1016/j.bbalip.2014.08.003; Khedoe PPSJ, 2015, J LIPID RES, V56, P51, DOI 10.1194/jlr.M052746; Klingenspor M, 1996, J LIPID RES, V37, P1685; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lynes MD, 2014, P NATL ACAD SCI USA, V111, P14318, DOI 10.1073/pnas.1416145111; Marcher AB, 2015, CELL REP, V13, P2000, DOI 10.1016/j.celrep.2015.10.069; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Powell WS, 1999, METH MOL B, V120, P11; Putri M, 2015, BIOCHEM BIOPH RES CO, V457, P520, DOI 10.1016/j.bbrc.2014.12.124; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P527, DOI 10.1210/jc.2006-1740; Richards MR, 2003, J BIOL CHEM, V278, P10477, DOI 10.1074/jbc.M212469200; Romu T, 2016, METABOLISM, V65, P926, DOI 10.1016/j.metabol.2016.03.012; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Schellen L, 2012, PHYSIOL BEHAV, V107, P252, DOI 10.1016/j.physbeh.2012.07.008; Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shabalina IG, 2016, ARCH TOXICOL, V90, P1117, DOI 10.1007/s00204-015-1535-4; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Sisemore MF, 2001, ARCH BIOCHEM BIOPHYS, V392, P32, DOI 10.1006/abbi.2001.2434; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thompson DA, 2007, J BIOSCIENCES, V32, P279, DOI 10.1007/s12038-007-0028-x; Townsend KL, 2012, ADIPOCYTE, V1, P13, DOI 10.4161/adip.18951; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Warner A, 2016, AM J PHYSIOL-ENDOC M, V311, pE901, DOI 10.1152/ajpendo.00204.2016; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	38	208	211	4	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					631	+		10.1038/nm.4297	http://dx.doi.org/10.1038/nm.4297			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28346411	Green Accepted, Green Published			2022-12-27	WOS:000400650700018
J	Himburg, HA; Doan, PL; Quarmyne, M; Yan, X; Sasine, J; Zhao, LM; Hancock, GV; Kan, J; Pohl, KA; Tran, E; Chao, NJ; Harris, JR; Chute, JP				Himburg, Heather A.; Doan, Phuong L.; Quarmyne, Mamle; Yan, Xiao; Sasine, Joshua; Zhao, Liman; Hancock, Grace V.; Kan, Jenny; Pohl, Katherine A.; Tran, Evelyn; Chao, Nelson J.; Harris, Jeffrey R.; Chute, John P.			Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms	NATURE MEDICINE			English	Article							STEM-CELL NICHE; BONE-MARROW; SELF-RENEWAL; LYMPHOID PROGENITORS; OXIDATIVE STRESS; WNT; MAINTENANCE; DIFFERENTIATION; RECONSTITUTION; ENGRAFTMENT	The role of osteolineage cells in regulating hematopoietic stem cell (HSC) regeneration following myelosuppression is not well understood. Here we show that deletion of the pro-apoptotic genes Bak and Bax in osterix (Osx, also known as Sp7 transcription factor 7)-expressing cells in mice promotes HSC regeneration and hematopoietic radioprotection following total body irradiation. These mice showed increased bone marrow (BM) levels of the protein dickkopf-1 (Dkk1), which was produced in Osx-expressing BM cells. Treatment of irradiated HSCs with Dkk1 in vitro increased the recovery of both long-term repopulating HSCs and progenitor cells, and systemic administration of Dkk1 to irradiated mice increased hematopoietic recovery and improved survival. Conversely, inducible deletion of one allele of Dkk1 in Osx-expressing cells in adult mice inhibited the recovery of BM stem and progenitor cells and of complete blood counts following irradiation. Dkk1 promoted hematopoietic regeneration via both direct effects on HSCs, in which treatment with Dkk1 decreased the levels of mitochondria! reactive oxygen species and suppressed senescence, and indirect effects on BM endothelial cells, in which treatment with Dkk1 induced epidermal growth factor (EGF) secretion. Accordingly, blockade of the EGF receptor partially abrogated Dkk1-mediated hematopoietic recovery. These data identify Dkk1 as a regulator of hematopoietic regeneration and demonstrate paracrine cross-talk between BM osteolineage cells and endothelial cells in regulating hematopoietic reconstitution following injury.	[Himburg, Heather A.; Quarmyne, Mamle; Yan, Xiao; Sasine, Joshua; Zhao, Liman; Kan, Jenny; Pohl, Katherine A.; Tran, Evelyn; Chute, John P.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA; [Doan, Phuong L.; Chao, Nelson J.; Harris, Jeffrey R.] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA; [Quarmyne, Mamle; Yan, Xiao] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Hancock, Grace V.] Univ Calif Los Angeles, Dept Cell & Dev Biol, Los Angeles, CA USA; [Chute, John P.] Univ Calif Los Angeles, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Chute, John P.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Duke University; Duke University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Chute, JP (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA.; Chute, JP (corresponding author), Univ Calif Los Angeles, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA.; Chute, JP (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	jchute@mednet.ucla.edu	Doan, Phuong L./Q-2093-2019	Doan, Phuong L./0000-0003-1361-2068; Sasine, Joshua/0000-0001-9866-462X; Tran, Evelyn/0000-0002-3731-5255; Himburg, Heather/0000-0002-9676-6371	NHLBI [HL-086998-05]; NIAID [AI-067769-11, AI-107333]; California Institute for Regenerative Medicine Leadership Award [LA1-08014]; NIAID Centers for Medical Countermeasures Against Radiation (CMCR) Pilot Award [2U19AI067773-11]; NATIONAL CANCER INSTITUTE [K08CA184552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769, U19AI067773, U19AI067798, U01AI107333] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California Institute for Regenerative Medicine Leadership Award; NIAID Centers for Medical Countermeasures Against Radiation (CMCR) Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Vainio (University of Oulu) for the Dkk1<SUP>FL/+</SUP> mice. This work was supported, in part, by NHLBI grant HL-086998-05 (J.P.C.), NIAID grants AI-067769-11 (J.P.C.) and AI-107333 (J.P.C.), the California Institute for Regenerative Medicine Leadership Award LA1-08014 (J.P.C.) and the NIAID Centers for Medical Countermeasures Against Radiation (CMCR) Pilot Award 2U19AI067773-11 (H.A.H.).	Boudousquie C, 2014, J IMMUNOL, V193, P2784, DOI 10.4049/jimmunol.1400465; Brault V, 2001, DEVELOPMENT, V128, P1253; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Cho J, 2014, J CLIN INVEST, V124, P3159, DOI 10.1172/JCI61636; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, NAT MED, V19, P295, DOI 10.1038/nm.3070; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Famili F, 2016, STEM CELL REP, V6, P652, DOI 10.1016/j.stemcr.2016.04.009; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Ishikawa ET, 2012, P NATL ACAD SCI USA, V109, P9071, DOI 10.1073/pnas.1120358109; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kim IG, 2014, BIOCHEM BIOPH RES CO, V443, P49, DOI 10.1016/j.bbrc.2013.11.038; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113; Li WS, 2013, BLOOD, V121, P4063, DOI 10.1182/blood-2012-12-473470; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Min JK, 2011, J CLIN INVEST, V121, P1882, DOI 10.1172/JCI42556; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	60	48	50	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					91	99		10.1038/nm.4251	http://dx.doi.org/10.1038/nm.4251			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27918563	Green Accepted			2022-12-27	WOS:000391646800017
J	Jarret, A; McFarland, AP; Horner, SM; Kell, A; Schwerk, J; Hong, M; Badil, S; Joslyn, RC; Baker, DP; Carrington, M; Hagedorn, CH; Gale, M; Savan, R				Jarret, Abigail; McFarland, Adelle P.; Horner, Stacy M.; Kell, Alison; Schwerk, Johannes; Hong, MeeAe; Badil, Samantha; Joslyn, Rochelle C.; Baker, Darren P.; Carrington, Mary; Hagedorn, Curt H.; Gale, Michael, Jr.; Savan, Ram			Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR MESSENGER-RNA; GENETIC-VARIATION; HCV INFECTION; IFN THERAPY; III IFN; EXPRESSION; IL28B; LIVER; ALPHA	Hepatitis C virus (HCV) infects 200 million people globally, and 60-80% of cases persist as a chronic infection that will progress to cirrhosis and liver cancer in 2-10% of patients(1-3). We recently demonstrated that HCV induces aberrant expression of two host microRNAs (miRNAs), miR-208b and miR-499a-5p, encoded by myosin genes in infected hepatocytes(4). These miRNAs, along with AU-rich-element-mediated decay, suppress IFNL2 and IFNL3, members of the type III interferon (IFN) gene family, to support viral persistence. In this study, we show that miR-208b and miR-499a-5p also dampen type I IFN signaling in HCV-infected hepatocytes by directly down-regulating expression of the type I IFN receptor chain, IFNAR1. Inhibition of these miRNAs by using miRNA inhibitors during HCV infection increased expression of IFNAR1. Additionally, inhibition rescued the antiviral response to exogenous type I IFN, as measured by a marked increase in IFN-stimulated genes and a decrease in HCV load. Treatment of HCV-infected hepatocytes with type I IFN increased expression of myosins over HCV infection alone. Since these miRNAs can suppress type III IFN family members, these data collectively define a novel cross-regulation between type I and III IFNs during HCV infection.	[Jarret, Abigail; McFarland, Adelle P.; Horner, Stacy M.; Kell, Alison; Schwerk, Johannes; Hong, MeeAe; Badil, Samantha; Joslyn, Rochelle C.; Gale, Michael, Jr.; Savan, Ram] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA USA; [Carrington, Mary] Frederick Natl Lab Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Leidos Biomed Res Frederick, Frederick, MD USA; [Carrington, Mary] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Genet Program, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [McFarland, Adelle P.] Univ Washington, Dept Microbiol, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Horner, Stacy M.] Duke Univ, Med Ctr, Ctr Virol, Dept Mol Genet & Microbiol, Durham, NC USA; [Baker, Darren P.] Sanofi Genzyme, Cambridge, MA USA	University of Washington; University of Washington Seattle; Biogen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Washington; University of Washington Seattle; Duke University; Sanofi-Aventis; Genzyme Corporation	Savan, R (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	savanram@uw.edu	Schwerk, Johannes/AAN-2937-2020	McFarland, Adelle/0000-0001-7534-1158; Kell, Alison/0000-0001-5550-1038; Schwerk, Johannes/0000-0002-5964-7162; Savan, Ram/0000-0002-3087-1355; Horner, Stacy/0000-0002-9351-7409	NATIONAL CANCER INSTITUTE [ZIABC010791, R21CA148068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108765, U19AI040035, R01AI060389, R01AI118916, R56AI060389] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA148068, HHSN261200800001E] Funding Source: Medline; NIAID NIH HHS [R01 AI118916, R01 AI108765, N01AI40035, R56 AI060389, R01 AI060389] Funding Source: Medline; CCR NIH HHS [HHSN261200800001C] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CCR NIH HHS		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; de Castellarnau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031016; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Eldrup AB, 2004, J MED CHEM, V47, P5284, DOI 10.1021/jm040068f; Fukuda R, 1996, J GASTROENTEROL, V31, P806, DOI 10.1007/BF02358606; Fukuda R, 1997, J HEPATOL, V26, P455, DOI 10.1016/S0168-8278(97)80407-2; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gonzalez G, 2007, J VIROL METHODS, V145, P14, DOI 10.1016/j.jviromet.2007.04.013; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Mathai J, 1999, J INTERF CYTOK RES, V19, P1011, DOI 10.1089/107999099313226; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Morita K, 1999, J MED VIROL, V58, P359, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;359::AID-JMV7&gt;3.0.CO;2-S; Morita K, 1998, J CLIN GASTROENTEROL, V26, P135, DOI 10.1097/00004836-199803000-00010; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Pedergnana V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038578; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Schwerk J, 2015, CURR OPIN VIROL, V12, P75, DOI 10.1016/j.coviro.2015.02.006; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Zeuzem S, 2011, J HEPATOL, V54, pS538, DOI 10.1016/S0168-8278(11)61362-7	41	33	34	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1475	+		10.1038/nm.4211	http://dx.doi.org/10.1038/nm.4211			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841874	Green Accepted			2022-12-27	WOS:000389549000026
J	Kim, D; Kim, YG; Seo, SU; Kim, DJ; Kamada, N; Prescott, D; Philpott, DJ; Rosenstiel, P; Inohara, N; Nunez, G				Kim, Donghyun; Kim, Yun-Gi; Seo, Sang-Uk; Kim, Dong-Jae; Kamada, Nobuhiko; Prescott, Dave; Philpott, Dana J.; Rosenstiel, Philip; Inohara, Naohiro; Nunez, Gabriel			Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin (vol 22, pg 524, 2016)	NATURE MEDICINE			English	Correction													Chamaillard, Mathias/L-6542-2013; Rosenstiel, Philip/A-5137-2009; Nuñez, Gabriel/A-7160-2014	Chamaillard, Mathias/0000-0002-0243-9717; Rosenstiel, Philip/0000-0002-9692-8828; Kamada, Nobuhiko/0000-0002-1980-4178				Kim D, 2016, NAT MED, V22, P524, DOI 10.1038/nm.4075	1	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					961	961		10.1038/nm0816-961	http://dx.doi.org/10.1038/nm0816-961			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27490437	Bronze			2022-12-27	WOS:000381000200023
J	Thalji, NK; Ivanciu, L; Davidson, R; Gimotty, PA; Krishnaswamy, S; Camire, RM				Thalji, Nabil K.; Ivanciu, Lacramioara; Davidson, Robert; Gimotty, Phyllis A.; Krishnaswamy, Sriram; Camire, Rodney M.			A rapid pro-hemostatic approach to overcome direct oral anticoagulants	NATURE MEDICINE			English	Article							FACTOR-XA INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATE; SYMPTOMATIC VENOUS THROMBOEMBOLISM; CATALYZED PROTEASE INACTIVATION; FACTOR PATHWAY INHIBITOR; COAGULATION-FACTOR XA; ACTIVATED FACTOR-VII; IN-VIVO; ANTITHROMBIN-III; ATRIAL-FIBRILLATION	Direct inhibitors of coagulation factor Xa (FXa) or thrombin are promising oral anticoagulants that are becoming widely adopted. The ability to reverse their anticoagulant effects is important when serious bleeding occurs or urgent medical procedures are needed. Here, using experimental mouse models of hemostasis, we show that a variant coagulation factor, FXa(I16L), rapidly restores hemostasis in the presence of the anticoagulant effects of these inhibitors. The ability of FXa(I16L) to reverse the anticoagulant effects of FXa inhibitor depends, at least in part, on the ability of the active site inhibitor to hinder antithrombin-dependent FXa inactivation, paradoxically allowing uninhibited FXa to persist in plasma. Because of its inherent catalytic activity, FXa(I16L) is more potent (by >50-fold) in the hemostasis models tested than a noncatalytic antidote that is currently in clinical development. FXa(I16L) also reduces the anticoagulant-associated bleeding in vivo that is induced by the thrombin inhibitor dabigatran. FXa(I16L) may be able to fill an important unmet clinical need for a rapid, pro-hemostatic agent to reverse the effects of several new anticoagulants.	[Thalji, Nabil K.; Ivanciu, Lacramioara; Davidson, Robert; Krishnaswamy, Sriram; Camire, Rodney M.] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Thalji, Nabil K.; Ivanciu, Lacramioara; Davidson, Robert; Camire, Rodney M.] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Thalji, Nabil K.; Ivanciu, Lacramioara; Krishnaswamy, Sriram; Camire, Rodney M.] Univ Penn, Dept Pediat, Perelman Sch Med, Div Hematol, Philadelphia, PA 19104 USA; [Gimotty, Phyllis A.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Div Hematol, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Gimotty, Phyllis/GWZ-4136-2022; Krishnaswamy, Sriram/Z-4380-2019	Gimotty, Phyllis/0000-0002-3850-9799; 	US National Institutes of Health (NIH) [F30 HL-120487, T32 HL-007439, T32 GM-007170, P01 HL-74124]; Penn-CHOP Blood Center for Patient Care and Discovery; Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, T32HL007439, F30HL120487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn-CHOP Blood Center for Patient Care and Discovery; Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the US National Institutes of Health (NIH) grants F30 HL-120487 (N.K.T.), T32 HL-007439 (N.K.T.), T32 GM-007170 (N.K.T.) and P01 HL-74124 (R.M.C. and S.K.), the Penn-CHOP Blood Center for Patient Care and Discovery (P.A.G.) and research funding from Pfizer (R.M.C.). We are grateful to V. Arruda (Children's Hospital of Philadelphia and University of Pennsylvania) and L. Brass (University of Pennsylvania) for useful suggestions and critical review of the manuscript.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Ansell JE, 2016, J THROMB THROMBOLYS, V41, P248, DOI 10.1007/s11239-015-1288-1; Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Bunce MW, 2011, BLOOD, V117, P290, DOI 10.1182/blood-2010-08-300756; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; CONARD J, 1983, HAEMOSTASIS, V13, P363; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; Crowther M, 2015, ARTERIOSCL THROM VAS, V35, P1736, DOI 10.1161/ATVBAHA.114.303402; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Esmon CT, 2004, J THROMB HAEMOST, V2, P209, DOI 10.1046/j.1538-7933.2003.00537.x; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; GITEL SN, 1984, J BIOL CHEM, V259, P6890; Glund S, 2015, LANCET, V386, P680, DOI 10.1016/S0140-6736(15)60732-2; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; GREEN RA, 1987, AM J VET RES, V48, P496; Herrmann R, 2014, THROMB HAEMOSTASIS, V111, P989, DOI 10.1160/TH13-07-0607; Huntington JA, 2013, J THROMB HAEMOST, V11, P254, DOI 10.1111/jth.12252; Husted S, 2016, DRUG SAFETY, V39, P5, DOI 10.1007/s40264-015-0357-x; Ivanciu L, 2014, BLOOD, V124, P1705, DOI 10.1182/blood-2014-03-565010; Ivanciu L, 2011, NAT BIOTECHNOL, V29, P1028, DOI 10.1038/nbt.1995; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Mark C, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3636.3636; MORITA T, 1986, J BIOL CHEM, V261, P4015; Mueck W, 2014, CLIN PHARMACOKINET, V53, P1, DOI 10.1007/s40262-013-0100-7; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; OLSON ST, 1986, J BIOL CHEM, V261, P3151; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Parry TJ, 2011, BLOOD COAGUL FIBRIN, V22, P720, DOI 10.1097/MBC.0b013e32834cb30e; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Perzborn E, 2014, THROMB RES, V133, P671, DOI 10.1016/j.thromres.2014.01.017; Perzborn E, 2013, THROMB HAEMOSTASIS, V110, P162, DOI 10.1160/TH12-12-0907; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; Samama MM, 2011, CLIN CHEM LAB MED, V49, P761, DOI 10.1515/CCLM.2011.134; Samama MM, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-11; Scaglione F, 2013, CLIN PHARMACOKINET, V52, P69, DOI 10.1007/s40262-012-0030-9; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Siegal DM, 2014, DRUG DISCOV TODAY, V19, P1465, DOI 10.1016/j.drudis.2014.05.013; Smith SA, 2008, J THROMB HAEMOST, V6, P1750, DOI 10.1111/j.1538-7836.2008.03104.x; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; Turecek PL, 2004, HAEMOPHILIA, V10, P3, DOI 10.1111/j.1365-2516.2004.00934.x; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Whinna HC, 2008, THROMB RES, V122, pS64, DOI 10.1016/S0049-3848(08)70022-7; Yeh CH, 2015, ARTERIOSCL THROM VAS, V35, P1056, DOI 10.1161/ATVBAHA.115.303397	63	27	27	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					924	+		10.1038/nm.4149	http://dx.doi.org/10.1038/nm.4149			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27455511				2022-12-27	WOS:000381000200018
J	Dauch, D; Rudalska, R; Cossa, G; Nault, JC; Kang, TW; Wuestefeld, T; Hohmeyer, A; Imbeaud, S; Yevsa, T; Hoenicke, L; Pantsar, T; Bozko, P; Malek, NP; Longerich, T; Laufer, S; Poso, A; Zucman-Rossi, J; Eilers, M; Zender, L				Dauch, Daniel; Rudalska, Ramona; Cossa, Giacomo; Nault, Jean-Charles; Kang, Tae-Won; Wuestefeld, Torsten; Hohmeyer, Anja; Imbeaud, Sandrine; Yevsa, Tetyana; Hoenicke, Lisa; Pantsar, Tatu; Bozko, Przemyslaw; Malek, Nisar P.; Longerich, Thomas; Laufer, Stefan; Poso, Antti; Zucman-Rossi, Jessica; Eilers, Martin; Zender, Lars			A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer	NATURE MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; N-MYC; INHIBITION; IDENTIFICATION; ACTIVATION; P53; SURVEILLANCE; DEGRADATION; RESISTANCE; SENESCENCE	MYC oncoproteins are involved in the genesis and maintenance of the majority of human tumors but are considered undruggable. By using a direct in vivo shRNA screen, we show that liver cancer cells that have mutations in the gene encoding the tumor suppressor protein p53 (Trp53 in mice and TP53 in humans) and that are driven by the oncoprotein NRAS become addicted to MYC stabilization via a mechanism mediated by aurora kinase A (AURKA). This MYC stabilization enables the tumor cells to overcome a latent G2/M cell cycle arrest that is mediated by AURKA and the tumor suppressor protein p19(ARF). MYC directly binds to AURKA, and inhibition of this protein-protein interaction by conformation-changing AURKA inhibitors results in subsequent MYC degradation and cell death. These conformation-changing AURKA inhibitors, with one of them currently being tested in early clinical trials, suppressed tumor growth and prolonged survival in mice bearing Trp53-deficient, NRAS-driven MYC-expressing hepatocellular carcinomas (HCCs). TP53-mutated human HCCs revealed increased AURKA expression and a positive correlation between AURKA and MYC expression. In xenograft models, mice bearing TP53-mutated or TP53-deleted human HCCs were hypersensitive to treatment with conformation-changing AURKA inhibitors, thus suggesting a therapeutic strategy for this subgroup of human HCCs.	[Dauch, Daniel; Rudalska, Ramona; Kang, Tae-Won; Wuestefeld, Torsten; Hohmeyer, Anja; Yevsa, Tetyana; Hoenicke, Lisa; Poso, Antti; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany; [Cossa, Giacomo; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Wurzburg, Germany; [Nault, Jean-Charles; Imbeaud, Sandrine; Zucman-Rossi, Jessica] INSERM, Paris, France; [Kang, Tae-Won; Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany; [Pantsar, Tatu; Poso, Antti] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Bozko, Przemyslaw; Malek, Nisar P.] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany; [Longerich, Thomas] Univ Hosp RWTH Aachen, Inst Pathol, Aachen, Germany; [Laufer, Stefan] Univ Tubingen, Dept Pharmaceut Chem, Tubingen, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	Eberhard Karls University of Tubingen; University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); University of Eastern Finland; Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; University of Wurzburg	Zender, L (corresponding author), Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany.; Zender, L (corresponding author), German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany.	Lars.Zender@med.uni-tuebingen.de	Kang, Tae Won/S-4864-2019; zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; Cossa, Giacomo/AAE-7255-2020; Imbeaud, Sandrine/P-8780-2017	Kang, Tae Won/0000-0003-1497-8926; zucman-rossi, Jessica/0000-0002-5687-0334; j, zucman-rossi/0000-0002-5687-0334; Cossa, Giacomo/0000-0001-5826-5165; Laufer, Stefan/0000-0001-6952-1486; Eilers, Martin/0000-0002-0376-6533; Pantsar, Tatu/0000-0002-0369-2909; Poso, Antti/0000-0003-4196-4204; Imbeaud, Sandrine/0000-0001-8439-6732; Yevsa, Tetyana/0000-0003-0377-9198; Hoenicke, Lisa/0000-0003-0613-8337; nault, jean charles/0000-0002-4875-9353	German Research Foundation (DFG) [FOR2314, SFB685]; Gottfried Wilhelm Leibniz Program; European Research Council; German Ministry for Education and Research. (BMBF); German Universities Excellence Initiative; German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST)	German Research Foundation (DFG)(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; European Research Council(European Research Council (ERC)European Commission); German Ministry for Education and Research. (BMBF)(Federal Ministry of Education & Research (BMBF)); German Universities Excellence Initiative; German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST)	We thank K. Schulze-Osthoff, S.W. Lowe, W Albrecht, K. Breuhahn, R. Geffers, S. Nahnsen, M. Gehringer, E. Rist, C. Fellmeth, P. Katiyar, S. Fillinger, M. Jarek, M. Scharfe, M. Diefenbacher and the members of the Zender laboratory for fruitful discussions, technical assistance or reagents. We thank the Center for Scientific Computing (Espoo, Finland) for software and hardware support. This work was supported by the German Research Foundation (DFG; grants FOR2314 (L.Z., D.D. and M.E.) and SFB685 (L.Z.)), the Gottfried Wilhelm Leibniz Program (L.Z.), the European Research Council (projects 'CholangioConcepf (L.Z.), 'Heptromic' (L.Z.) and 'Auromyc' (M.E.)), the German Ministry for Education and Research. (BMBF) (eMed (Multiscale HCC), the German Universities Excellence Initiative (third funding line: 'future concept') (L.Z.);the German Center for Translational Cancer Research (DKTK) (L.Z.) and the German-Israeli Cooperation in Cancer Research (DKFZ-MOST) (L.Z.).	Aliagas-Martin I, 2009, J MED CHEM, V52, P3300, DOI 10.1021/jm9000314; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Chan KL, 2004, HUM PATHOL, V35, P1324, DOI 10.1016/j.humpath.2004.06.012; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Diefenbacher ME, 2015, CANCER RES, V75, P1181, DOI 10.1158/0008-5472.CAN-14-1726; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Falchook G, 2014, INVEST NEW DRUG, V32, P1181, DOI 10.1007/s10637-014-0121-6; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Katsha A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0375-4; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kimura MT, 2005, CANCER RES, V65, P3548, DOI 10.1158/0008-5472.CAN-04-2149; Klein A, 2008, MOL BIOL CELL, V19, P3667, DOI 10.1091/mbc.E08-01-0042; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Lord R, 2011, INT J CLIN PRACT, V65, P182, DOI 10.1111/j.1742-1241.2010.02545.x; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Lu LF, 2015, MOL CARCINOGEN, V54, P1467, DOI 10.1002/mc.22223; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; TAMAYO RP, 1983, HEPATOLOGY, V3, P112; Tannapfel A, 2001, ONCOGENE, V20, P7104, DOI 10.1038/sj.onc.1204902; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Tward AD, 2005, COLD SH Q B, V70, P217, DOI 10.1101/sqb.2005.70.058; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Yuan HF, 2012, CARCINOGENESIS, V33, P285, DOI 10.1093/carcin/bgr278; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	60	159	164	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					744	753		10.1038/nm.4107	http://dx.doi.org/10.1038/nm.4107			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27213815				2022-12-27	WOS:000379366900013
J	Bivona, TG; Doebele, RC				Bivona, Trever G.; Doebele, Robert C.			A framework for understanding and targeting residual disease in oncogene-driven solid cancers	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; RANDOMIZED PHASE-II; ACQUIRED-RESISTANCE; COMBINED BRAF; COLORECTAL-CANCER; MEK INHIBITION; RAF INHIBITORS; FEEDBACK ACTIVATION; DRUG-RESISTANCE; EGFR	Molecular targeted therapy has the potential to dramatically improve survival in patients with cancer. However, complete and durable responses to targeted therapy are rare in individuals with advanced-stage solid cancers. Even the most effective targeted therapies generally do not induce a complete tumor response, resulting in residual disease and tumor progression that limits patient survival. We discuss the emerging need to more fully understand the molecular basis of residual disease as a prelude to designing therapeutic strategies to minimize or eliminate residual disease so that we can move from temporary to chronic control of disease, or a cure, for patients with advanced-stage solid cancers. Ultimately, we propose a shift from the current reactive paradigm of analyzing and treating acquired drug resistance to a pre-emptive paradigm of defining the mechanisms that result in residual disease, to target and limit this disease reservoir.	[Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bivona, Trever G.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Doebele, Robert C.] Univ Colorado, Dept Med & Med Oncol, Anschutz Med Campus, Aurora, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	trever.bivona@ucsf.edu	Doebele, Robert C./I-8230-2019	Doebele, Robert C./0000-0001-6728-6857	US National Institutes of Health Director's Office and Common Fund [DP2-CA174497]; National Cancer Institute [R01-CA169338]; HHMI Collaborative Innovation Award Program; Searle Scholars Program; Pew Charitable Trust; Addario Lung Cancer Foundation; V Foundation for Cancer Research; University of Colorado Lung Cancer SPORE; NATIONAL CANCER INSTITUTE [R01CA193935, R01CA169338, P50CA058187, DP2CA174497] Funding Source: NIH RePORTER	US National Institutes of Health Director's Office and Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI Collaborative Innovation Award Program; Searle Scholars Program; Pew Charitable Trust; Addario Lung Cancer Foundation; V Foundation for Cancer Research; University of Colorado Lung Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.G.B. acknowledges funding support from the US National Institutes of Health Director's Office and Common Fund (New Innovators Award DP2-CA174497), the National Cancer Institute (R01-CA169338), the HHMI Collaborative Innovation Award Program, the Searle Scholars Program, the Pew Charitable Trust, and the Addario Lung Cancer Foundation. R.C.D. acknowledges funding support from the V Foundation for Cancer Research and the University of Colorado Lung Cancer SPORE.	Ahronian LG, 2015, CANCER DISCOV, V5, P358, DOI 10.1158/2159-8290.CD-14-1518; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Behbehani GK, 2015, CANCER DISCOV, V5, P988, DOI 10.1158/2159-8290.CD-15-0298; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Blumenthal GM, 2015, J CLIN ONCOL, V33, P1008, DOI 10.1200/JCO.2014.59.0489; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Charakidis M, 2014, TRANSL LUNG CANCER R, V3, P395, DOI 10.3978/j.issn.2218-6751.2014.09.03; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Coombs C.C., 2015, NAT REV CLIN ONCOL; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; De Silva N, 2015, BRIT J CANCER, V113, P1305, DOI 10.1038/bjc.2015.342; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gingras I, 2015, CURR OPIN ONCOL, V27, P560, DOI 10.1097/CCO.0000000000000223; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; Hurvitz SA, 2015, LANCET ONCOL, V16, P816, DOI 10.1016/S1470-2045(15)00051-0; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2014, J THORAC ONCOL, V9, P316, DOI 10.1097/JTO.0000000000000088; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Johnson ML, 2015, J CLIN ONCOL, V33, P1666, DOI 10.1200/JCO.2014.59.7328; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lin NU, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0276-z; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Planchard D., 2011, ASCO ANN M AM SOC CL, V8006; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Price KA, 2010, J THORAC ONCOL, V5, P1623, DOI 10.1097/JTO.0b013e3181ec1531; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Sawyers Charles L, 2012, Trans Am Clin Climatol Assoc, V123, P114; Sawyers Charles L, 2009, Clin Adv Hematol Oncol, V7, P588; Sawyers CL, 2009, NAT MED, V15, P1158, DOI 10.1038/nm1009-1158; Schwaederle M, 2015, MOL CANCER THER, V14, P1488, DOI 10.1158/1535-7163.MCT-14-1061; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Spigel D.R., 2011, ASCO ANN M AM SOC CL, V7505; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Szmulewitz RZ, 2014, J CLIN PHARMACOL, V54, P375, DOI 10.1002/jcph.277; Thompson Craig B, 2009, Clin Adv Hematol Oncol, V7, P819; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Undevia SD, 2005, NAT REV CANCER, V5, P447, DOI 10.1038/nrc1629; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Varmus H, 2010, NEW ENGL J MED, V362, P2028, DOI 10.1056/NEJMe0911933; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Yaeger R, 2015, CLIN CANCER RES, V21, P1313, DOI 10.1158/1078-0432.CCR-14-2779; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	84	104	106	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					472	478		10.1038/nm.4091	http://dx.doi.org/10.1038/nm.4091			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149220	Green Accepted			2022-12-27	WOS:000375514000009
J	Siu, LL; Lawler, M; Haussler, D; Knoppers, BM; Lewin, J; Vis, DJ; Liao, RG; Andre, F; Banks, I; Barrett, JC; Caldas, C; Camargo, AA; Fitzgerald, RC; Mao, M; Mattison, JE; Pao, W; Sellers, WR; Sullivan, P; Teh, BT; Ward, RL; ZenKlusen, JC; Sawyers, CL; Voest, EE				Siu, Lillian L.; Lawler, Mark; Haussler, David; Knoppers, Bartha Maria; Lewin, Jeremy; Vis, Daniel J.; Liao, Rachel G.; Andre, Fabrice; Banks, Ian; Barrett, J. Carl; Caldas, Carlos; Camargo, Anamaria Aranha; Fitzgerald, Rebecca C.; Mao, Mao; Mattison, John E.; Pao, William; Sellers, William R.; Sullivan, Patrick; Teh, Bin Tean; Ward, Robyn L.; ZenKlusen, Jean Claude; Sawyers, Charles L.; Voest, Emile E.			Facilitating a culture of responsible and effective sharing of cancer genome data	NATURE MEDICINE			English	Article							GLOBAL ALLIANCE; PRIVACY; CONSENT; LEGAL; CARE; CONSORTIUM; PROTECTION; SCIENCE; EUROPE; RIGHTS	Rapid and affordable tumor molecular profiling has led to an explosion of clinical and genomic data poised to enhance the diagnosis, prognostication and treatment of cancer. A critical point has now been reached at which the analysis and storage of annotated clinical and genomic information in unconnected silos will stall the advancement of precision cancer care. Information systems must be harmonized to overcome the multiple technical and logistical barriers to data sharing. Against this backdrop, the Global Alliance for Genomic Health (GA4GH) was established in 2013 to create a common framework that enables responsible, voluntary and secure sharing of clinical and genomic data. This Perspective from the GA4GH Clinical Working Group Cancer Task Team highlights the data-aggregation challenges faced by the field, suggests potential collaborative solutions and describes how GA4GH can catalyze a harmonized data-sharing culture.	[Siu, Lillian L.; Lewin, Jeremy] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lawler, Mark] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Haussler, David] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Knoppers, Bartha Maria] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada; [Vis, Daniel J.; Voest, Emile E.] Netherlands Canc Inst, Amsterdam, Netherlands; [Liao, Rachel G.] Global Alliance Genom & Hlth, Toronto, ON, Canada; [Andre, Fabrice] Gustave Roussy, Villejuif, France; [Andre, Fabrice] Univ Paris 11, Villejuif, France; [Banks, Ian] European Canc Org, Patients Advocacy Comm, Brussels, Belgium; [Barrett, J. Carl] AstraZeneca, Oncol IMED, Translat Sci, Waltham, MA USA; [Caldas, Carlos; Fitzgerald, Rebecca C.] Univ Cambridge, Dept Oncol, Cambridge, England; [Camargo, Anamaria Aranha] Hosp Sirio Libanes, Sao Paulo, Brazil; [Mao, Mao] Yonsei Univ, Coll Med, Yonsei Canc Res Inst, Seoul, South Korea; [Mattison, John E.] Kaiser Permanente, Pasadena, CA USA; [Pao, William] Roche, Pharma Res & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA USA; [Sullivan, Patrick] Advocacy Canadian Children Oncol Network, Vancouver, BC, Canada; [Teh, Bin Tean] Natl Canc Ctr Singapore, Singapore, Singapore; [Ward, Robyn L.] Univ Queensland, St Lucia, Qld, Australia; [ZenKlusen, Jean Claude] NCI, Canc Genome Atlas, NIH, Bethesda, MD 20892 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Queens University Belfast; University of California System; University of California Santa Cruz; McGill University; Netherlands Cancer Institute; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; AstraZeneca; University of Cambridge; Hospital Sirio Libanes; Yonsei University; Yonsei University Health System; Kaiser Permanente; Roche Holding; Novartis; National Cancer Centre Singapore (NCCS); University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Memorial Sloan Kettering Cancer Center	Lawler, M (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	mark.lawler@qub.ac.uk	Caldas, Carlos/U-7250-2019; ANDRE, Fabrice/AAL-2683-2020; Camargo, Anamaria A/E-9388-2012; Ward, Robyn L/I-2313-2013	Caldas, Carlos/0000-0003-3547-1489; ANDRE, Fabrice/0000-0001-5795-8357; Camargo, Anamaria A/0000-0002-6076-9597; Ward, Robyn L/0000-0002-6877-8906; Teh, Bin Tean/0000-0003-1514-1124; Fitzgerald, Rebecca/0000-0002-3434-3568	Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; Cancer Research UK; US National Institutes of Health [U54HG007990]; Quebec Breast Cancer Foundation; Howard Hughes Medical Institute; US National Cancer Institute [CA008748]; Barcode for Life Foundation; Hartwig Medical Foundation; Cancer Research UK [22720, 16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10090, NF-SI-0611-10154] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER	Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quebec Breast Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barcode for Life Foundation; Hartwig Medical Foundation; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This manuscript is written on behalf of the GA4GH Clinical Working Group (WG). We thank the Data WG, Regulatory and Ethics WG and Security WG for their important contributions. L.L.S. is supported by the Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; M.L., C.C. and R.C.F. are supported by Cancer Research UK; D.H. is funded by the US National Institutes of Health (award #U54HG007990). B.M.K. is supported by the Quebec Breast Cancer Foundation; C.L.S. is supported by the Howard Hughes Medical Institute and US National Cancer Institute (Grant #CA008748); E.E.V. is supported by the Barcode for Life Foundation and the Hartwig Medical Foundation.	Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; American Association for Cancer Research, PROJ GENIE GEN EV NE; Andre F, 2014, ANN ONCOL, V25, P2295, DOI 10.1093/annonc/mdu478; Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Boutros PC, 2014, NAT GENET, V46, P318, DOI 10.1038/ng.2932; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Conley BA, 2014, SEMIN ONCOL, V41, P297, DOI 10.1053/j.seminoncol.2014.05.002; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Eggermont AMM, 2014, EUR J CANCER, V50, P2745, DOI 10.1016/j.ejca.2014.07.025; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; European Commission, 2012, PROP REG EUR PARL CO; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Gargis AS, 2015, NAT BIOTECHNOL, V33, P689, DOI 10.1038/nbt.3237; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Global Al liance for Genomics and Health, 2016, DAT SHAR LEX; Global Alliance for Genomics and Health, 2015, CONS POL; Global Alliance for Genomics and Health, SEC INFR STAND IMPL; Global Alliance for Genomics and Health, 2016, ACC POL; Global Alliance for Genomics and Health, 2014, FRAM RESP SHAR GEN H; Global Alliance for Genomics and Health, 2014, GA P3G IPAC CONS TOO; Global Alliance for Genomics and Health, 2013, WHIT PAP CREAT GLOB; Global Alliance for Genomics and Health, 2015, PRIV SEC POL; Green RC, 2015, NEW ENGL J MED, V372, P397, DOI 10.1056/NEJMp1404776; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Husedzinovic A, 2015, EUR J HUM GENET, V23, P1607, DOI 10.1038/ejhg.2015.27; Joly Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002549; Kaye J, 2015, INT LIBR ETH LAW TEC, V14, P101, DOI 10.1007/978-94-017-9573-9_8; Knoppers BM, 2014, HUM GENET, V133, P895, DOI 10.1007/s00439-014-1432-6; Knoppers BM, 2014, GENOME MED, V6, DOI 10.1186/gm530; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kosseim P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0430-2; Lacombe D, 2014, NAT REV CLIN ONCOL, V11, P492, DOI 10.1038/nrclinonc.2014.98; Lawler M, 2015, CANCER DISCOV, V5, P1133, DOI 10.1158/2159-8290.CD-15-0821; Lawler M, 2014, ONCOLOGIST, V19, P217, DOI 10.1634/theoncologist.2013-0452; Lawler M, 2014, LANCET ONCOL, V15, P258, DOI 10.1016/S1470-2045(13)70552-7; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lolkema MP, 2013, J CLIN ONCOL, V31, P1842, DOI 10.1200/JCO.2012.45.2789; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mancini Julien, 2011, J Natl Cancer Inst, V103, P154, DOI 10.1093/jnci/djq498; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i213; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McGuire AL, 2011, GENET MED, V13, P948, DOI 10.1097/GIM.0b013e3182227589; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; O'Doherty KC, 2011, SOC SCI MED, V73, P367, DOI 10.1016/j.socscimed.2011.05.046; Paten B, 2015, J AM MED INFORM ASSN, V22, P1143, DOI 10.1093/jamia/ocv047; Pillai U, 2014, BIOPRESERV BIOBANK, V12, P409, DOI 10.1089/bio.2014.0039; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Rogith D, 2014, J AM MED INFORM ASSN, V21, pE320, DOI 10.1136/amiajnl-2013-002579; Schilsky RL, 2014, J CLIN ONCOL, V32, P2373, DOI 10.1200/JCO.2014.56.2124; Schilsky RL, 2014, NAT REV CLIN ONCOL, V11, P432, DOI 10.1038/nrclinonc.2014.54; Sioutos N, 2007, J BIOMED INFORM, V40, P30, DOI 10.1016/j.jbi.2006.02.013; Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a; Tejpar S., 2012, 37 EUR SOC MED ONC C, p1382P; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; US National Institutes of Health, 2014, NAT I HLTH GEN DAT S; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wolf Leslie E, 2004, IRB, V26, P1, DOI 10.2307/3563696; Zika E, 2008, PHARMACOGENOMICS, V9, P773, DOI 10.2217/14622416.9.6.773	68	50	50	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					464	471		10.1038/nm.4089	http://dx.doi.org/10.1038/nm.4089			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149219	Green Accepted			2022-12-27	WOS:000375514000008
J	Marcais, A; Walzer, T				Marcais, Antoine; Walzer, Thierry			An immunosuppressive pathway for tumor progression	NATURE MEDICINE			English	Editorial Material							NK CELLS; CANCER; INHIBITION	An active immunosuppressive pathway is identified in colon cancer that confers immune evasion by the cancer and can be targeted to synergize with immunotherapies.	[Marcais, Antoine; Walzer, Thierry] CIRI, Lyon, France; [Marcais, Antoine; Walzer, Thierry] INSERM, U1111, Lyon, France; [Marcais, Antoine; Walzer, Thierry] Ecole Normale Super Lyon, Lyon, France; [Marcais, Antoine; Walzer, Thierry] Univ Lyon 1, Lyon, France; [Marcais, Antoine; Walzer, Thierry] CNRS, UMR 5308, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Walzer, T (corresponding author), CIRI, Lyon, France.; Walzer, T (corresponding author), INSERM, U1111, Lyon, France.; Walzer, T (corresponding author), Ecole Normale Super Lyon, Lyon, France.; Walzer, T (corresponding author), Univ Lyon 1, Lyon, France.; Walzer, T (corresponding author), CNRS, UMR 5308, Lyon, France.	thierry.walzer@inserm.fr	Marçais, Antoine/F-4341-2017; Walzer, Thierry/L-9418-2014	Marçais, Antoine/0000-0002-3591-6268; Walzer, Thierry/0000-0002-0857-8179				Cichocki F, 2017, CANCER RES, V77, P5664, DOI 10.1158/0008-5472.CAN-17-0799; D'Amico L, 2016, J EXP MED, V213, P827, DOI 10.1084/jem.20150950; Dyck L, 2017, EUR J IMMUNOL, V47, P765, DOI 10.1002/eji.201646875; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Patsoukis N, 2013, MOL CELL BIOL, V33, P3091, DOI 10.1128/MCB.00319-13; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Toh JWT, 2016, CLIN COLORECTAL CANC, V15, P285, DOI 10.1016/j.clcc.2016.07.007; Xiao Q, 2018, NAT MED, V24, P262, DOI 10.1038/nm.4496	11	7	7	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					260	261		10.1038/nm.4508	http://dx.doi.org/10.1038/nm.4508			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29509752				2022-12-27	WOS:000426700900007
J	Lehmann, LH; Jebessa, ZH; Kreusser, MM; Horsch, A; He, T; Kronlage, M; Dewenter, M; Sramek, V; Oehl, U; Krebs-Haupenthal, J; von der Lieth, AH; Schmidt, A; Sun, Q; Ritterhoff, J; Finke, D; Volkers, M; Jungmann, A; Sauer, SW; Thiel, C; Nickel, A; Kohlhaas, M; Schafer, M; Sticht, C; Maack, C; Gretz, N; Wagner, M; El-Armouche, A; Maier, LS; Londono, JEC; Meder, B; Freichel, M; Grone, HJ; Most, P; Muller, OJ; Herzig, S; Furlong, EEM; Katus, HA; Backs, J				Lehmann, Lorenz H.; Jebessa, Zegeye H.; Kreusser, Michael M.; Horsch, Axel; He, Tao; Kronlage, Mariya; Dewenter, Matthias; Sramek, Viviana; Oehl, Ulrike; Krebs-Haupenthal, Jutta; von der Lieth, Albert H.; Schmidt, Andrea; Sun, Qiang; Ritterhoff, Julia; Finke, Daniel; Voelkers, Mirko; Jungmann, Andreas; Sauer, Sven W.; Thiel, Christian; Nickel, Alexander; Kohlhaas, Michael; Schaefer, Michaela; Sticht, Carsten; Maack, Christoph; Gretz, Norbert; Wagner, Michael; El-Armouche, Ali; Maier, Lars S.; Londono, Juan E. Camacho; Meder, Benjamin; Freichel, Marc; Groene, Hermann-Josef; Most, Patrick; Mueller, Oliver J.; Herzig, Stephan; Furlong, Eileen E. M.; Katus, Hugo A.; Backs, Johannes			A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway	NATURE MEDICINE			English	Article							STROMAL INTERACTION MOLECULE-1; CAM KINASE-II; PATHOLOGICAL CARDIAC-HYPERTROPHY; LINKED N-ACETYLGLUCOSAMINE; OPERATED CALCIUM-ENTRY; NEONATAL CARDIOMYOCYTES; PRESSURE-OVERLOAD; O-GLCNAC; TRANSCRIPTION FACTORS; CONTRACTILE FUNCTION	The stress-responsive epigenetic repressor histone deacetylase 4 (HDAC4) regulates cardiac gene expression. Here we show that the levels of an N-terminal proteolytically derived fragment of HDAC4, termed HDAC4-NT, are lower in failing mouse hearts than in healthy control hearts. Virus-mediated transfer of the portion of the Hdac4 gene encoding HDAC4-NT into the mouse myocardium protected the heart from remodeling and failure; this was associated with decreased expression of Nr4a1, which encodes a nuclear orphan receptor, and decreased NR4A1-dependent activation of the hexosamine biosynthetic pathway (HBP). Conversely, exercise enhanced HDAC4-NT levels, and mice with a cardiomyocyte-specific deletion of Hdac4 show reduced exercise capacity, which was characterized by cardiac fatigue and increased expression of Nr4a1. Mechanistically, we found that NR4A1 negatively regulated contractile function in a manner that depended on the HBP and the calcium sensor STIM1. Our work describes a new regulatory axis in which epigenetic regulation of a metabolic pathway affects calcium handling. Activation of this axis during intermittent physiological stress promotes cardiac function, whereas its impairment in sustained pathological cardiac stress leads to heart failure.	[Lehmann, Lorenz H.; Jebessa, Zegeye H.; Kreusser, Michael M.; Horsch, Axel; He, Tao; Kronlage, Mariya; Dewenter, Matthias; Sramek, Viviana; Oehl, Ulrike; Krebs-Haupenthal, Jutta; von der Lieth, Albert H.; Schmidt, Andrea; Sun, Qiang; Finke, Daniel; Backs, Johannes] Heidelberg Univ, Dept Mol Cardiol & Epigenet, Heidelberg, Germany; [Lehmann, Lorenz H.; Jebessa, Zegeye H.; Kreusser, Michael M.; Horsch, Axel; He, Tao; Kronlage, Mariya; Dewenter, Matthias; Sramek, Viviana; Oehl, Ulrike; Krebs-Haupenthal, Jutta; von der Lieth, Albert H.; Schmidt, Andrea; Sun, Qiang; Ritterhoff, Julia; Finke, Daniel; Voelkers, Mirko; Jungmann, Andreas; Schaefer, Michaela; Londono, Juan E. Camacho; Meder, Benjamin; Freichel, Marc; Most, Patrick; Mueller, Oliver J.; Herzig, Stephan; Furlong, Eileen E. M.; Katus, Hugo A.; Backs, Johannes] German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, Heidelberg, Germany; [Lehmann, Lorenz H.; Kreusser, Michael M.; Kronlage, Mariya; Ritterhoff, Julia; Finke, Daniel; Voelkers, Mirko; Jungmann, Andreas; Meder, Benjamin; Most, Patrick; Mueller, Oliver J.; Katus, Hugo A.] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Sauer, Sven W.; Thiel, Christian] Heidelberg Univ, Dept 1, Ctr Child & Adolescent Med, Heidelberg, Germany; [Nickel, Alexander; Kohlhaas, Michael; Maack, Christoph] Saarland Univ Hosp, Dept Internal Med, Homburg Saar, Germany; [Schaefer, Michaela; Herzig, Stephan] Heidelberg Univ, Helmholtz Ctr Munich, IDC, Neuherberg, Germany; [Schaefer, Michaela; Herzig, Stephan] Heidelberg Univ, Joint Heidelberg IDC Translat Diabet Program, Neuherberg, Germany; [Sticht, Carsten; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany; [Wagner, Michael; El-Armouche, Ali] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Pharmacol & Toxicol, Dresden, Germany; [Maier, Lars S.] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Londono, Juan E. Camacho; Freichel, Marc] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Furlong, Eileen E. M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Nickel, Alexander; Kohlhaas, Michael; Maack, Christoph] Univ Hosp Wurzburg, Dept Translat Sci, Comprehens Heart Failure Ctr DZHI, Wurzburg, Germany; [Mueller, Oliver J.] Univ Kiel, Dept Internal Med 3, Kiel, Germany; [Mueller, Oliver J.] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Kiel, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universitatsklinikum des Saarlandes; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; University of Regensburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); University of Wurzburg; University of Kiel; German Centre for Cardiovascular Research	Backs, J (corresponding author), Heidelberg Univ, Dept Mol Cardiol & Epigenet, Heidelberg, Germany.; Backs, J (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, Heidelberg, Germany.	johannes.backs@med.uni-heidelberg.de	Müller, Oliver/AAA-4399-2021; Wagner, Michael/C-2670-2015; Lehmann, Lorenz/AAP-9161-2021; Maier, Lars/AAQ-8313-2021; El-Armouche, Ali/H-3161-2018; Volkers, Mirko/E-7947-2010	Müller, Oliver/0000-0001-8223-2638; Wagner, Michael/0000-0002-6300-5752; Lehmann, Lorenz/0000-0001-5077-8580; Maier, Lars/0000-0001-9915-4429; El-Armouche, Ali/0000-0003-2514-9429; Furlong, Eileen/0000-0002-9544-8339; Camacho Londono, Juan E./0000-0003-0673-7583; Ritterhoff, Julia/0000-0002-3419-4830; Maack, Christoph/0000-0003-3694-4559; Volkers, Mirko/0000-0003-2344-1856	Deutsche Forschungsgemeinschaft [BA 2258/2-1, SFB 1118, He3260/8-1, He3260/7-1, SFB1118, TR-SFB 152, EL 270/7-1, WA 2586/4-1]; European Commission [MEDIA-261409]; Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK; German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); Heidelberg Research Center for Molecular Medicine (HRCMM) Career Development Fellowship; Helmholtz Cross-Program Topic Metabolic Dysfunction; DZHK; BMBF; DFG (Heisenberg Programm) [SFB-894]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK; German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Heidelberg Research Center for Molecular Medicine (HRCMM) Career Development Fellowship; Helmholtz Cross-Program Topic Metabolic Dysfunction; DZHK; BMBF(Federal Ministry of Education & Research (BMBF)); DFG (Heisenberg Programm)(German Research Foundation (DFG))	We thank M. Oestringer, S. Harrack and X. Qi for technical help and M. Hagenmuller for organizational help. We thank Pineda antibody service (Berlin) for production of the HDAC4-NT-specific antibody. We thank M. Sussman for providing the NR4A1-expressing adenovirus, J. Hill for providing the Stim1-D76A adenovirus and E.N. Olson for the MEF2A, MEF2C and MEF2D expression constructs. We additionally thank M. D. Schneider for providing the Myh6-Cre transgenic mice, M. Ohora (Tokyo Medical and Dental University) for providing the Stim1- and Stim2-floxed mice, and S. Offermanns (Max-Planck Institute for Heart and Lung Research, Bad Nauheim) for providing the aMHC-CreER(T2) mice. We thank U. Haberkorn and W. Mier for synthesis of DIM-C-p-PhOH. J.B. was supported by grants from the Deutsche Forschungsgemeinschaft (BA 2258/2-1 and SFB 1118), the European Commission (FP7-Health-2010 and MEDIA-261409) and the Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK; German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). L.H.L. is recipient of the Heidelberg Research Center for Molecular Medicine (HRCMM) Career Development Fellowship. S.H. received grant support from the Deutsche Forschungsgemeinschaft (He3260/8-1, He3260/7-1 and SFB1118), and the Helmholtz Cross-Program Topic Metabolic Dysfunction. M.F. received grant support from the Deutsche Forschungsgemeinschaft (SFB1118 and TR-SFB 152), the DZHK and the BMBF. C.M. is supported by the DFG (Heisenberg Programm and SFB-894). M.W. and A.E.-A. are supported by the Deutsche Forschungsgemeinschaft (EL 270/7-1 (A.E.-A.) and WA 2586/4-1 (M.W.)). J.B. is in particular grateful to E.N. Olson who contributed to the inception of this work and to the Olson lab, where J.B. continued the generation of the conditional Hdac4 KO mice; work that was started by Junyoung Oh. This work is also dedicated to the memory of Junyoung Oh.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; BLACK BL, 1995, J BIOL CHEM, V270, P2889, DOI 10.1074/jbc.270.7.2889; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Chatham JC, 2012, CIRC RES, V111, P666, DOI 10.1161/CIRCRESAHA.112.277392; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Collins HE, 2014, AM J PHYSIOL-HEART C, V306, pH1231, DOI 10.1152/ajpheart.00075.2014; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; Dassanayaka S, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0612-7; DOUGLAS PS, 1987, CIRCULATION, V76, P1206, DOI 10.1161/01.CIR.76.6.1206; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Haworth RS, 2012, CIRC RES, V110, P1585, DOI 10.1161/CIRCRESAHA.111.263665; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Houser SR, 2014, CIRC RES, V114, P1320, DOI 10.1161/CIRCRESAHA.114.300569; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kreusser MM, 2014, CIRCULATION, V130, P1262, DOI 10.1161/CIRCULATIONAHA.114.006185; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SO, 2014, MOL ENDOCRINOL, V28, P1729, DOI 10.1210/me.2014-1102; Lehmann LH, 2014, CELL MOL LIFE SCI, V71, P1673, DOI 10.1007/s00018-013-1516-9; Li Y, 2007, BIOCHEMISTRY-US, V46, P13163, DOI 10.1021/bi700694c; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Medzikovic L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15404; Mela L, 1979, Methods Enzymol, V55, P39; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muller OJ, 2008, GENE THER, V15, P1558, DOI 10.1038/gt.2008.111; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; National Research Council, 2011, GUIDE CARE USE LAB A; Nickel A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0358-9; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Rossi DJ, 2001, EMBO J, V20, P2844, DOI 10.1093/emboj/20.11.2844; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Takefuji M, 2012, CIRCULATION, V126, P1972, DOI 10.1161/CIRCULATIONAHA.112.109256; Templin C, 2016, J AM COLL CARDIOL, V67, P1937, DOI 10.1016/j.jacc.2016.03.006; Trivax JE, 2012, CLIN CARDIOL, V35, P69, DOI 10.1002/clc.20994; Troupes CD, 2017, CIRC RES, V121, P125, DOI 10.1161/CIRCRESAHA.117.311094; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang RH, 2013, EMBO MOL MED, V5, P137, DOI 10.1002/emmm.201201369; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Weeks KL, 2015, J PHYSIOL-LONDON, V593, P1785, DOI 10.1113/jphysiol.2014.282442; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805; Werfel S, 2014, CARDIOVASC RES, V104, P15, DOI 10.1093/cvr/cvu174; Young ME, 2007, GENE REGUL SYST BIO, V1, P251; Zachara N., 2015, ESSENTIALS GLYCOBIOL, V3rd ed; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao GL, 2015, P NATL ACAD SCI USA, V112, pE4792, DOI 10.1073/pnas.1423295112; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zhu-Mauldin X, 2012, J BIOL CHEM, V287, P39094, DOI 10.1074/jbc.M112.383778; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	79	60	61	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					62	+		10.1038/nm.4452	http://dx.doi.org/10.1038/nm.4452			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29227474				2022-12-27	WOS:000422965900012
J	Zhang, P; Wang, PX; Zhao, LP; Zhang, X; Ji, YX; Zhang, XJ; Fang, C; Lu, YX; Yang, X; Gao, MM; Zhang, Y; Tian, S; Zhu, XY; Gong, J; Ma, XL; Li, F; Wang, ZH; Huang, Z; She, ZG; Li, HL				Zhang, Peng; Wang, Pi-Xiao; Zhao, Ling-Ping; Zhang, Xin; Ji, Yan-Xiao; Zhang, Xiao-Jing; Fang, Chun; Lu, Yue-Xin; Yang, Xia; Gao, Mao-Mao; Zhang, Yan; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Ma, Xin-Liang; Li, Feng; Wang, Zhihua; Huang, Zan; She, Zhi-Gang; Li, Hongliang			The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis	NATURE MEDICINE			English	Article							REGULATING KINASE 1; NF-KAPPA-B; FATTY LIVER-DISEASE; PATHOLOGICAL CARDIAC-HYPERTROPHY; ESSENTIAL NEGATIVE REGULATOR; A20 PROTECTS MICE; INSULIN-RESISTANCE; ISCHEMIA/REPERFUSION INJURY; LIPID-ACCUMULATION; SIGNALING PATHWAY	Activation of apoptosis signal-regulating kinase 1 (ASK1) in hepatocytes is a key process in the progression of nonalcoholic steatohepatitis (NASH) and a promising target for treatment of the condition. However, the mechanism underlying ASK1 activation is still unclear, and thus the endogenous regulators of this kinase remain open to be exploited as potential therapeutic targets. In screening for proteins that interact with ASK1 in the context of NASH, we identified the deubiquitinase tumor necrosis factor alpha-induced protein 3 (TNFAIP3) as a key endogenous suppressor of ASK1 activation, and we found that TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes. Hepatocyte-specific ablation of Tnfaip3 exacerbated nonalcoholic fatty liver disease-and NASH-related phenotypes in mice, including glucose metabolism disorders, lipid accumulation and enhanced inflammation, in an ASK1-dependent manner. In contrast, transgenic or adeno-associated virus-mediated TNFAIP3 gene delivery in the liver in both mouse and nonhuman primate models of NASH substantially blocked the onset and progression of the disease. These results implicate TNFAIP3 as a functionally important endogenous suppressor of ASK1 hyperactivation in the pathogenesis of NASH and identify it as a potential new molecular target for NASH therapy.	[Zhang, Peng; Zhang, Xiao-Jing; Wang, Zhihua; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Zhang, Peng; Wang, Pi-Xiao; Zhao, Ling-Ping; Zhang, Xin; Ji, Yan-Xiao; Zhang, Xiao-Jing; Fang, Chun; Lu, Yue-Xin; Yang, Xia; Gao, Mao-Mao; Zhang, Yan; Tian, Song; Zhu, Xue-Yong; Gong, Jun; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Inst Model Anim, Wuhan, Hubei, Peoples R China; [Zhang, Peng; Wang, Pi-Xiao; Zhao, Ling-Ping; Ji, Yan-Xiao; Fang, Chun; Lu, Yue-Xin; Yang, Xia; Gao, Mao-Mao; Zhang, Yan; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Li, Feng; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Basic Med Sch, Wuhan, Hubei, Peoples R China; [Zhang, Peng; Wang, Pi-Xiao; Zhao, Ling-Ping; Ji, Yan-Xiao; Fang, Chun; Lu, Yue-Xin; Yang, Xia; Gao, Mao-Mao; Zhang, Yan; Tian, Song; Zhu, Xue-Yong; Gong, Jun; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Hubei, Peoples R China; [Zhang, Xin; Gong, Jun; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Ji, Yan-Xiao; Li, Hongliang] Zhongnan Hosp, Med Sci Res Ctr, Wuhan, Hubei, Peoples R China; [Ma, Xin-Liang] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Zhang, Peng] Wuhan Univ, Med Sci Res Ctr, Zhongnan Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Jefferson University; Wuhan University	She, ZG; Li, HL (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China.; She, ZG; Li, HL (corresponding author), Wuhan Univ, Inst Model Anim, Wuhan, Hubei, Peoples R China.; She, ZG; Li, HL (corresponding author), Wuhan Univ, Basic Med Sch, Wuhan, Hubei, Peoples R China.; She, ZG; Li, HL (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Zhongnan Hosp, Med Sci Res Ctr, Wuhan, Hubei, Peoples R China.	zgshe@whu.edu.cn; lihl@whu.edu.cn	Wang, Zhihua/AAM-1486-2021	Huang, Zan/0000-0001-5623-6950	National Science Fund for Distinguished Young Scholars [81425005]; Key Project of the National Natural Science Foundation [81330005, 81630011]; National Science and Technology Support Project [2014BAI02B01, 2015BAI08B01]; National Key Research and Development Program [2013YQ030923-05, 2016YFF0101500]; National Natural Science Foundation of China [81770053]; Key Collaborative Project of the National Natural Science Foundation [91639304]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project of the National Natural Science Foundation; National Science and Technology Support Project; National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Collaborative Project of the National Natural Science Foundation	We thank H.-B. Shu (Medical Research Institute, Wuhan University) for providing ubiquitin and several of its derivative plasmids. We thank Y. Wang (University of California, Los Angeles) for his helpful suggestions regarding this research and for editing the manuscript. This work was supported by grants from the National Science Fund for Distinguished Young Scholars (no. 81425005, H.L.), the Key Project of the National Natural Science Foundation (no. 81330005 and no. 81630011, H.L.), the National Science and Technology Support Project (no. 2014BAI02B01 and no. 2015BAI08B01, H.L.), the National Key Research and Development Program (no. 2013YQ030923-05, H.L.; no. 2016YFF0101500, Z.-G.S.), the National Natural Science Foundation of China (no. 81770053, Z.-G.S.) and the Key Collaborative Project of the National Natural Science Foundation (no. 91639304, H.L. and Z.-G.S.).	Ai LY, 2015, INT J BIOL SCI, V11, P1436, DOI 10.7150/ijbs.13371; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boronkai A, 2009, EUR J CELL BIOL, V88, P753, DOI 10.1016/j.ejcb.2009.07.005; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Catrysse L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.154; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Czech MP, 2013, NAT MED, V19, P969, DOI 10.1038/nm.3293; Deng KQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11432; Feng J, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-27; Gao L, 2016, J HEPATOL, V65, P125, DOI 10.1016/j.jhep.2016.03.006; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang H, 2010, HYPERTENSION, V56, P232, DOI 10.1161/HYPERTENSIONAHA.110.149963; Huang QH, 2015, CIRCULATION, V131, P1082, DOI 10.1161/CIRCULATIONAHA.114.012725; Ji YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11267; Lawan A, 2015, MOL CELL BIOL, V35, P26, DOI 10.1128/MCB.00503-14; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lin JH, 2015, NEPHRON, V129, P29, DOI 10.1159/000369152; Longo CR, 2005, HEPATOLOGY, V42, P156, DOI 10.1002/hep.20741; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Maruyama H, 2016, INT J MED SCI, V13, P169, DOI 10.7150/ijms.13581; Maruyama T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004822; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McCommis KS, 2017, HEPATOLOGY, V65, P1543, DOI 10.1002/hep.29025; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Nishida T., 2017, ADV BIOL REGUL, P30119; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Okazaki T, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1883; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Petrvalska O, 2016, J BIOL CHEM, V291, P20753, DOI 10.1074/jbc.M116.724310; Ramsey HE, 2009, LIVER TRANSPLANT, V15, P1613, DOI 10.1002/lt.21879; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Studer P, 2015, CELL DEATH DIFFER, V22, P2068, DOI 10.1038/cdd.2015.52; Sun P, 2015, J HEPATOL, V63, P1198, DOI 10.1016/j.jhep.2015.06.033; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Villanueva MT, 2017, NAT REV DRUG DISCOV, V16, DOI 10.1038/nrd.2017.60; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Wang PX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10592; Wang PX, 2015, J HEPATOL, V62, P111, DOI 10.1016/j.jhep.2014.08.022; Weijman JF, 2017, P NATL ACAD SCI USA, V114, pE2096, DOI 10.1073/pnas.1620813114; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Xiang M, 2016, J HEPATOL, V64, P1365, DOI 10.1016/j.jhep.2016.02.002; Xie LF, 2016, J HEPATOL, V65, P113, DOI 10.1016/j.jhep.2016.03.008; Ye DW, 2016, J HEPATOL, V65, P988, DOI 10.1016/j.jhep.2016.05.041; Yu Z, 2016, ELIFE, V5, DOI 10.7554/eLife.14087; Zhang Y, 2014, CARDIOVASC RES, V102, P35, DOI 10.1093/cvr/cvu004; Zhao GN, 2017, NAT MED, V23, P742, DOI 10.1038/nm.4334; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200	68	118	120	6	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					84	+		10.1038/nm.4453	http://dx.doi.org/10.1038/nm.4453			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29227477				2022-12-27	WOS:000422965900014
J	Bunders, MJ; Altfeld, M				Bunders, Madeleine J.; Altfeld, Marcus			Can NK cells purge HIV sanctuaries?	NATURE MEDICINE			English	Editorial Material							HELPER T-CELLS; IN-VIVO; INFECTION; IL-15	A recent study identifies a population of CXCR5(+) natural killer (NK) cells patrolling B cell follicles in simian immunodeficiency virus (SIV)-infected African green monkeys that might contribute to the lack of disease progression in this nonpathogenic model.	[Bunders, Madeleine J.; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Bunders, Madeleine J.] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Bunders, Madeleine J.] Acad Med Ctr, Emma Childrens Hosp, Amsterdam, Netherlands; [Altfeld, Marcus] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany	Heinrich Pette Institute; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	marcus.altfeld@leibniz-hpi.de	Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997				Ayala VI, 2017, J VIROL, V91, DOI 10.1128/JVI.02507-16; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Boritz EA, 2016, CELL, V166, P1004, DOI 10.1016/j.cell.2016.06.039; Boumans MJH, 2011, ARTHRITIS RHEUM-US, V63, P3187, DOI 10.1002/art.30567; DeGottardi MQ, 2016, J IMMUNOL, V197, P1183, DOI 10.4049/jimmunol.1600065; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Huot N, 2017, NAT MED, V23, P1277, DOI 10.1038/nm.4421; Leone A, 2009, CURR HIV RES, V7, P83, DOI 10.2174/157016209787048519; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Seay K, 2015, J VIROL, V89, P6264, DOI 10.1128/JVI.00563-15	12	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1254	1255		10.1038/nm.4434	http://dx.doi.org/10.1038/nm.4434			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29117170				2022-12-27	WOS:000414548300006
J	Jin, X; Kim, LJY; Wu, QL; Wallace, LC; Prager, BC; Sanvoranart, T; Gimple, RC; Wang, XX; Mack, SC; Miller, TE; Huang, P; Valentim, CL; Zhou, QG; Barnholtz-Sloan, JS; Bao, SD; Sloan, AE; Rich, JN				Jin, Xun; Kim, Leo J. Y.; Wu, Qiulian; Wallace, Lisa C.; Prager, Briana C.; Sanvoranart, Tanwarat; Gimple, Ryan C.; Wang, Xiuxing; Mack, Stephen C.; Miller, Tyler E.; Huang, Ping; Valentim, Claudia L.; Zhou, Qi-gang; Barnholtz-Sloan, Jill S.; Bao, Shideng; Sloan, Andrew E.; Rich, Jeremy N.			Targeting glioma stem cells through combined BMI1 and EZH2 inhibition	NATURE MEDICINE			English	Article							TUMOR-INITIATING CELLS; HUMAN GLIOBLASTOMA; RADIATION RESPONSE; GENE-EXPRESSION; DNA-DAMAGE; DIFFERENTIATION; TUMORIGENICITY; METHYLATION; POLYCOMB; DRUG	Glioblastomas are lethal cancers defined by angiogenesis and pseudopalisading necrosis. Here, we demonstrate that these histological features are associated with distinct transcriptional programs, with vascular regions showing a proneural profile, and hypoxic regions showing a mesenchymal pattern. As these regions harbor glioma stem cells (GSCs), we investigated the epigenetic regulation of these two niches. Proneural, perivascular GSCs activated EZH2, whereas mesenchymal GSCs in hypoxic regions expressed BMI1 protein, which promoted cellular survival under stress due to downregulation of the E3 ligase RNF144A. Using both genetic and pharmacologic inhibition, we found that proneural GSCs are preferentially sensitive to EZH2 disruption, whereas mesenchymal GSCs are more sensitive to BMI1 inhibition. Given that glioblastomas contain both proneural and mesenchymal GSCs, combined EZH2 and BMI1 targeting proved more effective than either agent alone both in culture and in vivo, suggesting that strategies that simultaneously target multiple epigenetic regulators within glioblastomas may be effective in overcoming therapy resistance caused by intratumoral heterogeneity.	[Jin, Xun; Kim, Leo J. Y.; Wu, Qiulian; Wallace, Lisa C.; Prager, Briana C.; Sanvoranart, Tanwarat; Gimple, Ryan C.; Wang, Xiuxing; Mack, Stephen C.; Miller, Tyler E.; Huang, Ping; Valentim, Claudia L.; Zhou, Qi-gang; Bao, Shideng; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Jin, Xun] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China; [Jin, Xun] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Kim, Leo J. Y.; Prager, Briana C.; Gimple, Ryan C.; Miller, Tyler E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kim, Leo J. Y.; Prager, Briana C.; Gimple, Ryan C.; Miller, Tyler E.] Case Western Reserve Univ, Sch Med, Med Scientist Training Program, Cleveland, OH USA; [Kim, Leo J. Y.; Wu, Qiulian; Prager, Briana C.; Gimple, Ryan C.; Wang, Xiuxing; Rich, Jeremy N.] Univ San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92110 USA; [Prager, Briana C.; Bao, Shideng; Rich, Jeremy N.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Mack, Stephen C.] Baylor Coll Med, Dept Pediat, Div Pediat Hematol & Oncol, Houston, TX 77030 USA; [Barnholtz-Sloan, Jill S.; Bao, Shideng; Sloan, Andrew E.; Rich, Jeremy N.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Univ Hosp Cleveland Med Ctr, Dept Neurol Surg, Cleveland Med Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Tianjin Medical University; Wenzhou Medical University; Case Western Reserve University; Case Western Reserve University; University of San Diego; Case Western Reserve University; Cleveland Clinic Foundation; Baylor College of Medicine; Case Western Reserve University; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Rich, JN (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA.; Rich, JN (corresponding author), Univ San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92110 USA.; Rich, JN (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.; Sloan, AE; Rich, JN (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Sloan, AE (corresponding author), Univ Hosp Cleveland Med Ctr, Dept Neurol Surg, Cleveland Med Ctr, Cleveland, OH 44106 USA.	andrew.sloan@uhhospitals.org; drjeremyrich@gmail.com	Barnholtz-Sloan, Jill/A-4817-2011; Wang, Xiuxing/HGU-0583-2022; wang, xiuxing/AAY-4068-2021; Wang, Xiuxing/N-6759-2019; Wang, Xiuxing/ABF-8681-2020; Sloan, Andrew/AAE-9842-2020; Gimple, Ryan/AAU-8944-2020; Rich, Jeremy/AAM-1445-2021	Barnholtz-Sloan, Jill/0000-0001-6190-9304; Wang, Xiuxing/0000-0001-7115-729X; Wang, Xiuxing/0000-0002-5993-9368; Miller, Tyler E/0000-0002-1269-1895; Mack, Stephen C./0000-0001-9620-4742	National Institutes of Health grants [CA203101, CA183510, CA217065, CA217066, CA043703, CA169117, CA184090, NS091080, NS099175, CA197718, CA154130, CA171652, NS087913, NS089272]; Kimble Family Foundation; Ferry Foundation; Jerry Kaufman GBM Research Fund [CA217956]; General Program of the National Natural Science Foundation of China [81572891]; Canadian Institutes of Health Research Banting Fellowship; NATIONAL CANCER INSTITUTE [F30CA183510, F30CA217066, F30CA203101, R01CA169117, R01CA184090, R01CA171652, R35CA197718, R01CA154130, F30CA217065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091080, R01NS089272, R01NS099175, R01NS103434, R01NS087913] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimble Family Foundation; Ferry Foundation; Jerry Kaufman GBM Research Fund; General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research Banting Fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank PTC Therapeutics for providing PTC209 and PTC596, as well as performing measurement of drug levels. We thank E.P. Sulman (MD Anderson Cancer Center) and A.W. Boyd (Queensland Institute of Medical Research) for subtype-characterized GSCs (PN11, PN23, PN-JK2, PN-MMK1, MES20, MES28 and MES-MN1). We would like to thank N. DeWitt for editorial assistance, as well as the Cleveland Clinic Lerner Research Institute imaging core and proteomics core service teams. We also thank members of J.N.R.'s lab for input about the manuscript. Finally, we would like to thank our funding sources: the National Institutes of Health grants CA203101 (L.K.); CA183510 (T.E.M.); CA217065 (R.C.G.); CA217066 (B.C.P.); CA043703 (J.S.B.-S.); CA169117, CA184090, NS091080 and NS099175 (S.B.); CA197718, CA154130, CA169117, CA171652, NS087913 and NS089272 (J.N.R.); the Peter D. Cristal Chair, the Kimble Family Foundation, the Ferry Foundation, the Jerry Kaufman GBM Research Fund, and CA217956 (A.E.S.); the General Program of the National Natural Science Foundation of China (81572891) (X.J.); Canadian Institutes of Health Research Banting Fellowship (S.C.M.).	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fan TY, 2014, INT J CLIN EXP PATHO, V7, P6662; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Gynther M, 2008, J MED CHEM, V51, P932, DOI 10.1021/jm701175d; Hagerstrand D, 2011, NEURO-ONCOLOGY, V13, P1178, DOI 10.1093/neuonc/nor113; Halliday J, 2014, P NATL ACAD SCI USA, V111, P5248, DOI 10.1073/pnas.1321014111; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Ho SR, 2014, P NATL ACAD SCI USA, V111, pE2646, DOI 10.1073/pnas.1323107111; Jin X, 2013, CANCER LETT, V328, P235, DOI 10.1016/j.canlet.2012.09.005; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Jung JY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90019; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Marotta D, 2011, CANCER RES, V71, P779, DOI 10.1158/0008-5472.CAN-10-3061; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Mohammad F, 2017, NAT MED, V23, P483, DOI 10.1038/nm.4293; Oh YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103327; Park TS, 2014, CIRCULATION, V129, P359, DOI 10.1161/CIRCULATIONAHA.113.003000; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Segerman A, 2016, CELL REP, V17, P2994, DOI 10.1016/j.celrep.2016.11.056; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Venugopal C, 2012, STEM CELL RES, V8, P141, DOI 10.1016/j.scr.2011.09.008; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang Q., 2016, TUMOR EVOLUTION GLIO; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu ZY, 2013, J NEUROL SCI, V335, P191, DOI 10.1016/j.jns.2013.09.030; Zhang P, 2015, INT J CANCER, V137, P2007, DOI 10.1002/ijc.29566	58	192	196	5	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1352	+		10.1038/nm.4415	http://dx.doi.org/10.1038/nm.4415			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035367	Green Accepted			2022-12-27	WOS:000414548300017
J	Cimino, I; Coll, AP; Yeo, GSH				Cimino, Irene; Coll, Anthony P.; Yeo, Giles S. H.			GDF15 and energy balance: homing in on a mechanism	NATURE MEDICINE			English	Editorial Material							TGF-BETA SUPERFAMILY; CYTOKINE; ANOREXIA; MIC-1	Three recent studies in mice have identified a specific receptor, GFRAL, for the known anorectic peptide GDF15. The finding increases mechanistic understanding of its effect and paves the way for the development of novel anti-obesity therapeutics.	[Cimino, Irene; Coll, Anthony P.; Yeo, Giles S. H.] Univ Cambridge, Addenbrookes Hosp Cambridge, MRC Metab Dis Unit, Cambridge, England; [Cimino, Irene; Coll, Anthony P.; Yeo, Giles S. H.] Univ Cambridge, Addenbrookes Hosp Cambridge, Metab Res Labs, Wellcome Trust,MRC Inst Metab Sci, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Yeo, GSH (corresponding author), Univ Cambridge, Addenbrookes Hosp Cambridge, MRC Metab Dis Unit, Cambridge, England.; Yeo, GSH (corresponding author), Univ Cambridge, Addenbrookes Hosp Cambridge, Metab Res Labs, Wellcome Trust,MRC Inst Metab Sci, Cambridge, England.	gshy2@cam.ac.uk		Coll, Anthony Patrick/0000-0003-2594-7463; Yeo, Giles See How/0000-0001-8823-3615	Medical Research Council [MC_UU_12012/1] Funding Source: Medline; MRC [MC_UU_12012/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Corre J, 2013, STEM CELL TRANSL MED, V2, P946, DOI 10.5966/sctm.2013-0055; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Tsai VWW, 2016, INT J OBESITY, V40, P193, DOI 10.1038/ijo.2015.242; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394	10	12	14	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1119	1120		10.1038/nm.4414	http://dx.doi.org/10.1038/nm.4414			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985212				2022-12-27	WOS:000412431800004
J	Kuntz, EM; Baquero, P; Michie, AM; Dunn, K; Tardito, S; Holyoake, TL; Helgason, GV; Gottlieb, E				Kuntz, Elodie M.; Baquero, Pablo; Michie, Alison M.; Dunn, Karen; Tardito, Saverio; Holyoake, Tessa L.; Helgason, G. Vignir; Gottlieb, Eyal			Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells	NATURE MEDICINE			English	Article							SUPPORTING ASPARTATE BIOSYNTHESIS; COMPLETE MOLECULAR REMISSION; CHRONIC MYELOGENOUS LEUKEMIA; FATTY-ACID OXIDATION; KINASE-ACTIVITY; IMATINIB; METABOLISM; BCR; DIFFERENTIATION; DISCONTINUATION	Treatment of chronic myeloid leukemia (CML) with imatinib mesylate and other second-and/or third-generation c-Abl-specific tyrosine kinase inhibitors (TKIs) has substantially extended patient survival(1). However, TKIs primarily target differentiated cells and do not eliminate leukemic stem cells (LSCs)(2-4). Therefore, targeting minimal residual disease to prevent acquired resistance and/or disease relapse requires identification of new LSC-selective target(s) that can be exploited therapeutically(5,6). Considering that malignant transformation involves cellular metabolic changes, which may in turn render the transformed cells susceptible to specific assaults in a selective manner(7), we searched for such vulnerabilities in CML LSCs. We performed metabolic analyses on both stem cell-enriched (CD34(+) and CD34(+)CD38(-)) and differentiated (CD34(-)) cells derived from individuals with CML, and we compared the signature of these cells with that of their normal counterparts. Through combination of stable isotope-assisted metabolomics with functional assays, we demonstrate that primitive CML cells rely on upregulated oxidative metabolism for their survival. We also show that combination treatment with imatinib and tigecycline, an antibiotic that inhibits mitochondrial protein translation, selectively eradicates CML LSCs both in vitro and in a xenotransplantation model of human CML. Our findings provide a strong rationale for investigation of the use of TKIs in combination with tigecycline to treat patients with CML with minimal residual disease.	[Kuntz, Elodie M.; Tardito, Saverio; Gottlieb, Eyal] Canc Res UK, Beatson Inst, Glasgow, Lanark, Scotland; [Baquero, Pablo; Helgason, G. Vignir] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Michie, Alison M.; Dunn, Karen; Holyoake, Tessa L.] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gottlieb, Eyal] Technion Israel Inst Technol, Technion Integrated Canc Ctr, Fac Med, Haifa, Israel	Beatson Institute; Cancer Research UK; University of Glasgow; University of Glasgow; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Gottlieb, E (corresponding author), Canc Res UK, Beatson Inst, Glasgow, Lanark, Scotland.; Helgason, GV (corresponding author), Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.; Gottlieb, E (corresponding author), Technion Israel Inst Technol, Technion Integrated Canc Ctr, Fac Med, Haifa, Israel.	vignir.helgason@glasgow.ac.uk; e.gottlieb@technion.ac.il	Baquero, Pablo/Q-4469-2018; Tardito, Saverio/AAJ-7727-2020; Gottlieb, Eyal/G-6450-2010	Tardito, Saverio/0000-0002-5294-8683; Gottlieb, Eyal/0000-0002-9770-0956; Pablo, Baquero Valls/0000-0002-5292-071X; Gilbey, Thomas/0000-0001-5677-3318; Michie, Alison/0000-0002-5404-475X; Helgason, G Vignir/0000-0003-1616-132X	Cancer Research UK; Cancer ResearchUK Glasgow Centre [C596/A18076]; Cancer Research UK Beatson Institute [C596/A17196]; Medical Research Council/AstraZeneca [MR/K014854/1]; Chief Scientist's Office (Scotland); Howat Foundation and Friends of Paul O'Gorman; Bloodwise Specialist Programme [14033]; Kay Kendall Leukaemia Fund (KKLF) [KKL501, KKL698]; Lady Tata International Award; Leuka; Glasgow Experimental Cancer Medicine Centre (ECMC) - Cancer Research UK; MRC [MR/K014854/1] Funding Source: UKRI; Cancer Research UK [23982, 18278] Funding Source: researchfish; Medical Research Council [MR/K014854/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer ResearchUK Glasgow Centre; Cancer Research UK Beatson Institute(Cancer Research UK); Medical Research Council/AstraZeneca; Chief Scientist's Office (Scotland); Howat Foundation and Friends of Paul O'Gorman; Bloodwise Specialist Programme; Kay Kendall Leukaemia Fund (KKLF); Lady Tata International Award; Leuka; Glasgow Experimental Cancer Medicine Centre (ECMC) - Cancer Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all patients and healthy donors who contributed samples and National Health Service (NHS) Greater Glasgow and Clyde Biorepository; A. Hair for sample processing; T. Gilbey and T. Harvey for cell sorting; N. Van Den Broek and G. MacKay for technical assistance; and A. King for editorial work. This study was supported by Cancer Research UK; the Cancer ResearchUK Glasgow Centre (C596/A18076) and the Biological Services Unit facilities at the Cancer Research UK Beatson Institute (C596/A17196); Medical Research Council/AstraZeneca project grants (MR/K014854/1); the Glasgow Experimental Cancer Medicine Centre (ECMC), which is funded by Cancer Research UK and by the Chief Scientist's Office (Scotland); the Howat Foundation and Friends of Paul O'Gorman; the Bloodwise Specialist Programme (14033); the Kay Kendall Leukaemia Fund (KKLF) (KKL501 and KKL698); Lady Tata International Award; and Leuka. G.V.H. is a KKLF Intermediate Research Fellow, Leadership Fellow and John Goldman Fellow.	Abraham SA, 2016, NATURE, V534, P341, DOI 10.1038/nature18288; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Holyoake TL, 2015, IMMUNOL REV, V263, P106, DOI 10.1111/imr.12234; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Karvela M, 2016, AUTOPHAGY, V12, P936, DOI 10.1080/15548627.2016.1162359; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Mackay GM, 2015, METHOD ENZYMOL, V561, P171, DOI 10.1016/bs.mie.2015.05.016; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Norberg E, 2017, CELL DEATH DIFFER, V24, P251, DOI 10.1038/cdd.2016.116; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022	25	260	267	9	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1234	+		10.1038/nm.4399	http://dx.doi.org/10.1038/nm.4399			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28920959	Green Accepted			2022-12-27	WOS:000412431800019
J	Labonte, B; Engmann, O; Purushothaman, I; Menard, C; Wang, JS; Tan, CF; Scarpa, JR; Moy, G; Loh, YHE; Cahill, M; Lorsch, ZS; Hamilton, PJ; Calipari, ES; Hodes, GE; Issler, O; Kronman, H; Pfau, M; Obradovic, ALJ; Dong, Y; Neve, RL; Russo, S; Kazarskis, A; Tamminga, C; Mechawar, N; Turecki, G; Zhang, B; Shen, L; Nestler, EJ				Labonte, Benoit; Engmann, Olivia; Purushothaman, Immanuel; Menard, Caroline; Wang, Junshi; Tan, Chunfeng; Scarpa, Joseph R.; Moy, Gregory; Loh, Yong-Hwee E.; Cahill, Michael; Lorsch, Zachary S.; Hamilton, Peter J.; Calipari, Erin S.; Hodes, Georgia E.; Issler, Orna; Kronman, Hope; Pfau, Madeline; Obradovic, Aleksandar L. J.; Dong, Yan; Neve, Rachael L.; Russo, Scott; Kazarskis, Andrew; Tamminga, Carol; Mechawar, Naguib; Turecki, Gustavo; Zhang, Bin; Shen, Li; Nestler, Eric J.			Sex-specific transcriptional signatures in human depression	NATURE MEDICINE			English	Article							NATIONAL COMORBIDITY SURVEY; ANTERIOR CINGULATE CORTEX; GENE-EXPRESSION ANALYSIS; CHRONIC MILD STRESS; PREFRONTAL CORTEX; MAJOR DEPRESSION; GENDER-DIFFERENCES; RISK-FACTORS; BRAIN; MECHANISMS	Major depressive disorder (MDD) is a leading cause of disease burden worldwide. While the incidence, symptoms and treatment of MDD all point toward major sex differences, the molecular mechanisms underlying this sexual dimorphism remain largely unknown. Here, combining differential expression and gene coexpression network analyses, we provide a comprehensive characterization of male and female transcriptional profiles associated with MDD across six brain regions. We overlap our human profiles with those from a mouse model, chronic variable stress, and capitalize on converging pathways to define molecular and physiological mechanisms underlying the expression of stress susceptibility in males and females. Our results show a major rearrangement of transcriptional patterns in MDD, with limited overlap between males and females, an effect seen in both depressed humans and stressed mice. We identify key regulators of sex-specific gene networks underlying MDD and confirm their sex-specific impact as mediators of stress susceptibility. For example, downregulation of the female-specific hub gene Dusp6 in mouse prefrontal cortex mimicked stress susceptibility in females, but not males, by increasing ERK signaling and pyramidal neuron excitability. Such Dusp6 downregulation also recapitulated the transcriptional remodeling that occurs in prefrontal cortex of depressed females. Together our findings reveal marked sexual dimorphism at the transcriptional level in MDD and highlight the importance of studying sex-specific treatments for this disorder.	[Labonte, Benoit; Engmann, Olivia; Purushothaman, Immanuel; Menard, Caroline; Scarpa, Joseph R.; Moy, Gregory; Loh, Yong-Hwee E.; Cahill, Michael; Lorsch, Zachary S.; Hamilton, Peter J.; Calipari, Erin S.; Hodes, Georgia E.; Issler, Orna; Kronman, Hope; Pfau, Madeline; Obradovic, Aleksandar L. J.; Russo, Scott; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Labonte, Benoit; Engmann, Olivia; Purushothaman, Immanuel; Menard, Caroline; Scarpa, Joseph R.; Moy, Gregory; Loh, Yong-Hwee E.; Cahill, Michael; Lorsch, Zachary S.; Hamilton, Peter J.; Calipari, Erin S.; Hodes, Georgia E.; Issler, Orna; Kronman, Hope; Pfau, Madeline; Obradovic, Aleksandar L. J.; Russo, Scott; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Wang, Junshi; Dong, Yan] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Tan, Chunfeng; Tamminga, Carol] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Scarpa, Joseph R.; Kazarskis, Andrew; Zhang, Bin] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Scarpa, Joseph R.; Kazarskis, Andrew; Zhang, Bin] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Mechawar, Naguib; Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Mechawar, Naguib; Turecki, Gustavo] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); McGill University; McGill University	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.; Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	eric.nestler@mssm.edu	Dong, Yan/A-4154-2016; Hodes, Georgia/L-8022-2016; Obradovic, Aleksandar/AAO-9200-2020; Russo, Scott/R-7107-2019; Menard, Caroline/AAV-4017-2020; Labonte, Benoit/GPF-5629-2022	Dong, Yan/0000-0003-0016-9028; Hodes, Georgia/0000-0002-1551-2178; Obradovic, Aleksandar/0000-0003-0606-4913; Russo, Scott/0000-0002-6470-1805; Menard, Caroline/0000-0001-8202-7378; Labonte, Benoit/0000-0002-1251-5605; Hamilton, Peter/0000-0002-6819-8346; Cahill, Michael/0000-0003-0574-2655; Kronman, Hope/0000-0002-2828-723X; Wang, Junshi/0000-0002-2290-3759; Calipari, Erin/0000-0003-4723-0623; Turecki, Gustavo/0000-0003-4075-2736	National Institute of Mental Health (NIMH) [P50MH096890, R01MH051399]; Hope for Depression Research Foundation (HDRF); Frederick Banting and Charles Best postdoctoral fellowship from the Canadian Institute for Health Research (CIHR); Research Chair in Molecular Neurobiology of Mood Disorders; Fond de Recherche du Quebec-Sante (FRQ-S) Junior 1 award; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087004, F30MH106293, R01MH090264, T32MH096678, R01MH051399, P50MH096890, R01MH104559, F30MH110073, R21MH099562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA044538, R01DA034856, R01DA023206, R37DA023206, R00DA042111] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation (HDRF); Frederick Banting and Charles Best postdoctoral fellowship from the Canadian Institute for Health Research (CIHR); Research Chair in Molecular Neurobiology of Mood Disorders; Fond de Recherche du Quebec-Sante (FRQ-S) Junior 1 award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank V. Vialou for his in vivo expertise, K. Gleason at The University of Texas Southwestern Medical Center and Josee Prud'homme and Danielle Cecyre at the Douglas Bell- Canada Brain Bank for their help with procuring human brain samples, and O. Jabado for his expert advice on RNA-seq. This work was funded by National Institute of Mental Health (NIMH) grants P50MH096890 and R01MH051399 and by the Hope for Depression Research Foundation (HDRF) to E.J.N. B.L. was supported by a Frederick Banting and Charles Best postdoctoral fellowship from the Canadian Institute for Health Research (CIHR) and now by a Research Chair in Molecular Neurobiology of Mood Disorders and a Fond de Recherche du Quebec-Sante (FRQ-S) Junior 1 award.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bagot RC, 2016, NEURON, V90, P969, DOI 10.1016/j.neuron.2016.04.015; Bangasser DA, 2014, FRONT NEUROENDOCRIN, V35, P303, DOI 10.1016/j.yfrne.2014.03.008; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Chopra KK, 2009, PSYCHONEUROENDOCRINO, V34, P1235, DOI 10.1016/j.psyneuen.2009.03.014; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Frey BN, 2010, PSYCHIAT RES-NEUROIM, V183, P157, DOI 10.1016/j.pscychresns.2010.05.005; GALLUCCI WT, 1993, HEALTH PSYCHOL, V12, P420, DOI 10.1037/0278-6133.12.5.420; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Gray AL, 2015, MOL PSYCHIATR, V20, P1139, DOI 10.1038/mp.2015.114; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Haines DH., 2000, NEUROANATOMY ATLAS S, V5; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jiang P, 2015, CELL REP, V11, P835, DOI 10.1016/j.celrep.2015.04.003; Kang HJ, 2007, J NEUROSCI, V27, P13329, DOI 10.1523/JNEUROSCI.4083-07.2007; Kaufman J, 2015, NEUROPSYCHOPHARMACOL, V40, P1692, DOI 10.1038/npp.2015.15; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khan A, 2005, J CLIN PSYCHOPHARM, V25, P318, DOI 10.1097/01.jcp.0000168879.03169.ce; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Kornstein SG, 2000, J AFFECT DISORDERS, V60, P1, DOI 10.1016/S0165-0327(99)00158-5; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Labuda M, 1996, AM J HUM GENET, V59, P633; Lalovic A, 2010, J AFFECT DISORDERS, V120, P24, DOI 10.1016/j.jad.2009.04.007; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Lin LC, 2015, MOL PSYCHIATR, V20, P377, DOI 10.1038/mp.2014.184; Lin LC, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-18; Lisowski P, 2011, EUR NEUROPSYCHOPHARM, V21, P45, DOI 10.1016/j.euroneuro.2010.08.004; Mailliet F, 2008, EXP NEUROL, V211, P593, DOI 10.1016/j.expneurol.2008.02.030; Malki K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1431-6; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; McGirr A, 2006, SCHIZOPHR RES, V84, P132, DOI 10.1016/j.schres.2006.02.025; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Nolte J, 2002, HUMAN BRAIN INTRO IT; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Piper Michael, 2007, Novartis Found Symp, V288, P230; Quan MN, 2011, NEUROSCIENCE, V182, P88, DOI 10.1016/j.neuroscience.2011.03.026; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Seney ML, 2015, NEUROBIOL DIS, V73, P213, DOI 10.1016/j.nbd.2014.10.005; Seney ML, 2013, FRONT PSYCHIATRY, V4, P104, DOI [10.3389/fpsyt.2013.00104, DOI 10.3389/FPSYT.2013.00104]; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035367; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Underwood MD, 2012, INT J NEUROPSYCHOPH, V15, P435, DOI 10.1017/S1461145711000691; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Wang SS, 2008, MOL PSYCHIATR, V13, P786, DOI 10.1038/mp.2008.38; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	64	316	319	5	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1102	+		10.1038/nm.4386	http://dx.doi.org/10.1038/nm.4386			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28825715	Green Accepted			2022-12-27	WOS:000409996200018
J	Takashima, S; Hanash, AM				Takashima, Shuichiro; Hanash, Alan M.			The enteric virome in hematopoietic stem cell transplantation: ready for its close-up	NATURE MEDICINE			English	Editorial Material							VERSUS-HOST-DISEASE; ACUTE GVHD; ALLOREACTIVITY; LEUKEMIA	A new study highlights dynamic changes in the enteric virome after hematopoietic stem cell transplantation in humans, pointing to a correlation between these changes and graft-versus-host disease.	[Takashima, Shuichiro; Hanash, Alan M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Hanash, Alan M.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Hanash, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	hanasha@mskcc.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL115355] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bunting MD, 2017, BLOOD, V129, P630, DOI 10.1182/blood-2016-08-734020; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Dudakov J. A., 2017, BLOOD; Fuji S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00330; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hauri-Hohl MM, 2007, BLOOD, V109, P4080, DOI 10.1182/blood-2006-07-034157; Legoff J, 2017, NAT MED, V23, P1080, DOI 10.1038/nm.4380; Levine JE, 2015, LANCET HAEMATOL, V2, pE21, DOI 10.1016/S2352-3026(14)00035-0; Mensen A, 2014, BLOOD, V124, P963, DOI 10.1182/blood-2013-11-539031; O'Meara A, 2015, BONE MARROW TRANSPL, V50, P1105, DOI 10.1038/bmt.2015.109; Shono Y, 2010, BLOOD, V115, P5401, DOI 10.1182/blood-2009-11-253559; Wikstrom ME, 2015, BLOOD, V126, P1503, DOI 10.1182/blood-2015-01-622837	12	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1012	1013		10.1038/nm.4403	http://dx.doi.org/10.1038/nm.4403			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886006				2022-12-27	WOS:000409996200005
J	Xue, YH; Martelotto, L; Baslan, T; Vides, A; Solomon, M; Mai, TT; Chaudhary, N; Riely, GJ; Li, BT; Scott, K; Cechhi, F; Stierner, U; Chadalavada, K; de Stanchina, E; Schwartz, S; Hembrough, T; Nanjangud, G; Berger, MF; Nilsson, J; Lowe, SW; Reis, J; Rosen, N; Lito, P				Xue, Yaohua; Martelotto, Luciano; Baslan, Timour; Vides, Alberto; Solomon, Martha; Trang Thi Mai; Chaudhary, Neelam; Riely, Greg J.; Li, Bob T.; Scott, Kerry; Cechhi, Fabiola; Stierner, Ulrika; Chadalavada, Kalyani; de Stanchina, Elisa; Schwartz, Sarit; Hembrough, Todd; Nanjangud, Gouri; Berger, Michael F.; Nilsson, Jonas; Lowe, Scott W.; Reis-Filho, Jorge S.; Rosen, Neal; Lito, Piro			An approach to suppress the evolution of resistance in BRAF(V600E)-mutant cancer	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; BRAF-MUTANT; MEK INHIBITION; OPEN-LABEL; MELANOMA; FEEDBACK; MULTICENTER; DABRAFENIB; TRAMETINIB; TARGETS	The principles that govern the evolution of tumors exposed to targeted therapy are poorly understood. Here we modeled the selection and propagation of an amplification in the BRAF oncogene (BRAF(amp)) in patient-derived tumor xenografts (PDXs) that were treated with a direct inhibitor of the kinase ERK, either alone or in combination with other ERK signaling inhibitors. Single-cell sequencing and multiplex fluorescence in situ hybridization analyses mapped the emergence of extra-chromosomal amplification in parallel evolutionary trajectories that arose in the same tumor shortly after treatment. The evolutionary selection of BRAF(amp) was determined by the fitness threshold, the barrier that subclonal populations need to overcome to regain fitness in the presence of therapy. This differed for inhibitors of ERK signaling, suggesting that sequential monotherapy is ineffective and selects for a progressively higher BRAF copy number. Concurrent targeting of the RAF, MEK and ERK kinases, however, imposed a sufficiently high fitness threshold to prevent the propagation of subclones with high-level BRAF(amp). When administered on an intermittent schedule, this treatment inhibited tumor growth in 11/11 PDXs of lung cancer or melanoma without apparent toxicity in mice. Thus, gene amplification can be acquired and expanded through parallel evolution, enabling tumors to adapt while maintaining their intratumoral heterogeneity. Treatments that impose the highest fitness threshold will likely prevent the evolution of resistance-causing alterations and, thus, merit testing in patients.	[Xue, Yaohua; Martelotto, Luciano; Baslan, Timour; Vides, Alberto; Solomon, Martha; Trang Thi Mai] Human Oncol & Pathogenesis Program, Mem Sloan Kettering Canc Ctr MSKCC, New York, NY 96332 USA; [Trang Thi Mai; Riely, Greg J.; Scott, Kerry; Cechhi, Fabiola; Stierner, Ulrika] Weill Cornell Rockefeller Sloan Kettering Tri Ins, New York, NY USA; [Vides, Alberto; Solomon, Martha; Chaudhary, Neelam; Li, Bob T.; Cechhi, Fabiola] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA; [Vides, Alberto; Riely, Greg J.; Scott, Kerry] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY USA; [Trang Thi Mai; Chaudhary, Neelam; Li, Bob T.; Cechhi, Fabiola] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Vides, Alberto; Riely, Greg J.] NantOm, Rockville, MD USA; [Baslan, Timour; Trang Thi Mai; Riely, Greg J.; Scott, Kerry] Univ Gothenburg, Sahlgrenska Translat Melanoma Grp, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Vides, Alberto; Solomon, Martha; Chaudhary, Neelam; Li, Bob T.] Mem Sloan Kettering Canc Ctr, Mol Cytogenet Core Facil, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Gothenburg; Memorial Sloan Kettering Cancer Center	Xue, YH (corresponding author), Human Oncol & Pathogenesis Program, Mem Sloan Kettering Canc Ctr MSKCC, New York, NY 96332 USA.		Rosen, Neal/ABF-2677-2020; Martelotto, Luciano/D-1946-2015	Chaudhary, Neelam/0000-0002-0327-2824; Martelotto, Luciano/0000-0002-9625-1183; Nilsson, Jonas/0000-0003-0346-6837; Xue, Jenny/0000-0003-1192-1836	US National Institutes of Health (NIH) [K08 CA191082-01A1]; Uniting Against Lung Cancer Foundation; Damon Runyon Clinical Investigator Award; Josie Robertson Investigator Program at MSKCC; Druckenmiller Center for Lung Cancer Center at MSKCC; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH [T32GM007739]; MSKCC Pilot Center tor Precision Disease Modeling program [U54 OD020355]; William C. and Joyce C. O'Neil Charitable Trust; Memorial Sloan Kettering Single-Cell Sequencing Initiative; Knut and Alice Wallenberg Foundation; MSKCC Support Grant-Core Grant program [P30 CA008748]; NATIONAL CANCER INSTITUTE [K08CA191082, R35CA210085, P30CA008748, P01CA129243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniting Against Lung Cancer Foundation; Damon Runyon Clinical Investigator Award; Josie Robertson Investigator Program at MSKCC; Druckenmiller Center for Lung Cancer Center at MSKCC; Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH; MSKCC Pilot Center tor Precision Disease Modeling program; William C. and Joyce C. O'Neil Charitable Trust; Memorial Sloan Kettering Single-Cell Sequencing Initiative; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); MSKCC Support Grant-Core Grant program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank D. Solit, N. Bouvier and the Center for Molecular Oncology at MSKCC for assistance with next-generation sequencing, Z. Yao(MSKCC) for providing the A375 doxycycline-inducible BRAF<SUP>V600E</SUP> cells, as well as C. Sawyers, C. Rodin, J. Poirier and M. Mroczkowski for reviewing the manuscript. This work was supported by the US National Institutes of Health (NIH) (grant K08 CA191082-01A1; P.L.), the Uniting Against Lung Cancer Foundation (P.L.), the Damon Runyon Clinical Investigator Award (P.L.), the Josie Robertson Investigator Program at MSKCC (P.L.), the Druckenmiller Center for Lung Cancer Center at MSKCC (P.L.) and a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award number T32GM007739 to the Weill Cornell-Rockefeller-Sloan Kettering Tri-institutional MD-PhD Program (Y.X.). E.d.S. and S.W.L. are supported in part by the MSKCC Pilot Center tor Precision Disease Modeling program (U54 OD020355). T.B. is supported by the William C. and Joyce C. O'Neil Charitable Trust, Memorial Sloan Kettering Single-Cell Sequencing Initiative. J.N. is supported by the Knut and Alice Wallenberg Foundation. The authors also acknowledge the MSKCC Support Grant-Core Grant program (P30 CA008748).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Catenacci DVT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100586; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Einarsdottir BO, 2014, ONCOTARGET, V5, P9609, DOI 10.18632/oncotarget.2445; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gao RL, 2016, NAT GENET, V48, P1119, DOI 10.1038/ng.3641; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Hembrough T, 2013, J MOL DIAGN, V15, P454, DOI 10.1016/j.jmoldx.2013.03.002; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipinski KA, 2016, TRENDS CANCER, V2, P49, DOI 10.1016/j.trecan.2015.11.003; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nguyen A, 2016, J CLIN INVEST, V126, P681, DOI 10.1172/JCI83587; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2014, CANCER DISCOV, V4, P69, DOI 10.1158/2159-8290.CD-13-0279; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Wanjala J, 2015, MOL CANCER THER, V14, P278, DOI 10.1158/1535-7163.MCT-14-0542-T; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wong DJL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-194; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001	48	96	100	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					929	+		10.1038/nm.4369	http://dx.doi.org/10.1038/nm.4369			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28714990	Green Accepted			2022-12-27	WOS:000406947600008
J	Hara, M; Kobayakawa, K; Ohkawa, Y; Kumamaru, H; Yokota, K; Saito, T; Kijima, K; Yoshizaki, S; Harimaya, K; Nakashima, Y; Okada, S				Hara, Masamitsu; Kobayakawa, Kazu; Ohkawa, Yasuyuki; Kumamaru, Hiromi; Yokota, Kazuya; Saito, Takeyuki; Kijima, Ken; Yoshizaki, Shingo; Harimaya, Katsumi; Nakashima, Yasuharu; Okada, Seiji			Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury	NATURE MEDICINE			English	Article							GLIAL SCAR; UP-REGULATION; STEM-CELLS; EXPRESSION; REGENERATION; RECOVERY; ABLATION; NEUROPROTECTION; DEGENERATION; ASTROGLIOSIS	Central nervous system (CNS) injury transforms naive astrocytes into reactive astrocytes, which eventually become scar-forming astrocytes that can impair axonal regeneration and functional recovery. This sequential phenotypic change, known as reactive astrogliosis, has long been considered unidirectional and irreversible. However, we report here that reactive astrocytes isolated from injured spinal cord reverted in retrograde to naive astrocytes when transplanted into a naive spinal cord, whereas they formed astrocytic scars when transplanted into injured spinal cord, indicating the environment-dependent plasticity of reactive astrogliosis. We also found that type I collagen was highly expressed in the spinal cord during the scar-forming phase and induced astrocytic scar formation via the integrin-N-cadherin pathway. In a mouse model of spinal cord injury, pharmacological blockade of reactive astrocyte-type I collagen interaction prevented astrocytic scar formation, thereby leading to improved axonal regrowth and better functional outcomes. Our findings reveal environmental cues regulating astrocytic fate decisions, thereby providing a potential therapeutic target for CNS injury.	[Hara, Masamitsu; Saito, Takeyuki; Kijima, Ken; Yoshizaki, Shingo; Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka, Japan; [Hara, Masamitsu; Kobayakawa, Kazu; Kumamaru, Hiromi; Yokota, Kazuya; Saito, Takeyuki; Kijima, Ken; Yoshizaki, Shingo; Harimaya, Katsumi; Nakashima, Yasuharu; Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Okada, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka, Japan.; Okada, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan.	seokada@ortho.med.kyushu-u.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Kobayakawa, Kazu/0000-0002-7444-0661; Yoshizaki, Shingo/0000-0001-8221-1431	Ministry of Education, Science, and Sports [16K15668]; Comprehensive Brain Science Network and Foundation of Synapse Neurocircuit Pathology; research foundations from the general insurance association of Japan;  [25713053];  [16K20059]; Grants-in-Aid for Scientific Research [17K19356, 25116010] Funding Source: KAKEN	Ministry of Education, Science, and Sports; Comprehensive Brain Science Network and Foundation of Synapse Neurocircuit Pathology; research foundations from the general insurance association of Japan; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Tachibana (Osaka City University) for the gift of anti-nestin antibody. This study was supported by a Grant-in-Aid for Young Scientist (A) (25713053) (S.O.); Challenging Exploratory Research from the Ministry of Education, Science, and Sports (16K15668) (S.O.); a Grant-in-Aid for Young Scientist (B) (16K20059) (K. Kobayakawa); Scientific Research on Innovative Areas (Comprehensive Brain Science Network and Foundation of Synapse Neurocircuit Pathology) (K. Kobayakawa); and research foundations from the general insurance association of Japan (M.H.).	Abe K, 1996, BRAIN RES, V723, P206, DOI 10.1016/0006-8993(96)00253-3; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Cao J, 2015, SPINAL CORD, V53, P92, DOI 10.1038/sc.2014.188; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePaul MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139335; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FREEMAN L. W., 1954, ANN NEW YORK ACAD SCI, V58, P564, DOI 10.1111/j.1749-6632.1954.tb54093.x; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Garg A, 2014, CYTOTHERAPY, V16, P545, DOI 10.1016/j.jcyt.2013.10.003; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hagino S, 2003, GLIA, V42, P130, DOI 10.1002/glia.10207; Harada A, 2015, NUCLEIC ACIDS RES, V43, P775, DOI 10.1093/nar/gku1346; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hayashi M, 2016, J CELL BIOCHEM, V117, P780, DOI 10.1002/jcb.25368; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kumamaru H, 2013, STEM CELLS, V31, P1535, DOI 10.1002/stem.1404; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Dreau G, 2010, GLIA, V58, P1510, DOI 10.1002/glia.21025; Liddelow SA, 2016, NATURE, V532, P182, DOI 10.1038/nature17318; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Mckillop WM, 2013, GLIA, V61, P164, DOI 10.1002/glia.22424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Peglion F, 2012, CELL ADHES MIGR, V6, P327, DOI 10.4161/cam.20855; Previtali SC, 1997, AM J PATHOL, V151, P1425; Renault-Mihara F, 2011, EMBO MOL MED, V3, P682, DOI 10.1002/emmm.201100179; Repici M, 2012, NEUROBIOL DIS, V46, P710, DOI 10.1016/j.nbd.2012.03.014; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Silver J, 2016, EXP NEUROL, V286, P147, DOI 10.1016/j.expneurol.2016.06.018; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takahashi S, 2015, FEBS LETT, V589, P829, DOI 10.1016/j.febslet.2015.02.016; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Takeuchi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3740; Tran MD, 2008, J NEUROCHEM, V105, P272, DOI 10.1111/j.1471-4159.2008.05214.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vazquez-Chona F, 1999, BRAIN RES, V838, P45, DOI 10.1016/S0006-8993(99)01679-0; von Karstedt S, 2015, CANCER CELL, V27, P561, DOI 10.1016/j.ccell.2015.02.014; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Yokota K, 2015, STEM CELL REP, V5, P264, DOI 10.1016/j.stemcr.2015.06.004; Yonezawa T, 2010, GLIA, V58, P755, DOI 10.1002/glia.20959	61	244	258	6	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					818	+		10.1038/nm.4354	http://dx.doi.org/10.1038/nm.4354			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28628111	Green Accepted			2022-12-27	WOS:000405180100010
J	Winkler, CA; Nelson, GW				Winkler, Cheryl A.; Nelson, George W.			A mouse recapitulating APOL1-associated kidney disease	NATURE MEDICINE			English	Editorial Material							APOL1 RISK VARIANTS; INNATE IMMUNITY	In a recent study, researchers generated a mouse model expressing variant APOL1 that recapitulates human kidney disease. Variant APOL1 leads to caspase-1-dependent pyroptosis, which opens the door for the development of new druggable targets to treat APOL1-mediated kidney disease.	[Winkler, Cheryl A.] NCI, Basic Res Lab, Leidos Biomed Res, Frederick Natl Lab, Frederick, MD 21701 USA; [Nelson, George W.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Winkler, CA (corresponding author), NCI, Basic Res Lab, Leidos Biomed Res, Frederick Natl Lab, Frederick, MD 21701 USA.	winklerc@mail.nih.gov		Winkler, Cheryl/0000-0001-5552-0917	NATIONAL CANCER INSTITUTE [ZIABC010022, ZIABC010297] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bruggeman LA, 2016, J AM SOC NEPHROL, V27, P3600, DOI 10.1681/ASN.2015111220; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kruzel-Davila E., 2016, J AM SOC NEPHROL; Larsen CP, 2015, MODERN PATHOL, V28, P95, DOI 10.1038/modpathol.2014.92; Limou S, 2015, KIDNEY INT, V88, P28, DOI 10.1038/ki.2015.109; Ma L., 2016, J AM SOC NEPHROL; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Vezzani A, 2010, CURR OPIN INVEST DR, V11, P43	12	0	0	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					411	412		10.1038/nm.4318	http://dx.doi.org/10.1038/nm.4318			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388606				2022-12-27	WOS:000398768100007
J	Fisicaro, P; Barili, V; Montanini, B; Acerbi, G; Ferracin, M; Guerrieri, F; Salerno, D; Boni, C; Massari, M; Cavallo, MC; Grossi, G; Giuberti, T; Lampertico, P; Missale, G; Levrero, M; Ottonello, S; Ferrari, C				Fisicaro, Paola; Barili, Valeria; Montanini, Barbara; Acerbi, Greta; Ferracin, Manuela; Guerrieri, Francesca; Salerno, Debora; Boni, Carolina; Massari, Marco; Cavallo, M. Cristina; Grossi, Glenda; Giuberti, Tiziana; Lampertico, Pietro; Missale, Gabriele; Levrero, Massimo; Ottonello, Simone; Ferrari, Carlo			Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B	NATURE MEDICINE			English	Article							CHRONIC VIRAL-INFECTION; GENE-EXPRESSION; VIRUS-INFECTION; ACTIVATION; MEMORY; DIFFERENTIATION; DAMAGE; IMMUNITY; DEGRADATION; ANTIOXIDANT	Hepatitis B virus (HBV)-specific CD8 T cells are functionally exhausted in chronic hepatitis B infection, and this condition can be corrected only partially through the modulation of inhibitory pathways, which suggests that a more complex molecular interplay underlies T cell exhaustion. To gain broader insight into this process and identify additional targets for the restoration of T cell function, we compared the transcriptome profiles of HBV-specific CD8 T cells from patients with acute and chronic disease with those of HBV-specific CD8 T cells from patients able to resolve HBV infection spontaneously and influenza (FLU)-specific CD8 T cells from healthy participants. The results indicate that exhausted HBV-specific CD8 T cells are markedly impaired at multiple levels and show substantial downregulation of various cellular processes centered on extensive mitochondria! alterations. A notable improvement of mitochondrial and antiviral CD8 functions was elicited by mitochondrion-targeted antioxidants, which suggests a central role for reactive oxygen species (ROS) in T cell exhaustion. Thus, mitochondria represent promising targets for novel reconstitution therapies to treat chronic hepatitis B infection.	[Fisicaro, Paola; Barili, Valeria; Acerbi, Greta; Boni, Carolina; Cavallo, M. Cristina; Giuberti, Tiziana; Missale, Gabriele; Ferrari, Carlo] Univ Parma, Azienda Osped, Unit Infect Dis & Hepatol, Lab Viral Immunopathol, Parma, Italy; [Montanini, Barbara; Ottonello, Simone] Univ Parma, Dept Life Sci, Lab Funct Genom & Prot Engn, Biochem & Mol Biol Unit, Parma, Italy; [Ferracin, Manuela] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Guerrieri, Francesca; Salerno, Debora; Levrero, Massimo] Sapienza Univ, Ctr Life Nanosci Lab IIT CNLS, Rome, Italy; [Massari, Marco] Azienda Osped S Maria Nuova, IRCCS, Infect Dis Unit, Reggio Emilia, Italy; [Grossi, Glenda; Lampertico, Pietro] Univ Milan, Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Gastroenterol 1, Milan, Italy; [Levrero, Massimo] Sapienza Univ, Dept Internal Med DMISM, Rome, Italy; [Levrero, Massimo] CRCL, INSERM, U1052, Lyon, France; [Ottonello, Simone] Univ Parma, Biopharmanet Tec Lab, Parma, Italy; [Ferrari, Carlo] Univ Parma, Dept Med & Surg, Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University of Bologna; Sapienza University Rome; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); University of Parma; University of Parma	Ferrari, C (corresponding author), Univ Parma, Azienda Osped, Unit Infect Dis & Hepatol, Lab Viral Immunopathol, Parma, Italy.; Ferrari, C (corresponding author), Univ Parma, Dept Med & Surg, Parma, Italy.	cferrari00@gmail.com	Ferrari, Carlo/D-5663-2017; Massari, Marco/AAA-9907-2021; Lampertico, Pietro/J-8463-2018; Barili, Valeria/J-4899-2016; guerrieri, francesca/G-3908-2013; Ferracin, Manuela/K-2097-2016; Missale, Gabriele/J-6083-2016; Fisicaro, Paola/AAB-8643-2019; Salerno, Debora/AAM-9940-2021; Levrero, Massimo/G-5680-2016; Boni, Carolina/J-5249-2016	Ferrari, Carlo/0000-0002-5461-6842; Massari, Marco/0000-0002-0745-7519; Lampertico, Pietro/0000-0002-1026-7476; Barili, Valeria/0000-0001-7711-2156; Ferracin, Manuela/0000-0002-1595-6887; Missale, Gabriele/0000-0001-6691-8701; Fisicaro, Paola/0000-0003-3720-9214; Levrero, Massimo/0000-0002-4978-0875; Boni, Carolina/0000-0002-7630-5180; Guerrieri, Francesca/0000-0002-2021-4394; SALERNO, DEBORA/0000-0003-0504-1904; Montanini, Barbara/0000-0002-5419-7975	Regione Emilia-Romagna, Italy (Programma di Ricerca Regione-Universita) [PRUa1RI-2012-006]; Fondazione Cassa di Risparmio di Parma (Italy) [2012.0033]; FIRE grant from the Italian Ministry of Education, University and Research (MIUR) [RBAP10TPXK]	Regione Emilia-Romagna, Italy (Programma di Ricerca Regione-Universita); Fondazione Cassa di Risparmio di Parma (Italy); FIRE grant from the Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	We thank M. Murphy (MRC Mitochondrial Biology Unit Wellcome Trust, Cambridge, UK) for the gift of a MitoQ sample; S. Bicciato (Department of Life Sciences, University of Modena and Reggio Emilia, Italy) for introducing us to GSEA; and the Microarray Facility at the University of Ferrara (http://ltta.tecnopoloferrara.it/bioinformatica.php) for help in the initial phase of bioinformatic analysis. We are also grateful to A. Cossarizza (Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, Italy) and A. Merli (Department of Life Sciences, University of Parma, Italy) for their helpful discussions. This work was supported by a grant from Regione Emilia-Romagna, Italy (Programma di Ricerca Regione-Universita 2010-2012; PRUa1RI-2012-006 to C.F.), by a grant (2012.0033 to C.F.) from Fondazione Cassa di Risparmio di Parma (Italy), and by a FIRE grant (RBAP10TPXK to C.F.) from the Italian Ministry of Education, University and Research (MIUR to C.F.).	Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Bengsch B, 2014, J HEPATOL, V61, P1212, DOI 10.1016/j.jhep.2014.07.005; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Chondrogianni N, 2015, AGEING RES REV, V23, P37, DOI 10.1016/j.arr.2014.12.003; Cuervo AM, 2014, CURR OPIN IMMUNOL, V29, P97, DOI 10.1016/j.coi.2014.05.006; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Dessolin J, 2002, EUR J PHARMACOL, V447, P155, DOI 10.1016/S0014-2999(02)01839-3; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dimeloe S, 2016, J IMMUNOL, V196, P106, DOI 10.4049/jimmunol.1501766; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fisicaro P, 2012, GASTROENTEROLOGY, V143, P1576, DOI 10.1053/j.gastro.2012.08.041; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kumari S, 2014, BBA-BIOMEMBRANES, V1838, P546, DOI 10.1016/j.bbamem.2013.05.004; Latner DR, 2004, J VIROL, V78, P10953, DOI 10.1128/JVI.78.20.10953-10959.2004; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Petrovas C, 2007, BLOOD, V109, P2505, DOI 10.1182/blood-2006-05-021626; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Ron-Harel N, 2015, GERONTOLOGY, V61, P131, DOI 10.1159/000362502; Rowbotham NJ, 2007, CELL CYCLE, V6, P2138, DOI 10.4161/cc.6.17.4644; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0439; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanaka T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005533; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852	58	170	175	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					327	336		10.1038/nm.4275	http://dx.doi.org/10.1038/nm.4275			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28165481				2022-12-27	WOS:000395848400013
J	von Mutius, E				von Mutius, Erika			The shape of the microbiome in early life	NATURE MEDICINE			English	Editorial Material							SUCCESSION	A recent study shows that microbial-community structure and function substantially expand and diversify in all body sites from birth to age 4-6 weeks. It then resembles microbiota from its corresponding maternal body site, independently of the infant's mode of delivery or other prenatal factors.	[von Mutius, Erika] Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Dept Asthma & Allergy, Munich, Germany	University of Munich	von Mutius, E (corresponding author), Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, Dept Asthma & Allergy, Munich, Germany.	erika.von.mutius@med.lmu.de		von Mutius, Erika/0000-0002-8893-4515				Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328	10	12	13	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					274	275		10.1038/nm.4299	http://dx.doi.org/10.1038/nm.4299			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28267714				2022-12-27	WOS:000395848400005
J	Erasmus, JH; Auguste, AJ; Kaelber, JT; Luo, H; Rossi, SL; Fenton, K; Leal, G; Kim, DY; Chiu, W; Wang, T; Frolov, I; Nasar, F; Weaver, SC				Erasmus, Jesse H.; Auguste, Albert J.; Kaelber, Jason T.; Luo, Huanle; Rossi, Shannan L.; Fenton, Karla; Leal, Grace; Kim, Dal Y.; Chiu, Wah; Wang, Tian; Frolov, Ilya; Nasar, Farooq; Weaver, Scott C.			A chikungunya fever vaccine utilizing an insect-specific virus platform	NATURE MEDICINE			English	Article							FORMALDEHYDE INACTIVATION; NONHUMAN-PRIMATES; DENDRITIC CELLS; EILAT VIRUS; ANTIGEN; IMMUNOGENICITY; ALPHAVIRUSES; REPLICATION; DISEASE; ATTENUATION	Traditionally, vaccine development involves tradeoffs between immunogenicity and safety. Live-attenuated vaccines typically offer rapid and durable immunity but have reduced safety when compared to inactivated vaccines. In contrast, the inability of inactivated vaccines to replicate enhances safety at the expense of immunogenicity, often necessitating multiple doses and boosters. To overcome these tradeoffs, we developed the insect-specific alphavirus, Eilat virus (EILV), as a vaccine platform. To address the chikungunya fever (CHIKF) pandemic, we used an EILV cDNA clone to design a chimeric virus containing the chikungunya virus (CHIKV) structural proteins. The recombinant EILV/CHIKV was structurally identical at 10 A to wild-type CHIKV, as determined by single-particle cryo-electron microscopy, and it mimicked the early stages of CHIKV replication in vertebrate cells from attachment and entry to viral RNA delivery. Yet the recombinant virus remained completely defective for productive replication, providing a high degree of safety. A single dose of EILV/CHIKV produced in mosquito cells elicited rapid (within 4 d) and long-lasting (>290 d) neutralizing antibodies that provided complete protection in two different mouse models. In nonhuman primates, EILV/CHIKV elicited rapid and robust immunity that protected against viremia and telemetrically monitored fever. Our EILV platform represents the first structurally native application of an insect-specific virus in preclinical vaccine development and highlights the potential application of such viruses in vaccinology.	[Erasmus, Jesse H.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Erasmus, Jesse H.; Auguste, Albert J.; Luo, Huanle; Rossi, Shannan L.; Fenton, Karla; Leal, Grace; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Erasmus, Jesse H.; Auguste, Albert J.; Luo, Huanle; Rossi, Shannan L.; Fenton, Karla; Leal, Grace; Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Auguste, Albert J.; Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Kaelber, Jason T.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kaelber, Jason T.; Chiu, Wah] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Kim, Dal Y.; Frolov, Ilya] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Nasar, Farooq] US Army, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21701 USA; [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Medical Branch Galveston	Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	sweaver@utmb.edu	Erasmus, Jesse/J-8792-2019; Weaver, Scott C/D-6490-2011; Nasar, Farooq/C-7659-2019	Erasmus, Jesse/0000-0003-1612-2697; Weaver, Scott C/0000-0001-8016-8556; Nasar, Farooq/0000-0003-3658-9649; KIM, Dal Young/0000-0003-1756-3128; Auguste, Albert/0000-0001-9048-0041; Frolov, Ilya/0000-0002-8548-2517; Kaelber, Jason/0000-0001-9426-1030	NIH [AI120942, P41GM103832]; Welch Foundation; UTMB Technology Commercialization Program; UTMB McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI120942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UTMB Technology Commercialization Program; UTMB McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Klages and W Lawrence for their technical assistance with the nonhuman primate study, V. Popov and F. Murphy for providing electron microscopy training and discussion, N. Dobias and the UTMB research histology core for assistance with tissue preparations, O. Escaffre for confocal microscopy assistance, and C. Mire for critically reading the manuscript. Support for this work came from NIH grants AI120942 (to S.C.W.), a Welch Foundation grant (to WC.), and a grant from the UTMB Technology Commercialization Program. J.H.E. is supported by a UTMB McLaughlin Fellowship. Electron microscopy was supported by NIH grant P41GM103832 (to WC.). The views expressed in this article are those of the authors and do not reflect the official policy or position of the US Department of Defense, or the Department of the Army.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2005, CUTTER INCIDENT AM 1; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; CARDOSO AI, 1995, VIROLOGY, V212, P255, DOI 10.1006/viro.1995.1479; Delrue I, 2009, VET RES, V40, DOI 10.1051/vetres/2009047; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119; Eyden B., 1996, ORGANELLES TUMOR DIA; Fan YC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004167; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Kuhn RJ, 1996, J VIROL, V70, P7900, DOI 10.1128/JVI.70.11.7900-7909.1996; Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268; LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; NAKAO E, 1973, B WORLD HEALTH ORGAN, V48, P559; Nasar F, 2015, J VIROL, V89, P1404, DOI 10.1128/JVI.01856-14; Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109; Paessler S, 2003, J VIROL, V77, P9278, DOI 10.1128/JVI.77.17.9278-9286.2003; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; WHITE A, 1972, APPL MICROBIOL, V23, P951, DOI 10.1128/AEM.23.5.951-952.1972; Whittembury A, 2009, VACCINE, V27, P5974, DOI 10.1016/j.vaccine.2009.07.082; Wilton T, 2014, J VIROL, V88, P11955, DOI 10.1128/JVI.01809-14	44	73	74	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					192	199		10.1038/nm.4253	http://dx.doi.org/10.1038/nm.4253			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	27991917	Bronze, Green Accepted			2022-12-27	WOS:000393729000011
J	Cramer, SL; Saha, A; Liu, JY; Tadi, S; Tiziani, S; Yan, WP; Triplett, K; Lamb, C; Alters, SE; Rowlinson, S; Zhang, YJ; Keating, MJ; Huang, P; DiGiovanni, J; Georgiou, G; Stone, E				Cramer, Shiro L.; Saha, Achinto; Liu, Jinyun; Tadi, Surendar; Tiziani, Stefano; Yan, Wupeng; Triplett, Kendra; Lamb, Candice; Alters, Susan E.; Rowlinson, Scott; Zhang, Yan Jessie; Keating, Michael J.; Huang, Peng; DiGiovanni, John; Georgiou, George; Stone, Everett			Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth	NATURE MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROSTATE-CANCER; THIOREDOXIN REDUCTASE; EFFECTIVE ELIMINATION; MEDIATED MECHANISMS; OXIDATIVE STRESS; CARCINOMA-CELLS; CURCUMIN; PATHWAY; GLUTATHIONE	Cancer cells experience higher oxidative stress from reactive oxygen species (ROS) than do non-malignant cells because of genetic alterations and abnormal growth; as a result, maintenance of the antioxidant glutathione (GSH) is essential for their survival and proliferation(1-3). Under conditions of elevated ROS, endogenous L-cysteine (L-Cys) production is insufficient for GSH synthesis. This necessitates uptake of L-Cys that is predominantly in its disulfide form, L-cystine (CSSC), via the xCT(-) transporter. We show that administration of an engineered and pharmacologically optimized human cyst(e)inase enzyme mediates sustained depletion of the extracellular L-Cys and CSSC pool in mice and non-human primates. Treatment with this enzyme selectively causes cell cycle arrest and death in cancer cells due to depletion of intracellular GSH and ensuing elevated ROS; yet this treatment results in no apparent toxicities in mice even after months of continuous treatment. Cyst(e)inase suppressed the growth of prostate carcinoma allografts, reduced tumor growth in both prostate and breast cancer xenografts and doubled the median survival time of TCL1-Tg:p53(-/-) mice, which develop disease resembling human chronic lymphocytic leukemia. It was observed that enzyme-mediated depletion of the serum L-Cys and CSSC pool suppresses the growth of multiple tumors, yet is very well tolerated for prolonged periods, suggesting that cyst(e)inase represents a safe and effective therapeutic modality for inactivating antioxidant cellular responses in a wide range of malignancies(4,5).	[Cramer, Shiro L.; Triplett, Kendra; Lamb, Candice; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA; [Liu, Jinyun; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Tadi, Surendar; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Yan, Wupeng; Triplett, Kendra; Lamb, Candice; Zhang, Yan Jessie; Georgiou, George; Stone, Everett] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Alters, Susan E.; Rowlinson, Scott] Aeglea Biotherapeut, Austin, TX USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Georgiou, G; Stone, E (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	gg@che.utexas.edu; stonesci@utexas.edu	Saha, Achinto/K-1041-2019	Saha, Achinto/0000-0002-4810-551X; Liu, Jinyun/0000-0002-4763-2684	College of Natural Sciences; Office of the Executive Vice President and Provost; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Welch Foundation [F-1778]; NIH [1 R01 GM104896, 1 R01 CA172724, 1 R01 CA154754, 1 RO1 CA189623]; NCI [P30 CA54174]; Aeglea Biotherapeutics; NATIONAL CANCER INSTITUTE [R01CA154754, R01CA172724, R01CA189623, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104896] Funding Source: NIH RePORTER	College of Natural Sciences; Office of the Executive Vice President and Provost; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Aeglea Biotherapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Lowe (Aeglea Biotherapeutics), O. Paley, and M. Bonem for assistance with various aspects of this work and data interpretation and to L. Beltran and S. Carbajal for their expert technical assistance. Instrumentation and technical assistance for parts of this work were provided by the Macromolecular Crystallography Facility, with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost, and the Institute for Cellular and Molecular Biology at the University of Texas at Austin. Diffraction data was collected at the Advanced Light Source at the Berkeley Center for Structural Biology which is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported by funding from: Welch Foundation F-1778 (Y.J.Z.), NIH 1 R01 GM104896 (Y.J.Z.), NIH 1 R01 CA172724 (P.H.), NIH 1 R01 CA154754 (G.G., ES.), NIH 1 RO1 CA189623 (E.S., J.D. and G.G.), NCI P30 CA54174 (S. Tiziani) and Aeglea Biotherapeutics.	Afanas'ev I, 2011, AGING DIS, V2, P219; Belalcazar A. D., 2014, ISRN BIOCH, V2013, DOI DOI 10.1155/2013/637897; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chaiswing L, 2012, FREE RADICAL BIO MED, V52, P452, DOI 10.1016/j.freeradbiomed.2011.10.489; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Foye W. O., 2007, FOYES PRINCIPLES MED; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Holl M, 2016, MOL CARCINOGEN, V55, P27, DOI 10.1002/mc.22255; Huang SF, 2010, J MOL BIOL, V396, P708, DOI 10.1016/j.jmb.2009.11.058; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; KATO S, 1993, NEUROSCIENCE, V57, P473, DOI 10.1016/0306-4522(93)90080-Y; Kim JK, 2009, IEEE PHOTONIC TECH L, V21, P21, DOI 10.1109/LPT.2008.2007912; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lee WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10420; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu Haibo, 2011, Wei Sheng Yan Jiu, V40, P283; Liu J, 2014, LEUKEMIA, V28, P118, DOI 10.1038/leu.2013.125; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Narang VS, 2003, ANTICANCER RES, V23, P4571; Olsen LF, 2013, REDOX REP, V18, P245, DOI 10.1179/1351000213Y.0000000059; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Persa C, 2006, EXP EYE RES, V83, P817, DOI 10.1016/j.exer.2006.04.001; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Saha A, 2016, ONCOTARGET, V7, P25194, DOI 10.18632/oncotarget.7535; Sanchez Y, 2010, J PHARMACOL EXP THER, V335, P114, DOI 10.1124/jpet.110.168344; Shiozaki A., 2014, J GASTROENTEROL BOK, V49, P1; Stone E, 2012, ACS CHEM BIOL, V7, P1822, DOI 10.1021/cb300335j; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Timmerman L. A., 2013, CANCER CELL, V24, P853; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; You XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023788; Zhang W, 2005, CANCER RES, V65, P1554, DOI 10.1158/0008-5472.CAN-04-1554; Zhang W, 2015, MOL MED REP, V12, P7374, DOI 10.3892/mmr.2015.4364; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049683	48	261	266	7	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					120	127		10.1038/nm.4232	http://dx.doi.org/10.1038/nm.4232			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869804	Green Accepted			2022-12-27	WOS:000391646800021
J	Adriaens, C; Standaert, L; Barra, J; Latil, M; Verfaillie, A; Kalev, P; Boeckx, B; Wijnhoven, PWG; Radaelli, E; Vermi, W; Leucci, E; Lapouge, G; Beck, B; van den Oord, J; Nakagawa, S; Hirose, T; Sablina, AA; Lambrechts, D; Aerts, S; Blanpain, C; Marine, JC				Adriaens, Carmen; Standaert, Laura; Barra, Jasmine; latil, MathilDe; Verfaillie, Annelien; Kalev, Peter; Boeckx, Bram; Wijnhoven, Paul W. G.; Radaelli, Enrico; Vermi, William; Leucci, Eleonora; Lapouge, Gaelle; Beck, Benjamin; van den Oord, Joost; Nakagawa, Shinichi; Hirose, Tetsuro; Sablina, Anna A.; Lambrechts, Diether; Aerts, Stein; Blanpain, Cedric; Marine, Jean-Christophe			p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity	NATURE MEDICINE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; NONCODING RNA NEAT1; MOUSE SKIN; GENOME STABILITY; CANCER; MICE; ACTIVATION; EXPRESSION; CARCINOMA	In a search for mediators of the p53 tumor suppressor pathway, which induces pleiotropic and often antagonistic cellular responses, we identified the long noncoding RNA (lncRNA) NEAT1. NEAT1 is an essential architectural component of paraspeckle nuclear bodies, whose pathophysiological relevance remains unclear. Activation of p53, pharmacologically or by oncogene-induced replication stress, stimulated the formation of paraspeckles in mouse and human cells. Silencing Neat1 expression in mice, which prevents paraspeckle formation, sensitized preneoplastic cells to DNA-damage-induced cell death and impaired skin tumorigenesis. We provide mechanistic evidence that NEAT1 promotes ATR signaling in response to replication stress and is thereby engaged in a negative feedback loop that attenuates oncogene-dependent activation of p53. NEAT1 targeting in established human cancer cell lines induced synthetic lethality with genotoxic chemotherapeutics, including PARP inhibitors, and nongenotoxic activation of p53. This study establishes a key genetic link between NEAT1 paraspeckles, p53 biology and tumorigenesis and identifies NEAT1 as a promising target to enhance sensitivity of cancer cells to both chemotherapy and p53 reactivation therapy.	[Adriaens, Carmen; Standaert, Laura; Barra, Jasmine; Leucci, Eleonora; Marine, Jean-Christophe] Katholieke Univ Leuven, VIB, Ctr Biol Dis, Lab Mol Canc Biol, Leuven, Belgium; [Adriaens, Carmen; Standaert, Laura; Barra, Jasmine; Leucci, Eleonora; Marine, Jean-Christophe] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Canc Biol, Leuven, Belgium; [latil, MathilDe; Lapouge, Gaelle; Beck, Benjamin; Blanpain, Cedric] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium; [Verfaillie, Annelien; Aerts, Stein] Katholieke Univ Leuven, Lab Computat Biol, Ctr Human Genet, Leuven, Belgium; [Kalev, Peter; Sablina, Anna A.] Katholieke Univ Leuven, Lab Mech Cell Transformat, VIB, Ctr Biol Dis, Leuven, Belgium; [Kalev, Peter; Sablina, Anna A.] Katholieke Univ Leuven, Lab Mech Cell Transformat, Ctr Human Genet, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, VIB, Vesalius Res Ctr, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Lab Translat Genet, Dept Oncol, Leuven, Belgium; [Wijnhoven, Paul W. G.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge, England; [Radaelli, Enrico] Katholieke Univ Leuven, Mouse Histopathol Core Facil, VIB, Ctr Biol Dis, Leuven, Belgium; [Vermi, William] Univ Brescia, Dept Mol & Translat Med, Sect Pathol, Brescia, Italy; [Vermi, William] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [van den Oord, Joost] Katholieke Univ Leuven, Dept Pathol, Lab Translat Cell & Tissue Res, Leuven, Belgium; [van den Oord, Joost] UZ Leuven, Leuven, Belgium; [Nakagawa, Shinichi] RIKEN, RNA Biol Lab, Wako, Saitama, Japan; [Nakagawa, Shinichi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Hirose, Tetsuro] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Universite Libre de Bruxelles; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Brescia; Washington University (WUSTL); KU Leuven; KU Leuven; RIKEN; Hokkaido University; Hokkaido University; Universite Libre de Bruxelles; WELBIO	Marine, JC (corresponding author), Katholieke Univ Leuven, VIB, Ctr Biol Dis, Lab Mol Canc Biol, Leuven, Belgium.; Marine, JC (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Canc Biol, Leuven, Belgium.	jeanchristophe.marine@cme.vib-kuleuven.be	Hirose, Tetsuro/P-7367-2018; Nakagawa, Shinichi/I-4192-2014; Sablina, Anna/B-2217-2017; Blanpain, Cedric/ABD-8392-2021; Aerts, Stein/A-1100-2009; Marine, Jean-Christophe/K-3292-2016; Sablina, Anna/P-2818-2019; Leucci, Eleonora/G-4938-2011; Lambrechts, Diether/AAJ-3167-2020; Latil, Mathilde/E-2011-2017	Hirose, Tetsuro/0000-0003-1068-5464; Nakagawa, Shinichi/0000-0002-6806-7493; Sablina, Anna/0000-0001-9526-4014; Aerts, Stein/0000-0002-8006-0315; Marine, Jean-Christophe/0000-0003-2433-9837; Sablina, Anna/0000-0001-9526-4014; Leucci, Eleonora/0000-0002-2898-748X; Lambrechts, Diether/0000-0002-3429-302X; Barra, Jasmine/0000-0002-2400-1257; Adriaens, Carmen/0000-0001-5186-2741; Standaert, Laura/0000-0003-1208-4160; Beck, Benjamin/0000-0001-8162-7566; VERMI, WILLIAM/0000-0002-2291-2997	Interuniversitaire Attractiepolen (IUAP); Fund for Scientific Research Flanders (FWO); Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 15378]; Ministero Salute [RF-2010-2315888]; Institute for Science, Innovation and Technology (IWT) scholarship; Hercules grant [AKUL/09/037]	Interuniversitaire Attractiepolen (IUAP); Fund for Scientific Research Flanders (FWO)(FWO); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Salute(Ministry of Health, Italy); Institute for Science, Innovation and Technology (IWT) scholarship(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Hercules grant	We thank O. Van Goethem, G. Bervoets and S. Peeters for excellent technical assistance; E. Bonomi and M. Bugatti (Fondazione Beretta) for ISH analysis of human cancer samples; and S. Jackson for helpful comments on the manuscript and for imaging facility access. Imaging was done on a Nikon A1 confocal microscope acquired through a Hercules grant type 1 (AKUL/09/037) to W. Annaert. This work was supported by Interuniversitaire Attractiepolen (IUAP), an Institute for Science, Innovation and Technology (IWT) scholarship to C.A. and a Fund for Scientific Research Flanders (FWO) scholarship to L.S. W.V. is supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, IG 15378) and by Ministero Salute (RF-2010-2315888).	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Britton S, 2014, NUCLEIC ACIDS RES, V42, P9047, DOI 10.1093/nar/gku601; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobbelstein M, 2015, NAT REV DRUG DISCOV, V14, P405, DOI 10.1038/nrd4553; Ferriss JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030550; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Khoo KH, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4288; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Li Z, 2016, TUMOR BIOL, V37, P673, DOI 10.1007/s13277-015-3843-y; Llopis A, 2012, CELL CYCLE, V11, P3627, DOI 10.4161/cc.21917; Marin-Bejar O, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r104; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Rulten SL, 2014, NUCLEIC ACIDS RES, V42, P307, DOI 10.1093/nar/gkt835; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Specks J, 2015, MOL CELL BIOL, V35, P2910, DOI 10.1128/MCB.00475-15; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Sullivan KD, 2012, NAT CHEM BIOL, V8, P646, DOI [10.1038/nchembio.965, 10.1038/NCHEMBIO.965]; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wickramasinghe VO, 2016, MOL CELL, V61, P496, DOI 10.1016/j.molcel.2016.02.001; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Yamazaki Tomohiro, 2015, Front Biosci (Elite Ed), V7, P1; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	288	298	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					861	+		10.1038/nm.4135	http://dx.doi.org/10.1038/nm.4135			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376578				2022-12-27	WOS:000381000200011
J	Tutt, A; Tovey, H; Cheang, MCU; Kernaghan, S; Kilburn, L; Gazinska, P; Owen, J; Abraham, J; Barrett, S; Barrett-Lee, P; Brown, R; Chan, S; Dowsett, M; Flanagan, JM; Fox, L; Grigoriadis, A; Gutin, A; Harper-Wynne, C; Hatton, MQ; Hoadley, KA; Parikh, J; Parker, P; Perou, CM; Roylance, R; Shah, V; Shaw, A; Smith, IE; Timms, KM; Wardley, AM; Wilson, G; Gillett, C; Lanchbury, JS; Ashworth, A; Rahman, N; Harries, M; Ellis, P; Pinder, SE; Bliss, JM				Tutt, Andrew; Tovey, Holly; Cheang, Maggie Chon U.; Kernaghan, Sarah; Kilburn, Lucy; Gazinska, Patrycja; Owen, Julie; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee, Peter; Brown, Robert; Chan, Stephen; Dowsett, Mitchell; Flanagan, James M.; Fox, Lisa; Grigoriadis, Anita; Gutin, Alexander; Harper-Wynne, Catherine; Hatton, Matthew Q.; Hoadley, Katherine A.; Parikh, Jyoti; Parker, Peter; Perou, Charles M.; Roylance, Rebecca; Shah, Vandna; Shaw, Adam; Smith, Ian E.; Timms, Kirsten M.; Wardley, Andrew M.; Wilson, Gregory; Gillett, Cheryl; Lanchbury, Jerry S.; Ashworth, Alan; Rahman, Nazneen; Harries, Mark; Ellis, Paul; Pinder, Sarah E.; Bliss, Judith M.			Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial	NATURE MEDICINE			English	Article							HOMOLOGOUS RECOMBINATION DEFICIENCY; CONTAINING NEOADJUVANT CHEMOTHERAPY; PROMOTER METHYLATION; OVARIAN-CARCINOMA; 1ST-LINE THERAPY; PLUS GEMCITABINE; FANCONI-ANEMIA; DNA-REPAIR; OPEN-LABEL; PHASE-III	Germline mutations in BRCA1/2 predispose individuals to breast cancer (termed germline-mutated BRCA1/2 breast cancer, gBRCA-BC) by impairing homologous recombination (HR) and causing genomic instability. HR also repairs DNA lesions caused by platinum agents and PARP inhibitors. Triple-negative breast cancers (TNBCs) harbor subpopulations with BRCA1/2 mutations, hypothesized to be especially platinum-sensitive. Cancers in putative 'BRCAness' subgroups-tumors with BRCA1 methylation; low levels of BRCA1 mRNA (BRCA1 mRNA-low); or mutational signatures for HR deficiency and those with basal phenotypes-may also be sensitive to platinum. We assessed the efficacy of carboplatin and another mechanistically distinct therapy, docetaxel, in a phase 3 trial in subjects with unselected advanced TNBC. A prespecified protocol enabled biomarker-treatment interaction analyses in gBRCA-BC and BRCAness subgroups. The primary endpoint was objective response rate (ORR). In the unselected population (376 subjects; 188 carboplatin, 188 docetaxel), carboplatin was not more active than docetaxel (ORR, 31.4% versus 34.0%, respectively; P = 0.66). In contrast, in subjects with gBRCA-BC, carboplatin had double the ORR of docetaxel (68% versus 33%, respectively; biomarker, treatment interaction P = 0.01). Such benefit was not observed for subjects with BRCA1 methylation, BRCA1 mRNA-low tumors or a high score in a Myriad HRD assay. Significant interaction between treatment and the basal-like subtype was driven by high docetaxel response in the nonbasal subgroup. We conclude that patients with advanced TNBC benefit from characterization of BRCA1/2 mutations, but not BRCA1 methylation or Myriad HRD analyses, to inform choices on platinum-based chemotherapy. Additionally, gene expression analysis of basal-like cancers may also influence treatment selection.	[Tutt, Andrew; Dowsett, Mitchell] Breast Canc Now Res Ctr, Inst Canc Res, London, England; [Tutt, Andrew; Gazinska, Patrycja; Grigoriadis, Anita; Shah, Vandna] Guys Hosp, Kings Coll London, Fac Life Sci & Med, Sch Canc & Pharmaceut Sci,Breast Canc Now Res Uni, London, England; [Tovey, Holly; Cheang, Maggie Chon U.; Kernaghan, Sarah; Kilburn, Lucy; Fox, Lisa; Bliss, Judith M.] Inst Canc Res, Clin Trials & Stat Unit, London, England; [Owen, Julie; Gillett, Cheryl; Pinder, Sarah E.] Kings Coll London, Kings Hlth Partners Canc Biobank, London, England; [Abraham, Jacinta; Barrett-Lee, Peter] Velindre Canc Ctr, Cardiff, S Glam, Wales; [Barrett, Sophie] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Brown, Robert; Flanagan, James M.] Imperial Coll London, Dept Surg & Canc, London, England; [Brown, Robert] Inst Canc Res, Div Mol Pathol, London, England; [Chan, Stephen] Nottingham Univ Hosp NHS Trust, Dept Clin Oncol, Nottingham, England; [Dowsett, Mitchell] Royal Marsden Hosp, Ralph Lauren Ctr Breast Canc Res, London, England; [Gutin, Alexander; Timms, Kirsten M.; Lanchbury, Jerry S.] Myriad Genet Inc, Salt Lake City, UT USA; [Harper-Wynne, Catherine] Maidstone & Tunbridge Wells NHS Trust, Kent Oncol Ctr, Maidstone, Kent, England; [Hatton, Matthew Q.] Weston Pk Hosp, Dept Clin Oncol, Sheffield, S Yorkshire, England; [Hoadley, Katherine A.; Perou, Charles M.] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC USA; [Hoadley, Katherine A.; Perou, Charles M.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Parikh, Jyoti] Guys & St Thomas Hosp NHS Fdn Trust, Dept Radiol, London, England; [Parker, Peter] Kings Coll London, Sch Canc & Pharmaceut Sci, Guys Med Sch Campus, London, England; [Parker, Peter] Francis Crick Inst, Protein Phosphorylat Lab, London, England; [Roylance, Rebecca] Univ Coll London Hosp NHS Fdn Trust, Dept Oncol, London, England; [Roylance, Rebecca] NIHR Univ Coll London Hosp Biomed Res Ctr, London, England; [Shaw, Adam] Guys & St Thomas NHS Fdn Trust, Dept Med & Mol Genet, London, England; [Smith, Ian E.] Royal Marsden NHS Fdn Trust, Breast Unit, London, England; [Wardley, Andrew M.] Christie & Div Canc Sci, NIHR Manchester Clin Res Facil, Manchester, Lancs, England; [Wardley, Andrew M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Wilson, Gregory] Christie NHS Fdn Trust, Manchester, Lancs, England; [Gillett, Cheryl; Pinder, Sarah E.] Guys Hosp, Kings Coll London, Div Canc Studies, Res Oncol, London, England; [Ashworth, Alan] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, London, England; [Rahman, Nazneen] Royal Marsden NHS Fdn Trust, Cancer Genet Unit, London, England; [Harries, Mark; Ellis, Paul] Guys & St Thomas Fdn Trust, Dept Med Oncol, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; Velindre Cancer Centre; Beatson Oncology Centre; Imperial College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Nottingham University Hospital NHS Trust; Royal Marsden NHS Foundation Trust; Myriad Genetics, Inc; Weston Park Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Francis Crick Institute; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Tutt, A (corresponding author), Breast Canc Now Res Ctr, Inst Canc Res, London, England.; Tutt, A (corresponding author), Guys Hosp, Kings Coll London, Fac Life Sci & Med, Sch Canc & Pharmaceut Sci,Breast Canc Now Res Uni, London, England.	andrew.tutt@icr.ac.uk	Perren, Timothy J/D-5387-2013; Perou, Charles M/H-9934-2014; Wardley, Andrew Michael/GLU-5636-2022	Perren, Timothy J/0000-0001-8472-8856; Perou, Charles M/0000-0001-9827-2247; Wardley, Andrew Michael/0000-0002-9639-0888; Tutt, Andrew/0000-0001-8715-2901; Flanagan, James/0000-0003-4955-1383; Bliss, Judith/0000-0001-7957-7424; Cheang, Maggie Chon U/0000-0001-5718-2501; Grigoriadis, Anita/0000-0003-3434-201X; Hoadley, Katherine/0000-0002-1216-477X; Brown, Robert/0000-0001-7960-5755; Kilburn, Lucy/0000-0002-1987-7545; /0000-0003-4167-8910; Chan, Stephen/0000-0001-8865-6618; parker, peter/0000-0002-6218-2933	Cancer Research UK [CRUK/07/012]; National Institute for Health Research Cancer Research Networks in England; Myriad Genetics, Inc.; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); National Institute for Health Research Cancer Research Networks in England; Myriad Genetics, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank all subjects and the families of those who took part in the trial and all involved staff at the participating centers. In addition, we acknowledge R. Buus and B. Haynes for laboratory support for NanoString assays, S. Ferree of NanoString for provision of Prosigna reagents and manuscript review and R. Seitz of Insight Genetics for assistance in TNBC type analysis and manuscript review. The authors also acknowledge past and present colleagues on the TNT Trial Management Group, the Independent Data Monitoring Committee and Trial Steering Committee who oversaw the trial, the Response Evaluation Committee who conducted the independent radiology review and Cancer Research UK and Breast Cancer Now (and their legacy charity Breakthrough Breast Cancer) who funded the study (Cancer Research UK grant number CRUK/07/012) as well as the National Institute for Health Research Cancer Research Networks in England and their equivalent NHS research and development (R&D)-funded networks in Scotland, Wales, and Northern Ireland for ''in-kind' support. Funding was provided from Myriad Genetics, Inc., to cover costs of nucleic extraction from tumor blocks appropriate for next-generation sequencing, and Prosigna reagent kits were provided by NanoString Technologies, Inc.	Baldwin RL, 2000, CANCER RES, V60, P5329; Baselga J, 2013, J CLIN ONCOL, V31, P2586, DOI 10.1200/JCO.2012.46.2408; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Birkbak NJ, 2012, CANCER DISCOV, V2, P366, DOI 10.1158/2159-8290.CD-11-0206; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Catteau A, 2002, SEMIN CANCER BIOL, V12, P359, DOI 10.1016/S1044-579X(02)00056-1; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chiang JW, 2006, GYNECOL ONCOL, V101, P403, DOI 10.1016/j.ygyno.2005.10.034; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Geyer CE, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.520; Han HS, 2018, ANN ONCOL, V29, P154, DOI 10.1093/annonc/mdx505; Hu XC, 2015, LANCET ONCOL, V16, P436, DOI 10.1016/S1470-2045(15)70064-1; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Martin M, 2001, Clin Breast Cancer, V2, P190, DOI 10.3816/CBC.2001.n.022; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Mulligan JM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt335; O'Shaughnessy J, 2014, J CLIN ONCOL, V32, P3840, DOI 10.1200/JCO.2014.55.2984; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Schneeweiss A, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.518; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; SLEDGE GW, 1988, J CLIN ONCOL, V6, P1811, DOI 10.1200/JCO.1988.6.12.1811; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/S1470-2045(16)30559-9, 10.1016/s1470-2045(16)30559-9]; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; ter Brugge P, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw148; Timms KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0475-x; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Von Minckwitz G, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.1004; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; Watkins J, 2015, CANCER DISCOV, V5, P488, DOI 10.1158/2159-8290.CD-14-1092; Xu Y, 2013, ANN ONCOL, V24, P1498, DOI 10.1093/annonc/mdt011; YAU C, 2015, CANC RES, V75	50	460	480	6	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					628	+		10.1038/s41591-018-0009-7	http://dx.doi.org/10.1038/s41591-018-0009-7			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29713086	Green Submitted, Green Accepted			2022-12-27	WOS:000432126800020
J	Badders, NM; Korff, A; Miranda, HC; Vuppala, PK; Smith, RB; Winborn, BJ; Quemin, ER; Sopher, BL; Dearman, J; Messing, J; Kim, NC; Moore, J; Freibaum, BD; Kanagaraj, AP; Fan, BC; Tillman, H; Chen, PC; Wang, YZ; Freeman, BB; Li, Y; Kim, HJ; La Spada, AR; Taylor, JP				Badders, Nisha M.; Korff, Ane; Miranda, Helen C.; Vuppala, Pradeep K.; Smith, Rebecca B.; Winborn, Brett J.; Quemin, Emmanuelle R.; Sopher, Bryce L.; Dearman, Jennifer; Messing, James; Kim, Nam Chul; Moore, Jennifer; Freibaum, Brian D.; Kanagaraj, Anderson P.; Fan, Baochang; Tillman, Heather; Chen, Ping-Chung; Wang, Yingzhe; Freeman, Burgess B., III; Li, Yimei; Kim, Hong Joo; La Spada, Albert R.; Taylor, J. Paul			Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy	NATURE MEDICINE			English	Article							TRANSGENIC MOUSE MODEL; FUNCTION 3 BF3; PROSTATE-CANCER; TOLFENAMIC ACID; NUCLEAR RECEPTOR; BINDING; MUSCLE; MICE; REPEAT; SITE	Spinal bulbar muscular atrophy (SBMA) is a motor neuron disease caused by toxic gain of function of the androgen receptor (AR). Previously, we found that co-regulator binding through the activation function-2 (AF2) domain of AR is essential for pathogenesis, suggesting that AF2 may be a potential drug target for selective modulation of toxic AR activity. We screened previously identified AF2 modulators for their ability to rescue toxicity in a Drosophila model of SBMA. We identified two compounds, tolfenamic acid (TA) and 1-[2-(4-methylphenoxy)ethyl]-2-[(2-phenoxyethyl)sulfanyl]-1H-benzimidazole (MEPB), as top candidates for rescuing lethality, locomotor function and neuromuscular junction defects in SBMA flies. Pharmacokinetic analyses in mice revealed a more favorable bioavailability and tissue retention of MEPB compared with TA in muscle, brain and spinal cord. In a preclinical trial in a new mouse model of SBMA, MEPB treatment yielded a dose-dependent rescue from loss of body weight, rotarod activity and grip strength. In addition, MEPB ameliorated neuronal loss, neurogenic atrophy and testicular atrophy, validating AF2 modulation as a potent androgen-sparing strategy for SBMA therapy.	[Badders, Nisha M.; Korff, Ane; Smith, Rebecca B.; Winborn, Brett J.; Quemin, Emmanuelle R.; Dearman, Jennifer; Messing, James; Kim, Nam Chul; Moore, Jennifer; Freibaum, Brian D.; Kanagaraj, Anderson P.; Fan, Baochang; Kim, Hong Joo; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Korff, Ane; Messing, James; Taylor, J. Paul] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Miranda, Helen C.; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Vuppala, Pradeep K.; Wang, Yingzhe; Freeman, Burgess B., III] St Jude Childrens Res Hosp, Preclin Pharmacokinet Shared Resource, Memphis, TN 38105 USA; [Sopher, Bryce L.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [La Spada, Albert R.] Dept Neurol, Durham, NC USA; [La Spada, Albert R.] Dept Neurobiol, Durham, NC USA; [La Spada, Albert R.] Dept Cell Biol, Durham, NC USA; [La Spada, Albert R.] Duke Ctr Neurodegenerat & Neurotherapeut, Durham, NC USA; [Tillman, Heather] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Chen, Ping-Chung] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; [Li, Yimei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Vuppala, Pradeep K.; Quemin, Emmanuelle R.; Kim, Nam Chul] KinderPharm LLC, Exton, PA USA; [Quemin, Emmanuelle R.] Inst Pasteur, UBI, Dept Biol Cellulaire & Infect, Paris, France; [Quemin, Emmanuelle R.] Inst Pasteur, Ctr Innovat & Rech Technol, Paris, France; [Kim, Nam Chul] Univ Minnesota, Coll Pharm, Dept Pharm Practice & Pharmaceut Sci, Duluth, MN 55812 USA	St Jude Children's Research Hospital; Howard Hughes Medical Institute; University of California System; University of California San Diego; St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Duluth	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA.; Taylor, JP (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	jpaul.taylor@stjude.org	La Spada, Albert/AAG-8809-2020; Tillman, Heather/N-2526-2018; Wang, Yingzhe/AAA-4340-2020; KANAGARAJ, A/GZG-4720-2022	Tillman, Heather/0000-0002-9623-2812; Wang, Yingzhe/0000-0002-7382-9683; Kim, Nam Chul/0000-0003-1332-3071; Miranda, Helen/0000-0002-4064-9790; Kim, Hong Joo/0000-0002-9157-1612; , Palsamy Kanagaraj/0000-0003-3297-3125	Howard Hughes Medical Institute; American-Lebanese-Syrian Associated Charities; NIH [R01 NS053825, R01 NS100023]; Muscular Dystrophy Association; Kennedy's Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100023, R01NS053825] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American-Lebanese-Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Kennedy's Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Nedelsky for editorial assistance. We thank the transgenic core facility at St. Jude for production of AR121Q transgenic mice and ARC Technical Services at St. Jude for surgical and animal care assistance. We also thank W. Denney for guidance in use of the 'PKNCA' R package. This work was supported by the Howard Hughes Medical Institute (J.P.T.), the American-Lebanese-Syrian Associated Charities (J.P.T., H.T.), NIH R01 NS053825 (J.P.T.), NIH R01 NS100023 (A.R.L.), the Muscular Dystrophy Association (A.R.L.) and the Kennedy's Disease Association (H.C.M.).	Albertelli MA, 2008, HUM MOL GENET, V17, P98, DOI 10.1093/hmg/ddm287; [Anonymous], 2021, LANG ENV STAT COMP; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Axerio-Cilies P, 2011, J MED CHEM, V54, P6197, DOI 10.1021/jm200532b; Ban FQ, 2014, J MED CHEM, V57, P6867, DOI 10.1021/jm500684r; Banno H, 2009, ANN NEUROL, V65, P140, DOI 10.1002/ana.21540; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Bott LC, 2016, HUM MOL GENET, V25, P1979, DOI 10.1093/hmg/ddw073; Brooks BP, 1997, NEUROBIOL DIS, V3, P313, DOI 10.1006/nbdi.1997.0126; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Buchanan G, 2004, HUM MOL GENET, V13, P1677, DOI 10.1093/hmg/ddh181; Buchanan G, 2011, MOL CELL ENDOCRINOL, V342, P20, DOI 10.1016/j.mce.2011.05.023; CASHMAN NR, 1987, ANN NEUROL, V21, P481, DOI 10.1002/ana.410210512; Chahin N, 2008, NEUROLOGY, V70, P1967, DOI 10.1212/01.wnl.0000312510.49768.eb; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; CORELL T, 1994, PHARMACOL TOXICOL, V75, P14, DOI 10.1111/j.1600-0773.1994.tb01991.x; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Denney WS, 2015, J PHARMACOKINET PHAR, V42, pS65; Duhamel G, 2008, MAGN RESON MED, V59, P846, DOI 10.1002/mrm.21567; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025; Fratta P, 2014, NEUROLOGY, V82, P2077, DOI 10.1212/WNL.0000000000000507; Gargas ML, 2008, TOXICOL SCI, V104, P54, DOI 10.1093/toxsci/kfn064; Gibaldi M, 1982, PHARMACOKINETICS; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gosztonyi G, 2001, MICROSC RES TECHNIQ, V55, P187, DOI 10.1002/jemt.1170; HENDEL J, 1994, PHARMACOL TOXICOL, V75, P53, DOI 10.1111/j.1600-0773.1994.tb01998.x; HENDEL L, 1994, PHARMACOL TOXICOL, V75, P49, DOI 10.1111/j.1600-0773.1994.tb01996.x; Hodgson MC, 2008, MOL CANCER THER, V7, P3187, DOI 10.1158/1535-7163.MCT-08-0461; Jehle K, 2014, J BIOL CHEM, V289, P8839, DOI 10.1074/jbc.M113.534859; KALISS N, 1950, P SOC EXP BIOL MED, V75, P16, DOI 10.3181/00379727-75-18083; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Lack NA, 2011, J MED CHEM, V54, P8563, DOI 10.1021/jm201098n; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Marbini A, 2002, BRAIN DEV-JPN, V24, P63, DOI 10.1016/S0387-7604(01)00394-1; McIlwain DL, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-6; Munuganti RSN, 2014, CHEM BIOL, V21, P1476, DOI 10.1016/j.chembiol.2014.09.012; Munuganti RSN, 2013, J MED CHEM, V56, P1136, DOI 10.1021/jm3015712; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; PEDERSEN SB, 1994, PHARMACOL TOXICOL, V75, P22, DOI 10.1111/j.1600-0773.1994.tb01992.x; Poletti A, 2005, ENDOCRINE, V28, P243, DOI 10.1385/ENDO:28:3:243; Robins DM, 2008, J STEROID BIOCHEM, V108, P230, DOI 10.1016/j.jsbmb.2007.09.002; Rocchi A, 2016, ACTA NEUROPATHOL, V132, P127, DOI 10.1007/s00401-016-1550-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Soraru G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012; Sun JH, 2013, INT J MOL MED, V32, P1195, DOI 10.3892/ijmm.2013.1474; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; Yu ZG, 2006, AM J PATHOL, V168, P195, DOI 10.2353/ajpath.2006.050619; Yuan HQ, 2010, MOL CELL BIOCHEM, V339, P253, DOI 10.1007/s11010-010-0388-7	53	24	25	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					427	+		10.1038/nm.4500	http://dx.doi.org/10.1038/nm.4500			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29505030	Green Accepted			2022-12-27	WOS:000429639800014
J	Good, Z; Sarno, J; Jager, A; Samusik, N; Aghaeepour, N; Simonds, EF; White, L; Lacayo, NJ; Fantl, WJ; Fazio, G; Gaipa, G; Biondi, A; Tibshirani, R; Bendall, SC; Nolan, GP; Davis, KL				Good, Zinaida; Sarno, Jolanda; Jager, Astraea; Samusik, Nikolay; Aghaeepour, Nima; Simonds, Erin F.; White, Leah; Lacayo, Norman J.; Fantl, Wendy J.; Fazio, Grazia; Gaipa, Giuseppe; Biondi, Andrea; Tibshirani, Robert; Bendall, Sean C.; Nolan, Garry P.; Davis, Kara L.			Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; MASS CYTOMETRY; PROGNOSTIC-FACTORS; GENOMIC ANALYSIS; LYMPHOCYTES; PROGRESSION; RECEPTOR; AML; IMMUNOPHENOTYPE; HETEROGENEITY	Insight into the cancer cell populations that are responsible for relapsed disease is needed to improve outcomes. Here we report a single-cell-based study of B cell precursor acute lymphoblastic leukemia at diagnosis that reveals hidden developmentally dependent cell signaling states that are uniquely associated with relapse. By using mass cytometry we simultaneously quantified 35 proteins involved in B cell development in 60 primary diagnostic samples. Each leukemia cell was then matched to its nearest healthy B cell population by a developmental classifier that operated at the single-cell level. Machine learning identified six features of expanded leukemic populations that were sufficient to predict patient relapse at diagnosis. These features implicated the pro-BII subpopulation of B cells with activated mTOR signaling, and the pre-BI subpopulation of B cells with activated and unresponsive pre-B cell receptor signaling, to be associated with relapse. This model, termed 'developmentally dependent predictor of relapse' (DDPR), significantly improves currently established risk stratification methods. DDPR features exist at diagnosis and persist at relapse. By leveraging a data-driven approach, we demonstrate the predictive value of single-cell 'omics' for patient stratification in a translational setting and provide a framework for its application to human cancer.	[Good, Zinaida; Jager, Astraea; Samusik, Nikolay; Aghaeepour, Nima; Simonds, Erin F.; Nolan, Garry P.; Davis, Kara L.] Stanford Univ, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Good, Zinaida; Jager, Astraea; Samusik, Nikolay; Aghaeepour, Nima; Simonds, Erin F.; Nolan, Garry P.; Davis, Kara L.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Good, Zinaida; Bendall, Sean C.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Good, Zinaida] Stanford Univ, PhD Program Immunol, Stanford, CA 94305 USA; [Sarno, Jolanda; Jager, Astraea; White, Leah; Lacayo, Norman J.; Davis, Kara L.] Stanford Univ, Dept Pediat, Bass Ctr Childhood Canc, Stanford, CA 94305 USA; [Sarno, Jolanda; Fazio, Grazia; Gaipa, Giuseppe; Biondi, Andrea] Univ Milano Bicocca, M Tettamanti Res Ctr, Pediat Clin, Monza, Italy; [Fantl, Wendy J.] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Simonds, Erin F.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Simonds, Erin F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Milano-Bicocca; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Davis, KL (corresponding author), Stanford Univ, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.; Davis, KL (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Davis, KL (corresponding author), Stanford Univ, Dept Pediat, Bass Ctr Childhood Canc, Stanford, CA 94305 USA.	kardavis@stanford.edu	FAZIO, GRAZIA/K-1523-2016; Bendall, Sean/AGG-0126-2022; Biondi, Andrea/K-9997-2016; Biondi, Andrea/AAX-1865-2020; Nolan, Garry/AAE-7903-2019	FAZIO, GRAZIA/0000-0001-7077-8422; Biondi, Andrea/0000-0002-6757-6173; Gaipa, Giuseppe/0000-0002-1006-5946; Sarno, Jolanda/0000-0003-3488-0248; Good, Zinaida/0000-0003-2343-5771; Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453	Stanford Immunology NIH Training Program [5T32AI007290-29, 5T32AI007290-30, 5T32AI007290-32, 2T32AI007290-31]; Fondazione Italiana per la Ricerca sul Cancro (FIRC-AIRC) [19488]; M. Tettamanti Foundation; Benedetta e la vita ONLUS Foundation; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; US National Institutes of Health (NIH) [K99GM104148-01]; Associazione Italiana per la Ricerca sul Cancro [20564]; NIH grants [R01CA184968, 1R01GM10983601, 1R01NS08953301, 1R01CA19665701,, R01HL120724, 1R21CA183660, R33CA0183692, 1R33CA183654-01, U19AI057229, 1U19AI100627, U54-UCA149145A, N01-HV-00242 HHSN26820100034C, 5UH2AR067676]; NIH Northrop-Grumman Corporation [7500108142]; US Food and Drug Administration (FDA) [HHSF223201210194C, BAA-15-00121]; US Department of Defense (DOD) [OC110674, W81XWH-14-1-0180]; NWCRA Entertainment Industry Foundation; Bill and Melinda Gates Foundation [OPP1113682]; NetApp St. Baldrick's Foundation Scholar award; CureSearch Young Investigator award; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE [R21CA183660, R33CA183654, R01CA184968, U54CA149145, R33CA183692] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI100627, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM104148] Funding Source: NIH RePORTER	Stanford Immunology NIH Training Program; Fondazione Italiana per la Ricerca sul Cancro (FIRC-AIRC)(Fondazione AIRC per la ricerca sul cancro); M. Tettamanti Foundation; Benedetta e la vita ONLUS Foundation; Damon Runyon Cancer Research Foundation Fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Northrop-Grumman Corporation; US Food and Drug Administration (FDA)(United States Department of Health & Human Services); US Department of Defense (DOD)(United States Department of Defense); NWCRA Entertainment Industry Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NetApp St. Baldrick's Foundation Scholar award; CureSearch Young Investigator award; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Fragiadakis, M. H. Spitzer, P.F. Gherardini, A. Tsai, R.M. Angelo, J. Levine, M. O'Brien, D. Pe'er, M. Shipp and members of the ASH-EHA TRTH program for discussions. This work received funding from the Stanford Immunology NIH Training Program (grant no. 5T32AI007290-29, 5T32AI007290-30, 5T32AI007290-32 and 2T32AI007290-31; all to Z.G.), the Fondazione Italiana per la Ricerca sul Cancro (FIRC-AIRC; grant no. 19488; J.S.), the M. Tettamanti Foundation and Benedetta e la vita ONLUS Foundation (J.S.), a Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09; S.C.B.), the US National Institutes of Health (NIH) (grant no. K99GM104148-01; S.C.B.) and the Associazione Italiana per la Ricerca sul Cancro (grant no. 20564; A.B.). G.P.N. is supported by NIH grants R01CA184968, 1R01GM10983601, 1R01NS08953301, 1R01CA19665701, R01HL120724, 1R21CA183660, R33CA0183692, 1R33CA183654-01, U19AI057229, 1U19AI100627, U54-UCA149145A, N01-HV-00242 HHSN26820100034C and 5UH2AR067676, NIH Northrop-Grumman Corporation subcontract 7500108142, US Food and Drug Administration (FDA) grants HHSF223201210194C and BAA-15-00121, US Department of Defense (DOD) grants OC110674 and W81XWH-14-1-0180, the NWCRA Entertainment Industry Foundation, and the Bill and Melinda Gates Foundation grant OPP1113682. K.L.D. is supported by the NetApp St. Baldrick's Foundation Scholar award and a CureSearch Young Investigator award. Z.G. and G.P.N. are members of the Parker Institute for Cancer Immunotherapy, which supported the Stanford Cancer Immunotherapy Program.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Basso G, 2009, J CLIN ONCOL, V27, P5168, DOI 10.1200/JCO.2008.20.8934; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bhojwani D, 2006, BLOOD, V108, P711, DOI 10.1182/blood-2006-02-002824; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; CRIST W, 1989, BLOOD, V74, P1252; Duque-Afonso J, 2014, CANCER CELL, V25, P265, DOI 10.1016/j.ccr.2014.03.002; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; GREAVES MF, 1986, SCIENCE, V234, P697, DOI 10.1126/science.3535067; Hofling H, 2008, ANN APPL STAT, V2, P643, DOI 10.1214/07-AOAS152; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/nmeth.3863, 10.1038/NMETH.3863]; Shojaee S, 2016, NAT MED, V22, P379, DOI 10.1038/nm.4062; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Teachey DT, 2013, BRIT J HAEMATOL, V162, P606, DOI 10.1111/bjh.12442; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R.J., 2002, STAT APPL GENET MOL, V10, P1; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Uno H, 2007, J AM STAT ASSOC, V102, P527, DOI 10.1198/016214507000000149; Uno H, 2013, STAT MED, V32, P2430, DOI 10.1002/sim.5647; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; WHO, 2008, 2008 2013 ACT PLAN G, P1; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	50	66	69	6	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					474	+		10.1038/nm.4505	http://dx.doi.org/10.1038/nm.4505			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29505032	Green Accepted			2022-12-27	WOS:000429639800018
J	Wen, HJ; Ma, HJ; Cai, QC; Lin, SX; Lei, XX; He, B; Wu, SJ; Wang, ZF; Gao, Y; Liu, WS; Liu, WP; Tao, Q; Long, ZJ; Yan, M; Li, DL; Kelley, KW; Yang, YL; Huang, HQ; Liu, QT				Wen, Haijun; Ma, Huajuan; Cai, Qichun; Lin, Suxia; Lei, Xinxing; He, Bin; Wu, Sijin; Wang, Zifeng; Gao, Yan; Liu, Wensheng; Liu, Weiping; Tao, Qian; Long, Zijie; Yan, Min; Li, Dali; Kelley, Keith W.; Yang, Yongliang; Huang, Huiqiang; Liu, Quentin			Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma	NATURE MEDICINE			English	Article							CLINICAL-FEATURES; KAPPA-B; ARACHIDONIC-ACID; S100A9; NASAL; PHARMACOKINETICS; INFLAMMATION; PATHOGENESIS; INVOLVEMENT; ACTIVATION	Hemophagocytic syndrome (HPS) is a fatal hyperinflammatory disease with a poorly understood mechanism that occurs most frequently in extranodal natural killer/T cell lymphoma (ENKTL). Through exome sequencing of ENKTL tumor-normal samples, we have identified a hotspot mutation (c.419T>C) in the evolutionarily conserved signaling intermediate in Toll pathway (ECSIT) gene, encoding a V140A variant of ECSIT. ECSIT-V140A activated NF-kappa B more potently than the wild-type protein owing to its increased affinity for the S100A8 and S100A9 heterodimer, which promotes NADPH oxidase activity. ECSIT-T419C knock-in mice showed higher peritoneal NADPH oxidase activity than mice with wild-type ECSIT in response to LPS. ECSIT-T419C-transfected ENKTL cell lines produced tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma, which induced macrophage activation and massive cytokine secretion in cell culture and mouse xenografts. In individuals with ENKTL, ECSIT-V140A was associated with activation of NF-kappa B, higher HPS incidence, and poor prognosis. The immunosuppressive drug thalidomide prevented NF-kappa B from binding to the promoters of its target genes (including TNF and IFNG), and combination treatment with thalidomide and dexamethasone extended survival of mice engrafted with ECSIT-T419C-transfected ENKTL cells. We added thalidomide to the conventional dexamethasone-containing therapy regimen for two patients with HPS who expressed ECSIT-V140A, and we observed reversal of their HPS and disease-free survival for longer than 3 years. These findings provide mechanistic insights and a potential therapeutic strategy for ENKTL-associated HPS.	[Wen, Haijun; Ma, Huajuan; Cai, Qichun; Lin, Suxia; Lei, Xinxing; He, Bin; Wang, Zifeng; Gao, Yan; Liu, Wensheng; Yan, Min; Huang, Huiqiang; Liu, Quentin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Wen, Haijun; Liu, Quentin] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Wen, Haijun] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Ma, Huajuan] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Cai, Qichun] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China; [Cai, Qichun; Gao, Yan; Huang, Huiqiang] Sun Yat Sen Univ, Dept Med Oncol, Lymphoma Ctr, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Lin, Suxia] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wu, Sijin; Yang, Yongliang] Dalian Univ Technol, Sch Life Sci & Biotechnol, Ctr Mol Med, Dalian, Peoples R China; [Liu, Weiping] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Sichuan, Peoples R China; [Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Clin Oncol, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China; [Long, Zijie; Liu, Quentin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Li, Dali] East China Normal Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Kelley, Keith W.] Univ Illinois, Dept Anim Sci, Immunophysiol Lab, Coll Agr Consumer & Environm Sci ACES, Urbana, IL 61801 USA; [Kelley, Keith W.] Univ Illinois, Coll Med, Dept Pathol, Urbana, IL 61801 USA	State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University; Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Dalian University of Technology; Sichuan University; Chinese University of Hong Kong; State Key Lab Oncology South China; Sun Yat Sen University; East China Normal University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Huang, HQ; Liu, QT (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Liu, QT (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China.; Huang, HQ (corresponding author), Sun Yat Sen Univ, Dept Med Oncol, Lymphoma Ctr, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Yang, YL (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Ctr Mol Med, Dalian, Peoples R China.; Liu, QT (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	everbright99@foxmail.com; huanghq@sysucc.org.cn; liuq9@mail.sysu.edu.cn	Wu, Sijin/AAL-3482-2020; liu, wen/HGE-3071-2022; Wu, Sijin/AAB-2006-2020; Tao, Qian/T-4743-2018	Tao, Qian/0000-0001-5383-4808; Li, Dali/0000-0002-0046-8493; Yang, Yongliang/0000-0003-0449-0599; Lei, Xinxing/0000-0002-4443-616X	National Key Research and Development Program of China [2017YFA0505600-04]; National Natural Science Foundation of China [81630005, 81130040, 81573025, 81502594, 81773166]; Innovative Research Team in University of Ministry of Education of China [IRT13049]; Natural Science Foundation of Guangdong [2016A030311038, 2017A030313608]; Science and Technology Planning Project of Guangzhou [201604020163]; Fundamental Research Funds for the Central Universities [DUT15QY43]; Sun Yat-Sen University Clinical Research 5010 Program [2013011]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team in University of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Sun Yat-Sen University Clinical Research 5010 Program	This work was supported by the National Key Research and Development Program of China (2017YFA0505600-04 to Q.L.), the National Natural Science Foundation of China (81630005, 81130040, and 81573025 to Q.L.; 81502594 to H.W.), the Innovative Research Team in University of Ministry of Education of China (IRT13049 to Q.L.), the Natural Science Foundation of Guangdong (2016A030311038 and 2017A030313608 to Q.L.), the Science and Technology Planning Project of Guangzhou (201604020163 to Q.L.), Fundamental Research Funds for the Central Universities (DUT15QY43 to Y.Y.), the Sun Yat-Sen University Clinical Research 5010 Program (2013011 to H. H.), and the National Natural Science Foundation of China (81773166 to Z.W.). We thank X. Zhu at Sun Yat-sen University Cancer Center (SYSUCC) for providing the luciferasered fluorescent protein plasmid. We thank J. Shao in SYSUCC for T cell receptor gene rearrangement analysis. We thank H. Li from the Institute of Molecular Biophysics at Florida State University for the helpful comments and discussion on the molecular simulation work. We thank all members of the Liu laboratory for their critical comments and technical support.	Allory Y, 2001, AM J SURG PATHOL, V25, P865, DOI 10.1097/00000478-200107000-00004; Bellora F, 2012, EUR J IMMUNOL, V42, P1618, DOI 10.1002/eji.201142173; Bouchekioua A, 2014, LEUKEMIA, V28, P338, DOI 10.1038/leu.2013.157; BRADY ME, 1987, EUR J CLIN PHARMACOL, V32, P593, DOI 10.1007/BF02455994; CARLESIMO M, 1995, J AM ACAD DERMATOL, V32, P866, DOI 10.1016/0190-9622(95)91549-4; Cheung MMC, 1998, J CLIN ONCOL, V16, P70, DOI 10.1200/JCO.1998.16.1.70; Daver N, 2017, CANCER-AM CANCER SOC, V123, P3229, DOI 10.1002/cncr.30826; Dobashi A, 2016, GENE CHROMOSOME CANC, V55, P460, DOI 10.1002/gcc.22348; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Han AR, 2007, ANN HEMATOL, V86, P493, DOI 10.1007/s00277-007-0278-6; Han LJ, 2014, LEUKEMIA LYMPHOMA, V55, P2048, DOI 10.3109/10428194.2013.876629; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Huang HQ, 2011, LEUKEMIA LYMPHOMA, V52, P1041, DOI 10.3109/10428194.2011.561388; Izzo JG, 2006, J CLIN ONCOL, V24, P748, DOI 10.1200/JCO.2005.03.8810; Janka Gritta, 2005, Hematology Am Soc Hematol Educ Program, P82; Janka GE, 2013, HEMATOL-AM SOC HEMAT, P605, DOI 10.1182/asheducation-2013.1.605; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Kucuk C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7025; Laurent C, 2017, J CLIN ONCOL, V35, P2008, DOI 10.1200/JCO.2016.71.2083; Lay JD, 1997, J CLIN INVEST, V100, P1969, DOI 10.1172/JCI119728; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li YX, 2006, J CLIN ONCOL, V24, P181, DOI 10.1200/JCO.2005.03.2573; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Mehta PA, 2010, BIOL BLOOD MARROW TR, V16, P1458, DOI [10.1016/j.bbmt.2010.05.002, 10.1016/j.bbmt.2011.01.009]; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Postema PTE, 1996, EUR J GASTROEN HEPAT, V8, P929; Sano H, 2014, BRIT J HAEMATOL, V165, P786, DOI 10.1111/bjh.12823; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Soler-Lopez M, 2012, BIOESSAYS, V34, P532, DOI 10.1002/bies.201100193; Sopalla C, 2002, BIOL CHEM, V383, P1895, DOI 10.1515/BC.2002.213; Takahashi N, 2001, INT J HEMATOL, V74, P303, DOI 10.1007/BF02982065; Teo SK, 2004, CLIN PHARMACOKINET, V43, P311, DOI 10.2165/00003088-200443050-00004; TZANNOU I, 2011, HOSP CHRONICLES, V6, P110; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang M., 2006, J CLIN ONCOL, V24, P7522; Weitzman S, 2011, HEMATOL-AM SOC HEMAT, P178, DOI 10.1182/asheducation-2011.1.178; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603; Yan M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4661; Zhang F, 2015, PROTEOMICS, V15, P773, DOI 10.1002/pmic.201300494	49	34	40	2	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					154	+		10.1038/nm.4456	http://dx.doi.org/10.1038/nm.4456			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29291352				2022-12-27	WOS:000424327200012
J	Zhang, XJ; Cheng, X; Yan, ZZ; Fang, J; Wang, XZ; Wang, WJ; Liu, ZY; Shen, LJ; Zhang, P; Wang, PX; Liao, RF; Ji, YX; Wang, JY; Tian, S; Zhu, XY; Zhang, Y; Tian, RF; Wang, L; Ma, XL; Huang, Z; She, ZG; Li, HL				Zhang, Xiao-Jing; Cheng, Xu; Yan, Zhen-Zhen; Fang, Jing; Wang, Xiaozhan; Wang, Weijun; Liu, Zhen-Yu; Shen, Li-Jun; Zhang, Peng; Wang, Pi-Xiao; Liao, Rufang; Ji, Yan-Xiao; Wang, Jun-Yong; Tian, Song; Zhu, Xue-Yong; Zhang, Yan; Tian, Rui-Feng; Wang, Lin; Ma, Xin-Liang; Huang, Zan; She, Zhi-Gang; Li, Hongliang			An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury	NATURE MEDICINE			English	Article							PATHOLOGICAL CARDIAC-HYPERTROPHY; ISCHEMIA/REPERFUSION INJURY; LIVER ISCHEMIA; ACID RECEPTOR; 12-LIPOXYGENASE; MICE; INFLAMMATION; REGULATOR; INSIGHTS; TARGETS	Hepatic ischemia-reperfusion (IR) injury is a common clinical issue lacking effective therapy and validated pharmacological targets. Here, using integrative 'omics' analysis, we identified an arachidonate 12-lipoxygenase (ALOX12)-12-hydroxyeicosatetraenoic acid (12-HETE)-G-protein-coupled receptor 31 (GPR31) signaling axis as a key determinant of the hepatic IR process. We found that ALOX12 was markedly upregulated in hepatocytes during ischemia to promote 12-HETE accumulation and that 12-HETE then directly binds to GPR31, triggering an inflammatory response that exacerbates liver damage. Notably, blocking 12-HETE production inhibits IR-induced liver dysfunction, inflammation and cell death in mice and pigs. Furthermore, we established a nonhuman primate hepatic IR model that closely recapitulates clinical liver dysfunction following liver resection. Most strikingly, blocking 12-HETE accumulation effectively attenuated all pathologies of hepatic IR in this model. Collectively, this study has revealed previously uncharacterized metabolic reprogramming involving an ALOX12-12-HETE- GPR31 axis that functionally determines hepatic IR procession. We have also provided proof of concept that blocking 12-HETE production is a promising strategy for preventing and treating IR-induced liver damage.	[Zhang, Xiao-Jing; Wang, Xiaozhan; Shen, Li-Jun; Wang, Pi-Xiao; Tian, Song; Zhu, Xue-Yong; Zhang, Yan; Tian, Rui-Feng; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Zhang, Xiao-Jing; Wang, Xiaozhan; Liu, Zhen-Yu; Shen, Li-Jun; Zhang, Peng; Ji, Yan-Xiao; Wang, Jun-Yong; Tian, Song; Zhu, Xue-Yong; Zhang, Yan; Tian, Rui-Feng; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Inst Model Anim, Wuhan, Hubei, Peoples R China; [Zhang, Xiao-Jing; Zhang, Peng; Wang, Pi-Xiao; Ji, Yan-Xiao; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Basic Med Sch, Wuhan, Hubei, Peoples R China; [Zhang, Xiao-Jing; Cheng, Xu; Zhang, Peng; Wang, Pi-Xiao; Ji, Yan-Xiao; Wang, Jun-Yong; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Hubei, Peoples R China; [Yan, Zhen-Zhen; Liu, Zhen-Yu; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Fang, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Div Cardiothorac & Vasc Surg, Key Lab Organ Transplantat,Minist Educ,Tongji Hos, Wuhan, Hubei, Peoples R China; [Fang, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Organ Transplantat, Minist Hlth,Tongji Hosp, Wuhan, Hubei, Peoples R China; [Wang, Weijun] Huazhong Univ Sci & Technol, Union Hosp, Div Gastroenterol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Peng; Ji, Yan-Xiao; Li, Hongliang] Wuhan Univ, Med Sci Res Ctr, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Liao, Rufang] Wuhan Univ, Dept Radiol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Wang, Lin] Fourth Mil Med Univ, Xijing Hosp, Dept Hepat Surg, Xian, Shaanxi, Peoples R China; [Ma, Xin-Liang] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University; Wuhan University; Air Force Military Medical University; Jefferson University	Li, HL (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Inst Model Anim, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Basic Med Sch, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Med Sci Res Ctr, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.	lihl@whu.edu.cn		Liao, Rufang/0000-0001-9935-4535; Huang, Zan/0000-0001-5623-6950; Cheng, Xu/0000-0002-1577-7627	National Science Fund for Distinguished Young Scholars [81425005]; Key Project of the National Natural Science Foundation [81330005, 81630011]; National Science and Technology Support Project [2014BAI02B01, 2015BAI08B01]; National Key Research and Development Program [2013YQ030923-05, 2016YFF0101504]; National Natural Science Foundation of China [81770053]; Key Collaborative Project of the National Natural Science Foundation [91639304]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project of the National Natural Science Foundation; National Science and Technology Support Project; National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Collaborative Project of the National Natural Science Foundation	We thank Shanghai Metabolome Institute-Wuhan for their help in examining AA metabolites in the liver, serum and cell lysates. This work was supported by grants from the National Science Fund for Distinguished Young Scholars (no. 81425005; H.L.), the Key Project of the National Natural Science Foundation (no. 81330005 and 81630011; H.L.), the National Science and Technology Support Project (no. 2014BAI02B01 and 2015BAI08B01; H.L.), the National Key Research and Development Program (no. 2013YQ030923-05 (H.L.) and 2016YFF0101504 (Z.-G.S.)), the National Natural Science Foundation of China (no. 81770053; Z.-G.S.) and the Key Collaborative Project of the National Natural Science Foundation (no. 91639304; H.L. and Z.-G.S.).	Bao MW, 2015, J PATHOL, V236, P360, DOI 10.1002/path.4523; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; Cooper DKC, 2002, ANNU REV MED, V53, P133, DOI 10.1146/annurev.med.53.082901.103900; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fehrenbacher N, 2017, J CELL BIOL, V216, P2329, DOI 10.1083/jcb.201609096; Garcia V, 2017, CIRC RES, V120, P1776, DOI 10.1161/CIRCRESAHA.116.310525; Gregus AM, 2013, FASEB J, V27, P1939, DOI 10.1096/fj.12-217414; Guo S, 2015, J NEUROSCI, V35, P12047, DOI 10.1523/JNEUROSCI.1800-15.2015; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Honn KV, 2016, FASEB J, V30, P2360, DOI 10.1096/fj.201500076; Hu JF, 2016, J HEPATOL, V64, P146, DOI 10.1016/j.jhep.2015.08.021; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Im D. S., 2017, MOL ASPECTS MED; Ji YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11267; Jiang X, 2015, HYPERTENSION, V66, P356, DOI 10.1161/HYPERTENSIONAHA.115.05469; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li L., 2015, J NEUROCHEM; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu J, 2017, NAT STRUCT MOL BIOL, V24, P570, DOI 10.1038/nsmb.3417; Luci D., 2013, PROBE REPORTS NIH MO; Luci DK, 2014, J MED CHEM, V57, P495, DOI 10.1021/jm4016476; Martin-Venegas R, 2014, J CHROMATOGR B, V964, P41, DOI 10.1016/j.jchromb.2014.05.024; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; Milligan G, 2017, TRENDS PHARMACOL SCI, V38, P809, DOI 10.1016/j.tips.2017.06.006; Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Porro B, 2014, J CHROMATOGR B, V964, P26, DOI 10.1016/j.jchromb.2014.03.015; Powell WS, 2015, BBA-MOL CELL BIOL L, V1851, P340, DOI 10.1016/j.bbalip.2014.10.008; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Robertson FP, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070069; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimano H, 2017, NAT REV ENDOCRINOL; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Strasser A, 2017, TRENDS PHARMACOL SCI, V38, P717, DOI 10.1016/j.tips.2017.05.005; Sun P, 2015, J HEPATOL, V63, P1198, DOI 10.1016/j.jhep.2015.06.033; Tang KQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0382-5; Tourdot BE, 2017, TRENDS PHARMACOL SCI, V38, P1006, DOI 10.1016/j.tips.2017.08.001; Uchida Y, 2010, GASTROENTEROLOGY, V139, P2195, DOI 10.1053/j.gastro.2010.07.003; Un K, 2012, HEPATOLOGY, V56, P259, DOI 10.1002/hep.25607; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Wang X., 2017, J HEPATOL; Xiang J, 2016, TRENDS PHARMACOL SCI, V37, P1055, DOI 10.1016/j.tips.2016.09.009; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhao GN, 2017, NAT MED, V23, P742, DOI 10.1038/nm.4334; Zhu QF, 2015, J CHROMATOGR A, V1410, P154, DOI 10.1016/j.chroma.2015.07.100	64	113	122	5	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					73	+		10.1038/nm.4451	http://dx.doi.org/10.1038/nm.4451			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29227475				2022-12-27	WOS:000422965900013
J	Murgai, M; Ju, W; Eason, M; Kline, J; Beury, DW; Kaczanowska, S; Miettinen, MM; Kruhlak, M; Lei, HY; Shern, JF; Cherepanova, OA; Owens, GK; Kaplan, RN				Murgai, Meera; Ju, Wei; Eason, Matthew; Kline, Jessica; Beury, Daniel W.; Kaczanowska, Sabina; Miettinen, Markku M.; Kruhlak, Michael; Lei, Haiyan; Shern, Jack F.; Cherepanova, Olga A.; Owens, Gary K.; Kaplan, Rosandra N.			KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; PHENOTYPIC MODULATION; BLOOD-VESSELS; STEM-CELLS; CANCER; KLF4; PERICYTES; FIBROSIS; ACTIVATION; TUMORS	A deeper understanding of the metastatic process is required for the development of new therapies that improve patient survival. Metastatic tumor cell growth and survival in distant organs is facilitated by the formation of a pre-metastatic niche that is composed of hematopoietic cells, stromal cells and extracellular matrix (ECM). Perivascular cells, including vascular smooth muscle cells (vSMCs) and pericytes, are involved in new vessel formation and in promoting stem cell maintenance and proliferation. Given the well-described plasticity of perivascular cells, we hypothesized that perivascular cells similarly regulate tumor cell fate at metastatic sites. We used perivascular-cell-specific and pericyte-specific lineage-tracing models to trace the fate of perivascular cells in the pre-metastatic and metastatic microenvironments. We show that perivascular cells lose the expression of traditional vSMC and pericyte markers in response to tumor-secreted factors and exhibit increased proliferation, migration and ECM synthesis. Increased expression of the pluripotency gene Klf4 in these phenotypically switched perivascular cells promoted a less differentiated state, characterized by enhanced ECM production, that established a pro-metastatic fibronectin-rich environment. Genetic inactivation of Klf4 in perivascular cells decreased formation of a pre-metastatic niche and metastasis. Our data revealed a previously unidentified role for perivascular cells in pre-metastatic niche formation and uncovered novel strategies for limiting metastasis.	[Murgai, Meera; Ju, Wei; Eason, Matthew; Kline, Jessica; Beury, Daniel W.; Kaczanowska, Sabina; Lei, Haiyan; Shern, Jack F.; Kaplan, Rosandra N.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Miettinen, Markku M.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Kruhlak, Michael] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Cherepanova, Olga A.; Owens, Gary K.] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Cherepanova, Olga A.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia; University of Virginia	Kaplan, RN (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	rosie.kaplan@nih.gov	Murgai, Meera/AAW-1114-2021; Cherepanova, Olga E./K-1277-2015; Shern, Jack/V-4002-2019	Cherepanova, Olga E./0000-0001-7775-6488; Kaczanowska, Sabina/0000-0003-0191-6371; Murgai, Meera/0000-0001-5015-839X	US National Institutes of Health [1ZIABC011332-07, 1ZIABC011334-07, NIH HL057353, NIH HL135018]; NATIONAL CANCER INSTITUTE [ZIABC011332] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038854, R01HL136314, R01HL135018] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. McKinnon and C. Thiele for their advice, and Z. Liu, M. Kasai, J. Zhu and K. Bhatt for their technical assistance. This work was supported by the US National Institutes of Health (grants 1ZIABC011332-07, 1ZIABC011334-07, NIH HL057353 and NIH HL135018).	Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Baluk P., 2008, TUMOR ANGIOGENESIS, V557-576; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cherepanova OA, 2016, NAT MED, V22, P657, DOI 10.1038/nm.4109; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Ehling M, 2016, TRENDS MOL MED, V22, P85, DOI 10.1016/j.molmed.2015.12.009; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gajos-Michniewicz A, 2014, CANCER LETT, V347, P29, DOI 10.1016/j.canlet.2014.02.004; Giles AJ, 2016, CANCER RES, V76, P1335, DOI 10.1158/0008-5472.CAN-15-0204; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kim Kang Ho, 2015, Curr Protoc Mol Biol, V111, DOI 10.1002/0471142727.mb2806s111; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Le CTK, 2015, AM J PATHOL, V185, P2949, DOI 10.1016/j.ajpath.2015.07.010; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Meadors JL, 2011, PEDIATR BLOOD CANCER, V57, P921, DOI 10.1002/pbc.23048; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Murgai Meera, 2015, Critical Reviews in Oncogenesis, V20, P301, DOI 10.1615/CritRevOncog.2015013668; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Rafii S, 2006, NAT CELL BIOL, V8, P1321, DOI 10.1038/ncb1206-1321; Reddy VS, 2011, J CELL PHYSIOL, V226, P3303, DOI 10.1002/jcp.22676; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Salmon M, 2013, CIRCULATION, V128, pS163, DOI 10.1161/CIRCULATIONAHA.112.000238; Salmon M, 2012, CIRC RES, V111, P685, DOI 10.1161/CIRCRESAHA.112.269811; Sceneay J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22355; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Smith HA, 2013, J MOL MED, V91, P411, DOI 10.1007/s00109-013-1021-5; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Yang MJ, 2016, INFLAMMATION, V39, P16, DOI 10.1007/s10753-015-0218-x; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591	60	112	114	3	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1176	+		10.1038/nm.4400	http://dx.doi.org/10.1038/nm.4400			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28920957	Green Accepted			2022-12-27	WOS:000412431800013
J	Raimondi, I; Huarte, M				Raimondi, Ivan; Huarte, Maite			Noncoding RNAs as effective markers in cancer-care management	NATURE MEDICINE			English	Editorial Material								Two recent studies show that 'silent' variants can modulate regulatory circuits, including those in noncoding RNAs, affecting cancer predisposition and drug sensitivity.	[Raimondi, Ivan; Huarte, Maite] Univ Navarra, Ctr Appl Med Res, Dept Gene Therapy & Regulat Gene Express, Pamplona, Spain; [Raimondi, Ivan; Huarte, Maite] Inst Hlth Res Navarra IdiSNA, Pamplona, Spain	University of Navarra	Huarte, M (corresponding author), Univ Navarra, Ctr Appl Med Res, Dept Gene Therapy & Regulat Gene Express, Pamplona, Spain.; Huarte, M (corresponding author), Inst Hlth Res Navarra IdiSNA, Pamplona, Spain.	maitehuarte@unav.es	Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493; Raimondi, Ivan/0000-0002-9522-2794	European Research Council Starting Grant [281877]; Spanish Ministry of Science [BFU2014-58027-R]	European Research Council Starting Grant(European Research Council (ERC)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	M.H. and I.R. are supported by the European Research Council Starting Grant 281877 and the Spanish Ministry of Science Grant BFU2014-58027-R.	Bal E, 2017, NAT MED, V23, P1226, DOI 10.1038/nm.4368; Baron AT, 2003, CANCER EPIDEM BIOMAR, V12, P103; Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293; Heid HW, 2002, EXP CELL RES, V279, P177, DOI 10.1006/excr.2002.5603; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rivera C, 2015, INT J CLIN EXP PATHO, V8, P11884; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Tan DSW, 2017, NAT MED, V23, P1167, DOI 10.1038/nm.4401; Zampino MG, 2008, CANCER CHEMOTH PHARM, V63, P139, DOI 10.1007/s00280-008-0722-x	10	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1122	1123		10.1038/nm.4423	http://dx.doi.org/10.1038/nm.4423			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985204				2022-12-27	WOS:000412431800006
J	Crespo, M; Vilar, E; Tsai, SY; Chang, K; Amin, S; Srinivasan, T; Zhang, T; Pipalia, NH; Chen, HJ; Witherspoon, M; Gordillo, M; Xiang, JZ; Maxfield, FR; Lipkin, S; Evans, T; Chen, SB				Crespo, Miguel; Vilar, Eduardo; Tsai, Su-Yi; Chang, Kyle; Amin, Sadaf; Srinivasan, Tara; Zhang, Tuo; Pipalia, Nina H.; Chen, Huanhuan Joyce; Witherspoon, Mavee; Gordillo, Miriam; Xiang, Jenny Zhaoying; Maxfield, Frederick R.; Lipkin, Steven; Evans, Todd; Chen, Shuibing			Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing	NATURE MEDICINE			English	Article							DIFFERENTIATION; EXPRESSION; RESTORATION; POPULATIONS; EPITHELIUM; ENDODERM; PATTERNS; PROTEIN; POLYPS; MUCOSA	With the goal of modeling human disease of the large intestine, we sought to develop an effective protocol for deriving colonic organoids (COs) from differentiated human embryonic stem cells (hESCs) or induced pluripotent stem cells (iPSCs). Extensive gene and immunohistochemical profiling confirmed that the derived COs represent colon rather than small intestine, containing stem cells, transit-amplifying cells, and the expected spectrum of differentiated cells, including goblet and endocrine cells. We applied this strategy to iPSCs derived from patients with familial adenomatous polyposis (FAP-iPSCs) harboring germline mutations in the WNT-signaling-pathway-regulator gene encoding APC, and we generated COs that exhibit enhanced WNT activity and increased epithelial cell proliferation, which we used as a platform for drug testing. Two potential compounds, XAV939 and rapamycin, decreased proliferation in FAP-COs, but also affected cell proliferation in wild-type COs, which thus limits their therapeutic application. By contrast, we found that geneticin, a ribosome-binding antibiotic with translational 'read-through' activity, efficiently targeted abnormal WNT activity and restored normal proliferation specifically in APC-mutant FAP-COs. These studies provide an efficient strategy for deriving human COs, which can be used in disease modeling and drug discovery for colorectal disease.	[Crespo, Miguel; Tsai, Su-Yi; Amin, Sadaf; Gordillo, Miriam; Evans, Todd; Chen, Shuibing] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Vilar, Eduardo; Chang, Kyle] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Vilar, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA; [Vilar, Eduardo] Univ Texas MD Anderson Canc Ctr, Clin Canc Genet Program, Houston, TX 77030 USA; [Amin, Sadaf] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Srinivasan, Tara; Witherspoon, Mavee; Lipkin, Steven] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Zhang, Tuo; Xiang, Jenny Zhaoying] Weill Cornell Med Coll, Genom Core, New York, NY USA; [Pipalia, Nina H.; Maxfield, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Chen, Huanhuan Joyce; Chen, Shuibing] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10065 USA; [Tsai, Su-Yi] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan	Cornell University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; National Taiwan University	Evans, T; Chen, SB (corresponding author), Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA.; Chen, SB (corresponding author), Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10065 USA.	tre2003@med.cornell.edu; shc2034@med.cornell.edu		TSAI, SU-YI/0000-0002-7423-645X; Zhang, Tuo/0000-0001-5396-918X; Amin, Sadaf/0000-0002-3758-6485; Chang, Kyle/0000-0001-5295-9676	New York Stem Cell Foundation [R-103]; NIH/NIDDK [1 DP2 DK098093-01, DP3DK111907-01]; New York Department of Health (NYSTEM) [C029156]; Tri-institutional Stem Cell Initiative grant [2013-001]; Center for Advanced Digestion Care (CADC) at Weill Cornell Medical College; US National Institutes of Health/National Cancer Institute [R03CA176788]; MD Anderson Cancer Center Institutional Research Grant (IRG) Program; Cancer Prevention Educational Award, US National Institutes of Health/National Cancer Institute [R25T CA057730]; Arnold O. Beckman postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R25CA057730, R03CA176788, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK111907, DP2DK098093] Funding Source: NIH RePORTER	New York Stem Cell Foundation; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); New York Department of Health (NYSTEM); Tri-institutional Stem Cell Initiative grant; Center for Advanced Digestion Care (CADC) at Weill Cornell Medical College; US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center Institutional Research Grant (IRG) Program; Cancer Prevention Educational Award, US National Institutes of Health/National Cancer Institute; Arnold O. Beckman postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	S.C. is funded by The New York Stem Cell Foundation (R-103) and NIH/NIDDK (1 DP2 DK098093-01, DP3DK111907-01). This study was supported in part by a shared facility contract from the New York Department of Health (NYSTEM, C029156; to T.E. and S.C.); a Tri-institutional Stem Cell Initiative grant (2013-001; to F.M. and S.C.); and a pilot grant from the Center for Advanced Digestion Care (CADC) at Weill Cornell Medical College (to S.C. and S.L.). S.C. is New York Stem Cell Foundation-Robertson Investigator. This work was also supported by grants R03CA176788 (US National Institutes of Health/National Cancer Institute), the MD Anderson Cancer Center Institutional Research Grant (IRG) Program (E.V.), and a gift from the Feinberg Family to E.V.; Cancer Prevention Educational Award (R25T CA057730, US National Institutes of Health/National Cancer Institute (to K.C.); Arnold O. Beckman postdoctoral fellowship to H.J.C. We thank H.E. Varmus (Weill Cornell Medical College) for his support and J. Jin at Weill Cornell Medical College for kindly providing human aortic smooth muscle cells. We are grateful for the technical support and advice provided by H.S. Ralph in the Cell Screening Core Facility, J. McCormick in the Flow Cytometry Facility and L. Cohen-Gould in the Electron Microscopy Facility at Weill Cornell Medical College.	Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; [Anonymous], CA4; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bekku S, 1998, RES EXP MED, V198, P175, DOI 10.1007/s004330050101; Beuling E, 2008, DEV BIOL, V322, P179, DOI 10.1016/j.ydbio.2008.07.022; Borras E, 2016, CANCER PREV RES, V9, P417, DOI 10.1158/1940-6207.CAPR-16-0081; BRETSCHER A, 1979, P NATL ACAD SCI USA, V76, P2321, DOI 10.1073/pnas.76.5.2321; Choy JYH, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.63; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Durno CA, 2007, CAN J GASTROENTEROL, V21, P233, DOI 10.1155/2007/401674; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Floquet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024125; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; GREENE AE, 1972, IN VITRO CELL DEV B, V7, P313; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ignatenko NA, 2008, NUTR CANCER, V60, P30, DOI 10.1080/01635580802401317; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kanth P, 2016, CANCER PREV RES, V9, P456, DOI 10.1158/1940-6207.CAPR-15-0363; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEGAY C, 1983, NEUROCHEM INT, V5, P721, DOI 10.1016/0197-0186(83)90097-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; OCONNOR DT, 1983, LIFE SCI, V33, P1657, DOI 10.1016/0024-3205(83)90721-X; Pitera JE, 1999, GASTROENTEROLOGY, V117, P1339, DOI 10.1016/S0016-5085(99)70284-2; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; ROTH KA, 1992, AM J PHYSIOL, V263, pG174, DOI 10.1152/ajpgi.1992.263.2.G174; Sasikumar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022720; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taketo M M, 1999, Prog Exp Tumor Res, V35, P109; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu Bo, 2000, Molecular Cell Biology Research Communications, V3, P352, DOI 10.1006/mcbr.2000.0238; Zilberberg A, 2010, GUT, V59, P496, DOI 10.1136/gut.2008.169805	45	200	208	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					878	+		10.1038/nm.4355	http://dx.doi.org/10.1038/nm.4355			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28628110	Green Accepted			2022-12-27	WOS:000405180100017
J	Kuipers, F; Groen, AK				Kuipers, Folkert; Groen, Albert K.			An unexpected role for bile acid synthesis in adaptation to low temperature	NATURE MEDICINE			English	Editorial Material							ENERGY-EXPENDITURE	Enhanced conversion of dietary cholesterol to bile acids through the alternative pathway leads to cold-associated, metabolically beneficial changes in the intestinal microbiome and to elevated bile acid levels that contribute to adaptive thermogenesis.	[Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Groen, Albert K.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.; Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.	f.kuipers@umcg.nl		Kuipers, Folkert/0000-0003-2518-737X				Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Worthmann A, 2017, NAT MED, V23, P839, DOI 10.1038/nm.4357; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001; Zietak M, 2016, AM J PHYSIOL-ENDOC M, V310, pE346, DOI 10.1152/ajpendo.00485.2015	11	2	2	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					800	802		10.1038/nm.4365	http://dx.doi.org/10.1038/nm.4365			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28697185				2022-12-27	WOS:000405180100006
J	Sanyal, A; Mailliard, RB; Rinaldo, CR; Ratner, D; Ding, M; Chen, Y; Zerbato, JM; Giacobbi, NS; Venkatachari, NJ; Patterson, BK; Chargin, A; Sluis-Cremer, N; Gupta, P				Sanyal, Anwesha; Mailliard, Robbie B.; Rinaldo, Charles R.; Ratner, Deena; Ding, Ming; Chen, Yue; Zerbato, Jennifer M.; Giacobbi, Nicholas S.; Venkatachari, Narasimhan J.; Patterson, Bruce K.; Chargin, Amanda; Sluis-Cremer, Nicolas; Gupta, Phalguni			Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4(+) T cells	NATURE MEDICINE			English	Article							REAL-TIME PCR; ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; INFECTED INDIVIDUALS; PLASMA VIREMIA; CURE; QUANTIFICATION; PERSISTENCE; PROVIRUSES; BLOOD	Although antiretroviral therapy can suppress HIV-1 infection to undetectable levels of plasma viremia, integrated latent HIV-1 genomes that encode replication-competent virus persist in resting CD4(+) T cells. This latent HIV-1 reservoir represents a major barrier to a cure. Currently, there are substantial efforts to identify therapeutic approaches that will eliminate or reduce the size of this latent HIV-1 reservoir. In this regard, a sensitive assay that can accurately and rapidly quantify inducible, replication-competent latent HIV-1 from resting CD4(+) T cells is essential for HIV-1 eradication studies. Here we describe a reporter cell-based assay to quantify inducible, replication-competent latent HIV-1. This assay has several advantages over existing technology in that it (i) is sensitive; (ii) requires only a small blood volume; (iii) is faster, less labor intensive, and less expensive; and (iv) can be readily adapted into a high-throughput format. Using this assay, we show that the size of the inducible latent HIV-1 reservoir in aviremic participants on therapy is approximately 70-fold larger than previous estimates.	[Sanyal, Anwesha; Mailliard, Robbie B.; Rinaldo, Charles R.; Ratner, Deena; Ding, Ming; Chen, Yue; Venkatachari, Narasimhan J.; Gupta, Phalguni] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.; Gupta, Phalguni] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Zerbato, Jennifer M.; Giacobbi, Nicholas S.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA; [Patterson, Bruce K.; Chargin, Amanda] IncellDX, Menlo Pk, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gupta, P (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.; Gupta, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	pgupta1@pitt.edu	Mailiiard, Robbie/M-9723-2015	Mailliard, Robbie/0000-0001-5501-503X; Zerbato, Jennifer/0000-0001-9888-661X	NIH [U01-AI35041, R21-AI119117]; NIH Fogarty training grant fellowship [D43TW010039]; FOGARTY INTERNATIONAL CENTER [D43TW010039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119117, U01AI035041, R21AI060393, UM1AI035043, R01AI081571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty training grant fellowship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Caruso and A. Anthony (University of Pittsburgh, Pittsburgh) for their technical assistance; J. Mellors (University of Pittsburgh, Pittsburgh) for plasma viral-load measurements and for discussion during the development of the assay; P. Tarwater (University of Texas, El Paso) and C. Shen (University of Pittsburgh, Pittsburgh) for statistical consultation; W. Buchanan (University of Pittsburgh, Pittsburgh) for recruitment of the Multicenter AIDS Cohort Study participants for the study; and participants of the Pittsburgh portion of the MACS for donating blood for this study. This work was supported by NIH grants U01-AI35041 (C.R.R.), R21-AI119117 (N.S.C.) and NIH Fogarty training grant fellowship D43TW010039 (P.G.).	Ananworanich J, 2015, EBIOMEDICINE, V2, P788, DOI 10.1016/j.ebiom.2015.07.036; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Biswas N, 2012, VIROLOGY, V422, P265, DOI 10.1016/j.virol.2011.10.024; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Chargin A, 2015, J CLIN MICROBIOL, V53, P60, DOI 10.1128/JCM.02539-14; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Cillo AR, 2013, JAIDS-J ACQ IMM DEF, V63, P438, DOI 10.1097/QAI.0b013e31828e6163; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; GOEL R, 1993, BIOCHEMISTRY-US, V32, P13012, DOI 10.1021/bi00211a009; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; Malnati MS, 2008, NAT PROTOC, V3, P1240, DOI 10.1038/nprot.2008.108; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Rosenbloom DIS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv123; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14	25	53	55	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					885	+		10.1038/nm.4347	http://dx.doi.org/10.1038/nm.4347			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28553933	Green Accepted			2022-12-27	WOS:000405180100018
J	Zehir, A; Benayed, R; Shah, RH; Syed, A; Middha, S; Kim, HR; Srinivasan, P; Gao, JJ; Chakravarty, D; Devlin, SM; Hellmann, MD; Barron, DA; Schram, AM; Hameed, M; Dogan, S; Ross, DS; Hechtman, JF; DeLair, DF; Yao, JJ; Mandelker, DL; Cheng, DT; Chandramohan, R; Mohanty, AS; Ptashkin, RN; Jayakumaran, G; Prasad, M; Syed, MH; Rema, AB; Liu, ZY; Nafa, K; Borsu, L; Sadowska, J; Casanova, J; Bacares, R; Kiecka, IJ; Razumova, A; Son, JB; Stewart, L; Baldi, T; Mullaney, KA; Al-Ahmadie, H; Vakiani, E; Abeshouse, AA; Penson, AV; Jonsson, P; Camacho, N; Chang, MT; Won, HH; Gross, BE; Kundra, R; Heins, ZJ; Chen, HW; Phillips, S; Zhang, HX; Wang, JJ; Ochoa, A; Wills, J; Eubank, M; Thomas, SB; Gardos, SM; Reales, DN; Galle, J; Durany, R; Cambria, R; Abida, W; Cercek, A; Feldman, DR; Gounder, MM; Hakimi, AA; Harding, JJ; Iyer, G; Janjigian, YY; Jordan, EJ; Kelly, CM; Lowery, MA; Morris, LGT; Omuro, AM; Raj, N; Razavi, P; Shoushtari, AN; Shukla, N; Soumerai, TE; Varghese, AM; Yaeger, R; Coleman, J; Bochner, B; Riely, GJ; Saltz, LB; Scher, HI; Sabbatini, PJ; Robson, ME; Klimstra, DS; Taylor, BS; Baselga, J; Schultz, N; Hyman, DM; Arcila, ME; Solit, DB; Ladanyi, M; Berger, MF				Zehir, Ahmet; Benayed, Ryma; Shah, Ronak H.; Syed, Aijazuddin; Middha, Sumit; Kim, Hyunjae R.; Srinivasan, Preethi; Gao, Jianjiong; Chakravarty, Debyani; Devlin, Sean M.; Hellmann, Matthew D.; Barron, David A.; Schram, Alison M.; Hameed, Meera; Dogan, Snjezana; Ross, Dara S.; Hechtman, Jaclyn F.; DeLair, Deborah F.; Yao, JinJuan; Mandelker, Diana L.; Cheng, Donavan T.; Chandramohan, Raghu; Mohanty, Abhinita S.; Ptashkin, Ryan N.; Jayakumaran, Gowtham; Prasad, Meera; Syed, Mustafa H.; Rema, Anoop Balakrishnan; Liu, Zhen Y.; Nafa, Khedoudja; Borsu, Laetitia; Sadowska, Justyna; Casanova, Jacklyn; Bacares, Ruben; Kiecka, Iwona J.; Razumova, Anna; Son, Julie B.; Stewart, Lisa; Baldi, Tessara; Mullaney, Kerry A.; Al-Ahmadie, Hikmat; Vakiani, Efsevia; Abeshouse, Adam A.; Penson, Alexander V.; Jonsson, Philip; Camacho, Niedzica; Chang, Matthew T.; Won, Helen H.; Gross, Benjamin E.; Kundra, Ritika; Heins, Zachary J.; Chen, Hsiao-Wei; Phillips, Sarah; Zhang, Hongxin; Wang, Jiaojiao; Ochoa, Angelica; Wills, Jonathan; Eubank, Michael; Thomas, Stacy B.; Gardos, Stuart M.; Reales, Dalicia N.; Galle, Jesse; Durany, Robert; Cambria, Roy; Abida, Wassim; Cercek, Andrea; Feldman, Darren R.; Gounder, Mrinal M.; Hakimi, A. Ari; Harding, James J.; Iyer, Gopa; Janjigian, Yelena Y.; Jordan, Emmet J.; Kelly, Ciara M.; Lowery, Maeve A.; Morris, Luc G. T.; Omuro, Antonio M.; Raj, Nitya; Razavi, Pedram; Shoushtari, Alexander N.; Shukla, Neerav; Soumerai, Tara E.; Varghese, Anna M.; Yaeger, Rona; Coleman, Jonathan; Bochner, Bernard; Riely, Gregory J.; Saltz, Leonard B.; Scher, Howard I.; Sabbatini, Paul J.; Robson, Mark E.; Klimstra, David S.; Taylor, Barry S.; Baselga, Jose; Schultz, Nikolaus; Hyman, David M.; Arcila, Maria E.; Solit, David B.; Ladanyi, Marc; Berger, Michael F.			Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients	NATURE MEDICINE			English	Article							TERT PROMOTER MUTATIONS; SOLID TUMORS; PAIRED-END; VALIDATION; ONCOLOGY; VEMURAFENIB; MECHANISMS; RESISTANCE; INHIBITORS; SIGNATURES	Tumor molecular profiling is a fundamental component of precision oncology, enabling the identification of genomic alterations in genes and pathways that can be targeted therapeutically. The existence of recurrent targetable alterations across distinct histologically defined tumor types, coupled with an expanding portfolio of molecularly targeted therapies, demands flexible and comprehensive approaches to profile clinically relevant genes across the full spectrum of cancers. We established a large-scale, prospective clinical sequencing initiative using a comprehensive assay, MSK-IMPACT, through which we have compiled tumor and matched normal sequence data from a unique cohort of more than 10,000 patients with advanced cancer and available pathological and clinical annotations. Using these data, we identified clinically relevant somatic mutations, novel noncoding alterations, and mutational signatures that were shared by common and rare tumor types. Patients were enrolled on genomically matched clinical trials at a rate of 11%. To enable discovery of novel biomarkers and deeper investigation into rare alterations and tumor types, all results are publicly accessible.	[Zehir, Ahmet; Benayed, Ryma; Shah, Ronak H.; Syed, Aijazuddin; Middha, Sumit; Kim, Hyunjae R.; Srinivasan, Preethi; Hameed, Meera; Dogan, Snjezana; Ross, Dara S.; Hechtman, Jaclyn F.; DeLair, Deborah F.; Yao, JinJuan; Mandelker, Diana L.; Cheng, Donavan T.; Chandramohan, Raghu; Mohanty, Abhinita S.; Ptashkin, Ryan N.; Jayakumaran, Gowtham; Prasad, Meera; Syed, Mustafa H.; Rema, Anoop Balakrishnan; Liu, Zhen Y.; Nafa, Khedoudja; Borsu, Laetitia; Sadowska, Justyna; Casanova, Jacklyn; Bacares, Ruben; Kiecka, Iwona J.; Razumova, Anna; Son, Julie B.; Stewart, Lisa; Baldi, Tessara; Mullaney, Kerry A.; Al-Ahmadie, Hikmat; Vakiani, Efsevia; Camacho, Niedzica; Won, Helen H.; Klimstra, David S.; Arcila, Maria E.; Ladanyi, Marc; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Gao, Jianjiong; Chakravarty, Debyani; Gross, Benjamin E.; Kundra, Ritika; Heins, Zachary J.; Chen, Hsiao-Wei; Phillips, Sarah; Zhang, Hongxin; Wang, Jiaojiao; Ochoa, Angelica; Taylor, Barry S.; Schultz, Nikolaus; Solit, David B.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Marie Jose & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Devlin, Sean M.; Abeshouse, Adam A.; Penson, Alexander V.; Jonsson, Philip; Chang, Matthew T.; Taylor, Barry S.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA; [Hellmann, Matthew D.; Schram, Alison M.; Abida, Wassim; Cercek, Andrea; Feldman, Darren R.; Gounder, Mrinal M.; Harding, James J.; Iyer, Gopa; Janjigian, Yelena Y.; Jordan, Emmet J.; Kelly, Ciara M.; Lowery, Maeve A.; Raj, Nitya; Razavi, Pedram; Shoushtari, Alexander N.; Soumerai, Tara E.; Varghese, Anna M.; Yaeger, Rona; Riely, Gregory J.; Saltz, Leonard B.; Scher, Howard I.; Sabbatini, Paul J.; Robson, Mark E.; Baselga, Jose; Hyman, David M.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Barron, David A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Penson, Alexander V.; Jonsson, Philip; Chang, Matthew T.; Taylor, Barry S.; Baselga, Jose; Schultz, Nikolaus; Solit, David B.; Ladanyi, Marc; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Wills, Jonathan; Eubank, Michael; Thomas, Stacy B.; Gardos, Stuart M.] Mem Sloan Kettering Canc Ctr, Informat Syst, 1275 York Ave, New York, NY 10021 USA; [Reales, Dalicia N.; Galle, Jesse; Durany, Robert; Cambria, Roy; Coleman, Jonathan; Bochner, Bernard] Mem Sloan Kettering Canc Ctr, Clin Res Adm, 1275 York Ave, New York, NY 10021 USA; [Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Omuro, Antonio M.] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Shukla, Neerav] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Cheng, Donavan T.; Chandramohan, Raghu] Illumina Inc, San Francisco, CA USA; [Zehir, Ahmet; Benayed, Ryma] Baylor Coll Med, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Illumina; Baylor College of Medicine	Berger, MF (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.; Berger, MF (corresponding author), Mem Sloan Kettering Canc Ctr, Marie Jose & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA.; Berger, MF (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	bergerm1@mskcc.org	Zehir, Ahmet/ABE-7155-2020; Chandramohan, Raghu/AAV-9936-2020; Mohanty, Abhinita S/AAM-7687-2020; lowery, maeve/AAG-2575-2019; Balakrishnan Rema, Anoop/AAE-1889-2022; Solit, David B./AAC-5309-2019; Ladanyi, Marc/AAG-8585-2019; Kundra, Ritika/ABC-9927-2020; Shah, Ronak H/H-9726-2017; Arcila, Maria/ABE-2235-2021; Gao, JianJiong/B-5673-2016; Schultz, Nikolaus/ABE-6347-2020; Riely, Gregory/AAF-4300-2019; Srinivasan, Preethi/AAD-3555-2020; Kim, Hyunjae/J-5811-2015	Zehir, Ahmet/0000-0001-5406-4104; lowery, maeve/0000-0003-1354-7606; Balakrishnan Rema, Anoop/0000-0001-6104-5665; Shah, Ronak H/0000-0001-9042-6213; Gao, JianJiong/0000-0002-5739-1781; Mohanty, Abhinita/0000-0002-6876-0482; Kim, Hyunjae/0000-0002-1869-0412; Thomas, Stacy/0000-0003-3306-5655; Schram, Alison/0000-0002-6070-2413; Bochner, Bernard/0000-0003-0846-0848; Ochoa, Angelica/0000-0003-0615-1654; Middha, Sumit/0000-0003-4135-6268; Reales, Dalicia/0000-0001-7435-3616; Hechtman, Jaclyn/0000-0003-2645-0985; Srinivasan, Preethi/0000-0003-2624-2545; Coleman, Jonathan/0000-0002-6428-7835; Gardos, Stuart/0000-0003-4381-9211; Feldman, Darren/0000-0003-2424-4635; Casanova, Jacklyn/0000-0002-3586-7048; Razavi, Pedram/0000-0003-4236-0576; Solit, David/0000-0002-6614-802X; Harding, James/0000-0002-7029-4310	MSK Cancer Center Support Grant [P30 CA008748]; Cycle for Survival; Farmer Family Foundation; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NATIONAL CANCER INSTITUTE [T32CA009207, P30CA008748, P50CA092629, P01CA129243, R01CA182587, R01CA204749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE024774] Funding Source: NIH RePORTER	MSK Cancer Center Support Grant; Cycle for Survival; Farmer Family Foundation; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We gratefully acknowledge C. England, J. Somar, T. Malbari, P. Salazar, S. Islam, E. Gallagher, I. Rijo, N. Mensah, G. Lukose, T. Mitchell, A. Yannes, Y. Chekaluk, G. Jour, N. Sadri, K. Tian, C. Pagan, J. K. Killian, D. Alex, J. Gomez-Gelvez, C. Ho, S. Naupari, J. Arlequin, C. Carvajal, L. Tovar Ramirez, J. Bakas, P. Sukhadia, E. Paraiso and J. Rudolph for their important contributions. This study was supported by the MSK Cancer Center Support Grant (P30 CA008748), Cycle for Survival, the Farmer Family Foundation, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beltran H, 2015, JAMA ONCOL, V1, P466, DOI 10.1001/jamaoncol.2015.1313; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D., 2017, J CLIN ONCOL PRECISI; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Eubank MH, 2016, J AM MED INFORM ASSN, V23, P777, DOI 10.1093/jamia/ocw020; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gao K, 2016, ONCOTARGET, V7, P8712, DOI 10.18632/oncotarget.6007; Garofalo A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0333-9; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Jordan E.J., 2017, CANC DISCOV; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Menzies AM, 2015, PIGM CELL MELANOMA R, V28, P607, DOI 10.1111/pcmr.12388; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Piscuoglio S, 2016, J PATHOL, V238, P508, DOI 10.1002/path.4672; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Ross JS, 2016, INT J CANCER, V138, P881, DOI 10.1002/ijc.29825; Ross JS, 2015, JAMA ONCOL, V1, P40, DOI 10.1001/jamaoncol.2014.216; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Schrader KA, 2016, JAMA ONCOL, V2, P104, DOI 10.1001/jamaoncol.2015.5208; Schwaederle M, 2015, MOL CANCER THER, V14, P1488, DOI 10.1158/1535-7163.MCT-14-1061; Sholl LM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87062; Simen BB, 2015, ARCH PATHOL LAB MED, V139, P508, DOI 10.5858/arpa.2013-0710-OA; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Stockley TL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0364-2; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Varghese AM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0427-x; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	62	1709	1765	7	214	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					703	+		10.1038/nm.4333	http://dx.doi.org/10.1038/nm.4333			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28481359	Green Accepted			2022-12-27	WOS:000402768000013
J	Beckerman, P; Bi-Karchin, J; Park, ASD; Qiu, CX; Dummer, PD; Soomro, I; Boustany-Kari, CM; Pullen, SS; Miner, JH; Hu, CAA; Rohacs, T; Inoue, K; Ishibe, S; Saleem, MA; Palmer, MB; Cuervo, AM; Kopp, JB; Susztak, K				Beckerman, Pazit; Bi-Karchin, Jing; Park, Ae Seo Deok; Qiu, Chengxiang; Dummer, Patrick D.; Soomro, Irfana; Boustany-Kari, Carine M.; Pullen, Steven S.; Miner, Jeffrey H.; Hu, Chien-An A.; Rohacs, Tibor; Inoue, Kazunori; Ishibe, Shuta; Saleem, Moin A.; Palmer, Matthew B.; Cuervo, Ana Maria; Kopp, Jeffrey B.; Susztak, Katalin			Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice	NATURE MEDICINE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HIV-ASSOCIATED NEPHROPATHY; TRYPANOLYTIC FACTOR APOL1; LIPID-BINDING PROTEIN; AUTOPHAGIC CELL-DEATH; DIABETIC-NEPHROPATHY; AFRICAN-AMERICANS; DOMAIN; CKD; APOLIPOPROTEIN-L1	African Americans have a heightened risk of developing chronic and end-stage kidney disease, an association that is largely attributed to two common genetic variants, termed G1 and G2, in the APOL1 gene. Direct evidence demonstrating that these APOL1 risk alleles are pathogenic is still lacking because the APOL1 gene is present in only some primates and humans; thus it has been challenging to demonstrate experimental proof of causality of these risk alleles for renal disease. Here we generated mice with podocyte-specific inducible expression of the APOL1 reference allele (termed G0) or each of the risk-conferring alleles (G1 or G2). We show that mice with podocyte-specific expression of either APOL1 risk allele, but not of the G0 allele, develop functional (albuminuria and azotemia), structural (foot-process effacement and glomerulosclerosis) and molecular (gene-expression) changes that closely resemble human kidney disease. Disease development was cell-type specific and likely reversible, and the severity correlated with the level of expression of the risk allele. We further found that expression of the risk-variant APOL1 alleles interferes with endosomal trafficking and blocks autophagic flux, which ultimately leads to inflammatory-mediated podocyte death and glomerular scarring. In summary, this is the first demonstration that the expression of APOL1 risk alleles is causal for altered podocyte function and glomerular disease in vivo.	[Beckerman, Pazit; Bi-Karchin, Jing; Park, Ae Seo Deok; Qiu, Chengxiang; Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dummer, Patrick D.; Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD USA; [Soomro, Irfana] NYU, Div Nephrol, New York, NY USA; [Boustany-Kari, Carine M.; Pullen, Steven S.] Boehringer Ingelheim Pharmaceut, Dept Cardiometab Dis Res, Ridgefield, CT USA; [Miner, Jeffrey H.] Washington Univ, Sch Med, Div Nephrol, St Louis, MO USA; [Hu, Chien-An A.] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Hu, Chien-An A.] Hlth Sci Ctr, Albuquerque, NM USA; [Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Inoue, Kazunori; Ishibe, Shuta] Yale Univ, Sch Med, Div Nephrol, New Haven, CT USA; [Saleem, Moin A.] Univ Bristol, Sch Clin Sci, Bristol Renal & Childrens Renal Unit, Bristol, Avon, England; [Palmer, Matthew B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Susztak, Katalin] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); New York University; Boehringer Ingelheim; Washington University (WUSTL); University of New Mexico; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yale University; University of Bristol; University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; University of Pennsylvania; Pennsylvania Medicine	Susztak, K (corresponding author), Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA.; Susztak, K (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	ksusztak@mail.med.upenn.edu	Susztak, Katalin/ABE-7474-2021; Qiu, Chengxiang/X-5040-2019; Kopp, Jeffrey B/O-2681-2015	Susztak, Katalin/0000-0002-1005-3726; Qiu, Chengxiang/0000-0002-6346-8669; Kopp, Jeffrey B/0000-0001-9052-186X; Beckerman, Pazit/0000-0003-3061-6757; Saleem, Moin/0000-0002-9808-4518; Karchin, Jing/0000-0001-8057-7448; Cuervo, Ana Maria/0000-0002-0771-700X	US National Institutes of Health (NIH) [DK105821, DK087635, DK076077, DP3 DK108220]; Intramural Research Program, NIDDK, NIH; NIH [R01DK078314, R01DK058366, GM093290, NS055159, AG054108]; Kids Kidney Research; Bristol Nutrition NIHR-BRU;  [2T32DK007006]; Kidney Research UK [RP45/2008] Funding Source: researchfish; Medical Research Council [MR/L002418/1, G0800571] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083294, R01DK078314, T32DK007785, R01DK087635, T32DK007006, R01DK058366, DP3DK108220, ZIADK043308, R01DK076077, R01DK105821, P30DK020541, R21DK095419, R01DK093629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054108, P01AG031782, P30AG038072] Funding Source: NIH RePORTER; MRC [MR/L002418/1, G0800571] Funding Source: UKRI	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, NIDDK, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kids Kidney Research(Kidney Research UK (KRUK)); Bristol Nutrition NIHR-BRU; ; Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work performed in the Susztak lab is supported by US National Institutes of Health (NIH) grants DK105821, DK087635, DK076077 and DP3 DK108220. The human kidney RNA-sequencing project was performed in collaboration with Boehringer Ingelheim. J. Bi-Karchin was supported by 2T32DK007006. J.B. Kopp. and P.D.D. were supported by the Intramural Research Program, NIDDK, NIH. J.H.M. was supported by R01DK078314 and R01DK058366; T.R. by GM093290 and NS055159; and A.M.C. by AG054108 (NIH). M.A.S. was supported by Kids Kidney Research, and the Bristol Nutrition NIHR-BRU. We would also like to thank the Electron Microscopy Resource Laboratory (EMRL) core facility at the University of Pennsylvania for technical support.	Bruggeman LA, 2016, J AM SOC NEPHROL, V27, P3600, DOI 10.1681/ASN.2015111220; Byrne BG, 2013, MBIO, V4, DOI 10.1128/mBio.00620-12; Cheng DM, 2015, J LIPID RES, V56, P1583, DOI 10.1194/jlr.M059733; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Foster MC, 2013, J AM SOC NEPHROL, V24, P1484, DOI 10.1681/ASN.2013010113; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Friedman DJ, 2011, J CLIN INVEST, V121, P3367, DOI 10.1172/JCI46263; Furuta N, 2012, J ORAL BIOSCI, V54, P83, DOI 10.1016/j.job.2012.03.001; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Galindo-Moreno J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.237; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Haque S, 2016, AM J PATHOL, V186, P347, DOI 10.1016/j.ajpath.2015.10.002; Hartleben B, 2014, SEMIN NEPHROL, V34, P42, DOI 10.1016/j.semnephrol.2013.11.007; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Heneghan JF, 2015, AM J PHYSIOL-CELL PH, V309, pC332, DOI 10.1152/ajpcell.00142.2015; Inoki K, 2014, SEMIN NEPHROL, V34, P2, DOI 10.1016/j.semnephrol.2013.11.002; Jotwani V, 2015, AM J KIDNEY DIS, V65, P889, DOI 10.1053/j.ajkd.2015.02.329; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Kawakami T, 2015, J AM SOC NEPHROL, V26, P1040, DOI 10.1681/ASN.2013111202; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242; Larsen CP, 2015, MODERN PATHOL, V28, P95, DOI 10.1038/modpathol.2014.92; Lecordier L, 2015, MOL MICROBIOL, V97, P397, DOI 10.1111/mmi.13036; Ledo N, 2015, J AM SOC NEPHROL, V26, P692, DOI 10.1681/ASN.2014010028; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XB, 2014, J AM SOC NEPHROL, V25, P687, DOI 10.1681/ASN.2013070798; Lipworth L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048407; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Muller-Deile J, 2016, PEDIATR NEPHROL, V31, P393, DOI 10.1007/s00467-015-3116-4; Ng DK, 2016, NEPHROL DIAL TRANSPL; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Sampson MG, 2016, J AM SOC NEPHROL, V27, P814, DOI 10.1681/ASN.2014111131; Shahzad K, 2016, J AM SOC NEPHROL, V27, P2270, DOI 10.1681/ASN.2015060676; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Tagawa A, 2016, DIABETES, V65, P755, DOI 10.2337/db15-0473; Tao JL, 2014, KIDNEY INT, V85, P972, DOI 10.1038/ki.2013.463; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Tin A, 2016, CLIN J AM SOC NEPHRO, V11, P1353, DOI 10.2215/CJN.12221115; Turner CM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-21; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; USRDS. US Renal, 2015, US REN DAT SYST; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Yamamoto-Nonaka K, 2016, J AM SOC NEPHROL, V27, P2685, DOI 10.1681/ASN.2015040366; Yu HY, 2016, J CLIN INVEST, V126, P1067, DOI 10.1172/JCI82592; Zhaorigetu S, 2008, AUTOPHAGY, V4, P1079, DOI 10.4161/auto.7066	48	194	198	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					429	+		10.1038/nm.4287	http://dx.doi.org/10.1038/nm.4287			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28218918	Green Accepted, Green Submitted			2022-12-27	WOS:000398768100011
J	Kesarwani, M; Kincaid, Z; Gomaa, A; Huber, E; Rohrabaugh, S; Siddiqui, Z; Bouso, MF; Latif, T; Xu, M; Komurov, K; Mulloy, JC; Cancelas, JA; Grimes, HL; Azam, M				Kesarwani, Meenu; Kincaid, Zachary; Gomaa, Ahmed; Huber, Erika; Rohrabaugh, Sara; Siddiqui, Zain; Bouso, Muhammad F.; Latif, Tahir; Xu, Ming; Komurov, Kakajan; Mulloy, James C.; Cancelas, Jose A.; Grimes, H. Leighton; Azam, Mohammad			Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia	NATURE MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; COMPLETE MOLECULAR REMISSION; STEM-CELLS; PHILADELPHIA-CHROMOSOME; ONCOGENE ADDICTION; CANCER-THERAPY; IN-VIVO; DIFFERENTIAL REGULATION	Tyrosine-kinase inhibitor (TKI) therapy for human cancers is not curative, and relapse occurs owing to the continued presence of tumor cells, referred to as minimal residual disease (MRD). The survival of MRD stem or progenitor cells in the absence of oncogenic kinase signaling, a phenomenon referred to as intrinsic resistance, depends on diverse growth factors. Here we report that oncogenic kinase and growth-factor signaling converge to induce the expression of the signaling proteins FBJ osteosarcoma oncogene (c-FOS, encoded by Fos) and dual-specificity phosphatase 1 (DUSP1). Genetic deletion of Fos and Dusp1 suppressed tumor growth in a BCR-ABL fusion protein kinase-induced mouse model of chronic myeloid leukemia (CML). Pharmacological inhibition of c-FOS, DUSP1 and BCR-ABL eradicated MRD in multiple in vivo models, as well as in mice xenotransplanted with patient-derived primary CML cells. Growth-factor signaling also conferred TKI resistance and induced FOS and DUSP1 expression in tumor cells modeling other types of kinase-driven leukemias. Our data demonstrate that c-FOS and DUSP1 expression levels determine the threshold of TKI efficacy, such that growth-factor-induced expression of c-FOS and DUSP1 confers intrinsic resistance to TKI therapy in a wide-ranging set of leukemias, and might represent a unifying Achilles' heel of kinase-driven cancers.	[Kesarwani, Meenu; Kincaid, Zachary; Gomaa, Ahmed; Huber, Erika; Rohrabaugh, Sara; Siddiqui, Zain; Bouso, Muhammad F.; Komurov, Kakajan; Mulloy, James C.; Cancelas, Jose A.; Grimes, H. Leighton; Azam, Mohammad] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; [Latif, Tahir] Univ Cincinnati, Dept Med, Cincinnati, OH USA; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Box 428, Chicago, IL 60637 USA; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Azam, Mohammad] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Chicago; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Azam, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA.; Azam, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA.	mohammad.azam@cchmc.org	Cancelas, Jose/AAR-9324-2020; Latif, Tahir/AAE-1749-2021	Grimes, H. Leighton/0000-0001-8162-6758	NCI [1RO1CA155091]; Leukemia Research Foundation; V Foundation; NHLBI [R21HL114074-01]; NATIONAL CANCER INSTITUTE [R01CA155091] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL114074] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; V Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are thankful to H. Singh and Y. Zheng for providing critical feedback on this study. We are thankful to G. Daley for providing the BaF3-BA cells and T. Reya for the MSCV-BCR-ABL-Ires-YFP constructs. We are thankful to M. Carroll for providing the patient samples from the CML blast crisis. This study was supported by grants to M. A. from the NCI (1RO1CA155091), Leukemia Research Foundation and V Foundation and from the NHLBI (R21HL114074-01).	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; [Anonymous], [No title captured]; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Bruennert D, 2009, LEUKEMIA, V23, P983, DOI 10.1038/leu.2008.337; Chang KH, 2012, BLOOD, V120, P800, DOI 10.1182/blood-2011-06-361709; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; Copland M, 2008, BLOOD, V111, P2843, DOI 10.1182/blood-2007-09-112573; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dorfman K, 1996, ONCOGENE, V13, P925; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2003, MOL BIOL CELL, V14, P2201, DOI 10.1091/mbc.E02-11-0732; Kesarwani M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14538; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lawan A, 2013, CELL MOL LIFE SCI, V70, P223, DOI 10.1007/s00018-012-1041-2; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mills GB, 2001, P NATL ACAD SCI USA, V98, P10031, DOI 10.1073/pnas.191379498; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Padhye S, 2009, PHARM RES-DORDR, V26, P2438, DOI 10.1007/s11095-009-9955-6; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Park S, 1998, CANCER LETT, V127, P23, DOI 10.1016/S0304-3835(97)00543-0; RANSONE LJ, 1990, P NATL ACAD SCI USA, V87, P3806, DOI 10.1073/pnas.87.10.3806; Reddy A, 2002, CURR OPIN PHARMACOL, V2, P366, DOI 10.1016/S1471-4892(02)00178-9; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Sawyers CL, 2009, NAT MED, V15, P1158, DOI 10.1038/nm1009-1158; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2010, BIOCHEM PHARMACOL, V80, P666, DOI 10.1016/j.bcp.2010.03.001; Shojaee S, 2015, CANCER CELL, V28, P114, DOI 10.1016/j.ccell.2015.05.008; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Welner RS, 2015, CANCER CELL, V27, P671, DOI 10.1016/j.ccell.2015.04.004; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	61	47	52	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					472	+		10.1038/nm.4310	http://dx.doi.org/10.1038/nm.4310			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28319094	Green Accepted			2022-12-27	WOS:000398768100015
J	Koukouli, F; Rooy, M; Tziotis, D; Sailor, KA; O'Neill, HC; Levenga, J; Witte, M; Nilges, M; Changeux, JP; Hoeffer, CA; Stitzel, JA; Gutkin, BS; DiGregorio, DA; Maskos, U				Koukouli, Fani; Rooy, Marie; Tziotis, Dimitrios; Sailor, Kurt A.; O'Neill, Heidi C.; Levenga, Josien; Witte, Mirko; Nilges, Michael; Changeux, Jean-Pierre; Hoeffer, Charles A.; Stitzel, Jerry A.; Gutkin, Boris S.; DiGregorio, David A.; Maskos, Uwe			Nicotine reverses hypofrontality in animal models of addiction and schizophrenia	NATURE MEDICINE			English	Article							PREFRONTAL CORTEX; ACETYLCHOLINE-RECEPTORS; ATTENTION CIRCUITRY; INTERNEURONS; NEURONS; CONNECTIONS; INHIBITION; BEHAVIORS; VARIANTS; DEFICITS	The prefrontal cortex (PFC) underlies higher cognitive processes(1) that are modulated by nicotinic acetylcholine receptor (nAChR) activation by cholinergic inputs(2). PFC spontaneous default activity(3) is altered in neuropsychiatric disorders(4), including schizophrenia(5) a disorder that can be accompanied by heavy smoking(6). Recently, genome-wide association studies (GWAS) identified single-nucleotide polymorphisms (SNPs) in the human CHRNA5 gene, encoding the alpha 5 nAChR subunit, that increase the risks for both smoking and schizophrenia(7'8). Mice with altered nAChR gene function exhibit PFC-dependent behavioral deficits(9-11), but it is unknown how the corresponding human polymorphisms alter the cellular and circuit mechanisms underlying behavior. Here we show that mice expressing a human 5 SNP exhibit neurocognitive behavioral deficits in social interaction and sensorimotor gating tasks. Two-photon calcium imaging in awake mouse models showed that nicotine can differentially influence PFC pyramidal cell activity by nAChR modulation of layer II/III hierarchical inhibitory circuits. In 5-SNP-expressing and 5-knockout mice, lower activity of vasoactive intestinal polypeptide (VIP) interneurons resulted in an increased somatostatin (SOM) interneuron inhibitory drive over layer II/III pyramidal neurons. The decreased activity observed in 5-SNP-expressing mice resembles the hypofrontality observed in patients with psychiatric disorders, including schizophrenia and addiction(5,12).Chronic nicotine administration reversed this hypofrontality, suggesting that administration of nicotine may represent a therapeutic strategy for the treatment of schizophrenia, and a physiological basis for the tendency of patients with schizophrenia to self-medicate by smoking(13).	[Koukouli, Fani; Maskos, Uwe] Inst Pasteur, Neurobiol Integrat Syst Cholinerg, Paris, France; [Koukouli, Fani; Sailor, Kurt A.; Changeux, Jean-Pierre; DiGregorio, David A.; Maskos, Uwe] CNRS, UMR 3571, Paris, France; [Rooy, Marie; Gutkin, Boris S.] Ecole Normale Super, Dept Etud Cognit, Lab Neurosci Cognit, Grp Neural Theory,INSERM,Unite 969, Paris, France; [Tziotis, Dimitrios; Nilges, Michael] Inst Pasteur, Struct Bioinformat Unit, CNRS, UMR 3528, Paris, France; [Sailor, Kurt A.] Inst Pasteur, Percept & Memory Unit, Paris, France; [O'Neill, Heidi C.; Levenga, Josien; Hoeffer, Charles A.; Stitzel, Jerry A.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Witte, Mirko] Georg August Univ, Univ Med Gottingen, Inst Neuroanat, Gottingen, Germany; [Gutkin, Boris S.] Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia; [DiGregorio, David A.] Inst Pasteur, Dynam Neuronal Imaging Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Colorado System; University of Colorado Boulder; University of Gottingen; HSE University (National Research University Higher School of Economics); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Maskos, U (corresponding author), Inst Pasteur, Neurobiol Integrat Syst Cholinerg, Paris, France.; Maskos, U (corresponding author), CNRS, UMR 3571, Paris, France.	umaskos@pasteur.fr	Koukouli, Fani/AGG-7995-2022; O'Neill, Heidi/AAP-8909-2021; Nilges, Michael/E-4803-2011; Sailor, Kurt Andrew/AFN-4046-2022; Sailor, Kurt/GSO-2237-2022; Gutkin, Boris/A-7420-2014; Gutkin, Boris/ABC-5754-2020	Koukouli, Fani/0000-0003-1378-4863; Nilges, Michael/0000-0002-1451-8092; Sailor, Kurt Andrew/0000-0002-9574-6838; Sailor, Kurt/0000-0002-9574-6838; Gutkin, Boris/0000-0001-6409-979X; O'NEILL, HEIDI C./0000-0001-7250-1494	Ile-de-France Domaine d'Interet Majeur (DIM/NeRF); CNRS [UMR 3571]; Fondation de la Recherche Medicale (FRM) [DPA20140629803]; Agence Nationale de la Recherche (ANR); Laboratoire d'Excellence BIO-PSY; program Pasteurinnov; FP7 ERANET program NICO-GENE [n009 BLANC 20092009BLANC 20]; European Commission FP7 RTD Project [HEALTH-2009-Neurocyp.08-202088, 242167]; French National Cancer Institute [CANCEROPOLE IDF 2016-1-TABAC-01-IP-1 MASKOS]; NIH [CA089392, DA015663]; ANR [ANR-11-IDEX-0004-02]; Russian Academic Excellence Project '5-100'; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA015663] Funding Source: NIH RePORTER	Ile-de-France Domaine d'Interet Majeur (DIM/NeRF); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Laboratoire d'Excellence BIO-PSY; program Pasteurinnov; FP7 ERANET program NICO-GENE; European Commission FP7 RTD Project; French National Cancer Institute(Institut National du Cancer (INCA) France); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank S. Pons for valuable support and discussions on lentiviral constructs, and M. Soudant for production of lentiviral vectors. We also acknowledge the Pasteur Institute Shared Neuroscience Department imaging facility funded by Ile-de-France Domaine d'Interet Majeur (DIM/NeRF). We acknowledge the GENIE Program and the Janelia Research Campus and specifically V. Jayaraman, D.S. Kim, L.L. Looger and K. Svoboda from the GENIE Project, Janelia Research Campus, Howard Hughes Medical Institute for making AAV.Syn.GCaMP6f and AAV.Syn.Flex.GCaMP6f available. Finally, we thank G. Fond and M. Groszer for comments on the manuscript. F.K. is a scholar of the Pasteur Paris University Doctoral Program (PPU) and received a stipend from the Stavros Niarchos Foundation. This work was supported by the CNRS UMR 3571, the Fondation de la Recherche Medicale (FRM grant DPA20140629803), the Agence Nationale de la Recherche (ANR), the Laboratoire d'Excellence BIO-PSY (including salary support to F.K., AAP Fin de These 2015), the program Pasteurinnov 2012, the FP7 ERANET program NICO-GENE, Grant Agreement n009 BLANC 20092009BLANC 20, the European Commission FP7 RTD Project HEALTH-2009-Neurocyp.08-202088 Grant 242167, French National Cancer Institute Grant CANCEROPOLE IDF 2016-1-TABAC-01-IP-1 MASKOS (all to U.M.), and NIH grants CA089392 and DA015663 (to J.S.). The laboratories of U.M., B.S.G. and D.A.D. are part of the Ecole des Neurosciences de Paris Ile-de-France RTRA network. U.M. and D.A.D. are members of the Laboratory of Excellence, LabEx BIO-PSY. As such, this work was supported by French state funds managed by the ANR within the Investissements d'Avenir program under reference ANR-11-IDEX-0004-02. B.S.G. is a member of the Laboratory of Excellence, LabEx IEC. B.S.G. acknowledges support from the Russian Academic Excellence Project '5-100'.	Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; Bailey CDC, 2010, J NEUROSCI, V30, P9241, DOI 10.1523/JNEUROSCI.2258-10.2010; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bloem B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00017; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Derntl B, 2011, EUR ARCH PSY CLIN N, V261, P145, DOI 10.1007/s00406-011-0244-0; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Guillem K, 2011, SCIENCE, V333, P888, DOI 10.1126/science.1207079; Hambsch B, 2014, BRIT J PHARMACOL, V171, P1758, DOI 10.1111/bph.12578; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Poorthuis RB, 2013, J NEUROSCI, V33, P4843, DOI 10.1523/JNEUROSCI.5012-12.2013; Poorthuis RB, 2013, CEREB CORTEX, V23, P148, DOI 10.1093/cercor/bhr390; Porter JT, 1999, J NEUROSCI, V19, P5228; Proulx E, 2014, CELL MOL LIFE SCI, V71, P1225, DOI 10.1007/s00018-013-1481-3; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Sciaccaluga M, 2015, FASEB J, V29, P3389, DOI 10.1096/fj.14-268102; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008	34	112	114	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					347	354		10.1038/nm.4274	http://dx.doi.org/10.1038/nm.4274			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28112735	Green Accepted, Green Submitted			2022-12-27	WOS:000395848400015
J	Shankland, SJ; Jefferson, JA				Shankland, Stuart J.; Jefferson, J. Ashley			A bone marrow factor contributes to kidney disease	NATURE MEDICINE			English	Editorial Material							PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR	Soluble urokinase plasminogen activator receptor (suPAR) is a circulating biomarker of inflammation. A recent study identifies immature myeloid cells in the bone marrow as a major cellular source of suPAR that contributes to kidney disease.	[Shankland, Stuart J.; Jefferson, J. Ashley] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shankland, SJ (corresponding author), Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA.	stuartjs@uw.edu	Jefferson, Jonathan/AAA-9679-2019					Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	6	5	5	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					13	14		10.1038/nm.4263	http://dx.doi.org/10.1038/nm.4263			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	28060796				2022-12-27	WOS:000391646800007
J	Braso-Maristany, F; Filosto, S; Catchpole, S; Marlow, R; Quist, J; Francesch-Domenech, E; Plumb, DA; Zakka, L; Gazinska, P; Liccardi, G; Meier, P; Gris-Oliver, A; Cheang, MCU; Perdrix-Rosell, A; Shafat, M; Noel, E; Patel, N; McEachern, K; Scaltriti, M; Castel, P; Noor, F; Buus, R; Mathew, S; Watkins, J; Serra, V; Marra, P; Grigoriadis, A; Tutt, AN				Braso-Maristany, Fara; Filosto, Simone; Catchpole, Steven; Marlow, Rebecca; Quist, Jelmar; Francesch-Domenech, Erika; Plumb, Darren A.; Zakka, Leila; Gazinska, Patrycja; Liccardi, Gianmaria; Meier, Pascal; Gris-Oliver, Albert; Cheang, Maggie Chon U.; Perdrix-Rosell, Anna; Shafat, Manar; Noel, Elodie; Patel, Nirmesh; McEachern, Kristen; Scaltriti, Maurizio; Castel, Pau; Noor, Farzana; Buus, Richard; Mathew, Sumi; Watkins, Johnathan; Serra, Violeta; Marra, Pierfrancesco; Grigoriadis, Anita; Tutt, Andrew N.			PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer	NATURE MEDICINE			English	Article							MOLECULAR CHARACTERIZATION; PRECLINICAL MODELS; C-MYC; PHOSPHORYLATION; ACTIVATION; TRANSCRIPTION; PROGRESSION; SUBTYPES; PATHWAYS; SURVIVAL	Triple-negative breast cancers (TNBCs) have poor prognosis and lack targeted therapies. Here we identified increased copy number and expression of the PIM1 proto-oncogene in genomic data sets of patients with TNBC. TNBC cells, but not nonmalignant mammary epithelial cells, were dependent on PIM1 for proliferation and protection from apoptosis. PIM1 knockdown reduced expression of the anti-apoptotic factor BCL2, and dynamic BH3 profiling of apoptotic priming revealed that PIM1 prevents mitochondrial-mediated apoptosis in TNBC cell lines. In TNBC tumors and their cellular models, PIM1 expression was associated with several transcriptional signatures involving the transcription factor MYC, and PIM1 depletion in TNBC cell lines decreased, in a MYC-dependent manner, cell population growth and expression of the MYC target gene MCL1. Treatment with the pan-PIM kinase inhibitor AZD1208 impaired the growth of both cell line and patient-derived xenografts and sensitized them to standard-of-care chemotherapy. This work identifies PIM1 as a malignant-cell-selective target in TNBC and the potential use of PIM1 inhibitors for sensitizing TNBC to chemotherapy-induced apoptotic cell death.	[Braso-Maristany, Fara; Filosto, Simone; Catchpole, Steven; Marlow, Rebecca; Quist, Jelmar; Francesch-Domenech, Erika; Plumb, Darren A.; Zakka, Leila; Gazinska, Patrycja; Perdrix-Rosell, Anna; Shafat, Manar; Noel, Elodie; Patel, Nirmesh; Noor, Farzana; Mathew, Sumi; Watkins, Johnathan; Marra, Pierfrancesco; Grigoriadis, Anita; Tutt, Andrew N.] Kings Coll London, Guys Hosp, Fac Life Sci & Med, Breast Canc Now Res Unit,Div Canc Studies, London, England; [Quist, Jelmar; Grigoriadis, Anita] Kings Coll London, Fac Life Sci & Med, Div Canc Studies, Canc Bioinformat, London, England; [Liccardi, Gianmaria; Meier, Pascal; Cheang, Maggie Chon U.; Buus, Richard; Tutt, Andrew N.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Gris-Oliver, Albert; Serra, Violeta] Vall dHebron Inst Oncol, Expt Therapeut Grp, Barcelona, Spain; [McEachern, Kristen] AstraZeneca, Oncol iMed, Waltham, MA USA; [Scaltriti, Maurizio; Castel, Pau] Mem Sloan Kettering Canc Ctr, HOPP, 1275 York Ave, New York, NY 10021 USA; [Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Vall d'Hebron Institut d'Oncologia (VHIO); AstraZeneca; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tutt, AN (corresponding author), Kings Coll London, Guys Hosp, Fac Life Sci & Med, Breast Canc Now Res Unit,Div Canc Studies, London, England.; Tutt, AN (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England.	andrew.tutt@icr.ac.uk	Watkins, Johnathan/ABI-8343-2020; Serra, Violeta/AAG-8328-2019; Gris Oliver, Albert/AAL-6783-2021; Miquel, Josep Maria/AAG-3508-2019; Castel, Pau/AAL-5791-2020	Watkins, Johnathan/0000-0001-8370-6022; Gris Oliver, Albert/0000-0003-1802-9541; Castel, Pau/0000-0002-4972-4347; Tutt, Andrew/0000-0001-8715-2901; Serra, Violeta/0000-0001-6620-1065; Cheang, Maggie Chon U/0000-0001-5718-2501; Shafat, Manar/0000-0002-3493-9089; Grigoriadis, Anita/0000-0003-3434-201X; Braso Maristany, Fara/0000-0001-5440-9643; Filosto, Simone/0000-0002-7854-998X; Buus, Richard/0000-0002-3386-3465; Meier, Pascal/0000-0003-2760-6523	Breast Cancer Now at King's College London; Institute of Cancer Research London; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; US National Institutes of Health [P30 CA008748]; Breast Cancer Research Foundation; 'GHD-pink' research via the FERO Foundation; Experimental Cancer Medicine Centre at King's College London; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Biotechnology and Biological Sciences Research Council [BB/L021684/1] Funding Source: researchfish; Medical Research Council [G1000089, MR/M019217/1] Funding Source: researchfish; Worldwide Cancer Research [14-1328] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; BBSRC [BB/L021684/1] Funding Source: UKRI; MRC [G1000089, MR/M019217/1] Funding Source: UKRI	Breast Cancer Now at King's College London; Institute of Cancer Research London; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; 'GHD-pink' research via the FERO Foundation; Experimental Cancer Medicine Centre at King's College London; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Breast Cancer Now funding (A.N.T.) at King's College London and the Institute of Cancer Research London, the National Institute for Health Research Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, the US National Institutes of Health grant P30 CA008748 (M.S.) and the Breast Cancer Research Foundation (M.S.). The PDX studies were supported by a 'GHD-pink' research support via the FERO Foundation (VS.). Patient samples and data were provided by King's Health Partners Cancer Biobank, London, UK, which is supported by the Experimental Cancer Medicine Centre at King's College London and the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award. We thank S. Swift, S. Utting and M. Ferrao for technical and administrative assistance, AstraZeneca for providing AZD1208, D. Huszar (AstraZeneca) for providing information on the use of AZD1208, H. Mirza (King's College London) for his support with the bioinformatics analysis, J. Hurst (The Institute of Cancer Research London) for helping with the NanoString nCounter PanCancer Pathway analysis, M. Dowsett (Institute of Cancer Research and Royal Marsden Hospital National Institute for Health Research comprehensive Biomedical Research Centre London) for providing staff and infrastructure support for the NanoString NCounter work, T. Tenev (Institute of Cancer Research) for providing MDA-MB-231 containing the BCL2 pTIPZ overexpression vector and the Guy's Hospital Pharmacy for providing the chemotherapeutic drugs.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Canbay E, 2003, CELL BIOL INT, V27, P477, DOI 10.1016/S1065-6995(03)00039-8; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Garcia PD, 2014, CLIN CANCER RES, V20, P1834, DOI 10.1158/1078-0432.CCR-13-2062; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Grigoriadis A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-619; Horiuchi D., 2016, NAT MED; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Kirschner AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju407; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Magnuson NS, 2010, FUTURE ONCOL, V6, P1461, DOI 10.2217/FON.10.106; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McEachern K. A., 2014, 56 ASH ANN M EXP SAN; Miura K, 2013, ONCOGENE, V32, P5292, DOI 10.1038/onc.2012.571; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Morton JP, 2013, MOL ONCOL, V7, P248, DOI 10.1016/j.molonc.2013.02.015; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Raab M. S., 2013, 55 ASH ANN M EXP NEW; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner NC, 2013, CLIN CANCER RES, V19, P6380, DOI 10.1158/1078-0432.CCR-13-0915; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	48	144	151	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1303	1313		10.1038/nm.4198	http://dx.doi.org/10.1038/nm.4198			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27775704	Green Submitted, Green Accepted			2022-12-27	WOS:000387302300023
J	Traxler, EA; Yao, Y; Wang, YD; Woodard, KJ; Kurita, R; Nakamura, Y; Hughes, JR; Hardison, RC; Blobel, GA; Li, CL; Weiss, MJ				Traxler, Elizabeth A.; Yao, Yu; Wang, Yong-Dong; Woodard, Kaitly J.; Kurita, Ryo; Nakamura, Yukio; Hughes, Jim R.; Hardison, Ross C.; Blobel, Gerd A.; Li, Chunliang; Weiss, Mitchell J.			A genome-editing strategy to treat beta-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition	NATURE MEDICINE			English	Article							SICKLE-CELL-DISEASE; GAMMA-GLOBIN GENE; FETAL-HEMOGLOBIN; EPSILON-GLOBIN; BINDING; DELETION; ANEMIA; REGION; NFE3	Disorders resulting from mutations in the hemoglobin subunit beta gene (HBB; which encodes beta-globin), mainly sickle cell disease (SCD) and beta-thalassemia, become symptomatic postnatally as fetal gamma-globin expression from two paralogous genes, hemoglobin subunit gamma 1 (HBG1) and HBG2, decreases and adult beta-globin expression increases, thereby shifting red blood cell (RBC) hemoglobin from the fetal (referred to as HbF or alpha 2 gamma 2) to adult (referred to as HbA or alpha 2 beta 2) form. These disorders are alleviated when postnatal expression of fetal gamma-globin is maintained. For example, in hereditary persistence of fetal hemoglobin (HPFH), a benign genetic condition, mutations attenuate gamma-globin-to-beta-globin switching, causing high-level HbF expression throughout life. Co-inheritance of HPFH with beta-thalassemia- or SCD-associated gene mutations alleviates their clinical manifestations. Here we performed CRISPR-Cas9-mediated genome editing of human blood progenitors to mutate a 13-nt sequence that is present in the promoters of the HBG1 and HBG2 genes, thereby recapitulating a naturally occurring HPFH-associated mutation. Edited progenitors produced RBCs with increased HbF levels that were sufficient to inhibit the pathological hypoxia-induced RBC morphology found in SCD. Our findings identify a potential DNA target for genome-editing-mediated therapy of beta-hemoglobinopathies.	[Traxler, Elizabeth A.; Yao, Yu; Woodard, Kaitly J.; Weiss, Mitchell J.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Traxler, Elizabeth A.] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Kurita, Ryo; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Hughes, Jim R.] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Li, Chunliang] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital; RIKEN; University of Tsukuba; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital	Weiss, MJ (corresponding author), St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA.	mitch.weiss@stjude.org	Weiss, Mitchell J/W-9814-2018; , chunliang.li@stjude.org/P-4373-2018; Nakamura, Yukio/A-5263-2016; Hardison, Ross C/G-1142-2010	Weiss, Mitchell J/0000-0003-2460-3036; , chunliang.li@stjude.org/0000-0002-5938-5510; Nakamura, Yukio/0000-0001-8056-4946; Hardison, Ross C/0000-0003-4084-7516	US National Institutes of Health [4R01HL119479, 2R56DK0658, P30CA021765-37, F30DK102291]; American Lebanese Syrian Associated Charities; Assisi Foundation of Memphis; Wellcome Strategic Award; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065806, R24DK106766, F30DK102291] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12009/15] Funding Source: researchfish; MRC [MC_UU_12009/15] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Assisi Foundation of Memphis; Wellcome Strategic Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to P. Mead, G. Neale, S. Olsen, C. Sherr and Y. Yasui for valuable discussions and technical expertise. DNA sequencing studies were performed at the Hartwell Center, St. Jude Children's Research Hospital (SJCRH). FISH studies were performed by the SJCRH Cytogenetics Resource. Lentivirus was produced by the SJCRH Hematology Department Vector Core Facility. Allophycocyanin (APC)-conjugated anti-Band3 was a gift from X. An (New York Blood Center). The all-in-one expression plasmid spCas9 (BB)-2A-GFP (PX458, Addgene plasmid #48138) and lentiCRISPRv2 (Addgene plasmid #52961) were gifts from F. Zhang (Broad Institute). We thank D. Phillips for his support and encouragement. Support was provided by the US National Institutes of Health (grant no. 4R01HL119479 (G.A.B.), 2R56DK0658 (R.C.H.) and P30CA021765-37 (C.L.), and fellowship no. F30DK102291 (E.A.T.)), the American Lebanese Syrian Associated Charities (M.J.W.), the Assisi Foundation of Memphis (M.J.W.) and a Wellcome Strategic Award (J.R.H.). We thank our patients with SCD, who contributed samples for this study.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; de Vasconcellos JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106924; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; GILMAN JG, 1988, NUCLEIC ACIDS RES, V16, P10635, DOI 10.1093/nar/16.22.10635; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; KIDOGUCHI K, 1978, BLOOD, V52, P1115; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Liberati C, 2001, J BIOL CHEM, V276, P41700, DOI 10.1074/jbc.M102987200; MANTOVANI R, 1989, NUCLEIC ACIDS RES, V17, P6681, DOI 10.1093/nar/17.16.6681; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033013	21	211	233	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					987	+		10.1038/nm.4170	http://dx.doi.org/10.1038/nm.4170			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27525524	Green Accepted			2022-12-27	WOS:000382542800008
J	Zhou, HJ; Qin, LF; Zhang, HF; Tang, WW; Ji, WD; He, Y; Liang, XL; Wang, ZR; Yuan, QY; Vortmeyer, A; Toomre, D; Fuh, G; Yan, MH; Kluger, MS; Wu, DQ; Min, W				Zhou, Huanjiao Jenny; Qin, Lingfeng; Zhang, Haifeng; Tang, Wenwen; Ji, Weidong; He, Yun; Liang, Xiaoling; Wang, Zongren; Yuan, Qianying; Vortmeyer, Alexander; Toomre, Derek; Fuh, Germaine; Yan, Minghong; Kluger, Martin S.; Wu, Dianqing; Min, Wang			Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation	NATURE MEDICINE			English	Article							CELL-CELL; VASCULAR DEVELOPMENT; 2-HIT MECHANISM; MOUSE MODEL; ANGIOGENESIS; MUTATIONS; DISEASE; TIE2; GENE; PROTEINS	Cerebral cavernous malformations (CCMs) are vascular malformations that affect the central nervous system and result in cerebral hemorrhage, seizure and stroke. CCMs arise from loss-of-function mutations in one of three genes: KRIT1 (also known as CCM1), CCM2 or PDCD10 (also known as CCM3). PDCD10 mutations in humans often result in a more severe form of the disease relative to mutations in the other two CCM genes, and PDCD10-knockout mice show severe defects, the mechanistic basis for which is unclear. We have recently reported that CCM3 regulates exocytosis mediated by the UNC13 family of exocytic regulatory proteins. Here, in investigating the role of endothelial cell exocytosis in CCM disease progression, we found that CCM3 suppresses UNC13B- and vesicle-associated membrane protein 3 (VAMP3)-dependent exocytosis of angiopoietin 2 (ANGPT2) in brain endothelial cells. CCM3 deficiency in endothelial cells augments the exocytosis and secretion of ANGPT2, which is associated with destabilized endothelial cell junctions, enlarged lumen formation and endothelial cell-pericyte dissociation. UNC13B deficiency, which blunts ANGPT2 secretion from endothelial cells, or treatment with an ANGPT2-neutralizing antibody normalizes the defects in the brain and retina caused by endothelial-cell-specific CCM3 deficiency, including the disruption of endothelial cell junctions, vessel dilation and pericyte dissociation. Thus, enhanced secretion of ANGPT2 in endothelial cells contributes to the progression of CCM disease, providing a new therapeutic approach for treating this devastating pathology.	[Zhou, Huanjiao Jenny; Qin, Lingfeng; Zhang, Haifeng; Tang, Wenwen; He, Yun; Yuan, Qianying; Vortmeyer, Alexander; Kluger, Martin S.; Wu, Dianqing; Min, Wang] Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA; [Zhou, Huanjiao Jenny; Ji, Weidong; Wang, Zongren; Min, Wang] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou, Guangdong, Peoples R China; [Tang, Wenwen; Yuan, Qianying; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Ji, Weidong; Min, Wang] Guangzhou Darron Medsci, Guangzhou, Guangdong, Peoples R China; [He, Yun] Sun Yat Sen Univ Med Sci, Sch Publ Hlth, Dept Toxicol, Guangzhou, Guangdong, Peoples R China; [Liang, Xiaoling] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Toomre, Derek] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Fuh, Germaine] Genentech Inc, Dept Antibody Engn, San Francisco, CA USA; [Yan, Minghong] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA; [Kluger, Martin S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Yale University; Sun Yat Sen University; Yale University; Sun Yat Sen University; Sun Yat Sen University; Yale University; Roche Holding; Genentech; Roche Holding; Genentech; Yale University	Wu, DQ; Min, W (corresponding author), Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA.; Min, W (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou, Guangdong, Peoples R China.; Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.; Min, W (corresponding author), Guangzhou Darron Medsci, Guangzhou, Guangdong, Peoples R China.	dan.wu@yale.edu; wang.min@yale.edu	Yuan, Qianying/AAC-2375-2019; yuan, qianying/E-9114-2018; ji, weidong/AAX-7397-2020	Qin, Lingfeng/0000-0002-5381-6826; WANG, ZONGREN/0000-0002-4925-7232	US National Institutes of Health (NIH) [R01 HL109420, HL115148, GM109487]; National Natural Science Foundation of China [91539110]; Scientific Grants of Guangdong [2015B020225002, 2015A050502018]; American Heart Association [13SDG17110045, 14SDG20490020]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109420, R01HL136507, R01HL115148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109487] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Grants of Guangdong; American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Unc13B-deficient mice were a gift from N. Brose (Max Planck Institute of Experimental Medicine, Germany). We thank J. Pober, R. Liu and T. Manes for reagents and discussion. This work was partly supported by US National Institutes of Health (NIH) grants R01 HL109420 (W.M.), HL115148 (W.M.), GM109487 (D.W.), National Natural Science Foundation of China (no. 91539110) (W.M.), Scientific Grants of Guangdong (no. 2015B020225002 and 2015A050502018) (W.M.), American Heart Association grant 13SDG17110045 (H.Z.) and 14SDG20490020 (W.T.).	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Chang WG, 2013, CARDIOVASC RES, V100, P492, DOI 10.1093/cvr/cvt215; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Li SQ, 2011, MOL VIS, V17, P3566; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marchi S, 2015, EMBO MOL MED, V7, P1403, DOI 10.15252/emmm.201505316; McDonald DA, 2011, HUM MOL GENET, V20, P211, DOI 10.1093/hmg/ddq433; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Pouwels J, 2012, J CELL SCI, V125, P3271, DOI 10.1242/jcs.093641; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; Shenkar R, 2015, GENET MED, V17, P188, DOI 10.1038/gim.2014.97; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Song YJ, 2013, DEV CELL, V25, P507, DOI 10.1016/j.devcel.2013.05.002; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanriover G, 2013, CLIN NEUROL NEUROSUR, V115, P438, DOI 10.1016/j.clineuro.2012.06.023; Thomson BR, 2014, J CLIN INVEST, V124, P4320, DOI 10.1172/JCI77162; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang Y, 2013, DEV CELL, V27, P215, DOI 10.1016/j.devcel.2013.09.021; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou HJ, 2014, ARTERIOSCL THROM VAS, V34, P603, DOI 10.1161/ATVBAHA.113.303053; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	60	72	73	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1033	+		10.1038/nm.4169	http://dx.doi.org/10.1038/nm.4169			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27548575	Green Accepted			2022-12-27	WOS:000382542800014
J	Rolland, M				Rolland, Morgane			HIV-1 immune evasion-a threat to effective vaccines?	NATURE MEDICINE			English	Editorial Material							ESCAPE; EVOLUTION; TRANSMISSION; VARIANTS; IMPACT	A new study of the impact of cytotoxic T lymphocyte (CTL) escape mutations suggests that holes in the host immune repertoire contribute to poor disease outcomes, owing to a gradual deterioration of the host anti-HIV-1 immune response. This should be accounted for in HIV-1 vaccine development strategies.	[Rolland, Morgane] WRAIR, US Mil HIV Res Program, Silver Spring, MD USA; [Rolland, Morgane] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Rolland, M (corresponding author), WRAIR, US Mil HIV Res Program, Silver Spring, MD USA.; Rolland, M (corresponding author), Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA.	mrolland@hivresearch.org						Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Carlson JM, 2016, NAT MED, V22, P606, DOI 10.1038/nm.4100; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2013, J VIROL, V87, P5461, DOI 10.1128/JVI.03033-12; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316	12	3	3	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					580	581		10.1038/nm.4119	http://dx.doi.org/10.1038/nm.4119			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270774	Bronze			2022-12-27	WOS:000377476000007
J	Weske, S; Vaidya, M; Reese, A; Lipinski, KV; Keul, P; Bayer, JK; Fischer, JW; Flogel, U; Nelsen, J; Epple, M; Scatena, M; Schwedhelm, E; Dorr, M; Volzke, H; Moritz, E; Hannemann, A; Rauch, BH; Graler, MH; Heusch, G; Levkau, B				Weske, Sarah; Vaidya, Mithila; Reese, Alina; Lipinski, Karin von Wnuck; Keul, Petra; Bayer, Julia K.; Fischer, Jens W.; Floegel, Ulrich; Nelsen, Jens; Epple, Matthias; Scatena, Marta; Schwedhelm, Edzard; Doerr, Marcus; Voelzke, Henry; Moritz, Eileen; Hannemann, Anke; Rauch, Bernhard H.; Graeler, Markus H.; Heusch, Gerd; Levkau, Bodo			Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss	NATURE MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; ACTIVATED RECEPTOR-GAMMA; OSTEOBLAST DIFFERENTIATION; SPHINGOSINE 1-PHOSPHATE; C/EBP-ALPHA; PPAR-GAMMA; GENE-EXPRESSION; ADIPOSE-TISSUE; MICE; ADIPOGENESIS	Sphingosine-1-phosphate (S1P) signaling influences bone metabolism, but its therapeutic potential in bone disorders has remained unexplored. We show that raising S1P levels in adult mice through conditionally deleting or pharmacologically inhibiting S1P lyase, the sole enzyme responsible for irreversibly degrading S1P, markedly increased bone formation, mass and strength and substantially decreased white adipose tissue. S1P signaling through S1P(2) potently stimulated osteoblastogenesis at the expense of adipogenesis by inversely regulating osterix and PPAR-gamma, and it simultaneously inhibited osteoclastogenesis by inducing osteoprotegerin through newly discovered p38-GSK3 beta-beta-catenin and WNT5A-LRP5 pathways. Accordingly, S1P(2)-deficient mice were osteopenic and obese. In ovariectomy-induced osteopenia, S1P lyase inhibition was as effective as intermittent parathyroid hormone (iPTH) treatment in increasing bone mass and was superior to iPTH in enhancing bone strength. Furthermore, lyase inhibition in mice successfully corrected severe genetic osteoporosis caused by osteoprotegerin deficiency. Human data from 4,091 participants of the SHIP-Trend population-based study revealed a positive association between serum levels of S1P and bone formation markers, but not resorption markers. Furthermore, serum S1P levels were positively associated with serum calcium, negatively with PTH, and curvilinearly with body mass index. Bone stiffness, as determined through quantitative ultrasound, was inversely related to levels of both S1P and the bone formation marker PINP, suggesting that S1P stimulates osteoanabolic activity to counteract decreasing bone quality. S1P-based drugs should be considered as a promising therapeutic avenue for the treatment of osteoporotic diseases.	[Weske, Sarah; Vaidya, Mithila; Reese, Alina; Lipinski, Karin von Wnuck; Keul, Petra; Heusch, Gerd; Levkau, Bodo] Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany; [Bayer, Julia K.; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany; [Floegel, Ulrich] Univ Dusseldorf, Inst Mol Cardiol, Dusseldorf, Germany; [Fischer, Jens W.; Floegel, Ulrich] Univ Duisburg Essen, Inst Inorgan Chem, Essen, Germany; [Scatena, Marta] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Schwedhelm, Edzard] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Schwedhelm, Edzard] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg, Hamburg, Germany; [Doerr, Marcus; Moritz, Eileen; Rauch, Bernhard H.] DZHK, Partner Site Greifswald, Greifswald, Germany; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Moritz, Eileen; Rauch, Bernhard H.] Univ Med Greifswald, Dept Gen Pharmacol, Inst Pharmacol, Greifswald, Germany; [Hannemann, Anke] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Graeler, Markus H.] Univ Hosp Jena, Ctr Sepsis Control & Care, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Graeler, Markus H.] Univ Hosp Jena, Ctr Mol Biomed, Jena, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Washington; University of Washington Seattle; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Levkau, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany.	bodo.levkau@uni-due.de	Dörr, Marcus/F-1919-2010; Gräler, Markus/ABH-1905-2021; Heusch, Gerd/ABE-6675-2020; Epple, Matthias/AAX-9694-2020; Rauch, Bernhard/Q-6205-2018	Dörr, Marcus/0000-0001-7471-475X; Gräler, Markus/0000-0001-6650-7849; Epple, Matthias/0000-0002-1641-7068; Rauch, Bernhard/0000-0002-6003-4662	Deutsche Forschungsgemeinschaft [GRK 2098, SFB 1116]; Alexander von Humboldt Foundation; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Deutsches Zentrum fur Herz-Kreislauf-Forschung e.V.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Deutsches Zentrum fur Herz-Kreislauf-Forschung e.V.	We gratefully acknowledge excellent technical help by Kerstin Abou Hamed, forthcoming support by the Zentrales Tierlabor, Universitatsklinikum Essen (G. Hilken, P. Dammann, A. Wissmann, R. Waldschutz) and stimulating discussions with A. Levkau. I dedicate this work to my father, Lubomir Levkau. This work was supported in part by the Deutsche Forschungsgemeinschaft, GRK 2098, projects 9-11 (B.L., P.K.), SFB 1116, projects A08 (J.W.F.) and B02, B05 (U.F.). The work was also supported by the Alexander von Humboldt Foundation through a research fellowship awarded to M.V. The SHIP-Trend study is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (Grants 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. This work was also funded in part by grants from the Deutsches Zentrum fur Herz-Kreislauf-Forschung e.V. (B.H.R., M.D., E.S.).	A Kumar, 2008, Indian J Community Med, V33, P156, DOI 10.4103/0970-0218.42051; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Bae SJ, 2016, OSTEOPOROSIS INT, V27, P2533, DOI 10.1007/s00198-016-3565-z; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Billich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059630; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyce BF, 2005, CELL METAB, V2, P344, DOI 10.1016/j.cmet.2005.11.011; Burghoff S, 2013, ARCH PHYSIOL BIOCHEM, V119, P39, DOI 10.3109/13813455.2012.755547; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Goetzl EJ, 2007, FASEB J, V21, P638, DOI 10.1096/fj.06-6624hyp; Gunther T, 2007, NAT CELL BIOL, V9, P1229, DOI 10.1038/ncb1107-1229; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Hashimoto Y, 2015, MOL CELL BIOCHEM, V401, P39, DOI 10.1007/s11010-014-2290-1; Ishii M, 2013, BBA-MOL CELL BIOL L, V1831, P223, DOI 10.1016/j.bbalip.2012.06.002; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii T, 2011, MOL CELLS, V31, P399, DOI 10.1007/s10059-011-1010-x; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee SH, 2012, J CLIN ENDOCR METAB, V97, pE1421, DOI 10.1210/jc.2012-1044; Liang C, 2015, NAT MED, V21, P288, DOI 10.1038/nm.3791; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; McClung MR, 2017, BONE, V96, P3, DOI 10.1016/j.bone.2016.12.012; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moritz E, 2017, CLIN CHIM ACTA, V468, P25, DOI 10.1016/j.cca.2017.01.029; Parham KA, 2015, FASEB J, V29, P3638, DOI 10.1096/fj.14-261289; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Peptan IA, 2006, PLAST RECONSTR SURG, V117, P1462, DOI 10.1097/01.prs.0000206319.80719.74; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Schurer C, 2015, DTSCH ARZTEBL INT, V112, P365, DOI 10.3238/arztebl.2015.0365; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Stone CJ, 1985, P STAT COMP SECT AM, P45; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takahashi T, 2011, CALCIFIED TISSUE INT, V88, P336, DOI 10.1007/s00223-011-9461-9; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tucci S, 2011, AM J CLIN NUTR, V94, P439, DOI 10.3945/ajcn.111.012948; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Wu L, 2007, MOL CELL BIOCHEM, V301, P83, DOI 10.1007/s11010-006-9399-9; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Yu WH, 2012, INT J BIOCHEM CELL B, V44, P377, DOI 10.1016/j.biocel.2011.11.013; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813; Zoico E, 2016, ONCOTARGET, V7, P20223, DOI 10.18632/oncotarget.7936	73	67	71	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					667	+		10.1038/s41591-018-0005-y	http://dx.doi.org/10.1038/s41591-018-0005-y			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29662200				2022-12-27	WOS:000432126800024
J	Guo, NN; Soden, ME; Herber, C; Kim, MT; Besnard, A; Lin, PY; Ma, X; Cepko, CL; Zweifel, LS; Sahay, A				Guo, Nannan; Soden, Marta E.; Herber, Charlotte; Kim, Michael TaeWoo; Besnard, Antoine; Lin, Paoyan; Ma, Xiang; Cepko, Constance L.; Zweifel, Larry S.; Sahay, Amar			Dentate granule cell recruitment of feedforward inhibition governs engram maintenance and remote memory generalization	NATURE MEDICINE			English	Article							CONTEXTUAL FEAR MEMORY; SYNAPTIC PLASTICITY; EPISODIC MEMORY; BETA-ADDUCIN; CA3 OUTPUT; ACTIN; CONSOLIDATION; HIPPOCAMPUS; DYNAMICS; EXCITATION	Memories become less precise and generalized over time as memory traces reorganize in hippocampal-cortical networks. Increased time-dependent loss of memory precision is characterized by an overgeneralization of fear in individuals with post-traumatic stress disorder (PTSD) or age-related cognitive impairments. In the hippocampal dentate gyrus (DG), memories are thought to be encoded by so-called 'engram-bearing' dentate granule cells (eDGCs). Here we show, using rodents, that contextual fear conditioning increases connectivity between eDGCs and inhibitory interneurons (INs) in the downstream hippocampal CA3 region. We identify actin-binding LIM protein 3 (ABLIM3) as a mossy-fiber-terminal-localized cytoskeletal factor whose levels decrease after learning. Downregulation of ABLIM3 expression in DGCs was sufficient to increase connectivity with CA3 stratum lucidum INs (SLINs), promote parvalbumin (PV)-expressing SLIN activation, enhance feedforward inhibition onto CA3 and maintain a fear memory engram in the DG over time. Furthermore, downregulation of ABLIM3 expression in DGCs conferred conditioned context-specific reactivation of memory traces in hippocampal-cortical and amygdalar networks and decreased fear memory generalization at remote (i.e., distal) time points. Consistent with the observation of age-related hyperactivity of CA3, learning failed to increase DGC-SLIN connectivity in 17-month-old mice, whereas downregulation of ABLIM3 expression was sufficient to restore DGC-SLIN connectivity, increase PV+ SLIN activation and improve the precision of remote memories. These studies exemplify a connectivity-based strategy that targets a molecular brake of feedforward inhibition in DG-CA3 and may be harnessed to decrease time-dependent memory generalization in individuals with PTSD and improve memory precision in aging individuals.	[Guo, Nannan; Herber, Charlotte; Kim, Michael TaeWoo; Besnard, Antoine; Lin, Paoyan; Sahay, Amar] Massachusetts Gen Hosp MGH, Ctr Regenerat Med, Boston, MA 02114 USA; [Guo, Nannan; Herber, Charlotte; Kim, Michael TaeWoo; Besnard, Antoine; Lin, Paoyan; Sahay, Amar] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Guo, Nannan; Kim, Michael TaeWoo; Besnard, Antoine; Lin, Paoyan; Sahay, Amar] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ma, Xiang; Cepko, Constance L.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ma, Xiang; Cepko, Constance L.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Sahay, Amar] BROAD Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sahay, A (corresponding author), Massachusetts Gen Hosp MGH, Ctr Regenerat Med, Boston, MA 02114 USA.; Sahay, A (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Sahay, A (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA.; Sahay, A (corresponding author), BROAD Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA.	asahay@mgh.harvard.edu	Core, Vector/CAF-4832-2022; Sahay, Amar/J-3696-2014; Besnard, Antoine/H-4270-2019	Besnard, Antoine/0000-0002-0929-8873; Herber, Charlotte/0000-0002-6038-6799; Soden, Marta/0000-0002-0695-8653	US National Institutes of Health (NIH) [R01MH104450]; NIH Biobehavioral Research Awards for Innovative New Scientists (BRAINS) [R01MH104175]; NIH-National Institute on Aging (NIA) [R01AG048908]; NIH [1R01MH111729]; Ellison Medical Foundation New Scholar in Aging; Whitehall Foundation; Inscopix Decode award; NARSAD Independent Investigator Award; Ellison Family Philanthropic support; Blue Guitar Fund; Harvard Neurodiscovery Center-MADRC Center Pilot Grant award; Harvard Stem Cell Institute Development grant; HSCI seed grant; HSCI Harvard Internship Program Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111729, R01MH104175, R01MH104450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG048908] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Biobehavioral Research Awards for Innovative New Scientists (BRAINS); NIH-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation New Scholar in Aging(Lawrence Ellison Foundation); Whitehall Foundation; Inscopix Decode award; NARSAD Independent Investigator Award(NARSAD); Ellison Family Philanthropic support; Blue Guitar Fund; Harvard Neurodiscovery Center-MADRC Center Pilot Grant award; Harvard Stem Cell Institute Development grant; HSCI seed grant; HSCI Harvard Internship Program Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We wish to thank members of the Sahay lab for comments on the manuscript and the late N.J. Sahay for advice. We are thankful to S. Tonegawa (MIT) for the AAV9-tetO-ChR2 construct, M.E. Greenberg (Harvard Medical School) for the lentiviral pLLX vector, J. Rajagopal (MGH) for the HEK293T cells and S. Ramirez (Boston University) for the AAV9-tetO-ChR2-mCherry virus. L.Z. is supported by US National Institutes of Health (NIH) grant R01MH104450. C.C. is an investigator of the Howard Hughes Medical Institute. A.S. acknowledges support from the NIH Biobehavioral Research Awards for Innovative New Scientists (BRAINS; grant R01MH104175), the NIH-National Institute on Aging (NIA) grant R01AG048908, NIH grant 1R01MH111729, the Ellison Medical Foundation New Scholar in Aging, the Whitehall Foundation, an Inscopix Decode award, a NARSAD Independent Investigator Award, Ellison Family Philanthropic support, the Blue Guitar Fund, a Harvard Neurodiscovery Center-MADRC Center Pilot Grant award, and a Harvard Stem Cell Institute Development grant and HSCI seed grant. C.H. was supported by a 2016 HSCI Harvard Internship Program Award.	Acsady L, 1998, J NEUROSCI, V18, P3386; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; Bartos M, 2011, NEUROPHARMACOLOGY, V60, P730, DOI 10.1016/j.neuropharm.2010.12.017; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Besnard A, 2016, NEUROPSYCHOPHARMACOL, V41, P24, DOI 10.1038/npp.2015.167; Biedenkapp JC, 2007, LEARN MEMORY, V14, P200, DOI 10.1101/lm.499407; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Caliskan G, 2016, CEREB CORTEX, V26, P2325, DOI 10.1093/cercor/bhw001; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gan J, 2017, NEURON, V93, P308, DOI 10.1016/j.neuron.2016.12.018; GEINISMAN Y, 1992, HIPPOCAMPUS, V2, P437, DOI 10.1002/hipo.450020411; Girardeau G, 2017, NAT NEUROSCI, V20, P1634, DOI 10.1038/nn.4637; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jasnow AM, 2017, J NEUROSCI RES, V95, P821, DOI 10.1002/jnr.23837; Jones GL, 2015, ELIFE, V4, DOI 10.7554/eLife.08969; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; Leal SL, 2015, TRENDS NEUROSCI, V38, P800, DOI 10.1016/j.tins.2015.10.003; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Liu X, 2014, COLD SH Q B, V79, P59, DOI 10.1101/sqb.2014.79.024901; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Lynch JF, 2017, NEUROPSYCHOPHARMACOL, V42, P914, DOI 10.1038/npp.2016.255; Martin EA, 2015, ELIFE, V4, DOI 10.7554/eLife.09395; Matsuda M, 2010, EUR J CELL BIOL, V89, P807, DOI 10.1016/j.ejcb.2010.07.009; McAvoy KM, 2016, NEURON, V91, P1356, DOI 10.1016/j.neuron.2016.08.009; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Ognjanovski N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15039; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Poulos AM, 2016, LEARN MEMORY, V23, P379, DOI 10.1101/lm.041400.115; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Simkin D, 2015, J NEUROSCI, V35, P13206, DOI 10.1523/JNEUROSCI.0193-15.2015; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Thome A, 2016, MOL PSYCHIATR, V21, P1257, DOI 10.1038/mp.2015.160; Torborg CL, 2010, J NEUROSCI, V30, P15628, DOI 10.1523/JNEUROSCI.3099-10.2010; Vazdarjanova A, 1999, J NEUROSCI, V19, P6615; Villanueva-Castillo C, 2017, NEUROBIOL AGING, V49, P119, DOI 10.1016/j.neurobiolaging.2016.09.010; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	65	69	71	6	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					438	+		10.1038/nm.4491	http://dx.doi.org/10.1038/nm.4491			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29529016	Green Accepted			2022-12-27	WOS:000429639800015
J	Bartelt, A; Widenmaier, SB; Schlein, C; Johann, K; Goncalves, RLS; Eguchi, K; Fischer, AW; Parlakgul, G; Snyder, NA; Nguyen, TB; Bruns, OT; Franke, D; Bawendi, MG; Lynes, MD; Leiria, LO; Tseng, YH; Inouye, KE; Arruda, AP; Hotamisligil, GS				Bartelt, Alexander; Widenmaier, Scott B.; Schlein, Christian; Johann, Kornelia; Goncalves, Renata L. S.; Eguchi, Kosei; Fischer, Alexander W.; Parlakgul, Gunes; Snyder, Nicole A.; Nguyen, Truc B.; Bruns, Oliver T.; Franke, Daniel; Bawendi, Moungi G.; Lynes, Matthew D.; Leiria, Luiz O.; Tseng, Yu-Hua; Inouye, Karen E.; Arruda, Ana Paula; Hotamisligil, Gokhan S.			Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; DIET-INDUCED THERMOGENESIS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; LINKS OBESITY; ADULT HUMANS; FAT; DEGRADATION	Adipocytes possess remarkable adaptive capacity to respond to nutrient excess, fasting or cold exposure, and they are thus an important cell type for the maintenance of proper metabolic health. Although the endoplasmic reticulum (ER) is a critical organelle for cellular homeostasis, the mechanisms that mediate adaptation of the ER to metabolic challenges in adipocytes are unclear. Here we show that brown adipose tissue (BAT) thermogenic function requires an adaptive increase in proteasomal activity to secure cellular protein quality control, and we identify the ER-localized transcription factor nuclear factor erythroid 2-like 1 (Nfe2l1, also known as Nrf1) as a critical driver of this process. We show that cold adaptation induces Nrf1 in BAT to increase proteasomal activity and that this is crucial for maintaining ER homeostasis and cellular integrity, specifically when the cells are in a state of high thermogenic activity. In mice, under thermogenic conditions, brown-adipocyte-specific deletion of Nfe2l1 (Nrf1) resulted in ER stress, tissue inflammation, markedly diminished mitochondrial function and whitening of the BAT. In mouse models of both genetic and dietary obesity, stimulation of proteasomal activity by exogenously expressing Nrf1 or by treatment with the proteasome activator PA28 alpha in BAT resulted in improved insulin sensitivity. In conclusion, Nrf1 emerges as a novel guardian of brown adipocyte function, providing increased proteometabolic quality control for adapting to cold or to obesity.	[Bartelt, Alexander; Widenmaier, Scott B.; Schlein, Christian; Johann, Kornelia; Goncalves, Renata L. S.; Eguchi, Kosei; Fischer, Alexander W.; Parlakgul, Gunes; Snyder, Nicole A.; Nguyen, Truc B.; Inouye, Karen E.; Arruda, Ana Paula; Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Bartelt, Alexander; Widenmaier, Scott B.; Schlein, Christian; Johann, Kornelia; Goncalves, Renata L. S.; Eguchi, Kosei; Fischer, Alexander W.; Parlakgul, Gunes; Snyder, Nicole A.; Nguyen, Truc B.; Inouye, Karen E.; Arruda, Ana Paula; Hotamisligil, Gokhan S.] Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA USA; [Bruns, Oliver T.; Franke, Daniel; Bawendi, Moungi G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Lynes, Matthew D.; Leiria, Luiz O.; Tseng, Yu-Hua] Harvard Med Sch, Joslin Diabet Ctr, Res Div, Sect Integrat Physiol & Metab, Boston, MA USA; [Hotamisligil, Gokhan S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Bruns, Oliver T.] Helmholtz Zentrum Munchen, Helmholtz Pioneer Campus, Neuherberg, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hotamisligil, GS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA.; Hotamisligil, GS (corresponding author), Harvard TH Chan Sch Publ Hlth, Sabri Ulker Ctr, Boston, MA USA.; Hotamisligil, GS (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	ghotamis@hsph.harvard.edu	Bartelt, Alexander/ABC-2525-2020; Tseng, Yu-Hua/AAE-6471-2021; Bruns, Oliver T/D-6735-2015; Arruda, Ana Paula/AAA-6008-2022	Tseng, Yu-Hua/0000-0003-2053-9559; Bruns, Oliver T/0000-0002-5738-0126; Arruda, Ana Paula/0000-0001-6179-2687; Lynes, Matthew/0000-0003-0746-0854; Fischer, Alexander/0000-0001-6717-9090; Widenmaier, Scott/0000-0001-5684-2707; Parlakgul, Gunes/0000-0001-9365-7287; Johann, Kornelia/0000-0002-5089-7237; /0000-0001-6990-4372	Deutsche Forschungsgemeinschaft Research Fellowship [BA 4925/1-1]; Canadian Institutes of Health Research fellowship; University Medical Center Hamburg-Eppendorf MD/PhD program fellowship; Barth Syndrome Foundation; US National Institutes of Health (NIH) through the Laser Biomedical Research Center [P41-EB015871, 5-U54-CA151884]; National Science Foundation [ECCS-1449291]; Massachusetts Institute of Technology through the Institute for Soldier Nanotechnologies [W911NF13-D-0001]; Boehringer Ingelheim Fonds; European Molecular Biology Organization Long-term Fellowship; NIH [R01DK077097, R01DK102898, P30DK036836, T32DK007260, F32DK102320, K01DK111714]; Pew Foundation; Harvard University; Servier; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, P41EB015871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077097, F32DK102320, P30DK036836, T32DK007260, R01DK102898, K01DK111714] Funding Source: NIH RePORTER; Directorate For Engineering [1449291] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft Research Fellowship(German Research Foundation (DFG)); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); University Medical Center Hamburg-Eppendorf MD/PhD program fellowship; Barth Syndrome Foundation; US National Institutes of Health (NIH) through the Laser Biomedical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Massachusetts Institute of Technology through the Institute for Soldier Nanotechnologies; Boehringer Ingelheim Fonds(Boehringer Ingelheim); European Molecular Biology Organization Long-term Fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; Harvard University; Servier(Servier); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We are grateful to K. Claiborn for her expert editorial input, M. McGrath for his support of the project, M. Yilmaz, Y. Lee and V. Byles for assistance with experiments, K. Seedorf, P. Delerive and Servier for their continuous support of the project, R. Bronson and the Harvard Medical School Rodent Histopathology Core, M. Ericson and the Harvard Medical School Electron Microscopy Facility, N. Lupoli and the Harvard T.H. Chan School of Public Health Trace Metals Laboratory, and R. Kunz and the Thermo Fisher Scientific Center for Multiplexed Proteomics at Harvard Medical School and the Harvard T. H. Chan School of Public Health Animal Facility team for their support of the project. We acknowledge the prosperous scientific environment in the Hotamisligil lab and thank all lab members for their critical input and discussions. We are grateful to X. Wang (University of South Dakota) for generously sharing the PA28 alpha-expressing adenovirus, E. Rosen (Beth Israel Deaconess Medical Center) for providing us with the Ucp1-Cre and the Adipoq-Cre mouse models and T. Iwawaki (Gunma University) for the conditional Ern1-deletion mouse model. A.B. was supported by a Deutsche Forschungsgemeinschaft Research Fellowship (BA 4925/1-1). S.B.W. was supported by a Canadian Institutes of Health Research fellowship. C.S. was supported by a University Medical Center Hamburg-Eppendorf MD/PhD program fellowship. R.L.S.G. was supported by the Barth Syndrome Foundation. This work has received support in part from the US National Institutes of Health (NIH) through the Laser Biomedical Research Center grants P41-EB015871 (M.G.B.) and 5-U54-CA151884 (M.G.B.), by the National Science Foundation grant ECCS-1449291 (D.F. and M.G.B.) and by the Massachusetts Institute of Technology through the Institute for Soldier Nanotechnologies grant W911NF13-D-0001 (M.G.B.). D.F. was supported by a fellowship of the Boehringer Ingelheim Fonds. O.T.B. was supported by a European Molecular Biology Organization Long-term Fellowship. Y.-H.T. and L.O.L. were supported in part by NIH grants R01DK077097, R01DK102898 and P30DK036836. M.D.L. was supported by NIH grants T32DK007260, F32DK102320 and K01DK111714. A.P.A. was supported by the Pew Foundation. We apologize to colleagues whose work we could not cite due to space limitations. The study was supported by an industry-sponsored research agreement between Harvard University and Servier.	Adams J, 1999, CANCER RES, V59, P2615; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Bartelt A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15010; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bruns OT, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0056; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cannon Barbara, 2008, V456, P109, DOI 10.1007/978-1-59745-245-8_8; Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fu SN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9134; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gregor MF, 2013, CELL REP, V3, P1430, DOI 10.1016/j.celrep.2013.03.042; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119955; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tsujita T, 2015, GENES CELLS, V20, P563, DOI 10.1111/gtc.12248; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Widenmaier SB, 2017, CELL, V171, P1094, DOI 10.1016/j.cell.2017.10.003; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Zhang YG, 2016, BIOCHEM J, V473, P961, DOI 10.1042/BJ20151182; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	69	102	105	4	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					292	+		10.1038/nm.4481	http://dx.doi.org/10.1038/nm.4481			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29400713	Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000426700900012
J	Whitson, RJ; Lee, A; Urman, NM; Mirza, A; Yao, CY; Brown, AS; Li, JR; Shankar, G; Fry, MA; Atwood, SX; Lee, EY; Hollmig, ST; Aasi, SZ; Sarin, KY; Scott, MP; Epstein, EH; Tang, JY; Oro, AE				Whitson, Ramon J.; Lee, Alex; Urman, Nicole M.; Mirza, Amar; Yao, Catherine Y.; Brown, Alexander S.; Li, Jiang R.; Shankar, Gautam; Fry, Micah A.; Atwood, Scott X.; Lee, Eunice Y.; Hollmig, S. Tyler; Aasi, Sumaira Z.; Sarin, Kavita Y.; Scott, Matthew P.; Epstein, Ervin H., Jr.; Tang, Jean Y.; Oro, Anthony E.			Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas	NATURE MEDICINE			English	Article							TUMOR MICROENVIRONMENT; GENE-TRANSCRIPTION; GENOMIC ANALYSIS; ACTIN DYNAMICS; SRF; MYOCARDIN; SERUM; INHIBITORS; VISMODEGIB; GROWTH	Hedgehog pathway-dependent cancers can escape Smoothened (SMO) inhibition through mutations in genes encoding canonical hedgehog pathway components; however, around 50% of drug-resistant basal cell carcinomas (BCCs) lack additional variants of these genes. Here we use multidimensional genomics analysis of human and mouse drug-resistant BCCs to identify a noncanonical hedgehog activation pathway driven by the transcription factor serum response factor (SRF). Active SRF along with its coactivator megakaryoblastic leukemia 1 (MKL1) binds DNA near hedgehog target genes and forms a previously unknown protein complex with the hedgehog transcription factor glioma-associated oncogene family zinc finger-1 (GLI1), causing amplification of GLI1 transcriptional activity. We show that cytoskeletal activation through Rho and the formin family member Diaphanous (mDia) is required for SRF-MKL-driven GLI1 activation and for tumor cell viability. Remarkably, nuclear MKL1 staining served as a biomarker in tumors from mice and human subjects to predict tumor responsiveness to MKL inhibitors, highlighting the therapeutic potential of targeting this pathway. Thus, our study illuminates, for the first time, cytoskeletal-activation-driven transcription as a personalized therapeutic target for combatting drug-resistant malignancies.	[Whitson, Ramon J.; Mirza, Amar; Yao, Catherine Y.; Brown, Alexander S.; Li, Jiang R.; Shankar, Gautam; Atwood, Scott X.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA USA; [Whitson, Ramon J.; Urman, Nicole M.; Mirza, Amar; Yao, Catherine Y.; Brown, Alexander S.; Li, Jiang R.; Shankar, Gautam; Atwood, Scott X.; Lee, Eunice Y.; Hollmig, S. Tyler; Aasi, Sumaira Z.; Sarin, Kavita Y.; Scott, Matthew P.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA USA; [Lee, Alex; Fry, Micah A.; Epstein, Ervin H., Jr.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Atwood, Scott X.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	Stanford University; Stanford University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Irvine	Oro, AE (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA USA.; Oro, AE (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA USA.	oro@stanford.edu		Sarin, Kavita/0000-0001-5363-3053; Tang, Jean/0000-0002-5510-6502; Atwood, Scott/0000-0001-7407-9792; Oro, Anthony/0000-0002-6261-138X	V Foundation Translational Award; National Cancer Institute [R01CA157895]; National Institute of Arthritis and Musculoskeletal Disease [R01AR04786, 5ARO54780]; Stanford Epithelial Biology Training Grant [T32-AR007422]; National Institutes of Health (NIH) Pathway [4R00CA17684703]; Damon Runyon clinical investigatory award; National Center for Research Resources [1S10OD010580]; NIH S10 Shared Instrumentation Grant [S10OD018220]; NATIONAL CANCER INSTITUTE [F30CA217017, R00CA176847, R01CA157895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007422, R01AR046786, R01AR054780] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018220, S10OD010580] Funding Source: NIH RePORTER	V Foundation Translational Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Stanford Epithelial Biology Training Grant; National Institutes of Health (NIH) Pathway(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon clinical investigatory award; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH S10 Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to thank all members of the laboratory of A.E.O. and the Stanford Dermatology Department for suggestions and guidance. Specifically, the authors would like to thank S.P. Melo for guidance and assistance with ChIP-seq analyses. This work was funded by the V Foundation Translational Award, National Cancer Institute (R01CA157895), the National Institute of Arthritis and Musculoskeletal Disease (R01AR04786 and 5ARO54780), the Stanford Epithelial Biology Training Grant award to R.J.W. (T32- AR007422), National Institutes of Health (NIH) Pathway to Independence Award to S.X.A. (4R00CA17684703), and a Damon Runyon clinical investigatory award (J.Y.T.). The Stanford Cell Sciences Imaging Facility provided instrumentation and technical assistance for microscopy using a Leica SP8 confocal microscope funded by a National Center for Research Resources grant (1S10OD010580). The Stanford functional Genomics Facility provided sequencing services for ASZ RNA-seq and SRF ChIP seq using the Illumina HiSeq 4000 platform purchased using an NIH S10 Shared Instrumentation Grant (S10OD018220).	Ally MS, 2016, JAMA DERMATOL, V152, P452, DOI 10.1001/jamadermatol.2015.5473; Amaral L, 2012, ANTICANCER RES, V32, P2947; Atwood SX, 2015, J INVEST DERMATOL, V135, P2138, DOI 10.1038/jid.2015.115; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Atwood SX, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013581; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Basset-Seguin N, 2015, MOL CANCER THER, V14, P633, DOI 10.1158/1535-7163.MCT-14-0703; Blaker AL, 2009, ARTERIOSCL THROM VAS, V29, P2153, DOI 10.1161/ATVBAHA.109.197285; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Haak AJ, 2014, J PHARMACOL EXP THER, V349, P480, DOI 10.1124/jpet.114.213520; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mokady D, 2015, DRUG RESIST UPDATE, V19, P22, DOI 10.1016/j.drup.2015.01.001; Morita K, 2006, J DERMATOL SCI, V44, P11, DOI 10.1016/j.jdermsci.2006.06.001; Noubissi FK, 2014, J INVEST DERMATOL, V134, P1718, DOI 10.1038/jid.2014.17; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Ransohoff KJ, 2015, NEW ENGL J MED, V373, P1079, DOI 10.1056/NEJMc1504261; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Schneider P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9023; Sekulic A, 2015, J AM ACAD DERMATOL, V72, P1021, DOI 10.1016/j.jaad.2015.03.021; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Sisson TH, 2015, AM J PATHOL, V185, P969, DOI 10.1016/j.ajpath.2014.12.005; Sullivan AL, 2011, MOL CELL BIOL, V31, P861, DOI 10.1128/MCB.00836-10; Thomas-Schoemann A, 2014, CRIT REV ONCOL HEMAT, V89, P179, DOI 10.1016/j.critrevonc.2013.08.007; Vasudevan HN, 2014, DEV CELL, V31, P332, DOI 10.1016/j.devcel.2014.10.005; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Wang GY, 2011, J INVEST DERMATOL, V131, P2298, DOI 10.1038/jid.2011.204; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Webster DE, 2014, GENOME RES, V24, P751, DOI 10.1101/gr.166231.113; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099	52	54	55	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					271	+		10.1038/nm.4476	http://dx.doi.org/10.1038/nm.4476			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29400712	Green Submitted, Green Accepted			2022-12-27	WOS:000426700900009
J	Huot, N; Jacquelin, B; Garcia-Tellez, T; Rascle, P; Ploquin, MJ; Madec, Y; Reeves, RK; Derreudre-Bosquet, N; Muller-Trutwin, M				Huot, Nicolas; Jacquelin, Beatrice; Garcia-Tellez, Thalia; Rascle, Philippe; Ploquin, Mickael J.; Madec, Yoann; Reeves, R. Keith; Derreudre-Bosquet, Nathalie; Muller-Trutwin, Michaela			Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; FOLLICULAR HELPER-CELLS; NK CELLS; VIRAL LOAD; TRANS-PRESENTATION; SIVAGM INFECTION; GERMINAL-CENTERS; HIV-1 INFECTION; RHESUS MACAQUES; RESPONSES	Natural killer (NK) cells play an essential role in antiviral immunity, but knowledge of their function in secondary lymphoid organs is incomplete. Lymph node follicles constitute a major viral reservoir during infections with HIV-1 and simian immunodeficiency virus of macaques (SIVmac). In contrast, during nonpathogenic infection with SIV from African green monkeys (SIVagm), follicles remain generally virus free. We show that NK cells in secondary lymphoid organs from chronically SIVagm-infected African green monkeys (AGMs) were frequently CXCR5(+) and entered and persisted in lymph node follicles throughout the follow-up (240 d post-infection). These follicles were strongly positive for IL-15, which was primarily presented in its membrane-bound form by follicular dendritic cells. NK cell depletion through treatment with anti-IL-15 monoclonal antibody during chronic SIVagm infection resulted in high viral replication rates in follicles and the T cell zone and increased viral DNA in lymph nodes. Our data suggest that, in nonpathogenic SIV infection, NK cells migrate into follicles and play a major role in viral reservoir control in lymph nodes.	[Huot, Nicolas; Jacquelin, Beatrice; Garcia-Tellez, Thalia; Rascle, Philippe; Ploquin, Mickael J.; Muller-Trutwin, Michaela] Inst Pasteur, Unit HIV Inflammat & Persistence, Paris, France; [Huot, Nicolas; Rascle, Philippe; Muller-Trutwin, Michaela] Vaccine Res Inst, Creteil, France; [Rascle, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Madec, Yoann] Inst Pasteur, Epidemiol Unit, Paris, France; [Reeves, R. Keith] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Derreudre-Bosquet, Nathalie] Univ Paris Sud 11, Commissariat Energie Atom & Energies Alternat CEA, INSERM U1184,Infect Dis Models & Innovat Therapie, Immunol Viral Infect & Autoimmune Dis IMVA, Fontenay Aux Roses, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Muller-Trutwin, M (corresponding author), Inst Pasteur, Unit HIV Inflammat & Persistence, Paris, France.; Muller-Trutwin, M (corresponding author), Vaccine Res Inst, Creteil, France.	mmuller@pasteur.fr	Rascle, Philippe/AAD-5863-2022	JACQUELIN, Beatrice/0000-0002-1896-5092; Rascle, Philippe/0000-0001-8860-3938; Muller-Trutwin, Michaela/0000-0002-3854-2396	Investissements d'Avenir program [ANR-10-LABX-77]; French government's Investissements d'Avenir program for infrastructures (PIA) [ANR-11-INBS-0008]; PIA grant [ANR-10-EQPX-02-01]; National Institutes of Health (NIH) grant [RO1 DE026014]; French Vaccine Research Institute (Creteil, France) [AI126683, OD010976]; Sidaction; University Paris Diderot; Sorbonne Paris Cite (BIOSPC); Pasteur-Paris University PhD program; Institut Carnot Pasteur Microbes et Sante; ANRS; L'Oreal Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	Investissements d'Avenir program(French National Research Agency (ANR)); French government's Investissements d'Avenir program for infrastructures (PIA)(French National Research Agency (ANR)); PIA grant; National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Vaccine Research Institute (Creteil, France); Sidaction; University Paris Diderot; Sorbonne Paris Cite (BIOSPC); Pasteur-Paris University PhD program; Institut Carnot Pasteur Microbes et Sante; ANRS(ANRSFrench National Research Agency (ANR)); L'Oreal Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Investissements d'Avenir program managed by the National Agency of Research (ANR) under reference ANR-10-LABX-77, the ANRS and the L'Oreal Foundation. The Infectious Disease Models and Innovative Therapies (IDMIT) center in Fontenay-aux-Roses, France, was funded by the French government's Investissements d'Avenir program for infrastructures (PIA) under grant ANR-11-INBS-0008, the PIA grant ANR-10-EQPX-02-01 funding the FlowCyTech facility at IDMIT. R.K.R. was supported by National Institutes of Health (NIH) grant RO1 DE026014. The anti-IL-15 monoclonal antibody was a gift from the NIH Nonhuman Primate Reagent Resource, supported by AI126683 and OD010976. N.H. and M.J.P. were recipients of postdoctoral fellowships from the French Vaccine Research Institute (Creteil, France) and Sidaction, respectively. P.R. and T.G.-T. received a PhD fellowship from the University Paris Diderot, Sorbonne Paris Cite (BIOSPC), and the Pasteur-Paris University PhD program supported by the Institut Carnot Pasteur Microbes et Sante, respectively. We are grateful to the veterinarians and the staff of the IDMIT animal facility, in particular V. Contreras, B. Delache, J.-M. Helies, V. Monnet, J. Morin and C. Joubert, for their excellent work. We thank L. Irbah, T. Kortulewski and C. Chapon for access to the stellar IDMIT imaging core facility as well as C. Cassan, S. Guenounou and A. Cosma for access to the state-of-the-art IDMIT FlowCyTech core facility.	ABRUZZO LV, 1983, SCIENCE, V222, P581, DOI 10.1126/science.6685343; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Barao I, 2003, J IMMUNOL, V171, P683, DOI 10.4049/jimmunol.171.2.683; Beer B, 1996, VIROLOGY, V219, P367, DOI 10.1006/viro.1996.0262; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Blanca IR, 2001, J IMMUNOL, V167, P6132, DOI 10.4049/jimmunol.167.11.6132; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Carrega P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00347; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; CHAKRABARTI L, 1994, AM J PATHOL, V144, P1226; Chowdhury A, 2015, J IMMUNOL, V195, P3237, DOI 10.4049/jimmunol.1402701; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Cumont MC, 2008, J VIROL, V82, P1175, DOI 10.1128/JVI.00450-07; DeGottardi MQ, 2016, J IMMUNOL, V197, P1183, DOI 10.4049/jimmunol.1600065; Diop OM, 2000, J VIROL, V74, P7538, DOI 10.1128/JVI.74.16.7538-7547.2000; Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070; FOX CH, 1991, J INFECT DIS, V164, P1051, DOI 10.1093/infdis/164.6.1051; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Garrod KR, 2007, P NATL ACAD SCI USA, V104, P12081, DOI 10.1073/pnas.0702867104; Gaufin T, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-42; Goldstein S, 2000, J VIROL, V74, P11744, DOI 10.1128/JVI.74.24.11744-11753.2000; Gueye A, 2004, J MED PRIMATOL, V33, P83, DOI 10.1111/j.1600-0684.2004.00057.x; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Huot N, 2016, CURR OPIN VIROL, V19, P37, DOI 10.1016/j.coviro.2016.06.011; Jacquelin B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004241; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Lederman MM, 2008, SEMIN IMMUNOL, V20, P187, DOI 10.1016/j.smim.2008.06.001; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li JY, 2015, VACCINE, V33, P1188, DOI 10.1016/j.vaccine.2014.12.046; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Luteijn R, 2011, EUR J IMMUNOL, V41, P2729, DOI 10.1002/eji.201040886; Martinot AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057785; Miles B, 2016, TRENDS MICROBIOL, V24, P338, DOI 10.1016/j.tim.2016.02.006; Moreno-Nieves UY, 2014, EUR J IMMUNOL, V44, P2370, DOI 10.1002/eji.201344149; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Muller MC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1170, DOI 10.2741/1130; Onabajo OO, 2013, CURR HIV RES, V11, P595, DOI 10.2174/1570162X12666140225153552; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Park CS, 2004, J IMMUNOL, V173, P6676, DOI 10.4049/jimmunol.173.11.6676; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; RACZ P, 1989, APMIS, V97, P16; Reina JML, 2009, J VIROL, V83, P2770, DOI 10.1128/JVI.01841-08; Rydyznski C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7375; Saez-Cirion A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0436; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Schafer JL, 2015, J VIROL, V89, P6887, DOI 10.1128/JVI.00660-15; Schmitz JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000691; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Tamzalit F, 2014, P NATL ACAD SCI USA, V111, P8565, DOI 10.1073/pnas.1405514111; TennerRacz K, 1995, CURR TOP MICROBIOL, V201, P141; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Xu HB, 2016, J VIROL, V90, P1578, DOI 10.1128/JVI.02471-15; Younes SA, 2016, J CLIN INVEST, V126, P2745, DOI 10.1172/JCI85996; YUAN D, 1994, FASEB J, V8, P1012, DOI 10.1096/fasebj.8.13.7926365; Zahn RC, 2008, J VIROL, V82, P11577, DOI 10.1128/JVI.01779-08	60	73	73	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1277	+		10.1038/nm.4421	http://dx.doi.org/10.1038/nm.4421			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035370	Green Submitted, Green Accepted			2022-12-27	WOS:000414548300010
J	Wetsman, N				Wetsman, Nicole			The missing pieces: Lack of Zika data from Africa complicates search for answers	NATURE MEDICINE			English	Editorial Material							VIRUS											Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365; Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087; Zhang F., 2010, NUCLEIC ACIDS RES, V44, P8610	6	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					904	906		10.1038/nm0817-904	http://dx.doi.org/10.1038/nm0817-904			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28777794				2022-12-27	WOS:000406947600002
J	Giustacchini, A; Thongjuea, S; Barkas, N; Woll, PS; Povinelli, BJ; Booth, CAG; Sopp, P; Norfo, R; Rodriguez-Meira, A; Ashley, N; Jamieson, L; Vyas, P; Anderson, K; Segerstolpe, A; Qian, H; Olsson-Stromberg, U; Mustjoki, S; Sandberg, R; Jacobsen, SEW; Mead, AJ				Giustacchini, Alice; Thongjuea, Supat; Barkas, Nikolaos; Woll, Petter S.; Povinelli, Benjamin J.; Booth, Christopher A. G.; Sopp, Paul; Norfo, Ruggiero; Rodriguez-Meira, Alba; Ashley, Neil; Jamieson, Lauren; Vyas, Paresh; Anderson, Kristina; Segerstolpe, Asa; Qian, Hong; Olsson-Stromberg, Ulla; Mustjoki, Satu; Sandberg, Rickard; Jacobsen, Sten Eirik W.; Mead, Adam J.			Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia	NATURE MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PRIMITIVE HEMATOPOIETIC-CELLS; GENE-EXPRESSION ANALYSIS; ABL TYROSINE KINASE; RNA-SEQ; HETEROGENEITY; IMATINIB; IMPACT; CML; REMISSION	Recent advances in single-cell transcriptomics are ideally placed to unravel intratumoral heterogeneity and selective resistance of cancer stem cell (SC) subpopulations to molecularly targeted cancer therapies. However, current single-cell RNA-sequencing approaches lack the sensitivity required to reliably detect somatic mutations. We developed a method that combines high-sensitivity mutation detection with whole-transcriptome analysis of the same single cell. We applied this technique to analyze more than 2,000 SCs from patients with chronic myeloid leukemia (CML) throughout the disease course, revealing heterogeneity of CML-SCs, including the identification of a subgroup of CML-SCs with a distinct molecular signature that selectively persisted during prolonged therapy. Analysis of nonleukemic SCs from patients with CML also provided new insights into cell-extrinsic disruption of hematopoiesis in CML associated with clinical outcome. Furthermore, we used this single-cell approach to identify a blast-crisis-specific SC population, which was also present in a subclone of CML-SCs during the chronic phase in a patient who subsequently developed blast crisis. This approach, which might be broadly applied to any malignancy, illustrates how single-cell analysis can identify subpopulations of therapy-resistant SCs that are not apparent through cell-population analysis.	[Giustacchini, Alice; Thongjuea, Supat; Barkas, Nikolaos; Povinelli, Benjamin J.; Booth, Christopher A. G.; Sopp, Paul; Norfo, Ruggiero; Rodriguez-Meira, Alba; Ashley, Neil; Jamieson, Lauren; Vyas, Paresh; Jacobsen, Sten Eirik W.; Mead, Adam J.] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford, England; [Giustacchini, Alice; Thongjuea, Supat; Barkas, Nikolaos; Woll, Petter S.; Povinelli, Benjamin J.; Booth, Christopher A. G.; Sopp, Paul; Norfo, Ruggiero; Rodriguez-Meira, Alba; Ashley, Neil; Jamieson, Lauren; Jacobsen, Sten Eirik W.; Mead, Adam J.] Univ Oxford, Weatherall Inst Mol Med, Haemopoiet Stem Cell Biol Lab, Oxford, England; [Anderson, Kristina] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Cellular Therapy, Oslo, Norway; [Segerstolpe, Asa; Sandberg, Rickard; Jacobsen, Sten Eirik W.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Segerstolpe, Asa] Karolinska Inst, Integrated Cardio Metab Ctr, Huddinge, Sweden; [Qian, Hong; Jacobsen, Sten Eirik W.] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden; [Olsson-Stromberg, Ulla] Univ Hosp, Dept Med Sci, Uppsala, Sweden; [Olsson-Stromberg, Ulla] Univ Hosp, Div Hematol, Uppsala, Sweden; [Mustjoki, Satu] Univ Helsinki, Dept Clin Chem & Hematol, Hematol Res Unit Helsinki, Helsinki, Finland; [Mustjoki, Satu] Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland; [Sandberg, Rickard] Ludwig Inst Canc Res, Stockholm, Sweden; [Jacobsen, Sten Eirik W.] Karolinska Univ Hosp, Stockholm, Sweden; [Mead, Adam J.] Churchill Hosp, NIHR Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; University of Oslo; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital; University of Oxford	Jacobsen, SEW; Mead, AJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford, England.; Jacobsen, SEW; Mead, AJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Haemopoiet Stem Cell Biol Lab, Oxford, England.; Jacobsen, SEW (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Jacobsen, SEW (corresponding author), Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden.; Jacobsen, SEW (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Mead, AJ (corresponding author), Churchill Hosp, NIHR Biomed Res Ctr, Oxford, England.	sten.eirik.jacobsen@ki.se; adam.mead@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Vyas, Paresh/B-5708-2009; Giustacchini, Alice/D-4074-2018; Mead, Adam/A-8796-2012; Mustjoki, Satu/AAD-9974-2020; Qian, Hong/D-5588-2014	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Vyas, Paresh/0000-0003-3931-0914; Giustacchini, Alice/0000-0002-8733-8594; Mead, Adam/0000-0001-8522-1002; Mustjoki, Satu/0000-0002-0816-8241; Rodriguez Meira, Alba/0000-0001-9630-6968; Barkas, Nikolaos/0000-0002-4675-0718; Qian, Hong/0000-0002-2512-9199; Norfo, Ruggiero/0000-0002-9485-6285; Booth, Christopher/0000-0003-3841-6637; Ashley, Neil/0000-0002-1655-5137; Woll, Petter S./0000-0002-2340-2526; Thongjuea, Supat/0000-0002-9129-4694	Medical Research Council [MR/L006340/1]; MRC Confidence in Concept award [MC_PC_13073]; Rosetrees Trust award [A712]; MRC Molecular Haematology Unit core award [MC_UU_12009/5]; MRC [G0801073, MR/M00919X/1]; Swedish Research Council; Tobias Foundation; Center for Innovative Medicine (CIMED) at the Karolinska Institute; Oxford NIHR Biomedical Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Novartis; MRC HIU; MRC MHU [MC_UU_12009]; NIHR Oxford BRC; John Fell Fund [131/030, 101/517]; EPA fund [CF182, CF170]; WIMM Strategic Alliance awards [G0902418, MC_UU_12025]; Oxford-Wellcome Trust Institutional Strategic Support Fund; Finnish Cancer Institute; Finnish Cancer Organizations; MRC [MC_UU_12009/11, MC_U137961145, G0501838, MC_UU_12009/5, G1000729, MR/L006340/1, MC_PC_12020, MC_PC_13073, MR/L008963/1, MC_UU_00016/5] Funding Source: UKRI; Medical Research Council [G1000801c, G1000729, MC_UU_12009/5, MC_UU_12009/11, MR/L008963/1, MC_PC_12020, MC_UU_00016/5, MC_PC_13073, G0501838, MR/M00919X/1, MC_U137961145, G0801073] Funding Source: researchfish; Cancer Foundation Finland sr [160102, 100118, 140142] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Confidence in Concept award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust award; MRC Molecular Haematology Unit core award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tobias Foundation; Center for Innovative Medicine (CIMED) at the Karolinska Institute; Oxford NIHR Biomedical Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Novartis(Novartis); MRC HIU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC MHU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford BRC; John Fell Fund; EPA fund; WIMM Strategic Alliance awards; Oxford-Wellcome Trust Institutional Strategic Support Fund; Finnish Cancer Institute; Finnish Cancer Organizations; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cancer Foundation Finland sr	This work was funded by a Medical Research Council Senior Clinical Fellowship (MR/L006340/1), MRC Confidence in Concept award (MC_PC_13073) and Rosetrees Trust award (A712: Rosetrees Trust Award (A712)) to A.J.M., the MRC Molecular Haematology Unit core award (A.J.M. and S.E.W.J.; MC_UU_12009/5), a MRC programme grant to S.E.W.J. (G0801073), an international-recruitment award from the Swedish Research Council (S.E.W.J.), and grants from the Tobias Foundation (S.E.W.J.) and the Center for Innovative Medicine (CIMED) at the Karolinska Institute (S.E.W.J.). This work was also supported by the MRC-funded Oxford Consortium for Single-cell Biology (MR/M00919X/1) and the Oxford NIHR Biomedical Centre based at Oxford University Hospitals NHS Trust and University of Oxford. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or the NIH. The work was also supported by an educational grant from Novartis. The authors acknowledge the contributions of the WIMM Flow Cytometry Facility, supported by the MRC HIU; MRC MHU (MC_UU_12009); NIHR Oxford BRC and John Fell Fund (131/030 and 101/517), the EPA fund (CF182 and CF170) and by the WIMM Strategic Alliance awards G0902418 and MC_UU_12025. N.A. was supported by the Oxford-Wellcome Trust Institutional Strategic Support Fund. S.M. is supported by the Finnish Cancer Institute and the Finnish Cancer Organizations.	Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Beck D, 2013, BLOOD, V122, pE12, DOI 10.1182/blood-2013-03-490425; Bruns I, 2009, LEUKEMIA, V23, P892, DOI 10.1038/leu.2008.392; CASHMAN JD, 1990, BLOOD, V75, P96; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Gallipoli P, 2011, HEMATOL ONCOL CLIN N, V25, P951, DOI 10.1016/j.hoc.2011.09.001; Gerber JM, 2013, ONCOTARGET, V4, P715, DOI 10.18632/oncotarget.990; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Herrmann H, 2014, BLOOD, V123, P3951, DOI 10.1182/blood-2013-10-536078; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Jamieson Catriona H, 2008, Hematology Am Soc Hematol Educ Program, P436, DOI 10.1182/asheducation-2008.1.436; Kentsis A, 2012, NAT MED, V18, P1118, DOI 10.1038/nm.2819; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu JX, 2013, DEVELOPMENT, V140, P1067, DOI 10.1242/dev.086157; Longo DL, 2017, NEW ENGL J MED, V376, P982, DOI 10.1056/NEJMe1700833; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Miyawaki K, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.1477.1477; Mustjoki S, 2013, LEUKEMIA, V27, P1520, DOI 10.1038/leu.2013.19; Nievergall E, 2016, LEUKEMIA, V30, P1263, DOI 10.1038/leu.2016.34; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saadatpour A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0525-9; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Sloma I, 2013, EXP HEMATOL, V41, P837, DOI 10.1016/j.exphem.2013.07.001; Soverini S, 2016, BRIT J HAEMATOL, V173, P337, DOI 10.1111/bjh.13966; Streets AM, 2014, NAT BIOTECHNOL, V32, P1005, DOI 10.1038/nbt.3039; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Warfvinge R., 2017, BLOOD; Welner RS, 2015, CANCER CELL, V27, P671, DOI 10.1016/j.ccell.2015.04.004; Wills QF, 2015, HUM MOL GENET, V24, pR74, DOI 10.1093/hmg/ddv235; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; WU SQ, 1995, LEUKEMIA, V9, P858; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao K, 2014, INT J CLIN EXP MED, V7, P4787	63	227	230	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					692	+		10.1038/nm.4336	http://dx.doi.org/10.1038/nm.4336			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28504724	Green Submitted			2022-12-27	WOS:000402768000012
J	Toussaint, M; Jackson, DJ; Swieboda, D; Guedan, A; Tsourouktsoglou, TD; Ching, YM; Radermecker, C; Makrinioti, H; Aniscenko, J; Edwards, MR; Solari, R; Farnir, F; Papayannopoulos, V; Bureau, F; Marichal, T; Johnston, SL				Toussaint, Marie; Jackson, David J.; Swieboda, Dawid; Guedan, Anabel; Tsourouktsoglou, Theodora-Dorita; Ching, Yee Man; Radermecker, Coraline; Makrinioti, Heidi; Aniscenko, Julia; Edwards, Michael R.; Solari, Roberto; Farnir, Frederic; Papayannopoulos, Venizelos; Bureau, Fabrice; Marichal, Thomas; Johnston, Sebastian L.			Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation	NATURE MEDICINE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; PLASMACYTOID DENDRITIC CELLS; MOUSE MODEL; ELASTASE; INFLAMMATION; INFECTION; HYPERRESPONSIVENESS; CHALLENGE; CYTOKINES; SEVERITY	Respiratory viral infections represent the most common cause of allergic asthma exacerbations. Amplification of the type-2 immune response is strongly implicated in asthma exacerbation, but how virus infection boosts type-2 responses is poorly understood. We report a significant correlation between the release of host double-stranded DNA (dsDNA) following rhinovirus infection and the exacerbation of type-2 allergic inflammation in humans. In a mouse model of allergic airway hypersensitivity, we show that rhinovirus infection triggers dsDNA release associated with the formation of neutrophil extracellular traps (NETs), known as NETosis. We further demonstrate that inhibiting NETosis by blocking neutrophil elastase or by degrading NETs with DNase protects mice from type-2 immunopathology. Furthermore, the injection of mouse genomic DNA alone is sufficient to recapitulate many features of rhinovirus-induced type-2 immune responses and asthma pathology. Thus, NETosis and its associated extracellular dsDNA contribute to the pathogenesis and may represent potential therapeutic targets of rhinovirus-induced asthma exacerbations.	[Toussaint, Marie; Jackson, David J.; Swieboda, Dawid; Guedan, Anabel; Ching, Yee Man; Makrinioti, Heidi; Aniscenko, Julia; Edwards, Michael R.; Solari, Roberto; Johnston, Sebastian L.] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England; [Toussaint, Marie; Jackson, David J.; Swieboda, Dawid; Guedan, Anabel; Ching, Yee Man; Makrinioti, Heidi; Aniscenko, Julia; Edwards, Michael R.; Solari, Roberto; Johnston, Sebastian L.] MRC, London, England; [Toussaint, Marie; Jackson, David J.; Swieboda, Dawid; Guedan, Anabel; Ching, Yee Man; Makrinioti, Heidi; Aniscenko, Julia; Edwards, Michael R.; Solari, Roberto; Johnston, Sebastian L.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Jackson, David J.; Johnston, Sebastian L.] Imperial Coll Healthcare NHS Trust, London, England; [Jackson, David J.] Guys & St Thomas NHS Trust, London, England; [Papayannopoulos, Venizelos] Francis Crick Inst, London, England; [Radermecker, Coraline; Bureau, Fabrice; Marichal, Thomas] Univ Liege, Grp Interdisciplinaire Genoprote Appl, Lab Cellular & Mol Immunol, Liege, Belgium; [Radermecker, Coraline; Farnir, Frederic; Bureau, Fabrice; Marichal, Thomas] Univ Liege, Fac Vet Med, Liege, Belgium; [Farnir, Frederic] Univ Liege, Fundamental & Appl Res Anim & Hlth, Liege, Belgium; [Bureau, Fabrice] Walloon Excellence Life Sci & Biotechnol, WELBIO, Wallonia, Belgium	Imperial College London; University of London; King's College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Francis Crick Institute; University of Liege; University of Liege; University of Liege; WELBIO	Johnston, SL (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England.; Johnston, SL (corresponding author), MRC, London, England.; Johnston, SL (corresponding author), Asthma UK Ctr Allerg Mech Asthma, London, England.; Johnston, SL (corresponding author), Imperial Coll Healthcare NHS Trust, London, England.; Bureau, F; Marichal, T (corresponding author), Univ Liege, Grp Interdisciplinaire Genoprote Appl, Lab Cellular & Mol Immunol, Liege, Belgium.; Bureau, F; Marichal, T (corresponding author), Univ Liege, Fac Vet Med, Liege, Belgium.; Bureau, F (corresponding author), Walloon Excellence Life Sci & Biotechnol, WELBIO, Wallonia, Belgium.	fabrice.bureau@ulg.ac.be; t.marichal@ulg.ac.be; s.johnston@imperial.ac.uk	Johnston, Sebastian Lennox/I-2423-2012; Jackson, David/AAG-8818-2020	Johnston, Sebastian Lennox/0000-0003-3009-9200; Radermecker, Coraline/0000-0001-6254-5258; Guedan, Anabel/0000-0001-5732-4186; Papayannopoulos, Venizelos/0000-0002-3741-8190	Wallonie-Bruxelles International organization; European Academy of Allergy and Clinical Immunology; Acteria Foundation; European Research Council (ERC FP7 grant) [233015]; Chair from Asthma UK [CH11SJ]; Medical Research Council Centre [G1000758]; National Institute of Health Research (NIHR) Biomedical Research Centre [P26095]; Predicta FP7 Collaborative Project [260895]; NIHR Biomedical Research Centre at Imperial College London; MRC [G1100168, MC_PC_11005, G0601369, MR/L012693/1, G0600879, G1100238, G0601236] Funding Source: UKRI; Medical Research Council [G1100168, MC_PC_11005, G0600879, G0601236, G1000758, G0601369, G1100238, MR/L012693/1, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212, NF-SI-0514-10092] Funding Source: researchfish; Rosetrees Trust [M422] Funding Source: researchfish; Asthma UK [08/048, 06/050, MRC-AsthmaUKCentre, MRC-Asthma UK Centre, 05/067, CH11SJ] Funding Source: researchfish; The Francis Crick Institute [10129] Funding Source: researchfish	Wallonie-Bruxelles International organization; European Academy of Allergy and Clinical Immunology; Acteria Foundation; European Research Council (ERC FP7 grant); Chair from Asthma UK; Medical Research Council Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Predicta FP7 Collaborative Project; NIHR Biomedical Research Centre at Imperial College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Asthma UK; The Francis Crick Institute	The authors thank all the CBS team from Imperial College London for animal management, M. Paulsen of the Flow Cytometry Core Facility from St Mary's Campus (Imperial College London) for giving advice, and C. Tytgat for secretarial assistance. The authors also thank S. Ormenese and J.J. Goval of the Cell Imaging Platform of the Groupe Interdisciplinaire de Genoproteomique Appliquee (GIGA, Liege, Belgium) for help with confocal microscopy. M.T. is a postdoctoral fellow who has been supported by the Wallonie-Bruxelles International organization and by the European Academy of Allergy and Clinical Immunology. T.M. is a Research Associate of the F.R.S-FNRS and is supported by the Acteria Foundation. This work was supported by the European Research Council (ERC FP7 grant number 233015) to S.L.J. a Chair from Asthma UK (number CH11SJ) to S.L.J. the Medical Research Council Centre (grant number G1000758); National Institute of Health Research (NIHR) Biomedical Research Centre (grant number P26095); Predicta FP7 Collaborative Project (grant number 260895); and the NIHR Biomedical Research Centre at Imperial College London. S.L.J. is a NIHR Senior Investigator.	Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Bonhagen K, 2003, EUR J IMMUNOL, V33, P392, DOI 10.1002/immu.200310013; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Chan TK, 2016, J ALLERGY CLIN IMMUN, V138, P84, DOI 10.1016/j.jaci.2016.02.017; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Chrysanthopoulou A, 2014, J PATHOL, V233, P294, DOI 10.1002/path.4359; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Funchal GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124082; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Grabcanovic-Musija F, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0221-7; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Hahn S, 2013, SEMIN IMMUNOPATHOL, V35, P439, DOI 10.1007/s00281-013-0380-x; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Imanishi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4566; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Janss T, 2016, EUR J IMMUNOL, V46, P2614, DOI 10.1002/eji.201646513; Jenne CN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004546; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1999, PEDIATR PULM, P141; Koga H, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-8; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Maffia PC, 2007, AM J PATHOL, V171, P928, DOI 10.2353/ajpath.2007.061043; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Marichal T, 2010, J ALLERGY CLIN IMMUN, V126, P836, DOI 10.1016/j.jaci.2010.06.009; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Mesnil C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053242; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Roghanian A, 2006, AM J RESP CRIT CARE, V174, P1189, DOI 10.1164/rccm.200605-632OC; Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366; Singanayagam A, 2015, CLIN SCI, V129, P245, DOI 10.1042/CS20140654; Skrzeczynska-Moncznik J, 2013, AM J CLIN EXP IMMUNO, V2, P186; Suzuki T, 1996, AM J RESP CRIT CARE, V153, P1405, DOI 10.1164/ajrccm.153.4.8616573; Tateosian NL, 2011, CELL IMMUNOL, V269, P128, DOI 10.1016/j.cellimm.2011.03.013; Toussaint M, 2013, MUCOSAL IMMUNOL, V6, P485, DOI 10.1038/mi.2012.88; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhu J, 2014, CHEST, V145, P1219, DOI 10.1378/chest.13-1567	57	173	179	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					681	+		10.1038/nm.4332	http://dx.doi.org/10.1038/nm.4332			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28459437	Green Accepted, Green Submitted			2022-12-27	WOS:000402768000011
J	West, NR; Hegazy, AN; Owens, BMJ; Bullers, SJ; Linggi, B; Buonocore, S; Coccia, M; Gortz, D; This, S; Stockenhuber, K; Pott, J; Friedrich, M; Ryzhakov, G; Baribaud, F; Brodmerkel, C; Cieluch, C; Rahman, N; Muller-Newen, G; Owens, RJ; Kuhl, AA; Maloy, KJ; Plevy, SE; Keshav, S; Travis, SPL; Powrie, F				West, Nathaniel R.; Hegazy, Ahmed N.; Owens, Benjamin M. J.; Bullers, Samuel J.; Linggi, Bryan; Buonocore, Sofia; Coccia, Margherita; Gortz, Dieter; This, Sebastien; Stockenhuber, Krista; Pott, Johanna; Friedrich, Matthias; Ryzhakov, Grigory; Baribaud, Frederic; Brodmerkel, Carrie; Cieluch, Constanze; Rahman, Nahid; Mueller-Newen, Gerhard; Owens, Raymond J.; Kuhl, Anja A.; Maloy, Kevin J.; Plevy, Scott E.; Keshav, Satish; Travis, Simon P. L.; Powrie, Fiona		Oxford IBD Cohort Investigators	Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease (vol 23, pg 579, 2017)	NATURE MEDICINE			English	Correction													This, Sébastien/AAB-8888-2020	Keshav, Satish/0000-0003-0508-8665; Travis, Simon/0000-0002-2690-4361; Gortz, Dieter/0000-0002-1321-0416; Owens, Benjamin/0000-0003-4710-6841	MRC [G0200231] Funding Source: UKRI; Medical Research Council [G0200231] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307	1	14	14	3	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					788	788		10.1038/nm0617-788d	http://dx.doi.org/10.1038/nm0617-788d			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586341	Bronze			2022-12-27	WOS:000402768000026
J	Plovier, H; Everard, A; Druart, C; Depommier, C; Van Hul, M; Geurts, L; Chilloux, J; Ottman, N; Duparc, T; Lichtenstein, L; Myridakis, A; Delzenne, NM; Klievink, J; Bhattacharjee, A; van der Ark, KCH; Aalvink, S; Martinez, LO; Dumas, ME; Maiter, D; Loumaye, A; Hermans, MP; Thissen, JP; Belzer, C; de Vos, WM; Cani, PD				Plovier, Hubert; Everard, Amandine; Druart, Celine; Depommier, Clara; Van Hul, Matthias; Geurts, Lucie; Chilloux, Julien; Ottman, Noora; Duparc, Thibaut; Lichtenstein, Laeticia; Myridakis, Antonis; Delzenne, Nathalie M.; Klievink, Judith; Bhattacharjee, Arnab; van der Ark, Kees C. H.; Aalvink, Steven; Martinez, Laurent O.; Dumas, Marc-Emmanuel; Maiter, Dominique; Loumaye, Audrey; Hermans, Michel P.; Thissen, Jean-Paul; Belzer, Clara; de Vos, Willem M.; Cani, Patrice D.			A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice	NATURE MEDICINE			English	Article							GUT MICROBIOTA; INTESTINAL EPITHELIUM; INSULIN-RESISTANCE; ATHEROSCLEROSIS; SAFETY; MUCIN; TOLERANCE; DIET; INFLAMMATION; INTEGRITY	Obesity and type 2 diabetes are associated with low-grade inflammation and specific changes in gut microbiota composition(1-7). We previously demonstrated that administration of Akkermansia muciniphila to mice prevents the development of obesity and associated complications(8). However, the underlying mechanisms of this protective effect remain unclear. Moreover, the sensitivity of A. muciniphila to oxygen and the presence of animal-derived compounds in its growth medium currently limit the development of translational approaches for human medicine(9). We have addressed these issues here by showing that A. muciniphila retains its efficacy when grown on a synthetic medium compatible with human administration. Unexpectedly, we discovered that pasteurization of A. muciniphila enhanced its capacity to reduce fat mass development, insulin resistance and dyslipidemia in mice. These improvements were notably associated with a modulation of the host urinary metabolomics profile and intestinal energy absorption. We demonstrated that Amuc_1100, a specific protein isolated from the outer membrane of A. muciniphila, interacts with Toll-like receptor 2, is stable at temperatures used for pasteurization, improves the gut barrier and partly recapitulates the beneficial effects of the bacterium. Finally, we showed that administration of live or pasteurized A. muciniphila grown on the synthetic medium is safe in humans. These findings provide support for the use of different preparations of A. muciniphila as therapeutic options to target human obesity and associated disorders.	[Plovier, Hubert; Everard, Amandine; Druart, Celine; Depommier, Clara; Van Hul, Matthias; Geurts, Lucie; Delzenne, Nathalie M.; Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, WELBIO Walloon Excellence Life Sci & Blotechnol, Metab & Nutr Res Grp, Brussels, Belgium; [Chilloux, Julien; Myridakis, Antonis; Dumas, Marc-Emmanuel] Imperial Coll, Dept Surg & Canc, Div Computat & Syst Med, London, England; [Ottman, Noora; van der Ark, Kees C. H.; Aalvink, Steven; Belzer, Clara; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Duparc, Thibaut; Lichtenstein, Laeticia; Martinez, Laurent O.] INSERM, Inst Metab & Cardiovasc Dis, I2MC, UMR 1048, Toulouse, France; [Klievink, Judith; Bhattacharjee, Arnab; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, RPU Immunobiol, Helsinki, Finland; [Maiter, Dominique; Loumaye, Audrey; Hermans, Michel P.] Catholic Univ Louvain, Clin Univ St Luc, Inst Rech Expt & Clin IREC, Pole Endocrinol Diabet & Nutr, Brussels, Belgium; [Ottman, Noora] Univ Helsinki, Metapopulat Res Ctr, Helsinki, Finland	Universite Catholique Louvain; WELBIO; Imperial College London; Wageningen University & Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Helsinki; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Helsinki	Cani, PD (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, WELBIO Walloon Excellence Life Sci & Blotechnol, Metab & Nutr Res Grp, Brussels, Belgium.	patrice.cani@uclouvain.be	D., Cani Patrice/M-8055-2016; Martinez, Laurent O/B-8343-2015; Ottman, Noora/C-2225-2018; Martinez, Laurent O./ABD-6880-2020; Belzer, Clara/P-6500-2018; Delzenne, Nathalie/AAC-4628-2019; Dumas, Marc-Emmanuel/C-1736-2008; Plovier, Hubert/AAG-1533-2021; Plovier, Hubert/F-7082-2016	D., Cani Patrice/0000-0003-2040-2448; Martinez, Laurent O/0000-0002-0985-3152; Martinez, Laurent O./0000-0002-0985-3152; Belzer, Clara/0000-0001-6922-836X; Delzenne, Nathalie/0000-0003-2115-6082; Dumas, Marc-Emmanuel/0000-0001-9523-7024; Ottman, Noora/0000-0001-5011-9294; Plovier, Hubert/0000-0001-9494-8094; Druart, Celine/0000-0002-7786-9172; Everard, Amandine/0000-0001-8925-8144; Bhattacharjee, Arnab/0000-0002-9613-7911; Chilloux, Julien/0000-0002-0384-7317; Lichtenstein, Laeticia/0000-0003-3900-786X; Thibaut, DUPARC/0000-0002-6058-4656; Aalvink, Steven/0000-0001-7554-1723; Myridakis, Antonis/0000-0003-1690-6651; Van Hul, Matthias/0000-0002-5503-107X	FIRST Spin-Off grant from the Walloon Region [1410053]; ERC [250172, 336452-ENIGMO]; SIAM Gravity Grant [024.002.002]; Spinoza Award of the Netherlands Organization for Scientific Research; Academy of Finland [137389, 141140, 1272870]; FNRS [J.0084.15, 3.4579.11]; PDR (Projet de Recherche) [T.0138.14]; ARC (Action de Recherche Concertee-Communaute francaise de Belgique) [12/17-047]; FRFS-WELBIO [WELBIO-CR-2012S-02R]; Funds Baillet Latour; FIRST Spin-Off grant (FSO) from the Walloon Region, Belgium [1410053]; FP7 METACARDIS [HEALTH-F4-2012-305312]; POC ERC grant (European Research Council) [Microbes4U_713547]	FIRST Spin-Off grant from the Walloon Region; ERC(European Research Council (ERC)European Commission); SIAM Gravity Grant; Spinoza Award of the Netherlands Organization for Scientific Research; Academy of Finland(Academy of Finland); FNRS(Fonds de la Recherche Scientifique - FNRS); PDR (Projet de Recherche); ARC (Action de Recherche Concertee-Communaute francaise de Belgique); FRFS-WELBIO(WELBIO); Funds Baillet Latour; FIRST Spin-Off grant (FSO) from the Walloon Region, Belgium; FP7 METACARDIS; POC ERC grant (European Research Council)(European Research Council (ERC))	We wish to thank A. Barrois, H. Danthinne, M. De Barsy, R.-M. Goebbels and T. Pringels for excellent technical assistance; S. Matamoros for helpful discussion and aid during tissue sampling; and the individuals who participated in this study. C. Druart's researcher position is supported by a FIRST Spin-Off grant from the Walloon Region (convention 1410053). Research in the Wageningen and Helsinki labs of W.M.d.V. was partially supported by ERC Advanced Grant 250172 (Microbes Inside), the SIAM Gravity Grant 024.002.002 and Spinoza Award of the Netherlands Organization for Scientific Research, and Grants 137389, 141140 and 1272870 of the Academy of Finland. P.D.C. is the recipient of grants from FNRS (convention J.0084.15, convention 3.4579.11), PDR (Projet de Recherche, convention: T.0138.14) and ARC (Action de Recherche Concertee-Communaute francaise de Belgique convention: 12/17-047). This work was supported by the FRFS-WELBIO under grant WELBIO-CR-2012S-02R. This work is supported in part by the Funds Baillet Latour (Grant for Medical Research 2015), a FIRST Spin-Off grant (FSO) from the Walloon Region, Belgium (convention 1410053) and FP7 METACARDIS (HEALTH-F4-2012-305312). P.D.C. is a recipient of POC ERC grant 2016 (European Research Council, Microbes4U_713547) and ERC Starting Grant 2013 (Starting grant 336452-ENIGMO).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Burton JP, 2011, FOOD CHEM TOXICOL, V49, P2356, DOI 10.1016/j.fct.2011.06.038; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Everard A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6648; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Gu MJ, 2016, VET RES, V47, DOI 10.1186/s13567-016-0309-1; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Jones ML, 2012, REGUL TOXICOL PHARM, V63, P313, DOI 10.1016/j.yrtph.2012.04.003; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0140839, 10.1371/journal.pone.0128274]; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Ottman N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01157; Peng GC, 2005, PEDIAT ALLERG IMM-UK, V16, P433, DOI 10.1111/j.1399-3038.2005.00284.x; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reunanen J, 2015, APPL ENVIRON MICROB, V81, P3655, DOI 10.1128/AEM.04050-14; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sakai T, 2013, J NUTR SCI VITAMINOL, V59, P144, DOI 10.3177/jnsv.59.144; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wind RD, 2010, BRIT J NUTR, V104, P1806, DOI 10.1017/S0007114510002746	40	921	987	58	708	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					107	113		10.1038/nm.4236	http://dx.doi.org/10.1038/nm.4236			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27892954	Green Submitted			2022-12-27	WOS:000391646800019
J	Kwakkenbos, MJ; Diehl, SA; Yasuda, E; Bakker, AQ; van Geelen, CMM; Lukens, MV; van Bleek, GM; Widjojoatmodjo, MN; Bogers, WMJM; Mei, H; Radbruch, A; Scheeren, FA; Spits, H; Beaumont, T				Kwakkenbos, Mark J.; Diehl, Sean A.; Yasuda, Etsuko; Bakker, Arjen Q.; van Geelen, Caroline M. M.; Lukens, Michael V.; van Bleek, Grada M.; Widjojoatmodjo, Myra N.; Bogers, Willy M. J. M.; Mei, Henrik; Radbruch, Andreas; Scheeren, Ferenc A.; Spits, Hergen; Beaumont, Tim			Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming (vol 16, pg 123, 2010)	NATURE MEDICINE			English	Correction													Diehl, Sean/AAE-2779-2020	Diehl, Sean/0000-0001-9700-235X; Scheeren, Ferenc/0000-0002-8304-9023				Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071	1	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1502	1502		10.1038/nm1216-1502a	http://dx.doi.org/10.1038/nm1216-1502a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923028	Bronze			2022-12-27	WOS:000389549000030
J	Osuna, CE; Lim, SY; Deleage, C; Griffin, BD; Stein, D; Schroeder, LT; Omange, RW; Best, K; Luo, M; Hraber, PT; Andersen-Elyard, H; Ojeda, EFC; Huang, S; Vanlandingham, DL; Higgs, S; Perelson, AS; Estes, JD; Safronetz, D; Lewis, MG; Whitney, JB				Osuna, Christa E.; Lim, So-Yon; Deleage, Claire; Griffin, Bryan D.; Stein, Derek; Schroeder, Lukas T.; Omange, Robert Were; Best, Katharine; Luo, Ma; Hraber, Peter T.; Andersen-Elyard, Hanne; Ojeda, Erwing Fabian Cardozo; Huang, Scott; Vanlandingham, Dana L.; Higgs, Stephen; Perelson, Alan S.; Estes, Jacob D.; Safronetz, David; Lewis, Mark G.; Whitney, James B.			Zika viral dynamics and shedding in rhesus and cynomolgus macaques	NATURE MEDICINE			English	Article							NATURAL-KILLER-CELLS; SEXUAL TRANSMISSION; VIRUS-INFECTION; DENGUE VIRUS; OUTBREAK; SERUM; EXPRESSION; MOSQUITOS; RESPONSES; MEMORY	Infection with Zika virus has been associated with serious neurological complications and fetal abnormalities. However, the dynamics of viral infection, replication and shedding are poorly understood. Here we show that both rhesus and cynomolgus macaques are highly susceptible to infection by lineages of Zika virus that are closely related to, or are currently circulating in, the Americas. After subcutaneous viral inoculation, viral RNA was detected in blood plasma as early as 1 d after infection. Viral RNA was also detected in saliva, urine, cerebrospinal fluid (CSF) and semen, but transiently in vaginal secretions. Although viral RNA during primary infection was cleared from blood plasma and urine within 10 d, viral RNA was detectable in saliva and seminal fluids until the end of the study, 3 weeks after the resolution of viremia in the blood. The control of primary Zika virus infection in the blood was correlated with rapid innate and adaptive immune responses. We also identified Zika RNA in tissues, including the brain and male and female reproductive tissues, during early and late stages of infection. Re-infection of six animals 45 d after primary infection with a heterologous strain resulted in complete protection, which suggests that primary Zika virus infection elicits protective immunity. Early invasion of Zika virus into the nervous system of healthy animals and the extent and duration of shedding in saliva and semen underscore possible concern for additional neurologic complications and nonarthropod-mediated transmission in humans.	[Osuna, Christa E.; Lim, So-Yon; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Deleage, Claire; Estes, Jacob D.] Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA; [Griffin, Bryan D.; Stein, Derek; Schroeder, Lukas T.; Omange, Robert Were; Luo, Ma; Safronetz, David] Natl Microbiol Lab, Winnipeg, MB, Canada; [Best, Katharine; Hraber, Peter T.; Ojeda, Erwing Fabian Cardozo; Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA; [Andersen-Elyard, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD USA; [Huang, Scott; Vanlandingham, Dana L.; Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA; [Whitney, James B.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Los Alamos National Laboratory; BIOQUAL Inc.; Kansas State University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Whitney, JB (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA.; Whitney, JB (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	jwhitne2@bidmc.harvard.edu	Perelson, Alan S/Z-1959-2019; Omange, Were/F-1454-2016	Perelson, Alan S/0000-0002-2455-0002; Hraber, Peter/0000-0002-2920-4897; Osuna, Christa/0000-0003-2761-2456; Griffin, Bryan D/0000-0002-7950-1873; Omange, Were/0000-0002-0421-110X; Cardozo Ojeda, Erwing/0000-0001-8690-9896; Elyard, Hanne/0000-0003-1103-9608	National Cancer Institute ( NIH Contract) [HHSN261200800001E]; NIH [AI028433, OD0110995]; Public Health Agency of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028433, U24AI126683, R01AI028433] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095, R24OD010976] Funding Source: NIH RePORTER	National Cancer Institute ( NIH Contract); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Agency of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Finneyfrock, Z. Pippin, A. Dodson and A. Cook for their expert animal husbandry and care, and J. Guedj for suggestions about the model simulations. CD38 antibodies were obtained from the NIH Nonhuman Primate Reagent Resource supported by HHSN272200900037C and OD010976. The data presented in this study are tabulated in the main paper and in the supplementary materials. This work was supported in part by federal funds from the National Cancer Institute ( NIH Contract HHSN261200800001E). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government. A.S.P. acknowledges support from NIH grants AI028433 and OD0110995. D.S. acknowledges support from the Public Health Agency of Canada.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Banerjee S, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0130; Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901; BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Deleage Claire, 2016, Pathog Immun, V1, P68; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Fukuhara M, 2013, J VIROL, V87, P701, DOI 10.1128/JVI.01453-12; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; HARRISON RM, 1980, J MED PRIMATOL, V9, P265; Kuhrt D, 2011, J IMMUNOL METHODS, V363, P166, DOI 10.1016/j.jim.2010.09.017; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9; Millon P., 2015, EPIDEMIOLOGIE SYNDRO; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Townsend Peterson A, 2016, PLOS CURR; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Whitney JB, 2009, AIDS, V23, P1453, DOI 10.1097/QAD.0b013e32832b43d9	54	205	209	0	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1448	+		10.1038/nm.4206	http://dx.doi.org/10.1038/nm.4206			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27694931	Green Accepted, Green Submitted			2022-12-27	WOS:000389549000022
J	Zackular, JP; Moore, JL; Jordan, AT; Juttukonda, LJ; Noto, MJ; Nicholson, MR; Crews, JD; Semler, MW; Zhang, YF; Ware, LB; Washington, MK; Chazin, WJ; Caprioli, RM; Skaar, EP				Zackular, Joseph P.; Moore, Jessica L.; Jordan, Ashley T.; Juttukonda, Lillian J.; Noto, Michael J.; Nicholson, Maribeth R.; Crews, Jonathan D.; Semler, Matthew W.; Zhang, Yaofang; Ware, Lorraine B.; Washington, M. Kay; Chazin, Walter J.; Caprioli, Richard M.; Skaar, Eric P.			Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection (vol 16, pg 23, 2016)	NATURE MEDICINE			English	Correction													Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702	NHLBI NIH HHS [T32 HL087738] Funding Source: Medline; NIAID NIH HHS [R01 AI101171] Funding Source: Medline; NIGMS NIH HHS [T32 GM008320] Funding Source: Medline; BLRD VA [I01 BX002482] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002482] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BLRD VA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)		Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071	1	4	4	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1502	1502		10.1038/nm1216-1502d	http://dx.doi.org/10.1038/nm1216-1502d			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923021	Green Accepted, Bronze			2022-12-27	WOS:000389549000033
J	Bender, S; Gronych, J; Warnatz, HJ; Hutter, B; Grobner, S; Ryzhova, M; Pfaff, E; Hovestadt, V; Weinberg, F; Halbach, S; Kool, M; Northcott, PA; Sturm, D; Bjerke, L; Zichner, T; Stutz, AM; Schramm, K; Huang, B; Buchhalter, I; Heinold, M; Risch, T; Worst, BC; van Tilburg, CM; Weber, UD; Zapatka, M; Raeder, B; Milford, D; Heiland, S; von Kalle, C; Previti, C; Lawerenz, C; Kulozik, AE; Unterberg, A; Witt, O; von Deimling, A; Capper, D; Truffaux, N; Grill, J; Jabado, N; Sehested, AM; Sumerauer, D; Hmida-Ben Brahim, D; Trabelsi, S; Ng, HK; Zagzag, D; Allen, JC; Karajannis, MA; Gottardo, NG; Jones, C; Korbel, J; Schmidt, S; Wolf, S; Reifenberger, G; Felsberg, J; Brors, B; Herold-Mende, C; Lehrach, H; Brummer, T; Korshunov, A; Eils, R; Yaspo, ML; Pfister, SM; Lichter, P; Jones, DTW				Bender, Sebastian; Gronych, Jan; Warnatz, Hans-Joerg; Hutter, Barbara; Groebner, Susanne; Ryzhova, Marina; Pfaff, Elke; Hovestadt, Volker; Weinberg, Florian; Halbach, Sebastian; Kool, Marcel; Northcott, Paul A.; Sturm, Dominik; Bjerke, Lynn; Zichner, Thomas; Stutz, Adrian M.; Schramm, Kathrin; Huang, Bingding; Buchhalter, Ivo; Heinold, Michael; Risch, Thomas; Worst, Barbara C.; van Tilburg, Cornelis M.; Weber, Ursula D.; Zapatka, Marc; Raeder, Benjamin; Milford, David; Heiland, Sabine; von Kalle, Christof; Previti, Christopher; Lawerenz, Chris; Kulozik, Andreas E.; Unterberg, Andreas; Witt, Olaf; von Deimling, Andreas; Capper, David; Truffaux, Nathalene; Grill, Jacques; Jabado, Nada; Sehested, Astrid M.; Sumerauer, David; Hmida-Ben Brahim, Dorra; Trabelsi, Saoussen; Ng, Ho-Keung; Zagzag, David; Allen, Jeffrey C.; Karajannis, Matthias A.; Gottardo, Nicholas G.; Jones, Chris; Korbel, Jan; Schmidt, Sabine; Wolf, Stephan; Reifenberger, Guido; Felsberg, Jorg; Brors, Benedikt; Herold-Mende, Christel; Lehrach, Hans; Brummer, Tilman; Korshunov, Andrey; Eils, Roland; Yaspo, Marie-Laure; Pfister, Stefan M.; Lichter, Peter; Jones, David T. W.		Int Canc Genome Consortium	Recurrent MET fusion genes represent a drug target in pediatric glioblastoma	NATURE MEDICINE			English	Article							LARGE-CELL LYMPHOMA; GENOMIC LANDSCAPE; MUTATIONS; REARRANGEMENT; INHIBITION; TRANSCRIPT; RESISTANCE; REVEALS; GLIOMA; TUMORS	Pediatric glioblastoma is one of the most common and most deadly brain tumors in childhood. Using an integrative genetic analysis of 53 pediatric glioblastomas and five in vitro model systems, we identified previously unidentified gene fusions involving the MET oncogene in similar to 10% of cases. These MET fusions activated mitogen-activated protein kinase (MAPK) signaling and, in cooperation with lesions compromising cell cycle regulation, induced aggressive glial tumors in vivo. MET inhibitors suppressed MET tumor growth in xenograft models. Finally, we treated a pediatric patient bearing a MET-fusion-expressing glioblastoma with the targeted inhibitor crizotinib. This therapy led to substantial tumor shrinkage and associated relief of symptoms, but new treatment-resistant lesions appeared, indicating that combination therapies are likely necessary to achieve a durable clinical response.	[Bender, Sebastian; Groebner, Susanne; Pfaff, Elke; Kool, Marcel; Northcott, Paul A.; Sturm, Dominik; Worst, Barbara C.; Pfister, Stefan M.; Jones, David T. W.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Bender, Sebastian; Pfaff, Elke; Sturm, Dominik; Worst, Barbara C.; van Tilburg, Cornelis M.; Kulozik, Andreas E.; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Bender, Sebastian; Gronych, Jan; Groebner, Susanne; Pfaff, Elke; Hovestadt, Volker; Kool, Marcel; Northcott, Paul A.; Sturm, Dominik; Schramm, Kathrin; Worst, Barbara C.; van Tilburg, Cornelis M.; Weber, Ursula D.; Zapatka, Marc; von Deimling, Andreas; Capper, David; Brors, Benedikt; Korshunov, Andrey; Pfister, Stefan M.; Lichter, Peter; Jones, David T. W.] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Gronych, Jan; Hovestadt, Volker; Schramm, Kathrin; Weber, Ursula D.; Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Warnatz, Hans-Joerg; Risch, Thomas; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Berlin, Germany; [Hutter, Barbara; Buchhalter, Ivo; Heinold, Michael; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow, Russia; [Weinberg, Florian; Halbach, Sebastian; Brummer, Tilman] Univ Freiburg, Inst Mol Med & Cell Res IMMZ, Fac Med, Freiburg, Germany; [Weinberg, Florian; Brummer, Tilman] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany; [Bjerke, Lynn; Jones, Chris] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Bjerke, Lynn; Jones, Chris] Inst Canc Res, Div Canc Therapeut, Sutton, Surrey, England; [Zichner, Thomas; Stutz, Adrian M.; Raeder, Benjamin; Korbel, Jan] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Huang, Bingding; Buchhalter, Ivo; Lawerenz, Chris; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [van Tilburg, Cornelis M.; Brors, Benedikt] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Milford, David; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, Heidelberg, Germany; [von Kalle, Christof; Previti, Christopher; Schmidt, Sabine; Wolf, Stephan] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Unterberg, Andreas; Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Heidelberg, Germany; [von Deimling, Andreas; Capper, David; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [von Deimling, Andreas; Capper, David; Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Truffaux, Nathalene; Grill, Jacques] CNRS, UMR 8203, Lab Vectorol & Therapeut Anticanc, Villejuif, France; [Truffaux, Nathalene; Grill, Jacques] Univ Paris Sud, Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sehested, Astrid M.] Rigshosp, Dept Pediat Hematol & Oncol, Copenhagen, Denmark; [Sumerauer, David] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Sumerauer, David] Univ Hosp Motol, Prague, Czech Republic; [Hmida-Ben Brahim, Dorra; Trabelsi, Saoussen] Farhat Hached Hosp, Dept Cytogenet & Reprod Biol, Sousse, Tunisia; [Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Zagzag, David] NYU, Dept Pathol, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Zagzag, David] NYU, Dept Neurosurg, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Allen, Jeffrey C.; Karajannis, Matthias A.] NYU, Dept Pediat, Langone Med Ctr, New York, NY 10016 USA; [Gottardo, Nicholas G.] Princess Margaret Hosp Children, Dept Pediat Oncol & Haematol, Perth, WA, Australia; [Gottardo, Nicholas G.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Gottardo, Nicholas G.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA, Australia; [Stutz, Adrian M.; Reifenberger, Guido; Felsberg, Jorg] Heinrich Heine Univers Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Brummer, Tilman] Univ Freiburg, Med Ctr, Comprehens Canc Ctr Freiburg CCCF, Freiburg, Germany; [Brummer, Tilman] DKTK, Standort Freiburg, Germany; [Eils, Roland] Heidelberg Univ, IPMB, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, BioQuant Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; University of Freiburg; University of Freiburg; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; McGill University; McGill University; McGill University; Rigshospitalet; University of Copenhagen; Charles University Prague; Motol University Hospital; Universite de Sousse; Hopital Farhat Hached; Chinese University of Hong Kong; New York University; New York University; New York University; NYU Langone Medical Center; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Freiburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Pfister, SM; Jones, DTW (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany.; Pfister, SM (corresponding author), Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany.; Pfister, SM; Lichter, P; Jones, DTW (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.; Lichter, P (corresponding author), German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.	s.pfister@dkfz.de; peter.lichter@dkfz.de; david.jones@dkfz.de	Zapatka, Marc/G-9896-2013; Jones, David T. W./Z-1963-2019; Kulozik, Andreas/AAO-2432-2020; Northcott, Paul A/N-4022-2018; Sturm, Dominik/AAL-3689-2020; Grill, Jacques/R-8093-2019; Capper, David/I-8500-2014; Jones, Chris/ABE-6059-2021; Ng, Ho Keung/I-3952-2015; Brummer, Tilman/AAA-9428-2020; Jones, David TW/G-9588-2013; Ryzhova, Marina/G-4178-2014; Halbach, Sebastian/G-4021-2012; Brummer, Tilman/B-6218-2016; Jabado, Nada/AAN-4026-2020; Brors, Benedikt/E-5620-2013; Eils, Roland/B-6121-2009; Pfister, Stefan M/F-6860-2013; von Deimling, Andreas/F-7774-2013; Reifenberger, Guido/AAE-3599-2019; Karajannis, Matthias A/H-8845-2019	Zapatka, Marc/0000-0001-8287-5967; Northcott, Paul A/0000-0002-1220-5252; Sturm, Dominik/0000-0003-0250-1696; Capper, David/0000-0003-1945-497X; Jones, Chris/0000-0001-8118-2296; Brummer, Tilman/0000-0003-4387-7905; Jones, David TW/0000-0002-2036-5141; Ryzhova, Marina/0000-0001-7206-6365; Halbach, Sebastian/0000-0002-6827-8178; Brummer, Tilman/0000-0003-4387-7905; Brors, Benedikt/0000-0001-5940-3101; Eils, Roland/0000-0002-0034-4036; Pfister, Stefan M/0000-0002-5447-5322; von Deimling, Andreas/0000-0002-5863-540X; Karajannis, Matthias A/0000-0002-7151-6528; Gottardo, Nicholas/0000-0002-1082-6776; Buchhalter, Ivo/0000-0003-0764-5832; trabelsi, saoussen/0000-0002-2789-7167; Hovestadt, Volker/0000-0002-3480-6649; Raeder, Benjamin/0000-0002-9494-8884; Hutter, Barbara/0000-0002-9034-0329; Allen, Jeffrey/0000-0001-9957-6664; Gronych, Jan/0000-0003-0557-679X; Zichner, Thomas/0000-0001-9848-7598; Korshunov, Andrey/0000-0002-5257-3623	PedBrain Tumor Project; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, 0315416C, 01GS0883, 031A425A, 01ZX1302]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); German Cancer Consortium (DKTK, INFORM project); Max Planck Society (Munich, Germany); European Union (FP7) [262055]; Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC) [HA-305]; German Research Foundation (DFG) [LA2983/2-1]; EDM Foundation; Lemos Foundation; New York University Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center; Cancer Center Support Grant from the National Cancer Institute, US National Institutes of Health [P30 CA16087]; National Center for the Advancement of Translational Science (NCATS), US National Institutes of Health [UL 1 T12000038]; Making Headway Foundation; Dr. Mildred Scheel Foundation Scholarship; NHS; ICR; Cancer Research UK [13982, 11736] Funding Source: researchfish; The Brain Tumour Charity [16/193, 6/78] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER	PedBrain Tumor Project; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); German Cancer Consortium (DKTK, INFORM project); Max Planck Society (Munich, Germany)(Max Planck Society); European Union (FP7)(European Commission); Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC); German Research Foundation (DFG)(German Research Foundation (DFG)); EDM Foundation; Lemos Foundation; New York University Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center; Cancer Center Support Grant from the National Cancer Institute, US National Institutes of Health; National Center for the Advancement of Translational Science (NCATS), US National Institutes of Health; Making Headway Foundation; Dr. Mildred Scheel Foundation Scholarship; NHS; ICR; Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	For technical support and expertise, we thank A. Wittmann, L. Sieber, C. Xanthopoulos, D. Sohn and N. Mack, the DKFZ Genomics and Proteomics Core Facility, the DKFZ Center for Preclinical Research, R. Kabbe (Division of Theoretical Bioinformatics, DKFZ), M. Bieg and M. Schlesner (Division of Applied Bioinformatics, DKFZ), C. Jager-Schmidt (Data Management Group, DKFZ), S. Ruffer and T. Giese from the Heidelberg University Hospital, M. Rabenstein from the NCT Heidelberg, S. Thamm, D. Balzereit, S. Dokel, M. Linser, A. Kovacsovics and V. Amstislayskiy from the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin, the tissue bank of the National Center for Tumor Diseases (NCT, Heidelberg), and the Department of Oncogenomics (University of Amsterdam). Ntv-a; Cdkn2a<SUP>-/-</SUP>; Pten<SUP>fl/fl</SUP> mice were kindly provided by E. Holland (Fred Hutchinson Cancer Research Center). This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C, NGFNplus #01GS0883 and e:Med Joint Research Projects SYS-GLIO #031A425A and CancerTelSys #01ZX1302). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the German Cancer Consortium (DKTK, INFORM project), the Max Planck Society (Munich, Germany), the European Union (FP7/2007-2013, grant ESGI #262055), the Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC, grant number HA-305), the German Research Foundation (DFG, grant LA2983/2-1), the EDM and the Lemos Foundations, the New York University Langone Human Specimen Resource Center, Laura and Isaac Perlmutter Cancer Center, supported in part by the Cancer Center Support Grant, P30 CA16087 from the National Cancer Institute, US National Institutes of Health, UL 1 T12000038 from the National Center for the Advancement of Translational Science (NCATS), US National Institutes of Health, and grants from the Making Headway Foundation. J. Gronych was supported by a Dr. Mildred Scheel Foundation Scholarship. The authors acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and the ICR as well as the project (Ministry of Health, Czech Republic) for conceptual development of research organization 00064203 (University Hospital Motol, Prague, Czech Republic).	Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chi AS, 2012, J CLIN ONCOL, V30, pE30, DOI 10.1200/JCO.2011.38.4586; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Diamond JR, 2013, J CLIN ONCOL, V31, pE254, DOI 10.1200/JCO.2012.46.4289; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; GRECO A, 1995, MOL CELL BIOL, V15, P6118; Hernandez L, 1999, BLOOD, V94, P3265; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Korshunov A, 2015, ACTA NEUROPATHOL, V129, P669, DOI 10.1007/s00401-015-1405-4; Lai AZ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004839; Laser-Azogui A, 2014, ONCOGENE, V33, P1788, DOI 10.1038/onc.2013.138; Louis, 2016, WHO CLASSIFICATION G; Mak HHL, 2007, ONCOGENE, V26, P7213, DOI 10.1038/sj.onc.1210522; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Navis AC, 2015, ACTA NEUROPATHOL, V130, P131, DOI 10.1007/s00401-015-1420-5; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shin Clifford H, 2015, Genes Cancer, V6, P9; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Truffaux N, 2015, NEURO-ONCOLOGY, V17, P953, DOI 10.1093/neuonc/nou330; Weber RG, 2007, ONCOGENE, V26, P1088, DOI 10.1038/sj.onc.1209851; Worst BC, 2016, EUR J CANCER, V65, P91, DOI 10.1016/j.ejca.2016.06.009; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	33	128	134	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1314	1320		10.1038/nm.4204	http://dx.doi.org/10.1038/nm.4204			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27748748				2022-12-27	WOS:000387302300024
J	Kim, J; DeBerardinis, RJ				Kim, Jiyeon; DeBerardinis, Ralph J.			Blocking fatty acid synthesis reduces lung tumor growth in mice	NATURE MEDICINE			English	Editorial Material							CELLS	Tumors often overexpress enzymes that synthesize fatty acids, but the requirement for fatty acid synthesis in tumor growth is unclear. A new fatty acid synthesis inhibitor blunts lung tumor growth in mice, which implicates this process as a targetable liability.	[Kim, Jiyeon; DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Res Inst, Childrens Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBerardinis, RJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Res Inst, Childrens Med Ctr, Dallas, TX 75390 USA.	Ralph.Deberardinis@UTSouthwestern.edu						Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; BEATY NB, 1983, J BIOL CHEM, V258, P3051; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200	10	4	5	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1077	1078		10.1038/nm.4195	http://dx.doi.org/10.1038/nm.4195			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711061				2022-12-27	WOS:000384872500009
J	Seeley, RJ; Sandoval, DA				Seeley, Randy J.; Sandoval, Darleen A.			Targeting the brain as a cure for type 2 diabetes	NATURE MEDICINE			English	Editorial Material								A recent study has shown that a single dose of fibroblast growth factor (FGF) 1 into the central nervous system (CNS) of various mouse and rat models of type 2 diabetes results in profound and exceptionally long-lasting reductions in blood glucose. This work raises the possibility of truly revolutionary therapies for individuals with type 2 diabetes that target the brain FGF system.	[Seeley, Randy J.; Sandoval, Darleen A.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Seeley, Randy J.; Sandoval, Darleen A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Seeley, Randy J.; Sandoval, Darleen A.] Univ Michigan, Dept Nutr Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Seeley, RJ (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.; Seeley, RJ (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Seeley, RJ (corresponding author), Univ Michigan, Dept Nutr Sci, Ann Arbor, MI 48109 USA.	seeleyrj@med.umich.edu		Seeley, Randy/0000-0002-3721-5625				Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bernard C., 1854, LECONS PHYSL EXPT AP, VI; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Goodman T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00387; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Raju R., 2014, J SIGNAL TRANSDUCT, V2014, DOI DOI 10.1155/2014/962962; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Scarlett JM, 2016, NAT MED, V22, P800, DOI 10.1038/nm.4101; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540	12	7	7	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					709	711		10.1038/nm.4137	http://dx.doi.org/10.1038/nm.4137			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27387884				2022-12-27	WOS:000379366900007
J	Vaccari, M; Gordon, SN; Fourati, S; Schifanella, L; Liyanage, NPM; Cameron, M; Keele, BF; Shen, XY; Tomaras, GD; Billings, E; Rao, M; Chung, AW; Dowell, KG; Bailey-Kellogg, C; Brown, EP; Ackerman, ME; Vargas-Inchaustegui, DA; Whitney, S; Doster, MN; Binello, N; Pegu, P; Montefiori, DC; Foulds, K; Quinn, DS; Donaldson, M; Liang, F; Lore, K; Roederer, M; Koup, RA; McDermott, A; Ma, ZM; Miller, CJ; Phan, TB; Forthal, DN; Blackburn, M; Caccuri, F; Bissa, M; Ferrari, G; Kalyanaraman, V; Ferrari, MG; Thompson, D; Robert-Guroff, M; Ratto-Kim, S; Kim, JH; Michael, NL; Phogat, S; Barnett, SW; Tartaglia, J; Venzon, D; Stablein, DM; Alter, G; Sekaly, RP; Franchini, G				Vaccari, Monica; Gordon, Shari N.; Fourati, Slim; Schifanella, Luca; Liyanage, Namal P. M.; Cameron, Mark; Keele, Brandon F.; Shen, Xiaoying; Tomaras, Georgia D.; Billings, Erik; Rao, Mangala; Chung, Amy W.; Dowell, Karen G.; Bailey-Kellogg, Chris; Brown, Eric P.; Ackerman, Margaret E.; Vargas-Inchaustegui, Diego A.; Whitney, Stephen; Doster, Melvin N.; Binello, Nicolo; Pegu, Poonam; Montefiori, David C.; Foulds, Kathryn; Quinn, David S.; Donaldson, Mitzi; Liang, Frank; Lore, Karin; Roederer, Mario; Koup, Richard A.; McDermott, Adrian; Ma, Zhong-Min; Miller, Christopher J.; Phan, Tran B.; Forthal, Donald N.; Blackburn, Matthew; Caccuri, Francesca; Bissa, Massinilliano; Ferrari, Guido; Kalyanaraman, Vaniambadi; Ferrari, Maria G.; Thompson, DeVon; Robert-Guroff, Marjorie; Ratto-Kim, Silvia; Kim, Jerome H.; Michael, Nelson L.; Phogat, Sanjay; Barnett, Susan W.; Tartaglia, Jim; Venzon, David; Stablein, Donald M.; Alter, Galit; Sekaly, Rafick-Pierre; Franchini, Genoveffa			Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition	NATURE MEDICINE			English	Article							HIV-1 VACCINE EFFICACY; ACTIVATION; CELLS; PROTECTION; ANTIBODIES; INFECTION; IMMUNOGENICITY; GLYCOSYLATION; EXPRESSION; RESPONSES	A recombinant vaccine containing Aventis Pasteur's canarypox vector (ALVAC)-HIV and gp120 alum. decreased the risk of HIV acquisition in the RV144 vaccine trial. The substitution, of alum with the more immunogenic MF59 adjuvant is under consideration for the next efficacy human trial. We found here that an ALVAC-simian immunodeficiency virus (SIV) and gp120 alum (ALVAC-SIV + gp120) equivalent vaccine, but not an ALVAC-SIV + gp120 MF59 vaccine, was efficacious in delaying the onset of SIVmac251 in rhesus macaques, despite the higher immunogenicity of the latter adjuvant. Vaccine efficacy was associated with alum-induced, but not with MF59-induced, envelope (Env)-dependent mucosal innate lymphoid cells (ILCs) that produce interleukin (IL)-17, as well as with mucosal IgG to the gp120 variable region 2 (V2) and the expression of 12 genes, ten of which are part of the RAS pathway. The association between RAS activation and vaccine efficacy was also observed in an independent efficacious SIV-vaccine approach. Whether RAS activation, mucosal ILCs and antibodies to V2 are also important hallmarks of HIV-vaccine efficacy in humans will require further studies.	[Vaccari, Monica; Gordon, Shari N.; Schifanella, Luca; Liyanage, Namal P. M.; Doster, Melvin N.; Binello, Nicolo; Pegu, Poonam; Blackburn, Matthew; Caccuri, Francesca; Bissa, Massinilliano; Franchini, Genoveffa] NCI, Anim Models & Vaccine Sect, Bethesda, MD 20892 USA; [Fourati, Slim; Sekaly, Rafick-Pierre] Case Wetern Reserve, Dept Pathol, Cleveland, OH USA; [Schifanella, Luca] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Milan, Italy; [Cameron, Mark] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH USA; [Keele, Brandon F.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Shen, Xiaoying; Tomaras, Georgia D.; Ferrari, Guido] Duke Human Vaccine Inst, Durham, NC USA; [Billings, Erik; Rao, Mangala; Ratto-Kim, Silvia; Kim, Jerome H.; Michael, Nelson L.] Walter Red Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Chung, Amy W.; Alter, Galit] Massachusetts Inst Technol & Harvard, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Dowell, Karen G.; Bailey-Kellogg, Chris] Darthmouth Coll, Dept Comp Sci, Hanover, NH USA; [Brown, Eric P.; Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Vargas-Inchaustegui, Diego A.; Robert-Guroff, Marjorie] NCI, Immune Biol Retrovial Infect Sect, Bethesda, MD USA; [Whitney, Stephen; Kalyanaraman, Vaniambadi; Ferrari, Maria G.; Thompson, DeVon] Adv Biosci Labs, Rockville, MD USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Foulds, Kathryn; Quinn, David S.; Donaldson, Mitzi; Roederer, Mario; Koup, Richard A.; McDermott, Adrian] US Natl Inst Hlth, Vaccine Res Ctr, Bethesda, MD USA; [Liang, Frank; Lore, Karin] Karolinska Inst, Stockholm, Sweden; [Ma, Zhong-Min; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA USA; [Phan, Tran B.; Forthal, Donald N.] Univ Calif Irvine, Irvine Sch Med, Irvine, CA USA; [Phogat, Sanjay; Tartaglia, Jim] Sanofi Pasteur, Swiftwater, PA USA; [Barnett, Susan W.] Novartis Vaccines & Diagonst Inc, Cambridge, MA USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD USA; [Stablein, Donald M.] EMMES Corp, Rockville, MD USA; [Barnett, Susan W.] GSK Vaccines, Cambridge, MA USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; University of Milan; Luigi Sacco Hospital; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed Army Institute of Research (WRAIR); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Dartmouth College; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; National Institutes of Health (NIH) - USA; Karolinska Institutet; University of California System; University of California Davis; University of California System; University of California Irvine; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emmes Corporation; GlaxoSmithKline; International Vaccine Institute	Franchini, G (corresponding author), NCI, Anim Models & Vaccine Sect, Bethesda, MD 20892 USA.	franchig@mail.nih.gov	Roederer, Mario/G-1887-2011; Liyanage, Namal P M/AAU-1392-2021; Caccuri, Francesca/AAC-1281-2022; Liang, Frank/AAT-6566-2020; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Cameron, Mark/O-6775-2019	Liyanage, Namal P M/0000-0001-7362-3282; Caccuri, Francesca/0000-0002-1923-9033; Ferrari, Guido/0000-0001-7747-3349; Cameron, Mark/0000-0003-4768-4094; Chung, Amy/0000-0003-0020-9704; Quinn, David/0000-0002-5335-8968; Liang, Frank/0000-0003-3675-3816; Bissa, Massimiliano/0000-0003-3455-3992; Fourati, Slim/0000-0001-6609-7587; McDermott, Adrian/0000-0003-0616-9117; Ratto-Kim, Silvia/0000-0003-2025-6399	Simian Vaccine Evaluation Unit (SVEU) [HHSN266200600005C]; intramural US National Cancer Institute (NCI) program; extramural US National Institute of Allergy and Infectious Diseases (NIAID) program; US Army Medical Research and Material Command (USAMRMC) [W81XWH-07-2-0067]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense; Collaboration for AIDS Vaccine Discovery (CAVD) grants from the Bill and Melinda Gates Foundation [OPP1032325, OPP1032817]; NCI; US National Institutes of Health (NIH) [HHSN261200800001E]; NIH [HHSN27201100016C]; Center for AIDS Research [AI064518]; Bill and Melinda Gates' Foundation [OPP111572]; NIH/NIAID [5R01AI102691]; Intramural Research Program of the Vaccine Research Center, NIAID, NIH; CAVD from the Bill and Melinda Gates Foundation [OPP1032325, R01 AI118581, R01 AI102715]; NATIONAL CANCER INSTITUTE [ZIABC011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102715, ZICAI005103, R01AI118581, P30AI064518, R01AI102691] Funding Source: NIH RePORTER	Simian Vaccine Evaluation Unit (SVEU); intramural US National Cancer Institute (NCI) program; extramural US National Institute of Allergy and Infectious Diseases (NIAID) program; US Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense(United States Department of Defense); Collaboration for AIDS Vaccine Discovery (CAVD) grants from the Bill and Melinda Gates Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; Bill and Melinda Gates' Foundation(Bill & Melinda Gates Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CAVD from the Bill and Melinda Gates Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank T. Nolan and D. Abram for their editorial assistance, N. Miller and A. Shultz for their help in the study design, and J. Warren for support with systems biology and several antibody assays under Simian Vaccine Evaluation Unit (SVEU) contract number HHSN266200600005C, awarded to Advanced BioScience Laboratories, Inc. (ABL). This work was supported by the intramural US National Cancer Institute (NCI) program and the extramural US National Institute of Allergy and Infectious Diseases (NIAID) program, together with the US Army Medical Research and Material Command (USAMRMC) (W81XWH-07-2-0067), the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., the US Department of Defense, the Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1032325 and OPP1032817 from the Bill and Melinda Gates Foundation, and in part, with federal funds from the NCI, US National Institutes of Health (NIH), under contract no. HHSN261200800001E (to the whole team). We would like to acknowledge the following institutions for the grants supporting the authors: NIH primate grant HHSN27201100016C (D.M.); Center for AIDS Research grant AI064518 (G.F.); Bill and Melinda Gates' Foundation grant OPP111572 (M.E.A., C.B.K., E.F.B., K.G.D.); NIH/NIAID grant 5R01AI102691 (M.E.A, E.F.B.); Intramural Research Program of the Vaccine Research Center, NIAID, NIH, and CAVD from the Bill and Melinda Gates Foundation grants OPP1032325 (R.A.K.), R01 AI118581 and R01 AI102715 (D.F.). The views expressed are those of the authors and should not be construed to represent the positions of the US Army, the Department of Defense or the Department of Health and Human Services. Mention of trade names, commercial products, or organizations do not imply endorsement by the US Government. The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: CEM.NKR CCR5<SUP>+</SUP> by P. Creswell. The anti-alpha 4 beta 7 in APC was kindly provided by A. A. Ansari (cat. #11718, 1:50 dilution) through the NIH AIDS Reagent Program, Division of AIDS, NIAID.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Awad A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094492; Bambard ND, 2010, SCAND J IMMUNOL, V71, P210, DOI 10.1111/j.1365-3083.2009.02367.x; Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Fox CB, 2013, EXPERT REV VACCINES, V12, P747, DOI 10.1586/14760584.2013.811188; Franchini Genoveffa, 2004, Expert Rev Vaccines, V3, pS75, DOI 10.1586/14760584.3.4.S75; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Iborra S, 2011, BLOOD, V117, P5102, DOI 10.1182/blood-2010-10-315770; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Liu XV, 2012, J IMMUNOL, V189, P1826, DOI 10.4049/jimmunol.1200965; Liyanage NPM, 2014, VIROLOGY, V450, P359, DOI 10.1016/j.virol.2013.12.003; Nakajima C, 2002, EUR J IMMUNOL, V32, P1792, DOI 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanchez-Ruiz J, 2011, J IMMUNOL, V187, P2433, DOI 10.4049/jimmunol.1003089; Sedy JR, 2013, J IMMUNOL, V191, P828, DOI 10.4049/jimmunol.1300894; Selinger C, 2014, CLIN VACCINE IMMUNOL, V21, P1650, DOI 10.1128/CVI.00455-14; Strbo N, 2013, J IMMUNOL, V190, P2495, DOI 10.4049/jimmunol.1202655; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Underhill GH, 2003, BLOOD, V101, P4013, DOI 10.1182/blood-2002-08-2673; Vaccari M, 2013, J VIROL, V87, P3538, DOI 10.1128/JVI.02863-12; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Zhang Z, 2015, J CLIN INVEST, V125, P3692, DOI 10.1172/JCI82124	31	147	152	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					762	770		10.1038/nm.4105	http://dx.doi.org/10.1038/nm.4105			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27239761	Green Accepted			2022-12-27	WOS:000379366900015
J	Zaidi, M; Iqbal, J				Zaidi, Mone; Iqbal, Jameel			Closing the loop on the bone-resorbing osteoclast	NATURE MEDICINE			English	Editorial Material								A new study shows in mice that tumor necrosis factor (TNF) superfamily member 11 (TNFSF11, also known as RANKL), which stimulates osteoclasts to remove bone, binds to the G-protein-coupled receptor LGR4 to prevent excessive bone removal. In mouse models of osteoporosis, a recombinant LGR4 ectodomain reduces bone loss.	[Zaidi, Mone] Icahn Sch Med Mt Sinai, Mt Sinai Bone Program, New York, NY 10029 USA; [Iqbal, Jameel] Los Angeles VA Med Ctr, Dept Pathol, Los Angeles, CA USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Zaidi, M (corresponding author), Icahn Sch Med Mt Sinai, Mt Sinai Bone Program, New York, NY 10029 USA.	Mone.zaidi@mssm.edu						Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Ferlin A, 2010, BONE, V46, P504, DOI 10.1016/j.bone.2009.10.007; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Li HY, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.5166.5166; Li ZR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00131; Luo J, 2016, J NAT MED, V22, P539; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149	12	5	5	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					460	461		10.1038/nm.4104	http://dx.doi.org/10.1038/nm.4104			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149217				2022-12-27	WOS:000375514000006
J	Hyer, ML; Milhollen, MA; Ciavarri, J; Fleming, P; Traore, T; Sappal, D; Huck, J; Shi, J; Gavin, J; Brownell, J; Yang, Y; Stringer, B; Griffin, R; Bruzzese, F; Soucy, T; Duffy, J; Rabino, C; Riceberg, J; Hoar, K; Lublinsky, A; Menon, S; Sintchak, M; Bump, N; Pulukuri, SM; Langston, S; Tirrell, S; Kuranda, M; Veiby, P; Newcomb, J; Li, P; Wu, JT; Powe, J; Dick, LR; Greenspan, P; Galvin, K; Manfredi, M; Claiborne, C; Amidon, BS; Bence, NF				Hyer, Marc L.; Milhollen, Michael A.; Ciavarri, Jeff; Fleming, Paul; Traore, Tary; Sappal, Darshan; Huck, Jessica; Shi, Judy; Gavin, James; Brownell, Jim; Yang, Yu; Stringer, Bradley; Griffin, Robert; Bruzzese, Frank; Soucy, Teresa; Duffy, Jennifer; Rabino, Claudia; Riceberg, Jessica; Hoar, Kara; Lublinsky, Anya; Menon, Saurabh; Sintchak, Michael; Bump, Nancy; Pulukuri, Sai M.; Langston, Steve; Tirrell, Stephen; Kuranda, Mike; Veiby, Petter; Newcomb, John; Li, Ping; Wu, Jing Tao; Powe, Josh; Dick, Lawrence R.; Greenspan, Paul; Galvin, Katherine; Manfredi, Mark; Claiborne, Chris; Amidon, Benjamin S.; Bence, Neil F.			A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment	NATURE MEDICINE			English	Article							SUBSTRATE-ASSISTED INHIBITION; NEDD8-ACTIVATING ENZYME; PROTEASOME SYSTEM; E1 INHIBITOR; DNA-DAMAGE; PROTEIN; DEGRADATION; MYELOMA; MLN4924; KINASE	The ubiquitin-proteasome system (UPS) comprises a network of enzymes that is responsible for maintaining cellular protein homeostasis. The therapeutic potential of this pathway has been validated by the clinical successes of a number of UPS modulators, including proteasome inhibitors and immunomodulatory imide drugs (IMiDs). Here we identified TAK-243 (formerly known as MLN7243) as a potent, mechanism-based small-molecule inhibitor of the ubiquitin activating enzyme (UAE), the primary mammalian E1 enzyme that regulates the ubiquitin conjugation cascade. TAK-243 treatment caused depletion of cellular ubiquitin conjugates, resulting in disruption of signaling events, induction of proteotoxic stress, and impairment of cell cycle progression and DNA damage repair pathways. TAK-243 treatment caused death of cancer cells and, in primary human xenograft studies, demonstrated antitumor activity at tolerated doses. Due to its specificity and potency, TAK-243 allows for interrogation of ubiquitin biology and for assessment of UAE inhibition as a new approach for cancer treatment.	[Hyer, Marc L.; Milhollen, Michael A.; Ciavarri, Jeff; Fleming, Paul; Traore, Tary; Sappal, Darshan; Huck, Jessica; Shi, Judy; Gavin, James; Brownell, Jim; Yang, Yu; Stringer, Bradley; Griffin, Robert; Bruzzese, Frank; Soucy, Teresa; Duffy, Jennifer; Rabino, Claudia; Riceberg, Jessica; Hoar, Kara; Lublinsky, Anya; Menon, Saurabh; Sintchak, Michael; Bump, Nancy; Pulukuri, Sai M.; Langston, Steve; Tirrell, Stephen; Kuranda, Mike; Veiby, Petter; Newcomb, John; Li, Ping; Wu, Jing Tao; Powe, Josh; Dick, Lawrence R.; Greenspan, Paul; Galvin, Katherine; Manfredi, Mark; Claiborne, Chris; Amidon, Benjamin S.; Bence, Neil F.] Takeda Pharmaceut Inc, Cambridge, MA 02139 USA; [Hyer, Marc L.] Agios Pharmaceut, Cambridge, MA USA; [Bence, Neil F.] Nurix Inc, San Francisco, CA USA	Agios Pharmaceuticals	Milhollen, MA (corresponding author), Takeda Pharmaceut Inc, Cambridge, MA 02139 USA.	michael.milhollen@takeda.com	Wu, Jing/GZK-5063-2022; Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405	Takeda Pharmaceuticals Inc.	Takeda Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd)	The authors would like to thank W. Harper (Harvard Medical School) for the UBA6-knockout and control MEFs, A. Berger for critical review of the manuscript, and E. Koenig and P. Shah for genomic data analysis. We would also like to thank J. Afroze, I. Bharathan, J. Gaulin, M. Girad, C. McIntyre, F. Soucy, T.T. Wong and Y. Ye for performing the chemical synthesis of TAK-243. All activities were completed and funded through Takeda Pharmaceuticals Inc.	Amidon BS, 2017, U.S. patent, Patent No. [US9593121B2, 9593121]; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Duffey MO, 2012, J MED CHEM, V55, P197, DOI 10.1021/jm2011172; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gu JJ, 2013, ANTI-CANCER DRUG, V24, P1030, DOI 10.1097/CAD.0000000000000008; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Huang JW, 2015, CLIN CANCER RES, V21, P5532, DOI 10.1158/1078-0432.CCR-15-0254; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Misra M, 2017, STRUCTURE, V25, P1120, DOI 10.1016/j.str.2017.05.001; Moudry P, 2012, CELL CYCLE, V11, P1573, DOI 10.4161/cc.19978; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; National Research Council, 2011, GUIDE CARE USE LAB A; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Smith H.E, 2008, PLOS GENET, V4; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Ungermannova D, 2012, J BIOMOL SCREEN, V17, P421, DOI 10.1177/1087057111433843; Vlachostergios PJ, 2009, J CELL MOL MED, V13, P3019, DOI 10.1111/j.1582-4934.2009.00825.x; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wildey G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106784; Wilmott JS, 2013, BRIT J CANCER, V108, P924, DOI 10.1038/bjc.2013.29; Xu GW, 2010, BLOOD, V115, P2251, DOI 10.1182/blood-2009-07-231191; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358	44	156	158	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					186	+		10.1038/nm.4474	http://dx.doi.org/10.1038/nm.4474			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29334375				2022-12-27	WOS:000424327200015
J	Jansen, KU; Knirsch, C; Anderson, AS				Jansen, Kathrin U.; Knirsch, Charles; Anderson, Annaliesa S.			The role of vaccines in preventing bacterial antimicrobial resistance	NATURE MEDICINE			English	Review							RESPIRATORY SYNCYTIAL VIRUS; INVASIVE PNEUMOCOCCAL DISEASE; CLOSTRIDIUM-DIFFICILE INFECTION; PATHOGENIC ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; 5-COUNTRY ANALYSIS; CONJUGATE VACCINE; UNITED-STATES; IMMUNOGENICITY	Antimicrobial resistance (AMR) and the associated morbidity and mortality due to bacterial pathogens have been increasing globally to alarming levels. The World Health Organization (WHO) has called for global action on AMR, supported worldwide by governments, health ministries and health agencies. Many potential solutions to stem AMR are being discussed and implemented. These include increases in antimicrobial stewardship, investment in research and development to design new classes of antibiotics, and reduction of antibiotic use in rearing of livestock. However, vaccines as tools to reduce AMR have historically been under-recognized in these discussions, even though their effectiveness in reducing disease and AMR is well documented. This review article seeks to highlight the value of vaccines as an additional modality to combat AMR globally, using select examples. It also will provide perspectives on how vaccines could be more effectively used in this effort.	[Jansen, Kathrin U.; Knirsch, Charles; Anderson, Annaliesa S.] Pfizer Inc, Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA	Pfizer	Jansen, KU (corresponding author), Pfizer Inc, Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA.	kathrin.jansen@pfizer.com						Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; Aguinagalde L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137565; [Anonymous], 2017, VACC PREV DIS SURV R; Arboleya S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050649; Awad SS, 2012, SURG INFECT, V13, P234, DOI 10.1089/sur.2012.131; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Bezay N, 2016, VACCINE, V34, P2585, DOI 10.1016/j.vaccine.2016.03.098; Bozzola E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050688; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Caroom C, 2013, SPINE, V38, P1183, DOI 10.1097/BRS.0b013e31828fcfb5; Cawein A, 2017, ANN NY ACAD SCI, V1395, P3, DOI 10.1111/nyas.13316; Coates A.R.M., 2012, ANTIBIOTIC RESISTANC; Cohen Robert, 2017, Expert Rev Vaccines, V16, P625, DOI 10.1080/14760584.2017.1320221; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dayan GH, 2016, EXPERT REV VACCINES, V15, P1373, DOI 10.1080/14760584.2016.1179583; de Bruyn G, 2016, VACCINE, V34, P2170, DOI 10.1016/j.vaccine.2016.03.028; Falsey AR, 2008, J INFECT DIS, V198, P1317, DOI 10.1086/592168; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feldman Charles, 2016, F1000Res, V5, P2320; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Frenck RW, 2017, VACCINE, V35, P375, DOI 10.1016/j.vaccine.2016.11.010; Gaviola ML, 2016, PHARMACOTHERAPY, V36, P19, DOI 10.1002/phar.1678; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Goff DA, 2017, LANCET INFECT DIS, V17, pE56, DOI 10.1016/S1473-3099(16)30386-3; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Hampton LM, 2012, J INFECT DIS, V205, P401, DOI 10.1093/infdis/jir755; Hargreaves RM, 1996, BRIT MED J, V312, P160; Hasegawa K, 2003, MICROB DRUG RESIST, V9, P39, DOI 10.1089/107662903764736337; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Heilmann KP, 2005, ANTIMICROB AGENTS CH, V49, P2561, DOI 10.1128/aac.49.6.2561-2564.2005; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Hoban D, 2002, J ANTIMICROB CHEMOTH, V50, P49, DOI 10.1093/jac/dkf810; Huttner A, 2017, LANCET INFECT DIS, V17, P528, DOI [10.1016/s1473-3099(17)30108-1, 10.1016/S1473-3099(17)30108-1]; Jenkins PJ, 2010, J HOSP INFECT, V76, P231, DOI 10.1016/j.jhin.2010.06.011; Jerse AE, 2014, VACCINE, V32, P1579, DOI 10.1016/j.vaccine.2013.08.067; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Klatt TE, 2012, OBSTET GYNECOL, V119, P301, DOI 10.1097/AOG.0b013e318242032a; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Leroux-Roels G, 2016, VACCINE, V34, P1786, DOI 10.1016/j.vaccine.2016.02.044; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16; Lundberg U, 2013, HUM VACC IMMUNOTHER, V9, P497, DOI 10.4161/hv.23225; Mancini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147767; Matias G, 2014, INFLUENZA OTHER RESP, V8, P507, DOI 10.1111/irv.12258; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Middleton JR, 2008, EXPERT REV VACCINES, V7, P805, DOI 10.1586/14760584.7.6.805; Mike LA, 2016, P NATL ACAD SCI USA, V113, P13468, DOI 10.1073/pnas.1606324113; Mohamed N, 2017, BRIT J SURG, V104, pE41, DOI 10.1002/bjs.10454; Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; O'Neill J., 2015, TACKLING DRUG RESIST; Openshaw PJM, 2017, ANNU REV IMMUNOL, V35, P501, DOI 10.1146/annurev-immunol-051116-052206; Organization WH, 2016, GLOBAL TUBERCULOSIS; Ozgur SK, 2006, PEDIATR INFECT DIS J, V25, P401, DOI 10.1097/01.inf.0000217370.83948.51; PELTOLA H, 1990, REV INFECT DIS, V12, P708; Peltola H, 1999, J INFECT DIS, V179, P223, DOI 10.1086/314535; Peng Z, 2017, J CLIN MICROBIOL, V55, P1998, DOI 10.1128/JCM.02250-16; Poolman JT, 2016, J INFECT DIS, V213, P6, DOI 10.1093/infdis/jiv429; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Rey-Jurado E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030556; Salkind AR, 2011, AM FAM PHYSICIAN, V83, P585; Schaffer AC, 2009, INFECT DIS CLIN N AM, V23, P153, DOI 10.1016/j.idc.2008.10.005; Sheldon E, 2016, VACCINE, V34, P2082, DOI 10.1016/j.vaccine.2016.03.010; Sieradzki K, 1999, NEW ENGL J MED, V340, P517, DOI 10.1056/NEJM199902183400704; Simioni J, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0724-5; Simoes EAF, 2001, VACCINE, V20, P954, DOI 10.1016/S0264-410X(01)00388-7; Stalhammar-Carlemalm M, 2007, CELL HOST MICROBE, V2, P427, DOI 10.1016/j.chom.2007.10.003; Tangden T, 2011, J ANTIMICROB CHEMOTH, V66, P1161, DOI 10.1093/jac/dkr053; Tomczyk S, 2016, CLIN INFECT DIS, V62, P1119, DOI 10.1093/cid/ciw067; Tristram S, 2007, CLIN MICROBIOL REV, V20, P368, DOI 10.1128/CMR.00040-06; van den Dobbelsteen GPJM, 2016, VACCINE, V34, P4152, DOI 10.1016/j.vaccine.2016.06.067; Ventola C Lee, 2015, P T, V40, P277; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Walsh EE, 2017, CLIN CHEST MED, V38, P29, DOI 10.1016/j.ccm.2016.11.010; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; WHO, 2017, GLOB TUB REP; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	94	134	139	5	79	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					10	19		10.1038/nm.4465	http://dx.doi.org/10.1038/nm.4465			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29315295	Bronze			2022-12-27	WOS:000422965900006
J	Mullican, SE; Lin-Schmidt, X; Chin, CN; Chavez, JA; Furman, JL; Armstrong, AA; Beck, SC; South, VJ; Dinh, TQ; Cash-Mason, TD; Cavanaugh, CR; Nelson, S; Huang, CC; Hunter, MJ; Rangwala, SM				Mullican, Shannon E.; Lin-Schmidt, Xiefan; Chin, Chen-Ni; Chavez, Jose A.; Furman, Jennifer L.; Armstrong, Anthony A.; Beck, Stephen C.; South, Victoria J.; Dinh, Thai Q.; Cash-Mason, Tanesha D.; Cavanaugh, Cassandre R.; Nelson, Serena; Huang, Chichi; Hunter, Michael J.; Rangwala, Shamina M.			GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates	NATURE MEDICINE			English	Article							DIFFERENTIATION FACTOR 15; BETA SUPERFAMILY MEMBER; SIGNALING PATHWAY; CYTOKINE MIC-1; GDNF FAMILY; BRAIN-STEM; RET; BINDING; OBESITY; ASSOCIATION	Growth differentiation factor 15 (GDF15), a distant member of the transforming growth factor (TGF)-beta family, is a secreted protein that circulates as a 25-kDa dimer. In humans, elevated GDF15 correlates with weight loss, and the administration of GDF15 to mice with obesity reduces body weight, at least in part, by decreasing food intake. The mechanisms through which GDF15 reduces body weight remain poorly understood, because the cognate receptor for GDF15 is unknown. Here we show that recombinant GDF15 induces weight loss in mice fed a high-fat diet and in nonhuman primates with spontaneous obesity. Furthermore, we find that GDF15 binds with high affinity to GDNF family receptor alpha-like (GFRAL), a distant relative of receptors for a distinct class of the TGF-beta superfamily ligands. Gfral is expressed in neurons of the area postrema and nucleus of the solitary tract in mice and humans, and genetic deletion of the receptor abrogates the ability of GDF15 to decrease food intake and body weight in mice. In addition, diet-induced obesity and insulin resistance are exacerbated in GFRAL-deficient mice, suggesting a homeostatic role for this receptor in metabolism. Finally, we demonstrate that GDF15-induced cell signaling requires the interaction of GFRAL with the coreceptor RET. Our data identify GFRAL as a new regulator of body weight and as the bona fide receptor mediating the metabolic effects of GDF15, enabling a more comprehensive assessment of GDF15 as a potential pharmacotherapy for the treatment of obesity.	[Mullican, Shannon E.; Chavez, Jose A.; Beck, Stephen C.; Cash-Mason, Tanesha D.; Cavanaugh, Cassandre R.; Rangwala, Shamina M.] Janssen Res & Dev, Cardiovasc & Metab Therapeut Area, Spring House, PA 19477 USA; [Lin-Schmidt, Xiefan; Chin, Chen-Ni; Armstrong, Anthony A.; South, Victoria J.; Huang, Chichi] Janssen Res & Dev, Janssen BioTherapeut, Spring House, PA USA; [Furman, Jennifer L.; Dinh, Thai Q.; Nelson, Serena; Hunter, Michael J.] Janssen Res & Dev, Janssen BioTherapeut, La Jolla, CA USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Rangwala, SM (corresponding author), Janssen Res & Dev, Cardiovasc & Metab Therapeut Area, Spring House, PA 19477 USA.	srangwal@its.jnj.com		Cavanaugh, Cassandre/0000-0002-5446-2871; Lin-Schmidt, Xiefan/0000-0001-8292-3930	Common Fund of the Office of the Director of the US National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS	Common Fund of the Office of the Director of the US National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following people for technical assistance in carrying out this work: B. Geist, Y. Wang, L. Lu, M. Husovsky (all at Janssen Research and Development). We thank E. Chi, S. Fenton, V. Stojanovic-Susulic, R. Swanson, J. Leonard and M. Erion (Janssen Research and Development) for support and insightful discussions. S.C.B., T.D.C.-M., C.R.C., and V.J.S. were employees of Kelly Outsourcing & Consulting Group. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the US National Institutes of Health, and by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Alao JP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-853; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Artz A, 2016, BLOOD, V128, P529, DOI 10.1182/blood-2016-01-696617; Bauskin AR, 2000, EMBO J, V19, P2212, DOI 10.1093/emboj/19.10.2212; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Chrysovergis K, 2014, INT J OBESITY, V38, P1555, DOI 10.1038/ijo.2014.27; Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Ding Q, 2009, ENDOCRINOLOGY, V150, P1688, DOI 10.1210/en.2008-0952; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Hasebe T, 2017, J GASTROENTEROL, V52, P341, DOI 10.1007/s00535-016-1237-6; Hatinen T, 2007, MOL CELL NEUROSCI, V34, P155, DOI 10.1016/j.mcn.2006.10.009; Hayes MR, 2008, ENDOCRINOLOGY, V149, P4059, DOI 10.1210/en.2007-1743; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kempf T, 2007, EUR HEART J, V28, P2858, DOI 10.1093/eurheartj/ehm465; Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466; Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602; Li ZH, 2005, J NEUROCHEM, V95, P361, DOI 10.1111/j.1471-4159.2005.03372.x; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Parkash V, 2009, ACTA CRYSTALLOGR F, V65, P551, DOI 10.1107/S1744309109017722; Quartu M, 2007, BRAIN RES, V1173, P36, DOI 10.1016/j.brainres.2007.07.064; Tsai VWW, 2012, J CACHEXIA SARCOPENI, V3, P239, DOI 10.1007/s13539-012-0082-6; Tsai VWW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133362; Tsai VWW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100370; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Verdeguer F, 2016, MOL CELL BIOL, V36, P184, DOI 10.1128/MCB.00722-15; Vieira P, 2003, CELL MOL NEUROBIOL, V23, P43, DOI 10.1023/A:1022593001155; Wang CY, 2014, BIOCHEM J, V460, P35, DOI 10.1042/BJ20140155; Wang XY, 2014, AGING-US, V6, P690, DOI 10.18632/aging.100687	38	324	338	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1150	+		10.1038/nm.4392	http://dx.doi.org/10.1038/nm.4392			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28846097				2022-12-27	WOS:000412431800010
J	Sampaziotis, F; Justin, AW; Tysoe, OC; Sawiak, S; Godfrey, EM; Upponi, SS; Gieseck, RL; de Brito, MC; Berntsen, NL; Gomez-Vazquez, MJ; Ortmann, D; Yiangou, L; Ross, A; Bargehr, J; Bertero, A; Zonneveld, MCF; Pedersen, MT; Pawlowski, M; Valestrand, L; Madrigal, P; Georgakopoulos, N; Pirmadjid, N; Skeldon, GM; Casey, J; Shu, WM; Materek, PM; Snijders, KE; Brown, SE; Rimland, CA; Simonic, I; Davies, SE; Jensen, KB; Zilbauer, M; Gelson, WTH; Alexander, GJ; Sinha, S; Hannan, NRF; Wynn, TA; Karlsen, TH; Melum, E; Markaki, AE; Saeb-Parsy, K; Vallier, L				Sampaziotis, Fotios; Justin, Alexander W.; Tysoe, Olivia C.; Sawiak, Stephen; Godfrey, Edmund M.; Upponi, Sara S.; Gieseck, Richard L., III; de Brito, Miguel Cardoso; Berntsen, Natalie Lie; Gomez-Vazquez, Maria J.; Ortmann, Daniel; Yiangou, Loukia; Ross, Alexander; Bargehr, Johannes; Bertero, Alessandro; Zonneveld, Marielle C. F.; Pedersen, Marianne T.; Pawlowski, Matthias; Valestrand, Laura; Madrigal, Pedro; Georgakopoulos, Nikitas; Pirmadjid, Negar; Skeldon, Gregor M.; Casey, John; Shu, Wenmiao; Materek, Paulina M.; Snijders, Kirsten E.; Brown, Stephanie E.; Rimland, Casey A.; Simonic, Ingrid; Davies, Susan E.; Jensen, Kim B.; Zilbauer, Matthias; Gelson, William T. H.; Alexander, Graeme J.; Sinha, Sanjay; Hannan, Nicholas R. F.; Wynn, Thomas A.; Karlsen, Tom H.; Melum, Espen; Markaki, Athina E.; Saeb-Parsy, Kourosh; Vallier, Ludovic			Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; LIVER; RAT; MODEL; MICE	The treatment of common bile duct (CBD) disorders, such as biliary atresia or ischemic strictures, is restricted by the lack of biliary tissue from healthy donors suitable for surgical reconstruction. Here we report a new method for the isolation and propagation of human cholangiocytes from the extrahepatic biliary tree in the form of extrahepatic cholangiocyte organoids (ECOs) for regenerative medicine applications. The resulting ECOs closely resemble primary cholangiocytes in terms of their transcriptomic profile and functional properties. We explore the regenerative potential of these organoids in vivo and demonstrate that ECOs self-organize into bile duct-like tubes expressing biliary markers following transplantation under the kidney capsule of immunocompromised mice. In addition, when seeded on biodegradable scaffolds, ECOs form tissue-like structures retaining biliary characteristics. The resulting bioengineered tissue can reconstruct the gallbladder wall and repair the biliary epithelium following transplantation into a mouse model of injury. Furthermore, bioengineered artificial ducts can replace the native CBD, with no evidence of cholestasis or occlusion of the lumen. In conclusion, ECOs can successfully reconstruct the biliary tree, providing proof of principle for organ regeneration using human primary cholangiocytes expanded in vitro.	[Sampaziotis, Fotios; Tysoe, Olivia C.; de Brito, Miguel Cardoso; Ortmann, Daniel; Yiangou, Loukia; Ross, Alexander; Bargehr, Johannes; Bertero, Alessandro; Zonneveld, Marielle C. F.; Pawlowski, Matthias; Madrigal, Pedro; Snijders, Kirsten E.; Brown, Stephanie E.; Rimland, Casey A.; Zilbauer, Matthias; Sinha, Sanjay; Vallier, Ludovic] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Cambridge, England; [Sampaziotis, Fotios; Tysoe, Olivia C.; de Brito, Miguel Cardoso; Ortmann, Daniel; Bertero, Alessandro; Georgakopoulos, Nikitas; Pirmadjid, Negar; Brown, Stephanie E.; Rimland, Casey A.; Saeb-Parsy, Kourosh; Vallier, Ludovic] Univ Cambridge, Dept Surg, Cambridge, England; [Sampaziotis, Fotios; Tysoe, Olivia C.; de Brito, Miguel Cardoso; Ortmann, Daniel; Bertero, Alessandro; Georgakopoulos, Nikitas; Pirmadjid, Negar; Brown, Stephanie E.; Rimland, Casey A.; Saeb-Parsy, Kourosh; Vallier, Ludovic] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Sampaziotis, Fotios; Gelson, William T. H.] Cambridge Univ Hosp NHS Fdn Trust, Dept Hepatol, Cambridge, England; [Sampaziotis, Fotios; Gelson, William T. H.] Univ Cambridge, Dept Engn, Cambridge, England; [Sawiak, Stephen] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Godfrey, Edmund M.; Upponi, Sara S.] Cambridge Univ Hosp NHS Fdn Trust, Dept Radiol, Cambridge, England; [Gieseck, Richard L., III; Rimland, Casey A.; Wynn, Thomas A.] US Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Parasit Dis Lab, Immunopathogenesis Sect, Bethesda, MD USA; [Berntsen, Natalie Lie; Valestrand, Laura; Karlsen, Tom H.; Melum, Espen] Oslo Univ Hosp, Inflammatory Dis & Transplantat, Norwegian PSC Res Ctr, Dept Transplantat Med,Div Surg, Oslo, Norway; [Gomez-Vazquez, Maria J.] Univ Cambridge, Cambridge Genom Serv, Dept Pathol, Cambridge, England; [Yiangou, Loukia; Bargehr, Johannes; Alexander, Graeme J.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Yiangou, Loukia; Bargehr, Johannes; Zilbauer, Matthias; Alexander, Graeme J.] Univ Cambridge, Div Cardiovasc Med, Cambridge, England; [Ross, Alexander; Sinha, Sanjay] Univ Cambridge, Univ Dept Paediat, Cambridge, England; [Ross, Alexander] Univ Cambridge, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge, England; [Bargehr, Johannes] Univ Cambridge, Div Cardiovasc Med, Cambridge, England; [Pedersen, Marianne T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Madrigal, Pedro; Vallier, Ludovic] Wellcome Trust Sanger Inst, Hinxton, England; [Skeldon, Gregor M.; Shu, Wenmiao] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh, Midlothian, Scotland; [Skeldon, Gregor M.; Shu, Wenmiao] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Casey, John] Univ Edinburgh, Edinburgh Royal Infirm, Dept Surg, Edinburgh, Midlothian, Scotland; [Materek, Paulina M.] Univ Cambridge, Addenbrookes Hosp, NIHR Cambridge Biomed Ctr BRC hIPSCs Core Facilit, Cambridge, England; [Rimland, Casey A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Simonic, Ingrid] Cambridge Univ Hosp NHS Trust, Med Genet Lab, Cambridge, England; [Davies, Susan E.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Hannan, Nicholas R. F.] Univ Nottingham, Ctr Biomol Sci, Nottingham, England; [Hannan, Nicholas R. F.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham Digest Dis Ctr, Nottingham, England; [Hannan, Nicholas R. F.] Univ Nottingham, Nottingham, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oslo; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Copenhagen; Wellcome Trust Sanger Institute; Heriot Watt University; University of Strathclyde; Royal Infirmary of Edinburgh; University of Edinburgh; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Cambridge; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham	Vallier, L (corresponding author), Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Cambridge, England.; Vallier, L (corresponding author), Univ Cambridge, Dept Surg, Cambridge, England.; Vallier, L (corresponding author), NIHR Cambridge Biomed Res Ctr, Cambridge, England.; Vallier, L (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	lv225@cam.ac.uk	Markaki, Athina E/H-9676-2012; Wynn, Thomas A/AAO-3523-2021; Sinha, Sanjay/AAF-1692-2021; Zilbauer, Matthias/AAZ-2740-2020; Hannan, Nicholas/ABG-6497-2020; Madrigal, Pedro/AAG-8543-2019; Bertero, Alessandro/AAC-7409-2021; Sawiak, Stephen/I-8944-2012	Markaki, Athina E/0000-0002-2265-1256; Wynn, Thomas A/0000-0002-7244-8731; Sinha, Sanjay/0000-0001-5900-1209; Zilbauer, Matthias/0000-0002-7272-0547; Vallier, Ludovic/0000-0002-3848-2602; Pawlowski, Matthias/0000-0001-6259-6100; Madrigal, Pedro/0000-0003-1959-8199; Georgakopoulos, Nikitas/0000-0002-1879-6583; Rimland, Casey/0000-0002-5187-6921; Gieseck, Richard/0000-0003-0200-581X; Yiangou, Loukia/0000-0003-1477-005X; Pedersen, Marianne Terndrup/0000-0003-3808-0352; Sawiak, Stephen/0000-0003-4210-9816; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Hannan, Nicholas/0000-0002-9843-1559; Ross, Alexander/0000-0003-3776-3186; Bargehr, Johannes/0000-0002-9304-3573; Jensen, Kim/0000-0001-6569-1664; Bertero, Alessandro/0000-0002-4919-9087	ERC [281335]; Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Evelyn Trust; EU; Intramural Research Program of the NIH/NIAID; Addenbrooke's Charitable Trust Clinical Research Training Fellowship; MRC-Sparks Clinical Research Training Fellowship [MR/L016761/1]; EPSRC [EP/L504920/1]; Engineering for Clinical Practice Grant from the Department of Engineering, University of Cambridge; BHF Studentship [FS/13/65/30441]; EPSRC [EP/M506837/1] Funding Source: UKRI; MRC [MR/L016761/1] Funding Source: UKRI; British Heart Foundation [FS/13/29/30024, FS/13/65/30441] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1353455] Funding Source: researchfish; Medical Research Council [MR/L016761/1, 1621144, MC_PC_12009] Funding Source: researchfish; Sparks Charity [14CAM01] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); Cambridge Hospitals National Institute for Health Research Biomedical Research Centre; Evelyn Trust; EU(European Commission); Intramural Research Program of the NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Addenbrooke's Charitable Trust Clinical Research Training Fellowship; MRC-Sparks Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering for Clinical Practice Grant from the Department of Engineering, University of Cambridge; BHF Studentship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Sparks Charity	This work was funded by ERC starting grant Relieve IMDs (281335; L.V., N.R.F.H.), the Cambridge Hospitals National Institute for Health Research Biomedical Research Centre (L.V., N.R.F.H., S. Sinha., F.S.), the Evelyn Trust (N.H.) and the EU FP7 grant TissuGEN (M.C.D.B.) and was supported in part by the Intramural Research Program of the NIH/NIAID (R.L.G., C.A.R.). F.S. has been supported by an Addenbrooke's Charitable Trust Clinical Research Training Fellowship and a joint MRC-Sparks Clinical Research Training Fellowship. (MR/L016761/1) A.W.J. and A.E.M. acknowledge support from EPSRC (EP/L504920/1) and an Engineering for Clinical Practice Grant from the Department of Engineering, University of Cambridge. J.B. was supported by a BHF Studentship (Grant FS/13/65/30441).	Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Campos Priscila B, 2009, J Vis Exp, DOI 10.3791/1512; Caperna TJ, 2011, IN VITRO CELL DEV-AN, V47, P218, DOI 10.1007/s11626-010-9382-3; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014; Cizkova D, 2005, PHYSIOL RES, V54, P419, DOI 10.33549/physiolres.930674; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Enestvedt CK, 2013, LIVER TRANSPLANT, V19, P965, DOI 10.1002/lt.23696; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Felder SI, 2013, JAMA SURG, V148, P253, DOI 10.1001/jamasurg.2013.601; Gallo A, 2013, PEDIATR TRANSPLANT, V17, P95, DOI 10.1111/petr.12040; Gigliozzi A, 2000, GASTROENTEROLOGY, V119, P1113, DOI 10.1053/gast.2000.18156; Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168; Gong AY, 2003, AM J PHYSIOL-CELL PH, V284, pC1205, DOI 10.1152/ajpcell.00313.2002; Hannan NRF, 2013, STEM CELL REP, V1, P293, DOI 10.1016/j.stemcr.2013.09.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jablonska B, 2014, CAN J SURG, V57, P271, DOI 10.1503/cjs.016613; Kanno N, 2000, HEPATOLOGY, V31, P555, DOI 10.1002/hep.510310302; Koo B.-K., 2013, CURR PROTOC STEM CEL, V27; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; LeSage G, 2001, LIVER, V21, P73, DOI 10.1034/j.1600-0676.2001.021002073.x; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; Masyuk AI, 2008, DEV DYNAM, V237, P2007, DOI 10.1002/dvdy.21530; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; Perkins JD, 2007, LIVER TRANSPLANT, V13, P465; Sampaziotis F, 2017, NAT PROTOC, V12, P814, DOI 10.1038/nprot.2017.011; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Sampaziotis F, 2015, HEPATOLOGY, V62, P303, DOI 10.1002/hep.27651; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Skaro AI, 2009, SURGERY, V146, P543, DOI 10.1016/j.surg.2009.06.052; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Xia XF, 2006, WORLD J GASTROENTERO, V12, P3553, DOI 10.3748/wjg.v12.i22.3553	38	147	157	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					954	+		10.1038/nm.4360	http://dx.doi.org/10.1038/nm.4360			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28671689	Green Submitted, Green Accepted			2022-12-27	WOS:000406947600011
J	Zhao, GN; Zhang, P; Gong, J; Zhang, XJ; Wang, PX; Yin, M; Jiang, Z; Shen, LJ; Ji, YX; Tong, JJ; Wang, YT; Wei, QF; Wang, Y; Zhu, XY; Zhang, X; Fang, J; Xie, QG; She, ZG; Wang, ZH; Huang, Z; Li, HL				Zhao, Guang-Nian; Zhang, Peng; Gong, Jun; Zhang, Xiao-Jing; Wang, Pi-Xiao; Yin, Miao; Jiang, Zhou; Shen, Li-Jun; Ji, Yan-Xiao; Tong, Jingjing; Wang, Yutao; Wei, Qiao-Fang; Wang, Yong; Zhu, Xue-Yong; Zhang, Xin; Fang, Jing; Xie, Qingguo; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang			Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTOR-4; INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; NEGATIVE REGULATOR; UBIQUITIN LIGASES; GUT MICROBIOTA; OBESITY; INFLAMMATION; STEATOHEPATITIS; NAFLD	Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent liver pathology that can progress from non-alcoholic fatty liver disease (NAFLD), and it is a leading cause of cirrhosis and hepatocellular carcinoma. There is currently no pharmacological therapy for NASH. Defective lysosome-mediated protein degradation is a key process that underlies steatohepatitis and a well-recognized drug target in a variety of diseases; however, whether it can serve as a therapeutic target for NAFLD and NASH remains unknown. Here we report that transmembrane BAX inhibitor motif-containing 1 (TMBIM1) is an effective suppressor of steatohepatitis and a previously unknown regulator of the multivesicular body (MVB)-lysosomal pathway. Tmbim1 expression in hepatocytes substantially inhibited high-fat diet-induced insulin resistance, hepatic steatosis and inflammation in mice. Mechanistically, Tmbim1 promoted the lysosomal degradation of toll-like receptor 4 by cooperating with the ESCRT endosomal sorting complex to facilitate MVB formation, and the ubiquitination of Tmbim1 by the E3 ubiquitin ligase Nedd4l was required for this process. We also found that overexpression of Tmbim1 in the liver effectively inhibited a severe form of NAFLD in mice and NASH progression in monkeys. Taken together, these findings could lead to the development of promising strategies to treat NASH by targeting MVB regulators to properly orchestrate the lysosome-mediated protein degradation of key mediators of the disease.	[Zhao, Guang-Nian; Zhang, Peng; Ji, Yan-Xiao; Li, Hongliang] Wuhan Univ, Zhongnan Hosp, Med Sci Res Ctr, Wuhan, Peoples R China; [Zhao, Guang-Nian; Zhang, Peng; Gong, Jun; Zhang, Xiao-Jing; Wang, Pi-Xiao; Yin, Miao; Jiang, Zhou; Shen, Li-Jun; Ji, Yan-Xiao; Tong, Jingjing; Wang, Yutao; Wei, Qiao-Fang; Zhu, Xue-Yong; Zhang, Xin; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang] Wuhan Univ, Basic Med Sch, Wuhan, Peoples R China; [Zhao, Guang-Nian; Zhang, Peng; Gong, Jun; Zhang, Xiao-Jing; Wang, Pi-Xiao; Yin, Miao; Jiang, Zhou; Shen, Li-Jun; Ji, Yan-Xiao; Tong, Jingjing; Wang, Yutao; Wei, Qiao-Fang; Wang, Yong; Zhu, Xue-Yong; Zhang, Xin; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang] Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China; [Zhao, Guang-Nian; Zhang, Peng; Gong, Jun; Zhang, Xiao-Jing; Wang, Pi-Xiao; Yin, Miao; Jiang, Zhou; Shen, Li-Jun; Ji, Yan-Xiao; Tong, Jingjing; Wang, Yutao; Wei, Qiao-Fang; Zhu, Xue-Yong; Zhang, Xin; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang] Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Peoples R China; [Zhao, Guang-Nian; Gong, Jun; Jiang, Zhou; Tong, Jingjing; Wang, Yutao; Wei, Qiao-Fang; Zhang, Xin; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Zhang, Xiao-Jing; Wang, Pi-Xiao; Shen, Li-Jun; Tong, Jingjing; Wang, Yutao; Wei, Qiao-Fang; She, Zhi-Gang; Wang, Zhihua; Li, Hongliang] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China; [Fang, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll,Div Cardiothorac & Vasc Surg, Sinoswiss Heart Lung Transplantat Inst,Heart Lung, Wuhan, Peoples R China; [Xie, Qingguo] Huazhong Univ Sci & Technol, Biomed Engn Dept, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, HL (corresponding author), Wuhan Univ, Zhongnan Hosp, Med Sci Res Ctr, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Basic Med Sch, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China.	lihl@whu.edu.cn	Wang, Zhihua/AAM-1486-2021; Jiang, Zhou/ABF-2435-2021	Jiang, Zhou/0000-0003-4247-2949; Huang, Zan/0000-0001-5623-6950	National Science Fund for Distinguished Young Scholars [81425005]; National Natural Science Foundation [81330005, 81630011, 91329000]; National Science and Technology Support Project [2014BAI02B01, 2015BAI08B01]; National Key Research and Development Program [2013YQ030923-05, 2016YFF0101504]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Project; National Key Research and Development Program	We appreciate L. Wan and J. Li (Huazhong University of Science and Technology) for PET operation. We thank L. Ma (Wuhan University), a biostatistics expert, for his help with our statistical analyses. This work was supported by the National Science Fund for Distinguished Young Scholars (grant no. 81425005; H.L.), the National Natural Science Foundation (grant no. 81330005 (H.L.), 81630011 (H.L.) and 91329000 (H.L.)), National Science and Technology Support Project no. 2014BAI02B01 (H.L.) and 2015BAI08B01 (H.L.), and National Key Research and Development Program no. 2013YQ030923-05 (H.L.) and 2016YFF0101504 (Z.-G.S.).	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Cisco RM, 2004, J IMMUNOL, V172, P7162, DOI 10.4049/jimmunol.172.11.7162; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Czech MP, 2013, NAT MED, V19, P969, DOI 10.1038/nm.3293; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gao L, 2016, J HEPATOL, V65, P125, DOI 10.1016/j.jhep.2016.03.006; Haas JT, 2016, ANNU REV PHYSIOL, V78, P181, DOI 10.1146/annurev-physiol-021115-105331; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jacobs F, 2011, CURR PHARM DESIGN, V17, P2500, DOI 10.2174/138161211797247569; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Lisak DA, 2015, BBA-MOL CELL RES, V1853, P2104, DOI 10.1016/j.bbamcr.2015.03.002; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; National Research Council, 2011, GUID CAR US LAB AN, P8; Noureddin M, 2016, EXPERT OPIN EMERG DR, V21, P343, DOI 10.1080/14728214.2016.1220533; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Okin D, 2016, CELL, V165, P343, DOI 10.1016/j.cell.2016.02.023; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ratner M, 2016, NAT BIOTECHNOL, V34, P575, DOI 10.1038/nbt0616-575; Ren XF, 2011, TRAFFIC, V12, P1282, DOI 10.1111/j.1600-0854.2011.01208.x; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sharifnia T, 2015, AM J PHYSIOL-GASTR L, V309, pG270, DOI 10.1152/ajpgi.00304.2014; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shukla S, 2011, APOPTOSIS, V16, P162, DOI 10.1007/s10495-010-0556-y; Song CY, 2015, J GASTROEN HEPATOL, V30, P405, DOI 10.1111/jgh.12691; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Townsend SA, 2016, BRIT MED BULL, V119, P143, DOI 10.1093/bmb/ldw031; Velloso LA, 2015, ENDOCR REV, V36, P245, DOI 10.1210/er.2014-1100; Vespasiani-Gentilucci U, 2015, LIVER INT, V35, P569, DOI 10.1111/liv.12531; Wang LL, 2011, MOL THER, V19, P2012, DOI 10.1038/mt.2011.151; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Wang PX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10592; Wang XA, 2014, HEPATOLOGY, V59, P870, DOI 10.1002/hep.26751; Wang XA, 2013, HEPATOLOGY, V58, P603, DOI 10.1002/hep.26368; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Xiang M, 2016, J HEPATOL, V64, P1365, DOI 10.1016/j.jhep.2016.02.002; Xie LF, 2016, J HEPATOL, V65, P113, DOI 10.1016/j.jhep.2016.03.008; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yan F. J., 2016, HEPATOLOGY; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang HJ, 2016, JAMA INTERN MED, V176, P1074, DOI 10.1001/jamainternmed.2016.3202; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132575; Zhang RN, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(5)2015.27909; Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333; Zhao H, 2006, GENES GENET SYST, V81, P41, DOI 10.1266/ggs.81.41; Zhao HJ, 2006, CIRC J, V70, P615, DOI 10.1253/circj.70.615; Zlatic S.A., 2010, JOVE-J VIS EXP, V37, pe1855	78	92	94	3	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					742	+		10.1038/nm.4334	http://dx.doi.org/10.1038/nm.4334			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28481357				2022-12-27	WOS:000402768000017
J	Fenouille, N; Bassi, CF; Ben-Sahra, I; Benajiba, L; Alexe, G; Ramos, A; Pikman, Y; Conway, AS; Burgess, MR; Li, Q; Luciano, F; Auberger, P; Galinsky, I; DeAngelo, DJ; Stone, RM; Zhang, Y; Perkins, AS; Shannon, K; Hemann, MT; Puissant, A; Stegmaier, K				Fenouille, Nina; Bassi, Christopher F.; Ben-Sahra, Issam; Benajiba, Lina; Alexe, Gabriela; Ramos, Azucena; Pikman, Yana; Conway, Amy S.; Burgess, Michael R.; Li, Qing; Luciano, Frederic; Auberger, Patrick; Galinsky, Ilene; DeAngelo, Daniel J.; Stone, Richard M.; Zhang, Yi; Perkins, Archibald S.; Shannon, Kevin; Hemann, Michael T.; Puissant, Alexandre; Stegmaier, Kimberly			The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia	NATURE MEDICINE			English	Article							SUCCINATE-DEHYDROGENASE; CELL METABOLISM; BREAST-CANCER; HEXOKINASE-II; MUTATIONS; EVI1; EXPRESSION; DIFFERENTIATION; ABNORMALITIES; MITOCHONDRIA	Expression of the MECOM (also known as EVI1) proto-oncogene is deregulated by chromosomal translocations in some cases of acute myeloid leukemia (AML) and is associated with poor clinical outcome. Here, through transcriptomic and metabolomic profiling of hematopoietic cells, we reveal that EVIl overexpression alters cellular metabolism. A screen using pooled short hairpin RNAs (shRNAs) identified the ATP-buffering, mitochondrial creatine kinase CKMT1 as necessary for survival of EVI1-expressing cells in subjects with EVI1-positive AML. EVI1 promotes CKMT1 expression by repressing the myeloid differentiation regulator RUNX1. Suppression of arginine creatine metabolism by CKMT1-directed shRNAs or by the small molecule cyclocreatine selectively decreased the viability, promoted the cell cycle arrest and apoptosis of human EVI1-positive cell lines, and prolonged survival in both orthotopic xenograft models and mouse models of primary AML. CKMT1 inhibition altered mitochondrial respiration and ATP production, an effect that was abrogated by phosphocreatine-mediated reactivation of the arginine creatine pathway. Targeting CKMT1 is thus a promising therapeutic strategy for this EVI1-driven AML ubtype that is highly resistant to current treatment regimens.	[Fenouille, Nina; Ramos, Azucena; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bassi, Christopher F.; Benajiba, Lina; Alexe, Gabriela; Pikman, Yana; Conway, Amy S.; Puissant, Alexandre; Stegmaier, Kimberly] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bassi, Christopher F.; Benajiba, Lina; Alexe, Gabriela; Pikman, Yana; Conway, Amy S.; Puissant, Alexandre; Stegmaier, Kimberly] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Ben-Sahra, Issam] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [Alexe, Gabriela; Stegmaier, Kimberly] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA; [Alexe, Gabriela] Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA; [Burgess, Michael R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Li, Qing] Univ Michigan, Internal Med Hematol Oncol, Ann Arbor, MI 48109 USA; [Luciano, Frederic; Auberger, Patrick] Unive Cote dAzur, UMR INSERM U1065, C3M, Nice, France; [Galinsky, Ilene; DeAngelo, Daniel J.; Stone, Richard M.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Zhang, Yi; Perkins, Archibald S.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Shannon, Kevin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Puissant, Alexandre] Hop St Louis, Inst Univ Hematol, INSERM UMR 944, Paris, France	Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Rochester; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stegmaier, K (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Stegmaier, K (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.; Stegmaier, K (corresponding author), Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA.	kimberly_stegmaier@dfci.harvard.edu	Benajiba, Lina/AAA-2274-2022; Benajiba, Lina/AAX-8466-2021; AUBERGER, Patrick/G-1491-2013; Fenouille, Nina/AAI-1027-2021; Puissant, Alexandre/AAF-3875-2021; luciano, frederic/P-6264-2016	Benajiba, Lina/0000-0001-5440-1115; AUBERGER, Patrick/0000-0002-2481-8275; Puissant, Alexandre/0000-0002-3997-9282; luciano, frederic/0000-0001-9253-4998; Pikman, Yana/0000-0002-5336-0216; DeAngelo, Daniel/0000-0001-7865-2306; Zhang, Yi/0000-0003-2785-1780	US National Cancer Institute (NCI) [NIH 1R35 CA210030-01, R37 CA72614]; Stand-up-to-Cancer Program; Koch Institute for Integrative Cancer Research at MIT; Dana-Farber-Harvard Cancer Center (DF-HCC); Koch Institute Cancer Center Support (NCI) [P30-CA14051]; Cubans Curing Children's Cancers (4C's Fund); ATIP-AVENIR program; LNCC French research program; EHA research grant; St. Louis Association for leukemia research; 'Prix Jeune Chercheur' from the Bettencourt Foundation; Franco-American Exchange Prize from Philippe Foundation Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA128583, P30CA014051, R01CA180037, R37CA072614, R35CA210030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand-up-to-Cancer Program; Koch Institute for Integrative Cancer Research at MIT; Dana-Farber-Harvard Cancer Center (DF-HCC); Koch Institute Cancer Center Support (NCI); Cubans Curing Children's Cancers (4C's Fund); ATIP-AVENIR program; LNCC French research program; EHA research grant; St. Louis Association for leukemia research; 'Prix Jeune Chercheur' from the Bettencourt Foundation; Franco-American Exchange Prize from Philippe Foundation Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sato and M. Kurokawa (University of Tokyo) for providing plasmid constructs and detailed procedures for Evil overexpression in mouse hematopoietic cells. We also thank J.F. Clark (University of Cincinnati) for advice on the use of cyclocreatine in vivo. This research was supported with grants from the US National Cancer Institute (NCI) (NIH 1R35 CA210030-01 (K. Stegmaier) and R37 CA72614 (K. Shannon)), the Stand-up-to-Cancer Program (K. Stegmaier); the Bridge Project, a collaboration between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber-Harvard Cancer Center (DF-HCC) (K. Stegmaier and M.T.H.) and the Koch Institute Cancer Center Support (NCI grant P30-CA14051; M.T.H.), and with support from the Cubans Curing Children's Cancers (4C's Fund) (K. Stegmaier). A.P. is a recipient of support from the ATIP-AVENIR and LNCC French research programs, the EHA research grant for a Non-Clinical Advanced fellow, and is supported by the St. Louis Association for leukemia research. K. Stegmaier is an LLS Scholar. A.P., N.F. and I.B.-S. were awarded the 'Prix Jeune Chercheur' from the Bettencourt Foundation and the Franco-American Exchange Prize from Philippe Foundation Inc.	ARORA KK, 1988, J BIOL CHEM, V263, P17422; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Burgess MR, 2014, BLOOD, V124, P3947, DOI 10.1182/blood-2014-05-574582; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cimino D, 2008, INT J CANCER, V123, P1327, DOI 10.1002/ijc.23660; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; FURTER R, 1993, BIOCHEMISTRY-US, V32, P7022, DOI 10.1021/bi00078a030; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Glass C, 2014, BLOOD CELL MOL DIS, V53, P67, DOI 10.1016/j.bcmd.2014.01.002; Glass C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067134; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Groschel S, 2010, J CLIN ONCOL, V28, P2101, DOI 10.1200/JCO.2009.26.0646; Herranz D, 2015, NAT MED, V21, P1182, DOI 10.1038/nm.3955; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kim S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-299; Kustikova OS, 2013, LEUKEMIA, V27, P1127, DOI 10.1038/leu.2012.355; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Miraki-Moud F, 2015, BLOOD, V125, P4060, DOI 10.1182/blood-2014-10-608133; Mussai F, 2015, BLOOD, V125, P2386, DOI 10.1182/blood-2014-09-600643; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Plunkett W, 2015, BLOOD, V125, P3971, DOI 10.1182/blood-2015-05-643411; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	35	58	59	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					301	313		10.1038/nm.4283	http://dx.doi.org/10.1038/nm.4283			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28191887	Green Submitted, Green Accepted			2022-12-27	WOS:000395848400011
J	Oller, J; Mendez-Barbero, N; Ruiz, EJ; Villahoz, S; Renard, M; Canelas, LI; Briones, AM; Alberca, R; Lozano-Vidal, N; Hurle, MA; Milewicz, D; Evangelista, A; Salaices, M; Nistal, JF; Jimenez-Borreguero, LJ; De Backer, J; Campanero, MR; Redondo, JM				Oller, Jorge; Mendez-Barbero, Nerea; Josue Ruiz, E.; Villahoz, Silvia; Renard, Marjolijn; Canelas, Lizet I.; Briones, Ana M.; Alberca, Rut; Lozano-Vidal, Noelia; Hurle, Maria A.; Milewicz, Dianna; Evangelista, Arturo; Salaices, Mercedes; Nistal, J. Francisco; Jesus Jimenez-Borreguero, Luis; De Backer, Julie; Campanero, Miguel R.; Miguel Redondo, Juan			Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome	NATURE MEDICINE			English	Article							ANGIOTENSIN-II; ANEURYSM FORMATION; INFLAMMATORY ANEURYSM; THORACIC AORTA; IN-VIVO; SYNTHASE; EXPRESSION; DISSECTIONS; DISINTEGRIN; PROGRESSION	Heritable thoracic aortic aneurysms and dissections (TAAD), including Marfan syndrome (MFS), currently lack a cure, and causative mutations have been identified for only a fraction of affected families. Here we identify the metalloproteinase ADAMTS1 and inducible nitric oxide synthase (NOS2) as therapeutic targets in individuals with TAAD. We show that Adamts1 is a major mediator of vascular homeostasis, given that genetic haploinsufficiency of Adamts1 in mice causes TAAD similar to MFS. Aortic nitric oxide and Nos2 levels were higher in Adamts1-deficient mice and in a mouse model of MFS (hereafter referred to as MFS mice), and Nos2 inactivation protected both types of mice from aortic pathology. Pharmacological inhibition of Nos2 rapidly reversed aortic dilation and medial degeneration in young Adamts1-deficient mice and in young or old MFS mice. Patients with MFS showed elevated NOS2 and decreased ADAMTS1 protein levels in the aorta. These findings uncover a possible causative role for the ADAMTS1 NOS2 axis in human TAAD and warrant evaluation of NOS2 inhibitors for therapy.	[Oller, Jorge; Mendez-Barbero, Nerea; Josue Ruiz, E.; Villahoz, Silvia; Canelas, Lizet I.; Alberca, Rut; Lozano-Vidal, Noelia; Miguel Redondo, Juan] CNIC, Gene Regulat Cardiovasc Remodeling & Inflammat Gr, Madrid, Spain; [Renard, Marjolijn] Ghent Univ Hosp, Ctr Med Genet Ghent, Ghent, Belgium; [Briones, Ana M.; Salaices, Mercedes; De Backer, Julie] Univ Autonoma Madrid, Dept Pharmacol, Fac Med, Madrid, Spain; [Hurle, Maria A.; Nistal, J. Francisco] Univ Cantabria, Hosp Univ Marques de Valdecilla, IDIVAL, Cardiovasc Surg,Fac Med, Santander, Spain; [Hurle, Maria A.; Nistal, J. Francisco] Univ Cantabria, Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med,Dept Physiol & Pharmacol, Santander, Spain; [Milewicz, Dianna] Univ Texas Houston, Div Med Genet, Houston, TX USA; [Evangelista, Arturo] Hosp Valle De Hebron, Serv Cardiol, Barcelona, Spain; [Jesus Jimenez-Borreguero, Luis] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Jesus Jimenez-Borreguero, Luis] Hosp la Princesa, Madrid, Spain; [Campanero, Miguel R.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid, Spain; [Miguel Redondo, Juan] Ctr Invest Biomed RED Enfermedades Cardiovasc CIB, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Ghent University; Ghent University Hospital; Autonomous University of Madrid; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of Texas System; University of Texas Health Science Center Houston; Hospital Universitari Vall d'Hebron; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital de La Princesa; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Redondo, JM (corresponding author), CNIC, Gene Regulat Cardiovasc Remodeling & Inflammat Gr, Madrid, Spain.; Campanero, MR (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid, Spain.; Redondo, JM (corresponding author), Ctr Invest Biomed RED Enfermedades Cardiovasc CIB, Madrid, Spain.	mcampanero@iib.uam.es; jmredondo@cnic.es	Redondo, Juan Miguel/H-6351-2015; De Backer, Julie/B-2897-2014; Mendez-Barbero, Nerea/AAV-4643-2020; Campanero, Miguel R/A-4052-2013; Jimenez-Borreguero, Luis Jesus/L-8107-2014	Redondo, Juan Miguel/0000-0001-5779-9122; De Backer, Julie/0000-0001-8878-1507; Mendez-Barbero, Nerea/0000-0003-1620-3067; Campanero, Miguel R/0000-0003-1410-8621; Briones, Ana/0000-0001-8218-5579; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Lozano-Vidal, Noelia/0000-0003-4115-0227; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X; Oller Pedrosa, Jorge/0000-0002-2224-2954; Hurle, Maria Amor/0000-0002-7710-1358	Spanish Ministerio de Economia, Industria y Competitividad (MINECO); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award) [SEV-2015-0505]; MINECO [SAF2013-45258P, SAF2012-34296, SAF2015-636333R]; Fundacion La Marato (TV3 grant) [20151331, 20151330]; CSIC; CIBERCV of Ministerio de Sanidad [B16/11/00264]; Red de Investigacion Cardiovascular (RIC) of Ministerio de Sanidad [RD12/0042/0022, RD12/0042/0021, RD12/0042/0024, RD12/0042/0056, RD12/0042/0018]; Marie Sklodowska-Curie fellowship; FPI fellowships [BES 2010-034552, SVP-2013-067777]	Spanish Ministerio de Economia, Industria y Competitividad (MINECO)(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award)(Spanish Government); MINECO(Spanish Government); Fundacion La Marato (TV3 grant); CSIC; CIBERCV of Ministerio de Sanidad; Red de Investigacion Cardiovascular (RIC) of Ministerio de Sanidad; Marie Sklodowska-Curie fellowship; FPI fellowships	We thank B. Ibanez and G. Egea for reagents, S. Bartlett for English language editing, A.G. Arroyo, S. Lamas, J. Alegre-Cebollada and J. Ruiz-Cabello for critical reading of the manuscript and advice, and S. Pocock and J. Vazquez for advice on statistics. We also thank the CNIC histology facility, C. Velasco, A.V. Alonso and L. Flores for technical support. CNIC is supported by the Spanish Ministerio de Economia, Industria y Competitividad (MINECO) and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). Support was also provided by grants from MINECO (grants SAF2013-45258P (M.R.C.), SAF2012-34296 (J.M.R.) and SAF2015-636333R (J.M.R.)), Fundacion La Marato (TV3 grants 20151331 (J.M.R.) and 20151330 (A.E.)), CSIC (M.R.C.), the CIBERCV of Ministerio de Sanidad (grant CB16/11/00264; J.M.R.) and the Red de Investigacion Cardiovascular (RIC) of Ministerio de Sanidad (grants RD12/0042/0022 (J.M.R.), RD12/0042/0021 (A.E.), RD12/0042/0024 (KS.), RD12/0042/0056 (J.L.J.-B.) and RD12/0042/0018 (J.F.N.)), and by a Marie Sklodowska-Curie fellowship (E.J.R.) and FPI fellowships BES 2010-034552 (J.O.) and SVP-2013-067777 (S.V.). The cost of this publication has been paid in part with FEDER funds.	Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Chen XF, 2013, CURR OPIN PHARMACOL, V13, P180, DOI 10.1016/j.coph.2013.01.002; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; De Backer J, 2015, CURR PHARM DESIGN, V21, P4061, DOI 10.2174/1381612821666150826093152; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Escolano A, 2014, EMBO J, V33, P1117, DOI 10.1002/embj.201386369; Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forteza A, 2016, EUR HEART J, V37, P978, DOI 10.1093/eurheartj/ehv575; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; Gao YX, 2016, SCI CHINA LIFE SCI, V59, P59, DOI 10.1007/s11427-015-4959-4; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675; Girardi LN, 1997, ANN THORAC SURG, V64, P251, DOI 10.1016/S0003-4975(97)00458-X; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hubmacher D, 2011, CELL MOL LIFE SCI, V68, P3137, DOI 10.1007/s00018-011-0780-9; Johanning JM, 2002, ANN VASC SURG, V16, P65, DOI 10.1007/s10016-001-0139-z; Johanning JM, 2001, J VASC SURG, V33, P579, DOI 10.1067/mva.2001.111805; Karimi A, 2016, CAN J CARDIOL, V32, P26, DOI 10.1016/j.cjca.2015.11.004; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Lacro RV, 2014, NEW ENGL J MED, V371, P2061, DOI 10.1056/NEJMoa1404731; Le Goff C, 2011, HUM MOL GENET, V20, pR163, DOI 10.1093/hmg/ddr361; Lee JK, 2001, ARTERIOSCL THROM VAS, V21, P1393, DOI 10.1161/hq0901.095750; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Mendez-Barbero N, 2013, EMBO MOL MED, V5, P1901, DOI 10.1002/emmm.201302842; Milleron O, 2015, EUR HEART J, V36, P2160, DOI 10.1093/eurheartj/ehv151; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; O'Sullivan S, 2014, BBA-MOL CELL RES, V1843, P603, DOI 10.1016/j.bbamcr.2013.12.006; Oller J, 2015, MOL CELL BIOL, V35, P3409, DOI 10.1128/MCB.00494-15; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfeilschifter J, 2001, PFLUG ARCH EUR J PHY, V442, P479, DOI 10.1007/s004240100586; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Ren PP, 2013, ANN THORAC SURG, V95, P570, DOI 10.1016/j.athoracsur.2012.10.084; Renard M, 2013, INT J CARDIOL, V165, P314, DOI 10.1016/j.ijcard.2011.08.079; Roth M, 2002, J THORAC CARDIOV SUR, V123, P822, DOI 10.1067/mtc.2002.121291; Sadamasa N, 2003, STROKE, V34, P2980, DOI 10.1161/01.STR.0000102556.55600.3B; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Segura A. M., CIRCULATION, V98, P11331; Segura AM, 1998, CIRCULATION, V98, pII331; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Thai SNM, 2002, MECH DEVELOP, V115, P181, DOI 10.1016/S0925-4773(02)00115-6; Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005; Wu ZY, 2016, AM J TRANSL RES, V8, P1426; Zhang J, 2003, J VASC SURG, V38, P360, DOI 10.1016/S0741-5214(03)00148-4	58	92	93	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					200	212		10.1038/nm.4266	http://dx.doi.org/10.1038/nm.4266			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28067899	Green Submitted			2022-12-27	WOS:000393729000012
J	Troy, CM; Shelanski, ML				Troy, Carol M.; Shelanski, Michael L.			Caspase-2 and tau-a toxic partnership?	NATURE MEDICINE			English	Editorial Material							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN; PATHOLOGY; BRAIN	Misfolded and hyperphosphorylated forms of the microtubule-associated protein tau are thought to be responsible for some degree of neurodegeneration. The demonstration of a novel toxic cleavage of tau by caspase-2 opens up new therapeutic avenues.	[Troy, Carol M.; Shelanski, Michael L.] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Troy, Carol M.] Columbia Univ, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University; Columbia University	Shelanski, ML (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	mls7@columbia.edu	Troy, Carol/ABC-2771-2020		NINDS NIH HHS [R01 NS081333] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; MIGHELI A, 1988, J NEUROSCI, V8, P1846; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; Troy CM, 2000, J NEUROSCI, V20, P1386; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199	12	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1207	1208		10.1038/nm.4227	http://dx.doi.org/10.1038/nm.4227			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27824824	Green Accepted			2022-12-27	WOS:000387302300008
J	Waldorf, KMA; Stencel-Baerenwald, JE; Kapur, RP; Studholme, C; Boldenow, E; Vornhagen, J; Baldessari, A; Dighe, MK; Thiel, J; Merillat, S; Armistead, B; Tisoncik-Go, J; Green, RR; Davis, MA; Dewey, EC; Fairgrieve, MR; Gatenby, JC; Richards, T; Garden, GA; Diamond, MS; Juul, SE; Grant, RF; Kuller, L; Shaw, DWW; Ogle, J; Gough, GM; Lee', W; English, C; Hevner, RF; Dobyns, WB; Gale, M; Rajagopa, L				Waldorf, Kristina M. Adams; Stencel-Baerenwald, Jennifer E.; Kapur, Raj P.; Studholme, Colin; Boldenow, Erica; Vornhagen, Jay; Baldessari, Audrey; Dighe, Manjiri K.; Thiel, Jeff; Merillat, Sean; Armistead, Blair; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gatenby, J. Christopher; Richards, Todd; Garden, Gwenn A.; Diamond, Michael S.; Juul, Sandra E.; Grant, Richard F.; Kuller, LaRene; Shaw, Dennis W. W.; Ogle, Jason; Gough, G. Michael; Lee', Wonsok; English, Chris; Hevner, Robert F.; Dobyns, William B.; Gale, Michael, Jr.; Rajagopa, Lakshmi			Fetal brain lesions after sub-cutaneous inoculation of Zika virus in a pregnant nonhuman primate	NATURE MEDICINE			English	Article							ENCEPHALITIS; INFECTION; MACAQUE; DAMAGE; CELLS	We describe the development of fetal brain lesions after Zika virus (ZIKV) inoculation in a pregnant pigtail macaque. Periventricular lesions developed within 10 d and evolved asymmetrically in the occipital-parietal lobes. Fetal autopsy revealed ZIKV in the brain and significant cerebral white matter hypoplasia, periventricular white matter gliosis, and axonal and ependymal injury. Our observation of ZIKV-associated fetal brain lesions in a nonhuman primate provides a model for therapeutic evaluation.	[Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Kapur, Raj P.; Garden, Gwenn A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kapur, Raj P.] Seattle Childrens Hosp, Dept Pathol, Seattle, WA USA; [Studholme, Colin; Boldenow, Erica; Juul, Sandra E.; Dobyns, William B.; Rajagopa, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Studholme, Colin] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Studholme, Colin; Dighe, Manjiri K.; Thiel, Jeff; Gatenby, J. Christopher; Richards, Todd; Shaw, Dennis W. W.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Boldenow, Erica; Vornhagen, Jay; Merillat, Sean; Armistead, Blair; Rajagopa, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA; [Armistead, Blair; Rajagopa, Lakshmi] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baldessari, Audrey; Grant, Richard F.; Kuller, LaRene; Ogle, Jason; Gough, G. Michael; Lee', Wonsok; English, Chris] Washington Natl Primate Res Ctr, Seattle, WA USA; [Garden, Gwenn A.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA; [Shaw, Dennis W. W.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA; [Hevner, Robert F.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hevner, Robert F.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Boldenow, Erica] Calvin Coll, Dept Biol, Grand Rapids, MI 49506 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Calvin University	Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Rajagopa, L (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Rajagopa, L (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.; Rajagopa, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	adamsk@uw.edu; mgale@uw.edu; lakshmi.rajagopal@seattlechildrens.org	Dobyns, William/AAI-2768-2020; Dighe, Manjiri/D-9294-2018; Diamond, Michael/AAH-1733-2019; Garden, Gwenn/CAF-9344-2022; Vornahgen, Jay/AAI-1887-2019; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; Dighe, Manjiri/0000-0003-0047-5148; Diamond, Michael/0000-0002-8791-3165; Vornahgen, Jay/0000-0002-1685-302X; Gale, Michael/0000-0002-6332-7436; Garden, Gwenn/0000-0002-8753-6515; Davis, Michael/0000-0002-5406-4128; Green, Richard/0000-0001-8851-7204	University of Washington Department of Obstetrics and Gynecology; US National Institutes of Health (NIH) [R01AI100989, AI104002, AI083019, R01EB017133, R01NS055064, R01NS061957]; NIH [T32 HD007233, T32 AI07509]; Office of Research Infrastructure Programs (ORIP) of the NIH [P51OD010425]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100989, R01AI104002, T32AI007509, U19AI083019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055064, R01NS061957] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	University of Washington Department of Obstetrics and Gynecology; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs (ORIP) of the NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Seattle Genomics Core Laboratory of the Washington National Primate Research Center Systems Biology Division for sequence analysis and the Center for Innate Immunity and Immune Disease immuno-informatics core group for bioinformatics support. We would like to acknowledge J. Hamanishi for technical assistance with preparation of the figures and L. Brandao (neuroradiologist at the Clinica Felippe Mattoso) for providing images and clinical information from a child with congenital ZIKV syndrome. We thank R. Tesh (University of Texas Medical Branch at Galveston-World Reference Center for Emerging Viruses and Arboviruses) for providing viral seed stocks. We thank A. Powers (US Centers for Disease Control and Prevention) for technical guidance for the qPCR experiments and C. Hughes for administrative assistance. We also thank M.-T. Little for technical editing. This work was supported by funding from the University of Washington Department of Obstetrics and Gynecology (K.M.A.W.) and the US National Institutes of Health (NIH) (grant no. R01AI100989 (L.R. and K.M.A.W.), AI104002 (M.G.), AI083019 (M.G.), R01EB017133 (C.S.), R01NS055064 (C.S.) and R01NS061957 (C.S)). The NIH training grants T32 HD007233 and T32 AI07509 provided support for E.B. and respectively. This project was also supported by the Office of Research Infrastructure Programs (ORIP) of the NIH through grant no. P51OD010425 to the Washington National Primate Research Center (A.B., R.F.G., L.K., J.O., G.M.G., W.L. and C.E.). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health or other funders. The funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Brasil R, 2016, N ENGL J MED; Bruce AG, 2013, J VIROL, V87, P13676, DOI 10.1128/JVI.02331-13; CONRAD S, 1995, AM J PRIMATOL, V36, P15, DOI 10.1002/ajp.1350360103; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; HADDAD J, 1990, NEUROPEDIATRICS, V21, P215, DOI 10.1055/s-2008-1071500; Lennartsson F, 2014, INVEST OPHTH VIS SCI, V55, P8278, DOI 10.1167/iovs.14-14913; Leonard JR, 2000, AM J ROENTGENOL, V174, P1651, DOI 10.2214/ajr.174.6.1741651; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Nakgoi K, 2014, AM J PRIMATOL, V76, P97, DOI 10.1002/ajp.22213; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Putaporntip C, 2010, MOL ECOL, V19, P3466, DOI 10.1111/j.1365-294X.2010.04756.x; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Sourisseau M, 2013, GASTROENTEROLOGY, V145, P966, DOI 10.1053/j.gastro.2013.07.026; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58	19	177	179	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1256	1259		10.1038/nm.4193	http://dx.doi.org/10.1038/nm.4193			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27618651	Bronze, Green Accepted			2022-12-27	WOS:000387302300017
J	He, J; Zhang, X; Wei, YB; Sun, XL; Chen, YP; Deng, J; Jin, YB; Gan, YZ; Hu, X; Jia, RL; Xu, CH; Hou, ZH; Leong, YA; Zhu, L; Feng, JH; An, Y; Jia, Y; Li, C; Liu, X; Ye, H; Ren, LM; Li, R; Yao, HH; Li, YH; Chen, S; Zhang, XW; Su, Y; Guo, JP; Shen, N; Morand, EF; Yu, D; Li, ZG				He, Jing; Zhang, Xia; Wei, Yunbo; Sun, Xiaolin; Chen, Yaping; Deng, Jun; Jin, Yuebo; Gan, Yuzhou; Hu, Xin; Jia, Rulin; Xu, Chuanhui; Hou, Zhaohua; Leong, Yew Ann; Zhu, Lei; Feng, Jinhong; An, Yuan; Jia, Yuan; Li, Chun; Liu, Xu; Ye, Hua; Ren, Limin; Li, Ru; Yao, Haihong; Li, Yuhui; Chen, Shi; Zhang, Xuewu; Su, Yin; Guo, Jianping; Shen, Nan; Morand, Eric F.; Yu, Di; Li, Zhanguo			Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus	NATURE MEDICINE			English	Article							EXPRESSION; RESPONSES; THERAPY; TH17	Systemic lupus erythematosus (SLE) is a potentially life-threatening autoimmune disease characterized by altered balance of activity between effector and regulatory CD4(+) T cells. The homeostasis of CD4(+) T cell subsets is regulated by interleukin (IL)-2, and reduced production of IL-2 by T cells is observed in individuals with SLE. Here we report that treatment with low-dose recombinant human IL-2 selectively modulated the abundance of regulatory T (T-reg) cells, follicular helper T (T-FH) cells and IL-17-producing helper T (T(H)17) cells, but not T(H)1 or T(H)2 cells, accompanied by marked reductions of disease activity in patients with SLE.	[He, Jing; Zhang, Xia; Sun, Xiaolin; Jin, Yuebo; Gan, Yuzhou; Jia, Rulin; Xu, Chuanhui; Zhu, Lei; An, Yuan; Jia, Yuan; Li, Chun; Liu, Xu; Ye, Hua; Ren, Limin; Li, Ru; Yao, Haihong; Li, Yuhui; Chen, Shi; Zhang, Xuewu; Su, Yin; Guo, Jianping; Li, Zhanguo] Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Wei, Yunbo; Hou, Zhaohua; Feng, Jinhong; Yu, Di] Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Peoples R China; [Chen, Yaping; Hu, Xin; Leong, Yew Ann; Yu, Di] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Lab Mol Immunomodulat,Infect & Immun Program, Clayton, Vic, Australia; [Deng, Jun; Shen, Nan; Yu, Di] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Sch Med, Shanghai, Peoples R China; [Morand, Eric F.; Yu, Di] Monash Univ, Monash Hlth, Ctr Inflammatory Dis, Sch Clin Sci, Clayton, Vic, Australia	Peking University; Qilu University of Technology; Monash University; Shanghai Jiao Tong University; Monash University	Yu, D; Li, ZG (corresponding author), Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China.; Yu, D (corresponding author), Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Peoples R China.; Yu, D (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Lab Mol Immunomodulat,Infect & Immun Program, Clayton, Vic, Australia.; Yu, D (corresponding author), Shanghai Jiao Tong Univ, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Sch Med, Shanghai, Peoples R China.; Yu, D (corresponding author), Monash Univ, Monash Hlth, Ctr Inflammatory Dis, Sch Clin Sci, Clayton, Vic, Australia.	di.yu@monash.edu; li99@bjmu.edu.cn	Sun, Xiaolin/AAD-8492-2022; Hou, Zhaohua/A-1046-2018; Wei, Yunbo/AHE-8248-2022; Shen, Nan/AGK-6807-2022; Morand, Eric F/I-4718-2013; Morand, Eric/AAT-3259-2021; Yu, Di/C-2163-2009	Sun, Xiaolin/0000-0001-9709-1532; Hou, Zhaohua/0000-0003-3093-0279; Morand, Eric F/0000-0002-9507-3338; Morand, Eric/0000-0002-9507-3338; Yu, Di/0000-0003-1721-8922; Shen, Nan/0000-0002-5875-4417; Leong, Yew Ann/0000-0002-0999-7084; Xu, Chuanhui/0000-0002-3222-7168; Deng, Jun/0000-0002-8916-6503; Li, Zhanguo/0000-0002-2590-6242	National Sci-Tech Support Program [2014BAI07B01]; National Basic Research Program of China 973 Program [2014CB541903, 2014CB541901, 2010CB529104]; National Natural Science Foundation of China (NSFC) [81373117, 31570880, 31530020, 81429003, 81471601]; Beijing Key Laboratory for Rheumatism and Immune Diagnosis [BZ0135]; Peking-Tsinghua Center for Life Sciences; Priority Research Program of the Shandong Academy of Sciences; Shandong Province Taishan Scholar Program; Australian National Health and Medical Research Council (NHMRC) [GNT1085509]	National Sci-Tech Support Program; National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Key Laboratory for Rheumatism and Immune Diagnosis; Peking-Tsinghua Center for Life Sciences; Priority Research Program of the Shandong Academy of Sciences; Shandong Province Taishan Scholar Program; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by the National Sci-Tech Support Program (grant no. 2014BAI07B01; Z.L.), the National Basic Research Program of China 973 Program (grant no. 2014CB541903 (D.Y.), 2014CB541901 (N.S.) and 2010CB529104 (Z.L.)), the National Natural Science Foundation of China (NSFC) (grant no. 81373117 (J.H.), 31570880 (J.H.), 31530020 (Z.L.), 81429003 (D.Y.) and 81471601 (X.S.)), the Beijing Key Laboratory for Rheumatism and Immune Diagnosis (grant no. BZ0135; Z.L.), the Peking-Tsinghua Center for Life Sciences (Z.L.), the Priority Research Program of the Shandong Academy of Sciences (D.Y.), the Shandong Province Taishan Scholar Program (D.Y.) and the Australian National Health and Medical Research Council (NHMRC) Fellowship GNT1085509 (D.Y.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Castela E, 2014, JAMA DERMATOL, V150, P748, DOI 10.1001/jamadermatol.2014.504; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; Humrich JY, 2015, ANN RHEUM DIS, V74, P791, DOI 10.1136/annrheumdis-2014-206506; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Vincent FB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4277; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499	27	332	369	5	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					991	+		10.1038/nm.4148	http://dx.doi.org/10.1038/nm.4148			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27500725				2022-12-27	WOS:000382542800009
J	Li, S; Garrett-Bakelman, FE; Chung, SS; Sanders, MA; Hricik, T; Rapaport, F; Patel, J; Dillon, R; Vijay, P; Brown, AL; Perl, AE; Cannon, J; Bullinger, L; Luger, S; Becker, M; Lewis, ID; To, LB; Delwel, R; Lowenberg, B; Dohner, H; Guzman, ML; Hassane, DC; Roboz, GJ; Grimwade, D; Valk, PJM; D'Andrea, RJ; Carroll, M; Park, CY; Neuberg, D; Levine, R; Melnick, AM; Mason, CE				Li, Sheng; Garrett-Bakelman, Francine E.; Chung, Stephen S.; Sanders, Mathijs A.; Hricik, Todd; Rapaport, Franck; Patel, Jay; Dillon, Richard; Vijay, Priyanka; Brown, Anna L.; Perl, Alexander E.; Cannon, Joy; Bullinger, Lars; Luger, Selina; Becker, Michael; Lewis, Ian D.; To, Luen Bik; Delwel, Ruud; Lowenberg, Bob; Doehner, Hartmut; Guzman, Monica L.; Hassane, Duane C.; Roboz, Gail J.; Grimwade, David; Valk, Peter J. M.; D'Andrea, Richard J.; Carroll, Martin; Park, Christopher Y.; Neuberg, Donna; Levine, Ross; Melnick, Ari M.; Mason, Christopher E.			Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia	NATURE MEDICINE			English	Article							CLONAL EVOLUTION; DNA METHYLATION; MUTATIONS RESULT; TET2 FUNCTION; CHEMOTHERAPY; CTCF; AML	Genetic heterogeneity contributes to clinical outcome and progression of most tumors, but little is known about allelic diveisity for epigenetic compartments, and almost no data exist for acute myeloid leukemia (AML). We examined epigenetic heterogeneity as assessed by cytosine methylation within defined genomic loci with four CpGs (epialleles), somatic mutations, and transcriptomes of AML patient samples at serial time points. We observed that epigenetic allele burden is linked to inferior outcome and varies considerably during disease progression. Epigenetic and genetic allelic burden and patterning followed different patterns and kinetics during disease progression. We observed a subset of AMLs with high epiallele and low somatic mutation burden at diagnosis, a subset with high somatic mutation and lower epiallele burdens at diagnosis, and a subset with a mixed profile, suggesting distinct modes of tumor heterogeneity. Genes linked to promoter-associated epiallele shifts during tumor progression showed increased single-cell transcriptional variance and differential expression, suggesting functional impact on gene regulation. Thus, genetic and epigenetic heterogeneity can occur with distinct kinetics likely to affect the biological and clinical features of tumors.	[Li, Sheng; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Li, Sheng; Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al Sa, New York, NY 10065 USA; [Garrett-Bakelman, Francine E.; Guzman, Monica L.; Hassane, Duane C.; Roboz, Gail J.; Melnick, Ari M.] Weill Cornell Med, Div Hematol Med Oncol, Dept Med, New York, NY 10065 USA; [Chung, Stephen S.; Hricik, Todd; Rapaport, Franck; Patel, Jay; Levine, Ross] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Sanders, Mathijs A.; Delwel, Ruud; Lowenberg, Bob; Valk, Peter J. M.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Dillon, Richard; Grimwade, David] Kings Coll London, Dept Med & Mol Genet, Fac Life Sci & Med, London, England; [Vijay, Priyanka] Weill Cornell Med, Triinst Training Program Computat Biol & Med, New York, NY USA; [Brown, Anna L.; Lewis, Ian D.; D'Andrea, Richard J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Brown, Anna L.; Lewis, Ian D.; D'Andrea, Richard J.] Univ South Australia, Adelaide, SA, Australia; [Brown, Anna L.; D'Andrea, Richard J.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Brown, Anna L.; Lewis, Ian D.; To, Luen Bik; D'Andrea, Richard J.] SA Pathol, Dept Hematol, Adelaide, SA, Australia; [Brown, Anna L.; Lewis, Ian D.; To, Luen Bik; D'Andrea, Richard J.] Royal Adelaide Hosp, Adelaide, SA, Australia; [Perl, Alexander E.; Cannon, Joy; Luger, Selina; Carroll, Martin] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Bullinger, Lars; Doehner, Hartmut; Guzman, Monica L.] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Becker, Michael] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Lewis, Ian D.; To, Luen Bik] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Park, Christopher Y.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Mason, Christopher E.] Feil Family Brain & Mind Res Inst, New York, NY USA; [Li, Sheng] Weill Cornell Med, Dept Neurosurg, New York, NY USA	Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; Cornell University; Centre for Cancer Biology; SA Pathology; University of South Australia; University of South Australia; SA Pathology; Royal Adelaide Hospital; University of Pennsylvania; Ulm University; University of Rochester; University of Adelaide; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Cornell University	Mason, CE (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.; Mason, CE (corresponding author), Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al Sa, New York, NY 10065 USA.; Melnick, AM (corresponding author), Weill Cornell Med, Div Hematol Med Oncol, Dept Med, New York, NY 10065 USA.; Mason, CE (corresponding author), Feil Family Brain & Mind Res Inst, New York, NY USA.	amm2014@med.cornell.edu; chm2042@med.cornell.edu	Melnick, Ari/AAA-5763-2020; levine, ross/AAE-7658-2019; Valk, Peter/AAX-2823-2020; Döhner, Hartmut/C-8933-2016; Hassane, Duane/AAA-3456-2021; Mason, Christopher/HCH-3977-2022; Patel, Jay/HDM-6251-2022; Bullinger, Lars/AAL-7965-2020	Döhner, Hartmut/0000-0003-2116-5536; Brown, Anna/0000-0002-9023-0138; Dillon, Richard/0000-0001-9333-5296; Hassane, Duane/0000-0002-0719-9572; D'Andrea, Richard/0000-0002-4915-4612; Bullinger, Lars/0000-0002-5890-5510; Rapaport, Franck/0000-0001-6553-2110	Starr Cancer Consortium [I4-A442, I7-A765, I9-A9-071]; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; Bert L. and N. Kuggie Vallee Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance; NASA [NNX14AH50G]; LLS SCOR [7006-13]; NCI [K08CA169055]; American Society of Hematology award under the ASH-AMFDP partnership [ASHAMFDP-20121]; Robert Wood Johnson Foundation; ASH/EHA TRTH; Doris Duke Medical Foundation; Leukemia and Lymphoma Society Translational Research Program; Geoffrey Beene Cancer Center; Leukaemia and Lymphoma Research award; German Research Foundation (DFG) [SFB 1074]; DFG Heisenberg-Stipendium [BU 1339/3-1]; Australian National Health and Medical Research Council; Royal Adelaide Hospital Contributing Haematologists Fund; US National Institutes of Health [R01CA102031, R01NS076465]; Leukemia Fighters funding; NATIONAL CANCER INSTITUTE [R21CA176362, R01CA198089, K08CA169055, R01CA172546, R01CA102031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1151054] Funding Source: researchfish	Starr Cancer Consortium; Irma T. Hirschl Charitable Trust; Monique Weill-Caulier Charitable Trust; Bert L. and N. Kuggie Vallee Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); NASA(National Aeronautics & Space Administration (NASA)); LLS SCOR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Hematology award under the ASH-AMFDP partnership; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); ASH/EHA TRTH; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Geoffrey Beene Cancer Center; Leukaemia and Lymphoma Research award; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG Heisenberg-Stipendium(German Research Foundation (DFG)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Adelaide Hospital Contributing Haematologists Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Fighters funding; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	We thank J. Phillips, J. Ishii, L. Wang, J. Busuttil, T. Lee, P. Zumbo, J. Gandara, and A. Zeilemaker for technical support; C. Sheridan for technical support, assistance with organization, and maintenance of sample database and banking; M. Perugini, D. Iarossi, and I.S. Tiong for assistance with clinical database management; and Y. Neelamraju, Z. Li, J. Glass, and M.R. De Massy for data annotation and management. Next-generation sequencing protocols and sequencing were performed by the Weill Cornell Medicine Epigenomics Core and the New York Genome Center. We thank A. Viale from the Integrated Genomics Operation and N. Socci from the bioinformatics core at Memorial Sloan Kettering Cancer Center for sequencing services. We thank the South Australian Cancer Research Biobank for access to clinical samples. We thank F. Michor for recommendations regarding data analyses. This work was supported by Starr Cancer Consortium grant I4-A442 (A.M.M., R.L., and C.E.M.), STARR Cancer Consortium grant I7-A765 and I9-A9-071 (C.E.M.), the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts, Bert L. and N. Kuggie Vallee Foundation and the WorldQuant Foundation, Pershing Square Sohn Cancer Research Alliance, and NASA (NNX14AH50G) (C.E.M.); LLS SCOR 7006-13 (A.M.M.); NCI K08CA169055 (F.E.G.-B.); an American Society of Hematology (ASHAMFDP-20121) award under the ASH-AMFDP partnership with the Robert Wood Johnson Foundation and ASH/EHA TRTH (F.E.G.-B.); a Doris Duke Medical Foundation, Leukemia and Lymphoma Society Translational Research Program, and Geoffrey Beene Cancer Center (C.Y.P.); a Leukaemia and Lymphoma Research award (D.G. and R. Dillon); German Research Foundation (DFG) grant SFB 1074 (project B3; K.D. and L.B.); DFG Heisenberg-Stipendium BU 1339/3-1 (L.B.); an Australian National Health and Medical Research Council and the Royal Adelaide Hospital Contributing Haematologists Fund financial support (R.J.D., A.L.B., and I.D.L.); US National Institutes of Health R01CA102031 (G.J.R. and M.L.G.) and R01NS076465 (C.E.M. and A.M.M.); and Leukemia Fighters funding (G.J.R., M.L.G., and D.C.H.).	Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Chambwe N, 2014, BLOOD, V123, P1699, DOI 10.1182/blood-2013-07-509885; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Garrett-Bakelman FE, 2015, JOVE-J VIS EXP, DOI 10.3791/52246; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0472-5; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pan H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7921; Parkin B, 2013, BLOOD, V121, P369, DOI 10.1182/blood-2012-04-427039; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004; Roboz GJ, 2012, CURR OPIN ONCOL, V24, P711, DOI 10.1097/CCO.0b013e328358f62d; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Tawana K, 2015, BLOOD, V126, P1214, DOI 10.1182/blood-2015-05-647172; TESTA JR, 1979, CANCER RES, V39, P3619; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	48	219	224	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					792	799		10.1038/nm.4125	http://dx.doi.org/10.1038/nm.4125			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27322744	Green Accepted			2022-12-27	WOS:000379366900018
J	Scarlett, JM; Rojas, JM; Matsen, ME; Kaiyala, KJ; Stefanovski, D; Bergman, RN; Nguyen, HT; Dorfman, MD; Lantier, L; Wasserman, DH; Mirzadeh, Z; Unterman, TG; Morton, GJ; Schwartz, MW				Scarlett, Jarrad M.; Rojas, Jennifer M.; Matsen, Miles E.; Kaiyala, Karl J.; Stefanovski, Darko; Bergman, Richard N.; Nguyen, Hong T.; Dorfman, Mauricio D.; Lantier, Louise; Wasserman, David H.; Mirzadeh, Zaman; Unterman, Terry G.; Morton, Gregory J.; Schwartz, Michael W.			Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents	NATURE MEDICINE			English	Article							INTRAVENOUS GLUCOSE-TOLERANCE; INSULIN; TANYCYTES; SUPPRESSION; MODEL; DIETARY; BRAIN; FGF1	Type 2 diabetes (T2D) is among the most common and costly disorders worldwide(1). The goal of current medical management for T2D is to transiently ameliorate hyperglycemia through daily dosing of one or more antidiabetic drugs. Hypoglycemia and weight gain are common side effects of therapy, and sustained disease remission is not obtainable with nonsurgical approaches. On the basis of the potent glucose-lowering response elicited by activation of brain fibroblast growth factor (FGF) receptors(2-4), we explored the antidiabetic efficacy of centrally administered FGF1, which, unlike other FGF peptides, activates all FGF receptor subtypes(5). We report that a single intracerebroventricular injection of FGF1 at a dose one-tenth of that needed for antidiabetic efficacy following peripheral injection induces sustained diabetes remission in both mouse and rat models of T2D. This antidiabetic effect is not secondary to weight loss, does not increase the risk of hypoglycemia, and involves a novel and incompletely understood mechanism for increasing glucose clearance from the bloodstream. We conclude that the brain has an inherent potential to induce diabetes remission and that brain FGF receptors are potential pharmacological targets for achieving this goal.	[Scarlett, Jarrad M.; Rojas, Jennifer M.; Matsen, Miles E.; Nguyen, Hong T.; Dorfman, Mauricio D.; Morton, Gregory J.; Schwartz, Michael W.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA; [Scarlett, Jarrad M.] Seattle Childrens Hosp, Dept Pediat Gastroenterol & Hepatol, Seattle, WA USA; [Kaiyala, Karl J.] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Stefanovski, Darko] Univ Penn, Sch Vet Med, New Bolton Ctr, Philadelphia, PA 19104 USA; [Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Lantier, Louise; Wasserman, David H.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN USA; [Mirzadeh, Zaman] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60607 USA; [Unterman, Terry G.] Jesse Brown Virginia Med Ctr, Med Serv, Chicago, IL USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Pennsylvania; Cedars Sinai Medical Center; Vanderbilt University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schwartz, MW (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA.	mschwart@u.washington.edu		Bergman, Richard/0000-0003-1539-4471	US National Institute of Diabetes and Digestive and Kidney Diseases [DK083042, DK090320, DK101997, DK089056, DK007742, DK104461, DK007247, DK103375, DK27619, DK29867]; Department of Veterans Affairs Merit Review Program; Novo Nordisk; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816, R01DK090320, T32DK007247, R01DK027619, F32DK108596, U24DK059637, F32DK104461, F32DK103375, T32DK007742, P30DK017047, R01DK083042, R01DK089056, R01DK101997, R01DK029867] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to the Vanderbilt University Mouse Metabolic Phenotyping Center (DK059637) for the performance of the basal glucose turnover, FSIGT and [2-<SUP>14</SUP>C]DG studies, the Nutrition Obesity Research Center (DK035816), the Diabetes Research Center (DK017047) at the University of Washington, and the technical assistance provided by T. Meek, V. Damian, L. Nguyen, T. Harvey, and J. Brown (all at University of Washington) and by D. Bracy and A. Locke (both at Vanderbilt University). We gratefully acknowledge L. Schaffer (Novo Nordisk) for providing the insulin receptor antagonist (S961). This work was supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (grant nos. DK083042 (M.W.S.), DK090320 (M.W.S.), DK101997 (M.W.S.), DK089056 (G.J.M.), DK007742 (J.M.S.), DK104461 (J.M.S.), DK007247 (J.M.R.), DK103375 (J.M.R.), DK27619 (R.N.B.), and DK29867 (R.N.B.)), the Department of Veterans Affairs Merit Review Program (T.G.U.), and by funding supplied by Novo Nordisk (M.W.S.).	ADER M, 1985, DIABETES, V34, P1092, DOI 10.2337/diabetes.34.11.1092; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; BEST JD, 1981, DIABETES, V30, P847, DOI 10.2337/diabetes.30.10.847; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Cheng X, 2011, NEUROL RES, V33, P675, DOI 10.1179/1743132810Y.0000000004; DAVIS MA, 1987, METABOLISM, V36, P856, DOI 10.1016/0026-0495(87)90094-1; Elizondo-Vega R, 2015, J CELL MOL MED, V19, P1471, DOI 10.1111/jcmm.12590; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Grayson BE, 2013, NAT REV NEUROSCI, V14, P24, DOI 10.1038/nrn3409; Gresl TA, 2001, AM J PHYSIOL-ENDOC M, V281, pE757, DOI 10.1152/ajpendo.2001.281.4.E757; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Ito J, 2005, J LIPID RES, V46, P679, DOI 10.1194/jlr.M400313-JLR200; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; KAHN SE, 1994, DIABETES, V43, P587, DOI 10.2337/diabetes.43.4.587; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Lou G, 2012, NEUROSCIENCE, V223, P225, DOI 10.1016/j.neuroscience.2012.08.003; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Marcelin G, 2014, MOL METAB, V3, P19, DOI 10.1016/j.molmet.2013.10.002; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; OOMURA Y, 1992, AM J CLIN NUTR, V55, P278; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Perry RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7980; Pinto JGA, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00003; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Rojas JM, 2015, MOL METAB, V4, P561, DOI 10.1016/j.molmet.2015.05.005; Ryan KK, 2013, ENDOCRINOLOGY, V154, P9, DOI 10.1210/en.2012-1891; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Stefanovski D, 2012, DIABETES CARE, V35, P1015, DOI 10.2337/dc11-1540; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Suzuki S, 2001, EUR J NEUROSCI, V13, P2299, DOI 10.1046/j.0953-816x.2001.01606.x; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	40	89	94	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					800	806		10.1038/nm.4101	http://dx.doi.org/10.1038/nm.4101			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27213816	Green Accepted			2022-12-27	WOS:000379366900019
J	Engelberg, AB; Kesselheim, AS				Engelberg, Alfred B.; Kesselheim, Aaron S.			Use the Bayh-Dole Act to lower drug prices for government healthcare programs	NATURE MEDICINE			English	Editorial Material								As drug prices have increased, there is also greater pressure to find ways to ensure access to medicines. An existing provision of the Bayh-Dole Act could help to lower costs for qualifying drugs in federal programs such as Medicare and Medicaid.	[Engelberg, Alfred B.] Engelberg Fdn, Palm Beach, FL USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Boston, MA USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Engelberg, AB (corresponding author), Engelberg Fdn, Palm Beach, FL USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Watanabe T., 2016, LA TIMES        0403	1	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					576	576		10.1038/nm0616-576	http://dx.doi.org/10.1038/nm0616-576			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270771	Bronze			2022-12-27	WOS:000377476000004
J	Chapuy, B; Stewart, C; Dunford, AJ; Kim, J; Kamburov, A; Redd, RA; Lawrence, MS; Roemer, MGM; Li, AJ; Ziepert, M; Staiger, AM; Wala, JA; Ducar, MD; Leshchiner, I; Rheinbay, E; Taylor-Weiner, A; Coughlin, CA; Hess, JM; Pedamallu, CS; Livitz, D; Rosebrock, D; Rosenberg, M; Tracy, AA; Horn, H; van Hummelen, P; Feldman, AL; Link, BK; Novak, AJ; Cerhan, JR; Habermann, TM; Siebert, R; Rosenwald, A; Thorner, AR; Meyerson, ML; Golub, TR; Beroukhim, R; Wulf, GG; Ott, G; Rodig, SJ; Monti, S; Neuberg, DS; Loeffler, M; Pfreundschuh, M; Trumper, L; Getz, G; Shipp, MA				Chapuy, Bjoern; Stewart, Chip; Dunford, Andrew J.; Kim, Jaegil; Kamburov, Atanas; Redd, Robert A.; Lawrence, Mike S.; Roemer, Margaretha G. M.; Li, Amy J.; Ziepert, Marita; Staiger, Annette M.; Wala, Jeremiah A.; Ducar, Matthew D.; Leshchiner, Ignaty; Rheinbay, Ester; Taylor-Weiner, Amaro; Coughlin, Caroline A.; Hess, Julian M.; Pedamallu, Chandra S.; Livitz, Dimitri; Rosebrock, Daniel; Rosenberg, Mara; Tracy, Adam A.; Horn, Heike; van Hummelen, Paul; Feldman, Andrew L.; Link, Brian K.; Novak, Anne J.; Cerhan, James R.; Habermann, Thomas M.; Siebert, Reiner; Rosenwald, Andreas; Thorner, Aaron R.; Meyerson, Matthew L.; Golub, Todd R.; Beroukhim, Rameen; Wulf, Gerald G.; Ott, German; Rodig, Scott J.; Monti, Stefano; Neuberg, Donna S.; Loeffler, Markus; Pfreundschuh, Michael; Truemper, Lorenz; Getz, Gad; Shipp, Margaret A.			Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes	NATURE MEDICINE			English	Article							MARGINAL ZONE LYMPHOMA; INTEGRATIVE ANALYSIS REVEALS; NON-HODGKIN-LYMPHOMA; DNA-SEQUENCING DATA; SOMATIC MUTATIONS; FOLLICULAR LYMPHOMA; CODING GENOME; HUMAN CANCER; DISCOVERY; GENES	Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is a clinically and genetically heterogeneous disease that is further classified into transcriptionally defined activated B cell (ABC) and germinal center B cell (GCB) subtypes. We carried out a comprehensive genetic analysis of 304 primary DLBCLs and identified low-frequency alterations, captured recurrent mutations, somatic copy number alterations, and structural variants, and defined coordinate signatures in patients with available outcome data. We integrated these genetic drivers using consensus clustering and identified five robust DLBCL subsets, including a previously unrecognized group of low-risk ABC-DLBCLs of extrafollicular/marginal zone origin; two distinct subsets of GCB-DLBCLs with different outcomes and targetable alterations; and an ABC/GCB-independent group with biallelic inactivation of TP53, CDKN2A loss, and associated genomic instability. The genetic features of the newly characterized subsets, their mutational signatures, and the temporal ordering of identified alterations provide new insights into DLBCL pathogenesis. The coordinate genetic signatures also predict outcome independent of the clinical International Prognostic Index and suggest new combination treatment strategies. More broadly, our results provide a roadmap for an actionable DLBCL classification.	[Chapuy, Bjoern; Roemer, Margaretha G. M.; Coughlin, Caroline A.; Shipp, Margaret A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chapuy, Bjoern; Lawrence, Mike S.; Meyerson, Matthew L.; Golub, Todd R.; Beroukhim, Rameen; Rodig, Scott J.; Neuberg, Donna S.; Getz, Gad; Shipp, Margaret A.] Harvard Med Sch, Boston, MA 02115 USA; [Stewart, Chip; Dunford, Andrew J.; Kim, Jaegil; Kamburov, Atanas; Lawrence, Mike S.; Wala, Jeremiah A.; Leshchiner, Ignaty; Rheinbay, Ester; Taylor-Weiner, Amaro; Hess, Julian M.; Pedamallu, Chandra S.; Livitz, Dimitri; Rosebrock, Daniel; Rosenberg, Mara; Tracy, Adam A.; Meyerson, Matthew L.; Golub, Todd R.; Beroukhim, Rameen; Getz, Gad] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Redd, Robert A.; Neuberg, Donna S.] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Lawrence, Mike S.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Li, Amy J.; Monti, Stefano] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA; [Ziepert, Marita; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Staiger, Annette M.; Horn, Heike] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Staiger, Annette M.; Horn, Heike] Univ Tubingen, Tubingen, Germany; [Staiger, Annette M.; Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Ducar, Matthew D.; van Hummelen, Paul; Thorner, Aaron R.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Feldman, Andrew L.; Novak, Anne J.; Cerhan, James R.; Habermann, Thomas M.] Mayo Clin, Rochester, MN USA; [Link, Brian K.] Univ Iowa, Iowa City, IA USA; [Siebert, Reiner] Univ Ulm, Dept Human Genet, Ulm, Germany; [Rosenwald, Andreas] Univ Wurzburg, Dept Pathol, Wurzburg, Germany; [Wulf, Gerald G.; Truemper, Lorenz] Georg August Univ Gottingen, Dept Hematol & Oncol, Gottingen, Germany; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Pfreundschuh, Michael] Saarland Univ, Dept Med 1, Homburg, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Boston University; Leipzig University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Bosch; Robert Bosch Krankenhaus; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; University of Iowa; Ulm University; University of Wurzburg; University of Gottingen; Harvard University; Brigham & Women's Hospital; Universitatsklinikum des Saarlandes	Shipp, MA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Getz, G; Shipp, MA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Getz, G (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	gadgetz@broadinstitute.org; margaret_shipp@dfci.harvard.edu	Pedamallu, Chandra Sekhar/AAV-6745-2020; Pedamallu, Chandra Sekhar/AAV-6723-2020; Rodig, Scott/Y-3889-2019	Livitz, Dimitri/0000-0003-2528-1446; Rosenberg, Mara/0000-0001-6400-3161; van hummelen, paul/0000-0002-4801-8600; Kamburov, Atanas/0000-0002-0580-0619; Link, Brian/0000-0001-5084-0698; Meyerson, Matthew/0000-0002-9133-8108	Claudia Adams Barr Program in Basic Cancer Research; Medical Oncology Translational Grant Program; LLS Translational Research Awards; Lymphoma Target Testing Center; National Cancer Institute [U54HG003067, P01CA163222, R01CA18246, U24CA143845, U24CA210999, R01CA155010]; National Human Genome Research Institute; Leukemia & Lymphoma Society grant [0812-14]; US National Institutes of Health [P50 CA97274]; BMBF (Federal Ministry of Research, Germany) [FZK 031A428B, FZK 031A428H]; Deutsche Krebshilfe; NATIONAL CANCER INSTITUTE [P01CA163222, U24CA210999, P30CA086862, P50CA097274, R01CA155010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	Claudia Adams Barr Program in Basic Cancer Research; Medical Oncology Translational Grant Program; LLS Translational Research Awards; Lymphoma Target Testing Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Leukemia & Lymphoma Society grant(Leukemia and Lymphoma Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF (Federal Ministry of Research, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all of the members of the Broad Institute's Biological Samples Genetic Analysis Genome Sequencing Platforms. In addition, we thank all of the patients and their physicians for trial participation and donating the samples. This work was supported by a Claudia Adams Barr Program in Basic Cancer Research (B.C.), a Medical Oncology Translational Grant Program (B.C.), two LLS Translational Research Awards (M.A.S.), and the Lymphoma Target Testing Center (M.A.S.). The computational work for this study was supported by grants U54HG003067, P01CA163222, R01CA18246, U24CA143845, U24CA210999, and R01CA155010 from the National Cancer Institute and the National Human Genome Research Institute, as well as Leukemia & Lymphoma Society grant 0812-14. The Mayo group was supported by a grant from the US National Institutes of Health (P50 CA97274). R.S., M.L., and L.T. received Funding from BMBF (Federal Ministry of Research, Germany; Kennzeichen FZK 031A428B and FZK 031A428H). The Ricover60 Trial was supported by a research grant from Deutsche Krebshilfe (M.P.).	Abo RP, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1211; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Boice M, 2016, CELL, V167, P405, DOI 10.1016/j.cell.2016.08.032; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Burger JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11589; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapuy B, 2016, BLOOD, V127, P869, DOI 10.1182/blood-2015-10-673236; Chen LF, 2013, CANCER CELL, V23, P826, DOI 10.1016/j.ccr.2013.05.002; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Miranda NFCC, 2014, BLOOD, V124, P2544, DOI 10.1182/blood-2013-12-546309; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dierlamm J, 2008, HAEMATOLOGICA, V93, P688, DOI 10.3324/haematol.12057; Dubois S, 2017, CLIN CANCER RES, V23, P2232, DOI 10.1158/1078-0432.CCR-16-1922; Ennishi D, 2017, BLOOD, V129, P2760, DOI 10.1182/blood-2016-11-747022; Erdmann T, 2017, BLOOD, V130, P310, DOI 10.1182/blood-2016-12-758599; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Flossbach L, 2011, INT J CANCER, V129, P70, DOI 10.1002/ijc.25663; Georgiou K, 2016, BLOOD, V127, P3026, DOI 10.1182/blood-2015-12-686550; Giannakis M, 2016, CELL REP, V17, P1206, DOI 10.1016/j.celrep.2016.10.009; Giannikou K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006242; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Krysiak K, 2017, BLOOD, V129, P473, DOI 10.1182/blood-2016-07-729954; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li HX, 2014, BLOOD, V123, P1487, DOI 10.1182/blood-2013-05-500264; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; Lichtenstein L., 2016, CANC RES S, V76; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Novak AJ, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.69; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pham-Ledard A, 2014, JAMA DERMATOL, V150, P1173, DOI 10.1001/jamadermatol.2014.821; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Rovira J, 2016, CLIN CANCER RES, V22, P2755, DOI 10.1158/1078-0432.CCR-15-1525; Scott DW, 2012, BLOOD, V119, P4949, DOI 10.1182/blood-2012-02-414441; Sesques P, 2017, BLOOD, V129, P280, DOI 10.1182/blood-2016-02-636316; Spina V, 2016, BLOOD, V128, P1362, DOI 10.1182/blood-2016-02-696757; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Sun Z, 2014, CELL REP, V6, P844, DOI 10.1016/j.celrep.2014.01.030; Wala JA, 2018, GENOME RES, V28, P581, DOI 10.1101/gr.221028.117; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; Ying CY, 2013, NAT IMMUNOL, V14, P1084, DOI 10.1038/ni.2688; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zucca E, 2014, CLIN CANCER RES, V20, P5207, DOI 10.1158/1078-0432.CCR-14-0496	80	734	748	7	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					679	+		10.1038/s41591-018-0016-8	http://dx.doi.org/10.1038/s41591-018-0016-8			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29713087	Green Accepted			2022-12-27	WOS:000432126800025
J	Gilbert, JA; Blaser, MJ; Caporaso, JG; Jansson, JK; Lynch, SV; Knight, R				Gilbert, Jack A.; Blaser, Martin J.; Caporaso, J. Gregory; Jansson, Janet K.; Lynch, Susan V.; Knight, Rob			Current understanding of the human microbiome	NATURE MEDICINE			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; HUMAN GUT MICROBIOTA; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; SKIN MICROBIOME; IMMUNE-SYSTEM; EARLY-LIFE; DISEASE; BACTERIAL; ENTEROTYPES	Our understanding of the link between the human microbiome and disease, including obesity, inflammatory bowel disease, arthritis and autism, is rapidly expanding. Improvements in the throughput and accuracy of DNA sequencing of the genomes of microbial communities that are associated with human samples, complemented by analysis of transcriptomes, proteomes, metabolomes and immunomes and by mechanistic experiments in model systems, have vastly improved our ability to understand the structure and function of the microbiome in both diseased and healthy states. However, many challenges remain. In this review, we focus on studies in humans to describe these challenges and propose strategies that leverage existing knowledge to move rapidly from correlation to causation and ultimately to translation into therapies.	[Gilbert, Jack A.] Univ Chicago, Dept Surg, Microbiome Ctr, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Gilbert, Jack A.] Argonne Natl Lab, Biosci Div, Lemont, IL USA; [Gilbert, Jack A.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Blaser, Martin J.] NYU, Langone Med Ctr, New York, NY USA; [Caporaso, J. Gregory] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA; [Jansson, Janet K.] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA USA; [Lynch, Susan V.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Knight, Rob] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, Jacobs Sch Engn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Marine Biological Laboratory - Woods Hole; New York University; NYU Langone Medical Center; Northern Arizona University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Knight, R (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, Jacobs Sch Engn, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.	robknight@ucsd.edu	Gilbert, Jack/AAF-3270-2019	Blaser, Martin/0000-0003-2447-2443; Jansson, Janet/0000-0002-5487-4315; Knight, Rob/0000-0002-0975-9019; Caporaso, Greg/0000-0002-8865-1670	National Institutes of Health; National Science Foundation; Department of Energy; Alfred P. Sloan Foundation; NATIONAL CANCER INSTITUTE [U54CA143925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Many of the studies described here in our laboratories were supported by the National Institutes of Health, National Science Foundation, Department of Energy and the Alfred P. Sloan Foundation. We thank numerous members of our laboratories for constructive criticism on drafts of this article.	Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Benedict C, 2016, MOL METAB, V5, P1175, DOI 10.1016/j.molmet.2016.10.003; Biteen JS, 2016, ACS NANO, V10, P6, DOI 10.1021/acsnano.5b07826; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cook MD, 2016, IMMUNOL CELL BIOL, V94, P158, DOI 10.1038/icb.2015.108; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Debelius J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1086-x; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Durack J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03157-4; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jeffery IB, 2012, NAT REV MICROBIOL, V10, P591, DOI 10.1038/nrmicro2859; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Karczewski J, 2014, AUTOIMMUNITY, V47, P494, DOI 10.3109/08916934.2014.938322; Karl JP, 2017, AM J PHYSIOL-GASTR L, V312, pG559, DOI 10.1152/ajpgi.00066.2017; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kort R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-41; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Larsen PE, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0084-3; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Livanos AE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.140, 10.1038/nmicrobiol.2016.140]; Locey KJ, 2016, P NATL ACAD SCI USA, V113, P5970, DOI 10.1073/pnas.1521291113; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; LUCKEY TD, 1972, AM J CLIN NUTR, V25, P1292; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Maier TV, 2017, MBIO, V8, DOI [10.1128/mbio.01343-17, 10.1128/mBio.01343-17]; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McDonald Daniel, 2015, Microbial Ecology in Health and Disease, V26, P26555, DOI 10.3402/mehd.v26.26555; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; Mueller NT, 2017, INT J OBESITY, V41, P497, DOI 10.1038/ijo.2016.219; Ni J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6888; O'Toole PW, 2012, CLIN MICROBIOL INFEC, V18, P44, DOI 10.1111/j.1469-0691.2012.03867.x; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Punt CJA, 2017, NAT REV CLIN ONCOL, V14, P235, DOI 10.1038/nrclinonc.2016.171; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raveh-Sadka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05477; Ravel J, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-29; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Rosner J., 2014, MICROBE, V9, P47, DOI DOI 10.1128/MICROBE.9.47.2; Sahin M, 2015, SCIENCE, V350, P890, DOI 10.1126/science.aab3897; Schirmer M, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.11.046; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Snijders AM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.221; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uusitalo U, 2016, JAMA PEDIATR, V170, P20, DOI 10.1001/jamapediatrics.2015.2757; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; von Mutius E, 2016, J ALLERGY CLIN IMMUN, V137, P680, DOI 10.1016/j.jaci.2015.12.1301; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weng M, 2013, J DEV ORIG HLTH DIS, V4, P203, DOI 10.1017/S2040174412000712; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xiao BB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26674; Ying S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141842; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zheng WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09131; Zozaya M, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0161-6	105	843	882	32	511	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					392	400		10.1038/nm.4517	http://dx.doi.org/10.1038/nm.4517			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634682	Green Submitted, Green Accepted			2022-12-27	WOS:000429639800010
J	Kisalu, NK; Idris, AH; Weidle, C; Flores-Garcia, Y; Flynn, BJ; Sack, BK; Murphy, S; Schon, A; Freire, E; Francica, JR; Miller, AB; Gregory, J; March, S; Liao, HX; Haynes, BF; Wiehe, K; Trama, AM; Saunders, KO; Gladden, MA; Monroe, A; Bonsignori, M; Kanekiyo, M; Wheatley, AK; McDermott, AB; Farney, SK; Chuang, GY; Zhang, BS; Kc, N; Chakravarty, S; Kwong, PD; Sinnis, P; Bhatia, SN; Kappe, SHI; Sim, BKL; Hoffman, SL; Zavala, F; Pancera, M; Seder, RA				Kisalu, Neville K.; Idris, Azza H.; Weidle, Connor; Flores-Garcia, Yevel; Flynn, Barbara J.; Sack, Brandon K.; Murphy, Sean; Schoen, Arne; Freire, Ernesto; Francica, Joseph R.; Miller, Alex B.; Gregory, Jason; March, Sandra; Liao, Hua-Xin; Haynes, Barton F.; Wiehe, Kevin; Trama, Ashley M.; Saunders, Kevin O.; Gladden, Morgan A.; Monroe, Anthony; Bonsignori, Mattia; Kanekiyo, Masaru; Wheatley, Adam K.; McDermott, Adrian B.; Farney, S. Katie; Chuang, Gwo-Yu; Zhang, Baoshan; Kc, Natasha; Chakravarty, Sumana; Kwong, Peter D.; Sinnis, Photini; Bhatia, Sangeeta N.; Kappe, Stefan H. I.; Sim, B. Kim Lee; Hoffman, Stephen L.; Zavala, Fidel; Pancera, Marie; Seder, Robert A.			A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite	NATURE MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; MOLECULAR-DYNAMICS; HUMORAL PROTECTION; HEPARAN-SULFATE; RATIONAL DESIGN; B-CELLS; VACCINE; SPOROZOITES; BINDING	Development of a highly effective vaccine or antibodies for the prevention and ultimately elimination of malaria is urgently needed. Here we report the isolation of a number of human monoclonal antibodies directed against the Plasmodium falciparum (Pf) circumsporozoite protein (PfCSP) from several subjects immunized with an attenuated Pf whole-sporozoite (SPZ) vaccine (Sanaria PfSPZ Vaccine). Passive transfer of one of these antibodies, monoclonal antibody CIS43, conferred high-level, sterile protection in two different mouse models of malaria infection. The affinity and stoichiometry of CIS43 binding to PfCSP indicate that there are two sequential multivalent binding events encompassing the repeat domain. The first binding event is to a unique 'junctional' epitope positioned between the N terminus and the central repeat domain of PfCSP. Moreover, CIS43 prevented proteolytic cleavage of PfCSP on PfSPZ. Analysis of crystal structures of the CIS43 antigen-binding fragment in complex with the junctional epitope determined the molecular interactions of binding, revealed the epitope's conformational flexibility and defined Asn-Pro-Asn (NPN) as the structural repeat motif. The demonstration that CIS43 is highly effective for passive prevention of malaria has potential application for use in travelers, military personnel and elimination campaigns and identifies a new and conserved site of vulnerability on PfCSP for next-generation rational vaccine design.	[Kisalu, Neville K.; Idris, Azza H.; Flynn, Barbara J.; Francica, Joseph R.; Kanekiyo, Masaru; Wheatley, Adam K.; McDermott, Adrian B.; Farney, S. Katie; Chuang, Gwo-Yu; Zhang, Baoshan; Kwong, Peter D.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Weidle, Connor; Pancera, Marie] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Flores-Garcia, Yevel; Gregory, Jason; Sinnis, Photini; Zavala, Fidel] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA; [Sack, Brandon K.; Murphy, Sean; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA USA; [Schoen, Arne; Freire, Ernesto] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Miller, Alex B.; March, Sandra; Bhatia, Sangeeta N.] MIT, Inst Med Engn & Sci, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Miller, Alex B.; March, Sandra; Bhatia, Sangeeta N.] MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Liao, Hua-Xin; Haynes, Barton F.; Wiehe, Kevin; Trama, Ashley M.; Saunders, Kevin O.; Gladden, Morgan A.; Monroe, Anthony; Bonsignori, Mattia] Duke Human Vaccine Inst, Durham, NC USA; [Haynes, Barton F.; Wiehe, Kevin; Bonsignori, Mattia] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Saunders, Kevin O.] Duke Univ, Med Ctr, Sch Med, Dept Surg, Durham, NC 27710 USA; [Chakravarty, Sumana; Sim, B. Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Liao, Hua-Xin] Jinan Univ, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Wheatley, Adam K.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Center for Infectious Disease Research; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Duke University; Duke University; Duke University; Sanaria Inc.; Jinan University; University of Melbourne	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Pancera, M (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	mpancera@fredhutch.org; rseder@mail.nih.gov	Bonsignori, Mattia/AAE-7678-2019; Murphy, Sean C./AAC-7531-2019; Kanekiyo, Masaru/Y-9820-2018	Bonsignori, Mattia/0000-0003-2973-2101; Murphy, Sean C./0000-0002-2048-0131; Kanekiyo, Masaru/0000-0001-5767-1532; Wheatley, Adam/0000-0002-5593-9387; McDermott, Adrian/0000-0003-0616-9117; Miller, Alex/0000-0002-1847-4891	National Institutes of Health [GM56550]; National Science Foundation [MCB-1157506]; Vaccine and Infectious Disease Division Faculty Initiative Grant through the Fred Hutchinson Cancer Research Center; National Institute of General Medical Sciences, National Institutes of Health; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases Small Business Innovation Research Grants [5R44AI058375-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005112, ZIAAI005022, ZIAAI005107, R01AI132359, ZICAI005114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832, S10OD018164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Vaccine and Infectious Disease Division Faculty Initiative Grant through the Fred Hutchinson Cancer Research Center; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); Federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases Small Business Innovation Research Grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the study volunteers from the malaria clinical trials VRC312 and VRC314. We thank R. Bailer (Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health), for providing peripheral blood mononuclear cell samples. We thank R. Lynch, S. Narpala, M. Prabhakaran, R. Nguyen and X. Chen (Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health) for technical help and advice regarding the experiments. We thank I. Cockburn (Australian National University College of Health and Medicine) for providing some of the biotinylated (NANP) 9 probe used here. We thank T. Zhou (Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health) for providing monoclonal antibody VRC01. We thank C. Peckels, A. Foulger, A. Holland and M. Wang (Duke Human Vaccine Institute (DHVI)) for technical assistance and H. Bouton-Verville (DHVI) for project management. We are grateful to C. A. Schramm's expertise and assistance in analyzing the malaria Pf3K database. We thank the Sanaria Manufacturing Team for the production of fresh PfSPZ. We thank M. Nason for technical help with statistical analysis. We thank B. Graham (Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health) for insightful discussion regarding the project. We are particularly grateful to L. Stamatatos for use of laboratory space and equipment. We thank the J. B. Pendleton Charitable Trust for its generous support of Formulatrix robotic instruments. This work was supported by the National Institutes of Health grant GM56550 and the National Science Foundation grant MCB-1157506 to E.F. M.P. and C.W. were supported by a Vaccine and Infectious Disease Division Faculty Initiative Grant through the Fred Hutchinson Cancer Research Center. X-ray diffraction data was collected at the Berkeley Center for Structural Biology beamlines 5.0.1 and 5.0.2, which are supported in part by the National Institute of General Medical Sciences, National Institutes of Health. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under contract number DE-AC02-05CH11231. Work done at Duke Universiy has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. Production and characterization of the PfSPZ Vaccine were supported in part by the National Institute of Allergy and Infectious Diseases Small Business Innovation Research Grants 5R44AI058375-08 (to S.L.H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Briney BS, 2012, IMMUNOLOGY, V137, P56, DOI 10.1111/j.1365-2567.2012.03605.x; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENEA V, 1984, SCIENCE, V225, P628, DOI 10.1126/science.6204384; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Espinosa DA, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0011-y; Espinosa DA, 2015, J INFECT DIS, V212, P1111, DOI 10.1093/infdis/jiv154; Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Freire E, 2009, METHOD ENZYMOL, V455, P127, DOI 10.1016/S0076-6879(08)04205-5; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Kanekiyo M, 2015, CELL, V162, P1090, DOI 10.1016/j.cell.2015.07.043; Kublin JG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9099; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; March S, 2015, NAT PROTOC, V10, P2027, DOI 10.1038/nprot.2015.128; March S, 2013, CELL HOST MICROBE, V14, P104, DOI 10.1016/j.chom.2013.06.005; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Miller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060820; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; NUSSENZWEIG RS, 1989, REV INFECT DIS, V11, pS579; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyen D, 2017, P NATL ACAD SCI USA, V114, pE10438, DOI 10.1073/pnas.1715812114; Pall S, 2015, LECT NOTES COMPUT SC, V8759, P3, DOI 10.1007/978-3-319-15976-8_1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rich SM, 1997, P NATL ACAD SCI USA, V94, P13040, DOI 10.1073/pnas.94.24.13040; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Sack BK, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0028-2; Sack BK, 2014, INFECT IMMUN, V82, P808, DOI 10.1128/IAI.01249-13; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Tanabe K, 2013, VACCINE, V31, P1334, DOI 10.1016/j.vaccine.2012.12.039; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Topchiy E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-104; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zakeri S, 2007, AM J TROP MED HYG, V76, P1046, DOI 10.4269/ajtmh.2007.76.1046; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	71	149	155	2	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					408	+		10.1038/nm.4512	http://dx.doi.org/10.1038/nm.4512			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29554083	Green Published, Green Accepted			2022-12-27	WOS:000429639800012
J	Rosenzweig, ES; Brock, JH; Lu, P; Kumamaru, H; Salegio, EA; Kadoya, K; Weber, JL; Liang, JJ; Moseanko, R; Hawbecker, S; Huie, JR; Havton, LA; Nout-Lomas, YS; Ferguson, AR; Beattie, MS; Bresnahan, JC; Tuszynski, MH				Rosenzweig, Ephron S.; Brock, John H.; Lu, Paul; Kumamaru, Hiromi; Salegio, Ernesto A.; Kadoya, Ken; Weber, Janet L.; Liang, Justine J.; Moseanko, Rod; Hawbecker, Stephanie; Huie, J. Russell; Havton, Leif A.; Nout-Lomas, Yvette S.; Ferguson, Adam R.; Beattie, Michael S.; Bresnahan, Jacqueline C.; Tuszynski, Mark H.			Restorative effects of human neural stem cell grafts on the primate spinal cord	NATURE MEDICINE			English	Article							CORTICOSPINAL PROJECTIONS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; ANIMAL DEVELOPMENT; NERVOUS-SYSTEM; MACAQUE MONKEY; CNS INJURY; FETAL; PTEN; CONNECTIVITY	We grafted human spinal cord-derived neural progenitor cells (NPCs) into sites of cervical spinal cord injury in rhesus monkeys (Macaca mulatta). Under three-drug immunosuppression, grafts survived at least 9 months postinjury and expressed both neuronal and glial markers. Monkey axons regenerated into grafts and formed synapses. Hundreds of thousands of human axons extended out from grafts through monkey white matter and synapsed in distal gray matter. Grafts gradually matured over 9 months and improved forelimb function beginning several months after grafting. These findings in a 'preclinical trial' support translation of NPC graft therapy to humans with the objective of reconstituting both a neuronal and glial milieu in the site of spinal cord injury.	[Rosenzweig, Ephron S.; Brock, John H.; Lu, Paul; Kumamaru, Hiromi; Kadoya, Ken; Weber, Janet L.; Liang, Justine J.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Brock, John H.; Lu, Paul; Tuszynski, Mark H.] Vet Adm Med Ctr, La Jolla, CA USA; [Salegio, Ernesto A.; Moseanko, Rod; Hawbecker, Stephanie] Univ Calif Davis, California Natl Primate Res Ctr, Davis, CA 95616 USA; [Kadoya, Ken] Hokkaido Univ, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Huie, J. Russell; Ferguson, Adam R.; Beattie, Michael S.; Bresnahan, Jacqueline C.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Havton, Leif A.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Nout-Lomas, Yvette S.] Colorado State Univ, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Ferguson, Adam R.] Vet Adm Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Davis; Hokkaido University; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Colorado State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.; Tuszynski, MH (corresponding author), Vet Adm Med Ctr, La Jolla, CA USA.	mtuszynski@ucsd.edu	Rosenzweig, Ephron/AAI-7541-2020; Beattie, Michael S/A-8953-2009	Huie, J. Russell/0000-0001-5594-4277; Ferguson, Adam/0000-0001-7102-1608; Rosenzweig, Ephron/0000-0002-0370-9643	Veterans Administration (Gordon Mansfield Spinal Cord Injury Collaborative Consortium) [RRD B7332R, RRD RX001045]; National Institutes of Health [R01 NS042291, R01 NS104442]; Department of Defense [W81XWH-12-1-0592]; Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105478, R01NS042291, R01NS104442, R56NS042291] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001045, I01RX002245] Funding Source: NIH RePORTER	Veterans Administration (Gordon Mansfield Spinal Cord Injury Collaborative Consortium); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	Human 566RSC-UBQT neural stem cells were a gift from NeuralStem, Inc. This work was supported by the Veterans Administration (Gordon Mansfield Spinal Cord Injury Collaborative Consortium, RR&D B7332R, MHT; RR&D RX001045, JHB), the National Institutes of Health (R01 NS042291, MHT; R01 NS104442, MHT), the Department of Defense (W81XWH-12-1-0592; E.S.R.), the Craig H. Neilsen Foundation (M.H.T.), the Bernard and Anne Spitzer Charitable Trust (M.H.T.), and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (M.H.T.).	Anderson AJ, 2017, STEM CELL REP, V8, P249, DOI 10.1016/j.stemcr.2016.12.018; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dieni CV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11313; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Galea MP, 1997, J COMP NEUROL, V381, P307; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Golan N, 2008, GLIA, V56, P1176, DOI 10.1002/glia.20688; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Guo XF, 2010, J TISSUE ENG REGEN M, V4, P181, DOI 10.1002/term.223; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; KAISER HF, 1960, PSYCHOL REV, V67, P160, DOI 10.1037/h0047595; Kuypers H.G.J.M., 1981, HDB PHYSL; Kwon BK, 2015, EXP NEUROL, V269, P154, DOI 10.1016/j.expneurol.2015.04.008; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; Little R.J.A., 2002, STAT ANAL MISSING DA; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P., 2016, TRANSLATIONAL NEUROS; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Lu P, 2017, J CLIN INVEST, V127, P3293, DOI 10.1172/JCI92955; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Maor-Nof M, 2013, CURR OPIN NEUROBIOL, V23, P990, DOI 10.1016/j.conb.2013.06.007; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Nout YS, 2012, NEUROREHAB NEURAL RE, V26, P556, DOI 10.1177/1545968311421934; Nout YS, 2012, NEUROTHERAPEUTICS, V9, P380, DOI 10.1007/s13311-012-0114-0; Osorio MJ, 2016, EXP NEUROL, V283, P476, DOI 10.1016/j.expneurol.2016.05.010; Raff MC, 1996, CELL, V86, P173, DOI 10.1016/S0092-8674(00)80087-2; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; REIER PJ, 1992, EXP NEUROL, V115, P177, DOI 10.1016/0014-4886(92)90245-L; Ren YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41122; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Salegio EA, 2016, J NEUROTRAUM, V33, P439, DOI 10.1089/neu.2015.3956; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014; Sun W, 2017, J NEUROSCI, V37, P4493, DOI 10.1523/JNEUROSCI.3199-16.2017; Tuszynski M. H., 2016, TRANSLATIONAL NEUROS; Tuszynski MH, 2014, CELL, V156, P388, DOI 10.1016/j.cell.2014.01.016; Tuszynski MH, 1999, J NEUROTRAUM, V16, P523, DOI 10.1089/neu.1999.16.523; WICTORIN K, 1992, NEUROREPORT, V3, P1045, DOI 10.1097/00001756-199212000-00003; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974	65	172	177	5	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					484	+		10.1038/nm.4502	http://dx.doi.org/10.1038/nm.4502			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29480894	Green Accepted			2022-12-27	WOS:000429639800019
J	Mathew, NR; Baumgartner, F; Braun, L; O'Sullivan, D; Thomas, S; Waterhouse, M; Muller, TA; Hanke, K; Taromi, S; Apostolova, P; Illert, AL; Melchinger, W; Duquesne, S; Schmitt-Graeff, A; Osswald, L; Yan, KL; Weber, A; Tugues, S; Spath, S; Pfeifer, D; Follo, M; Claus, R; Lubbert, M; Rummelt, C; Bertz, H; Wasch, R; Haag, J; Schmidts, A; Schultheiss, M; Bettinger, D; Thimme, R; Ullrich, E; Tanriver, Y; Vuong, GL; Arnold, R; Hemmati, P; Wolf, D; Ditschkowski, M; Jilg, C; Wilhelm, K; Leiber, C; Gerull, S; Halter, J; Lengerke, C; Pabst, T; Schroeder, T; Kobbe, G; Rosler, W; Doostkam, S; Meckel, S; Stabla, K; Metzelder, SK; Halbach, S; Brummer, T; Hu, ZH; Dengjel, J; Hackanson, B; Schmid, C; Holtick, U; Scheid, C; Spyridonidis, A; Stolzel, F; Ordemann, R; Muller, LP; Sicre-de-Fontbrune, F; Ihorst, G; Kuball, J; Ehlert, JE; Feger, D; Wagner, EM; Cahn, JY; Schnell, J; Kuchenbauer, F; Bunjes, D; Chakraverty, R; Richardson, S; Gill, S; Kroger, N; Ayuk, F; Vago, L; Ciceri, F; Muller, AM; Kondo, T; Teshima, T; Klaeger, S; Kuster, B; Kim, D; Weisdorf, D; van der Velden, W; Dorfel, D; Bethge, W; Hilgendorf, I; Hochhaus, A; Andrieux, G; Borries, M; Busch, H; Magenau, J; Reddy, P; Labopin, M; Antin, JH; Henden, AS; Hill, GR; Kennedy, GA; Bar, M; Sarma, A; McLornan, D; Mufti, G; Oran, B; Rezvani, K; Shah, O; Negrin, RS; Nagler, A; Prinz, M; Burchert, A; Neubauer, A; Beelen, D; Mackensen, A; von Bubnoff, N; Herr, W; Becher, B; Socie, G; Caligiuri, MA; Ruggiero, E; Bonini, C; Hacker, G; Duyster, J; Finke, J; Pearce, E; Blazar, BR; Zeiser, R				Mathew, Nimitha R.; Baumgartner, Francis; Braun, Lukas; O'Sullivan, David; Thomas, Simone; Waterhouse, Miguel; Mueller, Tony A.; Hanke, Kathrin; Taromi, Sanaz; Apostolova, Petya; Illert, Anna L.; Melchinger, Wolfgang; Duquesne, Sandra; Schmitt-Graeff, Annette; Osswald, Lena; Yan, Kai-Li; Weber, Arnim; Tugues, Sonia; Spath, Sabine; Pfeifer, Dietmar; Follo, Marie; Claus, Rainer; Luebbert, Michael; Rummelt, Christoph; Bertz, Hartmut; Waesch, Ralph; Haag, Johanna; Schmidts, Andrea; Schultheiss, Michael; Bettinger, Dominik; Thimme, Robert; Ullrich, Evelyn; Tanriver, Yakup; Vuong, Giang Lam; Arnold, Renate; Hemmati, Philipp; Wolf, Dominik; Ditschkowski, Markus; Jilg, Cordula; Wilhelm, Konrad; Leiber, Christian; Gerull, Sabine; Halter, Joerg; Lengerke, Claudia; Pabst, Thomas; Schroeder, Thomas; Kobbe, Guido; Roesler, Wolf; Doostkam, Soroush; Meckel, Stephan; Stabla, Kathleen; Metzelder, Stephan K.; Halbach, Sebastian; Brummer, Tilman; Hu, Zehan; Dengjel, Joern; Hackanson, Bjoern; Schmid, Christoph; Holtick, Udo; Scheid, Christof; Spyridonidis, Alexandros; Stoelzel, Friedrich; Ordemann, Rainer; Mueller, Lutz P.; Sicre-de-Fontbrune, Flore; Ihorst, Gabriele; Kuball, Juergen; Ehlert, Jan E.; Feger, Daniel; Wagner, Eva-Maria; Cahn, Jean-Yves; Schnell, Jacqueline; Kuchenbauer, Florian; Bunjes, Donald; Chakraverty, Ronjon; Richardson, Simon; Gill, Saar; Kroeger, Nicolaus; Ayuk, Francis; Vago, Luca; Ciceri, Fabio; Mueller, Antonia M.; Kondo, Takeshi; Teshima, Takanori; Klaeger, Susan; Kuster, Bernhard; Kim, Dennis (Dong Hwan); Weisdorf, Daniel; van der Velden, Walter; Doerfel, Daniela; Bethge, Wolfgang; Hilgendorf, Inken; Hochhaus, Andreas; Andrieux, Geoffroy; Boerries, Melanie; Busch, Hauke; Magenau, John; Reddy, Pavan; Labopin, Myriam; Antin, Joseph H.; Henden, Andrea S.; Hill, Geoffrey R.; Kennedy, Glen A.; Bar, Merav; Sarma, Anita; McLornan, Donal; Mufti, Ghulam; Oran, Betul; Rezvani, Katayoun; Shah, Omid; Negrin, Robert S.; Nagler, Arnon; Prinz, Marco; Burchert, Andreas; Neubauer, Andreas; Beelen, Dietrich; Mackensen, Andreas; von Bubnoff, Nikolas; Herr, Wolfgang; Becher, Burkhard; Socie, Gerard; Caligiuri, Michael A.; Ruggiero, Eliana; Bonini, Chiara; Haecker, Georg; Duyster, Justus; Finke, Juergen; Pearce, Erika; Blazar, Bruce R.; Zeiser, Robert			Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; HOST-DISEASE; REGULATORY FACTOR; ACUTE GVHD; ALLO-SCT; TRANSPLANTATION; INTERLEUKIN-15; ACTIVATION; MAINTENANCE	Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after allogeneic hematopoietic cell transplantation (allo-HCT) have a 1-year survival rate below 20%. We observed that sorafenib, a multitargeted tyrosine kinase inhibitor, increased IL-15 production by FLT3-ITD+ leukemia cells. This synergized with the allogeneic CD8(+) T cell response, leading to long-term survival in six mouse models of FLT3-ITD+ AML. Sorafenib-related IL-15 production caused an increase in CD8(+) CD107a(+) IFN-gamma(+) T cells with features of longevity (high levels of Bcl-2 and reduced PD-1 levels), which eradicated leukemia in secondary recipients. Mechanistically, sorafenib reduced expression of the transcription factor ATF4, thereby blocking negative regulation of interferon regulatory factor 7 (IRF7) activation, which enhanced IL-15 transcription. Both IRF7 knockdown and ATF4 overexpression in leukemia cells antagonized sorafenib-induced IL-15 production in vitro. Human FLT3-ITD+ AML cells obtained from sorafenib responders following sorafenib therapy showed increased levels of IL-15, phosphorylated IRF7, and a transcriptionally active IRF7 chromatin state. The mitochondrial spare respiratory capacity and glycolytic capacity of CD8(+) T cells increased upon sorafenib treatment in sorafenib responders but not in nonresponders. Our findings indicate that the synergism of T cells and sorafenib is mediated via reduced ATF4 expression, causing activation of the IRF7-IL-15 axis in leukemia cells and thereby leading to metabolic reprogramming of leukemia-reactive T cells in humans. Therefore, sorafenib treatment has the potential to contribute to an immune-mediated cure of FLT3-ITD-mutant AML relapse, an otherwise fatal complication after allo-HCT.	[Mathew, Nimitha R.; Baumgartner, Francis; Braun, Lukas; Waterhouse, Miguel; Mueller, Tony A.; Hanke, Kathrin; Taromi, Sanaz; Apostolova, Petya; Illert, Anna L.; Melchinger, Wolfgang; Duquesne, Sandra; Osswald, Lena; Yan, Kai-Li; Pfeifer, Dietmar; Follo, Marie; Claus, Rainer; Luebbert, Michael; Rummelt, Christoph; Bertz, Hartmut; Waesch, Ralph; Haag, Johanna; Schmidts, Andrea; von Bubnoff, Nikolas; Duyster, Justus; Finke, Juergen; Zeiser, Robert] Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Mathew, Nimitha R.; Hanke, Kathrin] Univ Freiburg, Fac Biol, Freiburg, Germany; [O'Sullivan, David; Pearce, Erika] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Thomas, Simone; Herr, Wolfgang] Univ Hosp Regensburg, Dept Internal Med Hematol & Oncol 3, Hematol & Oncol, Regensburg, Germany; [Schmitt-Graeff, Annette] Univ Freiburg, Univ Med Ctr Freiburg, Dept Pathol, Freiburg, Germany; [Weber, Arnim; Tanriver, Yakup; Haecker, Georg] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med Microbiol & Hyg, Freiburg, Germany; [Tugues, Sonia; Spath, Sabine; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Schultheiss, Michael; Bettinger, Dominik; Thimme, Robert] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med 2, Fac Med, Freiburg, Germany; [Ullrich, Evelyn] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Div Stem Cell Transplantat & Immunol, Dept Children & Adolescents Med, Frankfurt, Germany; [Tanriver, Yakup] Univ Freiburg, Univ Med Ctr Freiburg, Dept Nephrol, Freiburg, Germany; [Vuong, Giang Lam; Arnold, Renate; Hemmati, Philipp] Charite Univ Med Berlin, Dept Stem Cell Transplantat, Berlin, Germany; [Wolf, Dominik] Univ Hosp Bonn UKB, Med Clin Oncol Hematol Immunooncol & Rheumatol 3, Bonn, Germany; [Wolf, Dominik] Univ Med Ctr Innsbruck, Dept Hematol, Innsbruck, Austria; [Ditschkowski, Markus] Univ Hosp Essen, West German Canc Ctr, Dept Bone Marrow Transplantat, Essen, Germany; [Jilg, Cordula; Wilhelm, Konrad; Leiber, Christian; Beelen, Dietrich] Univ Freiburg, Univ Med Ctr Freiburg, Dept Urol, Freiburg, Germany; [Gerull, Sabine; Halter, Joerg; Lengerke, Claudia] Univ Basel Hosp, Div Hematol, Basel, Switzerland; [Pabst, Thomas] Inselspital Univ Spital Bern, Dept Internal Med, Bern, Switzerland; [Schroeder, Thomas; Kobbe, Guido] Univ Klinikum, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany; [Roesler, Wolf] Univ Erlangen Nurnberg, Dept Hematol & Oncol, Erlangen, Germany; [Doostkam, Soroush; Mackensen, Andreas] Univ Freiburg, Inst Neuropathol, Freiburg, Germany; [Meckel, Stephan; Prinz, Marco] Univ Freiburg, Univ Med Ctr Freiburg, Dept Neuroradiol, Freiburg, Germany; [Stabla, Kathleen; Metzelder, Stephan K.; Neubauer, Andreas] Philipps Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany; [Stabla, Kathleen; Metzelder, Stephan K.; Neubauer, Andreas] Univ Hosp Giessen & Marburg, Dept Hematol, Marburg, Germany; [Halbach, Sebastian; Brummer, Tilman; Burchert, Andreas] Univ Freiburg, Univ Med Ctr Freiburg, Inst Mol Med & Cell Res IMMZ, Fac Med, Freiburg, Germany; [Brummer, Tilman; Andrieux, Geoffroy; Boerries, Melanie; Busch, Hauke] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany; [Brummer, Tilman; Prinz, Marco; Zeiser, Robert] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Freiburg, Germany; [Brummer, Tilman; Klaeger, Susan; Boerries, Melanie; Busch, Hauke] German Canc Res Ctr, Heidelberg, Germany; [Hu, Zehan; Dengjel, Joern] Univ Freiburg, Univ Med Ctr, Dept Dermatol, Freiburg, Germany; [Hu, Zehan; Dengjel, Joern] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Hackanson, Bjoern; Schmid, Christoph] Interdisciplinary Canc Ctr Augsburg ICCA II, Clin Internal Med, Augsburg, Germany; [Holtick, Udo; Scheid, Christof] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Spyridonidis, Alexandros] Univ Patras, Sch Med, Hematol Stem Cell Transplant Unit, Patras, Greece; [Stoelzel, Friedrich; Ordemann, Rainer] Univ Klinikum Carl Gustav Carus, Dept Hematol & Oncol, Dresden, Germany; [Stoelzel, Friedrich; Ordemann, Rainer] Tech Univ Dresden, Dresden, Germany; [Mueller, Lutz P.] Univ Klinikum Halle, Dept Hematol & Oncol, Halle, Germany; [Sicre-de-Fontbrune, Flore; Socie, Gerard] St Louis Hosp, Hematol Stem Cell Transplantat, AP HP, Paris, France; [Sicre-de-Fontbrune, Flore; Socie, Gerard] INSERM, UMR 1160, Paris, France; [Ihorst, Gabriele] Univ Freiburg, Univ Med Ctr, Clin Trials Unit, Fac Med, Freiburg, Germany; [Kuball, Juergen] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands; [Ehlert, Jan E.; Feger, Daniel] ProQinase, Freiburg, Germany; [Wagner, Eva-Maria] Univ Med Mainz, Dept Hematol & Oncol, Mainz, Germany; [Cahn, Jean-Yves] Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, France; [Schnell, Jacqueline; Kuchenbauer, Florian; Bunjes, Donald] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Chakraverty, Ronjon; Richardson, Simon] Royal Free Hosp, Canc Inst, London, England; [Chakraverty, Ronjon; Richardson, Simon] Royal Free Hosp, Inst Immun & Transplantat, London, England; [Gill, Saar] Hosp Univ Penn, Smilow Translat Res Ctr, 3400 Spruce St, Philadelphia, PA 19104 USA; [Kroeger, Nicolaus; Ayuk, Francis] Univ Hosp Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany; [Vago, Luca; Ciceri, Fabio; Ruggiero, Eliana; Bonini, Chiara] Ist Sci San Raffaele, Unit Immunogenet Leukemia Genom & Immunobiol, Milan, Italy; [Vago, Luca; Ciceri, Fabio; Ruggiero, Eliana; Bonini, Chiara] Ist Sci San Raffaele, Unit Hematol & Bone Marrow Transplantat, Milan, Italy; [Vago, Luca; Ciceri, Fabio; Ruggiero, Eliana; Bonini, Chiara] San Raffaele Univ, Univ Vita Salute, Dept Hematol, Milan, Italy; [Mueller, Antonia M.] Univ Hosp Zurich, Dept Hematol, Zurich, Switzerland; [Kondo, Takeshi; Teshima, Takanori] Hokkaido Univ, Dept Hematol, Sapporo, Hokkaido, Japan; [Klaeger, Susan; Kuster, Bernhard] Tech Univ Munich, Prote & Bioanalyt, Partner Site German Canc Consortium, Freising Weihenstephan, Germany; [Kim, Dennis (Dong Hwan)] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol Hematol, Toronto, ON, Canada; [Weisdorf, Daniel] Univ Minnesota, Hematol Oncol Transplantat, Minneapolis, MN USA; [van der Velden, Walter] Radboud Univ Nijmegen, Dept Hematol, Nijmegen, Netherlands; [Doerfel, Daniela; Bethge, Wolfgang] Univ Klinikum Tubingen, Med Klin 2, Tubingen, Germany; [Hilgendorf, Inken; Hochhaus, Andreas; Andrieux, Geoffroy] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany; [Andrieux, Geoffroy; Boerries, Melanie; Busch, Hauke] ALU, IMMZ, Syst Biol Cellular Microenvironm Grp, Freiburg, Germany; [Busch, Hauke] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany; [Magenau, John; Reddy, Pavan] Univ Michigan, Sch Med, Dept Hematol, Ann Arbor, MI USA; [Labopin, Myriam] Hop St Antoine Paris, EBMT Stat Unit, Paris, France; [Antin, Joseph H.] Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Henden, Andrea S.; Hill, Geoffrey R.] QIMR Berghofer Med Res Inst, Bone Marrow Transplant Lab, Brisbane, Qld, Australia; [Henden, Andrea S.; Hill, Geoffrey R.] Royal Brisbane Hosp, Dept Haematol, Brisbane, Qld, Australia; [Hill, Geoffrey R.; Kennedy, Glen A.] Royal Brisbane & Womens Hosp, Dept Haematol, Brisbane, Qld, Australia; [Bar, Merav] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Blood & Marrow Transplantat, Seattle, WA 98195 USA; [Sarma, Anita; McLornan, Donal; Mufti, Ghulam] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England; [Oran, Betul; Rezvani, Katayoun] MD Anderson Canc Ctr, Div Bone Marrow Transplantat, Houston, TX USA; [Shah, Omid; Negrin, Robert S.] Stanford Univ, Med Sch, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel; [Caligiuri, Michael A.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University of Freiburg; University of Freiburg; Max Planck Society; University of Regensburg; University of Freiburg; University of Freiburg; University of Zurich; University of Freiburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; University of Duisburg Essen; University of Freiburg; University of Basel; University of Bern; University Hospital of Bern; University of Erlangen Nuremberg; University of Freiburg; University of Freiburg; Philipps University Marburg; University Hospital of Giessen & Marburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Fribourg; University of Cologne; University of Patras; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Martin Luther University Halle Wittenberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; Utrecht University; Utrecht University Medical Center; Johannes Gutenberg University of Mainz; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Ulm University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Zurich; University Zurich Hospital; Hokkaido University; Technical University of Munich; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Minnesota System; University of Minnesota Twin Cities; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; University of Lubeck; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; King's College Hospital NHS Foundation Trust; University of Texas System; UTMD Anderson Cancer Center; Stanford University; Chaim Sheba Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities	Zeiser, R (corresponding author), Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany.; Zeiser, R (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Freiburg, Germany.	robert.zeiser@uniklinik-freiburg.de	Ihorst, Gabriele/AAA-7445-2021; Halbach, Sebastian/G-4021-2012; Claus, Rainer/AAZ-5606-2020; Gerull, Sabine/GLT-9589-2022; Burchert, Andreas/S-9563-2017; Brummer, Tilman/B-6218-2016; Lengerke, Claudia/AAV-8745-2021; Tanriver, Yakup/AAU-7064-2020; Illert, Anna L/G-8127-2019; Kobbe, Guido/ABG-9472-2021; Müller, Lutz/ABE-2941-2020; Brummer, Tilman/AAA-9428-2020; Kim, Dennis/AAH-8499-2019; Dengjel, Joern/AAI-3682-2020; Becher, Burkhard/ABE-4225-2020; Thomas, Simone/G-7445-2019; Ruggiero, Eliana/J-9060-2018; Stölzel, Friedrich/AAZ-8613-2021; Meckel, Stephan/I-5810-2018; Schmid, Christoph/AAS-6419-2021; Hilgendorf, Inken/M-2367-2019; Bettinger, Dominik/ABB-3929-2020; von Bubnoff, Nikolas/AAG-1845-2021; Hu, Zehan/AAZ-8321-2021; Henden, Andrea S/J-1487-2015; Ayuk, Francis/G-8439-2019; Kondo, Takeshi/G-2103-2012; Müller, Antonia/HCI-4374-2022; Kennedy, Glen/AAK-1644-2021; Waesch, Ralph/F-6282-2019; Apostolova, Petya/AAY-6644-2021; Hill, Geoffrey/O-2630-2016; Busch, Hauke/R-6452-2016	Halbach, Sebastian/0000-0002-6827-8178; Claus, Rainer/0000-0003-2617-8766; Burchert, Andreas/0000-0002-8411-8844; Brummer, Tilman/0000-0003-4387-7905; Lengerke, Claudia/0000-0001-5442-2805; Brummer, Tilman/0000-0003-4387-7905; Becher, Burkhard/0000-0002-1541-7867; Thomas, Simone/0000-0001-6308-3649; Ruggiero, Eliana/0000-0002-2954-8278; Meckel, Stephan/0000-0001-6468-4526; Schmid, Christoph/0000-0001-7070-487X; Hilgendorf, Inken/0000-0003-2038-9730; Henden, Andrea S/0000-0003-2261-169X; Kondo, Takeshi/0000-0001-7455-5824; Kennedy, Glen/0000-0002-7171-0435; Apostolova, Petya/0000-0002-3856-5109; Spath, Sabine/0000-0002-2689-1951; Kroger, Nicolaus/0000-0001-5103-9966; Rummelt, Christoph/0000-0002-6471-7030; Hu, Zehan/0000-0001-6182-4781; Beelen, Dietrich/0000-0001-5050-220X; Hill, Geoffrey/0000-0003-2994-0429; Reddy, Pavan/0000-0001-7264-8429; Ullrich, Evelyn/0000-0001-8530-1192; Kuchenbauer, Florian/0000-0002-9820-3409; Klaeger, Susan/0000-0002-0074-5163; Tanriver, Yakup/0000-0002-4806-2548; Dengjel, Joern/0000-0002-9453-4614; Vago, Luca/0000-0003-4247-3175; BONINI, Maria Chiara/0000-0002-0772-1674; Busch, Hauke/0000-0003-4763-4521; Muller, Tony/0000-0002-4139-2392; Muller, Antonia Maria Susanne/0000-0003-4420-9466; Zeiser, Robert/0000-0001-6565-3393; Richardson, Simon/0000-0003-4343-4784; Baumgartner, Francis/0000-0003-0768-1956; Chakraverty, Ronjon/0000-0003-2301-2664; Schmidts, Andrea/0000-0001-7035-1584; ANDRIEUX, GEOFFROY/0000-0002-5389-9481	German Research Foundation (DFG) Heisenberg Professorship [ZE 872/3-1]; DFG Sonderforschungsbereiche [SFB1074, SFB1160, SFB850, TRR167]; European Research Council (ERC) Consolidator [681012]; Deutsche Krebshilfe [111639]; Deutsche Jose Carreras Leukamie-Stiftung (DJCLS); Else Kroner-Fresenius Foundation (EKF) [2015_ A147]; INTERREG V Rhin Superieur; LOEWE-Gentherapie Frankfurt (CGT), Hessian Ministry of Higher Education, Research and the Arts, Germany [III L 4-518/17.004]; Max-Eder-Nachwuchsgruppenprogramm, Deutsche Krebshilfe [109420]; European Hematology Association fellowship [2010/04]; National Institutes of Health (NIH) [R01 CA-72669]; Associazione Italiana per la Ricerca sul Cancro (AIRC); European Union; National Institute for Health Research [CL-2016-18-002] Funding Source: researchfish; Versus Arthritis [20265] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA065493, R01CA072669] Funding Source: NIH RePORTER	German Research Foundation (DFG) Heisenberg Professorship(German Research Foundation (DFG)); DFG Sonderforschungsbereiche(German Research Foundation (DFG)); European Research Council (ERC) Consolidator(European Research Council (ERC)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Jose Carreras Leukamie-Stiftung (DJCLS); Else Kroner-Fresenius Foundation (EKF); INTERREG V Rhin Superieur; LOEWE-Gentherapie Frankfurt (CGT), Hessian Ministry of Higher Education, Research and the Arts, Germany; Max-Eder-Nachwuchsgruppenprogramm, Deutsche Krebshilfe(Deutsche Krebshilfe); European Hematology Association fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Prinz and H. Dierbach for their help with mouse experiments, K. Geiger and D. Herchenbach for cell sorting, and S. Decker (University of Freiburg) for providing NSG mice. We thank M.E.D. Flowers (University of Washington) for help with patient data. We thank D. Cittaro for the help with bioinformatic analysis. Il15<SUP>-/</SUP>-mice were provided by Y. Tanriver (University of Freiburg). Il15<SUP>-/-</SUP> mice were provided by B. Becher (University of Zurich). This study was supported by the German Research Foundation (DFG) Heisenberg Professorship ZE 872/3-1 (R.Z.), DFG Sonderforschungsbereiche 1074 (SFB1074; F.K.), SFB1160 (R.Z.), SFB850 (T.B.), and TRR167 (R.Z.); European Research Council (ERC) Consolidator Grant no. 681012 GvHDCure (R.Z.); Deutsche Krebshilfe no. 111639 (G. H., R.Z.); Deutsche Jose Carreras Leukamie-Stiftung (DJCLS; G. H., R.Z.); Else Kroner-Fresenius Foundation (EKF) Stiftung no. 2015_ A147 (P.A.), INTERREG V Rhin Superieur (P.A., R.Z.); LOEWE-Gentherapie Frankfurt (CGT), Hessian Ministry of Higher Education, Research and the Arts, Germany no. III L 4-518/17.004 (E.U.); Max-Eder-Nachwuchsgruppenprogramm, Deutsche Krebshilfe no. 109420 (F.K.); European Hematology Association fellowship 2010/04 (F.K.); and National Institutes of Health (NIH) grant no. R01 CA-72669 (B. R. B.). E.R. was supported by a fellowship from Associazione Italiana per la Ricerca sul Cancro (AIRC) that was cofunded by the European Union.	Antar A, 2015, CL LYMPH MYELOM LEUK, V15, P298, DOI 10.1016/j.clml.2014.12.005; Azimi N, 2000, J VIROL, V74, P7338, DOI 10.1128/JVI.74.16.7338-7348.2000; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bejanyan N, 2015, BIOL BLOOD MARROW TR, V21, P454, DOI 10.1016/j.bbmt.2014.11.007; Bernot KM, 2013, BLOOD, V122, P3778, DOI 10.1182/blood-2013-06-507426; Blaser BW, 2006, BLOOD, V108, P2463, DOI 10.1182/blood-2006-04-019059; Blaser BW, 2005, BLOOD, V105, P894, DOI 10.1182/blood-2004-05-1687; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brummer T, 2008, EMBO J, V27, P2305, DOI 10.1038/emboj.2008.159; Brunner AM, 2016, BRIT J HAEMATOL, V175, P496, DOI 10.1111/bjh.14260; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cario G, 2007, J CLIN ONCOL, V25, P4813, DOI 10.1200/JCO.2007.11.8166; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen GH, 2008, EUR J HAEMATOL, V81, P226, DOI 10.1111/j.1600-0609.2008.01108.x; Chen YB, 2014, BIOL BLOOD MARROW TR, V20, P2042, DOI 10.1016/j.bbmt.2014.09.007; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Kruger WH, 2012, BONE MARROW TRANSPL, V47, P137, DOI 10.1038/bmt.2011.7; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liang QM, 2011, J IMMUNOL, V186, P1001, DOI 10.4049/jimmunol.1002240; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Metzelder SK, 2012, LEUKEMIA, V26, P2353, DOI 10.1038/leu.2012.105; Nasilowska-Adamska B, 2016, EUR J HAEMATOL, V96, P236, DOI 10.1111/ejh.12575; Pandiyan P, 2012, J IMMUNOL, V189, P4237, DOI 10.4049/jimmunol.1201476; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pfirrmann M, 2012, LANCET ONCOL, V13, P207, DOI 10.1016/S1470-2045(11)70326-6; Rollig C, 2015, LANCET ONCOL, V16, P1691, DOI 10.1016/S1470-2045(15)00362-9; Romieu-Mourez R, 2006, CANCER RES, V66, P10576, DOI 10.1158/0008-5472.CAN-06-1279; Roychowdhury S, 2005, BLOOD, V106, P2433, DOI 10.1182/blood-2005-04-1597; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Sauter CT, 2013, BONE MARROW TRANSPL, V48, P1237, DOI 10.1038/bmt.2013.47; Schultze-Florey C, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.4605.4605; Schwab L, 2014, NAT MED, V20, P648, DOI 10.1038/nm.3517; Sengsayadeth SM, 2012, BONE MARROW TRANSPL, V47, P1535, DOI 10.1038/bmt.2012.88; Serve H, 2013, J CLIN ONCOL, V31, P3110, DOI 10.1200/JCO.2012.46.4990; Smith CC, 2015, LEUKEMIA, V29, P2390, DOI 10.1038/leu.2015.165; Steinmann J, 2015, BONE MARROW TRANSPL, V50, P690, DOI 10.1038/bmt.2015.10; Takami A, 2014, BIOL BLOOD MARROW TR, V20, P1785, DOI 10.1016/j.bbmt.2014.07.010; Tarlock K, 2015, PEDIATR BLOOD CANCER, V62, P1048, DOI 10.1002/pbc.25437; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Tschan-Plessl A, 2015, ANN HEMATOL, V94, P1899, DOI 10.1007/s00277-015-2461-5; van Bergen CAM, 2017, J CLIN INVEST, V127, P517, DOI 10.1172/JCI86175; van Bockel DJ, 2011, J IMMUNOL, V186, P359, DOI 10.4049/jimmunol.1001807; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wu SL, 2010, CANCER, V116, P387, DOI 10.1002/cncr.24729; Zorko NA, 2012, BLOOD, V120, P1130, DOI 10.1182/blood-2012-03-415067	53	153	156	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					282	+		10.1038/nm.4484	http://dx.doi.org/10.1038/nm.4484			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29431743	Green Accepted, Green Submitted			2022-12-27	WOS:000426700900010
J	Waldorf, KMA; Nelson, BR; Stencel-Baerenwald, JE; Studholme, C; Kapur, RP; Armistead, B; Walker, CL; Merillat, S; Vornhagen, J; Tisoncik-Go, J; Baldessari, A; Coleman, M; Dighe, MK; Shaw, DWW; Roby, JA; Santana-Ufret, V; Boldenow, E; Li, JW; Gao, XH; Davis, MA; Swanstrom, JA; Jensen, K; Widman, DG; Baric, RS; Medwid, JT; Hanley, KA; Ogle, J; Gough, GM; Lee, W; English, C; Durning, WM; Thiel, J; Gatenby, C; Dewey, EC; Fairgrieve, MR; Hodge, RD; Grant, RF; Kuller, L; Dobyns, WB; Hevner, RF; Gale, M; Rajagopal, L				Waldorf, Kristina M. Adams; Nelson, Branden R.; Stencel-Baerenwald, Jennifer E.; Studholme, Colin; Kapur, Raj P.; Armistead, Blair; Walker, Christie L.; Merillat, Sean; Vornhagen, Jay; Tisoncik-Go, Jennifer; Baldessari, Audrey; Coleman, Michelle; Dighe, Manjiri K.; Shaw, Dennis W. W.; Roby, Justin A.; Santana-Ufret, Veronica; Boldenow, Erica; Li, Junwei; Gao, Xiaohu; Davis, Michael A.; Swanstrom, Jesica A.; Jensen, Kara; Widman, Douglas G.; Baric, Ralph S.; Medwid, Joseph T.; Hanley, Kathryn A.; Ogle, Jason; Gough, G. Michael; Lee, Wonsok; English, Chris; Durning, W. McIntyre; Thiel, Jeff; Gatenby, Chris; Dewey, Elyse C.; Fairgrieve, Marian R.; Hodge, Rebecca D.; Grant, Richard F.; Kuller, LaRene; Dobyns, William B.; Hevner, Robert F.; Gale, Michael, Jr.; Rajagopal, Lakshmi			Congenital Zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain	NATURE MEDICINE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; NEURAL STEM-CELLS; DENGUE VIRUS; PROGENITORS; IMMUNITY; DISEASE; VACCINE; GROWTH; TBR2	Zika virus (ZIKV) is a flavivirus with teratogenic effects on fetal brain, but the spectrum of ZIKV-induced brain injury is unknown, particularly when ultrasound imaging is normal. In a pregnant pigtail macaque (Macaca nemestrina) model of ZIKV infection, we demonstrate that ZIKV-induced injury to fetal brain is substantial, even in the absence of microcephaly, and may be challenging to detect in a clinical setting. A common and subtle injury pattern was identified, including (i) periventricular T2-hyperintense foci and loss of fetal noncortical brain volume, (ii) injury to the ependymal epithelium with underlying gliosis and (iii) loss of late fetal neuronal progenitor cells in the subventricular zone (temporal cortex) and subgranular zone (dentate gyrus, hippocampus) with dysmorphic granule neuron patterning. Attenuation of fetal neurogenic output demonstrates potentially considerable teratogenic effects of congenital ZIKV infection even without microcephaly. Our findings suggest that all children exposed to ZIKV in utero should receive long-term monitoring for neurocognitive deficits, regardless of head size at birth.	[Waldorf, Kristina M. Adams; Walker, Christie L.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Waldorf, Kristina M. Adams; Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Roby, Justin A.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.; Rajagopal, Lakshmi] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Waldorf, Kristina M. Adams; Armistead, Blair; Vornhagen, Jay; Gale, Michael, Jr.; Rajagopal, Lakshmi] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Waldorf, Kristina M. Adams] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden; [Nelson, Branden R.; Dobyns, William B.; Hevner, Robert F.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Roby, Justin A.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Studholme, Colin; Coleman, Michelle; Boldenow, Erica; Dobyns, William B.; Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Studholme, Colin; Li, Junwei; Gao, Xiaohu] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Studholme, Colin; Dighe, Manjiri K.; Shaw, Dennis W. W.; Thiel, Jeff; Gatenby, Chris] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Kapur, Raj P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kapur, Raj P.] Seattle Childrens Hosp, Dept Pathol, Seattle, WA USA; [Armistead, Blair; Walker, Christie L.; Merillat, Sean; Vornhagen, Jay; Coleman, Michelle; Santana-Ufret, Veronica; Boldenow, Erica; Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA; [Baldessari, Audrey; Ogle, Jason; Gough, G. Michael; Lee, Wonsok; English, Chris; Durning, W. McIntyre; Grant, Richard F.; Kuller, LaRene] Washington Natl Primate Res Ctr, Seattle, WA USA; [Shaw, Dennis W. W.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA; [Swanstrom, Jesica A.; Jensen, Kara; Widman, Douglas G.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Medwid, Joseph T.; Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hodge, Rebecca D.] Allen Inst Brain Sci, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Gothenburg; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; Seattle Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New Mexico State University; Allen Institute for Brain Science	Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Waldorf, KMA; Rajagopal, L (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Waldorf, KMA; Rajagopal, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.; Rajagopal, L (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Rajagopal, L (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.	adamsk@uw.edu; mgale@uw.edu; lakshmi.rajagopal@seattlechildrens.org	Dobyns, William Brian/ABC-6525-2021; amsalu, ribka/G-8780-2019; Dobyns, William/AAI-2768-2020; Gao, Xiaohu/C-8869-2009; Vornahgen, Jay/AAI-1887-2019; Dighe, Manjiri/D-9294-2018; Adams Waldorf, Kristina/F-2608-2013	Dobyns, William/0000-0002-7681-2844; Vornahgen, Jay/0000-0002-1685-302X; Dighe, Manjiri/0000-0003-0047-5148; Davis, Michael/0000-0002-5406-4128; Coleman, Michelle/0000-0002-6752-3266; Roby, Justin/0000-0003-2434-4273; Widman, Douglas/0000-0002-3585-6373; Adams Waldorf, Kristina/0000-0002-6939-7224	University of Washington Department of Obstetrics & Gynecology, Seattle Children's Research Institute; National Institutes of Health (NIH) [R01AI100989, AI083019, AI104002, AI100625, AI107731, R01NS092339, R01NS085081, R21OD023838]; Keck Foundation; NIH training grants [T32 HD007233, T32 AI07509]; A Perkins Coie Award; NIH Office of Research Infrastructure Programs [P51 OD010425]; Allen Institute for Brain Science founders; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107731, U19AI100625, U19AI083019, R01AI104002, R01AI100989, T32AI007509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085081, R01NS092339, R01NS055064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011123, P51OD010425, R21OD023838] Funding Source: NIH RePORTER	University of Washington Department of Obstetrics & Gynecology, Seattle Children's Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NIH training grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A Perkins Coie Award; NIH Office of Research Infrastructure Programs; Allen Institute for Brain Science founders; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Hughes and G. Gallardo for administrative assistance. This work was primarily supported by generous private philanthropic gifts, mainly from five donors in Florida, who wish to remain anonymous. Further support was obtained from the University of Washington Department of Obstetrics & Gynecology, Seattle Children's Research Institute and the National Institutes of Health (NIH), grant no. R01AI100989 (L.R. and K.M.A.W.), AI083019 (M. G.), AI104002 (M. G.), AI100625 (R.S.B.), AI107731 (R.S.B.), R01NS092339 (R.F.H.), R01NS085081 (R.F.H.), R21OD023838 (B.R.N.), and the Keck Foundation (B.R.N.). The NIH training grants T32 HD007233 (principal investigator: L. Frenkel) and T32 AI07509 (principal investigator: L. Campbell) supported E.B. and J. V., respectively. A Perkins Coie Award for Discovery supported J.A.R. The NIH Office of Research Infrastructure Programs (P51 OD010425) also supported this project. The authors thank the Allen Institute for Brain Science founders, P. Allen and J. Allen, for their vision, encouragement and support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funders. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180; Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w; CONRAD S, 1995, AM J PRIMATOL, V36, P15, DOI 10.1002/ajp.1350360103; Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Fogtmann M, 2014, IEEE T MED IMAGING, V33, P272, DOI 10.1109/TMI.2013.2284014; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Habas PA, 2010, NEUROIMAGE, V53, P460, DOI 10.1016/j.neuroimage.2010.06.054; Hodge RD, 2013, J NEUROSCI, V33, P4165, DOI 10.1523/JNEUROSCI.4185-12.2013; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kim K, 2011, IEEE T MED IMAGING, V30, P1704, DOI 10.1109/TMI.2011.2143724; Kim K, 2010, IEEE T MED IMAGING, V29, P146, DOI 10.1109/TMI.2009.2030679; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2; Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008; Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI [10.1523/jneurosci.3124-16.2017, 10.1523/JNEUROSCI.3124-16.2017]; Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038; Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10; Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Woods SE, 2013, J AM ASSOC LAB ANIM, V52, P295; Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	51	77	78	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					368	+		10.1038/nm.4485	http://dx.doi.org/10.1038/nm.4485			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29400709	Green Accepted, Green Submitted			2022-12-27	WOS:000426700900019
J	Bolouri, H; Farrar, JE; Triche, T; Ries, RE; Lim, EL; Alonzo, TA; Ma, Y; Moore, R; Mungall, AJ; Marra, MA; Zhang, JH; Ma, XT; Liu, Y; Liu, YL; Auvil, JMG; Davidsen, TM; Gesuwan, P; Hermida, LC; Salhia, B; Capone, S; Ramsingh, G; Zwaan, CM; Noort, S; Piccolo, SR; Kolb, EA; Gamis, AS; Smith, MA; Gerhard, DS; Meshinchi, S				Bolouri, Hamid; Farrar, Jason E.; Triche, Timothy, Jr.; Ries, Rhonda E.; Lim, Emilia L.; Alonzo, Todd A.; Ma, Yussanne; Moore, Richard; Mungall, Andrew J.; Marra, Marco A.; Zhang, Jinghui; Ma, Xiaotu; Liu, Yu; Liu, Yanling; Auvil, Jaime M. Guidry; Davidsen, Tanja M.; Gesuwan, Patee; Hermida, Leandro C.; Salhia, Bodour; Capone, Stephen; Ramsingh, Giridharan; Zwaan, Christian Michel; Noort, Sanne; Piccolo, Stephen R.; Kolb, E. Anders; Gamis, Alan S.; Smith, Malcolm A.; Gerhard, Daniela S.; Meshinchi, Soheil			The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions	NATURE MEDICINE			English	Article							CHILDRENS-ONCOLOGY-GROUP; GENETIC-HETEROGENEITY; TRANSCRIPTION FACTOR; TREATMENT STRATEGY; DNMT3A MUTATIONS; STEM-CELLS; AML; EXPRESSION; CANCER; TRIAL	We present the molecular landscape of pediatric acute myeloid leukemia (AML) and characterize nearly 1,000 participants in Children's Oncology Group (COG) AML trials. The COG-National Cancer Institute (NCI) TARGET AML initiative assessed cases by whole-genome, targeted DNA, mRNA and microRNA sequencing and CpG methylation profiling. Validated DNA variants corresponded to diverse, infrequent mutations, with fewer than 40 genes mutated in >2% of cases. In contrast, somatic structural variants, including new gene fusions and focal deletions of MBNL1, ZEB2 and ELF1, were disproportionately prevalent in young individuals as compared to adults. Conversely, mutations in DNMT3A and TP53, which were common in adults, were conspicuously absent from virtually all pediatric cases. New mutations in GATA2, FLT3 and CBL and recurrent mutations in MYC-ITD, NRAS, KRAS and WT1 were frequent in pediatric AML. Deletions, mutations and promoter DNA hypermethylation convergently impacted Wnt signaling, Polycomb repression, innate immune cell interactions and a cluster of zinc finger-encoding genes associated with KMT2A rearrangements. These results highlight the need for and facilitate the development of age-tailored targeted therapies for the treatment of pediatric AML.	[Bolouri, Hamid] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Farrar, Jason E.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Farrar, Jason E.] Univ Arkansas Med Sci, Arkansas Childrens Res Inst, Little Rock, AR 72205 USA; [Triche, Timothy, Jr.; Capone, Stephen; Ramsingh, Giridharan; Meshinchi, Soheil] Univ Southern Calif, Jane Anne Nohl Div Hematol, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Ries, Rhonda E.; Meshinchi, Soheil] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Lim, Emilia L.; Ma, Yussanne; Moore, Richard; Mungall, Andrew J.; Marra, Marco A.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Alonzo, Todd A.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Alonzo, Todd A.] Childrens Oncol Grp, Monrovia, CA USA; [Zhang, Jinghui; Ma, Xiaotu; Liu, Yu; Liu, Yanling] St Jude Childrens Res Hosp, Div Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Auvil, Jaime M. Guidry; Davidsen, Tanja M.; Gesuwan, Patee; Hermida, Leandro C.; Gerhard, Daniela S.] NCI, Office Canc Genom, Bethesda, MD 20892 USA; [Salhia, Bodour] Univ Southern Calif, Keck Sch Med, Dept Translat Genom, Los Angeles, CA USA; [Zwaan, Christian Michel; Noort, Sanne] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol, Rotterdam, Netherlands; [Piccolo, Stephen R.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Piccolo, Stephen R.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Kolb, E. Anders] Alfred I DuPont Hosp Children, Nemours Ctr Canc & Blood Disorders, Wilmington, DE USA; [Gamis, Alan S.] Childrens Mercy Hosp & Clin, Div Hematol Oncol & Bone Marrow Transplantat, Kansas City, MO USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Triche, Timothy, Jr.] Van Andel Res Inst, Grand Rapids, MI USA	Fred Hutchinson Cancer Center; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Southern California; Fred Hutchinson Cancer Center; British Columbia Cancer Agency; University of Southern California; Children's Oncology Group (COG); St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); University of Southern California; Erasmus University Rotterdam; Erasmus MC; Brigham Young University; Utah System of Higher Education; University of Utah; Nemours Alfred I. duPont Hospital for Children; Children's Mercy Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Van Andel Institute	Bolouri, H (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.; Meshinchi, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	hbolouri@fhcrc.org; smeshinc@fhcrc.org	Marra, Marco A/B-5987-2008; Zhang, Jing/GWZ-7332-2022; Mungall, Andrew J./U-7067-2018; Capone, Stephen/AAZ-8379-2021; Farrar, Jason/G-8451-2017	Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Capone, Stephen/0000-0001-7231-1535; Hermida, Leandro Cruz/0000-0003-3887-518X; Triche, Tim/0000-0001-5665-946X; Farrar, Jason/0000-0003-2148-5839; Ries, Rhonda/0000-0002-3702-7923; Smith, Malcolm/0000-0001-9880-9876; Kolb, E. Anders/0000-0003-2854-9014	NCI [U10CA98543]; NCI, US National Institutes of Health [HHSN261200800001E]; Fred Hutchinson Scientific Computing; University of Southern California's Center for High-Performance Computing; National Science Foundation (NSF) [ACI-1341935]; COG [U10CA98543, U10CA180886]; COG Statistics and Data Center [U10CA098413, U10CA180899]; COG Specimen Banking [U24CA114766, R01CA114563]; St. Baldrick's Foundation; Alex's Lemonade Stand; Target Pediatric AML (TpAML) [P20GM121293]; Arkansas Biosciences Institute; Jane Anne Nohl Hematology Research Fund; NATIONAL CANCER INSTITUTE [U10CA098543, U10CA180899, U24CA114766, U10CA098413, P30CA021765, U10CA180886, R01CA114563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121293] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, US National Institutes of Health; Fred Hutchinson Scientific Computing; University of Southern California's Center for High-Performance Computing; National Science Foundation (NSF)(National Science Foundation (NSF)); COG; COG Statistics and Data Center; COG Specimen Banking; St. Baldrick's Foundation; Alex's Lemonade Stand; Target Pediatric AML (TpAML); Arkansas Biosciences Institute; Jane Anne Nohl Hematology Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dedicated to the memory of our colleague, mentor and friend, Dr. Robert Arceci, whose vision and perseverance set this effort in motion: "I may not have gone where I intended to go, but I think I have ended up where I needed to be" (Douglas Adams, The Long Dark Tea-Time of the Soul). The results published here are based on data generated by the TARGET initiative and TCGA. The TARGET initiative is supported by NCI Grant U10CA98543. Work performed under contracts from the NCI, US National Institutes of Health within HHSN261200800001E includes specimen processing (Children's Oncology Group Biopathology Center), WGS (Complete Genomics), and RNA-seq and TCS (British Columbia Cancer Agency). The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government. Computation for the work described in this paper was supported in part by Fred Hutchinson Scientific Computing, University of Southern California's Center for High-Performance Computing and National Science Foundation (NSF) award ACI-1341935. This work was additionally supported by COG Chairs U10CA180886 and U10CA98543; COG Statistics and Data Center U10CA098413 and U10CA180899; COG Specimen Banking U24CA114766; R01CA114563 (S.M.); St. Baldrick's Foundation (J.E.F., T.T. and S.M.); Alex's Lemonade Stand (S.M.); Target Pediatric AML (TpAML), P20GM121293 (J.E.F.); the Arkansas Biosciences Institute (J.E.F.); and the Jane Anne Nohl Hematology Research Fund (T.T.).	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Abrahamsson J, 2011, J CLIN ONCOL, V29, P310, DOI 10.1200/JCO.2010.30.6829; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Balgobind BV, 2011, HAEMATOL-HEMATOL J, V96, P1478, DOI 10.3324/haematol.2010.038976; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Caudell D, 2010, BLOOD, V115, P1194, DOI 10.1182/blood-2009-04-216184; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Cooper TM, 2012, CANCER-AM CANCER SOC, V118, P761, DOI 10.1002/cncr.26190; Creutzig U, 2005, LEUKEMIA, V19, P2030, DOI 10.1038/sj.leu.2403920; Creutzig U, 2006, J CLIN ONCOL, V24, P4499, DOI 10.1200/JCO.2006.06.5037; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Fooladinezhad H, 2016, BRIT J BIOMED SCI, V73, P129, DOI 10.1080/09674845.2016.1194564; Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gamis AS, 2014, J CLIN ONCOL, V32, P3021, DOI 10.1200/JCO.2014.55.3628; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gibson BES, 2005, LEUKEMIA, V19, P2130, DOI 10.1038/sj.leu.2403924; Gollner S, 2017, NAT MED, V23, P69, DOI 10.1038/nm.4247; Goossens S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6794; Goossens S, 2011, BLOOD, V117, P5620, DOI 10.1182/blood-2010-08-300236; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Guryanova OA, 2016, NAT MED, V22, P1488, DOI 10.1038/nm.4210; Ho PA, 2011, PEDIATR BLOOD CANCER, V57, P204, DOI 10.1002/pbc.23179; Hollink IHIM, 2009, LEUKEMIA, V23, P262, DOI 10.1038/leu.2008.313; Hollink IHIM, 2011, BLOOD, V118, P3645, DOI 10.1182/blood-2011-04-346643; Hollink IHIM, 2009, BLOOD, V113, P5951, DOI 10.1182/blood-2008-09-177949; Itskovich S.S., 2015, BLOOD, V126, P462; Kardos G, 2005, LEUKEMIA, V19, P2063, DOI 10.1038/sj.leu.2403873; Lange BJ, 2008, BLOOD, V111, P1044, DOI 10.1182/blood-2007-04-084293; Lavallee VP, 2016, LEUKEMIA, V30, P1621, DOI 10.1038/leu.2016.19; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li J, 2017, BLOOD, V129, P460, DOI 10.1182/blood-2016-05-714659; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Lim EL, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.687.687; Loghavi S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0074-4; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Maxson JE, 2016, BLOOD, V127, P3094, DOI 10.1182/blood-2016-04-709899; Mayakonda A, 2016, MAFTOOLS EFFICIENT A; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Nanbakhsh A, 2014, BLOOD, V123, P3585, DOI 10.1182/blood-2013-11-536219; Ng KP, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.41; Ostronoff F, 2014, BLOOD, V124, P2400, DOI 10.1182/blood-2014-04-570929; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Perel Y, 2002, J CLIN ONCOL, V20, P2774, DOI 10.1200/JCO.2002.07.300; Pession A, 2013, BLOOD, V122, P170, DOI 10.1182/blood-2013-03-491621; Quintana-Bustamante O, 2012, LEUKEMIA, V26, P1537, DOI 10.1038/leu.2012.38; Ramamurthy R, 2016, PEDIATR BLOOD CANCER, V63, P2096, DOI 10.1002/pbc.26157; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sinha S, 2015, BLOOD, V125, P316, DOI 10.1182/blood-2014-03-566018; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Tarlock K, 2015, BLOOD, V126, P87, DOI DOI 10.1182/BLOOD.V126.23.87.87; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Valencia A, 2009, LEUKEMIA, V23, P1658, DOI 10.1038/leu.2009.86; van Borkulo CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05918; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wang YA, 2005, CANCER BIOL THER, V4, P1138, DOI 10.4161/cbt.4.10.2073; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Xiang P, 2010, EXP HEMATOL, V38, P798, DOI 10.1016/j.exphem.2010.06.006; Xu B, 2011, J BIOL CHEM, V286, P13937, DOI 10.1074/jbc.M110.197830; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zeileis A, 2005, J STAT SOFTW, V14; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054; Zhang YW, 2017, J COMPUT GRAPH STAT, V26, P1, DOI [10.1080/10618600.2016.1154063, 10.1080/10618600.2016.114036]; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	82	320	325	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					103	+		10.1038/nm.4439	http://dx.doi.org/10.1038/nm.4439			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29227476	Green Submitted, Green Accepted			2022-12-27	WOS:000422965900016
J	He, LJ; Li, Y; Li, Y; Pu, WJ; Huang, XZ; Tian, XY; Wang, Y; Zhang, H; Liu, QZ; Zhang, LB; Zhao, H; Tang, J; Ji, HB; Cai, DQ; Han, ZB; Han, ZC; Nie, Y; Hu, SS; Wang, QD; Sun, RL; Fei, J; Wang, FC; Chen, T; Yan, Y; Huang, HF; Pu, WT; Zhou, B				He, Lingjuan; Li, Yan; Li, Yi; Pu, Wenjuan; Huang, Xiuzhen; Tian, Xueying; Wang, Yue; Zhang, Hui; Liu, Qiaozhen; Zhang, Libo; Zhao, Huan; Tang, Juan; Ji, Hongbin; Cai, Dongqing; Han, Zhibo; Han, Zhongchao; Nie, Yu; Hu, Shengshou; Wang, Qing-Dong; Sun, Ruilin; Fei, Jian; Wang, Fengchao; Chen, Ting; Yan, Yan; Huang, Hefeng; Pu, William T.; Zhou, Bin			Enhancing the precision of genetic lineage tracing using dual recombinases	NATURE MEDICINE			English	Article							CARDIAC STEM-CELLS; CRE RECOMBINASE; C-KIT(+) CELLS; PERIPORTAL HEPATOCYTES; ENDOTHELIAL-CELLS; DNA RECOMBINATION; MAMMALIAN-CELLS; DRE RECOMBINASE; NEURAL CREST; ADULT	The Cre-loxP recombination system is the most widely used technology for in vivo tracing of stem or progenitor cell lineages. The precision of this genetic system largely depends on the specificity of Cre recombinase expression in targeted stem or progenitor cells. However, Cre expression in nontargeted cell types can complicate the interpretation of lineage-tracing studies and has caused controversy in many previous studies. Here we describe a new genetic lineage tracing system that incorporates the Dre-rox recombination system to enhance the precision of conventional Cre-loxP-mediated lineage tracing. The Dre-rox system permits rigorous control of Cre-loxP recombination in lineage tracing, effectively circumventing potential uncertainty of the cell-type specificity of Cre expression. Using this new system we investigated two topics of recent debates-the contribution of c-Kit(+) cardiac stem cells to cardiomyocytes in the heart and the contribution of Sox9(+) hepatic progenitor cells to hepatocytes in the liver. By overcoming the technical hurdle of nonspecific Cre-loxP-mediated recombination, this new technology provides more precise analysis of cell lineage and fate decisions and facilitates the in vivo study of stem and progenitor cell plasticity in disease and regeneration.	[He, Lingjuan; Li, Yan; Li, Yi; Pu, Wenjuan; Huang, Xiuzhen; Tian, Xueying; Wang, Yue; Zhang, Hui; Liu, Qiaozhen; Zhang, Libo; Zhao, Huan; Tang, Juan; Ji, Hongbin; Zhou, Bin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol C, Shanghai, Peoples R China; [He, Lingjuan; Li, Yan; Li, Yi; Pu, Wenjuan; Huang, Xiuzhen; Tian, Xueying; Wang, Yue; Zhang, Hui; Liu, Qiaozhen; Zhang, Libo; Zhao, Huan; Tang, Juan] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutrit Sci, Shanghai, Peoples R China; [Ji, Hongbin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Cai, Dongqing; Zhou, Bin] Jinan Univ, Inst Aging & Regenerat Med, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Han, Zhibo; Han, Zhongchao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Han, Zhibo; Han, Zhongchao] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Han, Zhibo; Han, Zhongchao; Nie, Yu; Hu, Shengshou] Peking Union Med Coll, Tianjin, Peoples R China; [Nie, Yu; Hu, Shengshou] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Wang, Qing-Dong] AstraZeneca, IMED Biotech Unit, Cardiovasc & Metab Dis, Biosci Heart Failure, Gothenburg, Sweden; [Sun, Ruilin; Fei, Jian] Shanghai Model Organisms Ctr Inc, Shanghai, Peoples R China; [Wang, Fengchao; Chen, Ting] Natl Inst Biol Sci, Beijing, Peoples R China; [Yan, Yan] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Huang, Hefeng] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Pu, William T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Zhou, Bin] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Jinan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; AstraZeneca; National Institute of Biological Sciences, Beijing; Fudan University; Shanghai Jiao Tong University; Harvard University; Boston Children's Hospital; Harvard University; Tianjin Medical University	Zhou, B (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol C, Shanghai, Peoples R China.; Zhou, B (corresponding author), Jinan Univ, Inst Aging & Regenerat Med, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China.; Zhou, B (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China.	zhoubin@sibs.ac.cn	Huang, Hefeng/AAR-7184-2021; Pu, William/AAJ-8301-2020; Huang, He-Feng/AAN-7985-2020; Huang, Hefeng/ABF-1117-2020	Pu, William/0000-0002-4551-8079; Huang, He-Feng/0000-0003-4344-8019; NIE, Yu/0000-0002-8744-0046; Zhou, Bin/0000-0001-5278-5522	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB19000000]; National Science Foundation of China [31730112, 91639302, 31625019, 31571503, 31501172, 31601168, 31701292]; National Key Research and Development Program of China [2017YFC1001303, 2016YFC1300600]; Youth Innovation Promotion Association of CAS [2015218]; Key Project of Frontier Sciences of CAS [QYZDB-SSW-SMC003]; International Cooperation Fund of CAS; National Program for Support of Top-notch Young Professionals; Shanghai Science and Technology Commission [17ZR1449600, 17ZR1449800]; Young Elite Scientists Sponsorship Program by China Association for Science and Technology; Shanghai Yangfan Project [15YF1414000, 16YF1413400]; Rising-Star Program [15QA1404300]; China Postdoctoral Science Foundation; President Fund of Shanghai Institutes for Biological Sciences (SIBS); Astrazeneca; Sanofi-SIBS Fellowship; Boehringer Ingelheim; Royal Society-Newton Advanced Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, UM1HL098166, R01HL128694] Funding Source: NIH RePORTER	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Youth Innovation Promotion Association of CAS; Key Project of Frontier Sciences of CAS; International Cooperation Fund of CAS; National Program for Support of Top-notch Young Professionals; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Young Elite Scientists Sponsorship Program by China Association for Science and Technology; Shanghai Yangfan Project; Rising-Star Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); President Fund of Shanghai Institutes for Biological Sciences (SIBS); Astrazeneca(AstraZeneca); Sanofi-SIBS Fellowship; Boehringer Ingelheim(Boehringer Ingelheim); Royal Society-Newton Advanced Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Wu, G. Chen, Z. Weng and A. Huang for the animal husbandry and W. Bian for technical help. We thank H. Zeng at Allen Institute for sharing mouse lines and K. Anastassiadis for valuable suggestions and insightful advice on this study. We thank Shanghai Model Organisms Center, Inc. (SMOC) and Nanjing Biomedical Research Institute of Nanjing University for the generation of mouse lines. This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) (grant no. XDB19000000; B. Z.), the National Science Foundation of China (grant no. 31730112 (B. Z.), 91639302 (B. Z.), 31625019 (B. Z.), 31571503 (X.T.), 31501172 (H. Zhang), 31601168 (Q.L.) and 31701292 (L.H.)), the National Key Research and Development Program of China (grant no. 2017YFC1001303 (L.H.) and 2016YFC1300600 (X.T.)), the Youth Innovation Promotion Association of CAS (award no. 2015218; X.T.), the Key Project of Frontier Sciences of CAS (grant no. QYZDB-SSW-SMC003; B. Z.), the International Cooperation Fund of CAS (B. Z.), the National Program for Support of Top-notch Young Professionals (B. Z.), the Shanghai Science and Technology Commission (grant no. 17ZR1449600 (B. Z.) and 17ZR1449800 (X.T.)), the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (Q.L. and L.H.), the Shanghai Yangfan Project (award no. 15YF1414000 (H. Zhang) and 16YF1413400 (L.H.)) and Rising-Star Program (grant no. 15QA1404300; X.T.), the China Postdoctoral Science Foundation (Y.W., Q.L. and J.T.), the President Fund of Shanghai Institutes for Biological Sciences (SIBS) (B.Z.), Astrazeneca (B.Z.), Sanofi-SIBS Fellowship (X.T. and L.H.), Boehringer Ingelheim (B.Z.) and a Royal Society-Newton Advanced Fellowship (B.Z.).	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Chen Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12422; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hatzistergos KE, 2016, CIRC RES, V119, DOI 10.1161/CIRCRESAHA.116.309281; Hatzistergos KE, 2015, P NATL ACAD SCI USA, V112, P13051, DOI 10.1073/pnas.1517201112; He LJ, 2016, CARDIOVASC RES, V109, P419, DOI 10.1093/cvr/cvw005; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Liu QZ, 2015, NAT MED, V21, P866, DOI 10.1038/nm.3888; Liu QZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7020; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Molkentin JD, 2014, CIRC RES, V115, pE21, DOI 10.1161/CIRCRESAHA.114.305011; Molkentin JD, 2013, CIRC RES, V113, P1037, DOI 10.1161/CIRCRESAHA.113.302564; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Plummer NW, 2016, GENESIS, V54, P447, DOI 10.1002/dvg.22954; Plummer NW, 2015, DEVELOPMENT, V142, P4385, DOI 10.1242/dev.129981; Pu WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13369; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701; Tag CG, 2015, JOVE-J VIS EXP, DOI 10.3791/52438; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhang H, 2016, NAT GENET, V48, P537, DOI 10.1038/ng.3536; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	50	129	136	6	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1488	+		10.1038/nm.4437	http://dx.doi.org/10.1038/nm.4437			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29131159	Green Accepted			2022-12-27	WOS:000417278200019
J	LaGory, EL; Giaccia, AJ				LaGory, Edward L.; Giaccia, Amato J.			Long-range hypoxia signaling in NAFLD	NATURE MEDICINE			English	Editorial Material							LIPID-METABOLISM	A recent study describes a role for hypoxic signaling in the small intestine in the etiology of nonalcoholic fatty liver disease (NAFLD) and suggests that HIF-2. inhibitors may be an effective option for the treatment of this disease.	[LaGory, Edward L.; Giaccia, Amato J.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA	Stanford University	Giaccia, AJ (corresponding author), Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	giaccia@stantoid.edu		LaGory, Edward/0000-0002-0552-1695				Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Martinez-Saez O, 2017, CRIT REV ONCOL HEMAT, V111, P117, DOI 10.1016/j.critrevonc.2017.01.013; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Ramakrishnan SK, 2016, CELL METAB, V23, P505, DOI 10.1016/j.cmet.2016.01.004; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Xie C, 2017, NAT MED, V23, P1298, DOI 10.1038/nm.4412; Younossi Z., 2017, NAT REV GASROENTEROL	11	2	2	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1251	1252		10.1038/nm.4436	http://dx.doi.org/10.1038/nm.4436			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29117167				2022-12-27	WOS:000414548300004
J	Mire, CE; Cross, RW; Geisbert, JB; Borisevich, V; Agans, KN; Deer, DJ; Heinrich, ML; Rowland, MM; Goba, A; Momoh, M; Boisen, ML; Grant, DS; Fullah, M; Khan, SH; Fenton, KA; Robinson, JE; Branco, LM; Garry, RF; Geisbert, TW				Mire, Chad E.; Cross, Robert W.; Geisbert, Joan B.; Borisevich, Viktoriya; Agans, Krystle N.; Deer, Daniel J.; Heinrich, Megan L.; Rowland, Megan M.; Goba, Augustine; Momoh, Mambu; Boisen, Mathew L.; Grant, Donald S.; Fullah, Mohamed; Khan, Sheik Humarr; Fenton, Karla A.; Robinson, James E.; Branco, Luis M.; Garry, Robert F.; Geisbert, Thomas W.			Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever	NATURE MEDICINE			English	Article							CYNOMOLGUS MONKEYS; VIRUS-INFECTION; RIBAVIRIN; PLASMA	There are no approved treatments for Lassa fever, which is endemic to the same regions of West Africa that were recently devastated by Ebola. Here we show that a combination of human monoclonal antibodies that cross-react with the glycoproteins of all four clades of Lassa virus is able to rescue 100% of cynomolgus macaques when treatment is initiated at advanced stages of disease, including up to 8 d after challenge.	[Mire, Chad E.; Cross, Robert W.; Geisbert, Joan B.; Borisevich, Viktoriya; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Mire, Chad E.; Cross, Robert W.; Geisbert, Joan B.; Borisevich, Viktoriya; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Heinrich, Megan L.; Rowland, Megan M.; Boisen, Mathew L.; Branco, Luis M.; Garry, Robert F.] Zalgen Labs, Germantown, MD 20876 USA; [Goba, Augustine; Momoh, Mambu; Grant, Donald S.; Fullah, Mohamed; Khan, Sheik Humarr] Kenema Govt Hosp, Hemorrhag Fever Program, Kenema, Sierra Leone; [Goba, Augustine; Momoh, Mambu; Grant, Donald S.; Fullah, Mohamed; Khan, Sheik Humarr] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Momoh, Mambu] Polytech Coll, Kenema, Sierra Leone; [Robinson, James E.] Tulane Univ, Sch Med, Dept Pediat, Sect Infect Dis, New Orleans, LA 70112 USA; [Robinson, James E.] Tulane Univ, Sch Med, Dept Internal Med, Sect Infect Dis, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Garry, Robert F.] Tulane Univ, Dept Microbiol & Immunol, New Orleans, LA 70118 USA; [Garry, Robert F.] Tulane Univ, Global Viral Network, Tulane Ctr Excellence, New Orleans, LA 70118 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Kenema Government Hospital; Ministry of Health & Sanitation Sierra Leone; Tulane University; Tulane University; Tulane University; Tulane University	Geisbert, TW (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA.; Garry, RF (corresponding author), Zalgen Labs, Germantown, MD 20876 USA.; Garry, RF (corresponding author), Tulane Univ, Dept Microbiol & Immunol, New Orleans, LA 70118 USA.; Garry, RF (corresponding author), Tulane Univ, Global Viral Network, Tulane Ctr Excellence, New Orleans, LA 70118 USA.	rfgarry@tulane.edu; twgeisbe@utmb.edu	Cross, PhD, MPH, Robert W/ABD-6575-2021; Mire, Chad/Z-6338-2019; cross, bob/AAB-9461-2021	Cross, PhD, MPH, Robert W/0000-0001-7718-1522; Mire, Chad/0000-0001-7596-1808; Agans, Krystle/0000-0002-7319-6935; Boisen, Matthew/0000-0001-6043-8459; Branco, Luis/0000-0001-8161-0182; Garry, Robert/0000-0002-5683-3250	Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases Challenge and Partnership Grant [AI067188, AI082119]; Health and Human Services [HHSN272200900049C]; National Institutes of Health/National Institute of Allergy and Infectious Diseases grant [R01AI104621, U19AI109762, UC7AI094660]; Louisiana Board of Regents [RC-0013-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109762, R01AI132223, UC7AI094660, UC1AI067188, U01AI082119, R01AI104621] Funding Source: NIH RePORTER	Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases Challenge and Partnership Grant; Health and Human Services; National Institutes of Health/National Institute of Allergy and Infectious Diseases grant; Louisiana Board of Regents; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank K. Schuenke (UTMB) for administrative assistance; N. Dobias (UTMB) and the University of Texas Medical Branch (UTMB) Research Histology Core for assistance with tissue preparations; and C. Klages, J. Graber, and the UTMB Animal Resource Center for veterinary and husbandry support. The authors also thank all the members of the Viral Hemorrhagic Fever Consortium for their continued support and contributions to the VHF field (http://www.vhfc.org). In memoriam: Tragically, two co-authors, who contributed greatly to public-health and VHF research efforts in Sierra Leone, contracted Ebola hemorrhagic fever and lost their battle with the disease before this manuscript could be published: Mohamed Fullah and Sheik Humarr Khan. We wish to honor their memory. This work was supported by the Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases Challenge and Partnership Grant Numbers AI067188 (PI: R.F.G.) and AI082119 (PI: R.F.G.), Health and Human Services Contract HHSN272200900049C (PI: J.E.R.), and National Institutes of Health/National Institute of Allergy and Infectious Diseases grant number R01AI104621 (PI: R.F.G.), U19AI109762 (PI: E.O. Saphire), UC7AI094660 to UTMB for BSL-4 operations support of the Galveston National Laboratory, and RC-0013-07 (PI: R.F.G.) from the Louisiana Board of Regents.	Amorosa V, 2010, EMERG INFECT DIS, V16, P1598, DOI 10.3201/eid1610.100774; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Cross RW, 2016, ANTIVIR RES, V133, P218, DOI 10.1016/j.antiviral.2016.08.012; EMOND RTD, 1982, BRIT MED J, V285, P1001, DOI 10.1136/bmj.285.6347.1001; Fisher-Hoch SP, 2000, J VIROL, V74, P6777, DOI 10.1128/JVI.74.15.6777-6783.2000; FRAME JD, 1984, T ROY SOC TROP MED H, V78, P319, DOI 10.1016/0035-9203(84)90107-X; Geisbert TW, 2005, PLOS MED, V2, P537, DOI 10.1371/journal.pmed.0020183; Grove JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-314; JAHRLING PB, 1984, J INFECT DIS, V149, P420, DOI 10.1093/infdis/149.3.420; JAHRLING PB, 1980, J INFECT DIS, V141, P580, DOI 10.1093/infdis/141.5.580; JAHRLING PB, 1984, INFECT IMMUN, V44, P528, DOI 10.1128/IAI.44.2.528-533.1984; LEIFER E, 1970, AM J TROP MED HYG, V19, P677, DOI 10.4269/ajtmh.1970.19.677; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; Robinson JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11544; Schmitz H, 2002, MICROBES INFECT, V4, P43, DOI 10.1016/S1286-4579(01)01508-8; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; Thi EP, 2015, NATURE, V521, P362, DOI 10.1038/nature14442; Thi EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009706; World Health Organization, LASS FEV NIG	20	60	62	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1146	+		10.1038/nm.4396	http://dx.doi.org/10.1038/nm.4396			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28869611	Green Accepted, Bronze			2022-12-27	WOS:000412431800009
J	Stadler, CR; Bahr-Mahmud, H; Celik, L; Hebich, B; Roth, AS; Roth, RP; Kariko, K; Tueci, O; Sahin, U				Stadler, Christiane R.; Bahr-Mahmud, Hayat; Celik, Leyla; Hebich, Bernhard; Roth, Alexandra S.; Roth, Rene P.; Kariko, Katalin; Tueci, Ozlem; Sahin, Ugur			Elimination of large tumors in mice by mRNA-encoded bispecific antibodies (vol 23, pg 815, 2017)	NATURE MEDICINE			English	Correction																		Stadler CR, 2017, NAT MED, V23, P815, DOI 10.1038/nm.4356	1	2	3	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1241	1241		10.1038/nm1017-1241d	http://dx.doi.org/10.1038/nm1017-1241d			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985209	Bronze			2022-12-27	WOS:000412431800023
J	Allen, EK; Randolph, AG; Bhangale, T; Dogra, P; Ohlson, M; Oshansky, CM; Zamora, AE; Shannon, JP; Finkelstein, D; Dressen, A; DeVincenzo, J; Caniza, M; Youngblood, B; Rosenberger, CM; Thomas, PG				Allen, E. Kaitlynn; Randolph, Adrienne G.; Bhangale, Tushar; Dogra, Pranay; Ohlson, Maikke; Oshansky, Christine M.; Zamora, Anthony E.; Shannon, John P.; Finkelstein, David; Dressen, Amy; DeVincenzo, John; Caniza, Miguela; Youngblood, Ben; Rosenberger, Carrie M.; Thomas, Paul G.			SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans	NATURE MEDICINE			English	Article							GENOME; INFECTION; PROTEIN; DYSFUNCTION; TOPOLOGY; DOMAINS	Previous studies have reported associations of IFITM3 SNP rs12252 with severe influenza, but evidence of association and the mechanism by which risk is conferred remain controversial. We prioritized SNPs in IFITM3 on the basis of putative biological function and identified rs34481144 in the 5' UTR. We found evidence of a new association of rs34481144 with severe influenza in three influenza-infected cohorts characterized by different levels of influenza illness severity. We determined a role for rs34481144 as an expression quantitative trait locus (eQTL) for IFITM3, with the risk allele associated with lower mRNA expression. The risk allele was found to have decreased IRF3 binding and increased CTCF binding in promoter-binding assays, and risk allele carriage diminished transcriptional correlations among IFITM3-neighboring genes, indicative of CTCF boundary activity. Furthermore, the risk allele disrupts a CpG site that undergoes differential methylation in CD8(+) T cell subsets. Carriers of the risk allele had reduced numbers of CD8(+) T cells in their airways during natural influenza infection, consistent with IFITM3 promoting accumulation of CD8(+) T cells in airways and indicating that a critical function for IFITM3 may be to promote immune cell persistence at mucosal sites. Our study identifies a new regulator of IFITM3 expression that associates with CD8(+) T cell levels in the airways and a spectrum of clinical outcomes.	[Allen, E. Kaitlynn; Dogra, Pranay; Oshansky, Christine M.; Zamora, Anthony E.; Shannon, John P.; Youngblood, Ben; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Randolph, Adrienne G.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Anesthesia, Boston, MA USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Bhangale, Tushar; Dressen, Amy] Genentech Inc, Human Genet, San Francisco, CA 94080 USA; [Ohlson, Maikke] Genentech Inc, Biomarker Discovery, San Francisco, CA 94080 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [DeVincenzo, John] Univ Tennessee, Sch Med, Dept Pediat & Microbiol, Memphis, TN USA; [DeVincenzo, John] Univ Tennessee, Sch Med, Dept Immunol & Mol Biol, Memphis, TN USA; [DeVincenzo, John] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Caniza, Miguela] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Oshansky, Christine M.] US Dept HHS, BARDA, Off Assistant Secretary Preparedness & Response A, Washington, DC 20201 USA	St Jude Children's Research Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Roche Holding; Genentech; Roche Holding; Genentech; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	emma.allen@stjude.org; paul.thomas@stjude.org	Thomas, Paul G./H-1063-2018; Shannon, John/AAY-2423-2020; Zamora, Anthony E./O-2836-2017; caniza, miguela a/N-8138-2018; Youngblood, Benjamin/N-2508-2018	Thomas, Paul G./0000-0001-7955-0256; Zamora, Anthony E./0000-0001-5712-5339; caniza, miguela a/0000-0002-7846-9605; Youngblood, Benjamin/0000-0002-1261-9957; Ohlson, Maikke/0000-0002-1055-2269; Randolph, Adrienne/0000-0002-3084-3071; Shannon, John/0000-0002-8722-2209; Dogra, Pranay/0000-0003-2031-9855; Giuliano, John/0000-0003-2753-8460	National Institute of Allergy and Infectious Diseases, US National Institutes of Health, under HHS [HHSN266200700005C, HHSN272201400006C]; Genentech, Inc.; US National Institutes of Health [NIH AI084011]; Centers for Disease Control and Prevention (CDC); ALSAC; NATIONAL CANCER INSTITUTE [R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI128805, R56AI084011, R01AI084011] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, US National Institutes of Health, under HHS; Genentech, Inc.(Roche HoldingGenentech); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the participants who contributed in each of the studies described in this manuscript. For FLU09, they acknowledge the clinical work of L. Harrison and the clinical team at the UTHSC, Le Bonhour Children's Hospital. They thank J.J. Treanor (University of Rochester Medical Center) for providing counsel regarding study design; R. Bajracharya, T.H. Oguin III, and L. McClaren for technical assistance; A. Webb, J.C. Crumpton, K. Friedman, T. Jeevan, and S.-S. Wong for their help with virological assays; and P. McKenzie and K. Johnson for assisting in the study management. They thank M. Weilnau, J. Parker, R. Eila, and R. Tabrizi for data management. They thank the Genentech FluA team for access to clinical samples. For PICFlu, they acknowledge the hard work and collaboration of the PALISI PICFlu Study Site Investigators who critically reviewed the initial study proposal and all modifications and enrolled and collected data on the patients in this study: Arkansas Childrens Hospital, Little Rock, Arkansas, USA (R.C. Sanders, G. Hefley); Phoenix Childrens Hospital, Phoenix, Arizona, USA (D. Tellez, C. Bliss, A. Labell, D. Liss, A.L. Ortiz); Childrens Hospital of Los Angeles, Los Angeles, California, USA (B. Markovitz, J. Terry, R.S.P. Morzov); Childrens Hospital Central California, Madera, California, USA (A.L. Graciano, M. Baldwin); Childrens Hospital and Research Center, Oakland, California, USA (H. Flori, B. Brumfield, J. Simon); Childrens Hospital of Orange County, Orange, California, USA (N. Anas, A. Schwarz, C. Onwunyi, S. Osborne, T Patterson, O. Vargas-Shiraishi); UCSF Benioff Childrens Hospital, University of California, San Francisco, San Francisco, California, USA (A. Sapru, M. Convery, V. Lo); Childrens Hospital Colorado, Aurora, Colorado, USA (A. Czaja, P. Mourani, V. Batara Aymami, S. Burr, M. Brocato, S. Huston, E. Jewett, S.B. Lindahl, D. Loyola, Y. Sierra); Connecticut Childrens Medical Center, Hartford, Connecticut, USA (C. Carroll, K.A. Sala, S. Thornton-Thompson); Yale-New Haven Childrens Hospital, New Haven, Connecticut, USA (J.S. Giuliano Jr.); Holtz Childrens Hospital, Miami, Florida, USA (G. McLaughlin); Childrens Healthcare of Atlanta at Egleston, Atlanta, Georgia, USA (M. Paden, C.-C. Manghram, S. Meisner, C.L. Stone, R. Toney); University of Chicago Medicine Comer Childrens Hospital, Chicago, Illinois, USA (J. Bubeck Wardenburg, A. DeDent); Kosair Childrens Hospital, Louisville, Kentucky, USA (V. Montgomery, T. Evans, K. Richardson); Boston Childrens Hospital, Boston, Massachusetts, USA (A. Randolph, A.A. Ag , E.M. Smith, R.M. Sullivan, G. Yoon, M. Kiers, S.M. Keisling); Johns Hopkins Childrens Center, Baltimore, Maryland, USA (M. Bembea, E.D. White); Childrens Hospital and Clinics of Minnesota, Minneapolis, Minnesota, USA (S.C. Kurachek, A.A. Doucette, E. Zielinski); St. Louis Childrens Hospital, St. Louis, Missouri, USA (A. Doctor, M. Hartman, R. Jacobs); Childrens Hospital of Nebraska, Omaha, Nebraska, USA (E. Truemper, M. Dawson); Childrens Hospital at Dartmouth-Hitchcock, Lebanon, New Hampshire, USA (D.L. Levin, J.D. Jarvis); Childrens Hospital at Montefiore, Bronx, New York, USA (C. Katyal); Golisano Childrens Hospital, Rochester, New York, USA (K. Ackerman, L.E. Daugherty, L. Baglia); Nationwide Childrens Hospital, Columbus, Ohio, USA (M.W. Hall, K. Greathouse, L. Steele); Penn State Childrens Hospital, Hershey, Pennsylvania, USA (N. Thomas, J. Raymond, D. Spear); Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, USA (J. Fitzgerald, M. Helfaer, S. Weiss, J.L. Bush, M.A.; Diliberto, Egan, B.B. Park, M. Sisko); Monroe Carell Jr. Childrens Hospital at Vanderbilt, Nashville, Tennessee, USA (F.E. Barr, J. Arnold); Dell Childrens Medical Center of Central Texas, Austin, Texas, USA (R. Higgerson, L. Christie); Childrens Medical Center, Dallas, Texas, USA (M. Thompson); Texas Childrens Hospital, Houston, Texas, USA (L.L. Loftis, N. Jaimon, U. Kyle); University of Virginia Childrens Hospital, Charlottesville, Virginia, USA (D.F. Willson, C. Traul, R.L. Kelly); Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, USA (R. Gedeit, B.E. Horn, K. Luther, K. Murkowski); Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada (P.A. Jouvet, A.-M. Fontaine); Centre Hospitalier de l'Universite Laval, Quebec City, Quebec, Canada (M.-A. Dugas). This work was funded by the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, under HHS contracts HHSN266200700005C and HHSN272201400006C for the St. Jude Center of Excellence for Influenza Research a Surveillance (P.G.T.), Genentech, Inc. (P.G.T., C.M.R.), the US National Institutes of Health (NIH AI084011 to A.G.R.), the Centers for Disease Control and Prevention (CDC; A.G.R.), and ALSAC. C.M.R., T.B., A.D., and M.O. are employees of Genentech, Inc.	Allen EK, 2015, AM J RESP CRIT CARE, V191, P248, DOI 10.1164/rccm.201412-2245ED; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Centers for Disease Control and Prevention (CDC), 2010, WKLY REP, V59, P1057; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771; Deckmann K, 2012, MOL BIOSYST, V8, P1389, DOI 10.1039/c2mb05500g; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ea V, 2015, GENES-BASEL, V6, P734, DOI 10.3390/genes6030734; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Flail M. W., 2013, CRIT CARE MED, V41, P224; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Huang I.-C., 2011, PLOS PATHOG, V7; Infusini G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143539; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kim S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.33; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Rodriguez M, 2016, EUR J CLIN MICROBIOL, V35, P1811, DOI 10.1007/s10096-016-2732-7; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Nakamura S, 2016, J VIROL, V90, P1788, DOI 10.1128/JVI.02246-15; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Randolph A. G., 2017, J INFECT DIS; Rang Y.-II, 2013, NAT COMMUN, V4, P1418; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067816; Sun X., 2016, J VIROL; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124985; Zhang YH, 2015, AIDS, V29, P889, DOI 10.1097/QAD.0000000000000632; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	49	117	117	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					975	+		10.1038/nm.4370	http://dx.doi.org/10.1038/nm.4370			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28714988	Green Accepted			2022-12-27	WOS:000406947600013
J	Czech, MP				Czech, Michael P.			Insulin action and resistance in obesity and type 2 diabetes	NATURE MEDICINE			English	Article							HIGH-FAT DIET; DE-NOVO LIPOGENESIS; ADIPOSE-TISSUE INFLAMMATION; IMPAIRED GLUCOSE-TRANSPORT; AKT/PROTEIN-KINASE-B; PPAR-GAMMA; SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOCYTE LIPOLYSIS; METABOLIC HOMEOSTASIS	Nutritional excess is a major forerunner of type 2 diabetes. It enhances the secretion of insulin, but attenuates insulin's metabolic actions in the liver, skeletal muscle and adipose tissue. However, conflicting evidence indicates a lack of knowledge of the timing of these events during the development of obesity and diabetes, pointing to a key gap in our understanding of metabolic disease. This Perspective reviews alternate viewpoints and recent results on the temporal and mechanistic connections between hyperinsulinemia, obesity and insulin resistance. Although much attention has addressed early steps in the insulin signaling cascade, insulin resistance in obesity seems to be largely elicited downstream of these steps. New findings also connect insulin resistance to extensive metabolic cross-talk between the liver, adipose tissue, pancreas and skeletal muscle. These and other advances over the past 5 years offer exciting opportunities and daunting challenges for the development of new therapeutic strategies for the treatment of type 2 diabetes.	[Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.	michael.czech@umassmed.edu	Duarte, Graziela Biude Silva/Q-7728-2016		US National Institutes of Health (NIH) [DK 103047, DK 030898]; Isadore and Fannie Foxman endowed professorship in medical science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085753, R37DK030898, R01DK030898, R01DK103047] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Isadore and Fannie Foxman endowed professorship in medical science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I thank M. Birnbaum (Pfizer), S. O'Rahilly (University of Cambridge), and S. Corvera, J. Virbasius, A. Guilherme and D. Pedersen (University of Massachusetts Medical School) for their critical reading of the manuscript and their helpful comments. I also thank our laboratory group members for stimulating discussions on these topics, and L. Smith (University of Massachusetts Medical School) for her contributions to the formatting and editing of the manuscript. The work cited from our laboratory was funded by US National Institutes of Health (NIH) grants DK 103047 and DK 030898, and the Isadore and Fannie Foxman endowed professorship in medical science.	Abdennour M, 2014, J CLIN ENDOCR METAB, V99, P898, DOI 10.1210/jc.2013-3253; Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Baraille F, 2015, PHYSIOLOGY, V30, P428, DOI 10.1152/physiol.00016.2015; Barrett EJ, 2011, AM J PHYSIOL-ENDOC M, V301, pE252, DOI 10.1152/ajpendo.00186.2011; Barzel B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00469; Beck-Nielsen H, 2012, DIABETES-METAB RES, V28, P635, DOI 10.1002/dmrr.2337; BECKNIELSEN H, 1995, DIABETES RES CLIN PR, V28, pS13, DOI 10.1016/0168-8227(95)01082-O; Ben-Shlomo S, 2012, OBESITY, V20, P151, DOI 10.1038/oby.2011.261; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BODEN G, 1995, DIABETES, V44, P1239, DOI 10.2337/diabetes.44.10.1239; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; Bonadonna RC, 1996, DIABETES, V45, P915, DOI 10.2337/diabetes.45.7.915; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cahill F, 2011, AM J CLIN NUTR, V93, P741, DOI 10.3945/ajcn.110.003624; Caron A, 2015, ANNU REV NUTR, V35, P321, DOI 10.1146/annurev-nutr-071714-034355; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chen DL, 2015, J CLIN ENDOCR METAB, V100, P4082, DOI 10.1210/jc.2015-2712; Cherrington AD, 1998, DIABETOLOGIA, V41, P987, DOI 10.1007/s001250051021; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Commerford SR, 2002, AM J PHYSIOL-ENDOC M, V283, pE545, DOI 10.1152/ajpendo.00120.2002; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; CZECH MP, 1976, J CLIN INVEST, V57, P1523, DOI 10.1172/JCI108422; D'souza AM, 2016, MOL METAB, V5, P1103, DOI 10.1016/j.molmet.2016.09.007; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; DiPilato LM, 2015, MOL CELL BIOL, V35, P2752, DOI 10.1128/MCB.00422-15; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Dutta A, 2016, MOL CELL, V63, P547, DOI 10.1016/j.molcel.2016.06.038; Erion KA, 2015, J BIOL CHEM, V290, P16191, DOI 10.1074/jbc.M114.620351; Flach RJR, 2016, J BIOL CHEM, V291, P16221, DOI 10.1074/jbc.M116.718932; FURLER SM, 1991, AM J PHYSIOL, V261, pE337, DOI 10.1152/ajpendo.1991.261.3.E337; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Gealekman O, 2014, J BIOL CHEM, V289, P18327, DOI 10.1074/jbc.M113.545798; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guilherme A., MOL METAB IN PRESS; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Jansen HJ, 2013, DIABETOLOGIA, V56, P2573, DOI 10.1007/s00125-013-3018-6; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Kang L, 2016, DIABETES, V65, P1590, DOI 10.2337/db15-1434; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Kang S, 2016, TRENDS CELL BIOL, V26, P341, DOI 10.1016/j.tcb.2016.01.002; Kelley DE, 1996, J CLIN INVEST, V97, P2705, DOI 10.1172/JCI118724; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kim MK, 2015, OBESITY, V23, P2430, DOI 10.1002/oby.21256; Kim SH, 2008, DIABETES CARE, V31, P1433, DOI 10.2337/dc08-0045; Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; KOBAYASHI M, 1978, AM J PHYSIOL, V235, pE53, DOI 10.1152/ajpendo.1978.235.1.E53; Koren S, 2015, DIABETOLOGIA, V58, P1063, DOI 10.1007/s00125-015-3532-9; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE234, DOI 10.1152/ajpendo.00274.2003; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lagerpusch M, 2012, INT J OBESITY, V36, P1094, DOI 10.1038/ijo.2011.211; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee WL, 2016, PHYSIOLOGY, V31, P336, DOI 10.1152/physiol.00010.2016; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Manousaki D, 2016, DIABETES CARE, V39, P1889, DOI 10.2337/dc16-0769; Marban S.L.R.J., 1996, TRANSGENIC HYPERINSU; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Murdolo G, 2007, J CLIN ENDOCR METAB, V92, P2688, DOI 10.1210/jc.2006-2814; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694; Numao S, 2013, METABOLISM, V62, P1406, DOI 10.1016/j.metabol.2013.05.005; OLEFSKY J, 1975, METABOLISM, V24, P495, DOI 10.1016/0026-0495(75)90074-8; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Paglialunga S, 2015, DIABETOLOGIA, V58, P1071, DOI 10.1007/s00125-015-3531-x; Parker VER, 2011, DIABETIC MED, V28, P1476, DOI 10.1111/j.1464-5491.2011.03463.x; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pedersen DJ, 2015, MOL METAB, V4, P507, DOI 10.1016/j.molmet.2015.04.003; Pendergrass M, 2007, AM J PHYSIOL-ENDOC M, V292, pE92, DOI 10.1152/ajpendo.00617.2005; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen KF, 2002, J ROY SOC MED, V95, P8; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; PONTIROLI AE, 1990, J ENDOCRINOL INVEST, V13, P241, DOI 10.1007/BF03349549; Pories WJ, 2012, DIABETES CARE, V35, P2438, DOI 10.2337/dc12-0684; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846; RICHARDSON DK, 1978, AM J PHYSIOL, V234, pE182, DOI 10.1152/ajpendo.1978.234.2.E182; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Ryder JW, 2001, FRONT BIOSCI-LANDMRK, V6, pD154, DOI 10.2741/Ryder; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Scherer T, 2012, J BIOL CHEM, V287, P33061, DOI 10.1074/jbc.M111.307348; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shin AC, 2017, DIABETES, V66, P1560, DOI 10.2337/db16-1238; Siklova-Vitkova M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1154, DOI 10.1152/ajpendo.00086.2009; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Soccio RE, 2017, J CLIN INVEST, V127, P1451, DOI 10.1172/JCI91211; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Soop M, 2002, AM J PHYSIOL-ENDOC M, V282, pE1276, DOI 10.1152/ajpendo.00535.2001; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Sugii S, 2011, FEBS LETT, V585, P2121, DOI 10.1016/j.febslet.2011.05.007; Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tsiotra PC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/487081; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Turner N, 2014, J ENDOCRINOL, V220, pT61, DOI 10.1530/JOE-13-0397; US Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP 20; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Wadden D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045748; Waise TMZ, 2015, BIOCHEM BIOPH RES CO, V464, P1157, DOI 10.1016/j.bbrc.2015.07.097; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Westerbacka J, 2006, DIABETOLOGIA, V49, P132, DOI 10.1007/s00125-005-0075-5; Westerbacka J, 2008, AM J PHYSIOL-ENDOC M, V294, pE841, DOI 10.1152/ajpendo.00653.2006; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Williams AS, 2015, TRENDS ENDOCRIN MET, V26, P357, DOI 10.1016/j.tem.2015.05.006; Williams AS, 2015, J BIOL CHEM, V290, P6546, DOI 10.1074/jbc.M114.615716; Williams KV, 2001, DIABETES, V50, P2069, DOI 10.2337/diabetes.50.9.2069; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zechner R, 2015, EMBO MOL MED, V7, P359, DOI 10.15252/emmm.201404846; Zhang CB, 2015, J BIOL CHEM, V290, P3519, DOI 10.1074/jbc.M114.602789; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhou LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6949; Zierath JR, 1998, MOL CELL BIOCHEM, V182, P153, DOI 10.1023/A:1006861628496; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620	167	604	633	23	315	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					804	814		10.1038/nm.4350	http://dx.doi.org/10.1038/nm.4350			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28697184	Green Accepted			2022-12-27	WOS:000405180100008
J	Harlander, S; Schonenberger, D; Toussaint, NC; Prummer, M; Catalano, A; Brandt, L; Moch, H; Wild, PJ; Frew, IJ				Harlander, Sabine; Schonenberger, Desiree; Toussaint, Nora C.; Prummer, Michael; Catalano, Antonella; Brandt, Laura; Moch, Holger; Wild, Peter J.; Frew, Ian J.			Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice	NATURE MEDICINE			English	Article							MOUSE MODEL; TARGETED INACTIVATION; TUMOR PROGRESSION; COMBINED DELETION; C-MYC; EXPRESSION; KIDNEY; GENOME; HIF; ACTIVATION	Clear cell renal cell carcinomas (ccRCCs) frequently exhibit inactivation of the von Hippel-Lindau tumor-suppressor gene, VHL, and often harbor multiple copy-number alterations in genes that regulate cell cycle progression. We show here that modeling these genetic alterations by combined deletion of Vhl, Trp53 and Rb1 specifically in renal epithelial cells in mice caused ccRCC. These tumors arose from proximal tubule epithelial cells and shared molecular markers and mRNA expression profiles with human ccRCC. Exome sequencing revealed that mouse and human ccRCCs exhibit recurrent mutations in genes associated with the primary cilium, uncovering a mutational convergence on this organelle and implicating a subset of ccRCCs as genetic ciliopathies. Different mouse tumors responded differently to standard therapies for advanced human ccRCC, mimicking the range of clinical behaviors in the human disease. Inhibition of hypoxia-inducible factor (HIF)-alpha transcription factors with acriflavine as third-line therapy had therapeutic effects in some tumors, providing preclinical evidence for further investigation of HIF-alpha inhibition as a ccRCC treatment. This autochthonous mouse ccRCC model represents a tool to investigate the biology of ccRCC and to identify new treatment strategies.	[Harlander, Sabine; Schonenberger, Desiree; Catalano, Antonella; Brandt, Laura; Frew, Ian J.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Harlander, Sabine; Frew, Ian J.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Toussaint, Nora C.; Prummer, Michael] Swiss Fed Inst Technol, NEXUS Personalized Hlth Technol, Zurich, Switzerland; [Toussaint, Nora C.; Prummer, Michael] SIB Swiss Inst Bioinformat, Zurich, Switzerland; [Catalano, Antonella; Frew, Ian J.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Catalano, Antonella; Frew, Ian J.] Univ Freiburg, Ctr Translat Cell Res, Clin Internal Med 1, Fac Med, Freiburg, Germany; [Moch, Holger; Wild, Peter J.] Univ Zurich Hosp, Dept Pathol & Mol Pathol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Freiburg; University of Freiburg; University of Zurich; University Zurich Hospital	Frew, IJ (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Frew, IJ (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.; Frew, IJ (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.; Frew, IJ (corresponding author), Univ Freiburg, Ctr Translat Cell Res, Clin Internal Med 1, Fac Med, Freiburg, Germany.	ian.frew@uniklinik-freiburg.de	Prummer, Michael/G-6464-2011	Prummer, Michael/0000-0001-9896-3929; Toussaint, Nora/0000-0001-7911-7647; Wild, Peter Johannes/0000-0002-1017-3744; Frew, Ian/0000-0003-2735-5509; Harlander, Sabine/0000-0003-2827-425X	Swiss National Science Foundation [PP00P3_128257]; European Research Council [260316]; VHL Family Alliance	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); VHL Family Alliance	This work was supported by grants to I.J.F. from the Swiss National Science Foundation (PP00P3_128257), the European Research Council (260316) and the VHL Family Alliance. We are most grateful to Johannes Loffing (University of Zurich), Jurg Biber (University of Zurich) and the late Patrick Pollard (University of Oxford) for providing antibodies.	Albers J, 2013, EMBO MOL MED, V5, P949, DOI 10.1002/emmm.201202231; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cheval L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046876; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Frew IJ, 2015, ANNU REV PATHOL-MECH, V10, P263, DOI 10.1146/annurev-pathol-012414-040306; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Ghatalia P, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0458-0; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Guinot A, 2016, J PATHOL, V239, P365, DOI 10.1002/path.4736; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hase H, 2014, MOL CANCER RES, V12, P1807, DOI 10.1158/1541-7786.MCR-14-0233; Hsieh JJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.9; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Klatte T, 2012, CANCER-AM CANCER SOC, V118, P5777, DOI 10.1002/cncr.27607; Kurozumi A, 2016, INT J ONCOL, V48, P1837, DOI 10.3892/ijo.2016.3440; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lehmann H, 2015, J AM SOC NEPHROL, V26, P2778, DOI 10.1681/ASN.2014090875; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Marino S, 2000, GENE DEV, V14, P994; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore LE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002312; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nargund AM, 2017, CELL REP, V18, P2893, DOI 10.1016/j.celrep.2017.02.074; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nishikawa R, 2015, FEBS LETT, V589, P2136, DOI 10.1016/j.febslet.2015.06.005; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ricketts CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140257; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Schonenberger D, 2016, CANCER RES, V76, P2025, DOI 10.1158/0008-5472.CAN-15-1859; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Shay JES, 2014, CARCINOGENESIS, V35, P1067, DOI 10.1093/carcin/bgu004; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang SS, 2014, P NATL ACAD SCI USA, V111, P16538, DOI 10.1073/pnas.1414789111; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898	56	80	81	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					869	+		10.1038/nm.4343	http://dx.doi.org/10.1038/nm.4343			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28553932	Green Accepted			2022-12-27	WOS:000405180100016
J	Fujimura, KE; Sitarik, AR; Haystad, S; Lin, DL; Levan, S; Fadrosh, D; Panzer, AR; LaMere, B; Rackaityte, E; Lukacs, NW; Wegienka, G; Boushey, HA; Ownby, DR; Zoratti, EM; Levin, AM; Johnson, CC; Lynch, SV				Fujimura, Kei E.; Sitarik, Alexandra R.; Haystad, Suzanne; Lin, Din L.; Levan, Sophia; Fadrosh, Douglas; Panzer, Ariane R.; LaMere, Brandon; Rackaityte, Elze; Lukacs, Nicholas W.; Wegienka, Ganesa; Boushey, Homer A.; Ownby, Dennis R.; Zoratti, Edward M.; Levin, Albert M.; Johnson, Christine C.; Lynch, Susan V.			Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation	NATURE MEDICINE			English	Article							ACID	Gut microbiota bacterial depletions and altered metabolic activity at 3 months are implicated in childhood atopy and asthma(1). We hypothesized that compositionally distinct human neonatal gut microbiota (NGM) exist, and are differentially related to relative risk (RR) of childhood atopy and asthma. Using stool samples (n = 298; aged 1-11 months) from a US birth cohort and 16S rRNA sequencing, neonates (median age, 35 d) were divisible into three microbiota composition states (NGM1-3). Each incurred a substantially different RR for multisensitized atopy at age 2 years and doctor-diagnosed asthma at age 4 years. The highest risk group, labeled NGM3, showed lower relative abundance of certain bacteria (for example, Bifidobacterium, Akkermansia and Faecalibacterium), higher relative abundance of particular fungi (Candida and Rhodotorula) and a distinct fecal metabolome enriched for pro-inflammatory metabolites. Ex vivo culture of human adult peripheral T cells with sterile fecal water from NGM3 subjects increased the proportion of CD4(+) cells producing interleukin (IL)-4 and reduced the relative abundance of CD4(+)CD25(+)FOXP3(+) cells. 12,13-DiHOME, enriched in NGM3 versus lower-risk NGM states, recapitulated the effect of NGM3 fecal water on relative CD4(+)CD25(+)FOXP3(+) cell abundance. these findings suggest that neonatal gut microbiome dysbiosis might promote CD4(+) T cell dysfunction associated with childhood atopy.	[Fujimura, Kei E.; Lin, Din L.; Levan, Sophia; Fadrosh, Douglas; Panzer, Ariane R.; LaMere, Brandon; Rackaityte, Elze; Lynch, Susan V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA; [Sitarik, Alexandra R.; Haystad, Suzanne; Wegienka, Ganesa; Levin, Albert M.; Johnson, Christine C.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Lukacs, Nicholas W.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Boushey, Homer A.] Univ Calif San Francisco, Dept Med, Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA; [Ownby, Dennis R.] Augusta Univ, Sect Allergy Immunol, Augusta, GA USA; [Zoratti, Edward M.] Henry Ford Hlth Syst, Div Allergy & Immunol, Dept Internal Med, Detroit, MI USA	University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University System of Georgia; Augusta University; Henry Ford Health System; Henry Ford Hospital	Lynch, SV (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA.; Johnson, CC (corresponding author), Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA.	cjohnso1@hfhs.org; susan.lynch@ucsf.edu	Lukacs, Nicholas W/ABH-5583-2020	Sitarik, Alexandra/0000-0001-8957-389X	US National Institutes of Health; National Institute of Allergy and Infectious Diseases [P01 AI089473-01]; Alfred P. Sloan Foundation [2013-6-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089473] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the US National Institutes of Health and National Institute of Allergy and Infectious Diseases P01 AI089473-01 (C.C.J., D.R.O., H.A.B., N.W.L., S.V.L., G.W., and E.M.Z.) and the Alfred P. Sloan Foundation 2013-6-03 (S.V.L.). We thank C. Arrieta and B. Finlay for graciously sharing sequencing data from the CHILD study.	Aichbhaumik N, 2008, CLIN EXP ALLERGY, V38, P1787, DOI 10.1111/j.1365-2222.2008.03079.x; Amagai Y, 2015, J DERMATOL SCI, V79, P30, DOI 10.1016/j.jdermsci.2015.03.010; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Havstad S, 2014, J ALLERGY CLIN IMMUN, V134, P722, DOI 10.1016/j.jaci.2014.01.022; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Morin C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0653-y; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Weichert S, 2013, NUTR RES, V33, P831, DOI 10.1016/j.nutres.2013.07.009	12	534	558	7	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1187	1191		10.1038/nm.4176	http://dx.doi.org/10.1038/nm.4176			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27618652	Green Submitted, Green Accepted			2022-12-27	WOS:000384872500022
J	Pijacka, W; Moraes, DJA; Ratcliffe, LEK; Nightingale, AK; Hart, EC; da Silva, MP; Machado, BH; McBryde, FD; Abdala, AP; Ford, AP; Paton, JFR				Pijacka, Wioletta; Moraes, Davi J. A.; Ratcliffe, Laura E. K.; Nightingale, Angus K.; Hart, Emma C.; da Silva, Melina P.; Machado, Benedito H.; McBryde, Fiona D.; Abdala, Ana P.; Ford, Anthony P.; Paton, Julian F. R.			Purinergic receptors in the carotid body as a new drug target for controlling hypertension	NATURE MEDICINE			English	Article							BLOOD-PRESSURE; ARTERIOVENOUS ANASTOMOSIS; ARTERIAL CHEMORECEPTORS; SYMPATHETIC ACTIVITY; THERAPEUTIC TARGET; P2X3 RECEPTORS; TASK CHANNELS; ATP; RAT; RESPONSES	In view of the high proportion of individuals with resistance to antihypertensive medication and/or poor compliance or tolerance of this medication, new drugs to treat hypertension are urgently needed. Here we show that peripheral chemoreceptors generate aberrant signaling that contributes to high blood pressure in hypertension. We discovered that purinergic receptor P2X3 (P2rx3, also known as P2x3) mRNA expression is upregulated substantially in chemoreceptive petrosal sensory neurons in rats with hypertension. These neurons generate both tonic drive and hyperreflexia in hypertensive (but not normotensive) rats, and both phenomena are normalized by the blockade of P2X3 receptors. Antagonism of P2X3 receptors also reduces arterial pressure and basal sympathetic activity and normalizes carotid body hyperreflexia in conscious rats with hypertension; no effect was observed in rats without hypertension. We verified P2X3 receptor expression in human carotid bodies and observed hyperactivity of carotid bodies in individuals with hypertension. These data support the identification of the P2X3 receptor as a potential new target for the control of human hypertension.	[Pijacka, Wioletta; Hart, Emma C.; McBryde, Fiona D.; Abdala, Ana P.; Paton, Julian F. R.] Univ Bristol, Biomed Sci, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Moraes, Davi J. A.; da Silva, Melina P.; Machado, Benedito H.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Ratcliffe, Laura E. K.] Univ Bristol, Clin Res & Imaging Ctr, CardioNomics Res Grp, Bristol, Avon, England; [Nightingale, Angus K.] Univ Hosp Bristol Natl Hlth Serv Fdn Trust, Bristol Heart Inst, Dept Cardiol, CardioNomics Grp, Bristol, Avon, England; [McBryde, Fiona D.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Ford, Anthony P.] Afferent Pharmaceut, San Mateo, CA USA	University of Bristol; Universidade de Sao Paulo; University of Bristol; University of Bristol; University of Auckland	Paton, JFR (corresponding author), Univ Bristol, Biomed Sci, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Sheikh, Ana Paula Abdala/G-9104-2014; DA SILVA MORAES, MELINA PIRES/Z-2379-2019; Paton, Julian/AAM-2121-2020; Nightingale, Angus/O-5205-2019; Machado, Benedito Honorio/B-5139-2013; Pijacka, Wioletta/C-7151-2012; Hart, Emma/ABF-7649-2020; Moraes, Davi/AAG-6248-2019	Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Nightingale, Angus/0000-0001-9435-726X; Pijacka, Wioletta/0000-0002-3203-7356; McBryde, Fiona/0000-0002-5687-9101; Hart, Emma/0000-0002-4534-9586	British Heart Foundation [RG/12/6/29670]; Afferent Pharmaceuticals; James Tudor Foundation; National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' FAPESP [2013/06077-5, 2013/10484-5]; University of Bristol's Wolfson Bioimaging Facility BBSRC Alert 13 capital grant [BB/L014181/1]; Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program [612280]; National Institute for Health Research (NIHR); BBSRC [BB/L014181/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; National Center for Complementary & Integrative Health [R01AT008632] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Afferent Pharmaceuticals; James Tudor Foundation; National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust; University of Bristol; 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Bristol's Wolfson Bioimaging Facility BBSRC Alert 13 capital grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We wish to thank J.-C. Isner (School of Biological Sciences, University of Bristol) for his expertise on software used for analyzing aspects of some of the in vivo cardiovascular data. Technical support from P. Chappell (mechanical workshop) and D. Carr (electronic workshop) is appreciated. The research support of the British Heart Foundation RG/12/6/29670 (J.F.R.P.), Afferent Pharmaceuticals (A.P.F. & J.F.R.P.) and the James Tudor Foundation (J.F.R.P.) are acknowledged. This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Unit in Cardiovascular Disease at the University Hospitals Bristol National Health Service Foundation Trust and the University of Bristol (A.K.N. & J.F.R.P.). Studies in situ were supported by grants from 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' FAPESP Thematic Project 2013/06077-5 (B.H.M.) and research grant 2013/10484-5 (D.J.A.M.). The University of Bristol's Wolfson Bioimaging Facility BBSRC Alert 13 capital grant BB/L014181/1 is acknowledged. This project also received funding from the Marie Curie International Research Staff Exchange Scheme within the 7th European Community Framework Program under grant agreement no. 612280. This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health.	Abdala AP, 2012, J PHYSIOL-LONDON, V590, P4269, DOI 10.1113/jphysiol.2012.237800; Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Adriaensen D, 2015, AUTON NEUROSCI-BASIC, V191, P39, DOI 10.1016/j.autneu.2015.04.006; Brown MJ, 2008, CIRCULATION, V118, P773, DOI 10.1161/CIRCULATIONAHA.108.787630; Buckler KJ, 2015, PFLUG ARCH EUR J PHY, V467, P1013, DOI 10.1007/s00424-015-1689-1; Burchell AE, 2014, HYPERTENSION, V64, P6, DOI 10.1161/HYPERTENSIONAHA.114.02925; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Burnstock Geoffrey, 2009, Handb Exp Pharmacol, P333, DOI 10.1007/978-3-540-79090-7_10; CARDENAS H, 1981, NEUROSCI LETT, V24, P29, DOI 10.1016/0304-3940(81)90354-2; Carey RM, 2013, HYPERTENSION, V61, P673, DOI [10.1161/HYPERTENSIONAHA.111.00241, 10.1161/HYPERTENSIONAHA.111.00601]; CLARKE JA, 1993, ADV EXP MED BIOL, V337, P3; COMROE JH, 1953, HARVEY LECT, V48, P110; Daly DM, 2014, J PHYSIOL-LONDON, V592, P537, DOI 10.1113/jphysiol.2013.262634; Deiteren A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123810; Evans AM, 2012, ADV EXP MED BIOL, V758, P81, DOI 10.1007/978-94-007-4584-1_11; Fan J, 2009, J NEUROSCI RES, V87, P2757, DOI 10.1002/jnr.22107; Ford AP, 2015, AUTON NEUROSCI-BASIC, V191, P16, DOI 10.1016/j.autneu.2015.04.005; Ford AP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00267; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Gerevich Z, 2007, J BIOL CHEM, V282, P33949, DOI 10.1074/jbc.M705840200; Gever JR, 2010, BRIT J PHARMACOL, V160, P1387, DOI 10.1111/j.1476-5381.2010.00796.x; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hansen RR, 2012, EUR J PHARMACOL, V688, P27, DOI 10.1016/j.ejphar.2012.05.008; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Kahlin J, 2014, EXP PHYSIOL, V99, P1089, DOI 10.1113/expphysiol.2014.078873; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li Jianhua, 2014, J Mod Physiol Res, V1, P1; Liu M, 2001, J PHARMACOL EXP THER, V296, P1043; Lloyd A, 2003, PHARMACOECONOMICS, V21, P33, DOI 10.2165/00019053-200321001-00004; Lobo MD, 2015, LANCET, V385, P1634, DOI 10.1016/S0140-6736(14)62053-5; McBryde FD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3395; Moraes DJA, 2014, HYPERTENSION, V63, P1309, DOI 10.1161/HYPERTENSIONAHA.113.02283; NAKAYAMA K, 1961, DIS CHEST, V40, P595; Narkiewicz K, 1998, CIRCULATION, V97, P943; Nurse CA, 2014, J PHYSIOL-LONDON, V592, P3419, DOI 10.1113/jphysiol.2013.269829; Patel NK, 2011, NEUROLOGY, V76, P405, DOI 10.1212/WNL.0b013e3182088108; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Plump A, 2010, NAT REV DRUG DISCOV, V9, P823, DOI 10.1038/nrd3315; Prasad M, 2001, J PHYSIOL-LONDON, V537, P667; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Rong WF, 2003, J NEUROSCI, V23, P11315; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Schultz HD, 2015, EXP PHYSIOL, V100, P124, DOI 10.1113/expphysiol.2014.079517; SOMERS VK, 1988, HYPERTENSION, V11, P608, DOI 10.1161/01.HYP.11.6.608; SOMERS VK, 1991, J CLIN INVEST, V87, P1953, DOI 10.1172/JCI115221; Tan ZY, 2010, CIRC RES, V106, P536, DOI 10.1161/CIRCRESAHA.109.206946; WELSH MJ, 1978, J CLIN INVEST, V61, P708, DOI 10.1172/JCI108983; Yuan GX, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005846; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x; Zoccal DB, 2008, J PHYSIOL-LONDON, V586, P3253, DOI 10.1113/jphysiol.2008.154187	59	104	110	3	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1151	1159		10.1038/nm.4173	http://dx.doi.org/10.1038/nm.4173			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595323	Green Accepted, Green Submitted			2022-12-27	WOS:000384872500018
J	Cohn, LB; da Silva, IT; Valieris, R; Huang, AS; Lorenzi, JCC; Cohen, YZ; Pai, JA; Butler, AL; Caskey, M; Jankovic, M; Nussenzweig, MC				Cohn, Lillian B.; da Silva, Israel T.; Valieris, Renan; Huang, Amy S.; Lorenzi, Julio C. C.; Cohen, Yehuda Z.; Pai, Joy A.; Butler, Allison L.; Caskey, Marina; Jankovic, Mila; Nussenzweig, Michel C.			Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation	NATURE MEDICINE			English	Article							NEUTRALIZING ANTIBODIES; RNA; EXPANSION; MEMORY; PROLIFERATION; PROVIRUSES; SEQUENCE; BROAD	Despite suppressive combination antiretroviral therapy (ART), latent HIV-1 proviruses persist in patients. This latent reservoir is established within 48-72 h after infection, has a long half-life(1,2), enables viral rebound when ART is interrupted, and is the major barrier to a cure for HIV-13. Latent cells are exceedingly rare in blood (similar to 1 per 1 x 10(6) CD4(+) T cells) and are typically enumerated by indirect means, such as viral outgrowth assays(4,5). We report a new strategy to purify and characterize single reactivated latent cells from HIV1-infected individuals on suppressive ART. Surface expression of viral envelope protein was used to enrich reactivated latent T cells producing HIV RNA, and single-cell analysis was performed to identify intact virus. Reactivated latent cells produce full-length viruses that are identical to those found in viral outgrowth cultures and represent clones of in vivo expanded T cells, as determined by their T cell receptor sequence. Gene-expression analysis revealed that these cells share a transcriptional profile that includes expression of genes implicated in silencing the virus. We conclude that reactivated latent T cells isolated from blood can share a gene-expression program that allows for cell division without activation of the cell death pathways that are normally triggered by HIV-1 replication.	[Cohn, Lillian B.; Huang, Amy S.; Lorenzi, Julio C. C.; Cohen, Yehuda Z.; Pai, Joy A.; Butler, Allison L.; Caskey, Marina; Jankovic, Mila; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [da Silva, Israel T.; Valieris, Renan] AC Camargo Canc Ctr CIPE, Lab Computat Biol & Bioinformat, Sao Paulo, Brazil; [Nussenzweig, Michel C.] Rockefeller Univ, HHMI, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, HHMI, New York, NY 10021 USA.	nussen@rockefeller.edu	Silva, Israel T/N-3858-2014; Nussenzweig, Michel/AAE-7292-2019; Lorenzi, Julio/S-2394-2019	Silva, Israel T/0000-0002-4687-1499; Lorenzi, Julio/0000-0003-2492-3961; Cohen, Yehuda/0000-0001-6987-1478; Huang, Amy/0000-0002-5303-2191; Caskey, Marina/0000-0003-1727-8693	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1033115, OPP1124068]; National Institutes of Health (NIH) Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663]; BEAT-HIV Delaney Collaboratory [UM1 AI126620]; National Institute of Allergy and Infectious Diseases of the NIH [AI100148, AI037526]; Robertson Foundation; Rockefeller University; NIH [U01AI118536]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070084, P01AI100148, UM1AI126620, UM1AI100663, U01AI118536] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; National Institutes of Health (NIH) Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BEAT-HIV Delaney Collaboratory; National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robertson Foundation; Rockefeller University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all participants who contributed to this study; members of the Nussenzweig laboratory for helpful discussions, particularly E. Kara and T. Oliveira; our lab manager Z. Jankovic; L. Mesin and M. Biton for advice on scRNA-seq; A. Gazumyan for bNAb production; G. Breton for help with FACS; K. Gordon and N. Thomas for performing all FACSorting experiments; A. Han and M. Davis for TCR sequencing advice; D. Mucida, C. Rice and P. Bieniasz for helpful discussion; K. Millard for recruitment of study subjects; and M. Deal for assistance with figures. This work was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (OPP1033115 and OPP1124068), the National Institutes of Health (NIH) Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) (1UM1 AI100663), BEAT-HIV Delaney Collaboratory (UM1 AI126620), the National Institute of Allergy and Infectious Diseases of the NIH (AI100148, AI037526), the Robertson Foundation, and the Rockefeller University. M.C. is supported by NIH grant U01AI118536. M.C.N. is a Howard Hughes Medical Institute (HHMI) investigator.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baxter AE, 2016, CELL HOST MICROBE, V20, P368, DOI 10.1016/j.chom.2016.07.015; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Cockerham LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110731; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; de Masson A, 2014, AIDS, V28, P1567, DOI 10.1097/QAD.0000000000000295; Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doitsh G, 2016, CELL HOST MICROBE, V19, P280, DOI 10.1016/j.chom.2016.02.012; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Henrich TJ, 2017, J INFECT DIS, V215, pS134, DOI 10.1093/infdis/jiw648; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Horwitz JA, 2017, CELL, V170, P637, DOI 10.1016/j.cell.2017.06.048; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Hudspeth K, 2012, BLOOD, V119, P4013, DOI 10.1182/blood-2011-11-390153; Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lun Aaron T L, 2016, F1000Res, V5, P2122; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Michaels KK, 2015, J IMMUNOL, V194, P3267, DOI 10.4049/jimmunol.1402581; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mullins JI, 2017, J INFECT DIS, V215, pS119, DOI 10.1093/infdis/jiw636; Murray AJ, 2016, J IMMUNOL, V197, P407, DOI 10.4049/jimmunol.1600343; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Rosenbloom D. I. S., 2015, BIORXIV, DOI [10.1101/018911, DOI 10.1101/018911]; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Runarsson TP, 2005, IEEE T SYST MAN CY C, V35, P233, DOI 10.1109/TSMCC.2004.841906; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sherrill-Mix S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0205-1; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	51	75	76	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					604	+		10.1038/s41591-018-0017-7	http://dx.doi.org/10.1038/s41591-018-0017-7			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29686423	Green Accepted			2022-12-27	WOS:000432126800017
J	Ikeda, K; Kang, QQ; Yoneshiro, T; Camporez, JP; Maki, H; Homma, M; Shinoda, K; Chen, Y; Lu, XD; Maretich, P; Tajima, K; Ajuwon, KM; Soga, T; Kajimura, S				Ikeda, Kenji; Kang, Qianqian; Yoneshiro, Takeshi; Camporez, Joao Paulo; Maki, Hiroko; Homma, Mayu; Shinoda, Kosaku; Chen, Yong; Lu, Xiaodan; Maretich, Pema; Tajima, Kazuki; Ajuwon, Kolapo M.; Soga, Tomoyoshi; Kajimura, Shingo			UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; ADAPTIVE NONSHIVERING THERMOGENESIS; FK506-BINDING PROTEIN FKBP12.6; ENDOPLASMIC-RETICULUM STRESS; RYANODINE RECEPTOR GENE; RELEASE CHANNEL; UNCOUPLING PROTEIN-1; WHITE FAT; UCP1; ADIPOCYTES	Uncoupling protein 1 (UCP1) plays a central role in nonshivering thermogenesis in brown fat; however, its role in beige fat remains unclear. Here we report a robust UCP1-independent thermogenic mechanism in beige fat that involves enhanced ATP-dependent Ca2+ cycling by sarco/endoplasmic reticulum Ca2+-ATPase 2b (SERCA2b) and ryanodine receptor 2 (RyR2). Inhibition of SERCA2b impairs UCP1-independent beige fat thermogenesis in humans and mice as well as in pigs, a species that lacks a functional UCP1 protein. Conversely, enhanced Ca2+ cycling by activation of alpha 1-and/or beta 3-adrenergic receptors or the SERCA2b-RyR2 pathway stimulates UCP1-independent thermogenesis in beige adipocytes. In the absence of UCP1, beige fat dynamically expends glucose through enhanced glycolysis, tricarboxylic acid metabolism and pyruvate dehydrogenase activity for ATP-dependent thermogenesis through the SERCA2b pathway; beige fat thereby functions as a 'glucose sink' and improves glucose tolerance independently of body weight loss. Our study uncovers a noncanonical thermogenic mechanism through which beige fat controls whole-body energy homeostasis via Ca2+ cycling.	[Ikeda, Kenji; Kang, Qianqian; Yoneshiro, Takeshi; Shinoda, Kosaku; Chen, Yong; Lu, Xiaodan; Maretich, Pema; Tajima, Kazuki; Kajimura, Shingo] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Ikeda, Kenji; Kang, Qianqian; Yoneshiro, Takeshi; Shinoda, Kosaku; Chen, Yong; Lu, Xiaodan; Maretich, Pema; Tajima, Kazuki; Kajimura, Shingo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ikeda, Kenji; Kang, Qianqian; Yoneshiro, Takeshi; Shinoda, Kosaku; Chen, Yong; Lu, Xiaodan; Maretich, Pema; Tajima, Kazuki; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Camporez, Joao Paulo] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Camporez, Joao Paulo] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Maki, Hiroko; Homma, Mayu; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Yale University; Keio University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kajimura, S (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Kajimura, S (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Kajimura, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	shingo.kajimura@ucsf.edu	Kajimura, Shingo/AAC-5090-2019; Yoneshiro, Takeshi/V-3856-2019; Shinoda, Kosaku/V-1698-2019	Kajimura, Shingo/0000-0003-0672-5910; Yoneshiro, Takeshi/0000-0001-5298-5831; Shinoda, Kosaku/0000-0002-1928-0749; Maretich, Pema/0000-0001-5058-812X; Camporez, Joao Paulo/0000-0003-3486-4301	National Institutes of Health [DK97441, DK108822, DK110426]; Pew Charitable Trust; Japan Science and Technology Agency; Agency for Medical Research and Development-Core research for Revolutionary Science and Technology (AMED-CREST) from Japan Agency for Medical Research and Development; CREST from Japan Science and Technology Agency; Yamagata prefectural government; city of Tsuruoka; University of California San Francisco (UCSF) Diabetes Endocrinology Research Center (DERC) [DK63720]; Yale University Mouse Metabolic Phenotyping Center (MMPC) [U2CDK059635]; Manpei Suzuki Diabetes Foundation; China Scholarship Council [201506350063]; Ministry of Education, Culture, Sports, Science and Technology of Japan [2610103]; China Postdoctoral Council [2014M551176];  [DK40936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059635, R01DK040936, P30DK098722, P30DK063720, R01DK108822, R01DK097441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trust; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Agency for Medical Research and Development-Core research for Revolutionary Science and Technology (AMED-CREST) from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Yamagata prefectural government; city of Tsuruoka; University of California San Francisco (UCSF) Diabetes Endocrinology Research Center (DERC); Yale University Mouse Metabolic Phenotyping Center (MMPC); Manpei Suzuki Diabetes Foundation; China Scholarship Council(China Scholarship Council); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China Postdoctoral Council; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Chen at the University of Calgary for providing the RyR2 overexpression construct. We are also grateful to C. Paillart for his support in the CLAMS studies, Y. Seo for his support in [<SUP>18</SUP>F]FDG uptake assays, R. Zalpuri for technical assistance in electron microscope analysis, K. Nakamura for his advice in tissue temperature recording, and B.M. Spiegelman, E.T. Chouchani and L. Kazak for their feedback. This work was supported by the National Institutes of Health (DK97441 and DK108822), the Pew Charitable Trust and Japan Science and Technology Agency to S.K., and by Agency for Medical Research and Development-Core research for Revolutionary Science and Technology (AMED-CREST) from the Japan Agency for Medical Research and Development, CREST from the Japan Science and Technology Agency, and research funds from the Yamagata prefectural government and the city of Tsuruoka to T.S. We also acknowledge support from the University of California San Francisco (UCSF) Diabetes Endocrinology Research Center (DERC) (DK63720), the Yale University Mouse Metabolic Phenotyping Center (MMPC) (U2CDK059635) and DK40936. K.I. and K.T. are supported by the Manpei Suzuki Diabetes Foundation. Q.K. is supported by the China Scholarship Council (201506350063). T.Y. is supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (2610103). K.S. is supported by National Institutes of Health K99 grant (DK110426). X.L. is supported by China Postdoctoral Council (2014M551176).	Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Bertholet AM, 2017, CELL METAB, V25, P811, DOI 10.1016/j.cmet.2017.03.002; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Cinti S, 1999, ADIPOSE ORGAN; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feketa VV, 2013, AM J PHYSIOL-REG I, V305, pR1040, DOI 10.1152/ajpregu.00296.2013; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gomez AM, 2004, AM J PHYSIOL-HEART C, V287, pH1987, DOI 10.1152/ajpheart.00409.2004; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kramarova TV, 2008, FASEB J, V22, P55, DOI 10.1096/fj.07-8581com; LEE SC, 1993, AM J PHYSIOL, V264, pC217, DOI 10.1152/ajpcell.1993.264.1.C217; Loughrey CM, 2004, J PHYSIOL-LONDON, V556, P919, DOI 10.1113/jphysiol.2003.057166; Marks AR, 2002, J CELL PHYSIOL, V190, P1, DOI 10.1002/jcp.10031; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Okamatsu-Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084229; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Prestle J, 2001, CIRC RES, V88, P188; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shinoda K, 2015, CELL METAB, V22, P997, DOI 10.1016/j.cmet.2015.09.029; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125	54	295	296	7	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1454	+		10.1038/nm.4429	http://dx.doi.org/10.1038/nm.4429			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29131158	Green Accepted			2022-12-27	WOS:000417278200015
J	Mowat, AM; Scott, CL; Bain, CC				Mowat, Allan Mcl; Scott, Charlotte L.; Bain, Calum C.			Barrier-tissue macrophages: functional adaptation to environmental challenges	NATURE MEDICINE			English	Review							DENDRITIC CELL SUBSETS; REGULATORY T-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; HUMAN INTESTINAL MACROPHAGES; NEURO-IMMUNE INTERACTIONS; HIGH-DIMENSIONAL ANALYSIS; HEPATOCYTE GROWTH-FACTOR; INNATE LYMPHOID-CELLS; ALVEOLAR MACROPHAGES; LANGERHANS CELLS	Macrophages are found throughout the body, where they have crucial roles in tissue development, homeostasis and remodeling, as well as being sentinels of the innate immune system that can contribute to protective immunity and inflammation. Barrier tissues, such as the intestine, lung, skin and liver, are exposed constantly to the outside world, which places special demands on resident cell populations such as macrophages. Here we review the mounting evidence that although macrophages in different barrier tissues may be derived from distinct progenitors, their highly specific properties are shaped by the local environment, which allows them to adapt precisely to the needs of their anatomical niche. We discuss the properties of macrophages in steady-state barrier tissues, outline the factors that shape their differentiation and behavior and describe how macrophages change during protective immunity and inflammation.	[Mowat, Allan Mcl; Scott, Charlotte L.] Univ Glasgow, Coll Med Vet Med & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow, Lanark, Scotland; [Scott, Charlotte L.] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Scott, Charlotte L.] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Bain, Calum C.] Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland	University of Glasgow; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Edinburgh	Mowat, AM; Scott, CL (corresponding author), Univ Glasgow, Coll Med Vet Med & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow, Lanark, Scotland.; Scott, CL (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium.; Scott, CL (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Bain, CC (corresponding author), Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland.	allan.mowat@glasgow.ac.uk; charlotte.scott@irc.vib-ugent.be; calum.bain@ed.ac.uk	Scott, Charlotte/K-3563-2014	Scott, Charlotte/0000-0003-4914-6580; Bain, Calum/0000-0001-8884-327X	MRC; Wellcome Trust; Royal Society; MRC [MR/L008289/1] Funding Source: UKRI; Medical Research Council [MR/L008289/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are funded by the MRC, Wellcome Trust and The Royal Society (Sir Henry Wellcome Fellowship to C.L.S and a Sir Henry Dale Fellowship to C.C.B).	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Arnold IC, 2016, MUCOSAL IMMUNOL, V9, P352, DOI 10.1038/mi.2015.65; Artyomov MN, 2015, J EXP MED, V212, P743, DOI 10.1084/jem.20131675; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Asano K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8802; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bang BR, 2011, EXP MOL MED, V43, P275, DOI 10.3858/emm.2011.43.5.028; Barton JC, 2009, J CLIN GASTROENTEROL, V43, P890, DOI 10.1097/MCG.0b013e31819069c1; Beattie L, 2016, J HEPATOL, V65, P758, DOI 10.1016/j.jhep.2016.05.037; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bergmann TK, 2001, SCAND J GASTROENTERO, V36, P891, DOI 10.1080/003655201750313450; Bharat A, 2016, AM J RESP CELL MOL, V54, P147, DOI 10.1165/rcmb.2015-0147LE; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; BRODY AR, 1992, J LEUKOCYTE BIOL, V51, P640, DOI 10.1002/jlb.51.6.640; Burastero SE, 1999, J ALLERGY CLIN IMMUN, V103, P1136, DOI 10.1016/S0091-6749(99)70189-2; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Cakarova L, 2009, AM J RESP CRIT CARE, V180, P521, DOI 10.1164/rccm.200812-1837OC; CALLERY MP, 1989, TRANSPLANTATION, V47, P1092; CALLERY MP, 1989, J SURG RES, V46, P391, DOI 10.1016/0022-4804(89)90208-4; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; CANTOR HM, 1967, NATURE, V215, P744, DOI 10.1038/215744a0; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Chen YL, 2001, SURGERY, V129, P66, DOI 10.1067/msy.2001.109059; Chng SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23820; Cosin-Roger J, 2016, MUCOSAL IMMUNOL, V9, P986, DOI 10.1038/mi.2015.123; D'Angelo F, 2013, CLIN EXP IMMUNOL, V174, P60, DOI 10.1111/cei.12157; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Huynh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056951; Ellett JD, 2010, J IMMUNOL, V184, P5849, DOI 10.4049/jimmunol.0902024; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Farro G., 2017, GUT; Filbey KJ, 2014, IMMUNOL CELL BIOL, V92, P436, DOI 10.1038/icb.2013.109; Frank KM, 2011, NEW ENGL J MED, V364, P2563, DOI 10.1056/NEJMc1010939; Franken L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12940; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Giakoustidis DE, 2003, HEPATO-GASTROENTEROL, V50, P1587; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Hiemstra IH, 2014, IMMUNOLOGY, V142, P269, DOI 10.1111/imm.12251; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Ju C, 2003, CHEM RES TOXICOL, V16, P1514, DOI 10.1021/tx0341761; Kawano H, 2016, INT IMMUNOL, V28, P489, DOI 10.1093/intimm/dxw012; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Krause P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8055; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lahiri A, 2014, GASTROENTEROLOGY, V147, P835, DOI 10.1053/j.gastro.2014.06.024; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Little MC, 2014, J IMMUNOL, V193, P4684, DOI 10.4049/jimmunol.1400502; Magnan A, 1998, ALLERGY, V53, P1092, DOI 10.1111/j.1398-9995.1998.tb03821.x; Magnusson MK, 2016, MUCOSAL IMMUNOL, V9, P171, DOI 10.1038/mi.2015.48; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Malvin NP, 2012, MUCOSAL IMMUNOL, V5, P194, DOI 10.1038/mi.2011.65; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Melloni B, 1996, THORAX, V51, P781, DOI 10.1136/thx.51.8.781; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Mizuno S, 2014, INFLAMM BOWEL DIS, V20, P1426, DOI 10.1097/MIB.0000000000000105; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Morimoto K, 2001, AM J RESP CELL MOL, V24, P608, DOI 10.1165/ajrcmb.24.5.4292; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nahrendorf M, 2016, CIRC RES, V119, P414, DOI 10.1161/CIRCRESAHA.116.309194; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Navarro LA, 2015, J HEPATOL, V62, P412, DOI 10.1016/j.jhep.2014.09.015; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ortiz-Masia D, 2014, MUCOSAL IMMUNOL, V7, P929, DOI 10.1038/mi.2013.108; Osterholzer JJ, 2013, J IMMUNOL, V190, P3447, DOI 10.4049/jimmunol.1200604; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Rani R, 2011, EUR J IMMUNOL, V41, P2000, DOI 10.1002/eji.201041135; Reed JAH, 1997, AM J PHYSIOL-LUNG C, V273, pL715, DOI 10.1152/ajplung.1997.273.4.L715; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rossini V, 2014, MUCOSAL IMMUNOL, V7, P533, DOI 10.1038/mi.2013.70; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Sanders TJ, 2014, GASTROENTEROLOGY, V146, P1278, DOI 10.1053/j.gastro.2014.01.057; Sato K, 1996, J SURG RES, V63, P433, DOI 10.1006/jsre.1996.0288; Sauter KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105429; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schridde A., 2017, MUCOSAL IMMUNOL, V7, P32015; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seo SU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9010; Sharma M, 2015, J CLIN EXP HEPATOL, V5, P147, DOI 10.1016/j.jceh.2015.02.002; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Smythies LE, 2010, J BIOL CHEM, V285, P19593, DOI 10.1074/jbc.M109.069955; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tay SS, 2014, J IMMUNOL, V193, P2087, DOI 10.4049/jimmunol.1400037; Temelkovski J, 1997, EXP LUNG RES, V23, P377, DOI 10.3109/01902149709039233; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tomiyama K, 2008, HEPATOLOGY, V48, P1608, DOI 10.1002/hep.22482; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Waddell A, 2013, J IMMUNOL, V190, P4773, DOI 10.4049/jimmunol.1200057; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wiegard C, 2005, HEPATOLOGY, V42, P193, DOI 10.1002/hep.20756; Wu XD, 2016, J EXP MED, V213, P2553, DOI 10.1084/jem.20160600; Yang C.-Y., 2013, CLEC4F IS INDUCIBLE, V8; YANG R, 1994, J PEDIATR SURG, V29, P1145, DOI 10.1016/0022-3468(94)90297-6; Zhang WF, 2014, ANN HEPATOL, V13, P489, DOI 10.1016/S1665-2681(19)31247-5; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	184	79	81	3	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1258	1270		10.1038/nm.4430	http://dx.doi.org/10.1038/nm.4430			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29117177	Green Accepted			2022-12-27	WOS:000414548300008
J	Romero, R; Sayin, VI; Davidson, SM; Bauer, MR; Singh, SX; LeBoeuf, SE; Karakousi, TR; Ellis, DC; Bhutkar, A; Sanchez-Rivera, FJ; Subbaraj, L; Martinez, B; Bronson, RT; Prigge, JR; Schmidt, EE; Thomas, CJ; Goparaju, C; Davies, A; Dolgaley, I; Heguy, A; Allaj, V; Poirier, JT; Moreira, AL; Rudin, CM; Pass, HI; Vander Heiden, MG; Jacks, T; Papagiannakopoulos, T				Romero, Rodrigo; Sayin, Volkan I.; Davidson, Shawn M.; Bauer, Matthew R.; Singh, Simranjit X.; LeBoeuf, Sarah E.; Karakousi, Triantafyllia R.; Ellis, Donald C.; Bhutkar, Arjun; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Martinez, Britney; Bronson, Roderick T.; Prigge, Justin R.; Schmidt, Edward E.; Thomas, Craig J.; Goparaju, Chandra; Davies, Angela; Dolgaley, Igor; Heguy, Adriana; Allaj, Viola; Poirier, John T.; Moreira, Andre L.; Rudin, Charles M.; Pass, Harvey I.; Vander Heiden, Matthew G.; Jacks, Tyler; Papagiannakopoulos, Thales			Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis	NATURE MEDICINE			English	Article							SIGNALING PATHWAY; TUMOR INITIATION; NRF2; EXPRESSION; METABOLISM; ACTIVATION; METHYLATION; PROGRESSION; MUTATIONS; INDUCTION	Treating KRAS-mutant lung adenocarcinoma (LUAD) remains a major challenge in cancer treatment given the difficulties associated with directly inhibiting the KRAS oncoprotein(1). One approach to addressing this challenge is to define mutations that frequently co-occur with those in KRAS, which themselves may lead to therapeutic vulnerabilities in tumors. Approximately 20% of KRAS-mutant LUAD tumors carry loss-of-function mutations in the KEAP1 gene encoding Kelch-like ECH-associated protein 1 (refs. 2-4), a negative regulator of nuclear factor erythroid 2-like 2 (NFE2L2; hereafter NRF2), which is the master transcriptional regulator of the endogenous antioxidant response5-10. The high frequency of mutations in KEAP1 suggests an important role for the oxidative stress response in lung tumorigenesis. Using a CRISPR-Cas9-based approach in a mouse model of KRAS-driven LUAD, we examined the effects of Keap1 loss in lung cancer progression. We show that loss of Keap1 hyperactivates NRF2 and promotes KRAS-driven LUAD in mice. Through a combination of CRISPR-Cas9-based genetic screening and metabolomic analyses, we show that Keap1-or Nrf2-mutant cancers are dependent on increased glutaminolysis, and this property can be therapeutically exploited through the pharmacological inhibition of glutaminase. Finally, we provide a rationale for stratification of human patients with lung cancer harboring KRAS/KEAP1-or KRAS/ NRF2-mutant lung tumors as likely to respond to glutaminase inhibition.	[Romero, Rodrigo; Davidson, Shawn M.; Bauer, Matthew R.; Ellis, Donald C.; Bhutkar, Arjun; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Vander Heiden, Matthew G.; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Romero, Rodrigo; Davidson, Shawn M.; Ellis, Donald C.; Sanchez-Rivera, Francisco J.; Subbaraj, Lakshmipriya; Vander Heiden, Matthew G.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sayin, Volkan I.; Singh, Simranjit X.; LeBoeuf, Sarah E.; Karakousi, Triantafyllia R.; Martinez, Britney; Moreira, Andre L.; Papagiannakopoulos, Thales] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Bronson, Roderick T.] Tufts Univ, Boston, MA 02111 USA; [Bronson, Roderick T.] Harvard Med Sch, Boston, MA USA; [Prigge, Justin R.; Schmidt, Edward E.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Thomas, Craig J.] US Natl Inst Hlth, NIH, Chem Genom Ctr, Div Preclin Innovat,Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Goparaju, Chandra; Pass, Harvey I.] NYU, Dept Cardiothorac Surg, Langone Med Ctr, New York, NY USA; [Davies, Angela] Champ Oncol, Hackensack, NJ USA; [Heguy, Adriana] NYU, Sch Med, Genome Technol Ctr, New York, NY USA; [Poirier, John T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Poirier, John T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Papagiannakopoulos, Thales] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10003 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); New York University; Tufts University; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); New York University; NYU Langone Medical Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; New York University	Jacks, T (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jacks, T (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Papagiannakopoulos, T (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.; Jacks, T (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Papagiannakopoulos, T (corresponding author), NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10003 USA.	tjacks@mit.edu; papagt01@nyumc.org	Rudin, Charles/R-2530-2019; Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022; Sánchez-Rivera, Francisco J./AAV-6985-2020	Rudin, Charles/0000-0001-5204-3465; Dolgalev, Igor/0000-0003-4451-126X; Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Romero, Rodrigo/0000-0002-9388-8306; Sayin, Volkan/0000-0002-5225-8260; Subbaraj, Lakshmipriya/0000-0001-5777-3547; Singh, Simranjit/0000-0002-2556-9696; Romero, Rodrigo/0000-0003-1689-0784; Thomas, Craig/0000-0001-9386-9001; Pass, Harvey/0000-0003-3222-3471; Poirier, John/0000-0001-9795-5644; LeBoeuf, Sarah/0000-0003-1580-6536	National Institutes of Health (NIH); National Cancer Institute [P30-CA14051]; American Cancer Society; Hope Funds for Cancer Research; NIH [K22CA201088-01, 5T32HL007151-38]; New York University Department of Pathology Bridge Grant; National Science Foundation Graduate Research Fellowship [1122374]; Swedish Medical Research Council; AG Fond; Wenner-Gren Foundations; EMBO long-term fellowship - European Commission [ALTF 1451-2015, LTCOFUND2013, GA-2013-609409]; National Cancer Institute Early Detection Research Network grant [2U01CA 111295-04]; Cancer Center Support Grant [P30-CA14051]; Howard Hughes Medical Institute; Laura and Isaac Perlmutter Cancer Support Grant; NATIONAL CANCER INSTITUTE [K22CA201088, P30CA014051, P30CA016087, R37CA222504, U01CA111295, R01CA227649] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Hope Funds for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Department of Pathology Bridge Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AG Fond; Wenner-Gren Foundations; EMBO long-term fellowship - European Commission; National Cancer Institute Early Detection Research Network grant; Cancer Center Support Grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Laura and Isaac Perlmutter Cancer Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. McFadden, R. Possemato, S. Sayin, and T. Gonzalez-Robles for critical reading of the manuscript; T. Tammela, L. Sullivan, G. DeNicola, and I. Harris for scientific discussions and feedback; S. Levine and T. Mason for massively parallel sequencing expertise; M. Griffin, M. Jennings, and G. Paradis for fluorescence-activated cell sorting (FACS) support; K. Cormier and the Hope Babette Tang (1983) Histology Facility for histology support; I. Baptista, A. Deconinck, J. Teixeira, and K. Yee for administrative support; and the Swanson Biotechnology Center for excellent core facilities. This work was supported in part by the Laura and Isaac Perlmutter Cancer Support Grant, National Institutes of Health (NIH) S10 awards, and Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute. T.P. was supported by the American Cancer Society and Hope Funds for Cancer Research. The laboratory of T. P. is supported by the NIH (K22CA201088-01) and the New York University Department of Pathology Bridge Grant. R. R. was supported by the National Science Foundation Graduate Research Fellowship under grant number 1122374. V.I.S. received support from the Swedish Medical Research Council, the AG Fond, and the Wenner-Gren Foundations and is the recipient of EMBO long-term fellowship ALTF 1451-2015 that is co-funded by the European Commission (LTCOFUND2013, GA-2013-609409) with support from Marie Curie Actions. S.E.L. is supported by an NIH training grant (5T32HL007151-38). Human tumor collection by H.I.P. was supported by a National Cancer Institute Early Detection Research Network grant (2U01CA 111295-04). Research in the laboratory of T. J. was supported by Cancer Center Support Grant P30-CA14051 and the Howard Hughes Medical Institute.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bauer AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026590; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimitrova N, 2016, CANCER DISCOV, V6, P188, DOI 10.1158/2159-8290.CD-15-0854; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fabrizio FP, 2017, ONCOTARGET, V8, P11187, DOI 10.18632/oncotarget.14492; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006; Goldstein LD, 2016, CELL REP, V16, P2605, DOI 10.1016/j.celrep.2016.08.010; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Krail EB, 2017, ELIFE, V6, DOI [10.7554/eLife.18970, 10.7554/eLife.33173]; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Muscarella LA, 2011, EPIGENETICS-US, V6, P317, DOI 10.4161/epi.6.3.14408; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Satoh H, 2016, CANCER RES, V76, P3088, DOI 10.1158/0008-5472.CAN-15-1584; Satoh H, 2013, CANCER RES, V73, P4158, DOI 10.1158/0008-5472.CAN-12-4499; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schneeberger VE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160587; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632	70	323	327	13	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1362	+		10.1038/nm.4407	http://dx.doi.org/10.1038/nm.4407			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	28967920	Green Accepted, Green Submitted			2022-12-27	WOS:000414548300018
J	Wang, PX; Ji, YX; Zhang, XJ; Zhao, LP; Yan, ZZ; Zhang, P; Shen, LJ; Yang, X; Fang, J; Tian, S; Zhu, XY; Gong, J; Zhang, X; Wei, QF; Wang, Y; Li, J; Wan, L; Xie, QG; She, ZG; Wang, ZH; Huang, Z; Li, HL				Wang, Pi-Xiao; Ji, Yan-Xiao; Zhang, Xiao-Jing; Zhao, Ling-Ping; Yan, Zhen-Zhen; Zhang, Peng; Shen, Li-Jun; Yang, Xia; Fang, Jing; Tian, Song; Zhu, Xue-Yong; Gong, Jun; Zhang, Xin; Wei, Qiao-Fang; Wang, Yong; Li, Jing; Wan, Lu; Xie, Qingguo; She, Zhi-Gang; Wang, Zhihua; Huang, Zan; Li, Hongliang			Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates (vol 23, pg 439, 2017)	NATURE MEDICINE			English	Correction													Wang, Zhihua/AAM-1486-2021					PIXIAO W, 2017, NAT MED, V23, P439	1	3	3	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1241	1241		10.1038/nm1017-1241b	http://dx.doi.org/10.1038/nm1017-1241b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985205	Bronze			2022-12-27	WOS:000412431800021
J	Piunti, A; Hashizume, R; Morgan, MA; Bartom, ET; Horbinski, CM; Marshall, SA; Rendleman, EJ; Ma, QH; Takahashi, YH; Woodfin, AR; Misharin, AV; Abshiru, NA; Lulla, RR; Saratsis, AM; Kelleher, NL; James, CD; Shilatifard, A				Piunti, Andrea; Hashizume, Rintaro; Morgan, Marc A.; Bartom, Elizabeth T.; Horbinski, Craig M.; Marshall, Stacy A.; Rendleman, Emily J.; Ma, Quanhong; Takahashi, Yoh-hei; Woodfin, Ashley R.; Misharin, Alexander V.; Abshiru, Nebiyu A.; Lulla, Rishi R.; Saratsis, Amanda M.; Kelleher, Neil L.; James, C. David; Shilatifard, Ali			Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas	NATURE MEDICINE			English	Article							HISTONE H3; GENE-EXPRESSION; CELL; INHIBITION; TRANSCRIPTION; METHYLATION; ALIGNMENT; MUTATION	Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive pediatric brainstem tumor characterized by rapid and uniform patient demise(1). A heterozygous point mutation of histone H3 occurs in more than 80% of these tumors and results in a lysine-to-methionine substitution (H3K27M)(2,3). Expression of this histone mutant is accompanied by a reduction in the levels of polycomb repressive complex 2 (PRC2)-mediated H3K27 trimethylation (H3K27me3), and this is hypothesized to be a driving event of DIPG oncogenesis(4,5). Despite a major loss of H3K27me3, PRC2 activity is still detected in DIPG cells positive for H3K27M(6,7). To investigate the functional roles of H3K27M and PRC2 in DIPG pathogenesis, we profiled the epigenome of H3K27M-mutant DIPG cells and found that H3K27M associates with increased H3K27 acetylation (H3K27ac). In accordance with previous biochemical data5, the majority of the heterotypic H3K27M-K27ac nucleosomes colocalize with bromodomain proteins at the loci of actively transcribed genes, whereas PRC2 is excluded from these regions; this suggests that H3K27M does not sequester PRC2 on chromatin. Residual PRC2 activity is required to maintain DIPG proliferative potential, by repressing neuronal differentiation and function. Finally, to examine the therapeutic potential of blocking the recruitment of bromodomain proteins by heterotypic H3K27M-K27ac nucleosomes in DIPG cells, we performed treatments invivo with BET bromodomain inhibitors and demonstrate that they efficiently inhibit tumor progression, thus identifying this class of compounds as potential therapeutics in DIPG.	[Piunti, Andrea; Hashizume, Rintaro; Morgan, Marc A.; Bartom, Elizabeth T.; Marshall, Stacy A.; Rendleman, Emily J.; Ma, Quanhong; Takahashi, Yoh-hei; Woodfin, Ashley R.; James, C. David; Shilatifard, Ali] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Hashizume, Rintaro; Horbinski, Craig M.; Ma, Quanhong; Saratsis, Amanda M.; James, C. David] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Misharin, Alexander V.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Pulmonol, Chicago, IL 60611 USA; [Misharin, Alexander V.] Northwestern Univ, Dept Pediat, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Abshiru, Nebiyu A.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL USA; [Lulla, Rishi R.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Hematol Oncol Neurooncol & Stem Cell Tranpla, Chicago, IL 60611 USA; [Saratsis, Amanda M.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Surg, Div Pediat Neurosurg, Chicago, IL 60611 USA; [Saratsis, Amanda M.; James, C. David; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Robert H Lurie NCI Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	James, CD; Shilatifard, A (corresponding author), Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA.; James, CD (corresponding author), Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA.; James, CD; Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie NCI Comprehens Canc Ctr, Chicago, IL 60611 USA.	charles.james@northwestern.edu; ash@northwestern.edu	Misharin, Alexander/AAD-6456-2019; Bartom, Elizabeth/S-4475-2017	Woodfin, Ashley/0000-0003-4154-6002; Lulla, Rishi/0000-0003-4109-2207; Bartom, Elizabeth/0000-0002-5618-2582	EMBO fellowship [ALTF 372-2015]; AIRC; Marie Curie Actions-People-COFUND; US National Institutes of Health [RO1NS093079]; Matthew Larson Foundation; Bear Necessities Pediatric Cancer Foundation; Rally Foundation; NCI [CCSG P30CA060553, R35CA197569]; National Resource for Translational and Developmental Proteomics [P41GM108569]; J. McNicholas Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [P30CA060553, R35CA197569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM108569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS097624, R01NS093079] Funding Source: NIH RePORTER	EMBO fellowship(European Molecular Biology Organization (EMBO)); AIRC(Fondazione AIRC per la ricerca sul cancro); Marie Curie Actions-People-COFUND; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Matthew Larson Foundation; Bear Necessities Pediatric Cancer Foundation; Rally Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Resource for Translational and Developmental Proteomics; J. McNicholas Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the members of the Shilatifard lab for their useful comments and suggestions. We thank M. Monje (Stanford University) for use of the SU-DIPGIV cell line. We thank D. Pasini (European Institute of Oncology, IEO) for providing the SUZ12 and control vectors, and C. Rivetta for technical support. pInducer20 was a gift from S. Elledge (deposited in Addgene, plasmid #44012). A.P. is supported by a long-term EMBO fellowship (ALTF 372-2015), and his work in the Shilatifard lab is supported by AIRC and Marie Curie Actions-People-COFUND. R.H. is supported by US National Institutes of Health grant RO1NS093079, the Matthew Larson Foundation and the Bear Necessities Pediatric Cancer Foundation and Rally Foundation. Proteomics services were performed by the Northwestern Proteomics Core Facility, generously supported by NCI CCSG P30CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center, and the National Resource for Translational and Developmental Proteomics supported by P41GM108569. Studies in regards to the development of targeted therapeutics for DIPG within our groups are partially supported by the generous support of J. McNicholas Pediatric Brain Tumor Foundation. Studies in the Shilatifard laboratory are supported by NCI grant R35CA197569.	An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bhadury J, 2014, P NATL ACAD SCI USA, V111, pE2721, DOI 10.1073/pnas.1406722111; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Chen F, 2015, GENE DEV, V29, P39, DOI 10.1101/gad.246173.114; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Gordon J, 2013, METHODS MOL BIOL, V1078, P1, DOI 10.1007/978-1-62703-640-5_1; Grasso CS, 2015, NAT MED, V21, P827, DOI 10.1038/nm0715-827a; Gupta Sachin, 2010, Ther Adv Med Oncol, V2, P237, DOI 10.1177/1758834010366430; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Mueller S, 2014, NEURO-ONCOLOGY, V16, P352, DOI 10.1093/neuonc/not220; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Piunti A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4649; Qi J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018663; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schroeder KM, 2014, PEDIATR RES, V75, P205, DOI 10.1038/pr.2013.194; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Weiner A, 2016, NAT BIOTECHNOL, V34, P953, DOI 10.1038/nbt.3652; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	44	222	227	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					493	+		10.1038/nm.4296	http://dx.doi.org/10.1038/nm.4296			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28263307	Green Accepted			2022-12-27	WOS:000398768100017
J	Schneider, C; Oellerich, T; Baldauf, HM; Schwarz, SM; Thomas, D; Flick, R; Bohnenberger, H; Kaderali, L; Stegmann, L; Cremer, A; Martin, M; Lohmeyer, J; Michaelis, M; Hornung, V; Schliemann, C; Berdel, WE; Hartmann, W; Wardelmann, E; Comoglio, F; Hansmann, ML; Yakunin, AF; Geisslinger, G; Strobel, P; Ferreiros, N; Serve, H; Keppler, OT; Cinatl, J				Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Stroebel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T.; Cinatl, Jindrich, Jr.			SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia	NATURE MEDICINE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; RESTRICTION FACTOR SAMHD1; HIV-1 INFECTION; TRIPHOSPHOHYDROLASE; CELLS; VPX; TRIPHOSPHATES; METABOLISM; ACTIVATION; PROTEIN	The nucleoside analog cytarabine (Ara-C) is an essential component of primary and salvage chemotherapy regimens for acute myeloid leukemia (AML). After cellular uptake, Ara-C is converted into its therapeutically active triphosphate metabolite, Ara-CTP, which exerts antileukemic effects, primarily by inhibiting DNA synthesis in proliferating cells'. Currently, a substantial fraction of patients with AML fail to respond effectively to Ara-C therapy, and reliable biomarkers for predicting the therapeutic response to Ara-C are lacking(2,3). SAMHD1 is a deoxynucleoside triphosphate (dNTP) triphosphohydrolase that cleaves physiological dNTPs into deoxyribonucleosides and inorganic triphosphate(4,5). Although it has been postulated that SAMHD1 sensitizes cancer cells to nucleoside-analog derivatives through the depletion of competing dNTPs6, we show here that SAMHD1 reduces Ara-C cytotoxicity in AML cells. Mechanistically, dGTP-activated SAMHD1 hydrolyzes Ara-CTP, which results in a drastic reduction of Ara-CTP in leukemic cells. Loss of SAMHD1 activity through genetic depletion, mutational inactivation of its triphosphohydrolase activity or proteasomal degradation using specialized, virus-like particles(7,8) potentiates the cytotoxicity of Ara-C in AML cells. In mouse models of retroviral AML transplantation, as well as in retrospective analyses of adult patients with AML, the response to Ara-C-containing therapy was inversely correlated with SAMHD1 expression. These results identify SAMHD1 as a potential biomarker for the stratification of patients with AML who might best respond to Ara-C-based therapy and as a target for treating Ara-C-refractory AML.	[Schneider, Constanze; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Stegmann, Lena; Martin, Margarethe; Keppler, Oliver T.; Cinatl, Jindrich, Jr.] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany; [Oellerich, Thomas; Cremer, Anjali; Serve, Hubert] Goethe Univ Frankfurt, Dept Med Hematol & Oncol 2, Frankfurt, Germany; [Oellerich, Thomas; Comoglio, Federico] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Oellerich, Thomas; Serve, Hubert] German Canc Res Ctr, German Canc Consortium Partner Site, Heidelberg, Germany; [Baldauf, Hanna-Mari; Keppler, Oliver T.] Ludwig Maximilian Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany; [Thomas, Dominique; Geisslinger, Gerd; Ferreiros, Nerea] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Flick, Robert; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Bohnenberger, Hanibal; Stroebel, Philipp] Univ Med Ctr, Inst Pathol, Gottingen, Germany; [Kaderali, Lars] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany; [Michaelis, Martin] Univ Kent, Ctr Mol Proc & Sch Biosci, Canterbury, Kent, England; [Hornung, Veit] Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Hornung, Veit] Ludwig Maximilian Univ Munich, Gene Ctr, Munich, Germany; [Hornung, Veit] Ludwig Maximilian Univ Munich, Dept Biochem, Munich, Germany; [Schliemann, Christoph; Berdel, Wolfgang E.] Univ Hosp Munster, Dept Med Hematol A, Oncol, Munster, Germany; [Hartmann, Wolfgang; Wardelmann, Eva] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Hansmann, Martin-Leo] Goethe Univ Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany; [Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Goethe University Frankfurt; University of Toronto; University of Gottingen; Greifswald Medical School; University of Kent; University of Bonn; University of Munich; University of Munich; University of Munster; University of Munster; Goethe University Frankfurt; Fraunhofer Gesellschaft	Keppler, OT; Cinatl, J (corresponding author), Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany.; Keppler, OT (corresponding author), Ludwig Maximilian Univ Munich, Dept Virol, Max von Pettenkofer Inst, Munich, Germany.	keppler@mvp.uni-muenchen.de; Cinatl@em.uni-frankfurt.de	Bohnenberger, Hanibal/F-2317-2013; Hornung, Veit/C-3565-2012; Hartmann, Wolfgang/G-1893-2017	Hornung, Veit/0000-0002-4150-194X; Hartmann, Wolfgang/0000-0002-7609-5021; Comoglio, Federico/0000-0002-8970-6610; Michaelis, Martin/0000-0002-5710-5888; Kaderali, Lars/0000-0002-2359-2294; Serve, Hubert/0000-0001-8472-5516	EMBO long-term fellowship [1305-2015, LITCOFUND2013/GA-2013-609409]; Deutsche Forschungsgemeinschaft grant [DFG EXC 1003]; Medical Faculty of the University of Frankfurt; Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder; LOEWE Program of the State of Hessia (LOEWE Center for Translational Medicine and Pharmacology, Frankfurt); Jose Carreras Leukamie-Stiftung; Deutsche Forschungsgemeinschaft [KE 742/4-1, 1039/Z01]; NSERC Strategic Network grant IBN; Kent Cancer Trust; LMU Munich	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG)); Medical Faculty of the University of Frankfurt; Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder; LOEWE Program of the State of Hessia (LOEWE Center for Translational Medicine and Pharmacology, Frankfurt); Jose Carreras Leukamie-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSERC Strategic Network grant IBN; Kent Cancer Trust; LMU Munich	This study is dedicated to the memory of Professor Werner Reutter. We are grateful to T. Gramberg (Institute of Clinical and Molecular Virology, FAU Erlangen Nurnberg, Erlangen, Germany) for providing a codon-optimized SAMHD1 expression construct and I. Jeremias (Department of Gene Vectors, Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Munich, Germany) for providing AML-393. We thank S. Grothe, Y. Voges and K. Lehr for technical assistance, and A. Ruggieri for graphical artwork. We are grateful to R. Zehner for short tandem repeat (STR) profiling. We acknowledge logistic support by N. Herold for LC-MS/MS analyses in the period September to November 2014 as scientific staff in the laboratory of O.T.K. at Goethe University. F.C. is supported by an EMBO long-term fellowship (1305-2015 and Marie Curie Actions LITCOFUND2013/GA-2013-609409). The WEBs laboratory is supported by the Deutsche Forschungsgemeinschaft grant DFG EXC 1003 (H.S.). This work was supported in part by the Medical Faculty of the University of Frankfurt (O.T.K.), Hilfe fur krebskranke Kinder Frankfurt e.V. (J.C.), the Frankfurter Stiftung fur krebskranke Kinder (J.C.), by the LOEWE Program of the State of Hessia (LOEWE Center for Translational Medicine and Pharmacology, Frankfurt)(G.G. and H.S.), the Jose Carreras Leukamie-Stiftung (J.C.), the Deutsche Forschungsgemeinschaft (KE 742/4-1 (O.T.K.), SFB 1039/Z01 (G.G.)), the NSERC Strategic Network grant IBN (M. Michaelis), the Kent Cancer Trust (M. Michaelis) and the LMU Munich (O.T.K.).	Arnold LH, 2015, ANTIMICROB AGENTS CH, V59, P186, DOI 10.1128/AAC.03903-14; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballana E, 2014, ANTIMICROB AGENTS CH, V58, P4804, DOI 10.1128/AAC.03145-14; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; EARLY AP, 1982, CANCER RES, V42, P1587; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huber AD, 2014, ANTIMICROB AGENTS CH, V58, P4915, DOI 10.1128/AAC.02745-14; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Kohnken R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0446-6; Komanduri KV, 2016, ANNU REV MED, V67, P59, DOI 10.1146/annurev-med-051914-021329; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lamba JK, 2009, PHARMACOGENOMICS, V10, P1657, DOI [10.2217/pgs.09.118, 10.2217/PGS.09.118]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Lowenberg B, 2011, NEW ENGL J MED, V364, P1027, DOI 10.1056/NEJMoa1010222; Merati Miesha, 2015, JAAD Case Rep, V1, P227, DOI 10.1016/j.jdcr.2015.05.003; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796	25	84	85	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					250	255		10.1038/nm.4255	http://dx.doi.org/10.1038/nm.4255			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	27991919	Green Accepted			2022-12-27	WOS:000393729000017
J	Hahm, E; Wei, CL; Fernandez, I; Li, J; Tardi, NJ; Tracy, M; Wadhwani, S; Cao, YX; Peev, V; Zloza, A; Lusciks, J; Hayek, SS; O'Connor, C; Bitzer, M; Gupta, V; Sever, S; Sykes, DB; Scadden, DT; Reiser, J				Hahm, Eunsil; Wei, Changli; Fernandez, Isabel; Li, Jing; Tardi, Nicholas J.; Tracy, Melissa; Wadhwani, Shikha; Cao, Yanxia; Peev, Vasil; Zloza, Andrew; Lusciks, Jevgenijs; Hayek, Salim S.; O'Connor, Christopher; Bitzer, Markus; Gupta, Vineet; Sever, Sanja; Sykes, David B.; Scadden, David T.; Reiser, Jochen			Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease	NATURE MEDICINE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; SOLUBLE UROKINASE RECEPTOR; PLASMINOGEN-ACTIVATOR RECEPTOR; IDIOPATHIC NEPHROTIC SYNDROME; HEMATOPOIETIC STEM-CELLS; HUMANIZED MOUSE MODELS; GLOMERULAR-DISEASE; MICE; PODOCYTES; PERMEABILITY	Excess levels of protein in urine (proteinuria) is a hallmark of kidney disease that typically occurs in conjunction with diabetes, hypertension, gene mutations, toxins or infections but may also be of unknown cause (idiopathic)(1). Systemic soluble urokinase plasminogen activator receptor (suPAR) is a circulating factor implicated in the onset and progression of chronic kidney disease (CKD)(2), such as focal segmental glomeruloscierosis (FSGS)(3,4). The cellular source(s) of elevated suPAR associated with future and progressing kidney disease is unclear, but is likely extra-renal, as the pathological uPAR is circulating and FSGS can recur even after a damaged kidney is replaced with a healthy donor organ. Here we report that bone marrow (BM) Gr-1(lo) immature myeloid cells are responsible for the elevated, pathological levels of suPAR, as evidenced by BM chimera and BM ablation and cell transfer studies. A marked increase of Gr-1(lo) myeloid cells was commonly found in the BM of proteinuric animals having high suPAR, and these cells efficiently transmit proteinuria when transferred to healthy mice. In accordance with the results seen in suPAR-associated proteinuric animal models, in which kidney damage is caused not by local podocyte-selective injury but more likely by systemic insults, a humanized xenograft model of FSGS resulted in an expansion of Gr-1(lo) cells in the BM, leading to high plasma suPAR and proteinuric kidney disease. Together, these results identify suPAR as a functional connection between the BM and the kidney, and they implicate BM immature myeloid cells as a key contributor to glomerular dysfunction.	[Hahm, Eunsil; Wei, Changli; Fernandez, Isabel; Li, Jing; Tardi, Nicholas J.; Tracy, Melissa; Wadhwani, Shikha; Cao, Yanxia; Peev, Vasil; Zloza, Andrew; Lusciks, Jevgenijs; Gupta, Vineet; Reiser, Jochen] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Zloza, Andrew; Lusciks, Jevgenijs] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Zloza, Andrew] Rutgers Canc Inst New Jersey, Div Surg Oncol Res Sect, Sect Surg Oncol, New Brunswick, NJ USA; [Zloza, Andrew] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA; [Hayek, Salim S.] Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, Div Cardiol, Atlanta, GA 30322 USA; [O'Connor, Christopher; Bitzer, Markus] Univ Michigan, Dept Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Sever, Sanja] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Sykes, David B.; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ct Regenerat Med, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Sykes, David B.; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Rush University; Rush University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Emory University; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Reiser, J (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA.	Jochen_Reiser@rush.edu	Hayek, Salim S./E-6932-2013	Hayek, Salim S./0000-0003-0180-349X; Hahm, Eunsil/0000-0002-0343-7473; Bitzer, Markus/0000-0002-3711-2984; Zloza, Andrew/0000-0001-8844-6493	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK101350, R01DK106051, R01DK107984, R01DK084195]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100449, R01DK084195, R01DK106051, R01DK101350, R01DK107984] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A.S. Shaw (Washington University School of Medicine) for the Racl transgenic mice; S. Shankland (University of Washington) for providing the nephrotoxic serum (NTS); A. Finnegan (Rush University Medical Center) for reagents and advice; B. Samelko (ne Tryniszewska) (Rush University Medical Center) for technical assistance; and S. Mangos (Rush University Medical Center) for help with manuscript revisions. This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01DK101350 (J.R.), R01DK106051(J.R.), R01DK107984(V.G.) and R01DK084195(V.G.).	Alfano M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13647; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bertelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111285; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brehm MA, 2010, CURR OPIN ENDOCRINOL, V17, P120, DOI 10.1097/MED.0b013e328337282f; Cathelin D, 2014, J AM SOC NEPHROL, V25, P1662, DOI 10.1681/ASN.2013040425; Cravedi P, 2013, AM J TRANSPLANT, V13, P266, DOI 10.1111/ajt.12045; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Delville M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008538; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Fogo AB, 2015, NAT REV NEPHROL, V11, P76, DOI 10.1038/nrneph.2014.216; Gallon L, 2012, NEW ENGL J MED, V366, P1648, DOI 10.1056/NEJMc1202500; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Kistler AD, 2013, J BIOL CHEM, V288, P36598, DOI 10.1074/jbc.M113.488122; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kopp JB, 1996, LAB INVEST, V74, P991; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Niu HT, 2013, BLOOD, V121, P1986, DOI 10.1182/blood-2012-05-433755; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sellier-Leclerc AL, 2007, J AM SOC NEPHROL, V18, P2732, DOI 10.1681/ASN.2006121346; Shi X, 2013, INFECT IMMUN, V81, P2197, DOI 10.1128/IAI.01280-12; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Spinale JM, 2015, KIDNEY INT, V87, P564, DOI 10.1038/ki.2014.346; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	40	94	99	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					100	106		10.1038/nm.4242	http://dx.doi.org/10.1038/nm.4242			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27941791	Green Accepted			2022-12-27	WOS:000391646800018
J	Zhang, YF; Xu, JK; Ruan, YC; Yu, MK; O'Laughlin, M; Wise, H; Chen, D; Tian, L; Shi, DF; Wang, JL; Chen, SH; Feng, JQ; Chow, DHK; Xie, XH; Zheng, LZ; Huang, L; Huang, S; Leung, K; Lu, N; Zhao, L; Li, HF; Zhao, DW; Guo, X; Chan, KM; Witte, F; Chan, HC; Zheng, YF; Qin, L				Zhang, Yifeng; Xu, Jiankun; Ruan, Ye Chun; Yu, Mei Kuen; O'Laughlin, Micheal; Wise, Helen; Chen, Di; Tian, Li; Shi, Dufang; Wang, Jiali; Chen, Sihui; Feng, Jian Q.; Chow, Dick Ho Kiu; Xie, Xinhui; Zheng, Lizhen; Huang, Le; Huang, Shuo; Leung, Kwoksui; Lu, Na; Zhao, Lan; Li, Huafang; Zhao, Dewei; Guo, Xia; Chan, Kaiming; Witte, Frank; Chan, Hsiao Chang; Zheng, Yufeng; Qin, Ling			Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats	NATURE MEDICINE			English	Article							GENE-RELATED PEPTIDE; TRAUMATIC BRAIN-INJURY; IN-VITRO; VIVO; OSTEOPOROSIS; ALLOYS; DIFFERENTIATION; OSTEOARTHRITIS; INNERVATION; EXPRESSION	Orthopedic implants containing biodegradable magnesium have been used for fracture repair with considerable efficacy; however, the underlying mechanisms by which these implants improve fracture healing remain elusive. Here we show the formation of abundant new bone at peripheral cortical sites after intramedullary implantation of a pin containing ultrapure magnesium into the intact distal femur in rats. This response was accompanied by substantial increases of neuronal calcitonin gene-related polypeptide-alpha (CGRP) in both the peripheral cortex of the femur and the ipsilateral dorsal root ganglia (DRG). Surgical removal of the periosteum, capsaicin denervation of sensory nerves or knockdown in vivo of the CGRP-receptor-encoding genes Cakrl or Ramp1 substantially reversed the magnesium-induced osteogenesis that we observed in this model. Overexpression of these genes, however, enhanced magnesium-induced osteogenesis. We further found that an elevation of extracellular magnesium induces magnesium transporter 1 (MAGT1)-dependent and transient receptor potential cation channel, subfamily M, member 7 (TRPM7)-dependent magnesium entry, as well as an increase in intracellular adenosine triphosphate (ATP) and the accumulation of terminal synaptic vesicles in isolated rat DRG neurons. In isolated rat periosteum-derived stem cells, CGRP induces CALCRL- and RAMP1-dependent activation of cAMP-responsive element binding protein 1 (CREB1) and SP7 (also known as osterix), and thus enhances osteogenic differentiation of these stem cells. Furthermore, we have developed an innovative, magnesium containing intramedullary nail that facilitates femur fracture repair in rats with ovariectomy-induced osteoporosis. Taken together, these findings reveal a previously undefined role of magnesium in promoting CGRP-mediated osteogenic differentiation, which suggests the therapeutic potential of this ion in orthopedics.	[Zhang, Yifeng; Xu, Jiankun; O'Laughlin, Micheal; Tian, Li; Shi, Dufang; Wang, Jiali; Chen, Sihui; Chow, Dick Ho Kiu; Xie, Xinhui; Zheng, Lizhen; Huang, Le; Huang, Shuo; Leung, Kwoksui; Li, Huafang; Chan, Kaiming; Qin, Ling] Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China; [Ruan, Ye Chun; Yu, Mei Kuen; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Wise, Helen] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Di; Zhao, Lan] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Lu, Na] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhao, Dewei] Dalian Univ, Dept Orthoped, Zhongshan Hosp, Dalian, Peoples R China; [Guo, Xia] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Witte, Frank] Charite, Julius Wolff Inst, Berlin, Germany; [Witte, Frank] Charite, Ctr Musculoskeletal Surg, Berlin, Germany; [Witte, Frank] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Zheng, Yufeng] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China; [Qin, Ling] Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China; [Zhang, Yifeng] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Rush University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Hong Kong University of Science & Technology; Dalian University; Hong Kong Polytechnic University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Peking University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Nanjing University	Qin, L (corresponding author), Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.; Zheng, YF (corresponding author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China.; Qin, L (corresponding author), Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China.	yfzheng@pku.edu.cn; lingqin@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; Zheng, Yufeng/GQA-7172-2022; Chen, Di/AAJ-3665-2021; Chow, Dick Ho Kiu/C-6547-2014; Qin, Ling/J-9047-2018; RUAN, Ye Chun/T-5919-2017; Zheng, Yufeng/A-4146-2010; Li, Huafang/D-5486-2013; Ruan, Ye Chun/T-7531-2019; Zheng, Y.F./AAE-6697-2021; Witte, Frank/D-9294-2014	Zheng, Yufeng/0000-0002-7402-9979; Chow, Dick Ho Kiu/0000-0002-2836-3255; Qin, Ling/0000-0001-6173-6167; RUAN, Ye Chun/0000-0002-4266-6789; Zheng, Yufeng/0000-0002-7402-9979; Ruan, Ye Chun/0000-0002-4266-6789; Zhao, Lan/0000-0003-0865-2006; Witte, Frank/0000-0001-9154-6217	Hong Kong RGC Collaborative Research Fund [C4028-14GF]; General Research Fund [14112714, 14114415]; NSFC/RGC [N_CUHK449/13, 51361165101]; Innovation and Technology Fund [ITS/350/13]; SMART Program; National Basic Research Program of China (973 Program) [2012CB619102, 2012CB944903, 2013CB967401]; National Natural Science Foundation of China [51225101, 51431002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067935, R01AR054465, R01AR062136] Funding Source: NIH RePORTER	Hong Kong RGC Collaborative Research Fund; General Research Fund; NSFC/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Innovation and Technology Fund; SMART Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We acknowledge Li Ka Shing Institute of Health Sciences (LiHS) for providing a harmonious working environment. This work was supported by Hong Kong RGC Collaborative Research Fund (2014/2015, C4028-14GF to L.Q.), General Research Fund (no. 14112714, 14114415 to L.Q.), NSFC/RGC (N_CUHK449/13 to L.Q.; 51361165101 to Y.Z.), Innovation and Technology Fund (no. ITS/350/13 to L.Q.), SMART Program to K.C., L.Q., H.C.C. and Y.C.R. (Lui Che Woo Institute of Innovative Medicine in Faculty of Medicine, the Chinese University of Hong Kong), National Basic Research Program of China (973 Program, no. 2012CB619102 to Y.Z., no.2012CB944903 to H.C.C. and Y.C.R. and no. 2013CB967401 to H.C.C.), National Natural Science Foundation of China (no. 51225101; no. 51431002 to Y.Z.). We thank B. Hesse for collecting and analyzing the mu XRF data. We thank G. Wu and J. Lu for help with scanning electron microscopy analysis.	Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BRENNER SL, 1980, J BIOL CHEM, V255, P841; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Castaneda-Corral G, 2011, NEUROSCIENCE, V178, P196, DOI 10.1016/j.neuroscience.2011.01.039; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; Chaya A, 2015, J ORAL MAXIL SURG, V73, P295, DOI 10.1016/j.joms.2014.09.007; Cheung WH, 2012, J ORTHOP RES, V30, P129, DOI 10.1002/jor.21487; Chokshi R, 2012, CHANNELS, V6, P362, DOI 10.4161/chan.21628; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Ding YX, 2010, BONE, V46, P1591, DOI 10.1016/j.bone.2010.02.022; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fu SC, 2012, OSTEOARTHR CARTILAGE, V20, P1409, DOI 10.1016/j.joca.2012.08.006; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018; Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015; Hayes JS, 2010, EXPERT REV MED DEVIC, V7, P843, DOI [10.1586/erd.10.53, 10.1586/ERD.10.53]; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li HF, 2013, ACTA BIOMATER, V9, P8561, DOI 10.1016/j.actbio.2013.01.029; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Li R, 2001, J BONE MINER RES, V16, P1505; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Madsen JE, 1998, CLIN ORTHOP RELAT R, P230; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonald AC, 2003, BONE, V33, P788, DOI 10.1016/S8756-3282(03)00244-8; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Minardi S, 2015, BIOMATERIALS, V62, P128, DOI 10.1016/j.biomaterials.2015.05.011; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Niedermair T, 2014, MATRIX BIOL, V38, P22, DOI 10.1016/j.matbio.2014.06.007; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Qin L, 1999, ANAT RECORD, V255, P380; Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001; Seeman E, 2007, OSTEOPOROSIS INT, V18, P123, DOI 10.1007/s00198-006-0296-6; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; Tang J, 2013, J ORTHOP TRANSL, V1, P41, DOI 10.1016/j.jot.2013.06.003; Tian G, 2013, ACTA PHARMACOL SIN, V34, P1467, DOI 10.1038/aps.2013.41; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707; Wang XY, 2009, SPINE, V34, P2363, DOI 10.1097/BRS.0b013e3181b04e52; Weizbauer A, 2016, J BIOMED MATER RES B, V104, P525, DOI 10.1002/jbm.b.33422; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6; Zhang ZH, 2010, BIOMED PHARMACOTHER, V64, P430, DOI 10.1016/j.biopha.2009.06.009; Zhao DW, 2016, BIOMATERIALS, V81, P84, DOI 10.1016/j.biomaterials.2015.11.038; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	58	456	470	45	506	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1160	1169		10.1038/nm.4162	http://dx.doi.org/10.1038/nm.4162			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27571347	Green Accepted			2022-12-27	WOS:000384872500019
J	Lukjanenko, L; Jung, MJ; Hegde, N; Perruisseau-Carrier, C; Migliavacca, E; Rozo, M; Karaz, S; Jacot, G; Schmidt, M; Li, LJ; Metairon, S; Raymond, F; Lee, U; Sizzano, F; Wilson, DH; Dumont, NA; Palini, A; Fassler, R; Steiner, P; Descombes, P; Rudnicki, MA; Fan, CM; von Maltzahn, J; Feige, JN; Bentzinger, CF				Lukjanenko, Laura; Jung, M. Juliane; Hegde, Nagabhooshan; Perruisseau-Carrier, Claire; Migliavacca, Eugenia; Rozo, Michelle; Karaz, Sonia; Jacot, Guillaume; Schmidt, Manuel; Li, Liangji; Metairon, Sylviane; Raymond, Frederic; Lee, Umji; Sizzano, Federico; Wilson, David H.; Dumont, Nicolas A.; Palini, Alessio; Faessler, Reinhard; Steiner, Pascal; Descombes, Patrick; Rudnicki, Michael A.; Fan, Chen-Ming; von Maltzahn, Julia; Feige, Jerome N.; Bentzinger, C. Florian			Loss of fibronectin from the aged stem cell niche affects the regenerative capacity of skeletal muscle in mice	NATURE MEDICINE			English	Article							SELF-RENEWAL; EXTRACELLULAR-MATRIX; REJUVENATION; PROLIFERATION; STRENGTH; SURVIVAL; MOUSE; SKIN; FAK	Age-related changes in the niche have long been postulated to impair the function of somatic stem cells. Here we demonstrate that the aged stem cell niche in skeletal muscle contains substantially reduced levels of fibronectin (FN), leading to detrimental consequences for the function and maintenance of muscle stem cells (MuSCs). Deletion of the gene encoding FN from young regenerating muscles replicates the aging phenotype and leads to a loss of MuSC numbers. By using an extracellular matrix (ECM) library screen and pathway profiling, we characterize FN as a preferred adhesion substrate for MuSCs and demonstrate that integrin-mediated signaling through focal adhesion kinase and the p38 mitogen-activated protein kinase pathway is strongly de-regulated in MuSCs from aged mice because of insufficient attachment to the niche. Reconstitution of FN levels in the aged niche remobilizes stem cells and restores youth-like muscle regeneration. Taken together, we identify the loss of stem cell adhesion to FN in the niche ECM as a previously unknown aging mechanism.	[Lukjanenko, Laura; Hegde, Nagabhooshan; Perruisseau-Carrier, Claire; Migliavacca, Eugenia; Karaz, Sonia; Jacot, Guillaume; Metairon, Sylviane; Raymond, Frederic; Lee, Umji; Sizzano, Federico; Palini, Alessio; Steiner, Pascal; Descombes, Patrick; Feige, Jerome N.; Bentzinger, C. Florian] Ecole Polytech Fed Lausanne, NIHS, Campus Ecole Polytech Fed Lausanne,Innovat Pk, Lausanne, Switzerland; [Lukjanenko, Laura] Ecole Polytech Fed Lausanne, Doctoral Program Biotechnol & Bioengn, Lausanne, Switzerland; [Jung, M. Juliane; Schmidt, Manuel; von Maltzahn, Julia] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Rozo, Michelle; Li, Liangji; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA; [Wilson, David H.; Dumont, Nicolas A.; Rudnicki, Michael A.] Ottawa Hosp, Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Wilson, David H.; Dumont, Nicolas A.; Rudnicki, Michael A.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, Martinsried, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Carnegie Institution for Science; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Max Planck Society	Feige, JN; Bentzinger, CF (corresponding author), Ecole Polytech Fed Lausanne, NIHS, Campus Ecole Polytech Fed Lausanne,Innovat Pk, Lausanne, Switzerland.	jerome.feige@rd.nestle.com; florian.bentzinger@rd.nestle.com	Li, Liangji/AAM-7800-2021; Bentzinger, C. Florian/A-1151-2015; von Maltzahn, Julia/AFP-2284-2022; von Maltzahn, Julia/A-6689-2017	Bentzinger, C. Florian/0000-0003-0422-9622; von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Jacot, Guillaume/0000-0001-5821-2717; Wilson, David/0000-0001-8322-0380; Li, Liangji/0000-0002-6635-4800; Raymond, Frederic/0000-0002-6148-6898; Lee, Umji/0000-0003-0758-0979	German Research Foundation (DFG) [MA-3975/2-1]; Government of the Ontario Ministry of Research and Innovation (MRI) [ORF-RE05-084]; National Institutes of Health [HD075345, AR060042]; Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD075345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Government of the Ontario Ministry of Research and Innovation (MRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Ritchie for help with mouse husbandry. We are grateful to the NIHS community for fruitful discussions and support, in particular to the Aging and Stem Cells groups, and to E. Rolland and E. Baetge. We thank C. Poser for excellent technical assistance. ROSA26-CreER<SUP>T2</SUP> mice were provided by F. Stewart (Technische Universitat Dresden, Germany) as a kind gift to M.A.R. J.V.M. and M.J.J. were supported by a grant from the German Research Foundation (DFG) (grant MA-3975/2-1). M.A.R. holds the Canada Research Chair in Molecular Genetics and is supported by a grant from the Government of the Ontario Ministry of Research and Innovation (MRI) (grant ORF-RE05-084). M.R. and C.M.F. are supported by the National Institutes of Health grants (grants HD075345 and AR060042). C.F.B. is supported by the Fondation Suisse de Recherche sur les Maladies Musculaires (FSRMM).	Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Brafman DA, 2009, INTEGR BIOL, V1, P513, DOI 10.1039/b912926j; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; D'Souza DM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12506; Fujimaki S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/592915; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lukjanenko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071084; Lv HW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0083-4; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Muller M, 2011, INT ORTHOP, V35, P165, DOI 10.1007/s00264-010-1166-6; Plath T, 2000, J CELL BIOL, V150, P1467, DOI 10.1083/jcb.150.6.1467; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rozo M., 2016, NAT MED; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sousa-Victor P, 2015, TRENDS ENDOCRIN MET, V26, P287, DOI 10.1016/j.tem.2015.03.006; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tierney MT, 2016, CELL REP, V14, P1940, DOI 10.1016/j.celrep.2016.01.072; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; WATTERS JM, 1993, ANN SURG, V218, P380, DOI 10.1097/00000658-199309000-00017	46	141	142	5	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					897	+		10.1038/nm.4126	http://dx.doi.org/10.1038/nm.4126			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376579	Green Accepted			2022-12-27	WOS:000381000200015
J	Wirnsberger, G; Zwolanek, F; Asaoka, T; Kozieradzki, I; Tortola, L; Wimmer, RA; Kavirayani, A; Fresser, F; Baier, G; Langdon, WY; Ikeda, F; Kuchler, K; Penninger, JM				Wirnsberger, Gerald; Zwolanek, Florian; Asaoka, Tomoko; Kozieradzki, Ivona; Tortola, Luigi; Wimmer, Reiner A.; Kavirayani, Anoop; Fresser, Friedrich; Baier, Gottfried; Langdon, Wallace Y.; Ikeda, Fumiyo; Kuchler, Karl; Penninger, Josef M.			Inhibition of CBLB protects from lethal Candida albicans sepsis	NATURE MEDICINE			English	Article							C-TYPE LECTIN; CHRONIC MUCOCUTANEOUS CANDIDIASIS; INNATE IMMUNE-RESPONSE; CELL ANTIGEN RECEPTOR; SYK TYROSINE 317; HOST-DEFENSE; FUNGAL-INFECTIONS; GENETIC SUSCEPTIBILITY; ASPERGILLUS-FUMIGATUS; NEGATIVE REGULATION	Fungal infections claim an estimated 1.5 million lives each year. Mechanisms that protect from fungal infections are still elusive. Recognition of fungal pathogens relies on C-type lectin receptors (CLRs) and their downstream signaling kinase SYK. Here we report that the E3 ubiquitin ligase CBLB controls proximal CLR signaling in macrophages and dendritic cells. We show that CBLB associates with SYK and ubiquitinates SYK, dectin-1, and dectin-2 after fungal recognition. Functionally, CBLB deficiency results in increased inflammasome activation, enhanced reactive oxygen species production, and increased fungal killing. Genetic deletion of Cblb protects mice from morbidity caused by cutaneous infection and markedly improves survival after a lethal systemic infection with Candida albicans. On the basis of these findings, we engineered a cell-permeable CBLB inhibitory peptide that protects mice from lethal C. albicans infections. We thus describe a key role for Cblb in the regulation of innate antifungal immunity and establish a novel paradigm for the treatment of fungal sepsis.	[Wirnsberger, Gerald; Asaoka, Tomoko; Kozieradzki, Ivona; Tortola, Luigi; Wimmer, Reiner A.; Ikeda, Fumiyo; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Zwolanek, Florian; Kuchler, Karl] Med Univ Vienna, MFPL, Dept Med Biochem, Vienna, Austria; [Kavirayani, Anoop] VBCF, Vienna, Austria; [Fresser, Friedrich; Baier, Gottfried] Med Univ Innsbruck, Div Translat Cell Genet, Dept Pharmacol & Genet, Innsbruck, Austria; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA, Australia	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Innsbruck; University of Western Australia	Penninger, JM (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria.; Kuchler, K (corresponding author), Med Univ Vienna, MFPL, Dept Med Biochem, Vienna, Austria.	karl.kuchler@meduniwien.ac.at; josef.penninger@imba.oeaw.ac.at	Ikeda, Fumiyo/AAD-3770-2020; kuchler, karl/AAL-6937-2020; Penninger, Josef M/I-6860-2013	Ikeda, Fumiyo/0000-0003-0407-2768; kuchler, karl/0000-0003-2719-5955; Penninger, Josef M/0000-0002-8194-3777; Tortola, Luigi/0000-0002-8480-2080; Baier, Gottfried/0000-0002-2085-8325; Asaoka, Tomoko/0000-0001-5141-2353; Kavirayani, Anoop/0000-0003-3874-3101	consolidator ERC grant; EC FP7 project 'FUNGITECT'; FWF project [P-25333]; Marie-Curie Innovative Training Networks' ImResFun grant [MC-ITN-606786]; Advanced ERC grant; Era of Hope/Innovator Award; Helmsley foundation VEO-IBD network grant; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	consolidator ERC grant; EC FP7 project 'FUNGITECT'; FWF project(Austrian Science Fund (FWF)); Marie-Curie Innovative Training Networks' ImResFun grant; Advanced ERC grant; Era of Hope/Innovator Award; Helmsley foundation VEO-IBD network grant; Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank all members of the Penninger laboratory for helpful discussions and technical support. We thank all members of the IMP-IMBA Biooptics service facility, especially G. Schmauss and T. Lendl, for assistance in cell sorting and image quantification. We also thank A. Piszczek and M. Zeba from the Vienna Biocenter Core Facilities (VBCF) for excellent histopathology services, and K. Mechtler, R. Imre, and M. Madalinski from the Protein Biochemistry facility for providing excellent mass spectrometry and peptide synthesis services. This work was supported by a consolidator ERC grant (F.I.), the EC FP7 project 'FUNGITECT' (K.K.), the FWF project P-25333 (K.K.), a Marie-Curie Innovative Training Networks' ImResFun grant (contract MC-ITN-606786; K.K.), an Advanced ERC grant (J.M.P.), an 'Era of Hope/Innovator Award' (J.M.P.), a Helmsley foundation VEO-IBD network grant (J.M.P.), and the Austrian Academy of Sciences (J.M.P.).	Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bergholdt R, 2005, J LEUKOCYTE BIOL, V77, P579, DOI 10.1189/jlb.0904524; Bourgeois Christelle, 2009, V470, P125, DOI 10.1007/978-1-59745-204-5_11; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kosoy R, 2004, GENES IMMUN, V5, P232, DOI 10.1038/sj.gene.6364057; Lanternier F, 2013, CURR OPIN PEDIATR, V25, P736, DOI 10.1097/MOP.0000000000000031; Loeser S, 2007, CELL CYCLE, V6, P2478, DOI 10.4161/cc.6.20.4797; Marr KA, 2003, INFECT IMMUN, V71, P5280, DOI 10.1128/IAI.71.9.5280-5286.2003; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Plantinga TS, 2012, MED MYCOL, V50, P785, DOI 10.3109/13693786.2012.690902; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; QIAN QF, 1994, J IMMUNOL, V152, P5000; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Ravikumar S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01322; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Smeekens SP, 2013, EMBO MOL MED, V5, P805, DOI 10.1002/emmm.201201678; Smeekens SP, 2011, EUR J IMMUNOL, V41, P2915, DOI 10.1002/eji.201141418; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Stevens DA, 2012, CLIN DERMATOL, V30, P657, DOI 10.1016/j.clindermatol.2011.09.018; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van der Graaf CAA, 2003, NETH J MED, V61, P365; Wallner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065178; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Whibley N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004456; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 2004, J IMMUNOL, V173, P1811, DOI 10.4049/jimmunol.173.3.1811; Zheng J, 2015, EUR J IMMUNOL, V45, P2834, DOI 10.1002/eji.201445344; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017; Zou W, 2009, J BIOL CHEM, V284, P18833, DOI 10.1074/jbc.M109.012385; Zwolanek F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004525	56	69	72	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					915	+		10.1038/nm.4134	http://dx.doi.org/10.1038/nm.4134			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27428901	Green Accepted			2022-12-27	WOS:000381000200017
J	Xiao, Y; Tang, J; Guo, H; Zhao, YX; Tang, R; Ouyang, S; Zeng, QM; Rappleye, CA; Rajaram, MVS; Schlesinger, LS; Tao, LJ; Brown, GD; Langdon, WY; Li, BT; Zhang, J				Xiao, Yun; Tang, Juan; Guo, Hui; Zhao, Yixia; Tang, Rong; Ouyang, Song; Zeng, Qiuming; Rappleye, Chad A.; Rajaram, Murugesan V. S.; Schlesinger, Larry S.; Tao, Lijian; Brown, Gordon D.; Langdon, Wallace Y.; Li, Belinda T.; Zhang, Jian			Targeting CBLB as a potential therapeutic approach for disseminated candidiasis	NATURE MEDICINE			English	Article							C-TYPE LECTIN; PATTERN-RECOGNITION RECEPTOR; CELL-ACTIVATION THRESHOLD; HOST-DEFENSE; ASPERGILLUS-FUMIGATUS; TYROSINE KINASE; CUTTING EDGE; FC-RECEPTOR; DECTIN-1; INDUCTION	Disseminated candidiasis has become one of the leading causes of hospital-acquired blood stream infections with high mobility and mortality. However, the molecular basis of host defense against disseminated candidiasis remains elusive, and treatment options are limited. Here we report that the E3 ubiquitin ligase CBLB directs polyubiquitination of dectin-1 and dectin-2, two key pattern-recognition receptors for sensing Candida albicans, and their downstream kinase SYK, thus inhibiting dectin-1-and dectin-2-mediated innate immune responses. CBLB deficiency or inactivation protects mice from systemic infection with a lethal dose of C. albicans, and deficiency of dectin-1, dectin-2, or both in Cblb(-/-) mice abrogates this protection. Notably, silencing the Cblb gene in vivo protects mice from lethal systemic C. albicans infection. Our data reveal that CBLB is crucial for homeostatic control of innate immune responses mediated by dectin-1 and dectin-2. Our data also indicate that CBLB represents a potential therapeutic target for protection from disseminated candidiasis.	[Xiao, Yun; Tang, Juan; Guo, Hui; Zhao, Yixia; Tang, Rong; Ouyang, Song; Zeng, Qiuming; Rappleye, Chad A.; Rajaram, Murugesan V. S.; Schlesinger, Larry S.; Li, Belinda T.; Zhang, Jian] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Xiao, Yun; Tang, Juan; Tang, Rong; Tao, Lijian] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Xiao, Yun] Guangzhou Med Univ, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhao, Yixia] Cent S Univ, Xiangya Hosp, Dept Cardiol, Changsha, Hunan, Peoples R China; [Ouyang, Song; Zeng, Qiuming] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Ouyang, Song] Univ South China, Hosp Changsha 1, Dept Neurol, Changsha, Hunan, Peoples R China; [Rappleye, Chad A.] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, MRC Ctr Med Mycol, Aberdeen Fungal Grp, Aberdeen, Scotland; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia	University System of Ohio; Ohio State University; Central South University; Guangzhou Medical University; Central South University; Central South University; University of South China; University System of Ohio; Ohio State University; University of Aberdeen; University of Western Australia	Zhang, J (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	jian.zhang@osumc.edu	TAO, Li/HIR-4254-2022; Rajaram, Murugesan/E-5203-2013	Rappleye, Chad/0000-0001-7880-5958; Zhang, Jian/0000-0002-9523-5296; Rajaram, Murugesan/0000-0002-1515-1122	US National Institutes of Health [R01 AI090901, R01 AI123253, R21 AI117547]; American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant) [16GRNT26990004]; Ohio State University College of Medicine; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117547, R01AI090901, R01AI123253] Funding Source: NIH RePORTER; Medical Research Council [MR/N006364/1] Funding Source: researchfish; MRC [MR/N006364/1] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant); Ohio State University College of Medicine(Ohio State University); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J.M. Penninger (University of Toronto) for providing Cblb<SUP>-/-</SUP> mice, Y. Iwakura (Tokyo University of Science) for providing Clec4n<SUP>-/-</SUP> mice, S. Lipkowitz (National Cancer Institute, US National Institutes of Health) for providing Cblb constructs, X. Lin (MD Anderson Cancer Center) for providing the antibody to mouse dectin-3 and Card9<SUP>-/-</SUP> bone marrow cells, P.R. Sundstrom (Dartmouth University) for providing the C. albicans cap1 mutant, and L.D. Chaves (University at Buffalo) for flow cytometric analysis of myeloid cells in the kidneys. We also thank A. Lovett-Racke (Ohio State University) for her advice on in vivo Cblb-knockdown experiments. This work was supported by the US National Institutes of Health (grants R01 AI090901, R01 AI123253, and R21 AI117547; all to J.Z.), the American Heart Association (AHA Great Rivers Associate Grant-in-Aid grant 16GRNT26990004; J.Z.), a start-up fund from the Ohio State University College of Medicine (J.Z.), and the Wellcome Trust (G.D.B.).	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bahn YS, 2001, J BACTERIOL, V183, P3211, DOI 10.1128/JB.183.10.3211-3223.2001; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guo H, 2012, CELL REPORTS, V1, P472, DOI 10.1016/j.celrep.2012.04.008; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Li DD, 2004, J IMMUNOL, V173, P7135, DOI 10.4049/jimmunol.173.12.7135; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Liu QJ, 2014, CELL CYCLE, V13, P1875, DOI 10.4161/cc.29213; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Nicola AM, 2008, CURR OPIN MICROBIOL, V11, P313, DOI 10.1016/j.mib.2008.05.011; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Qiao GL, 2008, MOL CELL BIOL, V28, P2470, DOI 10.1128/MCB.01505-07; Qiao GL, 2014, CELL REP, V6, P709, DOI 10.1016/j.celrep.2014.01.012; Qiao GL, 2013, J IMMUNOL, V191, P632, DOI 10.4049/jimmunol.1202068; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Smeekens SP, 2015, CYTOKINE, V71, P215, DOI 10.1016/j.cyto.2014.10.013; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	49	59	60	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					906	+		10.1038/nm.4141	http://dx.doi.org/10.1038/nm.4141			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27428899	Green Accepted, Green Submitted			2022-12-27	WOS:000381000200016
J	Pao, W; Fodor, I				Pao, William; Fodor, Imola			Catalyzing the field of precision oncology, one basket at a time	NATURE MEDICINE			English	Editorial Material								A bedside strategy to overcome the limitations of testing in preclinical models and to determine the role of gene mutations and their targetability directly in patients is presented.	[Pao, William] F Hoffmann La Roche & Cie AG, Roche Innovat Ctr Basel, Basel, Switzerland; [Fodor, Imola] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Roche Holding; Genentech	Pao, W (corresponding author), F Hoffmann La Roche & Cie AG, Roche Innovat Ctr Basel, Basel, Switzerland.	william.pao@roche.com						Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Hainsworth JD, 2018, J CLIN ONCOL, V36, P536, DOI 10.1200/JCO.2017.75.3780; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062	5	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					387	388		10.1038/nm.4530	http://dx.doi.org/10.1038/nm.4530			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634693				2022-12-27	WOS:000429639800007
J	Morrow, JJ; Bayles, I; Funnell, APW; Miller, TE; Saiakhova, A; Lizardo, MM; Bartels, CF; Kapteijn, MY; Hung, S; Mendoza, A; Dhillon, G; Chee, DR; Myers, JT; Allen, F; Gambarotti, M; Righi, A; Difeo, A; Rubin, BP; Huang, AY; Meltzer, PS; Helman, LJ; Picci, P; Versteeg, HH; Stamatoyannopoulos, JA; Khanna, C; Scacheri, PC				Morrow, James J.; Bayles, Ian; Funnell, Alister P. W.; Miller, Tyler E.; Saiakhova, Alina; Lizardo, Michael M.; Bartels, Cynthia F.; Kapteijn, Maaike Y.; Hung, Stevephen; Mendoza, Arnulfo; Dhillon, Gursimran; Chee, Daniel R.; Myers, Jay T.; Allen, Frederick; Gambarotti, Marco; Righi, Alberto; Difeo, Analisa; Rubin, Brian P.; Huang, Alex Y.; Meltzer, Paul S.; Helman, Lee J.; Picci, Piero; Versteeg, Henri H.; Stamatoyannopoulos, John A.; Khanna, Chand; Scacheri, Peter C.			Positively selected enhancer elements endow osteosarcoma cells with metastatic competence	NATURE MEDICINE			English	Article							BREAST-CANCER METASTASIS; FUNCTIONAL INTERPRETATION; DISTANT METASTASIS; SUPER-ENHANCERS; GROWTH-HORMONE; TISSUE FACTOR; INHIBITION; PROGRESSION; EVOLUTION; INSIGHTS	Metastasis results from a complex set of traits acquired by tumor cells, distinct from those necessary for tumorigenesis. Here, we investigate the contribution of enhancer elements to the metastatic phenotype of osteosarcoma. Through epigenomic profiling, we identify substantial differences in enhancer activity between primary and metastatic human tumors and between near isogenic pairs of highly lung metastatic and nonmetastatic osteosarcoma cell lines. We term these regions metastatic variant enhancer loci (Met-VELs). Met-VELs drive coordinated waves of gene expression during metastatic colonization of the lung. Met-VELs cluster nonrandomly in the genome, indicating that activity of these enhancers and expression of their associated gene targets are positively selected. As evidence of this causal association, osteosarcoma lung metastasis is inhibited by global interruptions of Met-VEL-associated gene expression via pharmacologic BET inhibition, by knockdown of AP-1 transcription factors that occupy Met-VELs, and by knockdown or functional inhibition of individual genes activated by Met-VELs, such as that encoding coagulation factor III/tissue factor (F3). We further show that genetic deletion of a single Met-VEL at the F3 locus blocks metastatic cell outgrowth in the lung. These findings indicate that Met-VELs and the genes they regulate play a functional role in metastasis and may be suitable targets for antimetastatic therapies.	[Morrow, James J.; Miller, Tyler E.; Allen, Frederick; Huang, Alex Y.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Morrow, James J.; Bayles, Ian; Saiakhova, Alina; Bartels, Cynthia F.; Hung, Stevephen; Dhillon, Gursimran; Scacheri, Peter C.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Funnell, Alister P. W.; Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA USA; [Lizardo, Michael M.; Mendoza, Arnulfo; Helman, Lee J.; Khanna, Chand] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kapteijn, Maaike Y.; Versteeg, Henri H.] Leiden Univ, Thrombosis & Hemostasis Div, Dept Internal Med, Med Ctr, Leiden, Netherlands; [Chee, Daniel R.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Myers, Jay T.; Huang, Alex Y.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Gambarotti, Marco; Righi, Alberto; Picci, Piero; Scacheri, Peter C.] Ist Ortoped Rizzoli, Expt Oncol Lab, Bologna, Italy; [Difeo, Analisa] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, Dept Anat Pathol, Cleveland, OH 44106 USA; [Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA; [Rubin, Brian P.] Taussig Canc Ctr, Cleveland, OH USA; [Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Khanna, Chand] Ethos Discovery, Washington, DC USA; [Khanna, Chand] Ethos Vet Hlth, Woburn, MA USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Washington; University of Washington Seattle; Case Western Reserve University; IRCCS Istituto Ortopedico Rizzoli; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scacheri, PC (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Scacheri, PC (corresponding author), Ist Ortoped Rizzoli, Expt Oncol Lab, Bologna, Italy.	peter.scacheri@case.edu	Gambarotti, Marco/C-6878-2019; Righi, Alberto/J-6028-2016; Versteeg, Henri/G-1783-2018; Huang, Alex Y./ABG-8182-2021	Gambarotti, Marco/0000-0002-8080-4484; Righi, Alberto/0000-0002-1074-0155; Versteeg, Henri/0000-0003-4294-175X; Huang, Alex Y./0000-0002-5701-4521; Miller, Tyler E/0000-0002-1269-1895; DiFeo, Analisa/0000-0001-8319-6763	Case Western Reserve University School of Medicine's Genetics and Genome Sciences Department; Case Comprehensive Cancer Center [P30CA043703]; Liddy Shriver Sarcoma Initiative; QuadW Foundation; Sarcoma Foundation of America; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation; Hyundai Hope-on-Wheels Program; Pediatric Cancer Research Foundation; CCCC AYA Oncology Pilot Grant; National Institutes of Health (NIH) [F30 CA186633, F30 CA183510, T32 GM007250, R01CA193677, R01CA204279, R01CA160356, F31CA192874, R21CA218790]; NIH [15335]; NIH Intramural Research Program; NATIONAL CANCER INSTITUTE [R01CA204279, F31CA213965, R01CA160356, ZIABC010759, ZIABC011328, P30CA043703, R21CA218790, F30CA186633, R01CA193677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Case Western Reserve University School of Medicine's Genetics and Genome Sciences Department; Case Comprehensive Cancer Center; Liddy Shriver Sarcoma Initiative; QuadW Foundation; Sarcoma Foundation of America; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation; Hyundai Hope-on-Wheels Program; Pediatric Cancer Research Foundation; CCCC AYA Oncology Pilot Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the members of the Tesar, Kaplan, and Helman laboratories for their input throughout the course of the project as well as B. Decker for his input on the manuscript text. Additional support was provided by the Genomics Core Facility of the Case Western Reserve University School of Medicine's Genetics and Genome Sciences Department and the Case Comprehensive Cancer Center (P30CA043703). This work was supported by the Liddy Shriver Sarcoma Initiative (P.C.S., C.K., J.J.M.), the QuadW Foundation (P.C.S.), Sarcoma Foundation of America (P.C.S.), St. Baldrick's Foundation (A.Y.H.), Alex's Lemonade Stand Foundation (A.Y.H.), Hyundai Hope-on-Wheels Program (A.Y.H.), Pediatric Cancer Research Foundation (A.Y.H.), CCCC AYA Oncology Pilot Grant (A.Y.H.), National Institutes of Health (NIH) grants F30 CA186633 (J.J.M.), F30 CA183510 (T.E.M.), T32 GM007250 (J.J.M., T.E.M., S.H.), R01CA193677 (P.C.S.), R01CA204279 (P.C.S.), R01CA160356 (P.C.S.), F31CA192874 (F.A.), R21CA218790 (A.Y.H.), NIH Intramural Visiting Fellow Program 15335 (M.M.L.), and NIH Intramural Research Program (C.K.).	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Cohen AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14400; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Huang YM, 2009, CLIN MED INSIGHTS-ON, V3, P99; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; KERBEL RS, 1984, J CELL PHYSIOL, P87; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Lamoureux F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4511; Latil M, 2017, CELL STEM CELL, V20, P191, DOI 10.1016/j.stem.2016.10.018; Leaner VD, 2009, AM J PATHOL, V174, P265, DOI 10.2353/ajpath.2009.071006; Li N, 2015, ONCOGENE, V34, P1499, DOI 10.1038/onc.2014.94; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moelans CB, 2014, CANCER LETT, V344, P138, DOI 10.1016/j.canlet.2013.10.025; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Osborne TS, 2011, J PEDIAT HEMATOL ONC, V33, P524, DOI 10.1097/MPH.0b013e318223d0c1; PINSKI J, 1995, J NATL CANCER I, V87, P1787, DOI 10.1093/jnci/87.23.1787; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ren L, 2015, ONCOTARGET, V6, P29469, DOI 10.18632/oncotarget.5177; Rodenhiser DI, 2009, CLIN EXP METASTAS, V26, P5, DOI 10.1007/s10585-008-9166-2; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Song L., 2010, COLD SPRING HARB PRO; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	64	77	77	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					176	+		10.1038/nm.4475	http://dx.doi.org/10.1038/nm.4475			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29334376	Green Accepted, Green Submitted			2022-12-27	WOS:000424327200014
J	Hosen, N; Matsunaga, Y; Hasegawa, K; Matsuno, H; Nakamura, Y; Makita, M; Watanabe, K; Yoshida, M; Satoh, K; Morimoto, S; Fujiki, F; Nakajima, H; Nakata, J; Nishida, S; Tsuboi, A; Oka, Y; Manabe, M; Ichihara, H; Aoyama, Y; Mugitani, A; Nakao, T; Hino, M; Uchibori, R; Ozawa, K; Baba, Y; Terakura, S; Wada, N; Morii, E; Nishimura, J; Takeda, K; Oji, Y; Sugiyama, H; Takagi, J; Kumanogoh, A				Hosen, Naoki; Matsunaga, Yukiko; Hasegawa, Kana; Matsuno, Hiroshi; Nakamura, Yuki; Makita, Mio; Watanabe, Kouki; Yoshida, Mikako; Satoh, Kei; Morimoto, Soyoko; Fujiki, Fumihiro; Nakajima, Hiroko; Nakata, Jun; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Manabe, Masahiro; Ichihara, Hiroyoshi; Aoyama, Yasutaka; Mugitani, Atsuko; Nakao, Takafumi; Hino, Masayuki; Uchibori, Ryosuke; Ozawa, Keiya; Baba, Yoshihiro; Terakura, Seitaro; Wada, Naoki; Morii, Eiichi; Nishimura, Junichi; Takeda, Kiyoshi; Oji, Yusuke; Sugiyama, Haruo; Takagi, Junichi; Kumanogoh, Atsushi			The activated conformation of integrin beta(7) is a novel multiple myeloma-specific target for CAR T cell therapy	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; MATURATION ANTIGEN; ANTIBODY THERAPY; CANCER; EPITOPE; IDENTIFICATION; EXPRESSION; MADCAM-1; ADHESION; EGFR	Cancer-specific cell-surface antigens are ideal targets for monoclonal antibody (mAb)-based immunotherapy but are likely to have previously been identified in transcriptome or proteome analyses. Here, we show that the active conformer of an integrin can serve as a specific therapeutic target for multiple myeloma (MM). We screened >10,000 anti-MM mAb clones and identified MMG49 as an MM-specific mAb specifically recognizing a subset of integrin beta(7) molecules. The MMG49 epitope, in the N-terminal region of the beta(7) chain, is predicted to be inaccessible in the resting integrin conformer but exposed in the active conformation. Elevated expression and constitutive activation of integrin beta(7) conferred high MMG49 reactivity on MM cells, whereas MMG49 binding was scarcely detectable in other cell types including normal integrin beta(+)(7) lymphocytes. T cells transduced with MMG49-derived chimeric antigen receptor (CAR) exerted anti-MM effects without damaging normal hematopoietic cells. Thus, MMG49 CAR T cell therapy is promising for MM, and a receptor protein with a rare but physiologically relevant conformation can serve as a cancer immunotherapy target.	[Hosen, Naoki; Hasegawa, Kana; Nakamura, Yuki; Makita, Mio; Watanabe, Kouki; Yoshida, Mikako; Satoh, Kei; Oka, Yoshihiro] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan; [Nishida, Sumiyuki; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka, Japan; [Hosen, Naoki; Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Matsunaga, Yukiko; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Osaka, Japan; [Matsuno, Hiroshi; Nishimura, Junichi] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan; [Morimoto, Soyoko; Nakata, Jun; Tsuboi, Akihiro] Osaka Univ, Grad Sch Med, Dept Canc Immunotherapy, Osaka, Japan; [Fujiki, Fumihiro; Nakajima, Hiroko; Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Osaka, Japan; [Manabe, Masahiro] West Japan Railway Co, Osaka Gen Hosp, Dept Hematol, Osaka, Japan; [Ichihara, Hiroyoshi; Aoyama, Yasutaka; Mugitani, Atsuko] Fuchu Hosp, Dept Hematol, Osaka, Japan; [Nakao, Takafumi] Osaka City Gen Hosp, Dept Hematol, Osaka, Japan; [Hino, Masayuki] Osaka City Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan; [Uchibori, Ryosuke; Ozawa, Keiya] Jichi Med Univ, Div Immunogene & Cell Therapy Takara Bio, Shimotsuke, Tochigi, Japan; [Ozawa, Keiya] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Baba, Yoshihiro] Kyushu Univ, Med Inst Bioregulat, Div Immunol & Genome Biol, Fukuoka, Japan; [Terakura, Seitaro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Wada, Naoki; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka, Japan; [Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Osaka, Japan; [Takeda, Kiyoshi; Kumanogoh, Atsushi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Tokyo, Japan; [Oji, Yusuke] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan; [Matsunaga, Yukiko] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka City General Hospital; Osaka Metropolitan University; Jichi Medical University; University of Tokyo; Kyushu University; Nagoya University; Osaka University; Osaka University; Osaka University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Hosen, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Osaka, Japan.; Hosen, N (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan.	hnaoki@imed3.med.osaka-u.ac.jp	Terakura, Seitaro/A-6188-2011	Takeda, Kiyoshi/0000-0002-1778-6332; Matsunaga, Yukiko/0000-0002-1392-5681; Nakata, Jun/0000-0002-7494-1204	Ministry of Education, Culture, Sports, Science and Technology of Japan; Project for Development of Innovative Research on Cancer Therapeutics and Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development AMED; JSPS KAKENHI [JP26461404]; Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology grant [15652237]; Grants-in-Aid for Scientific Research [17H01420] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics and Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology grant(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Kinki Cord Blood Bank for CB samples and T. Yamane (Osaka City General Hospital) and K. Koh (Osaka General Hospital for West Japan Railway Company) for MM samples. We also thank K. Terasaki, S. Ikeda, Y. Hayami, R. Inada, R. Urakawa, S. Hashiguchi, M. Iwai, and A. Kosugi for technical assistance, and Y. Kanakura (Osaka University), R. Burger (University of Kiel), I. Weissman (Stanford University), T. Kitamura (Tokyo University), and the NIH AIDS Reagents program for providing materials. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (Analysis and Synthesis of Multidimensional Immune Organ Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to J.T.); the Project for Development of Innovative Research on Cancer Therapeutics and Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development AMED (to N.H.); JSPS KAKENHI grant JP26461404 (to N.H.); and Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology grant 15652237 (to A.K.).	Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; BERGSAGEL PL, 1995, BLOOD, V85, P436, DOI 10.1182/blood.V85.2.436.bloodjournal852436; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Carpenter RO, 2013, CLIN CANCER RES, V19, P2048, DOI 10.1158/1078-0432.CCR-12-2422; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; Chu JH, 2014, CLIN CANCER RES, V20, P3989, DOI 10.1158/1078-0432.CCR-13-2510; Coffman KT, 2003, CANCER RES, V63, P7907; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dimopoulos MA, 2015, NAT REV CLIN ONCOL, V12, P42, DOI 10.1038/nrclinonc.2014.200; ERLE DJ, 1994, J IMMUNOL, V153, P517; Gan HK, 2012, CANCER RES, V72, P2924, DOI 10.1158/0008-5472.CAN-11-3898; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Hosen N, 2012, BRIT J HAEMATOL, V156, P213, DOI 10.1111/j.1365-2141.2011.08941.x; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Johnsen HE, 2016, HAEMATOLOGICA, V101, P1451, DOI 10.3324/haematol.2015.138826; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P639, DOI 10.1073/pnas.232686499; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu XJ, 2015, CANCER RES, V75, P3596, DOI 10.1158/0008-5472.CAN-15-0159; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Neri P, 2011, BLOOD, V117, P6202, DOI 10.1182/blood-2010-06-292243; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Qi JP, 2012, J BIOL CHEM, V287, P15749, DOI 10.1074/jbc.M112.341263; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Terakura S, 2012, BLOOD, V119, P72, DOI 10.1182/blood-2011-07-366419; Tidswell M, 1997, J IMMUNOL, V159, P1497; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0	50	75	82	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1436	+		10.1038/nm.4431	http://dx.doi.org/10.1038/nm.4431			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29106400				2022-12-27	WOS:000417278200013
J	Zhang, DF; Chia, C; Jiao, X; Jin, WW; Kasagi, S; Wu, RQ; Konkel, JE; Nakatsukasa, H; Zanvit, P; Goldberg, N; Chen, QM; Sun, LY; Chen, ZJ; Chen, WJ				Zhang, Dunfang; Chia, Cheryl; Jiao, Xue; Jin, Wenwen; Kasagi, Shimpei; Wu, Ruiqing; Konkel, Joanne E.; Nakatsukasa, Hiroko; Zanvit, Peter; Goldberg, Nathan; Chen, Qianming; Sun, Lingyun; Chen, Zi-Jiang; Chen, WanJun			D-mannose induces regulatory T cells and suppresses immunopathology	NATURE MEDICINE			English	Article							TGF-BETA ACTIVATION; ESCHERICHIA-COLI; SMAD3; GENERATION; INDUCTION; COOPERATE; APOPTOSIS; PATHWAYS; GLUCOSE; WOMEN	D-mannose, a C-2 epimer of glucose, exists naturally in many plants and fruits, and is found in human blood at concentrations less than one-fiftieth of that of glucose. However, although the roles of glucose in T cell metabolism, diabetes and obesity are well characterized, the function of D-mannose in T cell immune responses remains unknown. Here we show that supraphysiological levels of D-mannose safely achievable by drinking-water supplementation suppressed immunopathology in mouse models of autoimmune diabetes and airway inflammation, and increased the proportion of Foxp3(+) regulatory T cells (T-reg cells) in mice. In vitro, D-mannose stimulated T-reg cell differentiation in human and mouse cells by promoting TGF-beta activation, which in turn was mediated by upregulation of integrin alpha(v)beta(8) and reactive oxygen species generated by increased fatty acid oxidation. This previously unrecognized immunoregulatory function of D-mannose may have clinical applications for immunopathology.	[Zhang, Dunfang; Chia, Cheryl; Jiao, Xue; Jin, Wenwen; Kasagi, Shimpei; Wu, Ruiqing; Konkel, Joanne E.; Nakatsukasa, Hiroko; Zanvit, Peter; Goldberg, Nathan; Chen, WanJun] NIDCR, Mucosal Immunol Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Zhang, Dunfang; Wu, Ruiqing; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Jiao, Xue; Chen, Zi-Jiang] Shandong Univ, Ctr Reprod Med, Jinan, Shandong, Peoples R China; [Sun, Lingyun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Nanjing, Jiangsu, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Sichuan University; Shandong University; Nanjing University	Chen, WJ (corresponding author), NIDCR, Mucosal Immunol Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA.	wchen@mail.nih.gov	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022; Li, Yuan/GXV-1310-2022	JIAO, XUE/0000-0002-2936-2166; Zhang, Dunfang/0000-0001-7545-9930; Chen, Zi-Jiang/0000-0001-6637-6631	Intramural Research Program of the NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of the NIH, NIDCR. We thank E. Shevach (NIAID, NIH, Bethesda, Maryland, USA) for providing the Itgb8<SUP>f/f</SUP>CD4-Cre mice, and C. Benoist and D. Mathis (Harvard Medical School, Boston, Massachusetts, USA) for providing the NOD-Foxp3<SUP>DTR</SUP> mice. We also thank the NIDCR flow cytometry core for support.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Alton G, 1998, GLYCOBIOLOGY, V8, P285, DOI 10.1093/glycob/8.3.285; Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen WJ, 2015, EUR J IMMUNOL, V45, P958, DOI 10.1002/eji.201444999; Chen Wanjun, 2002, Curr Dir Autoimmun, V5, P62; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Davis JA, 2001, BBA-GEN SUBJECTS, V1528, P116, DOI 10.1016/S0304-4165(01)00183-0; de Lonlay P, 2009, BBA-MOL BASIS DIS, V1792, P841, DOI 10.1016/j.bbadis.2008.11.012; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Edwards JP, 2014, J IMMUNOL, V193, P2843, DOI 10.4049/jimmunol.1401102; Etchison JR, 1997, CLIN CHEM, V43, P533; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Konkel JE, 2014, P NATL ACAD SCI USA, V111, pE465, DOI 10.1073/pnas.1320319111; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Kranjcec B, 2014, WORLD J UROL, V32, P79, DOI 10.1007/s00345-013-1091-6; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Massague J, 2000, GENE DEV, V14, P627; Mayatepek E, 1997, ACTA PAEDIATR, V86, P1138, DOI 10.1111/j.1651-2227.1997.tb14825.x; MICHAELS EK, 1983, UROL RES, V11, P97; Nakatsukasa H, 2015, NAT IMMUNOL, V16, P1077, DOI 10.1038/ni.3252; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rosca MG, 2012, DIABETES, V61, P2074, DOI 10.2337/db11-1437; SCHAEFFER AJ, 1984, J UROLOGY, V131, P906, DOI 10.1016/S0022-5347(17)50706-5; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takaoka A, 2001, J IMMUNOL, V167, P2349, DOI 10.4049/jimmunol.167.4.2349; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	55	100	118	9	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1036	+		10.1038/nm.4375	http://dx.doi.org/10.1038/nm.4375			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28759052	Green Submitted			2022-12-27	WOS:000409996200010
J	Herold, N; Rudd, SG; Ljungblad, L; Sanjiv, K; Myrberg, IH; Paulin, CBJ; Heshmati, Y; Hagenkort, A; Kutzner, J; Paget, BDG; Calderon-Montano, JM; Loseva, O; Jemth, AS; Bulli, L; Axelsson, H; Tesi, B; Valerie, NCK; Hoglund, A; Bladh, J; Wiita, E; Sundin, M; Uhlin, M; Rassidakis, G; Heyman, M; Tamm, KP; Warpman-Berglund, U; Walfridsson, J; Lehmann, S; Grander, D; Lundback, T; Kogner, P; Henter, JI; Helleday, T; Schaller, T				Herold, Nikolas; Rudd, Sean G.; Ljungblad, Linda; Sanjiv, Kumar; Myrberg, Ida Hed; Paulin, Cynthia B. J.; Heshmati, Yaser; Hagenkort, Anna; Kutzner, Juliane; Paget, Brent D. G.; Calderon-Montano, Jose M.; Loseva, Olga; Jemth, Ann-Sofie; Bulli, Lorenzo; Axelsson, Hanna; Tesi, Bianca; Valerie, Nicholas C. K.; Hoglund, Andreas; Bladh, Julia; Wiita, Elisee; Sundin, Mikael; Uhlin, Michael; Rassidakis, Georgios; Heyman, Mats; Tamm, Katja Pokrovskaja; Warpman-Berglund, Ulrika; Walfridsson, Julian; Lehmann, Soren; Grander, Dan; Lundback, Thomas; Kogner, Per; Henter, Jan-Inge; Helleday, Thomas; Schaller, Torsten			Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ARA-C SENSITIVITY; CYTOSINE-ARABINOSIDE; IN-VITRO; DRUG-RESISTANCE; CELLS; EXPRESSION; MUTATIONS; DNA	The cytostatic deoxycytidine analog cytarabine (ara-C) is the most active agent available against acute myelogenous leukemia (AML). Together with anthracyclines, ara-C forms the backbone of AML treatment for children and adults'. In AML, both the cytotoxicity of ara-C in vitro and the clinical response to ara-C therapy are correlated with the ability of AML blasts to accumulate the active metabolite ara-C triphosphate (ara-CTP)(2-5), which causes DNA damage through perturbation of DNA synthesis(6). Differences in expression levels of known transporters or metabolic enzymes relevant to ara-C only partially account for patient-specific differential ara-CTP accumulation in AML blasts and response to ara-C treatment(7-9). Here we demonstrate that the deoxynucleoside triphosphate (dNTP) triphosphohydrolase SAM domain and HD domain 1 (SAMHD1) promotes the detoxification of intracellular ara-CTP pools. Recombinant SAMHD1 exhibited ara-CTPase activity in vitro, and cells in which SAMHD1 expression was transiently reduced by treatment with the simian immunodeficiency virus (SIV) protein Vpx were dramatically more sensitive to ara-C-induced cytotoxicity. CRISPR-Cas9-mediated disruption of the gene encoding SAMHD1 sensitized cells to ara-C, and this sensitivity could be abrogated by ectopic expression of wild-type (WT), but not dNTPase-deficient, SAMHD1. Mouse models of AML lacking SAMHD1 were hypersensitive to ara-C, and treatment ex vivo with Vpx sensitized primary patient derived AML blasts to ara-C. Finally, we identified SAMHD1 as a risk factor in cohorts of both pediatric and adult patients with de novo AML who received ara-C treatment. Thus, SAMHD1 expression levels dictate patient sensitivity to ara-C, providing proof-of-concept that the targeting of SAMHD1 by Vpx could be an attractive therapeutic strategy for potentiating ara-C efficacy in hematological malignancies.	[Herold, Nikolas; Ljungblad, Linda; Myrberg, Ida Hed; Tesi, Bianca; Bladh, Julia; Heyman, Mats; Kogner, Per; Henter, Jan-Inge] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Herold, Nikolas; Ljungblad, Linda; Myrberg, Ida Hed; Tesi, Bianca; Bladh, Julia; Heyman, Mats; Kogner, Per; Henter, Jan-Inge] Karolinska Univ Hosp, Stockholm, Sweden; [Rudd, Sean G.; Sanjiv, Kumar; Paulin, Cynthia B. J.; Hagenkort, Anna; Paget, Brent D. G.; Calderon-Montano, Jose M.; Loseva, Olga; Jemth, Ann-Sofie; Axelsson, Hanna; Valerie, Nicholas C. K.; Hoglund, Andreas; Wiita, Elisee; Warpman-Berglund, Ulrika; Lundback, Thomas; Helleday, Thomas] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, Stockholm, Sweden; [Heshmati, Yaser; Walfridsson, Julian; Lehmann, Soren] Karolinska Hosp, Dept Med, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Heshmati, Yaser; Walfridsson, Julian; Lehmann, Soren] Karolinska Inst, Stockholm, Sweden; [Kutzner, Juliane; Bulli, Lorenzo; Schaller, Torsten] Univ Heidelberg Hosp, Dept Infect Dis, Virol, Heidelberg, Germany; [Axelsson, Hanna; Lundback, Thomas] Chem Biol Consortium, Stockholm, Sweden; [Sundin, Mikael] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Sundin, Mikael] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Paediat Blood Disorders Immunodeficiency & Stem C, Stockholm, Sweden; [Uhlin, Michael; Rassidakis, Georgios; Tamm, Katja Pokrovskaja; Grander, Dan] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Uhlin, Michael] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Lehmann, Soren] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Calderon-Montano, Jose M.] Univ Seville, CSIC, Andalusian Mol Biol & Regenerat Med Ctr CABIMER, Seville, Spain; [Lundback, Thomas] AstraZeneca R&D, Molndal, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Ruprecht Karls University Heidelberg; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); AstraZeneca	Herold, N (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden.; Herold, N (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Schaller, T (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Virol, Heidelberg, Germany.	nikolas.herold@ki.se; torsten.schaller@med.uni-heidelberg.de	Lundbäck, Thomas/G-8076-2018; Montaño, José Manuel Calderón/AAA-1742-2019; Schaller, Torsten/ABC-9153-2020; Axelsson, Hanna/AGG-7882-2022; Höglund, Andreas/AAP-3372-2021; Tesi, Bianca/AAH-6304-2021; Herold, Nikolas/M-6927-2016; Rudd, Sean/AAC-3150-2019; Paulin, Cynthia/HGA-1250-2022; Sundin, Mikael/E-5942-2013	Lundbäck, Thomas/0000-0002-8145-7808; Montaño, José Manuel Calderón/0000-0001-6845-797X; Schaller, Torsten/0000-0001-9597-4112; Axelsson, Hanna/0000-0003-2365-1749; Tesi, Bianca/0000-0002-8253-2507; Herold, Nikolas/0000-0001-9468-4543; Rudd, Sean/0000-0002-4368-3855; Hed Myrberg, Ida/0000-0002-8297-2238; Kogner, Per/0000-0002-2202-9694; Valerie, Nicholas/0000-0002-9423-964X; Ljungblad, Linda/0000-0002-1428-9090; Warpman Berglund, Ulrika/0000-0002-6372-1396; Helleday, Thomas/0000-0002-7384-092X; Jemth, Ann-Sofie/0000-0002-7550-1833; Henter, Jan-Inge/0000-0002-0629-2126; Pokrovskaja Tamm, Katja/0000-0001-6359-1256; Sundin, Mikael/0000-0002-9871-0961	Swedish Children's Cancer Foundation [TJ2016-0040, 2015-0005, PR2015-0009, PR2013-0002, PR2014-0048]; Swedish Cancer Society [CAN 2016/837, CAN 2014/814, CAN 2015/768, CAN 2013/396, CAN 2012/770, CAN 2015/255]; Swedish Research Council [2014-1839, 2015-02498, 2012-2037, 2012-5935, 2013-3791]; Radiumhemmet's Research Foundations [154242, 144063]; Knut and Alice Wallenberg Foundation [KAW2014.0273]; Swedish Pain Relief Foundation [SSF/01-05]; Torsten and Ragnar Soderberg Foundation; David and Astrid Hagelen Foundation [C24702193]; Stockholm County Council (ALF project) [20150353, 20150016]; German Research Foundation (DFG) [SCHA1950/1-1]; Federal Ministry of Education and Research of Germany (BMBF) [0316170]; HIVERA: EURECA project [01KI1307B]; EMBO Long-Term Fellowship [ALTF-605-2014]; Swedish Research Council, Science for Life Laboratories and Karolinska Institutet [829-2009-6241]	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Radiumhemmet's Research Foundations; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Pain Relief Foundation; Torsten and Ragnar Soderberg Foundation; David and Astrid Hagelen Foundation; Stockholm County Council (ALF project)(Stockholm County Council); German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); HIVERA: EURECA project; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Swedish Research Council, Science for Life Laboratories and Karolinska Institutet	We are grateful to M. Wickstrom, N. Eissler and L. Elfman for consulting and assistance with xenotransplantation. We thank S. Olsson and M. Gustafsson for assistance with animal work. We would like to thank I. Bodin for help with paraffin-embedding and processing of tumor tissue and A. Bjorklund for assistance with primary AML samples. We acknowledge M. Nordenskjold and S. Eriksson for laboratory assistance, D. Gavhed and K. Edfeldt for administrative assistance. We thank D. Trono for the gift of the pMD.G plasmid. We would like to thank J. Cinatl for initial discussions. We would like to express our gratitude to NCI's Office of Cancer Genomics (OCG), The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research To Generate Effective Treatments initiative (TARGET) for granting public access to their AML databases, and to the Broad Institute for access to the Cancer Therapeutics Response Portal (CTRP). This work was supported by grants from the Swedish Children's Cancer Foundation (TJ2016-0040 (to N.H.); 2015-0005 (to J.-I.H.); PR2015-0009 (to D.G.); and PR2013-0002 and PR2014-0048 (both to T.H.)), the Swedish Cancer Society (CAN 2016/837 to J.W.; CAN 2014/814 to S.L.; CAN 2015/768 to D.G.; CAN 2013/396 to J.-I.H.; and CAN 2012/770 and CAN 2015/255 to T.H.), the Swedish Research Council (2014-1839 to M.U.; 2015-02498 to S.L.; 2012-2037 to D.G.; and 2012-5935 and 2013-3791 to T.H.), Radiumhemmet's Research Foundations (154242 to G.R. and 144063 to D.G.), the Knut and Alice Wallenberg Foundation (KAW2014.0273 to T.H.), the Swedish Pain Relief Foundation (SSF/01-05 to T.H.), the Torsten and Ragnar Soderberg Foundation (to T.H.), the David and Astrid Hagelen Foundation (C24702193 to B.D.G.P.) and the Stockholm County Council (ALF project) (20150353 to S.L. and 20150016 to J.-I.H.). This work was supported by the German Research Foundation (DFG) (SCHA1950/1-1 to T.S.) and partially through the Federal Ministry of Education and Research of Germany (BMBF)-supported Immunoquant project (0316170 C to T.S.) and HIVERA: EURECA project (01KI1307B to T.S.). S.G.R. is supported by an EMBO Long-Term Fellowship (ALTF-605-2014). Chemical Biology Consortium Sweden is funded by the Swedish Research Council, Science for Life Laboratories and Karolinska Institutet (829-2009-6241 to H.A. and T.L.).	Arnold LH, 2015, ANTIMICROB AGENTS CH, V59, P186, DOI 10.1128/AAC.03903-14; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; Bai HT, 2012, J CANCER RES CLIN, V138, P595, DOI 10.1007/s00432-011-1137-3; Bhattacharya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31353; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; de Rooij JDE, 2015, J CLIN MED, V4, P127, DOI 10.3390/jcm4010127; de Silva S, 2014, J INVEST DERMATOL, V134, P562, DOI 10.1038/jid.2013.311; ESTEY E, 1987, LEUKEMIA, V1, P580; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Fernandez-Calotti P, 2005, LEUKEMIA LYMPHOMA, V46, P335, DOI 10.1080/10428190400015683; Galmarini CM, 2002, LEUKEMIA RES, V26, P621, DOI 10.1016/S0145-2126(01)00184-9; Genini D, 2000, BLOOD, V96, P3537; HEINEMANN V, 1990, LEUKEMIA, V4, P790; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Jin CZ, 2014, BIOCHEM BIOPH RES CO, V452, P760, DOI 10.1016/j.bbrc.2014.08.151; KESSEL D, 1969, CANCER RES, V29, P459; KUFE D, 1984, BLOOD, V64, P54; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lamba JK, 2009, PHARMACOGENOMICS, V10, P1657, DOI [10.2217/pgs.09.118, 10.2217/PGS.09.118]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li D, 2015, STEM CELL RES, V15, P271, DOI 10.1016/j.scr.2015.06.012; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Majda K, 2010, ANTICANCER RES, V30, P4601; Merati Miesha, 2015, JAAD Case Rep, V1, P227, DOI 10.1016/j.jdcr.2015.05.003; Ossenkoppele G, 2015, BLOOD, V125, P767, DOI 10.1182/blood-2014-08-551499; PLUNKETT W, 1986, SCAND J HAEMATOL, V36, P51; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/nchembio.1986, 10.1038/NCHEMBIO.1986]; Rentoft M, 2016, P NATL ACAD SCI USA, V113, P4723, DOI 10.1073/pnas.1519128113; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rowe JM, 2013, BEST PRACT RES CL HA, V26, P241, DOI 10.1016/j.beha.2013.10.002; Schaller T, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-29; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Styczynski J, 2007, CURR PHARM BIOTECHNO, V8, P59, DOI 10.2174/138920107780487465; Wang JL, 2014, BIOCHEM BIOPH RES CO, V455, P229, DOI 10.1016/j.bbrc.2014.10.153; Weng HY, 2015, CANCER GENET-NY, V208, P225, DOI 10.1016/j.cancergen.2014.12.006; Yamauchi T, 2009, BIOCHEM PHARMACOL, V77, P1780, DOI 10.1016/j.bcp.2009.03.011; Yue LJ, 2003, PHARMACOGENETICS, V13, P29, DOI 10.1097/00008571-200301000-00005; ZITTOUN R, 1987, SEMIN ONCOL, V14, P269	40	79	79	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					256	263		10.1038/nm.4265	http://dx.doi.org/10.1038/nm.4265			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28067901				2022-12-27	WOS:000393729000018
J	Muoio, DM				Muoio, Deborah M.			HDAC3 sets the timer on muscle fuel switching	NATURE MEDICINE			English	News Item							EXERCISE	In a recent study in mice, it is shown that circadian oscillations in genomic histone deactylase 3 (HDAC3) occupancy influence fuel switching and carbon flux in muscle to regulate glucose homeostasis and exercise performance.	[Muoio, Deborah M.] Duke Univ, Med Ctr, Nutr & Metab Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA	Duke University	Muoio, DM (corresponding author), Duke Univ, Med Ctr, Nutr & Metab Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA.	muoio@duke.edu	Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089312] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK089312] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arinze IJ, 2005, BIOCHEM MOL BIOL EDU, V33, P165, DOI 10.1002/bmb.2005.494033032469; Fang B, 2015, COLD SH Q B, V80, P233, DOI 10.1101/sqb.2015.80.027508; Hong SG, 2017, NAT MED, V23, P223, DOI 10.1038/nm.4245; Koren D, 2016, DIABETES METAB SYNDR, V9, P281, DOI 10.2147/DMSO.S95120; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009	9	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					148	150		10.1038/nm.4282	http://dx.doi.org/10.1038/nm.4282			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170378				2022-12-27	WOS:000393729000006
J	Huang, BH; Faucette, AN; Pawlitz, MD; Pei, B; Goyert, JW; Zhou, JZ; El-Hage, NG; Deng, J; Lin, J; Yao, FY; Dewar, RS; Jassal, JS; Sandberg, ML; Dai, J; Cols, M; Shen, C; Polin, LA; Nichols, RA; Jones, TB; Bluth, MH; Puder, KS; Gonik, B; Nayak, NR; Puscheck, E; Wei, WZ; Cerutti, A; Colonna, M; Chen, K				Huang, Bihui; Faucette, Azure N.; Pawlitz, Michael D.; Pei, Bo; Goyert, Joshua W.; Zhou, Jordan Zheng; El-Hage, Nadim G.; Deng, Jie; Lin, Jason; Yao, Fayi; Dewar, Robert S., III; Jassal, Japnam S.; Sandberg, Maxwell L.; Dai, Jing; Cols, Montserrat; Shen, Cong; Polin, Lisa A.; Nichols, Ronald A.; Jones, Theodore B.; Bluth, Martin H.; Puder, Karoline S.; Gonik, Bernard; Nayak, Nihar R.; Puscheck, Elizabeth; Wei, Wei-Zen; Cerutti, Andrea; Colonna, Marco; Chen, Kang			Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor	NATURE MEDICINE			English	Article							INDUCED BLOCKING FACTOR; REGULATORY T-CELLS; PROGESTERONE; PREGNANCY; LIPOPOLYSACCHARIDE; AUTOIMMUNE; IMMUNITY; IL-10; BLOOD	Preterm birth (PTB) is a leading cause of neonatal death worldwide(1). Intrauterine and systemic infection and inflammation cause 30-40% of spontaneous preterm labor (PTL)(2), which precedes PTB. Although antibody production is a major immune defense mechanism against infection, and B cell dysfunction has been implicated in pregnancy complications associated with PTL3,4, the functions of B cells in pregnancy are not well known(5-8). We found that choriodecidua of women undergoing spontaneous PTL harbored functionally altered B cell populations. B cell-deficient mice were markedly more susceptible than wild-type (WT) mice to PTL after inflammation, but B cells conferred interleukin (IL)-10-independent protection against PTL. B cell deficiency in mice resulted in a lower uterine level of active progesterone-induced blocking factor 1 (PIBF1), and therapeutic administration of PIBF1 mitigated PTL and uterine inflammation in B cell-deficient mice. B cells are a significant producer of PIBF1 in human choriodecidua and mouse uterus in late gestation. PIBF1 expression by B cells is induced by the mucosal alarmin IL-33 (ref. 9). Human PTL was associated with diminished expression of the alpha-chain of IL-33 receptor on choriodecidual B cells and a lower level of active PIBF1 in late gestation choriodecidua. These results define a vital regulatory cascade involving IL-33, decidual B cells and PIBF1 in safeguarding term pregnancy and suggest new therapeutic approaches based on IL-33 and PIBF1 to prevent human PTL.	[Huang, Bihui; Faucette, Azure N.; Pawlitz, Michael D.; Pei, Bo; Goyert, Joshua W.; Zhou, Jordan Zheng; El-Hage, Nadim G.; Lin, Jason; Yao, Fayi; Dewar, Robert S., III; Jassal, Japnam S.; Dai, Jing; Nichols, Ronald A.; Jones, Theodore B.; Puder, Karoline S.; Gonik, Bernard; Nayak, Nihar R.; Puscheck, Elizabeth; Chen, Kang] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Sandberg, Maxwell L.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Cols, Montserrat; Shen, Cong] Union Coll, Leadership Med Program, Schenectady, NY 12308 USA; [Polin, Lisa A.; Wei, Wei-Zen; Chen, Kang] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA; [Polin, Lisa A.; Chen, Kang] Wayne State Univ, Dept Oncol, Detroit, MI 48202 USA; [Nichols, Ronald A.; Jones, Theodore B.] Beaumont Dearborn Hosp, Dept Obstet & Gynecol Med Ed, Dearborn, MI USA; [Bluth, Martin H.] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Cerutti, Andrea] Catalan Inst Res & Adv Studies, Barcelona Biomed Res Pk, Barcelona, Spain; [Cerutti, Andrea] Inst Hosp Mar Invest Med, Program Inflammatory & Cardiovasc Disorders, Barcelona, Spain; [Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Cerutti, Andrea; Colonna, Marco; Chen, Kang] NIAID, Mucosal Immunol Studies Team, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Faucette, Azure N.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Faucette, Azure N.] CUNY, Kingsborough Community Coll, Dept Biol, Brooklyn, NY USA	Wayne State University; Yale University; Union College; Memorial Sloan Kettering Cancer Center; Wayne State University; Wayne State University; ICREA; Pompeu Fabra University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); City University of New York (CUNY) System	Chen, K (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.; Chen, K (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.; Chen, K (corresponding author), Wayne State Univ, Dept Oncol, Detroit, MI 48202 USA.; Chen, K (corresponding author), NIAID, Mucosal Immunol Studies Team, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kang@wayne.edu	dai, jing/GVS-5395-2022	Huang, Bihui/0000-0003-3084-7096; Goyert, Joshua/0000-0003-3820-970X; Pawlitz, Michael/0000-0002-7001-5676; Zhou, Jordan/0000-0001-6047-9285; Cerutti, Andrea/0000-0003-3026-4704	Burroughs Wellcome Fund; US National Institutes of Health [U01AI95776, R21AI122256, P30CA22453]; American Congress of Obstetricians and Gynecologists; Wayne State University (Perinatal Initiative); Wayne State University Office of the Vice President for Research; NATIONAL CANCER INSTITUTE [P30CA022453, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122256, U01AI095776] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Congress of Obstetricians and Gynecologists; Wayne State University (Perinatal Initiative); Wayne State University Office of the Vice President for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	We thank the European Conditional Mouse Mutagenesis Program and Barry Rosen (Wellcome Trust Sanger Institute) for mouse 1133 targeting vectors, the NIAID Mucosal Immunology Studies Team (MIST) mouse core for generating the Il33<SUP>-/-</SUP> lacZ reporter mice, and M. Treadwell (University of Michigan at Ann Arbor) and X. Xu (Bristol-Myers Squibb) for discussion of the manuscript. This study was supported by grants from the Burroughs Wellcome Fund (Preterm Birth Initiative), US National Institutes of Health (U01AI95776 MIST Young Investigator Award, R21AI122256, P30CA22453), American Congress of Obstetricians and Gynecologists and Wayne State University (Perinatal Initiative) (to K.C.). A.N.F. was partially supported by a fellowship from the Wayne State University Office of the Vice President for Research.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; BHAT NM, 1995, J REPROD IMMUNOL, V28, P53, DOI 10.1016/0165-0378(94)00907-O; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Candando KM, 2014, IMMUNOL REV, V259, P259, DOI 10.1111/imr.12176; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Frank HG, 2006, PATHOLOGY HUMAN PLAC, P191, DOI [10.1007/0-387-26742-5_9, DOI 10.1007/0-387-26742-5_9]; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez-Arenas A, 2014, J STEROID BIOCHEM, V144, P463, DOI 10.1016/j.jsbmb.2014.09.007; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hudic I, 2015, J REPROD IMMUNOL, V109, P36, DOI 10.1016/j.jri.2015.02.006; Jensen F, 2012, HYPERTENSION, V59, P861, DOI 10.1161/HYPERTENSIONAHA.111.188276; Lachmann M, 2004, INT J CANCER, V112, P51, DOI 10.1002/ijc.20326; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Moffett A, 2015, HUM REPROD, V30, P1519, DOI 10.1093/humrep/dev098; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Muzzio DO, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122366; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Polgar B, 2003, J IMMUNOL, V171, P5956, DOI 10.4049/jimmunol.171.11.5956; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SEMIN FETAL NEONAT M, V19, P15, DOI 10.1016/j.siny.2013.10.004; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sattler S, 2014, J AUTOIMMUN, V50, P107, DOI 10.1016/j.jaut.2014.01.032; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Szekeres-Bartho J, 2010, AM J REPROD IMMUNOL, V64, P77, DOI 10.1111/j.1600-0897.2010.00833.x; SZEKERESBARTHO J, 1985, AM J REPROD IM MIC, V9, P15; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Trundley A, 2004, TISSUE ANTIGENS, V63, P1, DOI 10.1111/j.1399-0039.2004.00170.x; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zimmer JP, 1998, AM J REPROD IMMUNOL, V40, P57	40	55	60	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					128	135		10.1038/nm.4244	http://dx.doi.org/10.1038/nm.4244			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27918564	Green Accepted			2022-12-27	WOS:000391646800022
J	Kato, AS; Burris, KD; Gardinier, KM; Gernert, DL; Porter, WJ; Reel, J; Ding, CJ; Tu, Y; Schober, DA; Lee, MR; Heinz, BA; Fitch, TE; Gleason, SD; Catlow, JT; Yu, H; Fitzjohn, SM; Pasqui, F; Wang, H; Qian, YW; Sher, E; Zwart, R; Wafford, KA; Rasmussen, K; Ornstein, PL; Isaac, JTR; Nisenbaum, ES; Bredt, DS; Witkin, JM				Kato, Akihiko S.; Burris, Kevin D.; Gardinier, Kevin M.; Gernert, Douglas L.; Porter, Warren J.; Reel, Jon; Ding, Chunjin; Tu, Yuan; Schober, Douglas A.; Lee, Matthew R.; Heinz, Beverly A.; Fitch, Thomas E.; Gleason, Scott D.; Catlow, John T.; Yu, Hong; Fitzjohn, Stephen M.; Pasqui, Francesca; Wang, He; Qian, Yuewei; Sher, Emanuele; Zwart, Ruud; Wafford, Keith A.; Rasmussen, Kurt; Ornstein, Paul L.; Isaac, John T. R.; Nisenbaum, Eric S.; Bredt, David S.; Witkin, Jeffrey M.			Forebrain-selective AMPA-receptor antagonism guided by TARP gamma-8 as an antiepileptic mechanism	NATURE MEDICINE			English	Article							AUXILIARY SUBUNITS; NEUROTRANSMITTER RECEPTORS; SYNAPTIC PLASTICITY; CORNICHON PROTEINS; KAINATE RECEPTORS; DISCOVERY; EXPRESSION; PERAMPANEL; SEIZURE; FAMILY	Pharmacological manipulation of specific neural circuits to optimize therapeutic index is an unrealized goal in neurology and psychiatry. AMPA receptors are important for excitatory synaptic transmission(1), and their antagonists are antiepileptic(2). Although efficacious, AMPA-receptor antagonists, including perampanel (Fycompa), the only approved antagonist for epilepsy, induce dizziness and motor impairment(3,4). We hypothesized that blockade of forebrain AMPA receptors without blocking cerebellar AMPA receptors would be antiepileptic and devoid of motor impairment. Taking advantage of an AMPA receptor auxiliary protein, TARP gamma-8, which is selectively expressed in the forebrain and modulates the pharmacological properties of AMPA receptors(5), we discovered that LY3130481 selectively antagonized recombinant and native AMPA receptors containing gamma-8, but not gamma-2 (cerebellum) or other TARP members. Two amino acid residues unique to gamma-8 determined this selectivity. We also observed antagonism of AMPA receptors expressed in hippocampal, but not cerebellar, tissue from an patient with epilepsy. Corresponding to this selective activity, LY3130481 prevented multiple seizure types in rats and mice and without motor side effects. These findings demonstrate the first rationally discovered molecule targeting specific neural circuitries for therapeutic advantage.	[Kato, Akihiko S.; Burris, Kevin D.; Gardinier, Kevin M.; Gernert, Douglas L.; Porter, Warren J.; Reel, Jon; Ding, Chunjin; Tu, Yuan; Schober, Douglas A.; Heinz, Beverly A.; Fitch, Thomas E.; Gleason, Scott D.; Catlow, John T.; Yu, Hong; Wang, He; Qian, Yuewei; Rasmussen, Kurt; Ornstein, Paul L.; Nisenbaum, Eric S.; Bredt, David S.; Witkin, Jeffrey M.] Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA; [Lee, Matthew R.] Eli Lilly & Co, Appl Mol Evolut, San Diego, CA USA; [Fitzjohn, Stephen M.; Pasqui, Francesca; Sher, Emanuele; Zwart, Ruud; Wafford, Keith A.; Isaac, John T. R.] Eli Lilly & Co, Lilly UK, Windlesham, Surrey, England; [Yu, Hong; Bredt, David S.] Janssen PRD, San Diego, CA USA; [Fitzjohn, Stephen M.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Ornstein, Paul L.] Roosevelt Univ, Coll Pharm, Schaumburg, IL USA; [Isaac, John T. R.] Wellcome Trust Res Labs, London, England	Eli Lilly; Eli Lilly; Eli Lilly; University of Bristol	Kato, AS; Witkin, JM (corresponding author), Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA.	katoak@lilly.com; jwitkin@lilly.com		Fitzjohn, Stephen/0000-0002-3859-7530; Wafford, Keith/0000-0003-4537-4690				Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Eusebi F, 2009, PROG NEUROBIOL, V88, P32, DOI 10.1016/j.pneurobio.2009.01.008; French JA, 2012, NEUROLOGY, V79, P589, DOI 10.1212/WNL.0b013e3182635735; Gardinier KM, 2016, J MED CHEM, V59, P4753, DOI 10.1021/acs.jmedchem.6b00125; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Gleason SD, 2015, CNS NEUROL DISORD-DR, V14, P612, DOI 10.2174/1871527314666150429114818; Harkin A, 2002, PHYSIOL BEHAV, V77, P65, DOI 10.1016/S0031-9384(02)00810-7; Hibi S, 2012, J MED CHEM, V55, P10584, DOI 10.1021/jm301268u; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kaminski RM, 2007, NEUROPHARMACOLOGY, V52, P895, DOI 10.1016/j.neuropharm.2006.10.007; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Miledi R, 2002, P NATL ACAD SCI USA, V99, P13238, DOI 10.1073/pnas.192445299; Miledi Ricardo, 2006, V322, P347; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Phillips KG, 2012, NEUROPHARMACOLOGY, V62, P1359, DOI 10.1016/j.neuropharm.2011.04.006; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2012, J PHYSIOL-LONDON, V590, P2217, DOI 10.1113/jphysiol.2011.221101; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Twele F, 2015, NEUROPHARMACOLOGY, V95, P234, DOI 10.1016/j.neuropharm.2015.03.014; Witkin JM, 2016, J PHARMACOL EXP THER, V358, P502, DOI 10.1124/jpet.116.234419; Zwart R, 2014, J PHARMACOL EXP THER, V351, P124, DOI 10.1124/jpet.114.212779	34	53	53	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1496	+		10.1038/nm.4221	http://dx.doi.org/10.1038/nm.4221			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27820603	Green Submitted			2022-12-27	WOS:000389549000029
J	Zeltner, N; Fattahi, F; Dubois, NC; Saurat, N; Lafaille, F; Shang, L; Zimmer, B; Tchieu, J; Soliman, MA; Lee, G; Casanova, JL; Studer, L				Zeltner, Nadja; Fattahi, Faranak; Dubois, Nicole C.; Saurat, Nathalie; Lafaille, Fabien; Shang, Lei; Zimmer, Bastian; Tchieu, Jason; Soliman, Mohamed A.; Lee, Gabsang; Casanova, Jean-Laurent; Studer, Lorenz			Capturing the biology of disease severity in a PSC-based model of familial dysautonomia	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE MODEL; INDUCTION; DIFFERENTIATION; SPECIFICATION; EXPRESSION; VARIANTS; MUTATION; GANGLIA; RESCUE	Familial dysautonomia (FD) is a debilitating disorder that affects derivatives of the neural crest (NC). For unknown reasons, people with FD show marked differences in disease severity despite carrying an identical, homozygous point mutation in IKBKAP, encoding I kappa B kinase complex-associated protein. Here we present disease-related phenotypes in human pluripotent stem cells (PSCs) that capture FD severity. Cells from individuals with severe but not mild disease show impaired specification of NC derivatives, including autonomic and sensory neurons. In contrast, cells from individuals with severe and mild FD show defects in peripheral neuron survival, indicating that neurodegeneration is the main culprit for cases of mild FD. Although genetic repair of the FD-associated mutation reversed early developmental NC defects, sensory neuron specification was not restored, indicating that other factors may contribute to disease severity. Whole-exome sequencing identified candidate modifier genes for individuals with severe FD. Our study demonstrates that PSC-based modeling is sensitive in recapitulating disease severity, which presents an important step toward personalized medicine.	[Zeltner, Nadja; Fattahi, Faranak; Saurat, Nathalie; Zimmer, Bastian; Tchieu, Jason; Soliman, Mohamed A.; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Zeltner, Nadja; Fattahi, Faranak; Saurat, Nathalie; Zimmer, Bastian; Tchieu, Jason; Soliman, Mohamed A.; Studer, Lorenz] Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY 10065 USA; [Fattahi, Faranak] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Dubois, Nicole C.] Icahn Sch Med Mt Sinai, Dev & Regenerat Biol, New York, NY 10029 USA; [Lafaille, Fabien; Shang, Lei; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Soliman, Mohamed A.] Weill Cornell Med Coll, New York, NY USA; [Lee, Gabsang] Johns Hopkins Univ, Inst Cell Engn, Baltimore, MD USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Icahn School of Medicine at Mount Sinai; Rockefeller University; Cornell University; Johns Hopkins University	Zeltner, N; Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.; Zeltner, N; Studer, L (corresponding author), Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY 10065 USA.	zeltnern@gmail.com; studerl@mskcc.org	Casanova, Jean-Laurent/I-3418-2017; Studer, Lorenz/ABH-1491-2021; Tchieu, Jason/AAG-1551-2020	Studer, Lorenz/0000-0003-0741-7987; Tchieu, Jason/0000-0002-9793-9836; Saurat, Nathalie/0000-0002-6439-5166; Casanova, Jean-Laurent/0000-0002-7782-4169; Zimmer, Bastian/0000-0003-0004-4890; Lee, Gabsang/0000-0002-5052-5927	NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Swiss National Science Foundation; US National Institutes of Health [P30CA08748]; New York State Stem Cell Science (NYSTEM) [C026446, C026447]; Tri-institutional Stem Cell Initiative (Starr Foundation); Robertson Investigator Award from New York Stem Cell Foundation; Maryland Stem Cell Research Funding (MSCRF/TEDCO); Adrienne Helis Malvin Medical Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM); Tri-institutional Stem Cell Initiative (Starr Foundation); Robertson Investigator Award from New York Stem Cell Foundation; Maryland Stem Cell Research Funding (MSCRF/TEDCO); Adrienne Helis Malvin Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J.-F. Brunet (Ecole Normale Superieure) for providing us with the PHOX2A antibody, S. Irion and M. Tomishima for critical review of the manuscript, A. Hudon for general help, H. Ralph (Weill Cornell Cell Screening Core) for image quantification and the Bioinformatics, Integrated Genomics Operations (funded by the NCI Cancer Center Support Grant (CCSG, P30 CA08748), Cycle for Survival and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology) and Flow Cytometry Core Facilities at Sloan Kettering Institute. This work was supported by the Swiss National Science Foundation (N.Z.); the US National Institutes of Health (P30CA08748), New York State Stem Cell Science (NYSTEM) (C026446 and C026447) and the Tri-institutional Stem Cell Initiative (Starr Foundation) (L.S.); and a Robertson Investigator Award from New York Stem Cell Foundation, Maryland Stem Cell Research Funding (MSCRF/TEDCO) and the Adrienne Helis Malvin Medical Research Foundation (G.L.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; AXELROD FB, 1981, PEDIATRICS, V67, P517; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong JL, 2002, AM J MED GENET, V110, P253, DOI 10.1002/ajmg.10450; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Grundy D, 2007, CURR OPIN GASTROEN, V23, P121, DOI 10.1097/MOG.0b013e3280287a23; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Itan Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-256; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Morini E, 2016, HUM MOL GENET, V25, P1116, DOI 10.1093/hmg/ddv634; Oh Y, 2016, CELL STEM CELL, V19, P95, DOI 10.1016/j.stem.2016.05.002; Ooi YH, 2009, INVEST OPHTH VIS SCI, V50, P4237, DOI 10.1167/iovs.08-2312; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wainger BJ, 2015, NAT NEUROSCI, V18, P17, DOI 10.1038/nn.3886; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zeltner N, 2015, CURR OPIN CELL BIOL, V37, P102, DOI 10.1016/j.ceb.2015.10.008; Zeltner N, 2014, JOVE-J VIS EXP, DOI 10.3791/51609	42	34	34	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1421	+		10.1038/nm.4220	http://dx.doi.org/10.1038/nm.4220			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27841875	Green Accepted			2022-12-27	WOS:000389549000019
J	Schroeder, B; Backhed, F				Schroeder, Bjoern; Backhed, Fredrik			Signals from the gut microbiota to distant organs in physiology and disease	NATURE MEDICINE			English	Review							DIET-INDUCED OBESITY; CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIA; ARYL-HYDROCARBON RECEPTOR; PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; WHITE ADIPOSE-TISSUE; 16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; BILE-ACID	The ecosystem of the human gut consists of trillions of bacteria forming a bioreactor that is fueled by dietary macronutrients to produce bioactive compounds. Thesd microbiota-derived metabolites signal to distant organs in the body, which enables the gut bacteria to connect to the immune and hormone system, to the brain (the gut brain axis) and to host metabolism, as well as other functions of the host. This microbe host communication is essential to maintain vital functions of the healthy host. Recently, however, the gut microbiota has been associated with a number of diseases, ranging from obesity and inflammatory diseases to behavioral and physiological abnormalities associated with neurodevelopmental disorders. In this Review, we will discuss microbiota-host cross-talk and intestinal microbiome signaling to extraintestinal organs. We will review mechanisms of how this communication might contribute to host physiology and discuss how misconfigured signaling might contribute to different diseases.	[Schroeder, Bjoern; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Schroeder, Bjoern; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark.	fredrik.backhed@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020; Schroeder, Bjoern O/F-3353-2011	Backhed, Fredrik/0000-0002-4871-8818; Schroeder, Bjoern O/0000-0002-6716-8284	Swedish Research Council; NovoNordisk foundation; Torsten Soderberg's foundation; Swedish Heart Lung Foundation; Goran Gustafsson's foundation; IngaBritt och Arne Lundbergs foundation; Knut and Alice Wallenberg foundation; FP7-program METACARDIS; Region Vastra Gotaland; Sahlgrenska University Hospital; ERC Consolidator Grant (European Research Council) [615362 - METABASE]; European Union [622909]; Human Frontier Science Program Long-Term Fellowship [LT000109/20144]; NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0008163] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk foundation(Novo Nordisk Foundation); Torsten Soderberg's foundation; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Goran Gustafsson's foundation; IngaBritt och Arne Lundbergs foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); FP7-program METACARDIS; Region Vastra Gotaland; Sahlgrenska University Hospital; ERC Consolidator Grant (European Research Council)(European Research Council (ERC)); European Union(European Commission); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank A. Hallen for her assistance with figures and artwork. Work in the authors' laboratory is supported by the Swedish Research Council, the NovoNordisk foundation, Torsten Soderberg's foundation, Swedish Heart Lung Foundation, Goran Gustafsson's foundation, IngaBritt och Arne Lundbergs foundation, Knut and Alice Wallenberg foundation, the FP7-sponsored program METACARDIS, the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital. F.B. is a recipient of an ERC Consolidator Grant (European Research Council, Consolidator grant 615362 - METABASE). B.O.S. is a recipient of an FP7 Marie Curie IEF Fellowship (622909 MUCUS AND METABOLISM) from the European Union and a Human Frontier Science Program Long-Term Fellowship (LT000109/20144).	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004; Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Connolly N, 2016, AUTISM RES, V9, P829, DOI 10.1002/aur.1586; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Fava S, 2014, CURR DIABETES REV, V10, P302, DOI 10.2174/1573399810666141030125830; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Haag LM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00489; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hersoug LG, 2016, OBES REV, V17, P297, DOI 10.1111/obr.12370; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Hofstra JJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1081-y; Hohmann EL, 2014, NEW ENGL J MED, V371, P668, DOI 10.1056/NEJMcpc1400842; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Houlden A., 2016, BRAIN BEHAV IMMUN; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jonsson AL, 2015, CELL, V163, P1565, DOI 10.1016/j.cell.2015.12.005; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koleva PT, 2015, BIRTH DEFECTS RES C, V105, P265, DOI 10.1002/bdrc.21117; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Kurdi P, 2006, J BACTERIOL, V188, P1979, DOI 10.1128/JB.188.5.1979-1986.2006; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Luche E, 2013, MOL METAB, V2, P281, DOI 10.1016/j.molmet.2013.06.005; Luczynski P., 2016, EUR J NEUROSCI; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; Makiura N, 2008, ORAL MICROBIOL IMMUN, V23, P348, DOI 10.1111/j.1399-302X.2007.00426.x; Mayer EA, 2014, BIOESSAYS, V36, P933, DOI 10.1002/bies.201400075; McGavigan A.K., 2015, GUT; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Perseus A., 2016, GUT; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sommer F, 2016, CELL REP, V14, P1655, DOI 10.1016/j.celrep.2016.01.026; Song H, 2016, J ALLERGY CLIN IMMUN, V137, P852, DOI 10.1016/j.jaci.2015.08.021; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sullivan EL, 2014, PHYSIOL BEHAV, V123, P236, DOI 10.1016/j.physbeh.2012.07.014; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Takahashi K, 2016, DIGESTION, V93, P59, DOI 10.1159/000441768; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	149	649	689	22	423	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1079	1089		10.1038/nm.4185	http://dx.doi.org/10.1038/nm.4185			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711063				2022-12-27	WOS:000384872500010
J	Bruner, KM; Murray, AJ; Pollack, RA; Soliman, MG; Laskey, SB; Capoferri, AA; Lai, J; Strain, MC; Lada, SM; Hoh, R; Ho, YC; Richman, DD; Deeks, SG; Siliciano, JD; Siliciano, RF				Bruner, Katherine M.; Murray, Alexandra J.; Pollack, Ross A.; Soliman, Mary G.; Laskey, Sarah B.; Capoferri, Adam A.; Lai, Jun; Strain, Matthew C.; Lada, Steven M.; Hoh, Rebecca; Ho, Ya-Chi; Richman, Douglas D.; Deeks, Steven G.; Siliciano, Janet D.; Siliciano, Robert F.			Defective proviruses rapidly accumulate during acute HIV-1 infection	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; VIRUS TYPE-1 INFECTION; IN-VIVO; LATENT RESERVOIR; INTEGRATION; GENOME; RECOMBINATION; HYPERMUTATION; QUANTITATION	Although antiretroviral therapy (ART) suppresses viral replication to clinically undetectable levels, human immunodeficiency virus type 1 (HIV-1) persists in CD4(+) T cells in a latent form that is not targeted by the immune system or by ART(1-5). This latent reservoir is a major barrier to curing individuals of HIV-1 infection. Many individuals initiate ART during chronic infection, and in this setting, most proviruses are defective6. However, the dynamics of the accumulation and the persistence of defective proviruses during acute HIV-1 infection are largely unknown. Here we show that defective proviruses accumulate rapidly within the first few weeks of infection to make up over 93% of all proviruses, regardless of how early ART is initiated. By using an unbiased method to amplify near-full-length proviral genomes from HIV-1-infected adults treated at different stages of infection, we demonstrate that early initiation of ART limits the size of the reservoir but does not profoundly affect the proviral landscape. This analysis allows us to revise our understanding of the composition of proviral populations and estimate the true reservoir size in individuals who were treated early versus late in infection. Additionally, we demonstrate that common assays for measuring the reservoir do not correlate with reservoir size, as determined by the number of genetically intact proviruses. These findings reveal hurdles that must be overcome to successfully analyze future HIV-1 cure strategies.	[Bruner, Katherine M.; Murray, Alexandra J.; Pollack, Ross A.; Soliman, Mary G.; Laskey, Sarah B.; Capoferri, Adam A.; Lai, Jun; Ho, Ya-Chi; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Capoferri, Adam A.; Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 21250 USA; [Strain, Matthew C.; Richman, Douglas D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Lada, Steven M.; Richman, Douglas D.] Vet Affairs VA San Diego Healthcare Syst, San Diego, CA USA; [Hoh, Rebecca; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Francisco; University of California System; University of California San Diego	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Siliciano, RF (corresponding author), Howard Hughes Med Inst, Baltimore, MD 21250 USA.	rsiliciano@jhmi.edu	Capoferri, Adam/AAM-9484-2021; Bruner, Katherine/AAN-7693-2021	Bender, Alexandra/0000-0002-6980-3878; Deeks, Steven/0000-0001-6371-747X; Ho, Ya-Chi/0000-0002-7046-0147	Genomics and Sequencing Core at the UCSD Center for AIDS Research [P30AI036214]; Pendleton Charitable Trust; VA San Diego Healthcare System; Veterans Medical Research Foundation; Martin Delaney CARE and DARE Collaboratories (US National Institutes of Health (NIH)) [AI096113, 1U19AI096109]; ARCHE Collaborative Research Grant from the Foundation for AIDS Research [amFAR 108165-50-RGRL]; Johns Hopkins Center for AIDS Research [P30AI094189]; NIH [43222, R21AI113147-02]; Howard Hughes Medical Institute; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, P30AI036214, R01AI043222, R33AI104283, R21AI113147, U19AI096113, U19AI096109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752, T32GM007309] Funding Source: NIH RePORTER	Genomics and Sequencing Core at the UCSD Center for AIDS Research; Pendleton Charitable Trust; VA San Diego Healthcare System(US Department of Veterans Affairs); Veterans Medical Research Foundation; Martin Delaney CARE and DARE Collaboratories (US National Institutes of Health (NIH)); ARCHE Collaborative Research Grant from the Foundation for AIDS Research; Johns Hopkins Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the study participants who have made this research possible. We also thank G. Laird for critical advice and discussion, L. Alston, H. McHugh and D. Xu for assistance with study participants, V. Walker-Sperling for providing the Ba-L virus, C. Pohlmeyer for providing a sample from a viremic subject, and all of the members of the Siliciano laboratory for valuable discussion and advice. This work was supported by the Genomics and Sequencing Core at the UCSD Center for AIDS Research (P30AI036214 (D.D.R.)), the Pendleton Charitable Trust (D.D.R.), the VA San Diego Healthcare System (D.D.R.), the Veterans Medical Research Foundation (D.D.R.), the Martin Delaney CARE and DARE Collaboratories (US National Institutes of Health (NIH) grants AI096113 (M.C.S., D.D.R. and R.F.S.) and 1U19AI096109 (S.G.D. and R.F.S.)), an ARCHE Collaborative Research Grant from the Foundation for AIDS Research (amFAR 108165-50-RGRL (R.F.S.)), the Johns Hopkins Center for AIDS Research grant P30AI094189 (R.F.S.), the NIH grants 43222 (R.F.S.) and R21AI113147-02 (J.D.S.), the Howard Hughes Medical Institute (R.F.S.), and the Bill and Melinda Gates Foundation (R.F.S.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Delviks-Frankenberry K, 2011, VIRUSES-BASEL, V3, P1650, DOI 10.3390/v3091650; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Harper MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005254; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P12209, DOI 10.1073/pnas.221289898; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kim M, 2014, NAT PROTOC, V9, P2755, DOI 10.1038/nprot.2014.188; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Massanella M., 2015, BIO-PROTOCOL, V5, pe1492; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rosenbloom DIS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv123; Rouzioux C, 2014, METHODS MOL BIOL, V1087, P261, DOI 10.1007/978-1-62703-670-2_21; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yu H, 1998, J BIOL CHEM, V273, P28384, DOI 10.1074/jbc.273.43.28384; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	43	419	422	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1043	+		10.1038/nm.4156	http://dx.doi.org/10.1038/nm.4156			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27500724	Green Accepted			2022-12-27	WOS:000382542800015
J	Theurl, I; Hilgendorf, I; Nairz, M; Tymoszuk, P; Haschka, D; Asshoff, M; He, S; Gerhardt, LMS; Holderried, TAW; Seifert, M; Sopper, S; Fenn, AM; Anzai, A; Rattik, S; McAlpine, C; Theurl, M; Wieghofer, P; Iwamoto, Y; Weber, GF; Harder, NK; Chousterman, BG; Arvedson, TL; McKee, M; Wang, FD; Lutz, OMD; Rezoagli, E; Babitt, JL; Berra, L; Prinz, M; Nahrendorf, M; Weiss, G; Weissleder, R; Lin, HY; Swirski, FK				Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; Tymoszuk, Piotr; Haschka, David; Asshoff, Malte; He, Shun; Gerhardt, Louisa M. S.; Holderried, Tobias A. W.; Seifert, Markus; Sopper, Sieghart; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Theurl, Milan; Wieghofer, Peter; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; Arvedson, Tara L.; McKee, Mary; Wang, Fudi; Lutz, Oliver M. D.; Rezoagli, Emanuele; Babitt, Jodie L.; Berra, Lorenzo; Prinz, Marco; Nahrendorf, Matthias; Weiss, Guenter; Weissleder, Ralph; Lin, Herbert Y.; Swirski, Filip K.			On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver	NATURE MEDICINE			English	Article							RED-BLOOD-CELLS; MOUSE MODEL; SPI-C; HOMEOSTASIS; HEPCIDIN; ANEMIA; FERROPORTIN; DEFICIENCY; MONOCYTES; STORAGE	Iron is an essential component of the erythrocyte protein hemoglobin and is crucial to oxygen transport in vertebrates. In the steady state, erythrocyte production is in equilibrium with erythrocyte removal(1). In various pathophysiological conditions, however, erythrocyte life span is compromised severely, which threatens the organism with anemia and iron toxicity(2,3). Here we identify an on-demand mechanism that clears erythrocytes and recycles iron. We show that monocytes that express high levels of lymphocyte antigen 6 complex, locus C1 (LY6C1, also known as Ly-6C) ingest stressed and senescent erythrocytes, accumulate in the liver via coordinated chemotactic cues, and differentiate into ferroportin 1 (FPN1, encoded by SLC40A1)-expressing macrophages that can deliver iron to hepatocytes. Monocyte-derived FPN(1+)Tim-4(neg) macrophages are transient, reside alongside embryonically derived T cell immunoglobulin and mucin domain containing 4 (Timd4, also known as Tim-4)(high) Kupffer cells (KCs), and depend on the growth factor Csf1 and the transcription factor Nrf2 (encoded by Nfe2/2). The spleen, likewise, recruits iron-loaded Ly-6C(high) monocytes, but these do not differentiate into iron-recycling macrophages, owing to the suppressive action of Csf2. The accumulation of a transient macrophage population in the liver also occurs in mouse models of hemolytic anemia, anemia of inflammation, and sickle cell disease. Inhibition of monocyte recruitment to the liver during stressed erythrocyte delivery leads to kidney and liver damage. These observations identify the liver as the primary organ that supports rapid erythrocyte removal and iron recycling, and uncover a mechanism by which the body adapts to fluctuations in erythrocyte integrity.	[Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; He, Shun; Gerhardt, Louisa M. S.; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; McKee, Mary; Babitt, Jodie L.; Nahrendorf, Matthias; Weissleder, Ralph; Lin, Herbert Y.; Swirski, Filip K.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; He, Shun; Gerhardt, Louisa M. S.; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; McKee, Mary; Rezoagli, Emanuele; Babitt, Jodie L.; Berra, Lorenzo; Nahrendorf, Matthias; Weissleder, Ralph; Lin, Herbert Y.; Swirski, Filip K.] Harvard Med Sch, Boston, MA 02115 USA; [Theurl, Igor; Hilgendorf, Ingo; Nairz, Manfred; He, Shun; Gerhardt, Louisa M. S.; Fenn, Ashley M.; Anzai, Atsushi; Rattik, Sara; McAlpine, Cameron; Iwamoto, Yoshiko; Weber, Georg F.; Harder, Nina K.; Chousterman, Benjamin G.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Theurl, Igor; Tymoszuk, Piotr; Haschka, David; Asshoff, Malte; Seifert, Markus; Weiss, Guenter] Med Univ Innsbruck, Dept Internal Med 6, Infect Dis, Immunol,Rheumatol,Pneumol, Innsbruck, Austria; [Hilgendorf, Ingo] Univ Freiburg, Heart Ctr Freiburg, Freiburg, Germany; [Holderried, Tobias A. W.] Univ Hosp Bonn, Dept Internal Med Oncol Hematol & Rheumatol 3, Bonn, Germany; [Sopper, Sieghart] Med Univ Innsbruck, Dept Internal Med 5, Innsbruck, Austria; [Theurl, Milan] Med Univ Innsbruck, Dept Ophthalmol & Optometry, Innsbruck, Austria; [Wieghofer, Peter; Prinz, Marco] Univ Freiburg, Med Ctr, Inst Neuropathol, Freiburg, Germany; [Wieghofer, Peter] Univ Freiburg, Fac Biol, Freiburg, Germany; [Arvedson, Tara L.] Amgen Inc, Dept Oncol, Thousand Oaks, CA 91320 USA; [McKee, Mary; Babitt, Jodie L.; Lin, Herbert Y.] Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA; [Wang, Fudi] Zhejiang Univ, Inst Nutr & Food Safety, Nutr Discovery Innovat Ctr, Dept Nutr,Sch Publ Hlth,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Lutz, Oliver M. D.] Austrian Drug Screening Inst, Innsbruck, Austria; [Rezoagli, Emanuele; Berra, Lorenzo] Massachusetts Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Medical University of Innsbruck; Universitats Herzzentrum Freiburg; University of Freiburg; University of Bonn; Medical University of Innsbruck; Medical University of Innsbruck; University of Freiburg; University of Freiburg; Amgen; Harvard University; Massachusetts General Hospital; Zhejiang University; Harvard University; Massachusetts General Hospital; University of Freiburg; Harvard University; Harvard Medical School	Lin, HY; Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.; Lin, HY; Swirski, FK (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Swirski, FK (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Lin, HY (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Program Membrane Biol, Boston, MA 02114 USA.	Lin.Herbert@mgh.harvard.edu; fswirski@mgh.harvard.edu	Mckee, Martin/E-6673-2018; Wieghofer, Peter/AAV-9572-2020; Swirski, Filip/AAF-1340-2019; Wang, Fudi/L-7888-2018; Hilgendorf, Ingo/AFM-6379-2022; Sopper, Sieghart/I-3155-2018; McKee, Marc D/E-2187-2011; Holderried, Tobias/ABG-1525-2020	Mckee, Martin/0000-0002-0121-9683; Wang, Fudi/0000-0001-8730-0003; Hilgendorf, Ingo/0000-0002-0024-1643; Sopper, Sieghart/0000-0003-2265-1974; McKee, Marc D/0000-0001-8349-965X; Holderried, Tobias/0000-0002-2474-523X; Chousterman, Benjamin Glenn/0000-0002-9592-7014; Rezoagli, Emanuele/0000-0002-4506-7212; Nairz, Manfred/0000-0001-9103-7041; Weiss, Guenter/0000-0003-0709-2158; /0000-0003-0828-4143; Theurl, Igor/0000-0003-3180-4784; Swirski, Filip/0000-0002-3163-9152; McAlpine, Cameron/0000-0002-9832-6345; Tymoszuk, Piotr/0000-0002-0398-6034	US National Institutes of Health (NIH) [1R01HL095612, R01HL128264, R56AI104695]; Massachusetts General Hospital's Howard M. Goodman Fellowship [R01DK071837]; Max Kade Foundation; Austrian Science Fund (FWF) [P28302-B30, P24749-B13, HI 1573/1-1, HI 1573/2-1]; German Research Foundation; FWF Erwin Schroedinger Fellowship [J3486-B13]; Boehringer Ingelheim Fonds; National Natural Science Foundation of China [31530034, 31225013]; Austrian Science Fund (FWF) [J 3486, P 24749] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128264, R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI104695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, R01DK071837] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital's Howard M. Goodman Fellowship; Max Kade Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG)); FWF Erwin Schroedinger Fellowship; Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US National Institutes of Health (NIH) grants 1R01HL095612, R01HL128264, R56AI104695 and the Massachusetts General Hospital's Howard M. Goodman Fellowship (to F.K.S.) and R01DK071837 (to H.Y.L.). I.T. was supported by the Max Kade Foundation and grants by the Austrian Science Fund (FWF) (P28302-B30 and P24749-B13)). I.H. (HI 1573/1-1, HI 1573/2-1) and G.F.W. were supported by the German Research Foundation. M. Nairz was supported by an FWF Erwin Schroedinger Fellowship (J3486-B13). L.M.S.G. and N.K.H. were supported by the Boehringer Ingelheim Fonds. F.W. was supported by the National Natural Science Foundation of China (31530034 and 31225013). We thank D. Capen for help in electron microscopy; N. Bonheur and M. Waring for help with cell sorting; A. Lindau for technical assistance; C. Haerdtner, J. Kornemann, and J. Zou for help with flow cytometry; D. Brown for interpretation of electron microscopy images; C. Robbins for the mouse drawing; and K. Joyes for editing the manuscript.	Boston Massachusetts USA, MASS INT MED, VVI; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grundy MA, 2004, J BIOCHEM BIOPH METH, V59, P195, DOI 10.1016/j.jbbm.2004.01.001; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Ludwiczek S, 2007, NAT MED, V13, P448, DOI 10.1038/nm1542; Luten M, 2008, TRANSFUSION, V48, P1478, DOI 10.1111/j.1537-2995.2008.01734.x; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PRASAD AS, 1968, J CLIN INVEST, V47, P1415, DOI 10.1172/JCI105833; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Sarrazin S, 2011, SEMIN IMMUNOL, V23, P326, DOI 10.1016/j.smim.2011.08.011; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Terpstra V, 2000, BLOOD, V95, P2157, DOI 10.1182/blood.V95.6.2157; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Theurl M, 2008, J MOL MED, V86, P825, DOI 10.1007/s00109-008-0346-y; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Weinberg ED, 2010, METALLOMICS, V2, P732, DOI 10.1039/c0mt00023j; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wilairat P, 1992, Southeast Asian J Trop Med Public Health, V23 Suppl 2, P74; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; ZOCCHI E, 1987, BIOTECHNOL APPL BIOC, V9, P423	40	220	229	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					945	+		10.1038/nm.4146	http://dx.doi.org/10.1038/nm.4146			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27428900	Green Accepted, Green Submitted			2022-12-27	WOS:000381000200021
J	Sassoon, DA				Sassoon, David A.			Fatty acid metabolism-the first trigger for cachexia?	NATURE MEDICINE			English	Editorial Material							SKELETAL-MUSCLE; MAPK	A recent study shows that skeletal muscle responds to tumor-secreted factors by undergoing a change in fatty acid metabolism, and that blocking this metabolic response in mice inhibits muscle wasting.	[Sassoon, David A.] Univ Paris 06, INSERM, ICAN, Stem Cells & Regenerat Med,UMRS 1166, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sassoon, DA (corresponding author), Univ Paris 06, INSERM, ICAN, Stem Cells & Regenerat Med,UMRS 1166, Paris, France.	david.a.sassoon@gmail.com	SASSOON, David A/G-2502-2013	SASSOON, David A/0000-0001-6074-048X				Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Brack AS, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0072-z; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fukawa T, 2016, NAT MED, V22, P666, DOI 10.1038/nm.4093; KRUSZYNSKA YT, 1987, BIOCHEM PHARMACOL, V36, P3917, DOI 10.1016/0006-2952(87)90458-8; Segales J, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0074-x; Tisdale MJ, 2010, FUTURE ONCOL, V6, P503, DOI 10.2217/FON.10.20	9	2	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					584	585		10.1038/nm.4121	http://dx.doi.org/10.1038/nm.4121			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270777				2022-12-27	WOS:000377476000010
J	Gammon, K				Gammon, Katharine			Experimenting with blockchain Can one technology boost both data integrity and patients' pocketbooks?	NATURE MEDICINE			English	News Item																		[Anonymous], 2016, HEALTHC RALL BLOCKCH; Benchoufi M, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2035-z; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Weigmann K, 2015, EMBO REP, V16, P566, DOI 10.15252/embr.201540398	6	24	25	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					378	381		10.1038/nm0418-378	http://dx.doi.org/10.1038/nm0418-378			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634691				2022-12-27	WOS:000429639800003
J	Schulte, ML; Fu, A; Zhao, P; Li, J; Geng, L; Smith, ST; Kondo, J; Coffey, RJ; Johnson, MO; Rathmell, JC; Sharick, JT; Skala, MC; Smith, JA; Berlin, J; Washington, MK; Nickels, ML; Manning, HC				Schulte, Michael L.; Fu, Allie; Zhao, Ping; Li, Jun; Geng, Ling; Smith, Shannon T.; Kondo, Jumpei; Coffey, Robert J.; Johnson, Marc O.; Rathmell, Jeffrey C.; Sharick, Joe T.; Skala, Melissa C.; Smith, Jarrod A.; Berlin, Jordan; Washington, M. Kay; Nickels, Michael L.; Manning, H. Charles			Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models	NATURE MEDICINE			English	Article							BREAST-CANCER; SIGNALING PATHWAYS; COLORECTAL-CANCER; LUNG-CANCER; CELL-GROWTH; IN-VIVO; METABOLISM; INHIBITION; EXPRESSION; AUTOPHAGY	The unique metabolic demands of cancer cells underscore potentially fruitful opportunities for drug discovery in the era of precision medicine. However, therapeutic targeting of cancer metabolism has led to surprisingly few new drugs to date. The neutral amino acid glutamine serves as a key intermediate in numerous metabolic processes leveraged by cancer cells, including biosynthesis, cell signaling, and oxidative protection. Herein we report the preclinical development of V-9302, a competitive small molecule antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2. Pharmacological blockade of ASCT2 with V-9302 resulted in attenuated cancer cell growth and proliferation, increased cell death, and increased oxidative stress, which collectively contributed to antitumor responses in vitro and in vivo. This is the first study, to our knowledge, to demonstrate the utility of a pharmacological inhibitor of glutamine transport in oncology, representing a new class of targeted therapy and laying a framework for paradigm-shifting therapies targeting cancer cell metabolism.	[Schulte, Michael L.; Fu, Allie; Zhao, Ping; Li, Jun; Geng, Ling; Smith, Shannon T.; Nickels, Michael L.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Mol Probes, Nashville, TN 37235 USA; [Schulte, Michael L.; Nickels, Michael L.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN 37235 USA; [Schulte, Michael L.; Nickels, Michael L.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Kondo, Jumpei; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Coffey, Robert J.; Berlin, Jordan; Washington, M. Kay; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Coffey, Robert J.] Tennessee Valley Healthcare Syst, Vet Hlth Adm, Nashville, TN USA; [Johnson, Marc O.; Rathmell, Jeffrey C.; Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Sharick, Joe T.; Skala, Melissa C.; Manning, H. Charles] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Smith, Jarrod A.] Vanderbilt Univ, Vanderbilt Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Smith, Jarrod A.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN 37235 USA; [Manning, H. Charles] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Skala, Melissa C.] Univ Wisconsin, Dept Biomed Engn, Morgridge Inst Res, Madison, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Mol Probes, Nashville, TN 37235 USA.; Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN 37235 USA.; Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA.; Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA.; Manning, HC (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.; Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN 37235 USA.; Manning, HC (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.	henry.c.manning@vanderbilt.edu	Kondo, Jumpei/AAC-4336-2020	Kondo, Jumpei/0000-0002-1350-0480; Coffey, Robert/0000-0002-2180-3844	Vanderbilt Ingram Cancer Center (National Institutes of Health (NIH) National Cancer Institute (NCI)) [P30CA068485]; Center for Small Animal Imaging; Kleberg Foundation; Vanderbilt Trans-Institutional Program (TIPS) Award; Vanderbilt Specialized Program of Research Excellence (SPORE) in Gastrointestinal Cancer [NIH NCI P50CA095103]; NCI [R35CA197570]; Vanderbilt Digestive Disease Research Center (NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)) [P30DK058404]; NATIONAL CANCER INSTITUTE [R01CA217987, R35CA197570, P50CA095103, R01CA046413, R01CA185747, R01CA211082, P30CA068485, R01CA205101] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019963] Funding Source: NIH RePORTER	Vanderbilt Ingram Cancer Center (National Institutes of Health (NIH) National Cancer Institute (NCI)); Center for Small Animal Imaging; Kleberg Foundation; Vanderbilt Trans-Institutional Program (TIPS) Award; Vanderbilt Specialized Program of Research Excellence (SPORE) in Gastrointestinal Cancer; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Digestive Disease Research Center (NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge M. Tantawy for assistance with PET imaging, F. Revetta for histology expertise, and A. Rosenberg and A. Cohen for helpful discussions and editorial assistance. The authors wish to acknowledge research support from the Vanderbilt Ingram Cancer Center Support Grant (National Institutes of Health (NIH) National Cancer Institute (NCI) P30CA068485, H.C.M.), which supports the Vanderbilt-Ingram Cancer Center (VICC) Chemical Synthesis Core, Vanderbilt University Medical Center (VUMC) Radiochemistry Core, and Center for Small Animal Imaging; the Kleberg Foundation (H.C.M.); a Vanderbilt Trans-Institutional Program (TIPS) Award to the Vanderbilt Center for Molecular Probes (H.C.M.); the Vanderbilt Specialized Program of Research Excellence (SPORE) in Gastrointestinal Cancer (NIH NCI P50CA095103, R.J.C. and H.C.M.); an Outstanding Investigator Award from the NCI (R35CA197570, R.J.C.); and the Vanderbilt Digestive Disease Research Center (NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) P30DK058404, H.C.M.).	Canul-Tec JC, 2017, NATURE, V544, P446, DOI 10.1038/nature22064; Chiu M, 2017, AMINO ACIDS, V49, P1365, DOI 10.1007/s00726-017-2436-z; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; HARDING JJ, 2015, J CLIN ONCOL S, V33; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Huang F, 2014, INT J CLIN EXP PATHO, V7, P1093; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; McKinley ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108193; McKinley ET, 2011, CLIN CANCER RES, V17, P3332, DOI 10.1158/1078-0432.CCR-10-2274; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pochini L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00061; Rathmell JC, 2011, IMMUNITY, V35, P845, DOI 10.1016/j.immuni.2011.12.001; Rhoads JM, 2000, GASTROENTEROLOGY, V118, P90, DOI 10.1016/S0016-5085(00)70417-3; Rhoads JM, 1997, AM J PHYSIOL-GASTR L, V272, pG943, DOI 10.1152/ajpgi.1997.272.5.G943; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; Santio NM, 2016, EXP CELL RES, V342, P113, DOI 10.1016/j.yexcr.2016.02.018; Schulte ML, 2017, MOL IMAGING BIOL, V19, P421, DOI 10.1007/s11307-016-1008-z; Schulte ML, 2016, BIOORG MED CHEM LETT, V26, P1044, DOI 10.1016/j.bmcl.2015.12.031; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shatz O, 2016, TRENDS BIOCHEM SCI, V41, P907, DOI 10.1016/j.tibs.2016.08.001; Shukla K, 2012, J MED CHEM, V55, P10551, DOI 10.1021/jm301191p; Skala M, 2010, METHODS MOL BIOL, V594, P155, DOI 10.1007/978-1-60761-411-1_11; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tresse E, 2008, AUTOPHAGY, V4, P680, DOI 10.4161/auto.6084; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walsh AJ, 2014, CANCER RES, V74, P5184, DOI 10.1158/0008-5472.CAN-14-0663; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Willems L, 2013, BLOOD, V122, P3521, DOI 10.1182/blood-2013-03-493163; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836	42	196	202	20	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					194	+		10.1038/nm.4464	http://dx.doi.org/10.1038/nm.4464			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29334372	Green Accepted			2022-12-27	WOS:000424327200016
J	Burma, NE; Bonin, RP; Leduc-Pessah, H; Baimel, C; Cairncross, ZF; Mousseau, M; Shankara, JV; Stemkowski, PL; Baimoukhametova, D; Bains, JS; Antle, MC; Zamponi, GW; Cahill, CM; Borgland, SL; DeKoninck, Y; Trang, T				Burma, Nicole E.; Bonin, Robert P.; Leduc-Pessah, Heather; Baimel, Corey; Cairncross, Zoe F.; Mousseau, Michael; Shankara, Jhenkruthi Vijaya; Stemkowski, Patrick L.; Baimoukhametova, Dinara; Bains, Jaideep S.; Antle, Michael C.; Zamponi, Gerald W.; Cahill, Catherine M.; Borgland, Stephanie L.; DeKoninck, Yves; Trang, Tuan			Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents (vol 23, pg 355, 2017)	NATURE MEDICINE			English	Correction													Leduc-Pessah, Heather/HCH-2964-2022; Cahill, Catherine/AAA-1611-2019	Zamponi, Gerald W./0000-0002-0644-9066	Alberta Innovates [201500085] Funding Source: researchfish	Alberta Innovates		Burma NE, 2017, NAT MED, V23, P355, DOI 10.1038/nm.4281	1	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					788	788		10.1038/nm0617-788c	http://dx.doi.org/10.1038/nm0617-788c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586339	Bronze, Green Published			2022-12-27	WOS:000402768000025
J	Chu, DM; Ma, J; Prince, AL; Antony, KM; Seferovic, MD; Aagaard, KM				Chu, Derrick M.; Ma, Jun; Prince, Amanda L.; Antony, Kathleen M.; Seferovic, Maxim D.; Aagaard, Kjersti M.			Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery	NATURE MEDICINE			English	Article							GUT MICROBIOME; INTESTINAL MICROBIOTA; BIRTH MODE; ASSOCIATION; BACTERIA; COLONIZATION; DIVERSITY; HABITATS; IMPACT; CELLS	Human microbial communities are characterized by their taxonomic, metagenomic and metabolic diversity, which varies by distinct body sites and influences human physiology. However, when and how microbial communities within each body niche acquire unique taxonomical and functional signatures in early life remains underexplored. We thus sought to determine the taxonomic composition and potential metabolic function of the neonatal and early infant microbiota across multiple body sites and assess the effect of the mode of delivery and its potential confounders or modifiers. A cohort of pregnant women in their early third trimester (n = 81) were prospectively enrolled for longitudinal sampling through 6 weeks after delivery, and a second matched cross-ectional cohort (n = 81) was additionally recruited for sampling once at the time of delivery. Samples across multiple body sites, including stool, oral gingiva, nares, skin and vagina were collected for each maternal-infant dyad. Whole-genome shotgun sequencing and sequencing analysis of the gene encoding the 16S rRNA were performed to interrogate the composition and function of the neonatal and maternal microbiota. We found that the neonatal microbiota and its associated functional pathways were relatively homogeneous across all body sites at delivery, with the notable exception of the neonatal meconium. However, by 6 weeks after delivery, the infant microbiota structure and function had substantially expanded and diversified, with the body site serving as the primary determinant of the composition of the bacterial community and its functional capacity. Although minor variations in the neonatal (immediately at birth) microbiota community structure were associated with the cesarean mode of delivery in some body sites (oral gingiva, nares and skin; R-2 = 0.038), this was not true for neonatal stool (meconium; Mann-Whitney P> 0.05), and there was no observable difference in community function regardless of delivery mode. For infants at 6 weeks of age, the microbiota structure and function had expanded and diversified with demonstrable body site specificity (P < 0.001, R-2 = 0.189) but without discernable differences in community structure or function between infants delivered vaginally or by cesarean surgery (P = 0.057, R-2 = 0.007). We conclude that within the first 6 weeks of life, the infant microbiota undergoes substantial reorganization, which is primarily driven by body site and not by mode of delivery.	[Chu, Derrick M.; Ma, Jun; Prince, Amanda L.; Antony, Kathleen M.; Seferovic, Maxim D.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Chu, Derrick M.; Aagaard, Kjersti M.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Chu, Derrick M.; Aagaard, Kjersti M.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Aagaard, KM (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA.	aagaardt@bcm.edu		Antony, Kathleen M/0000-0003-3537-8030	NIH [DP2 DP21DP20D001500]; NIH-NINR [NR014792-01]; NIH National Children's Study Formative Research [N01-HD-80020]; Burroughs Welcome Fund Preterm Birth Initiative; March of Dimes Preterm Birth Research Initiative; Baylor College of Medicine Medical Scientist Training Program [NIH NIGMS T32 GM007330]; National Institute of General Medical Sciences [T32GM088129]; Baylor Research Advocates for Student Scientists; Human Microbiome Project through the NIH Director's Common Fund at the National Institutes of Health; National Human Genome Research Institute (NHGRI) at NIH [U54HG004973]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD082969, R01HD091731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330, T32GM088129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIH National Children's Study Formative Research; Burroughs Welcome Fund Preterm Birth Initiative; March of Dimes Preterm Birth Research Initiative; Baylor College of Medicine Medical Scientist Training Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Baylor Research Advocates for Student Scientists; Human Microbiome Project through the NIH Director's Common Fund at the National Institutes of Health; National Human Genome Research Institute (NHGRI) at NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge the support of the NIH Director's New Innovator Award (DP2 DP21DP20D001500; K.M. Aagaard), the NIH-NINR (NR014792-01; K.M. Aagaard), the NIH National Children's Study Formative Research (N01-HD-80020; K.M. Aagaard), the Burroughs Welcome Fund Preterm Birth Initiative (K.M. Aagaard), the March of Dimes Preterm Birth Research Initiative (K.M. Aagaard), the Baylor College of Medicine Medical Scientist Training Program (NIH NIGMS T32 GM007330; D.C. and K.M. Aagaard), the National Institute of General Medical Sciences (T32GM088129; D.M.C.), Baylor Research Advocates for Student Scientists (D.M.C.) and the Human Microbiome Project funded through the NIH Director's Common Fund at the National Institutes of Health (as part of NIH RoadMap 1.5; K.M. Aagaard). All sequencing and adaptation of protocols for WGS sequencing were performed by the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC), which is funded by direct support from the National Human Genome Research Institute (NHGRI) at NIH (U54HG004973 (BCM); R. Gibbs, Principal Investigator). The authors also thank the staff members who were directly involved in clinical recruitment and specimen processing (M. Moller, B. Boggan, R. Benjamin, J. Chen, C. Cook and D. Racusin). The authors are grateful to M. Belfort, J. Versalovic, T. Savidge, R.A. Luna, D. Racusin, M. Suter and K. Meyer for critical review of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; Antony KM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.041; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Barber EL, 2011, OBSTET GYNECOL, V118, P29, DOI 10.1097/AOG.0b013e31821e5f65; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Black M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001973; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Chu Derrick M, 2016, Genome Med, V8, P77, DOI 10.1186/s13073-016-0330-z; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Kennedy DO, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020068; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mueller NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23133; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Osterman Michelle J K, 2014, Natl Vital Stat Rep, V63, P1; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917	60	494	522	9	245	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					314	326		10.1038/nm.4272	http://dx.doi.org/10.1038/nm.4272			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28112736	Green Accepted			2022-12-27	WOS:000395848400012
J	Mamonkin, M; Heslop, HE				Mamonkin, Maksim; Heslop, Helen E.			Exhausting alloreactivity of donor-derived CAR T cells	NATURE MEDICINE			English	News Item							CHIMERIC ANTIGEN RECEPTORS; MALIGNANCIES	A study in mouse models of allogeneic stem cell transplantation with donor-derived CD19 chimeric antigen receptor (CAR) T cells for the treatment of relapsed B cell malignancies indicates that T cell exhaustion might have a role in preventing allogeneic reactivity of CD19 CAR T cells.	[Heslop, Helen E.] Houston Methodist Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine	Heslop, HE (corresponding author), Houston Methodist Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	hheslop@bcm.edu	Heslop, Helen/AAC-9500-2020	Mamonkin, Maksim/0000-0001-7178-8163	NCI NIH HHS [P30 CA125123, P50 CA126752] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA126752, P30CA125123] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Ghosh A, 2017, NAT MED, V23, P242, DOI 10.1038/nm.4258; Jacoby E, 2016, BLOOD, V127, P1361, DOI 10.1182/blood-2015-08-664250; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Terakura S, 2012, BLOOD, V119, P72, DOI 10.1182/blood-2011-07-366419	9	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					147	148		10.1038/nm.4276	http://dx.doi.org/10.1038/nm.4276			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170385				2022-12-27	WOS:000393729000005
J	Malherbe, ST; Shenai, S; Ronacher, K; Loxton, AG; Dolganov, G; Kriel, M; Van, T; Chen, RY; Warwick, J; Via, LE; Song, T; Lee, M; Schoolnik, G; Tromp, G; Alland, D; Barry, CE; Winter, J; Walzl, G				Malherbe, Stephanus T.; Shenai, Shubhada; Ronacher, Katharina; Loxton, Andre G.; Dolganov, Gregory; Kriel, Magdalena; Tran Van; Chen, Ray Y.; Warwick, James; Via, Laura E.; Song, Taeksun; Lee, Myungsun; Schoolnik, Gary; Tromp, Gerard; Alland, David; Barry, Clifton E., III; Winter, Jill; Walzl, Gerhard		Catalysis TB-Biomarker Consortium	Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure	NATURE MEDICINE			English	Article							RECURRENT TUBERCULOSIS; PULMONARY IMPAIRMENT; SHORTENING TREATMENT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; RELAPSE; REINFECTION; SYMPTOMS; HIV; MOXIFLOXACIN	The absence of a gold standard to determine when antibiotics induce a sterilizing cure has confounded the development of new approaches to treat pulmonary tuberculosis (PTB). We detected positron emission tomography and computerized tomography (PET-CT) imaging response patterns consistent with active disease, along with the presence of Mycobacterium tuberculosis (MTB) mRNA in sputum and bronchoalveolar lavage samples, in a substantial proportion of adult, HIV-negative patients with PTB after a standard 6-month treatment plus 1 year follow-up, including patients with a durable cure and others who later developed recurrent disease. The presence of MTB mRNA in the context of nonresolving and intensifying lesions on PET-CT images might indicate ongoing transcription, suggesting that even apparently curative treatment for PTB may not eradicate all of the MTB bacteria in most patients. This suggests an important complementary role for the immune response in maintaining a disease-free state. Sterilizing drugs or host-directed therapies, and better treatment response markers, are probably needed for the successful development of improved and shortened PTB-treatment strategies.	[Malherbe, Stephanus T.; Ronacher, Katharina; Loxton, Andre G.; Kriel, Magdalena; Tromp, Gerard; Barry, Clifton E., III; Walzl, Gerhard] Univ Stellenbosch, Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Cape Town, South Africa; [Malherbe, Stephanus T.; Ronacher, Katharina; Loxton, Andre G.; Kriel, Magdalena; Tromp, Gerard; Barry, Clifton E., III; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, South African Med Res Council,Ctr TB Res, Cape Town, South Africa; [Shenai, Shubhada] Rutgers New Jersey Med Sch, Dept Med, Ctr Emerging Pathogens, Newark, NJ USA; [Dolganov, Gregory; Tran Van] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Chen, Ray Y.; Via, Laura E.] NIAID, TB Res Sect, Lab Clin Infect Dis, Div Intramural Res,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Warwick, James] Tygerberg Acad Hosp, Western Cape Acad Positron Emiss Tomog Computed T, Cape Town, South Africa; [Warwick, James] Univ Stellenbosch, Div Nucl Med, Dept Med Imaging & Clin Oncol, Fac Med & Hlth Sci, Cape Town, South Africa; [Via, Laura E.; Barry, Clifton E., III] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Clin Lab Sci, Cape Town, South Africa; [Song, Taeksun; Lee, Myungsun] Int TB Res Ctr, Seoul, South Korea; [Winter, Jill] Catalysis Fdn Hlth, Emeryville, CA USA; Natl Med Ctr, Seoul, South Korea; NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; Univ Stellenbosch, Divis Pulmonol, Fac Med & Hlth Sci, Cape Town, South Africa; Univ Stellenbosch, Fac Med & Hlth Sci, Med Imaging & Clin Oncol, Div Radiodiag, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University; South African Medical Research Council; Stellenbosch University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stellenbosch University; University of Cape Town; National Medical Center - Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stellenbosch University; Stellenbosch University	Malherbe, ST (corresponding author), Univ Stellenbosch, Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Cape Town, South Africa.; Malherbe, ST (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, South African Med Res Council,Ctr TB Res, Cape Town, South Africa.	malherbe@sun.ac.za	Via, Laura/AAD-3917-2021; Tromp, Gerard/B-2677-2017; Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019; Ronacher, Katharina/N-9603-2016; Barry, III, Clifton/H-3839-2012; van der Spuy, Gian/AAY-7701-2020; Barry, Clifton E/ABE-7992-2020; Walzl, Gerhard/N-6371-2016	Via, Laura/0000-0001-6074-9521; Tromp, Gerard/0000-0002-7761-0806; Ronacher, Katharina/0000-0002-6371-1462; Barry, III, Clifton/0000-0002-2927-270X; van der Spuy, Gian/0000-0002-9067-5903; Barry, Clifton E/0000-0002-2927-270X; Malherbe, Stephanus/0000-0002-7563-8231; Walzl, Gerhard/0000-0003-2487-125X; Loxton, Andre/0000-0003-0659-9803; Warwick, James/0000-0002-2810-0543; Beltran, Caroline/0000-0001-5208-0506; du Plessis, Nelita/0000-0001-7881-925X	Catalysis Foundation for Health (CFH); Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases, International Collaborations in Infectious Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001214, ZIAAI001067] Funding Source: NIH RePORTER	Catalysis Foundation for Health (CFH); Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, International Collaborations in Infectious Disease Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by grants from the Catalysis Foundation for Health (CFH) (G.W., C.E.B. and D.A.) the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (C.E.B.) and the National Institute of Allergy and Infectious Diseases, International Collaborations in Infectious Disease Research (G.W.), as well as by a bursary from the South African National Research Fund and the Medical Research Council's Clinician Scholarship Program (S.T.M.). We thank our participants for their willingness to take part in this study. We acknowledge R. Thayer and M. Urdea of CFH, the staff at the Stellenbosch University Immunology Research Group, the International TB Research Center (Seoul), the Western Cape Academic PET-CT Centre, Ithemba LABS, Tygerberg Academic Hospital's Nuclear Medicine Department and Pulmonology Unit, as well as the managers and healthcare providers from the City of Cape Town Health Department for assistance with the recruitment of participants and sample collection.	Baig IM, 2010, JCPSP-J COLL PHYSICI, V20, P542, DOI 08.2010/JCPSP.542544; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cheebsumon P, 2011, J NUCL MED, V52, P1550, DOI 10.2967/jnumed.111.088914; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Coleman MT, 2014, INFECT IMMUN, V82, P2400, DOI 10.1128/IAI.01599-13; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Demura Y, 2009, EUR J NUCL MED MOL I, V36, P632, DOI 10.1007/s00259-008-1009-5; Dibble EH, 2012, J NUCL MED, V53, P709, DOI 10.2967/jnumed.111.099531; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Dureja S, 2014, EUR SPINE J, V23, P2449, DOI 10.1007/s00586-014-3483-8; Nihues SDE, 2015, BRAZ J INFECT DIS, V19, P492, DOI 10.1016/j.bjid.2015.06.005; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Hu YM, 2000, J BACTERIOL, V182, P6358, DOI 10.1128/JB.182.22.6358-6365.2000; Huang W, 2011, EUR J NUCL MED MOL I, V38, P1628, DOI 10.1007/s00259-011-1838-5; Ignatov DV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2197-6; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Jones L. M. C. S., TUBERCULIST TB GENE; Lahtinen SJ, 2008, LETT APPL MICROBIOL, V46, P693, DOI 10.1111/j.1472-765X.2008.02374.x; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Luzze H, 2013, INT J TUBERC LUNG D, V17, P361, DOI 10.5588/ijtld.11.0692; Marais B, 2008, INT J TUBERC LUNG D, V12, P1217; Martinez V, 2012, INT J TUBERC LUNG D, V16, P1180, DOI 10.5588/ijtld.12.0010; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Middelkoop K, 2012, INT J TUBERC LUNG D, V16, P1510, DOI 10.5588/ijtld.12.0049; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; MITTL RL, 1994, AM J RESP CRIT CARE, V149, P630, DOI 10.1164/ajrccm.149.3.8118630; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pasipanodya JG, 2007, CHEST, V132, P1591, DOI 10.1378/chest.07-0755; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pasipanodya JG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-259; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Ramos Lucia Maria Macedo, 2006, J. bras. pneumol., V32, P43, DOI 10.1590/S1806-37132006000100010; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Sathekge M, 2011, J NUCL MED, V52, P880, DOI 10.2967/jnumed.110.083709; Seon HJ, 2014, INT J TUBERC LUNG D, V18, P341, DOI 10.5588/ijtld.13.0565; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Stelzmueller I, 2016, CLIN NUCL MED, V41, pE187, DOI 10.1097/RLU.0000000000001102; Stop TB Partnership, 2016, GLOB PLAN STOP TB 20; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149; Warner DF, 2014, NEW ENGL J MED, V371, P1642, DOI 10.1056/NEJMe1410977; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2015, GLOB TUB REP 2015; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	52	167	174	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1094	1100		10.1038/nm.4177	http://dx.doi.org/10.1038/nm.4177			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595324	Green Accepted			2022-12-27	WOS:000384872500012
J	Stellos, K; Gatsiou, A; Stamatelopoulos, K; Matic, LP; John, D; Lunella, FF; Jae, N; Rossbach, O; Amrhein, C; Sigala, F; Boon, RA; Furtig, B; Manavski, Y; You, XT; Uchida, S; Keller, T; Boeckel, JN; Franco-Cereceda, A; Maegdefessel, L; Chen, W; Schwalbe, H; Bindereif, A; Eriksson, P; Hedin, U; Zeiher, AM; Dimmeler, S				Stellos, Konstantinos; Gatsiou, Aikaterini; Stamatelopoulos, Kimon; Matic, Ljubica Perisic; John, David; Lunella, Federica Francesca; Jae, Nicolas; Rossbach, Oliver; Amrhein, Carolin; Sigala, Frangiska; Boon, Reinier A.; Fuertig, Boris; Manavski, Yosif; You, Xintian; Uchida, Shizuka; Keller, Till; Boeckel, Jes-Niels; Franco-Cereceda, Anders; Maegdefessel, Lars; Chen, Wei; Schwalbe, Harald; Bindereif, Albrecht; Eriksson, Per; Hedin, Ulf; Zeiher, Andreas M.; Dimmeler, Stefanie			Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation	NATURE MEDICINE			English	Article							BINDING PROTEIN HUR; HUMAN TRANSCRIPTOME; GENE-EXPRESSION; MESSENGER-RNA; ALU ELEMENTS; TUMOR-GROWTH; ENZYME ADAR1; LUNG INJURY; ANGIOGENESIS; STABILIZATION	Adenosine-to-inosine (A-to-I) RNA editing, which is catalyzed by a family of adenosine deaminase acting on RNA (ADAR) enzymes, is important in the epitranscriptomic regulation of RNA metabolism. However, the role of A-to-I RNA editing in vascular disease is unknown. Here we show that cathepsin S mRNA (CTSS), which encodes a cysteine protease associated with angiogenesis and atherosclerosis, is highly edited in human endothelial cells. The 3' untranslated region (3' UTR) of the CTSS transcript contains two inverted repeats, the AluJo and AluSx(+) regions, which form a long stem loop structure that is recognized by ADAR1 as a substrate for editing. RNA editing enables the recruitment of the stabilizing RNA-binding protein human antigen R (HuR; encoded by ELAVL1) to the 3' UTR of the CTSS transcript, thereby controlling CTSS mRNA stability and expression. In endothelial cells, ADAR1 overexpression or treatment of cells with hypoxia or with the inflammatory cytokines interferon-gamma and tumor-necrosis-factor-alpha induces CTSS RNA editing and consequently increases cathepsin S expression. ADAR1 levels and the extent of CTSS RNA editing are associated with changes in cathepsin S levels in patients with atherosclerotic vascular diseases, including subclinical atherosclerosis, coronary artery disease, aortic aneurysms and advanced carotid atherosclerotic disease. These results reveal a previously unrecognized role of RNA editing in gene expression in human atherosclerotic vascular diseases.	[Stellos, Konstantinos; Gatsiou, Aikaterini; John, David; Lunella, Federica Francesca; Jae, Nicolas; Amrhein, Carolin; Boon, Reinier A.; Manavski, Yosif; Uchida, Shizuka; Boeckel, Jes-Niels; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany; [Stellos, Konstantinos; Keller, Till; Zeiher, Andreas M.] Goethe Univ Frankfurt, Ctr Internal Med, Dept Cardiol, Frankfurt, Germany; [Stellos, Konstantinos; Gatsiou, Aikaterini; John, David; Lunella, Federica Francesca; Jae, Nicolas; Boon, Reinier A.; Manavski, Yosif; Uchida, Shizuka; Keller, Till; Boeckel, Jes-Niels; Zeiher, Andreas M.; Dimmeler, Stefanie] Deutsch Zentrum Herz Kreislaufforsch DZHK, German Ctr Cardiovasc Res, Rhein Main Partner Site, Frankfurt, Germany; [Stamatelopoulos, Kimon] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece; [Matic, Ljubica Perisic; Hedin, Ulf] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Rossbach, Oliver; Bindereif, Albrecht] Univ Giessen, Inst Biochem, Giessen, Germany; [Sigala, Frangiska] Univ Athens, Hippocratio Gen Hosp, Propaedeut Dept Surg 1, Dept Vasc Surg, Athens, Greece; [Fuertig, Boris; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, Frankfurt, Germany; [You, Xintian; Chen, Wei] Max Delbruck Ctr Mol Med Berlin Buch, Lab Funct Genom & Syst Biol, Berlin, Germany; [Franco-Cereceda, Anders] Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden; [Maegdefessel, Lars; Eriksson, Per] Karolinska Inst, Dept Med, Cardiovasc Med Unit, Stockholm, Sweden; [Maegdefessel, Lars] Tech Univ Munich, Dept Vasc & Endovasc Surg, Munich, Germany	Goethe University Frankfurt; Goethe University Frankfurt; German Centre for Cardiovascular Research; Alexandra Hospital; National & Kapodistrian University of Athens; Karolinska Institutet; Justus Liebig University Giessen; National & Kapodistrian University of Athens; Goethe University Frankfurt; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet; Karolinska Institutet; Technical University of Munich	Stellos, K; Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany.; Stellos, K (corresponding author), Goethe Univ Frankfurt, Ctr Internal Med, Dept Cardiol, Frankfurt, Germany.; Stellos, K; Dimmeler, S (corresponding author), Deutsch Zentrum Herz Kreislaufforsch DZHK, German Ctr Cardiovasc Res, Rhein Main Partner Site, Frankfurt, Germany.	konstantinos.stellos@gmail.com; dimmeler@em.uni-frankfurt.de	Rossbach, Oliver/AAO-2529-2020; Boon, Reinier A/E-8423-2011; Stamatelopoulos, Kimon/AAD-6993-2019; Uchida, Shizuka/AAC-6781-2019; Stellos, Konstantinos/AAF-2711-2020; Stellos, Konstantinos/ABH-1523-2021; Schwalbe, Harald J/F-9023-2010; Maegdefessel, Lars/AAW-8243-2020; Schwalbe, Harald/AAB-3143-2020; Maegdefessel, Lars/C-2955-2015	Boon, Reinier A/0000-0001-7944-9748; Stamatelopoulos, Kimon/0000-0001-6444-8734; Uchida, Shizuka/0000-0003-4787-8067; Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; YOU, Xintian/0000-0002-1684-7084; Gatsiou, Aikaterini/0000-0003-4144-4305; Maegdefessel, Lars/0000-0001-5228-2634; Keller, Till/0000-0002-0895-6491; Eriksson, Per/0000-0002-5635-2692; Rossbach, Oliver/0000-0002-1172-0359; Dimmeler, Stefanie/0000-0002-1045-2436; John, David/0000-0003-3217-5449; Stellos, Konstantinos/0000-0002-0194-0825; Hedin, Ulf/0000-0001-9212-3945	'FFF-Innovation' program of the J.W. Goethe University Frankfurt; August-Scheidel Stiftung; Excellence Cluster Cardio-Pulmonary System (ECCPS); Else Kroner-Fresenius-Stiftung; LOEWE Center for Cell and Gene Therapy (State of Hessen); German Center for Cardiovascular Research (DZHK); German Cardiac Society; DFG [SFB902]; Swedish Heart and Lung Foundation; Karolinska Institutet; Stockholm County Council; Foundation for Strategic Research; European Commission; Swedish Society for Medical Research (SSMF); Swedish Research Council; Swedish Heart-Lung Foundation; LOEWE program 'Medical RNomics' (State of Hessen); Uppdrag Besegra Stroke	'FFF-Innovation' program of the J.W. Goethe University Frankfurt; August-Scheidel Stiftung; Excellence Cluster Cardio-Pulmonary System (ECCPS)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; LOEWE Center for Cell and Gene Therapy (State of Hessen); German Center for Cardiovascular Research (DZHK); German Cardiac Society; DFG(German Research Foundation (DFG)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Foundation for Strategic Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Society for Medical Research (SSMF); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); LOEWE program 'Medical RNomics' (State of Hessen); Uppdrag Besegra Stroke	This work was funded by the 'FFF-Innovation 2012' program of the J.W. Goethe University Frankfurt (K. Stellos), the August-Scheidel Stiftung (K. Stellos), the Excellence Cluster Cardio-Pulmonary System (ECCPS) (K. Stellos), the Else Kroner-Fresenius-Stiftung (K. Stellos), the LOEWE Center for Cell and Gene Therapy (State of Hessen) (K. Stellos), the German Center for Cardiovascular Research (DZHK) (K. Stellos) and the German Cardiac Society (K. Stellos). H.S. and S.D. are members of the cluster of excellence 'macromolecular complexes. B.F., H.S. and S.D. are supported by DFG SFB902. The BiKE study (U.H.) was conducted with support from the Swedish Heart and Lung Foundation, the Swedish Research Council, Uppdrag Besegra Stroke, the Strategic Cardiovascular Programs of Karolinska Institutet and the Stockholm County Council, the Foundation for Strategic Research and the European Commission (CarTarDis, AtheroRemo, VIA and AtheroFlux projects). L.P.M. was supported by the Swedish Society for Medical Research (SSMF). The thoracic aortic aneurysm study (P.E.) was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation and a donation by F. Lundberg. O.R. is supported by the LOEWE program 'Medical RNomics' (State of Hessen). The authors would like to thank I. Dikic (Goethe University Frankfurt) for providing us with the HeLa cells, A. Knau for expert technical support, G. Georgiopoulos for statistical consulting, R. Achangwa and M. Sachse for proofreading, M. Karakitsou for technical assistance in subclinical atherosclerosis assessment, and A. Mareti, C. Kritsioti and A. Kotsogianni for helping with the recruitment of patients of the PBMC cohort.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Barak M, 2009, NUCLEIC ACIDS RES, V37, P6905, DOI 10.1093/nar/gkp729; Bass BL, 1997, RNA, V3, P947; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Chang SH, 2013, J BIOL CHEM, V288, P4908, DOI 10.1074/jbc.M112.423871; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Gandy SZ, 2007, J VIROL, V81, P13544, DOI 10.1128/JVI.01521-07; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Jobs E, 2011, JAMA-J AM MED ASSOC, V306, P1113, DOI 10.1001/jama.2011.1246; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nevo-Caspi Y, 2011, SHOCK, V35, P585, DOI 10.1097/SHK.0b013e31820fe4b7; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Perisic L, 2016, J INTERN MED, V279, P293, DOI 10.1111/joim.12448; Qiu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.125; Rabinovici R, 2001, CIRC RES, V88, P1066, DOI 10.1161/hh1001.090877; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Stamatelopoulos K, 2015, J AM COLL CARDIOL, V65, P904, DOI 10.1016/j.jacc.2014.12.035; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wu YM, 2009, SHOCK, V31, P410, DOI 10.1097/SHK.0b013e31817c1068; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yang JH, 2003, IMMUNOLOGY, V109, P15, DOI 10.1046/j.1365-2567.2003.01598.x	52	159	163	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1140	1150		10.1038/nm.4172	http://dx.doi.org/10.1038/nm.4172			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595325				2022-12-27	WOS:000384872500017
J	Ishizuka, AS; Lyke, KE; DeZure, A; Berry, AA; Richie, TL; Mendoza, FH; Enama, ME; Gordon, IJ; Chang, LJ; Sarwar, UN; Zephir, KL; Holman, LA; James, ER; Billingsley, PF; Gunasekera, A; Chakravarty, S; Manoj, A; Li, ML; Ruben, AJ; Li, T; Eappen, AG; Stafford, RE; Natasha, KC; Murshedkar, T; DeCederfelt, H; Plummer, SH; Hendel, CS; Novik, L; Costner, PJM; Saunders, JG; Laurens, MB; Plowe, CV; Flynn, B; Whalen, WR; Todd, JP; Noor, J; Rao, S; Sierra-Davidson, K; Lynn, GM; Epstein, JE; Kemp, MA; Fahle, GA; Mikolajczak, SA; Fishbaugher, M; Sack, BK; Kappe, SHI; Davidson, SA; Garver, LS; Bjorkstrom, NK; Nason, MC; Graham, BS; Roederer, M; Sim, BKL; Hoffman, SL; Ledgerwood, JE; Seder, RA				Ishizuka, Andrew S.; Lyke, Kirsten E.; DeZure, Adam; Berry, Andrea A.; Richie, Thomas L.; Mendoza, Floreliz H.; Enama, Mary E.; Gordon, Ingelise J.; Chang, Lee-Jah; Sarwar, Uzma N.; Zephir, Kathryn L.; Holman, LaSonji A.; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Chakravarty, Sumana; Manoj, Anita; Li, MingLin; Ruben, Adam J.; Li, Tao; Eappen, Abraham G.; Stafford, Richard E.; Natasha, K. C.; Murshedkar, Tooba; DeCederfelt, Hope; Plummer, Sarah H.; Hendel, Cynthia S.; Novik, Laura; Costner, Pamela J. M.; Saunders, Jamie G.; Laurens, Matthew B.; Plowe, Christopher V.; Flynn, Barbara; Whalen, William R.; Todd, J. P.; Noor, Jay; Rao, Srinivas; Sierra-Davidson, Kailan; Lynn, Geoffrey M.; Epstein, Judith E.; Kemp, Margaret A.; Fahle, Gary A.; Mikolajczak, Sebastian A.; Fishbaugher, Matthew; Sack, Brandon K.; Kappe, Stefan H. I.; Davidson, Silas A.; Garver, Lindsey S.; Bjorkstrom, Niklas K.; Nason, Martha C.; Graham, Barney S.; Roederer, Mario; Sim, B. Kim Lee; Hoffman, Stephen L.; Ledgerwood, Julie E.; Seder, Robert A.		VRC 312 & VRC 314 Study Team	Protection against malaria at 1 year and immune correlates following PfSPZ vaccination (vol 22, pg 614, 2016)	NATURE MEDICINE			English	Correction													Roederer, Mario/G-1887-2011; Graham, Barney S./AAC-5898-2019; Laurens, Matthew/E-7293-2013; Bjorkstrom, Niklas/N-2919-2017	Graham, Barney S./0000-0001-8112-0853; Laurens, Matthew/0000-0003-3874-581X; Richie, Thomas/0000-0002-2946-5456; Chang, Lee-Jah/0000-0003-1766-3153; Berry, Andrea/0000-0003-3140-3868; Mikolajczak, Sebastian/0000-0003-1996-9703; Bjorkstrom, Niklas/0000-0002-0967-076X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005021, ZICAI005103, ZICAI005101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					692	692		10.1038/nm0616-692c	http://dx.doi.org/10.1038/nm0616-692c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270781				2022-12-27	WOS:000377476000017
J	Satpathy, AT; Saligrama, N; Buenrostro, JD; Wei, YN; Wu, BJ; Rubin, AJ; Granja, JM; Lareau, CA; Li, R; Qi, YY; Parker, KR; Mumbach, MR; Serratelli, WS; Gennert, DG; Schep, AN; Corces, MR; Khodadoust, MS; Kim, YH; Khavari, PA; Greenleaf, WJ; Davis, MM; Chang, HY				Satpathy, Ansuman T.; Saligrama, Naresha; Buenrostro, Jason D.; Wei, Yuning; Wu, Beijing; Rubin, Adam J.; Granja, Jeffrey M.; Lareau, Caleb A.; Li, Rui; Qi, Yanyan; Parker, Kevin R.; Mumbach, Maxwell R.; Serratelli, William S.; Gennert, David G.; Schep, Alicia N.; Corces, M. Ryan; Khodadoust, Michael S.; Kim, Youn H.; Khavari, Paul A.; Greenleaf, William J.; Davis, Mark M.; Chang, Howard Y.			Transcript-indexed ATAC-seq for precision immune profiling	NATURE MEDICINE			English	Article							T-CELL LYMPHOMA; SEZARY-SYNDROME; CHROMATIN ACCESSIBILITY; MYCOSIS-FUNGOIDES; HELPER-CELLS; PERIPHERAL-BLOOD; MESSENGER-RNA; T(H)17 CELLS; ROR-GAMMA; C-MAF	T cells create vast amounts of diversity in the genes that encode their T cell receptors (TCRs), which enables individual clones to recognize specific peptide-major histocompatibility complex (MHC) ligands. Here we combined sequencing of the TCR-encoding genes with assay for transposase-accessible chromatin with sequencing (ATAC-seq) analysis at the single-cell level to provide information on the TCR specificity and epigenomic state of individual T cells. By using this approach, termed transcript-indexed ATAC-seq (T-ATAC-seq), we identified epigenomic signatures in immortalized leukemic T cells, primary human T cells from healthy volunteers and primary leukemic T cells from patient samples. In peripheral blood CD4(+) T cells from healthy individuals, we identified cis and trans regulators of naive and memory T cell states and found substantial heterogeneity in surface-marker-defined T cell populations. In patients with a leukemic form of cutaneous T cell lymphoma, T-ATAC-seq enabled identification of leukemic and nonleukemic regulatory pathways in T cells from the same individual by allowing separation of the signals that arose from the malignant clone from the background T cell noise. Thus, T-ATAC-seq is a new tool that enables analysis of epigenomic landscapes in clonal T cells and should be valuable for studies of T cell malignancy, immunity and immunotherapy.	[Satpathy, Ansuman T.; Wei, Yuning; Granja, Jeffrey M.; Li, Rui; Qi, Yanyan; Parker, Kevin R.; Mumbach, Maxwell R.; Gennert, David G.; Schep, Alicia N.; Corces, M. Ryan; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Saligrama, Naresha; Serratelli, William S.; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Buenrostro, Jason D.; Lareau, Caleb A.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Buenrostro, Jason D.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Wei, Yuning; Rubin, Adam J.; Li, Rui; Qi, Yanyan; Parker, Kevin R.; Corces, M. Ryan; Kim, Youn H.; Khavari, Paul A.; Chang, Howard Y.] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Wu, Beijing; Granja, Jeffrey M.; Mumbach, Maxwell R.; Gennert, David G.; Schep, Alicia N.; Greenleaf, William J.; Davis, Mark M.; Chang, Howard Y.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Khodadoust, Michael S.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Greenleaf, William J.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	mmdavis@stanford.edu; howchang@stanford.edu	Corces, M. Ryan/ABG-6947-2020; Khodadoust, Michael/AAU-3936-2020; Lareau, Caleb/ABF-9490-2020; Khodadoust, Michael/K-7764-2019	Corces, M. Ryan/0000-0001-7465-7652; Khodadoust, Michael/0000-0001-9061-7351; Lareau, Caleb/0000-0003-4179-4807; Khodadoust, Michael/0000-0001-9061-7351; Saligrama, Naresha/0000-0003-2526-7150; serratelli, william/0000-0001-7510-5462; Parker, Kevin/0000-0001-5532-238X; Satpathy, Ansuman/0000-0002-5167-537X; Davis, Mark/0000-0001-6868-657X	Parker Institute for Cancer Immunotherapy; US National Institutes of Health (NIH) [P50HG007735, 5U19AI057229, U19AI057266]; Scleroderma Research Foundation; Parker Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy; Cancer Research Institute Irvington Fellowship from the Cancer Research Institute; National Multiple Sclerosis Society Postdoctoral Fellowship; Broad Institute Fellows program; Harvard Society of Fellows program; Leukemia and Lymphoma Society Career Development Program; NIH [S10OD018220]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018220] Funding Source: NIH RePORTER	Parker Institute for Cancer Immunotherapy; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Parker Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy; Cancer Research Institute Irvington Fellowship from the Cancer Research Institute; National Multiple Sclerosis Society Postdoctoral Fellowship(National Multiple Sclerosis Society); Broad Institute Fellows program; Harvard Society of Fellows program; Leukemia and Lymphoma Society Career Development Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chang, Davis and Greenleaf laboratories, including Y. Shen and K. Qu, for helpful discussions. We thank X. Ji, D. Wagh and J. Coller at the Stanford Functional Genomics Facility. This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., H.Y.C. and M.M.D.), the US National Institutes of Health (NIH) grants P50HG007735 (H.Y.C. and W.J.G.), 5U19AI057229 (M.M.D.), and U19AI057266 (W.J.G), and the Scleroderma Research Foundation (H.Y.C.). A.T.S. was supported by a Parker Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy and a Cancer Research Institute Irvington Fellowship from the Cancer Research Institute. N.S. was supported by the National Multiple Sclerosis Society Postdoctoral Fellowship. J.D.B. acknowledges the Broad Institute Fellows and Harvard Society of Fellows programs for funding. M.R.C. was supported by a grant from the Leukemia and Lymphoma Society Career Development Program. W.J.G. is a Chan Zuckerberg Biohub investigator. M.M.D. is an investigator of the Howard Hughes Medical Institute. Sequencing was performed by the Stanford Functional Genomics Facility (which is supported by NIH grant S10OD018220).	Afik S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx615; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bernengo MG, 1998, ANN ONCOL, V9, P857, DOI 10.1023/A:1008397323199; Bigler RD, 1996, AM J PATHOL, V149, P1477; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buenrostro JD, 2017, BIORXIV, DOI [10.1101/109843, DOI 10.1101/109843]; Choi J, 2015, NAT GENET, V47, P1011, DOI 10.1038/ng.3356; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kelemen K, 2008, AM J CLIN PATHOL, V129, P146, DOI 10.1309/05GFG3LY3VYCDMEY; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kirsch IR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9122; Krejsgaard T, 2012, LEUKEMIA, V26, P424, DOI 10.1038/leu.2011.237; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Qu K, 2017, CANCER CELL, V32, P27, DOI 10.1016/j.ccell.2017.05.008; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; ROOK AH, 1993, ARCH DERMATOL, V129, P486, DOI 10.1001/archderm.129.4.486; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Sufficool KE, 2015, J AM ACAD DERMATOL, V73, P228, DOI 10.1016/j.jaad.2015.04.030; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Ungewickell A, 2015, NAT GENET, V47, P1056, DOI 10.1038/ng.3370; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; VOWELS BR, 1994, J INVEST DERMATOL, V103, P669, DOI 10.1111/1523-1747.ep12398454; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Weng WK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007420; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zhao CF, 2010, J EXP MED, V207, P2883, DOI 10.1084/jem.20100598; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	61	84	90	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					580	+		10.1038/s41591-018-0008-8	http://dx.doi.org/10.1038/s41591-018-0008-8			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29686426	Green Accepted, Green Submitted			2022-12-27	WOS:000432126800014
J	Baral, P; Umans, BD; Li, L; Wallrapp, A; Bist, M; Kirschbaum, T; Wei, YB; Zhou, Y; Kuchroo, VK; Burkett, PR; Yipp, BG; Liberles, SD; Chiu, IM				Baral, Pankaj; Umans, Benjamin D.; Li, Lu; Wallrapp, Antonia; Bist, Meghna; Kirschbaum, Talia; Wei, Yibing; Zhou, Yan; Kuchroo, Vijay K.; Burkett, Patrick R.; Yipp, Bryan G.; Liberles, Stephen D.; Chiu, Isaac M.			Nociceptor sensory neurons suppress neutrophil and gamma delta T cell responses in bacterial lung infections and lethal pneumonia	NATURE MEDICINE			English	Article							INNATE LYMPHOID-CELLS; IMMUNE INTERACTIONS; HOST-DEFENSE; MOUSE; PAIN; HYPERREACTIVITY; INFLAMMATION; MECHANISMS; POPULATION; EXPRESSION	Lung-innervating nociceptor sensory neurons detect noxious or harmful stimuli and consequently protect organisms by mediating coughing, pain, and bronchoconstriction. However, the role of sensory neurons in pulmonary host defense is unclear. Here, we found that TRPV1(+) nociceptors suppressed protective immunity against lethal Staphylococcus aureus pneumonia. Targeted TRPV1(+)-neuron ablation increased survival, cytokine induction, and lung bacterial clearance. Nociceptors suppressed the recruitment and surveillance of neutrophils, and altered lung gamma delta T cell numbers, which are necessary for immunity. Vagal ganglia TRPV1(+) afferents mediated immunosuppression through release of the neuropeptide calcitonin gene-related peptide (CGRP). Targeting neuroimmunological signaling may be an effective approach to treat lung infections and bacterial pneumonia.	[Baral, Pankaj; Bist, Meghna; Kirschbaum, Talia; Wei, Yibing; Zhou, Yan; Chiu, Isaac M.] Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Umans, Benjamin D.; Liberles, Stephen D.] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Li, Lu; Yipp, Bryan G.] Univ Calgary, Cumming Sch Med, Dept Crit Care, Calgary, AB, Canada; [Wallrapp, Antonia; Kuchroo, Vijay K.; Burkett, Patrick R.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA USA; [Wallrapp, Antonia; Kuchroo, Vijay K.; Burkett, Patrick R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Burkett, Patrick R.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Calgary; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Chiu, IM (corresponding author), Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	isaac_chiu@hms.harvard.edu	; Chiu, Isaac/R-3803-2016	Umans, Benjamin/0000-0002-8209-9731; Wallrapp, Antonia/0000-0002-3176-1553; Chiu, Isaac/0000-0002-0723-4841; Yipp, Bryan/0000-0002-5887-9551; Liberles, Stephen/0000-0002-2177-9741	National Institutes of Health (NIH) [DP2AT009499, K22AI114810, R01AI130019, 1KO8AI123516, R01HL132255]; HHMI Faculty Scholars Award; NIH [5F31HL132645]; Canadian Institutes of Health Research (CIHR) [RS-342013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [DP2AT009499] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132255, F31HL132645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI123516, K22AI114810, R01AI130019] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Faculty Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Blake and N. Lai for technical assistance, and J. Bubeck Wardenburg and C. Altier for helpful discussions. We thank M. Hoon (NIH) for Trpv1-Dtr mice, C. Benoist (Harvard Medical School) and A. Mann (Harvard Medical School) for Tcrd<SUP>-/-</SUP> mice, G. Pier (Brigham and Women's Hospital) and M. Gadjeva (Brigham and Women's Hospital) for P. aeruginosa, R. Malley (Boston Children's Hospital) for S. pneumoniae, and M. Otto (NIH) for S. aureus bacterial strains. This work was supported by National Institutes of Health (NIH) grants DP2AT009499 (I. M. C.), K22AI114810 (I.M.C.), R01AI130019 (I.M.C.), 1KO8AI123516 (P.R.B.), and R01HL132255 (S.D.L.); an HHMI Faculty Scholars Award (S.D.L.); NIH 5F31HL132645 (B.D.U.); and Canadian Institutes of Health Research (CIHR) grant RS-342013 (B.G.Y.).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Cheng M, 2017, IMMUNOLOGY, V151, P375, DOI 10.1111/imm.12764; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; FRANCOCERECEDA A, 1987, CIRC RES, V60, P393, DOI 10.1161/01.RES.60.3.393; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Ghasemlou N, 2015, P NATL ACAD SCI USA, V112, pE6808, DOI 10.1073/pnas.1501372112; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hommes TJ, 2014, CRIT CARE MED, V42, pE783, DOI 10.1097/CCM.0000000000000686; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159, DOI 10.2174/156802611796904924; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kwon MJ, 2015, J NEUROSCI, V35, P15934, DOI 10.1523/JNEUROSCI.1924-15.2015; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Pogorzala LA, 2013, J NEUROSCI, V33, P5533, DOI 10.1523/JNEUROSCI.5788-12.2013; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Sawant KV, 2015, J INNATE IMMUN, V7, P647, DOI 10.1159/000430914; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tay SS, 2014, CURR DERMATOL REP, V3, P13, DOI 10.1007/s13671-013-0063-9; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43	55	161	165	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					417	+		10.1038/nm.4501	http://dx.doi.org/10.1038/nm.4501			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29505031	Green Published, Green Accepted			2022-12-27	WOS:000429639800013
J	Chakradhar, S				Chakradhar, Shraddha			Going live How microRNAs might bring living vaccines back into the fold	NATURE MEDICINE			English	News Item							VIRUS											Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Brostoff T, 2016, VACCINE, V34, P5366, DOI 10.1016/j.vaccine.2016.08.063; Harding AT, 2017, MBIO, V8, DOI 10.1128/mBio.00669-17; HENDERSON DA, 1964, JAMA-J AM MED ASSOC, V190, P41; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Moller R, 2018, P NATL ACAD SCI USA, V115, P1069, DOI 10.1073/pnas.1719036115; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Skowronski DM, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.5.18-00035; Waring BM, 2018, J VIROL, V92, DOI 10.1128/JVI.01741-17	10	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					248	250		10.1038/nm0318-248	http://dx.doi.org/10.1038/nm0318-248			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29509751				2022-12-27	WOS:000426700900002
J	Lavine, KJ; Mann, DL				Lavine, Kory J.; Mann, Douglas L.			Recognition of self-DNA drives cardiac inflammation: why broken hearts fail	NATURE MEDICINE			English	Editorial Material							MONOCYTES	Signals that govern immune cells in the heart remain poorly defined. A new report in mice shows that pathways involved in sensing viruses orchestrate monocyte and macrophage activation through recognition of DNA derived from dying cardiomyocytes following myocardial infarction.	[Lavine, Kory J.; Mann, Douglas L.] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA; [Lavine, Kory J.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Lavine, Kory J.] Washington Univ, Sch Med, Dept Immunol & Pathol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA.	klavine@wustl.edu	Mann, Douglas Lowell/AAQ-3524-2021	Mann, Douglas/0000-0002-2516-0145	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139714] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Lu WB, 2015, INT HEART J, V56, P22, DOI 10.1536/ihj.14-174; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Shinagawa Hisahito, 2015, Curr Heart Fail Rep, V12, P247, DOI 10.1007/s11897-015-0255-7; Swirski FK, 2015, HAMOSTASEOLOGIE, V35, P34, DOI 10.5482/HAMO-14-09-0045; Wrigley BJ, 2013, EUR J CLIN INVEST, V43, P121, DOI 10.1111/eci.12023; Zhou X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003466	11	2	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1400	1401		10.1038/nm.4455	http://dx.doi.org/10.1038/nm.4455			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216037				2022-12-27	WOS:000417278200005
J	Estes, JD; Kityo, C; Ssali, F; Swainson, L; Makamdop, KN; Del Prete, GQ; Deeks, SG; Luciw, PA; Chipman, JG; Beilman, GJ; Hoskuldsson, T; Khoruts, A; Anderson, J; Deleage, C; Jasurda, J; Schmidt, TE; Hafertepe, M; Callisto, SP; Pearson, H; Reimann, T; Schuster, J; Schoephoerster, J; Southern, P; Perkey, K; Shang, L; Wietgrefe, SW; Fletcher, CV; Lifson, JD; Douek, DC; McCune, JM; Haase, AT; Schacker, TW				Estes, Jacob D.; Kityo, Cissy; Ssali, Francis; Swainson, Louise; Makamdop, Krystelle Nganou; Del Prete, Gregory Q.; Deeks, Steven G.; Luciw, Paul A.; Chipman, Jeffrey G.; Beilman, Gregory J.; Hoskuldsson, Torfi; Khoruts, Alexander; Anderson, Jodi; Deleage, Claire; Jasurda, Jacob; Schmidt, Thomas E.; Hafertepe, Michael; Callisto, Samuel P.; Pearson, Hope; Reimann, Thomas; Schuster, Jared; Schoephoerster, Jordan; Southern, Peter; Perkey, Katherine; Shang, Liang; Wietgrefe, Stephen W.; Fletcher, Courtney V.; Lifson, Jeffrey D.; Douek, Daniel C.; McCune, Joseph M.; Haase, Ashley T.; Schacker, Timothy W.			Defining total-body AIDS-virus burden with implications for curative strategies	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; COMBINATION ANTIRETROVIRAL THERAPY; PERSISTENT HIV-1 REPLICATION; LYMPHATIC TISSUE FIBROSIS; CENTRAL-NERVOUS-SYSTEM; SIMIAN IMMUNODEFICIENCY; COLLAGEN DEPOSITION; PRODUCTIVE INFECTION; LYMPHOID-TISSUES	In the quest for a functional cure or the eradication of HIV infection, it is necessary to know the sizes of the reservoirs from which infection rebounds after treatment interruption. Thus, we quantified SIV and HIV tissue burdens in tissues of infected nonhuman primates and lymphoid tissue (LT) biopsies from infected humans. Before antiretroviral therapy (ART), LTs contained >98% of the SIV RNA(+) and DNA(+) cells. With ART, the numbers of virus (v) RNA(+) cells substantially decreased but remained detectable, and their persistence was associated with relatively lower drug concentrations in LT than in peripheral blood. Prolonged ART also decreased the levels of SIV-and HIV-DNA(+) cells, but the estimated size of the residual tissue burden of 10(8) vDNA(+) cells potentially containing replication-competent proviruses, along with evidence of continuing virus production in LT despite ART, indicated two important sources for rebound following treatment interruption. The large sizes of these tissue reservoirs underscore challenges in developing 'HIV cure' strategies targeting multiple sources of virus production.	[Estes, Jacob D.; Del Prete, Gregory Q.; Deleage, Claire; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Kityo, Cissy; Ssali, Francis] Joint Clin Res Ctr, Kampala, Uganda; [Swainson, Louise; McCune, Joseph M.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Makamdop, Krystelle Nganou; Douek, Daniel C.] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Luciw, Paul A.] Univ Calif Sacramento, Dept Pathol & Lab Med, Sacramento, CA USA; [Chipman, Jeffrey G.; Beilman, Gregory J.; Hoskuldsson, Torfi] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Khoruts, Alexander; Anderson, Jodi; Jasurda, Jacob; Schmidt, Thomas E.; Hafertepe, Michael; Callisto, Samuel P.; Pearson, Hope; Reimann, Thomas; Schuster, Jared; Schoephoerster, Jordan; Schacker, Timothy W.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Southern, Peter; Perkey, Katherine; Shang, Liang; Wietgrefe, Stephen W.; Haase, Ashley T.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Fletcher, Courtney V.] Univ Nebraska Med Ctr, Coll Pharm, Omaha, NE USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Joint Clinic Research Center - United Arab Emirates; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; University of California System; University of California San Francisco; California State University System; California State University Sacramento; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Medical Center	Schacker, TW (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	schacker@umn.edu	Khoruts, Alexander/ABF-5119-2020	Khoruts, Alexander/0000-0002-3205-3188; Deeks, Steven/0000-0001-6371-747X	National Cancer Institute, National Institutes of Health [HHSN261200800001E];  [UL1TR000114];  [AI096109];  [OD011107];  [AI124965];  [AI074340]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494, UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124965, P30AI027763, P01AI074340, U19AI096109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank S. Povolny and C. Olson for help with manuscript preparation and editing, and the Antiviral Pharmacology Laboratory at the University of Nebraska for quantification of ARV concentrations. This work was supported by grants UL1TR000114 (T.W.S.), AI096109 (J.D.E., L. Swainson, S.G.D., J.A., J.J., T.E.S., J.M.M., and T.W.S.), OD011107 (P.A.L.), AI124965 (C.V.F.), and AI074340 (J.G.C., G.J.B., T.H., A.K.,J.A., J.J., T.E.S., M.H., S.P.C., J.S., C.V.F., A.T.H., and T.W.S.), and in part by federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E (J.D.E., C.D., and J.D.L.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Cavert W, 1997, SCIENCE, V276, P960, DOI 10.1126/science.276.5314.960; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Del Prete GQ, 2016, ANTIMICROB AGENTS CH, V60, P1560, DOI 10.1128/AAC.02625-15; Del Prete GQ, 2014, ANTIMICROB AGENTS CH, V58, P6790, DOI 10.1128/AAC.03746-14; Deleage Claire, 2016, Pathog Immun, V1, P68; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Faust RA, 1996, OTOLARYNG HEAD NECK, V114, P593, DOI 10.1016/S0194-5998(96)70252-8; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Lee EM, 2010, J VIROL METHODS, V163, P287, DOI 10.1016/j.jviromet.2009.10.012; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; Podany AT, 2014, ANTIMICROB AGENTS CH, V58, P2866, DOI 10.1128/AAC.02551-13; Reilly C, 2007, AIDS, V21, P163, DOI 10.1097/QAD.0b013e328012565b; Reinhart TA, 1997, J INFECT DIS, V176, P1198, DOI 10.1086/514113; Reinhart TA, 1997, NAT MED, V3, P218, DOI 10.1038/nm0297-218; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; Schacker T, 2000, J INFECT DIS, V181, P354, DOI 10.1086/315178; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Schacker TW, 2006, CLIN VACCINE IMMUNOL, V13, P556, DOI 10.1128/CVI.13.5.556-560.2006; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; US Department of Health and Human Services, 2001, BIOAN METH VAL; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	39	233	234	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1271	+		10.1038/nm.4411	http://dx.doi.org/10.1038/nm.4411			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	28967921	Green Accepted			2022-12-27	WOS:000414548300009
J	Scott, DA; Zhang, F				Scott, David A.; Zhang, Feng			Implications of human genetic variation in CRISPR-based therapeutic genome editing	NATURE MEDICINE			English	Article							HUMAN-CELLS; CAS9 NUCLEASES; DNA CLEAVAGE; TARGET DNA; SPECIFICITY; SYSTEMS; CPF1; SEQ; BREAKS	CRISPR-Cas genome-editing methods hold immense potential as therapeutic tools to fix disease-causing mutations at the level of DNA. In contrast to typical drug development strategies aimed at targets that are highly conserved among individual patients, treatment at the genomic level must contend with substantial inter-individual natural genetic variation. Here we analyze the recently released ExAC and 1000 Genomes data sets to determine how human genetic variation impacts target choice for Cas endonucleases in the context of therapeutic genome editing. We find that this genetic variation confounds the target sites of certain Cas endonucleases more than others, and we provide a compendium of guide RNAs predicted to have high efficacy in diverse patient populations. For further analysis, we focus on 12 therapeutically relevant genes and consider how genetic variation affects off-target candidates for these loci. Our analysis suggests that, in large populations of individuals, most candidate off-target sites will be rare, underscoring the need for prescreening of patients through whole-genome sequencing to ensure safety. This information can be integrated with empirical methods for guide RNA selection into a framework for designing CRISPR-based therapeutics that maximizes efficacy and safety across patient populations.	[Scott, David A.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Scott, David A.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020		US National Institutes of Health through the National Institute of Mental Health [5DP1-MH100706, 1R01-MH110049]; National Science Foundation; New York Stem Cell Foundation; Howard Hughes Medical Institute; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Skoltech-MIT Next-Generation Program; James and Patricia Poitras; Robert Metcalfe; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER	US National Institutes of Health through the National Institute of Mental Health; National Science Foundation(National Science Foundation (NSF)); New York Stem Cell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Skoltech-MIT Next-Generation Program; James and Patricia Poitras; Robert Metcalfe; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank R. Macrae, L. Francioli, S. Jones, J. Strecker, D. Cox, I. Slaymaker, and W. Yan for helpful discussions and insights. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the US National Institutes of Health through the National Institute of Mental Health (5DP1-MH100706 and 1R01-MH110049); the National Science Foundation; the New York Stem Cell Foundation; the Howard Hughes Medical Institute; the Simons Foundation; the Paul G. Allen Family Foundation; the Vallee Foundation; the Skoltech-MIT Next-Generation Program; James and Patricia Poitras; Robert Metcalfe; and David Cheng. The computer code and resources related to this work are available through the Zhang laboratory website (http://www.genome-engineering.org/) and GitHub (http://github.com/fengzhanglab).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Cameron P., 2017, PROTOCOL EXCHANGE; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Lu YF, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a008581; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Yan WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15058; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	29	70	72	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1095	+		10.1038/nm.4377	http://dx.doi.org/10.1038/nm.4377			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28759051	Green Submitted, Green Accepted			2022-12-27	WOS:000409996200017
J	Liu, RX; Hong, J; Xu, XQ; Feng, Q; Zhang, DY; Gu, YY; Shi, J; Zhao, SQ; Liu, W; Wang, XK; Xia, HH; Liu, ZP; Cui, B; Liang, PW; Xi, LQ; Jin, JB; Ying, XY; Wang, XL; Zhao, XJ; Li, WY; Jia, HJ; Lan, Z; Li, FY; Wang, R; Sun, YK; Yang, ML; Shen, YX; Jie, ZY; Li, JH; Chen, XM; Zhong, HZ; Xie, HL; Zhang, YF; Gu, WQ; Deng, XX; Shen, BY; Xu, X; Yang, HM; Xu, GW; Bi, YF; Lai, SH; Wang, J; Qi, L; Madsen, L; Wang, JQ; Ning, G; Kristiansen, K; Wang, WQ				Liu, Ruixin; Hong, Jie; Xu, Xiaoqiang; Feng, Qiang; Zhang, Dongya; Gu, Yanyun; Shi, Juan; Zhao, Shaoqian; Liu, Wen; Wang, Xiaokai; Xia, Huihua; Liu, Zhipeng; Cui, Bin; Liang, Peiwen; Xi, Liuqing; Jin, Jiabin; Ying, Xiayang; Wang, Xiaolin; Zhao, Xinjie; Li, Wanyu; Jia, Huijue; Lan, Zhou; Li, Fengyu; Wang, Rui; Sun, Yingkai; Yang, Minglan; Shen, Yuxin; Jie, Zhuye; Li, Junhua; Chen, Xiaomin; Zhong, Huanzi; Xie, Hailiang; Zhang, Yifei; Gu, Weiqiong; Deng, Xiaxing; Shen, Baiyong; Xu, Xun; Yang, Huanming; Xu, Guowang; Bi, Yufang; Lai, Shenghan; Wang, Jian; Qi, Lu; Madsen, Lise; Wang, Jiqiu; Ning, Guang; Kristiansen, Karsten; Wang, Weiqing			Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention	NATURE MEDICINE			English	Article							Y GASTRIC BYPASS; MONOSODIUM GLUTAMATE; BARIATRIC SURGERY; DIET; THETAIOTAOMICRON; GLUCOSE; IMPACT; ASSOCIATIONS; MODULATION; METAGENOME	Emerging evidence has linked the gut microbiome to human obesity. We performed a metagenome-wide association study and serum metabolomics profiling in a cohort of lean and obese, young, Chinese individuals. We identified obesity-associated gut microbial species linked to changes in circulating metabolites. The abundance of Bacteroides thetaiotaomicron, a glutamate-fermenting commensal, was markedly decreased in obese individuals and was inversely correlated with serum glutamate concentration. Consistently, gavage with B. thetaiotaomicron reduced plasma glutamate concentration and alleviated diet-induced body-weight gain and adiposity in mice. Furthermore, weight-loss intervention by bariatric surgery partially reversed obesity-associated microbial and metabolic alterations in obese individuals, including the decreased abundance of B. thetaiotaomicron and the elevated serum glutamate concentration. Our findings identify previously unknown links between intestinal microbiota alterations, circulating amino acids and obesity, suggesting that it may be possible to intervene in obesity by targeting the gut microbiota.	[Liu, Ruixin; Hong, Jie; Gu, Yanyun; Shi, Juan; Zhao, Shaoqian; Liu, Wen; Cui, Bin; Liang, Peiwen; Xi, Liuqing; Li, Wanyu; Wang, Rui; Sun, Yingkai; Yang, Minglan; Shen, Yuxin; Zhang, Yifei; Gu, Weiqiong; Bi, Yufang; Wang, Jiqiu; Ning, Guang; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Natl Clin Res Ctr Endocrine & Metab Dis, State Key Lab Med Genomes,Ruijin Hosp, Shanghai, Peoples R China; [Xu, Xiaoqiang; Feng, Qiang; Zhang, Dongya; Wang, Xiaokai; Xia, Huihua; Liu, Zhipeng; Jia, Huijue; Lan, Zhou; Li, Fengyu; Jie, Zhuye; Li, Junhua; Chen, Xiaomin; Zhong, Huanzi; Xie, Hailiang; Xu, Xun; Yang, Huanming; Wang, Jian; Madsen, Lise; Kristiansen, Karsten] BGI Shenzhen, Shenzhen, Peoples R China; [Xu, Xiaoqiang; Wang, Xiaokai] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen, Peoples R China; [Feng, Qiang] BGI Shenzhen, Shenzhen Engn Lab Detect & Intervent Human Intest, Shenzhen, Peoples R China; [Xia, Huihua; Jia, Huijue; Jie, Zhuye; Li, Junhua; Zhong, Huanzi; Xu, Xun; Kristiansen, Karsten] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Cui, Bin; Ning, Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China; [Cui, Bin; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Jin, Jiabin; Ying, Xiayang; Deng, Xiaxing; Shen, Baiyong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Pancreat Dis Ctr,Dept Gen Surg, Shanghai, Peoples R China; [Wang, Xiaolin; Zhao, Xinjie; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Jia, Huijue; Li, Junhua] BGI Shenzhen, Shenzhen Key Lab Human Commensal Microorganisms &, Shenzhen, Peoples R China; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Lai, Shenghan] Johns Hopkins Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Qi, Lu] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, Copenhagen, Denmark	Shanghai Jiao Tong University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Beijing Genomics Institute (BGI); Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Tulane University; University of Copenhagen	Ning, G; Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Natl Clin Res Ctr Endocrine & Metab Dis, State Key Lab Med Genomes,Ruijin Hosp, Shanghai, Peoples R China.; Kristiansen, K (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.; Kristiansen, K (corresponding author), BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China.; Ning, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China.; Ning, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.; Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, Copenhagen, Denmark.	gning@sibs.ac.cn; kk@bio.ku.dk; wqingw61@163.com	Jia, Huijue/M-3991-2015; liu, zhipeng/HCI-3638-2022; Kristiansen, Karsten/J-5148-2014; Xu, Guowang/L-6910-2014; chen, xia/GYR-3948-2022; Li, Junhua/AAG-3919-2019; chen, xia/GXM-5435-2022; Xu, Xun/AAI-6763-2020; chen, xi/GXH-3653-2022; Liu, Zhipeng/AAQ-8788-2021; Zhang, Yifei/GRO-3001-2022; Madsen, Lise/C-6246-2012; Wang, Jiqiu/AGM-1346-2022	Jia, Huijue/0000-0002-3592-126X; Kristiansen, Karsten/0000-0002-6024-0917; Xu, Guowang/0000-0003-4298-3554; Li, Junhua/0000-0001-6784-1873; Xu, Xun/0000-0002-5338-5173; Madsen, Lise/0000-0003-4468-1947; Wang, Jiqiu/0000-0002-9383-7656; wang, xiaokai/0000-0002-6055-0325; liu, zhipeng/0000-0002-0625-463X	National Natural Science Foundation of China [81621061, 81522011, 81370963, 81570758, 81370949, 81570757, 81471060, 81670761]; National International Science Cooperation Foundation [2015DFA30560]; 973 Foundation [2015CB553600]; Shenzhen Municipal Government of China [JSGG20140702161403250, DRC-SZ[2015]162, JSGG20160229172752028, JCYJ20160229172757249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National International Science Cooperation Foundation; 973 Foundation(National Basic Research Program of China); Shenzhen Municipal Government of China	The authors thank the field workers for their contribution and the participants for their cooperation. We thank H.B. Nielsen, S.B. Pedersen and H. Zhao for their contribution to data discussions. We thank P. Yin, S. Wang and H. Yu for their assistance in cultivating bacteria. This study was supported by grants from National Natural Science Foundation of China (no. 81621061 (G.N.), 81522011 (J.W.), 81370963 (R.L.), 81570758 (R.L.), 81370949 (J.W.), 81570757 (J.W.), 81471060 (J.H.) and 81670761 (Y.G.)), National International Science Cooperation Foundation (no. 2015DFA30560, W.W.), 973 Foundation (no. 2015CB553600, G.N.) and Shenzhen Municipal Government of China (no. JSGG20140702161403250 (Q.F.), DRC-SZ[2015]162 (Q.F.), JSGG20160229172752028 (J.L.) and JCYJ20160229172757249 (H.J.)).	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUNYAN J, 1976, BRIT J NUTR, V35, P25, DOI 10.1079/BJN19760005; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Dolnikoff M, 2001, INT J OBESITY, V25, P426, DOI 10.1038/sj.ijo.0801517; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gao XF, 2010, ANAL CHEM, V82, P6447, DOI 10.1021/ac1006552; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Gralka E, 2015, AM J CLIN NUTR, V102, P1313, DOI 10.3945/ajcn.115.110536; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Hermanussen M, 2006, EUR J CLIN NUTR, V60, P25, DOI 10.1038/sj.ejcn.1602263; Hooper LV, 2000, CURR OPIN MICROBIOL, V3, P79, DOI 10.1016/S1369-5274(99)00055-7; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kong LC, 2013, AM J CLIN NUTR, V98, P16, DOI 10.3945/ajcn.113.058743; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lips MA, 2014, DIABETES CARE, V37, P3150, DOI 10.2337/dc14-0195; Liu RX, 2017, DIABETES, V66, P935, DOI 10.2337/db16-0877; Luan HM, 2013, BIOMARKERS, V18, P314, DOI 10.3109/1354750X.2013.781222; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Rodriguez MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14600; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Peterson CT, 2015, CLIN EXP IMMUNOL, V179, P363, DOI 10.1111/cei.12474; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914	66	651	716	59	814	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					859	+		10.1038/nm.4358	http://dx.doi.org/10.1038/nm.4358			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28628112				2022-12-27	WOS:000405180100015
J	Jeon, OH; Kim, C; Laberge, RM; Demaria, M; Rathod, S; Vasserot, AP; Chung, JW; Kim, DH; Poon, Y; David, N; Baker, DJ; van Deursen, JM; Campisi, J; Elisseeff, JH				Jeon, Ok Hee; Kim, Chaekyu; Laberge, Remi-Martin; Demaria, Marco; Rathod, Sona; Vasserot, Alain P.; Chung, Jae Wook; Kim, Do Hun; Poon, Yan; David, Nathaniel; Baker, Darren J.; van Deursen, Jan M.; Campisi, Judith; Elisseeff, Jennifer H.			Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment	NATURE MEDICINE			English	Article							CELLULAR SENESCENCE; CHONDROCYTE SENESCENCE; STEM-CELLS; P16(INK4A); MATRIX; CANCER; HMGB1; MICE	Senescent cells (SnCs) accumulate in many vertebrate tissues with age and contribute to age-related pathologies(1-3), presumably through their secretion of factors contributing to the senescence-associated secretory phenotype (SASP)(4-6). Removal of SnCs delays several pathologies(7-9) and increases healthy lifespan(8). Aging and trauma are risk factors for the development of osteoarthritis (OA)(10), a chronic disease characterized by degeneration of articular cartilage leading to pain and physical disability. Senescent chondrocytes are found in cartilage tissue isolated from patients undergoing joint replacement surgery(11-14), yet their role in disease pathogenesis is unknown. To test the idea that SnCs might play a causative role in OA, we used the p16-3MR transgenic mouse, which harbors a p16(INK4a) (Cdkn2a) promoter driving the expression of a fusion protein containing synthetic Renilla luciferase and monomeric red fluorescent protein domains, as well as a truncated form of herpes simplex virus 1 thymidine kinase (HSV-TK)(15,16). This mouse strain allowed us to selectively follow and remove SnCs after anterior cruciate ligament transection (ACLT). We found that SnCs accumulated in the articular cartilage and synovium after ACLT, and selective elimination of these cells attenuated the development of post-traumatic OA, reduced pain and increased cartilage development. Intra-articular injection of a senolytic molecule that selectively killed SnCs validated these results in transgenic, non-transgenic and aged mice. Selective removal of the SnCs from in vitro cultures of chondrocytes isolated from patients with OA undergoing total knee replacement decreased expression of senescent and inflammatory markers while also increasing expression of cartilage tissue extracellular matrix proteins. Collectively, these findings support the use of SnCs as a therapeutic target for treating degenerative joint disease.	[Jeon, Ok Hee; Kim, Chaekyu; Rathod, Sona; Chung, Jae Wook; Kim, Do Hun; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA; [Jeon, Ok Hee; Kim, Chaekyu; Rathod, Sona; Chung, Jae Wook; Kim, Do Hun; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Kim, Chaekyu] Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan, South Korea; [Laberge, Remi-Martin; Demaria, Marco; Campisi, Judith] Buck Inst Res Aging, Novato, CA USA; [Laberge, Remi-Martin; Vasserot, Alain P.; Poon, Yan; David, Nathaniel] Unity Biotechnol Inc, Brisbane, CA USA; [Demaria, Marco] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Baker, Darren J.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Ulsan National Institute of Science & Technology (UNIST); Buck Institute for Research on Aging; University of Groningen; Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.; Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	jhe@jhu.edu	Jeon, Ok Hee/AAR-6270-2020; Demaria, Marco/AAH-9235-2019; Elisseeff, Jennifer/A-3324-2010; Kim, Chaekyu/F-5629-2013	Jeon, Ok Hee/0000-0002-3725-7526; Demaria, Marco/0000-0002-8429-4813; Elisseeff, Jennifer/0000-0002-5066-1996; Kim, Chaekyu/0000-0002-3269-6095; cho, junui/0000-0002-4883-7729; Baker, Darren/0000-0001-9006-1939	Unity Biotechnology, Inc.; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Morton Goldberg Professorship; National Institute on Aging (NIA) [AG017242, AG009909]; National Cancer Institute (NCI) [R01CA96985]; Paul F. Glenn Foundation; Institute of International Education; NATIONAL CANCER INSTITUTE [R01CA096985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242, R37AG009909, R56AG009909] Funding Source: NIH RePORTER	Unity Biotechnology, Inc.; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Morton Goldberg Professorship; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul F. Glenn Foundation; Institute of International Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Xu (F.M. Kirby Research Center at Johns Hopkins University) for in vivo luminescence imaging, A. Bendele (Bolder Biopath, Inc.) for the subchondral bone damage analysis and Y.Oh (Johns Hopkins University) for immunoblotting. This work was supported by Unity Biotechnology, Inc. (J.H.E., A.P.V., Y.P., N.D.), the Bloomberg-Kimmel Institute for Cancer Immunotherapy (J.H.E.), the Morton Goldberg Professorship (J.H.E.), National Institute on Aging (NIA) grant AG017242 (J.C.), AG009909 (M.D.), National Cancer Institute (NCI) grant R01CA96985 (J.M.v.D.), a grant from the Paul F. Glenn Foundation (J.M.v.D. and D.J.B.) and a Fulbright scholarship from the Institute of International Education (O.H.J.).	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Campisi J, 2000, IN VIVO, V14, P183; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Holmlund U, 2007, IMMUNOLOGY, V122, P430, DOI 10.1111/j.1365-2567.2007.02662.x; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Laberge RM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.199; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Martin JA, 2004, BIORHEOLOGY, V41, P479; McCulloch K, 2017, AGING CELL, V16, P210, DOI 10.1111/acel.12562; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Philipot D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4494; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; RUAN MZ, 2013, SCI TRANSLATIONAL ME, V0005; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Schreiber S, 1996, EUR NEUROPSYCHOPHARM, V6, P281, DOI 10.1016/S0924-977X(96)00031-4; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Wieland HA, 2005, NAT REV DRUG DISCOV, V4, P331, DOI 10.1038/nrd1693; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445	36	678	707	25	305	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					775	+		10.1038/nm.4324	http://dx.doi.org/10.1038/nm.4324			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28436958	Green Submitted, Green Accepted			2022-12-27	WOS:000402768000021
J	de Cabo, R; Navas, P				de Cabo, Rafael; Navas, Pacido			Spermidine to the rescue for an aging heart	NATURE MEDICINE			English	Editorial Material							AUTOPHAGY; RESVERATROL; POLYAMINES; LONGEVITY		[de Cabo, Rafael] NIA, US NIH, Baltimore, MD 21224 USA; [Navas, Pacido] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Inst Carlos III, CABD,CSIC,CIBERER, Seville, Spain	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	de Cabo, R (corresponding author), NIA, US NIH, Baltimore, MD 21224 USA.	decabora@grc.nia.nih.gov	de Cabo, Rafael/E-7996-2010; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442	Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000363] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Diaz M, 2016, EXP GERONTOL, V85, P41, DOI 10.1016/j.exger.2016.09.016; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Minois N, 2014, GERONTOLOGY, V60, P319, DOI 10.1159/000356748; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Soda K, 2009, J NUTR SCI VITAMINOL, V55, P361, DOI 10.3177/jnsv.55.361; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947	10	11	11	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1389	1390		10.1038/nm.4243	http://dx.doi.org/10.1038/nm.4243			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923032	Green Submitted, Green Accepted			2022-12-27	WOS:000389549000014
J	Webby, R				Webby, Richard			Understanding immune responses to the influenza vaccine	NATURE MEDICINE			English	Editorial Material							ADULTS		[Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webby, R (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.webby@stjude.org	Webby, Richard J/N-5657-2018					[Anonymous], 2016, Wkly Epidemiol Rec, V91, P469; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; KATZ JM, 1987, VIROLOGY, V156, P386, DOI 10.1016/0042-6822(87)90418-1; Krammer F, 2015, CURR TOP MICROBIOL, V386, P301, DOI 10.1007/82_2014_408; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111; Raymond DD, 2016, NAT MED, V22, P1465, DOI 10.1038/nm.4223; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Thompson MG, 2016, VACCINE, V34, P3443, DOI 10.1016/j.vaccine.2016.04.085	9	4	4	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1387	1388		10.1038/nm.4248	http://dx.doi.org/10.1038/nm.4248			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923018				2022-12-27	WOS:000389549000013
J	Du, Y; Yamaguchi, H; Wei, YK; Hsu, JL; Wang, HL; Hsu, YH; Lin, WC; Yu, WH; Leonard, PG; Lee, GR; Chen, MK; Nakai, K; Hsu, MC; Chen, CT; Sun, Y; Wu, Y; Chang, WC; Huang, WC; Liu, CL; Chang, YC; Chen, CH; Park, M; Jones, P; Hortobagyi, GN; Hung, MC				Du, Yi; Yamaguchi, Hirohito; Wei, Yongkun; Hsu, Jennifer L.; Wang, Hung-Ling; Hsu, Yi-Hsin; Lin, Wan-Chi; Yu, Wen-Hsuan; Leonard, Paul G.; Lee, Gilbert R.; Chen, Mei-Kuang; Nakai, Katsuya; Hsu, Ming-Chuan; Chen, Chun-Te; Sun, Ye; Wu, Yun; Chang, Wei-Chao; Huang, Wen-Chien; Liu, Chien-Liang; Chang, Yuan-Ching; Chen, Chung-Hsuan; Park, Morag; Jones, Philip; Hortobagyi, Gabriel N.; Hung, Mien-Chie			Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors (vol 22, pg 194, 2016)	NATURE MEDICINE			English	Correction													Hung, Mien-Chie/ABD-5911-2021; Hsu, MC/AAE-5310-2020; CHEN, MEI-KUANG/V-9284-2017	Hung, Mien-Chie/0000-0003-4317-4740; NAKAI, KATSUYA/0000-0003-4142-8508	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Du Y, 2016, NAT MED, V22, P194, DOI 10.1038/nm.4032	1	1	2	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1192	1192		10.1038/nm1016-1192c	http://dx.doi.org/10.1038/nm1016-1192c			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27711065	Bronze			2022-12-27	WOS:000384872500025
J	Rozo, M; Li, LJ; Fan, CM				Rozo, Michelle; Li, Liangji; Fan, Chen-Ming			Targeting beta 1-integrin signaling enhances regeneration in aged and dystrophic muscle in mice	NATURE MEDICINE			English	Article							RECEPTOR TYROSINE KINASES; SKELETAL-MUSCLE; SATELLITE CELLS; EXTRACELLULAR-MATRIX; SELF-RENEWAL; INTEGRINS; ADULT; PROLIFERATION; ACTIVATION; EXPRESSION	Interactions between stem cells and their microenvironment, or niche, are essential for stem cell maintenance and function. Our knowledge of the niche for the skeletal muscle stem cell, i.e., the satellite cell (SC), is incomplete. Here we show that beta 1-integrin is an essential niche molecule that maintains SC homeostasis, and sustains the expansion and self-renewal of this stem cell pool during regeneration. We further show that beta 1-integrin cooperates with fibroblast growth factor 2 (Fgf2), a potent growth factor for SCs, to synergistically activate their common downstream effectors, the mitogen-activated protein (MAP) kinase Erk and protein kinase B (Akt). Notably, SCs in aged mice show altered beta 1-integrin activity and insensitivity to Fgf2. Augmenting beta 1-integrin activity with a monoclonal antibody restores Fgf2 sensitivity and improves regeneration after experimentally induced muscle injury. The same treatment also enhances regeneration and function of dystrophic muscles in mdx mice, a model for Duchenne muscular dystrophy. Therefore, beta 1-integrin senses the SC niche to maintain responsiveness to Fgf2, and this integrin represents a potential therapeutic target for pathological conditions of the muscle in which the stem cell niche is compromised.	[Rozo, Michelle; Li, Liangji; Fan, Chen-Ming] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Rozo, Michelle; Li, Liangji; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA	Johns Hopkins University; Carnegie Institution for Science	Fan, CM (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Fan, CM (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA.	fan@ciwemb.edu	Li, Liangji/AAM-7800-2021		Carnegie Institution; National Institutes of Health (NIH) [AR060042]; NIH [HD075345]; Carnegie Institution of Washington internal funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD075345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	Carnegie Institution; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carnegie Institution of Washington internal funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank E. Dikovskaia and S. Satchell for technical assistance, and C. Lepper, Y. Zheng and members of the Fan laboratory for comments. We especially thank A. Wagers for generously sharing the FACS and SC isolation protocol. Funding for this work was provided by the Carnegie Institution (C.-M.F.) and the National Institutes of Health (NIH) (grant no. AR060042; C.-M.F.). M.R. is supported by a predoctoral fellowship from the NIH (HD075345), and L.L. is supported by Carnegie Institution of Washington internal funds.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Barton ER., 2008, MEASURING ISOMETRIC; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Hakim CH, 2013, JOVE-J VIS EXP, DOI 10.3791/50183; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Hogan B, 1994, MANIPULATING MOUSE E; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lukjanenko, 2016, NAT MED; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Mori S., 2013, MED SCI, V1, P20; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Polanska UM, 2009, DEV DYNAM, V238, P277, DOI 10.1002/dvdy.21757; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sahni A, 2004, BLOOD, V104, P3635, DOI 10.1182/blood-2004-04-1358; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014	46	105	107	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					889	+		10.1038/nm.4116	http://dx.doi.org/10.1038/nm.4116			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27376575	Green Accepted			2022-12-27	WOS:000381000200014
J	Fang, J; Liu, XN; Bolanos, L; Barker, B; Rigolino, C; Cortelezzi, A; Oliva, EN; Cuzzola, M; Grimes, HL; Fontanillo, C; Komurov, K; MacBeth, K; Starczynowski, DT				Fang, Jing; Liu, Xiaona; Bolanos, Lyndsey; Barker, Brenden; Rigolino, Carmela; Cortelezzi, Agostino; Oliva, Esther N.; Cuzzola, Maria; Grimes, H. Leighton; Fontanillo, Celia; Komurov, Kakajan; MacBeth, Kyle; Starczynowski, Daniel T.			A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes	NATURE MEDICINE			English	Article							CELL-LINE; MULTIPLE-MYELOMA; CHROMOSOME 5Q; DEL(5Q); DEGRADATION; EXPRESSION; PROTEINS; BIOLOGY; IKAROS; MDS	Despite the high response rates of individuals with myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)) to treatment with lenalidomide (LEN) and the recent identification of cereblon (CRBN) as the molecular target of LEN, the cellular mechanism by which LEN eliminates MDS clones remains elusive. Here we performed an RNA interference screen to delineate gene regulatory networks that mediate LEN responsiveness in an MDS cell line, MDSL. We identified GPR68, which encodes a G-protein-coupled receptor that has been implicated in calcium metabolism, as the top candidate gene for modulating sensitivity to LEN. LEN induced GPR68 expression via IKAROS family zinc finger 1 (IKZF1), resulting in increased cytosolic calcium levels and activation of a calcium-dependent calpain, CAPN1, which were requisite steps for induction of apoptosis in MDS cells and in acute myeloid leukemia (AML) cells. In contrast, deletion of GPR68 or inhibition of calcium and calpain activation suppressed LEN-induced cytotoxicity. Moreover, expression of calpastatin (CAST), an endogenous CAPN1 inhibitor that is encoded by a gene (CAST) deleted in del(5q) MDS, correlated with LEN responsiveness in patients with del(5q) MDS. Depletion of CAST restored responsiveness of LEN-resistant non-del(5q) MDS cells and AML cells, providing an explanation for the superior responses of patients with del(5q) MDS to LEN treatment. Our study describes a cellular mechanism by which LEN, acting through CRBN and IKZF1, has cytotoxic effects in MDS and AML that depend on a calcium- and calpain-dependent pathway.	[Fang, Jing; Liu, Xiaona; Bolanos, Lyndsey; Barker, Brenden; Grimes, H. Leighton; Komurov, Kakajan; Starczynowski, Daniel T.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Rigolino, Carmela; Cuzzola, Maria] Azienda Osped Bianchi Melacrino Morelli, Bone Marrow Transplant Unit, Reggio Di Calabria, Italy; [Cortelezzi, Agostino] Univ Milan, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Dept Hematol, Milan, Italy; [Oliva, Esther N.] Azienda Osped Bianchi Melacrino Morelli, Hematol Unit, Reggio Di Calabria, Italy; [Fontanillo, Celia] Celgene Corp, Seville, Spain; [MacBeth, Kyle] Celgene Corp, San Francisco, CA USA; [Starczynowski, Daniel T.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH USA; [Fang, Jing] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC USA	Cincinnati Children's Hospital Medical Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Bristol-Myers Squibb; Celgene Corporation; University System of Ohio; University of Cincinnati; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Starczynowski, DT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA.; Starczynowski, DT (corresponding author), Univ Cincinnati, Dept Canc Biol, Cincinnati, OH USA.	daniel.starczynowski@cchmc.org	cortelezzi, agostino/L-2633-2016	Fontanillo, Celia/0000-0002-3631-7881; Bolanos, Lyndsey/0000-0002-5447-5277; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Grimes, H. Leighton/0000-0001-8162-6758	Cincinnati Children's Hospital Research Foundation; NIDDK [P30DK090971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111103, R01HL114582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cincinnati Children's Hospital Research Foundation (D.T.S.). We thank J. Bailey and V. Summey for assistance with transplantations. The normal bone marrow samples were received through the Normal Donor Repository in the Translational Core Laboratory at Cincinnati Children's Research Foundation, which is supported through the NIDDK-funded Center of Excellence in Molecular Hematology (grant no. P30DK090971; to Y. Zheng (CCHMC)). We thank B. Ebert (Harvard Medical School; Dana-Farber Cancer Institute) for providing the EGI and EGI-IKZF1 vectors, and for his expertise and discussions. In addition, we thank Y. Xu (Indiana University School of Medicine) for providing the MIG-GPR68 vector and K. Tohyama (Kawasaki Medical School) for the MDSL cells.	Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Frick KK, 2009, J BONE MINER RES, V24, P305, DOI 10.1359/JBMR.081015; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Giagounidis AAN, 2012, SEMIN HEMATOL, V49, P312, DOI 10.1053/j.seminhematol.2012.07.001; Giorgi C, 2015, CELL CYCLE, V14, P933, DOI 10.1080/15384101.2015.1010973; Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112; Huang WC, 2008, CURR BIOL, V18, P781, DOI 10.1016/j.cub.2008.04.049; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuoka A, 2010, LEUKEMIA, V24, P748, DOI 10.1038/leu.2009.296; McDaniel Jessica M, 2012, Adv Hematol, V2012, P513702, DOI 10.1155/2012/513702; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Rhyasen GW, 2014, LEUKEMIA, V28, P1142, DOI 10.1038/leu.2013.372; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Russell JL, 2012, ACS CHEM BIOL, V7, P1077, DOI 10.1021/cb300001m; Saft L, 2014, HAEMATOLOGICA, V99, P1041, DOI 10.3324/haematol.2013.098103; Sorimachi H, 2011, J BIOCHEM, V150, P23, DOI 10.1093/jb/mvr070; TOHYAMA K, 1995, BRIT J HAEMATOL, V91, P795, DOI 10.1111/j.1365-2141.1995.tb05391.x; Wei S, 2013, ONCOGENE, V32, P1110, DOI 10.1038/onc.2012.139; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819	34	51	52	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					727	734		10.1038/nm.4127	http://dx.doi.org/10.1038/nm.4127			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27294874	Green Accepted			2022-12-27	WOS:000379366900011
J	You, JC; Muralidharan, K; Park, JW; Petrof, I; Pyfer, MS; Corbett, BF; LaFrancois, JJ; Zheng, Y; Zhang, XH; Mohila, CA; Yoshor, D; Rissman, RA; Nestler, EJ; Scharfman, HE; Chin, J				You, Jason C.; Muralidharan, Kavitha; Park, Jin W.; Petrof, Iraklis; Pyfer, Mark S.; Corbett, Brian F.; LaFrancois, John J.; Zheng, Yi; Zhang, Xiaohong; Mohila, Carrie A.; Yoshor, Daniel; Rissman, Robert A.; Nestler, Eric J.; Scharfman, Helen E.; Chin, Jeannie			Epigenetic suppression of hippocampal calbindin-D28k by Delta FosB drives seizure-related cognitive deficits	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; DENTATE GYRUS; GRANULE CELLS; EPILEPTIFORM ACTIVITY; KNOCKOUT MICE; MOUSE MODEL; EXPRESSION; NEUROGENESIS	The calcium-binding protein calbindin-D28k is critical for hippocampal function and cognition1-3, but its expression is markedly decreased in various neurological disorders associated with epileptiform activity and seizures4-7. In Alzheimer's disease (AD) and epilepsy, both of which are accompanied by recurrent seizures(8), the severity of cognitive deficits reflects the degree of calbindin reduction in the hippocampal dentate gyrus (DG) (4,9,10). However, despite the importance of calbindin in both neuronal physiology and pathology, the regulatory mechanisms that control its expression in the hippocampus are poorly understood. Here we report an epigenetic mechanism through which seizures chronically suppress hippocampal calbindin expression and impair cognition. We demonstrate that Delta FosB, a highly stable transcription factor, is induced in the hippocampus in mouse models of AD and seizures, in which it binds and triggers histone deacetylation at the promoter of the calbindin gene (Calb1) and downregulates Calb1 transcription. Notably, increasing DG calbindin levels, either by direct virus-mediated expression or inhibition of Delta FosB signaling, improves spatial memory in a mouse model of AD. Moreover, levels of DFosB and calbindin expression are inversely related in the DG of individuals with temporal lobe epilepsy (TLE) or AD and correlate with performance on the Mini-Mental State Examination (MMSE). We propose that chronic suppression of calbindin by Delta FosB is one mechanism through which intermittent seizures drive persistent cognitive deficits in conditions accompanied by recurrent seizures.	[You, Jason C.; Muralidharan, Kavitha; Petrof, Iraklis; Pyfer, Mark S.; Corbett, Brian F.; Zhang, Xiaohong; Chin, Jeannie] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Muralidharan, Kavitha; Petrof, Iraklis; Pyfer, Mark S.; Corbett, Brian F.; Zhang, Xiaohong; Chin, Jeannie] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [You, Jason C.; Muralidharan, Kavitha; Park, Jin W.; Zheng, Yi; Chin, Jeannie] Baylor Coll Med, Dept Neurosci, Mem & Brain Res Ctr, Houston, TX 77030 USA; [LaFrancois, John J.; Scharfman, Helen E.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA; [LaFrancois, John J.; Scharfman, Helen E.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Mohila, Carrie A.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Mohila, Carrie A.] Baylor Coll Med, Houston, TX 77030 USA; [Yoshor, Daniel] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Rissman, Robert A.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Rissman, Robert A.] VA San Diego Healthcare Syst, San Diego, CA USA; [Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Jefferson University; Jefferson University; Baylor College of Medicine; New York University; New York University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chin, J (corresponding author), Baylor Coll Med, Dept Neurosci, Mem & Brain Res Ctr, Houston, TX 77030 USA.	jeannie.chin@bcm.edu		Chin, Jeannie/0000-0001-9902-3744; MURALIDHARAN, KAVITHA/0000-0002-0112-2793	Margaret Q. Landenberger Research Foundation; Hassel Family Foundation; National Institutes of Health [NS085171, F30-AG048710, AG051848, BX003040, AG0051839, AG005131]; New York State Office of Mental Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085171, T32NS007413, R01NS086965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055328, R21AG051839, R01AG051848, R01AG018440, F30AG048710, P50AG005131] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003040] Funding Source: NIH RePORTER	Margaret Q. Landenberger Research Foundation; Hassel Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Mental Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Jagirdar for helpful comments on the manuscript. This work was supported by the Margaret Q. Landenberger Research Foundation (J.C.), the Hassel Family Foundation (J.C.), National Institutes of Health grant NS085171 (J.C.), F30-AG048710 (J.C.Y.), AG051848, BX003040, AG0051839, and AG005131 (R.A.R.), and the New York State Office of Mental Health (H.E.S., J.J.F.).	Abraham H, 2011, BRAIN RES, V1399, P66, DOI 10.1016/j.brainres.2011.05.010; Berton O, 2009, BIOL PSYCHIAT, V66, P554, DOI 10.1016/j.biopsych.2009.04.005; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; Carter DS, 2008, EPILEPSY RES, V79, P213, DOI 10.1016/j.eplepsyres.2008.02.006; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Eagle AL, 2015, J NEUROSCI, V35, P13773, DOI 10.1523/JNEUROSCI.2083-15.2015; Emmanuele V, 2012, J NEUROL SCI, V317, P29, DOI 10.1016/j.jns.2012.03.005; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; Iyengar SS, 2015, EXP NEUROL, V264, P135, DOI 10.1016/j.expneurol.2014.11.009; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jouvenceau A, 2002, NEUROPHARMACOLOGY, V42, P444, DOI 10.1016/S0028-3908(01)00202-7; Jouvenceau A, 1999, SYNAPSE, V33, P172, DOI 10.1002/(SICI)1098-2396(19990901)33:3<172::AID-SYN2>3.0.CO;2-S; Karadi K, 2012, EPILEPSY BEHAV, V25, P110, DOI 10.1016/j.yebeh.2012.06.007; Kesner RP, 2015, NEUROBIOL LEARN MEM, V118, P42, DOI 10.1016/j.nlm.2014.11.004; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Klapstein GJ, 1998, NEUROSCIENCE, V85, P361, DOI 10.1016/S0306-4522(97)00632-5; Kurushima H, 2005, CELL DEATH DIFFER, V12, P1078, DOI 10.1038/sj.cdd.4401648; Lam AD, 2017, NAT MED, V23, P678, DOI 10.1038/nm.4330; Lopez-Meraz ML, 2010, NEUROBIOL DIS, V37, P394, DOI 10.1016/j.nbd.2009.10.019; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Magloczky Z, 1997, NEUROSCIENCE, V76, P377, DOI 10.1016/S0306-4522(96)00440-X; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagerl UV, 1998, J PHYSIOL-LONDON, V509, P39, DOI 10.1111/j.1469-7793.1998.039bo.x; Nagerl UV, 2000, J NEUROSCI, V20, P1831; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Vossel KA, 2016, ANN NEUROL, V80, P858, DOI 10.1002/ana.24794; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Westerink RHS, 2012, BRAIN RES, V1450, P1, DOI 10.1016/j.brainres.2012.02.036; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	41	45	45	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1377	+		10.1038/nm.4413	http://dx.doi.org/10.1038/nm.4413			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035369	Green Accepted			2022-12-27	WOS:000414548300020
J	Chakradhar, S				Chakradhar, Shraddha			Breaking through: How researchers are gaining entry into barricaded bacteria	NATURE MEDICINE			English	Editorial Material																			0	8	9	3	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					907	910		10.1038/nm0817-907	http://dx.doi.org/10.1038/nm0817-907			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28777786				2022-12-27	WOS:000406947600003
J	Eisfeld, AJ; Kawaoka, Y				Eisfeld, Amie J.; Kawaoka, Yoshihiro			Calculated risk: a new single-nucleotide polymorphism linked to severe influenza disease	NATURE MEDICINE			English	Editorial Material							SUSCEPTIBILITY; IFITM3		[Eisfeld, Amie J.; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA.	yoshihiro.kawaoka@wisc.edu		Eisfeld, Amie/0000-0003-2231-3107	Leading Advanced Projects for medical innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED); National Institute of Allergy and Infectious Diseases, US National Institutes of Health [U19AI106772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106772] Funding Source: NIH RePORTER	Leading Advanced Projects for medical innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Leading Advanced Projects for medical innovation (LEAP) from the Japan Agency for Medical Research and Development (AMED); and grant U19AI106772 (to Y.K.), provided by the National Institute of Allergy and Infectious Diseases, US National Institutes of Health. The authors thank S. Watson for editing the manuscript.	Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; [Anonymous], 2010, N ENGL J MED, V362; Bailey C. C., 2011, ANON REV VIROL, V1, P261; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Horby P, 2013, INFLUENZA OTHER RESP, V7, P37, DOI 10.1111/irv.12079; Lopez-Rodriguez M, 2016, EUR J CLIN MICROBIOL, V35, P1811, DOI 10.1007/s10096-016-2732-7; Maestri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139681; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhou J, 2012, J INFECT DIS, V206, P495, DOI 10.1093/infdis/jis378; Zuniga J, 2012, EUR RESPIR J, V39, P604, DOI 10.1183/09031936.00020611	12	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					911	912		10.1038/nm.4383	http://dx.doi.org/10.1038/nm.4383			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28777788	Green Accepted			2022-12-27	WOS:000406947600004
J	Alexandre, C; Latremoliere, A; Ferreira, A; Miracca, G; Yamamoto, M; Scammell, TE; Woolf, CJ				Alexandre, Chloe; Latremoliere, Alban; Ferreira, Ashley; Miracca, Giulia; Yamamoto, Mihoko; Scammell, Thomas E.; Woolf, Clifford J.			Decreased alertness due to sleep loss increases pain sensitivity in mice	NATURE MEDICINE			English	Article							CHRONIC WIDESPREAD PAIN; PREPULSE INHIBITION; INSOMNIA SYMPTOMS; ANIMAL-MODELS; DOPAMINE; DEPRIVATION; HOMEOSTASIS; PERCEPTION; STRESS; RAT	Extended daytime and nighttime activities are major contributors to the growing sleep deficiency epidemic(1,2), as is the high prevalence of sleep disorders like insomnia. The consequences of chronic insufficient sleep for health remain uncertain3. Sleep quality and duration predict presence of pain the next day in healthy subjects(4-7), suggesting that sleep disturbances alone may worsen pain, and experimental sleep deprivation in humans supports this claim(8,9). We demonstrate that sleep loss, but not sleep fragmentation, in healthy mice increases sensitivity to noxious stimuli (referred to as 'pain') without general sensory hyper-responsiveness. Moderate daily repeated sleep loss leads to a progressive accumulation of sleep debt and also to exaggerated pain responses, both of which are rescued after restoration of normal sleep. Caffeine and modafinil, two wake-promoting agents that have no analgesic activity in rested mice, immediately normalize pain sensitivity in sleep-deprived animals, without affecting sleep debt. The reversibility of mild sleep-loss-induced pain by wake-promoting agents reveals an unsuspected role for alertness in setting pain sensitivity. Clinically, insufficient or poor-quality sleep may worsen pain and this enhanced pain may be reduced not by analgesics, whose effectiveness is reduced, but by increasing alertness or providing better sleep.	[Alexandre, Chloe; Yamamoto, Mihoko; Scammell, Thomas E.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Latremoliere, Alban; Ferreira, Ashley; Miracca, Giulia; Woolf, Clifford J.] Boston Childrens Hosp, Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Latremoliere, Alban; Ferreira, Ashley; Miracca, Giulia; Woolf, Clifford J.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Scammell, TE (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.; Woolf, CJ (corresponding author), Boston Childrens Hosp, Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Woolf, CJ (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	tscammel@bidmc.harvard.edu; clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010	Miracca, Giulia/0000-0002-9141-2806; Latremoliere, Alban/0000-0002-9212-1007	NIH [DE022912, NS038253-11S1, HL095491]; IDDRC of Boston Children's Hospital [U54 HD090255]; Metabolic Physiology Core [P30 DK057521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R37NS039518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDDRC of Boston Children's Hospital; Metabolic Physiology Core; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants DE022912 (C.J.W. and T.E.S.), NS038253-11S1 (C.J.W.) and HL095491 (T.E.S.), the IDDRC of Boston Children's Hospital (U54 HD090255) and the Metabolic Physiology Core (P30 DK057521). We are grateful to N. Andrews, O. Peroni, F. Latremoliere, T. Mochizuki, P.-A. Libourel and R. Hersher for advice and technical assistance and O. Mazor of the HMS Research Instrumentation Core for instrument design and fabrication.	Alexandre C, 2008, SLEEP, V31, P259, DOI 10.1093/sleep/31.2.259; Boada MD, 2008, J NEUROSCI, V28, P2006, DOI 10.1523/JNEUROSCI.5609-07.2008; Boada MD, 2007, J NEUROPHYSIOL, V98, P668, DOI 10.1152/jn.00264.2007; Bonaventura J, 2015, P NATL ACAD SCI USA, V112, pE3609, DOI 10.1073/pnas.1507704112; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Campbell CM, 2011, EUR J PAIN, V15, P561, DOI 10.1016/j.ejpain.2010.11.014; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Clasadonte J, 2014, J NEUROSCI, V34, P1879, DOI 10.1523/JNEUROSCI.2870-12.2014; Davies KA, 2008, RHEUMATOLOGY, V47, P1809, DOI 10.1093/rheumatology/ken389; DAVIS M, 1980, NEUROSCI BIOBEHAV R, V4, P241, DOI 10.1016/0149-7634(80)90016-0; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; Edwards RR, 2016, PAIN, V157, P1851, DOI 10.1097/j.pain.0000000000000602; Faraut B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117425; Ferraro L, 1996, EUR J PHARMACOL, V306, P33, DOI 10.1016/0014-2999(96)00182-3; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Fossum IN, 2014, BEHAV SLEEP MED, V12, P343, DOI 10.1080/15402002.2013.819468; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Haack M, 2009, PAIN, V145, P136, DOI 10.1016/j.pain.2009.05.029; HENNESSY MB, 1987, BEHAV NEUROSCI, V101, P237; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Kaprio J, 2002, TWIN RES, V5, P358, DOI 10.1375/twin.5.5.358; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Kuna ST, 2012, SLEEP, V35, P1223, DOI 10.5665/sleep.2074; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Le Bars D, 2001, PHARMACOL REV, V53, P597; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Libourel PA, 2015, SLEEP, V38, P815, DOI 10.5665/sleep.4682; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Mansfield KE, 2016, PAIN, V157, P55, DOI 10.1097/j.pain.0000000000000314; Meerlo P, 1997, NEUROSCI LETT, V225, P41, DOI 10.1016/S0304-3940(97)00180-8; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nielsen CS, 2008, PAIN, V136, P21, DOI 10.1016/j.pain.2007.06.008; Odegard SS, 2015, CLIN NEUROPHYSIOL, V126, P1979, DOI 10.1016/j.clinph.2014.12.011; Onen SH, 2001, BRAIN RES, V900, P261, DOI 10.1016/S0006-8993(01)02320-4; Petrovsky N, 2014, J NEUROSCI, V34, P9134, DOI 10.1523/JNEUROSCI.0904-14.2014; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Roehrs TA, 2012, SLEEP, V35, P1667, DOI 10.5665/sleep.2240; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schuh-Hofer S, 2013, PAIN, V154, P1613, DOI 10.1016/j.pain.2013.04.046; Skinner GO, 2011, PHARMACOL BIOCHEM BE, V99, P94, DOI 10.1016/j.pbb.2011.04.009; Smith MT, 2008, PAIN, V138, P497, DOI 10.1016/j.pain.2008.01.028; Smith MT, 2005, SLEEP, V28, P809, DOI 10.1093/sleep/28.7.809; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Solinas M, 2002, J NEUROSCI, V22, P6321; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Steinmiller CL, 2010, EXP CLIN PSYCHOPHARM, V18, P277, DOI 10.1037/a0018899; Taylor AMW, 2016, PAIN, V157, P1194, DOI 10.1097/j.pain.0000000000000494; Tiede W, 2010, PAIN, V148, P36, DOI 10.1016/j.pain.2009.08.029; Tomim DH, 2016, MOL NEUROBIOL, V53, P1706, DOI 10.1007/s12035-014-9059-0; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Vicuna L, 2015, NAT MED, V21, P518, DOI 10.1038/nm.3852; Volkow ND, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.46; Volkow ND, 2012, J NEUROSCI, V32, P6711, DOI 10.1523/JNEUROSCI.0045-12.2012; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wang PK, 2015, J PAIN, V16, P1186, DOI 10.1016/j.jpain.2015.07.006; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x	66	78	79	5	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					768	+		10.1038/nm.4329	http://dx.doi.org/10.1038/nm.4329			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28481358	Green Accepted			2022-12-27	WOS:000402768000020
J	Gao, JJ; Ward, JF; Pettaway, CA; Shi, LZ; Subudhi, SK; Vence, LM; Zhao, H; Chen, JF; Chen, H; Efstathiou, E; Troncoso, P; Allison, JP; Logothetis, CJ; Wistuba, II; Sepulveda, MA; Sun, JJ; Wargo, J; Blando, J; Sharma, P				Gao, Jianjun; Ward, John F.; Pettaway, Curtis A.; Shi, Lewis Z.; Subudhi, Sumit K.; Vence, Luis M.; Zhao, Hao; Chen, Jianfeng; Chen, Hong; Efstathiou, Eleni; Troncoso, Patricia; Allison, James P.; Logothetis, Christopher J.; Wistuba, Ignacio I.; Sepulveda, Manuel A.; Sun, Jingjing; Wargo, Jennifer; Blando, Jorge; Sharma, Padmanee			VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer	NATURE MEDICINE			English	Article							T-CELLS; ANTI-CTLA-4 THERAPY; BLOCKADE; CHEMOTHERAPY; FREQUENCY; TRIAL	To date, anti-CTLA-4 (ipilimumab) or anti-PD-1 (nivolumab) monotherapy has not been demonstrated to be of substantial clinical benefit in patients with prostate cancer. To identify additional immune-inhibitory pathways in the prostate-tumor microenvironment, we evaluated untreated and ipilimumab-treated tumors from patients in a presurgical clinical trial. Levels of the PD-L1 and VISTA inhibitory molecules increased on independent subsets of macrophages in treated tumors. Our data suggest that VISTA represents another compensatory inhibitory pathway in prostate tumors after ipilimumab therapy.	[Gao, Jianjun; Shi, Lewis Z.; Subudhi, Sumit K.; Chen, Jianfeng; Efstathiou, Eleni; Logothetis, Christopher J.; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Ward, John F.; Pettaway, Curtis A.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Vence, Luis M.; Zhao, Hao; Chen, Hong; Allison, James P.; Sun, Jingjing; Blando, Jorge; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA; [Troncoso, Patricia] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Allison, James P.; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Sepulveda, Manuel A.] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev LLC, Janssen Oncol Therapeut Area, Spring House, PA USA; [Wargo, Jennifer] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Immunotherapy Platform, Houston, TX 77030 USA.; Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	padsharma@mdanderson.org	Ward, John F/AAS-3393-2020	Ward, John F/0000-0001-6027-8774; Shi, Lewis/0000-0002-5351-8730; Allison, James/0000-0001-8980-5697	American Association for Cancer Research (AACR) Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant [SU2C-AACR-DT1012]; Prostate Cancer Foundation (PCF); PCF Young Investigator Award; Conquer Cancer Foundation-American Society of Clinical Oncology (ASCO); Cancer Prevention Research in Texas (CPRIT) [RP120108]; NIH/NCI [R01 CA1633793, K12 CA088084, P30CA016672, P50 CA140388]; NATIONAL CANCER INSTITUTE [K12CA088084, P30CA016672, R01CA163793, P50CA140388, K08CA160692] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	American Association for Cancer Research (AACR) Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant; Prostate Cancer Foundation (PCF); PCF Young Investigator Award; Conquer Cancer Foundation-American Society of Clinical Oncology (ASCO); Cancer Prevention Research in Texas (CPRIT); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the clinical and research team for this study, including P. Corn, J. Araujo, B. Chapin, S. Matin, A. Zurita-Saavedra, J. Davis, L. Pisters, and A. Aparicio for treatment and care of patients. We thank M. Campbell for assistance with clinical data collection; L. Xiong, B. Guan, J. Kim, M. Higa, J. Bustillos, D. Ng Tang, and S. Basu for technical support; M. Curran and M. Ai for help with the TRAMP-C2 mouse models; Janssen, CA, for providing the anti-VISTA antibody; and C.G. Liu of the Sequencing & Non-Coding RNA Program for microarray studies. The clinical trial was supported by Bristol-Myers-Squibb (BMS). The research work was also supported by funding from the American Association for Cancer Research (AACR) Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant (SU2C-AACR-DT1012; J.P.A., P.S., S.K.S., J.G.); the Prostate Cancer Foundation (PCF) Challenge Grant in Immunology (J.P.A., P.S.); a PCF 2014 Young Investigator Award (S.K.S.); a Conquer Cancer Foundation-American Society of Clinical Oncology (ASCO) 2012 Young Investigator Award (J.G.); Cancer Prevention Research in Texas (CPRIT) RP120108 (P.S.); NIH/NCI R01 CA1633793 (P.S.); and NIH/NCI K12 CA088084 (J.G.) and NIH/NCI P30CA016672 (MD Anderson Cancer Center institutional grant); NIH/NCI P50 CA140388 Prostate Cancer SPORE (P.S., J.P.A., S.K.S., C.J.L., E.E.).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Foster BA, 1997, CANCER RES, V57, P3325; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao J, 2015, ONCOGENE, V34, P5411, DOI 10.1038/onc.2015.5; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Lines JL, 2014, CANCER IMMUNOL RES, V2, P510, DOI 10.1158/2326-6066.CIR-14-0072; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12335; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Subudhi SK, 2016, P NATL ACAD SCI USA, V113, P11919, DOI 10.1073/pnas.1611421113; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wimberly H, 2015, CANCER IMMUNOL RES, V3, P326, DOI 10.1158/2326-6066.CIR-14-0133	20	333	360	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					551	+		10.1038/nm.4308	http://dx.doi.org/10.1038/nm.4308			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28346412	Green Accepted			2022-12-27	WOS:000400650700010
J	Romani, L; Oikonomou, V; Moretti, S; Iannitti, RG; D'Adamo, MC; Villella, VR; Pariano, M; Sforna, L; Borghi, M; Bellet, MM; Fallarino, F; Pallotta, MT; Servillo, G; Ferrari, E; Puccetti, P; Kroemer, G; Pessia, M; Maiuri, L; Goldstein, AL; Garaci, E				Romani, Luigina; Oikonomou, Vasilis; Moretti, Silvia; Iannitti, Rossana G.; D'Adamo, Maria Cristina; Villella, Valeria R.; Pariano, Marilena; Sforna, Luigi; Borghi, Monica; Bellet, Marina M.; Fallarino, Francesca; Pallotta, Maria Teresa; Servillo, Giuseppe; Ferrari, Eleonora; Puccetti, Paolo; Kroemer, Guido; Pessia, Mauro; Maiuri, Luigi; Goldstein, Allan L.; Garaci, Enrico			Thymosin alpha 1 represents a potential potent single-molecule-based therapy for cystic fibrosis	NATURE MEDICINE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; INDOLEAMINE 2,3-DIOXYGENASE; CFTR POTENTIATOR; MOUSE MODEL; DISEASE; AUTOPHAGY; PROTEIN; INFLAMMATION; CELLS; RESTORATION	Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) that compromise its chloride channel activity. The most common mutation, p.Phe508del, results in the production of a misfolded CFTR protein, which has residual channel activity but is prematurely degraded. Because of the inherent complexity of the pathogenetic mechanisms involved in CF, which include impaired chloride permeability and persistent lung inflammation, a multidrug approach is required for efficacious CF therapy. To date, no individual drug with pleiotropic beneficial effects is available for CF. Here we report on the ability of thymosin alpha 1 (T alpha 1)-a naturally occurring polypeptide with an excellent safety profile in the clinic when used as an adjuvant or an immunotherapeutic agent- to rectify the multiple tissue defects in mice with CF as well as in cells from subjects with the p.Phe508del mutation. T alpha 1 displayed two combined properties that favorably opposed CF symptomatology: it reduced inflammation and increased CFTR maturation, stability and activity. By virtue of this two-pronged action, T alpha 1 has strong potential to be an efficacious single-molecule-based therapeutic agent for CF.	[Romani, Luigina; Oikonomou, Vasilis; Moretti, Silvia; Iannitti, Rossana G.; Pariano, Marilena; Sforna, Luigi; Borghi, Monica; Bellet, Marina M.; Fallarino, Francesca; Pallotta, Maria Teresa; Servillo, Giuseppe; Puccetti, Paolo; Pessia, Mauro] Univ Perugia, Dept Expt Med, Perugia, Italy; [D'Adamo, Maria Cristina; Pessia, Mauro] Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Msida, Malta; [Villella, Valeria R.; Ferrari, Eleonora; Maiuri, Luigi] Ist Sci San Raffaele, European Inst Res Cyst Fibrosis, Div Genet & Cell Biol, Milan, Italy; [Kroemer, Guido] Univ Paris 05, Ctr Rech Cordeliers, INSERM U1138, Paris, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol Platform, Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Cell Biol Platform, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Maiuri, Luigi] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Goldstein, Allan L.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA; [Garaci, Enrico] Univ San Raffaele, Rome, Italy; [Garaci, Enrico] IRCCS San Raffaele, Rome, Italy	University of Perugia; University of Malta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital; University of Eastern Piedmont Amedeo Avogadro; George Washington University; Universita Telematica San Raffaele; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Romani, L (corresponding author), Univ Perugia, Dept Expt Med, Perugia, Italy.	luigina.romani@unipg.it	D'Adamo, Maria Cristina/AAD-3701-2022; Kroemer, Guido/AAY-9859-2020; Villella, Valeria Rachela/AAC-1075-2019; Sforna, Luigi/J-8343-2018; Bellet, Marina Maria/K-7794-2016; KROEMER, Guido/B-4263-2013; Oikonomou, Vasileios/ABC-7703-2021; Romani, Luigina/O-9987-2018; Pallotta, Maria Teresa/K-7021-2016; GARACI, ENRICO/AAB-3349-2021; Fallarino, Francesca/O-3358-2013	D'Adamo, Maria Cristina/0000-0002-6758-6064; Villella, Valeria Rachela/0000-0003-4858-4853; Sforna, Luigi/0000-0003-2145-3642; Bellet, Marina Maria/0000-0001-7604-0189; KROEMER, Guido/0000-0002-9334-4405; Pallotta, Maria Teresa/0000-0002-0417-1638; Oikonomou, Vasileios/0000-0002-7553-0159; Pessia, Mauro/0000-0002-2857-6795; MORETTI, Silvia/0000-0002-8177-7254; Romani, Luigina/0000-0002-1356-525X; Fallarino, Francesca/0000-0002-8501-2136; Servillo, Giuseppe/0000-0001-7960-7689; pariano, marilena/0000-0002-9896-171X; Borghi, Monica/0000-0002-6337-5999	European Economic Community European Coordination Action for Research in Cystic Fibrosis program [EU FP6 SHMCT-2005-018932]; Specific Targeted Research Project FunMeta [ERC-2011-AdG-293714]; Italian Cystic Fibrosis Research Foundation	European Economic Community European Coordination Action for Research in Cystic Fibrosis program; Specific Targeted Research Project FunMeta; Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	We thank the primary cell culture service offered from the Italian Cystic Fibrosis Research Foundation for kindly providing us with the HBE cells. We thank B. Scholte (Erasmus Medical Center Rotterdam), who provided Cftr<SUP>tm1EUR</SUP> mice (F508del mice, European Economic Community European Coordination Action for Research in Cystic Fibrosis program EU FP6 SHMCT-2005-018932). We thank G. Teti (University of Messina, Italy) for providing us with the TLR9-GFP-transfected HEK293 cells. This study was supported by the Specific Targeted Research Project FunMeta (ERC-2011-AdG-293714 to L.R.). M.P. gratefully acknowledges a fellowship from the Italian Cystic Fibrosis Research Foundation.	Ancell CD, 2001, AM J HEALTH-SYST PH, V58, P879, DOI 10.1093/ajhp/58.10.879; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Collawn JF, 2014, AM J PHYSIOL-LUNG C, V307, pL917, DOI 10.1152/ajplung.00326.2014; DALAKAS MC, 1981, J NEUROL SCI, V50, P239, DOI 10.1016/0022-510X(81)90170-2; Darrah RJ, 2016, J CYST FIBROS, V15, P736, DOI 10.1016/j.jcf.2016.05.002; de Benedictis FM, 2012, AM J RESP CRIT CARE, V185, P12, DOI 10.1164/rccm.201107-1174CI; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; de Luca A, 2010, CELL MOL IMMUNOL, V7, P459, DOI 10.1038/cmi.2010.43; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Devor DC, 1998, J CLIN INVEST, V102, P679, DOI 10.1172/JCI2614; Fajac I, 2017, PHARMACOL THERAPEUT, V170, P205, DOI 10.1016/j.pharmthera.2016.11.009; Galietta LJV, 2013, PEDIATR DRUGS, V15, P393, DOI 10.1007/s40272-013-0035-3; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Goldstein AL, 2009, EXPERT OPIN BIOL TH, V9, P593, DOI [10.1517/14712590902911412 , 10.1517/14712590902911412]; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Heard A, 2015, CURR DRUG TARGETS, V16, P958, DOI 10.2174/1389450116666150518102831; Hegde RN, 2015, ELIFE, V4, DOI 10.7554/eLife.10365; Hoffman LR, 2013, CHEST, V143, P207, DOI 10.1378/chest.12-1639; Iannitti RG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10791; Iannitti RG, 2013, AM J RESP CRIT CARE, V187, P609, DOI 10.1164/rccm.201207-1346OC; King J, 2016, J INFECTION, V72, pS50, DOI 10.1016/j.jinf.2016.04.022; King RS, 2015, EXPERT OPIN BIOL TH, V15, pS41, DOI [10.1517/14712598.20151008446, 10.1517/14712598.2015.1008446]; Kucera A, 2016, TRAFFIC, V17, P211, DOI 10.1111/tra.12357; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Loffing J, 1998, AM J PHYSIOL-CELL PH, V275, pC913, DOI 10.1152/ajpcell.1998.275.4.C913; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mandaliti W, 2016, AMINO ACIDS, V48, P1231, DOI 10.1007/s00726-016-2169-4; McGaha TL, 2015, ONCOTARGET, V6, P21771, DOI 10.18632/oncotarget.4846; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pica F, 2016, CLIN EXP IMMUNOL, V186, P39, DOI 10.1111/cei.12833; Pilewski JM, 2014, PEDIATR PULM, V49, P157; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; Romani L, 2006, BLOOD, V108, P2265, DOI 10.1182/blood-2006-02-004762; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rubin BK, 2014, PAEDIATR RESPIR REV, V15, P113, DOI 10.1016/j.prrv.2013.11.004; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Sarandeses CS, 2003, J BIOL CHEM, V278, P13286, DOI 10.1074/jbc.M213005200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Taillebourg E, 2012, AUTOPHAGY, V8, P767, DOI 10.4161/auto.19381; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Tuthill CW, 2013, CLIN EXP PHARMACOL P, V3, P133; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Villella VR, 2013, CELL DEATH DIFFER, V20, P1101, DOI 10.1038/cdd.2013.46; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Yuk JM, 2013, MOL CELLS, V36, P393, DOI 10.1007/s10059-013-0298-0; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155	69	80	82	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					590	+		10.1038/nm.4305	http://dx.doi.org/10.1038/nm.4305			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28394330	Green Accepted			2022-12-27	WOS:000400650700014
J	Cornu, TI; Mussolino, C; Cathomen, T				Cornu, Tatjana I.; Mussolino, Claudio; Cathomen, Toni			Refining strategies to translate genome editing to the clinic	NATURE MEDICINE			English	Review							ZINC-FINGER NUCLEASES; HOMOLOGY-DIRECTED REPAIR; HUMAN HEMATOPOIETIC STEM; IN-VIVO; GENE-THERAPY; DNA-CLEAVAGE; MOUSE MODEL; T-CELLS; WIDE SPECIFICITIES; SYSTEM ENABLES	Recent progress in developing programmable nucleases, such as zinc-finger nucleases, transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeat (CRISPR)-Cas nucleases, have paved the way for gene editing to enter clinical practice. This translation is a result of combining high nuclease activity with high specificity and successfully applying this technology in various preclinical disease models, including infectious disease, primary immunodeficiencies, hemoglobinopathies, hemophilia and muscular dystrophy. Several clinical gene-editing trials, both ex vivo and in vivo, have been initiated in the past 2 years, including studies that aim to knockout genes as well as to add therapeutic transgenes. Here we discuss the advances made in the gene-editing field in recent years, and specify priorities that need to be addressed to expand therapeutic genome editing to further disease entities.	[Cornu, Tatjana I.; Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany; [Cornu, Tatjana I.; Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Cathomen, T (corresponding author), Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany.; Cathomen, T (corresponding author), Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.; Cathomen, T (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	toni.cathomen@uniklinik-freiburg.de	Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630; Cornu, Tatjana/0000-0002-7206-7541	Federal Ministry of Education and Research [IFB01EO0803, iMACnet-01EK1602B, HBV-TALE-01DG15005]; German Research Foundation [SFB1160-TP17]; European Commission's Horizon 2020 Program [SCIDNET-666908, CARAT-667980]; Casebia Therapeutics [CAU-950-20140702]; German Academic Exchange Service	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); European Commission's Horizon 2020 Program; Casebia Therapeutics; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	We thank all members of the laboratories for helpful discussion. Current research in our labs is funded by the Federal Ministry of Education and Research (IFB01EO0803; iMACnet-01EK1602B; HBV-TALE-01DG15005), the German Research Foundation (SFB1160-TP17), the European Commission's Horizon 2020 Program (SCIDNET-666908; CARAT-667980), Casebia Therapeutics (CAU-950-20140702) and the German Academic Exchange Service.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Solinis MA, 2015, EUR J PHARM BIOPHARM, V95, P331, DOI 10.1016/j.ejpb.2014.12.022; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Ding WC, 2014, CLIN CANCER RES, V20, P6495, DOI 10.1158/1078-0432.CCR-14-0250; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/NMETH.3075, 10.1038/nmeth.3075]; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Juillerat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08150; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20657; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marketsandmarkets.com, 2016, GEN ED GEN ENG MARK; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; de Garibay APR, 2012, DRUG DES DEV THER, V6, P303, DOI 10.2147/DDDT.S36131; Pike-Overzet K, 2014, J ALLERGY CLIN IMMUN, V134, P242, DOI 10.1016/j.jaci.2014.04.033; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2015, MOL THER, V23, P1507, DOI 10.1038/mt.2015.104; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Williams DA, 2014, STEM CELL TRANSL MED, V3, P636, DOI 10.5966/sctm.2013-0206; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu KR, 2016, HUM GENE THER, V27, P729, DOI 10.1089/hum.2016.107; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	99	164	174	4	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					415	423		10.1038/nm.4313	http://dx.doi.org/10.1038/nm.4313			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28388605				2022-12-27	WOS:000398768100009
J	Osuna, CE; Lim, SY; Deleage, C; Griffin, BD; Stein, D; Schroeder, LT; Omage, R; Best, K; Luo, M; Hraber, PT; Andersen-Elyard, H; Ojeda, EFC; Huang, S; Vanlandingham, DL; Higgs, S; Perelson, AS; Estes, JD; Safronetz, D; Lewis, MG; Whitney, JB				Osuna, Christa E.; Lim, So-Yon; Deleage, Claire; Griffin, Bryan D.; Stein, Derek; Schroeder, Lukas T.; Omage, Robert; Best, Katharine; Luo, Ma; Hraber, Peter T.; Andersen-Elyard, Hanne; Ojeda, Erwing Fabian Cardozo; Huang, Scott; Vanlandingham, Dana L.; Higgs, Stephen; Perelson, Alan S.; Estes, Jacob D.; Safronetz, David; Lewis, Mark G.; Whitney, James B.			Zika viral dynamics and shedding in rhesus and cynomolgus macaques (vol 22, pg 1448, 2016)	NATURE MEDICINE			English	Correction													; Omange, Were/F-1454-2016	Cardozo Ojeda, Erwing/0000-0001-8690-9896; Omange, Were/0000-0002-0421-110X				Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206	1	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					264	264		10.1038/nm0217-264b	http://dx.doi.org/10.1038/nm0217-264b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170376	Bronze			2022-12-27	WOS:000393729000020
J	Carter, L; Rothwell, DG; Mesquita, B; Smowton, C; Leong, HS; Fernandez-Gutierrez, F; Li, YY; Burt, DJ; Antonello, J; Morrow, CJ; Hodgkinson, CL; Morris, K; Priest, L; Carter, M; Miller, C; Hughes, A; Blackhall, F; Dive, C; Brady, G				Carter, Louise; Rothwell, Dominic G.; Mesquita, Barbara; Smowton, Christopher; Leong, Hui Sun; Fernandez-Gutierrez, Fabiola; Li, Yaoyong; Burt, Deborah J.; Antonello, Jenny; Morrow, Christopher J.; Hodgkinson, Cassandra L.; Morris, Karen; Priest, Lynsey; Carter, Mathew; Miller, Crispin; Hughes, Andrew; Blackhall, Fiona; Dive, Caroline; Brady, Ged			Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer	NATURE MEDICINE			English	Article							TOPOTECAN; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; VINCRISTINE	In most patients with small-cell lung cancer (SCLC)-a metastatic, aggressive disease-the condition is initially chemosensitive but then relapses with acquired chemoresistance. In a minority of patients, however, relapse occurs within 3 months of initial treatment; in these cases, disease is defined as chemorefractory. The molecular mechanisms that differentiate chemosensitive from chemorefractory disease are currently unknown. To identify genetic features that distinguish chemosensitive from chemorefractory disease, we examined copy-number aberrations (CNAs) in circulating tumor cells (CTCs) from pretreatment SCLC blood samples. After analysis of 88 CTCs isolated from 13 patients (training set), we generated a CNA-based classifier that we validated in 18 additional patients (testing set, 112 CTC samples) and in six SCLC patient-derived CTC explant tumors(1). The classifier correctly assigned 83.3% of the cases as chemorefractory or chemosensitive. Furthermore, a significant difference was observed in progression-free survival (PFS) (Kaplan-Meier P value = 0.0166) between patients designated as chemorefractory or chemosensitive by using the baseline CNA classifier. Notably, CTC CNA profiles obtained at relapse from five patients with initially chemosensitive disease did not switch to a chemorefractory CNA profile, which suggests that the genetic basis for initial chemoresistance differs from that underlying acquired chemoresistance.	[Carter, Louise; Rothwell, Dominic G.; Mesquita, Barbara; Smowton, Christopher; Fernandez-Gutierrez, Fabiola; Burt, Deborah J.; Antonello, Jenny; Morrow, Christopher J.; Hodgkinson, Cassandra L.; Morris, Karen; Priest, Lynsey; Carter, Mathew; Dive, Caroline; Brady, Ged] Univ Manchester, CRUK Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England; [Leong, Hui Sun; Miller, Crispin] Univ Manchester, CRUK Manchester Inst, Computat Biol Support Grp, Manchester, Lancs, England; [Li, Yaoyong] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Miller, Crispin] Univ Manchester, CRUK Manchester Inst, RNA Biol Grp, Manchester, Lancs, England; [Hughes, Andrew] AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England; [Blackhall, Fiona] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Blackhall, Fiona; Dive, Caroline] Univ Manchester, CRUK Manchester Inst, Cancer Res UK Lung Canc Ctr Excellence, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; AstraZeneca; University of Manchester; University of Manchester	Dive, C; Brady, G (corresponding author), Univ Manchester, CRUK Manchester Inst, Clin & Expt Pharmacol Grp, Manchester, Lancs, England.; Dive, C (corresponding author), Univ Manchester, CRUK Manchester Inst, Cancer Res UK Lung Canc Ctr Excellence, Manchester, Lancs, England.	Caroline.Dive@cruk.manchester.ac.uk; Ged.Brady@cruk.manchester.ac.uk	; Blackhall, Fiona/N-2186-2015	Miller, Crispin/0000-0003-4341-1283; Carter, Louise/0000-0002-9854-2304; Blackhall, Fiona/0000-0001-8716-3395; Priest, Lynsey/0000-0003-3780-8508; Dive, Caroline/0000-0002-1726-8850; Rothwell, Dominic/0000-0002-8757-3893	CRUK; AstraZeneca [C147/A12328]; Menarini Biomarkers Singapore PTE Ltd.;  [C5759/A12328];  [A12197]; Cancer Research UK [20465, 15675, 19278] Funding Source: researchfish	CRUK(Cancer Research UK); AstraZeneca(AstraZeneca); Menarini Biomarkers Singapore PTE Ltd.; ; ; Cancer Research UK(Cancer Research UK)	L.C. was funded via a Clinical Pharmacology Fellowship educational grant from CRUK and AstraZeneca (C147/A12328). We would like to acknowledge the help of the CRUK Molecular Biology Core Facilities and members of the CRUK Manchester Institute Clinical and Experimental Pharmacology Group for their support of this study. We also thank the patients and healthy volunteers who provided their blood samples. This work was supported by core funding to CRUK Manchester Institute (C5759/A12328), and via Manchester CRUK Centre Award (A12197) and a research grant from Menarini Biomarkers Singapore PTE Ltd. (funding for all assigned to C.D.)	Chan BA, 2013, J THORAC DIS, V5, pS565, DOI 10.3978/j.issn.2072-1439.2013.07.43; Dowlati A, 2016, ANN ONCOL, V27, P642, DOI 10.1093/annonc/mdw005; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Hagmann R, 2015, J CANCER, V6, P1148, DOI 10.7150/jca.13080; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hou JM, 2009, AM J PATHOL, V175, P808, DOI 10.2353/ajpath.2009.090078; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Semenova EA, 2015, GENE DEV, V29, P1447, DOI 10.1101/gad.263145.115; Smyth G. K., STAT APPL GENET MOL, V3, P1544; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; von Pawel J, 1999, J CLIN ONCOL, V17, P658, DOI 10.1200/JCO.1999.17.2.658	18	206	214	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					114	119		10.1038/nm.4239	http://dx.doi.org/10.1038/nm.4239			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869802				2022-12-27	WOS:000391646800020
J	Pfluger, PT; Tschop, MH				Pfluger, Paul T.; Tschoep, Matthias H.			Obesity: will withaferin win the war?	NATURE MEDICINE			English	Editorial Material							CELASTROL	A new study shows that withaferin A, a steroidal lactone isolated from Withania somnifera, can exert profound metabolic benefits in mice, including body-weight loss, reduced hepatic steatosis and improved glucose control.	[Pfluger, Paul T.; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Neuherberg, Germany; [Pfluger, Paul T.; Tschoep, Matthias H.] German Ctr Diabet Res DZD, Neuherberg, Germany; [Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Neuherberg, Germany.; Tschop, MH (corresponding author), German Ctr Diabet Res DZD, Neuherberg, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Div Metab Dis, Munich, Germany.	matthias.tschoep@helmholtz-muenchen.de	Pfluger, Paul T/A-3770-2019	Pfluger, Paul T/0000-0002-8118-7588				Kim JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062068; Kleinridders A, 2013, J CLIN INVEST, V123, P4667, DOI 10.1172/JCI67615; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; McKenna MK, 2015, CANCER BIOL THER, V16, P1088, DOI 10.1080/15384047.2015.1046651; Myers MG, 2012, CELL METAB, V15, P150, DOI 10.1016/j.cmet.2012.01.002; Tschop MH, 2016, CELL METAB, V24, P51, DOI 10.1016/j.cmet.2016.06.021; Yang HJ, 2010, CURR DRUG TARGETS, V11, P733, DOI 10.2174/138945010791170842; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	10	6	6	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					970	971		10.1038/nm.4182	http://dx.doi.org/10.1038/nm.4182			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27603129	Green Submitted			2022-12-27	WOS:000382542800004
J	Guo, B; Huang, XX; Lee, MR; Lee, SA; Broxmeyer, HE				Guo, Bin; Huang, Xinxin; Lee, Man Ryul; Lee, Sang A.; Broxmeyer, Hal E.			Antagonism of PPAR-gamma signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis	NATURE MEDICINE			English	Article							UMBILICAL-CORD BLOOD; SELF-RENEWAL; NUCLEAR RECEPTORS; EXPANSION; DIFFERENTIATION; TRANSPLANTATION; LINEAGE; ENGRAFTMENT; INHIBITION	Hematopoietic stem cells (HSCs) quiescently reside in bone marrow niches and have the capacity to self-renew or differentiate to form all of the blood cells throughout the lifespan of an animal(1-3). Allogeneic HSC transplantation is a life-saving treatment for malignant and nonmalignant disorders(4,5). HSCs isolated from umbilical cord blood (CB) are used for hematopoietic cell transplantation (HCT)(6-11), but due to the limited numbers of HSCs in single units of umbilical CB, a number of methods have been proposed for ex vivo expansion of human HSCs7,8,12. We show here that antagonism of peroxisome proliferator-activated receptor (PPAR)-gamma promotes ex vivo expansion of phenotypically and functionally defined subsets of human CB HSCs and hematopoietic progenitor cells (HSPCs). PPAR-gamma antagonism in CB HSPCs strongly downregulated expression of several differentiation-associated genes, as well as fructose-bisphosphatase 1 (FBP1; which encodes a negative regulator of glycolysis), and enhanced glycolysis without compromising mitochondrial metabolism. The expansion of CB HSPCs by PPAR-gamma antagonism was completely suppressed by removal of glucose or inhibition of glycolysis. Moreover, knockdown of FBP1 expression promoted glycolysis and ex vivo expansion of long-term repopulating CB HSPCs, whereas overexpression of FBP1 suppressed the expansion of CB HSPCs that was induced by PPAR-gamma antagonism. Our study suggests the possibility for a new and simple means for metabolic reprogramming of CB HSPCs to improve the efficacy of HCT.	[Guo, Bin; Huang, Xinxin; Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Lee, Man Ryul; Lee, Sang A.] Soon Chun Hyang Univ, Soonchunhyang Inst Medibio Sci SIMS, Cheonan Si, South Korea	Indiana University System; Indiana University Bloomington; Soonchunhyang University	Broxmeyer, HE (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu	Guo, Bin/AAF-7324-2021	Huang, Xinxin/0000-0002-4298-4859	US Public Health Service Grants from the NIH [R01 HL112669, R01 HL056416, U54 DK106846]; National Research Foundation - Korean government [NRF-2017M3A9C6033069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112669, R01HL056416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106846] Funding Source: NIH RePORTER	US Public Health Service Grants from the NIH; National Research Foundation - Korean government(Korean Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Messina-Graham for technical support with the Seahorse assay, other members of the Broxmeyer laboratory for helpful discussions and assistance, and A.L. Sinn (In vivo Therapeutics Core, Indiana University School of Medicine) for assistance with the transplantation experiments. This work was supported by US Public Health Service Grants from the NIH (R01 HL112669, R01 HL056416 and U54 DK106846; all to H.E.B.) and by the National Research Foundation, which is funded by the Korean government (NRF-2017M3A9C6033069 to M.R.L.).	Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BROWN J, 1962, METABOLISM, V11, P1098; Broxmeyer HE, 2013, STEM CELLS DEV, V22, P103, DOI 10.1089/scd.2013.0382; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Chaurasia P, 2014, J CLIN INVEST, V124, P2378, DOI 10.1172/JCI70313; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Erion MD, 2005, P NATL ACAD SCI USA, V102, P7970, DOI 10.1073/pnas.0502983102; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Guo B, 2017, NAT MED, V23, P424, DOI 10.1038/nm.4298; Huang X, 2016, LEUKEMIA, V30, P144, DOI 10.1038/leu.2015.189; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jeong Y, 2009, EXP MOL MED, V41, P525, DOI 10.3858/emm.2009.41.8.091; Lee JH, 2011, J IMMUNOL, V187, P1778, DOI 10.4049/jimmunol.1003919; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Milano F, 2016, NEW ENGL J MED, V375, P944, DOI 10.1056/NEJMoa1602074; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nikiforow S, 2016, CELL STEM CELL, V18, P10, DOI 10.1016/j.stem.2015.12.011; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Ronn RE, 2015, STEM CELL REP, V4, P269, DOI 10.1016/j.stemcr.2015.01.009; Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2; Singh AK, 2016, CANCER RES, V76, P6445, DOI 10.1158/0008-5472.CAN-16-1311; Su HR, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.2387.2387; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Wu L, 2012, BLOOD, V119, P115, DOI 10.1182/blood-2011-06-363093; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	40	86	89	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					360	+		10.1038/nm.4477	http://dx.doi.org/10.1038/nm.4477			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29377004	Green Accepted, Green Submitted			2022-12-27	WOS:000426700900018
J	Boshuizen, J; Koopman, LA; Krijgsman, O; Shahrabi, A; Gresnigt-van den Heuvel, E; Ligtenberg, MA; Vredevoogd, DW; Kemper, K; Kuilman, T; Song, JY; Pencheva, N; Mortensen, JT; Foppen, MG; Rozeman, EA; Blank, CU; Janmaat, ML; Satijn, D; Breij, ECW; Peeper, DS; Parren, PWHI				Boshuizen, Julia; Koopman, Louise A.; Krijgsman, Oscar; Shahrabi, Aida; Gresnigt-van den Heuvel, Elke; Ligtenberg, Maarten A.; Vredevoogd, David W.; Kemper, Kristel; Kuilman, Thomas; Song, Ji-Ying; Pencheva, Nora; Mortensen, Jens Thing; Foppen, Marnix Geukes; Rozeman, Elisa A.; Blank, Christian U.; Janmaat, Maarten L.; Satijn, David; Breij, Esther C. W.; Peeper, Daniel S.; Parren, Paul W. H. I.			Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors	NATURE MEDICINE			English	Article							RECEPTOR TYROSINE KINASE; MAPK PATHWAY INHIBITORS; ACQUIRED-RESISTANCE; CANCER-THERAPY; MESENCHYMAL TRANSITION; MUTATED MELANOMA; UP-REGULATION; MONOCLONAL-ANTIBODY; IMPROVED SURVIVAL; MEK INHIBITION	Intratumor heterogeneity is a key factor contributing to therapeutic failure and, hence, cancer lethality. Heterogeneous tumors show partial therapy responses, allowing for the emergence of drug-resistant clones that often express high levels of the receptor tyrosine kinase AXL. In melanoma, AXL-high cells are resistant to MAPK pathway inhibitors, whereas AXL-low cells are sensitive to these inhibitors, rationalizing a differential therapeutic approach. We developed an antibody-drug conjugate, AXL-107-MMAE, comprising a human AXL antibody linked to the microtubule-disrupting agent monomethyl auristatin E. We found that AXL107-MMAE, as a single agent, displayed potent in vivo anti-tumor activity in patient-derived xenografts, including melanoma, lung, pancreas and cervical cancer. By eliminating distinct populations in heterogeneous melanoma cell pools, AXL-107-MMAE and MAPK pathway inhibitors cooperatively inhibited tumor growth. Furthermore, by inducing AXL transcription, BRAF/MEK inhibitors potentiated the efficacy of AXL-107-MMAE. These findings provide proof of concept for the premise that rationalized combinatorial targeting of distinct populations in heterogeneous tumors may improve therapeutic effect, and merit clinical validation of AXL-107-MMAE in both treatment-naive and drug-resistant cancers in mono-or combination therapy.	[Boshuizen, Julia; Krijgsman, Oscar; Shahrabi, Aida; Ligtenberg, Maarten A.; Vredevoogd, David W.; Kemper, Kristel; Kuilman, Thomas; Foppen, Marnix Geukes; Rozeman, Elisa A.; Blank, Christian U.; Peeper, Daniel S.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Koopman, Louise A.; Gresnigt-van den Heuvel, Elke; Pencheva, Nora; Mortensen, Jens Thing; Janmaat, Maarten L.; Satijn, David; Breij, Esther C. W.; Parren, Paul W. H. I.] Genmab, Utrecht, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Div Expt Anim Pathol, Amsterdam, Netherlands; [Parren, Paul W. H. I.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Netherlands Cancer Institute; Genmab; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Peeper, DS (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Breij, ECW (corresponding author), Genmab, Utrecht, Netherlands.	e.breij@genmab.com; d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	Vredevoogd, David/0000-0001-6718-1422; Parren, Paul/0000-0002-4365-3859; Janmaat, Maarten/0000-0003-4980-730X; Boshuizen, Julia/0000-0002-8135-0525; Kuilman, Thomas/0000-0001-6724-6767	Genmab; European Research Council under the European Union's Seventh Framework Programme/ERC [319661 COMBATCANCER]; Dutch Cancer Society (KWF) [NKI 2014-7241, NKI 2013-5799, NKI 2017-10425]	Genmab(Genmab); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	We thank all the members of the Peeper and Blank laboratories for their valuable input and the FACS facility and animal facility at the NKI for their support. We would like to acknowledge the NKI-AVL Core Facility Molecular Pathology & Biobanking (CFMPB) for supplying NKI-AVL Biobank material and lab support. We thank M. van der Ven and the intervention unit (NKI) for their help with animal experiments, M. Mertz and E. Gielen for their help with confocal microscopy, and H. Witteveen, M. Houtkamp, G. Rigter and T. Kroes for help with experiments. The research leading to these results has been funded by a grant from Genmab, by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC synergy grant agreement no 319661 COMBATCANCER and grants NKI 2014-7241, NKI 2013-5799 and NKI 2017-10425 from the Dutch Cancer Society (KWF).	Adams GP, 2001, CANCER RES, V61, P4750; Aguilera TA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13898; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Asundi J, 2014, MOL CANCER THER, V13, P1599, DOI 10.1158/1535-7163.MCT-13-0446; Bansal N, 2015, ONCOTARGET, V6, P15321, DOI 10.18632/oncotarget.4148; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Breij ECW, 2014, CANCER RES, V74, P1214, DOI 10.1158/0008-5472.CAN-13-2440; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen R, 2015, MOL CANCER THER, V14, P1376, DOI 10.1158/1535-7163.MCT-15-0036; Cichon MA, 2014, ONCOGENE, V33, P4185, DOI 10.1038/onc.2013.388; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Creedon H, 2016, ONCOTARGET, V7, P11539, DOI 10.18632/oncotarget.7317; Creedon H, 2014, BIOCHEM SOC T, V42, P822, DOI 10.1042/BST20140109; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; de Goeij BECG, 2016, CURR OPIN IMMUNOL, V40, P14, DOI 10.1016/j.coi.2016.02.008; Debruyne DN, 2016, ONCOGENE, V35, P3681, DOI 10.1038/onc.2015.434; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Donaghy H, 2016, MABS-AUSTIN, V8, P659, DOI 10.1080/19420862.2016.1156829; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Girotti MR, 2014, MOL ONCOL, V8, P1140, DOI 10.1016/j.molonc.2014.07.027; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Kemper K, 2016, CELL REP, V16, P263, DOI 10.1016/j.celrep.2016.05.064; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kurokawa M, 2013, CANCER SCI, V104, P904, DOI 10.1111/cas.12171; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Leucci E, 2017, PIGM CELL MELANOMA R, V30, P282, DOI 10.1111/pcmr.12583; Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Mak MP, 2016, CLIN CANCER RES, V22, P609, DOI 10.1158/1078-0432.CCR-15-0876; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Miller MA, 2016, CANCER DISCOV, V6, P382, DOI 10.1158/2159-8290.CD-15-0933; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Reichl P, 2015, HEPATOLOGY, V61, P930, DOI 10.1002/hep.27492; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Thomas A, 2016, LANCET ONCOL, V17, pE254, DOI 10.1016/S1470-2045(16)30030-4; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vink T, 2014, METHODS, V65, P5, DOI 10.1016/j.ymeth.2013.07.018; Wang C, 2016, THERANOSTICS, V6, P1205, DOI 10.7150/thno.15083; Xu W, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-7; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343	63	125	133	6	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					203	+		10.1038/nm.4472	http://dx.doi.org/10.1038/nm.4472			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29334371				2022-12-27	WOS:000424327200017
J	Maciocia, PM; Wawrzyniecka, PA; Philip, B; Ricciardelli, I; Akarca, AU; Onuoha, SC; Legut, M; Cole, DK; Sewell, AK; Gritti, G; Somja, J; Piris, MA; Peggs, KS; Linch, DC; Marafioti, T; Pule, MA				Maciocia, Paul M.; Wawrzyniecka, Patrycja A.; Philip, Brian; Ricciardelli, Ida; Akarca, Ayse U.; Onuoha, Shimobi C.; Legut, Mateusz; Cole, David K.; Sewell, Andrew K.; Gritti, Giuseppe; Somja, Joan; Piris, Miguel A.; Peggs, Karl S.; Linch, David C.; Marafioti, Teresa; Pule, Martin A.			Targeting the T cell receptor beta-chain constant region for immunotherapy of T cell malignancies	NATURE MEDICINE			English	Article							CHIMERIC ANTIGEN RECEPTOR; NON-HODGKINS-LYMPHOMA; THERAPY; ANTIBODY; CRYSTALLIZATION; MUTATIONS; LEUKEMIA; PEPTIDE; GENES	Mature T cell cancers are typically aggressive, treatment resistant and associated with poor prognosis. Clinical application of immunotherapeutic approaches has been limited by a lack of target antigens that discriminate malignant from healthy (normal) T cells. Unlike B cell depletion, pan-T cell aplasia is prohibitively toxic. We report a new targeting strategy based on the mutually exclusive expression of T cell receptor beta-chain constant domains 1 and 2 (TRBC1 and TRBC2). We identify an antibody with unique TRBC1 specificity and use it to demonstrate that normal and virus-specific T cell populations contain both TRBC1(+) and TRBC2(+) compartments, whereas malignancies are restricted to only one. As proof of concept for anti-TRBC immunotherapy, we developed anti-TRBC1 chimeric antigen receptor (CAR) T cells, which recognized and killed normal and malignant TRBC1(+), but not TRBC2(+), T cells in vitro and in a disseminated mouse model of leukemia. Unlike nonselective approaches targeting the entire T cell population, TRBC-targeted immunotherapy could eradicate a T cell malignancy while preserving sufficient normal T cells to maintain cellular immunity.				m.pule@ucl.ac.uk	Gritti, Giuseppe/K-7321-2019; Marafioti, Teresa/AAA-4652-2019; Piris, Miguel A/AAP-1445-2020; Sewell, Andrew/GPT-4220-2022; Ricciardelli, Ida/ABC-8937-2020	Gritti, Giuseppe/0000-0002-6789-5123; Marafioti, Teresa/0000-0003-1223-6275; Piris, Miguel A/0000-0001-5839-3634; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; Pule, Martin/0000-0002-8347-9867; Maciocia, Paul/0000-0002-9757-8073; Legut, Mateusz/0000-0002-8810-6971	Cancer Research UK; UK National Institute of Health Research University College London Hospital Biomedical Research Centre; Kay Kendall Leukaemia Fund [KKL872]; Innovate UK [102571]; National Institute for Health Research [CL-2015-18-502, ACF-2011-18-005] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK National Institute of Health Research University College London Hospital Biomedical Research Centre; Kay Kendall Leukaemia Fund; Innovate UK(UK Research & Innovation (UKRI)Innovate UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank M. Owen and J. Viney for helpful discussions and H. Stauss (University College London) for provision of the Jurkat TCR-null cell line. The RD114 viral envelope plasmid was a gift from M. Collins (University College London). PeqPam-env, a Gag-Pol expression plasmid, was a gift from E. Vanin (Baylor College of Medicine). P.M.M. was supported by a studentship from Cancer Research UK. M.A. Pule and T.M. were supported by the UK National Institute of Health Research University College London Hospital Biomedical Research Centre. A.U.A. and M.L. are supported by Cancer Research UK. D.K.C. is a Wellcome Trust Career Development Fellow. A.K.S. is a Wellcome Trust Senior Investigator. K.S.P. is the Scientific Director of the National Institute for Health Research Blood and Transplant Unit for stem cell transplantation and immunotherapy. This project was supported by grants from the Kay Kendall Leukaemia Fund (M. A. Pule and P.M.M.; KKL872) and Innovate UK (M. A. Pule and T.M.; 102571).	Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bruggemann M., 2007, POWERFUL STRATEGY PO, V21, P215; Chan WC, 1997, BLOOD, V89, P3909; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Delves P.J., 2012, IMMUNOLOGICAL METHOD, P178; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gao GH, 2010, ACTA ONCOL, V49, P3, DOI 10.3109/02841860903150502; Garboczi DN, 1996, J IMMUNOL, V157, P5403; HAMBLIN TJ, 1987, BLOOD, V69, P790; Jamal S, 2001, AM J CLIN PATHOL, V116, P512; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Mamonkin M, 2015, BLOOD, V126, P983, DOI 10.1182/blood-2015-02-629527; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Notarangelo LD, 2016, NAT REV IMMUNOL, V16, P234, DOI 10.1038/nri.2016.28; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Philip B, 2014, BLOOD, V124, P1277, DOI 10.1182/blood-2014-01-545020; Pinz K, 2016, LEUKEMIA, V30, P701, DOI 10.1038/leu.2015.311; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; PUI CH, 1990, BLOOD, V75, P174, DOI 10.1182/blood.V75.1.174.174; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Ramos CA, 2016, J CLIN INVEST, V126, P2588, DOI 10.1172/JCI86000; REFF ME, 1994, BLOOD, V83, P435; Ricciardelli I, 2014, BLOOD, V124, P2514, DOI 10.1182/blood-2014-01-553362; ROSENBERG WMC, 1992, EUR J IMMUNOL, V22, P541, DOI 10.1002/eji.1830220237; SIMS JE, 1984, NATURE, V312, P541, DOI 10.1038/312541a0; STEVENSON FK, 1986, BLOOD, V68, P430; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Swerdlow SH, 2008, WHO CLASSIFICATION T; TUNNACLIFFE A, 1985, P NATL ACAD SCI USA, V82, P5068, DOI 10.1073/pnas.82.15.5068; VINEY JL, 1992, HYBRIDOMA, V11, P701, DOI 10.1089/hyb.1992.11.701; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342; Went P, 2006, J CLIN ONCOL, V24, P2472, DOI 10.1200/JCO.2005.03.6327; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9	36	111	125	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1416	+		10.1038/nm.4444	http://dx.doi.org/10.1038/nm.4444			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29131157	Green Accepted			2022-12-27	WOS:000417278200011
J	Xie, C; Yagai, T; Luo, YH; Liang, XY; Chen, T; Wang, Q; Sun, DX; Zhao, J; Ramakrishnan, SK; Sun, LL; Jiang, CM; Xue, X; Tian, Y; Krausz, KW; Patterson, AD; Shah, YM; Wu, Y; Jiang, CT; Gonzalez, FJ				Xie, Cen; Yagai, Tomoki; Luo, Yuhong; Liang, Xianyi; Chen, Tao; Wang, Qiong; Sun, Dongxue; Zhao, Jie; Ramakrishnan, Sadeesh K.; Sun, Lulu; Jiang, Chunmei; Xue, Xiang; Tian, Yuan; Krausz, Kristopher W.; Patterson, Andrew D.; Shah, Yatrik M.; Wu, Yue; Jiang, Changtao; Gonzalez, Frank J.			Activation of intestinal hypoxia-inducible factor 2 alpha during obesity contributes to hepatic steatosis	NATURE MEDICINE			English	Article							FATTY LIVER-DISEASE; RENAL-CELL CARCINOMA; INSULIN-RESISTANCE; EXPERIMENTAL COLITIS; BARRIER REGULATION; SATURATED-FAT; HIF-ALPHA; FACTOR-I; METABOLISM; INFLAMMATION	Nonalcoholic fatty liver disease is becoming the most common chronic liver disease in Western countries, and limited therapeutic options are available. Here we uncovered a role for intestinal hypoxia-inducible factor (HIF) in hepatic steatosis. Human-intestine biopsies from individuals with or without obesity revealed that intestinal HIF-2 alpha signaling was positively correlated with body-mass index and hepatic toxicity. The causality of this correlation was verified in mice with an intestine-specific disruption of Hif2 alpha, in which high-fat-diet-induced hepatic steatosis and obesity were substantially lower as compared to control mice. PT2385, a HIF-2 alpha-specific inhibitor, had preventive and therapeutic effects on metabolic disorders that were dependent on intestine HIF-2 alpha. Intestine HIF-2 alpha inhibition markedly reduced intestine and serum ceramide levels. Mechanistically, intestine HIF-2 alpha regulates ceramide metabolism mainly from the salvage pathway, by positively regulating the expression of Neu3, the gene encoding neuraminidase 3. These results suggest that intestinal HIF-2 alpha could be a viable target for hepatic steatosis therapy.	[Xie, Cen; Yagai, Tomoki; Luo, Yuhong; Wang, Qiong; Sun, Dongxue; Zhao, Jie; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liang, Xianyi; Sun, Lulu; Jiang, Chunmei; Jiang, Changtao] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Liang, Xianyi; Sun, Lulu; Jiang, Chunmei; Jiang, Changtao] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Chen, Tao; Wu, Yue] Xi An Jiao Tong Univ, Dept Internal Med, Key Lab Environm & Genes Related Dis, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Ramakrishnan, Sadeesh K.; Xue, Xiang; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol, Div Gastroenterol, Ann Arbor, MI USA; [Ramakrishnan, Sadeesh K.; Xue, Xiang; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Integrat Physiol, Div Gastroenterol, Ann Arbor, MI USA; [Tian, Yuan; Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Tian, Yuan; Patterson, Andrew D.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Peking University; Xi'an Jiaotong University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Jiang, CT (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.; Jiang, CT (corresponding author), Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China.; Wu, Y (corresponding author), Xi An Jiao Tong Univ, Dept Internal Med, Key Lab Environm & Genes Related Dis, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	yue.wu@xjtu.edu.cn; jiangchangtao@bjmu.edu.cn; gonzalef@mail.nih.gov	Patterson, Andrew/ABF-1575-2020; LUO, YUHONG/GPW-8361-2022; Xue, Xiang/P-9071-2014	Patterson, Andrew/0000-0003-2073-0070; Xue, Xiang/0000-0003-4704-1814; Gonzalez, Frank/0000-0002-7990-2140; Sun, Lulu/0000-0001-8876-5099; Jiang, Changtao/0000-0002-5206-2372	National Cancer Institute Intramural Research Program; National Key Research and Development Program of China [2016YFC0903100, 2016YFC0903102]; National Natural Science Foundation of China [31401011, 81522007, 81403007]; National Institutes of Health grants [ES022186, CA148828, DK095201]; NIDDK [K99DK110537]; Peak Talent Foundation of Jiangsu Province Hospital of Chinese Medicine [Y2014RC18]; Jiangsu Government Scholarship for Overseas Studies; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [ZIABC005562, R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095201, K99DK110537] Funding Source: NIH RePORTER	National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Peak Talent Foundation of Jiangsu Province Hospital of Chinese Medicine; Jiangsu Government Scholarship for Overseas Studies; Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L.G. Byrd, Y. Zhang, X. Gao, W. Liu, X. Gong, and T. Yan (National Cancer Institute) for assistance with the mouse studies, and B. Liu and X. Wu (Chinese Academy of Sciences) for help with the immunohistochemistry. This project was funded in part by the National Cancer Institute Intramural Research Program to F.J.G., grants from the National Key Research and Development Program of China (2016YFC0903100, 2016YFC0903102) to Changtao Jiang, the National Natural Science Foundation of China (31401011 and 81522007 to CT.J., and 81403007 to X.C.), National Institutes of Health grants ES022186 to A.D.P., and CA148828 and DK095201 to Y.M.S. S.K.R. was supported by NIDDK (K99DK110537). Q.W. was supported by the Peak Talent Foundation of Jiangsu Province Hospital of Chinese Medicine (Y2014RC18) and Jiangsu Government Scholarship for Overseas Studies. D.S. and J.Z. were supported by fellowships from the Chinese Scholarship Council.	Anderson ER, 2012, MOL CELL BIOL, V32, P4068, DOI 10.1128/MCB.00723-12; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chaurasia B, 2016, CELL METAB, V24, P820, DOI 10.1016/j.cmet.2016.10.002; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Giussani P, 2014, INT J MOL SCI, V15, P4356, DOI 10.3390/ijms15034356; Glover LE, 2016, J CLIN INVEST, V126, P3680, DOI 10.1172/JCI84429; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kawano Y, 2016, CELL METAB, V24, P295, DOI 10.1016/j.cmet.2016.07.009; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rahman K, 2016, GASTROENTEROLOGY, V151, P733, DOI 10.1053/j.gastro.2016.06.022; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Ramakrishnan SK, 2016, CELL METAB, V23, P505, DOI 10.1016/j.cmet.2016.01.004; Ramakrishnan SK, 2016, ANNU REV PHYSIOL, V78, P301, DOI 10.1146/annurev-physiol-021115-105202; Ray K, 2013, NAT REV GASTRO HEPAT, V10, P621, DOI [10.1038/nrgastro.2013.184, 10.1038/nrgastro.2013.197]; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scaringi R, 2013, J BIOL CHEM, V288, P3153, DOI 10.1074/jbc.M112.404327; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Singh V, 2015, CELL METAB, V22, P983, DOI 10.1016/j.cmet.2015.09.028; Summers SA, 2016, J PHYSIOL-LONDON, V594, P3167, DOI 10.1113/JP271676; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Triner D, 2016, J CLIN INVEST, V126, P3689, DOI 10.1172/JCI84430; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Xie LW, 2014, MOL CELL BIOL, V34, P3013, DOI 10.1128/MCB.00324-14; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Yoshinaga A, 2016, EUR J PHARMACOL, V782, P21, DOI 10.1016/j.ejphar.2016.04.035; Yoshizumi S, 2007, METABOLISM, V56, P420, DOI 10.1016/j.metabol.2006.10.027; Zou Y, 2010, BIOORG MED CHEM LETT, V20, P7529, DOI 10.1016/j.bmcl.2010.09.111	60	78	86	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1298	+		10.1038/nm.4412	http://dx.doi.org/10.1038/nm.4412			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29035368	Green Accepted			2022-12-27	WOS:000414548300012
J	Ferrando, AA; Lopez-Otin, C				Ferrando, Adolfo A.; Lopez-Otin, Carlos			Clonal evolution in leukemia	NATURE MEDICINE			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; ACQUIRED APLASTIC-ANEMIA; HEMATOPOIETIC STEM-CELLS; DNA METHYLATION; MYELODYSPLASTIC SYNDROMES	Human leukemias are liquid malignancies characterized by diffuse infiltration of the bone marrow by transformed hematopoietic progenitors. The accessibility of tumor cells obtained from peripheral blood or through bone marrow aspirates, together with recent advances in cancer genomics and single-cell molecular analysis, have facilitated the study of clonal populations and their genetic and epigenetic evolution over time with unprecedented detail. The results of these analyses challenge the classic view of leukemia as a clonal homogeneous diffuse tumor and introduce a more complex and dynamic scenario. In this review, we present current concepts on the role of clonal evolution in lymphoid and myeloid leukemia as a driver of tumor initiation, disease progression and relapse. We also discuss the implications of these concepts in our understanding of the evolutionary mechanisms involved in leukemia transformation and therapy resistance.	[Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Lopez-Otin, Carlos] Ctr Invest Biomed Red Canc, Barcelona, Spain	Columbia University; Columbia University; Columbia University; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Ferrando, AA (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.; Ferrando, AA (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain.; Lopez-Otin, C (corresponding author), Ctr Invest Biomed Red Canc, Barcelona, Spain.	af2196@columbia.edu; clo@uniovi.es	López-Otín, Carlos/AAB-2106-2020	López-Otín, Carlos/0000-0001-6964-1904	National Cancer Institute (NCI) of the National Institutes of Health (NIH); Leukemia & Lymphoma Society; Chemotherapy Foundation; Rally Foundation; European Union (DeAge, ERC-Advanced Grant); Ministerio de Economia y Competitividad [SAF2014-52413-R]; Instituto de Salud Carlos III (RTICC); CIBERONC; Plan Feder; EDP Foundation	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; Rally Foundation; European Union (DeAge, ERC-Advanced Grant); Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III (RTICC)(Instituto de Salud Carlos III); CIBERONC; Plan Feder; EDP Foundation	We thank M. Mittelbrunn (CBM-Hospital 12 de Octubre, Madrid, Spain), X. S. Puente (Universidad de Oviedo, Oviedo, Spain), P. Menendez (J. Carreras Leukemia Research Institute, Barcelona, Spain), R. Rabadan (Columbia University, New York, New York, USA), J. Soulier (Universite Paris Diderot, Paris, France) and all members of our labs for their helpful comments on the manuscript. A.A.F. is supported by grants from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), the Leukemia & Lymphoma Society, the Chemotherapy Foundation and the Rally Foundation. C.L.-O. is supported by grants from European Union (DeAge, ERC-Advanced Grant), Ministerio de Economia y Competitividad SAF2014-52413-R, Instituto de Salud Carlos III (RTICC), CIBERONC, Plan Feder, and EDP Foundation. The generous support by J.I. Cabrera is also acknowledged.	Afable MG, 2011, BLOOD, V117, P6876, DOI 10.1182/blood-2010-11-314393; Ahn IE, 2017, BLOOD, V129, P1469, DOI 10.1182/blood-2016-06-719294; Amabile G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8091; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Aries IM, 2015, HAEMATOLOGICA, V100, pE132, DOI 10.3324/haematol.2014.112995; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bardini M, 2015, LEUKEMIA, V29, P38, DOI 10.1038/leu.2014.154; Batlevi CL, 2016, NAT REV CLIN ONCOL, V13, P25, DOI 10.1038/nrclinonc.2015.187; BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Burger JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11589; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Busque L, 1996, BLOOD, V88, P59; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Chung EY, 2012, J CLIN INVEST, V122, P2257, DOI 10.1172/JCI45851; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cortes JR, 2016, CURR OPIN HEMATOL, V23, P434, DOI 10.1097/MOH.0000000000000261; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; de Haas V, 2001, LEUKEMIA, V15, P134, DOI 10.1038/sj.leu.2401970; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dumitriu B, 2015, BLOOD, V125, P706, DOI 10.1182/blood-2014-10-607572; ESTEY E, 1995, LEUKEMIA, V9, P972; Evans AG, 2015, BRIT J HAEMATOL, V171, P205, DOI 10.1111/bjh.13562; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Geng HM, 2012, CANCER DISCOV, V2, P1004, DOI 10.1158/2159-8290.CD-12-0208; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Gibson CJ, 2017, J CLIN ONCOL, V35, P1598, DOI 10.1200/JCO.2016.71.6712; Gorre ME, 2002, CURR OPIN HEMATOL, V9, P303, DOI 10.1097/00062752-200207000-00007; Goto E, 2011, BLOOD, V118, P1600, DOI 10.1182/blood-2011-01-329433; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M, 2016, NAT REV CANCER, V16, P163, DOI 10.1038/nrc.2016.3; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Greenblatt SM, 2014, LEUKEMIA, V28, P1396, DOI 10.1038/leu.2014.94; Guieze R, 2015, BLOOD, V126, P445, DOI 10.1182/blood-2015-02-585042; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Heller G, 2016, LEUKEMIA, V30, P1861, DOI 10.1038/leu.2016.143; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Horiike S, 1999, LEUKEMIA, V13, P1235, DOI 10.1038/sj.leu.2401466; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jacoby E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12320; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2013, ONCOGENE, V32, P135, DOI 10.1038/onc.2012.48; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jones CL, 2015, BLOOD, V126, P2202, DOI 10.1182/blood-2015-04-639138; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Katagiri T, 2011, BLOOD, V118, P6601, DOI 10.1182/blood-2011-07-365189; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Kim JY, 2017, METHODS MOL BIOL, V1513, P61, DOI 10.1007/978-1-4939-6539-7_6; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kwok B, 2015, BLOOD, V126, P2355, DOI 10.1182/blood-2015-08-667063; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Li AH, 2001, LEUKEMIA RES, V25, P1033, DOI 10.1016/S0145-2126(01)00072-8; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Li S, 2016, CURR OPIN GENET DEV, V36, P100, DOI 10.1016/j.gde.2016.03.011; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Makishima H, 2017, NAT GENET, V49, P204, DOI 10.1038/ng.3742; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Moriyama T, 2015, LANCET ONCOL, V16, P1659, DOI 10.1016/S1470-2045(15)00369-1; Mossner M, 2016, BLOOD, V128, P1246, DOI 10.1182/blood-2015-11-679167; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nadeu F, 2016, BLOOD, V127, P2122, DOI 10.1182/blood-2015-07-659144; Noris P, 2013, BLOOD, V122, P1987, DOI 10.1182/blood-2013-04-499319; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349; Ogawa S, 2016, BLOOD, V128, P337, DOI 10.1182/blood-2016-01-636381; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Oshima K, 2016, P NATL ACAD SCI USA, V113, P11306, DOI 10.1073/pnas.1608420113; Paguirigan AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0763; Pan H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7921; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Parkin B, 2013, BLOOD, V121, P369, DOI 10.1182/blood-2012-04-427039; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Puente XS, 2013, NAT GENET, V45, P229, DOI 10.1038/ng.2556; Pui CH, 2015, LANCET ONCOL, V16, P465, DOI 10.1016/S1470-2045(15)70082-3; Quentin S, 2011, BLOOD, V117, pE161, DOI 10.1182/blood-2010-09-308726; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Rayes A, 2016, PEDIATR BLOOD CANCER, V63, P1113, DOI 10.1002/pbc.25953; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Rosenberg PS, 2010, BRIT J HAEMATOL, V150, P196, DOI 10.1111/j.1365-2141.2010.08216.x; Sandoval J, 2013, BRIT J HAEMATOL, V160, P406, DOI 10.1111/bjh.12113; Sanjuan-Pla A, 2015, BLOOD, V126, P2676, DOI 10.1182/blood-2015-09-667378; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Shaknovich R, 2014, BBA-REV CANCER, V1846, P477, DOI 10.1016/j.bbcan.2014.09.003; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Side LE, 2004, GENE CHROMOSOME CANC, V39, P217, DOI 10.1002/gcc.10320; Skokowa J, 2014, BLOOD, V123, P2229, DOI 10.1182/blood-2013-11-538025; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Socie G, 2000, SEMIN HEMATOL, V37, P91; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Sood R, 2016, LEUKEMIA, V30, P501, DOI 10.1038/leu.2015.141; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Takahashi K, 2017, LANCET ONCOL, V18, P100, DOI 10.1016/S1470-2045(16)30626-X; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Woods BA, 2015, IMMUNOL REV, V263, P22, DOI 10.1111/imr.12246; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoshizato T, 2015, NEW ENGL J MED, V373, P35, DOI 10.1056/NEJMoa1414799; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177; Zhang XT, 2016, NAT GENET, V48, P1014, DOI 10.1038/ng.3610	143	63	63	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1135	1145		10.1038/nm.4410	http://dx.doi.org/10.1038/nm.4410			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985206	Green Submitted			2022-12-27	WOS:000412431800008
J	Hause, RJ; Pritchard, CC; Shendure, J; Salipante, SJ				Hause, Ronald J.; Pritchard, Colin C.; Shendure, Jay; Salipante, Stephen J.			Classification and characterization of microsatellite instability across 18 cancer types (vol 22, pg 1342, 2016)	NATURE MEDICINE			English	Correction													Shendure, Jay/AAU-3684-2021					Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191	1	2	2	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1241	1241		10.1038/nm1017-1241a	http://dx.doi.org/10.1038/nm1017-1241a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985213	Bronze			2022-12-27	WOS:000412431800020
J	Zhang, PZ; Wang, DJ; Zhao, Y; Ren, SC; Gao, K; Ye, ZQ; Wang, SQ; Pan, CW; Zhu, YS; Yan, YQ; Yang, YH; Wu, D; He, YD; Zhang, J; Lu, DR; Liu, XP; Yu, L; Zhao, SM; Li, Y; Lin, D; Wang, YZ; Wang, LG; Chen, Y; Sun, YH; Wang, CJ; Huang, HJ				Zhang, Pingzhao; Wang, Dejie; Zhao, Yu; Ren, Shancheng; Gao, Kun; Ye, Zhenqing; Wang, Shangqian; Pan, Chun-Wu; Zhu, Yasheng; Yan, Yuqian; Yang, Yinhui; Wu, Di; He, Yundong; Zhang, Jun; Lu, Daru; Liu, Xiuping; Yu, Long; Zhao, Shimin; Li, Yao; Lin, Dong; Wang, Yuzhuo; Wang, Liguo; Chen, Yu; Sun, Yinghao; Wang, Chenji; Huang, Haojie			Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; RNA-SEQ; BROMODOMAIN INHIBITION; SELECTIVE-INHIBITION; ANDROGEN RECEPTOR; STEM-CELLS; BRD4; MUTATIONS; ENHANCERS; TARGET	Bromodomain and extraterminal domain (BET) protein inhibitors are emerging as promising anticancer therapies. The gene encoding the E3 ubiquitin ligase substrate-binding adaptor speckle-type POZ protein (SPOP) is the most frequently mutated in primary prostate cancer. Here we demonstrate that wild-type SPOP binds to and induces ubiquitination and proteasomal degradation of BET proteins (BRD2, BRD3 and BRD4) by recognizing a degron motif common among them. In contrast, prostate cancer-associated SPOP mutants show impaired binding to BET proteins, resulting in decreased proteasomal degradation and accumulation of these proteins in prostate cancer cell lines and patient specimens and causing resistance to BET inhibitors. Transcriptome and BRD4 cistrome analyses reveal enhanced expression of the GTPase RAC1 and cholesterol-biosynthesis-associated genes together with activation of AKT-mTORC1 signaling as a consequence of BRD4 stabilization. Our data show that resistance to BET inhibitors in SPOP-mutant prostate cancer can be overcome by combination with AKT inhibitors and further support the evaluation of SPOP mutations as biomarkers to guide BET-inhibitor-oriented therapy in patients with prostate cancer.	[Zhang, Pingzhao; Gao, Kun; Lu, Daru; Yu, Long; Zhao, Shimin; Li, Yao; Wang, Chenji] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai, Peoples R China; [Zhang, Pingzhao] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China; [Zhang, Pingzhao] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai, Peoples R China; [Wang, Dejie; Zhao, Yu; Pan, Chun-Wu; Yan, Yuqian; Yang, Yinhui; Wu, Di; He, Yundong; Huang, Haojie] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA; [Wang, Dejie] Nanchang Univ, Affiliated Hosp 1, Jiangxi Inst Gastroenterol & Hepatol, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China; [Wang, Dejie; Huang, Haojie] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ren, Shancheng; Zhu, Yasheng; Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Ye, Zhenqing; Wang, Liguo] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA; [Wang, Shangqian; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Zhang, Jun] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Liu, Xiuping] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Pathol, Shanghai, Peoples R China; [Lin, Dong; Wang, Yuzhuo] BC Canc Res Ctr, Dept Expt Therapeut, Vancouver, BC, Canada; [Huang, Haojie] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA	Fudan University; Fudan University; Fudan University; Mayo Clinic; Nanchang University; Mayo Clinic; Naval Medical University; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Fudan University; British Columbia Cancer Agency; Mayo Clinic	Wang, CJ (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai, Peoples R China.; Huang, HJ (corresponding author), Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA.; Huang, HJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	chenjiwang@fudan.edu.cn; huang.haojie@mayo.edu	Wang, Dejie/AAJ-9461-2020; Ye, Zhenqing/L-7954-2019; 高, 雨莉/HGU-8187-2022; Ye, Zhenqing/ABF-1433-2020; Zhao, Yu/GQR-1394-2022; zhao, yu/AAD-9494-2021; Yan, Yuqian/AAU-5681-2020; Yang, Yinhui/J-5164-2019	Yang, Yinhui/0000-0002-0233-1124; Wu, Di/0000-0003-4941-563X; Wang, Yuzhuo/0000-0002-9749-8591; Wang, Liguo/0000-0003-2072-4826	National Institutes of Health [CA134514, CA130908, CA193239]; US Department of Defense [W81XWH-09-1-622]; National Natural Science Foundation of China [81672558, 81201533, 81572768, 31560320, 31400753]; National Key Research and Development Plan of China-Precision Medicine Project [2016YFC0902202]; NATIONAL CANCER INSTITUTE [R01CA130908, K08CA140946, U54CA224079, R01CA193239, R01CA193837, P50CA092629, R01CA134514, R01CA208100, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China-Precision Medicine Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health (CA134514, CA130908 and CA193239 to H.H.), the US Department of Defense (W81XWH-09-1-622 to H.H.), the National Natural Science Foundation of China (81672558 and 81201533 to C.W.; 81572768 to P.Z.; 31560320 to D. Wang; 31400753 to K.G.), and the National Key Research and Development Plan of China-Precision Medicine Project (2016YFC0902202 to Y.S., C.W. and S.R.).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; An J, 2015, MOL CELL, V59, P904, DOI 10.1016/j.molcel.2015.07.025; An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Blattner M, 2017, CANCER CELL, V31, P436, DOI 10.1016/j.ccell.2017.02.004; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Blee AM, 2016, ONCOTARGET, V7, P38319, DOI 10.18632/oncotarget.9513; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chan SC, 2015, NUCLEIC ACIDS RES, V43, P5880, DOI 10.1093/nar/gkv262; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Drost J, 2016, NAT PROTOC, V11, P347, DOI 10.1038/nprot.2016.006; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Groner AC, 2016, CANCER CELL, V29, P846, DOI 10.1016/j.ccell.2016.04.012; Hagen RM, 2013, EXP MOL PATHOL, V95, P98, DOI 10.1016/j.yexmp.2013.05.008; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Patel AJ, 2014, CELL REP, V6, P81, DOI 10.1016/j.celrep.2013.12.001; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Renwick N, 2013, J CLIN INVEST, V123, P2694, DOI 10.1172/JCI68760; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Saura C, 2017, CANCER DISCOV, V7, P102, DOI 10.1158/2159-8290.CD-16-0512; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang L, 2013, EMBO J, V32, P1584, DOI 10.1038/emboj.2013.95; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zhao Y, 2016, CELL REP, V15, P599, DOI 10.1016/j.celrep.2016.03.038; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	50	160	167	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1055	+		10.1038/nm.4379	http://dx.doi.org/10.1038/nm.4379			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28805822	Green Accepted			2022-12-27	WOS:000409996200012
J	Blasco, B; Leroy, D; Fidock, DA				Blasco, Benjamin; Leroy, Didier; Fidock, David A.			Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic	NATURE MEDICINE			English	Review							DIHYDROARTEMISININ-PIPERAQUINE FAILURE; SULFADOXINE-PYRIMETHAMINE RESISTANCE; COPY NUMBER VARIATION; HIGH-THROUGHPUT ASSAY; CYTOCHROME-B GENE; CHLOROQUINE RESISTANCE; ATOVAQUONE-PROGUANIL; MALARIA PARASITES; ARTEMISININ RESISTANCE; IN-VITRO	The global adoption of artemisinin-based combination therapies (ACTs) in the early 2000s heralded a new era in effectively treating drug-resistant Plasmodium falciparum malaria. However, several Southeast Asian countries have now reported the emergence of parasites that have decreased susceptibility to artemisinin (ART) derivatives and ACT partner drugs, resulting in increasing rates of treatment failures. Here we review recent advances in understanding how antimalarials act and how resistance develops, and discuss new strategies for effectively combatting resistance, optimizing treatment and advancing the global campaign to eliminate malaria.	[Fidock, David A.] Med Malaria Venture, Geneva, Switzerland; [Leroy, Didier; Fidock, David A.] Columbia Univ, New York, NY 10025 USA	Columbia University	Fidock, DA (corresponding author), Med Malaria Venture, Geneva, Switzerland.	df2260@cumc.columbia.edu		Fidock, David/0000-0001-6753-8938; Blasco, Benjamin/0000-0002-1485-7887	US National Institutes of Health (NIH) [AI50234, AI109023, AI124678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050234, R01AI109023, R37AI050234, R01AI124678] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.A.F. was supported by US National Institutes of Health (NIH) R01 grants AI50234, AI109023 and AI124678.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Anderson TJC, 2017, MOL BIOL EVOL, V34, P131, DOI 10.1093/molbev/msw228; Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; Antoine T, 2014, J ANTIMICROB CHEMOTH, V69, P1005, DOI 10.1093/jac/dkt486; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451; Baumgartner F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1696-0; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Bhattacharjee S, 2012, TRENDS PARASITOL, V28, P555, DOI 10.1016/j.pt.2012.09.004; Birth D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5029; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Callaghan PS, 2015, BIOCHEMISTRY-US, V54, P5083, DOI 10.1021/acs.biochem.5b00412; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Cheeseman IH, 2016, MOL BIOL EVOL, V33, P603, DOI 10.1093/molbev/msv282; CHEN C, 1992, T ROY SOC TROP MED H, V86, P7, DOI 10.1016/0035-9203(92)90414-8; Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812; Combrinck JM, 2013, ACS CHEM BIOL, V8, P133, DOI 10.1021/cb300454t; Conrad MD, 2014, J INFECT DIS, V210, P344, DOI 10.1093/infdis/jiu141; Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901; Corredor V, 2010, ANTIMICROB AGENTS CH, V54, P3121, DOI 10.1128/AAC.00036-10; Cottrell G, 2014, ANTIMICROB AGENTS CH, V58, P4504, DOI 10.1128/AAC.02550-13; Cyrklaff M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13401; D'Alessandro S, 2016, J ANTIMICROB CHEMOTH, V71, P1148, DOI 10.1093/jac/dkv493; Daher W, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-11; Dhingra SK, 2017, MBIO, V8, DOI [10.1128/mBio.00303-17, 10.1128/mbio.00303-17]; Ding XC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-292; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Dogovski C, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002132; Dorplorp A. M., 2009, NEW ENGL J MED, V361, P455; Douglas RG, 2015, TRENDS PARASITOL, V31, P357, DOI 10.1016/j.pt.2015.04.010; Duru V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0539-5; Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fernandes S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1539-4; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Fowkes FJI, 2016, PARASITOLOGY, V143, P139, DOI 10.1017/S0031182015001249; Gabryszewski SJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005976; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Goodman CD, 2017, TRENDS PARASITOL, V33, P185, DOI 10.1016/j.pt.2016.10.002; Goodman CD, 2016, TRENDS PARASITOL, V32, P953, DOI 10.1016/j.pt.2016.09.011; Goodman CD, 2016, SCIENCE, V352, P349, DOI 10.1126/science.aad9279; Graves PM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008152.pub4; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Gunsaru B, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01913-16; Hastings IM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-62; Held J, 2015, LANCET INFECT DIS, V15, P1409, DOI 10.1016/S1473-3099(15)00079-1; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Ingasia LA, 2015, ANTIMICROB AGENTS CH, V59, P1818, DOI 10.1128/AAC.03956-14; Kakuru A, 2016, NEW ENGL J MED, V374, P928, DOI 10.1056/NEJMoa1509150; Kateera F, 2016, ACTA TROP, V164, P329, DOI 10.1016/j.actatropica.2016.09.008; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Kavishe R.A., 2017, FEBS J; Kelly JX, 2009, NATURE, V459, P270, DOI 10.1038/nature07937; Kesely KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164895; Kheir A, 2010, AM J TROP MED HYG, V82, P535, DOI 10.4269/ajtmh.2010.09-0378; Kirk K, 2015, ANNU REV MICROBIOL, V69, P341, DOI 10.1146/annurev-micro-091014-104506; Klonis N, 2013, P NATL ACAD SCI USA, V110, P5157, DOI 10.1073/pnas.1217452110; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Krudsood S, 2007, AM J TROP MED HYG, V76, P655, DOI 10.4269/ajtmh.2007.76.655; Kumpornsin K, 2014, MOL BIOL EVOL, V31, P1649, DOI 10.1093/molbev/msu140; Kuhen KL, 2014, ANTIMICROB AGENTS CH, V58, P5060, DOI 10.1128/AAC.02727-13; Kuhn S, 2005, AM J TROP MED HYG, V72, P407, DOI 10.4269/ajtmh.2005.72.407; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lee AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154166; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lekostaj JK, 2008, BIOCHEMISTRY-US, V47, P10394, DOI 10.1021/bi8010658; Leroy D, 2017, EMBO MOL MED, V9, P133, DOI 10.15252/emmm.201607295; Lewis I. A., 2014, PLOS GENET, V10; Li H, 2016, NATURE, V530, P233, DOI 10.1038/nature16936; Lim MYX, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.166, 10.1038/nmicrobiol.2016.166]; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; Lubell Y., 2011, MAILAR J, V13, P452; Lucantoni L, 2016, ANTIMICROB AGENTS CH, V60, P2097, DOI 10.1128/AAC.01949-15; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Magistrado PA, 2016, ACS INFECT DIS, V2, P816, DOI 10.1021/acsinfecdis.6b00025; Maiga H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162718; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-380; Mbanefo EC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45963; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; McCarthy JS, 2017, LANCET INFECT DIS, V17, P626, DOI [10.1016/S1473-3099(17)30171-8, 10.1016/s1473-3099(17)30171-8]; MCCARTHY JS, 2016, MALAR J, V15; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mishra N, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1636-4; Mita T, 2010, ACTA TROP, V114, P166, DOI 10.1016/j.actatropica.2009.07.008; Mok S, 2015, SCIENCE, V347, P431, DOI 10.1126/science.1260403; Musset L, 2007, MOL BIOL EVOL, V24, P1582, DOI 10.1093/molbev/msm087; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Ng C. L., TRENDS PARA IN PRESS; Nixon GL, 2013, J ANTIMICROB CHEMOTH, V68, P977, DOI 10.1093/jac/dks504; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; O'Neill PM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15159; Packard RM, 2014, NEW ENGL J MED, V371, P397, DOI 10.1056/NEJMp1403340; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Paquet T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9735; Pascual A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-431; Pelleau S, 2015, P NATL ACAD SCI USA, V112, P11672, DOI 10.1073/pnas.1507142112; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Phillips MA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6645; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; Phyo AP, 2016, LANCET INFECT DIS, V16, P61, DOI 10.1016/S1473-3099(15)00320-5; Plouffe DM, 2016, CELL HOST MICROBE, V19, P114, DOI 10.1016/j.chom.2015.12.001; Plucinski MM, 2015, ANTIMICROB AGENTS CH, V59, P437, DOI 10.1128/AAC.04181-14; Pongtavornpinyo W, 2009, EVOL APPL, V2, P52, DOI 10.1111/j.1752-4571.2008.00067.x; Pulcini S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14552; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Richards SN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005725; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sanchez CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004382; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Saunders DL, 2016, ANTIMICROB AGENTS CH, V60, P1896, DOI 10.1128/AAC.02302-15; Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007; Schwobel B, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-5; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Siciliano G, 2017, MOL MICROBIOL, V104, P306, DOI 10.1111/mmi.13626; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Sinden RE, 2017, ADV PARASIT, V97, P147, DOI 10.1016/bs.apar.2016.09.004; Siregar JE, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2014.09.011; Siriwardana A, 2016, ANTIMICROB AGENTS CH, V60, P6952, DOI 10.1128/AAC.00857-16; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Smith CM, 2015, BLOOD, V125, P534, DOI 10.1182/blood-2014-04-567149; Sonoiki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14574; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; St Laurent B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9614; Straimer J, 2017, MBIO, V8, DOI [10.1128/mBio.00172-17, 10.1128/mbio.00172-17]; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Sundararaman SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11078; Sutherland CJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-240; Takala-Harrison S, 2015, ANN NY ACAD SCI, V1342, P62, DOI 10.1111/nyas.12766; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI 10.1016/j.pt.2016.05.010; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Uhlemann AC, 2007, J INFECT DIS, V195, P134, DOI 10.1086/509809; Vaidya AB, 2012, TREATMENT PREVENTION, P127; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; van Pelt-Koops JC, 2012, ANTIMICROB AGENTS CH, V56, P3544, DOI 10.1128/AAC.06377-11; Vanaerschot M, 2014, FEMS MICROBIOL REV, V38, P41, DOI 10.1111/1574-6976.12032; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; Vial H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-396; Wells TNC, 2015, LANCET INFECT DIS, V15, P1365, DOI 10.1016/S1473-3099(15)00148-6; White LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001823; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; White NJ, 2016, NEW ENGL J MED, V375, P1152, DOI 10.1056/NEJMoa1602250; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; White NJ, 2013, ANTIMICROB AGENTS CH, V57, P5792, DOI 10.1128/AAC.00287-13; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO &VERBAR; World Health Organization, 2016, FACT SHEET WORLD MAL; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/s1473-3099(16)30415-7, 10.1016/S1473-3099(16)30415-7]; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Wong W, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.31; Woodrow CJ, 2017, FEMS MICROBIOL REV, V41, P34, DOI 10.1093/femsre/fuw037; World Health Organization, 2015, GUID TREATM MAL; Xie SC, 2016, J CELL SCI, V129, P406, DOI 10.1242/jcs.178830; Yang T, 2016, ANTIMICROB AGENTS CH, V60, P4501, DOI 10.1128/AAC.00574-16; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109; Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5	184	266	271	6	107	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					917	928		10.1038/nm.4381	http://dx.doi.org/10.1038/nm.4381			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28777791	Green Accepted			2022-12-27	WOS:000406947600007
J	Garre, JM; Silva, HM; Lafaille, JJ; Yang, G				Garre, Juan Mauricio; Silva, Hernandez Moura; Lafaille, Juan J.; Yang, Guang			CX3CR1(+) monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-alpha	NATURE MEDICINE			English	Article							DOUBLE-STRANDED-RNA; CENTRAL-NERVOUS-SYSTEM; NEUROPSYCHOLOGICAL IMPAIRMENT; INFLAMMATORY RESPONSES; SICKNESS BEHAVIOR; SYNAPSE FORMATION; VIRAL MENINGITIS; BRAIN; MICE; MICROGLIA	Impaired learning and cognitive function often occurs during systemic infection or inflammation. Although activation of the innate immune system has been linked to the behavioral and cognitive effects that are associated with infection, the underlying mechanisms remain poorly understood. Here we mimicked viral immune activation with poly(I: C), a synthetic analog of double-stranded RNA, and longitudinally imaged postsynaptic dendritic spines of layer V pyramidal neurons in the mouse primary motor cortex using two-photon microscopy. We found that peripheral immune activation caused dendritic spine loss, impairments in learning-dependent dendritic spine formation and deficits in multiple learning tasks in mice. These observed synaptic alterations in the cortex were mediated by peripheral-monocyte-derived cells and did not require microglial function in the central nervous system. Furthermore, activation of CX3CR1(high)Ly6C(low) monocytes impaired motor learning and learning-related dendritic spine plasticity through tumor necrosis factor (TNF)-alpha-dependent mechanisms. Taken together, our results highlight CX3CR1(high) monocytes and TNF-alpha as potential therapeutic targets for preventing infection-induced cognitive dysfunction.	[Garre, Juan Mauricio; Yang, Guang] NYU, Sch Med, Dept Anesthesiol Perioperat Care & Pain Med, New York, NY 10003 USA; [Silva, Hernandez Moura; Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, Skirball Inst Biomol Med, New York, NY USA; [Silva, Hernandez Moura; Lafaille, Juan J.] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University	Yang, G (corresponding author), NYU, Sch Med, Dept Anesthesiol Perioperat Care & Pain Med, New York, NY 10003 USA.	guang.yang@med.nyu.edu		Yang, Guang/0000-0002-5739-9126; Garre, Juan Mauricio/0000-0003-1578-6512	Whitehall Foundation Research Grant; US National Institutes of Health [R01GM107469, R21AG048410]; National Council for Scientific and Technological Development (CNPq) (Brazil) fellowship; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG048410] Funding Source: NIH RePORTER	Whitehall Foundation Research Grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council for Scientific and Technological Development (CNPq) (Brazil) fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank W.B. Gan (New York University) for the Cx3cr1-CreER mice and D.R. Littman (New York University) for the Cx3cr1-GFP mice. We also thank W.B. Gan and M.V. Bennett for critical reading of the manuscript. This work was supported by a Whitehall Foundation Research Grant (G.Y.), the US National Institutes of Health grants R01GM107469 (G.Y.) and R21AG048410 (G.Y.) and a National Council for Scientific and Technological Development (CNPq) (Brazil) fellowship (H.M.S.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Bucks RS, 2008, BRAIN BEHAV IMMUN, V22, P399, DOI 10.1016/j.bbi.2007.09.005; Clifford DB, 2013, LANCET INFECT DIS, V13, P976, DOI 10.1016/S1473-3099(13)70269-X; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Garre JM, 2016, J NEUROSCI, V36, P4785, DOI 10.1523/JNEUROSCI.4195-15.2016; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ibi D, 2009, NEUROSCI RES, V64, P297, DOI 10.1016/j.neures.2009.03.015; Imp BM, 2017, J INFECT DIS, V215, P114, DOI 10.1093/infdis/jiw506; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Konat G, 2016, NEUROCHEM RES, V41, P144, DOI 10.1007/s11064-015-1746-3; Kranjac D, 2012, BEHAV BRAIN RES, V228, P452, DOI 10.1016/j.bbr.2011.12.031; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Majde JA, 2000, J INTERF CYTOK RES, V20, P259, DOI 10.1089/107999000312397; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schmidt H, 2006, BRAIN, V129, P333, DOI 10.1093/brain/awh711; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Thomas P, 2013, J PSYCHIATR RES, V47, P1680, DOI 10.1016/j.jpsychires.2013.07.010; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Williams DW, 2014, CURR HIV RES, V12, P85, DOI 10.2174/1570162X12666140526114526; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2013, P NATL ACAD SCI USA, V110, P10306, DOI 10.1073/pnas.1222895110; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	62	73	75	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					714	+		10.1038/nm.4340	http://dx.doi.org/10.1038/nm.4340			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28504723	Green Accepted			2022-12-27	WOS:000402768000014
J	Chuang, CH; Greenside, PG; Rogers, ZN; Brady, JJ; Yang, D; Ma, RK; Caswell, DR; Chiou, SH; Winters, AF; Gruner, BM; Ramaswami, G; Spencley, AL; Kopecky, KE; Sayles, LC; Sweet-Cordero, EA; Li, JB; Kundaje, A; Winslow, MM				Chuang, Chen-Hua; Greenside, Peyton G.; Rogers, Zoe N.; Brady, Jennifer J.; Yang, Dian; Ma, Rosanna K.; Caswell, Deborah R.; Chiou, Shin-Heng; Winters, Aidan F.; Gruner, Barbara M.; Ramaswami, Gokul; Spencley, Andrew L.; Kopecky, Kimberly E.; Sayles, Leanne C.; Sweet-Cordero, E. Alejandro; Li, Jin Billy; Kundaje, Anshul; Winslow, Monte M.			Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis	NATURE MEDICINE			English	Article							K-RAS ONCOGENE; PRECLINICAL CHARACTERIZATION; ADENOCARCINOMA; CD109; EXPRESSION; PROGRESSION; ACTIVATION; INHIBITOR; SURVIVAL; IDENTIFICATION	Lung cancer is the leading cause of cancer deaths worldwide, with the majority of mortality resulting from metastatic spread. However, the molecular mechanism by which cancer cells acquire the ability to disseminate from primary tumors, seed distant organs, and grow into tissue-destructive metastases remains incompletely understood. We combined tumor barcoding in a mouse model of human lung adenocarcinoma with unbiased genomic approaches to identify a transcriptional program that confers metastatic ability and predicts patient survival. Small-scale in vivo screening identified several genes, including Cd 1 09, that encode novel pro-metastatic factors. We uncovered signaling mediated by Janus kinases (Jaks) and the transcription factor Stat3 as a critical, pharmacologically targetable effector of CD109-driven lung cancer metastasis. In summary, by coupling the systematic genomic analysis of purified cancer cells in distinct malignant states from mouse models with extensive human validation, we uncovered several key regulators of metastatic ability, including an actionable pro-metastatic CD109-Jak-Stat3 axis.	[Chuang, Chen-Hua; Rogers, Zoe N.; Brady, Jennifer J.; Ma, Rosanna K.; Chiou, Shin-Heng; Winters, Aidan F.; Gruner, Barbara M.; Ramaswami, Gokul; Li, Jin Billy; Kundaje, Anshul; Winslow, Monte M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Greenside, Peyton G.] Stanford Univ, Sch Med, Biomed Informat Training Program, Stanford, CA 94305 USA; [Yang, Dian; Caswell, Deborah R.; Spencley, Andrew L.; Sweet-Cordero, E. Alejandro; Winslow, Monte M.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Kopecky, Kimberly E.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Sayles, Leanne C.; Sweet-Cordero, E. Alejandro] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Kundaje, Anshul] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Winslow, Monte M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Winslow, MM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.; Winslow, MM (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mwinslow@stanford.edu	Grüner, Barbara M/T-1298-2018; Kundaje, Anshul/Y-2739-2019; Kundaje, Anshul/Y-2598-2019; Grüner, Barbara/AAB-9246-2020	Grüner, Barbara M/0000-0003-0974-4826; Kundaje, Anshul/0000-0003-3084-2287; Kundaje, Anshul/0000-0003-3084-2287; Grüner, Barbara/0000-0003-0974-4826; Ma, Rosanna/0000-0002-8980-8940	American Lung Association Fellowship; US National Institutes of Health (NIH) [F32-CA189659, T32-CA009302, R01-GM102484, R01-CA157510, R01-CA175336, R01-CA204620]; Stanford Biomedical Informatics Training Grant from the National Library of Medicine [LM-07033]; Bio-X Stanford Interdisciplinary Graduate Fellowship; Stanford Graduate Fellowships; National Science Foundation Graduate Research Fellowships; Spider Internship Funds; Alfred Sloan Fellowship; V Foundation for Cancer Research Martin D. Abeloff; Stanford Cancer Institute support grant [NIH P30-CA124435]; M.D.V Scholar Award; NATIONAL CANCER INSTITUTE [R01CA175336, R01CA204620, T32CA009302, P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102484] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	American Lung Association Fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Biomedical Informatics Training Grant from the National Library of Medicine; Bio-X Stanford Interdisciplinary Graduate Fellowship; Stanford Graduate Fellowships; National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Spider Internship Funds; Alfred Sloan Fellowship; V Foundation for Cancer Research Martin D. Abeloff; Stanford Cancer Institute support grant; M.D.V Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank P. Chu and S. Cheemalavagu for technical assistance, the Stanford Shared FACS Facility and Protein and Nucleic Acid Facility for expert assistance, J. Pollack and X. Gong for reagents, S. Dolan and A. Orantes for administrative support, and D. Feldser, C. Murray, and members of the Winslow lab for helpful comments. This work was supported by an American Lung Association Fellowship (C.-H.C.), the US National Institutes of Health (NIH) (grant no. F32-CA189659 (J.J.B.), T32-CA009302 (A.L.S.), R01-GM102484 (J.B.L.), R01-CA157510 (E.A.S.-C.), R01-CA175336 (M.M.W.), and R01-CA204620 (M.M.W.)), the Stanford Biomedical Informatics Training Grant from the National Library of Medicine (LM-07033; P.G.G.), a Bio-X Stanford Interdisciplinary Graduate Fellowship (P.G.G.), Stanford Graduate Fellowships (Z.N.R. and G.R.), National Science Foundation Graduate Research Fellowships (D.R.C. and Z.N.R.), the Spider Internship Funds (A.F.W.), an Alfred Sloan Fellowship (A.K.), a V Foundation for Cancer Research Martin D. Abeloff, M.D.V Scholar Award (M.M.W.), and, in part, by a Stanford Cancer Institute support grant (NIH P30-CA124435).	Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brady JJ, 2016, CANCER CELL, V29, P697, DOI 10.1016/j.ccell.2016.03.003; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Caswell DR, 2014, CANCER DISCOV, V4, P781, DOI 10.1158/2159-8290.CD-13-0862; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Chiou SH, 2015, GENE DEV, V29, P1576, DOI 10.1101/gad.264861.115; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Der SD, 2014, J THORAC ONCOL, V9, P59, DOI 10.1097/JTO.0000000000000042; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Greenleaf WJ, 2015, METHODS, V72, P51, DOI 10.1016/j.ymeth.2014.10.010; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hagiwara S, 2010, ONCOGENE, V29, P2181, DOI 10.1038/onc.2009.506; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jiang RC, 2011, MOL DIAGN THER, V15, P347, DOI 10.2165/11599190-000000000-00000; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Litvinov IV, 2011, EXP DERMATOL, V20, P627, DOI 10.1111/j.1600-0625.2011.01288.x; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Matsunaga Y, 2011, BIOCHEM BIOPH RES CO, V404, P261, DOI 10.1016/j.bbrc.2010.11.104; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mii S, 2012, AM J PATHOL, V181, P1180, DOI 10.1016/j.ajpath.2012.06.021; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; RODENHUIS S, 1988, CANCER RES, V48, P5738; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tao J, 2014, TUMOR BIOL, V35, P12083, DOI 10.1007/s13277-014-2509-5; Van Laar RK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-30; Van Rompaey L, 2013, J IMMUNOL, V191, P3568, DOI 10.4049/jimmunol.1201348; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu YH, 2014, EJSO-EUR J SURG ONC, V40, P311, DOI 10.1016/j.ejso.2013.11.012; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang FL, 2014, J PROTEOMICS, V102, P125, DOI 10.1016/j.jprot.2014.03.007; Zhang JM, 2015, BIOCHEM BIOPH RES CO, V459, P252, DOI 10.1016/j.bbrc.2015.02.093; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	54	87	94	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					291	300		10.1038/nm.4285	http://dx.doi.org/10.1038/nm.4285			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28191885	Green Accepted			2022-12-27	WOS:000395848400010
J	Khurana, S; Fuentes, S; Coyle, EM; Ravichandran, S; Davey, RT; Beigel, JH				Khurana, Surender; Fuentes, Sandra; Coyle, Elizabeth M.; Ravichandran, Supriya; Davey, Richard T., Jr.; Beigel, John H.			Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies	NATURE MEDICINE			English	Article							PROTECTS NONHUMAN-PRIMATES; RANDOMIZED CLINICAL-TRIAL; INFLUENZA VACCINE; MEDIATED PROTECTION; AFFINITY MATURATION; B-CELLS; INFECTION; RESPONSES; GLYCOPROTEIN; CHALLENGE	Development of an effective vaccine against Ebola virus is of high priority. However, knowledge about potential correlates of protection and the durability of immune response after vaccination is limited. Here, we elucidate the human antibody repertoire after administration of vesicular stomatitis virus (VSV)-Ebola vaccine at 3 million, 20 million and 100 million plaque-forming units (PFU) and homologous VSV-Ebola vaccine boost in healthy adult volunteers. Whole genome-fragment phage display libraries, expressing linear and conformational epitopes of Ebola glycoprotein (GP), showed higher diversity of antibody epitopes in individuals vaccinated with 20 million PFU than in those vaccinated with 3 million or 100 million PFU. Surface plasmon resonance kinetics showed higher levels of GP-binding antibodies after a single vaccination with 20 million or 100 million PFU than with 3 million PFU, and these correlated strongly with neutralization titers. A second vaccination did not boost antibody or virus neutralization titers, which declined rapidly, and induced only minimal antibody affinity maturation. Isotype analysis revealed a predominant IgM response even after the second vaccination, which contributed substantially to virus neutralization in vitro. These findings may help identify new vaccine targets and aid development and evaluation of effective countermeasures against Ebola.	[Khurana, Surender; Fuentes, Sandra; Coyle, Elizabeth M.; Ravichandran, Supriya] US FDA, Div Viral Prod, CBER, Silver Spring, MD 20993 USA; [Davey, Richard T., Jr.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Beigel, John H.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Frederick, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khurana, S (corresponding author), US FDA, Div Viral Prod, CBER, Silver Spring, MD 20993 USA.	surender.khurana@fda.hhs.gov	Beigel, John H/GNP-2628-2022; Beigel, John/AAQ-4289-2021	Beigel, John/0000-0002-4879-4941	US National Institute of Allergy and Infectious Diseases; FDA-MCMi-Ebola funds; US National Cancer Institute [HHSN261200800001E]; US Department of Defense (DoD) Medical Countermeasures Systems' Joint Vaccine Acquisition Program at Fort Detrick, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000984] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FDA-MCMi-Ebola funds; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense (DoD) Medical Countermeasures Systems' Joint Vaccine Acquisition Program at Fort Detrick, Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Rubin and H. Golding for reviewing the manuscript and J. Voell, P. Munoz, R. McConnell, H. Baus, C. Rehm and J. Metcalf for help with clinical studies. We thank J. Crowe (Vanderbilt University) for the gift of MAb 289 and MAb 324. The clinical trial from which the test sera were derived was funded partly by the US National Institute of Allergy and Infectious Diseases. The antibody characterization work described in this manuscript was supported by FDA-MCMi-Ebola funds to S.K. The latter funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This project was funded in whole or in part with federal funds from the US National Cancer Institute under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. We thank the US Army Medical Research Institute of Infectious Diseases team, including S. Kwilas, M. Wisniewski and J. Hooper, for providing the pseudovirion neutralization assay data used in this study. The pseudovirion work was funded by the US Department of Defense (DoD) Medical Countermeasures Systems' Joint Vaccine Acquisition Program at Fort Detrick, Maryland. The opinions, interpretations, conclusions and recommendations contained herein are those of the authors and are not necessarily endorsed by the US DoD.	Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Centers for Disease Control and Prevention, 2016, 2014 EB OUTBR W AFR; Chung KY, 2015, VACCINE, V33, P3953, DOI 10.1016/j.vaccine.2015.06.047; Cohen J, 2015, SCIENCE, V349, P1272, DOI 10.1126/science.349.6254.1272; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Halliley JL, 2015, J INFECT DIS, V212, P1270, DOI 10.1093/infdis/jiv210; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Holtsberg FW, 2016, J VIROL, V90, P266, DOI 10.1128/JVI.02171-15; Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Krause PR, 2015, LANCET, V386, P831, DOI 10.1016/S0140-6736(15)00002-1; Krause PR, 2015, LANCET INFECT DIS, V15, P627, DOI 10.1016/S1473-3099(15)00027-4; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Matassov D, 2015, J INFECT DIS, V212, pS443, DOI 10.1093/infdis/jiv316; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Regules JA, 2015, N ENGL J MED; Ruibal P, 2016, NATURE, V533, P100, DOI 10.1038/nature17949; Talaat KR, 2014, J INFECT DIS, V209, P1860, DOI 10.1093/infdis/jiu123; Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	40	68	70	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1439	+		10.1038/nm.4201	http://dx.doi.org/10.1038/nm.4201			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27798615	Bronze			2022-12-27	WOS:000389549000021
J	Rohm, M; Schafer, M; Laurent, V; Ustunel, BE; Niopek, K; Algire, C; Hautzinger, O; Sijmonsma, TP; Zota, A; Medrikova, D; Pellegata, NS; Ryden, M; Kulyte, A; Dahlman, I; Arner, P; Petrovic, N; Cannon, B; Amri, EZ; Kemp, BE; Steinberg, GR; Janovska, P; Kopecky, J; Wolfrum, C; Bluher, M; Diaz, MB; Herzig, S				Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Algire, Carolyn; Hautzinger, Oksana; Sijmonsma, Tjeerd P.; Zota, Annika; Medrikova, Dasa; Pellegata, Natalia S.; Ryden, Mikael; Kulyte, Agne; Dahlman, Ingrid; Arner, Peter; Petrovic, Natasa; Cannon, Barbara; Amri, Ez-Zoubir; Kemp, Bruce E.; Steinberg, Gregory R.; Janovska, Petra; Kopecky, Jan; Wolfrum, Christian; Blueher, Matthias; Diaz, Mauricio Berriel; Herzig, Stephan			An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice	NATURE MEDICINE			English	Article							WHOLE-BODY LIPOLYSIS; ADIPOCYTE LIPOLYSIS; LIPID HOMEOSTASIS; CELL-DEATH; MECHANISM; AICAR; ALPHA; CIDEA; LIPOGENESIS; RESISTANT	Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.	[Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Algire, Carolyn; Hautzinger, Oksana; Sijmonsma, Tjeerd P.; Zota, Annika; Medrikova, Dasa; Pellegata, Natalia S.; Diaz, Mauricio Berriel; Herzig, Stephan] Helmholtz Ctr Munich, IDC, Neuherberg, Germany; [Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Algire, Carolyn; Hautzinger, Oksana; Sijmonsma, Tjeerd P.; Zota, Annika; Medrikova, Dasa; Pellegata, Natalia S.; Diaz, Mauricio Berriel; Herzig, Stephan] Univ Heidelberg Hosp, Inner Med 1, Joint Heidelberg IDC Translat Diabet Program, Heidelberg, Germany; [Rohm, Maria; Schaefer, Michaela; Laurent, Victor; Uestuenel, Bilgen Ekim; Niopek, Katharina; Zota, Annika; Pellegata, Natalia S.; Diaz, Mauricio Berriel; Herzig, Stephan] Deutsch Zentrum Diabetesforsch, Neuherberg, Germany; [Ryden, Mikael; Kulyte, Agne; Dahlman, Ingrid; Arner, Peter] Karolinska Inst, Dept Med, Lipid Lab, Stockholm, Sweden; [Petrovic, Natasa; Cannon, Barbara] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Amri, Ez-Zoubir] Univ Cote Azur, Nice, France; [Amri, Ez-Zoubir] CNRS, Nice, France; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic, Australia; [Kemp, Bruce E.] Res Australian Catholic Univ, Mary MacKillop Inst Hlth, Melbourne, Vic, Australia; [Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Dept Med, Hamilton, ON, Canada; [Janovska, Petra; Kopecky, Jan] Acad Sci Czech Republ, Inst Physiol, Department Adipose Tissue Biol, Prague, Czech Republic; [Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Karolinska Institutet; Stockholm University; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); St. Vincent's Institute of Medical Research; University of Melbourne; Australian Catholic University; McMaster University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University	Herzig, S (corresponding author), Helmholtz Ctr Munich, IDC, Neuherberg, Germany.; Herzig, S (corresponding author), Univ Heidelberg Hosp, Inner Med 1, Joint Heidelberg IDC Translat Diabet Program, Heidelberg, Germany.; Herzig, S (corresponding author), Deutsch Zentrum Diabetesforsch, Neuherberg, Germany.	stephan.herzig@helmholtz-muenchen.de	Diaz, Mauricio Berriel/AAF-8285-2021; Pellegata, Natalia S/I-1256-2012; Kopecky, Jan/B-8244-2012; Rohm, Maria/O-4196-2017; Janovska, Petra/E-7160-2013; Kemp, Bruce/G-9602-2019; Cannon, Barbara/B-3089-2016	Pellegata, Natalia S/0000-0002-8000-7784; Kopecky, Jan/0000-0001-8072-2035; Rohm, Maria/0000-0003-3926-1534; Janovska, Petra/0000-0002-6154-2175; Kemp, Bruce/0000-0001-6735-5082; Berriel Diaz, Mauricio/0000-0003-4670-919X; Dahlman, Ingrid/0000-0003-3819-5977; Arner, Peter/0000-0002-6208-6220; Cannon, Barbara/0000-0001-6594-2363; Kulyte, Agne/0000-0001-7745-2767; Steinberg, Gregory/0000-0001-5425-8275; Wolfrum, Christian/0000-0002-3862-6805; amri, Ez-Zoubir/0000-0001-8426-5396	Swedish Cancer Fund; Deutsche Forschungsgemeinschaft [He3260/8-1]; European Foundation for the Study of Diabetes; EU FP7 project DIABAT [HEALTH-F2-2011-278373]; DKFZ-Bayer Cooperation Program; HGF Cross Program Topic 'Metabolic Dysfunction'; HGF 'ICEMED' Program; Novo Nordisk Fonden [NNF14OC0010187] Funding Source: researchfish	Swedish Cancer Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Foundation for the Study of Diabetes; EU FP7 project DIABAT; DKFZ-Bayer Cooperation Program; HGF Cross Program Topic 'Metabolic Dysfunction'; HGF 'ICEMED' Program; Novo Nordisk Fonden(Novo Nordisk Foundation)	We would like to thank K. Muller-Decker, K. Friedrich, D. Sohn, F. Ilmberger, Y. Feuchter, B. Meissburger, M. Kirilov, A. Vegiopoulos, P. Flachs, J. Hansikova, N. Petrovic and M. Christian for helpful discussions and experimental support and D.G. Hardie (University of Dundee) for Ampk-alpha 1-specific and Ampk-alpha 2-specific sheep antibodies. We particularly thank T. Schafmeier for comments on the manuscript. This work was supported by grants from the Swedish Cancer Fund (P.A.), the Deutsche Forschungsgemeinschaft grant He3260/8-1 (S.H.), the European Foundation for the Study of Diabetes (S.H.), the EU FP7 project DIABAT (HEALTH-F2-2011-278373; S.H.), the DKFZ-Bayer Cooperation Program (S.H.), the HGF Cross Program Topic 'Metabolic Dysfunction' (S.H.) and the HGF 'ICEMED' Program (S.H.).	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645; Batista ML, 2013, CYTOKINE, V61, P532, DOI 10.1016/j.cyto.2012.10.023; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; Bourron O, 2010, DIABETOLOGIA, V53, P768, DOI 10.1007/s00125-009-1639-6; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; de Vos-Geelen J, 2014, CURR OPIN CLIN NUTR, V17, P509, DOI 10.1097/MCO.0000000000000106; Deminice R., 2016, AMINO ACIDS; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Di Sebastiano KM, 2013, BRIT J NUTR, V109, P302, DOI 10.1017/S0007114512001067; Diao L, 2015, MOL MED, V21, P959, DOI 10.2119/molmed.2015.00123; Diaz MB, 2008, HEPATOLOGY, V48, P782, DOI 10.1002/hep.22383; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gaidhu MP, 2012, AM J PHYSIOL-CELL PH, V303, pC1192, DOI 10.1152/ajpcell.00159.2012; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jatoi A, 2010, LUNG CANCER, V68, P234, DOI 10.1016/j.lungcan.2009.06.020; Jones A, 2013, EMBO MOL MED, V5, P294, DOI 10.1002/emmm.201201869; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Kumar NB, 2010, CURR TREAT OPTION ON, V11, P107, DOI 10.1007/s11864-010-0127-z; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; Mondello P, 2015, NUTR CANCER, V67, P12, DOI 10.1080/01635581.2015.976318; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Nowakowska M, 2014, TUMOR BIOL, V35, P9291, DOI 10.1007/s13277-014-2196-2; Pausch T, 2012, SURGERY, V152, pS81, DOI 10.1016/j.surg.2012.05.028; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Schafer M, 2016, MOL METAB, V5, P67, DOI 10.1016/j.molmet.2015.11.004; SHERRY BA, 1989, FASEB J, V3, P1956, DOI 10.1096/fasebj.3.8.2721856; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; TANAKA Y, 1990, CANCER RES, V50, P2290; THEOLOGIDES A, 1979, CANCER-AM CANCER SOC, V43, P2004, DOI 10.1002/1097-0142(197905)43:5+<2004::AID-CNCR2820430708>3.0.CO;2-#; THURESONKLEIN A, 1976, ACTA PHYSIOL SCAND, V98, P8, DOI 10.1111/j.1748-1716.1976.tb10296.x; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Tsoli M, 2016, SEMIN CELL DEV BIOL, V54, P68, DOI 10.1016/j.semcdb.2015.10.039; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; VAUGHAN M, 1962, J BIOL CHEM, V237, P3354; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang ZG, 2011, AM J PHYSIOL-ENDOC M, V301, pE703, DOI 10.1152/ajpendo.00050.2011; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	55	73	75	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1120	1130		10.1038/nm.4171	http://dx.doi.org/10.1038/nm.4171			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27571348				2022-12-27	WOS:000384872500015
J	Zhao, HL; Mleynek, TM; Li, DY				Zhao, Helong; Mleynek, Tara M.; Li, Dean Y.			Dysregulated exocytosis of angiopoietin-2 drives cerebral cavernous malformation	NATURE MEDICINE			English	Editorial Material								A new study has proposed a mechanism for the pathogenesis of cerebral cavernous malformation (CCM) that links endothelial CCM3 deficiency to increased secretion of the vascular destabilizing protein angiopoietin-2 (ANGPT2).	[Zhao, Helong; Mleynek, Tara M.] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA; [Li, Dean Y.] Univ Utah, Sch Med & Hlth Sci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Li, DY (corresponding author), Univ Utah, Sch Med & Hlth Sci, Salt Lake City, UT 84112 USA.	dean.li@u2m2.utah.edu		Zhao, Helong/0000-0002-1472-2974				Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Gibson CC, 2015, CIRCULATION, V131, P289, DOI 10.1161/CIRCULATIONAHA.114.010403; Hapani S, 2009, LANCET ONCOL, V10, P559, DOI 10.1016/S1470-2045(09)70112-3; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	11	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					971	973		10.1038/nm.4178	http://dx.doi.org/10.1038/nm.4178			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27603130				2022-12-27	WOS:000382542800005
J	Tierney, MT; Sacco, A				Tierney, Matthew Timothy; Sacco, Alessandra			The role of muscle stem cell-niche interactions during aging	NATURE MEDICINE			English	Editorial Material							SKELETAL-MUSCLE; QUIESCENCE; SENESCENCE; EXPANSION	Two recent studies have shown that alterations in muscle stem cell-niche interactions during aging underlie the functional decline in regenerative potential. The reconstitution of this communication restores stem cell function and enhances skeletal muscle repair.	[Tierney, Matthew Timothy; Sacco, Alessandra] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA; [Tierney, Matthew Timothy] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Sacco, A (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.	asacco@sbpdiscovery.org			NIAMS NIH HHS [R01 AR064873] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064873] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656	10	3	6	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2016	22	8					837	838		10.1038/nm.4159	http://dx.doi.org/10.1038/nm.4159			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DS7YV	27490436				2022-12-27	WOS:000381000200008
J	Pozzi, C; Cuomo, A; Spadoni, I; Magni, E; Silvola, A; Conte, A; Sigismund, S; Ravenda, PS; Bonaldi, T; Zampino, MG; Cancelliere, C; Di Fiore, PP; Bardelli, A; Penna, G; Rescigno, M				Pozzi, Chiara; Cuomo, Alessandro; Spadoni, Ilaria; Magni, Elena; Silvola, Alessio; Conte, Alexia; Sigismund, Sara; Ravenda, Paola Simona; Bonaldi, Tiziana; Zampino, Maria Giulia; Cancelliere, Carlotta; Di Fiore, Pier Paolo; Bardelli, Alberto; Penna, Giuseppe; Rescigno, Maria			The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death	NATURE MEDICINE			English	Article							METASTATIC COLORECTAL-CANCER; 1ST-LINE TREATMENT; BRAF MUTATION; CALRETICULIN EXPOSURE; ENDOPLASMIC-RETICULUM; PLUS IRINOTECAN; POOLED ANALYSIS; COLON-CANCER; KRAS; EFFICACY	Cetuximab is a monoclonal antibody that is effective in the treatment of metastatic colorectal cancer (mCRC). Cetuximab blocks epidermal growth factor receptor (EGFR)-ligand interaction and inhibits downstream RAS-ERK activation. However, only some activating mutations in RAS affect cetuximab efficacy, and it is not clear what else mediates treatment success. Here we hypothesized that cetuximab induces immunogenic cell death (ICD) that activates a potent antitumor response. We found that cetuximab, in combination with chemotherapy, fostered ICD in CRC cells, which we measured via the endoplasmic reticulum (ER) stress response and an increase in phagocytosis by dendritic cells. ICD induction depended on the mutational status of the EGFR signaling pathway and on the inhibition of the splicing of X-box binding protein 1 (XBP1), an unfolded protein response (UPR) mediator. We confirmed the enhanced immunogenicity elicited by cetuximab in a mouse model of human EGFR-expressing CRC. Overall, we demonstrate a new, immune-related mechanism of action of cetuximab that may help to tailor personalized medicine.	[Pozzi, Chiara; Cuomo, Alessandro; Spadoni, Ilaria; Silvola, Alessio; Bonaldi, Tiziana; Di Fiore, Pier Paolo; Penna, Giuseppe; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Magni, Elena; Ravenda, Paola Simona; Zampino, Maria Giulia] European Inst Oncol, Div Med Oncol, Unit Gastrointestinal & Neuroendocrine Tumors, Milan, Italy; [Conte, Alexia; Sigismund, Sara; Di Fiore, Pier Paolo; Bardelli, Alberto] Fdn Ist FIRC Fdn Italiana Ric Canc Oncol Mol, IFOM, Milan, Italy; [Cancelliere, Carlotta] FPO, IRCCS, Candiolo Canc Inst, Candiolo, Italy; [Di Fiore, Pier Paolo; Rescigno, Maria] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; IRCCS Fondazione del Piemonte per l'Oncologia; University of Milan; University of Turin	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.; Rescigno, M (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.	maria.rescigno@ieo.eu	Spadoni, Ilaria/K-1054-2018; Penna, Giuseppe/AAB-8784-2019; Di Fiore, Pier Paolo/K-2130-2012; Zampino, Maria Giulia/AAQ-4795-2020; Pozzi, Chiara/K-4481-2018; cuomo, alessandro/AAB-7372-2019; Sigismund, Sara/H-3687-2017; Ravenda, Paola Simona/AAC-2048-2019; Rescigno, Maria/J-9704-2012; BARDELLI, Alberto/J-9721-2018; Bonaldi, Tiziana/K-5075-2016	Penna, Giuseppe/0000-0003-3534-7090; Di Fiore, Pier Paolo/0000-0002-2252-0950; Zampino, Maria Giulia/0000-0001-5142-1778; Pozzi, Chiara/0000-0003-2153-6130; Sigismund, Sara/0000-0002-1396-4453; Rescigno, Maria/0000-0002-6464-509X; BARDELLI, Alberto/0000-0003-1647-5070; Spadoni, Ilaria/0000-0002-1067-0695; Cuomo, Alessandro/0000-0002-9778-7190; Bonaldi, Tiziana/0000-0003-3556-1265	Italian Association for Cancer Research (AIRC) [IG11863]; Italian Ministry of Health [RF-2011-02348920]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by grants of the Italian Association for Cancer Research (AIRC) (IG11863 to M.R.) and the Italian Ministry of Health (Ricerca finalizzata) (RF-2011-02348920 to M.R.). We thank S. Chiocca for editing the manuscript.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fakih MG, 2015, J CLIN ONCOL, V33, P1809, DOI 10.1200/JCO.2014.59.7633; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Garrido G, 2011, J IMMUNOL, V187, P4954, DOI 10.4049/jimmunol.1003477; Karapetis CS, 2014, CLIN CANCER RES, V20, P744, DOI 10.1158/1078-0432.CCR-13-0606; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Kepp O, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.955691; Kishiki T, 2014, ONCOL REP, V32, P57, DOI 10.3892/or.2014.3179; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Licitra L, 2013, EUR J CANCER, V49, P1161, DOI 10.1016/j.ejca.2012.11.018; Modest DP, 2012, ONCOLOGY-BASEL, V83, P241, DOI 10.1159/000339534; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Peeters M, 2012, CANCER TREAT REV, V38, P397, DOI 10.1016/j.ctrv.2011.08.002; Pietrantonio F, 2015, EUR J CANCER, V51, P587, DOI 10.1016/j.ejca.2015.01.054; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Price TJ, 2014, LANCET ONCOL, V15, P569, DOI 10.1016/S1470-2045(14)70118-4; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Sahin IH, 2013, J CANCER, V4, P320, DOI 10.7150/jca.3619; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Sorich MJ, 2015, ANN ONCOL, V26, P13, DOI 10.1093/annonc/mdu378; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Tyanova S, 2014, METHODS MOL BIOL, V1188, P351, DOI 10.1007/978-1-4939-1142-4_24; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	40	157	158	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					624	+		10.1038/nm.4078	http://dx.doi.org/10.1038/nm.4078			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135741				2022-12-27	WOS:000377476000019
J	Souroullas, GP; Jeck, WR; Parker, JS; Simon, JM; Liu, JY; Paulk, J; Xiong, J; Clark, KS; Fedoriw, Y; Qi, J; Burd, CE; Bradner, JE; Sharpless, NE				Souroullas, George P.; Jeck, William R.; Parker, Joel S.; Simon, Jeremy M.; Liu, Jie-Yu; Paulk, Joshiawa; Xiong, Jessie; Clark, Kelly S.; Fedoriw, Yuri; Qi, Jun; Burd, Christin E.; Bradner, James E.; Sharpless, Norman E.			An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation	NATURE MEDICINE			English	Article							POLYCOMB-GROUP GENES; SOMATIC MUTATIONS; PROTEIN EZH2; MOUSE MODEL; CELL; LYMPHOMA; EXPRESSION; MYC; H3; HYPERTRIMETHYLATION	B cell lymphoma and melanoma harbor recurrent mutations in the gene encoding the EZH2 histone methyltransferase (EZH2), but the carcinogenic role of these mutations is unclear. Here we describe a mouse model in which the most common somatic Ezh2 gain-of-function mutation (EZH2(Y646F) in human; Ezh2(Y641F) in mouse) is conditionally expressed. Expression of Ezh2(Y641F) in mouse B cells or melanocytes caused high-penetrance lymphoma or melanoma, respectively. Overexpression of the anti-apoptotic protein Bcl2, but not the oncoprotein Myc, or loss of the tumor suppressor protein p53 (encoded by Trp53 in mice) further accelerated lymphoma progression. Expression of the mutant Braf but not the mutant Nras oncoprotein further accelerated melanoma progression. Although expression of Ezh2(Y641F) globally increased the abundance of trimethylated Lys27 of histone H3 (H3K27me3), it also caused a widespread redistribution of this repressive mark, including a loss of H3K27me3 that was associated with increased transcription at many loci. These results suggest that Ezh2(Y641F) induces lymphoma and melanoma through a vast reorganization of chromatin structure, inducing both repression and activation of polycomb-regulated loci.	[Souroullas, George P.; Jeck, William R.; Simon, Jeremy M.; Liu, Jie-Yu; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Souroullas, George P.; Jeck, William R.; Simon, Jeremy M.; Liu, Jie-Yu; Xiong, Jessie; Clark, Kelly S.; Fedoriw, Yuri; Sharpless, Norman E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Paulk, Joshiawa; Qi, Jun; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA; [Fedoriw, Yuri] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA.; Sharpless, NE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA.; Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA.	nes@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , Pathology Services Core/CEZ-2246-2022; , UNC Flow Cytometry Core/AGU-9839-2022; Parker, Joel/AAG-1108-2019	Sharpless, Norman/0000-0001-7078-9455; Souroullas, George P./0000-0003-2196-8662	US National Cancer Institute [R01-CA163896, CA185353, T32-CA009156]; US National Institute of Aging [R01-AG024379]; US National Heart, Lung and Blood Institute [F32-HL117581]; NATIONAL CANCER INSTITUTE [R01CA185353, P01CA142106, P30CA016086, P30CA016058, T32CA009156, R01CA163896] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL117581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the UNC Lineberger Animal Histopathology Core, Flow Cytometry Core, Animal Models Core and Microscopy Services Laboratory for technical assistance, and the Mouse Phase 1 Unit (D. Darr and J. Roques) for providing animals and expertise. This work was supported by the US National Cancer Institute grants R01-CA163896 (N.E.S.), CA185353 (N.E.S.) and T32-CA009156 (G.P.S.), the US National Institute of Aging grant R01-AG024379 (N.E.S.) and the US National Heart, Lung and Blood Institute grant F32-HL117581 (G.P.S.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boylan KLM, 2007, CANCER RES, V67, P4069, DOI 10.1158/0008-5472.CAN-06-3699; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	56	133	136	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					632	+		10.1038/nm.4092	http://dx.doi.org/10.1038/nm.4092			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135738	Green Submitted, Green Accepted			2022-12-27	WOS:000377476000020
J	Dardaei, L; Wang, HQ; Singh, M; Fordjour, P; Shaw, KX; Yoda, S; Kerr, G; Yu, K; Liang, JS; Cao, YC; Chen, Y; Lawrence, MS; Langenbucher, A; Gainor, JF; Friboulet, L; Dagogo-Jack, I; Myers, DT; Labrot, E; Ruddy, D; Parks, M; Lee, D; DiCecca, RH; Moody, S; Hao, HX; Mohseni, M; LaMarche, M; Williams, J; Hoffmaster, K; Caponigro, G; Shaw, AT; Hata, AN; Benes, CH; Li, F; Engelman, JA				Dardaei, Leila; Wang, Hui Qin; Singh, Manrose; Fordjour, Paul; Shaw, Katherine X.; Yoda, Satoshi; Kerr, Grainne; Yu, Kristine; Liang, Jinsheng; Cao, Yichen; Chen, Yan; Lawrence, Michael S.; Langenbucher, Adam; Gainor, Justin F.; Friboulet, Luc; Dagogo-Jack, Ibiayi; Myers, David T.; Labrot, Emma; Ruddy, David; Parks, Melissa; Lee, Dana; DiCecca, Richard H.; Moody, Susan; Hao, Huaixiang; Mohseni, Morvarid; LaMarche, Matthew; Williams, Juliet; Hoffmaster, Keith; Caponigro, Giordano; Shaw, Alice T.; Hata, Aaron N.; Benes, Cyril H.; Li, Fang; Engelman, Jeffrey A.			SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors	NATURE MEDICINE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CRIZOTINIB RESISTANCE; CHEMOTHERAPY; ACTIVATION; SHPTP2	Most anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung tumors initially respond to small-molecule ALK inhibitors, but drug resistance often develops(1-4). Of tumors that develop resistance to highly potent second-generation ALK inhibitors, approximately half harbor resistance mutations in ALK, while the other half have other mechanisms underlying resistance. Members of the latter group often have activation of at least one of several different tyrosine kinases driving resistance(5). Such tumors are not expected to respond to lorlatinib-a third-generation inhibitor targeting ALK that is able to overcome all clinically identified resistant mutations in ALK(5,6)-and further therapeutic options are limited(5). Herein, we deployed a shRNA screen of 1,000 genes in multiple ALK-inhibitor-resistant patient-derived cells (PDCs) to discover those that confer sensitivity to ALK inhibition. This approach identified SHP2, a nonreceptor protein tyrosine phosphatase, as a common targetable resistance node in multiple PDCs. SHP2 provides a parallel survival input downstream of multiple tyrosine kinases that promote resistance to ALK inhibitors. Treatment with SHP099, the recently discovered small-molecule inhibitor of SHP2, in combination with the ALK tyrosine kinase inhibitor (TKI) ceritinib halted the growth of resistant PDCs through preventing compensatory RAS and ERK1 and ERK2 (ERK1/2) reactivation. These findings suggest that combined ALK and SHP2 inhibition may be a promising therapeutic strategy for resistant cancers driven by several different ALK-independent mechanisms underlying resistance.	[Dardaei, Leila; Singh, Manrose; Shaw, Katherine X.; Yoda, Satoshi; Lawrence, Michael S.; Langenbucher, Adam; Gainor, Justin F.; Friboulet, Luc; Dagogo-Jack, Ibiayi; Myers, David T.; Parks, Melissa; Lee, Dana; DiCecca, Richard H.; Shaw, Alice T.; Hata, Aaron N.; Benes, Cyril H.] Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA 02129 USA; [Dardaei, Leila; Yoda, Satoshi; Shaw, Alice T.; Hata, Aaron N.; Benes, Cyril H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Wang, Hui Qin; Fordjour, Paul; Yu, Kristine; Liang, Jinsheng; Cao, Yichen; Chen, Yan; Labrot, Emma; Ruddy, David; Moody, Susan; Hao, Huaixiang; Mohseni, Morvarid; LaMarche, Matthew; Williams, Juliet; Hoffmaster, Keith; Caponigro, Giordano; Li, Fang; Engelman, Jeffrey A.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Kerr, Grainne] Novartis Inst BioMed Res, Basel, Switzerland; [Lawrence, Michael S.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Friboulet, Luc; Li, Fang] Univ Paris Saclay, INSERM U981, Gustave Roussy Canc Campus, Paris, France; [Friboulet, Luc; Li, Fang] Tango Therapeut, Cambridge, MA 02141 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Novartis; Novartis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Benes, CH (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA 02129 USA.; Benes, CH (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Li, F; Engelman, JA (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.; Li, F (corresponding author), Univ Paris Saclay, INSERM U981, Gustave Roussy Canc Campus, Paris, France.; Li, F (corresponding author), Tango Therapeut, Cambridge, MA 02141 USA.	cbenes@mghharvard.edu; fli@tangotx.com; jeffreyengelman@novartis.com	friboulet, luc/N-7276-2015; wang, hui/GRS-4730-2022; Gainor, Justin/T-5411-2019; Yoda, Satoshi/O-4304-2019; Lawrence, Michael/AAC-8202-2020	friboulet, luc/0000-0002-1129-4978; Yoda, Satoshi/0000-0003-4201-1392; Singh, Manrose/0000-0002-3636-8531; Parks, Melissa/0000-0002-9258-5813	Novartis Institutes for BioMedical Research; American Association for Cancer Research (AACR)-AstraZeneca Fellowship in Lung Cancer Research [17-40-12-DARD]; National Cancer Institute [R01CA164273]; Wellcome Trust [102696]; National Foundation for Cancer Research; Be a Piece of the Solution; LungStrong; NATIONAL CANCER INSTITUTE [R01CA164273] Funding Source: NIH RePORTER	Novartis Institutes for BioMedical Research; American Association for Cancer Research (AACR)-AstraZeneca Fellowship in Lung Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); National Foundation for Cancer Research; Be a Piece of the Solution; LungStrong; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Rakiec for help with NGS and C. Liu for help with in vivo experiments. This study was supported by grants from Novartis Institutes for BioMedical Research, American Association for Cancer Research (AACR)-AstraZeneca Fellowship in Lung Cancer Research (17-40-12-DARD to L.D.), National Cancer Institute (R01CA164273 to A.T.S.), the Wellcome Trust (102696 to C.H.B.) and the National Foundation for Cancer Research (to A.T.S.), by Be a Piece of the Solution and by LungStrong.	Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Gainor JF, 2016, CANCER DISCOV, V6, P1118, DOI 10.1158/2159-8290.CD-16-0596; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kim S, 2013, J THORAC ONCOL, V8, P415, DOI 10.1097/JTO.0b013e318283dcc0; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Van Vactor D, 1998, CURR OPIN GENET DEV, V8, P112, DOI 10.1016/S0959-437X(98)80070-1; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zou HY, 2015, CANCER CELL, V28, P70, DOI 10.1016/j.ccell.2015.05.010	29	115	121	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					512	+		10.1038/nm.4497	http://dx.doi.org/10.1038/nm.4497			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29505033	Green Accepted			2022-12-27	WOS:000429639800023
J	Carpenter, SM; Behar, SM				Carpenter, Stephen M.; Behar, Samuel M.			A new vaccine for tuberculosis in rhesus macaques	NATURE MEDICINE			English	Editorial Material							T-CELLS; PROTECTION	In a recent study using cytomegalovirus (CMV)-vectored vaccines in rhesus macaques, prevention of tuberculosis in over 40% of vaccinated animals is shown and is attributed to reprogrammed innate immunity and CMV's maintenance of vaccine-elicited effector memory T cells.	[Carpenter, Stephen M.; Behar, Samuel M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Carpenter, Stephen M.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital	Carpenter, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.	stephen.carpenter@umassmed.edu; samuel.behar@umassmed.edu		Carpenter, Stephen/0000-0001-9879-327X; Behar, Samuel/0000-0002-3374-6699				Carpenter SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006704; Carpenter SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005380; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Mishra BB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.72; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; WHO, 2017, GLOB TUB REP 2017	12	4	4	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					124	126		10.1038/nm.4488	http://dx.doi.org/10.1038/nm.4488			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29414932				2022-12-27	WOS:000424327200007
J	Hansen, SG; Zak, DE; Xu, GW; Ford, JC; Marshall, EE; Malouli, D; Gilbride, RM; Hughes, CM; Ventura, AB; Ainslie, E; Randall, KT; Selseth, AN; Rundstrom, P; Herlache, L; Lewis, MS; Park, H; Planer, SL; Turner, JM; Fischer, M; Armstrong, C; Zweig, RC; Valvo, J; Braun, JM; Shankar, S; Lu, L; Sylwester, AW; Legasse, AW; Messerle, M; Jarvis, MA; Amon, LM; Aderem, A; Alter, G; Laddy, DJ; Stone, M; Bonavia, A; Evans, TG; Axthelm, MK; Fruh, K; Edlefsen, PT; Picker, LJ				Hansen, Scott G.; Zak, Daniel E.; Xu, Guangwu; Ford, Julia C.; Marshall, Emily E.; Malouli, Daniel; Gilbride, Roxanne M.; Hughes, Colette M.; Ventura, Abigail B.; Ainslie, Emily; Randall, Kurt T.; Selseth, Andrea N.; Rundstrom, Parker; Herlache, Lauren; Lewis, Matthew S.; Park, Haesun; Planer, Shannon L.; Turner, John M.; Fischer, Miranda; Armstrong, Christina; Zweig, Robert C.; Valvo, Joseph; Braun, Jackie M.; Shankar, Smitha; Lu, Lenette; Sylwester, Andrew W.; Legasse, Alfred W.; Messerle, Martin; Jarvis, Michael A.; Amon, Lynn M.; Aderem, Alan; Alter, Galit; Laddy, Dominick J.; Stone, Michele; Bonavia, Aurelio; Evans, Thomas G.; Axthelm, Michael K.; Fruh, Klaus; Edlefsen, Paul T.; Picker, Louis J.			Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine	NATURE MEDICINE			English	Article							BACILLUS-CALMETTE-GUERIN; HIGHLY PATHOGENIC SIV; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; AEROSOL VACCINATION; BACTERIAL LOAD; INFECTION; CYNOMOLGUS; PROTECTION; NEUTROPHILS	Despite widespread use of the bacille Calmette-Guerin (BCG) vaccine, tuberculosis (TB) remains a leading cause of global mortality from a single infectious agent (Mycobacterium tuberculosis or Mtb). Here, over two independent Mtb challenge studies, we demonstrate that subcutaneous vaccination of rhesus macaques (RMs) with rhesus cytomegalovirus vectors encoding Mtb antigen inserts (hereafter referred to as RhCMV/TB)-which elicit and maintain highly effector-differentiated, circulating and tissue-resident Mtb-specific CD4(+) and CD8(+) memory T cell responses-can reduce the overall (pulmonary and extrapulmonary) extent of Mtb infection and disease by 68%, as compared to that in unvaccinated controls, after intrabronchial challenge with the Erdman strain of Mtb at similar to 1 year after the first vaccination. Fourteen of 34 RhCMV/TB-vaccinated RMs (41%) across both studies showed no TB disease by computed tomography scans or at necropsy after challenge (as compared to 0 of 17 unvaccinated controls), and ten of these RMs were Mtb-culture-negative for all tissues, an exceptional long-term vaccine effect in the RM challenge model with the Erdman strain of Mtb. These results suggest that complete vaccine-mediated immune control of highly pathogenic Mtb is possible if immune effector responses can intercept Mtb infection at its earliest stages.	[Hansen, Scott G.; Xu, Guangwu; Ford, Julia C.; Marshall, Emily E.; Malouli, Daniel; Gilbride, Roxanne M.; Hughes, Colette M.; Ventura, Abigail B.; Ainslie, Emily; Randall, Kurt T.; Selseth, Andrea N.; Rundstrom, Parker; Herlache, Lauren; Lewis, Matthew S.; Park, Haesun; Planer, Shannon L.; Turner, John M.; Fischer, Miranda; Armstrong, Christina; Zweig, Robert C.; Sylwester, Andrew W.; Legasse, Alfred W.; Axthelm, Michael K.; Fruh, Klaus; Picker, Louis J.] OHSU, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Hansen, Scott G.; Xu, Guangwu; Ford, Julia C.; Marshall, Emily E.; Malouli, Daniel; Gilbride, Roxanne M.; Hughes, Colette M.; Ventura, Abigail B.; Ainslie, Emily; Randall, Kurt T.; Selseth, Andrea N.; Rundstrom, Parker; Herlache, Lauren; Lewis, Matthew S.; Park, Haesun; Planer, Shannon L.; Turner, John M.; Fischer, Miranda; Armstrong, Christina; Zweig, Robert C.; Sylwester, Andrew W.; Legasse, Alfred W.; Axthelm, Michael K.; Fruh, Klaus; Picker, Louis J.] OHSU, ONPRC, Beaverton, OR 97006 USA; [Zak, Daniel E.; Valvo, Joseph; Braun, Jackie M.; Shankar, Smitha; Amon, Lynn M.; Aderem, Alan] Ctr Infect Dis Res, Seattle, WA USA; [Lu, Lenette; Alter, Galit] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lu, Lenette; Alter, Galit] Harvard Univ, Cambridge, MA 02138 USA; [Messerle, Martin] Hannover Med Sch, Dept Virol, Hannover, Germany; [Jarvis, Michael A.] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth, Devon, England; [Laddy, Dominick J.; Stone, Michele; Bonavia, Aurelio; Evans, Thomas G.] Aeras, Rockville, MD USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Hannover Medical School; University of Plymouth; Fred Hutchinson Cancer Center	Picker, LJ (corresponding author), OHSU, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Picker, LJ (corresponding author), OHSU, ONPRC, Beaverton, OR 97006 USA.	pickerl@ohsu.edu	Malouli, Daniel/AAX-1855-2021; DeHovitz Braun, Joan/D-8690-2018	Malouli, Daniel/0000-0003-1287-7283; Frueh, Klaus/0000-0001-8014-3877; DeHovitz Braun, Joan/0000-0001-9975-7959	AERAS; Bill and Melinda Gates Foundation [OPP1087783]; US National Institutes of Health (NIH); US National Institutes of Health (ONPRC) [U19 AI106761, P51 OD011092, U42 OD010426]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106761, K08AI130357] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, U42OD010426] Funding Source: NIH RePORTER	AERAS; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (ONPRC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Kahl, S. Hagen, J. Bae, I. Pelletier, Y. Guo, E.M. Borst, L. S. Uebelhoer and J. Womack for technical assistance, C. Scanga and J. Flynn for guidance on the RM model of TB (including sharing of NHP protocols and provision of Mtb challenge stocks), P. Barry (University of California, Davis) and T. Shenk (Princeton University) for the 68-1 and 68-1.2 BACs, respectively, J. Flynn (University of Pittsburgh) for Mtb Erdman, W. Hanekom, L. Stuart and D. Barber for helpful discussions, D. Casimiro for manuscript review, J. Strussenberg for management of the BSL3 facility, L. Boshears for administrative assistance and A. Townsend for figure preparation. This work was supported by AERAS, the Bill and Melinda Gates Foundation (grant no. OPP1087783; A.A. and D.E.Z.) and the US National Institutes of Health (NIH; grant no. U19 AI106761 (A. A.), P51 OD011092 (ONPRC); U42 OD010426 (ONPRC)).	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ambrose LR, 2009, BLOOD, V114, P3052, DOI 10.1182/blood-2009-02-203075; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BARCLAY WR, 1973, AM REV RESPIR DIS, V107, P351; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Beverley PCL, 2014, J IMMUNOL, V193, P2306, DOI 10.4049/jimmunol.1302523; Cambier CJ, 2014, CELL, V159, P1497, DOI 10.1016/j.cell.2014.11.024; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cicin-Sain L, 2011, J IMMUNOL, V187, P1722, DOI 10.4049/jimmunol.1100560; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; Darrah PA, 2014, J IMMUNOL, V193, P1799, DOI 10.4049/jimmunol.1400676; De Libero G, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018473; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Gormus BJ, 2004, J MED PRIMATOL, V33, P134, DOI 10.1111/j.1600-0684.2004.00062.x; Griffiths KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13894; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14; HOLM S, 1979, SCAND J STAT, V6, P65; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jarvis MA, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P450; Jeyanathan M, 2013, MUCOSAL IMMUNOL, V6, P612, DOI 10.1038/mi.2012.103; Jeyanathan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135009; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Luciw PA, 2011, AM J PHYSIOL-LUNG C, V301, pL731, DOI 10.1152/ajplung.00120.2011; Lyadova IV, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8619307; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Mattila JT, 2015, CELL MICROBIOL, V17, P1085, DOI 10.1111/cmi.12428; Mishra BB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.72; Mothe BR, 2015, TUBERCULOSIS, V95, P722, DOI 10.1016/j.tube.2015.07.005; National Research Council, 2011, GUIDE CARE USE LAB A; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Ong CWM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004917; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; R Core Team, 2013, R LANG ENV STAT COMP; Rayner EL, 2013, J COMP PATHOL, V149, P475, DOI 10.1016/j.jcpa.2013.05.005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubin GD, 2015, J THORAC IMAG, V30, P130, DOI 10.1097/RTI.0000000000000140; Rumboldt Z, 2009, AM J NEURORADIOL, V30, P1630, DOI 10.3174/ajnr.A1603; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Shaler CR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00030; Sharpe S, 2016, TUBERCULOSIS, V96, P1, DOI 10.1016/j.tube.2015.10.004; Sibley L, 2016, TUBERCULOSIS, V96, P141, DOI 10.1016/j.tube.2015.11.004; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tameris M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087340; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Thome JJC, 2015, TRENDS IMMUNOL, V36, P428, DOI 10.1016/j.it.2015.05.003; Verreck FAW, 2017, TUBERCULOSIS, V104, P46, DOI 10.1016/j.tube.2017.02.003; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Warren E, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020015; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	74	137	137	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					130	+		10.1038/nm.4473	http://dx.doi.org/10.1038/nm.4473			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29334373	Green Accepted, Green Submitted			2022-12-27	WOS:000424327200010
J	Krieg, C; Nowicka, M; Guglietta, S; Schindler, S; Hartmann, FJ; Weber, LM; Dummer, R; Robinson, MD; Levesque, MP; Becher, B				Krieg, Carsten; Nowicka, Malgorzata; Guglietta, Silvia; Schindler, Sabrina; Hartmann, Felix J.; Weber, Lukas M.; Dummer, Reinhard; Robinson, Mark D.; Levesque, Mitchell P.; Becher, Burkhard			High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy	NATURE MEDICINE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MASS CYTOMETRY; LUNG-CANCER; CLINICAL ACTIVITY; PERIPHERAL-BLOOD; PD-1 BLOCKADE; T-CELLS; MELANOMA; NIVOLUMAB; SAFETY	Immune-checkpoint blockade has revolutionized cancer therapy. In particular, inhibition of programmed cell death protein 1 (PD-1) has been found to be effective for the treatment of metastatic melanoma and other cancers. Despite a dramatic increase in progression-free survival, a large proportion of patients do not show durable responses. Therefore, predictive biomarkers of a clinical response are urgently needed. Here we used high-dimensional single-cell mass cytometry and a bioinformatics pipeline for the in-depth characterization of the immune cell subsets in the peripheral blood of patients with stage IV melanoma before and after 12 weeks of anti-PD-1 immunotherapy. During therapy, we observed a clear response to immunotherapy in the T cell compartment. However, before commencing therapy, a strong predictor of progression-free and overall survival in response to anti-PD-1 immunotherapy was the frequency of CD14(+)CD16-HLA-DRhi monocytes. We confirmed this by conventional flow cytometry in an independent, blinded validation cohort, and we propose that the frequency of monocytes in PBMCs may serve in clinical decision support.	[Krieg, Carsten; Hartmann, Felix J.; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Nowicka, Malgorzata; Weber, Lukas M.; Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Nowicka, Malgorzata; Weber, Lukas M.; Robinson, Mark D.] Univ Zurich, SIB, Zurich, Switzerland; [Guglietta, Silvia] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Schindler, Sabrina; Dummer, Reinhard; Levesque, Mitchell P.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Krieg, Carsten] Med Univ South Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Krieg, Carsten] Med Univ South Carolina, Dept Dermatol, Hollings Canc Ctr, Charleston, SC 29425 USA	University of Zurich; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; IRCCS European Institute of Oncology (IEO); University of Zurich; University Zurich Hospital; Medical University of South Carolina; Medical University of South Carolina	Krieg, C; Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.; Levesque, MP (corresponding author), Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland.; Krieg, C (corresponding author), Med Univ South Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA.; Krieg, C (corresponding author), Med Univ South Carolina, Dept Dermatol, Hollings Canc Ctr, Charleston, SC 29425 USA.	kriegc@musc.edu; mitchell.levesque@usz.ch; becher@immunology.uzh.ch	Robinson, Mark D./O-2254-2019; Becher, Burkhard/ABE-4225-2020; Krieg, Carsten/ABA-6734-2020	Robinson, Mark D./0000-0002-3048-5518; Becher, Burkhard/0000-0002-1541-7867; Krieg, Carsten/0000-0002-5145-7591; Guglietta, Silvia/0000-0001-9998-5716; Hogan (Schindler), Sabrina/0000-0003-3994-8109; Hartmann, Felix/0000-0002-4174-2276; Weber, Lukas M./0000-0002-3282-1730	University Research Priority Program (URPP) in Translational Cancer Research; Swiss National Science Foundation [310030_146130, 316030_150768]; European Union; European Training Network MELGEN	University Research Priority Program (URPP) in Translational Cancer Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); European Training Network MELGEN	We thank V. Tosevski and T.M. Brodie (mass cytometry core facility, University of Zurich), A. Langer (Department of Dermatology, University of Zurich), and C. Beisel and K. Eschbach (Genomics Facility, ETH Basel) for excellent technical assistance and N. Nunes, B. Chatterjee, E. Terskikh, and C. Gujer (all from the Institute of Experimental Immunology, University Zurich), A. Zollinger (Swiss Institute of Bioinformatics, Lausanne), all members of the COST Action BM1404 Mye-EUNITER (http://www.mye-euniter.eu/), and P. Cheng (University of Zurich) for discussions. We also thank C. Guglietta for graphical design and layout. This work received funding from the University Research Priority Program (URPP) in Translational Cancer Research (C. K.), the Swiss National Science Foundation (grants 310030_146130 and 316030_150768; B. B.), the European Union FP7 project ATECT (B. B.), and the European Training Network MELGEN (M.P.L.).	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Arvaniti E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14825; Bellucci R, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008824; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; CAUX C, 1992, BLOOD, V79, P2628; Center for Drug Evaluation Research, 2016, APPR DRUGS HEM ONC C; Chavan R, 2014, CANCER IMMUNOL RES, V2, P241, DOI 10.1158/2326-6066.CIR-13-0094; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gebhardt C, 2015, CLIN CANCER RES, V21, P5453, DOI 10.1158/1078-0432.CCR-15-0676; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hartmann FJ, 2016, J EXP MED, V213, P2621, DOI 10.1084/jem.20160897; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kluger HM, 2015, CLIN CANCER RES, V21, P3052, DOI 10.1158/1078-0432.CCR-14-3073; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nishino M, 2017, NAT REV CLIN ONCOL, V14, P655, DOI 10.1038/nrclinonc.2017.88; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perez-Callejo D, 2016, TRANSL LUNG CANCER R, V5, P455, DOI 10.21037/tlcr.2016.10.07; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Sade-Feldman M, 2016, CLIN CANCER RES, V22, P5661, DOI 10.1158/1078-0432.CCR-15-3104; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Spidlen J., 2016, CYTOMETRY B; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; Wistuba-Hamprecht K, 2017, J IMMUNOL, V198, P927, DOI 10.4049/jimmunol.1600875; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	49	395	413	11	192	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					144	+		10.1038/nm.4466	http://dx.doi.org/10.1038/nm.4466			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29309059	Green Accepted			2022-12-27	WOS:000424327200011
J	King, KR; Aguirre, AD; Ye, YX; Sun, Y; Roh, JD; Ng, RP; Kohler, RH; Arlauckas, SP; Iwamoto, Y; Savol, A; Sadreyev, RI; Kelly, M; Fitzgibbons, TP; Fitzgerald, KA; Mitchison, T; Libby, P; Nahrendorf, M; Weissleder, R				King, Kevin R.; Aguirre, Aaron D.; Ye, Yu-Xiang; Sun, Yuan; Roh, Jason D.; Ng, Richard P., Jr.; Kohler, Rainer H.; Arlauckas, Sean P.; Iwamoto, Yoshiko; Savol, Andrej; Sadreyev, Ruslan I.; Kelly, Mark; Fitzgibbons, Timothy P.; Fitzgerald, Katherine A.; Mitchison, Timothy; Libby, Peter; Nahrendorf, Matthias; Weissleder, Ralph			IRF3 and type I interferons fuel a fatal response to myocardial infarction	NATURE MEDICINE			English	Article							CYCLIC GMP-AMP; DIFFERENTIAL EXPRESSION ANALYSIS; TARGET GENES; INNATE; RECOGNITION; ACTIVATION; SYNTHASE; DISTINCT; PATHWAY; ROLES	Interferon regulatory factor 3 (IRF3) and type I interferons (IFNs) protect against infections(1) and cancer(2), but excessive IRF3 activation and type I IFN production cause autoinflammatory conditions such as Aicardi-Gouteres syndrome(3,4) and STING-associated vasculopathy of infancy (SAVI)(3). Myocardial infarction (MI) elicits inflammation(5), but the dominant molecular drivers of MI-associated inflammation remain unclear. Here we show that ischemic cell death and uptake of cell debris by macrophages in the heart fuel a fatal response to MI by activating IRF3 and type I IFN production. In mice, single-cell RNA-seq analysis of 4,215 leukocytes isolated from infarcted and non-infarcted hearts showed that MI provokes activation of an IRF3-interferon axis in a distinct population of interferon-inducible cells (IFNICs) that were classified as cardiac macrophages. Mice genetically deficient in cyclic GMP-AMP synthase (cGAS), its adaptor STING, IRF3, or the type I IFN receptor IFNAR exhibited impaired interferon-stimulated gene (ISG) expression and, in the case of mice deficient in IRF3 or IFNAR, improved survival after MI as compared to controls. Interruption of IRF3-dependent signaling resulted in decreased cardiac expression of inflammatory cytokines and chemokines and decreased inflammatory cell infiltration of the heart, as well as in attenuated ventricular dilation and improved cardiac function. Similarly, treatment of mice with an IFNAR-neutralizing antibody after MI ablated the interferon response and improved left ventricular dysfunction and survival. These results identify IRF3 and the type I IFN response as a potential therapeutic target for post-MI cardioprotection.	[King, Kevin R.; Aguirre, Aaron D.; Sun, Yuan; Ng, Richard P., Jr.; Kohler, Rainer H.; Arlauckas, Sean P.; Iwamoto, Yoshiko; Nahrendorf, Matthias; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [King, Kevin R.; Aguirre, Aaron D.; Ye, Yu-Xiang; Sun, Yuan; Ng, Richard P., Jr.; Kohler, Rainer H.; Arlauckas, Sean P.; Iwamoto, Yoshiko; Nahrendorf, Matthias; Weissleder, Ralph] Harvard Med Sch, Boston, MA 02115 USA; Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Jacobs Sch Engn, Dept Bioengn, La Jolla, CA 92093 USA; [King, Kevin R.; Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Aguirre, Aaron D.; Roh, Jason D.] Harvard Med Sch, Massachusetts Gen Hosp, Cardiol Div, Boston, MA USA; [Ye, Yu-Xiang] Eberhard Karls Univ Hosp, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Ng, Richard P., Jr.] Harvard Univ, Cambridge, MA USA; [Savol, Andrej; Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Savol, Andrej; Sadreyev, Ruslan I.; Nahrendorf, Matthias] Harvard Med Sch, Dept Genet, Boston, MA USA; [Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kelly, Mark; Fitzgibbons, Timothy P.] Univ Massachusetts, Sch Med, Dept Med, Cardiovasc Div, Worcester, MA USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Immunol, Worcester, MA USA; [Fitzgibbons, Timothy P.; Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	King, KR (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.; King, KR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; King, KR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA.	krking@ucsd.edu	Libby, Peter/AAY-6404-2021; Fitzgibbons, Timothy/AAG-3700-2020; Fitzgerald, Katherine/ABE-6317-2020	Libby, Peter/0000-0002-1502-502X; Ng, Richard/0000-0002-0501-2911; kelly, mark/0000-0001-9018-594X; kohler, rainer/0000-0001-6269-6590; Fitzgerald, Kate/0000-0003-3175-609X	US NIH grant [2U2C-DK093000]; Single-Cell Core at Harvard Medical School; NIH-NHLBI grant [T32HL007604]; Harvard Medical School LaDue Fellowship; NIH-NHLBI [1K99HL129168, R00HL129168, AHA14FTF20380185, AHA16FTF29630016]; Yeatts Fund for Innovative Research [AHA16POST27030088]; Deutsche Herzstiftung [S/05/12, R01HL117829, NIH-R01 HL080472]; RRM Charitable Fund;  [AHA17IRG33410543];  [5R01HL122208]; NATIONAL CANCER INSTITUTE [T32CA079443] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL129168, T32HL007604, R00HL129168, R01HL117829, R01HL122208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK093000] Funding Source: NIH RePORTER	US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Single-Cell Core at Harvard Medical School; NIH-NHLBI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harvard Medical School LaDue Fellowship; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Yeatts Fund for Innovative Research; Deutsche Herzstiftung; RRM Charitable Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Taniguchi (University of Tokyo) and M. Diamond (Washington University School of Medicine) for their gift of the Irf3<SUP>-/-</SUP> mice; P. Dutta, H. Sager, M. Hulsman, G. Courties, R. Giedt, and K. Yang for helpful discussions and technical assistance; B. Tricot for technical assistance with cardiac MRI as part of the Molecular Imaging Program core; and the Harvard Stem Cell Institute Flow Cytometry Core, the Massachusetts General Hospital NextGen Sequencing Core, the National Mouse Metabolic Phenotyping Center at the University of Massachusetts funded by US NIH grant 2U2C-DK093000, and the Single-Cell Core at Harvard Medical School. The work was funded in part by NIH-NHLBI grant T32HL007604, the Harvard Medical School LaDue Fellowship, and AHA17IRG33410543 and by NIH-NHLBI grants 1K99HL129168 and R00HL129168 (K. R. K.); AHA14FTF20380185 (A.D.A.); AHA16FTF29630016 and the Yeatts Fund for Innovative Research (J.D.R.); AHA16POST27030088 and Deutsche Herzstiftung S/05/12 (Y.-X.Y.); grant R01HL117829 (M.N.); grant NIH-R01 HL080472 and the RRM Charitable Fund (P.L.); and grant 5R01HL122208 (R.W.).	Aguirre AD, 2014, P NATL ACAD SCI USA, V111, P11257, DOI 10.1073/pnas.1401316111; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Corrales L, 2015, CLIN CANCER RES, V21, P4774, DOI 10.1158/1078-0432.CCR-15-1362; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Furie R, 2017, ARTHRITIS RHEUMATOL, V69, P376, DOI 10.1002/art.39962; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Goldberg A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4492; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Khamashta M, 2016, ANN RHEUM DIS, V75, P1909, DOI 10.1136/annrheumdis-2015-208562; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	52	225	237	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1481	+		10.1038/nm.4428	http://dx.doi.org/10.1038/nm.4428			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29106401	Green Accepted, Green Submitted			2022-12-27	WOS:000417278200018
J	Horvath, PM; Monteggia, LM				Horvath, Patricia M.; Monteggia, Lisa M.			Engineering MeCP2 to spy on its targets	NATURE MEDICINE			English	Editorial Material							RETT-SYNDROME; TRANSCRIPTIONAL REPRESSION; MOUSE MODEL; DISEASE	A new mouse model of Rett syndrome, in which MECP2 can be selectively biotinylated, allows for the investigation of cell-specific effects of Rett-causing mutations on gene expression, particularly in female mice.	[Horvath, Patricia M.; Monteggia, Lisa M.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Monteggia, LM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	lisa.monteggia@utsouthwestern.edu						Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Cuddapah VA, 2014, J MED GENET, V51, P152, DOI 10.1136/jmedgenet-2013-102113; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Johnson BS, 2017, NAT MED, V23, P1203, DOI 10.1038/nm.4406; Monteggia LM, 2009, BIOL PSYCHIAT, V65, P204, DOI 10.1016/j.biopsych.2008.10.036; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899	12	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1120	1122		10.1038/nm.4425	http://dx.doi.org/10.1038/nm.4425			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28985210				2022-12-27	WOS:000412431800005
J	Tan, DSW; Chong, FT; Leong, HS; Toh, SY; Lau, DP; Kwang, XL; Zhang, XQ; Sundaram, GM; Tan, GS; Chang, MM; Chua, BT; Lim, WT; Tan, EH; Ang, MK; Lim, TKH; Sampath, P; Chowbay, B; Skanderup, AJ; DasGupta, R; Iyer, NG				Tan, Daniel S. W.; Chong, Fui Teen; Leong, Hui Sun; Toh, Shen Yon; Lau, Dawn P.; Kwang, Xue Lin; Zhang, Xiaoqian; Sundaram, Gopinath M.; Tan, Gek San; Chang, Mei Mei; Chua, Boon Tin; Lim, Wan Teck; Tan, Eng Huat; Ang, Mei Kim; Lim, Tony K. H.; Sampath, Prabha; Chowbay, Balram; Skanderup, Anders J.; DasGupta, Ramanuj; Iyer, N. Gopalakrishna			Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma	NATURE MEDICINE			English	Article							NECK-CANCER; SOLUBLE EGFR; LUNG-CANCER; PHASE-II; HEAD; RECURRENT; GEFITINIB; CHEMOTHERAPY; EXPRESSION; ERLOTINIB	Targeting EGFR is a validated approach in the treatment of squamous-cell cancers (SCCs), although there are no established biomarkers for predicting response. We have identified a synonymous mutation in EGFR, c.2361G>A (encoding p. Gln787Gln), in two patients with head and neck SCC (HNSCC) who were exceptional responders to gefitinib, and we showed in patient-derived cultures that the A/A genotype was associated with greater sensitivity to tyrosine kinase inhibitors (TKIs) as compared to the G/A and G/G genotypes. Remarkably, single-copy G>A nucleotide editing in isogenic models conferred a 70-fold increase in sensitivity due to decreased stability of the EGFR-AS1 long noncoding RNA (lncRNA). In the appropriate context, sensitivity could be recapitulated through EGFR-AS1 knockdown in vitro and in vivo, whereas overexpression was sufficient to induce resistance to TKIs. Reduced EGFR-AS1 levels shifted splicing toward EGFR isoform D, leading to ligand-mediated pathway activation. In co-clinical trials involving patients and patient-derived xenograft (PDX) models, tumor shrinkage was most pronounced in the context of the A/A genotype for EGFR-Q787Q, low expression of EGFR-AS1 and high expression of EGFR isoform D. Our study reveals how a 'silent' mutation influences the levels of a lncRNA, resulting in noncanonical EGFR addiction, and delineates a new predictive biomarker suite for response to EGFR TKIs.	[Tan, Daniel S. W.; Chong, Fui Teen; Leong, Hui Sun; Toh, Shen Yon; Lau, Dawn P.; Kwang, Xue Lin; Iyer, N. Gopalakrishna] Natl Canc Ctr Singapore, Canc Therapeut Res Lab, Singapore, Singapore; [Tan, Daniel S. W.; Lim, Wan Teck; Tan, Eng Huat; Ang, Mei Kim] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Tan, Daniel S. W.; Zhang, Xiaoqian; Chang, Mei Mei; Skanderup, Anders J.; DasGupta, Ramanuj] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Sundaram, Gopinath M.; Sampath, Prabha] ASTAR, Inst Med Biol, Singapore, Singapore; [Tan, Gek San; Lim, Tony K. H.] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Chua, Boon Tin] Inst Mol & Cell Biol, IMCB NCC Singapore Oncogenome Program, Singapore, Singapore; [Sampath, Prabha; Iyer, N. Gopalakrishna] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Chowbay, Balram] Natl Canc Ctr Singapore, Lab Clin Pharmacol, Singapore, Singapore; [Chowbay, Balram] Duke NUS Med Sch, Off Clin Sci, Singapore, Singapore; [Iyer, N. Gopalakrishna] Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National Cancer Centre Singapore (NCCS)	Tan, DSW; Iyer, NG (corresponding author), Natl Canc Ctr Singapore, Canc Therapeut Res Lab, Singapore, Singapore.; Tan, DSW (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.; Tan, DSW (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.; Iyer, NG (corresponding author), Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.; Iyer, NG (corresponding author), Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore.	daniel.tan.s.w@nccs.com.sg; gopaliyer@nccs.com.sg	Sundaram, Gopi/AAE-5427-2020; Lim, Darren Wan-Teck/V-8435-2019; Lim, Darren Wan Teck/L-2007-2016; Skanderup, Anders Jacobsen/K-1081-2013	Sundaram, Gopi/0000-0002-8074-6624; Lim, Darren Wan-Teck/0000-0002-4655-0206; Lim, Darren Wan Teck/0000-0002-4655-0206; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Dasgupta, Ramanuj/0000-0001-9015-3729; Toh, Shen Yon/0000-0002-6421-0862	National Medical Research Council (NMRC) (Singapore) [NMRC/CSA/007/2016, NMRC/CSA/042/2012, NMRC/CSA-INV/011/2016]; NMRC [NMRC/1304/2011, NMRC/CIRG/1434/2015]; National Cancer Centre Research Funds; Singhealth Foundation [SHF/FG496P/2012]	National Medical Research Council (NMRC) (Singapore)(National Medical Research Council, Singapore); NMRC(National Medical Research Council, Singapore); National Cancer Centre Research Funds; Singhealth Foundation(SingHealth)	We would like to extend our gratitude to all patients and families involved in this study. We would also like to thank C. Chuan Young Ng of the National Cancer Centre Singapore Genomics Service for technical support with the NanoString assays. D.S.W.T. and N.G.I. are both supported by National Medical Research Council (NMRC) (Singapore) clinician-scientist awards (D.S.W.T.: NMRC/CSA/007/2016; N.G.I.: NMRC/CSA/042/2012, NMRC/CSA-INV/011/2016). Further support for this project was obtained from NMRC (grant no. NMRC/1304/2011, NMRC/CIRG/1434/2015), National Cancer Centre Research Funds and a Singhealth Foundation Grant (SHF/FG496P/2012).	Adamczyk KA, 2011, LIFE SCI, V89, P304, DOI 10.1016/j.lfs.2011.06.020; Albitar L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-166; Blythe AJ, 2016, BBA-GENE REGUL MECH, V1859, P46, DOI 10.1016/j.bbagrm.2015.08.009; Brown JA, 2014, NAT STRUCT MOL BIOL, V21, P633, DOI 10.1038/nsmb.2844; Brumbaugh CD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-479; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chia S., NAT COMMUN IN PRESS; Cohen EEW, 2005, CLIN CANCER RES, V11, P8418, DOI 10.1158/1078-0432.CCR-05-1247; Cohen EEW, 2009, ORAL ONCOL, V45, pE155, DOI 10.1016/j.oraloncology.2009.05.637; Cripps C, 2010, CURR ONCOL, V17, P37; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garrison P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176752; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Guillaudeau A, 2012, INT J ONCOL, V40, P1142, DOI 10.3892/ijo.2011.1287; Halle C, 2011, CLIN CANCER RES, V17, P5501, DOI 10.1158/1078-0432.CCR-11-0297; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Echarri MJ, 2016, CANCERS, V8, DOI 10.3390/cancers8030027; Kirby AM, 2006, BRIT J CANCER, V94, P631, DOI 10.1038/sj.bjc.6602999; Leong HS, 2014, STEM CELL TRANSL MED, V3, P1055, DOI 10.5966/sctm.2013-0214; Licitra L, 2011, ANN ONCOL, V22, P1078, DOI 10.1093/annonc/mdq588; Lococo F, 2015, INT J MOL SCI, V16, P19612, DOI 10.3390/ijms160819612; Montero PH, 2012, ARCH OTOLARYNGOL, V138, P817, DOI 10.1001/archoto.2012.1792; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Ng JH, 2017, HEAD NECK-J SCI SPEC, V39, P297, DOI 10.1002/hed.24589; Qi HL, 2016, TUMOR BIOL, V37, P1079, DOI 10.1007/s13277-015-3887-z; Rao SVK, 2013, ASIAN PAC J CANCER P, V14, P5567, DOI 10.7314/APJCP.2013.14.10.5567; Sacco AG, 2015, J CLIN ONCOL, V33, P3305, DOI 10.1200/JCO.2015.62.0963; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Taguchi T, 2008, ONCOL REP, V19, P65; Tan DSW, 2016, J CLIN ONCOL, V34, P91, DOI 10.1200/JCO.2015.62.0096; Tan DSW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-679; Tan DSW, 2009, CANCER J, V15, P406, DOI 10.1097/PPO.0b013e3181bd0445; Tan EH, 2012, ANN ONCOL, V23, P1010, DOI 10.1093/annonc/mdr327; Thomas F, 2007, CLIN CANCER RES, V13, P7086, DOI 10.1158/1078-0432.CCR-07-1370; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vettore AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0219-2; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Romero-Ventosa EY, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0891-0; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625; Zhou TY, 2016, METHODS MOL BIOL, V1402, P199, DOI 10.1007/978-1-4939-3378-5_16	43	118	124	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2017	23	10					1167	+		10.1038/nm.4401	http://dx.doi.org/10.1038/nm.4401			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FJ0WO	28920960				2022-12-27	WOS:000412431800012
J	Duman, RS				Duman, Ronald S.			Sex-specific disease-associated modules for depression	NATURE MEDICINE			English	Editorial Material							BEHAVIOR; STRESS	A recent study reveals sexually dimorphic disease-associated gene-expression modules and hub genes in postmortem brains from female and male individuals with depression. These modules are conserved in mouse models of depression.	[Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Duman, Ronald S.] Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06510 USA	Yale University; Yale University	Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA.; Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06510 USA.	ronald.duman@yale.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105910] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH105910] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bangasser DA, 2014, FRONT NEUROENDOCRIN, V35, P303, DOI 10.1016/j.yfrne.2014.03.008; Cowen L, 2017, NAT REV GENET, V18, P551, DOI 10.1038/nrg.2017.38; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Labonte B, 2017, NAT MED, V23, P1102, DOI 10.1038/nm.4386; Otte C, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.65; Schiller CE, 2016, COMPR PHYSIOL, V6, P1135, DOI 10.1002/cphy.c150014; Seney ML, 2013, FRONT PSYCHIATRY, V4, P104, DOI [10.3389/fpsyt.2013.00104, DOI 10.3389/FPSYT.2013.00104]; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002	11	6	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1015	1017		10.1038/nm.4391	http://dx.doi.org/10.1038/nm.4391			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28886002	Green Accepted			2022-12-27	WOS:000409996200007
J	Priller, J; Bottcher, C				Priller, Josef; Boettcher, Chotima			Patrolling monocytes sense peripheral infection and induce cytokine-mediated neuronal dysfunction	NATURE MEDICINE			English	Editorial Material							STEADY-STATE; INFLAMMATION; BRAIN; IMPAIRMENT; SICKNESS	A new study reveals that virus-associated activation of a subset of circulating monocytes results in the release of the proinflammatory cytokine tumor necrosis factor (TNF)-alpha, which induces increased turnover of synapses in the brain and learning deficits in mice.	[Priller, Josef; Boettcher, Chotima] Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany; [Priller, Josef; Boettcher, Chotima] Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany; [Priller, Josef] DZNE, Cluster Excellence NeuroCure, Berlin, Germany; [Priller, Josef] BIH, Berlin, Germany; [Priller, Josef] Univ Edinburgh, Edinburgh, Midlothian, Scotland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health; University of Edinburgh	Priller, J (corresponding author), Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany.; Priller, J (corresponding author), Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany.	josef.priller@charite.de	Priller, Josef/ABW-3835-2022	Bottcher, Chotima/0000-0002-6226-586X; Priller, Josef/0000-0001-7596-0979	Medical Research Council [MC_PC_16031] Funding Source: Medline; MRC [MC_PC_16031] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez-Tapia D, 2016, BEHAV BRAIN RES, V298, P261, DOI 10.1016/j.bbr.2015.11.013; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wolf Y, 2017, J EXP MED, V214, P905, DOI 10.1084/jem.20160499	12	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					659	+		10.1038/nm.4349	http://dx.doi.org/10.1038/nm.4349			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586340				2022-12-27	WOS:000402768000006
J	Fischer, K; Ruiz, HH; Jhun, K; Finan, B; Oberlin, DJ; van der Heide, V; Kalinovich, AV; Petrovic, N; Wolf, Y; Clemmensen, C; Shin, AC; Divanovic, S; Brombacher, F; Glasmacher, E; Keipert, S; Jastroch, M; Nagler, J; Schramm, KW; Medrikova, D; Collden, G; Woods, SC; Herzig, S; Homann, D; Jung, S; Nedergaard, J; Cannon, B; Tschop, MH; Muller, TD; Buettner, C				Fischer, Katrin; Ruiz, Henry H.; Jhun, Kevin; Finan, Brian; Oberlin, Douglas J.; van der Heide, Verena; Kalinovich, Anastasia V.; Petrovic, Natasa; Wolf, Yochai; Clemmensen, Christoffer; Shin, Andrew C.; Divanovic, Senad; Brombacher, Frank; Glasmacher, Elke; Keipert, Susanne; Jastroch, Martin; Nagler, Joachim; Schramm, Karl-Werner; Medrikova, Dasa; Collden, Gustav; Woods, Stephen C.; Herzig, Stephan; Homann, Dirk; Jung, Steffen; Nedergaard, Jan; Cannon, Barbara; Tschoep, Matthias H.; Mueller, Timo D.; Buettner, Christoph			Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis	NATURE MEDICINE			English	Article							BEIGE FAT; NORADRENALINE; METABOLISM; CLEARANCE; MICE	Adaptive thermogenesis is the process of heat generation in response to cold stimulation. It is under the control of the sympathetic nervous system, whose chief effector is the catecholamine norepinephrine (NE). NE enhances thermogenesis through beta 3-adrenergic receptors to activate brown adipose tissue and by 'browning' white adipose tissue. Recent studies have reported that alternative activation of macrophages in response to interleukin (IL)-4 stimulation induces the expression of tyrosine hydroxylase (TH), a key enzyme in the catecholamine synthesis pathway, and that this activation provides an alternative source of locally produced catecholamines during the thermogenic process. Here we report that the deletion of Th in hematopoietic cells of adult mice neither alters energy expenditure upon cold exposure nor reduces browning in inguinal adipose tissue. Bone marrow-derived macrophages did not release NE in response to stimulation with IL-4, and conditioned media from IL-4-stimulated macrophages failed to induce expression of thermogenic genes, such as uncoupling protein 1 (Ucp1), in adipocytes cultured with the conditioned media. Furthermore, chronic treatment with IL-4 failed to increase energy expenditure in wild-type, Ucp1(-/-) and interleukin-4 receptor-alpha double-negative (Il4ra(-/-)) mice. In agreement with these findings, adipose-tissue-resident macrophages did not express TH. Thus, we conclude that alternatively activated macrophages do not synthesize relevant amounts of catecholamines, and hence, are not likely to have a direct role in adipocyte metabolism or adaptive thermogenesis.	[Fischer, Katrin; Finan, Brian; Clemmensen, Christoffer; Glasmacher, Elke; Keipert, Susanne; Jastroch, Martin; Collden, Gustav; Tschoep, Matthias H.; Mueller, Timo D.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Inst Diabet & Obes, Munich, Germany; [Fischer, Katrin; Finan, Brian; Clemmensen, Christoffer; Glasmacher, Elke; Keipert, Susanne; Jastroch, Martin; Collden, Gustav; Tschoep, Matthias H.; Mueller, Timo D.] German Ctr Diabet Res DZD, Munich, Germany; [Fischer, Katrin; Finan, Brian; Clemmensen, Christoffer; Collden, Gustav; Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, Dept Med, Munich, Germany; [Ruiz, Henry H.; Jhun, Kevin; Oberlin, Douglas J.; van der Heide, Verena; Shin, Andrew C.; Homann, Dirk; Buettner, Christoph] Icahn Sch Med Mt Sinai, Diabet Metab & Obes Inst, New York, NY 10029 USA; [Kalinovich, Anastasia V.; Petrovic, Natasa; Nedergaard, Jan; Cannon, Barbara] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Wolf, Yochai; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Divanovic, Senad] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA; [Brombacher, Frank] Int Ctr Genet Engn & Biotechnol, Cape Town Component, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, IDM, Div Immunol, Cape Town, South Africa; [Brombacher, Frank] SAMRC, Cape Town, South Africa; [Jastroch, Martin] Philipps Univ Marburg, Dept Anim Physiol, Fac Biol, Marburg, Germany; [Nagler, Joachim; Schramm, Karl-Werner] Helmholtz Zentrum Munchen, German Natl Diabet Ctr DZD, Mol Expos, Neuherberg, Germany; [Medrikova, Dasa; Herzig, Stephan] Helmholtz Zentrum Munchen, German Natl Diabet Ctr DZD, IDC, Neuherberg, Germany; [Medrikova, Dasa; Herzig, Stephan] Heidelberg Univ Hosp, Joint IDC Heidelberg Translat Diabet Program, Inner Med 1, Heidelberg, Germany; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Metab Dis Inst, Cincinnati, OH USA; [Buettner, Christoph] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Shin, Andrew C.] Texas Tech Univ, Dept Nutr Sci, Coll Human Sci, Lubbock, TX 79409 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Icahn School of Medicine at Mount Sinai; Stockholm University; Weizmann Institute of Science; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; Texas Tech University System; Texas Tech University	Muller, TD (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Inst Diabet & Obes, Munich, Germany.; Muller, TD (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.; Buettner, C (corresponding author), Icahn Sch Med Mt Sinai, Diabet Metab & Obes Inst, New York, NY 10029 USA.; Buettner, C (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	timo.mueller@helmholtz-muenchen.de; christoph.buettner@mssm.edu	Jung, Steffen/K-1409-2012; van der Heide, Verena/AAO-7439-2020; Nedergaard, Jan/A-1706-2010; Nedergaard, Jan/Q-8286-2019; Clemmensen, Christoffer/AAM-3347-2020; Jastroch, Martin/I-7494-2017; Ruiz, Henry H./AAA-1872-2020; Müller, Timo D./AAZ-4445-2020; Shin, Andrew/T-6225-2019; Keipert, Susanne/V-2464-2017; Clemmensen, Christoffer/N-4680-2017; Cannon, Barbara/B-3089-2016	Jung, Steffen/0000-0003-4290-5716; van der Heide, Verena/0000-0002-3602-4405; Clemmensen, Christoffer/0000-0003-2456-9667; Ruiz, Henry H./0000-0002-0213-6759; Keipert, Susanne/0000-0002-6618-7379; Clemmensen, Christoffer/0000-0003-2456-9667; Homann, Dirk/0000-0002-7622-5754; Nedergaard, Jan/0000-0003-2070-1587; Wolf, Yochai/0000-0003-0270-2025; Fischer, Katrin/0000-0001-5278-3949; Cannon, Barbara/0000-0001-6594-2363; Muller, Timo/0000-0002-0624-9339	Alexander von Humboldt Foundation; Helmholtz Alliance ICEMED; Helmholtz Initiative on Personalized Medicine iMed by Helmholtz Association; Helmholtz cross-program topic "Metabolic Dysfunction"; German Research Foundation [DFG-TS226/1-1, DFG-TS226/3-1, SFB1123]; Nutripathos Project [ANR-15-CE14-0030]; European Research Council ERC AdG HypoFlam [695054]; DFG [He3260/8-1]; EU FP7 Network "DIABAT"; EU ITN Network "TRAIN" [721531]; NIH [R01 AA023416, DK082724, R01DK099222, DK17844]; American Diabetes Association; Israeli Science Foundation; European Research Council [340345]; Swedish Research Council; Knut and Alice Wallenberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017844, P30DK020541, R56DK083658, P30DK078392, R37DK017844, R01DK099222, R03DK082724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023416] Funding Source: NIH RePORTER; Lundbeck Foundation [R210-2015-4001] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Helmholtz Alliance ICEMED; Helmholtz Initiative on Personalized Medicine iMed by Helmholtz Association; Helmholtz cross-program topic "Metabolic Dysfunction"; German Research Foundation(German Research Foundation (DFG)); Nutripathos Project; European Research Council ERC AdG HypoFlam; DFG(German Research Foundation (DFG)); EU FP7 Network "DIABAT"; EU ITN Network "TRAIN"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Israeli Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Lundbeck Foundation(Lundbeckfonden)	We thank A. Fedl, L. Sehrer, L. Muller, S. Jall, D. Heine, T. Stankiewicz, K. Gaul and A. Stanley for assistance with in vitro and ex vivo analysis. The mice with floxed Th were kindly provided by R. Palmiter. This work was supported in part by funding to M.H.T. from the Alexander von Humboldt Foundation, the Helmholtz Alliance ICEMED & the Helmholtz Initiative on Personalized Medicine iMed by Helmholtz Association, and the Helmholtz cross-program topic "Metabolic Dysfunction." This work was further supported by grants from the German Research Foundation DFG-TS226/1-1, DFG-TS226/3-1, SFB1123, Nutripathos Project ANR-15-CE14-0030, European Research Council ERC AdG HypoFlam no. 695054 (to M.H.T.); DFG He3260/8-1, the EU FP7 Network "DIABAT," the EU ITN Network "TRAIN" 721531 (to S.H.); NIH R01 AA023416, DK082724 and a career-development award from the American Diabetes Association (to C.B.); NIH R01DK099222 (to S.D.); NIH DK17844 (to S.C.W.); the Israeli Science Foundation and European Research Council (AdvERC grant 340345) (to S.J.) and the Swedish Research Council and the Knut and Alice Wallenberg Foundation (to J.N. and B.C.). We would like to dedicate this manuscript to the memory of Tim Bartness, whose work delineates the important role of the SNS in adipose tissue function.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; HSIEH ACL, 1957, AM J PHYSIOL, V190, P243, DOI 10.1152/ajplegacy.1957.190.2.243; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jastroch M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12437; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2013, J BIOL CHEM, V288, P30105, DOI 10.1074/jbc.M113.481309; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Ussar S, 2016, MOL METAB, V5, P795, DOI 10.1016/j.molmet.2016.07.004; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	30	225	234	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					623	+		10.1038/nm.4316	http://dx.doi.org/10.1038/nm.4316			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28414329	Green Accepted, Green Submitted			2022-12-27	WOS:000400650700017
J	Burma, NE; Bonin, RP; Leduc-Pessah, H; Baimel, C; Cairncross, ZF; Mousseau, M; Shankara, JV; Stemkowski, PL; Baimoukhametova, D; Bains, JS; Antle, MC; Zamponi, GW; Cahill, CM; Borgland, SL; De Koninck, Y; Trang, T				Burma, Nicole E.; Bonin, Robert P.; Leduc-Pessah, Heather; Baimel, Corey; Cairncross, Zoe F.; Mousseau, Michael; Shankara, Jhenkruthi Vijaya; Stemkowski, Patrick L.; Baimoukhametova, Dinara; Bains, Jaideep S.; Antle, Michael C.; Zamponi, Gerald W.; Cahill, Catherine M.; Borgland, Stephanie L.; De Koninck, Yves; Tuan Trang			Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents	NATURE MEDICINE			English	Article							PORE FORMATION; ATP RELEASE; HEMICHANNELS; METHADONE; THERAPY; NEURONS; STATE	Opiates are essential for treating pain, but termination of opiate therapy can cause a debilitating withdrawal syndrome in chronic users. To alleviate or avoid the aversive symptoms of withdrawal, many of these individuals continue to use opiates(1-4). Withdrawal is therefore a key determinant of opiate use in dependent individuals, yet its underlying mechanisms are poorly understood and effective therapies are lacking. Here, we identify the pannexin-1 (Panx1) channel as a therapeutic target in opiate withdrawal. We show that withdrawal from morphine induces long-term synaptic facilitation in lamina I and II neurons within the rodent spinal dorsal horn, a principal site of action for opiate analgesia. Genetic ablation of Panxl in microglia abolished the spinal synaptic facilitation and ameliorated the sequelae of morphine withdrawal. Panx1 is unique in its permeability to molecules up to 1 kDa in size and its release of ATP(5,6). We show that Panx1 activation drives ATP release from microglia during morphine withdrawal and that degrading endogenous spinal ATP by administering apyrase produces a reduction in withdrawal behaviors. Conversely, we found that pharmacological inhibition of ATP breakdown exacerbates withdrawal. Treatment with a Panx1-blocking peptide ((10)panx) or the clinically used broad-spectrum Panx1 blockers, mefloquine or probenecid, suppressed ATP release and reduced withdrawal severity. Our results demonstrate that Panx1-mediated ATP release from microglia is required for morphine withdrawal in rodents and that blocking Panx1 alleviates the severity of withdrawal without affecting opiate analgesia.	[Burma, Nicole E.; Leduc-Pessah, Heather; Cairncross, Zoe F.; Mousseau, Michael; Tuan Trang] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Burma, Nicole E.; Leduc-Pessah, Heather; Baimel, Corey; Cairncross, Zoe F.; Mousseau, Michael; Stemkowski, Patrick L.; Baimoukhametova, Dinara; Bains, Jaideep S.; Antle, Michael C.; Zamponi, Gerald W.; Borgland, Stephanie L.; Tuan Trang] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Bonin, Robert P.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Shankara, Jhenkruthi Vijaya; Antle, Michael C.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Cahill, Catherine M.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA; [De Koninck, Yves] Univ Laval, Inst Univ Sante Mentale Quebec, Dept Psychiat & Neurosci, Ville De Quebec, PQ, Canada	University of Calgary; University of Calgary; University of Toronto; University of Calgary; University of California System; University of California Irvine; Laval University	Trang, T (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.; Trang, T (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	trangt@ucalgary.ca	Cahill, Catherine M/J-6524-2019; Borgland, Stephanie/GPC-5260-2022; Burma, Nicole E/AAA-9466-2022; Cahill, Catherine/AAA-1611-2019; De Koninck, Yves/C-2659-2008; Leduc-Pessah, Heather/HCH-2964-2022	Borgland, Stephanie/0000-0001-7546-5687; De Koninck, Yves/0000-0002-5779-9330; Bains, Jaideep/0000-0002-3634-6463; Antle, Michael/0000-0001-5178-4683; Bonin, Robert/0000-0002-3287-6803; Burma, Nicole/0000-0001-8076-1798; Zamponi, Gerald W./0000-0002-0644-9066	Vi Riddell Program for Pediatric Pain, Natural Sciences and Engineering Research Council of Canada [RGPIN418299]; Rita Allen Foundation; American Pain Society; Canadian Institutes of Health Research grants [MOP133523, MOP12942, FDN143336]; Hotchkiss Brain Institute Doctoral Scholarship; Queen Elizabeth II Scholarship; Canada Research Chairs; Alberta Innovates [201400227, 201500085] Funding Source: researchfish	Vi Riddell Program for Pediatric Pain, Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rita Allen Foundation; American Pain Society; Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); Hotchkiss Brain Institute Doctoral Scholarship; Queen Elizabeth II Scholarship; Canada Research Chairs(Canada Research ChairsCGIAR); Alberta Innovates	We thank D. Littman and W-B. Gan (both at New York University School of Medicine) for generously providing breeding pairs for the Cx3cr1-Cre<SUP>ERT2</SUP> mouse colony, R. Thompson (University of Calgary) for providing the Panx1<SUP>flx/flx</SUP> mice, and F. Visser for mouse genotyping. BV-2 microglial-like cells were provided by M. Tsuda (Kyushu University) and K. Biber (University of Groningen). We also thank K. Jhamandas and B. Zochodne for comments on the manuscript and the RUN CORE Facility for access to the Nikon C1S1 confocal and Ala multiphoton microscopes. This work was supported by grants from the Vi Riddell Program for Pediatric Pain, Natural Sciences and Engineering Research Council of Canada (RGPIN418299) and the Rita Allen Foundation and American Pain Society to T.T. Canadian Institutes of Health Research grants were also awarded to T.T. (MOP133523), Y.D.K. (MOP12942) and G.W.Z. (FDN143336). N.E.B. is supported by a Hotchkiss Brain Institute Doctoral Scholarship and a Queen Elizabeth II Scholarship. R.P.B., G.W.Z. and Y.D.K. hold Canada Research Chairs.	Bagley EE, 2011, NAT NEUROSCI, V14, P1548, DOI 10.1038/nn.2940; Beckel JM, 2015, J PHYSIOL-LONDON, V593, P1857, DOI 10.1113/jphysiol.2014.283119; Bonin RP, 2014, NAT NEUROSCI, V17, P1043, DOI 10.1038/nn.3758; Chiang CY, 2005, J NEUROPHYSIOL, V94, P1751, DOI 10.1152/jn.00223.2005; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Frank JW, 2016, PAIN MED, V17, P1838, DOI 10.1093/pm/pnw078; Han MH, 2006, J NEUROSCI, V26, P4624, DOI 10.1523/JNEUROSCI.4701-05.2006; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Koo JW, 2015, NAT NEUROSCI, V18, P415, DOI 10.1038/nn.3932; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Masuda T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4771; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Stotts AL, 2012, DRUG ALCOHOL DEPEN, V125, P215, DOI 10.1016/j.drugalcdep.2012.02.015; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Weiss RD, 2014, J SUBST ABUSE TREAT, V47, P140, DOI 10.1016/j.jsat.2014.03.004; Yarborough BJH, 2016, DRUG ALCOHOL DEPEN, V160, P112, DOI 10.1016/j.drugalcdep.2015.12.031; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954	27	93	96	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					355	360		10.1038/nm.4281	http://dx.doi.org/10.1038/nm.4281			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28134928	Green Published			2022-12-27	WOS:000395848400016
J	Martelotto, LG; Baslan, T; Kendall, J; Geyer, FC; Burke, KA; Spraggon, L; Piscuoglio, S; Chadalavada, K; Nanjangud, G; Ng, CKY; Moody, P; D'Italia, S; Rodgers, L; Cox, H; Paula, AD; Stepansky, A; Schizas, M; Wen, HY; King, TA; Norton, L; Weigelt, B; Hicks, JB; Reis-Filho, JS				Martelotto, Luciano G.; Baslan, Timour; Kendall, Jude; Geyer, Felipe C.; Burke, Kathleen A.; Spraggon, Lee; Piscuoglio, Salvatore; Chadalavada, Kalyani; Nanjangud, Gouri; Ng, Charlotte K. Y.; Moody, Pamela; D'Italia, Sean; Rodgers, Linda; Cox, Hilary; Paula, Arnaud da Cruz; Stepansky, Asya; Schizas, Michail; Wen, Hannah Y.; King, Tani A.; Norton, Larry; Weigelt, Britta; Hicks, James B.; Reis-Filho, Jorge S.			Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples	NATURE MEDICINE			English	Article							TUMOR GENETIC-HETEROGENEITY; BREAST CANCERS; CLONAL EVOLUTION; AMPLIFICATION; TISSUES; MULTIPLEX; MEDICINE	A substantial proportion of tumors consist of genotypically distinct subpopulations of cancer cells. This intratumor genetic heterogeneity poses a substantial challenge for the implementation of precision medicine. Single-cell genomics constitutes a powerful approach to resolve complex mixtures of cancer cells by tracing cell lineages and discovering cryptic genetic variations that would otherwise be obscured in tumor bulk analyses. Because of the chemical alterations that result from formalin fixation, single-cell genomic approaches have largely remained limited to fresh or rapidly frozen specimens. Here we describe the development and validation of a robust and accurate methodology to perform whole-genome copy-number profiling of single nuclei obtained from formalin-fixed paraffin embedded clinical tumor samples. We applied the single-cell sequencing approach described here to study the progression from in situ to invasive breast cancer, which revealed that ductal carcinomas in situ show intratumor genetic heterogeneity at diagnosis and that these lesions may progress to invasive breast cancer through a variety of evolutionary processes.	[Martelotto, Luciano G.; Geyer, Felipe C.; Burke, Kathleen A.; Spraggon, Lee; Piscuoglio, Salvatore; Ng, Charlotte K. Y.; Paula, Arnaud da Cruz; Wen, Hannah Y.; Weigelt, Britta; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Baslan, Timour; Kendall, Jude; Moody, Pamela; D'Italia, Sean; Rodgers, Linda; Cox, Hilary; Stepansky, Asya; Hicks, James B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Baslan, Timour] SUNY Stony Brook, Dept Mol & Cellular Biol, Stony Brook, NY USA; [Chadalavada, Kalyani; Nanjangud, Gouri] Mem Sloan Kettering Canc Ctr, Mol Cytogenet, New York, NY 10021 USA; [Paula, Arnaud da Cruz] Inst Portugues Oncol Francisco Gentil, Porto, Portugal; [Schizas, Michail; King, Tani A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Baslan, Timour] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [King, Tani A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [King, Tani A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Hicks, James B.] Univ Southern Calif, USC Dana & David Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90007 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Portuguese Institute of Oncology; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Southern California	Reis-Filho, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	weigeltb@mskcc.org; jameshic@usc.edu; reisfilj@mskcc.org	t, lf/AAJ-4924-2020; Ng, Charlotte K Y/AAY-3178-2021; Ng, Charlotte K Y/AAA-1670-2020; Piscuoglio, Salvatore/AAB-4959-2022; Martelotto, Luciano/D-1946-2015	Ng, Charlotte K Y/0000-0002-6100-0026; Piscuoglio, Salvatore/0000-0003-2686-2939; Martelotto, Luciano/0000-0002-9625-1183; Da Cruz Paula, Arnaud/0000-0001-7694-8760	National Cancer Institute Cancer Center Shared Grant [CA045508]; Susan G. Komen Investigator Initiated Research Grant [IIR13265578]; MSKCC Single-Cell Sequencing Initiative; William and Joyce O'Neil Research Fund; Susan G. Komen Postdoctoral Fellowship [PDF14298348]; Breast Cancer Research Foundation; Cancer Center Support Grant of the US National Institutes of Health-National Cancer Institute [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA045508, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Shared Grant; Susan G. Komen Investigator Initiated Research Grant(Susan G. Komen Breast Cancer Foundation); MSKCC Single-Cell Sequencing Initiative; William and Joyce O'Neil Research Fund; Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Cancer Center Support Grant of the US National Institutes of Health-National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the M. Wigler lab (CSHL) for kindly providing access to necessary equipment, and M. Schatz, T. Garvin and R. Aboukhalil (CSHL) for their assistance with Ginkgo, an interactive, online platform for the analysis of CNAs from single cells. We thank the CSHL Flow Cytometry Shared Resources, which is supported in part by the National Cancer Institute Cancer Center Shared Grant award number CA045508. We thank S. Turcan and J. Taranda for critically reviewing the manuscript. This work was funded in part by a Susan G. Komen Investigator Initiated Research Grant (IIR13265578; J.B.H., J.S.R.-E, T.A.K. and B.W.), and by the MSKCC Single-Cell Sequencing Initiative (T.B.) and the William and Joyce O'Neil Research Fund (T.B.). S.P. was funded in part by a Susan G. Komen Postdoctoral Fellowship grant (PDF14298348). J.S.R.-F. is funded in part by the Breast Cancer Research Foundation. Research reported in this publication was supported in part by the Cancer Center Support Grant of the US National Institutes of Health-National Cancer Institute (P30CA008748; MSKCC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bosso M, 2011, METHODS MOL BIOL, V724, P161, DOI 10.1007/978-1-61779-055-3_11; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Deleye L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11711; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Hosein AN, 2013, LAB INVEST, V93, P701, DOI 10.1038/labinvest.2013.54; Leung ML, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0616-2; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng CKY, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv015; Ng CKY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0657-6; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Voet T, 2013, NUCLEIC ACIDS RES, V41, P6119, DOI 10.1093/nar/gkt345; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Zardavas D, 2015, NAT REV CLIN ONCOL, V12, P381, DOI 10.1038/nrclinonc.2015.73; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	30	79	84	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					376	385		10.1038/nm.4279	http://dx.doi.org/10.1038/nm.4279			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28165479	Green Accepted			2022-12-27	WOS:000395848400019
J	Gattinoni, L; Speiser, DE; Lichterfeld, M; Bonini, C				Gattinoni, Luca; Speiser, Daniel E.; Lichterfeld, Mathias; Bonini, Chiara			T memory stem cells in health and disease	NATURE MEDICINE			English	Review							YELLOW-FEVER; BONE-MARROW; B-CELL; ANTIRETROVIRAL THERAPY; LINEAGE RELATIONSHIP; PROTECTIVE IMMUNITY; CUTTING EDGE; SELF-RENEWAL; HOMEOSTATIC PROLIFERATION; ANTITUMOR-ACTIVITY	T memory stem (TscM) cells are a rare subset of memory lymphocytes endowed with the stem cell like ability to self-renew and the multipotent capacity to reconstitute the entire spectrum of memory and effector T cell subsets. Cumulative evidence in mice, nonhuman primates and humans indicates that Tscm cells are minimally differentiated cells at the apex of the hierarchical system of memory T lymphocytes. Here we describe emerging findings demonstrating that Tscm cells, owing to their extreme longevity and robust potential for immune reconstitution, are central players in many physiological and pathological human processes. We also discuss how Tscm cell stemness could be leveraged therapeutically to enhance the efficacy of vaccines and adoptive T cell therapies for cancer and infectious diseases or, conversely, how it could be disrupted to treat Tscm cell driven and sustained diseases, such as autoimmunity, adult T cell leukemia and HIV-1.	[Gattinoni, Luca] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Speiser, Daniel E.] Univ Lausanne Hosp, Ludwig Canc Res, Dept Oncol, Lausanne, Switzerland; [Lichterfeld, Mathias] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Bonini, Chiara] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Expt Hematol Unit, Leukemia Unit, Milan, Italy; [Bonini, Chiara] Univ Vita Salute San Raffaele, Hematol Dept, Milan, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Gattinoni, L (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Speiser, DE (corresponding author), Univ Lausanne Hosp, Ludwig Canc Res, Dept Oncol, Lausanne, Switzerland.; Lichterfeld, M (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.; Bonini, C (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Expt Hematol Unit, Leukemia Unit, Milan, Italy.; Bonini, C (corresponding author), Univ Vita Salute San Raffaele, Hematol Dept, Milan, Italy.	gattinol@mail.nih.gov; doc@dspeiser.ch; mlichterfeld@mgh.harvard.edu; bonini.chiara@hsr.it	Speiser, Daniel E./F-2173-2013; Lichterfeld, Mathias/B-2042-2008; Gattinoni, Luca/A-2281-2008	Lichterfeld, Mathias/0000-0001-9865-8350; Gattinoni, Luca/0000-0003-2239-3282; BONINI, Maria Chiara/0000-0002-0772-1674	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research [ZIABC011480]; US National Institutes of Health (NIH) Bench-to-Bedside Award; NIH [AI098487, AI106468, AI114235, AI117841, AI120008, AI124776]; Cancer Research Institute; Ludwig Cancer Research; Swiss Cancer League [3507-08-2014]; Swiss National Science Foundation [320030_152856, CRSII3_160708]; SwissTransMed [KIP 18]; Italian Association for Cancer Research; SUPERSIST (EU-FP7 project); NATIONAL CANCER INSTITUTE [ZIABC011480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098487, R01AI120008, R01AI130005, U01AI117841, R21AI124776, R21AI106468, U01AI114235] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research; US National Institutes of Health (NIH) Bench-to-Bedside Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Ludwig Cancer Research; Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SwissTransMed; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); SUPERSIST (EU-FP7 project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research (ZIABC011480), the 2014 US National Institutes of Health (NIH) Bench-to-Bedside Award, (to L.G.) NIH grants AI098487, AI106468, AI114235, AI117841, AI120008, AI124776 (to M.L.), the Cancer Research Institute (N.Y.), the Ludwig Cancer Research (N.Y.), the Swiss Cancer League (3507-08-2014), the Swiss National Science Foundation (320030_152856, CRSII3_160708), the SwissTransMed (KIP 18) (to D.E.S.), the Italian Association for Cancer Research and the SUPERSIST (EU-FP7 project) (to C.B.).	Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Ali A, 2016, J VIROL, V90, P6999, DOI 10.1128/JVI.00805-16; Alp OS, 2015, EUR J IMMUNOL, V45, P975, DOI 10.1002/eji.201445295; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Axelsson-Robertson R, 2015, INT J INFECT DIS, V32, P13, DOI 10.1016/j.ijid.2014.12.017; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Boudousquie C, 2014, J IMMUNOL, V193, P2784, DOI 10.4049/jimmunol.1400465; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Busch DH, 2016, SEMIN IMMUNOL, V28, P28, DOI 10.1016/j.smim.2016.02.001; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Calascibetta F, 2016, J VIROL, V90, P7541, DOI 10.1128/JVI.00598-16; Cartwright EK, 2016, J VIROL, V90, P6699, DOI 10.1128/JVI.00492-16; Cartwright EK, 2014, J IMMUNOL, V192, P4666, DOI 10.4049/jimmunol.1303193; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Cieri N, 2015, BLOOD, V125, P2865, DOI 10.1182/blood-2014-11-608539; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Ciocca ML, 2012, J IMMUNOL, V188, P4145, DOI 10.4049/jimmunol.1200176; Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; Crompton JG, 2015, CANCER RES, V75, P296, DOI 10.1158/0008-5472.CAN-14-2277; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; De Gregorio E, 2012, MICROB BIOTECHNOL, V5, P149, DOI 10.1111/j.1751-7915.2011.00276.x; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Di Benedetto S, 2015, BIOGERONTOLOGY, V16, P631, DOI 10.1007/s10522-015-9563-2; Di Rosa F, 2016, TRENDS IMMUNOL, V37, P503, DOI 10.1016/j.it.2016.05.004; Ding ZC, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1171445; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gannon P., 2016, CLIN CANC RES; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2015, BLOOD, V125, P3519, DOI 10.1182/blood-2015-04-640631; Gattinoni L, 2014, IMMUNITY, V41, P7, DOI 10.1016/j.immuni.2014.07.003; Gattinoni L, 2013, BLOOD, V121, P567, DOI 10.1182/blood-2012-11-468660; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heninger AK, 2009, CURR DIABETES REP, V9, P113, DOI 10.1007/s11892-009-0020-y; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hosokawa K, 2016, J IMMUNOL, V196, P1568, DOI 10.4049/jimmunol.1501739; Huang JP, 2006, J IMMUNOL, V176, P7726, DOI 10.4049/jimmunol.176.12.7726; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jaafoura S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6407; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Klatt NR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004345; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2016, J CLIN INVEST, V126, P318, DOI 10.1172/JCI81217; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Li QS, 2011, IMMUNITY, V34, P541, DOI 10.1016/j.immuni.2011.04.006; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Liu L, 2015, J VIROL, V89, P6685, DOI 10.1128/JVI.00474-15; Long HM, 2013, J EXP MED, V210, P933, DOI 10.1084/jem.20121437; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Lu YJ, 2016, INFLAMMATION, V39, P10, DOI 10.1007/s10753-015-0217-y; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Lugli E, 2007, CYTOM PART A, V71A, P334, DOI 10.1002/cyto.a.20387; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Marraco SAF, 2015, GENOM DATA, V5, P297, DOI 10.1016/j.gdata.2015.06.024; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Mateus J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003432; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagai Y, 2015, BLOOD, V125, P3527, DOI 10.1182/blood-2014-10-607465; Oliveira G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8265; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ramishetti S, 2015, ACS NANO, V9, P6706, DOI 10.1021/acsnano.5b02796; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Ribeiro SP, 2014, VIROLOGY, V88, P13836; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Roberto A, 2015, BLOOD, V125, P2855, DOI 10.1182/blood-2014-11-608406; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sabatino M, 2016, BLOOD, V128, P519, DOI 10.1182/blood-2015-11-683847; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Schmueck-Henneresse M, 2015, J IMMUNOL, V194, P5559, DOI 10.4049/jimmunol.1402090; Scholz G, 2016, EBIOMEDICINE, V4, P50, DOI 10.1016/j.ebiom.2016.01.019; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Singh N, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5222; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Stemberger C, 2014, BLOOD, V124, P628, DOI 10.1182/blood-2013-12-547349; Stevanovic S, 2015, J CLIN ONCOL, V33, P1543, DOI 10.1200/JCO.2014.58.9093; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Tabler CO, 2014, J VIROL, V88, P4976, DOI 10.1128/JVI.00324-14; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Terakura S, 2012, BLOOD, V119, P72, DOI 10.1182/blood-2011-07-366419; Thucydides, 1676, PELOPONNESIAN WARRE; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van der Waart AB, 2014, BLOOD, V124, P3490, DOI 10.1182/blood-2014-05-578583; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Vigano S, 2015, J VIROL, V89, P7829, DOI 10.1128/JVI.00789-15; Wang XL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1072671; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Yi JS, 2010, J IMMUNOL, V185, P4835, DOI 10.4049/jimmunol.1001032; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	158	260	276	7	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					18	27		10.1038/nm.4241	http://dx.doi.org/10.1038/nm.4241			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	28060797	Green Accepted			2022-12-27	WOS:000391646800010
J	Frentzas, S; Simoneau, E; Bridgeman, VL; Vermeulen, PB; Foo, S; Kostaras, E; Nathan, MR; Wotherspoon, A; Gao, ZH; Shi, Y; Van den Eynden, G; Daley, F; Peckitt, C; Tan, X; Salman, A; Lazaris, A; Gazinska, P; Berg, TJ; Eltahir, Z; Ritsma, L; van Rheenen, J; Khashper, A; Brown, G; Nystrom, H; Sund, M; Van Laere, S; Loyer, E; Dirix, L; Cunningham, D; Metrakos, P; Reynolds, AR				Frentzas, Sophia; Simoneau, Eve; Bridgeman, Victoria L.; Vermeulen, Peter B.; Foo, Shane; Kostaras, Eleftherios; Nathan, Mark R.; Wotherspoon, Andrew; Gao, Zu-Hua; Shi, Yu; Van den Eynden, Gert; Daley, Frances; Peckitt, Clare; Tan, Xianming; Salman, Ayat; Lazaris, Anthoula; Gazinska, Patrycja; Berg, Tracy J.; Eltahir, Zak; Ritsma, Laila; van Rheenen, Jacco; Khashper, Alla; Brown, Gina; Nystrom, Hanna; Sund, Malin; Van Laere, Steven; Loyer, Evelyne; Dirix, Luc; Cunningham, David; Metrakos, Peter; Reynolds, Andrew R.			Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases	NATURE MEDICINE			English	Article							BEVACIZUMAB PLUS CAPECITABINE; PHASE-III TRIAL; ANTIANGIOGENIC THERAPY; TUMOR INVASION; EXPERT CONSENSUS; VEGF ANTIBODY; CANCER; GROWTH; PROGRESSION; CHEMOTHERAPY	The efficacy of angiogenesis inhibitors in cancer is limited by resistance mechanisms that are poorly understood. Notably, instead of through the induction of angiogenesis, tumor vascularization can occur through the nonangiogenic mechanism of vessel co-option. Here we show that vessel co-option is associated with a poor response to the anti-angiogenic agent bevacizumab in patients with colorectal cancer liver metastases. Moreover, we find that vessel co-option is also prevalent in human breast cancer liver metastases, a setting in which results with anti-angiogenic therapy have been disappointing. In preclinical mechanistic studies, we found that cancer cell motility mediated by the actin-related protein 2/3 complex (Arp2/3) is required for vessel co-option in liver metastases in vivo and that, in this setting, combined inhibition of angiogenesis and vessel co-option is more effective than the inhibition of angiogenesis alone. Vessel co-option is therefore a clinically relevant mechanism of resistance to anti-angiogenic therapy and combined inhibition of angiogenesis and vessel co-option might be a warranted therapeutic strategy.	[Frentzas, Sophia; Bridgeman, Victoria L.; Vermeulen, Peter B.; Foo, Shane; Kostaras, Eleftherios; Nathan, Mark R.; Berg, Tracy J.; Reynolds, Andrew R.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Tumour Biol Team, London, England; [Frentzas, Sophia; Wotherspoon, Andrew; Peckitt, Clare; Eltahir, Zak; Brown, Gina; Cunningham, David] Royal Marsden Hosp, London, England; [Simoneau, Eve; Gao, Zu-Hua; Shi, Yu; Salman, Ayat; Lazaris, Anthoula; Khashper, Alla; Metrakos, Peter] McGill Univ, Ctr Hlth, Royal Victoria Hosp Glen Site, Montreal, PQ, Canada; [Vermeulen, Peter B.; Van den Eynden, Gert; Nystrom, Hanna; Van Laere, Steven; Dirix, Luc] Gasthuiszusters Antwerpen Hosp St Augustinus, Translat Canc Res Unit, Antwerp, Belgium; [Daley, Frances] Royal Marsden Hosp, Breast Canc Now Histopathol Core Facil, London, England; [Tan, Xianming] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Gazinska, Patrycja] Kings Coll London, Sch Med, Guys Hosp, Breast Canc Now Unit, London, England; [Ritsma, Laila; van Rheenen, Jacco] Netherlands Hubrecht Inst Royal Netherlands Acad, Canc Genom Ctr, Utrecht, Netherlands; [Ritsma, Laila; van Rheenen, Jacco] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Nystrom, Hanna; Sund, Malin] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Loyer, Evelyne] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; McGill University; Royal Marsden NHS Foundation Trust; University of North Carolina; University of North Carolina Chapel Hill; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Utrecht University; Utrecht University; Utrecht University Medical Center; Umea University; University of Texas System; UTMD Anderson Cancer Center	Reynolds, AR (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, Tumour Biol Team, London, England.; Cunningham, D (corresponding author), Royal Marsden Hosp, London, England.; Metrakos, P (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp Glen Site, Montreal, PQ, Canada.	David.Cunningham@rmh.nhs.uk; peter.metrakos@mcgill.ca; andrew.reynolds@icr.ac.uk	metrakos, peter/D-3726-2013; Nystrom, Hanna/AAK-4743-2021; Van Laere, Steven/GQA-8872-2022; Dirix, Luc/AAI-8880-2020; Ritsma, Laila/AAZ-6620-2020; Eltahir, Zakaria/AGW-7511-2022; Eltahir, Zakaria/AAG-9869-2020	Van Laere, Steven/0000-0002-2640-0040; Ritsma, Laila/0000-0002-0214-2008; Eltahir, Zakaria/0000-0001-6815-4100; Eltahir, Zakaria/0000-0001-6815-4100; Brown, Gina/0000-0002-2336-622X; Cunningham, David/0000-0001-5158-1069	Breakthrough Breast Cancer; NHS; Liver Disease Biobank (Montreal); De Stichting tegen Kanker (Antwerp); Breast Cancer Now; National Institute for Health Research [NF-SI-0515-10045] Funding Source: researchfish	Breakthrough Breast Cancer; NHS; Liver Disease Biobank (Montreal); De Stichting tegen Kanker (Antwerp); Breast Cancer Now; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by Breakthrough Breast Cancer (which recently merged with the Breast Cancer Campaign to form Breast Cancer Now), NHS funding to the NIHR Biomedical Research Centre at RM/ICR (London), the Liver Disease Biobank (Montreal) and De Stichting tegen Kanker (Antwerp). We thank I. Hart, K. Hodivala-Dilke, C. Isacke, R. Kerbel, A. Tutt and the members of the Liver Metastasis Research Network for their critical comments on the work. We thank Genentech for providing B20-4.1.1, S. Petrillo for assistance with the Liver Disease Biobank, J. Campbell for advice on statistical analysis and M. Balazsi for assistance with digital pathology. For their technical assistance, we thank the staff of the ICR Biological Services Unit and the staff of the Breast Cancer Now Histopathology Core Facility.	Adams RB, 2013, HPB, V15, P91, DOI 10.1111/j.1477-2574.2012.00557.x; Boonsirikamchai P, 2011, AM J ROENTGENOL, V197, pW1060, DOI 10.2214/AJR.11.6459; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Bugyik E, 2011, J NEUROPATH EXP NEUR, V70, P979, DOI 10.1097/NEN.0b013e318233afd7; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Chaudhury P, 2010, HPB, V12, P37, DOI 10.1111/j.1477-2574.2009.00119.x; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Colpaert CG, 2003, HISTOPATHOLOGY, V42, P530, DOI 10.1046/j.1365-2559.2003.01629.x; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Depner C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12329; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gray MJ, 2008, ONCOGENE, V27, P7192, DOI 10.1038/onc.2008.356; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iwaya K, 2007, CANCER SCI, V98, P992, DOI 10.1111/j.1349-7006.2007.00488.x; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jeong HS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv155; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Kuczynski EA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw030; Kusters B, 2002, CANCER RES, V62, P341; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Naresh KN, 2001, HISTOPATHOLOGY, V38, P466, DOI 10.1046/j.1365-2559.2001.01061.x; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Nyati MK, 2002, GENE THER, V9, P844, DOI 10.1038/sj.gt.3301706; Otsubo T, 2004, MODERN PATHOL, V17, P461, DOI 10.1038/modpathol.3800062; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pezzella F, 1996, EUR J CANCER, V32A, P2494, DOI 10.1016/S0959-8049(96)00377-2; Pezzella F, 2000, LANCET, V355, P1787; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Semelka RC, 2000, RADIOLOGY, V215, P89, DOI 10.1148/radiology.215.1.r00mr2989; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shindoh J, 2012, J CLIN ONCOL, V30, P4566, DOI 10.1200/JCO.2012.45.2854; Stessels F, 2004, BRIT J CANCER, V90, P1429, DOI 10.1038/sj.bjc.6601727; Szabo V, 2015, J PATHOL, V235, P384, DOI 10.1002/path.4464; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931; Van den Eynden GG, 2012, CLIN EXP METASTAS, V29, P541, DOI 10.1007/s10585-012-9469-1; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Vermeulen PB, 2001, J PATHOL, V195, P336, DOI 10.1002/path.966; Wong R, 2011, ANN ONCOL, V22, P2042, DOI 10.1093/annonc/mdq714	53	240	245	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1294	1302		10.1038/nm.4197	http://dx.doi.org/10.1038/nm.4197			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27748747	Green Accepted, Green Submitted			2022-12-27	WOS:000387302300022
J	O'Donovan, MC; Owen, MJ				O'Donovan, Michael C.; Owen, Michael J.			The implications of the shared genetics of psychiatric disorders	NATURE MEDICINE			English	Article							COPY NUMBER VARIANTS; GLOBAL BURDEN; SCHIZOPHRENIA; DISEASE; RISK; LOCI; PSYCHOPATHOLOGY; CHALLENGES; PLEIOTROPY; MUTATIONS	Recent genomic studies have revealed the highly polygenic nature of psychiatric disorders, including schizophrenia, bipolar disorder and major depressive disorder. Many of the individual genetic associations are shared across multiple disorders in a way that points to extensive biological pleiotropy and further challenges the biological validity of existing diagnostic approaches. Here we argue that the existence of risk alleles specific to a single diagnostic category is unlikely. We also highlight some of the important clinical repercussions of pleiotropy.	[O'Donovan, Michael C.; Owen, Michael J.] Cardiff Univ, Sch Med, Div Psychiat & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales	Cardiff University	O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, Div Psychiat & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales.	odonovanmc@cardiff.ac.uk	O'Donovan, Michael C/P-7005-2018	O'Donovan, Michael C/0000-0001-7073-2379	Medical Research Council (MRC) [MR/L010305/1, G0800509]; Medical Research Council [MR/L010305/1, G0800509] Funding Source: researchfish; MRC [G0800509] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council (MRC) Centre grant MR/L010305/1 and program grant G0800509.	Antilla V., 2016, PREPRINT; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Consortium Cross-Disorder Group of the Psychiatric Genomics Consortium, 2012, NAT GENET, V45, P984; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Cuthbert BN, 2014, WORLD PSYCHIATRY, V13, P28, DOI 10.1002/wps.20087; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Flint J, 2014, TRENDS NEUROSCI, V37, P733, DOI 10.1016/j.tins.2014.08.007; Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Gershon ES, 2013, AM J PSYCHIAT, V170, P968, DOI 10.1176/appi.ajp.2013.12121558; Green EK, 2016, MOL PSYCHIATR, V21, P89, DOI 10.1038/mp.2014.174; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hamshere ML, 2013, BRIT J PSYCHIAT, V203, P107, DOI 10.1192/bjp.bp.112.117432; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; Malaspina D, 2013, SCHIZOPHR RES, V150, P21, DOI 10.1016/j.schres.2013.04.026; Niarchou M, 2014, BRIT J PSYCHIAT, V204, P46, DOI 10.1192/bjp.bp.113.132324; Owen MJ, 2014, NEURON, V84, P564, DOI 10.1016/j.neuron.2014.10.028; Paaby AB, 2013, TRENDS GENET, V29, P66, DOI 10.1016/j.tig.2012.10.010; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rees E, 2014, MOL PSYCHIATR, V19, P37, DOI 10.1038/mp.2013.156; Rees E, 2016, JAMA PSYCHIAT, V73, P963, DOI 10.1001/jamapsychiatry.2016.1831; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruderfer DM, 2011, MOL PSYCHIATR, V16, P887, DOI 10.1038/mp.2011.34; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Tansey KE, 2016, MOL PSYCHIATR, V21, P1085, DOI 10.1038/mp.2015.143; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Walters JTR, 2007, MOL PSYCHIATR, V12, P886, DOI 10.1038/sj.mp.4002068; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	44	86	87	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1214	1219		10.1038/nm.4196	http://dx.doi.org/10.1038/nm.4196			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783064	Green Accepted			2022-12-27	WOS:000387302300012
J	Zhao, XH; Kotilinek, LA; Smith, B; Hlynialuk, C; Zahs, K; Ramsden, M; Cleary, J; Ashe, KH				Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.			Caspase-2 cleavage of tau reversibly impairs memory	NATURE MEDICINE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; SILENT SYNAPSES; IN-VIVO; NEURODEGENERATION; ACTIVATION; APOPTOSIS; TAUOPATHY; PATHOLOGY; TANGLES	In Alzheimer's disease (AD) and other tauopathies, the tau protein forms fibrils, which are believed to be neurotoxic. However, fibrillar tau has been dissociated from neuron death and network dysfunction, suggesting the involvement of nonfibrillar species. Here we describe a novel pathological process in which caspase-2 cleavage of tau at Asp314 impairs cognitive and synaptic function in animal and cellular models of tauopathies by promoting the missorting of tau to dendritic spines. The truncation product, Delta tau314, resists fibrillation and is present at higher levels in brains from cognitively impaired mice and humans with AD. The expression of tau mutants that resisted caspase-2 cleavage prevented tau from infiltrating spines, dislocating glutamate receptors and impairing synaptic function in cultured neurons, and it prevented memory deficits and neurodegeneration in mice. Decreasing the levels of caspase-2 restored long-term memory in mice that had existing deficits. Our results suggest an overall treatment strategy for re-establishing synaptic function and restoring memory in patients with AD by preventing tau from accumulating in dendritic spines.	[Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.] Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA; [Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Zhao, Xiaohui; Kotilinek, Linda A.; Smith, Benjamin; Hlynialuk, Chris; Zahs, Kathleen; Ramsden, Martin; Cleary, James; Ashe, Karen H.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Cleary, James; Ashe, Karen H.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN 55417 USA; [Ramsden, Martin] R&D Syst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Ashe, KH (corresponding author), Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA.; Ashe, KH (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.; Ashe, KH (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.; Ashe, KH (corresponding author), Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN 55417 USA.	hsiao005@umn.edu	Zhao, Xiaohui/G-7626-2012		US National Institutes of Health (NIH) (EUREKA) [R01-NS63214, R01-NS79374]; T. and P. Grossman Family Foundation; Rush Alzheimer's Disease Center [R01-AG17917]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079374, R01NS063214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (EUREKA); T. and P. Grossman Family Foundation; Rush Alzheimer's Disease Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Sources of funding for this study include the US National Institutes of Health (NIH) (EUREKA grant no. R01-NS63214 (K.H.A.) and R01-NS79374 (K.H.A.)), the T. and P. Grossman Family Foundation (K.H.A.), B. Grossman (K.H.A.) and K. Moe (K.H.A.). We thank P. Davies (Albert Einstein College of Medicine) for the antibodies Alz-50, MC-1 and CP-13, as well as B. Roth (University of North Carolina at Chapel Hill) for the pAAV-CaMKIIa-EGFP vector. We are grateful to the participants of the Memory and Aging Project, as well as the staff and director (D. Bennett) of the Rush Alzheimer's Disease Center (grant no. R01-AG17917 (D. Bennett)). We thank L. Kemper, K. Leinonen and E. Steuer for excellent assistance with mouse breeding, genotyping and behavioral tests, M. Kuskowski for help with statistical analyses, and C. Wilmot, D. Liao, M. Koob and M. Walters for valuable advice and encouragement.	Abraha A, 2000, J CELL SCI, V113, P3737; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Carroll JB, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-59; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fath T, 2002, J NEUROSCI, V22, P9733; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GomezIsla T, 1996, ANN NEUROL, V39, P62, DOI 10.1002/ana.410390110; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kopeikina KJ, 2013, J COMP NEUROL, V521, P1334, DOI 10.1002/cne.23234; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lee Sangmook, 2012, Int J Alzheimers Dis, V2012, P731063, DOI 10.1155/2012/731063; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; lttner L. M., 2010, CELL, V142, P387; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Miller EC, 2014, EUR J NEUROSCI, V39, P1214, DOI 10.1111/ejn.12507; Pozueta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2927; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shalini S, 2015, ONCOGENE, V34, P4995, DOI 10.1038/onc.2014.413; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Tiwari M, 2014, AUTOPHAGY, V10, P1054, DOI 10.4161/auto.28528; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	37	106	113	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1268	1276		10.1038/nm.4199	http://dx.doi.org/10.1038/nm.4199			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27723722				2022-12-27	WOS:000387302300019
J	Ortuno, MJ; Robinson, ST; Subramanyam, P; Paone, R; Huang, YY; Guo, XE; Colecraft, HM; Mann, JJ; Ducy, P				Ortuno, Maria Jose; Robinson, Samuel T.; Subramanyam, Prakash; Paone, Riccardo; Huang, Yung-yu; Guo, X. Edward; Colecraft, Henry M.; Mann, J. John; Ducy, Patricia			Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect	NATURE MEDICINE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; LEPTIN REGULATION; RAT MODEL; FLUOXETINE; TRANSPORTER; 5-HYDROXYTRYPTAMINE; ANTAGONISTS; RECEPTORS	The use of selective serotonin-reuptake inhibitors (SSRIs) has been associated with an increased risk of bone fracture, raising concerns about their increasingly broader usage. This deleterious effect is poorly understood, and thus strategies to avoid this side effect remain elusive. We show here that fluoxetine (Flx), one of the most-prescribed SSRIs, acts on bone remodeling through two distinct mechanisms. Peripherally, Flx has anti-resorptive properties, directly impairing osteoclast differentiation and function through a serotonin-reuptake-independent mechanism that is dependent on intracellular Ca2+ levels and the transcription factor Nfatc1. With time, however, Flx also triggers a brain-serotonin-dependent rise in sympathetic output that increases bone resorption sufficiently to counteract its local anti-resorptive effect, thus leading to a net effect of impaired bone formation and bone loss. Accordingly, neutralizing this second mode of action through co-treatment with the beta-blocker propranolol, while leaving the peripheral effect intact, prevents Flx-induced bone loss in mice. Hence, this study identifies a dual mode of action of SSRIs on bone remodeling and suggests a therapeutic strategy to block the deleterious effect on bone homeostasis from their chronic use.	[Ortuno, Maria Jose; Paone, Riccardo] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY USA; [Robinson, Samuel T.; Guo, X. Edward] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Subramanyam, Prakash; Colecraft, Henry M.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Paone, Riccardo] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Huang, Yung-yu; Mann, J. John] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Ducy, Patricia] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; University of L'Aquila; Columbia University; Columbia University	Ducy, P (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.	pd2193@cumc.columbia.edu		Robinson, Samuel/0000-0003-2356-9905; Ortuno Romero, Maria Jose/0000-0002-0200-9952; Paone, Riccardo/0000-0002-8688-9191	US National Institutes of Health [AG032959]; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Luo for help with histomorphometry, T. Hanna for handling the mouse colony, and G. Karsenty and S. Kousteni for critically reading the manuscript. The US National Institutes of Health grant AG032959 (P.D.) supported this work.	Aydin H, 2011, J PSYCHIATR RES, V45, P1316, DOI 10.1016/j.jpsychires.2011.04.005; Baharav E, 2012, NEUROIMMUNOMODULAT, V19, P309, DOI 10.1159/000339109; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Blardi P, 2005, NEUROPSYCHOBIOLOGY, V51, P72, DOI 10.1159/000084163; Bliziotes M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P291; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Bonnet N, 2007, TOXICOL APPL PHARM, V221, P111, DOI 10.1016/j.taap.2007.02.005; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Branco-de-Almeida LS, 2012, J PERIODONTOL, V83, P664, DOI 10.1902/jop.2011.110370; Bristow LJ, 2000, NEUROPHARMACOLOGY, V39, P1222, DOI 10.1016/S0028-3908(99)00191-4; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Deak F, 2000, NEUROPHARMACOLOGY, V39, P1029, DOI 10.1016/S0028-3908(99)00206-3; Diem SJ, 2014, J CLIN ENDOCR METAB, V99, pE1732, DOI 10.1210/jc.2014-2288; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fox MA, 2007, PSYCHOPHARMACOLOGY, V195, P147, DOI 10.1007/s00213-007-0910-0; Fukunaga T, 2014, J BIOL CHEM, V289, P13554, DOI 10.1074/jbc.M114.550731; FULLER RW, 1990, ANN N Y ACAD SCI, V600, P68; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gebara MA, 2014, J AM GERIATR SOC, V62, P1434, DOI 10.1111/jgs.12945; Gobin V, 2015, CELL CALCIUM, V58, P254, DOI 10.1016/j.ceca.2015.06.003; Hahn SJ, 1999, EUR J PHARMACOL, V367, P113, DOI 10.1016/S0014-2999(98)00955-8; Haney EM, 2010, BONE, V46, P13, DOI 10.1016/j.bone.2009.07.083; HIDAKA H, 1981, MOL PHARMACOL, V20, P571; Hochberg MC, 2012, J RHEUMATOL, V39, P352, DOI 10.3899/jrheum.110307; Hodge JM, 2013, BIOL PSYCHIAT, V74, P32, DOI 10.1016/j.biopsych.2012.11.003; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kecskemeti V, 2005, BRAIN RES BULL, V67, P126, DOI 10.1016/j.brainresbull.2005.06.027; KENNETT GA, 1994, NEUROPHARMACOLOGY, V33, P1581, DOI 10.1016/0028-3908(94)90133-3; Kim HJ, 2013, BRAIN RES, V1490, P23, DOI 10.1016/j.brainres.2012.10.062; Kubera M, 2000, NEUROPSYCHOPHARMACOL, V23, P89, DOI 10.1016/S0893-133X(99)00150-5; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Misra M, 2010, CNS SPECTRUMS, V15, P579, DOI 10.1017/S1092852900000559; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323; Orleans RJ, 2014, NEW ENGL J MED, V370, P1777, DOI 10.1056/NEJMp1402080; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Pellegrino TC, 1998, PHARMACOL BIOCHEM BE, V59, P151, DOI 10.1016/S0091-3057(97)00382-1; Rizzoli R, 2012, BONE, V51, P606, DOI 10.1016/j.bone.2012.05.018; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI 10.1359/jbmr.090533; Seifert CF, 2013, CLIN THER, V35, P1412, DOI 10.1016/j.clinthera.2013.07.423; Shenoy AR, 2013, J NEUROIMMUNOL, V262, P46, DOI 10.1016/j.jneuroim.2013.06.006; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Wu Q, 2009, OSTEOPOROSIS INT, V20, P1309, DOI 10.1007/s00198-009-0918-x; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yamauchi M, 2004, PHARMACOL BIOCHEM BE, V78, P683, DOI 10.1016/j.pbb.2004.05.003; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	59	57	59	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1170	1179		10.1038/nm.4166	http://dx.doi.org/10.1038/nm.4166			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27595322	Green Accepted			2022-12-27	WOS:000384872500020
J	Yun, S; Reynolds, RP; Petrof, I; White, A; Rivera, PD; Segev, A; Gibson, AD; Suarez, M; DeSalle, MJ; Ito, N; Mukherjee, S; Richardson, DR; Kang, CE; Ahrens-Nicklas, RC; Soler, I; Chetkovich, DM; Kourrich, S; Coulter, DA; Eisch, AJ				Yun, Sanghee; Reynolds, Ryan P.; Petrof, Iraklis; White, Alicia; Rivera, Phillip D.; Segev, Amir; Gibson, Adam D.; Suarez, Maiko; DeSalle, Matthew J.; Ito, Naoki; Mukherjee, Shibani; Richardson, Devon R.; Kang, Catherine E.; Ahrens-Nicklas, Rebecca C.; Soler, Ivan; Chetkovich, Dane M.; Kourrich, Said; Coulter, Douglas A.; Eisch, Amelia J.			Stimulation of entorhinal cortex-dentate gyrus circuitry is antidepressive	NATURE MEDICINE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; DEPRESSION-LIKE BEHAVIORS; DEEP-BRAIN-STIMULATION; CELL-PROLIFERATION; NEURONAL-ACTIVITY; ANIMAL-MODEL; STEM-CELLS; IN-VIVO; ANXIETY; MEMORY	Major depressive disorder (MDD) is considered a 'circuitopathy', and brain stimulation therapies hold promise for ameliorating MDD symptoms, including hippocampal dysfunction. It is unknown whether stimulation of upstream hippocampal circuitry, such as the entorhinal cortex (Ent), is antidepressive, although Ent stimulation improves learning and memory in mice and humans. Here we show that molecular targeting (Ent-specific knockdown of a psychosocial stress-induced protein) and chemogenetic stimulation of Ent neurons induce antidepressive-like effects in mice. Mechanistically, we show that Ent-stimulation-induced antidepressive-like behavior relies on the generation of new hippocampal neurons. Thus, controlled stimulation of Ent hippocampal afferents is antidepressive via increased hippocampal neurogenesis. These findings emphasize the power and potential of Ent glutamatergic afferent stimulation-previously well-known for its ability to influence learning and memory-for MDD treatment.	[Yun, Sanghee; Soler, Ivan; Coulter, Douglas A.; Eisch, Amelia J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yun, Sanghee; Reynolds, Ryan P.; Petrof, Iraklis; White, Alicia; Gibson, Adam D.; Suarez, Maiko; DeSalle, Matthew J.; Ahrens-Nicklas, Rebecca C.; Soler, Ivan; Coulter, Douglas A.; Eisch, Amelia J.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Rivera, Phillip D.; Segev, Amir; Ito, Naoki; Mukherjee, Shibani; Richardson, Devon R.; Kourrich, Said; Eisch, Amelia J.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kang, Catherine E.; Chetkovich, Dane M.] Northwestern Univ, Dept Neurol & Clin Neurol Sci, Chicago, IL 60611 USA; [Rivera, Phillip D.] Massachusetts Gen Hosp Children, Dept Pediat, Charlestown, MA USA; [Ito, Naoki] Kitasato Univ, Oriental Med Res Ctr, Tokyo, Japan; [Chetkovich, Dane M.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; Kitasato University; Vanderbilt University	Eisch, AJ (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Eisch, AJ (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.; Eisch, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	eischa@email.chop.edu	Core, Vector/CAF-4832-2022; Yun, Sanghee/AAL-7543-2020; Chetkovich, Dane/AAV-5457-2021	Yun, Sanghee/0000-0001-7505-0836; Coulter, Douglas/0000-0002-1486-119X; Rivera, Phillip/0000-0002-7620-6094; Soler, Ivan/0000-0002-3639-9282; Reynolds, Ryan/0000-0002-3781-0766	National Institutes of Health [DA023701, DA023555, MH107945, NS059934, MH104471]; National Aeronautics and Space Administration [NNX07AP84G, NNX12AB55G, NNX15AE09G]; National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; National Institute of Mental Health Basic Science Institutional NRSA Training Grant (Training Program in the Neurobiology of Mental Illness) [T32-MH076690]; National Institute on Drug Abuse NRSA Institutional Training Grant (Basic Science Training Program in the Drug Abuse Research) [T32-DA007290]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH076690, R01MH106511, R21MH104471, R21MH107945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023701, K02DA023555, T32DA007290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; National Institute of Mental Health Basic Science Institutional NRSA Training Grant (Training Program in the Neurobiology of Mental Illness); National Institute on Drug Abuse NRSA Institutional Training Grant (Basic Science Training Program in the Drug Abuse Research); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. G. Birnbaum, I. M. Bowen, L. Peca, S. Stojadinovic, and Z. Zhang for assistance in experimental techniques. We thank E. D. Marsh and A. J. McCoy for guidance on use of computer code. We thank C. A. Tamminga and J. M. Zigman for sharing animals and tissues that were useful for pilot experiments. We thank G. A. Barr, I. M. Bowen, and S. E. Latchney for helpful discussions and feedback. This work was supported by grants from the National Institutes of Health to A. J. E. (DA023701, DA023555, MH107945) and D.M.C. (NS059934, MH104471), the National Aeronautics and Space Administration to A.J.E. (NNX07AP84G, NNX12AB55G, NNX15AE09G) and an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation to A.J.E. S.Y. was funded by a National Institute of Mental Health Basic Science Institutional NRSA Training Grant (Training Program in the Neurobiology of Mental Illness, T32-MH076690, principal investigator: C. A. Tamminga). P.D.R. was funded by National Institute on Drug Abuse NRSA Institutional Training Grant (Basic Science Training Program in the Drug Abuse Research, T32-DA007290, principal investigator: A. J. Eisch).	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Corbett BF, 2013, J NEUROSCI, V33, P7020, DOI 10.1523/JNEUROSCI.2325-12.2013; Crupi R, 2011, CURR MED CHEM, V18, P4284, DOI 10.2174/092986711797200417; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Dengler CG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42090; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gerritsen L, 2011, BIOL PSYCHIAT, V70, P373, DOI 10.1016/j.biopsych.2011.01.029; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Jacobs J, 2016, NEURON, V92, P983, DOI 10.1016/j.neuron.2016.10.062; Johnson J, 2012, MOL BIOL CELL, V23, P754, DOI 10.1091/mbc.E11-09-0824; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kourrich S., 2008, NEURAL PLAST, V2008; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kronmuller KT, 2008, BRIT J PSYCHIAT, V192, P472, DOI 10.1192/bjp.bp.107.040378; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Latchney SE, 2015, FASEB J, V29, P5059, DOI 10.1096/fj.15-275651; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Mulder GB, 2004, CONTEMP TOP LAB ANIM, V43, P39; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nakasato A, 2008, BRAIN RES, V1193, P128, DOI 10.1016/j.brainres.2007.11.043; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Stone EA, 2008, EUR J PHARMACOL, V580, P135, DOI 10.1016/j.ejphar.2007.10.045; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Trivedi MH, 2013, BIOL PSYCHIAT, V74, P2, DOI 10.1016/j.biopsych.2013.05.009; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Vismer MS, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00027; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; WHITE WF, 1977, NATURE, V270, P356, DOI 10.1038/270356a0; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yun S, 2016, NAT MED, V22, P1239, DOI 10.1038/nm.4218; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	69	49	53	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					658	+		10.1038/s41591-018-0002-1	http://dx.doi.org/10.1038/s41591-018-0002-1			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29662202	Green Accepted			2022-12-27	WOS:000432126800023
J	Zhang, B; Nguyen, LXT; Li, L; Zhao, DD; Kumar, B; Wu, H; Lin, A; Pellicano, F; Hopcroft, L; Su, YL; Copland, M; Holyoake, TL; Kuo, CJ; Bhatia, R; Snyder, DS; Ali, H; Stein, AS; Brewer, C; Wang, HF; McDonald, T; Swiderski, P; Troadec, E; Chen, CC; Dorrance, A; Pullarkat, V; Yuan, YC; Perrotti, D; Carlesso, N; Forman, SJ; Kortylewski, M; Kuo, YH; Marcucci, G				Zhang, Bin; Le Xuan Truong Nguyen; Li, Ling; Zhao, Dandan; Kumar, Bijender; Wu, Herman; Lin, Allen; Pellicano, Francesca; Hopcroft, Lisa; Su, Yu-Lin; Copland, Mhairi; Holyoake, Tessa L.; Kuo, Calvin J.; Bhatia, Ravi; Snyder, David S.; Ali, Haris; Stein, Anthony S.; Brewer, Casey; Wang, Huafeng; McDonald, Tinisha; Swiderski, Piotr; Troadec, Estelle; Chen, Ching-Cheng; Dorrance, Adrienne; Pullarkat, Vinod; Yuan, Yate-Ching; Perrotti, Danilo; Carlesso, Nadia; Forman, Stephen J.; Kortylewski, Marcin; Kuo, Ya-Huei; Marcucci, Guido			Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM; MYELOID-LEUKEMIA; ENDOTHELIAL-CELLS; IN-VIVO; EXPRESSION; NANOPARTICLES; ATTENUATION; PROGENITOR; SURVIVAL; PROTEIN	Leukemia stem cells (LSCs) in individuals with chronic myelogenous leukemia (CML) (hereafter referred to as CML LSCs) are responsible for initiating and maintaining clonal hematopoiesis. These cells persist in the bone marrow (BM) despite effective inhibition of BCR-ABL kinase activity by tyrosine kinase inhibitors (TKIs). Here we show that although the microRNA (miRNA) miR-126 supported the quiescence, self-renewal and engraftment capacity of CML LSCs, miR-126 levels were lower in CML LSCs than in long-term hematopoietic stem cells (LT-HSCs) from healthy individuals. Downregulation of miR-126 levels in CML LSCs was due to phosphorylation of Sprouty-related EVH1-domain-containing 1 (SPRED1) by BCR-ABL, which led to inhibition of the RAN-exportin-5-RCC1 complex that mediates miRNA maturation. Endothelial cells (ECs) in the BM supply miR-126 to CML LSCs to support quiescence and leukemia growth, as shown using mouse models of CML in which Mir126a (encoding miR-126) was conditionally knocked out in ECs and/or LSCs. Inhibition of BCR-ABL by TKI treatment caused an undesired increase in endogenous miR-126 levels, which enhanced LSC quiescence and persistence. Mir126a knockout in LSCs and/or ECs, or treatment with a miR-126 inhibitor that targets miR-126 expression in both LSCs and ECs, enhanced the in vivo anti-leukemic effects of TKI treatment and strongly diminished LSC leukemia-initiating capacity, providing a new strategy for the elimination of LSCs in individuals with CML.	[Zhang, Bin; Le Xuan Truong Nguyen; Li, Ling; Zhao, Dandan; Kumar, Bijender; Wu, Herman; Lin, Allen; Snyder, David S.; Ali, Haris; Stein, Anthony S.; Brewer, Casey; Wang, Huafeng; McDonald, Tinisha; Swiderski, Piotr; Troadec, Estelle; Chen, Ching-Cheng; Pullarkat, Vinod; Yuan, Yate-Ching; Carlesso, Nadia; Forman, Stephen J.; Kuo, Ya-Huei; Marcucci, Guido] City Hope Med Ctr, Hematol Malignancies & Stem Cell Transplantat Ins, Gehr Family Ctr Leukemia Res, Duarte, CA 91010 USA; [Le Xuan Truong Nguyen] Biotechnol Ctr Ho Chi Minh City, Dept Med Biotechnol, Ho Chi Minh City, Vietnam; [Pellicano, Francesca; Hopcroft, Lisa; Copland, Mhairi; Holyoake, Tessa L.] Univ Glasgow, Coll Med Vet & Life Sci, Paul O Gorman Leukemia Res Ctr, Inst Canc Sci, Glasgow, Lanark, Scotland; [Su, Yu-Lin; Kortylewski, Marcin] City Hope Med Ctr, Dept Immunooncol, Duarte, CA USA; [Kuo, Calvin J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Bhatia, Ravi] Univ Alabama Birmingham, Birmingham, AL USA; [Wang, Huafeng] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Hematol, Hangzhou, Zhejiang, Peoples R China; [Dorrance, Adrienne] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Perrotti, Danilo] Univ Maryland, Sch Med Baltimore, Dept Med Biochem & Mol Biol, Baltimore, MD 21201 USA; [Perrotti, Danilo] Univ Maryland, Sch Med Baltimore, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Perrotti, Danilo] Imperial Coll London, Hammersmith Hosp, Dept Hematol, London, England	City of Hope; University of Glasgow; City of Hope; Stanford University; University of Alabama System; University of Alabama Birmingham; Zhejiang University; University System of Ohio; Ohio State University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Imperial College London	Zhang, B; Marcucci, G (corresponding author), City Hope Med Ctr, Hematol Malignancies & Stem Cell Transplantat Ins, Gehr Family Ctr Leukemia Res, Duarte, CA 91010 USA.	bzhang@coh.org; gmarcucci@coh.org	Kortylewski, Marcin/H-8052-2019	Kortylewski, Marcin/0000-0002-6003-1816; Kuo, Calvin/0000-0002-7427-5985; Hopcroft, Lisa/0000-0002-7022-1322	National Cancer Institute (NCI) of the US National Institutes of Health (NIH) [P30CA33572]; NCI [CA205247, CA102031, CA201184, CA213131, CA180861, CA158350, CA163800, CA184411]; Gehr Family Foundation; George Hoag Family Foundation; Cancer Research UK program [C11074/A11008]; Howat Foundation; NATIONAL CANCER INSTITUTE [R01CA102031, R00CA184411, U10CA180861, R01CA205247, R01CA172447, P30CA016058, R01CA213131, K99CA184411, P30CA033572, R01CA158350, R01CA163800, R01CA201184] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gehr Family Foundation; George Hoag Family Foundation; Cancer Research UK program(Cancer Research UK); Howat Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the support of the Animal Resources Center, Analytical Cytometry, Pathology (Liquid Tumor), Bioinformatics, Electron Microscopy, Light Microscopy, Integrative Genomics and DNA/RNA Cores at City of Hope (COH) Comprehensive Cancer Center, which is supported by the National Cancer Institute (NCI) of the US National Institutes of Health (NIH) under award number P30CA33572. We thank C.J. Kuo (Stanford University) for the Mir126a<SUP>flox/flox</SUP> mice and are grateful to the COH Comprehensive Cancer Center, the Glasgow Experimental Cancer Medicine Centre and the SPIRIT trials, together with the patients and their physicians, for providing primary patient material for this study. This work was supported in part by NCI grants CA205247 (Y.-H.K.), CA102031 (G.M.), CA201184 (G.M.), CA213131 (M.K.), CA180861 (G.M.), CA158350 (G.M.), CA163800 (P.D.), and CA184411 (L.L.), the Gehr Family Foundation (G.M.), the George Hoag Family Foundation (G.M.), Cancer Research UK program grant C11074/A11008 (T.L.H.) and The Howat Foundation (T.L.H.).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BHATIA R, 1995, BLOOD, V85, P3636, DOI 10.1182/blood.V85.12.3636.bloodjournal85123636; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Branford S, 1999, BRIT J HAEMATOL, V107, P587; Chitteti BR, 2014, BLOOD, V124, P519, DOI 10.1182/blood-2014-03-565721; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; de Leeuw DC, 2014, CANCER RES, V74, P2094, DOI 10.1158/0008-5472.CAN-13-1733; Dorrance AM, 2015, LEUKEMIA, V29, P2143, DOI 10.1038/leu.2015.139; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Galante JM, 2009, J SURG RES, V152, P18, DOI 10.1016/j.jss.2008.05.017; Holyoake TL, 2017, BLOOD, V129, P1595, DOI 10.1182/blood-2016-09-696013; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Huang XM, 2013, CLIN CANCER RES, V19, P2355, DOI 10.1158/1078-0432.CCR-12-3191; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lechman ER, 2016, CANCER CELL, V29, P602, DOI 10.1016/j.ccell.2016.03.015; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Li ZJ, 2015, BLOOD, V126, P2005, DOI 10.1182/blood-2015-04-639062; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Nechaev S, 2013, J CONTROL RELEASE, V170, P307, DOI 10.1016/j.jconrel.2013.06.007; Nucera S, 2016, CANCER CELL, V29, P905, DOI 10.1016/j.ccell.2016.05.007; Quintanar-Audelo M, 2011, J BIOL CHEM, V286, P23102, DOI 10.1074/jbc.M110.212662; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Welten SMJ, 2016, CARDIOVASC RES, V110, P6, DOI 10.1093/cvr/cvw039; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yeh YC, 2002, ATHEROSCLEROSIS, V161, P95, DOI 10.1016/S0021-9150(01)00642-6; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhang QF, 2016, BLOOD, V127, P1687, DOI 10.1182/blood-2015-08-665604	41	81	83	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					450	+		10.1038/nm.4499	http://dx.doi.org/10.1038/nm.4499			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29505034	Green Accepted			2022-12-27	WOS:000429639800016
J	Sallam, T; Jones, M; Thomas, BJ; Wu, XH; Gilliland, T; Qian, K; Eskin, A; Casero, D; Zhang, ZY; Sandhu, J; Salisbury, D; Rajbhandari, P; Civelek, M; Hong, C; Ito, A; Liu, X; Daniel, B; Lusis, AJ; Whitelegge, J; Nagy, L; Castrillo, A; Smale, S; Tontonoz, P				Sallam, Tamer; Jones, Marius; Thomas, Brandon J.; Wu, Xiaohui; Gilliland, Thomas; Qian, Kevin; Eskin, Ascia; Casero, David; Zhang, Zhengyi; Sandhu, Jaspreet; Salisbury, David; Rajbhandari, Prashant; Civelek, Mete; Hong, Cynthia; Ito, Ayaka; Liu, Xin; Daniel, Bence; Lusis, Aldons J.; Whitelegge, Julian; Nagy, Laszlo; Castrillo, Antonio; Smale, Stephen; Tontonoz, Peter			Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA	NATURE MEDICINE			English	Article							CASSETTE TRANSPORTER 1; GENE-EXPRESSION; BINDING PROTEINS; TANGIER-DISEASE; MICE LACKING; LXR-ALPHA; ATHEROSCLEROSIS; GENOME; METABOLISM; CHROMATIN	Nuclear receptors regulate gene expression in response to environmental cues, but the molecular events governing the cell type specificity of nuclear receptors remain poorly understood. Here we outline a role for a long noncoding RNA (lncRNA) in modulating the cell type-specific actions of liver X receptors (LXRs), sterol-activated nuclear receptors that regulate the expression of genes involved in cholesterol homeostasis and that have been causally linked to the pathogenesis of atherosclerosis. We identify the lncRNA MeXis as an amplifier of LXR-dependent transcription of the gene Abca1, which is critical for regulation of cholesterol efflux. Mice lacking the MeXis gene show reduced Abca1 expression in a tissue-selective manner. Furthermore, loss of MeXis in mouse bone marrow cells alters chromosome architecture at the Abca1 locus, impairs cellular responses to cholesterol overload, and accelerates the development of atherosclerosis. Mechanistic studies reveal that MeXis interacts with and guides promoter binding of the transcriptional coactivator DDX17. The identification of MeXis as a lncRNA modulator of LXR-dependent gene expression expands understanding of the mechanisms underlying cell type-selective actions of nuclear receptors in physiology and disease.	[Sallam, Tamer; Jones, Marius; Gilliland, Thomas; Qian, Kevin; Casero, David; Sandhu, Jaspreet; Salisbury, David; Rajbhandari, Prashant; Hong, Cynthia; Ito, Ayaka; Tontonoz, Peter] Univ Calif Los Angeles, Mol Biol Inst, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Sallam, Tamer; Wu, Xiaohui; Zhang, Zhengyi; Salisbury, David; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA; [Thomas, Brandon J.; Liu, Xin; Smale, Stephen] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Thomas, Brandon J.; Liu, Xin; Smale, Stephen] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA; [Eskin, Ascia; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Civelek, Mete] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Civelek, Mete] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Daniel, Bence; Nagy, Laszlo] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL USA; [Daniel, Bence; Nagy, Laszlo] Res Ctr Mol Med, Dept Biochem & Mol Biol, Orlando, FL USA; [Whitelegge, Julian] Univ Calif Los Angeles, Semel Inst, UCLA Neuropsychiat Inst NPI, Pasarow Mass Spectrometry Lab, Los Angeles, CA USA; [Castrillo, Antonio] Univ Las Palmas Gran Canaria, Univ Autonoma Madrid, CSIC,Unidad Asociada CSIC, Inst Invest Biomed Alberto Sols,Unidad Biomed, Las Palmas Gran Canaria, Spain; [Castrillo, Antonio] ULPGC, IUIBS, Las Palmas Gran Canaria, Spain	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Virginia; University of Virginia; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Los Angeles; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Sallam, T; Tontonoz, P (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA.; Sallam, T (corresponding author), Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA.	tsallam@mednet.ucla.edu; ptontonoz@mednet.ucla.edu	Zhang, Zhengyi/GOP-1139-2022; Nagy, Laszlo/A-3814-2008; Casero, David/E-7365-2010	Zhang, Zhengyi/0000-0001-9094-1223; Nagy, Laszlo/0000-0001-6653-2155; Casero, David/0000-0002-7347-3330; Rajbhandari, Prashant/0000-0002-8146-3861	National Institutes of Health [HL030568, HL066088, HL128822]; Burroughs Wellcome Fund Career Award for Medical Scientists; UCLA Cardiovascular Discovery Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, K08HL128822, P01HL030568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); UCLA Cardiovascular Discovery Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Tontonoz, Smale, Black, and Nagy laboratories and the University of California Los Angeles (UCLA) Atherosclerosis Research Unit for technical assistance and useful discussions. This work was supported by the National Institutes of Health grants HL030568, HL066088, HL128822, the Burroughs Wellcome Fund Career Award for Medical Scientists, and the UCLA Cardiovascular Discovery Fund (Lauren B. Leichtman and Arthur E. Levine Investigator Award).	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Cheng JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12648; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Feig JE, 2013, METHODS MOL BIOL, V1027, P123, DOI 10.1007/978-1-60327-369-5_5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sallam T, 2016, NATURE, V534, P124, DOI 10.1038/nature17674; Sallam T, 2014, J LIPID RES, V55, P1120, DOI 10.1194/jlr.M047548; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wongpalee SP, 2016, ELIFE, V5, DOI 10.7554/eLife.19743; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang L, 2017, ELIFE, V6, DOI 10.7554/eLife.28766.001; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	50	131	136	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					304	+		10.1038/nm.4479	http://dx.doi.org/10.1038/nm.4479			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29431742	Green Submitted, Green Accepted			2022-12-27	WOS:000426700900013
J	Ji, YX; Huang, Z; Yang, X; Wang, XZ; Zhao, LP; Wang, PX; Zhang, XJ; Alves-Bezerra, M; Cai, L; Zhang, P; Lu, YX; Bai, L; Gao, MM; Zhao, H; Tian, S; Wang, Y; Huang, ZX; Zhu, XY; Zhang, Y; Gong, J; She, ZG; Li, F; Cohen, DE; Li, HL				Ji, Yan-Xiao; Huang, Zan; Yang, Xia; Wang, Xiaozhan; Zhao, Ling-Ping; Wang, Pi-Xiao; Zhang, Xiao-Jing; Alves-Bezerra, Michele; Cai, Lin; Zhang, Peng; Lu, Yue-Xin; Bai, Lan; Gao, Mao-Mao; Zhao, Huan; Tian, Song; Wang, Yong; Huang, Zhi-Xiang; Zhu, Xue-Yong; Zhang, Yan; Gong, Jun; She, Zhi-Gang; Li, Feng; Cohen, David E.; Li, Hongliang			The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis	NATURE MEDICINE			English	Article							FATTY LIVER-DISEASE; TUMOR-SUPPRESSOR CYLD; NEGATIVE REGULATOR; INSULIN-RESISTANCE; TAK1; INFLAMMATION; APOPTOSIS; FIBROSIS; ACTS; MICE	Nonalcoholic steatohepatitis (NASH) is a common clinical condition that can lead to advanced liver diseases. Lack of effective pharmacotherapies for NASH is largely attributable to an incomplete understanding of its pathogenesis. The deubiquitinase cylindromatosis (CYLD) plays key roles in inflammation and cancer. Here we identified CYLD as a suppressor of NASH in mice and in monkeys. CYLD is progressively degraded upon interaction with the E3 ligase TRIM47 in proportion to NASH severity. We observed that overexpression of Cyld in hepatocytes concomitantly inhibits lipid accumulation, insulin resistance, inflammation and fibrosis in mice with NASH induced in an experimental setting. Mechanistically, CYLD interacts directly with the kinase TAK1 and removes its K63-linked polyubiquitin chain, which blocks downstream activation of the JNK-p38 cascades. Notably, reconstitution of hepatic CYLD expression effectively reverses disease progression in mice with dietary or genetically induced NASH and in high-fat diet-fed monkeys predisposed to metabolic syndrome. Collectively, our findings demonstrate that CYLD mitigates NASH severity and identify the CYLD-TAK1 axis as a promising therapeutic target for management of the disease.	[Ji, Yan-Xiao; Cai, Lin; Zhang, Peng; Li, Hongliang] Wuhan Univ, Zhongnan Hosp, Med Sci Res Ctr, Wuhan, Hubei, Peoples R China; [Ji, Yan-Xiao; Yang, Xia; Wang, Xiaozhan; Zhao, Ling-Ping; Wang, Pi-Xiao; Zhang, Xiao-Jing; Cai, Lin; Zhang, Peng; Lu, Yue-Xin; Bai, Lan; Gao, Mao-Mao; Tian, Song; Wang, Yong; Huang, Zhi-Xiang; Zhu, Xue-Yong; Zhang, Yan; Gong, Jun; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Inst Model Anim, Wuhan, Hubei, Peoples R China; [Ji, Yan-Xiao; Yang, Xia; Wang, Xiaozhan; Zhao, Ling-Ping; Wang, Pi-Xiao; Cai, Lin; Zhang, Peng; Lu, Yue-Xin; Gao, Mao-Mao; Tian, Song; Zhu, Xue-Yong; Zhang, Yan; Gong, Jun; She, Zhi-Gang; Li, Feng; Li, Hongliang] Wuhan Univ, Basic Med Sch, Wuhan, Hubei, Peoples R China; [Ji, Yan-Xiao; Yang, Xia; Wang, Xiaozhan; Zhao, Ling-Ping; Wang, Pi-Xiao; Zhang, Peng; Lu, Yue-Xin; Gao, Mao-Mao; Tian, Song; Zhu, Xue-Yong; Zhang, Yan; Gong, Jun; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Hubei, Peoples R China; [Huang, Zan; Zhao, Huan; Gong, Jun] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Wang, Xiaozhan; Wang, Pi-Xiao; Zhang, Xiao-Jing; Bai, Lan; She, Zhi-Gang; Li, Hongliang] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Alves-Bezerra, Michele; Cohen, David E.] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, New York, NY 10065 USA	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University; Cornell University	Li, HL (corresponding author), Wuhan Univ, Zhongnan Hosp, Med Sci Res Ctr, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Inst Model Anim, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Basic Med Sch, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan, Hubei, Peoples R China.; Li, HL (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China.; Cohen, DE (corresponding author), Weill Cornell Med Coll, Div Gastroenterol & Hepatol, New York, NY 10065 USA.	dcohen@med.cornell.edu; lihl@whu.edu.cn	Alves-Bezerra, Michele/AAJ-8017-2021; Alves-Bezerra, Michele/B-4662-2014	Alves-Bezerra, Michele/0000-0003-4430-6434; Alves-Bezerra, Michele/0000-0003-4430-6434; Yang, Xia/0000-0001-9701-7594; Huang, Zan/0000-0001-5623-6950	National Science Fund for Distinguished Young Scholars [81425005]; National Natural Science Foundation [81330005, 81630011, 91639304]; National Science and Technology Support Project [2014BAI02B01, 2015BAI08B01]; National Key Research and Development Program [2013YQ030923-05, 2016YFF0101500]; National Natural Science Foundation of China [81770053, 91729303]; National Institutes of Health [DK048873, DK056626, DK103046]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056626, R37DK048873] Funding Source: NIH RePORTER	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Project; National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H.-B. Shu (Medical Research Institute, Wuhan University) for providing ubiquitin and several of its derivative plasmids. We thank Y. Rao, M. Guo and R. Zhang (Institute of Model Animal of Wuhan University) for their assistance in monkey experiments. This work was supported by grants from the National Science Fund for Distinguished Young Scholars (no. 81425005; H.L.), the Key Project of the National Natural Science Foundation (no. 81330005 and 81630011; H.L.), the National Science and Technology Support Project (no. 2014BAI02B01 and 2015BAI08B01; H.L.), the National Key Research and Development Program (no. 2013YQ030923-05 (H.L.) and no. 2016YFF0101500 (Z.-G.S.)), the National Natural Science Foundation of China (no. 81770053 (Z.-G.S.) and no. 91729303 (L.C.)), the Key Collaborative Project of the National Natural Science Foundation (no. 91639304; H.L.) and the National Institutes of Health (no. DK048873, DK056626 and DK103046; D.E.C.).	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; An SM, 2017, HEPATOLOGY, V66, P1866, DOI 10.1002/hep.29375; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Caldwell S, 2017, CLIN MOL HEPATOL, V23, P103, DOI 10.3350/cmh.2017.0103; Chalasani N, 2017, HEPATOLOGY; Dai L, 2012, IUBMB LIFE, V64, P825, DOI 10.1002/iub.1078; Gao L, 2016, J HEPATOL, V65, P125, DOI 10.1016/j.jhep.2016.03.006; Haas JT, 2016, ANNU REV PHYSIOL, V78, P181, DOI 10.1146/annurev-physiol-021115-105331; Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Hellerbrand C, 2016, MED RES REV, V36, P342, DOI 10.1002/med.21381; Hu JF, 2016, J HEPATOL, V64, P146, DOI 10.1016/j.jhep.2015.08.021; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Ji YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11267; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee BC, 2016, P NATL ACAD SCI USA, V113, pE165, DOI 10.1073/pnas.1518615113; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Mathis BJ, 2015, CURR DRUG TARGETS, V16, P284, DOI 10.2174/1389450115666141024152421; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Oseini AM, 2017, LIVER INT, V37, P97, DOI 10.1111/liv.13302; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Reissig S, 2015, IMMUNOL CELL BIOL, V93, P558, DOI 10.1038/icb.2014.122; Reissig S, 2012, J IMMUNOL, V189, P4770, DOI 10.4049/jimmunol.1201993; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Roh YS, 2014, J GASTROENTEROL, V49, P185, DOI 10.1007/s00535-013-0931-x; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Sanches SCL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/574832; Seki E, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.968507; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Suzuki A, 2017, ANNU REV MED, V68, P85, DOI 10.1146/annurev-med-051215-031109; Tey SK, 2017, CANCER LETT, V411, P150, DOI 10.1016/j.canlet.2017.09.047; Trompouki E, 2009, NEOPLASIA, V11, P469, DOI 10.1593/neo.81424; Tsagaratou A, 2010, J IMMUNOL, V185, P2032, DOI 10.4049/jimmunol.0903919; Urbanik T, 2012, J HEPATOL, V57, P995, DOI 10.1016/j.jhep.2012.06.017; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Wang PX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10592; Wu XM, 2014, ONCOTARGET, V5, P4211, DOI 10.18632/oncotarget.1971; Xiang M, 2016, J HEPATOL, V64, P1365, DOI 10.1016/j.jhep.2016.02.002; Yan FJ, 2017, HEPATOLOGY, V65, P1492, DOI 10.1002/hep.28971; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yu B, 2017, ARTERIOSCL THROM VAS, V37, P1698, DOI 10.1161/ATVBAHA.117.309859; Zhang XF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.411; Zhao GN, 2017, NAT MED, V23, P742, DOI 10.1038/nm.4334; Zhao N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-35; Zhao XH, 2017, BIOCHEM BIOPH RES CO, V492, P255, DOI 10.1016/j.bbrc.2017.08.061; Zhao YG, 2015, J BIOL CHEM, V290, P22076, DOI 10.1074/jbc.M115.658096	58	80	82	5	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2018	24	2					213	+		10.1038/nm.4461	http://dx.doi.org/10.1038/nm.4461			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FV1MQ	29291351				2022-12-27	WOS:000424327200018
J	Brunner, AM; Graubert, TA				Brunner, Andrew M.; Graubert, Timothy A.			Genomics in childhood acute myeloid leukemia comes of age	NATURE MEDICINE			English	News Item							MUTATIONS; GENES; IDH2; AML	A Children's Oncology Group study of nearly 1,000 pediatric acute myeloid leukemia (AML) cases reveals marked differences between the genomic landscapes of pediatric and adult AML and offers directions for future work.	[Brunner, Andrew M.; Graubert, Timothy A.] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Graubert, TA (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA.	tgraubert@mgh.harvard.edu						Bolouri H, 2018, NAT MED, V24, P103, DOI 10.1038/nm.4439; Bonaventure A, 2017, LANCET HAEMATOL, V4, pE202, DOI 10.1016/S2352-3026(17)30052-2; Brown P, 2007, BLOOD, V110, P979, DOI 10.1182/blood-2007-02-076604; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Ho PA, 2011, PEDIATR BLOOD CANCER, V57, P204, DOI 10.1002/pbc.23179; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Schlenk RF, 2014, BLOOD, V124, P3441, DOI 10.1182/blood-2014-05-578070; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	12	7	7	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					7	9		10.1038/nm.4469	http://dx.doi.org/10.1038/nm.4469			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29315296				2022-12-27	WOS:000422965900005
J	Khetarpal, SA; Zeng, XM; Millar, JS; Vitali, C; Somasundara, AVH; Zanoni, P; Landro, JA; Barucci, N; Zavadoski, WJ; Sun, ZY; de Haard, H; Toth, IV; Peloso, GM; Natarajan, P; Cuchel, M; Lund-Katz, S; Phillips, MC; Tall, AR; Kathiresan, S; DaSilva-Jardine, P; Yates, NA; Rader, DJ				Khetarpal, Sumeet A.; Zeng, Xuemei; Millar, John S.; Vitali, Cecilia; Somasundara, Amritha Varshini Hanasoge; Zanoni, Paolo; Landro, James A.; Barucci, Nicole; Zavadoski, William J.; Sun, Zhiyuan; de Haard, Hans; Toth, Ildiko V.; Peloso, Gina M.; Natarajan, Pradeep; Cuchel, Marina; Lund-Katz, Sissel; Phillips, Michael C.; Tall, Alan R.; Kathiresan, Sekar; DaSilva-Jardine, Paul; Yates, Nathan A.; Rader, Daniel J.			A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels	NATURE MEDICINE			English	Article							APOLIPOPROTEIN-C-III; LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; OF-FUNCTION MUTATIONS; FAMILIAL HYPERCHOLESTEROLEMIA; TRANSGENIC MICE; CARDIOVASCULAR EVENTS; PLASMA-CHOLESTEROL; MOUSE MODELS; RISK	Recent large-scale genetic sequencing efforts have identified rare coding variants in genes in the triglyceride-rich lipoprotein (TRL) clearance pathway that are protective against coronary heart disease (CHD), independently of LDL cholesterol (LDL-C) levels(1). Insight into the mechanisms of protection of these variants may facilitate the development of new therapies for lowering TRL levels. The gene APOC3 encodes apoC-III, a critical inhibitor of triglyceride (TG) lipolysis and remnant TRL clearance(2). Here we report a detailed interrogation of the mechanism of TRL lowering by the APOC3 Ala43Thr (A43T) variant, the only missense (rather than protein-truncating) variant in APOC3 reported to be TG lowering and protective against CHD3-5. We found that both human APOC3 A43T heterozygotes and mice expressing human APOC3 A43T display markedly reduced circulating apoC-III levels. In mice, this reduction is due to impaired binding of A43T apoC-III to lipoproteins and accelerated renal catabolism of free apoC-III. Moreover, the reduced content of apoC-III in TRLs resulted in accelerated clearance of circulating TRLs. On the basis of this protective mechanism, we developed a monoclonal antibody targeting lipoprotein-bound human apoC-III that promotes circulating apoC-III clearance in mice expressing human APOC3 and enhances TRL catabolism in vivo. These data reveal the molecular mechanism by which a missense variant in APOC3 causes reduced circulating TG levels and, hence, protects from CHD. This protective mechanism has the potential to be exploited as a new therapeutic approach to reduce apoC-III levels and circulating TRL burden.	[Khetarpal, Sumeet A.; Somasundara, Amritha Varshini Hanasoge; Zanoni, Paolo; Lund-Katz, Sissel; Phillips, Michael C.; Rader, Daniel J.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Khetarpal, Sumeet A.; Millar, John S.; Vitali, Cecilia; Somasundara, Amritha Varshini Hanasoge; Zanoni, Paolo; Cuchel, Marina; Lund-Katz, Sissel; Phillips, Michael C.; Rader, Daniel J.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zeng, Xuemei; Sun, Zhiyuan; Yates, Nathan A.] Univ Pittsburgh, Sch Hlth Sci, Biomed Mass Spectrometry Ctr, Pittsburgh, PA USA; [Landro, James A.; Barucci, Nicole; Zavadoski, William J.; DaSilva-Jardine, Paul] Staten Biotechnol BV, Nijmegen, Netherlands; [de Haard, Hans] Argenx BVBA, Zwjnaarde, Belgium; [Toth, Ildiko V.] Fair Journey Biol, Oporto, Portugal; [Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Natarajan, Pradeep; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Natarajan, Pradeep; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA USA; [Natarajan, Pradeep; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY USA; [Yates, Nathan A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rader, DJ (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.; Rader, DJ (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Tall, Alan/AAT-8528-2021; Natarajan, Pradeep/H-9764-2019	Natarajan, Pradeep/0000-0001-8402-7435; Cuchel, Marina/0000-0001-6808-3824; Hanasoge Somasundara, Amritha Varshini/0000-0001-9411-0873	NIH [R01HL133502, R37HL055323, F30HL124967]; Foundation Leducq CVGeneF(x) Transatlantic Network of Excellence; NIH award [P30CA047904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134853, R37HL055323, F30HL124967, K01HL125751, R01HL055323, R01HL133502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq CVGeneF(x) Transatlantic Network of Excellence; NIH award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank A. Wilson, E. Edouard, J. McParland, M. McCoy, K. Trindade, S. DerOrhannessian, M. Risman, K. Burton, and M. Sun for technical expertise and M. Lazar, M. Bucan, Z. Arany, B. Garcia, N. Hand, D. Marchadier, D. Conlon, and R. Bauer for helpful discussions. This work was supported in part by NIH grants R01HL133502 and R37HL055323 and a grant from the Foundation Leducq CVGeneF(x) Transatlantic Network of Excellence to D. J. R. and by NIH grant F30HL124967 to S.A.K. This project also used the UPCI Cancer Proteomics Facility, which is supported in part by NIH award P30CA047904. Recruitment to the Penn Medicine BioBank was supported by the Penn Cardiovascular Institute, the Perelman School of Medicine of the University of Pennsylvania, and a gift from the Smilow family.	AaltoSetala K, 1996, J LIPID RES, V37, P1802; AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Cain WJ, 2005, J LIPID RES, V46, P2681, DOI 10.1194/jlr.M500249-JLR200; Caron S, 2011, ARTERIOSCL THROM VAS, V31, P513, DOI 10.1161/ATVBAHA.110.220723; Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54; Chan DC, 2002, METABOLISM, V51, P1041, DOI 10.1053/meta.2002.33339; Chen SJ, 2013, HUM GENE THER CL DEV, V24, P154, DOI 10.1089/humc.2013.082; Cohn JS, 2003, J LIPID RES, V44, P1976, DOI 10.1194/jlr.M300209-JLR200; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; DESILVA HV, 1994, J BIOL CHEM, V269, P2324; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; EISENBERG S, 1979, J BIOL CHEM, V254, P2603; Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283; Ginsberg HN, 2008, ARTERIOSCL THROM VAS, V28, P1685, DOI 10.1161/ATVBAHA.108.174185; Ginsberg HN, 2011, J LIPID RES, V52, P1071, DOI 10.1194/jlr.E015958; Ginsberg HN, 2011, ARTERIOSCL THROM VAS, V31, P471, DOI 10.1161/ATVBAHA.110.221846; Gordts PLSM, 2016, J CLIN INVEST, V126, P2855, DOI 10.1172/JCI86610; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Ibrahim S, 2016, CARDIOVASC RES, V110, P23, DOI 10.1093/cvr/cvw010; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kassim SH, 2013, HUM GENE THER, V24, P19, DOI 10.1089/hum.2012.108; Kathiresan S, 2015, J AM COLL CARDIOL, V65, P1562, DOI 10.1016/j.jacc.2015.02.049; Khetarpal SA, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0609-y; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MALMENDIER CL, 1988, ATHEROSCLEROSIS, V69, P51, DOI 10.1016/0021-9150(88)90288-2; MALMENDIER CL, 1989, ATHEROSCLEROSIS, V77, P139, DOI 10.1016/0021-9150(89)90075-0; MasucciMagoulas L, 1997, SCIENCE, V275, P391, DOI 10.1126/science.275.5298.391; Mauger JF, 2006, J LIPID RES, V47, P1212, DOI 10.1194/jlr.M500455-JLR200; McCoy MG, 2002, J LIPID RES, V43, P921; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mucaki EJ, 2013, HUM MUTAT, V34, P557, DOI 10.1002/humu.22277; Musunuru K, 2016, CIRC RES, V118, P579, DOI 10.1161/CIRCRESAHA.115.306398; Nagashima K, 2005, J CLIN INVEST, V115, P1323, DOI 10.1172/JCI200523219; Nguyen MN, 2006, J LIPID RES, V47, P1274, DOI 10.1194/jlr.M600018-JLR200; Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Ooi EMM, 2011, J LIPID RES, V52, P794, DOI 10.1194/jlr.M011163; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qamar A, 2015, ARTERIOSCL THROM VAS, V35, P1880, DOI 10.1161/ATVBAHA.115.305415; RADER DJ, 1991, J LIPID RES, V32, P1849; Shin MJ, 2010, ATHEROSCLEROSIS, V211, P337, DOI 10.1016/j.atherosclerosis.2010.02.025; Somanathan S, 2014, CIRC RES, V115, P591, DOI 10.1161/CIRCRESAHA.115.304008; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; von Ballmoos MCW, 2015, J CLIN LIPIDOL, V9, P498, DOI 10.1016/j.jacl.2015.05.002; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang XH, 2016, J LIPID RES, V57, P706, DOI 10.1194/jlr.M066399	53	68	73	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1086	+		10.1038/nm.4390	http://dx.doi.org/10.1038/nm.4390			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28825717	Green Accepted			2022-12-27	WOS:000409996200016
J	Stadler, CR; Bahr-Mahmud, H; Celik, L; Hebich, B; Roth, AS; Roth, RP; Kariko, K; Tureci, O; Sahin, U				Stadler, Christiane R.; Baehr-Mahmud, Hayat; Celik, Leyla; Hebich, Bernhard; Roth, Alexandra S.; Roth, Rene P.; Kariko, Katalin; Tuereci, Oezlem; Sahin, Ugur			Elimination of large tumors in mice by mRNA-encoded bispecific antibodies	NATURE MEDICINE			English	Article							THERAPY; PSEUDOURIDINE; BLINATUMOMAB; CHEMOTHERAPY; TRANSLATION; CAPACITY	The potential of bispecific T cell-engaging antibodies is hindered by manufacturing challenges and short serum half-life. We circumvented these limitations by treating mice with in vitro-transcribed pharmacologically optimized, nucleoside-modified mRNA encoding the antibody. We achieved sustained endogenous synthesis of the antibody, which eliminated advanced tumors as effectively as the corresponding purified bispecific antibody. Because manufacturing of pharmaceutical mRNA is fast, this approach could accelerate the clinical development of novel bispecific antibodies.	[Stadler, Christiane R.; Baehr-Mahmud, Hayat; Celik, Leyla; Hebich, Bernhard; Roth, Alexandra S.; Roth, Rene P.; Kariko, Katalin; Sahin, Ugur] BioNTech, Mainz, Germany; [Tuereci, Oezlem] Cluster Individualized Immunointervent CI3, Mainz, Germany; [Sahin, Ugur] Johannes Gutenberg Univ Mainz, Dept Internal Med 3, Mainz, Germany; [Sahin, Ugur] Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Mainz, Germany	BioNTech SE; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Sahin, U (corresponding author), BioNTech, Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med 3, Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Mainz, Germany.	sahin@uni-mainz.de	Sahin, Ugur/L-4818-2017	Sahin, Ugur/0000-0003-0363-1564; Roth, Rene/0000-0002-4333-695X				Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; GALLIE DR, 1995, GENE, V165, P233, DOI 10.1016/0378-1119(95)00521-7; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; LANZAVECCHIA A, 1987, EUR J IMMUNOL, V17, P105, DOI 10.1002/eji.1830170118; Micke P, 2014, INT J CANCER, V135, P2206, DOI 10.1002/ijc.28857; Roovers RC, 1998, BRIT J CANCER, V78, P1407, DOI 10.1038/bjc.1998.700; Sahin U., 2013, US patent, Patent No. [8,425,902, 8425902]; Sahin U., 2016, US patent, Patent No. [9,487,584, 9487584]; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Sahin U, 2008, CLIN CANCER RES, V14, P7624, DOI 10.1158/1078-0432.CCR-08-1547; Schuler M, 2016, ANN ONCOL, V27; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Stadler CR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1091555; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; TRAUNECKER A, 1991, EMBO J, V10, P3655, DOI 10.1002/j.1460-2075.1991.tb04932.x; Vallazza B, 2015, WIRES RNA, V6, P471, DOI 10.1002/wrna.1288	22	112	120	9	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2017	23	7					815	+		10.1038/nm.4356	http://dx.doi.org/10.1038/nm.4356			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FA1DS	28604701				2022-12-27	WOS:000405180100009
J	Lam, AD; Deck, G; Goldman, A; Eskandar, EN; Noebels, J; Cole, AJ				Lam, Alice D.; Deck, Gina; Goldman, Alica; Eskandar, Emad N.; Noebels, Jeffrey; Cole, Andrew J.			Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; MILD COGNITIVE IMPAIRMENT; EPILEPTIFORM ACTIVITY; MOUSE MODEL; DEMENTIA; SLEEP; LEVETIRACETAM; RISK	We directly assessed mesial temporal activity using intracranial foramen ovale electrodes in two patients with Alzheimer's disease (AD) without a history or EEG evidence of seizures. We detected clinically silent hippocampal seizures and epileptiform spikes during sleep, a period when these abnormalities were most likely to interfere with memory consolidation. The findings in these index cases support a model in which early development of occult hippocampal hyperexcitability may contribute to the pathogenesis of AD.	[Lam, Alice D.; Deck, Gina; Cole, Andrew J.] Massachusetts Gen Hosp, MGH Epilepsy Serv, Boston, MA 02114 USA; [Lam, Alice D.; Deck, Gina; Eskandar, Emad N.; Cole, Andrew J.] Harvard Med Sch, Boston, MA USA; [Goldman, Alica; Noebels, Jeffrey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Harvard University; Massachusetts General Hospital	Cole, AJ (corresponding author), Massachusetts Gen Hosp, MGH Epilepsy Serv, Boston, MA 02114 USA.	cole.andrew@mgh.harvard.edu			NIH-NINDS [R25-NS065743, U01-NS090362, R01-NS029709]; Massachusetts General Hospital Executive Committee on Research; Citizens United for Research in Epilepsy; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS088568, R01NS029709, R25NS065743, U01NS090362] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Massachusetts General Hospital Executive Committee on Research; Citizens United for Research in Epilepsy; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-NINDS R25-NS065743 (A.D.L.), the Massachusetts General Hospital Executive Committee on Research (A.D.L.), NIH-NINDS U01-NS090362 (A.G.), Citizens United for Research in Epilepsy (A.G.), NIH-NINDS R01-NS029709 (J.N.), and the Blue Bird Circle Foundation (J.N.).	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Alzheimer A, 1906, NEUROLOGISCHES CENTR, V23, P1129; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Binnie CD, 2003, LANCET NEUROL, V2, P725, DOI 10.1016/S1474-4422(03)00584-2; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Blocq P., 1892, SEM MED, V12, P445; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Kam K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20119; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kleen JK, 2013, NEUROLOGY, V81, P18, DOI 10.1212/WNL.0b013e318297ee50; Koliatsos VE, 2006, ACTA NEUROPATHOL, V112, P147, DOI 10.1007/s00401-006-0068-6; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Malow BA, 1998, EPILEPSIA, V39, P1309, DOI 10.1111/j.1528-1157.1998.tb01329.x; Mander BA, 2016, TRENDS NEUROSCI, V39, P552, DOI 10.1016/j.tins.2016.05.002; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Pastor J, 2008, EPILEPSIA, V49, P464, DOI 10.1111/j.1528-1167.2007.01314.x; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sarkis RA, 2016, J NEUROPSYCH CLIN N, V28, P56, DOI 10.1176/appi.neuropsych.15060143; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sheth SA, 2014, EPILEPSIA, V55, P713, DOI 10.1111/epi.12571; Tatum WO, 1998, NEUROLOGY, V50, P1472, DOI 10.1212/WNL.50.5.1472; Vossel KA, 2016, ANN NEUROL, V80, P858, DOI 10.1002/ana.24794; WHITE JC, 1977, NEUROLOGY, V27, P1061, DOI 10.1212/WNL.27.11.1061; WIESER HG, 1985, ELECTROEN CLIN NEURO, V61, P314, DOI 10.1016/0013-4694(85)91098-3	29	185	186	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					678	+		10.1038/nm.4330	http://dx.doi.org/10.1038/nm.4330			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28459436	Green Accepted, Green Submitted			2022-12-27	WOS:000402768000010
J	Cantin, AM; Hanrahan, JW				Cantin, Andre M.; Hanrahan, John W.			Thymosin alpha 1: a single drug with multiple targets in cystic fibrosis	NATURE MEDICINE			English	Editorial Material							INDOLEAMINE 2,3-DIOXYGENASE; MURINE; CELLS	A new study in mice suggests that a single drug, thymosin. 1, may simultaneously rectify the impaired trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in cystic fibrosis (CF) and reduce inflammation, offering new hope for CF treatment.	[Cantin, Andre M.] Univ Sherbrooke, Pulm Div, Fac Med, Sherbrooke, PQ, Canada; [Hanrahan, John W.] McGill Univ, Dept Physiol, Montreal, PQ, Canada	University of Sherbrooke; McGill University	Cantin, AM (corresponding author), Univ Sherbrooke, Pulm Div, Fac Med, Sherbrooke, PQ, Canada.	andre.cantin@usherbrooke.ca	Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039				Atlante A, 2016, J BIOENERG BIOMEMBR, V48, P197, DOI 10.1007/s10863-016-9663-y; Carlile GW, 2015, J CYST FIBROS, V14, P16, DOI 10.1016/j.jcf.2014.06.001; Hisert K.B., 2017, AM J RESP CRIT CARE; Iannitti RG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10791; Iannitti RG, 2013, AM J RESP CRIT CARE, V187, P609, DOI 10.1164/rccm.201207-1346OC; LOW TLK, 1979, J BIOL CHEM, V254, P981; Maghzal GJ, 2008, J BIOL CHEM, V283, P12014, DOI 10.1074/jbc.M710266200; Romani L, 2017, NAT MED, V23, P590, DOI 10.1038/nm.4305; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Spielberg DR, 2016, ANNU REV GENOM HUM G, V17, P155, DOI 10.1146/annurev-genom-090314-050024; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922	12	2	3	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					536	538		10.1038/nm.4339	http://dx.doi.org/10.1038/nm.4339			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28475572				2022-12-27	WOS:000400650700006
J	Honeycutt, JB; Thayer, WO; Baker, CE; Ribeiro, RM; Lada, SM; Cao, YF; Cleary, RA; Hudgens, MG; Richman, DD; Garcia, JV				Honeycutt, Jenna B.; Thayer, William O.; Baker, Caroline E.; Ribeiro, Ruy M.; Lada, Steven M.; Cao, Youfang; Cleary, Rachel A.; Hudgens, Michael G.; Richman, Douglas D.; Garcia, J. Victor			HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy	NATURE MEDICINE			English	Article							HIGHLY PATHOGENIC SIV; TREATMENT INTERRUPTION; INFECTION; DYNAMICS; CELLS; LYMPHOCYTES; GENERATION; RESERVOIRS; CLEARANCE; MONOCYTES	Despite years of fully suppressive antiretroviral therapy (ART), HIV persists in its hosts and is never eradicated. One major barrier to eradication is that the virus infects multiple cell types that may individually contribute to HIV persistence. Tissue macrophages are critical contributors to HIV pathogenesis(1-3); however, their specific role in HIV persistence during long-term suppressive ART has not been established(4-6). Using humanized myeloid-only mice (MoM), we demonstrate that HIV infection of tissue macrophages is rapidly suppressed by ART, as reflected by a rapid drop in plasma viral load and a dramatic decrease in the levels of cell-associated viral RNA and DNA. No viral rebound was observed in the plasma of 67% of the ART-treated animals at 7 weeks after ART interruption, and no replication-competent virus was rescued from the tissue macrophages obtained from these animals. In contrast, in a subset of animals (similar to 33%), a delayed viral rebound was observed that is consistent with the establishment of persistent infection in tissue macrophages. These observations represent the first direct evidence, to our knowledge, of HIV persistence in tissue macrophages in vivo.	[Honeycutt, Jenna B.; Thayer, William O.; Baker, Caroline E.; Cleary, Rachel A.; Garcia, J. Victor] Univ N Carolina, Sch Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Ribeiro, Ruy M.; Cao, Youfang] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM USA; [Lada, Steven M.; Richman, Douglas D.] San Diego Healthcare Syst, Vet Affairs, San Diego, CA USA; [Hudgens, Michael G.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; United States Department of Energy (DOE); Los Alamos National Laboratory; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Garcia, JV (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA.	victor_garcia@med.unc.edu		Ribeiro, Ruy/0000-0002-3988-8241; Honeycutt, Jenna/0000-0002-4715-6796	National Institute of Mental Health [MH-108179]; National Institute of Allergy and Infectious Diseases (NIAID) [AI-111899]; UNC CFAR [P30 AI050410]; CARE, a Martin Delaney Collaboratory; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) of the National Institutes of Health [1UM1AI126619-01]; Virology Training Grant [T32 AI-007419]; NIAID [R01 AI-104373]; BEAT-HIV Delaney Collaboration [1UM1AI126620]; UCSD CFAR [AI306214]; Department of Veterans Affairs; James B. Pendleton Charitable Trust	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNC CFAR; CARE, a Martin Delaney Collaboratory; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH) of the National Institutes of Health; Virology Training Grant; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BEAT-HIV Delaney Collaboration; UCSD CFAR; Department of Veterans Affairs(US Department of Veterans Affairs); James B. Pendleton Charitable Trust	We thank N. Archin (University of North Carolina at Chapel Hill) for providing the CD8<SUP>+</SUP>-depleted feeder cells for in vitro viral outgrowth analysis; J. Kappes and C. Ochsenbauer (University of Alabama at Birmingham) for providing CH040 (11740) via the AIDS Research and Reference Reagent Program; R. Swanstrom (University of North Carolina at Chapel Hill) for providing 4013-env for use in our studies; J. Clements, R. Siliciano, and D. Margolis for their intellectual input in these studies; M. Cohen, B. Haynes, S. Lemon, A. Wahl, and M. Kovarova for their comments and suggestions regarding this manuscript; and former and current members of the Garcia laboratory and the husbandry technicians at the UNC Division of Laboratory Animal Medicine for their assistance. J.V.G. was supported by grants from the National Institute of Mental Health (MH-108179) and the National Institute of Allergy and Infectious Diseases (NIAID) (AI-111899) and by the UNC CFAR (P30 AI050410). Research reported in this publication was also supported by CARE, a Martin Delaney Collaboratory, the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH) of the National Institutes of Health, grant number 1UM1AI126619-01 (J.V.G. and D.D.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J.B.H. was supported in part by the Virology Training Grant (T32 AI-007419). R.M R. was supported by the NIAID (R01 AI-104373). D.D.R. was also supported by the BEAT-HIV Delaney Collaboration (1UM1AI126620), the UCSD CFAR (AI306214), the Department of Veterans Affairs, and the James B. Pendleton Charitable Trust. The funders had no part in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Avalos CR, 2016, J VIROL, V90, P5643, DOI 10.1128/JVI.00290-16; Calin R, 2016, AIDS, V30, P761, DOI 10.1097/QAD.0000000000000987; Campbell JH, 2014, AIDS, V28, P2175, DOI 10.1097/QAD.0000000000000408; Collman RG, 2003, J LEUKOCYTE BIOL, V74, P631, DOI 10.1189/jlb.0703357; Denton PW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003872; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Gillespie BW, 2010, EPIDEMIOLOGY, V21, pS64, DOI 10.1097/EDE.0b013e3181ce9f08; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hill AL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005535; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Honeycutt JB, 2016, J CLIN INVEST, V126, P1353, DOI 10.1172/JCI84456; Honeycutt JB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-121; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Joseph SB, 2015, J NEUROVIROL, V21, P276, DOI 10.1007/s13365-014-0287-x; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Kumar Amit, 2014, Mol Cell Ther, V2, P10, DOI 10.1186/2052-8426-2-10; Lafleur Bonnie, 2011, J Carcinog, V10, P12, DOI 10.4103/1477-3163.79681; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Micci L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004467; Nath A, 2011, AIDS, V25, P577, DOI 10.1097/QAD.0b013e3283437d2f; Olesen R, 2011, J REPROD IMMUNOL, V88, P195, DOI 10.1016/j.jri.2010.11.005; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Sattentau QJ, 2016, CELL HOST MICROBE, V19, P304, DOI 10.1016/j.chom.2016.02.013; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Sung JA, 2015, J INFECT DIS, V212, P258, DOI 10.1093/infdis/jiv022; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Zhang DH, 2009, STAT MED, V28, P700, DOI 10.1002/sim.3488	39	184	188	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					638	+		10.1038/nm.4319	http://dx.doi.org/10.1038/nm.4319			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28414330	Green Accepted, Green Submitted			2022-12-27	WOS:000400650700019
J	Kim, WM; Kaser, A; Blumberg, RS				Kim, Walter M.; Kaser, Arthur; Blumberg, Richard S.			A role for oncostatin M in inflammatory bowel disease	NATURE MEDICINE			English	Editorial Material							MAINTENANCE THERAPY; ULCERATIVE-COLITIS; CROHNS-DISEASE; INDUCTION; VEDOLIZUMAB	A new study identifies oncostatin M (OSM) as a potential biomarker and therapeutic target for anti-tumor necrosis factor (TNF)-refractory inflammatory bowel disease (IBD), and pinpoints mucosal stromal cells as key players in OSM-mediated inflammation.	[Kim, Walter M.; Blumberg, Richard S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; [Kaser, Arthur] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Cambridge	Blumberg, RS (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA.	rblumberg@bwh.harvard.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK044319, R01 DK051362, R01 DK053056, R01 DK088199, T32 DK007533]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319, T32DK007533, R01DK088199, R01DK053056, R01DK051362, P30DK034854] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R01 DK044319, R01 DK051362, R01 DK053056 and R01 DK088199 to R.S.B.; and T32 DK007533 to W.M.K.).	Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093498; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Guerra I, 2014, CLIN EXP GASTROENTER, V7, P359, DOI 10.2147/CEG.S45297; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Sanchez AL, 2003, J INTERF CYTOK RES, V23, P193, DOI 10.1089/107999003765027393; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sands BE, 2017, INFLAMM BOWEL DIS, V23, P97, DOI 10.1097/MIB.0000000000000979; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307	12	14	14	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					535	536		10.1038/nm.4338	http://dx.doi.org/10.1038/nm.4338			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28475567	Green Accepted			2022-12-27	WOS:000400650700005
J	Drysdale, AT; Grosenick, L; Downar, J; Dunlop, K; Mansouri, F; Meng, Y; Fetcho, RN; Zebley, B; Oathes, DJ; Etkin, A; Schatzberg, AF; Sudheimer, K; Keller, J; Mayberg, HS; Gunning, FM; Alexopoulos, GS; Fox, MD; Pascual-Leone, A; Voss, HU; Casey, BJ; Dubin, MJ; Liston, C				Drysdale, Andrew T.; Grosenick, Logan; Downar, Jonathan; Dunlop, Katharine; Mansouri, Farrokh; Meng, Yue; Fetcho, Robert N.; Zebley, Benjamin; Oathes, Desmond J.; Etkin, Amit; Schatzberg, Alan F.; Sudheimer, Keith; Keller, Jennifer; Mayberg, Helen S.; Gunning, Faith M.; Alexopoulos, George S.; Fox, Michael D.; Pascual-Leone, Alvaro; Voss, Henning U.; Casey, B. J.; Dubin, Marc J.; Liston, Conor			Resting-state connectivity biomarkers define neurophysiological subtypes of depression (vol 23, pg 28, 2016)	NATURE MEDICINE			English	Correction													Oathes, Desmond/AAW-3048-2021; Etkin, Amit/ABD-5761-2021; Pascual-Leone, Alvaro/AAC-5101-2019; Downar, Jonathan/I-9002-2016; Fox, Michael D./AAZ-3928-2020; , Conor Liston/GQH-8931-2022	Pascual-Leone, Alvaro/0000-0001-8975-0382; Downar, Jonathan/0000-0002-5140-174X; Fox, Michael D./0000-0001-8848-6399; 	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS083741] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000457] Funding Source: Medline; NIMH NIH HHS [R21 MH099196] Funding Source: Medline; NINDS NIH HHS [K23 NS083741] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246	1	26	27	5	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					264	264		10.1038/nm0217-264d	http://dx.doi.org/10.1038/nm0217-264d			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28170383	Green Accepted			2022-12-27	WOS:000393729000022
J	Kim, Y; Lee, HM; Xiong, Y; Sciaky, N; Hulbert, SW; Cao, XY; Everitt, JI; Jin, J; Roth, BL; Jiang, YH				Kim, Yuna; Lee, Hyeong-Min; Xiong, Yan; Sciaky, Noah; Hulbert, Samuel W.; Cao, Xinyu; Everitt, Jeffrey I.; Jin, Jian; Roth, Bryan L.; Jiang, Yong-hui			Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome	NATURE MEDICINE			English	Article							SMALL NUCLEOLAR RNA; NOVO DNA METHYLATION; PATERNAL DELETION; CHEMICAL PROBE; REGION; UBE3A; GLP; MUTATIONS; MAGEL2; TRANSCRIPT	Prader-Willi syndrome (PWS) is an imprinting disorder caused by a deficiency of paternally expressed gene(s) in the 15q11-q13 chromosomal region. The regulation of imprinted gene expression in this region is coordinated by an imprinting center (PWS-IC). In individuals with PWS, genes responsible for PWS on the maternal chromosome are present, but repressed epigenetically, which provides an opportunity for the use of epigenetic therapy to restore expression from the maternal copies of PWS-associated genes. Through a high-content screen (HCS) of >9,000 small molecules, we discovered that UNC0638 and UNC0642 two selective inhibitors of euchromatic histone lysine N-methyltransferase-2 (EHMT2, also known as G9a)-activated the maternal (m) copy of candidate genes underlying PWS, including the SnoRNA cluster SNORD116, in cells from humans with PWS and also from a mouse model of PWS carrying a paternal (p) deletion from small nuclear ribonucleoprotein N (Snrpn (S)) to ubiquitin protein ligase E3A (Ube3a (U)) (mouse model referred to hereafter as m(+)/p(Delta s-U)). Both UNC0642 and UNC0638 caused a selective reduction of the dimethylation of histone H3 lysine 9 (H3K9me2) at PWS-IC, without changing DNA methylation, when analyzed by bisulfite genomic sequencing. This indicates that histone modification is essential for the imprinting of candidate genes underlying PWS. UNC0642 displayed therapeutic effects in the PWS mouse model by improving the survival and the growth of in m(+)/p(Delta s-U) newborn pups. This study provides the first proof of principle for an epigenetics-based therapy for PWS.	[Kim, Yuna; Cao, Xinyu; Jiang, Yong-hui] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27708 USA; [Lee, Hyeong-Min] Univ N Carolina, Dept Cell Biol & Physiol, Sch Med, Chapel Hill, NC USA; [Lee, Hyeong-Min; Sciaky, Noah; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27514 USA; [Xiong, Yan; Jin, Jian] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Xiong, Yan; Jin, Jian] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Hulbert, Samuel W.; Jiang, Yong-hui] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA; [Everitt, Jeffrey I.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Program Neurosci, Chapel Hill, NC 27514 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27514 USA; [Jiang, Yong-hui] Duke Univ, Sch Med, Program Genet & Genom, Durham, NC 27708 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Jiang, YH (corresponding author), Duke Univ, Sch Med, Dept Pediat, Durham, NC 27708 USA.; Roth, BL (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27514 USA.; Jiang, YH (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA.; Roth, BL (corresponding author), Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Program Neurosci, Chapel Hill, NC 27514 USA.; Roth, BL (corresponding author), Univ N Carolina, Sch Med, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27514 USA.; Jiang, YH (corresponding author), Duke Univ, Sch Med, Program Genet & Genom, Durham, NC 27708 USA.	bryan_roth@med.unc.edu; yong-hui.jiang@duke.edu	Roth, Bryan L/F-3928-2010; Lee, HM/ABC-2680-2020; Lee, HM/D-2777-2011; Kim, Yuna/GXV-6765-2022; xiong, yan/H-7881-2018; Roth, Bryan/ABE-7032-2020	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611; Roth, Bryan/0000-0002-0561-6520; Everitt, Jeffrey/0000-0003-0273-6284	US National Institutes of Health [HD077197, R01GM103893]; Foundation for Prader Willi Syndrome Research (FPWR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122749, R01GM103893] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Prader Willi Syndrome Research (FPWR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Beaudet at Baylor College of Medicine for providing the SnrpnEGFP mice and some of the PWS cell lines; B. Philpot and M. Zlyka (University of North Carolina at Chapel Hill) for discussion. K. Konze for his advice on the ChIP experiment; S.-O. Han for his advice on blood-sample collection; C. Means and R. Rodriguiz for their assistance with neurological screening; and A. Bey for proofreading and discussion. This study is supported by grants from the US National Institutes of Health (HD077197 to Y.-H.J. and R01GM103893 to J.J.). Y.-H. Jiang is also supported by a grant from the Foundation for Prader Willi Syndrome Research (FPWR). We thank the International Rett Syndrome Foundation and GlaxoSmithKline for providing the CNS-penetrating drug library (SMART library) and Published Kinase Inhibitor Set (PKIS), the NIMH Psychoactive Drug Screening Program (B.L. Roth) and the Michael Hooker Chair of Translational Proteomics (B.L. Roth).	Auclair G, 2016, GENOME RES, V26, P192, DOI 10.1101/gr.198291.115; Bieth E, 2015, EUR J HUM GENET, V23, P252, DOI 10.1038/ejhg.2014.103; Bittencourt D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-27; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Buiting K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-40; Buiting K, 2010, AM J MED GENET C, V154C, P365, DOI 10.1002/ajmg.c.30273; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Collins R, 2010, NUCLEIC ACIDS RES, V38, P3503, DOI 10.1093/nar/gkq081; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cruvinel E, 2014, HUM MOL GENET, V23, P4674, DOI 10.1093/hmg/ddu187; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Fulmer-Smentek SB, 2001, HUM MOL GENET, V10, P645, DOI 10.1093/hmg/10.6.645; Galiveti CR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06445; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Garcia-Manero G, 2013, J CLIN ONCOL, V31, P2548, DOI 10.1200/JCO.2012.44.6823; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Le Meur E, 2005, DEV BIOL, V286, P587, DOI 10.1016/j.ydbio.2005.07.030; Leung DC, 2011, P NATL ACAD SCI USA, V108, P5718, DOI 10.1073/pnas.1014660108; Liu F, 2013, J MED CHEM, V56, P8931, DOI 10.1021/jm401480r; Liu F, 2011, J MED CHEM, V54, P6139, DOI 10.1021/jm200903z; Lu XY, 2013, J AM CHEM SOC, V135, P9315, DOI 10.1021/ja4044856; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Martins-Taylor K, 2014, HUM MOL GENET, V23, P2364, DOI 10.1093/hmg/ddt628; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Treppendahl MB, 2014, J CLIN INVEST, V124, P47, DOI 10.1172/JCI69737; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106	54	63	70	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					213	222		10.1038/nm.4257	http://dx.doi.org/10.1038/nm.4257			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28024084	Green Accepted, Green Submitted			2022-12-27	WOS:000393729000013
J	Moynihan, KD; Opel, CF; Szeto, GL; Tzeng, A; Zhu, EF; Engreitz, JM; Williams, RT; Rakhra, K; Zhang, MH; Rothschilds, AM; Kumari, S; Kelly, RL; Kwan, BH; Abraham, W; Hu, K; Mehta, NK; Kauke, MJ; Suh, H; Cochran, JR; Lauffenburger, DA; Wittrup, KD; Irvine, DJ				Moynihan, Kelly D.; Opel, Cary F.; Szeto, Gregory L.; Tzeng, Alice; Zhu, Eric F.; Engreitz, Jesse M.; Williams, Robert T.; Rakhra, Kavya; Zhang, Michael H.; Rothschilds, Adrienne M.; Kumari, Sudha; Kelly, Ryan L.; Kwan, Byron H.; Abraham, Wuhbet; Hu, Kevin; Mehta, Naveen K.; Kauke, Monique J.; Suh, Heikyung; Cochran, Jennifer R.; Lauffenburger, Douglas A.; Wittrup, K. Dane; Irvine, Darrell J.			Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses	NATURE MEDICINE			English	Article							T-CELL IMMUNITY; DENDRITIC CELLS; CANCER-IMMUNOTHERAPY; METASTATIC MELANOMA; MYELOID COMPARTMENT; BREAST-CANCER; ANTIGEN; ANTIBODY; THERAPY; REGRESSION	Checkpoint blockade with antibodies specific for cytotoxic T lymphocyte-associated protein (CTLA)-4 or programmed cell death 1 (PDCD1; also known as PD-1) elicits durable tumor regression in metastatic cancer, but these dramatic responses are confined to a minority of patients. This suboptimal outcome is probably due in part to the complex network of immunosuppressive pathways present in advanced tumors, which are unlikely to be overcome by intervention at a single signaling checkpoint. Here we describe a combination immunotherapy that recruits a variety of innate and adaptive immune cells to eliminate large tumor burdens in syngeneic tumor models and a genetically engineered mouse model of melanoma; to our knowledge tumors of this size have not previously been curable by treatments relying on endogenous immunity. Maximal antitumor efficacy required four components: a tumor-antigen-targeting antibody, a recombinant interleukin-2 with an extended half-life, anti-PD-1 and a powerful T cell vaccine. Depletion experiments revealed that CD8(+) T cells, cross-presenting dendritic cells and several other innate immune cell subsets were required for tumor regression. Effective treatment induced infiltration of immune cells and production of inflammatory cytokines in the tumor, enhanced antibody-mediated tumor antigen uptake and promoted antigen spreading. These results demonstrate the capacity of an elicited endogenous immune response to destroy large, established tumors and elucidate essential characteristics of combination immunotherapies that are capable of curing a majority of tumors in experimental settings typically viewed as intractable.	[Moynihan, Kelly D.; Opel, Cary F.; Szeto, Gregory L.; Tzeng, Alice; Zhu, Eric F.; Rakhra, Kavya; Zhang, Michael H.; Rothschilds, Adrienne M.; Kumari, Sudha; Kelly, Ryan L.; Kwan, Byron H.; Abraham, Wuhbet; Mehta, Naveen K.; Kauke, Monique J.; Suh, Heikyung; Lauffenburger, Douglas A.; Wittrup, K. Dane; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moynihan, Kelly D.; Szeto, Gregory L.; Tzeng, Alice; Rothschilds, Adrienne M.; Kelly, Ryan L.; Kwan, Byron H.; Hu, Kevin; Mehta, Naveen K.; Lauffenburger, Douglas A.; Wittrup, K. Dane; Irvine, Darrell J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Moynihan, Kelly D.; Szeto, Gregory L.; Lauffenburger, Douglas A.; Irvine, Darrell J.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA; [Opel, Cary F.; Zhu, Eric F.; Kauke, Monique J.; Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Engreitz, Jesse M.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Williams, Robert T.] MIT, Dept Biol, Cambridge, MA USA; [Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Canc Inst, Stanford, CA USA; [Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Szeto, Gregory L.; Zhang, Michael H.] Univ Maryland, Dept Chem Biochem & Environm Engn, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Stanford Cancer Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore	Wittrup, KD; Irvine, DJ (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Wittrup, KD; Irvine, DJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA.; Wittrup, KD (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.; Irvine, DJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	wittrup@mit.edu; djirvine@mit.edu	Szeto, Gregory/N-9648-2019	Szeto, Gregory/0000-0001-7604-1333; Kumari, Sudha/0000-0001-7082-2825; Tzeng, Alice/0000-0001-7316-6923; Williams, Robert/0000-0002-9509-9327; Engreitz, Jesse/0000-0002-5754-1719; Moynihan, Kelly/0000-0001-6200-7863; Kelly, Ryan/0000-0001-5003-9104	Koch Institute from the National Cancer Institute [P30-CA14051]; US National Institutes of Health (NIH) [CA174795]; Koch Institute for Integrative Cancer Research; Dana Farber-Harvard Cancer Center (DF-HCC); V Foundation; Ragon Institute; Fannie and John Hertz Foundation Fellowship; NSF Graduate Research Fellowships; NIGMS-NIH Interdepartmental Biotechnology Training Program (NIH) [T32GM008334]; Siebel Scholarship; NIH; Ruth L. Kirschstein National Research Service Award [CA180586]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA174795, F32CA180586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334] Funding Source: NIH RePORTER	Koch Institute from the National Cancer Institute; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute for Integrative Cancer Research; Dana Farber-Harvard Cancer Center (DF-HCC); V Foundation; Ragon Institute; Fannie and John Hertz Foundation Fellowship; NSF Graduate Research Fellowships(National Science Foundation (NSF)); NIGMS-NIH Interdepartmental Biotechnology Training Program (NIH); Siebel Scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, the US National Institutes of Health (NIH) grant CA174795 (K.D.W.), the Bridge Project partnership between the Koch Institute for Integrative Cancer Research and the Dana Farber-Harvard Cancer Center (DF-HCC) (D.J.I.), the V Foundation (D.J.I.) and the Ragon Institute (D.J.I.). K.D.M. and J.M.E. are supported by the Fannie and John Hertz Foundation Fellowship; K.D.M., C.F.O., J.M.E., B.H.K. and E.F.Z. are supported by NSF Graduate Research Fellowships; A.M.R. is supported by the NIGMS-NIH Interdepartmental Biotechnology Training Program (NIH #T32GM008334); A.T. is supported by the Siebel Scholarship; and G.L.S. was supported by the NIH with a Ruth L. Kirschstein National Research Service Award (CA180586). We thank T.C. Wu (Johns Hopkins University) for kindly providing the TC-1 tumor cells, D. Sabatini (Whitehead Institute) for providing the Cas9 constructs and G. Dranoff (Dana-Farber Cancer Institute) for providing the DD-Her2/neu and B16-OVA cells. We thank M. Ghebremichael (Ragon Institute of MGH, MIT and Harvard) for helpful statistical advice. We thank the Koch Institute Swanson Biotechnology Center for technical support, specifically the applied therapeutics and wholeanimal imaging core facility, the histology and the flow cytometry core facilities. D.J.I. is an investigator of the Howard Hughes Medical Institute.	Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen G, 2014, CANCER IMMUNOL RES, V2, P949, DOI 10.1158/2326-6066.CIR-14-0058; Clatworthy MR, 2014, NAT MED, V20, P1458, DOI 10.1038/nm.3709; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Drake CG, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds262; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Gajewski TF, 2015, SEMIN ONCOL, V42, P663, DOI 10.1053/j.seminoncol.2015.05.011; Gasteiger G, 2013, J EXP MED, V210, P1167, DOI 10.1084/jem.20122462; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hooijkaas AI, 2012, AM J PATHOL, V181, P785, DOI 10.1016/j.ajpath.2012.06.002; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; LIST J, 1992, CANCER RES, V52, P1123; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Lum LG, 2015, CLIN CANCER RES, V21, P2305, DOI 10.1158/1078-0432.CCR-14-2280; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mendiratta SK, 2001, CANCER RES, V61, P859; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14598, DOI 10.1073/pnas.1311333110; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nelson MH, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0110-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Phan GQ, 2001, J CLIN ONCOL, V19, P3477, DOI 10.1200/JCO.2001.19.15.3477; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Rapoport AP, 2014, CLIN CANCER RES, V20, P1355, DOI 10.1158/1078-0432.CCR-13-2817; Ribas A., 2015, ASCO ANN M P, V33; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Stromnes IM, 2015, CANCER CELL, V28, P638, DOI 10.1016/j.ccell.2015.09.022; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tzeng A, 2015, P NATL ACAD SCI USA, V112, P3320, DOI 10.1073/pnas.1416159112; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van Egmond M, 2013, SEMIN CANCER BIOL, V23, P190, DOI 10.1016/j.semcancer.2012.12.002; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; Vigneron Nathalie, 2013, Cancer Immun, V13, P15; Weiskopf K, 2015, MABS-AUSTIN, V7, P303, DOI 10.1080/19420862.2015.1011450; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	64	315	327	10	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1402	+		10.1038/nm.4200	http://dx.doi.org/10.1038/nm.4200			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27775706	Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000389549000017
J	Liang, JR; Zhang, YL; Xie, T; Liu, NS; Chen, HY; Geng, Y; Kurkciyan, A; Mena, JM; Stripp, BR; Jiang, DH; Noble, PW				Liang, Jiurong; Zhang, Yanli; Xie, Ting; Liu, Ningshan; Chen, Huaiyong; Geng, Yan; Kurkciyan, Adrianne; Mena, Jessica Monterrosa; Stripp, Barry R.; Jiang, Dianhua; Noble, Paul W.			Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice	NATURE MEDICINE			English	Article							TOLL-LIKE RECEPTORS; CAPILLARY VASCULAR NICHE; STEM-CELLS; LUNG EPITHELIUM; REPAIR; PROLIFERATION; REGENERATION; EXPRESSION; INJURY; INFLAMMATION	Successful recovery from lung injury requires the repair and regeneration of alveolar epithelial cells to restore the integrity of gas-exchanging regions within the lung and preserve organ function. Improper regeneration of the alveolar epithelium is often associated with severe pulmonary fibrosis, the latter of which involves the recruitment and activation of fibroblasts, as well as matrix accumulation. Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to the lung repair process. The mechanisms that regulate AEC2 renewal are incompletely understood. We provide evidence that expression of the innate immune receptor Toll-like receptor 4 (TLR4) and the extracellular matrix glycosaminoglycan hyaluronan (HA) on AEC2s are important for AEC2 renewal, repair of lung injury and limiting the extent of fibrosis. Either deletion of TLR4 or HA synthase 2 in surfactant-protein-C-positive AEC2s leads to impaired renewal capacity, severe fibrosis and mortality. Furthermore, AEC2s from patients with severe pulmonary fibrosis have reduced cell surface HA and impaired renewal capacity, suggesting that HA and TLR4 are key contributors to lung stem cell renewal and that severe pulmonary fibrosis is the result of distal epithelial stem cell failure.	[Liang, Jiurong; Zhang, Yanli; Xie, Ting; Liu, Ningshan; Geng, Yan; Kurkciyan, Adrianne; Mena, Jessica Monterrosa; Stripp, Barry R.; Jiang, Dianhua; Noble, Paul W.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Liang, Jiurong; Zhang, Yanli; Xie, Ting; Liu, Ningshan; Geng, Yan; Kurkciyan, Adrianne; Mena, Jessica Monterrosa; Stripp, Barry R.; Jiang, Dianhua; Noble, Paul W.] Cedars Sinai Med Ctr, Womens Guild Lung Inst, Los Angeles, CA 90048 USA; [Chen, Huaiyong] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Zhang, Yanli] Tsinghua Univ, Dept Biochem & Mol Biol, Peking Union Med Coll, Beijing, Peoples R China; [Chen, Huaiyong] Tianjin Haihe Hosp, Tianjin, Peoples R China; [Chen, Huaiyong] Tianjin Inst Resp Dis, Tianjin, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Duke University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Jiang, DH; Noble, PW (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.; Jiang, DH; Noble, PW (corresponding author), Cedars Sinai Med Ctr, Womens Guild Lung Inst, Los Angeles, CA 90048 USA.	dianhua.jiang@cshs.org; paul.noble@cshs.org	Xie, Ting/I-9538-2019; Geng, Yan/ABH-7789-2022; Stripp, Barry/AAI-1467-2021; Chen, Huaiyong/G-3822-2014; Jiang, Dianhua/B-1421-2009; Liang, Carol Jiurong/AAI-4963-2021	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016; Stripp, Barry/0000-0003-4348-2137; Monterrosa, Jessica/0000-0002-3315-4431; Xie, Ting/0000-0002-9958-3888; Geng, Yan/0000-0001-8861-7686	US National Institute of Health (NIH) [P01 HL108793, R01 HL060539, AI052201, R01 HL122068]; California Institute for Regenerative Medicine [RB5-07302]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060539, P01HL108793, R01HL122068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052201] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Leonado, Y. Jung and V. Hu for technical support. This work was supported by US National Institute of Health (NIH) grants P01 HL108793 (P.W.N.), R01 HL060539 (P.W.N.), AI052201 (P.W.N.) and R01 HL122068 (D.J.),. and California Institute for Regenerative Medicine grant RB5-07302 (P.W.N.). We thank B.L.M. Hogan for critical reading of the manuscript and for providing invaluable comments. We are grateful to S. Akira (University of Osaka, Japan), Y. Yamaguchi (Sanford-Burnham Medical Research Institute) and L. Dobbs (University of California, San Francisco) for providing critical reagents for the study.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Garcia Christine Kim, 2011, Proc Am Thorac Soc, V8, P158, DOI 10.1513/pats.201008-056MS; Gonzalez RF, 2010, J HISTOCHEM CYTOCHEM, V58, P891, DOI 10.1369/jhc.2010.956433; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; Hofer CC, 2015, AM J PHYSIOL-LUNG C, V308, pL628, DOI 10.1152/ajplung.00373.2014; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu YR, 2015, AM J RESP CELL MOL, V53, P113, DOI 10.1165/rcmb.2013-0497OC; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Neal MD, 2012, J BIOL CHEM, V287, P37296, DOI 10.1074/jbc.M112.375881; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Oh K, 2011, J EXP MED, V208, P1707, DOI 10.1084/jem.20101457; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Selman MS, 2004, DRUGS, V64, P405, DOI 10.2165/00003495-200464040-00005; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Zhang SJ, 2014, STEM CELLS, V32, P1616, DOI 10.1002/stem.1632	46	167	172	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1285	1293		10.1038/nm.4192	http://dx.doi.org/10.1038/nm.4192			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27694932	Green Accepted			2022-12-27	WOS:000387302300021
J	Eichner, R; Heider, M; Fernandez-Saiz, V; van Bebber, F; Garz, AK; Lemeer, S; Rudelius, M; Targosz, BS; Jacobs, L; Knorn, AM; Slawska, J; Platzbecker, U; Germing, U; Langer, C; Knop, S; Einsele, H; Peschel, C; Haass, C; Keller, U; Schmid, B; Gotze, KS; Kuster, B; Bassermann, F				Eichner, Ruth; Heider, Michael; Fernandez-Saiz, Vanesa; van Bebber, Frauke; Garz, Anne-Kathrin; Lemeer, Simone; Rudelius, Martina; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Platzbecker, Uwe; Germing, Ulrich; Langer, Christian; Knop, Stefan; Einsele, Herrmann; Peschel, Christian; Haass, Christian; Keller, Ulrich; Schmid, Bettina; Goetze, Katharina S.; Kuster, Bernhard; Bassermann, Florian			Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity	NATURE MEDICINE			English	Article							E3 UBIQUITIN LIGASE; T-CELL-ACTIVATION; MULTIPLE-MYELOMA; DEXAMETHASONE COMBINATION; MYELODYSPLASTIC SYNDROMES; LENALIDOMIDE; CEREBLON; THALIDOMIDE; CD147; DEGRADATION	Immunomodulatory drugs (IMiDs), such as thalidomide and its derivatives lenalidomide and pomalidomide, are key treatment modalities for hematologic malignancies, particularly multiple myeloma (MM) and del(5q) myelodysplastic syndrome (MDS). Cereblon (CRBN), a substrate receptor of the CRL4 ubiquitin ligase complex, is the primary target by which IMiDs mediate anticancer and teratogenic effects. Here we identify a ubiquitin-independent physiological chaperone-like function of CRBN that promotes maturation of the basigin (BSG; also known as CD147) and solute carrier family 16 member 1 (SLC16A1; also known as MCT1) proteins. This process allows for the formation and activation of the CD147-MCT1 transmembrane complex, which promotes various biological functions, including angiogenesis, proliferation, invasion and lactate export. We found that IMiDs outcompete CRBN for binding to CD147 and MCT1, leading to destabilization of the CD147-MCT1 complex. Accordingly, IMiD-sensitive MM cells lose CD147 and MCT1 expression after being exposed to IMiDs, whereas IMiD-resistant cells retain their expression. Furthermore, del(5q) MDS cells have elevated CD147 expression, which is attenuated after IMiD treatment. Finally, we show that BSG (CD147) knockdown phenocopies the teratogenic effects of thalidomide exposure in zebrafish. These findings provide a common mechanistic framework to explain both the teratogenic and pleiotropic antitumor effects of IMiDs.	[Eichner, Ruth; Heider, Michael; Fernandez-Saiz, Vanesa; Garz, Anne-Kathrin; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Peschel, Christian; Keller, Ulrich; Goetze, Katharina S.; Bassermann, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, Munich, Germany; [Fernandez-Saiz, Vanesa; Garz, Anne-Kathrin; Peschel, Christian; Keller, Ulrich; Goetze, Katharina S.; Kuster, Bernhard; Bassermann, Florian] German Canc Consortium DKTK, Heidelberg, Germany; [Fernandez-Saiz, Vanesa; Garz, Anne-Kathrin; Peschel, Christian; Keller, Ulrich; Goetze, Katharina S.; Kuster, Bernhard; Bassermann, Florian] German Canc Res Ctr, Heidelberg, Germany; [van Bebber, Frauke; Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Dept Prote & Bioanalyt, Freising Weihenstephan, Germany; [Rudelius, Martina] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Rudelius, Martina] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Platzbecker, Uwe] Tech Univ, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany; [Germing, Ulrich] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany; [Langer, Christian] Univ Ulm, Dept Internal Med 3, Ulm, Germany; [Knop, Stefan; Einsele, Herrmann] Univ Wurzburg, Med Ctr, Dept Internal Med 2, Div Hematol & Med Oncol, Wurzburg, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Haass, Christian] Univ Munich, Biomed Ctr, Munich, Germany; [Kuster, Bernhard] Ctr Integrated Prot Sci Munich CIPSM, Freising Weihenstephan, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Wurzburg; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Heinrich Heine University Dusseldorf; Ulm University; University of Wurzburg; University of Munich; University of Munich	Bassermann, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, Munich, Germany.; Bassermann, F (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Bassermann, F (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	florian.bassermann@tum.de	Germing, Ulrich/AAX-1036-2021; Kuster, Bernhard/Q-6031-2016; Fernandez, Vanesa/ABD-6688-2021; Keller, Ulrich/L-1763-2016	Kuster, Bernhard/0000-0002-9094-1677; Eichner, Ruth/0000-0002-8433-9452; Heider, Michael/0000-0001-6218-8828; Fernandez-Saiz, Vanesa/0000-0002-7139-8680; Keller, Ulrich/0000-0002-8485-1958	Helmholtz cross-program topic 'Metabolic Dysfunction'; TU Munich (KKF) [B10-13]; Jose Carreras Leukemia Foundation [DJCLS R 14/16]; German Research Foundation [FOR2033 GO 713/2-1, SFB 1243, SFB 824, KE 222/7-1, BA 2851/4-1]; German Cancer Aid [111051, 111305, 111430]; Wilhelm Sander Stiftung [2012.096.1]	Helmholtz cross-program topic 'Metabolic Dysfunction'; TU Munich (KKF); Jose Carreras Leukemia Foundation; German Research Foundation(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Wilhelm Sander Stiftung	We thank M. Buschbeck (Institute of Predictive and Personalized Medicine of Cancer, Barcelona) for the SKK-1 and SKM-1 cell lines, X. Bustelo (Centro de Investigacion del Cancer, Salamanca) for a EGFP-CD147 expression plasmid, Y. Cang (Life Science Institute, Zheijang University) for a CRBN expression construct, B. Ebert (Dana-Farber Cancer Institute) for an IKZF3 expression construct, A. Halestrap (School of Biochemistry, University of Bristol) for MCT1 expression constructs, H. Handa (Tokyo Institute of Technology Japan) for an aliquot of mouse monoclonal CRBN-specific antibody, K. Kadomatsu (Department of Molecular Biology, Nagoya University) for CD147 expression constructs, W. Kaelin (Dana-Farber Cancer Institute) for CRISPR-based HEK293FT CBRN<SUP>-/-</SUP> cells and two clones of MM1.S CBRN<SUP>-/-</SUP> cells (T11, T21), D. Sabatini (Whitehead Institute) for a MCT1 and an shMCT1 construct, K. Stewart (Mayo Clinic) for a shCRBN plasmid, N. Thoma (Friedrich Miescher Institute for Biomedical Research, Basel) for a MEIS2 expression construct and purified CRL4<SUP>CRBN</SUP> protein, K. Tohyama (Kawasaki Medical School, Okayama) for the del(5q) MDS cell line MDSL, N. Thoma and E. Fisher for suggestions, R. Rojas for fish care and B. Nuscher for help with gel filtration chromatography. This work was supported by the Helmholtz cross-program topic 'Metabolic Dysfunction' (B.S.), a fellowship of the TU Munich (KKF # B10-13; to R.E.), grants from the Jose Carreras Leukemia Foundation (DJCLS R 14/16; to K.S.G.), the German Research Foundation (FOR2033 GO 713/2-1 and SFB 1243 (K.S.G.), SFB 824 (U.K.), KE 222/7-1 (U.K.), BA 2851/4-1 (F.B.) and SFB 1243 (F.B.)), the German Cancer Aid (#111051 (M.H.), #111305 (U.K.) and #111430 (F.B.)) and the Wilhelm Sander Stiftung (#2012.096.1; to F.B.). An application for a patent has been filed at the European Patent Office.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Baumann U, 2014, NAT MED, V20, P1401, DOI 10.1038/nm.3740; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Giagounidis A, 2014, ANN HEMATOL, V93, P1, DOI 10.1007/s00277-013-1863-5; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Hu JS, 2010, J CELL MOL MED, V14, P2132, DOI 10.1111/j.1582-4934.2010.01012.x; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kelaidi C, 2008, LEUKEMIA RES, V32, P1049, DOI 10.1016/j.leukres.2007.11.037; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kumar SK, 2014, LANCET ONCOL, V15, P1503, DOI 10.1016/S1470-2045(14)71125-8; Landskron J, 2013, CELL IMMUNOL, V282, P17, DOI 10.1016/j.cellimm.2013.04.008; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mahony C, 2013, P NATL ACAD SCI USA, V110, P12703, DOI 10.1073/pnas.1307684110; MELLIN GW, 1962, NEW ENGL J MED, V267, P1238, DOI 10.1056/NEJM196212132672407; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Roussel M, 2014, J CLIN ONCOL, V32, P2712, DOI 10.1200/JCO.2013.54.8164; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Staffler G, 2003, J IMMUNOL, V171, P1707, DOI 10.4049/jimmunol.171.4.1707; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Strupp C, 2003, LEUKEMIA, V17, P1200, DOI 10.1038/sj.leu.2402894; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Walters DK, 2013, CELL CYCLE, V12, P3175, DOI 10.4161/cc.26193; Zhu D, 2015, NAT MED, V21, P572, DOI 10.1038/nm.3867; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	43	115	119	4	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					735	743		10.1038/nm.4128	http://dx.doi.org/10.1038/nm.4128			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27294876				2022-12-27	WOS:000379366900012
J	Reinisch, A; Thomas, D; Corces, MR; Zhang, XH; Gratzinger, D; Hong, WJ; Schallmoser, K; Strunk, D; Majeti, R				Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Gratzinger, Dita; Hong, Wan-Jen; Schallmoser, Katharina; Strunk, Dirk; Majeti, Ravindra			A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells	NATURE MEDICINE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; STEM-CELL; CD34(+) CELLS; GM-CSF; MICE; NICHE; PROGENITORS; IDENTIFICATION; MYELOFIBROSIS	Xenotransplantation models represent powerful tools for the investigation of healthy and malignant human hematopoiesis. However, current models do not fully mimic the components of the human bone marrow (BM) microenvironment, and they enable only limited engraftment of samples from some human malignancies. Here we show that a xenotransplantation model bearing subcutaneous humanized ossicles with an accessible BM microenvironment, formed by in situ differentiation of human BM-derived mesenchymal stromal cells, enables the robust engraftment of healthy human hematopoietic stem and progenitor cells, as well as primary acute myeloid leukemia (AML) samples, at levels much greater than those in unmanipulated mice. Direct intraossicle transplantation accelerated engraftment and resulted in the detection of substantially higher leukemia-initiating cell (LIC) frequencies. We also observed robust engraftment of acute promyelocytic leukemia (APL) and myelofibrosis (MF) samples, and identified LICs in these malignancies. This humanized ossicle xenotransplantation approach provides a system for, modeling a wide variety of human hematological diseases.	[Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Inst Canc, Sch Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Gratzinger, Dita] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Schallmoser, Katharina] Paracelsus Med Univ, Dept Blood Grp Serol & Transfus Med, Salzburg, Austria; [Schallmoser, Katharina; Strunk, Dirk] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Strunk, Dirk] Paracelsus Med Univ, Expt & Clin Cell Therapy Inst, Salzburg, Austria	Stanford University; Stanford University; Stanford University; Stanford University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Majeti, R (corresponding author), Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA.; Majeti, R (corresponding author), Stanford Univ, Inst Canc, Sch Med, Stanford, CA 94305 USA.; Majeti, R (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	rmajeti@stanford.edu	Strunk, Dirk/V-4598-2017; Schallmoser, Katharina/V-4734-2017; Corces, M. Ryan/ABG-6947-2020	Strunk, Dirk/0000-0003-1810-867X; Schallmoser, Katharina/0000-0002-7204-0058; Corces, M. Ryan/0000-0001-7465-7652; Reinisch, Andreas/0000-0001-9333-7689; Gratzinger, Dita/0000-0002-9182-8123; Majeti, Ravindra/0000-0002-5814-0984	Erwin-Schroedinger Research Fellowship (Austrian Science Fund); CJ Martin Overseas Biomedical Research Fellowship (NHMRC, Australia); New York Stem Cell Foundation; National Institutes of Health [R01CA188055, U01HL099999]; European Union [668724]; Austrian Science Fund (FWF) [J 3358] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA188055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999] Funding Source: NIH RePORTER	Erwin-Schroedinger Research Fellowship (Austrian Science Fund); CJ Martin Overseas Biomedical Research Fellowship (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); New York Stem Cell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the Hematology Division Tissue Bank and the patients for donating their samples. We acknowledge F. Zhao for lab management; N. Hofmann and B. Luo for technical assistance with ossicle analysis and calreticulin sequencing; and the Stanford Cytogenetics Lab for FISH analysis. A.R. is supported by an Erwin-Schroedinger Research Fellowship (Austrian Science Fund) and D.T. by a CJ Martin Overseas Biomedical Research Fellowship (NHMRC, Australia). R.M. is a New York Stem Cell Foundation Robertson Investigator. This research was supported by the New York Stem Cell Foundation and National Institutes of Health grants R01CA188055 and U01HL099999 to R.M. and by funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 668724 to D.S.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; Grimwade D, 2004, LEUKEMIA, V18, P375, DOI 10.1038/sj.leu.2403234; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Haferlach T, 1998, BRIT J HAEMATOL, V103, P93, DOI 10.1046/j.1365-2141.1998.00959.x; Ishii T, 2007, EXP HEMATOL, V35, P1633, DOI 10.1016/j.exphem.2007.07.005; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; James C, 2008, BLOOD, V112, P2429, DOI 10.1182/blood-2008-02-137877; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; KNUUTILA S, 1994, GENE CHROMOSOME CANC, V10, P95, DOI 10.1002/gcc.2870100204; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Matsushita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111082; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Patel S, 2012, LEUKEMIA, V26, P2432, DOI 10.1038/leu.2012.154; Pettway GJ, 2005, BONE, V36, P959, DOI 10.1016/j.bone.2005.02.015; Reinisch A, 2015, BLOOD, V125, P249, DOI 10.1182/blood-2014-04-572255; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071; TAKATSUKI H, 1993, BRIT J HAEMATOL, V85, P477; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; Wang XL, 2012, J CLIN INVEST, V122, P3888, DOI 10.1172/JCI64397; Wang XL, 2010, BLOOD, V116, P5972, DOI 10.1182/blood-2010-02-269696; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	46	138	140	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					812	821		10.1038/nm.4103	http://dx.doi.org/10.1038/nm.4103			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27213817	Green Accepted			2022-12-27	WOS:000379366900021
J	Lee, SCW; Dvinge, H; Kim, E; Cho, H; Micol, JB; Chung, YR; Durham, BH; Yoshimi, A; Kim, YJ; Thomas, M; Lobry, C; Chen, CW; Pastore, A; Taylor, J; Wang, XJ; Krivtsov, A; Armstrong, SA; Palacino, J; Buonamici, S; Smith, PG; Bradley, RK; Abdel-Wahab, O				Lee, Stanley Chun-Wei; Dvinge, Heidi; Kim, Eunhee; Cho, Hana; Micol, Jean-Baptiste; Chung, Young Rock; Durham, Benjamin H.; Yoshimi, Akihide; Kim, Young Joon; Thomas, Michael; Lobry, Camille; Chen, Chun-Wei; Pastore, Alessandro; Taylor, Justin; Wang, Xujun; Krivtsov, Andrei; Armstrong, Scott A.; Palacino, James; Buonamici, Silvia; Smith, Peter G.; Bradley, Robert K.; Abdel-Wahab, Omar			Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins (vol 22, pg 672, 2016)	NATURE MEDICINE			English	Correction													Krivtsov, Andrei/AAJ-9966-2021; Kim, Eunhee/Q-9162-2016; lobry, camille/A-6188-2015	Kim, Eunhee/0000-0001-7143-7769; Yoshimi, Akihide/0000-0002-0664-7281; Krivtsov, Andrei/0000-0002-5511-1686; lobry, camille/0000-0003-0550-4921; Durham, Benjamin/0000-0001-8090-5448	NATIONAL CANCER INSTITUTE [K08CA160647] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128239] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA160647] Funding Source: Medline; NHLBI NIH HHS [R01 HL128239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Lee SCW, 2016, NAT MED, V22, P672, DOI 10.1038/nm.4097	1	13	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					692	692		10.1038/nm0616-692d	http://dx.doi.org/10.1038/nm0616-692d			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27270779	Green Accepted, Bronze			2022-12-27	WOS:000377476000018
J	Mount, CW; Majzner, RG; Sundaresh, S; Arnold, EP; Kadapakkam, M; Haile, S; Labanieh, L; Hulleman, E; Woo, PJ; Rietberg, SP; Vogel, H; Monje, M; Mackall, CL				Mount, Christopher W.; Majzner, Robbie G.; Sundaresh, Shree; Arnold, Evan P.; Kadapakkam, Meena; Haile, Samuel; Labanieh, Louai; Hulleman, Esther; Woo, Pamelyn J.; Rietberg, Skyler P.; Vogel, Hannes; Monje, Michelle; Mackall, Crystal L.			Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; HISTONE H3.3; ANTIGEN; MUTATIONS; IMMUNOTHERAPY; GLIOBLASTOMA; SUBGROUPS; REMISSION; ANTIBODY; TUMORS	Diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMGs) with mutated histone H3 K27M (H3-K27M)(1-5) are aggressive and universally fatal pediatric brain cancers(6). Chimeric antigen receptor (CAR)-expressing T cells have mediated impressive clinical activity in B cell malignancies(7-10), and recent results suggest benefit in central nervous system malignancies(11-13). Here, we report that patient-derived H3-K27M-mutant glioma cell cultures exhibit uniform, high expression of the disialoganglioside GD2. Anti-GD2 CAR T cells incorporating a 4-1BBz costimulatory domain(14) demonstrated robust antigen-dependent cytokine generation and killing of DMG cells in vitro. In five independent patient-derived H3-K27M(+) DMG orthotopic xenograft models, systemic administration of GD2-targeted CAR T cells cleared engrafted tumors except for a small number of residual GD2(lo) glioma cells. To date, GD2-targeted CAR T cells have been well tolerated in clinical trials(15-17). Although GD2-targeted CAR T cell administration was tolerated in the majority of mice bearing orthotopic xenografts, peritumoral neuroinflammation during the acute phase of antitumor activity resulted in hydrocephalus that was lethal in a fraction of animals. Given the precarious neuroanatomical location of midline gliomas, careful monitoring and aggressive neurointensive care management will be required for human translation. With a cautious multidisciplinary clinical approach, GD2-targeted CAR T cell therapy for H3-K27M(+) diffuse gliomas of pons, thalamus and spinal cord could prove transformative for these lethal childhood cancers.	[Mount, Christopher W.; Sundaresh, Shree; Arnold, Evan P.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Mount, Christopher W.] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Mount, Christopher W.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Majzner, Robbie G.; Kadapakkam, Meena; Haile, Samuel; Labanieh, Louai; Rietberg, Skyler P.; Vogel, Hannes; Monje, Michelle; Mackall, Crystal L.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Labanieh, Louai] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Hulleman, Esther] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Monje, Michelle; Mackall, Crystal L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Monje, Michelle] Stanford Univ, Sch Med, Stanford Inst Stem Cell & Regenerat Med, Stanford, CA 94305 USA; [Mackall, Crystal L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Vrije Universiteit Amsterdam; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University	Monje, M (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.; Monje, M; Mackall, CL (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Monje, M; Mackall, CL (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Sch Med, Stanford Inst Stem Cell & Regenerat Med, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	mmonje@stanford.edu; cmackall@stanford.edu	Hulleman, Esther/AAD-7073-2021	Sundaresh, Shree/0000-0003-4507-1032; Mount, Christopher/0000-0003-1635-2492; Vogel, Otto Hannes/0000-0002-0960-3508; Hulleman, Esther/0000-0001-9256-947X; Monje, Michelle/0000-0002-3547-237X	Stand Up To Cancer-St. Baldrick's-National Cancer Institute Pediatric Dream Team Translational Cancer Research Grant; National Institute of Neurological Disorders and Stroke [F31NS098554, R01NS092597]; Abbie's Army Foundation; Unravel Pediatric Cancer; Maiy's Miracle Foundation; Stella S. Jones Foundation; McKenna Claire Foundation; Alex's Lemonade Stand Foundation; Stanford University Cancer Immunotherapy Program; Izzy's Infantry Foundation; Cure Starts Now Foundation; DIPG Collaborative; Lyla Nsouli Foundation; Declan Gloster Memorial Fund; N8 Foundation; Fly a Kite Foundation; Liwei Wang Research Fund; Virginia and D.K. Ludwig Fund for Cancer Research; Sam Jeffers Foundation; Michael Mosier DEFEAT DIPG Foundation; ChadTough Foundation; Reller Family Research Fund; Child Health Research Institute at Stanford and SPARK program; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092597] Funding Source: NIH RePORTER	Stand Up To Cancer-St. Baldrick's-National Cancer Institute Pediatric Dream Team Translational Cancer Research Grant; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Abbie's Army Foundation; Unravel Pediatric Cancer; Maiy's Miracle Foundation; Stella S. Jones Foundation; McKenna Claire Foundation; Alex's Lemonade Stand Foundation; Stanford University Cancer Immunotherapy Program; Izzy's Infantry Foundation; Cure Starts Now Foundation; DIPG Collaborative; Lyla Nsouli Foundation; Declan Gloster Memorial Fund; N8 Foundation; Fly a Kite Foundation; Liwei Wang Research Fund; Virginia and D.K. Ludwig Fund for Cancer Research; Sam Jeffers Foundation; Michael Mosier DEFEAT DIPG Foundation; ChadTough Foundation; Reller Family Research Fund; Child Health Research Institute at Stanford and SPARK program; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Stand Up To Cancer-St. Baldrick's-National Cancer Institute Pediatric Dream Team Translational Cancer Research Grant (C.L.M.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. C.L.M is a member of the Parker Institute for Cancer Immunotherapy, which supports the Stanford University Cancer Immunotherapy Program. The authors gratefully acknowledge support from the National Institute of Neurological Disorders and Stroke (F31NS098554 to C.W.M. and R01NS092597 to M.M.), Abbie's Army Foundation (M.M.), Unravel Pediatric Cancer (M.M.), Maiy's Miracle Foundation (E.P.A.), Stella S. Jones Foundation (M.M.), McKenna Claire Foundation (M.M.), Alex's Lemonade Stand Foundation (M.M.), Izzy's Infantry Foundation (M.M.), The Cure Starts Now Foundation and DIPG Collaborative (M.M.), Lyla Nsouli Foundation (M.M.), Declan Gloster Memorial Fund (M.M.), N8 Foundation (M.M.), Fly a Kite Foundation (M.M.), Liwei Wang Research Fund (M.M.), Virginia and D.K. Ludwig Fund for Cancer Research (M. M. and C.L.M.), Sam Jeffers Foundation (M.M.), Michael Mosier DEFEAT DIPG Foundation (M.M.), ChadTough Foundation (M.M.), Reller Family Research Fund, Child Health Research Institute at Stanford and SPARK program (M.M.) and the Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases (M.M.).	Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gardner RA, 2017, BLOOD, V129, P3322, DOI 10.1182/blood-2017-02-769208; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Heczey A, 2017, MOL THER, V25, P2214, DOI 10.1016/j.ymthe.2017.05.012; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hong JJ, 2010, CLIN CANCER RES, V16, P4892, DOI 10.1158/1078-0432.CCR-10-1507; Horta ZP, 2016, IMMUNOTHERAPY-UK, V8, P1097, DOI 10.2217/imt-2016-0021; Jena B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057838; Jones C, 2017, NEURO-ONCOLOGY, V19, P153, DOI 10.1093/neuonc/now101; Kramer K, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26754; Kramer K, 2010, J NEURO-ONCOL, V97, P409, DOI 10.1007/s11060-009-0038-7; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lin GL, 2017, JOVE-J VIS EXP, DOI 10.3791/55360; Long AH, 2016, CANCER IMMUNOL RES, V4, P869, DOI 10.1158/2326-6066.CIR-15-0230; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lynn RC, 2015, BLOOD, V125, P3466, DOI 10.1182/blood-2014-11-612721; Majzner RG, 2017, CANCER CELL, V31, P476, DOI 10.1016/j.ccell.2017.03.002; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Nagaraja S, 2017, CANCER CELL, V31, P635, DOI 10.1016/j.ccell.2017.03.011; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Qin EY, 2017, CELL, V170, P845, DOI 10.1016/j.cell.2017.07.016; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sen G, 1998, J IMMUNOTHER, V21, P75, DOI 10.1097/00002371-199801000-00010; SUZUKI K, 1965, J NEUROCHEM, V12, P629, DOI 10.1111/j.1471-4159.1965.tb04256.x; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Thomas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152196; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	47	212	222	5	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					572	+		10.1038/s41591-018-0006-x	http://dx.doi.org/10.1038/s41591-018-0006-x			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29662203	Green Accepted			2022-12-27	WOS:000432126800013
J	Roswall, P; Bocci, M; Bartoschek, M; Li, H; Kristiansen, G; Jansson, S; Lehn, S; Sjolund, J; Reid, S; Larsson, C; Eriksson, P; Anderberg, C; Cortez, E; Saal, LH; Orsmark-Pietras, C; Cordero, E; Haller, BK; Hakkinen, J; Burvenich, IJG; Lim, E; Orimo, A; Hoglund, M; Ryden, L; Moch, H; Scott, AM; Eriksson, U; Pietras, K				Roswall, Pernilla; Bocci, Matteo; Bartoschek, Michael; Li, Hong; Kristiansen, Glen; Jansson, Sara; Lehn, Sophie; Sjolund, Jonas; Reid, Steven; Larsson, Christer; Eriksson, Pontus; Anderberg, Charlotte; Cortez, Eliane; Saal, Lao H.; Orsmark-Pietras, Christina; Cordero, Eugenia; Haller, Bengt Kristian; Hakkinen, Jari; Burvenich, Ingrid J. G.; Lim, Elgene; Orimo, Akira; Hoglund, Mattias; Ryden, Lisa; Moch, Holger; Scott, Andrew M.; Eriksson, Ulf; Pietras, Kristian			Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling	NATURE MEDICINE			English	Article							INTERNATIONAL EXPERT CONSENSUS; CARCINOMA-ASSOCIATED FIBROBLASTS; PDGFR-ALPHA; PRIMARY THERAPY; MOLECULAR PORTRAITS; LUMINAL SUBTYPE; MAMMARY-TUMORS; EXPRESSION; MET; HIGHLIGHTS	Breast tumors of the basal-like, hormone receptor-negative subtype remain an unmet clinical challenge, as there is high rate of recurrence and poor survival in patients following treatment. Coevolution of the malignant mammary epithelium and its underlying stroma instigates cancer-associated fibroblasts (CAFs) to support most, if not all, hallmarks of cancer progression. Here we delineate a previously unappreciated role for CAFs as determinants of the molecular subtype of breast cancer. We identified paracrine crosstalk between cancer cells expressing platelet-derived growth factor (PDGF)-CC and CAFs expressing the cognate receptors in human basal-like mammary carcinomas. Genetic or pharmacological intervention of PDGF-CC activity in mouse models of cancer resulted in conversion of basal-like breast cancers into a hormone receptor-positive state that enhanced sensitivity to endocrine therapy in previously resistant tumors. We conclude that specification of breast cancer to the basal-like subtype is under microenvironmental control and is therapeutically actionable.	[Roswall, Pernilla; Bocci, Matteo; Bartoschek, Michael; Lehn, Sophie; Sjolund, Jonas; Reid, Steven; Larsson, Christer; Anderberg, Charlotte; Cortez, Eliane; Cordero, Eugenia; Pietras, Kristian] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden; [Roswall, Pernilla; Li, Hong; Haller, Bengt Kristian; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Kristiansen, Glen] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Jansson, Sara; Eriksson, Pontus; Saal, Lao H.; Hakkinen, Jari; Hoglund, Mattias; Ryden, Lisa] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Orsmark-Pietras, Christina] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden; [Burvenich, Ingrid J. G.; Scott, Andrew M.] La Trobe Univ, Olivia Newton John Canc Res Inst, Sch Canc Med, Melbourne, Vic, Australia; [Burvenich, Ingrid J. G.; Scott, Andrew M.] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia; [Lim, Elgene] Garvan Inst Med Res, Sydney, NSW, Australia; [Burvenich, Ingrid J. G.] Univ New South Wales, Sydney, NSW, Australia; [Orimo, Akira] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo, Japan; [Moch, Holger] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland	Lund University; Karolinska Institutet; University of Bonn; Lund University; Lund University; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; Garvan Institute of Medical Research; University of New South Wales Sydney; Juntendo University; University of Zurich; University Zurich Hospital	Pietras, K (corresponding author), Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden.	kristian.pietras@med.lu.se	Lim, Elgene/AAS-7280-2020; Bocci, Matteo/AAB-5016-2021; Reid, Steven/AAB-4506-2021; Pietras, Kristian/ABG-2097-2021; Häkkinen, Jari/AHH-4463-2022; Pietras, Kristian/ABE-8727-2020; Saal, Lao/A-2919-2011	Lim, Elgene/0000-0001-8065-8838; Reid, Steven/0000-0002-6103-3354; Pietras, Kristian/0000-0001-6738-4705; Scott, Andrew/0000-0002-6656-295X; Orsmark-Pietras, Christina/0000-0002-6533-0305; Saal, Lao/0000-0002-0815-1896; Sjolund, Jonas/0000-0002-6992-3415; Burvenich, Ingrid/0000-0001-8384-2403; Orimo, Akira/0000-0001-5330-7282; Eriksson, Pontus/0000-0003-3317-865X; Haller, Kristian/0000-0002-9060-0928; Bocci, Matteo/0000-0002-8774-0006; Hakkinen, Jari/0000-0002-8466-9179	European Research Council (TUMORGAN project) [309322]; Swedish Research Council; Swedish Cancer Society; STARGET consortium (Swedish Research Council Linnaeus network); BioCARE; Lund University; Karolinska Institutet; Ludwig Institute for Cancer Research; National Health and Medical Research Council (NHMRC) [1084178, 10927888]; Operational Infrastructure Support Program by the Victorian Government, Australia; Grants-in-Aid for Scientific Research [15K14385, 15K15611] Funding Source: KAKEN; National Breast Cancer Foundation [EC-17-002, PRAC-14-002] Funding Source: researchfish	European Research Council (TUMORGAN project); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); STARGET consortium (Swedish Research Council Linnaeus network); BioCARE; Lund University; Karolinska Institutet(Karolinska Institutet); Ludwig Institute for Cancer Research; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program by the Victorian Government, Australia; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Breast Cancer Foundation	We gratefully acknowledge expert help with pathology assessments from the late D. Grabau and provision of the Tam2Y cohort by M. Ferno. Further, we would like to thank D. Cao, M. O'Brien and C. Murone for their technical support and P.-O. Bendahl for statistical assistance. K.P. is the Goran & Birgitta Grosskopf Professor at Lund University. The research presented herein was supported by grants from the following agencies to K.P.: a Consolidator Grant from the European Research Council (the TUMORGAN project, grant 309322), the Swedish Research Council, the Swedish Cancer Society, the STARGET consortium (a Swedish Research Council Linnaeus network), BioCARE and Lund University. U.E. acknowledges funding support from the Swedish Research Council, the Swedish Cancer Society, Karolinska Institutet and Ludwig Institute for Cancer Research. A.M.S. acknowledges funding support from National Health and Medical Research Council (NHMRC) Fellowship 1084178 and Grant 10927888 and the Operational Infrastructure Support Program provided by the Victorian Government, Australia.	Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brechbuhl HM, 2017, CLIN CANCER RES, V23, P1710, DOI 10.1158/1078-0432.CCR-15-2851; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Chebil G, 2003, ACTA ONCOL, V42, P719, DOI 10.1080/02841860310004724; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Falck AK, 2013, BREAST CANCER RES TR, V140, P93, DOI 10.1007/s10549-013-2617-8; Falck AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-403; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Gastaldi S, 2013, ONCOGENE, V32, P1428, DOI 10.1038/onc.2012.154; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Ho-Yen CM, 2014, CANCER-AM CANCER SOC, V120, P163, DOI 10.1002/cncr.28386; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Ignatiadis M, 2013, NAT REV CLIN ONCOL, V10, P494, DOI 10.1038/nrclinonc.2013.124; Jansson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102176; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0587-9; Kim YJ, 2014, INT J CANCER, V134, P2424, DOI 10.1002/ijc.28566; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Marsh T, 2013, BBA-MOL BASIS DIS, V1832, P1070, DOI 10.1016/j.bbadis.2012.10.013; Marzec KA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/638526; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; Meng FY, 2015, CANCER RES, V75, P584, DOI 10.1158/0008-5472.CAN-13-3029; Molyneux G, 2011, J MAMMARY GLAND BIOL, V16, P51, DOI 10.1007/s10911-011-9202-8; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Ray PS, 2010, CANCER RES, V70, P3870, DOI 10.1158/0008-5472.CAN-09-4120; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Sikora-Wohlfeld W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003342; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su Y, 2015, CELL REP, V11, P1549, DOI 10.1016/j.celrep.2015.05.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024	67	89	93	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					463	+		10.1038/nm.4494	http://dx.doi.org/10.1038/nm.4494			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29529015	Green Accepted			2022-12-27	WOS:000429639800017
J	Monga, SP				Monga, Satdarshan P.			Lipid metabolic reprogramming in hepatic ischemia-reperfusion injury	NATURE MEDICINE			English	News Item							ISCHEMIA/REPERFUSION; TRANSLATION	In a recent study of hepatic ischemia-reperfusion injury (IRI), Zhang et al. use tandem 'omics' approaches in mice, pigs, and nonhuman primates to identify lipid metabolic reprogramming as a key determinant of IRI, thus providing novel mechanistic and therapeutic insights.	[Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Dept Pathol, Div Expt Pathol, Pittsburgh, PA 15260 USA; [Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Med, Pittsburgh, PA 15260 USA; [Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15260 USA; [Monga, Satdarshan P.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monga, SP (corresponding author), Univ Pittsburgh, Med Ctr, Dept Pathol, Div Expt Pathol, Pittsburgh, PA 15260 USA.; Monga, SP (corresponding author), Univ Pittsburgh, Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Med, Pittsburgh, PA 15260 USA.; Monga, SP (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15260 USA.; Monga, SP (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	smonga@pitt.edu		Monga, Satdarshan/0000-0002-8437-3378				Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; JENNINGS RB, 1960, ARCH PATHOL, V70, P68; Konishi Takanori, 2017, Gene Expression, V17, P277, DOI 10.3727/105221617X15042750874156; Luci DK, 2014, J MED CHEM, V57, P495, DOI 10.1021/jm4016476; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225; Zhang P, 2018, NAT MED, V24, P84, DOI 10.1038/nm.4453	11	17	17	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					6	7		10.1038/nm.4468	http://dx.doi.org/10.1038/nm.4468			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29315298				2022-12-27	WOS:000422965900004
J	Vu, LP; Pickering, BF; Cheng, YM; Zaccara, S; Nguyen, D; Minuesa, G; Chou, T; Chow, A; Saletore, Y; MacKay, M; Schulman, J; Famulare, C; Patel, M; Klimek, VM; Garrett-Bakelman, FE; Melnick, A; Carroll, M; Mason, CE; Jaffrey, SR; Kharas, MG				Vu, Ly P.; Pickering, Brian F.; Cheng, Yuanming; Zaccara, Sara; Diu Nguyen; Minuesa, Gerard; Chou, Timothy; Chow, Arthur; Saletore, Yogesh; MacKay, Matthew; Schulman, Jessica; Famulare, Christopher; Patel, Minal; Klimek, Virginia M.; Garrett-Bakelman, Francine E.; Melnick, Ari; Carroll, Martin; Mason, Christopher E.; Jaffrey, Samie R.; Kharas, Michael G.			The N-6-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells	NATURE MEDICINE			English	Article							INTERNAL RIBOSOME ENTRY; STEM-CELLS; C-MYC; RNA; METHYLATION; TRANSLATION; EXPRESSION; REVEALS; ENRICHMENT; DYNAMICS	N-6-methyladenosine (m(6)A) is an abundant nucleotide modification in mRNA that is required for the differentiation of mouse embryonic stem cells. However, it remains unknown whether the m(6)A modification controls the differentiation of normal and/or malignant myeloid hematopoietic cells. Here we show that shRNA-mediated depletion of the m(6)A-forming enzyme METTL3 in human hematopoietic stem/progenitor cells (HSPCs) promotes cell differentiation, coupled with reduced cell proliferation. Conversely, overexpression of wild-type METTL3, but not of a catalytically inactive form of METTL3, inhibits cell differentiation and increases cell growth. METTL3 mRNA and protein are expressed more abundantly in acute myeloid leukemia (AML) cells than in healthy HSPCs or other types of tumor cells. Furthermore, METTL3 depletion in human myeloid leukemia cell lines induces cell differentiation and apoptosis and delays leukemia progression in recipient mice in vivo. Single-nucleotide-resolution mapping of m(6)A coupled with ribosome profiling reveals that m(6)A promotes the translation of c-MYC, BCL2 and PTEN mRNAs in the human acute myeloid leukemia MOLM-13 cell line. Moreover, loss of METTL3 leads to increased levels of phosphorylated AKT, which contributes to the differentiation-promoting effects of METTL3 depletion. Overall, these results provide a rationale for the therapeutic targeting of METTL3 in myeloid leukemia.	[Vu, Ly P.; Cheng, Yuanming; Diu Nguyen; Minuesa, Gerard; Chou, Timothy; Chow, Arthur; Kharas, Michael G.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Ctr Stein Cell Biol, Ctr Expt Therapeut,Ctr Hematol Malignancies,Mol P, 1275 York Ave, New York, NY 10021 USA; [Pickering, Brian F.; Zaccara, Sara; Jaffrey, Samie R.] Cornell Univ, Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA; [Saletore, Yogesh; MacKay, Matthew; Mason, Christopher E.] Cornell Univ, Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10021 USA; [Schulman, Jessica] Mem Sloan Kettering Canc Ctr, Dept Med, Hematol Oncol Tissue Bank, 1275 York Ave, New York, NY 10021 USA; [Famulare, Christopher; Patel, Minal] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Klimek, Virginia M.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Garrett-Bakelman, Francine E.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Garrett-Bakelman, Francine E.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Melnick, Ari] Cornell Univ, Weill Cornell Med, Div Hematol & Med Oncol, Dept Med, New York, NY 10021 USA; [Melnick, Ari] Cornell Univ, Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA; [Carroll, Martin] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Mason, Christopher E.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Virginia; University of Virginia; Cornell University; Cornell University; University of Pennsylvania; Cornell University; Cornell University	Kharas, MG (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Ctr Stein Cell Biol, Ctr Expt Therapeut,Ctr Hematol Malignancies,Mol P, 1275 York Ave, New York, NY 10021 USA.; Jaffrey, SR (corresponding author), Cornell Univ, Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA.	srj2003@med.cornell.edu; kharasm@mskcc.org	Mason, Christopher/HCH-3977-2022; Cheng, Yuanming/AFQ-2871-2022; Melnick, Ari/AAA-5763-2020	Chow, Arthur/0000-0003-4922-0410; Kharas, Michael/0000-0002-1165-6991; Jaffrey, Samie/0000-0003-3615-6958; Minuesa, Gerard/0000-0001-9911-8428; Nguyen, Diu/0000-0001-8328-0009; Vu, Ly/0000-0002-1682-7702	US National Institutes of Health National Institute of Diabetes Digestive and Kidney Diseases; NIDDK NIH [R01-DK101989-01A1]; NCI [1R01CA193842-01, CA16672]; Kimmel Scholar Award; V-Scholar Award; Geoffrey Beene Award; Leukemia Lymphoma Society; Alex's Lemonade Stand A Award; Tri-Institutional Stem Cell Award [R01CA186702, T32CA062948]; Ruth L. Kirschstein National Research Service Award [1F32CA22104-01]; Damon Runyon-Sohn Pediatric Cancer Fellowship Award [DRSG10-14]; American-Italian Cancer Foundation; NIH/NCI [P30 CA08748]; NATIONAL CANCER INSTITUTE [R01CA186702, F32CA221104, T32CA062948] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Diabetes Digestive and Kidney Diseases; NIDDK NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; V-Scholar Award; Geoffrey Beene Award; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Alex's Lemonade Stand A Award; Tri-Institutional Stem Cell Award; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon-Sohn Pediatric Cancer Fellowship Award; American-Italian Cancer Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Bachovchin (MSKCC, New York) for the MOLM-13 constitutively expressing Cas9 cell line, and C. Vakoc (Cold Spring Harbor Laboratory, New York) for the constitutively expressing Cas9-RN2c cell line. We would like to thank the members of the Scaltriti laboratory (MSKCC, New York) for providing us with PI3K/AKT inhibitors. We thank the Weill Cornell Medicine Epigenomics Core for their assistance with sequencing. M.G.K. was supported by the US National Institutes of Health National Institute of Diabetes Digestive and Kidney Diseases Career Development Award, NIDDK NIH R01-DK101989-01A1, NCI 1R01CA193842-01, Kimmel Scholar Award, V-Scholar Award, Geoffrey Beene Award, Leukemia Lymphoma Society Career Development Award and Alex's Lemonade Stand A Award. This work was also supported by a Tri-Institutional Stem Cell Award (M.G.K. and S.R.J.), R01CA186702 (S.R.J.), T32CA062948 (B.F.P.), Ruth L. Kirschstein National Research Service Award 1F32CA22104-01 (B.F.P.), a Damon Runyon-Sohn Pediatric Cancer Fellowship Award DRSG10-14 (L.P.V.), and the American-Italian Cancer Foundation (S.Z.). The research was funded in part through the NIH/NCI Cancer Support Core Grant P30 CA08748 MGK. The RPPA core facility is funded by NCI #CA16672.	Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kruse S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00126; Kwok CT, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0410-6; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Olarerin-George Anthony O, 2017, Bioinformatics, V33, P1563, DOI 10.1093/bioinformatics/btx002; PANDEY S, 1995, J CELL BIOCHEM, V58, P135, DOI 10.1002/jcb.240580203; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Reid DW, 2015, METHODS, V91, P69, DOI 10.1016/j.ymeth.2015.07.003; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; SOMMER S, 1978, J MOL BIOL, V124, P487, DOI 10.1016/0022-2836(78)90183-3; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang X, 2017, NATURE, V542, P260, DOI 10.1038/nature21073; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013	38	657	686	13	204	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1369	+		10.1038/nm.4416	http://dx.doi.org/10.1038/nm.4416			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	28920958	Green Accepted			2022-12-27	WOS:000414548300019
J	Janouskova, H; Tekle, G; Bellini, E; Udeshi, ND; Rinaldi, A; Ulbricht, A; Bernasocchi, T; Civenni, G; Losa, M; Svinkina, T; Bielski, CM; Kryukov, GV; Cascione, L; Napoli, S; Enchev, RI; Mutch, DG; Carney, ME; Berchuck, A; Winterhoff, BJN; Broaddus, RR; Schraml, P; Moch, H; Bertoni, F; Catapano, CV; Peter, M; Carr, SA; Garraway, LA; Wild, PJ; Theurillat, JPP				Janouskova, Hana; El Tekle, Geniver; Bellini, Elisa; Udeshi, Namrata D.; Rinaldi, Anna; Ulbricht, Anna; Bernasocchi, Tiziano; Civenni, Gianluca; Losa, Marco; Svinkina, Tanya; Bielski, Craig M.; Kryukov, Gregory V.; Cascione, Luciano; Napoli, Sara; Enchev, Radoslav I.; Mutch, David G.; Carney, Michael E.; Berchuck, Andrew; Winterhoff, Boris J. N.; Broaddus, Russell R.; Schraml, Peter; Moch, Holger; Bertoni, Francesco; Catapano, Carlo V.; Peter, Matthias; Carr, Steven A.; Garraway, Levi A.; Wild, Peter J.; Theurillat, Jean-Philippe P.			Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors	NATURE MEDICINE			English	Article							PROSTATE-CANCER; BREAST-CANCER; BROMODOMAIN INHIBITORS; ENDOMETRIAL CARCINOMAS; GENOMIC LANDSCAPE; UBIQUITIN LIGASE; MUTATIONS; RESISTANCE; RECEPTOR; TUMORS	It is generally assumed that recurrent mutations within a given cancer driver gene elicit similar drug responses. Cancer genome studies have identified recurrent but divergent missense mutations affecting the substrate-recognition domain of the ubiquitin ligase adaptor SPOP in endometrial and prostate cancers. The therapeutic implications of these mutations remain incompletely understood. Here we analyzed changes in the ubiquitin landscape induced by endometrial cancer-associated SPOP mutations and identified BRD2, BRD3 and BRD4 proteins (BETs) as SPOP-CUL3 substrates that are preferentially degraded by endometrial cancer-associated SPOP mutants. The resulting reduction of BET protein levels sensitized cancer cells to BET inhibitors. Conversely, prostate cancer-specific SPOP mutations resulted in impaired degradation of BETs, promoting their resistance to pharmacologic inhibition. These results uncover an oncogenomics paradox, whereby mutations mapping to the same domain evoke opposing drug susceptibilities. Specifically, we provide a molecular rationale for the use of BET inhibitors to treat patients with endometrial but not prostate cancer who harbor SPOP mutations.	[Janouskova, Hana; El Tekle, Geniver; Rinaldi, Anna; Bernasocchi, Tiziano; Civenni, Gianluca; Losa, Marco; Cascione, Luciano; Napoli, Sara; Bertoni, Francesco; Catapano, Carlo V.; Theurillat, Jean-Philippe P.] Oncol Inst Southern Switzerland, Oncol Res Inst, Bellinzona, Switzerland; [Janouskova, Hana; El Tekle, Geniver; Rinaldi, Anna; Bernasocchi, Tiziano; Civenni, Gianluca; Losa, Marco; Cascione, Luciano; Napoli, Sara; Bertoni, Francesco; Catapano, Carlo V.; Theurillat, Jean-Philippe P.] Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland; [El Tekle, Geniver; Bernasocchi, Tiziano; Catapano, Carlo V.; Theurillat, Jean-Philippe P.] Univ Lausanne, Ctr Hosp Univ Vaudois, Lausanne, Switzerland; [Bellini, Elisa; Schraml, Peter; Moch, Holger; Wild, Peter J.] Univ Hosp Zurich, Inst Surg Pathol, Zurich, Switzerland; [Udeshi, Namrata D.; Svinkina, Tanya; Bielski, Craig M.; Kryukov, Gregory V.; Carr, Steven A.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Ulbricht, Anna; Enchev, Radoslav I.; Peter, Matthias] Swiss Fed Inst Technol, Dept Biochem, Zurich, Switzerland; [Mutch, David G.] Washington Univ, Div Gynecol Oncol, St Louis, MO USA; [Carney, Michael E.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Obstet Gynecol & Womens Hlth, Honolulu, HI 96822 USA; [Berchuck, Andrew] Duke Canc Ctr, Div Gynecol Oncol, Durham, NC USA; [Winterhoff, Boris J. N.] Univ Minnesota, Div Gynecol Oncol, Minneapolis, MN USA; [Broaddus, Russell R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Bielski, Craig M.] Mem Sloan Kettering Canc Ctr, Mol Oncol, 1275 York Ave, New York, NY 10021 USA	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Washington University (WUSTL); University of Hawaii System; University of Hawaii Manoa; Duke University; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center	Theurillat, JPP (corresponding author), Oncol Inst Southern Switzerland, Oncol Res Inst, Bellinzona, Switzerland.; Theurillat, JPP (corresponding author), Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland.; Theurillat, JPP (corresponding author), Univ Lausanne, Ctr Hosp Univ Vaudois, Lausanne, Switzerland.	jeanp_theurillat@ior.iosi.ch	Bernasocchi, Tiziano/AAT-5122-2021; Carr, Steven A./AAH-8366-2019; Cascione, Luciano/X-3115-2019; Bertoni, Francesco/G-6922-2014	Cascione, Luciano/0000-0002-4606-0637; Bertoni, Francesco/0000-0001-5637-8983; Catapano, Carlo V./0000-0002-7079-557X; Rinaldi, Anna/0000-0003-4106-8127; Wild, Peter Johannes/0000-0002-1017-3744; Peter, Matthias/0000-0002-2160-6824; Kryukov, Gregory/0000-0002-6131-9483; Civenni, Gianluca/0000-0003-1921-161X; Bernasocchi, Tiziano/0000-0002-7130-5317	Swiss National Science Foundation Professorship [PP00P3_150645]; Swiss Cancer League [KSL-3654-02-2015]; Jubilaumsstiftung Swiss Life AG; Vontobel Stiftung; Swiss National Science Foundation [310030B_160312/1]; European Research Council [268930]; SystemsX IPhD [2013/128]; Krebsforschungs Schweiz [KFS-3498-08-2014]; GRL grant from the Korean government fund; Oncosuisse [KLS-3384-02-2014-R]; Foundation for Research in Science and the Humanities at the University of Zurich (SWF)	Swiss National Science Foundation Professorship(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Jubilaumsstiftung Swiss Life AG; Vontobel Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); SystemsX IPhD; Krebsforschungs Schweiz; GRL grant from the Korean government fund; Oncosuisse; Foundation for Research in Science and the Humanities at the University of Zurich (SWF)	We thank M. Losa, M. Storz, P. Schraml, S. Dettwiler and F. Prutek for help with tissue handling and histology assistance. We thank Q. Zhong for his help with the next-generation sequencing bioinformatics pipeline. We thank all members of the IRB animal core facility for technical assistance and the animal work. We thank E. Samartzis and K. Dedes (University Hospital Zurich) for providing AN3CA, HEC1A, HEC1B, HEC116, SNG-II, EFE184 and KLE cell lines. We thank the Oregon Health & Science University (OHSU) and the Cooperative Human Tissue Network (CHTN) for the tissue repository. We also thank all members of the laboratory for scientific discussions. J.-P.P.T. is funded by a Swiss National Science Foundation Professorship (PP00P3_150645) grant, a Swiss Cancer League (KSL-3654-02-2015) grant, a grant by the Jubilaumsstiftung Swiss Life AG and a grant by the Vontobel Stiftung. The Swiss National Science Foundation (310030B_160312/1), the European Research Council (268930), SystemsX IPhD (2013/128), Krebsforschungs Schweiz (KFS-3498-08-2014) and a GRL grant from the Korean government fund M. P. This work was also funded in part by a grant to P.J.W. provided by Oncosuisse (KLS-3384-02-2014-R) and the Foundation for Research in Science and the Humanities at the University of Zurich (SWF).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; An J, 2015, MOL CELL, V59, P904, DOI 10.1016/j.molcel.2015.07.025; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Blattner M, 2017, CANCER CELL, V31, P436, DOI 10.1016/j.ccell.2017.02.004; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Boi M, 2015, CLIN CANCER RES, V21, P1628, DOI 10.1158/1078-0432.CCR-14-1561; Dellas A, 2009, CLIN CANCER RES, V15, P2456, DOI 10.1158/1078-0432.CCR-08-1732; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gan WJ, 2015, MOL CELL, V59, P917, DOI 10.1016/j.molcel.2015.07.026; Geng C, 2014, CANCER RES, V74, P5631, DOI 10.1158/0008-5472.CAN-14-0476; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Groner AC, 2016, CANCER CELL, V29, P846, DOI 10.1016/j.ccell.2016.04.012; Jones S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6006; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Kurimchak AM, 2016, CELL REP, V16, P1273, DOI 10.1016/j.celrep.2016.06.091; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lebeau A, 2008, J PATHOL, V216, P151, DOI 10.1002/path.2405; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Mosadeghi R, 2016, ELIFE, V5, DOI 10.7554/eLife.12102; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roychowdhury S, 2014, ANNU REV GENOM HUM G, V15, P395, DOI 10.1146/annurev-genom-090413-025552; Sahai V, 2016, ONCOTARGET, V7, P53997, DOI 10.18632/oncotarget.9804; Salmans ML, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3408; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi XR, 2016, P NATL ACAD SCI USA, V113, pE4558, DOI 10.1073/pnas.1608319113; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Wang CY, 2015, TRENDS BIOCHEM SCI, V40, P468, DOI 10.1016/j.tibs.2015.06.002; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	45	102	109	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1046	+		10.1038/nm.4372	http://dx.doi.org/10.1038/nm.4372			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	28805821	Green Submitted, Green Accepted			2022-12-27	WOS:000409996200011
J	Benoit, B; Meugnier, E; Castelli, M; Chanon, S; Vieille-Marchiset, A; Durand, C; Bendridi, N; Pesenti, S; Monternier, PA; Durieux, AC; Freyssenet, D; Rieusset, J; Lefai, E; Vidal, H; Ruzzin, J				Benoit, Berengere; Meugnier, Emmanuelle; Castelli, Martina; Chanon, Stephanie; Vieille-Marchiset, Aurelie; Durand, Christine; Bendridi, Nadia; Pesenti, Sandra; Monternier, Pierre-Axel; Durieux, Anne-Cecile; Freyssenet, Damien; Rieusset, Jennifer; Lefai, Etienne; Vidal, Hubert; Ruzzin, Jerome			Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice	NATURE MEDICINE			English	Article							BETA-KLOTHO; ATROPHY; FGF19; METABOLISM; SUPPRESSOR; EXPRESSION; RESISTANCE	The endocrine-derived hormone fibroblast growth factor (FGF) 19 has recently emerged as a potential target for treating metabolic disease(1). Given that skeletal muscle is a key metabolic organ, we explored the role of FGF19 in that tissue. Here we report a novel function of FGF19 in regulating skeletal muscle mass through enlargement of muscle fiber size, and in protecting muscle from atrophy. Treatment with FGF19 causes skeletal muscle hypertrophy in mice, while physiological and pharmacological doses of FGF19 substantially increase the size of human myotubes in vitro. These effects were not elicited by FGF21, a closely related endocrine FGF member. Both in vitro and in vivo, FGF19 stimulates the phosphorylation of the extracellular-signal-regulated protein kinase 1/2 (ERK1/2) and the ribosomal protein S6 kinase (S6K1), an mTOR-dependent master regulator of muscle cell growth. Moreover, mice with a skeletal-muscle-specific genetic deficiency of beta-Klotho (KLB), an obligate co-receptor for FGF15/19 (refs. 2,3), were unresponsive to the hypertrophic effect of FGF19. Finally, in mice, FGF19 ameliorates skeletal muscle atrophy induced by glucocorticoid treatment or obesity, as well as sarcopenia. Taken together, these findings provide evidence that the enterokine FGF19 is a novel factor in the regulation of skeletal muscle mass, and that it has therapeutic potential for the treatment of muscle wasting.	[Benoit, Berengere; Castelli, Martina; Ruzzin, Jerome] Univ Bergen, Dept Biol, Bergen, Norway; [Meugnier, Emmanuelle; Chanon, Stephanie; Vieille-Marchiset, Aurelie; Durand, Christine; Bendridi, Nadia; Pesenti, Sandra; Monternier, Pierre-Axel; Rieusset, Jennifer; Lefai, Etienne; Vidal, Hubert] Univ Claude Bernard Lyon1, Univ Lyon, INRA 1397, CarMeN Lab,INSA Lyon,INSERM 1060, Oullins, France; [Durieux, Anne-Cecile; Freyssenet, Damien] Univ Jean Monnet, Univ Lyon, Lab Interuniv Biol Motricite, EA7424, St Etienne, France	University of Bergen; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Ruzzin, J (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	jerome.ruzzin@bio.uib.no	Lefai, Etienne/E-9615-2019; Ruzzin, Jerome/AAA-5826-2020; Carmen, Team2/Y-7383-2019; Vidal, Hubert/M-6674-2017; Lefai, Etienne/L-7961-2019; Carmen, Team1/Y-7382-2019; Rieusset, Jennifer/F-1595-2018; Ruzzin, Jérôme/U-1688-2017	Lefai, Etienne/0000-0002-3042-7801; Carmen, Team2/0000-0001-9867-5724; Vidal, Hubert/0000-0002-9467-0317; Lefai, Etienne/0000-0002-3042-7801; Carmen, Team1/0000-0003-4234-1746; Rieusset, Jennifer/0000-0002-1587-2253; Ruzzin, Jérôme/0000-0003-3676-8145; Chanon, Stephanie/0000-0001-6930-6671; Pesenti, Sandra/0000-0003-4037-208X; meugnier, emmanuelle/0000-0002-2291-7691; Lab, Carmen/0000-0002-5935-3236; BENDRIDI, Nadia/0000-0003-0456-7007	Research Council of Norway [230394, 228135]; INSERM; INRA; Environmental Exposures and Health Outcomes programme from the Research Council of Norway; FRIPRO Young Research Talents programme from the Research Council of Norway	Research Council of Norway(Research Council of Norway); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Environmental Exposures and Health Outcomes programme from the Research Council of Norway; FRIPRO Young Research Talents programme from the Research Council of Norway	We thank D.J. Mangelsdorf and S.A. Kliewer (University of Texas Southwestern Medical Center, Dallas, Texas, USA) for providing the Klb<SUP>+/-</SUP>, Klb<SUP>-/-</SUP> and Klb<SUP>fl/fl</SUP> mice and J. Melki (Universite Paris Sud, Paris, France) for providing the HSA-Cre mice. We thank the Plateau de Biologie Experimentale de la Souris (Ecole Normale Superieure, Lyon, France) for excellent animal care and breeding. This work was supported by the Research Council of Norway (projects #230394 and #228135) and from INSERM and INRA research funds. B.B. is supported by a grant from the Environmental Exposures and Health Outcomes programme from the Research Council of Norway. J. Ruzzin is supported by the FRIPRO Young Research Talents programme from the Research Council of Norway.	Adams H. C., 2013, MOL METAB, V2, P21; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Baskin KK, 2015, CELL METAB, V21, P237, DOI 10.1016/j.cmet.2014.12.021; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; De Larichaudy J, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-2; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Gravard A., 2011, DIABETES, V60, P258; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lin B. O., 2007, J BIOL CHEER, V282, P21217; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Miyata M, 2011, BIOL PHARM BULL, V34, P1885, DOI 10.1248/bpb.34.1885; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; ROWE RWD, 1969, J ANAT, V104, P519; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	36	111	119	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					990	+		10.1038/nm.4363	http://dx.doi.org/10.1038/nm.4363			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28650457	Green Submitted			2022-12-27	WOS:000406947600015
J	Shichita, T; Ito, M; Morita, R; Komai, K; Noguchi, Y; Ooboshi, H; Koshida, R; Takahashi, S; Kodama, T; Yoshimura, A				Shichita, Takashi; Ito, Minako; Morita, Rimpei; Komai, Kyoko; Noguchi, Yoshiko; Ooboshi, Hiroaki; Koshida, Ryusuke; Takahashi, Satoru; Kodama, Tatsuhiko; Yoshimura, Akihiko			MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1	NATURE MEDICINE			English	Article							CEREBRAL-ARTERY OCCLUSION; BRAIN-INJURY; SCAVENGER RECEPTORS; ADULT BRAIN; T-CELLS; MACROPHAGES; MICROGLIA; NEURONS; SYSTEM; MODELS	Damage-associated molecular patterns (DAMPs) trigger sterile inflammation after tissue injury, but the mechanisms underlying the resolution of inflammation remain unclear. In this study, we demonstrate that common DAMPs, such as high-mobility-group box 1 (HMGB1), peroxiredoxins (PRXs), and S100A8 and S100A9, were internalized through the class A scavenger receptors MSR1 and MARCO in vitro. In ischemic murine brain, DAMP internalization was largely mediated by MSR1. An elevation of MSR1 levels in infiltrating myeloid cells observed 3 d after experimental stroke was dependent on the transcription factor Mafb. Combined deficiency for Msr1 and Marco, or for Mafb alone, in infiltrating myeloid cells caused impaired clearance of DAMPs, more severe inflammation, and exacerbated neuronal injury in a murine model of ischemic stroke. The retinoic acid receptor (RAR) agonist Am80 increased the expression of Mafb, thereby enhancing MSR1 expression. Am80 exhibited therapeutic efficacy when administered, even at 24 h after the onset of experimental stroke. Our findings uncover cellular mechanisms contributing to DAMP clearance in resolution of the sterile inflammation triggered by tissue injury.	[Shichita, Takashi; Ito, Minako; Morita, Rimpei; Komai, Kyoko; Noguchi, Yoshiko; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Shichita, Takashi; Ito, Minako; Morita, Rimpei; Komai, Kyoko; Noguchi, Yoshiko; Yoshimura, Akihiko] Japan Agcy Med Res & Dev AMED, Core Res Evolut Sci & Technol, Tokyo, Japan; [Shichita, Takashi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Shichita, Takashi] Tokyo Metropolitan Inst Med Sci, Stroke Renaissance Project, Tokyo, Japan; [Shichita, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan; [Ooboshi, Hiroaki] Fukuoka Dent Coll, Med & Dent Hosp, Dept Internal Med, Fukuoka, Japan; [Koshida, Ryusuke; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo, Japan	Keio University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science; Kyushu University; Fukuoka Dental College (FDC); University of Tsukuba; University of Tokyo	Shichita, T; Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.; Shichita, T; Yoshimura, A (corresponding author), Japan Agcy Med Res & Dev AMED, Core Res Evolut Sci & Technol, Tokyo, Japan.; Shichita, T (corresponding author), Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan.; Shichita, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Stroke Renaissance Project, Tokyo, Japan.; Shichita, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan.	shichita@z2.keio.jp; yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	Koshida, Ryusuke/0000-0003-4726-7282	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [15H01387]; JSPS [26870571, 25221305]; Advanced Research & Development Programs for Medical Innovation (AMED-CREST); Toray Science and Technology Grant; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Heart Foundation Research Grant; SENSHIN Medical Research Foundation; Keio Gijuku Academic Developmental Funds; Open Research for Young Academics and Specialists from MEXT; PRESTO from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [16H06276] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Research & Development Programs for Medical Innovation (AMED-CREST); Toray Science and Technology Grant(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Heart Foundation Research Grant; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Keio Gijuku Academic Developmental Funds; Open Research for Young Academics and Specialists from MEXT; PRESTO from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Shiino, A. Ino, and M. Asakawa for their technical assistance and H. Yao for his technical advice on the MCAO model. Msr1/Marco-deficient mice were kindly provided by K. Tryggvason (Duke-NUS Medical School). This work was supported by PRESTO from the Japan Science and Technology Agency (T.S.), a Grant-in-Aid for Scientific Research on Innovative Areas (Homeostatic regulation by various types of cell death) (15H01387) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (T.S.), JSPS KAKENHI Grants-in-Aid for Young Scientists (B) (26870571) (T.S.) and (S) (25221305) (A.Y.), Advanced Research & Development Programs for Medical Innovation (AMED-CREST) (A.Y.), a Toray Science and Technology Grant (T.S.), the Takeda Science Foundation (T.S.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.S.), a Japan Heart Foundation Research Grant (T.S.), the SENSHIN Medical Research Foundation (A.Y.), Keio Gijuku Academic Developmental Funds (A.Y.), and Open Research for Young Academics and Specialists from MEXT (A.Y.).	Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen YY, 2005, J IMMUNOL, V175, P8173, DOI 10.4049/jimmunol.175.12.8173; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; Desestret V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067063; Dirnagl U, 2014, STROKE, V45, P1510, DOI 10.1161/STROKEAHA.113.004075; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Hamada M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4147; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Katsuki H, 2009, J NEUROCHEM, V110, P707, DOI 10.1111/j.1471-4159.2009.06171.x; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Klichko VI, 2016, BBA-MOL BASIS DIS, V1862, P265, DOI 10.1016/j.bbadis.2015.12.008; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuang X, 2014, FREE RADICAL BIO MED, V71, P165, DOI 10.1016/j.freeradbiomed.2014.03.028; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Matsushita H, 2011, J CEREBR BLOOD F MET, V31, P222, DOI 10.1038/jcbfm.2010.80; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Muto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074639; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Rashidian J, 2009, J NEUROSCI, V29, P12497, DOI 10.1523/JNEUROSCI.3892-09.2009; Riddell J. R., 2011, CANCER RES, V71, P1; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Schlegel J, 2004, J NEUROSCI METH, V137, P215, DOI 10.1016/j.jneumeth.2004.02.010; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Takeuchi H, 2013, J IMMUNOL, V191, P3725, DOI 10.4049/jimmunol.1300032; Uzawa A, 2015, J NEUROIMMUNOL, V287, P16, DOI 10.1016/j.jneuroim.2015.07.013; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wieghofer P, 2015, GLIA, V63, P1, DOI 10.1002/glia.22727; Yao H, 2003, STROKE, V34, P2716, DOI 10.1161/01.STR.0000094730.38343.73; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003; Zimmer S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6100	59	105	108	5	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					723	+		10.1038/nm.4312	http://dx.doi.org/10.1038/nm.4312			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28394332				2022-12-27	WOS:000402768000015
J	Morel, AP; Ginestier, C; Pommier, RM; Cabaud, O; Ruiz, E; Wicinski, J; Devouassoux-Shisheboran, M; Combaret, V; Finetti, P; Chassot, C; Pinatel, C; Fauvet, F; Saintigny, P; Thomas, E; Moyret-Lalle, C; Lachuer, J; Despras, E; Jauffret, JL; Bertucci, F; Guitton, J; Wierinckx, A; Wang, Q; Radosevic-Robin, N; Penault-Llorca, F; Cox, DG; Hollande, F; Ansieau, S; Caramel, J; Birnbaum, D; Vigneron, AM; Tissier, A; Charafe-Jauffret, E; Puisieux, A				Morel, Anne-Pierre; Ginestier, Christophe; Pommier, Roxane M.; Cabaud, Olivier; Ruiz, Emmanuelle; Wicinski, Julien; Devouassoux-Shisheboran, Mojgan; Combaret, Valerie; Finetti, Pascal; Chassot, Christelle; Pinatel, Christiane; Fauvet, Frederique; Saintigny, Pierre; Thomas, Emilie; Moyret-Lalle, Caroline; Lachuer, Joel; Despras, Emmanuelle; Jauffret, Jean-Luc; Bertucci, Francois; Guitton, Jerome; Wierinckx, Anne; Wang, Qing; Radosevic-Robin, Nina; Penault-Llorca, Frederique; Cox, David G.; Hollande, Frederic; Ansieau, Stephane; Caramel, Julie; Birnbaum, Daniel; Vigneron, Arnaud M.; Tissier, Agnes; Charafe-Jauffret, Emmanuelle; Puisieux, Alain			A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability	NATURE MEDICINE			English	Article							DNA-DAMAGE RESPONSE; EPITHELIAL-MESENCHYMAL TRANSITION; ONCOGENE-INDUCED SENESCENCE; ACTIVATED PROTEIN-KINASE; PROBE LEVEL DATA; CYCLIN-E; MOLECULAR CHARACTERIZATION; HUMAN-CELLS; TUMOR; INSTABILITY	Chromosomal instability (CIN), a feature of most adult neoplasms from their early stages onward, is a driver of tumorigenesis. However, several malignancy subtypes, including some triple-negative breast cancers, display a paucity of genomic aberrations, thus suggesting that tumor development may occur in the absence of CIN. Here we show that the differentiation status of normal human mammary epithelial cells dictates cell behavior after an oncogenic event and predetermines the genetic routes toward malignancy. Whereas oncogene induction in differentiated cells induces massive DNA damage, mammary stem cells are resistant, owing to a preemptive program driven by the transcription factor ZEB1 and the methionine sulfoxide reductase MSRB3. The prevention of oncogene-induced DNA damage precludes induction of the oncosuppressive p53-dependent DNA-damage response, thereby increasing stem cells' intrinsic susceptibility to malignant transformation. In accord with this model, a subclass of breast neoplasms exhibit unique pathological features, including high ZEB1 expression, a low frequency of TP53 mutations and low CIN.	[Morel, Anne-Pierre; Pommier, Roxane M.; Ruiz, Emmanuelle; Devouassoux-Shisheboran, Mojgan; Chassot, Christelle; Pinatel, Christiane; Fauvet, Frederique; Saintigny, Pierre; Moyret-Lalle, Caroline; Lachuer, Joel; Wierinckx, Anne; Cox, David G.; Ansieau, Stephane; Caramel, Julie; Vigneron, Arnaud M.; Tissier, Agnes; Puisieux, Alain] Univ Claude Bernard Lyon 1, Ctr Leon Berard, Equipe Labellisee Ligue Canc, INSERM 1052,CNRS 5286,Canc Res Ctr Lyon, Lyon, France; [Morel, Anne-Pierre; Pommier, Roxane M.; Ruiz, Emmanuelle; Devouassoux-Shisheboran, Mojgan; Chassot, Christelle; Pinatel, Christiane; Fauvet, Frederique; Saintigny, Pierre; Moyret-Lalle, Caroline; Lachuer, Joel; Wierinckx, Anne; Cox, David G.; Ansieau, Stephane; Caramel, Julie; Vigneron, Arnaud M.; Tissier, Agnes; Puisieux, Alain] Univ Lyon, LabEx DEVweCAN, Lyon, France; [Ginestier, Christophe; Cabaud, Olivier; Wicinski, Julien; Finetti, Pascal; Bertucci, Francois; Birnbaum, Daniel; Charafe-Jauffret, Emmanuelle] Univ Aix Marseille, INSERM, Inst Paoli Calmettes, CRCM,Mol Oncol,Equipe Labellisee Ligue Canc,CNRS, Marseille, France; [Devouassoux-Shisheboran, Mojgan] Hosp Civils Lyon, Hop Croix Rousse, Lyon, France; [Combaret, Valerie; Wang, Qing] Ctr Leon Berard, Lyon, France; [Thomas, Emilie] Fdn Synergie Lyon Canc, Ctr Leon Berard, Lyon, France; [Lachuer, Joel; Wierinckx, Anne] ProfileXpert, Bron, France; [Despras, Emmanuelle] Univ Paris Sud, Unit Genet Stabil & Oncogenesis, Inst Cancerol Gustave Roussy, Equipe Labellisee Ligue Canc,CNRS UMR 8200, Villejuif, France; [Jauffret, Jean-Luc] Clin Phenicia, Marseille, France; [Guitton, Jerome] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France; [Radosevic-Robin, Nina; Penault-Llorca, Frederique] Univ Auvergne, Dept Pathol, Jean Perrin Canc Ctr, Clermont Ferrand, France; [Radosevic-Robin, Nina; Penault-Llorca, Frederique] Univ Auvergne, ERTICa Res Grp, Clermont Ferrand, France; [Hollande, Frederic] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); CHU Lyon; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); University of Melbourne	Puisieux, A (corresponding author), Univ Claude Bernard Lyon 1, Ctr Leon Berard, Equipe Labellisee Ligue Canc, INSERM 1052,CNRS 5286,Canc Res Ctr Lyon, Lyon, France.; Puisieux, A (corresponding author), Univ Lyon, LabEx DEVweCAN, Lyon, France.	alain.puisieux@lyon.unicancer.fr	Cox, David G/A-2023-2009; Moyret-Lalle, Caroline/G-2742-2013; Ansieau, Stephane/I-6195-2016; Vigneron, Arnaud/ABC-7306-2021; Hollande, Frederic/GLS-4120-2022; MOREL, Anne-Pierre/AAN-7072-2021; Ginestier, Christophe/M-8828-2017; Wierinckx, Anne/AAF-5233-2021; Cox, David/ABA-7454-2020; Tissier, Agnes/I-4850-2018; Finetti, Pascal/O-8669-2017	Cox, David G/0000-0002-2152-9259; Moyret-Lalle, Caroline/0000-0002-8359-2018; Vigneron, Arnaud/0000-0003-4161-0676; Hollande, Frederic/0000-0002-7046-8392; Ginestier, Christophe/0000-0002-7477-3837; Wierinckx, Anne/0000-0002-0186-6645; ANSIEAU, Stephane/0000-0003-0989-2108; Caramel, Julie/0000-0002-8883-918X; Thomas, Emilie/0000-0002-8313-7218; lachuer, joel/0000-0002-5209-5094; TISSIER, Agnes/0000-0002-5676-8719; Birnbaum, Daniel/0000-0001-7920-9883; PUISIEUX, Alain/0000-0002-9938-3798; Saintigny, Pierre/0000-0002-8090-9323; Guitton, Jerome/0000-0001-6180-5708; Cox, David/0000-0003-2047-4687; Bertucci, Francois/0000-0002-0157-0959; Finetti, Pascal/0000-0002-2674-3123; POMMIER, Roxane/0000-0002-5351-7367	Ligue Nationale contre le Cancer [EL2011.LNCC/AP, EL2016.LNCC/AIP]; Project National Cancer Association; Lyon Integrated Research Institute in Cancer (LYRIC) [INCa 4664]; Institut National contre le Cancer [PLBio 2015-266, PLBIO12-007]; Cancer-DGOS grant [TRANSLA11-103]; Marseille Integrated Research Institute in Cancer [INCa 6038]	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Project National Cancer Association; Lyon Integrated Research Institute in Cancer (LYRIC); Institut National contre le Cancer; Cancer-DGOS grant; Marseille Integrated Research Institute in Cancer	The authors thank I. Treilleux and G. Clapisson (Resource Biological Center) for providing tumor samples; N. Nazaret for sequencing analysis; P. Kannouche for providing help and laboratory space for the DNA-fiber spreading analysis; I. Iacono, S. Brejon, A. Pierrot, J. Perrossier and S. Croze for technical support; D. Negre (CIRI/EVIR) for providing the pWPIR-GFP lentiviral vector; C. Eaves (Terry Fox Laboratory) for providing cells; and M. Tommasino (IARC) for providing vectors. We thank the CRCM animal core facility for animal housing and the CRCM flow cytometry core (M.L. Thibullt) for technical assistance. We also thank B. Manship for critical reading of the manuscript. This work was supported by funding from the Ligue Nationale contre le Cancer (EL2011.LNCC/AP and EL2016.LNCC/AIP) and the Project National Cancer Association, Lyon Integrated Research Institute in Cancer (LYRIC, INCa 4664) to A.P. This work was additionally supported by funding from the Institut National contre le Cancer (project PLBio 2015-266) to P.S., the Institut National contre le Cancer (project PLBIO12-007) to E.D., a Cancer-DGOS grant (TRANSLA11-103) to E.C.-J. and the Marseille Integrated Research Institute in Cancer (INCa 6038) to D.B.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Barton MC, 2006, J CELL PHYSIOL, V209, P686, DOI 10.1002/jcp.20818; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Carr D., 2011, HEXBIN HEXAGONAL BIN; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chen X, 2015, ONCOGENE, V34, P5207, DOI 10.1038/onc.2014.474; Comaills V, 2016, CELL REP, V17, P2632, DOI 10.1016/j.celrep.2016.11.022; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dou QP, 1996, NAT MED, V2, P254, DOI 10.1038/nm0396-254a; Eirew P, 2012, STEM CELLS, V30, P344, DOI 10.1002/stem.1001; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Ghebeh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-289; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grigoriadis A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-619; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Machon C, 2014, ANAL BIOANAL CHEM, V406, P2925, DOI 10.1007/s00216-014-7711-1; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nguyen LV, 2015, NATURE, V528, P267, DOI 10.1038/nature15742; Nielsen NH, 1996, BRIT J CANCER, V74, P874, DOI 10.1038/bjc.1996.451; Omberg L, 2013, NAT GENET, V45, P1121, DOI 10.1038/ng.2761; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; R Core Team, 2018, R LANG ENV STAT COMP; Schepeler T, 2013, ONCOGENE, V32, P3577, DOI 10.1038/onc.2012.381; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran PT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002650; Voduc D, 2008, HUM PATHOL, V39, P1431, DOI 10.1016/j.humpath.2008.03.004; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Walker LC, 2008, GENE CHROMOSOME CANC, V47, P405, DOI 10.1002/gcc.20545; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Weigelt B, 2015, MODERN PATHOL, V28, P340, DOI 10.1038/modpathol.2014.142; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y; Yang CC, 2015, AM J TRANSL RES, V7, P1009; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013	76	88	90	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2017	23	5					568	+		10.1038/nm.4323	http://dx.doi.org/10.1038/nm.4323			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ET9TI	28394329				2022-12-27	WOS:000400650700012
J	Chang, JL; Mancuso, MR; Maier, C; Liang, XB; Yuki, K; Yang, L; Kwong, JW; Wang, J; Vallon, VRM; Vallon, M; Kosinski, C; Zhang, JJH; Mah, AT; Xu, LJ; Li, L; Gholamin, S; Reyes, TF; Li, R; Kuhnert, F; Han, XY; Yuan, J; Chiou, SH; Brettman, AD; Daly, L; Corney, DC; Cheshier, SH; Shortliffe, LD; Wu, XW; Snyder, M; Chan, P; Giffard, RG; Chang, HY; Andreasson, K; Kuo, CJ				Chang, Junlei; Mancuso, Michael R.; Maier, Carolina; Liang, Xibin; Yuki, Kanako; Yang, Lu; Kwong, Jeffrey W.; Wang, Jing; Rao, Varsha; Vallon, Mario; Kosinski, Cynthia; Zhang, J. J. Haijing; Mah, Amanda T.; Xu, Lijun; Li, Le; Gholamin, Sharareh; Reyes, Teresa F.; Li, Rui; Kuhnert, Frank; Han, Xiaoyuan; Yuan, Jenny; Chiou, Shin-Heng; Brettman, Ari D.; Daly, Lauren; Corney, David C.; Cheshier, Samuel H.; Shortliffe, Linda D.; Wu, Xiwei; Snyder, Michael; Chan, Pak; Giffard, Rona G.; Chang, Howard Y.; Andreasson, Katrin; Kuo, Calvin J.			Gpr124 is essential for blood-brain barrier integrity in central nervous system disease	NATURE MEDICINE			English	Article							RETINAL VASCULAR DEVELOPMENT; TUMOR-SUPPRESSOR PROTEIN; CEREBRAL-HEMORRHAGE; ENDOTHELIAL-CELLS; COUPLED RECEPTOR; CNS ANGIOGENESIS; PERICYTES; EXPRESSION; NORRIN; BETA	Although blood-brain barrier (BBB) compromise is central to the etiology of diverse central nervous system (CNS) disorders, endothelial receptor proteins that control BBB function are poorly defined. The endothelial G-protein-coupled receptor (GPCR) Gpr124 has been reported to be required for normal forebrain angiogenesis and BBB function in mouse embryos, but the role of this receptor in adult animals is unknown. Here Gpr124 conditional knockout (CKO) in the endothelia of adult mice did not affect homeostatic BBB integrity, but resulted in BBB disruption and microvascular hemorrhage in mouse models of both ischemic stroke and glioblastoma, accompanied by reduced cerebrovascular canonical Wnt-b-catenin signaling. Constitutive activation of Wnt-b-catenin signaling fully corrected the BBB disruption and hemorrhage defects of Gpr124-CKO mice, with rescue of the endothelial gene tight junction, pericyte coverage and extracellular-matrix deficits. We thus identify Gpr124 as an endothelial GPCR specifically required for endothelial Wnt signaling and BBB integrity under pathological conditions in adult mice. This finding implicates Gpr124 as a potential therapeutic target for human CNS disorders characterized by BBB disruption.	[Chang, Junlei; Mancuso, Michael R.; Yuki, Kanako; Kwong, Jeffrey W.; Vallon, Mario; Kosinski, Cynthia; Zhang, J. J. Haijing; Mah, Amanda T.; Reyes, Teresa F.; Kuhnert, Frank; Yuan, Jenny; Brettman, Ari D.; Daly, Lauren; Corney, David C.; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Maier, Carolina; Gholamin, Sharareh; Cheshier, Samuel H.; Chan, Pak] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Liang, Xibin; Wang, Jing; Andreasson, Katrin] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Yang, Lu; Wu, Xiwei] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA USA; [Yang, Lu; Wu, Xiwei] City Hope Natl Med Ctr, Integrat Genom Core, Duarte, CA USA; [Rao, Varsha; Chiou, Shin-Heng; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Xu, Lijun; Li, Le; Giffard, Rona G.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Li, Rui; Chang, Howard Y.] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Han, Xiaoyuan; Shortliffe, Linda D.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Sch Med, Stanford, CA 94305 USA; [Chang, Junlei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Antibody Drug, Shenzhen, Peoples R China	Stanford University; Stanford University; Stanford University; City of Hope; City of Hope; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Kuo, CJ (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	cjkuo@stanford.edu	Daly, Lauren/ABE-4154-2020; Chang, Junlei/K-2696-2017; Han, Xiaoyuan/AAY-1974-2020; Zhang, JJ H/F-1557-2019	Daly, Lauren/0000-0002-4506-9736; Chang, Junlei/0000-0002-0319-9022; Han, Xiaoyuan/0000-0001-6394-3055; Zhang, JJ H/0000-0003-3077-0770; Snyder, Michael/0000-0003-0784-7987; Gholamin, Sharareh/0000-0001-7425-6074; Giffard, Rona/0000-0003-2173-4436; Kuo, Calvin/0000-0002-7427-5985	NIH [S10RR025518-01, S10RR027431-01, P50-HG007735, R01HL074267, R01NS064517, U01DK085527, R01CA158528]; American Heart Association [15POST23020039]; Stanford Medical Scientist Training Program (NIGMS) [GM07365]; Howard Hughes Medical Institute Medical Research Fellows Program; American Heart Association Innovative Science Award [12PILT12850014]; Stanford Stroke Collaborative Action Network Pilot Grant; NATIONAL CANCER INSTITUTE [R01CA158528, T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431, S10RR025518] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074267] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064517] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stanford Medical Scientist Training Program (NIGMS); Howard Hughes Medical Institute Medical Research Fellows Program(Howard Hughes Medical Institute); American Heart Association Innovative Science Award; Stanford Stroke Collaborative Action Network Pilot Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to members of the Kuo laboratory, J. Yang and P. Han for helpful comments. We thank P. Chu (Stanford Histology Core Facility), J. Perrino (Stanford Electron Microscopy Facility) and C. Crumpton, T. Knaak, B. Gomez, O. Herman and M. Bigos (Stanford Shared FACS Facility). FACS sorting and analysis used instruments in the Shared FACS Facility, obtained using NIH S10 Shared Instrument Grant (S10RR025518-01, S10RR027431-01) to the Stanford Shared FACS Facility. We thank M. Edwards (Department of Neurosurgery, Stanford University) for providing the human glioblastoma specimens. We thank R. Adams (Max Planck Institute for Molecular Biomedicine) for providing the Cdh5-CreER mice. We thank the National Cancer Institute-DCTD Repository for providing the GL261 cell line. J.C. was supported by an American Heart Association Postdoctoral Fellowship (15POST23020039) and M. R. M. was supported by the Stanford Medical Scientist Training Program (NIGMS GM07365). J.H.Z. was supported by a Howard Hughes Medical Institute Medical Research Fellows Program grant. H.Y.C. was supported by NIH grant P50-HG007735. This work was also supported by American Heart Association Innovative Science Award 12PILT12850014, a Stanford Stroke Collaborative Action Network Pilot Grant and NIH grants R01HL074267, R01NS064517, U01DK085527 and R01CA158528 to C.J.K.	Airley R, 2001, CLIN CANCER RES, V7, P928; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Burgi S, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00029; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chandana EPS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-84; Chen ZL, 2013, J CELL BIOL, V202, P381, DOI 10.1083/jcb.201212032; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dejana E, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001793; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Ritzel RM, 2013, HORM BEHAV, V63, P238, DOI 10.1016/j.yhbeh.2012.04.007; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Tran KA, 2016, CIRCULATION, V133, P177, DOI 10.1161/CIRCULATIONAHA.115.015982; Ulrich F, 2016, DEVELOPMENT, V143, P1055, DOI 10.1242/dev.136507; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Vanhollebeke B, 2015, ELIFE, V4, DOI 10.7554/eLife.06489; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang HA, 2010, J NEUROCHEM, V115, P385, DOI 10.1111/j.1471-4159.2010.06933.x; Wang W, 2016, MOL NEUROBIOL, V53, P7028, DOI 10.1007/s12035-015-9607-2; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wu CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16151; Xiong XX, 2015, STROKE, V46, P2271, DOI 10.1161/STROKEAHA.115.008897; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	64	111	111	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					450	+		10.1038/nm.4309	http://dx.doi.org/10.1038/nm.4309			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28288111	Green Submitted, Green Accepted			2022-12-27	WOS:000398768100013
J	Guo, B; Huang, XX; Cooper, S; Broxmeyer, HE				Guo, Bin; Huang, Xinxin; Cooper, Scott; Broxmeyer, Hal E.			Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment	NATURE MEDICINE			English	Article							RECEPTOR; CXCR4; COREGULATORS; EXPRESSION; EXPANSION	Efficient hematopoietic stem cell (HSC) homing is important for hematopoietic cell transplantation (HCT), especially when HSC numbers are limited, as in the use of cord blood (CB). In a screen of small-molecule compounds, we identified glucocorticoid (GC) hormone signaling as an activator of CXCR4 expression in human CB HSCs and hematopoietic progenitor cells (HPCs). Short-term GC pretreatment of human CB HSCs and HPCs promoted SDF-1-CXCR4-axis-mediated chemotaxis, homing, and long-term engraftment when these cells were transplanted into primary-and secondary-recipient NSG mice. Mechanistically, activated glucocorticoid receptor binds directly to a glucocorticoid response element in the CXCR4 promoter and recruits the SRC-1-p300 complex to promote H4K5 and H4K16 histone acetylation, facilitating transcription of CXCR4. These results suggest a new and readily available means to enhance the clinical efficacy of CB HCT.	[Guo, Bin; Huang, Xinxin; Cooper, Scott; Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Broxmeyer, HE (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu		Huang, Xinxin/0000-0002-4298-4859	US Public Health Service Grants from NIH [R01 HL112669, R01 HL056416, U54 DK106846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056416, R01HL112669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106846] Funding Source: NIH RePORTER	US Public Health Service Grants from NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US Public Health Service Grants from the NIH to H.E.B. (R01 HL112669, R01 HL056416, U54 DK106846).	Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Capitano ML, 2015, STEM CELLS, V33, P1975, DOI 10.1002/stem.1988; Capitano ML, 2016, BIOMEDICAL SCI ENCY, V3, P624; Chaurasia P, 2014, J CLIN INVEST, V124, P2378, DOI 10.1172/JCI70313; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Gul H, 2009, STEM CELLS DEV, V18, P831, DOI 10.1089/scd.2008.0235; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; HOGGER P, 1994, STEROIDS, V59, P597, DOI 10.1016/0039-128X(94)90054-X; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595	20	59	60	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					424	+		10.1038/nm.4298	http://dx.doi.org/10.1038/nm.4298			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28263313	Green Accepted, Green Submitted			2022-12-27	WOS:000398768100010
J	Misu, H; Takayama, H; Saito, Y; Mita, Y; Kikuchi, A; Ishii, K; Chikamoto, K; Kanamori, T; Tajima, N; Lan, F; Takeshita, Y; Honda, M; Tanaka, M; Kato, S; Matsuyama, N; Yoshioka, Y; Iwayama, K; Tokuyama, K; Akazawa, N; Maeda, S; Takekoshi, K; Matsugo, S; Noguchi, N; Kaneko, S; Takamura, T				Misu, Hirofumi; Takayama, Hiroaki; Saito, Yoshiro; Mita, Yuichiro; Kikuchi, Akihiro; Ishii, Kiyo-aki; Chikamoto, Keita; Kanamori, Takehiro; Tajima, Natsumi; Lan, Fei; Takeshita, Yumie; Honda, Masao; Tanaka, Mutsumi; Kato, Seiji; Matsuyama, Naoto; Yoshioka, Yuya; Iwayama, Kaito; Tokuyama, Kumpei; Akazawa, Nobuhiko; Maeda, Seiji; Takekoshi, Kazuhiro; Matsugo, Seiichi; Noguchi, Noriko; Kaneko, Shuichi; Takamura, Toshinari			Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle	NATURE MEDICINE			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; SKELETAL-MUSCLE; INSULIN-RESISTANCE; MITOCHONDRIAL BIOGENESIS; POSTMENOPAUSAL WOMEN; HUMAN PLASMA; SELENIUM; ADAPTATION; HEALTH; GENE	Exercise has numerous health-promoting effects in humans(1); however, individual responsiveness to exercise with regard to endurance or metabolic health differs markedly(2-4). This 'exercise resistance' is considered to be congenital, with no evident acquired causative factors. Here we show that the anti-oxidative hepatokine selenoprotein P (SeP)(5-7) causes exercise resistance through its muscle receptor low-density lipoprotein receptor-related protein 1 (LRP1)(8). SeP-deficient mice showed a 'super-endurance' phenotype after exercise training, as well as enhanced reactive oxygen species (ROS) production, AMP-activated protein kinase (AMPK) phosphorylation(9) and peroxisome proliferative activated receptor gamma coactivator (Ppargc)-1 alpha (also known as PGC-1 alpha; encoded by Ppargc1a)(10) expression in skeletal muscle. Supplementation with the anti-oxidant N-acetylcysteine (NAC) reduced ROS production and the endurance capacity in SeP-deficient mice. SeP treatment impaired hydrogen-peroxide-induced adaptations through LRP1 in cultured myotubes and suppressed exercise-induced AMPK phosphorylation and Ppargc1a gene expression in mouse skeletal muscle-effects which were blunted in mice with a muscle-specific LRP1 deficiency. Furthermore, we found that increased amounts of circulating SeP predicted the ineffectiveness of training on endurance capacity in humans. Our study suggests that inhibitors of the SeP-LRP1 axis may function as exercise-enhancing drugs to treat diseases associated with a sedentary lifestyle.	[Misu, Hirofumi; Takayama, Hiroaki; Kikuchi, Akihiro; Ishii, Kiyo-aki; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa, Japan; [Misu, Hirofumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Takayama, Hiroaki; Kikuchi, Akihiro; Ishii, Kiyo-aki; Chikamoto, Keita; Kanamori, Takehiro; Tajima, Natsumi; Lan, Fei; Takeshita, Yumie; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Syst Biol, Kanazawa, Ishikawa, Japan; [Saito, Yoshiro; Mita, Yuichiro; Yoshioka, Yuya; Noguchi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Kyotanabe, Japan; [Chikamoto, Keita; Matsugo, Seiichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kanazawa, Ishikawa, Japan; [Lan, Fei] Chengdu First Peoples Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China; [Tanaka, Mutsumi; Kato, Seiji; Matsuyama, Naoto] Alfresa Pharma Corp, R&D Headquarters, Diagnost R&D, Ibaraki, Japan; [Iwayama, Kaito; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, Tsukuba, Ibaraki, Japan; [Akazawa, Nobuhiko; Maeda, Seiji] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Takekoshi, Kazuhiro] Univ Tsukuba, Div Sports Sci, Fac Med, Tsukuba, Ibaraki, Japan; [Matsugo, Seiichi] Kanazawa Univ, Fac Nat Syst, Inst Sci & Engn, Kanazawa, Ishikawa, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Kanazawa University; Doshisha University; Kanazawa University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Kanazawa University	Misu, H; Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa, Japan.; Misu, H (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	hmisu@m-kanazawa.jp; ttakamura@m-kanazawa.jp	Takayama, Hiroaki/C-4694-2015; Saito, Yoshiro/H-4597-2019; Akazawa, Nov/AAY-5496-2021; AKAZAWA, Nobuhiko/AAW-9680-2021	Takayama, Hiroaki/0000-0003-4792-3868; Saito, Yoshiro/0000-0002-0559-5889; Ishii, Kiyo-aki/0000-0001-9846-5575; Kikuchi, Akihiro/0000-0001-9332-1273	JSPS KAKENHI [25461334, 25292078, 16K09740, 26461329, 26253046]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan; JST Adaptable and Seamless Technology Transfer Program (A-STEP) [AS2311400F, 15im0302407]; Grants-in-Aid for Scientific Research [26461328] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan; JST Adaptable and Seamless Technology Transfer Program (A-STEP); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Furuta, M. Wakabayashi, M. Kawamura, Y. Yamashita and A. Hayashi for technical assistance and H. Asakura for advice on statistical analysis. We also thank K.E. Hill and R.F. Burk (Vanderbilt University School of Medicine) for the Sepp1-knockout mice and C.R. Kahn (Joslin Diabetes Center) for the MCK-Cre transgenic mice. This work was supported by JSPS KAKENHI grants 25461334 (H. M.), 25292078 (Y.S.), 16K09740 (H. M.), 26461329 (T.T.) and 26253046 (S. Kaneko), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (H. M.), the Takeda Science Foundation (H. M.), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan for years 2012-2016 (N.N.) and JST Adaptable and Seamless Technology Transfer Program (A-STEP) grants AS2311400F (H. M., Y. S. and M.T.) and 15im0302407 (H.M., Y.S. and M.T.).	Akazawa N, 2012, NUTR RES, V32, P795, DOI 10.1016/j.nutres.2012.09.002; Arteel GE, 1998, BIOL CHEM, V379, P1201; Bamman MM, 1998, J APPL PHYSIOL, V84, P157, DOI 10.1152/jappl.1998.84.1.157; Barres R, 2016, NAT REV ENDOCRINOL, V12, P441, DOI 10.1038/nrendo.2016.87; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bishop-Bailey D, 2013, BRIT J PHARMACOL, V170, P1153, DOI 10.1111/bph.12399; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2011, COMPR PHYSIOL, V1, P1603, DOI 10.1002/cphy.c100059; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burk RF, 2014, FASEB J, V28, P3579, DOI 10.1096/fj.14-252874; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Caito SW, 2011, BRAIN RES, V1398, P1, DOI 10.1016/j.brainres.2011.04.046; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007; Chida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060561; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 1996, BBA-MOL CELL RES, V1313, P29, DOI 10.1016/0167-4889(96)00047-X; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Jeon YH, 2014, BBA-MOL CELL RES, V1843, P1356, DOI 10.1016/j.bbamcr.2014.04.002; Kacerovsky-Bielesz G, 2009, DIABETES, V58, P1333, DOI 10.2337/db08-1240; Kang C, 2009, FREE RADICAL BIO MED, V47, P1394, DOI 10.1016/j.freeradbiomed.2009.08.007; Kitajima S, 2015, CLIN EXP NEPHROL, V19, P278, DOI 10.1007/s10157-014-0987-9; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Niess AM, 2007, FRONT BIOSCI-LANDMRK, V12, P4826, DOI 10.2741/2431; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Osler ME, 2015, DIABETES CARE, V38, P1154, DOI 10.2337/dc14-2606; Rasmussen LB, 2009, J TRACE ELEM MED BIO, V23, P265, DOI 10.1016/j.jtemb.2009.03.009; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Saito Y, 2000, J HEALTH SCI, V46, P409; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Saito Y, 2002, EUR J BIOCHEM, V269, P5746, DOI 10.1046/j.1432-1033.2002.03298.x; Saito Y, 2001, J HEALTH SCI, V47, P346, DOI 10.1248/jhs.47.346; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stephens NA, 2015, J CLIN ENDOCR METAB, V100, P43, DOI 10.1210/jc.2014-2545; Tanaka M, 2016, J CLIN LAB ANAL, V30, P114, DOI 10.1002/jcla.21824; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; Yao HD, 2013, BBA-GEN SUBJECTS, V1830, P3112, DOI 10.1016/j.bbagen.2013.01.007; Yoshizawa M, 2009, AM J PHYSIOL-HEART C, V297, pH1899, DOI 10.1152/ajpheart.00433.2009	58	96	95	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2017	23	4					508	+		10.1038/nm.4295	http://dx.doi.org/10.1038/nm.4295			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	ER4KJ	28263310				2022-12-27	WOS:000398768100019
J	Steinhart, Z; Pavlovic, Z; Chandrashekhar, M; Hart, T; Wang, XW; Zhang, XY; Robitaille, M; Browne, KR; Jaksani, S; Overmeer, R; Boj, SF; Adams, J; Pan, J; Clevers, H; Sidhu, S; Moffat, J; Angers, S				Steinhart, Zachary; Pavlovic, Zvezdan; Chandrashekhar, Megha; Hart, Traver; Wang, Xiaowei; Zhang, Xiaoyu; Robitaille, Melanie; Browne, Kevin R.; Jaksani, Sridevi; Overmeer, Rene; Boj, Sylvia F.; Adams, Jarrett; Pan, James; Clevers, Hans; Sidhu, Sachdev; Moffat, Jason; Angers, Stephane			Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors	NATURE MEDICINE			English	Article							MUTATIONAL LANDSCAPE; ESSENTIAL GENES; HUMAN-CELLS; WNT; CANCER; GROWTH; RNF43; INHIBITION; MECHANISMS; RECEPTORS	Forward genetic screens with CRISPR-Cas9 genome editing enable high-resolution detection of genetic vulnerabilities in cancer cells. We conducted genome-wide CRISPR-Cas9 screens in RNF43-mutant pancreatic ductal adenocarcinoma (PDAC) cells, which rely on Wnt signaling for proliferation. Through these screens, we discovered a unique requirement for a Wnt signaling circuit: engaging FZD5, one of the ten Frizzled receptors encoded in the human genome. Our results uncover an underappreciated level of context-dependent specificity at the Wnt receptor level. We further derived a panel of recombinant antibodies that reports the expression of nine FZD proteins and confirms that FZD5 functional specificity cannot be explained by protein expression patterns. Additionally, antibodies that specifically bind FZD5 and FZD8 robustly inhibited the growth of RNF43-mutant PDAC cells grown in vitro and as xenografts in vivo, providing orthogonal support for the functional specificity observed genetically. Proliferation of a patient-derived PDAC cell line harboring an RNF43 variant was also selectively inhibited by the FZD5 antibodies, further demonstrating their use as a potential targeted therapy. Tumor organoid cultures from colorectal carcinoma patients that carried RNF43 mutations were also sensitive to the FZD5 antibodies, highlighting the potential generalizability of these findings beyond PDAC. Our results show that CRIPSR-based genetic screens can be leveraged to identify and validate cell surface targets for antibody development and therapy.	[Steinhart, Zachary; Robitaille, Melanie; Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Pavlovic, Zvezdan; Chandrashekhar, Megha; Hart, Traver; Wang, Xiaowei; Zhang, Xiaoyu; Browne, Kevin R.; Adams, Jarrett; Pan, James; Sidhu, Sachdev; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Chandrashekhar, Megha; Zhang, Xiaoyu; Sidhu, Sachdev; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Wang, Xiaowei; Pan, James] Ctr Commercializat Antibodies & Biol, Toronto, ON, Canada; [Jaksani, Sridevi; Overmeer, Rene; Clevers, Hans] Univ Med Ctr, Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Jaksani, Sridevi; Overmeer, Rene; Clevers, Hans] Fdn Hubrecht Organoid Technol, Utrecht, Netherlands; [Moffat, Jason] Canadian Inst Adv Res, Toronto, ON, Canada; [Angers, Stephane] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Hart, Traver] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX USA	University of Toronto; University of Toronto; University of Toronto; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Canadian Institute for Advanced Research (CIFAR); University of Toronto; University of Texas System; UTMD Anderson Cancer Center	Angers, S (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada.; Sidhu, S; Moffat, J (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Sidhu, S; Moffat, J (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Moffat, J (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.; Angers, S (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	sachdev.sidhu@utoronto.ca; j.moffat@utoronto.ca; stephane.angers@utoronto.ca	Wang, Xiaowei/R-3888-2019; Robitaille, Melanie/ABA-5861-2020; Angers, Stephane/E-1432-2014; Zhang, xiaoyu/GXA-3206-2022; Moffat, Jason/AAC-1110-2020; Overmeer, René M/E-5698-2011	Wang, Xiaowei/0000-0001-8658-7399; Robitaille, Melanie/0000-0001-9354-5162; Angers, Stephane/0000-0001-7241-9044; Moffat, Jason/0000-0002-5663-8586; Brown, Kevin/0000-0002-5514-2538; Hart, Traver/0000-0002-1880-3341	Canadian Institutes for Health Research [CIHR-273548, CIHR-342551]; Ontario Research Fund; Ontario Research Fund [19442, 30961]; Canadian Foundation for Innovation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Ontario Research Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation)	We wish to thank members of the Angers and Moffat labs for discussions. We are thankful to D. Hedley (Princess Margaret Hospital, Toronto, Canada) and M. Tsao (Ontario Cancer Institute, Toronto, Canada) for providing the patient-derived xenograft cells; P. Mero (Moffat lab) for help with images. This work was supported from grants funded by the Canadian Institutes for Health Research to S.A. (CIHR-273548) and J.M. (CIHR-342551) and by the Ontario Research Fund to S.S. J.M. holds a Canada Research Chair in Functional Genomics of Cancer and S.A. holds a Canada Research Chair in Functional Architecture of Signal Transduction. Some of the equipment used in this study was supported by The 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project numbers 19442 and 30961.	Afelik S, 2015, DEV BIOL, V399, P204, DOI 10.1016/j.ydbio.2014.12.031; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jo YS, 2015, HUM PATHOL, V46, P1640, DOI 10.1016/j.humpath.2015.07.004; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Madan B, 2015, MOL CANCER THER, V14, P1087, DOI 10.1158/1535-7163.MCT-14-1038; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Polakis P, 2012, COLD SPRING HARB PER, V4; Ryland GL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0210-y; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	31	176	181	8	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					60	68		10.1038/nm.4219	http://dx.doi.org/10.1038/nm.4219			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27869803				2022-12-27	WOS:000391646800014
J	Mercer, PF; Chambers, RC				Mercer, Paul F.; Chambers, Rachel C.			Innate immune signaling and stem cell renewal in idiopathic pulmonary fibrosis	NATURE MEDICINE			English	Editorial Material							LUNG FIBROSIS; HYALURONAN; PROGRESSION; DISEASE; INJURY; REPAIR; MUC5B	Aberrant injury responses in the distal lung likely underpin the development of idiopathic pulmonary fibrosis (IPF). A recent study shows that defective Toll-like receptor 4 (TLR4)-mediated hyaluronan binding impairs alveolar type 2 cell renewal, which may contribute to a dysregulated lung-injury response in IPF.	[Mercer, Paul F.; Chambers, Rachel C.] UCL, UCL Div Med, UCL Resp, Ctr Inflammat & Tissue Repair, London, England	University of London; University College London	Chambers, RC (corresponding author), UCL, UCL Div Med, UCL Resp, Ctr Inflammat & Tissue Repair, London, England.	r.chambers@ucl.ac.uk		Chambers, Rachel/0000-0003-1370-9417				BJERMER L, 1989, THORAX, V44, P126, DOI 10.1136/thx.44.2.126; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Evans CM, 2016, PHYSIOL REV, V96, P1567, DOI 10.1152/physrev.00004.2016; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liang JR, 2016, NAT MED, V22, P1285, DOI 10.1038/nm.4192; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; Oldham JM, 2015, AM J RESP CRIT CARE, V192, P1475, DOI 10.1164/rccm.201505-1010OC; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660	12	3	3	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1210	1212		10.1038/nm.4230	http://dx.doi.org/10.1038/nm.4230			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27824820				2022-12-27	WOS:000387302300010
J	Tavana, O; Li, DW; Dai, C; Lopez, G; Banerjee, D; Kon, N; Chen, C; Califano, A; Yamashiro, DJ; Sun, HB; Gu, W				Tavana, Omid; Li, Dawei; Dai, Chao; Lopez, Gonzalo; Banerjee, Debarshi; Kon, Ning; Chen, Chao; Califano, Andrea; Yamashiro, Darrell J.; Sun, Hongbin; Gu, Wei			HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma	NATURE MEDICINE			English	Article							SMALL-MOLECULE INHIBITOR; TARGETED DISRUPTION; EMBRYONIC LETHALITY; P53; USP7/HAUSP; PHOSPHORYLATION; COMPLEX; PROTEIN; CANCER; AURORA	The MYCN proto-oncogene is amplified in a number of advanced-stage human tumors, such as neuroblastomas. Similar to other members of the MYC family of oncoproteins, MYCN (also known as N-Myc) is a transcription factor, and its stability and activity are tightly controlled by ubiquitination-dependent proteasome degradation(1-4). Although numerous studies have demonstrated that N-Myc is a driver of neuroblastoma tumorigenesis, therapies that directly suppress N-Myc activity in human tumors are limited. Here we have identified ubiquitin-specific protease 7 (USP7; also known as HAUSP)(5-7) as a regulator of N-Myc function in neuroblastoma. HAUSP interacts with N-Myc, and HAUSP expression induces deubiquitination and subsequent stabilization of N-Myc. Conversely, RNA interference (RNAi)-mediated knockdown of USP7 in neuroblastoma cancer cell lines, or genetic ablation of Usp7 in the mouse brain, destabilizes N-Myc, which leads to inhibition of N-Myc function. Notably, HAUSP is more abundant in patients with neuroblastoma who have poorer prognosis, and HAUSP expression substantially correlates with N-Myc transcriptional activity. Furthermore, small-molecule inhibitors of HAUSP's deubiquitinase activity markedly suppress the growth of MYCN-amplified human neuroblastoma cell lines in xenograft mouse models. Taken together, our findings demonstrate a crucial role of HAUSP in regulating N-Myc function in vivo and suggest that HAUSP inhibition is a potential therapy for MYCN-amplified tumors.	[Tavana, Omid; Li, Dawei; Dai, Chao; Lopez, Gonzalo; Kon, Ning; Califano, Andrea; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY USA; [Tavana, Omid; Li, Dawei; Dai, Chao; Lopez, Gonzalo; Banerjee, Debarshi; Kon, Ning; Califano, Andrea; Yamashiro, Darrell J.; Gu, Wei] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Lopez, Gonzalo; Califano, Andrea] Columbia Univ, Dept Syst Biol, Coll Phys & Surg, New York, NY USA; [Lopez, Gonzalo; Califano, Andrea] Columbia Univ, Coll Phys & Surg, Ctr Computat Biol & Bioinformat, New York, NY USA; [Banerjee, Debarshi; Yamashiro, Darrell J.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA; [Chen, Chao; Sun, Hongbin] China Pharmaceut Univ, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Chao; Sun, Hongbin] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Califano, Andrea] Columbia Univ, Dept Biomed Informat Biochem & Mol Biophys, Coll Phys & Surg, New York, NY USA; [Gu, Wei] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; China Pharmaceutical University; China Pharmaceutical University; Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY USA.; Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY USA.; Gu, W (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA.	wg8@cumc.columbia.edu	banerjee, debarshi/AAF-5704-2020	Yamashiro, Darrell/0000-0002-1250-0235; Tavana, Omid/0000-0001-8401-4546; Califano, Andrea/0000-0003-4742-3679; Lopez, Gonzalo/0000-0002-5092-1284; Li, Dawei/0000-0002-1094-9282	National Cancer Institute, US National Institutes of Health (NIH) [5R01CA193890, 5RO1CA190477, 5RO1CA085533, 2P01CA080058]; NIH cancer biology training grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [T32CA009503, U01CA217858, U01CA168426, P01CA080058, R01CA085533, R01CA193890, R01CA190477] Funding Source: NIH RePORTER	National Cancer Institute, US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH cancer biology training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank J. Maris (Children's Hospital of Philadelphia) for providing cell lines. This work was supported by the National Cancer Institute, US National Institutes of Health (NIH) (grant no. 5R01CA193890, 5RO1CA190477, 5RO1CA085533 and 2P01CA080058; all to W.G.) and was partially supported by the NIH cancer biology training grant T32-CA09503 (O.T.). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Cheng CD, 2013, ONCOL REP, V29, P1730, DOI 10.3892/or.2013.2342; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Kim ES, 2002, P NATL ACAD SCI USA, V99, P11399, DOI 10.1073/pnas.172398399; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kon N, 2011, CELL DEATH DIFFER, V18, P1366, DOI 10.1038/cdd.2011.12; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Pfoh R, 2015, ENDOCR-RELAT CANCER, V22, pT35, DOI 10.1530/ERC-14-0516; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; SAWAI S, 1993, DEVELOPMENT, V117, P1445; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	40	110	115	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1180	1186		10.1038/nm.4180	http://dx.doi.org/10.1038/nm.4180			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27618649	Green Accepted			2022-12-27	WOS:000384872500021
J	Banga, R; Procopio, FA; Noto, A; Pollakis, G; Cavassini, M; Ohmiti, K; Corpataux, JM; de Leval, L; Pantaleo, G; Perreau, M				Banga, Riddhima; Procopio, Francesco Andrea; Noto, Alessandra; Pollakis, Georgios; Cavassini, Matthias; Ohmiti, Khalid; Corpataux, Jean-Marc; de Leval, Laurence; Pantaleo, Giuseppe; Perreau, Matthieu			PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals	NATURE MEDICINE			English	Article							CXC CHEMOKINE RECEPTOR-5; LATENT RESERVOIR; STEM-CELL; REPLICATION	The mechanisms responsible for the persistence of HIV-1 after many years of suppressive antiretroviral therapy (ART) have been only partially elucidated. Most of the studies investigating HIV-1 persistence have been performed with blood, although it is well known that germinal centers (GCs) within lymph nodes (LNs) serve as primary sites for HIV-1 replication. We sought to identify the memory CD4 T cell populations in blood and LNs that are responsible for the production of replication-competent and infectious HIV-1, as well as for active and persistent virus transcription in ART-treated (for 1.5-14.0 years), aviremic (<50 HIV RNA copies/ml) HIV-infected individuals. We demonstrate that LN CD4 T cells that express programmed cell death 1 (PDCD1; also known as PD-1), which are composed of about 65% T follicular helper cells as defined by the expression of the cell surface receptors CXCR5 and PD-1, are the major source of replication-competent HIV-1 and of infectious virus, as compared to any other (CXCR5-PD-1- and CXCR5(+)PD-1(-)) blood or LN memory CD4 T cell populations. LN PD-1(+) cells accounted for 46% and 96% of the total pools of memory CD4 T cells containing inducible replication-competent or infectious virus, respectively. Notably, higher levels of cell-associated HIV-1 RNA were present in LN PD-1(+) cells after long-term (up to 12 years) ART than in other memory CD4 T cell subpopulations. These results indicate that LN PD-1(+) cells are the major CD4 T cell compartment in the blood and LNs for the production of replication-competent and infectious HIV-1, and for active and persistent virus transcription in long-term-ART-treated aviremic individuals. Thus, these cells may represent a major obstacle to finding a functional cure for HIV-1 infection.	[Banga, Riddhima; Procopio, Francesco Andrea; Noto, Alessandra; Ohmiti, Khalid; Pantaleo, Giuseppe; Perreau, Matthieu] Univ Lausanne, Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Pollakis, Georgios] Univ Liverpool, Inst Infect & Global Hlth IGH, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool, Merseyside, England; [Cavassini, Matthias] Univ Lausanne, Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Corpataux, Jean-Marc] Univ Lausanne, Univ Lausanne Hosp, Serv Vasc Surg, Lausanne, Switzerland; [de Leval, Laurence] Univ Lausanne, Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Pantaleo, Giuseppe] Univ Lausanne, Univ Lausanne Hosp, Swiss Vaccine Res Inst, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Liverpool; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pantaleo, G; Perreau, M (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland.; Pantaleo, G (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Swiss Vaccine Res Inst, Lausanne, Switzerland.	giuseppe.pantaleo@chuv.ch; matthieu.perreau@chuv.ch	Perreau, Matthieu/D-6309-2017; Pantaleo, Giuseppe/K-6163-2016; Georgios, Pollakis/Y-2341-2019; de Leval, Laurence/M-4889-2017; Procopio, Francesco/ABD-8065-2021; cavassini, matthias/F-8987-2017	de Leval, Laurence/0000-0003-3994-516X; Pollakis, Georgios/0000-0002-9659-5461; cavassini, matthias/0000-0003-0933-7833	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	We are grateful to N. Grandchamp, P. Pochon, X. Bron, M: Graff, A. Cretignier, R. Mamin, F. Bellanger, L. Leuenberger and C. Andre for technical assistance, and to D. Alves and the study manager N. Rettby. This work was funded by an educational grant from Bristol-Myers Squibb (M.P.).	Altman D.G., 1991, PRACTICAL STATISTIC; Banga R, 2016, J VIROL, V90, P1858, DOI 10.1128/JVI.02359-15; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Casazza J.P.I., 2015, C RETR OPP INF SEATT, V49; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sobolewski M.C.A., 2013, C RETR OPP INF ATL I, V174LB; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	25	300	309	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					754	761		10.1038/nm.4113	http://dx.doi.org/10.1038/nm.4113			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27239760				2022-12-27	WOS:000379366900014
J	Fan, RR; Toubal, A; Goni, S; Drareni, K; Huang, ZQ; Alzaid, F; Ballaire, R; Ancel, P; Liang, N; Damdimopoulos, A; Hainault, I; Soprani, A; Aron-Wisnewsky, J; Foufelle, F; Lawrence, T; Gautier, JF; Venteclef, N; Treuter, E				Fan, Rongrong; Toubal, Amine; Goni, Saioa; Drareni, Karima; Huang, Zhiqiang; Alzaid, Fawaz; Ballaire, Raphaelle; Ancel, Patricia; Liang, Ning; Damdimopoulos, Anastasios; Hainault, Isabelle; Soprani, Antoine; Aron-Wisnewsky, Judith; Foufelle, Fabienne; Lawrence, Toby; Gautier, Jean-Francois; Venteclef, Nicolas; Treuter, Eckardt			Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; COREPRESSOR COMPLEX; INSULIN-RESISTANCE; KAPPA-B; RECEPTOR; INFLAMMATION; PATHWAYS; HDAC3; SMRT; PHOSPHORYLATION	Humans with obesity differ in their susceptibility to developing insulin resistance and type 2 diabetes (T2D). This variation may relate to the extent of adipose tissue (AT) inflammation that develops as their obesity progresses. The state of macrophage activation has a central role in determining the degree of AT inflammation and thus its dysfunction, and these states are driven by epigenomic alterations linked to gene expression. The underlying mechanisms that regulate these alterations, however, are poorly defined. Here we demonstrate that a co-repressor complex containing G protein pathway suppressor 2 (GPS2) crucially controls the macrophage epigenome during activation by metabolic stress. The study of AT from humans with and without obesity revealed correlations between reduced GPS2 expression in macrophages, elevated systemic and AT inflammation, and diabetic status. The causality of this relationship was confirmed by using macrophage-specific Gps2-knockout (KO) mice, in which inappropriate co-repressor complex function caused enhancer activation, pro-inflammatory gene expression and hypersensitivity toward metabolic-stress signals. By contrast, transplantation of GPS2-overexpressing bone marrow into two mouse models of obesity (ob/ob and diet-induced obesity) reduced inflammation and improved insulin sensitivity. Thus, our data reveal a potentially reversible disease mechanism that links co-repressor-dependent epigenomic alterations in macrophages to AT inflammation and the development of T2D.	[Fan, Rongrong; Goni, Saioa; Huang, Zhiqiang; Liang, Ning; Damdimopoulos, Anastasios; Treuter, Eckardt] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Toubal, Amine; Drareni, Karima; Alzaid, Fawaz; Ballaire, Raphaelle; Hainault, Isabelle; Soprani, Antoine; Foufelle, Fabienne; Gautier, Jean-Francois; Venteclef, Nicolas] Univ Paris 06, Sorbonne Univ, INSERM, UMR S Cordeliers Res 1138, Paris, France; [Toubal, Amine; Drareni, Karima; Alzaid, Fawaz; Ballaire, Raphaelle; Hainault, Isabelle; Aron-Wisnewsky, Judith; Foufelle, Fabienne; Venteclef, Nicolas] Inst Cardiometab & Nutr, Paris, France; [Ancel, Patricia] Aix Marseille Univ, Nutr Obesite & Risque Thrombot, INSERM, UMR 1062,INRA 1260, Marseille, France; [Soprani, Antoine] Clin Geoffroy St Hilaire, Gen Sante, Paris, France; [Aron-Wisnewsky, Judith] Hop La Pitie Salpetriere, AP HP, Heart & Metab Div, Paris, France; [Aron-Wisnewsky, Judith] Univ Paris 06, Sorbonne Univ, INSERM, NutriOm Team,UMR S U1166, Paris, France; [Lawrence, Toby] Aix Marseille Univ, CIML, UM2, Marseille, France; [Lawrence, Toby] INSERM, U1104, Marseille, France; [Lawrence, Toby] CNRS, UMR7280, Marseille, France; [Gautier, Jean-Francois] Univ Paris Diderot, Lariboisiere Hosp, AP HP, Dept Diabet,Clin Invest Ctr CIC 9504, Paris, France	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Treuter, E (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.; Venteclef, N (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, UMR S Cordeliers Res 1138, Paris, France.; Venteclef, N (corresponding author), Inst Cardiometab & Nutr, Paris, France.	nicolas.venteclef@upmc.fr; eckardt.treuter@ki.se	ARON-WISNEWSKY, judith/AAH-7608-2020; Ancel, Patricia/AAK-4469-2020; Fan, Rongrong/N-3446-2017; Fan, Rongrong/AAG-2200-2019; Venteclef, Nicolas/K-8484-2017; Lawrence, Toby/GLU-3895-2022; Goñi Irigoyen, Saioa/M-6330-2015	Ancel, Patricia/0000-0001-5567-1539; Fan, Rongrong/0000-0002-5707-1497; Fan, Rongrong/0000-0002-5707-1497; Lawrence, Toby/0000-0003-0967-6122; Goñi Irigoyen, Saioa/0000-0002-2368-7373; Venteclef, Nicolas/0000-0002-6313-1214; Huang, Zhiqiang/0000-0001-5208-008X; FOUFELLE, Fabienne/0000-0002-0752-622X; Liang, Ning/0000-0002-7848-2893; Treuter, Eckardt/0000-0002-4147-8989; Damdimopoulos, Anastasios/0000-0003-4425-1189; Alzaid, Fawaz/0000-0003-3056-3640	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden); Swedish Diabetes Foundation (Diabetesfonden); Novo Nordisk Foundation (Novo Nordisk Fonden); Center for Biosciences (CIMED) at Karolinska Institutet; French National Agency of Research (CONRAD); French National Agency of Research [ANR CE12 2014]; French National Agency of Research (FATMAC); Region Ile de France (CORDDIM); Paris city (EMERGENCE); French Foundation for Medical Research [Equipe FRM DEQ20140329504]; French government [ANR-10-IAH, ICAN MetaMACS]; Assistance Publique des Hopitaux de Paris (APHP), Programs of Clinical Investigation (CRC Fibrota) [AOO759-32]; PHRC Glucostress [P081122]; 'Ministere de la Recherche et de l'Enseignement superieur'; China Scholarship Council (CRC); Karolinska Institutet (KID)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Diabetes Foundation (Diabetesfonden); Novo Nordisk Foundation (Novo Nordisk Fonden)(Novo Nordisk); Center for Biosciences (CIMED) at Karolinska Institutet; French National Agency of Research (CONRAD); French National Agency of Research(French National Research Agency (ANR)); French National Agency of Research (FATMAC); Region Ile de France (CORDDIM)(Region Ile-de-France); Paris city (EMERGENCE); French Foundation for Medical Research(Fondation pour la Recherche Medicale); French government; Assistance Publique des Hopitaux de Paris (APHP), Programs of Clinical Investigation (CRC Fibrota); PHRC Glucostress; 'Ministere de la Recherche et de l'Enseignement superieur'; China Scholarship Council (CRC)(China Scholarship Council); Karolinska Institutet (KID)	We acknowledge Ozgene Pty, Ltd. for generating foxed GPS2 mice. We acknowledge V. Benes and the team at the EMBL Genomics Core Facility for ChIP-seq library preparation and sequencing. We thank S. Mandrup (University of Southern Denmark), K. de Bosscher (Ghent University), J. Taipale (Karolinska Institutet), and F. Zhang (Broad Institute) for providing plasmids, and T. Jakobsson for his advice in establishing the CRISPR-Cas9 system. We also thank F. Fagerstrom-Billai and co-workers at the BEA Core Facility (Karolinska Institutet) for microarray preparation and analysis. For assistance with pathological analysis and FACS sorting, we thank R. Kuiper, T. Schroder, and A.-L. Dackland (Department of Laboratory Medicine, Karolinska Institutet). We thank R. Chiche, J. Cady, and S. Gueroult (Geoffroy Saint-Hilaire Clinic Paris) for human AT sampling, and J.-L. Nguewa for his help in PHRC Glucostress. This work was supported by grants from the Swedish Research Council (Vetenskapsradet, E.T.); the Swedish Cancer Society (Cancerfonden, E.T.); the Swedish Diabetes Foundation (Diabetesfonden, E.T.); the Novo Nordisk Foundation (Novo Nordisk Fonden, E.T.); the Center for Biosciences (former CB, now CIMED) at Karolinska Institutet (E.T.); the French National Agency of Research (CONRAD, N.V.; ANR CE12 2014, FATMAC, T.B.); Region Ile de France (CORDDIM, N.V.); Paris city (EMERGENCE, N.V.); the French Foundation for Medical Research (Equipe FRM DEQ20140329504, N.V. and F.F.); a French government grant managed by the National Agency of Research (program 'Investments for the Future reference ANR-10-IAH, ICAN MetaMACS, N.V. and F.F.); Assistance Publique des Hopitaux de Paris (APHP), Programs of Clinical Investigation (CRC Fibrota AOO759-32 to J.A.-W.; and PHRC Glucostress P081122 to J.-F.G.). A.T. and K.D. received a doctoral fellowship from the 'Ministere de la Recherche et de l'Enseignement superieur'. Z.H. received a doctoral fellowship from the China Scholarship Council (CRC), and N.L. received a doctoral faculty grant from the Karolinska Institutet (KID funding).	Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Arner E, 2010, NEW ENGL J MED, V362, P1151, DOI 10.1056/NEJMc0910718; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Dalmas E, 2015, NAT MED, V21, P610, DOI 10.1038/nm.3829; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gosselin D, 2014, IMMUNOL REV, V262, P96, DOI 10.1111/imr.12213; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang S, 2015, NAT CELL BIOL, V17, P44, DOI 10.1038/ncb3080; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Link V.M., 2015, COLD SPRING HARB SYM; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Toubal A, 2013, TRENDS ENDOCRIN MET, V24, P625, DOI 10.1016/j.tem.2013.09.006; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	51	57	59	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					780	791		10.1038/nm.4114	http://dx.doi.org/10.1038/nm.4114			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27270589				2022-12-27	WOS:000379366900017
J	Chakradhar, S				Chakradhar, Shraddha			A tale of two diseases: Aging HIV patients inspire a closer look at Alzheimer's disease	NATURE MEDICINE			English	Editorial Material							AMYLOID-BETA; IMPAIRMENT; INFECTION											Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8; Ances BM, 2010, NEUROLOGY, V75, P111, DOI 10.1212/WNL.0b013e3181e7b66e; Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899; Bourgade K, 2016, J ALZHEIMERS DIS, V50, P1227, DOI 10.3233/JAD-150652; Giunta B, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-23; Levine AJ, 2016, J NEUROVIROL, V22, P431, DOI 10.1007/s13365-015-0410-7; Soontornniyomkij V, 2014, AIDS, V28, P1297, DOI 10.1097/QAD.0000000000000262; Turner Raymond Scott, 2016, Alzheimers Dement (Amst), V4, P1, DOI 10.1016/j.dadm.2016.03.009; Zhang Y, 2016, HUM BRAIN MAPP, V37, P4523, DOI 10.1002/hbm.23326	9	11	11	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					376	+		10.1038/nm0418-376	http://dx.doi.org/10.1038/nm0418-376			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634694				2022-12-27	WOS:000429639800002
J	Goldman, SA				Goldman, Steven A.			Transplanted neural progenitors bridge gaps to benefit spinal cord-injured monkeys	NATURE MEDICINE			English	Editorial Material							STEM-CELLS; CONNECTIVITY; THERAPY	Human neural progenitor cells have been grafted successfully into rhesus monkeys with spinal cord hemisection, resulting in anatomic integration and improved neurological function.	[Goldman, Steven A.] Univ Rochester, Ctr Translat Neuromed, Rochester, NY 14620 USA; [Goldman, Steven A.] Univ Copenhagen, Ctr Translat Neuromed, Copenhagen, Denmark	University of Rochester; University of Copenhagen	Goldman, SA (corresponding author), Univ Rochester, Ctr Translat Neuromed, Rochester, NY 14620 USA.; Goldman, SA (corresponding author), Univ Copenhagen, Ctr Translat Neuromed, Copenhagen, Denmark.	steven_goldman@urmc.rochester.edu		Goldman, Steven/0000-0002-5498-4303	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104701, R01MH099578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS110776] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH104701, R01 MH099578] Funding Source: Medline; NINDS NIH HHS [R01 NS110776] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler AF, 2017, STEM CELL REP, V8, P1525, DOI 10.1016/j.stemcr.2017.04.004; Benraiss A, 2013, CELL STEM CELL, V12, P787, DOI 10.1016/j.stem.2013.04.014; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dobkin BH, 2004, ANNU REV MED, V55, P255, DOI 10.1146/annurev.med.55.091902.104338; Goldman SA, 2016, CELL STEM CELL, V18, P174, DOI 10.1016/j.stem.2016.01.012; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Lu P, 2017, J CLIN INVEST, V127, P3293, DOI 10.1172/JCI92955; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502	12	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2018	24	4					388	390		10.1038/nm.4531	http://dx.doi.org/10.1038/nm.4531			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GC2VD	29634690	Green Accepted			2022-12-27	WOS:000429639800008
J	Marton, RM; Pasca, SP				Marton, Rebecca M.; Pasca, Sergiu P.			A human cellular model of amyotrophic lateral sclerosis	NATURE MEDICINE			English	Editorial Material							RNA FOCI; REPEAT; ALS; DROSOPHILA; PROTEINS	Stem cell-derived human motor neurons were used to investigate the cellular mechanisms underlying C9ORF72-related amyotrophic lateral sclerosis.	[Marton, Rebecca M.] Stanford Univ, Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Marton, Rebecca M.; Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Pasca, SP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	spasca@stanford.edu	Pasca, Sergiu/AAY-3949-2021	Pasca, Sergiu/0000-0002-3216-3248				Chan S, 2003, NEUROIMAG CLIN N AM, V13, P307, DOI 10.1016/S1052-5149(03)00018-2; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Davidson YS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-70; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gitler AD, 2016, BRAIN RES, V1647, P19, DOI 10.1016/j.brainres.2016.04.004; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Leblond CS, 2014, EXP NEUROL, V262, P91, DOI 10.1016/j.expneurol.2014.04.013; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Tran H, 2015, NEURON, V87, P1207, DOI 10.1016/j.neuron.2015.09.015	13	0	0	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2018	24	3					256	257		10.1038/nm.4509	http://dx.doi.org/10.1038/nm.4509			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FY3EN	29509753				2022-12-27	WOS:000426700900005
J	Kerur, N; Fukuda, S; Banerjee, D; Kim, Y; Fu, DX; Apicella, I; Varshney, A; Yasuma, R; Fowler, BJ; Baghdasaryan, E; Marion, KM; Huang, XW; Yasuma, T; Hirano, Y; Serbulea, V; Ambati, M; Ambati, VL; Kajiwara, Y; Ambati, K; Hirahara, S; Bastos-Carvalho, A; Ogura, Y; Terasaki, H; Oshika, T; Kim, KB; Hinton, DR; Leitinger, N; Cambier, JC; Buxbaum, JD; Kenney, MC; Jazwinski, SM; Nagai, H; Hara, I; West, AP; Fitzgerald, KA; Sadda, SR; Gelfand, BD; Ambati, J				Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan; Kim, Younghee; Fu, Dongxu; Apicella, Ivana; Varshney, Akhil; Yasuma, Reo; Fowler, Benjamin J.; Baghdasaryan, Elmira; Marion, Kenneth M.; Huang, Xiwen; Yasuma, Tetsuhiro; Hirano, Yoshio; Serbulea, Vlad; Ambati, Meenakshi; Ambati, Vidya L.; Kajiwara, Yuji; Ambati, Kameshwari; Hirahara, Shuichiro; Bastos-Carvalho, Ana; Ogura, Yuichiro; Terasaki, Hiroko; Oshika, Tetsuro; Kim, Kyung Bo; Hinton, David R.; Leitinger, Norbert; Cambier, John C.; Buxbaum, Joseph D.; Kenney, M. Cristina; Jazwinski, S. Michal; Nagai, Hiroshi; Hara, Isao; West, A. Phillip; Fitzgerald, Katherine A.; Sadda, SriniVas R.; Gelfand, Bradley D.; Ambati, Jayakrishna			cGAS drives noncanonical-inflammasome activation in age-related macular degeneration	NATURE MEDICINE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; RETINAL-PIGMENT EPITHELIUM; INNATE IMMUNE-RESPONSES; NLRP3 INFLAMMASOME; CELL-DEATH; ALU RNA; OXIDIZED PHOSPHOLIPIDS; CORNEAL ENDOTHELIUM; GENE-EXPRESSION; ARPE-19 CELLS	Geographic atrophy is a blinding form of age-related macular degeneration characterized by retinal pigmented epithelium (RPE) death; the RPE also exhibits DICER1 deficiency, resultant accumulation of endogenous Alu-retroelement RNA, and NLRP3-inflammasome activation. How the inflammasome is activated in this untreatable disease is largely unknown. Here we demonstrate that RPE degeneration in human-cell-culture and mouse models is driven by a noncanonical-inflammasome pathway that activates caspase-4 (caspase-11 in mice) and caspase-1, and requires cyclic GMP-AMP synthase (cGAS)dependent interferon-b production and gasdermin D-dependent interleukin-18 secretion. Decreased DICER1 levels or AluRNA accumulation triggers cytosolic escape of mitochondrial DNA, which engages cGAS. Moreover, caspase-4, gasdermin D, interferon-b, and cGAS levels were elevated in the RPE in human eyes with geographic atrophy. Collectively, these data highlight an unexpected role of cGAS in responding to mobile-element transcripts, reveal cGAS-driven interferon signaling as a conduit for mitochondrial-damage-induced inflammasome activation, expand the immune-sensing repertoire of cGAS and caspase-4 to noninfectious human disease, and identify new potential targets for treatment of a major cause of blindness.	[Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan; Kim, Younghee; Fu, Dongxu; Apicella, Ivana; Varshney, Akhil; Yasuma, Reo; Ambati, Kameshwari; Hirahara, Shuichiro; Gelfand, Bradley D.; Ambati, Jayakrishna] Univ Virginia, Sch Med, Ctr Adv Vis Sci, Charlottesville, VA 22908 USA; [Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan; Kim, Younghee; Fu, Dongxu; Apicella, Ivana; Varshney, Akhil; Yasuma, Reo; Ambati, Kameshwari; Hirahara, Shuichiro; Gelfand, Bradley D.; Ambati, Jayakrishna] Univ Virginia, Sch Med, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Kerur, Nagaraj; Banerjee, Daipayan; Kim, Younghee; Yasuma, Reo; Fowler, Benjamin J.; Ambati, Kameshwari; Bastos-Carvalho, Ana; Gelfand, Bradley D.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Fukuda, Shinichi; Yasuma, Tetsuhiro; Hirano, Yoshio; Oshika, Tetsuro] Univ Tsukuba, Dept Ophthalmol, Ibaraki, Japan; [Baghdasaryan, Elmira; Marion, Kenneth M.; Huang, Xiwen; Sadda, SriniVas R.] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA; [Baghdasaryan, Elmira; Sadda, SriniVas R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Yasuma, Tetsuhiro; Terasaki, Hiroko] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Nagoya, Aichi, Japan; [Hirano, Yoshio; Ogura, Yuichiro] Nagoya City Univ, Dept Ophthalmol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Serbulea, Vlad; Leitinger, Norbert] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Ambati, Meenakshi; Ambati, Vidya L.] Ctr Digital Image Evaluat, Charlottesville, VA USA; [Kajiwara, Yuji; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Kim, Kyung Bo] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA; [Hinton, David R.] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Pathol, Los Angeles, CA USA; [Hinton, David R.] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Ophthalmol, Los Angeles, CA USA; [Cambier, John C.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Kenney, M. Cristina] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA; [Jazwinski, S. Michal] Tulane Univ, Tulane Ctr Aging, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Jazwinski, S. Michal] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Nagai, Hiroshi] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol, Kobe, Hyogo, Japan; [Hara, Isao] Wakayama Med Univ, Dept Urol, Wakayama, Japan; [West, A. Phillip] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Gelfand, Bradley D.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA; [Ambati, Jayakrishna] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Ambati, Jayakrishna] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Kentucky; University of Tsukuba; Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nagoya University; Nagoya City University; University of Virginia; Icahn School of Medicine at Mount Sinai; University of Kentucky; University of Southern California; University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; Tulane University; Tulane University; Kobe University; Wakayama Medical University; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester; University of Virginia; University of Virginia; University of Virginia	Kerur, N (corresponding author), Univ Virginia, Sch Med, Ctr Adv Vis Sci, Charlottesville, VA 22908 USA.; Kerur, N (corresponding author), Univ Virginia, Sch Med, Dept Ophthalmol, Charlottesville, VA 22908 USA.; Kerur, N (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.; Ambati, J (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.; Ambati, J (corresponding author), Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	nk8m@virginia.edu; ja9qr@virginia.edu	West, A. Phillip/W-8171-2019; Fitzgerald, Katherine/ABE-6317-2020; Buxbaum, Joseph D/G-6001-2010; Gelfand, Brad/L-3926-2019	West, A. Phillip/0000-0003-2884-6895; Varshney, Akhil/0000-0003-0759-0982; Fitzgerald, Kate/0000-0003-3175-609X; Serbulea, Vlad/0000-0002-9988-4410; Fukuda, Shinichi/0000-0002-4160-8229; Hirano, Yoshio/0000-0002-9173-0839; Buxbaum, Joseph/0000-0001-8898-8313	NIH [DP1GM114862, R01EY018350, R01EY018836, R01EY020672, R01EY022238, R01EY024068, K99EY024336, R00EY024336, T32HL091812, UL1RR033173, R01EY001545, R21AI099346, R37AG006168, T32GM007055, F31DK108553, R01DK096076, P01 HL120840]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Ellison Medical Foundation Senior Scholar in Aging Award; John Templeton Foundation; Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Beckman Initiative for Macular Research (BIMR); Japan Eye Bank Association and Society for the Promotion of Science (JSPS); Association for Research in Vision and Ophthalmology (ARVO)/Alcon Early Career Clinician-Scientist Research Award; Fight for Sight postdoctoral award; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal; Research to Prevent Blindness; Japan Eye Bank Association; American Heart Association; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY001545, R01EY018350, R01EY024068, K99EY024336, R01EY020672, R00EY024336, R01EY022238, R01EY018836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120840, T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497, R01AI124487, R21AI099346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096076, F31DK108553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM114862, T32GM007055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Ellison Medical Foundation Senior Scholar in Aging Award(Lawrence Ellison Foundation); John Templeton Foundation; Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Beckman Initiative for Macular Research (BIMR); Japan Eye Bank Association and Society for the Promotion of Science (JSPS); Association for Research in Vision and Ophthalmology (ARVO)/Alcon Early Career Clinician-Scientist Research Award; Fight for Sight postdoctoral award; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Japan Eye Bank Association; American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Z. Chen, V. Tarallo, and P. Pinton for valuable discussions. We thank H. Virgin (Washington University in St. Louis), G. Shadel (Yale University), W.T. Wong (NIH), L. Zhao (NIH), and V. Dixit (Genentech) for reagents. We thank G. Pattison, E. Ghias, K. Langberg, D. Robertson, E. Doswell, X. Zhou, K. Atwood, R. Makin, O. Kirillina, A. Bobrov, E. Dinning, L. Pandya, C. Payne, G. Botzet, N. Bell, R. King, L. Xu, L. Toll, and A. Uittenbogaard for technical assistance, and the University of Kentucky Viral Core (COBRE) for providing lentiviral vectors. J.A. was supported by NIH grants (DP1GM114862, R01EY018350, R01EY018836, R01EY020672, R01EY022238, and R01EY024068), a Doris Duke Distinguished Clinical Scientist Award, a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, an Ellison Medical Foundation Senior Scholar in Aging Award, and the John Templeton Foundation; as the Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; and through a DuPont Guerry, III Professorship. N.K. was supported by NIH grants K99EY024336 and R00EY024336, and the Beckman Initiative for Macular Research (BIMR). S.F. was supported by a Research Grant from the Japan Eye Bank Association and Society for the Promotion of Science (JSPS) Overseas Research Fellowship. B.J.F. was supported by NIH grants T32HL091812 and UL1RR033173. R.Y. was supported by an Association for Research in Vision and Ophthalmology (ARVO)/Alcon Early Career Clinician-Scientist Research Award. T.Y. was supported by a Fight for Sight postdoctoral award. A.B.-C. was supported by the Programme for Advanced Medical Education (sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal). D.R.H. was supported by NIH R01EY001545 and an unrestricted departmental grant from Research to Prevent Blindness. J.C.C. was supported by NIH R21AI099346. S.F. was supported by a Research Grant from the Japan Eye Bank Association. S.M.J. was supported by NIH R37AG006168. B.D.G. was supported by the American Heart Association and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1TR000117. V.S. was supported by NIH grants T32GM007055 and F31DK108553. N.L. was supported by NIH grants R01DK096076 and P01 HL120840. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ach T, 2015, INVEST OPHTH VIS SCI, V56, P3242, DOI 10.1167/iovs.14-16274; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bonora M, 2016, NAT PROTOC, V11, P1067, DOI 10.1038/nprot.2016.064; Brandstetter C, 2015, J MOL MED, V93, P905, DOI 10.1007/s00109-015-1275-1; Doughty MJ, 2000, CORNEA, V19, P148, DOI 10.1097/00003226-200003000-00006; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gelfand BD, 2015, CELL REP, V11, P1686, DOI 10.1016/j.celrep.2015.05.023; Grossniklaus HE, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12711; Hirano Y, 2014, NAT MED, V20, P1372, DOI 10.1038/nm.3671; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang J., 2017, EYE CONTACT LENS; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; INABA M, 1985, ACTA OPHTHALMOL, V63, P232; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/nchembio.2238, 10.1038/NCHEMBIO.2238]; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karijolich J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005260; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; LAING RA, 1975, ARCH OPHTHALMOL-CHIC, V93, P143; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; McLeod DS, 2016, INVEST OPHTH VIS SCI, V57, P5843, DOI 10.1167/iovs.16-20049; Miceli MV, 2005, INVEST OPHTH VIS SCI, V46, P1765, DOI 10.1167/iovs.04-1327; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagai H, 2002, J INVEST DERMATOL, V119, P541, DOI 10.1046/j.1523-1747.2002.01866.x; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suschak JJ, 2016, J IMMUNOL, V196, P310, DOI 10.4049/jimmunol.1501836; Suzuki M, 2007, MOL VIS, V13, P772; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang XM, 2012, AM J PHYSIOL-REG I, V302, pR805, DOI 10.1152/ajpregu.00350.2011; Wang X, 2016, J NEUROSCI, V36, P2827, DOI 10.1523/JNEUROSCI.3575-15.2016; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yan YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080029; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08	81	148	156	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					50	+		10.1038/nm.4450	http://dx.doi.org/10.1038/nm.4450			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29176737	Green Accepted			2022-12-27	WOS:000422965900010
J	Schmiechen, AC; Batista, PJ				Schmiechen, Alexandra C.; Batista, Pedro J.			An epitranscriptomic vulnerability in myeloid malignancies	NATURE MEDICINE			English	Editorial Material							RNA; N-6-METHYLADENOSINE	A recent study finds that the N-6-methyladenosine (m(6)A) modifier METTL3 regulates proliferation and differentiation in myeloid cells and acute myeloid leukemia (AML).	[Schmiechen, Alexandra C.; Batista, Pedro J.] NCI, Cell Biol Lab, Ctr Canc Res, US NIH, Bldg 37, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Batista, PJ (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, US NIH, Bldg 37, Bethesda, MD 20892 USA.	pedro.batista@nih.gov		Batista, Pedro/0000-0003-1055-2354				Batista PJ, 2017, GENOM PROTEOM BIOINF, V15, P154, DOI 10.1016/j.gpb.2017.03.002; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Khwaja A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.10; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013	12	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2017	23	11					1252	1254		10.1038/nm.4435	http://dx.doi.org/10.1038/nm.4435			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FL9CN	29117175				2022-12-27	WOS:000414548300005
J	Bilkei-Gorzo, A; Albayram, O; Draffehn, A; Michel, K; Piyanova, A; Oppenheimer, H; Dvir-Ginzberg, M; Racz, I; Ulas, T; Imbeault, S; Bab, I; Schultze, JL; Zimmer, A				Bilkei-Gorzo, Andras; Albayram, Onder; Draffehn, Astrid; Michel, Kerstin; Piyanova, Anastasia; Oppenheimer, Hannah; Dvir-Ginzberg, Mona; Racz, Ildiko; Ulas, Thomas; Imbeault, Sophie; Bab, Itai; Schultze, Joachim L.; Zimmer, Andreas			A chronic low dose of Delta(9)-tetrahydrocannabinol (THC) restores cognitive function in old mice	NATURE MEDICINE			English	Article							CANNABINOID RECEPTOR-BINDING; SIGNAL-REGULATED KINASE; MESSENGER-RNA LEVELS; ENDOCANNABINOID SYSTEM; HISTONE ACETYLATION; ALZHEIMERS-DISEASE; AGED RATS; SYNAPTIC PLASTICITY; CALCIUM REGULATION; CB1 RECEPTORS	The balance between detrimental, pro-aging, often stochastic processes and counteracting homeostatic mechanisms largely determines the progression of aging. There is substantial evidence suggesting that the endocannabinoid system (ECS) is part of the latter system because it modulates the physiological processes underlying aging(1,2). The activity of the ECS declines during aging, as CB1 receptor expression and coupling to G proteins are reduced in the brain tissues of older animals(3-5) and the levels of the major endocannabinoid 2-arachidonoylglycerol (2-AG) are lower(6). However, a direct link between endocannabinoid tone and aging symptoms has not been demonstrated. Here we show that a low dose of Delta(9)-tetrahydrocannabinol (THC) reversed the age-related decline in cognitive performance of mice aged 12 and 18 months. This behavioral effect was accompanied by enhanced expression of synaptic marker proteins and increased hippocampal spine density. THC treatment restored hippocampal gene transcription patterns such that the expression profiles of THC-treated mice aged 12 months closely resembled those of THC-free animals aged 2 months. The transcriptional effects of THC were critically dependent on glutamatergic CB1 receptors and histone acetylation, as their inhibition blocked the beneficial effects of THC. Thus, restoration of CB1 signaling in old individuals could be an effective strategy to treat age-related cognitive impairments.	[Bilkei-Gorzo, Andras; Albayram, Onder; Michel, Kerstin; Piyanova, Anastasia; Racz, Ildiko; Imbeault, Sophie; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Draffehn, Astrid; Ulas, Thomas; Schultze, Joachim L.] LIMES Inst, Genom & Immunoregulat, Bonn, Germany; [Oppenheimer, Hannah; Dvir-Ginzberg, Mona; Bab, Itai] Hebrew Univ Jerusalem, Inst Dent Sci, Jerusalem, Israel	University of Bonn; University of Bonn; Hebrew University of Jerusalem	Zimmer, A (corresponding author), Univ Bonn, Inst Mol Psychiat, Bonn, Germany.	neuro@uni-bonn.de	Zimmer, Andreas/B-8357-2009; Bilkei-Gorzo, Andras/F-8114-2010; Schultze, Joachim L./ABA-8176-2020; Racz, I./C-3074-2009; Chan, Edward/B-5671-2009	Schultze, Joachim L./0000-0003-2812-9853; Racz, I./0000-0002-1549-3616; Chan, Edward/0000-0003-3938-9503; Imbeault, Sophie/0000-0003-1454-9267; Albayram, Onder/0000-0002-2028-1458	Deutsche Forschungsgemeinschaft [FOR926 (SP2), FOR926 (CP2), BI-1227/5, SFB645]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft grants FOR926 (SP2 and CP2), BI-1227/5 and SFB645. J.L.S. and A.Z. are members of the DFG Cluster of Excellence ImmunoSensation.	Albayram O, 2011, P NATL ACAD SCI USA, V108, P11256, DOI 10.1073/pnas.1016442108; Barnes CA, 1997, NATURE, V388, P272, DOI 10.1038/40859; Berrendero F, 1998, BBA-MOL BASIS DIS, V1407, P205, DOI 10.1016/S0925-4439(98)00042-8; Bilkei-Gorzo A, 2005, P NATL ACAD SCI USA, V102, P15670, DOI 10.1073/pnas.0504640102; Bilkei-Gorzo A, 2012, PHILOS T R SOC B, V367, P3326, DOI 10.1098/rstb.2011.0388; Cannich A, 2004, LEARN MEMORY, V11, P625, DOI 10.1101/lm.77904; Cuenco KT, 2011, NEUROBIOL AGING, V32, P249, DOI 10.1016/j.neurobiolaging.2009.02.014; Das C, 2014, P NATL ACAD SCI USA, V111, pE1072, DOI 10.1073/pnas.1319122111; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Gao H, 2016, MOL NEUROBIOL, V53, P4772, DOI 10.1007/s12035-015-9393-x; Gemma C, 2007, REV NEUROSCIENCE, V18, P137; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Head E, 2009, NEUROBIOL AGING, V30, P1125, DOI 10.1016/j.neurobiolaging.2007.10.001; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Khodosevich K, 2013, NEURON, V79, P1136, DOI 10.1016/j.neuron.2013.07.011; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchalant Y, 2009, MOL PSYCHIATR, V14, P1068, DOI 10.1038/mp.2009.62; Masso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143623; Miro X, 2009, DIS MODEL MECH, V2, P412, DOI 10.1242/dmm.001602; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Neidl R, 2016, J NEUROSCI, V36, P4351, DOI 10.1523/JNEUROSCI.3239-15.2016; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Piyanova A, 2013, MECH AGEING DEV, V134, P391, DOI 10.1016/j.mad.2013.08.001; Piyanoya A, 2015, MECH AGEING DEV, V150, P55, DOI 10.1016/j.mad.2015.08.005; Puighermanal E, 2012, PHILOS T R SOC B, V367, P3254, DOI 10.1098/rstb.2011.0384; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Romero J, 1998, NEUROSCIENCE, V84, P1075, DOI 10.1016/S0306-4522(97)00552-6; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Semba RD, 2011, J GERONTOL A-BIOL, V66, P794, DOI 10.1093/gerona/glr058; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Valjent E, 2001, EUR J NEUROSCI, V14, P342, DOI 10.1046/j.0953-816x.2001.01652.x; Varvel SA, 2006, PSYCHOPHARMACOLOGY, V186, P226, DOI 10.1007/s00213-006-0356-9; Varvel SA, 2005, PSYCHOPHARMACOLOGY, V178, P317, DOI 10.1007/s00213-004-1988-2; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	56	126	127	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					782	+		10.1038/nm.4311	http://dx.doi.org/10.1038/nm.4311			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28481360				2022-12-27	WOS:000402768000022
J	Davidson, SM; Jonas, O; Keibler, MA; Hou, HW; Luengo, A; Mayers, JR; Wyckoff, J; Del Rosario, AM; Whitman, M; Chin, CR; Condon, KJ; Lammers, A; Kellersberger, KA; Stall, BK; Stephanopoulos, G; Bar-Sagi, D; Han, J; Rabinowitz, JD; Cima, MJ; Langer, R; Vander Heiden, MG				Davidson, Shawn M.; Jonas, Oliver; Keibler, Mark A.; Hou, Han Wei; Luengo, Alba; Mayers, Jared R.; Wyckoff, Jeffrey; Del Rosario, Amanda M.; Whitman, Matthew; Chin, Christopher R.; Condon, Kendall J.; Lammers, Alex; Kellersberger, Katherine A.; Stall, Brian K.; Stephanopoulos, Gregory; Bar-Sagi, Dafna; Han, Jongyoon; Rabinowitz, Joshua D.; Cima, Michael J.; Langer, Robert; Vander Heiden, Matthew G.			Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors	NATURE MEDICINE			English	Article							SERUM-ALBUMIN; PICHIA-PASTORIS; DEGRADATION; MACROPINOCYTOSIS; ADENOCARCINOMA; METABOLISM; EXPRESSION; SURVIVAL	Mammalian tissues rely on a variety of nutrients to support their physiological functions'. It is known that altered metabolism is involved in the pathogenesis of cancer, but which nutrients support the inappropriate growth of intact malignant tumors is incompletely understood(2,3). Amino acids are essential nutrients for many cancer cells(4,5) that can be obtained through the scavenging and catabolism of extracellular protein via macropinocytosis(6,7). In particular, macropinocytosis can be a nutrient source for pancreatic cancer cells, but it is not fully understood how the tumor environment influences metabolic phenotypes(8) and whether macropinocytosis supports the maintenance of amino acid levels within pancreatic tumors. Here we utilize miniaturized plasma exchange to deliver labeled albumin to tissues in live mice, and we demonstrate that breakdown of albumin contributes to the supply of free amino acids in pancreatic tumors. We also deliver albumin directly into tumors using an implantable microdevice, which was adapted and modified from ref. 9. Following implantation, we directly observe protein catabolism and macropinocytosis in situ by pancreatic cancer cells, but not by adjacent, non-cancerous pancreatic tissue. In addition, we find that intratumoral inhibition of macropinocytosis decreases amino acid levels. Taken together, these data suggest that pancreatic cancer cells consume extracellular protein, including albumin, and that this consumption serves as an important source of amino acids for pancreatic cancer cells in vivo.	[Davidson, Shawn M.; Jonas, Oliver; Luengo, Alba; Mayers, Jared R.; Wyckoff, Jeffrey; Del Rosario, Amanda M.; Whitman, Matthew; Chin, Christopher R.; Lammers, Alex; Cima, Michael J.; Langer, Robert; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Davidson, Shawn M.; Luengo, Alba; Mayers, Jared R.; Condon, Kendall J.; Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Davidson, Shawn M.; Vander Heiden, Matthew G.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Jonas, Oliver] Brigham & Womens Hosp, Dept Radiol, Cambridge, MA USA; [Jonas, Oliver] Harvard Med Sch, Cambridge, MA USA; [Keibler, Mark A.; Stephanopoulos, Gregory; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Hou, Han Wei; Han, Jongyoon] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Kellersberger, Katherine A.; Stall, Brian K.] Bruker Daltron Inc, Billerica, MA USA; [Bar-Sagi, Dafna] NYU, Sch Med, New York, NY USA; [Han, Jongyoon] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem & Integrat Genom, Princeton, NJ 08544 USA; [Cima, Michael J.] MIT, Dept Mat Sci, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Harvard Med Sch, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Bruker Corporation; New York University; Massachusetts Institute of Technology (MIT); Princeton University; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Vander Heiden, MG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mvh@mit.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; /0000-0002-9515-8892; Mayers, Jared/0000-0002-8607-1787; Chin, Christopher/0000-0002-2140-3197; Luengo, Alba/0000-0002-4236-0229; Hou, Han Wei/0000-0001-6631-6321; Lammers, Alex/0000-0002-2401-8331; Bar-Sagi, Dafna/0000-0003-2597-8948; Whitman, Matthew/0000-0002-5399-5318	National Science Foundation [T32 GM007287]; Koch Institute Frontier Grant; Prostate Cancer Foundation; NCI [F30CA183474]; NIGMS [T32 GM007753]; NIH [1R01 DK075850-01, 1R01 CA160458-01A1, P30 CA1405141, R01 CA168653]; Lustgarten Foundation; Ludwig Center at MIT; Broad Institute SPARC program; Burroughs Wellcome Fund; SU2C; DARPA's Dialysis-Like Therapy (DLT) program [N66001-11-1-4182]; MIT's Microsystems Technology Laboratories; NATIONAL CANCER INSTITUTE [R01CA160458, P30CA014051, R01CA168653, R21CA177391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Koch Institute Frontier Grant; Prostate Cancer Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; Ludwig Center at MIT; Broad Institute SPARC program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); SU2C; DARPA's Dialysis-Like Therapy (DLT) program; MIT's Microsystems Technology Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to dedicate this paper to the memory of Katherine Kellersberger. We thank the MIT Department of Chemical Engineering and). Francois-Hamel for access to bioreactor equipment, R. Bronson for pathological grading of tumors and A. Lau for providing tumor-bearing mice. S.M.D. and A.L. received support from a National Science Foundation Graduate Research Award Fellowship, and support from T32 GM007287 is also acknowledged. O.J. received support from the Koch Institute Frontier Grant and the Prostate Cancer Foundation. J.R.M. acknowledges support from grant F30CA183474 from the NCI and grant T32 GM007753 from NIGMS. M.A.K. and G.S. acknowledge support from NIH grants 1R01 DK075850-01 and 1R01 CA160458-01A1. M.G.V.H. acknowledges support from the Lustgarten Foundation, the Ludwig Center at MIT, the Broad Institute SPARC program, the Burroughs Wellcome Fund, SU2C and the NIH (P30 CA1405141, R01 CA168653). H.W.H. and J.H. acknowledge support by DARPA's Dialysis-Like Therapy (DLT) program under SSC Pacific grant N66001-11-1-4182. This work is also supported by the use of MIT's Microsystems Technology Laboratories.	ANDERSSON C, 1990, J SURG RES, V49, P23, DOI 10.1016/0022-4804(90)90105-B; ANDERSSON C, 1991, J SURG RES, V50, P156, DOI 10.1016/0022-4804(91)90240-M; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; BRENNER DA, 1990, J CLIN INVEST, V85, P248, DOI 10.1172/JCI114419; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Fearon KCH, 1998, ANN SURG, V227, P249, DOI 10.1097/00000658-199802000-00015; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hou HW, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4710992; Hou HW, 2010, LAB CHIP, V10, P2605, DOI 10.1039/c003873c; JEWELL WR, 1975, CANCER RES, V35, P405; Jonas O, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010564; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Klionsky D. J., 2009, METHOD ENZYMOL, V452, pxxi; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Manic G, 2014, MOL CELL ONCOL, V1, DOI 10.4161/mco.29911; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; ROTHSCHILD MA, 1975, ANNU REV MED, V26, P91, DOI 10.1146/annurev.me.26.020175.000515; SCHILLING U, 1992, NUCL MED BIOL, V19, P685; STEINFELD JL, 1960, CANCER, V13, P974, DOI 10.1002/1097-0142(196009/10)13:5<974::AID-CNCR2820130519>3.0.CO;2-Y; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tolner B, 2006, NAT PROTOC, V1, P1006, DOI 10.1038/nprot.2006.126; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wosikowski K, 2003, CLIN CANCER RES, V9, P1917	36	202	205	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					235	241		10.1038/nm.4256	http://dx.doi.org/10.1038/nm.4256			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28024083	Green Submitted, Green Accepted			2022-12-27	WOS:000393729000015
J	Lee, J; Boutz, DR; Chromikova, V; Joyce, MG; Vollmers, C; Leung, K; Horton, AP; DeKosky, BJ; Lee, CH; Lavinder, JJ; Murrin, EM; Chrysostomou, C; Hoi, KH; Tsybovsky, Y; Thomas, PV; Druz, A; Zhang, BS; Zhang, Y; Wang, LS; Kong, WP; Park, D; Popova, LI; Dekker, CL; Davis, MM; Carter, CE; Ross, TM; Ellington, AD; Wilson, PC; Marcotte, EM; Mascola, JR; Ippolito, GC; Krammer, F; Quake, SR; Kwong, PD; Georgiou, G				Lee, Jiwon; Boutz, Daniel R.; Chromikova, Veronika; Joyce, M. Gordon; Vollmers, Christopher; Leung, Kwanyee; Horton, Andrew P.; DeKosky, Brandon J.; Lee, Chang-Han; Lavinder, Jason J.; Murrin, Ellen M.; Chrysostomou, Constantine; Hoi, Kam Hon; Tsybovsky, Yaroslav; Thomas, Paul V.; Druz, Aliaksandr; Zhang, Baoshan; Zhang, Yi; Wang, Lingshu; Kong, Wing-Pui; Park, Daechan; Popova, Lyubov I.; Dekker, Cornelia L.; Davis, Mark M.; Carter, Chalise E.; Ross, Ted M.; Ellington, Andrew D.; Wilson, Patrick C.; Marcotte, Edward M.; Mascola, John R.; Ippolito, Gregory C.; Krammer, Florian; Quake, Stephen R.; Kwong, Peter D.; Georgiou, George			Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; IN-VIVO; NEUTRALIZING EPITOPE; VIRUS HEMAGGLUTININ; ELECTRON-MICROSCOPY; H5N1 VACCINATION; GLOBULAR HEAD; B VIRUSES; PROTECTION; VACCINES	Molecular understanding of serological immunity to influenza has been confounded by the complexity of the polyclonal antibody response in humans. Here we used high-resolution proteomics analysis of immunoglobulin (referred to as Ig-seq) coupled with high-throughput sequencing of transcripts encoding B cell receptors (BCR-seq) to quantitatively determine the antibody repertoire at the individual clonotype level in the sera of young adults before and after vaccination with trivalent seasonal influenza vaccine. The serum repertoire comprised between 40 and 147 clonotypes that were specific to each of the three monovalent components of the trivalent influenza vaccine, with boosted pre-existing clonotypes accounting for similar to 60% of the response. An unexpectedly high fraction of serum antibodies recognized both the H1 and H3 monovalent vaccines. Recombinant versions of these H1 + H3 cross-reactive antibodies showed broad binding to hemagglutinins (HAs) from previously circulating virus strains; several of these antibodies, which were prevalent in the serum of multiple donors, recognized the same conserved epitope in the HA head domain. Although the HA-head-specific H1 + H3 antibodies did not show neutralization activity in vitro, they protected mice against infection with the H1N1 and H3N2 virus strains when administered before or after challenge. Collectively, our data reveal unanticipated insights regarding the serological response to influenza vaccination and raise questions about the added benefits of using a quadrivalent vaccine instead of a trivalent vaccine.	[Lee, Jiwon; DeKosky, Brandon J.; Lee, Chang-Han; Lavinder, Jason J.; Murrin, Ellen M.; Chrysostomou, Constantine; Park, Daechan; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Boutz, Daniel R.; Horton, Andrew P.; Ellington, Andrew D.; Marcotte, Edward M.; Georgiou, George] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Chromikova, Veronika; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Joyce, M. Gordon; Leung, Kwanyee; Thomas, Paul V.; Druz, Aliaksandr; Zhang, Baoshan; Zhang, Yi; Wang, Lingshu; Kong, Wing-Pui; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Vollmers, Christopher; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Hoi, Kam Hon; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Tsybovsky, Yaroslav] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Canc Res Technol Program, Leidos Biomed Res Inc, Frederick, MD USA; [Popova, Lyubov I.; Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Gwen Knapp Ctr Lupus & Immunol Res, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Dekker, Cornelia L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Davis, Mark M.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Carter, Chalise E.; Ross, Ted M.] Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Ellington, Andrew D.; Marcotte, Edward M.; Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [DeKosky, Brandon J.] NIAID, Vaccine Res Ctr, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hoi, Kam Hon] Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA; [Popova, Lyubov I.] SRI Int, Div Infect Dis, Harrisonburg, VA USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Georgia; University of Georgia; University of Texas System; University of Texas Austin; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Roche Holding; Genentech; SRI International	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Georgiou, G (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	gg@che.utexas.edu	Krammer, Florian/H-3237-2019; Lee, Chang-Han/AAG-9178-2019; Wilson, Patrick/HGC-3157-2022; Mascola, John/AAI-7193-2021; Ippolito, Gregory C./AAR-2930-2021	Krammer, Florian/0000-0003-4121-776X; Lee, Chang-Han/0000-0002-7156-4423; Ippolito, Gregory C./0000-0002-7565-7002; Park, Daechan/0000-0003-4991-5247; Lee, Jiwon/0000-0001-7835-3621; Hoi, Kam Hon/0000-0003-4158-0446; Marcotte, Edward/0000-0001-8808-180X; Ross, Ted/0000-0003-1947-7469; Wang, Lingshu/0000-0002-8404-4910; Davis, Mark/0000-0001-6868-657X	NIH [5U19AI057234-09, PO1 AI089618, U19 AI109946]; NIH-NCRR CTSA award [UL1 RR025744]; Intramural Research Program of the Vaccine Research Center, NIAID, NIH; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Leidos Biomedical Research, Inc.; DTRA contract [HDTRA1-12-C-0105]; CPRIT grant [673 RP100890]; Clayton Foundation; Centers of Influenza Virus Research and Surveillance (CEIRS) [HHSN272201400008C, HHSN272201400005C]; Welch Foundation [F1515, F1654]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946, ZICAI005112, ZICAI005113, ZIAAI005022, U19AI057229, P01AI089618, U19AI057234, U19AI082724] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCRR CTSA award; Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Frederick National Laboratory for Cancer Research, NIH; Leidos Biomedical Research, Inc.; DTRA contract; CPRIT grant; Clayton Foundation; Centers of Influenza Virus Research and Surveillance (CEIRS); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to C. Das for help with monoclonal antibody expression, G. Wu, S. Schatzle and Y. Wine for preliminary experiments and advice, and S. Harrison and A. Schmidt (Harvard Medical School) for providing rHAs and critical comments on the manuscript. We are indebted to Sanofi-Pasteur for their kind gift of IIV1s and to BEI Resources for rHAs. We also thank our study volunteers and S. Mackey for clinical project management, and regulatory and data management support, and S. Swope for conducting the study visits. This work was supported by NIH grants 5U19AI057234-09 (G. G.), PO1 AI089618 (G. G.) and U19 AI109946 (F.K. and P.C.W.), NIH-NCRR CTSA award number UL1 RR025744 (C.L.D.), the Intramural Research Program of the Vaccine Research Center, NIAID, NIH (M.G.J., K.L., P.V.T., A.D., B.Z., Y.Z., L.W., W.-P.K., J.R.M. and P.D.K.), federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E and Leidos Biomedical Research, Inc. (Y.T.), DTRA contract HDTRA1-12-C-0105 (G.G.), CPRIT grant 673 RP100890 for LC-MS/MS instrumentation at University of Texas at Austin (G. G.), the Clayton Foundation (G. G.), the Centers of Influenza Virus Research and Surveillance (CEIRS) contracts HHSN272201400008C (F.K.) and HHSN272201400005C (P.C.W.), and Welch Foundation grants F1515 (E.M.Marcotte) and F1654 (A.D.E.).	Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Baz M, 2012, EMERG INFECT DIS, V18, P1132, DOI 10.3201/eid1807.111680; Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Iba Y, 2014, J VIROL, V88, P7130, DOI 10.1128/JVI.00420-14; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; Lee PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4614; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McDaniel JR, 2016, NAT PROTOC, V11, P429, DOI 10.1038/nprot.2016.024; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; MORRIS JA, 1966, NEW ENGL J MED, V274, P527, DOI 10.1056/NEJM196603102741001; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Radigan KA, 2015, INFECT DRUG RESIST, V8, P311, DOI 10.2147/IDR.S58551; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tinoco JC, 2014, VACCINE, V32, P1480, DOI 10.1016/j.vaccine.2014.01.022; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wine Y, 2015, CURR OPIN IMMUNOL, V35, P89, DOI 10.1016/j.coi.2015.06.009; Wohlbold TJ, 2016, J VIROL, V90, P851, DOI 10.1128/JVI.02275-15; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	59	160	175	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1456	+		10.1038/nm.4224	http://dx.doi.org/10.1038/nm.4224			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27820605	Green Accepted			2022-12-27	WOS:000389549000023
J	Xu, M; Lee, EM; Wen, ZX; Cheng, YC; Huang, WK; Qian, XY; Julia, TCW; Kouznetsova, J; Ogden, SC; Hammack, C; Jacob, F; Nguyen, HN; Itkin, M; Hanna, C; Shinn, P; Allen, C; Michael, SG; Simeonov, A; Huang, WW; Christian, KM; Goate, A; Brennand, KJ; Huang, RL; Xia, MH; Ming, GL; Zheng, W; Song, HJ; Tang, HL				Xu, Miao; Lee, Emily M.; Wen, Zhexing; Cheng, Yichen; Huang, Wei-Kai; Qian, Xuyu; Julia, T. C. W.; Kouznetsova, Jennifer; Ogden, Sarah C.; Hammack, Christy; Jacob, Fadi; Ha Nam Nguyen; Itkin, Misha; Hanna, Catherine; Shinn, Paul; Allen, Chase; Michael, Samuel G.; Simeonov, Anton; Huang, Wenwei; Christian, Kimberly M.; Goate, Alison; Brennand, Kristen J.; Huang, Ruili; Xia, Menghang; Ming, Guo-li; Zheng, Wei; Song, Hongjun; Tang, Hengli			Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen	NATURE MEDICINE			English	Article							SEXUAL TRANSMISSION; CDK9 INHIBITORS; REPLICATION; ORGANOIDS; THERAPY; BIOLOGY; MODEL	In response to the current global health emergency posed by the Zika virus (ZIKV) outbreak and its link to microcephaly and other neurological conditions, we performed a drug repurposing screen of similar to 6,000 compounds that included approved drugs, clinical trial drug candidates and pharmacologically active compounds; we identified compounds that either inhibit ZIKV infection or suppress infection-induced caspase-3 activity in different neural cells. A pan-caspase inhibitor, emricasan, inhibited ZIKV-induced increases in caspase-3 activity and protected human cortical neural progenitors in both monolayer and three-dimensional organoid cultures. Ten structurally unrelated inhibitors of cyclin-dependent kinases inhibited ZIKV replication. Niclosamide, a category B anthelmintic drug approved by the US Food and Drug Administration, also inhibited ZIKV replication. Finally, combination treatments using one compound from each category (neuroprotective and antiviral) further increased protection of human neural progenitors and astrocytes from ZIKV-induced cell death. Our results demonstrate the efficacy of this screening strategy and identify lead compounds for anti-ZIKV drug development.	[Xu, Miao; Kouznetsova, Jennifer; Itkin, Misha; Shinn, Paul; Michael, Samuel G.; Simeonov, Anton; Huang, Wenwei; Huang, Ruili; Xia, Menghang; Zheng, Wei] NIH, Natl Ctr Adv Translat, Bldg 10, Bethesda, MD 20892 USA; [Xu, Miao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China; [Lee, Emily M.; Cheng, Yichen; Ogden, Sarah C.; Hammack, Christy; Hanna, Catherine; Allen, Chase; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Wen, Zhexing] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Wen, Zhexing] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Wen, Zhexing; Huang, Wei-Kai; Qian, Xuyu; Jacob, Fadi; Ha Nam Nguyen; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Huang, Wei-Kai] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Qian, Xuyu; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21218 USA; [Julia, T. C. W.; Goate, Alison] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Jacob, Fadi; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Ha Nam Nguyen; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; Zhejiang University; State University System of Florida; Florida State University; Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University	Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat, Bldg 10, Bethesda, MD 20892 USA.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21218 USA.; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21218 USA.	gming1@jhmi.edu; wzheng@mail.nih.gov; shongju1@jhmi.edu; tang@bio.fsu.edu	Huang, WW/GXH-0977-2022; Wen, Zhexing/L-1228-2018; Brennand, Kristen J/J-8704-2012; Huang, Wei-Kai/GRR-9057-2022; xu, miao/U-1176-2017; Zheng, Wei/GOE-5990-2022; Zheng, Wei/J-8889-2014; Brennand, Kristen J/U-5470-2019; Qian, Xuyu/C-1240-2017; Huang, Wenwei/AFO-1997-2022	Wen, Zhexing/0000-0002-1518-3845; Brennand, Kristen J/0000-0003-0993-5956; Zheng, Wei/0000-0003-1034-0757; Qian, Xuyu/0000-0001-5944-3816; Jacob, Fadi/0000-0002-0094-8454; Ming, Guo-li/0000-0002-2517-6075; Goate, Alison/0000-0002-0576-2472	Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); Florida State University; Emory University; Brain and Behavior Research Foundation; New York Stem Cell Foundation; Maryland Stem Cell Research Fund; Simons Foundation Autism Research Initiative [308988]; NIH [NS048271, NS095348, MH105128, NS047344, NS097206, MH106434, MH101454, MH106056, AG005138, AG046170, AI119530]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000269, ZIATR000018, ZICTR000242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH106434, R01MH106056, T32MH015330, R56MH101454, R01MH105128, R01MH101454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS095348, R37NS047344, R56NS047344, P01NS097206, R01NS048271, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046170, P50AG005138] Funding Source: NIH RePORTER	Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); Florida State University; Emory University; Brain and Behavior Research Foundation; New York Stem Cell Foundation; Maryland Stem Cell Research Fund; Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Tesh and P.-Y. Shi (University of Texas Medical Branch) and the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA) for the FSS-13025 isolate of ZIKV, and D. Meckes (Florida State University) for the glioblastoma SNB-19 cell line. We also thank L. Liu and Y. Cai for technical support. This work was supported by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) (W.Z.), ZIKV seed funding from Florida State University (H.T.), a start-up fund from Emory University (Z.W.), the Brain and Behavior Research Foundation (K.J.B.), the New York Stem Cell Foundation (K.J.B.), the Maryland Stem Cell Research Fund (G.M. and H.S.), the Simons Foundation Autism Research Initiative (award no. 308988; H.S.), and partially by NIH grants NS048271 (G.M.), NS095348 (G.M.), MH105128 (G.M.), NS047344 (H.S.), NS097206 (H.S.), MH106434 (H.S.), MH101454 (K.J.B.), MH106056 (K.J.B.), AG005138 (K.J.B.), AG046170 (K.J.B.) and AI119530 (H.T.).	Abbink P., 2016, SCIENCE; Al-Hadiya Badraddin M H, 2005, Profiles Drug Subst Excip Relat Methodol, V32, P67, DOI 10.1016/S0099-5428(05)32002-8; ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; [Anonymous], NATURE; Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035; Badia R, 2016, J ANTIMICROB CHEMOTH, V71, P387, DOI 10.1093/jac/dkv363; Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570; Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Brasil P., 2016, N ENGL J MED; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425; Fontes C. A., 2016, NEURORADIOLOGY; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Haddad JJ, 2013, RECENT PATENTS INFLA, V7, P229, DOI 10.2174/1872213X113079990017; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Hoglen NC, 2004, J PHARMACOL EXP THER, V309, P634, DOI 10.1124/jpet.103.062034; Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38; Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nemeth G, 2011, CURR MED CHEM, V18, P342, DOI 10.2174/092986711794839188; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Okamoto M, 2015, ANTIVIR RES, V123, P1, DOI 10.1016/j.antiviral.2015.08.012; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Pfizer Inc, 2015, IBR PALB CAPS PRESCR; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015; Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743; Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070506; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005; Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58; Yamamoto M, 2014, J CLIN INVEST, V124, P3479, DOI 10.1172/JCI73805; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JJ, 2010, J VIROL, V84, P12619, DOI 10.1128/JVI.01696-10	59	443	457	6	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2016	22	10					1101	1107		10.1038/nm.4184	http://dx.doi.org/10.1038/nm.4184			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DY1RQ	27571349	Green Accepted, Bronze			2022-12-27	WOS:000384872500013
J	Lin, CH; Chi, CY; Shih, HP; Ding, JY; Lo, CC; Wang, SY; Kuo, CY; Yeh, CF; Tu, KH; Liu, SH; Chen, HK; Ho, CH; Ho, MW; Lee, CH; Lai, HC; Ku, CL				Lin, Chia-Hao; Chi, Chih-Yu; Shih, Han-Po; Ding, Jing-Ya; Lo, Chia-Chi; Wang, Shang-Yu; Kuo, Chen-Yen; Yeh, Chun-Fu; Tu, Kun-Hua; Liu, Shou-Hsuan; Chen, Hung-Kai; Ho, Chen-Hsuan; Ho, Mao-Wang; Lee, Chen-Hsiang; Lai, Hsin-Chin; Ku, Cheng-Lung			Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease	NATURE MEDICINE			English	Article							IFN-GAMMA; MOLECULAR MIMICRY; GM-CSF; MENDELIAN SUSCEPTIBILITY; BIOLOGICAL-ACTIVITY; CLINICAL-FEATURES; CRYSTAL-STRUCTURE; INFECTION; RITUXIMAB; IMMUNODEFICIENCY	The binding of autoantibodies (autoAbs) to interferon (IFN)-gamma in people with mycobacterial diseases has become an emerging medical concern. Many patients display specific human leukocyte antigen (HLA) class II haplotypes, which suggests that a common T cell-dependent and B cell-dependent mechanism might underlie the production of specific anti-IFN-gamma autoAbs. We show here that these autoAbs target a major epitope (amino acids 121-131, designated position (P)(121-131)) in a region crucial for IFN-gamma receptor (IFN-gamma R) activation to impair IFN-gamma-mediated activities. The amino acid sequence of this epitope is highly homologous to a stretch in the Noc2 protein of Aspergillus spp., which was cross-reactive with autoAbs from patients. Rats immunized with Aspergillus Noc2 developed antibodies that reacted with human IFN-gamma. We generated an epitope-erased variant of IFN-gamma (EE-IFN-gamma), in which the major neutralizing epitope region was altered. The binding affinity of anti-IFN-gamma autoAbs for EE-IFN-gamma was reduced by about 40%, as compared to that for IFN-(gamma 1-131). Moreover, EE-IFN-gamma activated the IFN-gamma R downstream signaling pathway ex vivo, irrespectively of anti-IFN-gamma autoAbs. In conclusion, we identified a common, crucial B cell epitope that bound to anti-IFN-gamma autoAbs in patients, and we propose a molecular-mimicry model for autoAb development. In addition, treatment with EE-IFN-gamma might be worth investigating in patients producing anti-IFN-gamma autoAbs.	[Lin, Chia-Hao; Chi, Chih-Yu; Shih, Han-Po; Ding, Jing-Ya; Lo, Chia-Chi; Wang, Shang-Yu; Kuo, Chen-Yen; Yeh, Chun-Fu; Tu, Kun-Hua; Liu, Shou-Hsuan; Ku, Cheng-Lung] Chang Gung Univ, Grad Inst Clin Med Sci, Lab Human Immunol & Infect Dis, Taoyuan, Taiwan; [Lin, Chia-Hao; Lai, Hsin-Chin] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Chi, Chih-Yu; Ho, Mao-Wang] China Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Chi, Chih-Yu] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Wang, Shang-Yu] Chang Gung Mem Hosp, Dept Gen Surg, Div Trauma & Emergency Surg, Taoyuan, Taiwan; [Kuo, Chen-Yen] Chang Gung Mem Hosp, Dept Pediat, Div Infect Dis, Taoyuan, Taiwan; [Yeh, Chun-Fu; Ku, Cheng-Lung] Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Taoyuan, Taiwan; [Yeh, Chun-Fu; Tu, Kun-Hua; Liu, Shou-Hsuan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tu, Kun-Hua; Liu, Shou-Hsuan] Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taipei, Taiwan; [Chen, Hung-Kai; Ho, Chen-Hsuan] Dev Ctr Biotechnol, Lab Translat Med, New Taipei, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lai, Hsin-Chin; Ku, Cheng-Lung] Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan; [Lai, Hsin-Chin; Ku, Cheng-Lung] Chang Gung Univ, Taoyuan, Taiwan; [Ku, Cheng-Lung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	Chang Gung University; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan	Ku, CL (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Lab Human Immunol & Infect Dis, Taoyuan, Taiwan.; Ku, CL (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Taoyuan, Taiwan.; Ku, CL (corresponding author), Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan.; Ku, CL (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Ku, CL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	clku@mail.cgu.edu.tw	Tu, Kun-Hua/ABD-1751-2021; KU, Cheng-Lung/AAT-1033-2020	Tu, Kun-Hua/0000-0002-7146-4481; KU, Cheng-Lung/0000-0002-0643-2256; Wang, Shang Yu/0000-0003-1514-3015; Chen, Hung-Kai/0000-0002-2169-4924; Chi, Chih-Yu/0000-0002-1425-8585	Taiwan National Health Research Institutes [NHRI-EX100-10028SC]; Taiwan Ministry of Science and Technology [100-2314-B-182-050, 102-2320-B-182-024, 103-2320-B-182-012]; Chang Gung Memorial Hospital [CMRPD1F0201, CORPD1F0041, BMRPB98]	Taiwan National Health Research Institutes; Taiwan Ministry of Science and Technology; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	We thank all the clinicians and patients who participated in this study. This work was supported by the Taiwan National Health Research Institutes grant NHRI-EX100-10028SC (C.-L.K.), Taiwan Ministry of Science and Technology grant 100-2314-B-182-050 (C.-L.K.), 102-2320-B-182-024 (C.-L.K.) and 103-2320-B-182-012 (C.-L.K.), and Chang Gung Memorial Hospital grant CMRPD1F0201 (C.-L.K.), CORPD1F0041 (C.-L.K.) and BMRPB98 (C.-L.K.).	Barnes PD, 2006, INFECT DIS CLIN N AM, V20, P545, DOI 10.1016/j.idc.2006.06.001; BASHAM TY, 1983, J IMMUNOL, V130, P1492; Baxter CG, 2013, CLIN MICROBIOL INFEC, V19, pE197, DOI 10.1111/1469-0691.12133; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Browne SK, 2014, ANNU REV IMMUNOL, V32, P635, DOI 10.1146/annurev-immunol-032713-120222; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Browne SK, 2012, BLOOD, V119, P3933, DOI 10.1182/blood-2011-12-395707; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Casanova JL, 1996, PEDIATRICS, V98, P774; Chaudhary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009036; Chi CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003927; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Keating GM, 2010, DRUGS, V70, P1445, DOI 10.2165/11201110-000000000-00000; Ku CL, 2016, J ALLERGY CLIN IMMUN, V137, P945, DOI 10.1016/j.jaci.2015.09.018; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lee WI, 2013, IMMUNOBIOLOGY, V218, P762, DOI 10.1016/j.imbio.2012.08.281; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; LUNDELL D, 1991, PROTEIN ENG, V4, P335, DOI 10.1093/protein/4.3.335; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Puel A, 2013, BLOOD, V121, P1246, DOI 10.1182/blood-2013-01-474213; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rao VK, 2009, PEDIATR BLOOD CANCER, V52, P847, DOI 10.1002/pbc.21965; Rosen LB, 2015, CLIN INFECT DIS, V60, P1017, DOI 10.1093/cid/ciu968; Rosen LB, 2013, J IMMUNOL, V190, P3959, DOI 10.4049/jimmunol.1202526; ROWLEY D, 1962, NATURE, V193, P151, DOI 10.1038/193151a0; Savan R, 2009, CYTOKINE GROWTH F R, V20, P115, DOI 10.1016/j.cytogfr.2009.02.006; SEELIG GF, 1988, BIOCHEMISTRY-US, V27, P1981, DOI 10.1021/bi00406a026; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sologuren I, 2011, HUM MOL GENET, V20, P1509, DOI 10.1093/hmg/ddr029; Thiel DJ, 2000, STRUCTURE, V8, P927, DOI 10.1016/S0969-2126(00)00184-2; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Wang YN, 2013, P NATL ACAD SCI USA, V110, P7832, DOI 10.1073/pnas.1216011110	46	52	52	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					994	+		10.1038/nm.4158	http://dx.doi.org/10.1038/nm.4158			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27525523				2022-12-27	WOS:000382542800010
J	Massoud, AH; Charbonnier, LM; Lopez, D; Pellegrini, M; Phipatanakul, W; Chatila, TA				Massoud, Amir Hossein; Charbonnier, Louis-Marie; Lopez, David; Pellegrini, Matteo; Phipatanakul, Wanda; Chatila, Talal A.			An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to T(H)17-like cells	NATURE MEDICINE			English	Article							IL-4; CYTOKINE; HYPERRESPONSIVENESS; GENERATION; MUTATION; STAT6; DIFFERENTIATION; ACTIVATION; PATHWAYS; DISTINCT	Mechanisms by which regulatory T (T-reg) cells fail to control inflammation in asthma remain poorly understood. We show that a severe asthma-associated polymorphism in the gene encoding the interleukin (IL)-4 receptor alpha chain (Il4ra(R576)) promotes conversion of induced T-reg (iT(reg)) cells toward a T helper 17 (T(H)17) cell fate. This skewing is mediated by the recruitment by IL-4R alpha(R576) of the growth-factor-receptor-bound protein 2 (GRB2) adaptor protein, which drives IL-17 expression by activating a pathway that involves extracellular-signal-regulated kinase, IL-6 and the transcription factor STAT3. T-reg cell-specific deletion of genes that regulate T(H)17 cell differentiation, including Il6ra and RAR-related orphan receptor gamma (Rorc), but not of Il4 or Il13, prevented exacerbated airway inflammation in mice expressing Il4ra(R576) (hereafter referred to as Il4ra(R576) mice). Furthermore, treatment of Il4ra(R576) mice with a neutralizing IL-6-specific antibody prevented iT(reg) cell reprogramming into TH17-like cells and protected against severe airway inflammation. These findings identify a previously unknown mechanism for the development of mixed TH2-TH17 cell inflammation in genetically prone individuals and point to interventions that stabilize iT(reg) cells as potentially effective therapeutic strategies.	[Massoud, Amir Hossein; Charbonnier, Louis-Marie; Phipatanakul, Wanda; Chatila, Talal A.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Massoud, Amir Hossein; Charbonnier, Louis-Marie; Phipatanakul, Wanda; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Lopez, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Chatila, TA (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA USA.	talal.chatila@childrens.harvard.edu	Massoud, Amir Hossein/AAO-2940-2021	Charbonnier, Louis-Marie/0000-0002-4594-7893; Chatila, Talal/0000-0001-7439-2762; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health [R01 AI065617, U10HL098102, U10HL109172]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109172, U10HL098102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065617, K24AI106822, U01AI126614, U01AI110397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grants R01 AI065617 (T.A.C.), U10HL098102 (W.P.) and U10HL109172 (W.P.). We thank E. Crestani, D. Schierembergg and A. Cunningham for help with patient recruitment, and H.C. Oettgen and L.-M. Charbonnier for their critical review of the manuscript.	Al-Muhsen S, 2014, ANN THORAC MED, V9, P81, DOI 10.4103/1817-1737.128849; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhakta NR, 2014, J ALLERGY CLIN IMMUN, V134, P1187, DOI 10.1016/j.jaci.2014.07.034; Blaeser F, 2003, J EXP MED, V198, P1189, DOI 10.1084/jem.20030471; Carrera P, 2001, Methods Mol Biol, V163, P95; Charbonnier LM, 2015, NAT IMMUNOL, V16, P1162, DOI 10.1038/ni.3288; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Ford AQ, 2009, J IMMUNOL, V183, P1607, DOI 10.4049/jimmunol.0803266; Gour N, 2015, CYTOKINE, V75, P68, DOI 10.1016/j.cyto.2015.05.014; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hou LF, 2015, J AUTOIMMUN, V65, P56, DOI 10.1016/j.jaut.2015.08.006; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Little S., 2001, CURR PROTOC HUM GENE, V7, P98; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Muraro A, 2016, J ALLERGY CLIN IMMUN, V137, P1347, DOI 10.1016/j.jaci.2016.03.010; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Rosa-Rosa L, 1999, J ALLERGY CLIN IMMUN, V104, P1008, DOI 10.1016/S0091-6749(99)70082-5; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ryan JJ, 1998, J IMMUNOL, V161, P1811; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Stephenson L, 2004, J IMMUNOL, V173, P4523, DOI 10.4049/jimmunol.173.7.4523; Tachdjian R, 2010, J ALLERGY CLIN IMMUN, V125, P1128, DOI 10.1016/j.jaci.2010.01.054; Tachdjian R, 2009, J EXP MED, V206, P2191, DOI 10.1084/jem.20091480; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Voehringer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-69; Wang HY, 1999, J IMMUNOL, V162, P4385; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	66	106	111	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2016	22	9					1013	+		10.1038/nm.4147	http://dx.doi.org/10.1038/nm.4147			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DU9MW	27479084	Green Submitted, Green Accepted			2022-12-27	WOS:000382542800012
J	Fry, TJ; Shah, NN; Orentas, RJ; Stetler-Stevenson, M; Yuan, CM; Ramakrishna, S; Wolters, P; Martin, S; Delbrook, C; Yates, B; Shalabi, H; Fountaine, TJ; Shern, JF; Majzner, RG; Stroncek, DF; Sabatino, M; Feng, Y; Dimitrov, DS; Zhang, L; Nguyen, S; Qin, HY; Dropulic, B; Lee, DW; Mackall, CL				Fry, Terry J.; Shah, Nirali N.; Orentas, Rimas J.; Stetler-Stevenson, Maryalice; Yuan, Constance M.; Ramakrishna, Sneha; Wolters, Pamela; Martin, Staci; Delbrook, Cindy; Yates, Bonnie; Shalabi, Haneen; Fountaine, Thomas J.; Shern, Jack F.; Majzner, Robbie G.; Stroncek, David F.; Sabatino, Marianna; Feng, Yang; Dimitrov, Dimiter S.; Zhang, Ling; Sang Nguyen; Qin, Haiying; Dropulic, Boro; Lee, Daniel W.; Mackall, Crystal L.			CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHIMERIC ANTIGEN RECEPTOR; MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOCYTIC-LEUKEMIA; INOTUZUMAB OZOGAMICIN; PHASE-II; CLINICAL-TRIAL; YOUNG-ADULTS; CHILDHOOD; THERAPY	Chimeric antigen receptor (CAR) T cells targeting CD19 mediate potent effects in relapsed and/or refractory pre-B cell acute lymphoblastic leukemia (B-ALL), but antigen loss is a frequent cause of resistance to CD19-targeted immunotherapy. CD22 is also expressed in most cases of B-ALL and is usually retained following CD19 loss. We report results from a phase 1 trial testing a new CD22-targeted CAR (CD22-CAR) in 21 children and adults, including 17 who were previously treated with CD19-directed immunotherapy. Dose-dependent antileukemic activity was observed, with complete remission obtained in 73% (11/15) of patients receiving >= 1 x 10(6) CD22-CAR T cells per kg body weight, including 5 of 5 patients with CD19(dim) or CD19(-) B-ALL. Median remission duration was 6 months. Relapses were associated with diminished CD22 site density that likely permitted CD22(+) cell escape from killing by CD22-CAR T cells. These results are the first to establish the clinical activity of a CD22-CAR in B-ALL, including leukemia resistant to anti-CD19 immunotherapy, demonstrating potency against B-ALL comparable to that of CD19-CAR at biologically active doses. Our results also highlight the critical role played by antigen density in regulating CAR function.	[Fry, Terry J.; Shah, Nirali N.; Orentas, Rimas J.; Ramakrishna, Sneha; Wolters, Pamela; Martin, Staci; Delbrook, Cindy; Yates, Bonnie; Shalabi, Haneen; Fountaine, Thomas J.; Shern, Jack F.; Zhang, Ling; Sang Nguyen; Qin, Haiying; Lee, Daniel W.] NIH, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA; [Stetler-Stevenson, Maryalice; Yuan, Constance M.] NIH, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Majzner, Robbie G.; Mackall, Crystal L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Stroncek, David F.; Sabatino, Marianna] NIH, Dept Transfus Med, NIH Clin Ctr, Bethesda, MD 20892 USA; [Feng, Yang; Dimitrov, Dimiter S.] NCI, Canc & Inflammat Program, NIH, Bethesda, MD 20892 USA; [Dropulic, Boro] Lentigen Corp, Gaithersburg, MD USA; [Mackall, Crystal L.] Stanford Univ, Standford Canc Ctr, Stanford, CA 94305 USA; [Orentas, Rimas J.; Dropulic, Boro] Lentigen Technol Inc, Miltenyi Biotec, Gaithersburg, MD USA; [Lee, Daniel W.] Univ Virginia, Dept Pediat, Div Pediat Hematol & Oncol, Charlottesville, VA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Miltenyi Biotec; University of Virginia	Fry, TJ (corresponding author), NIH, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	fryt@mail.nih.gov	Stetler-Stevenson, Maryalice/AAV-7393-2020; Shern, Jack/V-4002-2019	Fry, Terry/0000-0001-8044-5226; Nguyen, Sang/0000-0002-6864-8044; Lee, Darrall/0000-0002-6990-4441; Ramakrishna, Sneha/0000-0001-7445-3190	Intramural Research Program National Institute of Health; National Cancer Institute National Institute of Health; NIH Clinical Center National Institute of Health; Stand Up to Cancer-St. Baldrick's Pediatric Dream Team translational [SU2C-AACR-DT113]; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [ZIABC011565, ZIABC011295, ZIABC011734] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002120] Funding Source: NIH RePORTER	Intramural Research Program National Institute of Health; National Cancer Institute National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Clinical Center National Institute of Health; Stand Up to Cancer-St. Baldrick's Pediatric Dream Team translational; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	We gratefully acknowledge the study participants and their families, referring medical care teams, the faculty and staff of the NIH and the data managers involved with this work. This work was supported in part by the Intramural Research Program, National Cancer Institute and NIH Clinical Center, National Institutes of Health, by a Stand Up to Cancer-St. Baldrick's Pediatric Dream Team translational research grant (SU2C-AACR-DT113) and by a St. Baldrick's Foundation Scholar Award (D.W.L.). Stand Up to Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. C.L.M. is a member of the Parker Institute for Cancer Immunotherapy, which supports the Stanford University Cancer Immunotherapy Program. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Borowitz MJ, 2015, BLOOD, V126, P964, DOI 10.1182/blood-2015-03-633685; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Chevallier P, 2009, LEUKEMIA, V23, P806, DOI 10.1038/leu.2008.303; Chevallier P, 2015, LANCET HAEMATOL, V2, pE108, DOI 10.1016/S2352-3026(15)00020-4; Chevallier P, 2015, HAEMATOLOGICA, V100, pE128, DOI 10.3324/haematol.2014.120220; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Essig S, 2014, LANCET ONCOL, V15, P841, DOI 10.1016/S1470-2045(14)70265-7; Faderl S, 2010, CANCER-AM CANCER SOC, V116, P1165, DOI 10.1002/cncr.24862; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Grant BW, 2013, CANCER-AM CANCER SOC, V119, P3797, DOI 10.1002/cncr.28299; Grupp SA, 2015, BLOOD, V126, P681, DOI DOI 10.1158/1078-0432.CCR-08-0144; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guo B., 2016, J CELLULAR IMMUNOTHE, V2, P28, DOI DOI 10.1042/BSR20150089; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Jacoby E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12320; Jasper GA, 2011, CYTOM PART B-CLIN CY, V80B, P83, DOI 10.1002/cyto.b.20567; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kantarjian H, 2013, CANCER-AM CANCER SOC, V119, P2728, DOI 10.1002/cncr.28136; Kantarjian H, 2012, LANCET ONCOL, V13, P403, DOI 10.1016/S1470-2045(11)70386-2; Kantarjian HM, 2016, NEW ENGL J MED, V375, P740, DOI 10.1056/NEJMoa1509277; Kawalekar OU, 2016, IMMUNITY, V44, P712, DOI 10.1016/j.immuni.2016.02.023; Kero AE, 2016, CANCER EPIDEMIOL, V41, P42, DOI 10.1016/j.canep.2016.01.009; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Lucio P, 2001, LEUKEMIA, V15, P1185, DOI 10.1038/sj.leu.2402150; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Olejniczak SH, 2006, IMMUNOL INVEST, V35, P93, DOI 10.1080/08820130500496878; Pui CH, 2015, J CLIN ONCOL, V33, P2938, DOI 10.1200/JCO.2014.59.1636; Pui CH, 2015, LANCET ONCOL, V16, P465, DOI 10.1016/S1470-2045(15)70082-3; Qin H, 2015, BLOOD, V126, P4427, DOI DOI 10.1182/blood.V126.23.4427.4427; Raetz EA, 2015, PEDIATR BLOOD CANCER, V62, P1171, DOI 10.1002/pbc.25454; Ram R, 2012, AM J HEMATOL, V87, P472, DOI 10.1002/ajh.23149; Ramos CA, 2016, J CLIN INVEST, V126, P2588, DOI 10.1172/JCI86000; Raponi S, 2011, LEUKEMIA LYMPHOMA, V52, P1098, DOI 10.3109/10428194.2011.559668; Ritchie DS, 2013, MOL THER, V21, P2122, DOI 10.1038/mt.2013.154; Rytting ME, 2014, CANCER-AM CANCER SOC, V120, P3660, DOI 10.1002/cncr.28930; Shah NN, 2015, PEDIATR BLOOD CANCER, V62, P964, DOI 10.1002/pbc.25410; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Stroncek DF, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1160-5; Stroncek DF, 2016, CYTOTHERAPY, V18, P893, DOI 10.1016/j.jcyt.2016.04.003; Tembhare PR, 2013, AM J CLIN PATHOL, V140, P813, DOI 10.1309/AJCPYFQ4XMGJD6TI; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Turatti F, 2007, J IMMUNOTHER, V30, P684, DOI 10.1097/CJI.0b013e3180de5d90; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Watanabe K, 2015, J IMMUNOL, V194, P911, DOI 10.4049/jimmunol.1402346; Wayne AS, 2010, CLIN CANCER RES, V16, P1894, DOI 10.1158/1078-0432.CCR-09-2980; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Xiao XD, 2009, MABS-AUSTIN, V1, P297, DOI 10.4161/mabs.1.3.8113	58	731	774	8	202	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2018	24	1					20	+		10.1038/nm.4441	http://dx.doi.org/10.1038/nm.4441			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FT2JB	29155426	Green Accepted			2022-12-27	WOS:000422965900007
J	Gamu, D; Tupling, AR				Gamu, Daniel; Tupling, A. Russell			Fattening the role of Ca2+ cycling in adaptive thermogenesis	NATURE MEDICINE			English	Editorial Material							BEIGE ADIPOCYTES; SARCOLIPIN; ABLATION; MUSCLE	A new study shows that deleting uncoupling protein 1 activates Ca2+ cycling thermogenesis within beige fat, protecting mice against cold-induced hypothermia and dysglycemia following diet-induced obesity.	[Gamu, Daniel; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada	University of Waterloo	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	rtupling@uwaterloo.ca		Tupling, A. Russell/0000-0002-3895-6767				Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bertholet AM, 2017, CELL METAB, V25, P811, DOI 10.1016/j.cmet.2017.03.002; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Chen KY, 2016, CELL METAB, V24, P210, DOI 10.1016/j.cmet.2016.07.014; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Leitner BP, 2017, P NATL ACAD SCI USA, V114, P8649, DOI 10.1073/pnas.1705287114; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	10	2	2	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2017	23	12					1403	1404		10.1038/nm.4457	http://dx.doi.org/10.1038/nm.4457			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FP0GU	29216033				2022-12-27	WOS:000417278200007
J	Kemaladewi, DU; Maino, E; Hyatt, E; Hou, HY; Ding, M; Place, KM; Zhu, XY; Bassi, P; Baghestani, Z; Deshwar, AG; Merico, D; Xiong, HY; Frey, BJ; Wilson, MD; Ivakine, EA; Cohn, RD				Kemaladewi, Dwi U.; Maino, Eleonora; Hyatt, Elzbieta; Hou, Huayun; Ding, Maylynn; Place, Kara M.; Zhu, Xinyi; Bassi, Prabhpreet; Baghestani, Zahra; Deshwar, Amit G.; Merico, Daniele; Xiong, Hui Y.; Frey, Brendan J.; Wilson, Michael D.; Ivakine, Evgueni A.; Cohn, Ronald D.			Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism	NATURE MEDICINE			English	Article							CRISPR-CAS9; EXPRESSION; SITES; MICE; CAS9	Splice-site defects account for about 10% of pathogenic mutations that cause Mendelian diseases(1). Prevalence is higher in neuromuscular disorders (NMDs)(2), owing to the unusually large size and multi-exonic nature of genes encoding muscle structural proteins. Therapeutic genome editing to correct disease-causing splice-site mutations has been accomplished only through the homology-directed repair pathway(3-5), which is extremely inefficient in postmitotic tissues such as skeletal muscle(6). Here we describe a strategy using nonhomologous end-joining (NHEJ) to correct a pathogenic splice-site mutation. As a proof of principle, we focus on congenital muscular dystrophy type 1A (MDC1A), which is characterized by severe muscle wasting and paralysis(7). Specifically, we correct a splice-site mutation that causes the exclusion of exon 2 from Lama2 mRNA and the truncation of Lama2 protein in the dy(2J)/dy(2J) mouse model of MDC1A(8). Through systemic delivery of adeno-associated virus (AAV) carrying clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 genome-editing components, we simultaneously excise an intronic region containing the mutation and create a functional donor splice site through NHEJ. This strategy leads to the inclusion of exon 2 in the Lama2 transcript and restoration of full-length Lama2 protein. Treated dy(2J)/dy(2J) mice display substantial improvement in muscle histopathology and function without signs of paralysis.	[Kemaladewi, Dwi U.; Maino, Eleonora; Hyatt, Elzbieta; Hou, Huayun; Ding, Maylynn; Place, Kara M.; Zhu, Xinyi; Bassi, Prabhpreet; Baghestani, Zahra; Merico, Daniele; Wilson, Michael D.; Ivakine, Evgueni A.; Cohn, Ronald D.] Hosp Sick Children Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada; [Maino, Eleonora; Hou, Huayun; Bassi, Prabhpreet; Wilson, Michael D.; Cohn, Ronald D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Deshwar, Amit G.; Merico, Daniele; Xiong, Hui Y.; Frey, Brendan J.] Deep Genom, Toronto, ON, Canada; [Merico, Daniele] Hosp Sick Children Res Inst, Ctr Appl Genom TCAG, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Wilson, Michael D.] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada; [Cohn, Ronald D.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Cohn, Ronald D.] Hosp Sick Children, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ivakine, EA; Cohn, RD (corresponding author), Hosp Sick Children Res Inst, Program Genet & Genome Biol, Toronto, ON, Canada.; Cohn, RD (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Cohn, RD (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.; Cohn, RD (corresponding author), Hosp Sick Children, Toronto, ON, Canada.	zhenya.ivakine@sickkids.ca; ronald.cohn@sickkids.ca	Wilson, Michael D/K-6294-2014; Cohn, Ronald/AAC-5835-2021	Wilson, Michael D/0000-0002-4015-3066; Ivakine, Evgueni/0000-0003-2132-4699; Kemaladewi, Dwi/0000-0002-0747-4589; Merico, Daniele/0000-0002-3728-4401	AFM-Telethon postdoctoral fellowship and Cure CMD; Ermenegildo Zegna Founder's scholarship; Canada Research Chair (Tier 2) in Comparative Genomics; Ontario Ministry of Research, Innovation and Science; Canadian Institute for Health Research; Natural Sciences and Engineering Research Council of Canada; SickKids Foundation; RS McLaughlin Foundation; Women's Auxiliary Chairs	AFM-Telethon postdoctoral fellowship and Cure CMD; Ermenegildo Zegna Founder's scholarship; Canada Research Chair (Tier 2) in Comparative Genomics; Ontario Ministry of Research, Innovation and Science; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); SickKids Foundation; RS McLaughlin Foundation; Women's Auxiliary Chairs	The Cohn lab members are gratefully acknowledged for their technical support and critical input in this study. We thank I. Vukobradovic and A. Fleniken (Clinical Phenotyping Core, Toronto Centre for Phenogenomics), C. Rand (Aurora Scientific), and M. Justice, J. Dowling, and J. Ruston (Genetics and Genome Biology) for their critical inputs to this study. T. Paton, S. Perreira, G. Casallo, B. Thiruvahindrapuram, W. Sung (Toronto Center for Applied Genomics), and A. Cui (Deep Genomics) are acknowledged for their support in genomic and bioinformatics analyses. This work was supported by an AFM-Telethon postdoctoral fellowship and Cure CMD (to D.U.K.); an Ermenegildo Zegna Founder's scholarship (to E.M.); a Canada Research Chair (Tier 2) in Comparative Genomics and an Early Researcher Award from the Ontario Ministry of Research, Innovation and Science (to M.D.W.); and the Canadian Institute for Health Research, Natural Sciences and Engineering Research Council of Canada, the SickKids Foundation, RS McLaughlin Foundation and Women's Auxiliary Chairs (to R.D.C.).	Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Call JA, 2016, METHODS MOL BIOL, V1460, P3, DOI 10.1007/978-1-4939-3810-0_1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Durbeej M, 2015, CURR TOP MEMBR, V76, P31, DOI 10.1016/bs.ctm.2015.05.002; Ferdousi LV, 2014, STEM CELL RES, V13, P492, DOI 10.1016/j.scr.2014.08.005; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iyer SR, 2016, METHODS MOL BIOL, V1460, P293, DOI 10.1007/978-1-4939-3810-0_20; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kemaladewi DU, 2012, FASEB J, V26, P1462, DOI 10.1096/fj.11-191189; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Lampe SEG, 2014, JOVE-J VIS EXP, DOI 10.3791/52037; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Stepson P.D., 2014, HUM GENET, V133, P1; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Tan JZ, 2016, NUCLEIC ACIDS RES, V44, P3908, DOI 10.1093/nar/gkw163; Tanguy Y, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00036; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vilquin JT, 2000, NEUROMUSCULAR DISORD, V10, P59, DOI 10.1016/S0960-8966(99)00056-5; Wojtal D, 2016, AM J HUM GENET, V98, P90, DOI 10.1016/j.ajhg.2015.11.012; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078318, 10.1371/journal.pone.0059627]; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	40	43	47	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2017	23	8					984	+		10.1038/nm.4367	http://dx.doi.org/10.1038/nm.4367			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FC6JY	28714989				2022-12-27	WOS:000406947600014
J	Ozaita, A; Aso, E				Ozaita, Andres; Aso, Ester			The cannabis paradox: when age matters	NATURE MEDICINE			English	Editorial Material							ENDOCANNABINOID SYSTEM; MICE; MODULATION	New evidence in mouse models reveals that exposure to Delta(9)-tetrahydrocannabinol (THC), the main psychoactive component in Cannabis sativa, might improve cognitive performance in aging animals.	[Ozaita, Andres] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Aso, Ester] Bellvitge Univ Hosp, Pathol Anat Serv, Lhospitalet De Llobregat, Spain; [Aso, Ester] Carlos III Hlth Inst, Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain	Pompeu Fabra University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital	Ozaita, A (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	andres.ozaita@upf.edu; aso@bellvitgehospital.cat	Ozaita, Andres/H-3411-2015; Aso, Ester/K-4484-2014	Ozaita, Andres/0000-0002-2239-7403; Aso, Ester/0000-0003-1836-1747				Aso E, 2015, J ALZHEIMERS DIS, V43, P977, DOI 10.3233/JAD-141014; Bilkei-Gorzo A, 2017, NAT MED, V23, P782, DOI 10.1038/nm.4311; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; European Monitoring Centre for Drugs and Drug Addiction, 2016, EUR DRUG REP 2016 TR; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Morena M, 2014, NEUROBIOL LEARN MEM, V112, P30, DOI 10.1016/j.nlm.2013.12.010; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057	9	6	6	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2017	23	6					661	662		10.1038/nm.4348	http://dx.doi.org/10.1038/nm.4348			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EW8KQ	28586333	Green Accepted			2022-12-27	WOS:000402768000007
J	Pisarsky, L; Dai, JX; Ghajar, CM				Pisarsky, Laura; Dai, Jinxiang; Ghajar, Cyrus M.			Taking inventory of metastasis effectors	NATURE MEDICINE			English	Editorial Material							EARLY DISSEMINATION; CANCER; THERAPY; CELLS	In a recent study in mice, researchers combined tumor barcoding with unbiased genomic analysis and identified Cd109 as a hub gene involved in metastatic progression. They show that pharmacological inhibition of its downstream effectors JAK1 and STAT3 curtails metastatic growth.	[Pisarsky, Laura; Dai, Jinxiang; Ghajar, Cyrus M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA; [Pisarsky, Laura; Dai, Jinxiang; Ghajar, Cyrus M.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Ghajar, CM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA.; Ghajar, CM (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	cghajar@fredhutch.org	Dai, Jin/GVT-2414-2022	Dai, Jin/0000-0003-3063-746X; Pisarsky, Laura/0000-0002-5585-9221				Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chuang CH, 2017, NAT MED, V23, P291, DOI 10.1038/nm.4285; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P71, DOI 10.1016/j.semcancer.2010.12.004; Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Howlader N., 2016, SEER CANC STAT REV 1; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	12	0	0	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					275	276		10.1038/nm.4301	http://dx.doi.org/10.1038/nm.4301			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28267712				2022-12-27	WOS:000395848400006
J	Zhao, XQ; Guo, YH; Jiang, CY; Chang, Q; Zhang, SL; Luo, TM; Zhang, B; Jia, XM; Hung, MC; Dong, C; Lin, X				Zhao, Xueqiang; Guo, Yahui; Jiang, Changying; Chang, Qing; Zhang, Shilei; Luo, Tianming; Zhang, Bin; Jia, Xinming; Hung, Mien-Chie; Dong, Chen; Lin, Xin			JNK1 negatively controls antifungal innate immunity by suppressing CD23 expression	NATURE MEDICINE			English	Article							PATTERN-RECOGNITION RECEPTORS; HOST-DEFENSE; LECTIN RECEPTORS; CELL-DIFFERENTIATION; SIGNALING PATHWAY; MACROPHAGES; DECTIN-1; KINASE; NEUTROPHILS; ACTIVATION	Opportunistic fungal infections are a leading cause of death among immune-compromised patients, and there is a pressing need to develop new antifungal therapeutic agents because of toxicity and resistance to the antifungal drugs currently in use. Although C-type lectin receptor- and Toll-like receptor-induced signaling pathways are key activators of host antifungal immunity, little is known about the mechanisms that negatively regulate host immune responses to a fungal infection. Here we found that JNK1 activation suppresses antifungal immunity in mice. We showed that JNK1-deficient mice had a significantly higher survival rate than wild-type control mice in response to Candida albicans infection, and the expression of JNK1 in hematopoietic innate immune cells was critical for this effect. JNK1 deficiency leads to significantly higher induction of CD23, a novel C-type lectin receptor, through NFATcl-mediated regulation of the CD23 gene promoter. Blocking either CD23 upregulation or CD23dependent nitric oxide production eliminated the enhanced antifungal response found in JNK1-deficient mice. Notably, JNK inhibitors exerted potent antifungal therapeutic effects in both mouse and human cells infected with C. albicans, indicating that JNK1 may be a therapeutic target for treating fungal infection.	[Zhao, Xueqiang; Guo, Yahui; Chang, Qing; Luo, Tianming; Zhang, Bin; Dong, Chen; Lin, Xin] Tsinghua Univ, Sch Med, Inst Immunol, Beijing, Peoples R China; [Jiang, Changying; Hung, Mien-Chie; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol Oncol, Houston, TX 77030 USA; [Jiang, Changying; Hung, Mien-Chie; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Cellular Oncol, Houston, TX 77030 USA; [Zhang, Shilei; Jia, Xinming] Tongji Univ, Sch Med, Dept Immunol, Shanghai, Peoples R China	Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tongji University	Zhao, XQ (corresponding author), Tsinghua Univ, Sch Med, Inst Immunol, Beijing, Peoples R China.	zhaoxueqiang@tsinghua.edu.cn; linxin307@tsinghua.edu.cn	Guo, Yahui/GQP-9675-2022; Hung, Mien-Chie/ABD-5911-2021; Guo, Yahui/M-6552-2019; Jiang, Changying/AAL-3711-2020; dong, chen/B-3181-2009	Hung, Mien-Chie/0000-0003-4317-4740; Guo, Yahui/0000-0003-1587-4619; dong, chen/0000-0002-0084-9130; Jiang, Changying/0000-0003-3778-4438; CHANG, QING/0000-0002-9259-7734; zhang, bin/0000-0001-6232-6768	National Natural Science Foundation of China [81502460, 31670904, 91542107, 81630058, 81571611]; National Institutes of Health [AI116722]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116722] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Hu, Y. Shang and L. Ni for helpful discussion. We thank X. Xu, L. Mu, S. Xie and T. Xia for technical assistance. We thank D.C. Lin for editing the English in this manuscript. This work was partially supported by grants from the National Natural Science Foundation of China (81502460 and 31670904 to X.Z., 91542107 and 81630058 to X.L., 81571611 to X.J.) and National Institutes of Health (AI116722 to X.L.).	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Aubry JP, 1997, J IMMUNOL, V159, P614; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Debnath I, 2007, J IMMUNOL, V178, P7139, DOI 10.4049/jimmunol.178.11.7139; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Ersland K, 2010, CELL HOST MICROBE, V7, P474, DOI 10.1016/j.chom.2010.05.010; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249; Kim JY, 2016, J MICROBIOL, V54, P145, DOI 10.1007/s12275-016-0647-8; Kneitz C, 2002, BBA-MOL BASIS DIS, V1588, P41, DOI 10.1016/S0925-4439(02)00114-X; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7; Mossalayi MD, 2009, INFECT IMMUN, V77, P5537, DOI 10.1128/IAI.01457-08; Plato A, 2015, SEMIN IMMUNOPATHOL, V37, P97, DOI 10.1007/s00281-014-0462-4; Rambert J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004834; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romero-Puertas MC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00316; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2015, IMMUNITY, V43, P845, DOI 10.1016/j.immuni.2015.10.023; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vonk AG, 2002, J MICROBIOL METH, V49, P55, DOI 10.1016/S0167-7012(01)00348-7; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Vouldoukis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018289; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wirnsberger G, 2016, NAT MED, V22, P915, DOI 10.1038/nm.4134; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Wuthrich M, 2012, ANNU REV IMMUNOL, V30, P115, DOI 10.1146/annurev-immunol-020711-074958; Xiao Y, 2016, NAT MED, V22, P906, DOI 10.1038/nm.4141; Zanoni I, 2012, EUR J IMMUNOL, V42, P1924, DOI 10.1002/eji.201242580; Zhu LL, 2016, J EXP MED, V213, P1555, DOI 10.1084/jem.20151932; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	48	60	66	5	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2017	23	3					337	346		10.1038/nm.4260	http://dx.doi.org/10.1038/nm.4260			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EN2NY	28112734	Green Accepted			2022-12-27	WOS:000395848400014
J	Corder, G; Tawfik, VL; Wang, D; Sypek, EI; Low, SA; Dickinson, JR; Sotoudeh, C; Clark, JD; Barres, BA; Bohlen, CJ; Scherrer, G				Corder, Gregory; Tawfik, Vivianne L.; Wang, Dong; Sypek, Elizabeth I.; Low, Sarah A.; Dickinson, Jasmine R.; Sotoudeh, Chaudy; Clark, J. David; Barres, Ben A.; Bohlen, Christopher J.; Scherrer, Gregory			Loss of mu opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia	NATURE MEDICINE			English	Article							LONG-TERM POTENTIATION; MESSENGER-RNA EXPRESSION; RAT SPINAL-CORD; INDUCED HYPERALGESIA; MOLECULAR-MECHANISMS; INDUCED CONSTIPATION; CHRONIC PAIN; METHYLNALTREXONE; WITHDRAWAL; NEURONS	Opioid pain medications have detrimental side effects including analgesic tolerance and opioid-induced hyperalgesia (OIH). Tolerance and OIH counteract opioid analgesia and drive dose escalation. The cell types and receptors on which opioids act to initiate these maladaptive processes remain disputed, which has prevented the development of therapies to maximize and sustain opioid analgesic efficacy. We found that opioid receptors (MORs) expressed by primary afferent nociceptors initiate tolerance and OIH development. RNA sequencing and histological analysis revealed that MORs are expressed by nociceptors, but not by spinal microglia. Deletion of MORs specifically in nociceptors eliminated morphine tolerance, OIH and pronociceptive synaptic long-term potentiation without altering antinociception. Furthermore, we found that co-administration of methylnaltrexone bromide, a peripherally restricted MOR antagonist, was sufficient to abrogate morphine tolerance and OIH without diminishing antinociception in perioperative and chronic pain models. Collectively, our data support the idea that opioid agonists can be combined with peripheral MOR antagonists to limit analgesic tolerance and OIH.	[Corder, Gregory; Tawfik, Vivianne L.; Wang, Dong; Sypek, Elizabeth I.; Low, Sarah A.; Dickinson, Jasmine R.; Sotoudeh, Chaudy; Clark, J. David; Scherrer, Gregory] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Corder, Gregory; Tawfik, Vivianne L.; Wang, Dong; Sypek, Elizabeth I.; Low, Sarah A.; Sotoudeh, Chaudy; Scherrer, Gregory] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Corder, Gregory; Tawfik, Vivianne L.; Wang, Dong; Low, Sarah A.; Sotoudeh, Chaudy; Scherrer, Gregory] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Corder, Gregory; Tawfik, Vivianne L.; Wang, Dong; Low, Sarah A.; Sotoudeh, Chaudy; Barres, Ben A.; Bohlen, Christopher J.; Scherrer, Gregory] Stanford Neurosci Inst, Stanford, CA 94305 USA; [Sypek, Elizabeth I.] Stanford Univ, Neurosci Grad Program, Stanford, CA 94305 USA; [Dickinson, Jasmine R.] Stanford Univ, Biol Grad Program, Stanford, CA 94305 USA; [Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, Palo Alto, CA USA; [Barres, Ben A.; Bohlen, Christopher J.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Scherrer, G (corresponding author), Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA.; Scherrer, G (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Scherrer, G (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.; Scherrer, G (corresponding author), Stanford Neurosci Inst, Stanford, CA 94305 USA.	gs25@stanford.edu		Tawfik, Vivianne/0000-0002-4422-2014; Scherrer, Gregory/0000-0002-1983-5126; sypek, elizabeth/0000-0001-6904-2426; LOW, SARAH/0000-0002-3847-2965	US National Institutes of Health (NIH) [DA031777]; Rita Allen Foundation; American Pain Society Award in Pain; NIH [F32DA041029, T32GM089626, T32DA35165, R37DA15043]; Foundation for Anesthesia Education and Research (FAER) Mentored Research Training grant; DoD National Defense Science and Engineering Graduate (NDSEG) Fellowship; NSF Graduate Research Fellowship; Damon Runyon Cancer Research Foundation postdoctoral fellowship; Stanford Bio-X Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015043, T32DA035165, K99DA031777, R00DA031777, F32DA041029] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; American Pain Society Award in Pain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Anesthesia Education and Research (FAER) Mentored Research Training grant; DoD National Defense Science and Engineering Graduate (NDSEG) Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation postdoctoral fellowship; Stanford Bio-X Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Kieffer (McGill University) for providing the Oprml foxed mice and MOR-mCherry mice, C. Evans (University of California, Los Angeles) and F. Simonin (Universite de Strasbourg) for providing critical immunohistochemical and pharmacological reagents, J. Kaslow and A. Yu-Chun Wong for assistance with data analysis, and H. Nguyen (Stanford University) for assistance with illustration design. This work was supported by US National Institutes of Health (NIH) grant DA031777 (G.S.), the Rita Allen Foundation and American Pain Society Award in Pain (G.S.), NIH Fellowships F32DA041029 (G.C.), T32GM089626 (D.W.), and T32DA35165 (G.C.), Foundation for Anesthesia Education and Research (FAER) Mentored Research Training grant (V.L.T.), DoD National Defense Science and Engineering Graduate (NDSEG) Fellowship (E.I.S.), NSF Graduate Research Fellowship. and Stanford Bio-X Graduate Fellowship (J.R.D.), NIH grant R37DA15043 (B.A.B.), and Damon Runyon Cancer Research Foundation postdoctoral fellowship (C.J.B.).	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Caldeira C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00152; Carroll IR, 2004, REGION ANESTH PAIN M, V29, P576, DOI 10.1016/j.rapm.2004.06.009; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Chen Li Hui, 2014, NCHS Data Brief, P1; Chen SR, 2007, NEUROSCIENCE, V145, P676, DOI 10.1016/j.neuroscience.2006.12.016; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; Collett BJ, 1998, BRIT J ANAESTH, V81, P58, DOI 10.1093/bja/81.1.58; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Fukagawa H, 2013, J ANESTH, V27, P93, DOI 10.1007/s00540-012-1469-4; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; He SQ, 2013, PAIN, V154, P2477, DOI 10.1016/j.pain.2013.07.023; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Jagla C, 2014, PAIN, V155, P2056, DOI 10.1016/j.pain.2014.07.011; Joseph EK, 2010, J NEUROSCI, V30, P4660, DOI 10.1523/JNEUROSCI.5530-09.2010; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kao SC, 2012, NEUROREPORT, V23, P378, DOI 10.1097/WNR.0b013e3283522e1b; Kemp T, 1996, NEUROSCIENCE, V75, P1231, DOI 10.1016/0306-4522(96)00333-8; Kronschlager MT, 2016, SCIENCE, V354, P1144, DOI 10.1126/science.aah5715; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mattioli TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097361; Pasternak GW, 2014, NEUROPHARMACOLOGY, V76, P198, DOI 10.1016/j.neuropharm.2013.03.039; Poelaert J, 2015, CLIN THER, V37, P784, DOI 10.1016/j.clinthera.2015.02.010; Raghavendra V, 2004, NEUROPSYCHOPHARMACOL, V29, P327, DOI 10.1038/sj.npp.1300315; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Rivat C, 2016, PAIN REP, V1, DOI 10.1097/PR9.0000000000000570; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Rosow CE, 2007, CLIN PHARMACOL THER, V82, P48, DOI 10.1038/sj.clpt.6100164; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; RUSSELL J, 1982, EUR J PHARMACOL, V78, P255, DOI 10.1016/0014-2999(82)90026-7; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Simon LS, 2012, J PAIN PALLIATIVE CA, V26, P197, DOI DOI 10.3109/15360288.2012.678473; Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017; Stiene-Martin A, 1998, GLIA, V22, P249, DOI 10.1002/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0; Thomas J, 2008, NEW ENGL J MED, V358, P2332, DOI 10.1056/NEJMoa0707377; Trang T, 2015, J NEUROSCI, V35, P13879, DOI 10.1523/JNEUROSCI.2711-15.2015; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; Webster LR, 2015, J PAIN RES, V8, P771, DOI 10.2147/JPR.S88203; Yu CS, 2011, DIS COLON RECTUM, V54, P570, DOI 10.1007/DCR.0b013e3182092bde; Zacny JP, 2015, PSYCHOPHARMACOLOGY, V232, P63, DOI 10.1007/s00213-014-3637-8; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2011, NEUROSCI LETT, V489, P43, DOI 10.1016/j.neulet.2010.11.063; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	57	175	185	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2017	23	2					164	173		10.1038/nm.4262	http://dx.doi.org/10.1038/nm.4262			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EK2AH	28092666	Green Accepted			2022-12-27	WOS:000393729000008
J	Chun, SK; Du, F; Westmoreland, JJ; Han, SB; Wang, YD; Eddins, D; Bayazitov, IT; Devaraju, P; Yu, J; Lagarde, MMM; Anderson, K; Zakharenko, SS				Chun, Sungkun; Du, Fei; Westmoreland, Joby J.; Han, Seung Baek; Wang, Yong-Dong; Eddins, Donnie; Bayazitov, Ildar T.; Devaraju, Prakash; Yu, Jing; Lagarde, Marcia M. Mellado; Anderson, Kara; Zakharenko, Stanislav S.			Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion	NATURE MEDICINE			English	Article							CARDIO-FACIAL SYNDROME; PREPULSE INHIBITION; DELETION SYNDROME; PSYCHIATRIC-DISORDERS; SCHIZOPHRENIA; DOPAMINE; HALLUCINATIONS; DYSFUNCTION; ADULTS; BRAIN	Although 22q11.2 deletion syndrome (22q11DS) is associated with early-life behavioral abnormalities, affected individuals are also at high risk for the development of schizophrenia symptoms, including psychosis, later in life. Auditory thalamocortical (TC) projections recently emerged as a neural circuit that is specifically disrupted in mouse models of 22q11DS (hereafter referred to as 22q11DS mice), in which haploinsufficiency of the microRNA (miRNA)-processing-factor-encoding gene Dgcr8 results in the elevation of the dopamine receptor Drd2 in the auditory thalamus, an abnormal sensitivity of thalamocortical projections to antipsychotics, and an abnormal acoustic-startle response. Here we show that these auditory TC phenotypes have a delayed onset in 22q11DS mice and are associated with an age-dependent reduction of miR-338-3p, a miRNA that targets Drd2 and is enriched in the thalamus of both humans and mice. Replenishing depleted miR-338-3p in mature 22q11DS mice rescued the TC abnormalities, and deletion of Mir338 (which encodes miR-338-3p) or reduction of miR-338-3p expression mimicked the TC and behavioral deficits and eliminated the age dependence of these deficits. Therefore, miR-338-3p depletion is necessary and sufficient to disrupt auditory TC signaling in 22q11DS mice, and it may mediate the pathogenic mechanism of 22q11DS-related psychosis and control its late onset.	[Chun, Sungkun; Du, Fei; Westmoreland, Joby J.; Han, Seung Baek; Eddins, Donnie; Bayazitov, Ildar T.; Devaraju, Prakash; Yu, Jing; Lagarde, Marcia M. Mellado; Anderson, Kara; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Chun, Sungkun; Du, Fei; Westmoreland, Joby J.] Chonbuk Natl Univ, Sch Med, Dept Physiol, Jeonju, South Korea; [Chun, Sungkun; Du, Fei; Westmoreland, Joby J.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Chun, Sungkun; Du, Fei; Westmoreland, Joby J.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Jeonbuk National University; Harvard University; Brigham & Women's Hospital; Tulane University	Zakharenko, SS (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA.	stanislav.zakharenko@stjude.org	Zakharenko, Stanislav/D-3287-2013; Chun, Sungkun/R-1614-2016	Zakharenko, Stanislav/0000-0001-8115-202X; Chun, Sungkun/0000-0001-9837-2299; Han, Seung Baek/0000-0002-9798-0679; Devaraju, Prakash/0000-0002-9744-0488	National Institutes of Health [MH097742, DC012833, MH095810]; NARSAD Independent Investigator Award; ALSAC; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Independent Investigator Award(NARSAD); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health grants MH097742 (S.S.Z.), DC012833 (S.S.Z.), and MH095810 (S.S.Z.), the NARSAD Independent Investigator Award (S.S.Z.), and ALSAC (S.S.Z.). The funding sources had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. We thank the St. Jude Vector Core for producing the AAVs, the St. Jude Hartwell Center for Biotechnology and Bioinformatics for performing the microarrays, the Maryland Brain Collection for providing post-mortem human brain samples, and A. McArthur for editing the manuscript. Knockout mice, viruses and other materials described in this manuscript can be obtained through a material transfer agreement.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; ALMEIDA OP, 1995, BRIT J PSYCHIAT, V166, P205, DOI 10.1192/bjp.166.2.205; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bassett AS, 2000, AM J MED GENET, V97, P45, DOI 10.1002/(SICI)1096-8628(200021)97:1<45::AID-AJMG6>3.0.CO;2-9; Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Bauer SM, 2011, COMPR PSYCHIAT, V52, P319, DOI 10.1016/j.comppsych.2010.06.008; Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; Chow EWC, 2006, SCHIZOPHR RES, V87, P270, DOI 10.1016/j.schres.2006.04.007; Chun S, 2014, SCIENCE, V344, P1178, DOI 10.1126/science.1253895; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Conn PJ, 2008, MOL INTERV, V8, P99, DOI 10.1124/mi.8.2.7; Cronenwett WJ, 2010, CURR TOP BEHAV NEURO, V4, P509, DOI 10.1007/7854_2010_55; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Earls LR, 2014, NEUROSCIENTIST, V20, P257, DOI 10.1177/1073858413498307; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Feinstein C, 2002, BIOL PSYCHIAT, V51, P312, DOI 10.1016/S0006-3223(01)01231-8; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fung WLA, 2010, AM J PSYCHIAT, V167, P998, DOI 10.1176/appi.ajp.2010.09101463; Gothelf D, 1999, SCHIZOPHR RES, V35, P105, DOI 10.1016/S0920-9964(98)00114-5; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Horga G, 2014, J NEUROSCI, V34, P8072, DOI 10.1523/JNEUROSCI.0200-14.2014; Javitt DC, 2015, NAT REV NEUROSCI, V16, P535, DOI 10.1038/nrn4002; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; OKE AF, 1988, BIOL PSYCHIAT, V24, P79, DOI 10.1016/0006-3223(88)90123-0; Pulver AE, 2000, BIOL PSYCHIAT, V47, P221; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Sobin C, 2005, MOL PSYCHIATR, V10, P553, DOI 10.1038/sj.mp.4001609; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; Vorstman JAS, 2013, SCHIZOPHR RES, V143, P55, DOI 10.1016/j.schres.2012.10.010; Welsh R.C., 2010, SCHIZOPHR B, V36, P713; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Woo Peter Ym, 2014, J Med Case Rep, V8, P400, DOI 10.1186/1752-1947-8-400; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zhang JH, 1999, PSYCHOPHARMACOLOGY, V141, P189, DOI 10.1007/s002130050824	60	36	37	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2017	23	1					39	48		10.1038/nm.4240	http://dx.doi.org/10.1038/nm.4240			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EH3CN	27892953	Green Accepted			2022-12-27	WOS:000391646800012
J	Peinado, H; Kovic, MA; Lavotshkin, S; Matei, I; Costa-Silva, B; Moreno-Bueno, G; Hergueta-Redondo, M; Williams, C; Garcia-Santos, G; Ghajar, CM; Nitadori-Hoshino, A; Hoffman, C; Badal, K; Garcia, BA; Callahan, MK; Yuan, JD; Martins, VR; Skog, J; Kaplan, RN; Brady, MS; Wolchok, JD; Chapman, PB; Kang, YB; Bromberg, J; Lyden, D				Peinado, Hector; Kovic, Masa Alec; Lavotshkin, Simon; Matei, Irina; Costa-Silva, Bruno; Moreno-Bueno, Gema; Hergueta-Redondo, Marta; Williams, Caitlin; Garcia-Santos, Guillermo; Ghajar, Cyrus M.; Nitadori-Hoshino, Ayuko; Hoffman, Caitlin; Badal, Karen; Garcia, Benjamin A.; Callahan, Margaret K.; Yuan, Jianda; Martins, Vilma R.; Skog, Johan; Kaplan, Rosandra N.; Brady, Mary S.; Wolchok, Jedd D.; Chapman, Paul B.; Kang, Yibin; Bromberg, Jacqueline; Lyden, David			Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET (vol 18, pg 883, 2012)	NATURE MEDICINE			English	Correction													Moreno-Bueno, Gema/K-9354-2016; Garcia-Santos, Guillermo/ABG-4631-2020	Moreno-Bueno, Gema/0000-0002-5030-6687; Skog, Johan/0000-0002-0926-1691	NATIONAL CANCER INSTITUTE [ZIABC011332] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753	1	36	40	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2016	22	12					1502	1502		10.1038/nm1216-1502b	http://dx.doi.org/10.1038/nm1216-1502b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EE4CI	27923027	Bronze			2022-12-27	WOS:000389549000031
J	Marin, O				Marin, Oscar			Developmental timing and critical windows for the treatment of psychiatric disorders	NATURE MEDICINE			English	Article							FRAGILE-X-SYNDROME; CRITICAL PERIOD PLASTICITY; ULTRA-HIGH RISK; PRIMARY SOMATOSENSORY CORTEX; AUTISM SPECTRUM DISORDERS; 22Q11.2 DELETION SYNDROME; FAST-SPIKING INTERNEURONS; PREVENTS ADULT DEFICITS; KNOCK-OUT MICE; AGE-OF-ONSET	There is a growing understanding that pathological genetic variation and environmental insults during sensitive periods in brain development have long-term consequences on brain function, which range from learning disabilities to complex psychiatric disorders such as schizophrenia. Furthermore, recent experiments in animal models suggest that therapeutic interventions during sensitive periods, typically before the onset of clear neurological and behavioral symptoms, might prevent or ameliorate the development of specific pathologies. These studies suggest that understanding the dynamic nature of the pathophysiological mechanisms underlying psychiatric disorders is crucial for the development of effective therapies. In this Perspective, I explore the emerging concept of developmental windows in psychiatric disorders, their relevance for understanding disease progression and their potential for the design of new therapies. The limitations and caveats of early interventions in psychiatric disorders are also discussed in this context.	[Marin, Oscar] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Dev Neurobiol, London WC2R 2LS, England; [Marin, Oscar] Kings Coll London, MRC Ctr Neurodev Disorders, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Marin, O (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Dev Neurobiol, London WC2R 2LS, England.; Marin, O (corresponding author), Kings Coll London, MRC Ctr Neurodev Disorders, London WC2R 2LS, England.	oscar.marin@kcl.ac.uk	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	European Research Council [ERC-2011-AdG 293683]; Wellcome Trust [103714MA]; Simons Foundation Autism Research Initiative [SFARI 239766OM]; De Spoelberch Foundation; MRC [MR/N026063/1] Funding Source: UKRI; Medical Research Council [MR/N026063/1] Funding Source: researchfish; Wellcome Trust [103714/Z/14/Z] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Simons Foundation Autism Research Initiative; De Spoelberch Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	I apologize for not citing all relevant references, owing to space limitations. I thank B. Rico and members of the Marin lab for valuable discussions and their critical reading of this manuscript. The European Research Council (ERC-2011-AdG 293683), Wellcome Trust (103714MA), Simons Foundation Autism Research Initiative (SFARI 239766OM) and De Spoelberch Foundation support work on this topic in my laboratory. O.M. is a Wellcome Trust Investigator.	Anderson PJ, 2012, NEUROPSYCHOL REV, V22, P345, DOI 10.1007/s11065-012-9220-3; Andreou C, 2015, SCHIZOPHRENIA BULL, V41, P930, DOI 10.1093/schbul/sbu121; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2015, NAT REV NEUROSCI, V16, P498, DOI 10.1038/nrn3956; Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109; Berry-Kravis E, 2010, AJIDD-AM J INTELLECT, V115, P461, DOI 10.1352/1944-7558-115.6.461; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bodatsch M, 2015, BIOL PSYCHIAT, V77, P951, DOI 10.1016/j.biopsych.2014.09.025; Bousman CA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.23; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brugger S, 2011, BIOL PSYCHIAT, V69, P495, DOI 10.1016/j.biopsych.2010.10.004; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Cabungcal JH, 2014, NEURON, V83, P1073, DOI 10.1016/j.neuron.2014.07.028; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Corcoran CM, 2012, SCHIZOPHR RES, V135, P170, DOI 10.1016/j.schres.2011.11.035; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Dobbs D, 2010, NATURE, V468, P154, DOI 10.1038/468154a; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Du YJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1881, DOI 10.1038/npp.2013.101; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Egerton A, 2012, CURR PHARM DESIGN, V18, P466, DOI 10.2174/138161212799316244; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Farokhnia M, 2013, CLIN NEUROPHARMACOL, V36, P185, DOI 10.1097/WNF.0000000000000001; Friedmann N, 2015, CURR OPIN NEUROBIOL, V35, P27, DOI 10.1016/j.conb.2015.06.003; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Green J, 2013, J AUTISM DEV DISORD, V43, P2502, DOI 10.1007/s10803-013-1797-8; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Greenhill SD, 2015, SCIENCE, V349, P424, DOI 10.1126/science.aaa8481; Hadjikhani N, 2015, AUTISM, V19, P149, DOI 10.1177/1362361313514141; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hall J, 2015, BIOL PSYCHIAT, V77, P52, DOI 10.1016/j.biopsych.2014.07.011; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; He Q, 2014, J NEUROSCI, V34, P446, DOI 10.1523/JNEUROSCI.4447-13.2014; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Howes O, 2011, MOL PSYCHIATR, V16, P885, DOI 10.1038/mp.2011.20; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hubener M, 2014, CELL, V159, P727, DOI 10.1016/j.cell.2014.10.035; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Jeste SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9874; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935; Kalia A, 2014, P NATL ACAD SCI USA, V111, P2035, DOI 10.1073/pnas.1311041111; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Katz DM, 2016, TRENDS NEUROSCI, V39, P100, DOI 10.1016/j.tins.2015.12.008; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kim H, 2013, J NEUROSCI, V33, P15686, DOI 10.1523/JNEUROSCI.3246-12.2013; Kim IH, 2015, NAT NEUROSCI, V18, P883, DOI 10.1038/nn.4015; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Koseki T, 2012, INT J NEUROPSYCHOPH, V15, P1489, DOI 10.1017/S1461145711001672; Kraguljac NV, 2013, JAMA PSYCHIAT, V70, P1294, DOI 10.1001/jamapsychiatry.2013.2437; Krishnan K, 2015, P NATL ACAD SCI USA, V112, pE4782, DOI 10.1073/pnas.1506499112; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Lee FS, 2014, SCIENCE, V346, P547, DOI 10.1126/science.1260497; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Lin A, 2015, AM J PSYCHIAT, V172, P249, DOI 10.1176/appi.ajp.2014.13030418; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Maayan L, 2011, J CHILD ADOL PSYCHOP, V21, P517, DOI 10.1089/cap.2011.0015; Marguet SL, 2015, NAT MED, V21, P1436, DOI 10.1038/nm.3987; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mierau SB, 2016, BIOL PSYCHIAT, V79, P746, DOI 10.1016/j.biopsych.2015.05.018; Miklowitz DJ, 2014, J AM ACAD CHILD PSY, V53, P848, DOI 10.1016/j.jaac.2014.04.020; Millan MJ, 2016, NAT REV DRUG DISCOV, V15, P485, DOI 10.1038/nrd.2016.28; Modinos G, 2015, TRENDS NEUROSCI, V38, P129, DOI 10.1016/j.tins.2014.12.005; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Morishita H, 2015, BIOL PSYCHIAT, V78, P396, DOI 10.1016/j.biopsych.2014.12.026; Mukai J, 2015, NEURON, V86, P680, DOI 10.1016/j.neuron.2015.04.003; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Nabel Elisa M, 2013, Front Psychiatry, V4, P146, DOI 10.3389/fpsyt.2013.00146; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Patrizi A, 2016, BIOL PSYCHIAT, V79, P755, DOI 10.1016/j.biopsych.2015.08.018; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perkins DO, 2015, SCHIZOPHRENIA BULL, V41, P419, DOI 10.1093/schbul/sbu099; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Richtand NM, 2006, NEUROPSYCHOPHARMACOL, V31, P77, DOI 10.1038/sj.npp.1300791; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Scharf SH, 2015, CURR OPIN PHARMACOL, V20, P124, DOI 10.1016/j.coph.2014.11.004; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Sourdet V, 2003, J NEUROSCI, V23, P10238; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; Su T, 2011, PSYCHOPHARMACOLOGY, V215, P291, DOI 10.1007/s00213-010-2130-2; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun LM, 2013, SCHIZOPHR RES, V150, P519, DOI 10.1016/j.schres.2013.08.023; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025; Till SM, 2012, HUM MOL GENET, V21, P2143, DOI 10.1093/hmg/dds030; Tognin S, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00187; Toyoizumi T, 2013, NEURON, V80, P51, DOI 10.1016/j.neuron.2013.07.022; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Veenstra-VanderWeele J, 2015, NEUROPSYCHOPHARMACOL, V40, P225, DOI 10.1038/npp.2014.232; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; Willsey AJ, 2015, CURR OPIN NEUROBIOL, V30, P92, DOI 10.1016/j.conb.2014.10.015; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; WYATT RJ, 1991, SCHIZOPHRENIA BULL, V17, P325, DOI 10.1093/schbul/17.2.325; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003	156	173	179	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2016	22	11					1229	1238		10.1038/nm.4225	http://dx.doi.org/10.1038/nm.4225			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	EB3XK	27783067	Green Submitted			2022-12-27	WOS:000387302300014
